PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Stickley, A; Sumiyoshi, T; Narita, Z; Oh, H; DeVylder, JE; Jacob, L; Koyanagi, A				Stickley, A.; Sumiyoshi, T.; Narita, Z.; Oh, H.; DeVylder, J. E.; Jacob, L.; Koyanagi, A.			Physical injury and psychotic experiences in 48 low- and middle-income countries	PSYCHOLOGICAL MEDICINE			English	Article						Delusion; epidemiology; hallucination; injuries; World Health Survey	WORLD-HEALTH-ORGANIZATION; TRAUMATIC BRAIN INJURY; GENERAL-POPULATION; PSYCHOLOGICAL TRAUMA; DISORDERS FINDINGS; SOCIAL DEFEAT; SUBSTANCE USE; ASSOCIATION; SYMPTOMS; RISK	Background. Psychotic experiences (PEs) may be associated with injuries, but studies focusing specifically on low- and middle-income countries (LAMICs) are scarce. Thus, the current study examined the link between injuries and PEs in a large number of LAMICs. Method. Cross-sectional data were used from 242 952 individuals in 48 LAMICs that were collected during the World Health Survey in 2002-2004 to examine the association between traffic-related and other (non-traffic-related) forms of injury and PEs. Multivariable logistic regression analysis and meta-analysis were used to examine associations while controlling for a variety of covariates including depression. Results. In fully adjusted analyses, any injury [odds ratio (OR) 2.07, 95% confidence interval (CI) 1.85-2.31], traffic injury (OR 1.84, 95% CI 1.53-2.21) and other injury (OR 2.09, 95% CI 1.84-2.37) were associated with higher odds for PEs. Results from a country-wise analysis showed that any injury was associated with significantly increased odds for PEs in 39 countries with the overall pooled OR estimated by meta-analysis being 2.46 (95% CI 2.22-2.74) with a moderate level of between-country heterogeneity (I-2 = 56.3%). Similar results were observed across all country income levels (low, lower-middle and upper-middle). Conclusions. Different types of injury are associated with PEs in LAMICs. Improving mental health systems and trauma capacity in LAMICs may be important for preventing injury-related negative mental health outcomes.	[Stickley, A.; Sumiyoshi, T.] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Prevent Intervent Psychiat Disorders, Kodaira, Tokyo, Japan; [Stickley, A.] Sodertorn Univ, Stockholm Ctr Hlth & Social Change SCOHOST, Huddinge, Sweden; [Narita, Z.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Oh, H.] Univ Southern Calif, Suzanne Dworak Peck Sch Social Work, Los Angeles, CA USA; [DeVylder, J. E.] Fordham Univ, Grad Sch Social Serv, New York, NY USA; [Jacob, L.] Univ Versailles St Quentin En Yveiines, Fac Med, F-78180 Montigny Ie Bretonneux, France; [Jacob, L.; Koyanagi, A.] CIBERSAM, Res & Dev Unit, Parc Sanitari St Joan Deu, Barcelona, Spain; [Koyanagi, A.] ICREA, Pg Liuis Companys 23, Barcelona, Spain		Stickley, A (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Prevent Intervent Psychiat Disorders, Kodaira, Tokyo, Japan.; Stickley, A (corresponding author), Sodertorn Univ, Stockholm Ctr Hlth & Social Change SCOHOST, Huddinge, Sweden.	amstick66@gmail.com	Jacob, Louis/AAL-3956-2020; Koyanagi, Ai/D-3833-2018	Jacob, Louis/0000-0003-1071-1239; Koyanagi, Ai/0000-0002-9565-5004			Alsawy S, 2015, PSYCHOL MED, V45, P2849, DOI 10.1017/S003329171500080X; Blows S, 2005, ADDICTION, V100, P605, DOI 10.1111/j.1360-0443.2005.01100.x; Ciaramitaro P, 2010, J PERIPHER NERV SYST, V15, P120, DOI 10.1111/j.1529-8027.2010.00260.x; Clausen T, 2015, SUBST ABUS-RES TREAT, V9, P125, DOI 10.4137/SART.S23549; Cooper L, 1998, J PSYCHIATR RES, V32, P361, DOI 10.1016/S0022-3956(98)00021-1; Degenhardt L, 2018, ADDICTION, V113, P924, DOI 10.1111/add.14145; DeVylder JE, 2014, PSYCHOL MED, V44, P3503, DOI 10.1017/S0033291714000944; Freeman D, 2009, PSYCHIAT RES, V169, P107, DOI 10.1016/j.psychres.2008.07.009; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Geddes G, 2016, PSYCHIAT RES, V246, P601, DOI 10.1016/j.psychres.2016.10.081; Gilboa D, 2001, BURNS, V27, P335, DOI 10.1016/S0305-4179(00)00125-X; Gracie A, 2007, ACTA PSYCHIAT SCAND, V116, P280, DOI 10.1111/j.1600-0447.2007.01011.x; Hanssen M, 2005, BRIT J CLIN PSYCHOL, V44, P181, DOI 10.1348/014466505X29611; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Herrera-Escobar JP, 2018, SURGERY, V164, P1246, DOI 10.1016/j.surg.2018.07.017; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoffman RE, 2007, SCHIZOPHRENIA BULL, V33, P1066, DOI 10.1093/schbul/sbm079; Honings S, 2016, PSYCHOL MED, V46, P237, DOI 10.1017/S0033291715001841; Jacob KS, 2007, LANCET, V370, P1061, DOI 10.1016/S0140-6736(07)61241-0; Jeavons S, 2000, BEHAV RES THER, V38, P499, DOI 10.1016/S0005-7967(99)00073-X; Keraite A, 2016, SCHIZOPHR RES, V171, P79, DOI 10.1016/j.schres.2016.01.026; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Konings M, 2006, ACTA PSYCHIAT SCAND, V114, P55, DOI 10.1111/j.1600-0447.2005.00741.x; Koyanagi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145533; Koyanagi A, 2015, SLEEP, V38, P1875, DOI 10.5665/sleep.5232; Koyanagi A, 2015, J PSYCHIATR RES, V69, P19, DOI 10.1016/j.jpsychires.2015.07.020; Linscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626; McGrath JJ, 2017, BRIT J PSYCHIAT, V211, P373, DOI 10.1192/bjp.bp.117.205955; McGrath JJ, 2015, JAMA PSYCHIAT, V72, P697, DOI 10.1001/jamapsychiatry.2015.0575; Mock C, 2009, BURNS, V35, P615, DOI 10.1016/j.burns.2008.08.016; Moreno C, 2013, WORLD PSYCHIATRY, V12, P251, DOI 10.1002/wps.20070; Nantulya Vinand M, 2003, Inj Control Saf Promot, V10, P13, DOI 10.1076/icsp.10.1.13.14116; Navarro-Mateu F, 2017, ACTA PSYCHIAT SCAND, V136, P74, DOI 10.1111/acps.12749; Nuevo R, 2012, SCHIZOPHRENIA BULL, V38, P475, DOI 10.1093/schbul/sbq099; Oh H, 2019, COMPR PSYCHIAT, V90, P1, DOI 10.1016/j.comppsych.2018.12.007; Oh H, 2018, SCHIZOPHR RES, V193, P343, DOI 10.1016/j.schres.2017.07.049; Oh H, 2015, BRIT J SOC WORK, V45, P2003, DOI 10.1093/bjsw/bct199; Oh H, 2015, WORLD PSYCHIATRY, V14, P101, DOI 10.1002/wps.20196; Patten SB, 2010, CAN J PSYCHIAT, V55, P313, DOI 10.1177/070674371005500507; Reynolds TA, 2017, ANNU REV PUBL HEALTH, V38, P507, DOI 10.1146/annurev-publhealth-032315-021412; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Saha S, 2011, PSYCHIAT RES, V189, P259, DOI 10.1016/j.psychres.2011.03.019; Scott J, 2007, BRIT J PSYCHIAT, V190, P339, DOI 10.1192/bjp.bp.106.026708; Scott KM, 2018, PSYCHOL MED, V48, P2730, DOI 10.1017/S0033291718000363; Selten JP, 2017, SCHIZOPHRENIA BULL, V43, P287, DOI 10.1093/schbul/sbw180; Selten JP, 2013, SCHIZOPHRENIA BULL, V39, P1180, DOI 10.1093/schbul/sbt134; Selten JP, 2005, BRIT J PSYCHIAT, V187, P101, DOI 10.1192/bjp.187.2.101; Semrau M, 2018, EPIDEMIOL PSYCH SCI, V27, P11, DOI 10.1017/S2045796017000452; Sharifi V, 2015, BRIT J PSYCHIAT, V207, P30, DOI 10.1192/bjp.bp.113.143198; Spauwen J, 2006, BRIT J PSYCHIAT, V188, P527, DOI 10.1192/bjp.bp.105.011346; Stickley A, 2020, EPIDEMIOL PSYCH SCI, V29, DOI 10.1017/S2045796019000210; Stubbs B, 2016, ACTA PSYCHIAT SCAND, V134, P546, DOI 10.1111/acps.12654; Stubbs B, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0734-z; Wong EG, 2015, J SURG RES, V193, P217, DOI 10.1016/j.jss.2014.08.055; World Health Organization, 2002, INT GUID MON ALC CON; World Health Organization, 2014, INJ VIOL FACTS 2014	56	1	1	0	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0033-2917	1469-8978		PSYCHOL MED	Psychol. Med.	DEC	2020	50	16					2751	2758	PII S0033291719002897	10.1017/S0033291719002897			8	Psychology, Clinical; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	PS0DF	WOS:000607598500014	31637996				2022-02-06	
J	Taylor, DJ; Pruiksma, KE; Mintz, J; Slavish, DC; Wardle-Pinkston, S; Tyler, H; Dondanville, KA; Young-McCaughan, S; Scullin, MK; Nicholson, KL; Litz, BT; Dietch, JR; Williamson, DE; Keane, TM; Peterson, AL; Resick, PA				Taylor, Daniel J.; Pruiksma, Kristi E.; Mintz, Jim; Slavish, Danica C.; Wardle-Pinkston, Sophie; Tyler, Hannah; Dondanville, Katherine A.; Young-McCaughan, Stacey; Scullin, Michael K.; Nicholson, Karin L.; Litz, Brett T.; Dietch, Jessica R.; Williamson, Douglas E.; Keane, Terence M.; Peterson, Alan L.; Resick, Patricia A.		Consortium Alleviate PTSD	Treatment of comorbid sleep disorders and posttraumatic stress disorder in active duty military: Design and methodology of a randomized clinical trial	CONTEMPORARY CLINICAL TRIALS			English	Article						Posttraumatic stress disorder; Insomnia; Nightmare; Therapy	COGNITIVE-PROCESSING THERAPY; TRAUMATIC BRAIN-INJURY; BEHAVIORAL TREATMENT; NICOTINE DEPENDENCE; IMAGERY REHEARSAL; RESIDUAL INSOMNIA; AMERICAN-ACADEMY; FAGERSTROM TEST; PTSD; DISTURBANCES	Many individuals with posttraumatic stress disorder (PTSD) also suffer from insomnia and nightmares, which may be symptoms of PTSD or constitute partially independent comorbid disorders. Sleep disturbances are resistant to current treatments for PTSD, and those suffering from PTSD, insomnia, and nightmares have worse PTSD treatment outcomes. In addition, insomnia and nightmares are risk factors for depression, substance abuse, anxiety, and suicide. Cognitive-Behavioral Therapy for Insomnia and Nightmares (CBT-I&N) and Cognitive Processing Therapy (CPT) for PTSD are first line treatments of these conditions. CPT does not typically address insomnia or nightmares, and CBT-I&N does not typically address other symptoms of PTSD. There are limited scientific data on how best to provide these therapies to individuals suffering with all three disorders. This project aims to inform the most effective way to treat individuals suffering from PTSD, insomnia, and nightmares, potentially changing the standard of care. U.S. military personnel and recently discharged Veterans who served in support of combat operations following 9/11 aged 18-65 with PTSD, insomnia, and nightmares (N = 222) will be randomly assigned to one of the following 18-session individual treatment conditions delivered over 12-weeks: (1) 6 sessions of CBT-I&N followed by 12 sessions of CPT; (2) 12 sessions of CPT followed by 6 sessions of CBT-I & N; or (3) 12 sessions of CPT followed by an additional 6 sessions of CPT. All participants will be assessed at baseline, during treatment, and at 1-week, 1-month, 3-months, and 6-months posttreatment. The primary outcome will be PTSD symptom severity.	[Taylor, Daniel J.; Slavish, Danica C.; Wardle-Pinkston, Sophie; Dietch, Jessica R.] Univ North Texas, Dept Psychol, 1155 Union Circle 311280, Denton, TX 76203 USA; [Pruiksma, Kristi E.; Mintz, Jim; Tyler, Hannah; Dondanville, Katherine A.; Young-McCaughan, Stacey; Peterson, Alan L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat & Behav Sci, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Scullin, Michael K.] Baylor Univ, Dept Psychol & Neurosci, One Bear Pl 97334, Waco, TX 76798 USA; [Nicholson, Karin L.] Carl R Darnall Army Med Ctr, 36065 Santa Fe Ave, Ft Hood, TX 76544 USA; [Litz, Brett T.] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, 150 Hungtington Ave, Boston, MA 02130 USA; [Litz, Brett T.; Keane, Terence M.] Boston Univ, Dept Psychiat, Sch Med, 72 East Concord St, Boston, MA 02118 USA; [Litz, Brett T.] Boston Univ, Dept Psychol & Brain Sci, 64 Cummington Mall, Boston, MA 02215 USA; [Williamson, Douglas E.; Resick, Patricia A.] Duke Univ, Dept Psychiat & Behav Sci, Med Ctr, 1121 West Chapel Hill St,Suite 201, Durham, NC 27701 USA; [Williamson, Douglas E.] Durham VA Hlth Care Syst, Durham, NC USA; [Keane, Terence M.] VA Boston Healthcare Syst, Behav Sci Div, Natl Ctr PTSD, 150 South Huntington Ave, Boston, MA 02130 USA; [Peterson, Alan L.] South Texas Vet Hlth Care Syst, Res & Dev Serv, 7400 Merton Minter, San Antonio, TX 78229 USA; [Peterson, Alan L.] Univ Texas San Antonio, Dept Psychol, 1 UTSA Circle, San Antonio, TX 78249 USA; [Taylor, Daniel J.; Wardle-Pinkston, Sophie] Univ Arizona, Dept Psychol, 1503 E Univ Blvd, Tucson, AZ 85721 USA; [Dietch, Jessica R.] Stanford Univ, Sch Med, 291 Campus Dr, Stanford, CA 94305 USA; [Dietch, Jessica R.] VA Palo Alto Hlth Care Syst, 3801 Miranda Ave, Palo Alto, CA 94304 USA		Taylor, DJ (corresponding author), Univ Arizona, Dept Psychol, 1503 E Univ Blvd, Tucson, AZ 85721 USA.	DanielJTaylor@arizona.edu; Pruiksma@uthscsa.edu; Mintz@uthscsa.edu; Danica.Slavish@unt.edu; swpinkston@email.arizona.edu; TylerH@uthscsa.edu; Dondanville@uthscsa.edu; Youngs1@uthscsa.edu; Michael_Scullin@baylor.edu; Karin.L.Nicholson.mil@mail.mil; LitzB@bu.edu; Jessica.Dietch@va.gov; douglas.williamson@duke.edu; Terry.Keane@va.gov; Petersona3@uthscsa.edu; Patricia.Resick@duke.edu		Tyler, Hannah/0000-0002-0217-0850	Consortium to Alleviate PTSD (CAP) award from the U.S. Department of Defense, Defense Health Program, Psychological Health and Traumatic Brain Injury Research Program (PH/TBI RP) [W81XWH-13-2-0065]; U.S. Department of Veterans Affairs, Office of Research & Development, Clinical Science Research & Development Service [I01CX001136-01]	This research was supported by Consortium to Alleviate PTSD (CAP) award numbers W81XWH-13-2-0065 from the U.S. Department of Defense, Defense Health Program, Psychological Health and Traumatic Brain Injury Research Program (PH/TBI RP), and I01CX001136-01 from the U.S. Department of Veterans Affairs, Office of Research & Development, Clinical Science Research & Development Service.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Babor TF, 2001, AUDIT ALCOHOL USE DI; Backhaus J, 2006, BIOL PSYCHIAT, V60, P1324, DOI 10.1016/j.biopsych.2006.03.051; Baddeley J.L., 2013, AM J PSYCHOTHER, V67, P199, DOI [DOI 10.1176/APPI.PSYCHOTHERAPY.2013.67.2.203, 10.1176/appi, DOI 10.1176/APPI]; Barnes B.J., 2018, MIL MED, V184, pe218; Belleville G, 2011, J PSYCHOSOM RES, V70, P318, DOI 10.1016/j.jpsychores.2010.09.022; Brownlow JA, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0587-8; Buysse DJ, 2010, SLEEP, V33, P781, DOI 10.1093/sleep/33.6.781; Byllesby BM, 2019, BEHAV RES THER, V123, DOI 10.1016/j.brat.2019.103483; Cahill S.P., 2009, EFFECTIVE TREATMENTS; Center for Deployment Psychology, 2011, EV BAS WORKSH MIL CI; Cervena K, 2004, J SLEEP RES, V13, P385, DOI 10.1111/j.1365-2869.2004.00431.x; Colvonen PJ, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0916-9; Cranston CC, 2017, J TRAUMA DISSOCIATIO, V18, P88, DOI 10.1080/15299732.2016.1191578; Davis, 2009, TREATING POSTTRAUMA; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; DeViva JC, 2005, J TRAUMA STRESS, V18, P155, DOI 10.1002/jts.20015; Ebbert JO, 2006, ADDICT BEHAV, V31, P1716, DOI 10.1016/j.addbeh.2005.12.015; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Forbes D, 2001, J TRAUMA STRESS, V14, P433, DOI 10.1023/A:1011133422340; Forbes D, 2003, J TRAUMA STRESS, V16, P509, DOI 10.1023/A:1025718830026; Galovski TE, 2016, J CONSULT CLIN PSYCH, V84, P167, DOI 10.1037/ccp0000059; Galovski TE, 2012, J CONSULT CLIN PSYCH, V80, P968, DOI 10.1037/a0030600; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Haynes PL, 2020, BEHAV SLEEP MED, V18, P809, DOI 10.1080/15402002.2019.1692848; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hedeker D, 1999, J EDUC BEHAV STAT, V24, P70, DOI 10.3102/10769986024001070; Hirano K, 2003, ECONOMETRICA, V71, P1161, DOI 10.1111/1468-0262.00442; Institute of Medicine, 2008, TREATM POSTTR STRESS; Karlin BE, 2010, J TRAUMA STRESS, V23, P663, DOI 10.1002/jts.20588; Kazis Lewis E, 2004, J Ambul Care Manage, V27, P263; Keane TM, 2013, LIFE EVENTS CHECKLIS; Koffel E, 2016, PSYCHIAT ANN, V46, P173, DOI 10.3928/00485713-20160125-01; Kraemer HC, 2006, ARCH GEN PSYCHIAT, V63, P484, DOI 10.1001/archpsyc.63.5.484; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014; Krakow B, 2002, J ANXIETY DISORD, V16, P175, DOI 10.1016/S0887-6185(02)00093-2; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Larsen SE, 2019, PSYCHOL TRAUMA-US, V11, P207, DOI 10.1037/tra0000384; Marx B.P., 2013, DTIC DOCUMENT; Metalsky GI, 1997, COGNITIVE THER RES, V21, P359, DOI 10.1023/A:1021882717784; Morgenthaler T, 2006, SLEEP, V29, P1415; Morgenthaler TI, 2018, J CLIN SLEEP MED, V14, P1041, DOI 10.5664/jcsm.7178; Morin CM, 1993, INSOMNIA PSYCHOL ASS; Neylan TC, 1998, AM J PSYCHIAT, V155, P929, DOI 10.1176/ajp.155.7.929; Nock M. K., 2007, SELF INJURIOUS THOUG; Novaco R. W., 1975, DIMENSIONS ANGER REA; Ohayon MM, 2000, COMPR PSYCHIAT, V41, P469, DOI 10.1053/comp.2000.16568; Pace-Schott EF, 2009, SLEEP, V32, P19; Pruiksma KE, 2020, J CLIN SLEEP MED, V16, P29, DOI 10.5664/jcsm.8116; Pruiksma KE, 2016, PSYCHOL TRAUMA-US, V8, P697, DOI 10.1037/tra0000150; Pruiksma KE, 2014, J CLIN SLEEP MED, V10, P551, DOI 10.5664/jcsm.3710; Randler C, 2009, BIOL RHYTHM RES, V40, P413, DOI 10.1080/09291010902731213; Resick P.A., 2020, STRONG STAR CONSORTI; Resick P. A., 2016, COGNITIVE PROCESSING; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; Resick PA, 2017, JAMA PSYCHIAT, V74, P28, DOI 10.1001/jamapsychiatry.2016.2729; Resick PA, 2015, J CONSULT CLIN PSYCH, V83, P1058, DOI 10.1037/ccp0000016; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rosenthal R., 2000, CONTRASTS EFFECT SIZ; Schnurr PP, 2019, DEPRESS ANXIETY, V36, P162, DOI 10.1002/da.22871; Schwab KA, 2006, NEUROLOGY, V66, pA235; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Simor P, 2012, EUR ARCH PSY CLIN N, V262, P687, DOI 10.1007/s00406-012-0318-7; Sobell LC, 2003, J STUD ALCOHOL, V64, P858, DOI 10.15288/jsa.2003.64.858; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; Straus LD, 2018, NEUROBIOL STRESS, V9, P22, DOI 10.1016/j.ynstr.2018.07.001; Straus LD, 2017, BIOL PSYCHIAT-COGN N, V2, P123, DOI 10.1016/j.bpsc.2016.05.004; Taylor A, 2020, COGN BEHAV THERAPY, V49, P242, DOI 10.1080/16506073.2019.1641146; Taylor DJ, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy069; Taylor DJ, 2018, J CLIN SLEEP MED, V14, P459, DOI 10.5664/jcsm.7000; Taylor DJ, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx075; Ulmer CS, 2011, J CLIN SLEEP MED, V7, P57; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Walker MP, 2009, PSYCHOL BULL, V135, P731, DOI 10.1037/a0016570; Walters EM, 2020, PSYCHOL TRAUMA-US, V12, P175, DOI 10.1037/tra0000478; Weathers F., 2013, CLINICIAN ADMINISTER; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Yu L, 2012, BEHAV SLEEP MED, V10, P6, DOI 10.1080/15402002.2012.636266; Zayfert C, 2004, J TRAUMA STRESS, V17, P69, DOI 10.1023/B:JOTS.0000014679.31799.e7	83	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	DEC	2020	99								106186	10.1016/j.cct.2020.106186			9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine; Pharmacology & Pharmacy	PG1ST	WOS:000599523300020	33091589				2022-02-06	
J	Tummala, SR; Hemphill, MA; Nam, A; Meaney, DF				Tummala, Shanti R.; Hemphill, Matthew A.; Nam, Andrea; Meaney, David F.			Concussion increases CA1 activity during prolonged inactivity in a familiar environment	EXPERIMENTAL NEUROLOGY			English	Article						TBI; Blast; Miniscope; Novel; Open field; Home cage; CNMF-E; GCamp6f	BRAIN-INJURY; HIPPOCAMPAL	Although hippocampal damage plays a key role in impairments after concussion, differences in hippocampal information processing during recovery are unknown. Micro-endoscopic calcium imaging was performed before and after primary blast injury in freely behaving mice in two environments: their familiar home cage and a novel open field. Results show that after concussion CA1 activity increased in the familiar environment in which animals were awake and mostly immobile but was unaltered in a novel environment which the animals actively and constantly explored. As awake immobility parallels cognitive rest, a common treatment for patients, the results imply that prolonged cognitive rest may unwittingly impede concussion recovery.	[Tummala, Shanti R.; Hemphill, Matthew A.; Nam, Andrea; Meaney, David F.] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA		Tummala, SR; Meaney, DF (corresponding author), Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA.	stummala@seas.upenn.edu; dmeaney@seas.upenn.edu		Meaney, David/0000-0002-0954-4122	Paul G. Allen Frontiers group grant [12347]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 088176]	The authors thank Drs. Mikhail Y Lipin, Brian N Johnson, and Guoxiang Xiong for their invaluable technical assistance, Konrad Kording for suggestions on the data and Bonnie Firestein for comments on the manuscript. Funding was provided by the Paul G. Allen Frontiers group grant #12347 and NIH NS 088176.	Atkins CM, 2011, TRANSL STROKE RES, V2, P546, DOI 10.1007/s12975-011-0123-z; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Carrillo-Reid L, 2017, ANNU REV BIOPHYS, V46, P271, DOI 10.1146/annurev-biophys-070816-033647; Chen Yuan-Hao, 2018, Oncotarget, V9, P11515, DOI 10.18632/oncotarget.23923; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Johnson BN, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00435; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Patel D, 2014, 2014 IEEE 13TH INTERNATIONAL CONFERENCE ON COGNITIVE INFORMATICS & COGNITIVE COMPUTING (ICCI-CC), P8, DOI 10.1109/ICCI-CC.2014.6921434; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Zhou H, 2019, ELIFE, V8, DOI 10.7554/eLife.39777; Zhou P, 2018, ELIFE, V7, DOI 10.7554/eLife.28728	16	1	1	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2020	334								113435	10.1016/j.expneurol.2020.113435			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OO4ZW	WOS:000587389600002	32818488	Green Accepted			2022-02-06	
J	van den Brand, CL; Perotti, JR; van der Linden, MC; Tolido, T; Jellema, K				van den Brand, Crispijn L.; Perotti, Joeri R.; van der Linden, M. Christien; Tolido, Tanya; Jellema, Korne			Effect of the implementation of a new guideline for minor head injury on computed tomography-ratio and hospitalizations in the Netherlands	EUROPEAN JOURNAL OF EMERGENCY MEDICINE			English	Article						computed tomography; craniocerebral trauma; guideline; minor head injury; traumatic brain injuries	NEW-ORLEANS CRITERIA; EXTERNAL VALIDATION; EMERGENCY-DEPARTMENT; DECISION RULES; UNITED-STATES; CT; MILD; MORTALITY; TRAUMA	Objective A new nationwide guideline for minor head injury was introduced in the Netherlands in 2010. The effect on computed tomography (CT) ratio and hospital admission ratio after introduction of the guideline is unknown. The aim was to reduce these numbers as part of cost-effective health care. Therefore, we assessed the effect on these variables after introduction of the guideline. Methods We used an interrupted time-series study design. Data selection was done 3 years before (2007-2009) and several years after (2012, 2014, 2015) introduction of the guideline. Results Data collection was performed for 3880 patients. Introduction of the new guideline was associated with an increase in CT ratio from 24.6% before to 55% after introduction (P < 0.001). This increase is the result of both the new guideline and a secular trend. Besides this, hospital admissions increased from 14.7 to 23.4% (P < 0.001) during the study period. This increase was less clearly associated with the new guideline. After introduction of the guideline there was no significant difference in (intra)cranial traumatic findings (2.6% vs. 3.4%; P = 0.13) and neurosurgical interventions (0.1% vs. 0.2%; P = 0.50). Conclusion Between 2007 and 2015, a marked increase in CT ratio and hospital admissions has been observed. The increase in CT ratio seems to be caused both by the new guideline and by a secular trend to perform more CT scans. Adaptations to the guideline should be considered to improve patient care and cost-effectiveness in patients with minor head injury.	[van den Brand, Crispijn L.; van der Linden, M. Christien] Haaglanden Med Ctr, Emergency Dept, POB 432, NL-2501 CK The Hague, Netherlands; [Perotti, Joeri R.; Jellema, Korne] Haaglanden Med Ctr, Dept Neurol, The Hague, Netherlands; [Tolido, Tanya] Haaglanden Med Ctr, Intens Care Unit, The Hague, Netherlands		van den Brand, CL (corresponding author), Haaglanden Med Ctr, Emergency Dept, POB 432, NL-2501 CK The Hague, Netherlands.	drcrispijn@hotmail.com					af Geijerstam JL, 2005, EMERG MED J, V22, P103, DOI 10.1136/emj.2004.015396; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; DeAngelis J, 2017, WEST J EMERG MED, V18, P821, DOI 10.5811/westjem.2017.6.33685; Foks KA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3527; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Hageman G, 2010, FEDERATIE MEDISCH SP; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; Kontopantelis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2750; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Sharp AL, 2018, ANN EMERG MED, V71, P54, DOI 10.1016/j.annemergmed.2017.06.022; Smits M, 2007, J NEUROL NEUROSUR PS, V78, P1359, DOI 10.1136/jnnp.2007.117143; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stiell IG, 2007, ACAD EMERG MED, V14, P955, DOI 10.1197/j.aem.2007.06.039; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Van den Brand CL, 2018, EUR J EMERG MED, V25, P355, DOI 10.1097/MEJ.0000000000000457; Venkatesh AK, 2021, AM J EMERG MED, V39, P102, DOI 10.1016/j.ajem.2020.01.029	21	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0969-9546	1473-5695		EUR J EMERG MED	Eur. J. Emerg. Med.	DEC	2020	27	6					441	446		10.1097/MEJ.0000000000000714			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	OJ5IZ	WOS:000583996200014	32433335				2022-02-06	
J	Wallace, J; Schatz, P; Covassin, T; Iverson, GL				Wallace, Jessica; Schatz, Philip; Covassin, Tracey; Iverson, Grant L.			Brief iPad-Based Assessment of Cognitive Functioning with ImPACT (R) Quick Test: Prevalence of Low Scores Using Multivariate Base Rates	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						ImPACT Quick Test; neurocognitive; base rates; iPad; attention tracker; memory; processing speed	CONCUSSION; IMPAIRMENT; COMMON	Objective: The ImPACT (R) Quick Test is a brief iPad-based battery of neurocognitive tests that has been standardized on a sample of children, adolescents, and adults (ages 12-70). This study provides information on the prevalence of ImPACT (R) Quick Test scores falling below specific percentiles in the normative sample to aid in clinical interpretation and reduce the risk of over-interpreting, or misinterpreting, a single low score. Method: Participants were 683 individuals ranging in age from 12 to 70, who were assessed individually. The ImPACT (R) Quick Test includes five subtests, contributing to three factor scores: motor speed, memory, and attention tracker. The prevalence of low factor scores, stratified by age and sex, were calculated using multivariate base rates. Results: In the total sample, obtaining 1 or more scores below the 25th percentile was common (base rate, BR = 47.2%), but obtaining 2 or more scores in this range was uncommon (BR = 15.3%). Similarly, obtaining 1 or more scores below the 16th percentile was common (BR = 31.4%), but obtaining two or more scores in this range was uncommon (BR = 6.9%). There were small differences in BRs between sexes and the number of low scores was fairly similar across the age groups. Conclusion: Results from this study parallel previous work illustrating that a substantial percentage of healthy individuals will obtain one or more low test scores when administered a brief battery of cognitive tests. Given that some healthy individuals will obtain a single score below expected cut-offs, clinicians should caution against overinterpreting a single low test score.	[Wallace, Jessica] Univ Alabama, Dept Hlth Sci, 270 Kilgore Lane,2105 Capital Hall, Tuscaloosa, AL 35487 USA; [Wallace, Jessica] Harvard TH Chan Sch Publ Hlth, 270 Kilgore Lane,2105 Capital Hall, Tuscaloosa, AL 35487 USA; [Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Iverson, Grant L.] Harvard Med Sch, Charlestown, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Iverson, Grant L.] Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.] MassGen Hosp Children Sports Concuss Program, Charlestown, MA USA; [Iverson, Grant L.] Home Base, Charlestown, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Charlestown, MA USA		Wallace, J (corresponding author), Univ Alabama, Dept Hlth Sci, 270 Kilgore Lane,2105 Capital Hall, Tuscaloosa, AL 35487 USA.; Wallace, J (corresponding author), Harvard TH Chan Sch Publ Hlth, 270 Kilgore Lane,2105 Capital Hall, Tuscaloosa, AL 35487 USA.	jswallace1@ua.edu					Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Brooks BL, 2008, J INT NEUROPSYCH SOC, V14, P463, DOI 10.1017/S1355617708080521; Cheever KM, 2018, INT J SPORTS MED, V39, P141, DOI 10.1055/s-0043-118339; Holdnack JA, 2017, REHABIL PSYCHOL, V62, P474, DOI 10.1037/rep0000145; Holdnack JA, 2017, ARCH CLIN NEUROPSYCH, V32, P574, DOI 10.1093/arclin/acx032; Houck ZM, 2020, CLIN NEUROPSYCHOL, V34, P561, DOI 10.1080/13854046.2019.1666923; ImPACTT Quick Test, 2017, ADM SCORING INTERPRE; Iverson GL, 2008, NEUROPSYCHOLOGY COUR, P243; Iverson GL, 2019, DEV NEUROPSYCHOL, V44, P43, DOI 10.1080/87565641.2018.1545844; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Iverson GL, 2011, J AFFECT DISORDERS, V132, P360, DOI 10.1016/j.jad.2011.03.001; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Mayer AR, 2018, J NEUROTRAUM, V35, P1178, DOI 10.1089/neu.2017.5340; Sinnott AM, 2019, J SCI MED SPORT, V22, P1292, DOI 10.1016/j.jsams.2019.08.004; Sufrinko AM, 2019, CLIN J SPORT MED, V29, P318, DOI 10.1097/JSM.0000000000000528; Wallace J, 2021, PHYSICIAN SPORTSMED, V49, P165, DOI 10.1080/00913847.2020.1790983	18	1	1	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2020	35	8			SI		1276	1282		10.1093/arclin/acaa078			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	PA2QS	WOS:000595479000010	33000122	Bronze			2022-02-06	
J	Wasfie, T; Maxwell, J; Parsons, A; Hille, J; Yapchai, R; Hella, J; Cwalina, N; Barber, KR; Shapiro, B				Wasfie, Tarik; Maxwell, Jordan; Parsons, Andrea; Hille, Jennifer; Yapchai, Raquel; Hella, Jennifer; Cwalina, N.; Barber, Kimberly R.; Shapiro, Brian			Traumatic Brain Injury in the Elderly: Can We Reduce Readmissions? A Community Hospital Experience	AMERICAN SURGEON			English	Article						traumatic brain injury; readmissions		Background Traumatic brain injury (TBI) is a leading cause of mortality and long-term morbidity in trauma patients, with a growing incidence among the elderly. Injury-related disability has many costs, and rehospitalization is a significant part of that. The current study was carried out in an elderly population with TBI to identify risk factors and measures associated with rehospitalization. Methods We performed a retrospective analysis of 299 patients with a primary diagnosis of TBI admitted between 2016 and 2018. Variables selected for analysis encompassed the following: patient age, sex, comorbidities, diagnosis, length of stay, use of anticoagulants, 6-month readmission rate, and diagnosis for readmission. Chi-square analysis was used to identify potential risk factors, and multiple regression analysis was conducted to model the relationship. Results 209 patients met inclusion criteria, with a mean age of 69 years (SD +/- 18.6 years), with (51.5%) males and (48.5%) females. 188 (62.9%) patients were on anticoagulant therapy. 120 patients were discharged to home (40.1%). 79 patients (26.4%) were readmitted within 6 months of discharge, the majority of whom (48 patients, 60.8%) presented with a subdural hematoma (SDH). 38 readmitted patients (49%) came from home, and 57 patients (80%) were on anticoagulant therapy. Conclusion In elderly patients with TBI, discharge to a home setting correlates with a higher risk of readmission within 6 months, a majority with a diagnosis of recurrent SDH. Anticoagulant therapy and frequent past readmissions also correlated with a higher risk of subsequent readmission.	[Wasfie, Tarik] Ascension Genesys Med Ctr, Med Educ Surg Program, Grand Blanc, MI USA; [Maxwell, Jordan; Parsons, Andrea; Hille, Jennifer; Yapchai, Raquel; Cwalina, N.; Shapiro, Brian] Ascension Genesys Med Ctr, Genesys Trauma Serv, Grand Blanc, MI USA; [Hella, Jennifer; Barber, Kimberly R.] Ascension Genesys Med Ctr, Clin & Acad Res Dept, Grand Blanc, MI USA		Barber, KR (corresponding author), Ascension Genesys Hosp, Genesys Res Off Ste 2442,One Genesys Pkwy, Grand Blanc, MI 48439 USA.	kimberly.barber@ascension.org					Arora S, 2010, HEPATOLOGY, V52, P1124, DOI 10.1002/hep.23802; Brito A, 2019, J SURG RES, V244, P332, DOI 10.1016/j.jss.2019.06.071; Canner JK, 2016, BRAIN INJURY, V30, P1570, DOI 10.1080/02699052.2016.1199898; Chan Vincy, 2017, BMC Res Notes, V10, P371, DOI 10.1186/s13104-017-2682-x; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; Evans David C, 2011, Int J Crit Illn Inj Sci, V1, P104, DOI 10.4103/2229-5151.84793; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Kalanithi P, 2011, J NEUROSURG, V115, P1013, DOI 10.3171/2011.6.JNS101989; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822	9	1	1	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	DEC	2020	86	12					1647	1650		10.1177/0003134820933560			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	QA9YA	WOS:000613799200007	32683939				2022-02-06	
J	Wettervik, TS; Engquist, H; Howells, T; Rostami, E; Hillered, L; Enblad, P; Lewen, A				Wettervik, Teodor Svedung; Engquist, Henrik; Howells, Timothy; Rostami, Elham; Hillered, Lars; Enblad, Per; Lewen, Anders			Arterial lactate in traumatic brain injury - Relation to intracranial pressure dynamics, cerebral energy metabolism and clinical outcome	JOURNAL OF CRITICAL CARE			English	Article						Cerebral energy metabolism; Clinical outcome; Lactate; Neurointensive-care; Pressure reactivity; Traumatic brain injury	BLOOD LACTATE; INTRACEREBRAL MICRODIALYSIS; NEUROINTENSIVE CARE; GLUTAMATE UPTAKE; BASE DEFICIT; REACTIVITY; CLEARANCE; MUSCLE	Purpose: High arterial lactate is associated with disturbed systemic physiology. Lactate can also be used as alternative cerebral fuel and it is involved in regulating cerebral blood flow. This study explored the relation of endogenous arterial lactate to systemic physiology, pressure autoregulation, cerebral energy metabolism, and clinical outcome in traumatic brain injury (TBI). Method: A retrospective study including 115 patients (consent given) with severe TBI treated in the neurointensive care unit, Uppsala university hospital, Sweden, 2008-2018. Data from cerebral microdialysis, arterial blood gases, hemodynamics and intracranial pressure were analyzed the first ten days post-injury. Results: Arterial lactate peaked on day 1 post-injury (mean 1.7 +/- 0.7 mM) and gradually decreased. Higher arterial lactate correlated with lower age (p-value < 0.05), higher Marshall score (p-value < 0.05) and higher arterial glucose (p-value < 0.001) in a multiple regression analysis. Higher arterial lactate was associated with poor pressure autoregulation (p-value < 0.01), but not to worse cerebral energy metabolism. Higher arterial lactate was also associated with unfavorable clinical outcome (p-value < 0.05). Conclusions: High endogenous arterial lactate is a biomarker of poor systemic physiology and may disturb cerebral blood flow autoregulation. (C) 2020 Elsevier Inc. All rights reserved.	[Wettervik, Teodor Svedung; Howells, Timothy; Rostami, Elham; Hillered, Lars; Enblad, Per; Lewen, Anders] Uppsala Univ, Sect Neurosurg, Dept Neurosci, SE-75185 Uppsala, Sweden; [Engquist, Henrik] Uppsala Univ, Dept Surg Sci Anesthesia & Intens Care, SE-75185 Uppsala, Sweden		Wettervik, TS (corresponding author), Uppsala Univ, Sect Neurosurg, Dept Neurosci, SE-75185 Uppsala, Sweden.	teodor.svedung-wettervik@neuro.uu.se			Department of Neuroscience/Neurosurgery, Uppsala University, Sweden	The research was supported by the Department of Neuroscience/Neurosurgery, Uppsala University, Sweden.	Alessandri B, 2012, J NEUROTRAUM, V29, P2181, DOI 10.1089/neu.2011.2067; ALMENOFF PL, 1989, CRIT CARE MED, V17, P870, DOI 10.1097/00003246-198909000-00004; Andersen LW, 2013, MAYO CLIN PROC, V88, P1127, DOI 10.1016/j.mayocp.2013.06.012; Arnold RC, 2009, SHOCK, V32, P35, DOI 10.1097/SHK.0b013e3181971d47; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bakker J, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-12; Blow O, 1999, J TRAUMA, V47, P964, DOI 10.1097/00005373-199911000-00028; Boumezbeur F, 2010, J NEUROSCI, V30, P13983, DOI 10.1523/JNEUROSCI.2040-10.2010; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Carteron L, 2018, CRIT CARE MED, V46, P1649, DOI 10.1097/CCM.0000000000003274; Cerovic O, 2003, INTENS CARE MED, V29, P1300, DOI 10.1007/s00134-003-1753-8; Cureton EL, 2010, J SURG RES, V159, P468, DOI 10.1016/j.jss.2009.04.020; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Davis JW, 2018, AM J SURG, V215, P682, DOI 10.1016/j.amjsurg.2018.01.025; DRUML W, 1991, CRIT CARE MED, V19, P1120, DOI 10.1097/00003246-199109000-00005; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Glenn TC, 2015, J NEUROTRAUM, V32, P811, DOI 10.1089/neu.2014.3482; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Ido Y, 2001, FASEB J, V15, P1419, DOI 10.1096/fj.00-0652fje; INAO S, 1988, J NEUROSURG, V69, P736, DOI 10.3171/jns.1988.69.5.0736; Jalloh I, 2013, J NEUROTRAUM, V30, P2031, DOI 10.1089/neu.2013.2947; Juneja D, 2011, J CRIT CARE, V26, P316, DOI 10.1016/j.jcrc.2010.11.009; Kaukonen KM, 2014, CRIT CARE MED, V42, P1379, DOI 10.1097/CCM.0000000000000214; MANIKIS P, 1995, AM J EMERG MED, V13, P619, DOI 10.1016/0735-6757(95)90043-8; MohazzabH KM, 1997, CIRCULATION, V96, P614; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Patet C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0638-5; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Quintard H, 2016, J NEUROTRAUM, V33, P681, DOI 10.1089/neu.2015.4057; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Ronne-Engstrom E, 2001, J NEUROSURG, V94, P397, DOI 10.3171/jns.2001.94.3.0397; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35; Vary TC, 1996, SHOCK, V6, P89, DOI 10.1097/00024382-199608000-00002; Wettervik TS, 2020, WORLD NEUROSURG, V133, pE567, DOI 10.1016/j.wneu.2019.09.099; Wettervik TS, 2019, NEUROCRIT CARE, V31, P526, DOI 10.1007/s12028-019-00743-2; Wettervik TS, 2019, J NEUROTRAUM, V36, P1818, DOI 10.1089/neu.2018.6157; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zacchetti L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1137-9; Zehtabchi S, 2007, EMERG MED J, V24, P333, DOI 10.1136/emj.2006.044578	47	1	1	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	DEC	2020	60						218	225		10.1016/j.jcrc.2020.08.014			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PG1GP	WOS:000599491300038	32882604				2022-02-06	
J	Wilson, K; Lesica, S; Donders, J				Wilson, Kate; Lesica, Sofia; Donders, Jacobus			Clinical Utility of the Child and Adolescent Memory Profile (ChAMP) After Pediatric Traumatic Brain Injury	ASSESSMENT			English	Article						learning; memory; brain injury; neuropsychological assessment		Sixty-one children and adolescents with traumatic brain injury completed the Child and Adolescent Memory Profile (ChAMP; Sherman & Brooks, 2015) within 1 to 12 months post injury. Most of the ChAMP index scores demonstrated statistically significant negative correlations with time to follow commands following traumatic brain injury. Compared with demographically matched neurologically healthy controls, selected from the ChAMP standardization sample, participants with traumatic brain injury had statistically significantly lower scores on all ChAMP index scores but sensitivity and specificity were suboptimal. We conclude that the ChAMP has modest clinical utility as part of a more comprehensive evaluation of sequelae of traumatic brain injury in children and adolescents.	[Wilson, Kate; Lesica, Sofia; Donders, Jacobus] Mary Free Bed Rehabil Hosp, Grand Rapids, MI USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Dept Psychol, 235 Wealthy Southeast, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com		Donders, Jacobus/0000-0002-5087-8028			American Educational Research Association American Psychological Association & National Council on Measurement in Education, 2014, STAND ED PSYCH TEST; Ashwal S, 2014, J CHILD NEUROL, V29, P1704, DOI 10.1177/0883073814538504; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Donders J, 2003, J HEAD TRAUMA REHAB, V18, P106, DOI 10.1097/00001199-200303000-00002; Donders J, 2019, J INT NEUROPSYCH SOC, V25, P355, DOI 10.1017/S1355617719000109; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Johnson VM, 2018, APPL NEUROPSYCH-CHIL, V7, P298, DOI 10.1080/21622965.2017.1330688; Konigs M, 2018, BRAIN IMAGING BEHAV, V12, P29, DOI 10.1007/s11682-017-9673-3; Laatsch L, 2020, NEUROPSYCHOL REHABIL, V30, P130, DOI 10.1080/09602011.2019.1678490; Menlove L, 2015, SEIZURE-EUR J EPILEP, V25, P126, DOI 10.1016/j.seizure.2014.10.002; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Murphy K.R., 2014, STAT POWER ANAL SIMP, V4th ed., DOI [10.4324/9781315773155, DOI 10.4324/9781315773155]; Ober, 1984, CALIFORNIA VERBAL LE; Papoutsis J, 2014, DEV NEUROPSYCHOL, V39, P638, DOI 10.1080/87565641.2014.979926; Reynolds C.R., 1994, TEST MEMORY LEARNING; Roebuck-Spencer T, 2018, NEUROPSYCHOLOGICAL CONDITIONS ACROSS THE LIFESPAN, P139; Salorio CF, 2005, J INT NEUROPSYCH SOC, V11, P686, DOI 10.1017/S1355617705050885; Sherman E.M.S., 2015, CHILD ADOLESCENT MEM; Sheslow D., 1990, WIDE RANGE ASSESSMEN; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thaler NS, 2011, APPL NEUROPSYCHOL, V18, P168, DOI 10.1080/09084282.2011.595443; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Viot S, 2019, BRAIN INJURY, V33, P1208, DOI 10.1080/02699052.2019.1631485; Yeates, 2016, NEW FRONTIERS PEDIAT, DOI [10.4324/9780203868621, DOI 10.4324/9780203868621]	29	1	1	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	MAR	2022	29	2					309	316	1073191120976855	10.1177/1073191120976855		DEC 2020	8	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	YM9AC	WOS:000624215100001	33256457				2022-02-06	
J	Wong, A; Prin, M; Purcell, LN; Kadyaudzu, C; Charles, A				Wong, Abby; Prin, Meghan; Purcell, Laura N.; Kadyaudzu, Clement; Charles, Anthony			Intensive Care Unit Bed Utilization and Head Injury Burden in a Resource-Poor Setting	AMERICAN SURGEON			English	Article						critical care bed utilization; ICU bed management; ICU and head injury		Introduction In high-income countries (HICs), the intensive care unit (ICU) bed density is approximately 20-32 beds/100 000 population compared with countries in sub-Saharan Africa, like Malawi, with an ICU bed density of 0.1 beds/100 000 population. We hypothesize that the ICU bed utilization in Malawi will be high. Methods This is an observational study at a tertiary care center in Malawi from August 2016 to May 2018. Variables used to evaluate ICU bed utilization include ICU length of stay (LOS), bed occupancy rates (average daily ICU census/number of ICU beds), bed turnover (total number of admissions/number of ICU beds), and turnover intervals (number of ICU bed days/total number of admissions - average ICU LOS). Results 494 patients were admitted to the ICU during the study period. The average LOS during the study period was 4.8 +/- 6.0 days. Traumatic brain injury patients had the most extended LOS (8.7 +/- 6.8 days) with a 49.5% ICU mortality. The bed occupancy rate per year was 74.7%. The calculated bed turnover was 56.5 persons treated per bed per year. The average turnover interval, defined as the number of days for a vacant bed to be occupied by the successive patient admission, was 1.63 days. Conclusion Despite the high burden of critical illness, the bed occupancy rates, turn over days, and turnover interval reveal significant underutilization of the available ICU beds. ICU bed underutilization may be attributable to the absence of an admission and discharge protocols. A lack of brain death policy further impedes appropriate ICU utilization.	[Wong, Abby] Columbia Univ, Med Ctr, Dept Surg, New York, NY USA; [Prin, Meghan; Purcell, Laura N.] Univ Colorado, Dept Anesthesiol, Denver, CO 80202 USA; [Kadyaudzu, Clement; Charles, Anthony] Univ N Carolina, Dept Surg, Chapel Hill, NC 27515 USA; [Charles, Anthony] Kamuzu Cent Hosp, Dept Surg, Lilongwe, Malawi		Charles, A (corresponding author), UNC Sch Med, Dept Surg, 4008 Burnett Womack Bldg,CB 7228, Chapel Hill, NC 27515 USA.	anthchar@med.unc.edu			NIH Fogarty International Center Postdoctoral Research Fellowship	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported in part by the NIH Fogarty International Center Postdoctoral Research Fellowship to Dr Prin and Purcell.	Abizanda R., 1990, MANAGEMENT ICU GUIDE, P55; Agha RA, 2017, INT J SURG, V46, P198, DOI 10.1016/j.ijsu.2017.08.586; Austin S, 2014, INTENS CARE MED, V40, P342, DOI 10.1007/s00134-013-3174-7; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Costa AX, 2003, ANAESTHESIA, V58, P320, DOI 10.1046/j.1365-2044.2003.03042.x; Dahn Cassidy M, 2018, Int J Crit Illn Inj Sci, V8, P117, DOI 10.4103/IJCIIS.IJCIIS_22_18; Garrouste-Orgeas M, 2005, CRIT CARE MED, V33, P750, DOI 10.1097/01.CCM.0000157752.26180.F1; Gooch RA, 2014, JAMA-J AM MED ASSOC, V311, P567, DOI 10.1001/jama.2013.283800; Halpern NA, 2015, CRIT CARE MED, V43, P2452, DOI 10.1097/CCM.0000000000001227; Iapichino G, 2004, INTENS CARE MED, V30, P290, DOI 10.1007/s00134-003-2113-4; Lyons RA, 2000, LANCET, V355, P595, DOI 10.1016/S0140-6736(00)01265-4; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Murthy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116949; Murthy S, 2012, CRIT CARE, V16, DOI 10.1186/cc11140; Prin M, 2019, TROP DOCT, V49, P107, DOI 10.1177/0049475518821201; Riviello ED, 2011, CRIT CARE MED, V39, P860, DOI 10.1097/CCM.0b013e318206d6d5; Robert R, 2012, AM J RESP CRIT CARE, V185, P1081, DOI 10.1164/rccm.201104-0729OC; Saigal S, 2017, INDIAN J CRIT CARE M, V21, P625, DOI [10.4103/ijccm.IJCCM_193_17, 10.4103/ijccm.ICCM_193_17]; Shrestha RR., 2015, POSTGRAD MED, V15; Sinuff T, 2004, CRIT CARE MED, V32, P1588, DOI 10.1097/01.CCM.0000130175.38521.9F; Tomlinson J, 2013, TROP DOCT, V43, P27, DOI 10.1177/0049475513480773; Uche E O, 2012, Niger J Med, V21, P70; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8	23	1	1	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	DEC	2020	86	12					1736	1740		10.1177/0003134820950282			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	QA9YA	WOS:000613799200023	32902325				2022-02-06	
J	Wongchareon, K; Thompson, HJ; Mitchell, PH; Barber, J; Temkin, N				Wongchareon, Kwankaew; Thompson, Hilaire J.; Mitchell, Pamela H.; Barber, Jason; Temkin, Nancy			IMPACT and CRASH prognostic models for traumatic brain injury: external validation in a South-American cohort	INJURY PREVENTION			English	Article						traumatic brain injury; outcome evaluation; functional outcome; low-middle income country	INTERNATIONAL MISSION; CLINICAL-TRIALS; LATIN-AMERICA; CLASSIFICATION; RANDOMIZATION; PREDICTION	Objective To develop a robust prognostic model, the more diverse the settings in which the system is tested and found to be accurate, the more likely it will be generalisable to untested settings. This study aimed to externally validate the International Mission for Prognosis and Clinical Trials in Traumatic Brain Injury (IMPACT) and Corticosteroid Randomization after Significant Head Injury (CRASH) models for low-income and middle-income countries using a dataset of patients with severe traumatic brain injury (TBI) from the Benchmark Evidence from South American Trials: Treatment of Intracranial Pressure study and a simultaneously conducted observational study. Method A total of 550 patients with severe TBI were enrolled in the study, and 466 of those were included in the analysis. Patient admission characteristics were extracted to predict unfavourable outcome (Glasgow Outcome Scale: GOS<3) and mortality (GOS 1) at 14 days or 6 months. Results There were 48% of the participants who had unfavourable outcome at 6 months and these included 38% who had died. The area under the receiver operating characteristic curve (AUC) values were 0.683-0.775 and 0.640-0.731 for the IMPACT and CRASH models respectively. The IMPACT CT model had the highest AUC for predicting unfavourable outcomes, and the IMPACT Lab model had the best discrimination for predicting 6-month mortality. The discrimination for both the IMPACT and CRASH models improved with increasing complexity of the models. Calibration revealed that there were disagreement between observed and predicted outcomes in the IMPACT and CRASH models. Conclusion The overall performance of all IMPACT and CRASH models was adequate when used to predict outcomes in the dataset. However, some disagreement in calibration suggests the necessity for updating prognostic models to maintain currency and generalisability.	[Wongchareon, Kwankaew] Naresuan Univ, Fac Nursing, Adult & Gerontol Nursing, Phitsanulok 65000, Thailand; [Thompson, Hilaire J.; Mitchell, Pamela H.] Univ Washington, Biobehav Nursing & Hlth Informat, Seattle, WA 98195 USA; [Barber, Jason; Temkin, Nancy] Univ Washington, Neurosurg, Seattle, WA 98195 USA		Wongchareon, K (corresponding author), Naresuan Univ, Fac Nursing, Adult & Gerontol Nursing, Phitsanulok 65000, Thailand.	kwankaeww@nu.ac.th; temkin@uw.edu	Wongchareon, Kwankaew/AAU-8714-2021	Wongchareon, Kwankaew/0000-0003-1971-4452; Thompson, Hilaire/0000-0002-5472-478X			Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.3.CO;2-X; [Anonymous], 2008, BMJ-BRIT MED J, V336, P425, DOI DOI 10.1136/bmj.39461.643438.25; Carney N, 2012, J NEUROTRAUM, V29, P2022, DOI 10.1089/neu.2011.2019; Charry JD, 2017, WORLD NEUROSURG, V101, P554, DOI 10.1016/j.wneu.2017.02.051; Chesnut RM, 2018, J NEUROTRAUM, V35, P54, DOI 10.1089/neu.2016.4472; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; D'Agostino RB, 2013, GLOB HEART, V8, P11, DOI 10.1016/j.gheart.2013.01.001; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Faried A, 2018, WORLD NEUROSURG, V116, pE239, DOI 10.1016/j.wneu.2018.04.180; Gao JX, 2015, INT J CLIN EXP MED, V8, P19881; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Hosmer DW, 2013, WILEY SER PROBAB ST, P153; Jakobsen JC, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0442-1; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Puvanachandra P, 2008, SALUD PUBLICA MEXICO, V50, pS3; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Subaiya S, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-17; Wan XY, 2017, WORLD NEUROSURG, V103, P584, DOI 10.1016/j.wneu.2017.04.069	30	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	DEC	2020	26	6					546	554		10.1136/injuryprev-2019-043466			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	OY4IN	WOS:000594212000008	31959626				2022-02-06	
J	Xu, L; Xu, FF; Li, L; Liu, WM; Leung, GKK; Liu, BY				Xu, Long; Xu, Feifan; Li, Liang; Liu, Weiming; Leung, Gilberto Ka Kit; Liu, Baiyun			The Surgical Strategies and Techniques of Transorbital Nonmissile Brain Injury	WORLD NEUROSURGERY			English	Article						Foreign body; Orbit; Penetrating brain injury; Transorbital brain injury; Traumatic brain injury	PENETRATING CEREBRAL INJURY; WOODEN FOREIGN-BODY; OF-THE-LITERATURE; INTRACRANIAL INJURY; CASE SERIES; MANAGEMENT; REMOVAL	OBJECTIVE: This study aimed to summarize the experience with the management of transorbital brain injury (TOBI) at our institution that may help inform surgical decision-making. METHODS: Four adults with TOBIs were admitted to our hospital and received surgical treatment. The patients' clinical manifestations, physical findings, imaging data, surgical treatment, and postoperative outcome were prospectively collected and subject to retrospective analysis. RESULTS: All patients were male. In 2 patients, the entry point of the cranium was the superior orbital fissure, whereas in the other 2, the entry point was the orbital roof. Thorough physical examination and comprehensive diagnostic imaging were performed preoperatively in all patients for careful assessment of the foreign body and its surrounding important structures. In collaboration with our multidisciplinary trauma team, individualized surgeries were successfully designed and performed in the 4 patients to remove the foreign bodies along the path of their trajectories. Three patients had uneventful postoperative courses, whereas 1 patient died because of severe cerebral ischemia and refractory brain swelling after decompressive craniectomy. CONCLUSIONS: A comprehensive understanding of the regional anatomy of the trajectory is the cornerstone for surgical management of TOBIs. Adequate preoperative imaging examinations are essential for the evaluation of surgical risks and for making a tailored management strategy. Early surgical exploration through multidisciplinary collaboration is highly recommended for achieving a favorable outcome.	[Xu, Long; Liu, Weiming; Liu, Baiyun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Xu, Long; Liu, Weiming; Liu, Baiyun] China Natl Clin Res Ctr Neurol Dis NCRC ND, Beijing, Peoples R China; [Xu, Feifan; Li, Liang] Peking Univ First Hosp, Dept Neurosurg, Beijing, Peoples R China; [Leung, Gilberto Ka Kit] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Div Neurosurg,Dept Surg, Hong Kong, Peoples R China		Liu, BY (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.; Liu, BY (corresponding author), China Natl Clin Res Ctr Neurol Dis NCRC ND, Beijing, Peoples R China.	liubaiyun1212@hotmail.com	Liu, Weiming/E-7512-2015; Liu, Weiming/O-7968-2019; Leung, Gilberto Ka Kit/C-4337-2009	Liu, Weiming/0000-0002-6245-6287; Liu, Weiming/0000-0002-6245-6287; Leung, Gilberto Ka Kit/0000-0003-3147-3057			Arslan M, 2012, J NEUROSCI RURAL PRA, V3, P178, DOI 10.4103/0976-3147.98228; Borkar SA, 2014, CHILD NERV SYST, V30, P1441, DOI 10.1007/s00381-014-2364-0; Cunningham EJ, 2004, NEUROSURGERY, V55, P1225, DOI 10.1227/01.NEU.0000140991.82075.01; Di Roio C, 2000, CHILD NERV SYST, V16, P503, DOI 10.1007/s003810000291; Erkutlu I, 2011, ULUS TRAVMA ACIL CER, V17, P79, DOI 10.5505/tjtes.2011.49092; Kahler RJ, 1998, NEUROSURGERY, V42, P1370, DOI 10.1097/00006123-199806000-00108; Kawamura Shingo, 1997, Neurologia Medico-Chirurgica, V37, P332, DOI 10.2176/nmc.37.332; Klancnik M, 2018, ACTA CLIN CROAT, V57, P792, DOI 10.20471/acc.2018.57.04.26; Matsumoto S, 1998, AM J NEURORADIOL, V19, P1163; Matsuyama T, 2001, NEUROL MED-CHIR, V41, P345, DOI 10.2176/nmc.41.345; Mitilian D, 2009, ACTA NEUROCHIR, V151, P1295, DOI 10.1007/s00701-009-0418-y; Mzimbiri JM, 2016, WORLD NEUROSURG, V87, P26, DOI 10.1016/j.wneu.2015.12.063; Nishio Y, 2004, ACTA NEUROCHIR, V146, P847, DOI 10.1007/s00701-004-0283-7; Park SH, 2006, PEDIATR NEUROSURG, V42, P138, DOI 10.1159/000091855; Sarkar S, 2015, J CLIN DIAGN RES, V9, pPD8, DOI 10.7860/JCDR/2015/14257.6434; Satyarthee GD, 2009, NEUROL INDIA, V57, P331, DOI 10.4103/0028-3886.53285; Schreckinger M, 2011, J NEUROSURG, V114, P53, DOI 10.3171/2010.8.JNS10301; Shin TH, 2012, J KOREAN NEUROSURG S, V52, P414, DOI 10.3340/jkns.2012.52.4.414; Smely C, 1999, BRIT J NEUROSURG, V13, P206, DOI 10.1080/02688699944014; Sun GZ, 2016, WORLD NEUROSURG, V95, DOI 10.1016/j.wneu.2016.07.104; Sweeney Justin M, 2011, Skull Base Rep, V1, P39, DOI 10.1055/s-0031-1275257; Tabibkhooei A, 2019, WORLD NEUROSURG, V131, P213, DOI 10.1016/j.wneu.2019.06.234; Tenenholz T, 1999, AM J ROENTGENOL, V173, P144, DOI 10.2214/ajr.173.1.10397115; Turbin RE, 2006, SURV OPHTHALMOL, V51, P449, DOI 10.1016/j.survophthal.2006.06.008; Xu FF, 2013, BRAIN INJURY, V27, P951, DOI 10.3109/02699052.2013.775502	25	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2020	144						E856	E865		10.1016/j.wneu.2020.09.091			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	PH8PV	WOS:000600668300101	32971278				2022-02-06	
J	Zhao, QH; Xie, F; Guo, DZ; Ju, FD; He, J; Yao, TT; Zhao, PX; Pan, SY; Ma, XM				Zhao, Qing-hui; Xie, Fei; Guo, Da-zhi; Ju, Fang-di; He, Jin; Yao, Ting-ting; Zhao, Peng-xiang; Pan, Shu-yi; Ma, Xue-mei			Hydrogen inhalation inhibits microglia activation and neuroinflammation in a rat model of traumatic brain injury	BRAIN RESEARCH			English	Article						Traumatic brain injury; Hydrogen inhalation; Microglia activation; Neuroinflammation; Cytokines	CELLS	Traumatic brain injury (TBI) is a major cause of mortality and disability worldwide. To date, therapies to treat any forms of TBI are still limited. Recent studies have demonstrated the potential neuroprotective effects of molecular hydrogen on TBI. Although it has been demonstrated that hydrogen inhalation (HI) for about 5 hrs immediately after TBI has a beneficial effect on brain injury, the most effective intervention procedure in the treatment of TBI remains unknown. The mechanism underlying the neuroprotective effects of HI on TBI also needs to be further investigated. Our results showed that inhalation of 4% hydrogen during the first day after TBI was the most effective hydrogen intervention procedure in the treatment of TBI. Pathological examination showed that HI could attenuate TBI-induced reactive astrocytosis and microglial activation. Nissl staining demonstrated a significant decrease in the number of nissl-stained dark neurons (N-DNs) in HI group compared to TBI group at 2 h post-TBI, and the TBI-induced neuronal loss was attenuated by HI at day 3 post-TBI. IHC staining showed that HI resulted a decrease in CD16-positive cells and a further increase in CD206-positive cells as compared to TBI group. Multiplex cytokine assay demonstrated the most profound regulatory effects induced by HI on the levels of IL-12, IFN-gamma, and GM-CSF at 24 h post-TBI, which confirmed the inhibitory effect of hydrogen on microglia activation. We concluded that inhalation of 4% hydrogen during the first day after TBI was the most effective intervention procedure in the treatment of TBI. Our results also showed that hydrogen may exert its protective effects on TBI via inhibition of microglia activation and neuroinflammation.	[Zhao, Qing-hui; Xie, Fei; Ju, Fang-di; He, Jin; Yao, Ting-ting; Zhao, Peng-xiang; Ma, Xue-mei] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China; [Zhao, Qing-hui; Xie, Fei; Ju, Fang-di; He, Jin; Yao, Ting-ting; Zhao, Peng-xiang; Ma, Xue-mei] Beijing Mol Hydrogen Res Ctr, Beijing 100124, Peoples R China; [Guo, Da-zhi; Pan, Shu-yi] Peoples Liberat Army Gen Hosp, Med Ctr 6, Dept Hyperbar Oxygen, Beijing 100048, Peoples R China		Pan, SY; Ma, XM (corresponding author), Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China.	zhqh@emails.bjut.edu.cn; xiefei990815@bjut.edu.cn; psy9992011@163.com; xmma@bjtu.edu.cn			Military Logistics Key Open Research Projects [BHJ17L018]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31500828]	This work was supported by Military Logistics Key Open Research Projects (BHJ17L018) and National Natural Science Foundation of China (grant number: 31500828).	Becher B, 1996, J CLIN INVEST, V98, P1539, DOI 10.1172/JCI118946; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Clausen F, 2019, J NEUROTRAUM, V36, P201, DOI 10.1089/neu.2018.5636; Dohi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108034; Esen N, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-10; Hou ZG, 2012, BRAIN RES BULL, V88, P560, DOI 10.1016/j.brainresbull.2012.06.006; Hwang IK, 2017, MOL MED REP, V15, P4148, DOI 10.3892/mmr.2017.6525; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Ji XT, 2010, BRAIN RES, V1354, P196, DOI 10.1016/j.brainres.2010.07.038; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Kawanokuchi J, 2006, MULT SCLER J, V12, P558, DOI 10.1177/1352458506070763; Li J, 2010, BRAIN RES, V1328, P152, DOI 10.1016/j.brainres.2010.02.046; Liu C, 2014, SCI REP-UK, V4, DOI 10.1038/srep05485; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ooigawa H, 2006, ACTA NEUROPATHOL, V112, P471, DOI 10.1007/s00401-006-0108-2; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Tian S, 2016, CANCER INFORM, V15, P1, DOI 10.4137/CIN.S40300; Wang L, 2018, SHOCK, V50, P308, DOI 10.1097/SHK.0000000000001018; Xu H., 2017, NEURAL PLAST, V2017, P1; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yuan J, 2018, J SURG RES, V228, P238, DOI 10.1016/j.jss.2018.03.024	24	1	1	6	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 1	2020	1748								147053	10.1016/j.brainres.2020.147053			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OC8TB	WOS:000579428000003	32814064				2022-02-06	
J	Giannakakis, E; Han, CE; Weber, B; Hutchings, F; Kaiser, M				Giannakakis, Emmanouil; Han, Cheol E.; Weber, Bernd; Hutchings, Frances; Kaiser, Marcus			Towards simulations of long-term behavior of neural networks: Modeling synaptic plasticity of connections within and between human brain regions	NEUROCOMPUTING			English	Article						Brain simulation; Optimization; Neural mass model; Biological neural network modeling		Simulations of neural networks can be used to study the direct effect of internal or external changes on brain dynamics. However, some changes are not immediate but occur on the timescale of weeks, months, or years. Examples include effects of strokes, surgical tissue removal, or traumatic brain injury but also gradual changes during brain development. Simulating network activity over a long time, even for a small number of nodes, is a computational challenge. Here, we model a coupled network of human brain regions with a modified Wilson-Cowan model representing dynamics for each region and with synaptic plasticity adjusting connection weights within and between regions. Using strategies ranging from different models for plasticity, vectorization and a different differential equation solver setup, we achieved one second runtime for one second biological time. (C) 2020 The Author(s). Published by Elsevier B.V.	[Giannakakis, Emmanouil; Hutchings, Frances; Kaiser, Marcus] Newcastle Univ, Sch Comp, Interdisciplinary Comp & Complex BioSyst ICOS Grp, Newcastle Upon Tyne NE4 5TG, Tyne & Wear, England; [Kaiser, Marcus] Newcastle Univ, Inst Neurosci, Henry Wellcome Bldg, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Han, Cheol E.] Korea Univ, Dept Elect & Informat Engn, Sejong, South Korea; [Weber, Bernd] Univ Bonn, Inst Expt Epileptol & Cognit Res, Bonn, Germany; [Kaiser, Marcus] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Funct Neurosurg, Shanghai 200025, Peoples R China		Giannakakis, E (corresponding author), Newcastle Univ, Sch Comp, Interdisciplinary Comp & Complex BioSyst ICOS Grp, Newcastle Upon Tyne NE4 5TG, Tyne & Wear, England.	giannakakismanos@gmail.com	Weber, Bernd/H-5244-2012; Kaiser, Marcus/A-7166-2008; Han, Cheol/AAR-9212-2021	Weber, Bernd/0000-0002-7811-9605; Kaiser, Marcus/0000-0002-4654-3110; 	CANDO project through the Wellcome Trust [102037]; EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [NS/A0 00026/1]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/T004347/1]; Portabolomics project through EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/N031962/1]; Wellcome TrustWellcome TrustEuropean Commission [105617/Z/14/Z]; EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/N031962/1] Funding Source: UKRI; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/T004347/1] Funding Source: UKRI	MK was supported by the CANDO project (http://www.cando.ac.uk/) funded through the Wellcome Trust (102037) and EPSRC (NS/A0 00026/1), Medical Research Council (MR/T004347/1), and by the Portabolomics project funded through EPSRC (EP/N031962/1). PNT was supported by Wellcome Trust (105617/Z/14/Z).	Ahnert K., 2014, NUMERICAL COMPUTATIO, P125; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Arsiwalla XD, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00002; Brette R, 2007, J COMPUT NEUROSCI, V23, P349, DOI 10.1007/s10827-007-0038-6; Cheung K, 2016, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00516; Doiron B, 2001, NEURAL COMPUT, V13, P227, DOI 10.1162/089976601300014691; Freestone DR, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00383; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; FRISTON KJ, 1993, P ROY SOC B-BIOL SCI, V254, P47, DOI 10.1098/rspb.1993.0125; Furber SB, 2013, IEEE T COMPUT, V62, P2454, DOI 10.1109/TC.2012.142; Gerrow K, 2010, CURR OPIN NEUROBIOL, V20, P631, DOI 10.1016/j.conb.2010.06.010; Gonzalez-de-Aledo P, 2018, ADV ENG SOFTW, V121, P262, DOI 10.1016/j.advengsoft.2018.03.010; Hahne J, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00034; Hutchings F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004642; Jeffers J., 2013, INTEL XEON PHI COPRO, P325; Jin X. A, 2010, PARALLEL SIMULATION; Jin X, 2010, COMPUT SCI ENG, V12, P91, DOI 10.1109/MCSE.2010.112; Johansen-Berg H, 2012, NEURON, V73, P1058, DOI 10.1016/j.neuron.2012.03.001; Jordan J, 2018, FRONT NEUROINFORM, V12, DOI 10.3389/fninf.2018.00002; Kunkel S, 2012, FRONT NEUROINFORM, V5, DOI 10.3389/fninf.2011.00035; Lee H.J., 2003, ORDINARY PARTIAL DIF; Lovden M, 2013, NEUROSCI BIOBEHAV R, V37, P2296, DOI 10.1016/j.neubiorev.2013.02.014; Papasavvas CA, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.032723; Shampine L. F., 2000, SOLVING DELAY DIFFER; Taylor PN, 2017, SCI REP-UK, V7, DOI 10.1038/srep39859; Tetzlaff C., 2012, TIME SCALES MEMORY L, V106; Tikidji-Hamburyan RA, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00046; Tomsett RJ, 2015, BRAIN STRUCT FUNCT, V220, P2333, DOI 10.1007/s00429-014-0793-x; Uy J, 2003, NEUROLOGY, V61, P982, DOI 10.1212/01.WNL.0000078809.33581.1F; van Albada SJ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00291; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Xin J., 2008, P IEEE INT JOINT C N; Yokokawa M., 2011, P IEEE ACM INT S LOW; Zenke F, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0259	34	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0925-2312	1872-8286		NEUROCOMPUTING	Neurocomputing	NOV 27	2020	416						38	44		10.1016/j.neucom.2020.01.050			7	Computer Science, Artificial Intelligence	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	OG2XW	WOS:000581754500005	33250573	hybrid, Green Published			2022-02-06	
J	Xu, G; Sheng, QQ; Xin, QG; Song, YX; Zhang, GY; Yuan, L; Zhao, P; Liang, J				Xu, Gang; Sheng, Qianqian; Xin, Qinggang; Song, Yanxin; Zhang, Gaoyan; Yuan, Lin; Zhao, Peng; Liang, Jun			EEG Assessment in a 2-Year-Old Child with Prolonged Disorders of Consciousness: 3 Years' Follow-up	COMPUTATIONAL INTELLIGENCE AND NEUROSCIENCE			English	Article							INTERICTAL EPILEPTIFORM DISCHARGES; ACQUIRED BRAIN-INJURY; VEGETATIVE STATE; COGNITIVE IMPAIRMENT; PREVALENCE; COMA	A 2-year-old girl, diagnosed with traumatic brain injury and epilepsy following car trauma, was followed up for 3 years (a total of 15 recordings taken at 0, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 14, 19, 26, and 35 months). There is still no clear guidance on the diagnosis, treatment, and prognosis of children with disorders of consciousness. At each appointment, recordings included the child's height, weight, pediatric Glasgow Coma Scale (pGCS), Coma Recovery Scale-Revised (CRS-R), Gesell Developmental Schedule, computed tomography or magnetic resonance imaging, electroencephalogram, frequency of seizures, oral antiepileptic drugs, stimulation with subject's own name (SON), and median nerve electrical stimulation (MNS). Growth and development were deemed appropriate for the age of the child. The pGCS and Gesell Developmental Schedule provided a comprehensive assessment of consciousness and mental development; the weighted Phase Lag Index (wPLI ) in the beta-band (13-25 Hz) can distinguish unresponsive wakefulness syndrome from minimally conscious state and confirm that the SON and MNS were effective. The continuous increase of delta-band power indicates a poor prognosis. Interictal epileptiform discharges (IEDs) have a cumulative effect and seizures seriously affect the prognosis.	[Xu, Gang; Sheng, Qianqian; Xin, Qinggang; Yuan, Lin; Zhao, Peng] Tianjin Children Hosp, Rehabil Branch, Tianjin 300400, Peoples R China; [Song, Yanxin] Tianjin Tianshi Univ, Med Coll, Tianjin 301700, Peoples R China; [Zhang, Gaoyan] Tianjin Univ, Sch Artificial Intelligence, Coll Intelligence & Comp, Tianjin 300354, Peoples R China; [Liang, Jun] Tianjin Med Univ Gen Hosp, Dept Rehabil, Tianjin 300041, Peoples R China; [Liang, Jun] Tianjin Univ, Coll Precis Instruments & Optoelect Engn, Dept Biomed Engn, Lab Neural Engn & Rehabil, Tianjin 300354, Peoples R China		Zhao, P (corresponding author), Tianjin Children Hosp, Rehabil Branch, Tianjin 300400, Peoples R China.; Liang, J (corresponding author), Tianjin Med Univ Gen Hosp, Dept Rehabil, Tianjin 300041, Peoples R China.; Liang, J (corresponding author), Tianjin Univ, Coll Precis Instruments & Optoelect Engn, Dept Biomed Engn, Lab Neural Engn & Rehabil, Tianjin 300354, Peoples R China.	xugangrehab@163.com; shengqianqianvip@163.com; 617396119@qq.com; 553690127@qq.com; zhanggaoyan@tju.edu.cn; 514793211@qq.com; patrickzhao@163.com; 15122878711@163.com		Zhang, Gaoyan/0000-0001-5189-9229; Xu, Gang/0000-0003-2389-664X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61876126]	This work was supported in part by the National Natural Science Foundation of China (no. 61876126).	Aldenkamp AP, 2004, EPILEPSY BEHAV, V5, pS25, DOI 10.1016/j.yebeh.2003.11.005; Andre-Obadia N., 2018, NEUROPHYSIOLOGIE CLI, V48; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Babiloni C, 2020, CLIN NEUROPHYSIOL, V131, P285, DOI 10.1016/j.clinph.2019.06.234; Bai Y, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00471; Bareham CA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00676; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Belkacem AN, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00692; Braun KPJ, 2017, CURR OPIN NEUROL, V30, P140, DOI 10.1097/WCO.0000000000000424; Cavinato M, 2015, BRAIN TOPOGR, V28, P570, DOI 10.1007/s10548-014-0383-5; Chaitanya K., 2018, CHILDS NERVOUS SYSTE, V34; Corchs S, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01323; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Donis J, 2011, BRAIN INJURY, V25, P1101, DOI 10.3109/02699052.2011.577047; Dovgialo M, 2019, INT J NEURAL SYST, V29, DOI 10.1142/S012906571850048X; Ebus S, 2012, EUR J PAEDIATR NEURO, V16, P697, DOI 10.1016/j.ejpn.2012.05.010; Eisermann M, 2013, NEUROPHYSIOL CLIN, V43, P35, DOI 10.1016/j.neucli.2012.09.091; Fingelkurts Andrew A, 2012, Open Neuroimag J, V6, P55, DOI 10.2174/1874440001206010055; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2018, NEUROLOGY, V91, pXX; Glennon JM, 2016, EPILEPSIA, V57, P1436, DOI 10.1111/epi.13479; Goldfine AM, 2011, CLIN NEUROPHYSIOL, V122, P2157, DOI 10.1016/j.clinph.2011.03.022; Gosseries O, 2011, FRONT COLLECT, P29, DOI 10.1007/978-3-642-18047-7_2; Hotz GA, 2006, BRAIN INJURY, V20, P879, DOI 10.1080/02699050600832635; Houston AL, 2020, EUR J PAEDIATR NEURO, V25, P40, DOI 10.1016/j.ejpn.2020.01.015; Jochumsen M, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aae4b8; Kaminska A., 2019, HDB CLIN NEUROLOGY, V160; Kinney-Lang E, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/6/061002; Kondziella D, 2020, EUR J NEUROL, V27, P741, DOI 10.1111/ene.14151; Lavrijsen JCM, 2005, J NEUROL NEUROSUR PS, V76, P1420, DOI 10.1136/jnnp.2004.058198; Lehembre R, 2012, FUNCT NEUROL, V27, P41; Leon-Carrion J, 2008, CLIN NEUROPHYSIOL, V119, P1506, DOI 10.1016/j.clinph.2008.03.030; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Listed N., 1994, MULTISOC TASK FORCE, V330, P1572; Molteni E, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10030162; Motes MA, 2018, PSYCHOL AGING, V33, P1070, DOI 10.1037/pag0000299; Noreika V, 2020, INFANT BEHAV DEV, V58, DOI 10.1016/j.infbeh.2019.101393; Pozzi M, 2019, BRAIN INJURY, V33, P1522, DOI 10.1080/02699052.2019.1658128; Qian Xuguang, 2018, Zhongguo Zhen Jiu, V38, P723, DOI 10.13703/j.0255-2930.2018.07.011; Qiao LX, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1509-4; Shahwan A, 2010, EPILEPSIA, V51, P1198, DOI 10.1111/j.1528-1167.2009.02517.x; Skoe E, 2015, CEREB CORTEX, V25, P1415, DOI 10.1093/cercor/bht311; Strauss DJ, 2000, PEDIATR NEUROL, V23, P312, DOI 10.1016/S0887-8994(00)00194-6; Tang XR, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00469; Turner-Stokes L, 2014, CLIN MED, V14, P4, DOI 10.7861/clinmedicine.14-1-4; Wang XT, 2012, EXP THER MED, V4, P923, DOI 10.3892/etm.2012.697; Wu HW, 2018, MINERVA PEDIATR, V70, P539, DOI 10.23736/S0026-4946.17.04792-2; Zhang J, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00024	48	1	1	2	6	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-5265	1687-5273		COMPUT INTEL NEUROSC	Comput. Intell. Neurosci.	NOV 27	2020	2020								8826238	10.1155/2020/8826238			8	Mathematical & Computational Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Neurosciences & Neurology	PE6ER	WOS:000598457400001	33293944	Green Published, gold			2022-02-06	
J	Guo, YS; Chen, TN; Wang, S; Zhou, XJ; Zhang, H; Li, DD; Mu, N; Tang, MJ; Hu, MD; Tang, DY; Yang, ZB; Zhong, JJ; Tang, YZ; Feng, H; Zhang, XH; Wang, HB				Guo, Yuansen; Chen, Tunan; Wang, Shi; Zhou, Xiaojie; Zhang, Hua; Li, Dandan; Mu, Ning; Tang, Mingjie; Hu, Meidie; Tang, Dongyun; Yang, Zhongbo; Zhong, Jiajia; Tang, Yuzhao; Feng, Hua; Zhang, Xuehua; Wang, Huabin			Synchrotron Radiation-Based FTIR Microspectroscopic Imaging of Traumatically Injured Mouse Brain Tissue Slices	ACS OMEGA			English	Article							RATS	Traumatic brain injury (TBI) is a health problem of global concern because of its serious adverse effects on public health and social economy. A technique that can be used to precisely detect TBI is highly demanded. Here, we report on a synchrotron radiation-based Fourier transform infrared (SR-FTIR) microspectroscopic imaging technique that can be exploited to identify TBI-induced injury by examining model mouse brain tissue slices. The samples were first examined by conventional histopathological techniques including hematoxylin and eosin (H&E) staining and 2,3,5-triphenyltetrazolium chloride staining and then spectroscopically imaged by SR-FTIR. SR-FTIR results show that the contents of protein and nucleic acid in the injured region are lower than their counterparts in the normal region. The injured and normal regions can be unambiguously distinguished from each other by the principle component analysis of the SR-FTIR spectral data corresponding to protein or nucleic acid. The images built from the spectral data of protein or nucleic acid clearly present the injured region of the brain tissue, which is in good agreement with the H&E staining image and optical image of the sample. Given the label-free and fingerprint features, the demonstrated method suggests potential application of SR-FTIR spectroscopic mapping for the digital and intelligent diagnosis of TBI by providing spatial and chemical information of the sample simultaneously.	[Guo, Yuansen; Zhang, Hua; Li, Dandan; Tang, Mingjie; Hu, Meidie; Tang, Dongyun; Yang, Zhongbo; Wang, Huabin] Chinese Acad Sci, Ctr Appl Phys, Chongqing 400714, Peoples R China; [Guo, Yuansen; Zhang, Hua; Li, Dandan; Tang, Mingjie; Hu, Meidie; Tang, Dongyun; Yang, Zhongbo; Wang, Huabin] Chinese Acad Sci, Chongqing Engn Res Ctr High Resolut & Three Dimen, Chongqing Inst Green & Intelligent Technol, Chongqing 400714, Peoples R China; [Guo, Yuansen; Tang, Mingjie] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Chen, Tunan; Wang, Shi; Mu, Ning; Feng, Hua] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Army Med Univ, Chongqing 400038, Peoples R China; [Chen, Tunan; Wang, Shi; Mu, Ning; Feng, Hua] Third Mil Med Univ, Key Lab Neurotrauma, Southwest Hosp, Army Med Univ, Chongqing 400038, Peoples R China; [Zhou, Xiaojie; Zhong, Jiajia; Tang, Yuzhao] Chinese Acad Sci, Shanghai Adv Res Inst, Zhangjiang Lab, Natl Facil Prot Sci Shanghai, Shanghai 201210, Peoples R China; [Zhang, Hua; Tang, Dongyun] Univ Chinese Acad Sci, Chongqing Sch, Chongqing 400714, Peoples R China; [Zhang, Xuehua] Univ Alberta, Dept Chem & Mat Engn, Calgary, AB T6G 1H9, Canada		Wang, HB (corresponding author), Chinese Acad Sci, Ctr Appl Phys, Chongqing 400714, Peoples R China.; Wang, HB (corresponding author), Chinese Acad Sci, Chongqing Engn Res Ctr High Resolut & Three Dimen, Chongqing Inst Green & Intelligent Technol, Chongqing 400714, Peoples R China.; Tang, YZ (corresponding author), Chinese Acad Sci, Shanghai Adv Res Inst, Zhangjiang Lab, Natl Facil Prot Sci Shanghai, Shanghai 201210, Peoples R China.	tangyuzhao@zjlab.org.cn; wanghuabin@citig.ac.cn	Feng, Hua/AAX-4121-2021; Wang, Huabin/AAA-1398-2022	Feng, Hua/0000-0003-4489-9217; Tunan, Chen/0000-0003-0460-5632; Mu, Ning/0000-0002-5195-4838	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [U1932132, 11604332, U1632273, U1732130]; Central Government Supported Key Instrument Program of China [YXGYQ201700136]; Natural Science Foundation of ChongqingNatural Science Foundation of Chongqing [cstc2018jcyjAX0405, cstc2019jcyj-msxmX0654]; Chongqing Collaborative Innovation Center for Brain Science	The authors would like to thank the staff from BL01B beamline of National Facility for Protein Science in Shanghai (NFPS) at Shanghai Synchrotron Radiation Facility for assistance during data collection. This work was supported by National Natural Science Foundation of China (U1932132, 11604332, U1632273 and U1732130), Central Government Supported Key Instrument Program of China (YXGYQ201700136), Natural Science Foundation of Chongqing (cstc2018jcyjAX0405 and cstc2019jcyj-msxmX0654), and the Chongqing Collaborative Innovation Center for Brain Science.	Ara S.A., 2011, INT J DENT CLIN, V3, P65; Augustyniak K, 2019, J BIOPHOTONICS, V12, DOI 10.1002/jbio.201800345; Bambery KR, 2006, BBA-BIOMEMBRANES, V1758, P900, DOI 10.1016/j.bbamem.2006.05.004; Bassan P, 2010, ANALYST, V135, P268, DOI 10.1039/b921056c; Bonnier F, 2012, ANALYST, V137, P322, DOI 10.1039/c1an15821j; Caine S, 2012, NEUROIMAGE, V59, P3624, DOI 10.1016/j.neuroimage.2011.11.033; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Dernby KG, 1918, J BIOL CHEM, V35, P179; Diem M, 2004, INFRARED PHYS TECHN, V45, P331, DOI 10.1016/j.infrared.2004.01.013; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fernandez DC, 2005, NAT BIOTECHNOL, V23, P469, DOI 10.1038/nbt1080; Geng GS, 2019, BIOTECHNOL PROGR, V35, DOI 10.1002/btpr.2741; Holman HYN, 2009, ANAL CHEM, V81, P8564, DOI 10.1021/ac9015424; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Jamin N, 2003, BIOPOLYMERS, V72, P366, DOI 10.1002/bip.10435; Kimber JA, 2016, FARADAY DISCUSS, V187, P69, DOI 10.1039/c5fd00158g; Krafft C, 2006, BIOPOLYMERS, V82, P301, DOI 10.1002/bip.20492; Kramer M, 2010, J NEUROSCI METH, V187, P84, DOI 10.1016/j.jneumeth.2009.12.020; Li ZZ, 2014, J NEUROL SCI, V338, P112, DOI 10.1016/j.jns.2013.12.027; Liao CR, 2013, ANALYST, V138, P3991, DOI 10.1039/c3an00295k; Ling SJ, 2015, J MATER CHEM B, V3, P834, DOI 10.1039/c4tb01808g; Ling SJ, 2014, PHYS CHEM CHEM PHYS, V16, P7741, DOI 10.1039/c4cp00556b; Liu GZ, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201807862; Liu ZX, 2016, BIOCHEM BIOPH RES CO, V478, P1286, DOI 10.1016/j.bbrc.2016.08.112; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maziak DE, 2007, CANCER DETECT PREV, V31, P244, DOI 10.1016/j.cdp.2007.03.003; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miller LM, 2006, BBA-BIOMEMBRANES, V1758, P846, DOI 10.1016/j.bbamem.2006.04.010; Miller LM, 2010, CURR OPIN STRUC BIOL, V20, P649, DOI 10.1016/j.sbi.2010.07.007; Nakajima S, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2433035; Nallala J, 2016, ANALYST, V141, P630, DOI 10.1039/c5an01871d; Nasse MJ, 2011, NAT METHODS, V8, P413, DOI [10.1038/NMETH.1585, 10.1038/nmeth.1585]; Pilling M, 2016, CHEM SOC REV, V45, P1935, DOI 10.1039/c5cs00846h; Pilling MJ, 2015, ANALYST, V140, P2383, DOI 10.1039/c4an01975j; Rosas-Hernandez H, 2019, NEUROCHEM RES, V44, P2546, DOI 10.1007/s11064-019-02872-8; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shi J, 2018, OPT EXPRESS, V26, P6371, DOI 10.1364/OE.26.006371; Spadoni AD, 2018, CURR TOP BEHAV NEURO, V38, P163, DOI 10.1007/7854_2017_35; Stem MR, 2008, J CHEM EDUC, V85, P983, DOI 10.1021/ed085p983; Surowka AD, 2015, ANALYST, V140, P2428, DOI 10.1039/c4an01867b; Surowka AD, 2017, ANALYST, V142, P156, DOI 10.1039/c6an01797e; Tang MJ, 2013, ANAL BIOANAL CHEM, V405, P1577, DOI 10.1007/s00216-012-6556-8; Toyran N, 2004, EUR BIOPHYS J BIOPHY, V33, P549, DOI 10.1007/s00249-004-0396-1; Xiao LF, 2013, ANAL METHODS-UK, V5, P874, DOI 10.1039/c2ay25951f; Xu SY, 2019, GENES DIS, V6, P398, DOI 10.1016/j.gendis.2019.01.002; Yu GL, 2004, BRAIN RES, V1015, P50, DOI 10.1016/j.brainres.2004.04.055; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhang J, 2015, J FORENSIC SCI, V60, P759, DOI 10.1111/1556-4029.12743; Zhang XD, 2016, ADV MATER, V28, P6872, DOI 10.1002/adma.201600706; Zhao HL, 2018, J BIOMED OPT, V23, DOI 10.1117/1.JBO.23.3.036015	53	1	1	6	9	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2470-1343			ACS OMEGA	ACS Omega	NOV 24	2020	5	46					29698	29705		10.1021/acsomega.0c03285			8	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	PA3HF	WOS:000595527600008	33251405	gold, Green Published			2022-02-06	
J	Li, YC; Wang, PT; Vaidya, MP; Flint, RD; Liu, CY; Slutzky, MW; Do, AH				Li, Yongcheng; Wang, Po T.; Vaidya, Mukta P.; Flint, Robert D.; Liu, Charles Y.; Slutzky, Marc W.; Do, An H.			Refinement of High-Gamma EEG Features From TBI Patients With Hemicraniectomy Using an ICA Informed by Simulated Myoelectric Artifacts	FRONTIERS IN NEUROSCIENCE			English	Article						EEG; EMG artifacts removal; ICA; high-gamma; TBI	LOCAL-FIELD POTENTIALS; EMPIRICAL-MODE DECOMPOSITION; FRACTAL DIMENSION; SOURCE SEPARATION; EMG; SIGNALS; SYNCHRONIZATION; CORTEX; SKULL	Recent studies have shown the ability to record high-gamma signals (80-160 Hz) in electroencephalogram (EEG) from traumatic brain injury (TBI) patients who have had hemicraniectomies. However, extraction of the movement-related high-gamma remains challenging due to a confounding bandwidth overlap with surface electromyogram (EMG) artifacts related to facial and head movements. In our previous work, we described an augmented independent component analysis (ICA) approach for removal of EMG artifacts from EEG, and referred to as EMG Reduction by Adding Sources of EMG (ERASE). Here, we tested this algorithm on EEG recorded from six TBI patients with hemicraniectomies while they performed a thumb flexion task. ERASE removed a mean of 52 +/- 12% (mean +/- S.E.M) (maximum 73%) of EMG artifacts. In contrast, conventional ICA removed a mean of 27 +/- 19% (mean +/- S.E.M) of EMG artifacts from EEG. In particular, high-gamma synchronization was significantly improved in the contralateral hand motor cortex area within the hemicraniectomy site after ERASE was applied. A more sophisticated measure of high-gamma complexity is the fractal dimension (FD). Here, we computed the FD of EEG high-gamma on each channel. Relative FD of high-gamma was defined as that the FD in move state was subtracted by FD in idle state. We found relative FD of high-gamma over hemicraniectomy after applying ERASE were strongly correlated to the amplitude of finger flexion force. Results showed that significant correlation coefficients across the electrodes related to thumb flexion averaged similar to 0.76, while the coefficients across the homologous electrodes in non-hemicraniectomy areas were nearly 0. After conventional ICA, a correlation between relative FD of high-gamma and force remained high in both hemicraniectomy areas (up to 0.86) and non-hemicraniectomy areas (up to 0.81). Across all subjects, an average of 83% of electrodes significantly correlated with force was located in the hemicraniectomy areas after applying ERASE. After conventional ICA, only 19% of electrodes with significant correlations were located in the hemicraniectomy. These results indicated that the new approach isolated electrophysiological features during finger motor activation while selectively removing confounding EMG artifacts. This approach removed EMG artifacts that can contaminate high-gamma activity recorded over the hemicraniectomy.	[Li, Yongcheng; Do, An H.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Wang, Po T.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Vaidya, Mukta P.; Flint, Robert D.; Slutzky, Marc W.] Northwestern Univ, Dept Neurol, Chicago, IL USA; [Vaidya, Mukta P.; Flint, Robert D.; Slutzky, Marc W.] Northwestern Univ, Dept Physiol, Chicago, IL USA; [Vaidya, Mukta P.; Flint, Robert D.; Slutzky, Marc W.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Liu, Charles Y.] Univ Southern Calif, Dept Neurosurg, Los Angeles, CA 90007 USA; [Liu, Charles Y.] Rancho Los Amigos Natl Rehabil Ctr, Downey, CA USA; [Liu, Charles Y.] Univ Southern Calif, Neurorestorat Ctr, Los Angeles, CA 90007 USA		Li, YC; Do, AH (corresponding author), Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA.	yongchel@uci.edu; and@uci.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS094748]	This study was funded by the National Institutes of Health, R01NS094748.	Acharya R, 2005, COMPUT METH PROG BIO, V80, P37, DOI 10.1016/j.cmpb.2005.06.011; Branco MP, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/ab3189; Chen X, 2018, IEEE T INSTRUM MEAS, V67, P359, DOI 10.1109/TIM.2017.2759398; Chen X, 2014, J APPL MATH, DOI 10.1155/2014/261347; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Dalal SS, 2011, BRAIN STRUCT FUNCT, V216, P77, DOI 10.1007/s00429-011-0307-z; Dannhauer M, 2011, HUM BRAIN MAPP, V32, P1383, DOI 10.1002/hbm.21114; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Duchene J, 2000, IEEE T BIO-MED ENG, V47, P192, DOI 10.1109/10.821754; Esteller R, 2001, IEEE T CIRCUITS-I, V48, P177, DOI 10.1109/81.904882; Fatourechi M, 2007, CLIN NEUROPHYSIOL, V118, P480, DOI 10.1016/j.clinph.2006.10.019; Flint RD, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2560/14/1/016005; Flint RD, 2014, NEUROIMAGE, V101, P695, DOI 10.1016/j.neuroimage.2014.07.049; Flint RD, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046006; Flint RD, 2012, J NEUROPHYSIOL, V108, P18, DOI 10.1152/jn.00832.2011; Goncharova II, 2003, CLIN NEUROPHYSIOL, V114, P1580, DOI 10.1016/S1388-2457(03)00093-2; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; James CJ, 2005, PHYSIOL MEAS, V26, pR15, DOI 10.1088/0967-3334/26/1/R02; Jiang TX, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00100; KATZ MJ, 1988, COMPUT BIOL MED, V18, P145, DOI 10.1016/0010-4825(88)90041-8; Lanfer B, 2012, NEUROIMAGE, V62, P418, DOI 10.1016/j.neuroimage.2012.05.006; Li Y., 2020, ARXIV200703130; Li Yongcheng, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P6014, DOI 10.1109/EMBC.2018.8513658; Liu JZ, 2005, BIOL CYBERN, V93, P131, DOI 10.1007/s00422-005-0561-3; Lu W, 2005, IEEE T NEURAL NETWOR, V16, P203, DOI 10.1109/TNN.2004.836795; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; McCrimmon CM, 2018, CEREB CORTEX, V28, P2752, DOI 10.1093/cercor/bhx155; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Mijovic B, 2010, IEEE T BIO-MED ENG, V57, P2188, DOI 10.1109/TBME.2010.2051440; Miller KJ, 2007, J NEUROSCI, V27, P2424, DOI 10.1523/JNEUROSCI.3886-06.2007; Miller KJ, 2007, J NEUROSCI METH, V162, P303, DOI 10.1016/j.jneumeth.2007.01.019; Mourad N, 2013, 2013 PROCEEDINGS OF THE 21ST EUROPEAN SIGNAL PROCESSING CONFERENCE (EUSIPCO); Mowla MR, 2015, BIOMED SIGNAL PROCES, V22, P111, DOI 10.1016/j.bspc.2015.06.009; Mucarquer JA, 2020, IEEE T INSTRUM MEAS, V69, P815, DOI [10.1109/TIM.2019.2906967, 10.1109/tim.2019.2906967]; Muthukumaraswamy SD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00138; Nolan H, 2010, J NEUROSCI METH, V192, P152, DOI 10.1016/j.jneumeth.2010.07.015; Nunez P. L., 2006, ELECT FIELDS BRAIN N; Pfurtscheller G, 2003, CLIN NEUROPHYSIOL, V114, P1226, DOI 10.1016/S1388-2457(03)00067-1; Pistohl T, 2012, NEUROIMAGE, V59, P248, DOI 10.1016/j.neuroimage.2011.06.084; Romero S, 2008, COMPUT BIOL MED, V38, P348, DOI 10.1016/j.compbiomed.2007.12.001; Safieddine D, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-127; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Soper HE, 1915, BIOMETRIKA, V11, P328; STEGEMAN DF, 1992, J ELECTROMYOGR KINES, V2, P130, DOI 10.1016/1050-6411(92)90010-G; Subha DP, 2010, J MED SYST, V34, P195, DOI 10.1007/s10916-008-9231-z; Vaidya M, 2019, IEEE T NEUR SYS REH, V27, P1467, DOI 10.1109/TNSRE.2019.2912298; Voytek B, 2010, J COGNITIVE NEUROSCI, V22, P2491, DOI 10.1162/jocn.2009.21384; Wang PT, 2017, BRAIN STRUCT FUNCT, V222, P3705, DOI 10.1007/s00429-017-1429-8; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Zeng H, 2013, SENSORS-BASEL, V13, P14839, DOI 10.3390/s131114839; Zhuang J, 2010, IEEE ENG MED BIO, P4347, DOI 10.1109/IEMBS.2010.5626228	51	1	1	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	NOV 24	2020	14								599010	10.3389/fnins.2020.599010			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PB5SS	WOS:000596381200001	33328870	Green Published, gold			2022-02-06	
J	Spencer, RJ; Amer, S; St George, EJ				Spencer, R. J.; Amer, S.; St George, E. J.			A retrospective analysis of emergency referrals and admissions to a regional neurosurgical centre 2016-2018	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Neurosurgical emergencies; emergency referrals; service provision; referral pattern		Background and objectives Emergencies account for 60% of UK neurosurgical workload. We analysed the emergency referrals made to the on-call neurosurgical registrar in a regional centre over three years, aiming to identify temporal trends in volume of referrals, admission practices and major diagnostic categories contributing to referrals and admissions. Methods Individual referrals recorded in on-call databases were processed to extract basic demographics, call timing, diagnosis category and whether the patient was admitted under neurosurgery. Linear regression analysis was used to identify temporal trends across the three years. Results A total of 18128 calls were made to the on-call registrar between 2016 and 2018, with a significant increase in monthly calls. On average, one call was received every 88 minutes. An increasing proportion of these calls were taken out of office hours. Diagnostic categories accounting for the largest percentage of calls were traumatic brain injury (17.7%) and cauda equina syndrome (13%). Significant increases in referral volume were seen in cauda equina syndrome, traumatic brain injury, spinal trauma and spinal tumours, while no category had a significant decrease. The admission rate was 17.1% - no change was seen in this across the study period, resulting in increasing numbers of admissions, reflecting increasing referrals. Categories most likely to result in admission were hydrocephalus (41.1%), spontaneous subarachnoid haemorrhage (39.4%), intracranial infection (32.6%) and chronic subdural haematoma (CSDH, 32.2%). A change in admission rate was seen only for CSDH, with a significant increase in the percentage of referrals across the study period. Conclusion Emergency neurosurgical referrals continue to rise in the UK at a rate exceeding population growth. This implies a decreasing referral threshold. However, the constant admission rate suggests either an increasing amount of neurosurgical pathology, the threshold for admission/intervention has decreased, or a combination. Neurosurgical services need to adapt in order to meet increasing demands.	[Spencer, R. J.; Amer, S.] NHS Greater Glasgow & Clyde, Glasgow, Lanark, Scotland; [St George, E. J.] Inst Neurol Sci, Glasgow, Lanark, Scotland		Spencer, RJ (corresponding author), Inst Neurol Sci, Dept Neurosurg, Queen Elizabeth Univ Hosp Campus,Govan Rd, Glasgow G51 4TF, Lanark, Scotland.	robert.spencer@ggc.scot.nhs.uk	Spencer, Robert J/D-5688-2017	Spencer, Robert J/0000-0001-9045-6260			[Anonymous], 2019, OPERATIVE NEUROSURGE; Fountain DM, 2019, BRIT J NEUROSURG, V33, P624, DOI 10.1080/02688697.2019.1648757; Gardner A, 2011, EUR SPINE J, V20, P690, DOI 10.1007/s00586-010-1668-3; Hauptfleisch J, 2013, CLIN RADIOL, V68, pE245, DOI 10.1016/j.crad.2012.12.007; Hutton M, 2019, SPINAL SERVICES GIRF; NOCKA LM, 2013, BR J NEUROSURG, V27; Office for National Statistics, 2019, OV UK POP AUG; Society of British Neurological Surgeons, 2000, BRIT NEUR WORKF PLAN	8	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	JUL 4	2021	35	4					438	443		10.1080/02688697.2020.1853675		NOV 2020	6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	XN6LU	WOS:000597040100001	33292027				2022-02-06	
J	Roby, PR; Duquette, P; Kerr, ZY; Register-Mihalik, J; Stoner, L; Mihalik, JP				Roby, Patricia R.; Duquette, Peter; Kerr, Zachary Y.; Register-Mihalik, Johna; Stoner, Lee; Mihalik, Jason P.			Repetitive Head Impact Exposure and Cerebrovascular Function in Adolescent Athletes	JOURNAL OF NEUROTRAUMA			English	Article						cerebrovascular reactivity; high school; neurovascular coupling; transcranial Doppler	IMPAIRED CEREBRAL VASOREACTIVITY; TRAUMATIC BRAIN-INJURY; TRANSCRANIAL DOPPLER; HIGH-SCHOOL; BLOOD-FLOW; FOOTBALL; VALIDITY; UTILITY; SEASON	The purpose of this study was to determine how subconcussive head impact exposure in high school collision sport student-athletes influenced cerebrovascular function. Transcranial Doppler was used to assess pre- to post-season changes in: (1) resting middle (MCA) and posterior cerebral arteries (PCA), (2) cerebrovascular reactivity (CVR) via breath-holding index (BHI), vasomotor reactivity response (VMRr) and overall MCA response curve, and (3) neurovascular coupling (NVC) via NVC response magnitude and overall PCA response curve. Fifty-three high school-aged athletes (age = 15.8 +/- 1.2years, height = 175.8 +/- 8.1cm, mass = 69.4 +/- 13.5kg) were recruited into two groups (collision vs. non-collision sport). All participants completed a pre-season cerebrovascular function assessment. Following a 4- to 5-month window (118.6 +/- 12.2 days), 48 athletes from the original sample (age = 16.0 +/- 1.2 years, height = 175.5 +/- 8.1 cm, mass = 68.6 +/- 4.0 kg) repeated the cerebrovascular assessment. There were no group differences in any cerebrovascular measures at pre-season testing (p > 0.05). At post-season testing, collision sport athletes demonstrated greater positive change in BHI (t(44) = -2.21, p = 0.03) while non-collision sport athletes demonstrated greater negative change in the NVC response magnitude to the reading task (t(44) = 1.98, p = 0.048), and lower overall PCA response curve to the reading task (F-1,F-2710 = 101.54, p < 0.001). All other pre- to post-season change values were non-significant (p > 0.05). Our data indicate that single-season changes in cerebrovascular outcomes may differ between collision and non-collision sport athletes. Although the clinical interpretation is still unclear, our study demonstrates that CVR and NVC assessments may be sensitive to the dynamic cerebrovascular changes occurring in adolescent athletes. Future research should continue to assess these outcomes following both subconcussive head impact exposure and throughout the recovery trajectory following concussion.	[Roby, Patricia R.; Duquette, Peter; Kerr, Zachary Y.; Register-Mihalik, Johna; Mihalik, Jason P.] Univ N Carolina, Sch Med, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [Stoner, Lee] Univ N Carolina, Sch Med, Dept Exercise & Sport Sci, UNC Cardiometab Lab, Chapel Hill, NC 27515 USA; [Roby, Patricia R.; Kerr, Zachary Y.; Register-Mihalik, Johna; Stoner, Lee; Mihalik, Jason P.] Univ N Carolina, Sch Med, Dept Allied Hlth Sci, Curriculum Human Movement Sci, Chapel Hill, NC 27515 USA; [Duquette, Peter] Univ N Carolina, Sch Med, Dept Phys Med & Rehabil, Chapel Hill, NC 27515 USA		Mihalik, JP (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 2201 Stallings Evans Sports Med Complex, Chapel Hill, NC 27599 USA.	jmihalik@email.unc.edu	Stoner, Lee/C-8504-2011	Stoner, Lee/0000-0002-0682-2270			Akca O, 2006, CURR OPIN ANESTHESIO, V19, P19; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; CHIRON C, 1992, J NUCL MED, V33, P696; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; IPAQ Research Committee, 2005, GUID DAT PROC AN INT; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Konrad K, 2013, DTSCH ARZTEBL INT, V110, P425, DOI 10.3238/arztebl.2013.0425; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Macedo-Campos RD, 2018, J STROKE CEREBROVASC, V27, P2703, DOI 10.1016/j.jstrokecerebrovasdis.2018.05.042; MARKUS HS, 1992, STROKE, V23, P668, DOI 10.1161/01.STR.23.5.668; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; National Collegiate Athletic Association, 2019, EST PROB COMP COLL A; National Council of Youth Sports, 2008, REP TRENDS PART ORG, P1; Phillips AA, 2016, J CEREBR BLOOD F MET, V36, P647, DOI 10.1177/0271678X15617954; Purkayastha S, 2019, J NEUROTRAUM, V36, P2385, DOI 10.1089/neu.2018.5861; Raask T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169527; Rangul V, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-47; Saghafi B., 2018, P SPIE INT SOC OPT E; Satterthwaite TD, 2014, P NATL ACAD SCI USA, V111, P8643, DOI 10.1073/pnas.1400178111; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Smirl JD, 2016, J NEUROSCI METH, V270, P92, DOI 10.1016/j.jneumeth.2016.06.007; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Staszewski J, 2019, J ULTRAS MED, V38, P975, DOI 10.1002/jum.14782; Svaldi DO, 2020, BRAIN IMAGING BEHAV, V14, P164, DOI 10.1007/s11682-018-9983-0; Svaldi DO, 2015, DEV NEUROPSYCHOL, V40, P80, DOI 10.1080/87565641.2014.973959; Tarar JM, 2015, CAN J SCH PSYCHOL, V30, P320, DOI 10.1177/0829573515594334; Tegeler CH, 2013, J NEUROIMAGING, V23, P466, DOI 10.1111/j.1552-6569.2012.00711.x; Thibeault CM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00200; Torgesesn J.K., 2012, TEST WORD READING EF; Totaro R., 1999, CEREBROVASCULAR REAC, P142; Valadi N, 2006, NEUROLOGY, V67, P572, DOI 10.1212/01.wnl.0000230150.39429.8e; Willie CK, 2011, J NEUROSCI METH, V196, P221, DOI 10.1016/j.jneumeth.2011.01.011; Wright AD, 2020, CLIN J SPORT MED, V30, pS53, DOI 10.1097/JSM.0000000000000578	45	1	1	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2021	38	7					837	847		10.1089/neu.2020.7350		NOV 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RI3KN	WOS:000592471500001	33081565				2022-02-06	
J	Zou, WJ; Wang, XX; Zhang, R; Abdelrahim, MEA; Zhao, ZY				Zou, WenJun; Wang, Xinxue; Zhang, Rong; Abdelrahim, Mohamed E. A.; Zhao, Zeyu			Prevalence of persistent vegetative state compared to recovery, disability, and death in subjects with severe traumatic brain injury: A meta-analysis	INTERNATIONAL JOURNAL OF CLINICAL PRACTICE			English	Article							SEVERE HEAD-INJURY; OUTCOME PREDICTION; EPIDEMIOLOGY	Background The persistent vegetative state has drawn considerable attention since it is the poorest result apart from mortality in subjects with severe traumatic brain injury. This meta-analysis was performed to evaluate its prevalence compared to recovery, disability, and death 6 months post severe traumatic brain injury. Methods A systematic-literature search up to May 2020 was performed and 19 studies were detected with 10 368 subjects. They contained data about the subject's status 6 months post severe traumatic brain injury (recovery, disability, persistent vegetative state, and death). Odds ratio (OR) with 95% confidence intervals (CIs) was calculated comparing the prevalence of persistent vegetative state to that of recovery, disability, and death; 6 months post severe traumatic brain injury using the dichotomous method with a random- or fixed-effect model. Results Significantly higher prevalence was found of recovery (OR, 0.08; 95% CI, 0.03-0.20, P < .001); disability (OR, 0.09; 95% CI, 0.06-0.15, P < .001); and death (OR, 0.07; 95% CI, 0.04-0.11, P < .001) compared to the prevalence of persistent vegetative state. The prevalence of persistent vegetative state was variable over time. Also, the prevalence of persistent vegetative states in developing countries was much higher than in developed countries. Conclusions However, persistent vegetative state is the poorest result apart from mortality in subjects with severe traumatic brain injury. Its prevalence is lower than the recovery, disability, and death even in developing counties with its lower healthcare services. The prevalence was variable over time and higher in developing countries. This relationship forces us to recommend improving healthcare services to the extent that a persistent vegetative state could be avoided as much as possible.	[Zou, WenJun] Fourth Peoples Hosp Sichuan Prov, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China; [Wang, Xinxue; Zhang, Rong; Zhao, Zeyu] Chengdu Univ TCM, Dept Anesthesiol, Sichuan Bayi Rehabil Ctr, Chengdu 611135, Sichuan, Peoples R China; [Abdelrahim, Mohamed E. A.] Beni Suef Univ, Fac Pharm, Clin Pharm Dept, Bani Suwayf, Egypt		Zhao, ZY (corresponding author), Chengdu Univ TCM, Dept Anesthesiol, Sichuan Bayi Rehabil Ctr, Chengdu 611135, Sichuan, Peoples R China.	gyzhaozy@sina.com		abdelrahim, mohamed/0000-0003-0227-8404; zhao, ze yu/0000-0003-2402-7753			Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bouzat P, 2019, J NEUROTRAUM, V36, P2506, DOI 10.1089/neu.2019.6432; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Gupta A, 2018, AM J CLIN ONCOL-CANC, V41, P874, DOI 10.1097/COC.0000000000000388; Hayden JA, 2013, ANN INTERN MED, V158, P280, DOI 10.7326/0003-4819-158-4-201302190-00009; HEIDEN JS, 1983, PHYS THER, V63, P1946, DOI 10.1093/ptj/63.12.1946; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Jha AN, 2020, STRATEGIC SYSTEM ASS, P419; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; JUDSON JA, 1990, CRIT CARE MED, V18, P363, DOI 10.1097/00003246-199004000-00003; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Le Roux P, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0331-2; Mamelak AN, 1996, J TRAUMA, V41, P91, DOI 10.1097/00005373-199607000-00014; McCauley SR, 2013, J NEUROTRAUM, V30, P1506, DOI 10.1089/neu.2013.2925; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nordstrom C H, 1989, Brain Inj, V3, P247, DOI 10.3109/02699058909029639; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; SELLADURAI BM, 1992, BRIT J NEUROSURG, V6, P549, DOI 10.3109/02688699209002372; Sheikhbahaei S, 2016, ONCOLOGIST, V21, P931, DOI 10.1634/theoncologist.2015-0353; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; TURAZZI S, 1987, ACTA NEUROCHIR, V85, P87, DOI 10.1007/BF01456103; TURAZZI S, 1984, ACTA NEUROCHIR, V72, P167, DOI 10.1007/BF01406869; Wang V, 2019, ANN PHYS REHABIL MED, V62, P28, DOI 10.1016/j.rehab.2018.08.003; Watanabe T, 2018, NEUROL MED-CHIR, V58, P393, DOI 10.2176/nmc.oa.2018-0116	31	1	2	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-5031	1742-1241		INT J CLIN PRACT	Int. J. Clin. Pract.	APR	2021	75	4							e13835	10.1111/ijcp.13835		NOV 2020	7	Medicine, General & Internal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pharmacology & Pharmacy	RC8GK	WOS:000591561800001	33187025				2022-02-06	
J	Gallant, C; Luczon, R; Ryan, D; Good, D				Gallant, Caitlyn; Luczon, Rachel; Ryan, Dawn; Good, Dawn			Investigating cannabis use and associated symptoms among university students with and without a history of concussion	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Concussion; Traumatic Brain Injury; Cannabis; Substance Use; Post-Concussive Symptoms	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; GOOD-OLD-DAYS; SUBSTANCE-ABUSE; COGNITIVE PERFORMANCE; DIAGNOSIS THREAT; DECISION-MAKING; SEX-DIFFERENCES; TRANSIENT LOSS; MENTAL-HEALTH	Recently, there has been a growing interest in the use of cannabis after traumatic brain injury (TBI); however, little is known about the long-term effects of cannabis on milder injuries and post-concussive symptoms. Further, substance use often increases post-TBI and, thus, individuals who chronically use cannabis may unknowingly be exceeding safe or therapeutic doses. The current cross-sectional study explores the prevalence of cannabis use among university students with and without a history of concussion and examines the relationship between concussion and post-concussive symptoms as a function of cannabis use. Eighty-four undergraduates (n = 51 without a prior concussion; n = 33 with a prior concussion) completed a series of questionnaires, capturing their head injury history, current and past substance use, and post-concussive symptomatology. Results indicated that those with a history of concussion were more likely to use cannabis and had higher cannabis use severity scores compared to those without a previous concussion. Further, among cannabis users only, concussion severity demonstrated a significant positive association with post-concussive symptom (e.g., headaches, memory problems) severity (i.e., frequency, intensity, duration). Taken together, the long-term use of cannabis may be detrimental to individuals with a history of concussion, exacerbating, rather than mitigating, post-concussive symptoms.	[Gallant, Caitlyn; Ryan, Dawn; Good, Dawn] Brock Univ, Dept Psychol, 1812 Sir Isaac Brock Way, St Catharines, ON L2S 3A1, Canada; [Luczon, Rachel; Good, Dawn] Brock Univ, Ctr Neurosci, St Catharines, ON, Canada		Gallant, C (corresponding author), Brock Univ, Dept Psychol, 1812 Sir Isaac Brock Way, St Catharines, ON L2S 3A1, Canada.	cg14xx@brocku.ca		Ryan, A.D./0000-0003-3118-6939; Gallant, Caitlyn/0000-0003-4305-1425	Vanier Canada Graduate Scholarships (Vanier CGS) program	CG received support from the Vanier Canada Graduate Scholarships (Vanier CGS) program during the preparation, data collection, analysis, and writing of this research.	Adams RS, 2016, J HEAD TRAUMA REHAB, V31, P13, DOI 10.1097/HTR.0000000000000082; Adamson SJ, 2010, DRUG ALCOHOL DEPEN, V110, P137, DOI 10.1016/j.drugalcdep.2010.02.017; Alcock Bradey, 2018, Addict Behav Rep, V7, P58, DOI 10.1016/j.abrep.2018.02.001; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Ashton CH, 1999, BRIT J ANAESTH, V83, P637, DOI 10.1093/bja/83.4.637; Baker JM, 2014, BRAIN INJURY, V28, P51, DOI 10.3109/02699052.2013.857787; Battistella G, 2014, NEUROPSYCHOPHARMACOL, V39, P2041, DOI 10.1038/npp.2014.67; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; BROWN JD, 2019, J CLIN MED, V8, DOI DOI https://doi.org/10.3390/jcm8070989; BROWN M, 2016, BREAST CANCER RES S1, V18, DOI DOI https://doi.org/10.10826084.2016.1188955; Calabrese EJ, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12920; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Colell E, 2013, INT J DRUG POLICY, V24, P319, DOI 10.1016/j.drugpo.2012.09.006; Corrigan J. D., 1999, REHABILITATION ADULT; Corrigan JD, 2005, PSYCHOL ADDICT BEHAV, V19, P131, DOI 10.1037/0893-164X.19.2.131; Corrigan JD, 2008, BRAIN INJURY, V22, P223, DOI 10.1080/02699050801938967; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Cuttler C, 2016, CANNABIS CANNABINOID, V1, P166, DOI 10.1089/can.2016.0010; Degenhardt L, 2003, ADDICTION, V98, P1493, DOI 10.1046/j.1360-0443.2003.00437.x; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Durazzo TC, 2013, J NEUROTRAUM, V30, P1013, DOI 10.1089/neu.2012.2676; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; GALLANT C, 2019, APPL NEUROPSYCH 0927, DOI DOI https://doi.org/10.1080/23279095.2019.1670181; Gallant C, 2020, CLIN NEUROPSYCHOL, V34, P296, DOI 10.1080/13854046.2019.1612946; Gallant C, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1038; Gardner E. L., 2011, CHRONIC PAIN ADDICTI; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Grenier K, 2020, CAN J NEUROL SCI, V47, P11, DOI 10.1017/cjn.2019.298; Grotenhermen F, 2003, CLIN PHARMACOKINET, V42, P327, DOI 10.2165/00003088-200342040-00003; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hanson KL, 2016, J CLIN EXP NEUROPSYC, V38, P1115, DOI 10.1080/13803395.2016.1198468; Harvey MA, 2007, DRUG ALCOHOL REV, V26, P309, DOI 10.1080/09595230701247772; Hawley LA, 2018, ARCH PHYS MED REHAB, V99, P1584, DOI 10.1016/j.apmr.2018.02.003; Hirvonen J, 2012, MOL PSYCHIATR, V17, P642, DOI 10.1038/mp.2011.82; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Hser YI, 2017, J SUBST ABUSE TREAT, V81, P53, DOI 10.1016/j.jsat.2017.07.012; Hunt C, 2016, CANADA CONCUSSION, V1, pCNC21, DOI DOI https://doi.org/10.2217/cnc-2016-0009; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P663, DOI 10.1007/978-0-387-76978-3_21; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Kennedy E, 2017, EUR CHILD ADOLES PSY, V26, P1197, DOI 10.1007/s00787-017-0975-1; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Lawrence DW, 2020, BRAIN INJURY, V34, P42, DOI 10.1080/02699052.2019.1679885; Little R. J., 2019, STAT ANAL MISSING DA, V793; London AS, 2020, SUBST USE MISUSE, V55, P1288, DOI 10.1080/10826084.2020.1735438; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McGee R, 2000, ADDICTION, V95, P491, DOI 10.1046/j.1360-0443.2000.9544912.x; McHugh L, 2008, BRAIN INJURY, V22, P715, DOI 10.1080/02699050802263027; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Meier MH, 2012, P NATL ACAD SCI USA, V109, pE2657, DOI 10.1073/pnas.1206820109; Merkel SF, 2017, CELL TRANSPLANT, V26, P1178, DOI 10.1177/0963689717714341; Morales D., 2007, BRAIN CONTUSION; NEWMAN SD, 2019, J NEUROTRAUM 0918, DOI DOI https://doi.org/10.1089/neu.2019.6550; O'Jile JR, 2004, APPL NEUROPSYCHOL, V11, P107, DOI 10.1207/s15324826an1102_7; Olson-Madden JH, 2010, J HEAD TRAUMA REHAB, V25, P470, DOI 10.1097/HTR.0b013e3181d717a7; Owings JT, 1998, ARCH SURG-CHICAGO, V133, P941, DOI 10.1001/archsurg.133.9.941; Pacula RL, 2016, ADDICTION, V111, P973, DOI 10.1111/add.13282; Phan KL, 2008, J NEUROSCI, V28, P2313, DOI 10.1523/JNEUROSCI.5603-07.2008; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2013, J CLIN EXP NEUROPSYC, V35, P103, DOI 10.1080/13803395.2012.752437; Potter A, 2019, HIGH TIME: THE LEGALIZATION AND REGULATION OF CANNABIS IN CANADA, P1; Prigatano GP, 1998, J HEAD TRAUMA REHAB, V13, P29, DOI 10.1097/00001199-199810000-00005; Rogers G, 2011, BRIT J GEN PRACT, V61, P40, DOI 10.3399/bjgp11X548965; Rotermann M, 2020, HEALTH REP, V31, P11, DOI 10.25318/82-003-x202000200002-eng; Sarne Y, 2004, MED HYPOTHESES, V63, P187, DOI 10.1016/j.mehy.2004.02.043; Sarne Y, 2011, BRIT J PHARMACOL, V163, P1391, DOI 10.1111/j.1476-5381.2011.01280.x; SCHURMAN LD, 2017, FRONT PHARMACOL, V8, DOI DOI https://doi.org/10.3389/fphar.2017.00069; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; SPSS I, 2012, STAT PACK SOC SCI; Starkey NJ, 2018, BRAIN INJURY, V32, P617, DOI 10.1080/02699052.2018.1439533; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sznitman SR, 2017, INT J DRUG POLICY, V42, P15, DOI 10.1016/j.drugpo.2016.11.010; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; van Gastel WA, 2013, PSYCHOL MED, V43, P1849, DOI 10.1017/S0033291712002723; van Noordt S, 2011, BRAIN INJURY, V25, P707, DOI 10.3109/02699052.2011.580312; Vandrey R, 2017, J ANAL TOXICOL, V41, P83, DOI 10.1093/jat/bkx012; VELIZ P, 2019, SUBST ABUS 1017, DOI DOI https://doi.org/10.1080/08897077.2019.1671938; Weil ZM, 2019, EXP NEUROL, V317, P284, DOI 10.1016/j.expneurol.2019.03.012; Weil ZM, 2016, J NEUROTRAUM, V33, P895, DOI 10.1089/neu.2015.3953; WEIL ZM, 2017, FRONT BEHAV NEUROSCI, V11, DOI DOI https://doi.org/10.3389/fnbeh.2017.00135	89	1	1	1	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2020.1847148		NOV 2020	25	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	OS7VV	WOS:000590367900001	33208035				2022-02-06	
J	Zhao, YH; Gao, H; Ma, C; Huang, WH; Pan, ZY; Wang, ZF; Li, ZQ				Zhao, Yu-Hang; Gao, Hong; Ma, Chao; Huang, Wen-Hong; Pan, Zhi-Yong; Wang, Ze-Fen; Li, Zhi-Qiang			Earlier cranioplasty following posttraumatic craniectomy is associated with better neurological outcomes at one-year follow-up: a two-centre retrospective cohort study	BRITISH JOURNAL OF NEUROSURGERY			English	Article; Early Access						Cranioplasty; decompressive craniectomy; neurological functional outcome; complications	CEREBRAL-BLOOD-FLOW; DECOMPRESSIVE CRANIECTOMY; STROKE; COMPLICATIONS; IMPROVEMENT; IMPACT	Purpose Cranioplasty (CP) after decompressive craniectomy (DC) is routinely performed for reconstructive purposes and improves rehabilitation. However, the optimal timing of CP remains controversial. This study aimed to assess differences in clinical outcomes following different timings of CP in patients with traumatic brain injury. Materials and methods Patients with traumatic brain injury who underwent CP after DC in Zhongnan Hospital of Wuhan University from 1 January 2010 to 1 May 2017, and in Affiliated Hospital of Guizhou Medical University from 1 January 2015, to 1 May 2017, were retrospectively reviewed. According to the timing of CP, patients were divided into an 'early group' (3-6 months) and a 'late group' (6-12 months). The clinical characteristics of patients and postoperative complications occurred within 1-year follow-up were analysed. The neurological function was assessed with Barthel Index (BI). Results A total of 100 patients (58 cases in early group and 42 cases in late group) were included. The median interval between DC and CP was 135 days and 225 days in the early and late CP groups, respectively. The overall complication rate after CP was 16%, and no significant difference in complication rate was observed between the early and late CP groups (17.2% vs.14.3%, p = 0.69). The neurological function was improved in early CP group (pre-CP 85.77 +/- 11.61 vs. post-CP 95.34 +/- 9.02, p < 0.001, but not in late CP group (pre-CP 82.74 +/- 22.82 vs. post-CP 88.93 +/- 22.86, p = 0.22). In addition, a significantly higher proportion of patients in the early CP group showed neurological functional improvement in comparison with the late CP group (early vs. late: 74.1% vs. 57.1%, p = 0.04). Multivariate analysis further demonstrated that the timing of CP is an independent predictor for neurological outcomes (OR = 0.32, 95% CI 0.13-0.82, p = 0.02). Conclusion Early CP (3-6 months) following posttraumatic DC was associated with better neurological outcomes than late CP (>6 months).	[Zhao, Yu-Hang; Ma, Chao; Huang, Wen-Hong; Pan, Zhi-Yong; Li, Zhi-Qiang] Wuhan Univ, Zhongnan Hosp, Dept Neurosurg, Donghu Rd 169, Wuhan 430071, Peoples R China; [Gao, Hong] Guizhou Med Univ, Affiliated Hosp, Dept Neurosurg, Guiyang, Peoples R China; [Wang, Ze-Fen] Wuhan Univ, Dept Physiol, Sch Basic Med Sci, Wuhan, Peoples R China		Li, ZQ (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Neurosurg, Donghu Rd 169, Wuhan 430071, Peoples R China.	lizhiqiang@whu.edu.cn		Zhiqiang, LI/0000-0002-4148-780X	Hubei Province Health and Family Planning Scientific Research Project [WJ2017H0012]; Wuhan Science and Technology Bureau [2018060401011312]	This research was supported by grants from the Hubei Province Health and Family Planning Scientific Research Project [No. WJ2017H0012] and from the Wuhan Science and Technology Bureau [No. 2018060401011312].	Bender A, 2013, BRAIN INJURY, V27, P1073, DOI 10.3109/02699052.2013.794972; Bjornson A, 2019, ACTA NEUROCHIR, V161, P467, DOI 10.1007/s00701-019-03820-9; Borger V, 2016, WORLD NEUROSURG, V92, P83, DOI 10.1016/j.wneu.2016.04.113; Chaturvedi J, 2016, BRIT J NEUROSURG, V30, P264, DOI 10.3109/02688697.2015.1054356; Chibbaro S, 2013, REV NEUROL-FRANCE, V169, P240, DOI 10.1016/j.neurol.2012.06.016; Corallo F, 2017, INT J NEUROSCI, V127, P688, DOI 10.1080/00207454.2016.1235045; De Cola MC, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1106; Di Stefano C, 2016, BRAIN INJURY, V30, P164, DOI 10.3109/02699052.2015.1090013; Drozdowska BA, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00274; Feng JF, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-162; Feroze AH, 2015, J NEUROSURG, V123; Halani SH, 2017, NEUROSURGERY, V81, P204, DOI 10.1093/neuros/nyx054; Intercollegiate Stroke Working Party, 2012, INT STROK WORK PART; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Kuo JR, 2004, J CLIN NEUROSCI, V11, P486, DOI 10.1016/j.jocn.2003.06.005; Marinkovic I, 2009, NEUROSURGERY, V65, P780, DOI 10.1227/01.NEU.0000351775.30702.A9; Marion DW, 2006, NEUROSURGERY, V58, P655; Paredes I, 2015, NEUROCIRUGIA, V26, P115, DOI 10.1016/j.neucir.2014.10.001; Piedra Mark P, 2014, Surg Neurol Int, V5, P25, DOI 10.4103/2152-7806.127762; Piedra MP, 2013, J NEUROSURG, V118, P109, DOI 10.3171/2012.10.JNS121037; Powers WJ, 2018, STROKE, V2018, P49; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; Shahid AH, 2018, J NEUROSURG, V128, P229, DOI 10.3171/2016.10.JNS16678; Song J, 2014, ACTA NEUROCHIR, V156, P193, DOI 10.1007/s00701-013-1908-5; Walcott BP, 2013, J NEUROSURG, V118, P757, DOI 10.3171/2013.1.JNS121626; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Yoshida K, 1996, J NEUROL NEUROSUR PS, V61, P166, DOI 10.1136/jnnp.61.2.166; Zhang GL, 2010, CHIN J TRAUMATOL, V13, P259, DOI 10.3760/cma.j.issn.1008-1275.2010.05.001	28	1	1	4	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.												10.1080/02688697.2020.1853042		NOV 2020	4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	PD5BB	WOS:000597698700001	33252289				2022-02-06	
J	Bramblett, GT; Harris, JN; Scott, LL; Holt, AW				Bramblett, Gregory T.; Harris, Jason N.; Scott, Laura L.; Holt, Andrew W.			Traumatic Optic Nerve Injury Elevates Plasma Biomarkers of Traumatic Brain Injury in a Porcine Model	JOURNAL OF NEUROTRAUMA			English	Article						optic nerve; porcine model; traumatic optic neuropathy	FIBRILLARY ACIDIC PROTEIN; C-TERMINAL HYDROLASE-L1; AXONAL DEGENERATION; NEUROPATHY; MILD; SURVEILLANCE; REGENERATION; MODERATE; S100B	A diagnosis of traumatic brain injury (TBI) is typically based on patient medical history, a clinical examination, and imaging tests. Elevated plasma levels of glial fibrillary acidic protein (GFAP), ubiquitin c-terminal hydrolase L1 (UCH-L1), and neurofilament light chain (NFL) have been observed in numerous studies of TBI patients. It is reasonable to view traumatic optic neuropathy (TON) as a focal form of TBI. The purpose of this study was to assess if circulating GFAP, UCH-L1, and NFL are also elevated in a porcine model of TON. Serum levels of GFAP, UCH-L1, and NFL were measured immediately before optic nerve crush and 1 h post-injury in 10 Yucatan minipigs. Severity of optic nerve crush was confirmed by visual inspection of the optic nerve at time of injury, loss of visual function as measured by flash visual evoked potential (fVEP) at 7 and 14 days, and histological analysis of axonal transport of cholera toxin-beta (CT-beta) within the optic nerve. Post-crush concentrations of GFAP, UCH-L1, and NFL were all significantly elevated compared with pre-crush concentrations (p < 0.01, p = 0.01, and p < 0.01, respectively). The largest increase was observed for GFAP with the post-injury median concentration increasing nearly sevenfold. The use of these TBI biomarkers for diagnosing and managing TON may be helpful for non-ophthalmologists in particular in diagnosing this condition. In addition, the potential utility of these biomarkers for diagnosing other optic nerve and/or retinal pathologies should be evaluated.	[Bramblett, Gregory T.; Harris, Jason N.; Scott, Laura L.; Holt, Andrew W.] US Army, Inst Surg Res, 3698 Chambers Pass, Ft Sam Houston, TX 78234 USA		Harris, JN (corresponding author), US Army, Inst Surg Res, 3698 Chambers Pass, Ft Sam Houston, TX 78234 USA.	jason.n.harris.mil@mail.mil			United States Army Medical Research and Development Command (MRDC) Clinical and Rehabilitative Medicine Research Program [CRM 0007]	This research was funded by the United States Army Medical Research and Development Command (MRDC) Clinical and Rehabilitative Medicine Research Program (CRM 0007).	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; BRAMBLETT G, 2019, INVEST OPHTH VIS SCI, V60; Childs C, 2013, CLIN CHEM LAB MED, V51, pE195, DOI 10.1515/cclm-2013-0216; DeQuesada IM, 2014, SEMIN ROENTGENOL, V49, P64, DOI 10.1053/j.ro.2013.10.003; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dowling J.E., 1987, RETINA APPROACHABLE; Ford RL, 2012, J AAPOS, V16, P413, DOI 10.1016/j.jaapos.2012.04.009; Garman RH, 2011, TOXICOL PATHOL, V39, P22, DOI 10.1177/0192623310389621; Goldenberg-Cohen N, 2004, J AAPOS, V8, P20, DOI 10.1016/j.jaapos.2003.08.009; Harris J, 2017, CONSTANTINOPLE: CAPITAL OF BYZANTIUM, SECOND EDITION, P113; Holt D, 2018, INVEST OPHTH VIS SCI, V59; Hosseini HS, 2018, PROG BIOPHYS MOL BIO, V137, P25, DOI 10.1016/j.pbiomolbio.2018.01.004; Kanamori A, 2012, AM J PATHOL, V181, P62, DOI 10.1016/j.ajpath.2012.03.030; Kurimoto T, 2010, J NEUROSCI, V30, P15654, DOI 10.1523/JNEUROSCI.4340-10.2010; Lee Bruce, 2005, NeuroRx, V2, P372; Lee V, 2010, EYE, V24, P240, DOI 10.1038/eye.2009.79; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Levin LA, 1999, OPHTHALMOLOGY, V106, P1268, DOI 10.1016/S0161-6420(99)00707-1; Li YQ, 2017, P NATL ACAD SCI USA, V114, pE209, DOI 10.1073/pnas.1616811114; London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227; Ludwig P.E., 2019, STATPEARLS; Mann I, 1964, DEV HUMAN EYE; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Meier TB, 2017, J NEUROTRAUM, V34, P3134, DOI 10.1089/neu.2017.5046; Miller W, 2005, SYMMETRY INTEGR GEOM, V1, DOI 10.3842/SIGMA.2005.015; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Papa L, 2016, SPORTS MED ARTHROSC, V24, P108, DOI 10.1097/JSA.0000000000000117; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Rajiniganth MG, 2003, ARCH OTOLARYNGOL, V129, P1203, DOI 10.1001/archotol.129.11.1203; Raz N, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00068; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Saggu SK, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-97; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Steinsapir KD, 2011, AM J OPHTHALMOL, V151, P928, DOI 10.1016/j.ajo.2011.02.007; Trakhtenberg EF, 2018, EXP NEUROL, V300, P22, DOI 10.1016/j.expneurol.2017.10.025; TSO MOM, 1975, ARCH OPHTHALMOL-CHIC, V93, P815; Tuttle R, 1998, DEVELOPMENT, V125, P791; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033; Welch RD, 2017, J NEUROTRAUM, V34, P1957, DOI 10.1089/neu.2016.4772; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Wilkinson J.L., 2014, NEUROANATOMY MED STU	46	1	1	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2021	38	8					1000	1005		10.1089/neu.2020.7039		NOV 2020	6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RJ3OX	WOS:000592939900001	33096971	hybrid, Green Published			2022-02-06	
J	Novakovic-Agopian, T; Posecion, L; Kornblith, E; Abrams, G; McQuaid, JR; Neylan, TC; Burciaga, J; Joseph, J; Carlin, G; Groberio, J; Maruyama, B; Chen, AJW				Novakovic-Agopian, Tatjana; Posecion, Lainie; Kornblith, Erica; Abrams, Gary; McQuaid, John R.; Neylan, Thomas C.; Burciaga, Joaquin; Joseph, Jeremy; Carlin, Gerald; Groberio, Jessica; Maruyama, Brian; Chen, Anthony J. W.			Goal-Oriented Attention Self-Regulation Training Improves Executive Functioning in Veterans with Post-Traumatic Stress Disorder and Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognitive rehabilitation; post-traumatic stress disorder; traumatic brain injury; veterans	REHABILITATION; SATISFACTION; AFGHANISTAN; MANAGEMENT; CONFLICTS; BEHAVIOR; IRAQ; CARE; WAR	Difficulties in executive-control functions are common sequelae of both traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD). The goal of this study was to assess whether a cognitive rehabilitation training that was applied successfully in civilian and military TBI would be effective for military Veterans with comorbid PTSD and mild TBI (mTBI). In the previous study, Veterans with a history of mild to severe TBI improved significantly after goal-oriented attentional self-regulation (GOALS) training on measures of attention/executive function, functional task performance, and emotional regulation. The objective of this study was to assess effects of GOALS training in Veterans with comorbid PTSD and mTBI. Forty Veterans with a current PTSD diagnosis and history of mTBI (6+ months post) were randomized to either five weeks of GOALS or Brain-Health Education (BHE) training matched in time and intensity. Evaluator-blinded assessments at baseline and post-training included neuropsychological and complex functional task performance, and self-report measures of emotional functioning/regulation. After GOALS but not BHE training, participants significantly improved from baseline on primary outcome measures of: overall complex attention/executive function neuropsychological performance composite (F = 12.35, p = 0.001; Cohen d = 0.48), and overall mood disturbance -POMS emotional regulation self-report (F = 4.29, p = 0.05, Cohen d = 0.41). In addition, GOALS but not BHE participants indicated a significant decrease in PTSD symptoms (PCL-M Total Score) (F = 4.80, p = 0.05, Cohen d = 0.60), and demonstrated improvement on complex functional task performance-GPS Learning and Memory (F = 5.06, p = 0.05, Cohen d = 0.56]. Training in attentional self-regulation applied to participant-defined goals may improve cognitive functioning in Veterans with comorbid PTSD and mTBI. Improving cognitive control functioning may also improve functioning in other domains such as emotional regulation and functional performance, potentially making it particularly relevant for Veterans with a history of mTBI and comorbid psychiatric symptoms.	[Novakovic-Agopian, Tatjana; Posecion, Lainie; Kornblith, Erica; Abrams, Gary; McQuaid, John R.; Neylan, Thomas C.; Burciaga, Joaquin; Joseph, Jeremy; Carlin, Gerald; Groberio, Jessica; Maruyama, Brian] San Francisco VA Hlth Care Syst, 4150 Clement St 116c, San Francisco, CA 94121 USA; [Novakovic-Agopian, Tatjana; Kornblith, Erica; Abrams, Gary; McQuaid, John R.; Neylan, Thomas C.; Joseph, Jeremy; Chen, Anthony J. W.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Novakovic-Agopian, Tatjana; Chen, Anthony J. W.] VA Northern Calif Hlth Care Syst, Martinez, CA USA		Novakovic-Agopian, T (corresponding author), San Francisco VA Hlth Care Syst, 4150 Clement St 116c, San Francisco, CA 94121 USA.	Tatjana.Novakovic-Agopian@va.gov		KORNBLITH, ERICA/0000-0002-2802-7454	Department of Veterans Affairs Rehabilitation Research and Development Service Merit Review Award [VA 1IO1RX001111-01A1]	This material is based upon work supported by the Department of Veterans Affairs Rehabilitation Research and Development Service Merit Review Award to Novakovic-Agopian T.: VA 1IO1RX001111-01A1.	Adams SW, 2019, PSYCHOL TRAUMA-US, V11, P156, DOI 10.1037/tra0000404; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; Binder D., 2009, BRAIN HLTH ED WORKSH; Blake D, 2000, CLIN ADM PTSD SCALE; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bufkin JL, 2005, TRAUMA VIOLENCE ABUS, V6, P176, DOI 10.1177/1524838005275089; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cohen J., 1988, STAT POWER ANAL BEHA; Cornis-Pop M, 2012, J REHABIL RES DEV, V49, pXI, DOI 10.1682/JRRD.2012.03.0048; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Donovan J, 2014, CHIROPR MAN THER, V22, DOI 10.1186/s12998-014-0038-3; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Halligan P.W., 2005, EFFECTIVENESS REHABI; Heaton RK, 2004, COMPREHENSIVE NORMS; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; IBM Corp, 2016, IBM SPSS STAT WIND V; Jak AJ, 2019, J NEUROL NEUROSUR PS, V90, P333, DOI 10.1136/jnnp-2018-319315; Jurick SM, 2018, J HEAD TRAUMA REHAB, V33, pE41, DOI 10.1097/HTR.0000000000000313; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Loya F, 2017, REHABIL RES PRACT, V2017, DOI 10.1155/2017/8379347; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; MacEachron A., 2012, ADV SOC WORK, V13, P586, DOI 10.18060/2391; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Malec J., 2005, MAYO PORTLAND ADAPTA; McNair DM, 1992, MANUAL PROFILE MOOD; Miotto EC, 2009, NEUROPSYCHOL REHABIL, V19, P517, DOI 10.1080/09602010802332108; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Morris SB, 2008, ORGAN RES METHODS, V11, P364, DOI 10.1177/1094428106291059; National Center for Posttraumatic Stress Disorder, 2019, PTSD CHECKL DSM 5 PC; Novakovic-Agopian T., 2007, GOAL ORIENTED ATTENT; Novakovic-Agopian T., 2019, AM C REH MED C CHIC; Novakovic-Agopian T, 2018, J NEUROTRAUM, V35, P2784, DOI 10.1089/neu.2017.5529; Novakovic-Agopian T, 2019, BRAIN INJURY, V33, P1513, DOI 10.1080/02699052.2019.1645357; Novakovic-Agopian T, 2014, J HEAD TRAUMA REHAB, V29, P136, DOI 10.1097/HTR.0b013e3182691b15; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Reiber GE, 2010, J REHABIL RES DEV, V47, P275, DOI 10.1682/JRRD.2010.01.0009; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rutherford GW, 2009, J HEAD TRAUMA REHAB, V24, P421, DOI 10.1097/HTR.0b013e3181c13439; SAVITZ DA, 1995, AM J EPIDEMIOL, V142, P904, DOI 10.1093/oxfordjournals.aje.a117737; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Stuss DT, 1988, CLIN NEUROPSYCHOL, V2, P246, DOI [DOI 10.1080/13854048808520107, 10.1080/13854048808520107]; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tsao J.W., 2020, TRAUMATIC BRAIN INJU; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling J., 2007, RES QUART, VQuarterly, P1; Vasterling J., 2005, NEUROPSYCHOLOGY PTSD; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254; Weathers F.W., 1994, PTSD CHECKLIST MILIT; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	61	1	1	3	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2021	38	5					582	592		10.1089/neu.2019.6806		NOV 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	QP9GR	WOS:000592935000001	33019861				2022-02-06	
J	Koch, KM; Nencka, AS; Swearingen, B; Bauer, A; Meier, TB; McCrea, M				Koch, Kevin M.; Nencka, Andrew S.; Swearingen, Brad; Bauer, Anne; Meier, Timothy B.; McCrea, Michael			Acute Post-Concussive Assessments of Brain Tissue Magnetism Using Magnetic Resonance Imaging	JOURNAL OF NEUROTRAUMA			English	Article						MRI; quantitative susceptibility mapping; sports concussion; susceptibility weighted imaging; tissue magnetism; traumatic brain injury	DIFFUSION TENSOR; INJURY	Recent studies have demonstrated the promising capabilities of magnetic resonance imaging (MRI)-based quantitative susceptibility maps (QSM) in producing biomarkers of brain injury. The present study aims to further explore acute QSM changes in athletes after sports concussion and investigate prognostication capabilities of QSM-derived imaging metrics. The QSM were derived from neurological MRI data acquired on a cohort (n = 78) of concussed male American football athletes within 48 h of injury. The MRI-derived QSM values in subcortical gray and white matter compartments after concussion showed differences relative to a matched uninjured control group (white matter: z = 3.04, p = 0.002, subcortical gray matter: z = -2.07, p = 0.04). Subcortical gray matter QSM MRI measurements also correlated strongly with duration of symptoms (rho = -0.46, p = 0.002) within a subcohort of subjects who had symptom durations for at least one week (n = 39). The acute QSM MRI metrics showed promising prognostication capabilities, with subcortical gray matter compartment QSM values yielding a mean classification area under the curve performance of 0.78 when predicting symptoms of more than two weeks in duration. The results of the study reproduce previous acute post-concussion group QSM findings and provide promising initial prognostication capabilities of acute QSM measurements in a post-concussion setting.	[Koch, Kevin M.; Nencka, Andrew S.; Swearingen, Brad] Med Coll Wisconsin, Dept Radiol, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA; [Meier, Timothy B.; McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Bauer, Anne] New York Times Co, Data Sci Grp, New York, NY USA		Koch, KM (corresponding author), Med Coll Wisconsin, Dept Radiol, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.	kmkoch@mcw.edu	Koch, Kevin/AAD-6403-2021		Department of Defense Broad Agency Announcement for Extramural Medical Research [W81XWH-14-1-0561]; National Center for Advancing Translational Sciences, NIH [UL1TR001436]	Supported by the Department of Defense Broad Agency Announcement for Extramural Medical Research through award number W81XWH-14-1-0561.; The REDCap electronic database and the Adult Translational Research Unit used for this project were supported by the National Center for Advancing Translational Sciences, NIH, award number UL1TR001436.	Anderson C., 2016, P ISMRM, P1108; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bollmann S, 2019, NEUROIMAGE, V195, P373, DOI 10.1016/j.neuroimage.2019.03.060; Borg Jorgen, 2004, Journal of Rehabilitation Medicine Supplement, P76; Clarke LP, 2014, TRANSL ONCOL, V7, P1, DOI 10.1593/tlo.13832; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Faden AI, 2001, ARCH NEUROL-CHICAGO, V58, P1553, DOI 10.1001/archneur.58.10.1553; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Japkowicz N., 2002, Intelligent Data Analysis, V6, P429; JARQUE CM, 1987, INT STAT REV, V55, P163, DOI 10.2307/1403192; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Koch KM, 2018, AM J NEURORADIOL, V39, P1215, DOI 10.3174/ajnr.A5692; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Li W, 2014, HUM BRAIN MAPP, V35, P2698, DOI 10.1002/hbm.22360; Liu J., 2019, MRI TISSUE MAGNETISM; Liu J, 2012, NEUROIMAGE, V59, P2560, DOI 10.1016/j.neuroimage.2011.08.082; Liu W, 2016, RADIOLOGY, V278, P536, DOI 10.1148/radiol.2015150160; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mazziotta J, 2001, J AM MED INFORM ASSN, V8, P401, DOI 10.1136/jamia.2001.0080401; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mori S, 2005, MRI ATLAS HUMAN WHIT; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Reichenbach JR, 2015, CLIN NEURORADIOL, V25, P225, DOI 10.1007/s00062-015-0432-9; Schweser F, 2019, NEUROIMAGE, V200, P250, DOI 10.1016/j.neuroimage.2019.06.024; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sun HF, 2014, MAGN RESON MED, V71, P1151, DOI 10.1002/mrm.24765; TEASDALE G, 1974, LANCET, V2, P81; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wang Y, 2015, MAGN RESON MED, V73, P82, DOI 10.1002/mrm.25358; Xu B, 2017, CIKM'17: PROCEEDINGS OF THE 2017 ACM CONFERENCE ON INFORMATION AND KNOWLEDGE MANAGEMENT, P2395, DOI 10.1145/3132847.3133049; Yoon J, 2018, NEUROIMAGE, V179, P199, DOI 10.1016/j.neuroimage.2018.06.030	39	1	1	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2021	38	7					848	857		10.1089/neu.2020.7322		NOV 2020	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RI3KN	WOS:000592659900001	33066712				2022-02-06	
J	Rass, V; Huber, L; Ianosi, BA; Kofler, M; Lindner, A; Picetti, E; Ortolano, F; Beer, R; Rossi, S; Smielewski, P; Stocchetti, N; Helbok, R				Rass, Verena; Huber, Lukas; Ianosi, Bogdan-Andrei; Kofler, Mario; Lindner, Anna; Picetti, Edoardo; Ortolano, Fabrizio; Beer, Ronny; Rossi, Sandra; Smielewski, Peter; Stocchetti, Nino; Helbok, Raimund		CENTER-TBI HR ICU	The Effect of Temperature Increases on Brain Tissue Oxygen Tension in Patients with Traumatic Brain Injury: A Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury Substudy	THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT			English	Article						traumatic brain injury; temperature increases; brain tissue oxygen tension; critical care; CENTER-TBI	INTRACRANIAL-PRESSURE; BLOOD-FLOW; HYPERTHERMIA; CARE; HYPOTHERMIA; MANAGEMENT; METABOLISM; IMPACT	Fever may aggravate secondary brain injury after traumatic brain injury (TBI). The aim of this study was to identify episodes of temperature increases through visual plot analysis and algorithm supported detection, and to describe associated patterns of changes in on brain tissue oxygen tension (PbtO2). Data derive from the high-resolution cohort of the multicenter prospective Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) study. Temperature increases (>= 0.5 degrees C) were visually identified in 33 patients within the first 11 days of monitoring. Generalized estimating equations were used to detect significant changes of systemic and neuromonitoring parameters from baseline to the highest temperature. Patients were median 50 (interquartile range [IQR], 35-62) years old, and presented with a Glasgow Coma Scale (GCS) of 8 (IQR, 4-10). In 202 episodes of temperature increases, mean temperature rose by 1.0 degrees C +/- 0.5 degrees C within 4 hours. Overall, PbtO2 slightly increased (Delta PbtO2 = 0.9 +/- 6.1 mmHg, p = 0.022) during temperature increases. PbtO2 increased in 35% (p < 0.001), was stable in 49% (p = 0.852), and decreased in 16% (p < 0.001) of episodes. During episodes of temperature increases and simultaneous drops in PbtO2, cerebral perfusion pressure (CPP) decreased (Delta CPP -6.3 +/- 11.5 mmHg; p < 0.001). Brain tissue hypoxia (PbtO2 <20 mmHg) developed during 27/164 (17%) episodes of effervescences, in the remaining 38/202 episodes baseline PbtO2 was already <20 mmHg. Comparable results were found when using algorithm-supported detection of temperature increases. In conclusion, during effervescences, PbtO2 was mostly stable or slightly increased. A decrease of PbtO2 was observed in every sixth episode, where it was associated with a decrease in CPP. Our data highlight the need for special attention to CPP monitoring and maintenance during episodes of fever.	[Rass, Verena; Ianosi, Bogdan-Andrei; Kofler, Mario; Lindner, Anna; Beer, Ronny; Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Anichstr 35, A-6020 Innsbruck, Austria; [Huber, Lukas; Ianosi, Bogdan-Andrei] UMIT Univ Hlth Sci Med Informat & Technol, Inst Med Informat, Hall In Tirol, Austria; [Picetti, Edoardo; Rossi, Sandra] Parma Univ Hosp, Dept Anesthesia & Intens Care, Parma, Italy; [Ortolano, Fabrizio; Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Anesthesia & Crit Care, Neurosci Intens Care Unit, Milan, Italy; [Smielewski, Peter] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Div Neurosurg, Brain Phys Lab, Cambridge, England; [Stocchetti, Nino] Univ Milan, Dept Pathophysiol & Transplants, Milan, Italy		Helbok, R (corresponding author), Med Univ Innsbruck, Dept Neurol, Anichstr 35, A-6020 Innsbruck, Austria.	raimund.helbok@tirol-kliniken.at	Helbok, Raimund/AAA-8361-2021; Rass, Verena/AAR-1731-2021; Sahuquillo, Juan/B-3577-2008; Moller, Kirsten/A-4751-2009; Raj, Rahul/K-7693-2012	Sahuquillo, Juan/0000-0003-0713-5875; Radoi, Andreea/0000-0002-0677-3544; Moller, Kirsten/0000-0003-3058-1072; Raj, Rahul/0000-0003-4243-9591; Sakowitz, Oliver/0000-0003-3248-6335; Zeiler, Frederick/0000-0003-1737-0510; Rossi, Sandra/0000-0002-9963-8121; Rass, Verena/0000-0002-4241-5891; Kondziella, Daniel/0000-0001-5562-9808	European Union 7th Framework program (EC grant) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (United States); Integra LifeSciences Corporation (United States)	Data used in preparation of this article were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (United States), and from Integra LifeSciences Corporation (United States).	Abu-Arafeh A, 2018, CRIT CARE MED, V46, P223, DOI 10.1097/CCM.0000000000002832; Bain AR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00092; BUSIJA DW, 1988, AM J PHYSIOL, V255, pH343, DOI 10.1152/ajpheart.1988.255.2.H343; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Comtois D, 2019, SUMMARYTOOLS TOOLS Q; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Flynn LMC, 2015, THER HYPOTHERMIA TEM, V5, P143, DOI 10.1089/ther.2015.0002; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; HOLTZCLAW BJ, 1992, HEART LUNG, V21, P482; Ianosi B, 2020, THER HYPOTHERMIA TEM, V10, P27, DOI 10.1089/ther.2018.0046; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Mcilvoy Laura, 2004, J Neurosci Nurs, V36, P23; Myers RB, 2016, CRIT CARE MED, V44, P1754, DOI 10.1097/CCM.0000000000001838; Nyholm L, 2017, UPSALA J MED SCI, V122, P177, DOI 10.1080/03009734.2017.1319440; Picetti E, 2019, J NEUROSURG ANESTH, V31, P399, DOI 10.1097/ANA.0000000000000536; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; SIGGAARDANDERSEN O, 1984, CLIN CHEM, V30, P1646; Spiotta AM, 2008, NEUROSURGERY, V62, P864, DOI 10.1227/01.neu.0000316900.63124.ce; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Stocchetti N, 2005, J NEUROL NEUROSUR PS, V76, P1135, DOI 10.1136/jnnp.2004.041269; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Walter EJ, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1375-5; Wang H, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00307; Weng WJ, 2019, J NEUROTRAUM, V36, P1168, DOI 10.1089/neu.2018.5881; Zeileis A, 2005, J STAT SOFTW, V14; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4	31	1	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2153-7658	2153-7933		THER HYPOTHERMIA TEM	Ther. Hypothermia Temp. Manag.	JUN 1	2021	11	2					122	131		10.1089/ther.2020.0027		NOV 2020	10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SO3AG	WOS:000592661000001	33202157	Green Submitted			2022-02-06	
J	Kjeldgard, L; Stigson, H; Alexanderson, K; Friberg, E				Kjeldgard, Linnea; Stigson, Helena; Alexanderson, Kristina; Friberg, Emilie			Sequence analysis of sickness absence and disability pension in the year before and the three years following a bicycle crash; a nationwide longitudinal cohort study of 6353 injured individuals	BMC PUBLIC HEALTH			English	Article						Sick leave; Traffic injury; Sequence analysis; Longitudinal cohort; Bicycle crash; Disability pension; real-world data	RISK-FACTORS; BODY REGION; ALL-CAUSE; LEAVE; DIAGNOSIS; LIFE; CONSEQUENCES; TRAJECTORIES; POPULATION; MORTALITY	BackgroundBicyclists are the road user group with the highest number of severe injuries in the EU, yet little is known about sickness absence (SA) and disability pension (DP) following such injuries.AimsTo explore long-term patterns of SA and DP among injured bicyclists, and to identify characteristics associated with the specific patterns.MethodsA longitudinal register-based study was conducted, including all 6353 individuals aged 18-59years and living in Sweden in 2009, who in 2010 had incident in-patient or specialized out-patient healthcare after a bicycle crash. Information about sociodemographic factors, the injury, SA (SA spells >14days), and DP was obtained from nationwide registers. Weekly SA/DP states over 1 year before through 3 years after the crash date were used in sequence and cluster analyses. Multinomial logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) for factors associated with each identified sequence cluster.ResultsSeven clusters were identified: "No SA or DP" (58.2% of the cohort), "Low SA or DP" (7.4%), "Immediate SA" (20.3%), "Episodic SA" (5.9%), "Long-term SA" (1.7%), "Ongoing part-time DP" (1.7%), and "Ongoing full-time DP" (4.8%). Compared to the cluster "No SA or DP", all other clusters had higher ORs for women, and higher age. All clusters but "Low SA and DP" had higher ORs for inpatient healthcare. The cluster "Immediate SA" had a higher OR for: fractures (OR 4.3; CI 3.5-5.2), dislocation (2.8; 2.0-3.9), sprains and strains (2.0; 1.5-2.7), and internal injuries (3.0; 1.3-6.7) compared with external injuries. The cluster "Episodic SA" had higher ORs for: traumatic brain injury, not concussion (4.2; 1.1-16.1), spine and back (4.5; 2.2-9.5), torso (2.5; 1.4-4.3), upper extremities (2.9; 1.9-4.5), and lower extremities (3.5; 2.2-5.5) compared with injuries to the head, face, and neck (not traumatic brain injuries). The cluster "Long-term SA" had higher ORs for collisions with motor vehicles (1.9;1.1-3.2) and traumatic brain injury, not concussion (18.4;2.2-155.2).ConclusionSequence analysis enabled exploration of the large heterogeneity of SA and DP following a bicycle crash. More knowledge is needed on how to prevent bicycle crashes and especially those crashes/injuries leading to long-term consequences.	[Kjeldgard, Linnea; Stigson, Helena; Alexanderson, Kristina; Friberg, Emilie] Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, SE-17177 Stockholm, Sweden; [Stigson, Helena] Chalmers Univ Technol, Dept Appl Mech, Vehicle Safety Div, Gothenburg, Sweden; [Stigson, Helena] Folksam Insurance Grp, Folksam Res, Stockholm, Sweden		Kjeldgard, L (corresponding author), Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, SE-17177 Stockholm, Sweden.	linnea.kjeldgard@ki.se		Kjeldgard, Linnea/0000-0002-4575-7483; Friberg, Emilie/0000-0001-7874-4243	Skyltfonden at the Swedish Transport Administration; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Karolinska InstitutetKarolinska Institutet	This study was financially supported by Skyltfonden at the Swedish Transport Administration and the Swedish Research Council. The funding bodies had no influence over study design, analyses, interpretation of data, or the writing of the manuscript. Open Access funding provided by Karolinska Institutet.	Aisenbrey S, 2010, SOCIOL METHOD RES, V38, P420, DOI 10.1177/0049124109357532; Alexanderson K, 2004, SCAND J PUBLIC HEALT, V32, P12, DOI 10.1080/14034950410021808; Allebeck P, 2004, SCAND J PUBLIC HEALT, V32, P49, DOI 10.1080/14034950410021853; Allebeck P, 2004, SCAND J PUBLIC HEALT, V32, P36, DOI 10.1080/14034950410021835; Amoros E, 2006, ACCIDENT ANAL PREV, V38, P627, DOI 10.1016/j.aap.2005.11.006; [Anonymous], 2014, SAF CYCL COMM STRAT; [Anonymous], 1997, NOLLV TRAF SAMH; [Anonymous], 2019, TRAFF SAF BAS FACTS; [Anonymous], 2017, AN ROAD SAF TRENDS 2, V098; [Anonymous], 1997, VAG MOT TRAF SAMH; [Anonymous], 1997, 199798TU4 SWED PARL; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Berecki-Gisolf J, 2013, ACCIDENT ANAL PREV, V51, P129, DOI 10.1016/j.aap.2012.11.010; BJORNSTIG U, 1984, ACTA CHIR SCAND, V150, P353; de Hartog JJ, 2011, CIENC SAUDE COLETIVA, V16, P4731, DOI 10.1590/S1413-81232011001300022; Elrud R, 2017, IRCOBI C P, P79; Elrud R, 2019, ACCIDENT ANAL PREV, V127, P35, DOI 10.1016/j.aap.2019.02.019; Gabadinho A, 2011, J STAT SOFTW, V40, P1; HANSSON PG, 1976, SCAND J SOC MED, V4, P103; Hensing G, 1998, SCAND J SOC MED, V26, P133, DOI 10.1177/14034948980260020201; Hensing G, 2004, SCAND J PUBLIC HEALT, V32, P44, DOI 10.1080/14034950410021844; Holm AL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001135; Jansson C, 2012, PAIN, V153, P998, DOI 10.1016/j.pain.2012.01.028; Karlsson NE, 2008, EUR J PUBLIC HEALTH, V18, P224, DOI 10.1093/eurpub/ckm128; Kjeldgard L, 2010, SJUKFRANVARO BLAND K; Kjeldgard L, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7284-1; Kvillemo P, 2017, J CLIN ONCOL, V35, P2044, DOI 10.1200/JCO.2015.66.0613; Laaksonen M, 2013, J OCCUP ENVIRON MED, V55, P99, DOI 10.1097/JOM.0b013e318270d724; Lindholdt L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015661; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Madsen AA, 2020, SCAND J PUBLIC HEALT, V48, P134, DOI 10.1177/1403494818821003; MARMOT M, 1995, J EPIDEMIOL COMMUN H, V49, P124, DOI 10.1136/jech.49.2.124; McLeod CB, 2018, SCAND J WORK ENV HEA, V44, P147, DOI 10.5271/sjweh.3701; Mittendorfer-Rutz E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099869; Nilsson P, 2017, ACCIDENT ANAL PREV, V100, P30, DOI 10.1016/j.aap.2016.12.020; Ohlin M, 2018, J TRANSP HEALTH, V9, P275, DOI 10.1016/j.jth.2018.01.011; OLKKONEN S, 1993, SCAND J SOC MED, V21, P98, DOI 10.1177/140349489302100207; ONU, 2015, TRANSF OUR WORLD 203; Riksforsakringsverket, 1988, FORS ALLM FORS; Rissanen R, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031132; Rizzi M, 2013, IRCOBI C 2013 GOTH S; Roelen CAM, 2011, OCCUP MED-OXFORD, V61, P96, DOI 10.1093/occmed/kqq181; Sabbath EL, 2015, AM J PUBLIC HEALTH, V105, pE96, DOI 10.2105/AJPH.2014.302471; Social insurance in figures 2016, 2016, SOC INS FIG 2016; Studer M, 2016, J R STAT SOC A STAT, V179, P481, DOI 10.1111/rssa.12125; Wang M, 2014, OCCUP ENVIRON MED, V71, P12, DOI 10.1136/oemed-2013-101462; World Health Organization, 1993, INT STAT CLASS DIS R; Zetterstrom K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115540	49	1	1	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2458		BMC PUBLIC HEALTH	BMC Public Health	NOV 16	2020	20	1							1710	10.1186/s12889-020-09788-x			16	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	OZ5UL	WOS:000594990500004	33198682	gold, Green Published			2022-02-06	
J	Negi, T; Arunachalam, K				Negi, Tripti; Arunachalam, Kusum			Study on prevalence of ixodid tick infestation on bovines of Dehradun district, Uttarakhand	BIOLOGICAL RHYTHM RESEARCH			English	Article						Ticks prevalence; bovines; infestation	CATTLE; ECTOPARASITES	Reviewing the economic concussion of various tick species on livestock, the present study cum survey was undertaken to understand the epidemiological characteristics of ticks infesting bovines (cattle and buffaloes). The survey was conducted at various locations of Dehradun region of Uttarakhand state in India. A total of 490 bovines were examined on a random basis between the month of July 2017 and June 2018. Overall tick infestation rate was found to be 66.32%. The month of September showed the highest prevalence (52.32%), while the lowest rate was reported in January (39.73%). Similarly, the season-wise prevalence was recorded highest in rainy season (61.29%), followed by summer (51.62%) and lowest in winter (41.09%). Age-wise tick infestations were observed highest in Group I animals of less than 1 year age (60%), followed by Group II animals aged between 1 and 3 years (47.5%), and lowest in Group III animals of age greater than 3 years (32.25%). Sex wise, the females had higher infestation rate than the males (66.67% and 45.2%, respectively).	[Negi, Tripti; Arunachalam, Kusum] Doon Univ, Sch Environm & Nat Resources, Dehra Dun, Uttarakhand, India		Negi, T (corresponding author), Doon Univ, Sch Environm & Nat Resources, Dehra Dun, Uttarakhand, India.	triptinegi.doon@gmail.com		Arunachalam, Kusum/0000-0001-6590-4113; Negi, Tripti/0000-0003-1559-2347	Council of Scientific and Industrial Research (CSIR)Council of Scientific & Industrial Research (CSIR) - India [09/947(0800)/2016 EMR-I]	The study was financially supported by the Council of Scientific and Industrial Research (CSIR) in the form of a Research Associateship to Tripti Negi (File No.: 09/947(0800)/2016 EMR-I).	Atif F. A., 2012, Pakistan Journal of Science, V64, P49; Bianchin I, 2007, TROP ANIM HEALTH PRO, V39, P287, DOI 10.1007/s11250-007-9017-1; Bilkis GD, 2007, PROGR AGR, V22, P65; Chhillar Shivani, 2014, Journal of Entomology and Zoology Studies, V2, P99; Colebrook E, 2004, VET PARASITOL, V120, P251, DOI 10.1016/j.vetpar.2004.01.012; Das S. S., 1994, Journal of Parasitology and Applied Animal Biology, V3, P71; Delinger D, 1985, COMPREHENSIVE INSECT, V8, P335; Gray J. S., 1991, Review of Medical and Veterinary Entomology, V79, P323; Kabir MHB, 2011, AFR J MICROBIOL RES, V5, P346; Kaur D, 2015, IOSR J PHARM BIOL SC, V10, P1; Khajuria Varun, 2015, J Parasit Dis, V39, P418, DOI 10.1007/s12639-013-0354-x; Khan M. H., 1994, Journal of Veterinary Parasitology, V8, P21; Lahkar B. C., 1994, Journal of the Assam Veterinary Council, V4, P46; Latha BR, 2004, TROP ANIM HEALTH PRO, V36, P123, DOI 10.1023/B:TROP.0000012108.42526.11; Lloyd M., 1983, J VET RES, V6, P64; Mamun MAA, 2010, J BANGLADESH AGR, V8, P61; Manan A., 2007, J AGRI BIOL SCI, V2, P21; Minjauw B., 2003, RES REPORT; MISRA SC, 1984, CHEIRON, V13, P5; Patel Geeta, 2013, Journal of Parasitic Diseases, V37, P173, DOI 10.1007/s12639-012-0154-8; Pawlos Wasihun, 2013, Journal of Veterinary Medicine and Animal Health, V5, P73; Poonam Singh, 2017, Asian Journal of Animal Science, V12, P38, DOI 10.15740/has/tajas/12.1/38-42; Rony S. A., 2010, Bangladesh Journal of Veterinary Medicine, V8, P27; Sajid MS, 2009, PREV VET MED, V92, P386, DOI 10.1016/j.prevetmed.2009.09.001; Singh N, 2012, THESIS; Singh NK, 2013, ASIAN PAC J TROP MED, V6, P947, DOI 10.1016/S1995-7645(13)60169-8; Solis SS, 1991, P 2 INT SEM AN PAR T, P19; Stuti Vatsya, 2007, Journal of Veterinary Parasitology, V21, P125; SUTHERST RW, 1983, AUST J AGR RES, V34, P329, DOI 10.1071/AR9830329; Vatsya S, 2008, INDIAN J ANIM SCI, V78, P40	30	1	2	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0929-1016	1744-4179		BIOL RHYTHM RES	Biol. Rhythm Res.	NOV 16	2020	51	8					1288	1297		10.1080/09291016.2019.1571708			10	Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Physiology	OO6OM	WOS:000587496800010					2022-02-06	
J	Shi, QX; Chen, B; Nie, C; Zhao, ZP; Zhang, JH; Si, SY; Cui, SJ; Gu, JW				Shi, Quan-xing; Chen, Bing; Nie, Chuang; Zhao, Zhi-ping; Zhang, Jun-hai; Si, Shao-yan; Cui, Shao-jie; Gu, Jian-wen			Improvement in cognitive dysfunction following blast induced traumatic brain injury by thymosin alpha 1 in rats: Involvement of inhibition of tau phosphorylation at the Thr205 epitope	BRAIN RESEARCH			English	Article						Traumatic brain injury; Blast; Thymosin alpha 1; Tau; Rat	THYMECTOMY-INDUCED DETERIORATION; MODEL; EXPOSURE; MOUSE; EXPRESSION; CHEMISTRY; DEFICITS; THERAPY; BIOLOGY; TH1	Cognitive impairment is a significant sequela of traumatic brain injury (TBI) especially blast induced traumatic brain injury (bTBI), which is characterized by rapid impairments of learning and memory ability. Although several neuro-protective agents have been postulated as promising drugs for bTBI in animal studies, very few ideal therapeutic options exist to improve cognitive impairment following bTBI. Thymosin alpha 1(T alpha 1), a 28-amino-acid protein that possesses immunomodulatory functions, has exhibited beneficial effects in the treatment of infectious diseases, im-munodeficiency diseases and cancers. However, it remains unclear whether T alpha 1 has a therapeutic role in bTBI. Thus, we hypothesized that T alpha 1 administration could reverse the outcomes of bTBI. The blast induced TBI (bTBI) rat model was established with the compressed gas driven blast injury model system. A consecutive T alpha 1 therapy (in 1 ml saline, twice a day) at a dose of 200 mu g/kg or normal saline (NS) (1 ml, twice a day) for 3 days or 2 weeks was performed. Utilizing our newly designed bTBI model, we investigated the beneficial effects of T alpha 1 therapy on rats exposed to bTBI including: cognitive functions, general histology, regulatory T (Treg) cells, edema, inflammation reactions and the expression and phosphorylation level of tau via Morris Water Maze test (MWM test), HE staining, flow cytometry, brain water content (BWC) calculation, IL-6 assay and Western blotting, respectively. T alpha 1 treatment seemed to reduce the 24 -hour mortality, albeit with no statistical significance. Moreover, T alpha 1 treatment markedly improved cognitive dys-function by decreasing the escape latency in the acquisition phase, and increasing the crossing numbers in the probe phase of MWM test. More interestingly, T alpha 1 significantly inhibited tau phosphorylation at the Thr205 epitope, but not at the Ser404 and Ser262 epitopes. T alpha 1 increased the percentage of Treg cells and inhibited plasma IL-6 production on 3d post bTBI. Moreover, T alpha 1 suppressed brain edema as demonstrated by decrease of BWC. However, there was a lack of obvious change in histopathology in the brain upon T alpha 1 treatment. This is the first study showing that T alpha 1 improves neurological deficits after bTBI in rats, which is potentially related to the inhibition of tau phosphorylation at the Thr205 epitope, increased Treg cells and decreased inflammatory reactions and brain edema.	[Shi, Quan-xing] Third Mil Med Univ, Dept Grad Sch, Army Mil Med Univ, Chongqing, Peoples R China; [Chen, Bing] Univ Chinese Acad Sci, Savaid Med Coll, Beijing 100101, Peoples R China; [Shi, Quan-xing; Nie, Chuang] 306th Hosp, Dept Ophthalmol, Beijing 100101, Peoples R China; [Zhao, Zhi-ping] Beihang Univ, Sch Biol Sci & Med Engn, Beijing 100101, Peoples R China; [Zhang, Jun-hai; Cui, Shao-jie; Gu, Jian-wen] 306th Hosp, Dept Neurosurg, Beijing 100101, Peoples R China; [Si, Shao-yan] 306th Hosp, Dept Pathol & Expt Med, Beijing 100101, Peoples R China		Gu, JW (corresponding author), 306th Hosp, 9 North Anxiang Rd, Beijing 100101, Peoples R China.	gujianwen196606@163.com			Logistics Research Projects of the Chinese People's Liberation Army [BWS16J035, BWS12J019]; Research Project of the 306th Hospital of PLA in 2019 [19ZX26]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31770386]	We thank Dr. Ning Jiang and Prof. Li-na Qu for their technical support on Morris water maze experiment. We thank Ying-ying Wu and Ran Duan for their technical support on flow cytometry. The study was supported by the Logistics Research Projects of the Chinese People's Liberation Army (BWS16J035, BWS12J019), the Research Project of the 306th Hospital of PLA in 2019 (19ZX26) and the National Natural Science Foundation of China (31770386).	Ademoglu E, 1998, ANN NUTR METAB, V42, P283, DOI 10.1159/000012745; Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; Camerini R, 2015, EXPERT OPIN BIOL TH, V15, pS117, DOI 10.1517/14712598.2015.1033393; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chakraborty S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0625-x; Despres C, 2017, P NATL ACAD SCI USA, V114, P9080, DOI 10.1073/pnas.1708448114; Effgen GB, 2016, J NEUROTRAUM, V33, P1901, DOI 10.1089/neu.2015.4327; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gokkusu C, 1996, LIFE SCI, V59, P1059, DOI 10.1016/0024-3205(96)00421-3; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hernandez A, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0408-1; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Li CC, 2015, INT J INFECT DIS, V33, P90, DOI 10.1016/j.ijid.2014.12.032; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; LOW TLK, 1979, J BIOL CHEM, V254, P987; LOW TLK, 1979, J BIOL CHEM, V254, P981; Lunin SM, 2010, EXPERT OPIN THER TAR, V14, P775, DOI 10.1517/14728222.2010.499127; Malinda KM, 1998, J IMMUNOL, V160, P1001; Ning YL, 2013, J CEREBR BLOOD F MET, V33, P1789, DOI 10.1038/jcbfm.2013.127; Nishiyama N, 2001, CELL MOL BIOL, V47, P161; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Panigrahi B, 2018, PROC IEEE MICR ELECT, P10, DOI 10.1109/MEMSYS.2018.8346468; Qiu LX, 2009, INT J MOL MED, V23, P597, DOI 10.3892/ijmm_00000169; Rachmany L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03792-9; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; Romani L, 2007, ANN NY ACAD SCI, V1112, P326, DOI 10.1196/annals.1415.002; Romani L, 2017, NAT MED, V23, P590, DOI 10.1038/nm.4305; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Shi QX, 2013, AM J THER, V20, P493, DOI 10.1097/MJT.0b013e3182456676; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; Tweedie D, 2016, ALZHEIMERS DEMENT, V12, P34, DOI 10.1016/j.jalz.2015.07.489; Wang G, 2017, NEUROSCI BULL, V33, P675, DOI 10.1007/s12264-017-0162-x; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Xiong XY, 2016, CIRCULATION, V134, P1025, DOI 10.1161/CIRCULATIONAHA.116.021881; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2012, ANN NY ACAD SCI, V1270, P51, DOI 10.1111/j.1749-6632.2012.06683.x; Xiong Y, 2012, J NEUROSURG, V116, P1081, DOI 10.3171/2012.1.JNS111729; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Yang S, 2003, NEUROSCI LETT, V350, P81, DOI 10.1016/S0304-3940(03)00862-0; Yang X, 2012, BRAZ J MED BIOL RES, V45, P25, DOI [10.1590/S0100-879X2011007500159, 10.1590/S0100-879X2012000100005]; Zhang YL, 2017, J NEUROSURG, V126, P782, DOI 10.3171/2016.3.JNS152699; ZHANG YX, 1994, BRAIN RES, V658, P127, DOI 10.1016/S0006-8993(09)90018-X; Zhao ZA, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.98; Zhou Y, 2018, CHINESE MED J-PEKING, V131, P2447, DOI 10.4103/0366-6999.243558	57	1	1	6	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 15	2020	1747								147038	10.1016/j.brainres.2020.147038			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NP5VP	WOS:000570244100004	32738231				2022-02-06	
J	Tsuda, S; Golam, M; Hou, JM; Nelson, R; Bernavil, P; Richardson, K; Wang, KKW; Thompson, F; Bose, P				Tsuda, Shigeharu; Golam, Mustafa; Hou, Jiamei; Nelson, Rachel; Bernavil, Phillip; Richardson, Kenneth; Wang, Kevin K. W.; Thompson, Floyd; Bose, Prodip			Altered monoaminergic levels, spasticity, and balance disability following repetitive blast-induced traumatic brain injury in rats	BRAIN RESEARCH			English	Article						Monoamine; Spasticity; Balance; Traumatic brain injury	5-HT1A RECEPTOR AGONIST; CORTICOTROPIN-RELEASING-FACTOR; INTRATHECAL BACLOFEN INFUSION; MIDTHORACIC SPINAL-CORD; DEPENDENT ANKLE TORQUE; MOTOR CORTEX; HINDLIMB MOTONEURONS; SEROTONERGIC NEURONS; VESTIBULAR NUCLEUS; FUSIMOTOR ACTIVITY	Spasticity and balance disability are major complications following traumatic brain injury (TBI). Although monoaminergic inputs provide critical adaptive neuromodulations to the motor system, data are not available regarding the levels of monoamines in the brain regions related to motor functions following repetitive blast TBI (bTBI). The objective of this study was to determine if mild, repetitive bTBI results in spasticity/balance deficits and if these are correlated with altered levels of norepinephrine, dopamine, and serotonin in the brain regions related to the motor system. Repetitive bTBI was induced by a blast overpressure wave in male rats on days 1, 4, and 7. Following bTBI, physiological/behavioral tests were conducted and tissues in the central motor system (i.e., motor cortex, locus coeruleus, vestibular nuclei, and lumbar spinal cord) were collected for electrochemical detection of norepinephrine, dopamine, and serotonin by high-performance liquid chromatography. The results showed that norepinephrine was significantly increased in the locus coeruleus and decreased in the vestibular nuclei, while dopamine was significantly decreased in the vestibular nuclei. On the other hand, serotonin was significantly increased in the motor cortex and the lumbar spinal cord. Because these monoamines play important roles in regulating the excitability of neurons, these results suggest that mild, repetitive bTBI-induced dysregulation of monoaminergic inputs in the central motor system could contribute to spasticity and balance disability. This is the first study to report altered levels of multiple monoamines in the central motor system following acute mild, repetitive bTBI.	[Tsuda, Shigeharu; Golam, Mustafa; Hou, Jiamei; Nelson, Rachel; Bernavil, Phillip; Richardson, Kenneth; Thompson, Floyd; Bose, Prodip] North Florida South Georgia Vet Hlth Syst, Brain Rehabil Res Ctr, Malcom Randall VA Med Ctr, 1601 SW Archer Rd, Gainesville, FL 32608 USA; [Tsuda, Shigeharu; Hou, Jiamei; Bose, Prodip] Univ Florida, Coll Med, Dept Anesthesiol, 1600 SW Archer Rd M509, Gainesville, FL 32610 USA; [Golam, Mustafa; Thompson, Floyd] Univ Florida, Dept Physiol Sci, 1333 Ctr Dr, Gainesville, FL 32603 USA; [Wang, Kevin K. W.] Univ Florida, Dept Emergency Med, 1329 SW 16th St,Suite 5270, Gainesville, FL 32610 USA; [Thompson, Floyd] Univ Florida, Dept Neurosci, 1149 Newell Dr, Gainesville, FL 32610 USA; [Bose, Prodip] Univ Florida, Dept Neurol, 1149 Newell Dr, Gainesville, FL 32611 USA		Bose, P (corresponding author), North Florida South Georgia Vet Hlth Syst, Brain Rehabil Res Ctr, Malcom Randall VA Med Ctr, 1601 SW Archer Rd, Gainesville, FL 32608 USA.	pkbose@ufl.edu		Bose, Prodip/0000-0002-1378-3644; Tsuda, Shigeharu/0000-0002-2937-5936; Wang, Kevin/0000-0002-9343-6473	United States Department of Veterans Affairs Rehabilitation Research and Development Service [1I01RX003123-01A1, 1I01RX00100501A2]; NIH Translational Outcomes Project in Neurotrauma (TOP-NT)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UG3/UH3, 1 UG3 NS106938-01]	This study was supported by the United States Department of Veterans Affairs Rehabilitation Research and Development Service [Merit Review Award nos. 1I01RX003123-01A1 and 1I01RX00100501A2]. This work was also partly supported by NIH Translational Outcomes Project in Neurotrauma (TOP-NT) (UG3/UH3) [grant #1 UG3 NS106938-01]. We thank graphic artist, Emma Nicole Raymaker for her drawings of the brain, spinal cord, and muscle tissues, as well as Corey Astrom, ELS, for her editorial expertise.	AHLMAN H, 1971, BRAIN RES, V27, P393, DOI 10.1016/0006-8993(71)90269-1; ANDREWS C, 1973, J NEUROL SCI, V18, P217, DOI 10.1016/0022-510X(73)90008-7; ASANUMA H, 1972, BRAIN RES, V40, P3, DOI 10.1016/0006-8993(72)90098-4; Awenowicz PW, 2002, J NEUROPHYSIOL, V88, P3439, DOI 10.1152/jn.00078.2002; Barresi M, 2014, NEUROSCIENCE, V265, P172, DOI 10.1016/j.neuroscience.2014.01.054; Barresi M, 2009, NEUROSCI LETT, V464, P173, DOI 10.1016/j.neulet.2009.08.035; Bennett DJ, 1996, J PHYSIOL-LONDON, V496, P837, DOI 10.1113/jphysiol.1996.sp021731; Bennett DJ, 1996, J PHYSIOL-LONDON, V495, P835, DOI 10.1113/jphysiol.1996.sp021636; Bennett DJ, 1998, J NEUROPHYSIOL, V80, P2023, DOI 10.1152/jn.1998.80.4.2023; Bennett DJ, 1998, J NEUROPHYSIOL, V80, P2038, DOI 10.1152/jn.1998.80.4.2038; Borrini L, 2014, ARCH PHYS MED REHAB, V95, P1032, DOI 10.1016/j.apmr.2013.12.019; Bos R, 2013, P NATL ACAD SCI USA, V110, P348, DOI 10.1073/pnas.1213680110; Bose P, 2002, J NEUROTRAUM, V19, P1231, DOI 10.1089/08977150260338029; Bose P., 2001, SOC NEUROSCIENCE, V771.3; Bose P, 2013, J NEUROTRAUM, V30, P1177, DOI 10.1089/neu.2012.2740; Bose PK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00258; BOTTE MJ, 1988, CLIN ORTHOP RELAT R, P7; Brown AR, 2014, J NEUROSCI, V34, P13574, DOI 10.1523/JNEUROSCI.2500-14.2014; Busto R, 1997, J NEUROTRAUM, V14, P35, DOI 10.1089/neu.1997.14.35; Calabro RS, 2014, J SEX MED, V11, P1807, DOI 10.1111/jsm.12569; Cardoso A.L., 2014, BMJ CASE REP, V2014; Celada P, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00025; Chen YH, 2015, CELL TRANSPLANT, V24, P2113, DOI 10.3727/096368914X683584; Chiasson R., 1980, LAB ANATOMY WHITE RA; Corneil BD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00489; D'Amico JM, 2013, J NEUROPHYSIOL, V109, P1485, DOI 10.1152/jn.00822.2012; Dentel C, 2013, BRAIN, V136, P483, DOI 10.1093/brain/aws274; Di Mauro M, 2008, NEUROSCIENCE, V153, P1320, DOI 10.1016/j.neuroscience.2008.02.014; Ebbesen CL, 2018, J NEUROSCI, V38, P9402, DOI 10.1523/JNEUROSCI.1671-18.2018; Ebbesen CL, 2017, NAT REV NEUROSCI, V18, P694, DOI 10.1038/nrn.2017.119; Ellaway PH, 2015, J ANAT, V227, P157, DOI 10.1111/joa.12299; ELLAWAY PH, 1975, J PHYSL, V249, pP5; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Francois B, 2001, J TRAUMA, V50, P158, DOI 10.1097/00005373-200101000-00035; Garcia-Ramirez DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089999; Gracies JM, 2015, LANCET NEUROL, V14, P992, DOI 10.1016/S1474-4422(15)00216-1; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Heckman CJ, 2005, MUSCLE NERVE, V31, P135, DOI 10.1002/mus.20261; Herbin M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155058; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hornung JP, 2003, J CHEM NEUROANAT, V26, P331, DOI 10.1016/j.jchemneu.2003.10.002; Hosp JA, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00145; Hosp JA, 2011, J NEUROSCI, V31, P2481, DOI 10.1523/JNEUROSCI.5411-10.2011; Hou JM, 2014, J NEUROTRAUM, V31, P1088, DOI 10.1089/neu.2013.3096; Jang SH, 2004, YONSEI MED J, V45, P743, DOI 10.3349/ymj.2004.45.4.743; Jankowska E, 1998, J PHYSIOL-LONDON, V512, P521, DOI 10.1111/j.1469-7793.1998.521be.x; Jeong HJ, 2001, NEUROPHARMACOLOGY, V41, P175, DOI 10.1016/S0028-3908(01)00062-4; Kawa L, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00479; Kawa L, 2015, J NEUROTRAUM, V32, P1190, DOI 10.1089/neu.2014.3669; Kline AE, 2004, J NEUROTRAUM, V21, P175, DOI 10.1089/089771504322778631; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Lehmann O, 2000, EUR J NEUROSCI, V12, P67, DOI 10.1046/j.1460-9568.2000.00881.x; LICATA F, 1993, NEUROSCIENCE, V53, P149, DOI 10.1016/0306-4522(93)90293-O; LIPOSITS Z, 1986, HISTOCHEMISTRY, V84, P201, DOI 10.1007/BF00495783; Liu M, 2017, J NEUROTRAUM, V34, P414, DOI 10.1089/neu.2015.4361; Llado-Pelfort L, 2010, BRIT J PHARMACOL, V160, P1929, DOI 10.1111/j.1476-5381.2010.00738.x; Lorentzen J, 2012, DISABIL REHABIL, V34, P1978, DOI 10.3109/09638288.2012.665132; Lucetti C, 2007, MOVEMENT DISORD, V22, P2170, DOI 10.1002/mds.21576; Mas M.F., 2018, PM R; McCall AA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00112; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; MENDELL LM, 1984, PHYSIOL REV, V64, P260, DOI 10.1152/physrev.1984.64.1.260; Miller DM, 2014, CLIN NEUROPHYSIOL, V125, P2070, DOI 10.1016/j.clinph.2014.01.035; Mizoguchi K, 2003, PHARMACOL BIOCHEM BE, V75, P419, DOI 10.1016/S0091-3057(03)00131-X; Mizoguchi K, 2002, PHARMACOL BIOCHEM BE, V72, P723, DOI 10.1016/S0091-3057(02)00747-5; Mizoguchi K, 2002, PHARMACOL BIOCHEM BE, V71, P79, DOI 10.1016/S0091-3057(01)00636-0; Monaco CM, 2014, J NEUROTRAUM, V31, P1934, DOI 10.1089/neu.2014.3541; Motta F, 2014, J NEUROSURG-PEDIATR, V13, P301, DOI 10.3171/2013.11.PEDS13253; Mustafa G, 2016, NEUROPHARMACOLOGY, V107, P27, DOI 10.1016/j.neuropharm.2016.03.016; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1861, DOI 10.1016/j.apmr.2013.05.027; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Niogi S, 2010, FRONT NEUROANAT, V4, DOI [10.3389/neuro.05.002.2010, 10.3389/fneur.2010.00149]; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; Ordia JI, 2002, NEUROMODULATION, V5, P103, DOI 10.1046/j.1525-1403.2002.02015.x; Pasquina P, 2014, SEMIN NEUROL, V34, P572, DOI 10.1055/s-0034-1396010; Paxinos G, 2009, RAT BRAIN STEREOTAXI; Peng SY, 2016, J NEUROSCI RES, V94, P736, DOI 10.1002/jnr.23745; Perez-Arredondo A, 2016, CLIN NEUROPHARMACOL, V39, P311, DOI 10.1097/WNF.0000000000000179; Perrier JF, 2013, CURR PHARM DESIGN, V19, P4371, DOI 10.2174/13816128113199990341; Phelps TI, 2017, NEUROREHAB NEURAL RE, V31, P25, DOI 10.1177/1545968316650281; PLOTSKY PM, 1989, ENDOCR REV, V10, P437, DOI 10.1210/edrv-10-4-437; Podda MV, 2001, NEUROSCI LETT, V298, P91, DOI 10.1016/S0304-3940(00)01750-X; Potter-Nerger M, 2012, MOVEMENT DISORD, V27, P1268, DOI 10.1002/mds.25061; POMPEIANO O, 1991, ARCH ITAL BIOL, V129, P21; POMPEIANO O, 1991, PROG BRAIN RES, V88, P435; Puig MV, 2010, J NEUROSCI, V30, P2211, DOI 10.1523/JNEUROSCI.3335-09.2010; Reinhoud NJ, 2013, ACS CHEM NEUROSCI, V4, P888, DOI 10.1021/cn400044s; Ricciardi L, 2018, J NEUROL SCI, V390, P84, DOI 10.1016/j.jns.2018.04.016; Rifici C, 1994, Funct Neurol, V9, P29; Russell AL, 2018, NEUROSCIENCE, V392, P1, DOI 10.1016/j.neuroscience.2018.09.014; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Schiemann J, 2015, CELL REP, V11, P1319, DOI 10.1016/j.celrep.2015.04.042; Schindler AG, 2017, NEUROBIOL DIS, V106, P23, DOI 10.1016/j.nbd.2017.06.004; Schmit BD, 2001, ANN BIOMED ENG, V29, P330, DOI 10.1114/1.1359496; Schuerger RJ, 1999, BRAIN RES REV, V30, P189, DOI 10.1016/S0165-0173(99)00015-6; SCHUERGER RJ, 1993, EXP BRAIN RES, V92, P351; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Taira T, 2013, NEUROMODULATION, V16, P266, DOI 10.1111/ner.12010; Tanaka YH, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00012; Thompson FJ, 1998, J NEUROTRAUM, V15, P495, DOI 10.1089/neu.1998.15.495; THOMPSON FJ, 1992, J NEUROPHYSIOL, V68, P1473, DOI 10.1152/jn.1992.68.5.1473; Thompson FJ, 1996, NEUROREPORT, V7, P2273; Thompson FJ, 2001, J CHILD NEUROL, V16, P2, DOI 10.1177/088307380101600102; Thompson FJ, 2001, J NEUROTRAUM, V18, P931, DOI 10.1089/089771501750451848; THOMPSON FJ, 1975, BRAIN RES, V97, P33, DOI 10.1016/0006-8993(75)90912-9; THOMPSON FJ, 1993, ADV NEUROL, V59, P175; Toklu HZ, 2018, BEHAV BRAIN RES, V340, P14, DOI 10.1016/j.bbr.2017.04.025; Trimble M H, 2001, J Spinal Cord Med, V24, P74; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; van Bregt DR, 2012, EXP NEUROL, V234, P8, DOI 10.1016/j.expneurol.2011.12.003; Vitrac C, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00072; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Wang DC, 2002, J NEUROTRAUM, V19, P875, DOI 10.1089/08977150260190465; Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P1; Wei KL, 2014, J NEUROSCI, V34, P12690, DOI 10.1523/JNEUROSCI.1855-14.2014; Xu XP, 2016, BRAIN RES BULL, V124, P214, DOI 10.1016/j.brainresbull.2016.05.010; Yablon SA, 1996, NEUROLOGY, V47, P939, DOI 10.1212/WNL.47.4.939; Zhai F, 2019, NEUROREPORT, V30, P53, DOI 10.1097/WNR.0000000000000977; Zong H., 2016, BIOSCIENCE REP, V36	123	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 15	2020	1747								147060	10.1016/j.brainres.2020.147060			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NR3EY	WOS:000571446800001	32828734				2022-02-06	
J	Dang, DD; Mugge, L; Awan, O; Dang, J; Shenai, M				Dang, Danielle D.; Mugge, Luke; Awan, Omar; Dang, John; Shenai, Mahesh			Spontaneous or Traumatic Intratumoral Hemorrhage? A Rare Presentation of Parafalcine Meningioma	CUREUS			English	Article						meningioma; traumatic brain injury; intratumoral hemorrhage; intracranial hemorrhage	SUBDURAL-HEMATOMA; MECHANISM	While hemorrhage is commonly encountered in various intracranial tumors, it is relatively rare in benign meningiomas. We present an interesting case report of a 75-year-old male who fell during intoxication, sustaining right frontal cranial trauma, coincidentally directly overlying a previously undiagnosed right frontal meningioma. He experienced an acute neurological decline and was found to have an intracranial hematoma, causing significant mass effect and herniation. Based on the radiographic appearance, an underlying neoplasm with significant edema was suspected. Intraoperatively, the hematoma and mass were successfully evacuated, and post-operative pathology confirmed the presence of a World Health Organization Grade I meningioma with a microcystic and angiomatous pattern. We speculate on the mechanism of injury and hemorrhage in this patient through review of the literature and discussion of medical and pathological risk factors.	[Dang, Danielle D.; Mugge, Luke; Awan, Omar] Inova Hosp Syst, Neurol Surg, Falls Church, VA 22042 USA; [Dang, John] Walter Reed Natl Mil Med Ctr, Internal Med, Bethesda, MD USA; [Shenai, Mahesh] Nova Hlth Syst, Neurol Surg, Falls Church, VA USA		Dang, DD (corresponding author), Inova Hosp Syst, Neurol Surg, Falls Church, VA 22042 USA.	danielle.dang@inova.org					Bellut D, 2011, J CLIN NEUROSCI, V18, P992, DOI 10.1016/j.jocn.2011.01.007; Bosnjak R, 2005, J NEUROSURG, V103, P473, DOI 10.3171/jns.2005.103.3.0473; CHASKIS C, 1992, CLIN NEUROL NEUROSUR, V94, P269, DOI 10.1016/0303-8467(92)90103-A; Deprez FC, 2012, JBR-BTR, V95, P309, DOI 10.5334/jbr-btr.660; Entezami P, 2018, WORLD NEUROSURG, V117, P252, DOI 10.1016/j.wneu.2018.06.100; Grasso G, 2016, WORLD NEUROSURG, V95, P599, DOI 10.1016/j.wneu.2016.07.118; Hasselblatt M, 2004, AM J SURG PATHOL, V28, P390, DOI 10.1097/00000478-200403000-00013; HELLE TL, 1980, J NEUROL NEUROSUR PS, V43, P725, DOI 10.1136/jnnp.43.8.725; Kim DG, 2000, ACTA NEUROCHIR, V142, P165, DOI 10.1007/s007010050019; LATCHAW JP, 1981, NEUROSURGERY, V9, P433, DOI 10.1227/00006123-198110000-00017; Lefranc F, 2001, ACTA NEUROCHIR, V143, P977, DOI 10.1007/s007010170002; Matsuoka G, 2019, WORLD NEUROSURG, V124, P75, DOI 10.1016/j.wneu.2018.12.124; MODESTI LM, 1976, J NEUROSURG, V45, P437, DOI 10.3171/jns.1976.45.4.0437; Niiro M, 2003, ACTA NEUROCHIR, V145, P767, DOI 10.1007/s00701-003-0089-z; Pressman E, 2020, WORLD NEUROSURG, V135, DOI 10.1016/j.wneu.2019.10.173; WAKAI S, 1982, NEUROSURGERY, V10, P437, DOI 10.1227/00006123-198204000-00004; Wang HC, 2016, WORLD NEUROSURG, V94, P319, DOI 10.1016/j.wneu.2016.07.042; Wen Patrick Y, 2017, Continuum (Minneap Minn), V23, P1531, DOI 10.1212/CON.0000000000000536; Worm PV, 2009, ARQ NEURO-PSIQUIAT, V67, P308, DOI 10.1590/S0004-282X2009000200028	19	1	1	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	NOV 14	2020	12	11							e11486	10.7759/cureus.11486			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	OR1JH	WOS:000589232000007	33329982	Green Published, gold			2022-02-06	
J	Silva, MJ; Antunes, N				Silva, Marta Joao; Antunes, Natalia			The utility of heart rate variability as a prognostic factor in children with traumatic brain injury	BRAIN INJURY			English	Article						Autonomic dysfun; child; head trauma; prognosis		Objective This study aimed to do a literature review to prove the hypothesis that a change in autonomous nervous system regulation, more precisely a decrease in heart rate variability (HRV), is associated with a worse outcome and could be used as a prognostic factor in children with TBI. Methods Databases (Pubmed, World of Science and Scopus) studies were conducted from 1996 to 2017, considering HRV in children with TBI. Seven studies were analyzed. Results Patients that became brain dead had a markedly lower LF/HF ratio, with a significant decrease after the first few hours of hospitalization. Patients with a more favorable prognosis had significantly higher LF/HF ratios. Discussion The HRV can be useful when determining the severity of neurological damage and a prognostic factor in the evaluation of its recovery. However, to assess the true value of HRV monitoring in children with TBI, a prospective study with identified thresholds for HRV, comparison to the standard methods of assessment and predictions should be made blinded to outcome at admission and then through the clinical course including the post-acute phase of rehabilitation. In the absence of this, any recommendation for its use as a prognostic tool may be premature.	[Silva, Marta Joao] Ctr Hosp Univ Sao Joao, Pediat Intens Care Unit, Porto, Portugal; [Antunes, Natalia] Univ Porto, Fac Med, Dept Gynecol Obstet & Pediat, Porto, Portugal		Silva, MJ (corresponding author), Ctr Hosp Univ Sao Joao, Pediat Intens Care Unit, Porto, Portugal.	martajoaosilva@gmail.com		Silva, Marta/0000-0002-5627-7282			Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Almeida R, 2010, COMPUT CARDIOL, V40; Alofisan TO, 2019, PEDIATR CRIT CARE ME, V20, P252, DOI 10.1097/PCC.0000000000001811; Alvares GA, 2016, J PSYCHIATR NEUROSCI, V41, P89, DOI 10.1503/jpn.140217; Baguley I, 2000, BRAIN INJURY, V14, P505; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P1000, DOI 10.1016/j.apmr.2015.02.002; Camm AJ, 1996, CIRCULATION, V93, P1043; Clifton GL, 1998, NEUROSURGERY, V8; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; FARRIS HE, 2011, ANESTHESIOL RES PRAC, V2, DOI DOI 10.1038/NCOMMS1417; FINLEY JP, 1995, J AUTONOM NERV SYST, V51, P103, DOI 10.1016/0165-1838(94)00117-3; Goldstein B, 1998, CRIT CARE MED, V26, P352, DOI 10.1097/00003246-199802000-00040; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Goldstein B, 1996, CRIT CARE MED, V24, P234, DOI 10.1097/00003246-199602000-00009; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Katz-Leurer M, 2016, BRAIN INJURY, V30, P1239, DOI 10.1080/02699052.2016.1179343; Katz-Leurer M, 2010, BRAIN INJURY, V24, P110, DOI 10.3109/02699050903508234; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Kim SW, 2017, ANN REHABIL MED-ARM, V41, P951, DOI 10.5535/arm.2017.41.6.951; King ML, 1997, BRAIN INJURY, V11, P445; Kirk KA, 2012, DEV MED CHILD NEUROL, V54, P759, DOI 10.1111/j.1469-8749.2012.04322.x; Krach LE, 1997, J NEUROL REHABIL, V11, P41; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; Lowensohn I, 1997, LANCET, V1; Massimo SS, 2001, INT J CARDIOL, V81, DOI [10.1016/S0167-5273(01)00537-X, DOI 10.1016/S0167-5273(01)00537-X]; McMillan TM, 2014, J NEUROL NEUROSUR PS, V85, P1214, DOI 10.1136/jnnp-2013-307279; Pertab JL, 2018, NEUROREHABILITATION, V42, P397, DOI 10.3233/NRE-172298; Pozzi M, 2015, J HEAD TRAUMA REHAB, V30, P357, DOI 10.1097/HTR.0000000000000084; Pozzi M, 2014, J NEUROTRAUM, V31, P1897, DOI 10.1089/neu.2014.3540; Rodriguez N, 2006, REV NEUROLOGIA, V43, P143, DOI 10.33588/rn.4303.2004453; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Su CF, 2005, CLIN NEUROPHYSIOL, V116, P1273, DOI 10.1016/j.clinph.2005.01.010; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	38	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 5	2020	34	13-14					1693	1700		10.1080/02699052.2020.1836401		NOV 2020	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PH5MZ	WOS:000589530400001	33190529				2022-02-06	
J	Cassel, A; McDonald, S; Kelly, M				Cassel, A.; McDonald, S.; Kelly, M.			Establishing 'proof of concept' for a social cognition group treatment program (SIFT IT) after traumatic brain injury: two case studies	BRAIN INJURY			English	Article						Social cognition; emotion perception; perspective taking; group treatment; case study	CLINICALLY IMPORTANT DIFFERENCE; IMPAIRED SELF-AWARENESS; EMOTION PERCEPTION; GROUP-THERAPY; RATING-SCALE; QUESTIONNAIRE; PSYCHOTHERAPY; SCHIZOPHRENIA; DEFICITS; ANXIETY	Objective Social cognitive deficits are prevalent after traumatic brain injury (TBI). Despite this, few remediation studies exist. This study aimed to demonstrate 'proof of concept' for a novel group treatment that comprehensively targeted the core processes of social cognition. Design Pre-post case study with two participants, "Greg" and "Aaron", living with severe TBI, with three assessment time points. Method Participants were screened at baseline to confirm social cognitive deficits: Greg exhibited difficulties with emotion perception and detecting hints; Aaron with detecting sarcasm and hints. Both reported everyday social problems. Participants then completed the 14-week group treatment program (SIFT IT). Feasibility and outcome measures were repeated post-group and at three-month follow-up. Results The study procedure was implemented with 100% assessment and 89% SIFT IT session attendance, albeit with a lack of proxy-report measures. Both participants described procedures as acceptable, although suggested more group participants could be beneficial. They both demonstrated reliable improvements (RCI > 1.96) on relevant social cognitive measures. Qualitative feedback corroborated findings: Greg reported generalization of therapeutic gains, Aaron reported increased self-awareness but nominal generalization. Conclusion Feasibility and limited efficacy outcomes established 'proof of concept' of SIFT IT. Findings will inform the study protocol for a larger randomized-controlled trial.	[Cassel, A.; McDonald, S.] Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Kelly, M.] Univ Newcastle, Sch Psychol, Newcastle, NSW, Australia		Cassel, A (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia.	anneli.cassel@unsw.edu.au	Kelly, Michelle/J-9739-2019; McDonald, Skye/G-4118-2014	Kelly, Michelle/0000-0003-0375-816X; McDonald, Skye/0000-0003-0723-6094	Australian Government Research Training Program (RTP) ScholarshipAustralian GovernmentDepartment of Industry, Innovation and Science; Centre for Research Excellence (CRE) in Brain Recovery Seed Grant	This research was supported by an Australian Government Research Training Program (RTP) Scholarship and a Centre for Research Excellence (CRE) in Brain Recovery Seed Grant.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Arain M, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-67; Armitage SG, 1946, PSYCHOL MONOGR, V60, P1; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; Beer JS, 2006, BRAIN RES, V1079, P1, DOI 10.1016/j.brainres.2006.02.001; Bivona U, 2015, RESTOR NEUROL NEUROS, V33, P335, DOI 10.3233/RNN-140484; Bornhofen C, 2009, READING SMILE OTHER; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Brandon AR, 2012, ARCH WOMEN MENT HLTH, V15, P469, DOI 10.1007/s00737-012-0311-1; Burgess P.W., 1997, HAYLING BRIXTON TEST; Canty AL, 2017, NEUROPSYCHOL REHABIL, V27, P834, DOI 10.1080/09602011.2015.1052820; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Cassel A, 2019, NEUROPSYCHOL REHABIL, V29, P22, DOI 10.1080/09602011.2016.1257435; Channon S, 2010, NEUROPSYCHOL REHABIL, V20, P739, DOI 10.1080/09602011003794583; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Conner KM, 2000, BR J PSYCHIAT, V176; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; Cotter J, 2018, NEUROSCI BIOBEHAV R, V84, P92, DOI 10.1016/j.neubiorev.2017.11.014; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Driscoll DM, 2011, J NEUROTRAUM, V28, P319, DOI 10.1089/neu.2010.1523; Francis HM, 2017, BRAIN INJURY, V31, P336, DOI 10.1080/02699052.2016.1250954; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Glynn SM, 2009, PSYCHIATR REHABIL J, V33, P278, DOI 10.2975/33.4.2010.278.287; Green MF, 2008, SCHIZOPHRENIA BULL, V34, P1211, DOI 10.1093/schbul/sbm145; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS282, DOI 10.1016/j.apmr.2014.11.029; Hawley LA, 2010, BRAIN INJURY, V24, P1292, DOI 10.3109/02699052.2010.506866; Healey KM, 2015, COGN NEUROPSYCHIATRY, V20, P198, DOI 10.1080/13546805.2014.999915; Henry JD, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.229; Hezel DM, 2014, BEHAV THER, V45, P530, DOI 10.1016/j.beth.2014.02.010; Honan CA, 2019, NEUROPSYCHOL REHABIL, V29, P896, DOI 10.1080/09602011.2017.1339616; Honan CA, 2016, CLIN NEUROPSYCHOL, V30, P243, DOI 10.1080/13854046.2015.1136691; Hornyak M, 2008, J NEUROL NEUROSUR PS, V79, P823, DOI 10.1136/jnnp.2007.138867; Hsieh MY, 2012, BRAIN INJURY, V26, P126, DOI 10.3109/02699052.2011.635365; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JACOBSON NS, 1984, BEHAV THER, V15, P336, DOI 10.1016/S0005-7894(84)80002-7; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Kelly A, 2016, TALKABOUT SOCIAL COM; Kelly M, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000269; Kelly M, 2017, BRAIN IMPAIR, V18, P11, DOI 10.1017/BrImp.2016.34; Kurtz MM, 2012, SCHIZOPHRENIA BULL, V38, P1092, DOI 10.1093/schbul/sbr036; Lenton-Brym AP, 2018, ANXIETY STRESS COPIN, V31, P487, DOI 10.1080/10615806.2018.1483021; Lezak MD, 1978, J CLIN PSYCHOL, V58; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Machamer J, 2013, J NEUROTRAUM, V30, P1845, DOI 10.1089/neu.2013.2920; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Malec JF, 2020, ARCH PHYS MED REHAB, V101, P1090, DOI 10.1016/j.apmr.2019.12.008; Malec JF, 2018, ARCH PHYS MED REHAB, V99, P603, DOI 10.1016/j.apmr.2017.06.038; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; McDonald S, 2017, NEUROPSYCHOLOGICAL REHABILITATION: THE INTERNATIONAL HANDBOOK, P266; McDonald S, 2011, BRAIN IMPAIR, V12, P165; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; Morley S, 2014, MANUAL LEEDS RELIABL; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; O'Callaghan A, 2012, BRAIN INJURY, V26, P1599, DOI 10.3109/02699052.2012.698788; Patterson F, 2016, DISABIL REHABIL, V38, P1961, DOI 10.3109/09638288.2015.1111436; Penn D, 2005, SCHIZOPHR RES, V80, P357, DOI 10.1016/j.schres.2005.07.011; PERDICES M, 2005, BRAIN IMPAIRMENT, V0006, P00219; Randolph C., 1998, REPEATABLE BATTERY A; Reniers RLEP, 2011, J PERS ASSESS, V93, P84, DOI 10.1080/00223891.2010.528484; Roberts DL, 2012, BEHAV COGN PSYCHOTH, V40, P491, DOI 10.1017/S1352465812000082; Robey RR, 2004, J COMMUN DISORD, V37, P401, DOI 10.1016/j.jcomdis.2004.04.003; Roelofs RL, 2017, BRAIN IMPAIR, V18, P138, DOI 10.1017/BrImp.2016.31; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Russell TA, 2006, BRIT J CLIN PSYCHOL, V45, P579, DOI 10.1348/014466505X90866; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; Sloane S, 2002, COMMUNICATE CONFIDEN; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Tate RL, 2015, RISK BIAS N 1 TRIALS; Tate RL, 2014, NEUROPSYCHOL REHABIL, V24, P315, DOI 10.1080/09602011.2013.875043; Tate RL, 2013, NEUROPSYCHOL REHABIL, V23, P619, DOI 10.1080/09602011.2013.824383; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Togher L, 2010, AUST COMMUN Q, V12; Turner D, 2010, J CLIN EPIDEMIOL, V63, P28, DOI 10.1016/j.jclinepi.2009.01.024; Videler AC, 2014, INT PSYCHOGERIATR, V26, P1709, DOI 10.1017/S1041610214001264; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; WechslerD, 2001, WECHSLER TEST ADULT; Westerhof-Evers HJ, 2017, J HEAD TRAUMA REHAB, V32, P296, DOI 10.1097/HTR.0000000000000332; Whiting DL, 2018, CLIN PSYCHOL-UK, V22, P230, DOI 10.1111/cp.12118; Whiting DL, 2017, NEUROPSYCHOL REHABIL, V27, P263, DOI 10.1080/09602011.2015.1062115; Winegardner J, 2016, NEUROREHABILITATION, V39, P153, DOI 10.3233/NRE-161347; Wong DN, 2019, CLIN REHABIL, V33, P1079, DOI 10.1177/0269215519831048; Yeates G, 2016, NEUROREHABILITATION, V38, P299, DOI 10.3233/NRE-161321; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	88	1	1	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 5	2020	34	13-14					1781	1793		10.1080/02699052.2020.1831072		NOV 2020	13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PH5MZ	WOS:000588818100001	33180565				2022-02-06	
J	Natividad, GC; Theodossiou, SK; Schiele, NR; Murdoch, GK; Tsamis, A; Tanner, B; Potirniche, G; Mortazavi, M; Vorp, DA; Martin, BA				Conley Natividad, Gabryel; Theodossiou, Sophia K.; Schiele, Nathan R.; Murdoch, Gordon K.; Tsamis, Alkiviadis; Tanner, Bertrand; Potirniche, Gabriel; Mortazavi, Martin; Vorp, David A.; Martin, Bryn A.			Ex-vivo quantification of ovine pia arachnoid complex biomechanical properties under uniaxial tension	FLUIDS AND BARRIERS OF THE CNS			English	Article							SPINAL SUBARACHNOID SPACE; ANATOMICAL FINE-STRUCTURE; MECHANICAL-PROPERTIES; CEREBROSPINAL-FLUID; BRAIN-TISSUE; OPTIC-NERVE; CSF FLOW; SYRINGOMYELIA; PRESSURE; MODEL	Background The pia arachnoid complex (PAC) is a cerebrospinal fluid-filled tissue conglomerate that surrounds the brain and spinal cord. Pia mater adheres directly to the surface of the brain while the arachnoid mater adheres to the deep surface of the dura mater. Collagen fibers, known as subarachnoid trabeculae (SAT) fibers, and microvascular structure lie intermediately to the pia and arachnoid meninges. Due to its structural role, alterations to the biomechanical properties of the PAC may change surface stress loading in traumatic brain injury (TBI) caused by sub-concussive hits. The aim of this study was to quantify the mechanical and morphological properties of ovine PAC. Methods Ovine brain samples (n = 10) were removed from the skull and tissue was harvested within 30 min post-mortem. To access the PAC, ovine skulls were split medially from the occipital region down the nasal bone on the superior and inferior aspects of the skull. A template was used to remove arachnoid samples from the left and right sides of the frontal and occipital regions of the brain. 10 ex-vivo samples were tested with uniaxial tension at 2 mm s(-1), average strain rate of 0.59 s(-1), until failure at < 5 h post extraction. The force and displacement data were acquired at 100 Hz. PAC tissue collagen fiber microstructure was characterized using second-harmonic generation (SHG) imaging on a subset of n = 4 stained tissue samples. To differentiate transverse blood vessels from SAT by visualization of cell nuclei and endothelial cells, samples were stained with DAPI and anti-von Willebrand Factor, respectively. The Mooney-Rivlin model for average stress-strain curve fit was used to model PAC material properties. Results The elastic modulus, ultimate stress, and ultimate strain were found to be 7.7 +/- 3.0, 2.7 +/- 0.76 MPa, and 0.60 +/- 0.13, respectively. No statistical significance was found across brain dissection locations in terms of biomechanical properties. SHG images were post-processed to obtain average SAT fiber intersection density, concentration, porosity, tortuosity, segment length, orientation, radial counts, and diameter as 0.23, 26.14, 73.86%, 1.07 +/- 0.28, 17.33 +/- 15.25 mu m, 84.66 +/- 49.18 degrees, 8.15%, 3.46 +/- 1.62 mu m, respectively. Conclusion For the sizes, strain, and strain rates tested, our results suggest that ovine PAC mechanical behavior is isotropic, and that the Mooney-Rivlin model is an appropriate curve-fitting constitutive equation for obtaining material parameters of PAC tissues.	[Conley Natividad, Gabryel; Theodossiou, Sophia K.; Schiele, Nathan R.; Martin, Bryn A.] Univ Idaho, Dept Chem & Biol Engn, 875 Perimeter Dr,MS0904, Moscow, ID 83844 USA; [Murdoch, Gordon K.] Univ Idaho, Dept Anim & Vet Sci, 875 Perimeter Dr,MC1122, Moscow, ID 83844 USA; [Tsamis, Alkiviadis] Univ Leicester, Sch Engn, Univ Rd, Leicester LE1 7RH, Leics, England; [Tanner, Bertrand] Washington State Univ, Dept Integrated Physiol & Neurosci, 1815 Ferdinands Lane, Pullman, WA 99164 USA; [Potirniche, Gabriel] Univ Idaho, Dept Mech Engn, 875 Perimeter Dr,MC1122, Moscow, ID 83844 USA; [Mortazavi, Martin] Natl Skull Base Fdn, 2100 Lynn Rd 120, Thousand Oaks, CA 91360 USA; [Vorp, David A.] Univ Pittsburgh, Dept Bioengn, 3700 OHara St, Pittsburgh, PA 15261 USA; [Vorp, David A.] Univ Pittsburgh, Dept Cardiothorac Surg, 3700 OHara St, Pittsburgh, PA 15261 USA; [Vorp, David A.] Univ Pittsburgh, Dept Surg, 3700 OHara St, Pittsburgh, PA 15261 USA; [Vorp, David A.] Univ Pittsburgh, Dept Chem & Petr Engn, 3700 OHara St, Pittsburgh, PA 15261 USA; [Vorp, David A.] Univ Pittsburgh, Clin & Translat Sci Inst, 3700 OHara St, Pittsburgh, PA 15261 USA; [Martin, Bryn A.] Alcy One Therapeut Inc, Lowell, MA 01852 USA		Martin, BA (corresponding author), Univ Idaho, Dept Chem & Biol Engn, 875 Perimeter Dr,MS0904, Moscow, ID 83844 USA.	brynm@uidaho.edu	Martin, Bryn/N-6640-2016	Martin, Bryn/0000-0003-1234-7880; TSAMIS, Alkiviadis/0000-0001-8101-3302; Tanner, Bertrand/0000-0003-1711-8526	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of health (NIH) [P20GM1033408, 4U54GM104944-04TBD]; NIH National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS111283]; American Heart AssociationAmerican Heart Association [19TPA34860008]; National Science FoundationNational Science Foundation (NSF) [1656450]	This work was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of health (NIH) under Grant #P20GM1033408 (Martin & Schiele) and #4U54GM104944-04TBD (Martin), NIH National Institute of Neurological Disorders and Stroke under Grant #R01NS111283, American Heart Association under Grant [19TPA34860008 to BCWT] (Tanner), and National Science Foundation under Grant [1656450 to BCWT] (Tanner).	Aimedieu P, 2004, J NEUROSURG, V100, P111, DOI 10.3171/jns.2004.100.1.0111; Benko N, 2020, J ANAT, V237, P275, DOI 10.1111/joa.13186; Bertram CD, 2008, MED BIOL ENG COMPUT, V46, P701, DOI 10.1007/s11517-008-0332-0; BETSCH DF, 1980, BIORHEOLOGY, V17, P83; Bilston LE, 2006, CLIN BIOMECH, V21, P579, DOI 10.1016/j.clinbiomech.2006.01.009; Cheng S, 2012, J BIOMECH, V45, P1186, DOI 10.1016/j.jbiomech.2012.01.050; Dalley AF., 1999, CLIN ORIENTED ANATOM; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Davidoff CL, 2017, WORLD NEUROSURG, V107, P565, DOI 10.1016/j.wneu.2017.08.064; Elliott NSJ, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005849; Fabris G, 2019, ACTA BIOMATER, V100, P29, DOI 10.1016/j.actbio.2019.09.044; FALLENSTEIN GT, 1969, J BIOMECH, V2, P217, DOI 10.1016/0021-9290(69)90079-7; Fratzl P, 1998, J STRUCT BIOL, V122, P119, DOI 10.1006/jsbi.1998.3966; Garo A, 2007, BIORHEOLOGY, V44, P51; Gottschalk A, 2010, J MAGN RESON IMAGING, V32, P218, DOI 10.1002/jmri.22207; Guerin HAL, 2005, J BIOMECH ENG-T ASME, V127, P345, DOI 10.1115/1.1865212; Gupta S, 2010, J R SOC INTERFACE, V7, P1195, DOI 10.1098/rsif.2010.0033; Haines DE., 2018, FUNDAMENTAL NEUROSCI; Hartmann K, 2019, THER ADV NEUROL DISO, V12, DOI 10.1177/1756286419843040; Hosseini Farid M, 2017, ASME 2017 INT MECH E; Hu T, 2004, LECT NOTES COMPUT SC, V3078, P28; Jayasuriya AC, 2003, J BIOMED MATER RES A, V66A, P260, DOI 10.1002/jbm.a.10536; Jin X., 2009, BIOMECHANICAL RESPON; Jin Xin, 2006, Stapp Car Crash J, V50, P637; Jin X, 2014, ANN BIOMED ENG, V42, P812, DOI 10.1007/s10439-013-0948-6; Jin X, 2011, J BIOMECH, V44, P467, DOI 10.1016/j.jbiomech.2010.09.035; Jin X, 2007, STAPP CAR CRASH JO, V51, P115; Killer HE, 2003, BRIT J OPHTHALMOL, V87, P777, DOI 10.1136/bjo.87.6.777; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; Klekamp J, 2002, J NEUROSURG, V97, P317, DOI 10.3171/spi.2002.97.3.0317; Koch RG, 2014, J BIOMECH, V47, P935, DOI 10.1016/j.jbiomech.2014.01.027; Koyanagi I, 2005, SURG NEUROL, V63, P350, DOI 10.1016/j.surneu.2004.05.038; Leclerc GE, 2012, J BIOMECH, V45, P952, DOI 10.1016/j.jbiomech.2012.01.017; Linge SO, 2010, AM J NEURORADIOL, V31, P185, DOI 10.3174/ajnr.A1766; Margulies S, 2006, FORENSIC SCI INT, V164, P278, DOI 10.1016/j.forsciint.2005.12.018; Marshall-Goebel K, 2017, J APPL PHYSIOL, V123, P1139, DOI 10.1152/japplphysiol.00256.2017; Martin BA, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-17; MENDELSON NH, 1989, J BACTERIOL, V171, P1055, DOI 10.1128/jb.171.2.1055-1062.1989; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Mortazavi MM, 2018, WORLD NEUROSURG, V111, P279, DOI 10.1016/j.wneu.2017.12.041; Nyman JS, 2006, J BIOMECH, V39, P931, DOI 10.1016/j.jbiomech.2005.01.012; Ozawa H, 2004, J NEUROSURG-SPINE, V1, P122, DOI 10.3171/spi.2004.1.1.0122; Ramo NL, 2018, ACTA BIOMATER, V75, P253, DOI 10.1016/j.actbio.2018.05.045; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Raveling AR, 2018, METHODSX, V5, P924, DOI 10.1016/j.mex.2018.08.001; Saccomandi G, 2019, INT J NONLIN MECH, V109, P9, DOI 10.1016/j.ijnonlinmec.2018.09.008; Scott GG, 2015, IEEE T MED IMAGING, V34, P1452, DOI 10.1109/TMI.2015.2396527; Shen F, 2006, J BIOMECH ENG-T ASME, V128, P797, DOI 10.1115/1.2264393; Stockman HW, 2007, J BIOMECH ENG-T ASME, V129, P666, DOI 10.1115/1.2768112; Stockman HW, 2006, J BIOMECH ENG-T ASME, V128, P106, DOI 10.1115/1.2132372; Stoverud KH, 2016, COMPUT METHOD BIOMEC, V19, P686, DOI 10.1080/10255842.2015.1058927; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P79; Tamura Atsutaka, 2002, Stapp Car Crash J, V46, P55; Tangen KM, 2015, J BIOMECH, V48, P2144, DOI 10.1016/j.jbiomech.2015.02.018; Thornton GM, 2001, J ORTHOPAED RES, V19, P845, DOI 10.1016/S0736-0266(01)00005-5; Tsamis A, 2007, AM J PHYSIOL-HEART C, V293, pH3130, DOI 10.1152/ajpheart.00684.2007; VIIDIK A, 1982, BIORHEOLOGY, V19, P437	57	1	1	3	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-8118			FLUIDS BARRIERS CNS	Fluids Barriers CNS	NOV 12	2020	17	1							68	10.1186/s12987-020-00229-w			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OQ9DR	WOS:000589075600001	33183314	Green Submitted, gold, Green Published			2022-02-06	
J	Hunfalvay, M; Murray, NP; Roberts, CM; Tyagi, A; Barclay, KW; Carrick, FR				Hunfalvay, Melissa; Murray, Nicholas P.; Roberts, Claire-Marie; Tyagi, Ankur; Barclay, Kyle William; Carrick, Frederick Robert			Oculomotor Behavior as a Biomarker for Differentiating Pediatric Patients With Mild Traumatic Brain Injury and Age Matched Controls	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						eye-tracking; oculomotor; mTBI; concussion; pediateric case	PURSUIT EYE-MOVEMENTS; SMOOTH-PURSUIT; UNITED-STATES; REACTION-TIME; CONCUSSION; TRACKING; DEFICITS; QUANTIFICATION; EPIDEMIOLOGY; FIXATIONS	Importance Children have the highest incidence of mild traumatic brain injury (mTBI) in the United States. However, mTBI, specifically pediatric patients with mTBI, are notoriously difficult to detect, and with a reliance on traditional, subjective measurements of eye movements, the subtle but key oculomotor deficits are often missed. Objective The purpose of this project is to determine if the combined measurement of saccades, smooth pursuit, fixations and reaction time represent a biomarker for differentiating pediatric patients with mild traumatic brain injury compared to age matched controls. Design This study used cross-sectional design. Each participant took part in a suite of tests collectively labeled the "Brain Health EyeQ" to measure saccades, smooth pursuit, fixations and reaction time. Participants The present study recruited 231 participants - 91 clinically diagnosed with a single incident mTBI in the last 2 days as assessed by both the Glasgow Coma Scale (GCS) and Graded Symptoms Checklist (GSC), and 140 age and gender-matched controls (n = 165 male, n = 66 female, M age = 14.20, SD = 2.78). Results One-way univariate analyses of variance examined the differences in performance on the tests between participants with mTBI and controls. ROC curve analysis examined the sensitivity and specificity of the tests. Results indicated that together, the "Brain Health EyeQ" tests were successfully able to identify participants with mTBI 75.3% of the time, providing further validation to a growing body of literature supporting the use of eye tracking technology for mTBI identification and diagnosis.	[Hunfalvay, Melissa; Tyagi, Ankur] RightEye LLC, Bethesda, MD USA; [Murray, Nicholas P.] East Carolina Univ, Dept Kinesiol, Greensville, NC 27834 USA; [Roberts, Claire-Marie] Univ West England, Hlth & Social Sci, Bristol, Avon, England; [Barclay, Kyle William] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Carrick, Frederick Robert] Univ Cambridge, Ctr Mental Hlth Res Assoc, Cambridge, England; [Carrick, Frederick Robert] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA; [Carrick, Frederick Robert] MGH Inst Hlth Profess, Boston, MA USA		Murray, NP (corresponding author), East Carolina Univ, Dept Kinesiol, Greensville, NC 27834 USA.	murrayni@ecu.edu		Carrick, Frederick/0000-0002-2818-6551			Adjorlolo S, 2018, ASSESSMENT, V25, P498, DOI 10.1177/1073191116646445; Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Arbour C, 2016, CRIT CARE MED, V44, pE1186, DOI 10.1097/CCM.0000000000001960; Armstrong RA, 2018, CLIN EXP OPTOM, V101, P716, DOI 10.1111/cxo.12670; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bedell HE, 2013, VISION RES, V90, P32, DOI 10.1016/j.visres.2013.02.001; Brickell TA, 2017, J NEUROTRAUM, V34, P300, DOI 10.1089/neu.2016.4403; CIUFFREDA KJ, 2004, INVEST OPHTH VIS S1, V45; DiCesare CA, 2017, BEHAV RES METHODS, V49, P258, DOI 10.3758/s13428-015-0693-x; Ettenhofer ML, 2018, BRAIN INJURY, V32, P1740, DOI 10.1080/02699052.2018.1511067; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Ghaffarpasand Fariborz, 2013, Bull Emerg Trauma, V1, P135; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Han SJ, 2010, OPHTHAL PHYSL OPT, V30, P95, DOI 10.1111/j.1475-1313.2009.00681.x; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Hoffer ME, 2017, LARYNGOSCOPE INVEST, V2, P157, DOI 10.1002/lio2.74; Holmqvist K., 2011, EYE TRACKING COMPREH; Howell DR, 2018, J CHILD NEUROL, V33, P794, DOI 10.1177/0883073818789320; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Hunfalvay Melissa, 2019, Concussion, V4, pCNC60, DOI 10.2217/cnc-2019-0001; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; KNOPMAN D, 1991, J CLIN EXP NEUROPSYC, V13, P880, DOI 10.1080/01688639108405105; Komogortsev OV, 2013, BEHAV RES METHODS, V45, P203, DOI 10.3758/s13428-012-0234-9; Kooiker MJG, 2016, ACTA OPHTHALMOL, V94, P599, DOI 10.1111/aos.13038; Lai ML, 2013, EDUC RES REV-NETH, V10, P90, DOI 10.1016/j.edurev.2013.10.001; Lange B., 2018, OPTOM VIS PERF, V6, P165; Langlois J. A., 2004, EMERGENCY DEP VISITS; Leigh RJ, 2015, NEUROLOGY EYE MOVEME, DOI [10.1093/med/9780199969289.001.0001, DOI 10.1093/MED/9780199969289.001.0001]; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; Maruta J, 2014, MIL MED, V179, P619, DOI 10.7205/MILMED-D-13-00420; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Mollenbach E, 2013, J EYE MOVEMENT RES, V6; Munoz DP, 2002, PROG BRAIN RES, V140, P89; Murray N., 2019, VIS DEV REHABIL, V5, P269, DOI [10.31707/vdr2019.5.4.p269, DOI 10.31707/VDR2019.5.4.P269]; Murtha S, 2002, J INT NEUROPSYCH SOC, V8, P360, DOI 10.1017/S1355617702813170; Niehorster DC, 2018, BEHAV RES METHODS, V50, P213, DOI 10.3758/s13428-017-0863-0; Oakes K., 2018, CLIN NEUROLOGY NEWS; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Renard D, 2015, MUSCLE NERVE, V52, P554, DOI 10.1002/mus.24600; Schunk JE, 2012, PEDIATR REV, V33, P398, DOI 10.1542/pir.33-9-398; Shelton J., 2010, NEUROSCI MED, V1, P30, DOI [DOI 10.4236/NM.2010.11004, 10.4236/nm.2010.11004]; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Sussman ES, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15610; Tatler B., 2009, LOOKING ACTING VISIO, DOI [10.1093/acprof:oso/9780198570943.001.0001, DOI 10.1093/ACPROF:OSO/9780198570943.001.0001]; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Williams IM, 1997, J CLIN NEUROSCI, V4, P186, DOI 10.1016/S0967-5868(97)90072-2; Wong AMF., 2007, EYE MOVEMENT DISORDE; Zomeren A.H., 1994, CLIN NEUROPSYCHOLOGY	58	1	1	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	NOV 12	2020	14								581819	10.3389/fnbeh.2020.581819			9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	OV5VY	WOS:000592278500001	33281574	Green Published, gold			2022-02-06	
J	Jang, SH; Kwon, HG				Jang, Sung Ho; Kwon, Hyeok Gyu			Relationship between depression and dorsolateral prefronto-thalamic tract injury in patients with mild traumatic brain injury	SCIENTIFIC REPORTS			English	Article							GRAY-MATTER; MICROSTRUCTURAL ABNORMALITIES; VOLUME CHANGES; CORTEX; LIFE; METAANALYSIS; DISORDER; TRACTOGRAPHY; CONNECTIONS; RTMS	The prefrontal lobe has been considered to be closely related to depression. This study examined the relationship between depression and three prefronto-thalamic tract (PF-TT) regions (the dorsolateral prefronto-thalamic tract [DLPF-TT], ventrolateral prefronto-thalamic tract [VLPF-TT], and the orbitofronto-thalamic tract [OF-TT]) in patients with mild traumatic brain injury (TBI), using diffusion tensor tractography (DTT). Thirty-seven patients with depression following mild TBI were recruited based on Beck Depression Inventory-II (BDI-II) scores. Thirty-one normal control subjects were also recruited. The three regions of the PF-TTs were reconstructed using probabilistic tractography and DTT parameters for each of the three PF-TT regions were determined. The tract volume of the DLPF-TT and OF-TT in the patient group showed a significant decrease compared to that of the control group (p<0.05). The BDI-II score of the patient group showed a moderate negative correlation with the tract volume value of the right (r=-0.33) and left (r=-0.41) DLPF-TT (p<0.05). On the other hand, no significant correlations were detected between the BDI-II score of the patient group and the values of the other DTT parameters values for the three PF-TT regions (p>0.05). Using DTT, depression was found to be closely related to a DLPF-TT injury in patients with mild TBI. We believe that evaluation of the DLPF-TT using DTT would be helpful when assessing patients with depression following mild TBI. These results can provide useful information regarding the proper application of neuromodulation in the management of depression.	[Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Daegu, South Korea; [Kwon, Hyeok Gyu] Eulji Univ, Coll Hlth Sci, Dept Phys Therapy, Sansungdaero 533, Sungnam Si 13135, Gyeonggi, South Korea		Kwon, HG (corresponding author), Eulji Univ, Coll Hlth Sci, Dept Phys Therapy, Sansungdaero 533, Sungnam Si 13135, Gyeonggi, South Korea.	khg0715@hanmail.net			Medical Research Center Program [2015R1A5A2009124]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; BENCH CJ, 1992, PSYCHOL MED, V22, P607, DOI 10.1017/S003329170003806X; Bhowmik D., 2012, PHARM INNOVATION, V1, P37; Blood AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013945; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Chang CC, 2011, PSYCHIAT RES-NEUROIM, V193, P1, DOI 10.1016/j.pscychresns.2011.01.003; DOLAN RJ, 1993, J NEUROL NEUROSUR PS, V56, P1290, DOI 10.1136/jnnp.56.12.1290; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Gordon EM, 2018, J NEUROTRAUM, V35, P767, DOI 10.1089/neu.2017.5428; Grieve SM, 2013, NEUROIMAGE-CLIN, V3, P332, DOI 10.1016/j.nicl.2013.08.016; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jang S.H., 2018, TRAUMATIC BRAIN INJU; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005009; Jang SH, 2014, YONSEI MED J, V55, P709, DOI 10.3349/ymj.2014.55.3.709; Lim HK, 2012, NEUROPSYCHOPHARMACOL, V37, P838, DOI 10.1038/npp.2011.264; Lopez KC, 2018, COGN AFFECT BEHAV NE, V18, P232, DOI 10.3758/s13415-018-0564-x; Main KL, 2017, NEUROIMAGE-CLIN, V16, P1, DOI 10.1016/j.nicl.2017.06.031; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Martin DM, 2017, DEPRESS ANXIETY, V34, P1029, DOI 10.1002/da.22658; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Pagani E, 2008, NEUROIMAGE, V41, P657, DOI 10.1016/j.neuroimage.2008.03.021; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Siddiqi SH, 2019, J NEUROPSYCH CLIN N, V31, P254, DOI 10.1176/appi.neuropsych.18100230; Sivertsen H, 2015, DEMENT GERIATR COGN, V40, P311, DOI 10.1159/000437299; Slotema CW, 2010, J CLIN PSYCHIAT, V71, P873, DOI 10.4088/JCP.08m04872gre; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Taylor WD, 2004, AM J PSYCHIAT, V161, P1293, DOI 10.1176/appi.ajp.161.7.1293; Toenders YJ, 2019, DEV COGN NEUROS-NETH, V39, DOI 10.1016/j.dcn.2019.100700; Wang YP, 2013, CLINICS, V68, P1274, DOI 10.6061/clinics/2013(09)15; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yang Q, 2007, INT PSYCHOGERIATR, V19, P757, DOI 10.1017/S1041610207004875; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358	37	1	1	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	NOV 12	2020	10	1							19728	10.1038/s41598-020-76889-3			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9RI	WOS:000595255700121	33184443	gold, Green Published			2022-02-06	
J	Luong, L; Lachaud, J; Kouyoumdjian, FG; Hwang, SW; Mejia-Lancheros, C				Luong, Linh; Lachaud, James; Kouyoumdjian, Fiona G.; Hwang, Stephen W.; Mejia-Lancheros, Cilia			The impact of a Housing First intervention and health-related risk factors on incarceration among people with experiences of homelessness and mental illness in Canada	CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE			English	Article						Homeless persons; Mental health; Prisons; Public health; Substance-related disorders	TRAUMATIC BRAIN-INJURY; CRIMINAL HISTORY; ADULTS; INDIVIDUALS; VICTIMIZATION; INVOLVEMENT; CHALLENGES; VETERANS; BEHAVIOR; OUTCOMES	Objective To examine the effect of a Housing First (HF) intervention and health-related risk factors on incarceration among adults with experiences of homelessness and mental illness. Methods Participants (N = 508) were recruited at the Toronto site of the At Home/Chez Soi study. The outcome was incarceration in Ontario from 2009 to 2014. Exposures were intervention group (HF vs. treatment as usual), Axis I mental health diagnoses, emergency department (ED) visit, and history of traumatic brain injury (TBI). Logistic regression was used to examine the association between exposures and incarceration. Results Of 508 participants, 220 (43.3%) were incarcerated at least once during the study period. Among those incarcerated, 81.9% were male, 52.7% had been diagnosed with alcohol dependence/abuse, 60.9% had been diagnosed with substance dependence/abuse, 65.1% reported having visited an ED within the last 6 months, and 66.4% had a history of TBI. After adjusting for demographic covariates, substance dependence/abuse (aOR: 2.06; 95% CI: 1.40, 3.03), alcohol dependence/abuse (aOR: 1.52, 95% CI: 1.04, 2.22), ED visit (aOR: 1.54; 95% CI: 1.02, 2.32), and history of TBI (aOR: 2.60; 95% CI: 1.75, 3.85) were associated with incarceration. We found no significant effect of the HF intervention on incarceration outcome (aOR: 1.08; 95% CI: 0.76, 1.55). Conclusions Among adults with experiences of homelessness and severe mental illness, those with substance and alcohol dependence/abuse disorders, history of TBI, and recent ED visits were at increased odds of incarceration. Strategies are needed to prevent and reduce incarceration for this population, including treatment of mental illness in the community.	[Luong, Linh; Lachaud, James; Kouyoumdjian, Fiona G.; Hwang, Stephen W.; Mejia-Lancheros, Cilia] St Michaels Hosp, Li Ka Shing Knowledge Inst, Unity Hlth Toronto, MAP Ctr Urban Hlth Solut, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Kouyoumdjian, Fiona G.] McMaster Univ, Dept Family Med, Hamilton, ON, Canada; [Hwang, Stephen W.] Univ Toronto, Div Gen Internal Med, Toronto, ON, Canada; [Mejia-Lancheros, Cilia] Univ Nacl Colombia, Res Grp Nursing Care & Practice, Family Hlth Nursing & Hlth Measures, Bogota, Colombia; [Mejia-Lancheros, Cilia] Univ Nacl Colombia, Nursing Fac, Bogota, Colombia		Mejia-Lancheros, C (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Unity Hlth Toronto, MAP Ctr Urban Hlth Solut, 30 Bond St, Toronto, ON M5B 1W8, Canada.; Mejia-Lancheros, C (corresponding author), Univ Nacl Colombia, Res Grp Nursing Care & Practice, Family Hlth Nursing & Hlth Measures, Bogota, Colombia.; Mejia-Lancheros, C (corresponding author), Univ Nacl Colombia, Nursing Fac, Bogota, Colombia.	Cilia.Mejia-Lancheros@unityhealth.to	Mejia-Lancheros, Cilia/ABG-6716-2020; Hwang, Stephen/D-2297-2011	Hwang, Stephen/0000-0002-1276-1101; Kouyoumdjian, Fiona/0000-0002-6869-7516; Mejia-Lancheros, Cilia/0000-0003-1131-8439; Lachaud, James/0000-0001-8498-8922	Health Canada; Ontario Ministry of Health and Long-Term Care (HSRF) [259]; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP-130405]	This study was supported by a financial contribution from the Health Canada to the Mental Health Commission of Canada, the Ontario Ministry of Health and Long-Term Care (HSRF #259), and the Canadian Institutes of Health Research (CIHR MOP-130405). The funding institutions had no role in the collection, analysis, and interpretation of the data nor in the preparation, revision, or approval of the present manuscript. The views expressed in this publication are the views of the authors.	Aubry T, 2016, PSYCHIAT SERV, V67, P275, DOI 10.1176/appi.ps.201400587; BARKER S, 1994, COMMUNITY MENT HLT J, V30, P459, DOI 10.1007/BF02189063; Baxter AJ, 2019, J EPIDEMIOL COMMUN H, V73, P379, DOI 10.1136/jech-2018-210981; Beckett K, 2010, LAW SOCIAL INQUIRY, V35, P1, DOI 10.1111/j.1747-4469.2009.01176.x; Brink J., 2011, STUDY PEOPLE MENTAL; Calsyn Robert J, 2005, Crim Behav Ment Health, V15, P236, DOI 10.1002/cbm.24; Carroll Megan, 2016, Health Justice, V4, P11; Chappell D, 2010, POLICE PRACT RES, V11, P289, DOI 10.1080/15614263.2010.497028; Cheung AM, 2004, CAN MED ASSOC J, V170, P1243, DOI 10.1503/cmaj.1031167; Colantonio A, 2014, J CORRECT HEALTH CAR, V20, P271, DOI 10.1177/1078345814541529; Cox R, 2021, JUSTICE Q, V38, P1070, DOI 10.1080/07418825.2019.1709883; Crawford A, 2009, BRIT J CRIMINOL, V49, P810, DOI 10.1093/bjc/azp041; Elbogen EB, 2009, ARCH GEN PSYCHIAT, V66, P152, DOI 10.1001/archgenpsychiatry.2008.537; Ellsworth JT, 2019, VICTIMS OFFENDERS, V14, P96, DOI 10.1080/15564886.2018.1547997; Fazel S, 2006, AM J PSYCHIAT, V163, P1397, DOI 10.1176/appi.ajp.163.8.1397; Gonzalez JR, 2018, AM J CRIM JUSTICE, V43, P158, DOI 10.1007/s12103-017-9413-7; Hedrich D, 2012, ADDICTION, V107, P501, DOI 10.1111/j.1360-0443.2011.03676.x; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Hwang SW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-787; Hwang SW, 2001, CAN MED ASSOC J, V164, P229; Kouyoumdjian FG, 2019, CAN J PSYCHIAT, V64, P718, DOI 10.1177/0706743719861386; Kriegel LS, 2016, COMMUNITY MENT HLT J, V52, P46, DOI 10.1007/s10597-015-9946-5; Leclair MC, 2019, CAN J PSYCHIAT, V64, P525, DOI 10.1177/0706743718815902; Luciano A, 2014, PSYCHIAT SERV, V65, P1325, DOI 10.1176/appi.ps.201300408; Malone DK, 2009, PSYCHIAT SERV, V60, P224, DOI 10.1176/appi.ps.60.2.224; McGuire JF, 2004, PSYCHIAT SERV, V55, P42, DOI 10.1176/appi.ps.55.1.42; McIsaac Kathryn E, 2016, CMAJ Open, V4, pE746, DOI 10.9778/cmajo.20160072; Mitchell JN, 2017, COMMUNITY MENT HLT J, V53, P901, DOI 10.1007/s10597-017-0089-8; Montgomery AE, 2013, J COMMUNITY PSYCHOL, V41, P505, DOI 10.1002/jcop.21554; O'Grady B, 2013, CAN PUBLIC POL, V39, P541, DOI 10.3138/CPP.39.4.541; Patterson ML, 2015, PSYCHIATR REHABIL J, V38, P81, DOI 10.1037/prj0000101; Perry AE, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010862.pub2; Roy D, 2017, J NEUROPSYCH CLIN N, V29, P334, DOI 10.1176/appi.neuropsych.16050088; Roy L, 2016, INT J LAW PSYCHIAT, V49, P75, DOI 10.1016/j.ijlp.2016.05.013; Roy L, 2014, PSYCHIAT SERV, V65, P739, DOI 10.1176/appi.ps.201200515; Saddichha S, 2014, INT J SOC PSYCHIATR, V60, P795, DOI 10.1177/0020764014522776; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; STERGIOPOULOS V, 2015, JAMA-J AM MED ASSOC, V313, P905, DOI DOI 10.1001/JAMA.2015.1163; Stergiopoulos V, 2019, LANCET PSYCHIAT, V6, P915, DOI 10.1016/S2215-0366(19)30371-2; Stubbs JL, 2020, LANCET PUBLIC HEALTH, V5, pE19, DOI 10.1016/S2468-2667(19)30188-4; Tejani N, 2014, COMMUNITY MENT HLT J, V50, P514, DOI 10.1007/s10597-013-9611-9; Tsai J, 2014, ADM POLICY MENT HLTH, V41, P360, DOI 10.1007/s10488-013-0483-7; Tsai J, 2012, J FORENSIC PSYCHOL P, V12, P307, DOI 10.1080/15228932.2012.695653; Tsai J, 2010, PSYCHOL SERV, V7, P219, DOI 10.1037/a0020460; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Whittaker E, 2016, PSYCHIAT SERV, V67, P1090, DOI 10.1176/appi.ps.201500446	47	1	1	0	5	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0008-4263	1920-7476		CAN J PUBLIC HEALTH	Can. J. Public Health-Rev. Can. Sante Publ.	APR	2021	112	2			SI		270	279		10.17269/s41997-020-00433-z		NOV 2020	10	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	QN2XC	WOS:000588281300002	33170496	Green Published			2022-02-06	
J	Ohri, SS; Burke, DA; Andres, KR; Hetman, M; Whittemore, SR				Saraswat Ohri, Sujata; Burke, Darlene A.; Andres, Kariena R.; Hetman, Michal; Whittemore, Scott R.			Acute Neural and Proteostasis Messenger Ribonucleic Acid Levels Predict Chronic Locomotor Recovery after Contusive Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						endoplasmic reticulum stress response; locomotor recovery; neural cell survival; qPCR; spinal cord injury	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; IMPROVES FUNCTIONAL RECOVERY; BRAIN ISCHEMIA; ER STRESS; INHIBITION; DELETION; ACTIVATION; DISEASE; DAMAGE	One of the difficulties in identifying novel therapeutic strategies to manage central nervous system (CNS) trauma is the need for behavioral assays to assess chronic functional recovery. In vitro assays and/or acute behavioral assessments cannot accurately predict long-term functional outcome. Using data from 13 independent T9 moderate contusive spinal cord injury (SCI) studies, we asked whether the ratio of acute (24-72 h post-injury) changes in the levels of neuron-, oligodendrocyte-, astrocyte-specific and/or endoplasmic reticulum stress response (ERSR) messenger ribonucleic acids (mRNAs) could predict the extent of chronic functional recovery. Increased levels of neuron, oligodendrocyte, and astrocyte mRNAs all correlated with enhanced Basso Mouse Scale (BMS) scores. Reduced levels of the ERSR mRNAs Atf4 and Chop correlate with improved chronic locomotor function. Neither neural or ERSR mRNAs were predictive for chronic recovery across all behavioral changes. The ratio of oligodendrocyte/ERSR mRNAs, however, did predict "improved," "no change," or "worse" functional recovery. Neuronal/ERSR mRNA ratios predicted functional improvement, but could not distinguish between worse or no change outcomes. Astrocyte/ERSR mRNA ratios were not predictive. This approach can be used to confirm biological action of injected drugs in vivo and to optimize dose and therapeutic window. It may prove useful in cervical and lumbar SCI and in other traumatic CNS injuries such as traumatic brain injury and stroke, where prevention of neuronal loss is paramount to functional recovery. Although the current analysis was directed toward ERSR whose activity was targeted in all but one study, acute mRNA markers for other pathophysiological cascades may be as predictive of chronic recovery when those cascades are targeted for neuroprotection.	[Saraswat Ohri, Sujata; Burke, Darlene A.; Andres, Kariena R.; Hetman, Michal; Whittemore, Scott R.] Univ Louisville, Sch Med, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; [Saraswat Ohri, Sujata; Burke, Darlene A.; Andres, Kariena R.] Univ Louisville, Sch Med, Dept Neurol Surg, Louisville, KY 40292 USA; [Hetman, Michal; Whittemore, Scott R.] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Hetman, Michal; Whittemore, Scott R.] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA		Whittemore, SR (corresponding author), Univ Louisville, Sch Med, Kentucky Spinal Cord Injury Res Ctr, Dept Neurol Surg, 511 S Floyd St,MDR616, Louisville, KY 40292 USA.	swhittemore@louisville.edu			Kentucky Spinal Cord and Head Injury Research Trust [08-15]; Norton Healthcare; Commonwealth of Kentucky Challenge for Excellence;  [NS108529];  [NS073584];  [P20/P30 GM103507]	The data presented here were supported by NS108529, NS073584, P20/P30 GM103507, Kentucky Spinal Cord and Head Injury Research Trust 08-15, Norton Healthcare, and the Commonwealth of Kentucky Challenge for Excellence. We thank Christine Yarberry for surgical assistance and Johnny Morehouse and Jason Beare for behavioral analyses.	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Alexander JK, 2009, PROG BRAIN RES, V175, P125, DOI 10.1016/S0079-6123(09)17508-8; Anuncibay-Soto B, 2018, BIOCHEM PHARMACOL, V151, P26, DOI 10.1016/j.bcp.2018.02.029; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Chen D, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1077-9; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Colak A, 2008, J CLIN NEUROSCI, V15, P665, DOI 10.1016/j.jocn.2007.06.002; Dash PK, 2015, J NEUROTRAUM, V32, P1608, DOI 10.1089/neu.2014.3772; Fassbender JM, 2012, CURR NEUROVASC RES, V9, P274; Fernandez-Real JM, 2005, THROMB HAEMOSTASIS, V94, P615, DOI 10.1160/TH04-12-0831; Hadi B, 2000, J NEUROSURG, V93, P266, DOI 10.3171/spi.2000.93.2.0266; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Hassannejad Z, 2018, IRAN J BASIC MED SCI, V21, P546, DOI 10.22038/IJBMS.2018.24239.6052; Hetz C, 2019, NAT CHEM BIOL, V15, P764, DOI 10.1038/s41589-019-0326-2; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Hetz C, 2017, NAT REV NEUROL, V13, P477, DOI 10.1038/nrneurol.2017.99; Hylin MJ, 2018, DEV NEUROSCI-BASEL, V40, P175, DOI 10.1159/000488343; Jin SLC, 2005, J IMMUNOL, V175, P1523, DOI 10.4049/jimmunol.175.3.1523; Jin XY, 2018, NEUROCHEM RES, V43, P1348, DOI 10.1007/s11064-018-2550-7; Karuppagounder SS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac6008; Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001; Kawada K, 2014, J NEUROSCI RES, V92, P1122, DOI 10.1002/jnr.23389; Klaips CL, 2018, J CELL BIOL, V217, P51, DOI 10.1083/jcb.201709072; Klopstein A, 2012, J NEUROSCI, V32, P14478, DOI 10.1523/JNEUROSCI.0923-12.2012; Kurtishi A, 2019, MOL NEUROBIOL, V56, P3676, DOI 10.1007/s12035-018-1334-z; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lenna S, 2012, CURR OPIN RHEUMATOL, V24, P663, DOI 10.1097/BOR.0b013e3283588dbb; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Lucke-Wold BP, 2016, J NEUROSURG, V124, P687, DOI 10.3171/2015.3.JNS141802; Ma MH, 2001, EXP NEUROL, V169, P239, DOI 10.1006/exnr.2001.7679; Magnuson DSK, 2005, J NEUROTRAUM, V22, P529, DOI 10.1089/neu.2005.22.529; Magnuson DSK, 1999, EXP NEUROL, V156, P191, DOI 10.1006/exnr.1999.7016; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Morihara R, 2018, J NEUROSCI RES, V96, P1707, DOI 10.1002/jnr.24270; Myers SA, 2019, NEUROBIOL DIS, V124, P353, DOI 10.1016/j.nbd.2018.12.008; O'Shea TM, 2017, J CLIN INVEST, V127, P3265, DOI 10.1172/JCI90608; Ohri SS, 2018, J NEUROSCI, V38, P5900, DOI 10.1523/JNEUROSCI.0679-17.2018; Ohri SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109703; Ohri SS, 2013, NEUROBIOL DIS, V58, P29, DOI 10.1016/j.nbd.2013.04.021; Ohri SS, 2012, J NEUROTRAUM, V29, P579, DOI 10.1089/neu.2011.1940; Ohri SS, 2011, GLIA, V59, P1489, DOI 10.1002/glia.21191; Okada S, 2018, NEUROSCI RES, V126, P39, DOI 10.1016/j.neures.2017.10.004; Patel SP, 2012, NEUROSCIENCE, V210, P296, DOI 10.1016/j.neuroscience.2012.03.006; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Pilakka-Kanthikeel S, 2012, PEDIATR INFECT DIS J, V31, P583, DOI 10.1097/INF.0b013e31824da0f5; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubovitch V, 2015, NEUROMOL MED, V17, P58, DOI 10.1007/s12017-015-8340-3; Saraswat O. S, 2018, J NEUROTRAUM, V35, P486, DOI [10.1089/neu.2015.3993, DOI 10.1089/NEU.2015.3993]; Ohri SS, 2021, GLIA, V69, P424, DOI 10.1002/glia.23907; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Soares TR, 2019, AGEING RES REV, V49, P92, DOI 10.1016/j.arr.2018.11.006; Sumida Y, 2018, NEUROREPORT, V29, P1443, DOI 10.1097/WNR.0000000000001128; Tan HP, 2018, NEURAL REGEN RES, V13, P827, DOI 10.4103/1673-5374.232477; Tanabe N, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00446; Valenzuela V, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.8; van Niekerk EA, 2016, MOL CELL PROTEOMICS, V15, P394, DOI 10.1074/mcp.R115.053751; Wu JF, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070693; Yang W, 2016, J CEREBR BLOOD F MET, V36, P2044, DOI 10.1177/0271678X16674488; Yoshikawa A, 2015, J NEUROCHEM, V132, P342, DOI 10.1111/jnc.12981; Zhang ZM, 2018, CELL STRESS CHAPERON, V23, P551, DOI 10.1007/s12192-017-0862-1; Zhou YL, 2016, AM J TRANSL RES, V8, P1864	63	1	1	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 1	2021	38	3					365	372		10.1089/neu.2020.7258		NOV 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QA4YS	WOS:000590815900001	33076743				2022-02-06	
J	Chen, J; Liu, J; Dong, KH; Wang, YL; Zhao, XQ; Wang, YJ; Gong, XP				Chen, Jie; Liu, Jia; Dong, Kehui; Wang, Yilong; Zhao, Xingquan; Wang, Yongjun; Gong, Xiping			Impaired Dynamic Cerebral Autoregulation in Cerebral Venous Thrombosis	FRONTIERS IN NEUROLOGY			English	Article						homeostasis; cerebral venous thrombosis (CVT); transcranial doppler (TCD); cerebral autoregulation (CA); transfer function	CEREBROVASCULAR PRESSURE REACTIVITY; COMPLEXITY	Background: Cerebral autoregulation is crucial in traumatic brain injury, which might be used for determining the optimal intracranial pressure. Cerebral venous thrombosis (CVT) is a cerebral vascular disease with features of high intracranial pressure. However, the autoregulatory mechanism of CVT remains unknown. We aimed to investigate the capacity of cerebral autoregulation in patients with CVT. Methods: This study consecutively enrolled 23 patients with CVT and 16 controls from December 2018 to May 2019. Cerebral autoregulation was assessed by transfer function analysis (rate of recovery/phase/gain) using the spontaneous oscillations of the cerebral blood flow velocity and arterial blood pressure. Results: In total, 76 middle cerebral arteries (MCAs) were investigated, including 44 MCAs in patients with CVT and 32 normal ones. The phase shift estimated in patients with CVT was significantly different from that of the controls (37.37 +/- 36.53 vs. 54.00 +/- 26.78, p = 0.03). The rate of recovery and gain in patients with CVT were lower than those in controls but without statistical significance. Conclusion: To our knowledge, this is the first time that a study has indicated that patients with CVT were more likely to have impaired cerebral autoregulation. Hence, cautious blood pressure control is required in such patients to prevent hyper- or hypoperfusion.	[Chen, Jie; Dong, Kehui; Wang, Yilong; Zhao, Xingquan; Wang, Yongjun; Gong, Xiping] Capital Med Univ, Beijing Trantan Hosp, Dept Neurol, Vasc Neurol, Beijing, Peoples R China; [Liu, Jia] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China		Gong, XP (corresponding author), Capital Med Univ, Beijing Trantan Hosp, Dept Neurol, Vasc Neurol, Beijing, Peoples R China.	xipinggong@163.com			Capital's Funds for Health Improvement and Research [2018-4-2045]	This study was supported by grants from Capital's Funds for Health Improvement and Research (2018-4-2045).	Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Chen J, 2020, BMC NEUROL, DOI [10.21203/rs.2.23732/v1, DOI 10.21203/RS.2.23732/V1]; Chen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088232; Chen J, 2013, CNS NEUROSCI THER, V19, P638, DOI 10.1111/cns.12130; Coutinho JM, 2015, J THROMB HAEMOST, V13, pS238, DOI 10.1111/jth.12945; De-Lima-Oliveira M, 2018, WORLD NEUROSURG, V113, P110, DOI 10.1016/j.wneu.2018.01.194; Dias C, 2014, J NEUROTRAUM, V31, P1872, DOI 10.1089/neu.2014.3376; Gao L, 2016, J NEUROTRAUM, V33, P2011, DOI 10.1089/neu.2015.4228; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Lam JMK, 2000, NEUROSURGERY, V47, P819, DOI 10.1097/00006123-200010000-00004; Liu J, 2005, PHYSIOL MEAS, V26, P725, DOI 10.1088/0967-3334/26/5/012; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Minhas JS, 2019, J CLIN ULTRASOUND, V47, P14, DOI 10.1002/jcu.22645; Panerai RB, 2004, BRIT J NEUROSURG, V18, P471, DOI 10.1080/02688690400012343; Panerai RB, 2008, CARDIOVASC ENG, V8, P42, DOI 10.1007/s10558-007-9044-6; Reinhard M, 2008, J NEUROL, V255, P1182, DOI 10.1007/s00415-008-0865-z; Stam J, 2005, NEW ENGL J MED, V352, P1791, DOI 10.1056/NEJMra042354; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233	19	1	1	1	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 9	2020	11								570306	10.3389/fneur.2020.570306			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OU1UE	WOS:000591319500001	33240198	Green Submitted, gold, Green Published			2022-02-06	
J	Erlick, MR; Vavilala, MS; Jaffe, KM; Blayney, CB; Moore, M				Erlick, Mariah R.; Vavilala, Monica S.; Jaffe, Kenneth M.; Blayney, Carolyn B.; Moore, Megan			Provider Perspectives on Early Psychosocial Interventions after Pediatric Severe Traumatic Brain Injury: An Implementation Framework	JOURNAL OF NEUROTRAUMA			English	Article						family-centered care; traumatic brain injury	FAMILY-CENTERED CARE; CHILDREN; SERVICES; BURDEN	This study created a framework incorporating provider perspectives of best practices for early psychosocial intervention to improve caregiver experiences and outcomes after severe pediatric traumatic brain injury (TBI). A purposive sample of 23 healthcare providers from the emergency, intensive care, and acute care departments, was selected based on known clinical care of children with severe TBI at a level 1 trauma center and affiliated children's hospital. Semistructured interviews and directed content analysis were used to assess team and caregiver communication processes and topics, prognostication, and recommended interventions. Providers recommended a dual approach of institutional and individual factors contributing to an effective framework for addressing psychosocial needs. Healthcare providers recommended interventions in three domains: (1) presenting coordinated, clear messages to caregivers, (2) reducing logistical and emotional burden of care transitions, and (3) assessing and addressing caregiver needs and concerns. Specific family-centered and trauma-informed interventions included: (1) creating and sharing interdisciplinary plans with caregivers, (2) coordinating prognostication meetings and communications, (3) tracking family education, (4) improving institutional coordination and workflow, (5) training caregivers to support family involvement, (6) performing biopsychosocial assessment, and (7) using systematic prompts for difficult conversations and to address family needs at regular intervals. Healthcare workers from a variety of disciplines want to incorporate certain trauma-informed and family-centered practices at each stage of treatment to improve experiences for caregivers and outcomes for pediatric patients with severe TBI. Future research should test the feasibility and effectiveness of incorporating routine psychosocial interventions for these patients.	[Erlick, Mariah R.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Jaffe, Kenneth M.] Univ Washington, Dept Rehabil Med, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Blayney, Carolyn B.] Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Moore, Megan] Univ Washington, Sch Social Work, Harborview Injury Prevent & Res Ctr, 4101 15th Ave NE, Seattle, WA 98105 USA		Moore, M (corresponding author), Univ Washington, Sch Social Work, Harborview Injury Prevent & Res Ctr, 4101 15th Ave NE, Seattle, WA 98105 USA.	mm99@uw.edu			National Institutes of Health Research Education ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R25HD094336-02]	National Institutes of Health Research Education Program, Grant #R25HD094336-02.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Braaf S, 2019, BRAIN INJURY, V33, P574, DOI 10.1080/02699052.2019.1566835; Brolliar SM, 2016, J NEUROTRAUM, V33, P1554, DOI 10.1089/neu.2015.4183; Carney NA, 2003, J TRAUMA, V54, pS236, DOI 10.1097/00005373-200306001-00002; Coats H, 2018, AM J CRIT CARE, V27, P52, DOI 10.4037/ajcc2018353; Curtis JR, 2018, JAMA INTERN MED, V178, P930, DOI 10.1001/jamainternmed.2018.2317; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; HCUP Nationwide Emergency Department Sample, 2014, HEALTHC COST UT PROJ; Keenan Alanna, 2010, Can J Neurosci Nurs, V32, P25; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS3, DOI 10.1097/PCC.0b013e31823f437e; Lever K, 2019, J HEAD TRAUMA REHAB, V34, pE21, DOI 10.1097/HTR.0000000000000433; Marshall MN, 1996, FAM PRACT, V13, P522, DOI 10.1093/fampra/13.6.522; Moore M, 2017, BRAIN INJURY, V31, P1876, DOI 10.1080/02699052.2017.1346291; Moore M, 2016, AM J PHYS MED REHAB, V95, P204, DOI 10.1097/PHM.0000000000000362; Moore M, 2015, PEDIATR CRIT CARE ME, V16, P758, DOI 10.1097/PCC.0000000000000494; Raj SP, 2018, J HEAD TRAUMA REHAB, V33, pE19, DOI 10.1097/HTR.0000000000000388; Rakes L., 2016, BMJ QUAL IMPROV REP, V5, pu213581; Reuter-Rice K, 2017, J PEDIATR NURS, V34, P84, DOI 10.1016/j.pedn.2016.12.017; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Vavilala MS, 2019, LANCET CHILD ADOLESC, V3, P23, DOI 10.1016/S2352-4642(18)30341-9; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507	22	1	1	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2021	38	4					513	518		10.1089/neu.2020.7323		NOV 2020	6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QC1FI	WOS:000590791300001	33040670				2022-02-06	
J	Fino, PC; Raffegeau, TE; Parrington, L; Peterka, RJ; King, LA				Fino, Peter C.; Raffegeau, Tiphanie E.; Parrington, Lucy; Peterka, Robert J.; King, Laurie A.			Head stabilization during standing in people with persisting symptoms after mild traumatic brain injury	JOURNAL OF BIOMECHANICS			English	Article						Posture; Balance; Sway; Sensory Integration; Concussion; Stability	POSTURAL-CONTROL; SENSORY INTEGRATION; LOCOMOTOR TASKS; BALANCE CONTROL; FRONTAL PLANE; QUIET; STANCE; COORDINATION; VALIDATION; CONCUSSION	Increased postural sway is often observed in people with mild traumatic brain injury (mTBI), but our understanding of how individuals with mTBI control their head during stance is limited. The purpose of this study was to determine if people with mTBI exhibit increased sway at the head compared with healthy controls. People with persisting symptoms after mTBI (n = 59, 41 women) and control participants (n = 63, 38 women) stood quietly for one minute in four conditions: eyes open on a firm surface (EO-firm), eyes closed on a firm surface (EC-firm), eyes open on a foam pad (EO-foam), and eyes closed on foam (EC-foam). Inertial sensors at the head, sternum, and lumbar region collected tri-axial accelerations. Root-mean-square (RMS) accelerations in anteroposterior (AP) and mediolateral (ML) directions and sway ratios between the head and sternum, head and lumbar, and sternum and lumbar region were compared between groups. Temporal coupling of anti-phase motion between the upper and lower body angular accelerations was assessed with magnitude squared coherence and cross-spectral phase angles. People with mTBI demonstrated greater sway than controls across conditions and directions. During foam-surface conditions, the control group, but not the mTBI group, reduced ML sway at their head and trunk relative to their lumbar by increasing the expression of an anti-phase hip strategy within the frontal plane. These results are consistent with suggestions of inflexible or inappropriate postural control in people with mTBI. (C) 2020 Elsevier Ltd. All rights reserved.	[Fino, Peter C.; Raffegeau, Tiphanie E.] Univ Utah, Dept Hlth & Kinesiol, Salt Lake City, UT USA; [Parrington, Lucy; Peterka, Robert J.; King, Laurie A.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR USA; [Peterka, Robert J.; King, Laurie A.] VA Portland Hlth Care Syst, Natl Ctr Rehabil Auditory Res, Portland, OR USA		Fino, PC (corresponding author), 250 S 1850 E,Rm 257, Salt Lake City, UT 84112 USA.	peter.fino@utah.edu			Assistant Secretary of Defense for Health Affairs [W81XWH-15-1-0620]; Eunice Kennedy Shiver National Institute of Child Health & Human Development of the National Institutes of Health [K12HD073945]	The authors would like to acknowledge the research assistants who contributed to the subject recruitment, enrollment, and data collection throughout this process. This work was supported by the Assistant Secretary of Defense for Health Affairs under Award No. W81XWH-15-1-0620. Additionally, PCF was supported by the Eunice Kennedy Shiver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number K12HD073945. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense or the official views of the National Institutes of Health.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brandt T, 2001, J NEUROL NEUROSUR PS, V71, P8, DOI 10.1136/jnnp.71.1.8; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Creath R, 2005, NEUROSCI LETT, V377, P75, DOI 10.1016/j.neulet.2004.11.071; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; DiFabio RP, 1997, PHYS THER, V77, P458, DOI 10.1093/ptj/77.5.458; Farkhatdinov I, 2019, P ROY SOC A-MATH PHY, V475, DOI 10.1098/rspa.2018.0010; Fino PC, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0812-7; Fino PC, 2016, GAIT POSTURE, V50, P69, DOI 10.1016/j.gaitpost.2016.08.026; Freeman L, 2018, J GERIATR PHYS THER, V41, P77, DOI 10.1519/JPT.0000000000000110; Fujisawa N, 2005, MED BIOL ENG COMPUT, V43, P107, DOI 10.1007/BF02345130; Gage WH, 2004, GAIT POSTURE, V19, P124, DOI 10.1016/S0966-6362(03)00037-7; Gera G, 2018, MIL MED, V183, P327, DOI 10.1093/milmed/usx162; Goodworth AD, 2010, J NEUROPHYSIOL, V104, P1103, DOI 10.1152/jn.00916.2009; GROSSMAN GE, 1988, EXP BRAIN RES, V70, P470; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Hansson EE, 2010, ACTA OTO-LARYNGOL, V130, P1358, DOI 10.3109/00016489.2010.498024; Haran FJ, 2016, J NEUROTRAUM, V33, P705, DOI 10.1089/neu.2015.4060; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Hsu WL, 2007, J NEUROPHYSIOL, V97, P3024, DOI 10.1152/jn.01142.2006; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; LUND S, 1983, ACTA PHYSIOL SCAND, V117, P307, DOI 10.1111/j.1748-1716.1983.tb07212.x; Mancini M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-59; Mergner T, 1998, BRAIN RES REV, V28, P118, DOI 10.1016/S0165-0173(98)00032-0; Moe-Nilssen R, 2002, GAIT POSTURE, V16, P60, DOI 10.1016/S0966-6362(01)00200-4; Moe-Nilssen R, 1998, CLIN BIOMECH, V13, P320, DOI 10.1016/S0268-0033(98)00089-8; Nicholas SC, 1998, J VESTIBUL RES-EQUIL, V8, P187; Paloski WH, 2006, GAIT POSTURE, V23, P315, DOI 10.1016/j.gaitpost.2005.04.009; Pettorossi VE, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00895; POZZO T, 1990, EXP BRAIN RES, V82, P97; POZZO T, 1991, EXP BRAIN RES, V85, P208; POZZO T, 1995, EXP BRAIN RES, V106, P327; Sakaguchi Masanori, 1995, Auris Nasus Larynx, V22, P151; Schmidt JD, 2018, J ATHL TRAINING, V53, P109, DOI 10.4085/1062-6050-326-16; Scoppa F, 2013, GAIT POSTURE, V37, P290, DOI 10.1016/j.gaitpost.2012.07.009; Sessoms PH, 2015, MIL MED, V180, P135, DOI 10.7205/MILMED-D-14-00386; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stoffregen TA, 2000, HUM FACTORS, V42, P458, DOI 10.1518/001872000779698097; Woodson J., 2015, TRAUMATIC BRAIN INJU; Zajac FE., 1993, PROG BRAIN RES, P349; Zhang YF, 2007, GAIT POSTURE, V26, P263, DOI 10.1016/j.gaitpost.2006.09.007	46	1	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	NOV 9	2020	112								110045	10.1016/j.jbiomech.2020.110045			10	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	PH3AW	WOS:000600291100001	33011672	Green Accepted, Green Submitted, Bronze			2022-02-06	
J	Joseph, ALC; Lippa, SM; Moore, B; Bagri, M; Row, J; Chan, L; Zampieri, C				Joseph, Annie-Lori C.; Lippa, Sara M.; Moore, Brian; Bagri, Manjot; Row, Jessica; Chan, Leighton; Zampieri, Cris			Relating Self-Reported Balance Problems to Sensory Organization and Dual-Tasking in Chronic Traumatic Brain Injury	PM&R			English	Article							LONGITUDINAL FOLLOW-UP; VESTIBULAR REHABILITATION; SERVICE MEMBERS; SINGLE-TASK; HEAD-INJURY; CONCUSSION; DIZZINESS; FALLS; GAIT; ASSOCIATIONS	Background Individuals who have experienced a traumatic brain injury (TBI) often have residual balance problems. It remains unclear whether these balance problems are driven by vestibular dysfunction or gait automaticity deficits, particularly in the chronic stages of TBI recovery, because most studies include only acute/subacute cases. Objectives Compare performance on the Sensory Organization Test vestibular score and Dual-Task test in individuals with and without subjective balance problems at least 1 year after a TBI. Investigate the ability of each test to predict perceived balance problems. Design Prospective cohort study. Setting Rehabilitation department within a single institution. Participants Fifty adults (21-71 years) with a history of mild, moderate, or severe TBI 1 to 5 years following nonpenetrating TBI. Interventions N/A. Methods Measures included the Dual-Task test, Sensory Organization Test, Neurobehavioral Symptom Inventory, Dizziness Handicap Inventory, and assessments of four cognitive domains and depression. Participants who endorsed "feeling dizzy" and "loss of balance" on the Neurobehavioral Symptom Inventory were classified as symptomatic (n = 26) and others as asymptomatic (n = 24). T-tests, chi-square, and regression analyses predicting the Dizziness Handicap Inventory total score were performed. Results Dual-task gait cost was negatively associated with the Dizziness Handicap Inventory (P = .044), controlling for depression and gender, whereas vestibular scores failed to predict balance-related disability. Symptomatic individuals endorsed more balance problems (P < .001) and depression symptoms (P = .007), had poorer dual-task cognitive output (P = .036), and slower dual-task gait velocity (P = .036) than asymptomatic participants. Groups did not differ on Sensory Organization Test scores. Conclusions The nature of balance problems in chronic TBI may be related to automaticity of gait. These findings suggest that patients in the chronic stages of TBI may benefit from dual-task assessments and interventions. Balance rehabilitation should be tailored to patient needs and assess cognition and affect.	[Joseph, Annie-Lori C.; Lippa, Sara M.; Bagri, Manjot; Row, Jessica; Chan, Leighton; Zampieri, Cris] NIH, Rehabil Med Dept, Clin Ctr, 10 Ctr Dr, Bethesda, MD 20892 USA; [Lippa, Sara M.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lippa, Sara M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Moore, Brian; Chan, Leighton] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Zampieri, C (corresponding author), NIH, Rehabil Med Dept, Clin Ctr, 10 Ctr Dr, Bethesda, MD 20892 USA.	cristiane.zampieri-gallagher@nih.gov	Joseph, Annie-Lori C/AAX-3221-2021	Zampieri, Cris/0000-0003-4632-7941; Joseph, Annie-Lori/0000-0002-6773-7934	National Institutes of Health (NIH) Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense	This work was supported by the National Institutes of Health (NIH) Intramural Research Program and the Center for Neuroscience and Regenerative Medicine.	Academy of Neurological Physical Therapy, 2013, TBI EDGE OUTC MEAS I; Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; [Anonymous], 2016, VA DOD CLIN PRACT GU; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Brandler TC, 2012, AM J GERIAT PSYCHIAT, V20, P425, DOI 10.1097/JGP.0b013e31821181c6; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; de Groot MH, 2013, DRUG AGING, V30, P901, DOI 10.1007/s40266-013-0113-9; DeFilippis N., 1997, BOOKLET CATEGORY TES, V2nd; Dretsch M, 2016, J HEAD TRAUMA REHAB, V31, P23, DOI 10.1097/HTR.0000000000000109; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Green P, 2004, GREENS MED SYMPTOM V; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Gurr B, 2001, BRAIN INJURY, V15, P387, DOI 10.1080/02699050010005904; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hays K, 2019, BRAIN INJURY, V33, P435, DOI 10.1080/02699052.2019.1565900; Herdman SJ, 2014, VESTIBULAR REHABILIT; Honrubia V, 1996, AM J OTOL, V17, P595; Howell David R, 2018, Concussion, V3, pCNC54, DOI 10.2217/cnc-2017-0014; IBM Corp, 2019, IBM SPSS STAT WINDOW; Ingriselli JM, 2014, J SCI MED SPORT, V17, P580, DOI 10.1016/j.jsams.2013.11.006; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P663, DOI 10.1007/978-0-387-76978-3_21; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kleffelgaard I, 2016, PHYS THER, V96, P839, DOI 10.2522/ptj.20150095; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Kolev OI, 2016, FUNCT NEUROL, V31, P75; Mancini M, 2010, EUR J PHYS REHAB MED, V46, P239; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Nashner LM, 1997, HDB BALANCE FUNCTION; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Pearson N. C. S., 2009, TEST PREMORBID FUNCT; Perry SB, 2014, J HEAD TRAUMA REHAB, V29, P117, DOI 10.1097/HTR.0b013e3182864f2f; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Popescu C, 2015, J Med Life, V8, P272; Reitan RM, 1979, MANUAL ADM SCORING T; Roth, 2014, MILD TRAUMATIC BRAIN, P321; Row J, 2019, J NEUROTRAUM, V36, P2435, DOI 10.1089/neu.2018.5755; Ruet A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00120; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Turcu A, 2004, GERONTOLOGY, V50, P303, DOI 10.1159/000079128; Umphred D. A., 2001, NEUROLOGICAL REHABIL; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wei TS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177136; Wenzler S, 2017, PSYCHIAT RES, V253, P303, DOI 10.1016/j.psychres.2017.03.040; Wolfson D, 1989, CLIN NEUROPSYCHOL, V3, P70, DOI [10.1080/13854048908404078, DOI 10.1080/13854048908404078]; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357	61	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	AUG	2021	13	8					870	879		10.1002/pmrj.12478		NOV 2020	10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	TU8UF	WOS:000590813500001	32844594	Bronze			2022-02-06	
J	Wang, XZ; Ge, RX; Yuan, JL; Xu, SS; Fang, XG; Dai, Y; Jiang, XC				Wang, Xuanzhi; Ge, Ruixiang; Yuan, Jinlong; Xu, Shanshui; Fang, Xinggen; Dai, Yi; Jiang, Xiaochun			Risk Factors and Prognostic Value of Swirl Sign in Traumatic Acute Epidural Hematoma	FRONTIERS IN NEUROLOGY			English	Article						swirl sign; risk factor; prognostic; surgical; acute epidural hematoma		Objective: Acute epidural hematoma (AEDH) is one of the deadliest lesions in patients after traumatic brain injury. AEDH with swirl sign progresses rapidly and requires timely surgical treatment. This study aims to investigate the risk factors for the occurrence of AEDH with swirl sign and its prognostic value. Methods: Retrospective analysis was performed on 131 AEDH patients, who were divided into swirl sign group and non-swirl sign group based on the brain computed tomographic (CT) scan. Patient information, including gender, age, hypertension, mechanism of injury, Glasgow Coma Scale (GCS) score on admission, time from injury to CT scan, pupillary light reactivity on admission, midline shift, location of hematoma, hematoma volume on admission, oral anticoagulation, and Glasgow Outcome Scale (GOS) score at 3 months were collected. Univariate analysis was used to determine the risk factors for the occurrence of swirl sign. The factors with P < 0.05 were recruited into the multivariate logistic regression analysis and predictive receiver operating characteristic (ROC) curve model. Results: Univariate analysis demonstrated that the GCS score on admission (P = 0.007), pupillary light reactivity (P = 0.003), location of hematoma (P < 0.0001), and GOS score at 3 months (P = 0.007) were risk factors for the occurrence of swirl sign. Multivariate logistic regression model revealed that the location of hematoma (OR = 0.121; 95% CI: 0.019-0.786; P = 0.027) was an independent risk factor for swirl sign, and the occurrence of swirl sign was a significant predictor of unfavorable neurological outcomes (OR = 0.100; 95% CI: 0.016-0.630; P = 0.014). ROC curves demonstrated that the GCS score on admission (AUC = 0.655; 95% CI: 0.506-0.804), pupillary light reactivity (AUC = 0.625; 95% CI: 0.474-0.777) and location of hematoma (AUC = 0.788; 95% CI: 0.682-0.893) can predict the occurrence of swirl sign, respectively. Remarkably, the combination of these three factors (AUC = 0.829; 95% CI: 0.753-0.906) provided a greater power to predict the swirl sign. Conclusion: GCS score on admission, pupillary light reactivity, and location of hematoma are risk factors for the occurrence of swirl sign, respectively. The combination of these three factors might be used to predict whether there is swirl sign in AEDH after traumatic brain injury. Furthermore, swirl sign can be used as an effective predictor of poor prognosis in patients.	[Wang, Xuanzhi] Univ Sci & Technol China, Div Life Sci & Med, Affiliated Hosp USTC 1, Dept Neurosurg, Hefei, Peoples R China; [Ge, Ruixiang; Yuan, Jinlong; Xu, Shanshui; Fang, Xinggen; Dai, Yi; Jiang, Xiaochun] Wannan Med Coll, Yijishan Hosp, Affiliated Hosp 1, Dept Neurosurg, Wuhu, Peoples R China		Wang, XZ (corresponding author), Univ Sci & Technol China, Div Life Sci & Med, Affiliated Hosp USTC 1, Dept Neurosurg, Hefei, Peoples R China.	wangxuanzhi2013@163.com			Anhui Provincial Natural Science FoundationNatural Science Foundation of Anhui Province [2008085QH421]; Key Scientific Research Project of Wannan Medical College [WK2019ZF02]; Special Scientific Research Fund for Talents Introduction in Yijishan Hospital of Wannan Medical College [YR202008]	This research was supported by the following programs: Supported by Anhui Provincial Natural Science Foundation (2008085QH421); the Key Scientific Research Project of Wannan Medical College (WK2019ZF02); and Special Scientific Research Fund for Talents Introduction in Yijishan Hospital of Wannan Medical College (YR202008).	Al-Nakshabandi NA, 2001, RADIOLOGY, V218, P433, DOI 10.1148/radiology.218.2.r01fe09433; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Chelly H, 2019, EUR J TRAUMA EMERG S, V45, P245, DOI 10.1007/s00068-017-0885-4; Guo C, 2017, NEUROL SCI, V38, P2111, DOI 10.1007/s10072-017-3121-4; Gupta VK, 2019, WORLD NEUROSURG, V121, P95, DOI 10.1016/j.wneu.2018.10.010; Gurer B, 2017, TURK NEUROSURG, V27, P37, DOI 10.5137/1019-5149.JTN.14809-15.0; Gutowski P, 2018, WORLD NEUROSURG, V118, pE166, DOI 10.1016/j.wneu.2018.06.147; Jahns FP, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2436-3; Mishra GP, 2015, INT J MED RES REV, V10, P1146, DOI [10.17511/ijmrr.2015.i10.207, DOI 10.17511/IJMRR.2015.I10.207]; Ndoumbe A, 2017, OPEN J MODERN NEUROS, V8, P109, DOI [10.4236/ojmn.2018.81009, DOI 10.4236/OJMN.2018.81009]; Pouraghaei M, 2013, LIFE SCI J, V10, P220; Rosa M, 2019, ARQ NEURO-PSIQUIAT, V77, P140, DOI [10.1590/0004-282X20190010, 10.1590/0004-282x20190010]; Rosenthal AA, 2017, AM SURGEON, V83, pE438; Rosyidi RM, 2019, INTERDISCIP NEUROSUR, V17, P12, DOI 10.1016/j.inat.2019.01.021; Soon WC, 2016, BRIT J NEUROSURG, V30, P233, DOI 10.3109/02688697.2015.1119237; Udoh DO, 2012, NIGER J CLIN PRACT, V15, P104, DOI 10.4103/1119-3077.94111; Volpi PC, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0197-y	17	1	1	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 9	2020	11								543536	10.3389/fneur.2020.543536			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OU1NB	WOS:000591300500001	33240193	gold, Green Published			2022-02-06	
J	Bordoni, L; Li, BQ; Kura, S; Boas, DA; Sakadzic, S; Ostergaard, L; Frische, S; Gutierrez-Jimenez, E				Bordoni, Luca; Li, Baoqiang; Kura, Sreekanth; Boas, David A.; Sakadzic, Sava; ostergaard, Leif; Frische, Sebastian; Gutierrez-Jimenez, Eugenio			Quantification of Capillary Perfusion in an Animal Model of Acute Intracranial Hypertension	JOURNAL OF NEUROTRAUMA			English	Article						brain edema; capillary perfusion; cerebral perfusion pressure; intracranial hypertension; optical imaging	TRAUMATIC BRAIN-INJURY; TRANSIT-TIME HETEROGENEITY; CEREBRAL-BLOOD-FLOW; PRESSURE THRESHOLDS; MANAGEMENT; EDEMA; PATHOGENESIS; OXYGENATION; REACTIVITY; GUIDELINES	Intracranial hypertension (IH) is a common feature of many pathologies, including brain edema. In the brain, the extended network of capillaries ensures blood flow to meet local metabolic demands. Capillary circulation may be severely affected by IH, but no studies have quantified the effect of intracranial pressure (ICP) and cerebral perfusion pressure (CPP) on capillary perfusion during the development of brain edema. We used optical coherence tomography angiography to quantify relative changes of fractional perfused volume (FPV) in cortical capillaries and simultaneously monitored ICP and blood pressure (BP) in anesthetized male C57Bl/6NTac mice during development of brain edema induced by water intoxication (WI) within 30 min. WI induced severe IH and brain herniation. ICP and CPP reached 90.2 mm Hg and 38.4 mm Hg, respectively. FPV was significantly affected already at normal ICP (ICP <15 mm Hg, slope approximate to -1.46, p < 0.001) and, at the onset of IH (ICP = 20-22 mm Hg), FPV was 17.9 +/- 13.3% lower than baseline. A decreasing trend was observed until the ICP peak (Delta%FPV = -43.6 +/- 19.2%). In the ICP range of 7-42 mm Hg, relative changes in FPV were significantly correlated with ICP, BP, and CPP (p < 0.001), with ICP and CPP being the best predictors. In conclusion, elevated ICP induces a gradual collapse of the cerebral microvasculature, which is initiated before the clinical threshold of IH. In summary, the estimate of capillary perfusion might be essential in patients with IH to assess the state of the brain microcirculation and to improve the availability of oxygen and nutrients to the brain.	[Bordoni, Luca; Frische, Sebastian] Aarhus Univ, Inst Biomed, Aarhus C, Denmark; [ostergaard, Leif; Gutierrez-Jimenez, Eugenio] Aarhus Univ, Dept Clin Med, Aarhus C, Denmark; [Li, Baoqiang] Chinese Acad Sci, Brain Cognit & Brain Dis Inst, Shenzhen, Peoples R China; [Li, Baoqiang] Shenzhen Fundamental Res Inst, Shenzhen Hong Kong Inst Brain Sci, Shenzhen, Peoples R China; [Kura, Sreekanth; Boas, David A.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Boas, David A.; Sakadzic, Sava] Harvard Med Sch, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [ostergaard, Leif] Aarhus Univ Hosp, Dept Neuroradiol, Aarhus C, Denmark		Gutierrez-Jimenez, E (corresponding author), Aarhus Univ Hosp, Ctr Funct Integrat Neurosci, Norrebrogade 44,Bldg 1A, DK-8000 Aarhus C, Denmark.	eugenio@cfin.au.dk	Frische, Sebastian/B-2332-2009	Frische, Sebastian/0000-0002-0270-3602; Bordoni, Luca/0000-0002-2428-0874	Danish Medical Research Council (DFF grant) [4004-00504]; VELUX foundation (ARCADIA); Korningfonden; Hojmosegardgrant (Laegeforeningen) [2017-1064/102 KBN]	This study was supported by the following grant from the Danish Medical Research Council (DFF grant id: 4004-00504) and VELUX foundation (ARCADIA). Further financial support was obtained from Korningfonden and the Hojmosegardgrant (Laegeforeningen, 2017-1064/102 KBN).	Al-Mujaini Abdullah, 2013, Oman Med J, V28, P86, DOI 10.5001/omj.2013.24; Alosh H, 2016, J APPL PHYSIOL, V121, P255, DOI 10.1152/japplphysiol.00760.2015; Angleys H, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00103; Angleys H, 2015, J CEREBR BLOOD F MET, V35, P806, DOI 10.1038/jcbfm.2014.254; Bordoni L, 2020, EXP ANIM TOKYO, V69, P92, DOI 10.1538/expanim.19-0040; Bragin DE, 2016, ACTA NEUROCHIR SUPPL, V122, P255, DOI 10.1007/978-3-319-22533-3_51; Bragin DE, 2011, J NEUROTRAUM, V28, P775, DOI 10.1089/neu.2010.1692; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2013, INTENS CARE MED, V39, P771, DOI 10.1007/s00134-013-2852-9; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Dai XP, 2016, CRIT CARE MED, V44, pE633, DOI 10.1097/CCM.0000000000001625; de Noriega FR, 2018, J CLIN NEUROSCI, V58, P192, DOI 10.1016/j.jocn.2018.10.051; Donnelly J, 2018, ACTA NEUROCHIR SUPPL, V126, P47, DOI 10.1007/978-3-319-65798-1_10; Dreier JP, 2018, ANN NEUROL, V83, P295, DOI 10.1002/ana.25147; Erdener SE, 2019, J CEREBR BLOOD F MET, V39, DOI 10.1177/0271678X17743877; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/bfb0056195; Guild SJ, 2015, J APPL PHYSIOL, V119, P576, DOI 10.1152/japplphysiol.00165.2015; Gutierrez-Jimenez E, 2016, J CEREBR BLOOD F MET, V36, P2072, DOI 10.1177/0271678X16631560; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Helbok R, 2018, INTENS CARE MED, V44, P1318, DOI 10.1007/s00134-018-5249-y; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Jha RM, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0912-9; Khanna A, 2014, TRANSL STROKE RES, V5, P3, DOI 10.1007/s12975-013-0307-9; Leinonen V, 2018, HAND CLINIC, V145, P25, DOI 10.1016/B978-0-12-802395-2.00004-3; Madhok DY, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0905-8; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Maresova D, 2014, NEUROENDOCRINOL LETT, V35, P274; Mestre H, 2020, SCIENCE, V367, P1211, DOI 10.1126/science.aax7171; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Moazen M, 2016, J BIOMECH, V49, P123, DOI 10.1016/j.jbiomech.2015.11.012; Munakomi, 2020, BRAIN HERNIATION; Nase G, 2008, GLIA, V56, P895, DOI 10.1002/glia.20664; Ostergaard L, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0557-x; Ostergaard L, 2014, J CEREBR BLOOD F MET, V34, P1585, DOI 10.1038/jcbfm.2014.131; Pedersen SH, 2018, WORLD NEUROSURG, V110, pE119, DOI 10.1016/j.wneu.2017.10.086; Pinto V.L., 2018, INCREASED INTRACRANI; Pires PW, 2013, AM J PHYSIOL-HEART C, V304, pH1598, DOI 10.1152/ajpheart.00490.2012; Rasmussen PM, 2015, J CEREBR BLOOD F MET, V35, P432, DOI 10.1038/jcbfm.2014.213; Rodriguez CLR, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.2.025004; Rungta RL, 2015, CELL, V161, P610, DOI 10.1016/j.cell.2015.03.029; Sakadzic S, 2010, NAT METHODS, V7, P755, DOI 10.1038/nmeth.1490; Schmidt E.A., 2018, FRONT PHYSIOL, P9; Schuller K, 2013, JOVE-J VIS EXP, DOI 10.3791/50845; Smith AF, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00233; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Srinivasan VJ, 2010, OPT EXPRESS, V18, P2477, DOI 10.1364/OE.18.002477; Srinivasan VJ, 2010, OPT LETT, V35, P43, DOI 10.1364/OL.35.000043; Stocchetti N, 2018, INTENS CARE MED, V44, P1321, DOI 10.1007/s00134-018-5251-4; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Vollmar B, 1999, J TRAUMA, V46, P91, DOI 10.1097/00005373-199901000-00015	54	1	1	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2021	38	4					446	454		10.1089/neu.2019.6901		NOV 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QC1FI	WOS:000590828400001	32998634				2022-02-06	
J	Mattke, S; Cramer, SC; Wang, M; Bettger, JP; Cockroft, KM; Feng, WW; Jaffee, M; Oyesanya, TO; Puccio, AM; Temkin, N; Winstein, C; Wolf, SL; Yochelson, MR				Mattke, Soeren; Cramer, Steven C.; Wang, Mo; Bettger, Janet Prvu; Cockroft, Kevin M.; Feng, Wuwei; Jaffee, Michael; Oyesanya, Tolu O.; Puccio, Ava M.; Temkin, Nancy; Winstein, Carolee; Wolf, Steven L.; Yochelson, Michael R.			Estimating minimal clinically important differences for two scales in patients with chronic traumatic brain injury	CURRENT MEDICAL RESEARCH AND OPINION			English	Article						Expert panel; minimal clinically important difference; outcomes measurement; traumatic brain injury	FUGL-MEYER ASSESSMENT; UPPER-EXTREMITY; OUTCOME MEASURES; STROKE; RESPONSIVENESS; IMPAIRMENT; RECOVERY; MODERATE	Background This study aimed to establish the minimal clinically important difference (MCID) for the Fugl-Meyer Motor Scale (FMMS) and the Disability Rating Scale (DRS) to evaluate interventions in patients with motor deficits in the chronic phase after traumatic brain injury (TBI). Methods MCIDs were established with a structured expert consultation process, the RAND/UCLA modified Delphi method. This process consisted of a literature review and input from a 10-person, multidisciplinary expert panel. The experts were asked to rate meaningfulness of improvements in hypothetical patients and numeric changes via two rounds of ratings and an in-person meeting. Results The estimated MCIDs were six and five points on the FMMS Upper and Lower Extremity Scale, respectively, and one point on the DRS. The experts argued against establishing an MCID for the combined FMMS because the same change was more likely to be meaningful if concentrated in one extremity and because a meaningful improvement in one extremity implies meaningfulness irrespective of the changes in the other. Conclusions This study is the first to establish MCIDs for the FMMS and the DRS in the chronic phase after TBI. The results may be helpful for the design and interpretation of clinical trials of interventions.	[Mattke, Soeren; Wang, Mo; Winstein, Carolee] Univ Southern Calif, Dept Econ, Los Angeles, CA 90007 USA; [Cramer, Steven C.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Bettger, Janet Prvu; Oyesanya, Tolu O.] Duke Univ, Hlth Serv Res, Durham, NC USA; [Cockroft, Kevin M.] Penn State Univ, Coll Med, Dept Neurosurg, University Pk, PA 16802 USA; [Feng, Wuwei] Duke Univ, Sch Med, Dept Neurol, Durham, NC USA; [Jaffee, Michael] Univ Florida, Dept Neurol, Gainesville, FL USA; [Puccio, Ava M.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Temkin, Nancy] Univ Washington, Dept Neurosurg, Seattle, WA USA; [Wolf, Steven L.] Emory Univ, Sch Med, Dept Phys Therapy, Atlanta, GA USA; [Wolf, Steven L.] Atlanta VA Hlth Syst, VA Ctr Visual & Neurocognit Rehabil, Atlanta, GA USA; [Yochelson, Michael R.] Shepherd Ctr, Dept Neurol, Atlanta, GA USA		Mattke, S (corresponding author), Univ Southern Calif, Ctr Improving Chron Illness Care, 635 Downey Way, Los Angeles, CA 90089 USA.	mattke@usc.edu		Oyesanya, Tolu/0000-0001-8821-4510; Feng, Wuwei/0000-0001-6230-4905			Arya KN, 2011, TOP STROKE REHABIL, V18, P599, DOI 10.1310/tsr18s01-599; BROOKS RA, 1986, IEEE T ROBOTIC AUTOM, V2, P14, DOI 10.1109/JRA.1986.1087032; Bushnell C, 2015, CIRC CARDIOVASC Q S3, V8, pS163, DOI 10. 1161/CIRCOUTCOMES. 115. 002098; Control CoD, TBI DAT STAT; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Fan MC, 2020, WORLD NEUROSURG, V137, pE183, DOI 10.1016/j.wneu.2020.01.113; Fitch K, 2001, RANDUCLA APPROPRIATE; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Henderson EJ, 2019, PARKINSONISM RELAT D, V61, P106, DOI 10.1016/j.parkreldis.2018.11.008; Horner MD, 2008, J HEAD TRAUMA REHAB, V23, P74, DOI 10.1097/01.HTR.0000314526.01006.c8; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Lundquist CB, 2017, DISABIL REHABIL, V39, P934, DOI 10.3109/09638288.2016.1163422; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Malec JF, 2020, ARCH PHYS MED REHAB, V101, P1090, DOI 10.1016/j.apmr.2019.12.008; McCulloch KL, 2016, J NEUROL PHYS THER, V40, P269, DOI 10.1097/NPT.0000000000000145; Page SJ, 2012, PHYS THER, V92, P791, DOI 10.2522/ptj.20110009; Pandian S, 2016, TOP STROKE REHABIL, V23, P233, DOI 10.1179/1945511915Y.0000000003; Rai SK, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0658-6; See J, 2013, NEUROREHAB NEURAL RE, V27, P732, DOI 10.1177/1545968313491000; Steinberg G.K., 2018, J NEUROSURG, V23, P1, DOI DOI 10.3171/2018.5.JNS173147); Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Unsworth CA, 2015, DISABIL REHABIL, V37, P997, DOI 10.3109/09638288.2014.952450; van der Lee JH, 2001, J REHABIL MED, V33, P110; van der Lee JH, 2004, STROKE, V35, P1410, DOI 10.1161/01.STR.0000126900.24964.7e; van der Lee JH, 1999, STROKE, V30, P2369, DOI 10.1161/01.STR.30.11.2369; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wang YC, 2011, PHYS THER, V91, P675, DOI 10.2522/ptj.20100229; Williams MW, 2017, REHABIL PSYCHOL, V62, P407, DOI 10.1037/rep0000168; Wu X, 2015, SPINAL CORD, V53, P84, DOI 10.1038/sc.2014.232; Zhou YX, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00301	32	1	1	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0300-7995	1473-4877		CURR MED RES OPIN	Curr. Med. Res. Opin.	DEC 1	2020	36	12					1999	2007		10.1080/03007995.2020.1841616		NOV 2020	9	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Research & Experimental Medicine	PC2KX	WOS:000587849300001	33095678	hybrid			2022-02-06	
J	Wong, JYH; Choi, AWM; Wong, JKS; Ng, ZLH; Cheung, KY; Lau, CL; Kam, CW; Fong, DYT				Wong, Janet Yuen-Ha; Choi, Anna Wai-Man; Wong, John Kit-Shing; Ng, Zoe Lai-Han; Cheung, Kai-Yeung; Lau, Chu-Leung; Kam, Chak-Wah; Fong, Daniel Yee-Tak			Impact of mild traumatic brain injury on physical, mental and cognitive functioning of abused women admitted to emergency units	HEALTH & SOCIAL CARE IN THE COMMUNITY			English	Article; Early Access						cognitive functioning; emergency units; intimate partner violence; mild traumatic brain injury; women	INTIMATE PARTNER VIOLENCE; HEALTH SURVEY; CHRONIC PAIN; EQUIVALENT; SYMPTOMS; VICTIMS	Limited studies exist on women's mild traumatic brain injury received from episode of intimate partner violence. This study aims to identify the occurrence of intimate partner violence-related mild traumatic brain injury in Chinese women admitted to emergency units; and examine the physical, mental, and cognitive functioning of abused women with mild traumatic brain injury related to violent episodes. Eighty-six Chinese abused women presenting at emergency units in four major local hospitals in Hong Kong between January 2014 and December 2016 were recruited. They were admitted for the treatment of intimate partner violence-related physical injuries and were screened for traumatic brain injury by the emergency unit nurses at triage. Participants were assessed for traumatic brain injury based on the definition from US Center for Disease Control and Prevention, post-concussion physical symptoms, anxiety and depression, health-related quality of life, and cognitive functioning. Structured multiphase regression was used to examine the impact of intimate partner violence-related mild traumatic brain injury on physical, mental, and cognitive functioning of participants. We found that 24.4% of participants had intimate partner violence-related mild traumatic brain injury. There were significantly more severe post-concussion physical symptoms in abused women with intimate partner violence-related mild traumatic brain injury than those without mild traumatic brain injury (estimate = 18.7, 95% CI = 10.9 to 26.6, p < 0.001). The Mental Component Summary was also significantly associated with intimate partner violence-related mild traumatic brain injury (estimate = -7.9, 95% CI = -13.8 to -2.1, p = 0.009). Regarding cognitive functioning, the mean total test scores indicated that both groups were cognitively abnormal and there was no significant impact from mild traumatic brain injury. This study provides evidence on the impact of mild traumatic brain injury and implications in screening for mild traumatic brain injury and early intervention for improving quality of life in abused women.	[Wong, Janet Yuen-Ha; Ng, Zoe Lai-Han; Fong, Daniel Yee-Tak] Univ Hong Kong, Li Ka Shing Fac Med, Sch Nursing, Pokfulam, 4-F,William MW Mong Block,21 Sassoon Rd, Hong Kong, Peoples R China; [Choi, Anna Wai-Man] City Univ Hong Kong, Dept Social & Behav Sci, Hong Kong, Peoples R China; [Wong, John Kit-Shing; Lau, Chu-Leung; Kam, Chak-Wah] Hosp Author Hong Kong, Tuen Mun Hosp, Dept Accid & Emergency Med, Hong Kong, Peoples R China; [Cheung, Kai-Yeung] Hosp Author Hong Kong, United Christian Hosp, Accid & Emergency Dept, Hong Kong, Peoples R China		Fong, DYT (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Nursing, Pokfulam, 4-F,William MW Mong Block,21 Sassoon Rd, Hong Kong, Peoples R China.	dytfong@hku.hk	Fong, Daniel/C-4269-2009; Choi, Wai Man/F-9776-2012; Wong, Janet Yuen Ha/F-4433-2011	Fong, Daniel/0000-0001-7365-9146; Choi, Wai Man/0000-0002-9341-8515; Wong, Janet Yuen Ha/0000-0002-3000-4577	Early Career Schemes, Hong Kong Research Grants Council, UGC [HKU 757213H, HKU 759213H]	Early Career Schemes, Hong Kong Research Grants Council, UGC, Grant/Award Number: HKU 757213H and HKU 759213H	Ahmad I, 2017, J CLIN NURS, V26, P3271, DOI 10.1111/jocn.13706; Arosarena OA, 2009, ARCH FACIAL PLAST S, V11, P48, DOI 10.1001/archfacial.2008.507; Breiding MJ., 2015, INTIMATE PARTNER VIO; Centers for Disease Control and Prevention, 2003, HEADS BRAIN INJ YOUR; Centers for Disease Control and Prevention, 2014, INJ PREV CONTR TRAUM; Chan KL., 2005, STUDY CHILD ABUSE SP; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Fennema-Notestine C, 2002, BIOL PSYCHIAT, V52, P1089, DOI 10.1016/S0006-3223(02)01413-0; Granziera C, 2015, NEUROIMAGE-CLIN, V8, P631, DOI 10.1016/j.nicl.2015.06.003; Guglielmetti M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114024; Haag Halina Lin, 2019, Trauma Violence Abuse, p1524838019850623, DOI 10.1177/1524838019850623; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lam CLK, 2005, QUAL LIFE RES, V14, P539, DOI 10.1007/s11136-004-0704-3; Lam ETP, 2013, J EVAL CLIN PRACT, V19, P200, DOI 10.1111/j.1365-2753.2011.01800.x; Lau C. L., 2008, Hong Kong Medical Journal, V14, P451; Leung C M, 1993, Int J Psychosom, V40, P29; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Murray CE, 2016, TRAUMA VIOLENCE ABUS, V17, P298, DOI 10.1177/1524838015584364; O'Doherty L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007007.pub3; Peterson C, 2018, AM J PREV MED, V55, P433, DOI 10.1016/j.amepre.2018.04.049; Picard N, 1999, H128A0002 US DEP ED; Shields C, 2016, NEUROPSYCHOL REHABIL, V26, P410, DOI 10.1080/09602011.2015.1037772; Smith S.G., 2017, NATL INTIMATE PARTNE; St Ivany A, 2018, J FORENSIC NURS, V14, P198, DOI 10.1097/JFN.0000000000000220; Tiwari A, 2013, J INTERPERS VIOLENCE, V28, P1067, DOI 10.1177/0886260512459380; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Wong A, 2009, DEMENT GERIATR COGN, V28, P81, DOI 10.1159/000232589; Wong JYH, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-6; World Health Organization, 2002, WORLD REPORT VIOLENC; Wuest J, 2008, J PAIN, V9, P1049, DOI 10.1016/j.jpain.2008.06.009; Yang CW, 2012, APPL RES QUAL LIFE, V7, P63, DOI 10.1007/s11482-011-9148-4	37	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0966-0410	1365-2524		HEALTH SOC CARE COMM	Health Soc. Care Community												10.1111/hsc.13218		NOV 2020	7	Public, Environmental & Occupational Health; Social Work	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Social Work	ON6VL	WOS:000586835800001	33159412				2022-02-06	
J	Yang, J; Ma, K; Zhang, CP; Liu, YF; Liang, F; Hu, WZ; Bian, XW; Yang, SM; Fu, XB				Yang, Jie; Ma, Kui; Zhang, Cuiping; Liu, Yufan; Liang, Feng; Hu, Wenzhi; Bian, Xiaowei; Yang, Siming; Fu, Xiaobing			Burns Impair Blood-Brain Barrier and Mesenchymal Stem Cells Can Reverse the Process in Mice	FRONTIERS IN IMMUNOLOGY			English	Article						burns; blood&#8211; brain barrier; mesenchymal stem cells; interleukin-6; interleukin-1&#946; Mfsd2a	CATENIN; INJURY; DISRUPTION; EXPRESSION; TRANSPORT; STRESS; TISSUE	Neurological syndromes are observed in numerous patients who suffer burns, which add to the economic burden of societies and families. Recent studies have implied that blood-brain barrier (BBB) dysfunction is the key factor that induces these central nervous system (CNS) syndromes in peripheral traumatic disease, e.g., surgery and burns. However, the effect of burns on BBB and the underlying mechanism remains, largely, to be determined. The present study aimed to investigate the effect of burns on BBB and the potential of umbilical cord-derived mesenchymal stem cells (UC-MSCs), which have strong anti-inflammatory and repairing ability, to protect the integrity of BBB. BBB permeability was evaluated using dextran tracer (immunohistochemistry imaging and spectrophotometric quantification) and western blot, interleukin (IL)-6, and IL-1 beta levels in blood and brain were measured by enzyme-linked immunosorbent assay. Furthermore, transmission electron microscopy (TEM) was used to detect transcellular vesicular transport (transcytosis) in BBB. We found that burns increased mouse BBB permeability to both 10-kDa and 70-kDa dextran. IL-6 and IL-1 beta levels increased in peripheral blood and CNS after burns. In addition, burns decreased the level of tight junction proteins (TJs), including claudin-5, occludin, and ZO-1, which indicated increased BBB permeability due to paracellular pathway. Moreover, increased vesicular density after burns suggested increased transcytosis in brain microvascular endothelial cells. Finally, administering UC-MSCs at 1 h after burns effectively reversed these adverse effects and protected the integrity of BBB. These results suggest that burns increase BBB permeability through both paracellular pathway and transcytosis, the potential mechanism of which might be through increasing IL-6 and IL-1 beta levels and decreasing Mfsd2a level, and appropriate treatment with UC-MSCs can reverse these effects and protect the integrity of BBB after burns.	[Yang, Jie; Ma, Kui; Zhang, Cuiping; Liu, Yufan; Liang, Feng; Hu, Wenzhi; Bian, Xiaowei; Yang, Siming; Fu, Xiaobing] Chinese Peoples Liberat Army PLA Gen Hosp, Med Innovat Res Dept, Res Ctr Tissue Repair & Regenerat, Beijing, Peoples R China; [Yang, Jie; Ma, Kui; Zhang, Cuiping; Liu, Yufan; Liang, Feng; Hu, Wenzhi; Bian, Xiaowei; Yang, Siming; Fu, Xiaobing] PLA Med Coll, Beijing, Peoples R China; [Yang, Jie; Liu, Yufan; Yang, Siming; Fu, Xiaobing] Peoples Liberat Army Gen Hosp, Med Ctr 4, Dept Dermatol, Beijing, Peoples R China; [Bian, Xiaowei] Tianjin Med Univ, Tianjin, Peoples R China		Yang, SM; Fu, XB (corresponding author), Chinese Peoples Liberat Army PLA Gen Hosp, Med Innovat Res Dept, Res Ctr Tissue Repair & Regenerat, Beijing, Peoples R China.; Yang, SM; Fu, XB (corresponding author), PLA Med Coll, Beijing, Peoples R China.; Yang, SM; Fu, XB (corresponding author), Peoples Liberat Army Gen Hosp, Med Ctr 4, Dept Dermatol, Beijing, Peoples R China.	ysm0117@126.com; fuxiaobing@vip.sina.com	Hu, wenzhi/ABI-6970-2020		National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801909, 81830064, 81721092]; Beijing Natural Science FoundationBeijing Natural Science Foundation [7184245]; National Key Research and Development Plan [2017YFC1103304]; Military Medical Research and Development Projects [18-JCJQQT-020, AWS17J005]	This study was supported in part by the National Nature Science Foundation of China (81801909, 81830064, 81721092), Beijing Natural Science Foundation (7184245), the National Key Research and Development Plan (2017YFC1103304), and the Military Medical Research and Development Projects (18-JCJQQT-020, AWS17J005).	Antonio N, 2019, REV PORT CARDIOL, V38, P657, DOI 10.1016/j.repc.2019.10.003; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bajorek AJ, 2017, PM&R, V9, P1, DOI 10.1016/j.pmrj.2016.06.023; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Bouhrira N, 2020, BIOFABRICATION, V12, DOI 10.1088/1758-5090/ab5898; Caplan AI, 2017, STEM CELL TRANSL MED, V6, P1445, DOI 10.1002/sctm.17-0051; Chen XD, 2018, BRAIN BEHAV IMMUN, V67, P24, DOI 10.1016/j.bbi.2017.08.002; Cheng ZB, 2018, MEDITERR J MATH, V15, DOI 10.1007/s00009-018-1184-y; Ciotti JR, 2018, CURR TREAT OPTION NE, V20, DOI 10.1007/s11940-018-0496-3; Clayton NA, 2018, BURNS, V44, P1997, DOI 10.1016/j.burns.2018.07.010; Dai TH, 2011, PHOTOCHEM PHOTOBIOL, V87, P342, DOI 10.1111/j.1751-1097.2011.00886.x; Danielson M, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1318-y; Dhanda S, 2018, MOL NEUROBIOL, V55, P3642, DOI 10.1007/s12035-017-0521-7; Ding DC, 2015, CELL TRANSPLANT, V24, P339, DOI 10.3727/096368915X686841; Duan TJ, 2020, BRAIN PATHOL, V30, P13, DOI 10.1111/bpa.12793; Foroshani MS, 2018, J STROKE CEREBROVASC, V27, P3053, DOI 10.1016/j.jstrokecerebrovasdis.2018.06.042; Freeze WM, 2020, NEUROBIOL AGING, V85, P113, DOI 10.1016/j.neurobiolaging.2019.09.017; Fulop GA, 2019, GEROSCIENCE, V41, P575, DOI 10.1007/s11357-019-00110-1; Gate D, 2020, NATURE, V577, P399, DOI 10.1038/s41586-019-1895-7; Greer N, 2018, J HEAD TRAUMA REHAB, V33, pE16, DOI 10.1097/HTR.0000000000000304; Holloman JP, 2013, AM J STEM CELLS, V2, P95; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jung YJ, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00313; Kafi MA, 2019, J MATER SCI-MATER M, V30, DOI 10.1007/s10856-019-6341-8; Kurte M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00802; Kutuzov N, 2018, P NATL ACAD SCI USA, V115, pE9429, DOI 10.1073/pnas.1802155115; Lammers T, 2015, ADV FUNCT MATER, V25, P36, DOI 10.1002/adfm.201401199; Li LH, 2011, FASEB J, V25, P1556, DOI 10.1096/fj.10-177279; Li ZQ, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00105; Linden JR, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008014; Liu J, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00660; Liu YQ, 2020, MOL NEUROBIOL, V57, P3891, DOI 10.1007/s12035-020-01998-z; Mansour A, 2020, J NEUROSURG, V133, P1460, DOI 10.3171/2019.7.JNS19212; Menge T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004660; Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y; Obeid DA, 2018, INT J BURNS TRAUMA, V8, P145; Ocak PE, 2020, EXP NEUROL, V326, DOI 10.1016/j.expneurol.2020.113203; Ohtsuki S, 2007, PHARM RES-DORDR, V24, P1745, DOI 10.1007/s11095-007-9374-5; Padden M, 2007, ACTA NEUROPATHOL, V113, P177, DOI 10.1007/s00401-006-0145-x; Partyka PP, 2017, BIOMATERIALS, V115, P30, DOI 10.1016/j.biomaterials.2016.11.012; Pati S, 2011, STEM CELLS DEV, V20, P89, DOI 10.1089/scd.2010.0013; Purohit M, 2014, ARCH PHYS MED REHAB, V95, P1342, DOI 10.1016/j.apmr.2014.01.029; Qu CH, 2020, BEHAV BRAIN RES, V379, DOI 10.1016/j.bbr.2019.112385; Randolph AC, 2019, SHOCK, V51, P634, DOI 10.1097/SHK.0000000000001196; Rashaan ZM, 2019, BURNS, V45, P1283, DOI 10.1016/j.burns.2019.03.025; Reyes R, 2009, J NEUROSURG, V110, P1218, DOI 10.3171/2008.8.JNS08382; Reza-Zaldivar EE, 2019, NEURAL REGEN RES, V14, P1626, DOI 10.4103/1673-5374.255978; Sun TJ, 2014, EUR REV MED PHARMACO, V18, P2460; Swan AA, 2018, BRAIN INJURY, V32, P1197, DOI 10.1080/02699052.2018.1495340; Tang GH, 2014, STEM CELLS, V32, P3150, DOI 10.1002/stem.1808; Tang Y, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1342-y; Thrippleton MJ, 2019, ALZHEIMERS DEMENT, V15, P840, DOI 10.1016/j.jalz.2019.01.013; Uchida T, 2017, MULT SCLER J, V23, P1072, DOI 10.1177/1352458516672015; Ude CC, 2018, MILITARY MED RES, V5, DOI 10.1186/s40779-018-0154-9; Ueno M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102600; Valenza M, 2020, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01656; Wang FX, 2020, J SOC INF DISPLAY, V28, P16, DOI 10.1002/jsid.857; Wang SS, 2018, J ALZHEIMERS DIS, V61, P1005, DOI 10.3233/JAD-170848; Wanga B, 2017, CURR NEUROVASC RES, V14, P359, DOI 10.2174/1567202614666171009105825; Wasiak J, 2017, INJURY, V48, P87, DOI 10.1016/j.injury.2016.07.032; Watson EJR, 2018, BURNS, V44, P1167, DOI 10.1016/j.burns.2018.04.011; Wen J, 2015, J AUTOIMMUN, V60, P40, DOI 10.1016/j.jaut.2015.03.005; Williams FN, 2019, WORLD J SURG, V43, P3035, DOI 10.1007/s00268-019-05165-x; Wojsiat J, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/6435861; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Wu MY, 2020, BRAIN RES, V1727, DOI 10.1016/j.brainres.2019.146553; Xu ZP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096752; Yahfoufi N, 2020, J GERONTOL A-BIOL, V75, P1251, DOI 10.1093/gerona/glaa006; Yahyapour R, 2018, MILITARY MED RES, V5, DOI 10.1186/s40779-018-0156-7; Yamamoto M, 2019, J NEUROSCI, V39, P4179, DOI 10.1523/JNEUROSCI.2506-18.2019; Yan L, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0091-0; Yang SM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00902; Yin F, 2019, WORLD J STEM CELLS, V11, P548, DOI 10.4252/wjsc.v11.i8.548; Yu S, 2018, ONCOL LETT, V15, P7443, DOI 10.3892/ol.2017.7543; Zhang C, 2017, J ALZHEIMERS DIS, V57, P505, DOI 10.3233/JAD-161268; Zhang H, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0897-3; Zhang HB, 2006, NEUROL RES, V28, P104, DOI 10.1179/016164106X91960; Zhang QH, 2020, EXP NEUROL, V323, DOI 10.1016/j.expneurol.2019.113084; Zhang YY, 2012, ANN NEUROL, V72, P630, DOI 10.1002/ana.23683; Zhao J, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0785-5; Zhao QC, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1495-3; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	83	1	1	2	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	NOV 6	2020	11								578879	10.3389/fimmu.2020.578879			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OT0LP	WOS:000590546400001	33240266	Green Published, gold			2022-02-06	
J	Sicard, V; Moore, RD; Simard, A; Lavoie, G; Ellemberg, D				Sicard, Veronik; Moore, Robert Davis; Simard, Alexe; Lavoie, Gabriel; Ellemberg, Dave			Psychometric properties of a color-shape version of the switch task	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Adults; assessment; cognitive control; computerized testing; convergent validity; test-retest reliability	EXECUTIVE FUNCTIONS; COGNITIVE CONTROL; COMPREHENSIVE TRAIL; TEST-PERFORMANCE; RELIABILITY; VALIDITY; INTERFERENCE; CONCUSSION; MANAGEMENT; COSTS	The current study aims to examine the psychometric properties of a color-shape version of the switch task. In Study 1, 128 participants completed a battery of standardized measures of executive functions (EFs) as well as the switch task to determine the construct validity of three traditionally computed costs (global, switch, and mixing) and primary variables (accuracy [ACC], reaction time [RT], and inverse efficiency score [IES] of the heterogeneous condition). In Study 2, 48 participants completed the task twice, seven days apart, to evaluate its short-term test-retest reliability. Results do not support the construct validity and the test-retest reliability of switch and mixing costs. The overall higher psychometric properties of the global costs (RT and IES), and primary variables (Hetero RT and IES) suggest that they may be useful measures for clinicians to assess EFs. The latter variables show evidence of convergent validity with standardized measures of EFs and good test-rest reliability (ICC >= .68).	[Sicard, Veronik; Simard, Alexe; Lavoie, Gabriel; Ellemberg, Dave] Univ Montreal, Sch Kinesiol & Exercise Sci, Montreal, PQ H3C 3J7, Canada; [Sicard, Veronik; Lavoie, Gabriel; Ellemberg, Dave] Univ Montreal, Ctr Rech Neuropsychol & Cognit, Montreal, PQ, Canada; [Moore, Robert Davis] Univ South Carolina, Arnold Sch Publ Hlth, Columbia, SC USA		Sicard, V (corresponding author), Univ Montreal, Sch Kinesiol & Exercise Sci, Montreal, PQ H3C 3J7, Canada.	veronik.sicard@gmail.com					Abma Inger L, 2016, BMC Res Notes, V9, P226, DOI 10.1186/s13104-016-2034-2; Allen D. N, 2009, CHILD NEUROPSYCHOL, V15, DOI [10.1080/0929704092748234, DOI 10.1080/0929704092748234]; Allen DN, 2012, PSYCHOL ASSESSMENT, V24, P556, DOI 10.1037/a0026263; Allport A, 1999, ATTENTION SPACE ACTI; Anderson C. M., 1998, COMMUN REP, V11, P1, DOI DOI 10.1080/08934219809367680; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beck A. T, 1990, BAI BECK ANXIETY INV; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Bruyer R, 2011, PSYCHOL BELG, V51, P5, DOI 10.5334/pb-51-1-5; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Dai CT, 2013, BRAIN COGNITION, V83, P153, DOI 10.1016/j.bandc.2013.07.007; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Delis DC., 2001, DELIS KAPLAN EXECUTI; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Gagnon Y, 2001, ALTERNATIVE POSSIBLE; Gray R, 2006, J PSYCHOEDUCATIONAL, V24; Grissom NM, 2019, NEUROPSYCHOPHARMACOL, V44, P86, DOI 10.1038/s41386-018-0179-5; Hedge C, 2018, BEHAV RES METHODS, V50, P1166, DOI 10.3758/s13428-017-0935-1; Hillman CH, 2006, INT J PSYCHOPHYSIOL, V59, P30, DOI 10.1016/j.ijpsycho.2005.04.009; Hirsch P, 2018, ADV COGN PSYCHOL, V14, P62, DOI 10.5709/acp-0239-y; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Hughes MM, 2014, BEHAV RES METHODS, V46, P702, DOI 10.3758/s13428-013-0411-5; Johnco C, 2014, PSYCHOL ASSESSMENT, V26, P1381, DOI 10.1037/a0038009; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kamijo K, 2012, OBESITY, V20, P2406, DOI 10.1038/oby.2012.112; Kiesel A, 2010, PSYCHOL BULL, V136, P849, DOI 10.1037/a0019842; Koch I, 2010, PSYCHON B REV, V17, P1, DOI 10.3758/PBR.17.1.1; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lane K. A., 2007, IMPLICIT MEASURES AT; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Liefooghe B, 2008, J EXP PSYCHOL LEARN, V34, P478, DOI 10.1037/0278-7393.34.3.478; Mayr U, 2001, PSYCHOL AGING, V16, P96, DOI 10.1037/0882-7974.16.1.96; Mayr U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091379; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Monsell S., 2003, TRENDS COGN SCI, V7, P3, DOI DOI 10.1016/S1364-6613(03)00028-7; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Moses J. A. Jr, 2004, COMPREHENSIVE TRAIL; Okumura MS, 2013, MED SCI SPORT EXER, V45, P1038, DOI 10.1249/MSS.0b013e318281e1fb; Pontifex M., 2012, HLTH BEHAV COGNITION; RAND Health, 2017, 36 IT SHORT FORM SUR; Raven J., 2003, MANUAL RAVENS PROGR; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Riemann B. L, 2018, J ATHL TRAINING, V53, DOI [10.4085/1062-503-16, DOI 10.4085/1062-503-16]; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Roth R.M., 2005, BRIEF BEHAV RATING I; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Smith SR, 2008, CLIN NEUROPSYCHOL, V22, P507, DOI 10.1080/13854040701399269; Sparrow E, 1999, CONNERS ADULT ADHD R; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Taylor AM, 2012, CURR OPIN PEDIATR, V24, P717, DOI 10.1097/MOP.0b013e32835a279b; Teuber H. L, 2012, ACTA NEUROBIOLOGIA E, V32; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Weschler, 2008, WAIS 4 ADM SCORING M; Wylie G, 2000, PSYCHOL RES-PSYCH FO, V63, P212, DOI 10.1007/s004269900003	56	1	1	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2020.1842410		NOV 2020	10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	PC5JM	WOS:000597037200001	33297758				2022-02-06	
J	Degeneffe, CE; Tucker, MS; Ahonle, ZJ				Degeneffe, Charles Edmund; Tucker, Mark Steven; Ahonle, Zaccheus James			Brief Report: Participation Among Transition-Aged Youth With Traumatic Brain Injury in the State/Federal Vocational Rehabilitation System	REHABILITATION COUNSELING BULLETIN			English	Article; Early Access						adolescents; transition; brain injury		This study aimed to understand the level of participation among transition-aged youth with traumatic brain injury (TBI) in the State/Federal Vocational Rehabilitation (VR) System in the context of the Workforce Innovation and Opportunity Act (WIOA). Case closures, case duration, and case expenditures in Federal fiscal years (FYs) 2014, 2015, and 2016 were examined among transition-aged youth (i.e., State VR clients under the age of 22 years at application) with TBI, autism spectrum order (ASD), and intellectual disability (ID), using a nonexperimental and descriptive design. A disproportionate number of transition-aged youth with ASD and ID had closed State VR cases compared with transition-aged youth with TBI. Alternatively, there were greater State VR case duration levels and case service expenditures for persons with TBI compared with those with ASD or ID. The disproportionate participation with State VR was consistent among these three groups via eligibility for services under the Individuals with Disabilities Education Act. This article highlights areas of attention concerning transition-aged youth with TBI and will hopefully stimulate future dialogue, research, and policy development concerning participation with State VR for this population.	[Degeneffe, Charles Edmund; Tucker, Mark Steven] San Diego State Univ, San Diego, CA 92182 USA; [Ahonle, Zaccheus James] Mississippi State Univ, Starkville, MS USA		Degeneffe, CE (corresponding author), San Diego State Univ, Rehabil Counseling Program, Dept Adm Rehabil & Postsecondary Educ, Coll Educ, 5500 Campanile Dr, San Diego, CA 92182 USA.	cdegenef@sdsu.edu					Administration for Community Living, 2020, TRAUMATIC BRAIN INJU; Brain Injury Research Institute, 2019, WHAT IS CONC; Bruyere S.M., 2000, WORKING EFFECTIVELY; Centers for Disease Control and Prevention, 2019, TBI GET FACTS; Centers for Disease Control and Prevention, 2010, HEADS UP CONC HIGH S; Degeneffe C.E., 2014, MILITARY DEPLOYMENT, P293; Degeneffe C.E., 2019, J APPL REHABIL COUS, V50, P252; Degeneffe CE, 2015, SOC WORK, V60, P19, DOI 10.1093/sw/swu047; East B., 2015, WORKFORCE INNOVATION; Friedman C, 2018, REHABIL RES POL EDUC, V32, P123, DOI 10.1891/2168-6653.32.2.123; Institute on Disability, 2020, 2017 ANN DIS STAT CO; Miles SH, 2016, AM J BIOETHICS, V16, P6, DOI 10.1080/15265161.2016.1128751; National Federation of State High School Associations, 2017, SUGG GUID MAN CONC S; U.S. Department of Education, IDEA; University of Kansas, 2019, TIM IND DIS ED ACT; Vaughn S., 2015, STATE PROGRAMS SERVI	16	1	1	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0034-3552	1538-4853		REHABIL COUNS BULL	Rehabil. Couns. Bull.											0034355220967109	10.1177/0034355220967109		NOV 2020	5	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	PE5LP	WOS:000598407400001					2022-02-06	
J	Bossers, SM; Boer, C; Bloemers, FW; Van Lieshout, EMM; Den Hartog, D; Hoogerwerf, N; Innemee, G; van der Naalt, J; Absalom, AR; Peerdeman, SM; de Visser, M; de Leeuw, MA; Schwarte, LA; Loer, SA; Schober, P				Bossers, Sebastiaan M.; Boer, Christa; Bloemers, Frank W.; Van Lieshout, Esther M. M.; Den Hartog, Dennis; Hoogerwerf, Nico; Innemee, Gerard; van der Naalt, Joukje; Absalom, Anthony R.; Peerdeman, Saskia M.; de Visser, Matthijs; de Leeuw, Marcel A.; Schwarte, Lothar A.; Loer, Stephan A.; Schober, Patrick		BRAIN-PROTECT Collaborators	Epidemiology, Prehospital Characteristics and Outcomes of Severe Traumatic Brain Injury in The Netherlands: The BRAIN-PROTECT Study	PREHOSPITAL EMERGENCY CARE			English	Article						brain injuries; traumatic; emergency medical services; air ambulances; treatment outcome; epidemiology; characteristics; incidence rate	GUIDELINES; MORTALITY; SCALE	Objective A thorough understanding of the epidemiology, patient characteristics, trauma mechanisms, and current outcomes among patients with severe traumatic brain injury (TBI) is important as it may inform potential strategies to improve prehospital emergency care. The aim of this study is to describe the prehospital epidemiology, characteristics and outcome of (suspected) severe TBI in the Netherlands. Methods The BRAIN-PROTECT study is a prospective observational study on prehospital management of patients with severe TBI in the Netherlands. The study population comprised all consecutive patients with clinical suspicion of TBI and a prehospital GCS score <= 8, who were managed by one of the 4 Helicopter Emergency Medical Services (HEMS). Patients were followed-up in 9 trauma centers until 1 year after injury. Planned sub-analyses were performed for patients with "confirmed" and "isolated" TBI. Results Data from 2,589 patients, of whom 2,117 (81.8%) were transferred to a participating trauma center, were analyzed. The incidence rate of prehospitally suspected and confirmed severe TBI were 3.2 (95% CI: 3.1;3.4) and 2.7 (95% CI: 2.5;2.8) per 100,000 inhabitants per year, respectively. Median patient age was 46 years, 58.4% were involved in traffic crashes, of which 37.4% were bicycle related. 47.6% presented with an initial GCS of 3. The median time from HEMS dispatch to hospital arrival was 54 minutes. The overall 30-day mortality was 39.0% (95% CI: 36.8;41.2). Conclusion This article summarizes the prehospital epidemiology, characteristics and outcome of severe TBI in the Netherlands, and highlights areas in which primary prevention and prehospital care can be improved.	[Bossers, Sebastiaan M.; Boer, Christa; de Leeuw, Marcel A.; Schwarte, Lothar A.; Loer, Stephan A.; Schober, Patrick] Univ Amsterdam, Dept Anesthesiol, Locat VUmc, Med Ctr, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands; [Bloemers, Frank W.] Univ Amsterdam, Dept Surg, Locat VUmc, Med Ctr, Amsterdam, Netherlands; [Van Lieshout, Esther M. M.; Den Hartog, Dennis] Univ Med Ctr Rotterdam, Trauma Res Unit, Erasmus MC, Dept Surg, Rotterdam, Netherlands; [Hoogerwerf, Nico] Radboud Univ Nijmegen, Dept Anesthesiol, Med Ctr, Nijmegen, Netherlands; [Hoogerwerf, Nico] Helicopter Emergency Med Serv Lifeliner 3, Nijmegen, Netherlands; [Innemee, Gerard] Reg Ambulance Serv Gooi & Vechtstreek, Hilversum, Netherlands; [van der Naalt, Joukje] Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Absalom, Anthony R.] Univ Med Ctr Groningen, Dept Anesthesiol, Groningen, Netherlands; [Peerdeman, Saskia M.] Univ Amsterdam, Dept Neurosurg, Locat VUmc, Med Ctr, Amsterdam, Netherlands; [de Visser, Matthijs] Reg Ambulance Serv Hollands Midden, Leiden, Netherlands; [de Leeuw, Marcel A.; Schwarte, Lothar A.; Schober, Patrick] Helicopter Emergency Med Serv Lifeliner 1, Amsterdam, Netherlands		Bossers, SM (corresponding author), Univ Amsterdam, Dept Anesthesiol, Locat VUmc, Med Ctr, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	s.bossers@amsterdamumc.nl	Schober, Patrick/G-7400-2012; Hoogerwerf, Nico/L-4388-2015	Schober, Patrick/0000-0003-0814-081X; Absalom, Anthony/0000-0001-7563-9157; Hoogerwerf, Nico/0000-0003-1815-6989; van der Naalt, Joukje/0000-0001-9873-2418	Dutch Brain Foundation ("Hersenstichting") [F2010(1)-14]; Achmea Healthcare Foundation ("Stichting Achmea Gezondheidszorg") [Z644]	This work was supported by the Dutch Brain Foundation ("Hersenstichting") under Grant F2010(1)-14; Achmea Healthcare Foundation ("Stichting Achmea Gezondheidszorg") under Grant Z644. The funding sources have no role in the design or execution of this study, and will not have any role during analysis and interpretation of the data, or decision to submit results.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bossers SM, 2019, PREHOSP EMERG CARE, V23, P820, DOI 10.1080/10903127.2019.1587126; Bossers SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141034; Bossers SM, 2020, J HEAD TRAUMA REHAB; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; CBS, 2019, DUTCH POP DENS STAT; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Dawes AJ, 2015, JAMA SURG, V150, P965, DOI 10.1001/jamasurg.2015.1678; Franschman G, 2013, INJURY, V44, P1232, DOI 10.1016/j.injury.2013.06.002; Franschman G, 2012, INJURY, V43, P1838, DOI 10.1016/j.injury.2012.05.020; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lenartova L, 2007, WIEN KLIN WOCHENSCHR, V119, P35, DOI 10.1007/s00508-006-0762-3; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Meerhoff S R, 2000, Ned Tijdschr Geneeskd, V144, P1915; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Ringdal KG, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-7; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Schober P, 2019, ANESTH ANALG, V129, P1445, DOI 10.1213/ANE.0000000000004480; Schober P, 2018, ANESTH ANALG, V127, P792, DOI 10.1213/ANE.0000000000003653; Schober P, 2018, ANESTH ANALG, V126, P1068, DOI 10.1213/ANE.0000000000002798; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Spaite DW, 2019, JAMA SURG, V154, DOI 10.1001/jamasurg.2019.1152; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; van Dijck JTJM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216743; Vetter TR, 2018, ANESTH ANALG, V127, P277, DOI 10.1213/ANE.0000000000003424; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	34	1	1	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	AUG 31	2021	25	5					644	655		10.1080/10903127.2020.1824049		NOV 2020	12	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	UK6ZS	WOS:000584765500001	32960672	Green Published, hybrid			2022-02-06	
J	Di Vita, A; Procacci, MA; Bellagamba, M; Jacomini, M; Massicci, R; Ciurli, MP				Di Vita, Antonella; Procacci, Mario Augusto; Bellagamba, Martina; Jacomini, Maria; Massicci, Roberta; Ciurli, Maria Paola			Psychotherapy and Art Therapy: A pilot study of group treatment for patients with traumatic brain injury	JOURNAL OF HEALTH PSYCHOLOGY			English	Article; Early Access						Awareness; rehabilitation outcome; self-identity; quality of life; well-being		Here we investigated the efficacy of group Psychotherapy and Art Therapy in rebuilding self-identity after traumatic brain injury (TBI), assessing their effects on psychological aspects in twelve patients with severe TBI. Overall, the results show an increased ability to adapt to the experiences of life as well as a higher level of awareness, social functioning and emotional autoregulation. Furthermore, patients exhibited a reduction in depressive symptoms and in the perception of physical problems. Results highlight the importance of treatments focusing on the patients' emotional needs, in addition to the classic rehabilitation (i.e. physiotherapy, cognitive therapy).	[Di Vita, Antonella; Procacci, Mario Augusto] Sapienza Univ Rome, Dept Psychol, Via Marsi 78, I-00185 Rome, Italy; [Di Vita, Antonella; Bellagamba, Martina; Massicci, Roberta] IRCCS Santa Lucia Fdn, Cognit & Motor Rehabil & Neuroimaging Unit, Rome, Italy; [Procacci, Mario Augusto; Jacomini, Maria] Hairam Onlus Assoc, Rome, Italy; [Procacci, Mario Augusto] SIFP Scuola Italiana Formaz Psicoterapia, Rome, Italy; [Jacomini, Maria] Acad Belle Arti, Specializat Arts Therapy, Rome, Italy; [Jacomini, Maria] SIPEA Scuola Specializzaz Artiterapie, Rome, Italy; [Ciurli, Maria Paola] IRCCS Santa Lucia Fdn, Neuropsychol Diag & Rehabil Unit, Rome, Italy		Di Vita, A (corresponding author), Sapienza Univ Rome, Dept Psychol, Via Marsi 78, I-00185 Rome, Italy.	antonella.divita@uniroma1.it	DI VITA, ANTONELLA/I-8584-2018	DI VITA, ANTONELLA/0000-0003-2345-4809			Allamandri D., 2012, NEEDS BROKEN NEEDS F; Allamri D., 2016, TRANSACTIONAL ANAL J, V46, P196; Andrewes HE, 2014, BRAIN INJURY, V28, P965, DOI 10.3109/02699052.2014.888764; Ashman T, 2014, J HEAD TRAUMA REHAB, V29, P467, DOI 10.1097/HTR.0000000000000098; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; Berne E., 1966, PRINCIPLES GROUP TRE; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Cattelani R, 2009, EUR J PHYS REHAB MED, V45, P513; Chancellor B, 2014, J ALZHEIMERS DIS, V39, P1, DOI 10.3233/JAD-131295; Ciurli MP., 2017, EMPATHY BRAIN DAMAGE, P205; Conti L., 2000, REPERTOIRE EVALUATIO, VThird; Crawford MJ, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16080; Di Maria F., 2002, GROUPS METHODS INSTR; Diamond-Raab L, 2002, CHILD ADOL PSYCH CL, V11, P343, DOI 10.1016/S1056-4993(01)00008-6; Fuhriman A., 1994, HDB GROUP PSYCHOTHER, P3; Ghisi M., 2006, BECK DEPRESSION INVE, VSecond; Giustini M, 2014, FUNCT NEUROL, V29, P167, DOI 10.11138/FNeur/2014.29.3.167; Gonen J, 2000, ART PSYCHOTHER, V27, P41, DOI 10.1016/S0197-4556(99)00022-2; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P522, DOI 10.1080/09602010802141509; Gussak D, 2007, INT J OFFENDER THER, V51, P444, DOI 10.1177/0306624X06294137; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; Jacomini M., 2016, NUOVA FORMA NASCENTE; Kennett CE, 2000, PALLIATIVE MED, V14, P419, DOI 10.1191/026921600701536255; Kim MK, 2013, YONSEI MED J, V54, P15, DOI 10.3349/ymj.2013.54.1.15; Lazzari R., 1980, STATE TRAIT ANXIETY; Leurent B, 2014, SOC PSYCH PSYCH EPID, V49, P1703, DOI 10.1007/s00127-014-0876-2; Lo Coco G., 2006, RES PSYCHOTHERAPY MO, P753; Mimica N, 2011, PSYCHIAT DANUB, V23, P125; Musso R., 2012, RIV ITALIANA ANALISI, V25, P54; Ownsworth T., 2014, SELF IDENTITY BRAIN; Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465, DOI 10.1080/09602010050143559; Palmieri G, 2009, CLIN PSYCHOL PSYCHOT, V16, P444, DOI 10.1002/cpp.646; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP., 1999, PRINCIPLES NEUROPSYC, P244; Reynolds F, 2012, ART PSYCHOTHER, V39, P239, DOI 10.1016/j.aip.2012.03.006; Ruddle JA., 2005, ILLNESS, V13, P235; Saviola D., 2011, TRAUMA CRANICO TERAP, P21; Saviola D., 2010, TRAUMA CRANICO DISAB, P205; Schore AN, 1996, DEV PSYCHOPATHOL, V8, P59, DOI 10.1017/S0954579400006970; Siegel DJ, 2001, INFANT MENT HEALTH J, V22, P67, DOI 10.1002/1097-0355(200101/04)22:1<67::AID-IMHJ3>3.0.CO;2-G; Sighinolfi C, 2010, PSICOTER COGN COMPOR, V16, P141; TEASDALE G, 1974, LANCET, V2, P81; Vickery CD, 2006, REHABIL PSYCHOL, V51, P30, DOI 10.1037/0090-5550.51.1.30; Walker AJ, 2010, BRAIN INJURY, V24, P517, DOI 10.3109/02699051003601721; Warren B, 1995, ART THERAPY ED REHAB; Wiart L, 2016, ANN PHYS REHABIL MED, V59, P31, DOI 10.1016/j.rehab.2015.12.001; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832	49	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1359-1053	1461-7277		J HEALTH PSYCHOL	J. Health Psychol.											1359105320967099	10.1177/1359105320967099		NOV 2020	11	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	QW9FN	WOS:000628953100001	33138657				2022-02-06	
J	Appelbaum, R; Hoover, T; Azari, S; Dunstan, M; Li, PM; Sandhu, R; Browne, M				Appelbaum, Rachel; Hoover, Travis; Azari, Sarah; Dunstan, Michele; Li, P. Mark; Sandhu, Rovinder; Browne, Marybeth			Development and Implementation of a Pilot Radiation Reduction Protocol for Pediatric Head Injury	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	15th Annual Meeting of the Academic-Surgical-Congress (ASC) / 15th Academic Surgical Congress of the Association-for-Academic-Surgery and Society-of-University-Surgeons	FEB 02-06, 2020	Assoc Acad Surg, Orlando, FL	Acad Surg Congress, Soc Univ Surg, Assoc Acad Surg	Assoc Acad Surg	Pediatric closed head injury; Intracranial hemorrhage; CT head; MRI head	TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; MILD; MODERATE; MRI	Background: Traumatic brain injury is the leading cause of morbidity and mortality for children in the United States. The aim of this study was to develop and implement a guideline to reduce radiation exposure in the pediatric head injury patient by identifying the patient population where repeat imaging is necessary and to establish rapid brain protocol magnetic resonance imaging as the first-line modality. Methods: A retrospective chart review of trauma patients between 0 and 14 y of age admitted at a pediatric level 2 trauma center was performed between January 2013 and June 2019. The guideline established the appropriateness of repeat scans for patients with Glasgow Coma Scale >13 with clinical neurological deterioration or patients with Glasgow Coma Scale <= 13 and intracranial hemorrhagic lesion on initial head computed tomography (CT). Results: Our trauma registry included 592 patients during the study period, 415 before implementation and 161 after implementation. A total of 132 patients met inclusion criteria, 116 pre-guideline and 16 post-guideline. The number of patients receiving repeat head CTs significantly decreased from 34.5% to 6.3% (P < 0.02). There was also a significant decrease in the mean number of head CT/patient pre-guideline 1.63 (range 1-7) compared with post-guideline 1.06 (range 1-2) (P < 0.02). Conclusions: CT head imaging is invaluable in the initial trauma evaluation of pediatric patients. However, it can be overused, and the radiation may lead to long-term deleterious effects. Establishing a head imaging guideline which limits use with clinical criteria can be effective in reducing radiation exposure without missing injuries. (C) 2020 Elsevier Inc. All rights reserved.	[Appelbaum, Rachel; Hoover, Travis; Azari, Sarah] Lehigh Valley Hlth Network, Allentown, PA USA; [Li, P. Mark] Lehigh Valley Hlth Network, Div Neurosurg, Allentown, PA USA; [Dunstan, Michele; Sandhu, Rovinder] Lehigh Valley Hlth Network, Div Bariatr & Trauma Surg, Allentown, PA USA; [Browne, Marybeth] Lehigh Valley Reilly Childrens Hosp, Div Pediat Surg Specialties, Lehigh Valley Hlth Network, Allentown, PA 18103 USA		Browne, M (corresponding author), Lehigh Valley Reilly Childrens Hosp, Div Pediat Surg Specialties, 1210 St Cedar Crest Blvd Suite 1100, Allentown, PA 18103 USA.	marybeth.browne@lvhn.org		Azari, Sarah/0000-0001-7194-7873			Aziz H, 2013, J TRAUMA ACUTE CARE, V75, P550, DOI 10.1097/TA.0b013e3182a53a77; Bata SC, 2014, ANZ J SURG, V84, P438, DOI 10.1111/ans.12582; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Buttram Sandra D W, 2015, Hosp Pediatr, V5, P79, DOI 10.1542/hpeds.2014-0094; Cohen AR, 2015, AM J EMERG MED, V33, P887, DOI 10.1016/j.ajem.2015.03.052; Coon ER, 2021, PEDIATR EMERG CARE, V37, P55, DOI 10.1097/PEC.0000000000001475; Da Dalt L, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-017-0442-0; Flaherty BF, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0385; Goldberg J, 2011, J PEDIATR SURG, V46, P1777, DOI 10.1016/j.jpedsurg.2011.02.052; Hill EP, 2017, J TRAUMA ACUTE CARE, V82, P896, DOI 10.1097/TA.0000000000001406; Holdsworth SJ, NTR; Howe J, 2014, J TRAUMA ACUTE CARE, V76, P292, DOI 10.1097/TA.0000000000000119; Kim WH, 2015, J KOREAN NEUROSURG S, V58, P125, DOI 10.3340/jkns.2015.58.2.125; Kralik SF, 2017, AM J NEURORADIOL, V38, P807, DOI 10.3174/ajnr.A5093; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; da Silva PSL, 2008, J TRAUMA, V65, P1293, DOI 10.1097/TA.0b013e318156866c; Mehta H, 2016, AM J NEURORADIOL, V37, P11, DOI 10.3174/ajnr.A4464; Patel SK, 2018, J PEDIATR SURG, V53, P2048, DOI 10.1016/j.jpedsurg.2018.04.027; Sheppard John P, 2018, Brain Tumor Res Treat, V6, P1, DOI 10.14791/btrt.2018.6.e4; Sheridan DC, 2017, J NEUROSURG-PEDIATR, V19, P259, DOI 10.3171/2016.7.PEDS16204; Wylie MC, 2014, PEDIATR EMERG CARE, V30, P680, DOI 10.1097/PEC.0000000000000227	21	1	1	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	NOV	2020	255						111	117		10.1016/j.jss.2020.05.051			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	OF3LU	WOS:000581114600016	32543375				2022-02-06	
J	Beakey, M; Keenan, B; Tiernan, S; Collins, K				Beakey, Mark; Keenan, Brian; Tiernan, Stephen; Collins, Kieran			Is It Time to Give Athletes a Voice in the Dissemination Strategies of Concussion-Related Information? Exploratory Examination of 2444 Adolescent Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						SRC; adolescent athletes; sex; knowledge transfer; educational intervention	KNOWLEDGE TRANSFER; SPORT CONCUSSION; IMPLEMENTATION; GUIDELINES; STATEMENT; EDUCATION; FOOTBALL; COACHES; LEGISLATION; MANAGEMENT	Objective: The objective of the research was to screen male and female adolescent athletes on their concussion educational histories and preferred future methods of education in terms of educational messenger, modality, and concussion-related areas of interest. Design: Cross-sectional survey. Setting: Examination setting within the classroom. Participants: Adolescent male (n = 1854) and female (n = 590) athletes aged 12 to 18 years. Main Outcome Measures: To explore the concussion educational histories and preferred future methods of education in Irish male and female adolescent athletes. Results: 19.7% (n = 482) of the sample received education in the past 12 months. Male athletes had a significantly higher rate of previous education than female athletes (41% vs 17%). The methods used in previous educational interventions are failing to match the interests of the athletes. Sex played a significant role in the preferred educational methods, as male and female athletes had significant differences in their choice of educational messenger, modality, and concussion-related areas of interest. Conclusions: The current disparity in previous concussion education rates between male and female adolescent athletes should be addressed. Forthcoming research should explore the efficacy of tailoring knowledge translation strategies to match the specific needs of the recipient.	[Beakey, Mark; Keenan, Brian; Collins, Kieran] Inst Technol, Dept Sci, Dublin D24 FKT9 24, Ireland; [Tiernan, Stephen] Inst Technol, Dept Engn, Dublin, Ireland; [Collins, Kieran] Inst Technol, Gael Res Sport Ctr, Dublin, Ireland		Beakey, M (corresponding author), Inst Technol, Dept Sci, Dublin D24 FKT9 24, Ireland.	mark.beakey@postgrad.ittdublin.ie	Collins, Kieran/AAW-5613-2021	Collins, Kieran/0000-0003-1653-2071	Institute of Technology, Tallaght, Dublin, through their President's Research Award Scheme 2016	Supported by the Institute of Technology, Tallaght, Dublin, through their President's Research Award Scheme 2016.	Ahmed OH, 2012, BRIT J SPORT MED, V46, P675, DOI 10.1136/bjsm.2010.081620; Ahmed OH, 2010, DISABIL REHABIL, V32, P1877, DOI 10.3109/09638281003734409; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Beakey M, 2017, EUR J SPORT MED, V3:, P1; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Chinn N.R., 2016, BMJ OPEN SPORT EXERC, V2, P000118, DOI [10.1136/bmjsem-2016-000118, DOI 10.1136/BMJSEM-2016-000118]; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Delahunty SE, 2015, J SCHOOL HEALTH, V85, P17, DOI 10.1111/josh.12219; Donaldson A, 2016, AM J LIFESTYLE MED, V10, P120, DOI 10.1177/1559827614538751; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kemp JL, 2016, J SCI MED SPORT, V19, P305, DOI 10.1016/j.jsams.2015.03.010; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, ANN BEHAV MED, V49, P532, DOI 10.1007/s12160-014-9683-y; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Lenhart A, 2015, TEENS SOCIAL MEDIA T, P4; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Mairs K, 2013, HEALTH INFO LIBR J, V30, P261, DOI 10.1111/hir.12048; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Newton JD, 2014, J SCI MED SPORT, V17, P469, DOI 10.1016/j.jsams.2013.10.240; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Russell K, 2017, CAN J NEUROL SCI, V44, P225, DOI 10.1017/cjn.2016.423; Sarmiento K, 2017, J SCHOOL HEALTH, V87, P790, DOI 10.1111/josh.12552; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Sullivan L, 2018, J SPORT HEALTH SCI, V7, P102, DOI 10.1016/j.jshs.2017.05.003; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; Tomei KL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12280; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211	46	1	1	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2020	30	6					562	567		10.1097/JSM.0000000000000653			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	OP0UO	WOS:000587794700017	30119086	Green Submitted			2022-02-06	
J	Carlozzi, NE; Lange, RT; Boileau, NR; Kallen, MA; Sander, AM; Hanks, RA; Nakase-Richardson, R; Tulsky, DS; Massengale, JP; French, LM; Brickell, TA				Carlozzi, Noelle E.; Lange, Rael T.; Boileau, Nicholas R.; Kallen, Michael A.; Sander, Angelle M.; Hanks, Robin A.; Nakase-Richardson, Risa; Tulsky, David S.; Massengale, Jill P.; French, Louis M.; Brickell, Tracey A.			TBI-CareQOL Family Disruption: Family Disruption in Caregivers of Persons With TBI	REHABILITATION PSYCHOLOGY			English	Article						caregivers; quality of life; brain injuries; traumatic	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; MENTAL-HEALTH; VETERANS; DEPLOYMENT; POLYTRAUMA; SOLDIERS; CHILDREN; CRITERIA; IMPACT	Purpose: Family disruption is often an indirect consequence of providing care for a person with traumatic brain injury (TBI). This article describes the development and preliminary validation of a Family Disruption scale designed for inclusion within the TBI-CareQOL, measurement system. Method/Design: Five hundred thirty-four caregivers of persons with TBI (service member/veteran n = 316; civilian n = 218) completed the Family Disruption scale, alongside several other measures of caregiver strain and health-related quality of life. Classical test theory and item response theory (IRT)-based analyses were conducted to develop, and establish reliability and validity of, this scale. Results: Exploratory and confirmatory factor analysis, as well as Samejima's graded response model-related IRT fit analyses. supported the development of a 3-item scale. This final scale is scored on a T score metric (M = 50; SD = 10); higher scores are indicative of more family disruption. Reliability (internal consistency; test-retest stability) was supported for both caregiver groups, and average administration times were under 10 s. Convergent and discriminant validity were supported by strong correlations between Family Disruption and measures of caregiver burden, and smaller correlations with positive aspects of caregiving. As evidence of known-groups validity, caregivers of lower-functioning persons with TBI experienced more family disruption than caregivers of higher functioning individuals. Conclusions: The TBI-CareQOL Family Disruption scale is a brief, reliable, and valid assessment of caregiver perceptions of how caring for an individual with a TBI interferes with family life. This measure is well-suited for inclusion in studies seeking to support family functioning in persons with TBI.	[Carlozzi, Noelle E.; Boileau, Nicholas R.] Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Lange, Rael T.; French, Louis M.; Brickell, Tracey A.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.; French, Louis M.; Brickell, Tracey A.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Kallen, Michael A.] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Evanston, IL 60208 USA; [Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Harris Hlth Syst, Houston, TX 77030 USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Hanks, Robin A.] Rehabil Inst Michigan, Dept Psychol & Neuropsychol, Detroit, MI USA; [Hanks, Robin A.] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI 48202 USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Serv MHBS, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Def & Vet Brain Injury Ctr, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Morsani Coll Med, Tampa, FL 33620 USA; [Tulsky, David S.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Newark, DE 19716 USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, Newark, DE 19716 USA; [Tulsky, David S.] Univ Delaware, Dept Psychol Brain Sci, Newark, DE 19716 USA; [Massengale, Jill P.] James A Haley Vet Hosp, Nursing Serv, Tampa, FL 33612 USA; [French, Louis M.; Brickell, Tracey A.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA		Carlozzi, NE (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu	Boileau, Nicholas/V-4832-2019	Tulsky, David/0000-0002-4335-4509; french, louis/0000-0002-9451-0604; Boileau, Nicholas/0000-0002-4056-4404	National Institutes of Health (NIH), National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]; General Dynamics Information Technology, Inc. [DVBIC-SC-14-003, W91YTZ-13-C-0015]	Work on this article was supported by Grant R01NR013658 from the National Institutes of Health (NIH), National Institute of Nursing Research, the National Center for Advancing Translational Sciences (UL1TR000433), as well as contract funding from General Dynamics Information Technology, Inc., subcontractor for the Defense and Veterans Brain Injury Center (DVBIC; DVBIC-SC-14-003; W91YTZ-13-C-0015). We thank the investigators and research associates/coordinators who worked on the study, the study participants, and organizations who supported recruitment efforts. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. TBI-CareQOL Site Investigators and Coordinators: Noelle E. Carlozzi, Anna Kratz, Jenna Freedman, Jenna Russell, Jennifer Miner (University of Michigan, Ann, Arbor, Michigan); Angelle M. Sander (Baylor College of Medicine and TIRR Memorial Hermann, Houston, Texas); Curtisa Light (TIRR Memorial Hermann, Houston, Texas); Robin A. Hanks, Daniela Ristova-Trendov (Wayne State University/Rehabilitation Institute of Michigan, Detroit, Michigan); Tracey A. Brickell, Rael T. Lange, Louis M. French, Sara Lippa, Rachel Gartner, Megan Wright, Angela Driscoll, Diana Nora, Jamie Sullivan, Nicole Varbedian, Lauren Johnson, Heidi Mahatan, Paula Bellini, Jayne Holzinger, Jennifer Freud, Ashley Schaper, Maryetta Reese, Elizabeth Barnhart, Vanessa Ndege, Yasmine Eshera, Jenna Weintraub, Mary Andrews, Kaitlyn Casey, Gabrielle Robinson (Walter Reed National Military Medical Center/Defense and Veterans Brain Injury Center, Bethesda, MD); Jill P. Massengale, Risa Nakase-Richardson, Leah Drasher-Phillips, Kristina Martinez, Padmaja Ramaiah (James A. Haley Veterans Hospital, Tampa, Florida). For the Walter Reed National Military Medical Center participants, this study forms part of the larger Defense and Veterans Brain Injury Center (DVBIC) 15-Year Longitudinal TBI Study developed to respond to a Congressional mandate (Sec721 NDAA FY2007). The identification of specific products or scientific instrumentation does not constitute endorsement or implied endorsement on the part of the author, DoD, Veterans Affairs, or any component agency. While we generally reference product companies, manufacturers, organizations, etc. in government-produced works, the abstracts produced and other similarly situated research presents a special circumstance when such product inclusions become an integral part of the scientific endeavor. The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official Department of Veterans Affairs position or any other federal agency, policy, or decision unless so designated by other official documentation.	Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Cai L, 2015, IRTPRO FOR WINDOWS; Carlozzi NE, 2018, J HEAD TRAUMA REHAB, V33, P342, DOI 10.1097/HTR.0000000000000373; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Chandra A, 2010, J ADOLESCENT HEALTH, V46, P218, DOI 10.1016/j.jadohealth.2009.10.009; Cohen J., 2013, STAT POWER ANAL BEHA; Collins RC, 2008, J CLIN PSYCHOL, V64, P993, DOI 10.1002/jclp.20515; Cook KF, 2009, QUAL LIFE RES, V18, P447, DOI 10.1007/s11136-009-9464-4; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Cozza SJ, 2005, PSYCHIAT QUART, V76, P371, DOI 10.1007/s11126-005-4973-y; Cramer D, 2004, SAGE DICT STAT PRACT, DOI [10.4135/9780857020123, DOI 10.4135/9780857020123]; Dausch BM, 2009, REHABIL PSYCHOL, V54, P279, DOI 10.1037/a0016809; Department of Defense, 2016, 2015 DEM PROF MIL CO; DeVellis R.F., 2017, SCALE DEV THEORY APP; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Finley Erin P, 2016, Mil Behav Health, V4, P205, DOI 10.1080/21635781.2016.1153530; Flake EM, 2009, J DEV BEHAV PEDIATR, V30, P271, DOI 10.1097/DBP.0b013e3181aac6e4; Gibbs DA, 2007, JAMA-J AM MED ASSOC, V298, P528, DOI 10.1001/jama.298.5.528; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Gosling J, 1999, BRAIN INJURY, V13, P785; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Hanauer DA, 2015, J BIOMED INFORM, V55, P290, DOI 10.1016/j.jbi.2015.05.003; Hatcher L, 1994, STEP BY STEP APPROAC, P325; HealthMeasures, 2019, PROMIS INSTR DEV PSY; Holmes AK, 2013, FUTURE CHILD, V23, P143, DOI 10.1353/foc.2013.0017; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hyatt K, 2014, MIL MED, V179, P849, DOI 10.7205/MILMED-D-13-00526; Johnson S., 2007, PSYCHOL NEEDS US MIL; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; Lester P, 2010, J AM ACAD CHILD PSY, V49, P310, DOI 10.1016/j.jaac.2010.01.003; Malec J., 2005, MAYO PORTLAND ADAPTA; Mansfield AJ, 2010, NEW ENGL J MED, V362, P101, DOI 10.1056/NEJMoa0900177; McCubbin H. I., 1993, FAMILY ASSESSMENT RE, P783; McDonald R, 1999, TEST THEORY UNIFIED; McFarlane AC, 2009, CURR OPIN PSYCHIATR, V22, P369, DOI 10.1097/YCO.0b013e32832c9064; McNulty P. A., 2010, FEDERAL PRACTITIONER, V27, P18; McNulty P. A., 2013, FEDERAL PRACTITIONER, V30, P14; MetaMetrics, 1995, LEXILE FRAMEWORK REA; Muthen L.K., 2011, MPLUS USERS GUIDE, V6th ed.; OLSON DH, 1983, FAM PROCESS, V22, P69, DOI 10.1111/j.1545-5300.1983.00069.x; Patel BR, 2015, SOC WORK, V60, P9, DOI 10.1093/sw/swu043; Qadeer A, 2017, CUREUS, V9, DOI 10.7759/cureus.1590; Ramsay J., 2000, TESTGRAF; Reise SP, 2007, QUAL LIFE RES, V16, P19, DOI 10.1007/s11136-007-9183-7; Renshaw KD, 2009, ANXIETY STRESS COPIN, V22, P101, DOI 10.1080/10615800802354000; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; Samejima F., 1997, HDB MODERN ITEM RESP, P85, DOI [10.1007/978-1-4757-2691-6_5, DOI 10.1007/978-1-4757-2691-6_5]; Sander AM, 2003, ARCH PHYS MED REHAB, V84, P197, DOI 10.1053/apmr.2003.50105; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Stevens LF, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/185941; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Stull D., 1996, J CLIN GEROPSYCHOL, V2, P175; Taft CT, 2008, J CONSULT CLIN PSYCH, V76, P648, DOI 10.1037/a0012576; van Wijngaarden B, 2002, FAMILY INTERVENTIONS IN MENTAL ILLNESS: INTERNATIONAL PERSPECTIVES, P145; Yambo TW, 2016, J NURS SCHOLARSHIP, V48, P543, DOI 10.1111/jnu.12237	63	1	1	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2020	65	4					390	400		10.1037/rep0000297			11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	OW5SF	WOS:000592945400007	31841019	Bronze, Green Accepted			2022-02-06	
J	Carlozzi, NE; Lange, RT; Kallen, MA; Boileau, NR; Sander, AM; Massengale, JP; Nakase-Richardson, R; Tulsky, DS; French, LM; Hahn, EA; Ianni, PA; Miner, JA; Hanks, R; Brickell, TA				Carlozzi, Noelle E.; Lange, Rael T.; Kallen, Michael A.; Boileau, Nicholas R.; Sander, Angelle M.; Massengale, Jill P.; Nakase-Richardson, Risa; Tulsky, David S.; French, Louis M.; Hahn, Elizabeth A.; Ianni, Phillip A.; Miner, Jennifer A.; Hanks, Robin; Brickell, Tracey A.			Assessing Vigilance in Caregivers After Traumatic Brain Injury: TBI-CareQOL Caregiver Vigilance	REHABILITATION PSYCHOLOGY			English	Article						health-related quality of life; traumatic brain injury; caregiver; caregiver burden; patient-reported outcomes	POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; PERSONALITY CHANGES; SERVICE MEMBERS; RESPONSE THEORY; VETERANS; MODEL; IRAQ; AFGHANISTAN; FAMILIES	Objective: Caregivers of individuals with traumatic brain injury (TBI) frequently experience anxiety related to the caregiver role. Often this is due to a caregiver's perceived need to avoid people and situations that might upset or "trigger" the care recipient. There are currently no self-report measures that capture these feelings; thus, this article describes the development and preliminary validation efforts for the TBI-Caregiver Quality of Life (CareQOL) Caregiver Vigilance item bank. Design: A sample of 532 caregivers of civilians (n = 218) or service members/veterans (SMVs; n = 314) with TBI completed 32 caregiver vigilance items, other measures of health-related quality of life (RAND-12, Patient-Reported Outcomes Measurement Information System [PROMIS] Depression, PROMIS Social Isolation, Caregiver Appraisal Scale), and the Mayo-Portland Adaptability Inventory-4. Results: The final item bank contains 18 items, as supported by exploratory and confirmatory factor analysis, item response theory graded response modeling (GRM), and differential item functioning investigations. Expert review and GRM calibration data informed the selection of a 6-item short form and programming of a computer adaptive test. Internal consistency reliability for the different administration formats were excellent (reliability coefficients >=.90). Three-week test-retest stability was supported (i.e., r >= .78). Correlations between vigilance and other self-report measures supported convergent and discriminant validity (0.01 <= r <= .69). Known-groups validity was also supported. Conclusions: The new TBI-CareQOL Caregiver Vigilance computer adaptive test and corresponding 6-item short form were developed using established rigorous measurement development standards, providing the first self-report measure to evaluate caregiver vigilance. This development work indicates that this measure exhibits strong psychometric properties.	[Carlozzi, Noelle E.; Boileau, Nicholas R.; Miner, Jennifer A.] Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Lange, Rael T.; French, Louis M.; Brickell, Tracey A.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.; French, Louis M.; Brickell, Tracey A.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Kallen, Michael A.; Hahn, Elizabeth A.] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Evanston, IL 60208 USA; [Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Harris Hlth Syst, Houston, TX 77030 USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Massengale, Jill P.] James A Haley Vet Hosp, Nursing Serv, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, MHBS, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Def & Vet Brain Injury Ctr, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Morsani Coll Med, Tampa, FL 33620 USA; [Tulsky, David S.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Dept Phys Therapy, Newark, DE 19716 USA; [Tulsky, David S.] Univ Delaware, Dept Psychol Brain Sci, Newark, DE 19716 USA; [French, Louis M.; Brickell, Tracey A.] Uniformed Serv Univ Hlth Sci, Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Ianni, Phillip A.] Univ Michigan, Michigan Inst Clin & Hlth Res, Ann Arbor, MI 48109 USA; [Hanks, Robin] Rehabil Inst Michigan, Dept Psychol & Neuropsychol, Detroit, MI USA; [Hanks, Robin] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI 48202 USA		Carlozzi, NE (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu	Boileau, Nicholas/V-4832-2019	Tulsky, David/0000-0002-4335-4509; Boileau, Nicholas/0000-0002-4056-4404; french, louis/0000-0002-9451-0604	National Institutes of Health, National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658]; General Dynamics Information Technology [DVBIC-SC-14-003, W91YTZ-13-C-0015]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]	Work on this article was supported by Grant R01NR013658 from the National Institutes of Health, National Institute of Nursing Research, and we received contract funding (Awards DVBIC-SC-14-003 and W91YTZ-13-C-0015) from General Dynamics Information Technology, subcontractor for the Defense and Veterans Brain Injury Center. Funding from the National Center for Advancing Translational Sciences (Award UL1TR000433) provided support for data collection. We thank the investigators and research associates/coordinators who worked on the study, the study participants, and organizations who supported recruitment efforts. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; Bailey EK, 2017, J HEAD TRAUMA REHAB, V32, P245, DOI 10.1097/HTR.0000000000000317; Beks T, 2016, QUAL REP, V21, P645; Ben Arzi N, 2000, BRAIN INJURY, V14, P725; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Cai L, 2015, IRTPRO FOR WINDOWS; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS110, DOI 10.1016/j.apmr.2018.06.026; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS43, DOI 10.1016/j.apmr.2018.06.025; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Chen FN, 2008, SOCIOL METHOD RES, V36, P462, DOI 10.1177/0049124108314720; Choi SW, 2011, J STAT SOFTW, V39, P1; Choi SW, 2009, APPL PSYCH MEAS, V33, P644, DOI 10.1177/0146621608329892; CLAUSER BE, 1994, J EDUC MEAS, V31, P88; Cohen J., 1988, STAT POWER ANAL BEHA, VChap. 1, P1; Cook KF, 2009, QUAL LIFE RES, V18, P447, DOI 10.1007/s11136-009-9464-4; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cramer D, 2004, SAGE DICT STAT PRACT, DOI [10.4135/9780857020123, DOI 10.4135/9780857020123]; Crane PK, 2006, MED CARE, V44, pS115, DOI 10.1097/01.mlr.0000245183.28384.ed; Dausch BM, 2009, REHABIL PSYCHOL, V54, P279, DOI 10.1037/a0016809; Defense and Veterans Brain Injury Center, 2015, DOD WORLDW NUMB TBI; DeVellis R.F., 2017, SCALE DEV THEORY APP; Diaz AP, 2014, CNS NEUROSCI THER, V20, P479, DOI 10.1111/cns.12256; Easther R, 2003, J COSMOL ASTROPART P; EVERITT BS, 1975, BRIT J PSYCHIAT, V126, P237, DOI 10.1192/bjp.126.3.237; Fann JR, 2009, J HEAD TRAUMA REHAB, V24, P272, DOI 10.1097/HTR.0b013e3181a66342; Frank R. G., 2010, HDB REHABILITATION P, DOI [10.1037/15972-000, DOI 10.1037/15972-000]; French L. M., 2012, NEUROPSYCHOLOGICAL A, P127; Golden Z, 2003, INT J NEUROSCI, V113, P733, DOI 10.1080/00207450390200044; Gorsuch R.L., 1983, FACTOR ANAL; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Grimm L.G., 1995, READING UNDERSTANDIN, P99; Hanauer DA, 2015, J BIOMED INFORM, V55, P290, DOI 10.1016/j.jbi.2015.05.003; Hatcher L, 1994, STEP BY STEP APPROAC, P325; Hays RD, 1995, USERS MANUAL MED OUT; Heaton R. K., 2004, REVISED COMPREHENSIV; Hines LA, 2014, CAN J PSYCHIAT, V59, P468, DOI 10.1177/070674371405900903; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Knight RG, 1997, J CLIN EXP NEUROPSYC, V19, P7, DOI 10.1080/01688639708403832; Lange R. T., 2019, POSTTRAUMATIC UNPUB; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; Malec J., 2005, MAYO PORTLAND ADAPTA; Mansfield AJ, 2014, PROF PSYCHOL-RES PR, V45, P488, DOI 10.1037/a0038422; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; McDonald R, 1999, TEST THEORY UNIFIED; Monson CM, 2009, CLIN PSYCHOL REV, V29, P707, DOI 10.1016/j.cpr.2009.09.002; Muthen L.K., 2011, MPLUS USERS GUIDE, V6th ed.; Norup A, 2015, ARCH PHYS MED REHAB, V96, P56, DOI 10.1016/j.apmr.2014.08.009; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; R Core Team, 2014, R LANG ENV STAT COMP; Ramchand R., 2014, HIDDEN HEROES AM MIL; Ramsay J. O., 2000, TESTGRAF PROGRAM GRA; Rao V, 2008, J NEUROPSYCH CLIN N, V20, P118, DOI 10.1176/jnp.2008.20.1.118; Reise SP, 2007, QUAL LIFE RES, V16, P19, DOI 10.1007/s11136-007-9183-7; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; SAMEJIMA F, 1969, PSYCHOMETRIKA, V34, P1; Samejima F., 1997, HDB MODERN ITEM RESP, P85, DOI [10.1007/978-1-4757-2691-6_5, DOI 10.1007/978-1-4757-2691-6_5]; Sammons MT, 2008, J CLIN PSYCHOL, V64, P921, DOI 10.1002/jclp.20519; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2008, AM J PUBLIC HEALTH, V98, P714, DOI 10.2105/AJPH.2007.115519; Sherer M., 2005, FORENSIC NEUROPSYCHO, P237; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; The Management of Concussion/mTBI Working Group, 2009, VA DOD CLIN PRACT GU; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Ware J.E., 1994, SF 36 PHYS MENTAL SU; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Whittaker TA, 2012, J EXP EDUC, V80, P26, DOI 10.1080/00220973.2010.531299; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zarit SH., 1985, HIDDEN VICTIMS ALZHE	78	1	1	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2020	65	4					418	431		10.1037/rep0000302			14	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	OW5SF	WOS:000592945400010	31971432	Green Accepted, Bronze			2022-02-06	
J	Cook, NE; Huebschmann, NA; Iverson, GL				Cook, Nathan E.; Huebschmann, Nathan A.; Iverson, Grant L.			Safety and Tolerability of an Innovative Virtual Reality-Based Deep Breathing Exercise in Concussion Rehabilitation: A Pilot Study	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Concussion; pediatric rehabilitation; deep breathing; virtual reality	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; HEART-RATE-VARIABILITY; POSTCONCUSSION SYNDROME; EXPOSURE THERAPY; BALANCE MODULE; HIGH-SCHOOL; CHILDREN; RELIABILITY; BIOFEEDBACK	Objective To examine the safety and tolerability of a virtual reality-based deep breathing exercise for children and adolescents who are slow to recover from concussion. Methods: Fifteen participants (ages 11 to 22; mean = 16.9 years) were recruited from a specialty concussion clinic within a tertiary care medical center. Participants completed a 5-min paced deep breathing exercise administered via a virtual reality headset. Results: Nearly all participants (93.3%) reported the experience was either positive or extremely positive. No participants reported significant discomfort or discontinued the exercise. Three participants reported a mild increase in headache, dizziness, or nausea. Participants reported significant decreases in stress (r =.57), tension (r =.73), fatigue (r =.73), and confusion (r =.67), with large effect sizes, following the deep breathing exercise. Conclusion: A brief, virtual reality-based deep breathing exercise is worthy of additional study as a rehabilitation component for children and adolescents with prolonged concussion recoveries.	[Cook, Nathan E.; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Cook, Nathan E.; Huebschmann, Nathan A.; Iverson, Grant L.] Spaulding Rehabil Hosp, Spaulding Res Inst, Charlestown, MA USA; [Cook, Nathan E.; Huebschmann, Nathan A.; Iverson, Grant L.] MassGen Hosp, Children Sports Concuss Program, Boston, MA 02114 USA; [Iverson, Grant L.] Ctr Hlth & Rehabil Res, Charlestown, MA USA		Cook, NE (corresponding author), MassGen Hosp, Children Sports Concuss Program, Boston, MA 02114 USA.	necook@mgh.harvard.edu		Iverson, Grant/0000-0001-7348-9570	Louis V. Gerstner III Research Scholar Award; ImPACT Applications, Inc.; Mooney-Reed Charitable Foundation; Spaulding Research Institute	This work was supported by the Louis V. Gerstner III Research Scholar Award. Grant Iverson, Ph.D. acknowledges unrestricted philanthropic support from ImPACT Applications, Inc., the Mooney-Reed Charitable Foundation, and the Spaulding Research Institute.	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Beidas RS, 2010, CLIN PSYCHOL-SCI PR, V17, P1, DOI 10.1111/j.1468-2850.2009.01187.x; Busch V, 2012, PAIN MED, V13, P215, DOI 10.1111/j.1526-4637.2011.01243.x; Chansky T., 2004, FREEING YOUR CHILD A; Cohen J, 1998, STAT POWER ANAL BEHA; De Luca R, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/9268179; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gottshall KR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00106; GROVE JR, 1992, INT J SPORT PSYCHOL, V23, P93; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Iverson GL, 2021, CLIN J SPORT MED, V31, pE188, DOI 10.1097/JSM.0000000000000767; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kendall P.C., 2006, COGNITIVE BEHAV THER, V3; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Larsson B, 1996, J PEDIATR PSYCHOL, V21, P603, DOI 10.1093/jpepsy/21.5.603; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lehrer PM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00756; Lehrer PM, 2003, PSYCHOSOM MED, V65, P796, DOI 10.1097/01.PSY.0000089200.81962.19; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Man DWK, 2013, BRAIN INJURY, V27, P1016, DOI 10.3109/02699052.2013.794969; Martin SL, 2012, J PAIN, V13, P755, DOI 10.1016/j.jpain.2012.05.001; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Parsons TD, 2008, J BEHAV THER EXP PSY, V39, P250, DOI 10.1016/j.jbtep.2007.07.007; Parsons TD, 2009, DEV NEUROREHABIL, V12, P224, DOI 10.1080/17518420902991719; Pertab JL, 2018, NEUROREHABILITATION, V42, P397, DOI 10.3233/NRE-172298; Powers MB, 2008, J ANXIETY DISORD, V22, P561, DOI 10.1016/j.janxdis.2007.04.006; Powers SW, 2001, NEUROLOGY, V56, P133, DOI 10.1212/WNL.56.1.133; Rabago CA, 2011, J NEUROL PHYS THER, V35, P185, DOI 10.1097/NPT.0b013e318235d7e6; Russell MEB, 2014, APPL PSYCHOPHYS BIOF, V39, P269, DOI 10.1007/s10484-014-9265-6; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Sessoms PH, 2015, MIL MED, V180, P143, DOI 10.7205/MILMED-D-14-00385; Shen JB, 2020, AM J LIFESTYLE MED, V14, P6, DOI 10.1177/1559827618756588; Shiri S, 2013, PAIN MED, V14, P621, DOI 10.1111/pme.12083; Slobounov S, 2006, CYBERPSYCHOL BEHAV, V9, P188, DOI 10.1089/cpb.2006.9.188; Teel EF, 2016, CLIN J SPORT MED, V26, P162, DOI 10.1097/JSM.0000000000000210; Teel EF, 2015, CLIN J SPORT MED, V25, P144, DOI 10.1097/JSM.0000000000000109; Toldo I, 2017, EUR J PAEDIAT NEUROL, V21, pe208; Turner WA, 2014, CLIN PSYCHOL REV, V34, P634, DOI 10.1016/j.cpr.2014.10.003; Van Diest I, 2014, APPL PSYCHOPHYS BIOF, V39, P171, DOI 10.1007/s10484-014-9253-x; Wang M, 2011, NEUROEPIDEMIOLOGY, V36, P2, DOI 10.1159/000320847; Zaccaro A, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00353; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	50	1	1	1	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.	MAY 19	2021	24	4					222	229		10.1080/17518423.2020.1839981		NOV 2020	8	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	RJ9TZ	WOS:000582965700001	33126815				2022-02-06	
J	Dabrowski, W; Siwicka-Gieroba, D; Robba, C; Badenes, R; Kotfis, K; Schlegel, TT; Jaroszynski, A				Dabrowski, Wojciech; Siwicka-Gieroba, Dorota; Robba, Chiara; Badenes, Rafael; Kotfis, Katarzyna; Schlegel, Todd T.; Jaroszynski, Andrzej			Decompressive Craniectomy Improves QTc Interval in Traumatic Brain Injury Patients	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						traumatic brain injury; cardiac disorders; electrocardiography; cardiac arrhythmias; the index of cardio-electrophysiological balance	CARDIAC ELECTROPHYSIOLOGICAL BALANCE; ELECTROCARDIOGRAPHIC ABNORMALITIES; RISK-FACTORS; ARRHYTHMIAS; INDEX; ANGLE; PROLONGATION; BIOMARKER; ICEB	Background: Traumatic brain injury (TBI) is commonly associated with cardiac dysfunction, which may be reflected by abnormal electrocardiograms (ECG) and/or contractility. TBI-related cardiac disorders depend on the type of cerebral injury, the region of brain damage and the severity of the intracranial hypertension. Decompressive craniectomy (DC) is commonly used to reduce intra-cranial hypertension (ICH). Although DC decreases ICH rapidly, its effect on ECG has not been systematically studied. The aim of this study was to analyze the changes in ECG in patients undergoing DC. Methods: Adult patients without previously known cardiac diseases treated for isolated TBI with DC were studied. ECG variables, such as: spatial QRS-T angle (spQRS-T), corrected QT interval (QTc), QRS and T axes (QRS(ax) and T-ax, respectively), STJ segment and the index of cardio-electrophysiological balance (iCEB) were analyzed before DC and at 12-24 h after DC. Changes in ECG were analyzed according to the occurrence of cardiac arrhythmias and 28-day mortality. Results: 48 patients (17 female and 31 male) aged 18-64 were studied. Intra-cranial pressure correlated with QTc before DC (p < 0.01, r = 0.49). DC reduced spQRS-T (p < 0.001) and QTc interval (p < 0.01), increased Tax (p < 0.01) and changed STJ in a majority of leads but did not affect QRS(ax) and iCEB. The iCEB was relatively increased before DC in patients who eventually experienced cardiac arrhythmias after DC (p < 0.05). Higher post-DC iCEB was also noted in non-survivors (p < 0.05), although iCEB values were notably heart rate-dependent. Conclusions: ICP positively correlates with QTc interval in patients with isolated TBI, and DC for relief of ICH reduces QTc and spQRS-T. However, DC might also increase risk for life-threatening cardiac arrhythmias, especially in ICH patients with notably prolonged QTc before and increased iCEB after DC.	[Dabrowski, Wojciech; Siwicka-Gieroba, Dorota] Med Univ Lublin, Dept Anaesthesiol & Intens Care, PL-20954 Lublin, Poland; [Robba, Chiara] Policlin San Martino, Dept Anaesthesia & Intens Care, I-1100 Genoa, Italy; [Badenes, Rafael] Univ Valencia, Hosp Clin Univ Valencia, Dept Anaesthesiol & Intens Care, Valencia 46010, Spain; [Kotfis, Katarzyna] Pomeranian Med Univ, Dept Anaesthesiol Intens Therapy & Acute Intoxica, PL-70111 Szczecin, Poland; [Schlegel, Todd T.] Karolinska Inst, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden; [Schlegel, Todd T.] Nicollier Schlegel SARL, CH-1270 Trelex, Switzerland; [Jaroszynski, Andrzej] Jan Kochanowski Univ Humanities & Sci, Coll Med, Dept Nephrol, PL-25736 Kielce, Poland		Dabrowski, W (corresponding author), Med Univ Lublin, Dept Anaesthesiol & Intens Care, PL-20954 Lublin, Poland.	w.dabrowski5@yahoo.com; dsiw@wp.pl; kiarobba@gmail.com; rafaelbadenes@gmail.com; katarzyna.kotfis@pum.edu.pl; ttschlegel@gmail.com; jaroszynskiaj@interia.pl	Kotfis, Katarzyna/O-4355-2014	Kotfis, Katarzyna/0000-0001-8430-1369; Schlegel, Todd/0000-0003-1997-3227; Siwicka-Gieroba, Dorota/0000-0002-1001-0080; Dabrowski, Wojciech/0000-0003-0449-2375; Jaroszynski, Andrzej/0000-0001-8194-1723; Badenes, Rafael/0000-0001-7017-0150			Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Battaglini D, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02885-8; Brown DA, 2017, HAND CLINIC, V140, P299, DOI 10.1016/B978-0-444-63600-3.00016-7; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen WQ, 2017, BRAIN RES BULL, V130, P47, DOI 10.1016/j.brainresbull.2017.01.003; Cortez DL, 2010, J ELECTROCARDIOL, V43, P302, DOI 10.1016/j.jelectrocard.2010.03.010; Dabrowski W, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051293; Dabrowski W, 2018, J ELECTROCARDIOL, V51, P499, DOI 10.1016/j.jelectrocard.2017.12.038; Davey P, 2000, EUR J HEART FAIL, V2, P265, DOI 10.1016/S1388-9842(00)00065-9; Desgranges FP, 2014, CHILD NERV SYST, V30, P1393, DOI 10.1007/s00381-014-2417-4; EDENBRANDT L, 1988, J ELECTROCARDIOL, V21, P361, DOI 10.1016/0022-0736(88)90113-6; El-Menyar A, 2017, CARDIOL REV, V25, P279, DOI 10.1097/CRD.0000000000000167; Elming Hanne, 2002, Card Electrophysiol Rev, V6, P289, DOI 10.1023/A:1016345412555; Frangiskakis JM, 2009, NEUROCRIT CARE, V10, P287, DOI 10.1007/s12028-009-9188-x; Gibbs C, 2019, EUROPACE, V21, P1254, DOI 10.1093/europace/euz058; Grosse-Wortmann L, 2006, PEDIATR CARDIOL, V27, P286, DOI 10.1007/s00246-005-1248-1; Hasanin A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0246-z; Hnatkova K, 2018, EUROPACE, V20, P1352, DOI 10.1093/europace/eux246; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JACHUCK SJ, 1975, BRIT MED J, V1, P242, DOI 10.1136/bmj.1.5952.242; Katsanos AH, 2013, INT J CARDIOL, V167, P328, DOI 10.1016/j.ijcard.2012.06.107; Keller C, 1993, J Neurosci Nurs, V25, P349; Koiv L, 1997, ACTA NEUROL SCAND, V96, P52; Kuck K, 2018, J ELECTROCARDIOL, V51, P768, DOI 10.1016/j.jelectrocard.2018.05.011; Liu YQ, 2020, CAN J PHYSIOL PHARM, V98, P332, DOI 10.1139/cjpp-2019-0290; Lu HR, 2013, J PHARMACOL TOX MET, V68, P250, DOI 10.1016/j.vascn.2013.01.003; Machhada A, 2015, HEART RHYTHM, V12, P2285, DOI 10.1016/j.hrthm.2015.06.005; Nguyen H, 2009, CURR NEUROL NEUROSCI, V9, P486, DOI 10.1007/s11910-009-0071-0; Oji M, 2013, J CLIN MONIT COMPUT, V27, P243, DOI 10.1007/s10877-012-9420-7; OPPENHEIMER SM, 1994, CURR OPIN NEUROL, V7, P20, DOI 10.1097/00019052-199402000-00005; Ozdemir L, 2020, J ELECTROCARDIOL, V59, P41, DOI 10.1016/j.jelectrocard.2020.01.003; Robyns T, 2016, ANN NONINVAS ELECTRO, V21, P294, DOI 10.1111/anec.12309; Sijercic Selma, 2018, Med Arch, V72, P316, DOI 10.5455/medarh.2018.72.316-318; Sivri S, 2019, J ELECTROCARDIOL, V54, P72, DOI 10.1016/j.jelectrocard.2019.03.011; Taggart P, 2016, AUTON NEUROSCI-BASIC, V199, P54, DOI 10.1016/j.autneu.2016.08.013; Tian RF, 2019, WORLD NEUROSURG, V126, pE101, DOI 10.1016/j.wneu.2019.01.246; Tse G, 2017, EUROPACE, V19, P712, DOI 10.1093/europace/euw280; Vandael E, 2017, INT J CLIN PHARM-NET, V39, P16, DOI 10.1007/s11096-016-0414-2; Whang W, 2012, AM J CARDIOL, V109, P981, DOI 10.1016/j.amjcard.2011.11.027; Xue JQ, 2006, COMPUT CARDIOL, V33, P385; Yamazaki T, 2005, HEART RHYTHM, V2, P73, DOI 10.1016/j.hrthm.2004.10.040	42	1	1	0	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	NOV	2020	17	22							8653	10.3390/ijerph17228653			15	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	OZ1PA	WOS:000594705400001	33233364	gold, Green Published			2022-02-06	
J	Dobney, DM; Grilli, L; Beaulieu, C; Straub, M; Galli, C; Saklas, M; Friedman, D; Dubrovsky, AS; Gagnon, IJ				Dobney, Danielle M.; Grilli, Lisa; Beaulieu, Christine; Straub, Meghan; Galli, Carlo; Saklas, Mitchell; Friedman, Debbie; Dubrovsky, Alexander Sasha; Gagnon, Isabelle J.			Feasibility of Early Active Rehabilitation for Concussion Recovery in Youth: A Randomized Trial	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; rehabilitation	SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; INTERNATIONAL-CONFERENCE; AGREEMENT STATEMENT; CONSENSUS STATEMENT; PHYSICAL-THERAPY; SYMPTOMS; CHILDREN; RECOMMENDATIONS; ZURICH	Objective: The primary objective is to evaluate the feasibility (safety and acceptability) of implementing early active rehabilitation (AR) for concussion management in youth with symptoms persisting 2 weeks after injury. A secondary and exploratory objective was to estimate the potential efficacy of early AR compared with standard AR. We hypothesize that AR at 2-weeks postconcussion will be safe and acceptable to patients. Design: Randomized clinical trial. Setting: The Montreal Children's Hospital of the McGill University Health Center (MCH-MUHC), a tertiary care pediatric teaching hospital affiliated with McGill University in Montreal, Canada. Participants: Twenty youth aged 9 to 17 years old with postconcussion symptoms for at least 2 weeks. Intervention: Active rehabilitation (aerobic exercise, coordination drills, visualization, and education/reassurance) was administered by physiotherapists in-person, and then continued as a home program. Methods: Twenty participants were randomized to either early AR (initiated 2 weeks after injury) or standard AR (initiated 4 weeks after injury). Results: Two adverse events (one in each group) were identified through an online survey more than one-month postconcussion. Postconcussion symptoms decreased over time for both groups. Conclusions: The results from this pilot study indicate that a full clinical trial estimating the efficacy of early AR (starting 2 weeks after injury) is feasible. Further study is needed to determine the superiority of this strategy over current treatment approaches.	[Dobney, Danielle M.; Saklas, Mitchell; Gagnon, Isabelle J.] McGill Univ, Sch Phys & Occupat Therapy, Fac Med, Montreal, PQ, Canada; [Grilli, Lisa; Beaulieu, Christine; Straub, Meghan; Galli, Carlo; Friedman, Debbie; Gagnon, Isabelle J.] McGill Univ, Hlth Ctr, Trauma Ctr, Montreal Childrens Hosp, Montreal, PQ, Canada; [Friedman, Debbie] Govt Canada, Canadian Hosp Injury Reporting & Prevent Program, Ottawa, ON, Canada; [Friedman, Debbie] McGill Univ, Dept Pediat Surg, Fac Med, Montreal, PQ, Canada; [Friedman, Debbie] McGill Univ, Fac Med, Sch Phys & Occupat Therapy, Nursing, Montreal, PQ, Canada; [Friedman, Debbie] McGill Univ, Fac Med, Sch Commun Sci, Nursing, Montreal, PQ, Canada; [Friedman, Debbie] McGill Univ, Fac Med, Sch Disorders, Nursing, Montreal, PQ, Canada; [Friedman, Debbie] McGill Univ, Dept Pediat, Fac Med, Montreal, PQ, Canada; [Dubrovsky, Alexander Sasha; Gagnon, Isabelle J.] McGill Univ, Fac Med, Dept Pediat Emergency Med, Montreal, PQ, Canada		Gagnon, IJ (corresponding author), McGill Univ, Trauma Ctr, Sch Phys & Occupat Therapy, Fac Med, 5252 Boul Maisonneuve Ouest, Montreal, PQ H4A 3S5, Canada.	Isabelle.gagnon8@mcgill.ca		Gagnon, Isabelle/0000-0003-2043-1644	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Fonds de la recherche du Quebec-santeFonds de la Recherche en Sante du Quebec	Supported by a grant from the Canadian Institutes of Health Research and the Fonds de la recherche du Quebec-sante	Adamo KB, 2009, INT J PEDIATR OBES, V4, P2, DOI 10.1080/17477160802315010; Alla S, 2012, BRIT J SPORT MED, V46, P562, DOI 10.1136/bjsm.2010.081299; Arain M, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-67; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Chan C, 2018, ARCH PHYS MED REHAB, V99, P242, DOI 10.1016/j.apmr.2017.09.108; Chrisman SPD, 2017, NEUROREHABILITATION, V40, P493, DOI 10.3233/NRE-161436; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Dobney DM, 2017, BRAIN INJURY, V31, P1753, DOI 10.1080/02699052.2017.1346294; Eldridge Sandra M, 2016, BMJ, V355, pi5239, DOI 10.1136/bmj.i5239; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Hertzog MA, 2008, RES NURS HEALTH, V31, P180, DOI 10.1002/nur.20247; Hugentobler JA, 2015, INT J SPORTS PHYS TH, V10, P676; Isaac S, 1971, HDB RES EVALUATION C; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moser Rosemarie Scolaro, 2012, Front Neurol, V3, P171, DOI 10.3389/fneur.2012.00171; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; SWANSON GM, 1995, J NATL CANCER I, V87, P1747, DOI 10.1093/jnci/87.23.1747; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Wells EM, 2016, J CHILD NEUROL, V31, P86, DOI 10.1177/0883073815570152; Hunt AW, 2016, J ATHL TRAINING, V51, P749, DOI 10.4085/1062-6050-51.11.12; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	38	1	1	2	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2020	30	6					519	525		10.1097/JSM.0000000000000671			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	OP0UO	WOS:000587794700010	33141524				2022-02-06	
J	Dolenec, P; Pilipovic, K; Jankovic, T; Zupan, G				Dolenec, Petra; Pilipovic, Kristina; Jankovic, Tamara; Zupan, Gordana			Pattern of Neuronal and Axonal Damage, Glial Response, and Synaptic Changes in Rat Cerebellum within the First Week following Traumatic Brain Injury	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Cerebellum; Neurodegeneration; Neuroglia; Rat; Synapses; Traumatic brain injury	LATERAL FLUID-PERCUSSION; APOPTOSIS-INDUCING FACTOR; PURKINJE-CELL VULNERABILITY; CYTOCHROME-C RELEASE; WHITE-MATTER; PROGRESSIVE ATROPHY; REACTIVE ASTROCYTES; CASPASE ACTIVATION; DEATH MECHANISMS; TIME-COURSE	We examined damage and repair processes in the rat cerebellum within the first week following moderate traumatic brain injury (TBI) induced by lateral fluid percussion injury (LFPI) over the left parietal cortex. Rats were killed 1, 3, or 7 days after the injury or sham procedure. Fluoro-Jade B staining revealed 2 phases of neurodegenerative changes in the cell bodies and fibers: first, more focal, 1 day after the LFPI, and second, widespread, starting on post-injury day 3. Purkinje cell loss was detected in posterior lobule IX 1 day following LFPI. Apoptosis was observed in the cerebellar cortex, on days 1 and 7 following LFPI, and was not caspase- or apoptosis-inducing factor (AIF)-mediated. AIF immunostaining indicated axonal damage in the cerebellar white matter tracts 3- and 7-days postinjury. Significant astrocytosis and microgliosis were noticed on day 7 following LFPI at the sites of neuronal damage and loss. Immunohistochemical labeling with the presynaptic markers synaptophysin and growth-associated protein-43 revealed synaptic perturbations already on day 1 that were more pronounced at later time points following LFPI. These results provide new insights into pathophysiological alterations in the cerebellum and their mechanisms following cerebral TBI.	[Dolenec, Petra; Pilipovic, Kristina; Jankovic, Tamara; Zupan, Gordana] Univ Rijeka, Fac Med, Dept Pharmacol, Brace Branchetta 20, Rijeka 51000, Croatia		Zupan, G (corresponding author), Univ Rijeka, Fac Med, Dept Pharmacol, Brace Branchetta 20, Rijeka 51000, Croatia.	gordana.zupan@medri.uniri.hr	Zupan, Gordana/AAO-7057-2021; Pilipovic, Kristina/Q-5974-2018; Zupan, Gordana/AAO-7020-2021; Dolenec, Petra/AAV-1118-2021	Zupan, Gordana/0000-0002-4422-9021; Pilipovic, Kristina/0000-0002-7129-1621; Dolenec, Petra/0000-0002-9960-0385	University of Rijeka [uniri-biomed-18-204]; Ministry of Science, Education and Sports of the Republic of CroatiaMinistry of Science, Education and Sports, Republic of Croatia [062-0620529-0519]	This work has been supported by the University of Rijeka under the projects uniri-biomed-18-204 to G. Z.; and by Grant 062-0620529-0519 to G. Z. from The Ministry of Science, Education and Sports of the Republic of Croatia.	Ai JL, 2007, EXP BRAIN RES, V177, P95, DOI 10.1007/s00221-006-0654-9; Ai JL, 2004, PHARMACOLOGY, V71, P192, DOI 10.1159/000078085; Ai JL, 2002, NEUROSCI LETT, V332, P155, DOI 10.1016/S0304-3940(02)00945-X; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Artus C, 2010, EMBO J, V29, P1585, DOI 10.1038/emboj.2010.43; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Buki A, 2000, J NEUROSCI, V20, P2825; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Conti AC, 1998, J NEUROSCI, V18, P5663; Denecker G, 2001, CELL DEATH DIFFER, V8, P829, DOI 10.1038/sj.cdd.4400883; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; Dolenec P, 2015, J NEUROPATH EXP NEUR, V74, P512, DOI 10.1097/NEN.0000000000000194; Dusart I, 2005, BRAIN RES REV, V49, P300, DOI 10.1016/j.brainresrev.2004.11.007; DUSART I, 1994, J COMP NEUROL, V347, P211, DOI 10.1002/cne.903470206; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Emery DL, 2000, J COMP NEUROL, V424, P521; Fujita R, 2001, CELL MOL NEUROBIOL, V21, P317, DOI 10.1023/A:1012645920229; Fukuda K, 1996, BRAIN RES, V736, P68, DOI 10.1016/0006-8993(96)00680-4; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; GIULIAN D, 1987, J NEUROSCI RES, V18, P155, DOI 10.1002/jnr.490180123; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Gwag BJ, 1999, NEUROSCIENCE, V90, P1339, DOI 10.1016/S0306-4522(98)00508-9; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hanrahan F, 2016, FRONTIERS NEUROSCIEN; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Hoshino S, 2003, NEUROL MED-CHIR, V43, P165, DOI 10.2176/nmc.43.165; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; IACOPINO A, 1992, MOL BRAIN RES, V13, P251, DOI 10.1016/0169-328X(92)90033-8; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Liu ZW, 2014, GLIA, V62, P2022, DOI 10.1002/glia.22723; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Matthews MA, 1998, BRAIN RES, V794, P1, DOI 10.1016/S0006-8993(98)00107-3; Mautes AEM, 1996, NEUROSCI LETT, V214, P95, DOI 10.1016/0304-3940(96)12916-5; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Mazzanti M, 2001, NEUROSCIENTIST, V7, P396, DOI 10.1177/107385840100700509; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Milenkovic I, 2005, NEUROCHEM RES, V30, P207, DOI 10.1007/s11064-004-2443-9; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Munivenkatappa A, 2016, J NEUROSCI RURAL PRA, V7, pS76, DOI 10.4103/0976-3147.196468; OESTREICHER AB, 1986, BRAIN RES, V375, P267, DOI 10.1016/0006-8993(86)90747-X; Ordek G, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00197; Park E, 2007, PROG BRAIN RES, V161, P327, DOI 10.1016/S0079-6123(06)61023-6; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Park E, 2007, EXP NEUROL, V204, P49, DOI 10.1016/j.expneurol.2006.09.012; Park E, 2006, J NEUROPATH EXP NEUR, V65, P226, DOI 10.1097/01.jnen.0000202888.29705.93; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pekny M, 2007, INT REV NEUROBIOL, V82, P95, DOI 10.1016/S0074-7742(07)82005-8; Pellerin L, 2004, NEUROSCIENTIST, V10, P53, DOI 10.1177/1073858403260159; Pilipovic K, 2015, PROG NEURO-PSYCHOPH, V59, P8, DOI 10.1016/j.pnpbp.2015.01.003; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; RINK A, 1995, AM J PATHOL, V147, P1575; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rossi F, 2006, CEREBELLUM, V5, P174, DOI 10.1080/14734220600786444; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rubenstein R, 2018, BEHAV BRAIN RES, V340, P29, DOI 10.1016/j.bbr.2016.04.041; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schirmer L, 2013, BRAIN PATHOL, V23, P2, DOI 10.1111/j.1750-3639.2012.00608.x; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; Slemmer JE, 2005, PROG BRAIN RES, V148, P367, DOI 10.1016/S0079-6123(04)48029-7; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Sophie Su Y, 2016, FRONTIERS NEUROSCIEN; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tam WY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07279; Taylor SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097096; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; van Loo G, 2002, CELL DEATH DIFFER, V9, P1031, DOI 10.1038/sj.cdd.4401088; Veenith Tonny, 2009, World J Emerg Surg, V4, P7, DOI 10.1186/1749-7922-4-7; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang HM, 2004, J NEUROSCI, V24, P10963, DOI 10.1523/JNEUROSCI.3461-04.2004; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong Y, 2001, NEUROL RES, V23, P129, DOI 10.1179/016164101101198460; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x; Zhu C, 2007, CELL DEATH DIFFER, V14, P775, DOI 10.1038/sj.cdd.4402053; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	127	1	1	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	NOV	2020	79	11					1163	1182		10.1093/jnen/nlaa111			20	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pathology	PQ9ED	WOS:000606843800003	33057716	Bronze			2022-02-06	
J	Fan, YY; Wang, YJ; Guo, J; Wu, MN; Zhang, MS; Niu, BL; Li, Y; Zhao, J; Yang, CH; Li, Y; Chen, M; Jiao, XY				Fan, Yan-Ying; Wang, Ying-Jing; Guo, Jie; Wu, Mei-Na; Zhang, Ming-Sheng; Niu, Bao-Long; Li, Yu; Zhao, Jing; Yang, Cai-Hong; Li, Yan; Chen, Min; Jiao, Xiang-Ying			Delayed metformin treatment improves functional recovery following traumatic brain injury via central AMPK-dependent brain tissue repair	BRAIN RESEARCH BULLETIN			English	Article						Delayed metformin treatment; Traumatic brain injury; Functional recovery; Brain tissue repair; Central AMPK activation	AXONAL REGENERATION; ANGIOGENESIS; NEUROGENESIS; CELLS; NEUROINFLAMMATION; NEUROPROTECTION; PRETREATMENT; ASTROCYTES	Accumulating evidence suggests that chronic metformin posttreatment offers potent neuroreparative effects against acute brain injury. However, in previous studies, metformin was not initially administered beyond 24 h postinjury, and the effects of delayed metformin treatment in traumatic brain injury (TBI) and other types of acute brain injury and the related mechanisms are unclear. To test this, male C57BL/6 mice received once daily metformin treatment (20, 50 or 100 mg/kg/d, i.p.) at day 1-14, day 1-2, day 1-10, day 3-10, day 5-12 or day 5-28 after cryogenic TBI (cTBI). The results showed that 100 mg/kg/d metformin administered at day 1-14 postinjury significantly promoted motor functional recovery in the beam walking and gait tests and reduced the infarct volume. Metformin (100 mg/kg/d) administered at day 1-10 or day 3-10 but not day 1-2 or day 5-12 after cTBI significantly improved motor functional outcomes at day 7 and 14, and reduced the infarct volume at day 14. Interestingly, the therapeutic time window was further expanded when the duration of metformin treatment starting at day 5 postinjury was extended to 2 weeks. Furthermore, compared with cTBI, the administration of metformin at day 3-10 or day 5-28 after cTBI significantly elevated the expression of phosphorylated adenosine monophosphate-activated protein kinase (AMPK) and growth associated protein 43 (an axonal regeneration marker) and the number of vascular branch points and decreased the area of glial scar and the number of amoeboid microglia in the peri-infarct area at day 14 or 28 postinjury. The above beneficial effects of metformin were blocked by the intracerebroventricular injection of the AMPK inhibitor compound C (40 mu g/ mouse/d). Our data provide the first evidence that metformin has a wide therapeutic time window for at least 5 days after cTBI, during which it can improve functional recovery by promoting tissue repair and inhibiting glial scar formation and microglial activation in a central AMPK-dependent manner.	[Fan, Yan-Ying; Wang, Ying-Jing; Wu, Mei-Na; Jiao, Xiang-Ying] Shanxi Med Univ, Dept Physiol, Key Lab Cellular Physiol, Minist Educ, Taiyuan 030001, Peoples R China; [Fan, Yan-Ying; Wang, Ying-Jing; Guo, Jie; Zhang, Ming-Sheng; Li, Yu; Zhao, Jing; Yang, Cai-Hong; Li, Yan; Chen, Min] Shanxi Med Univ, Dept Pharmacol, Taiyuan 030001, Peoples R China; [Niu, Bao-Long] Taiyuan Univ Technol, Coll Mat Sci & Engn, Taiyuan 030024, Peoples R China		Fan, YY (corresponding author), Shanxi Med Univ, Dept Pharmacol, Taiyuan 030001, Peoples R China.; Jiao, XY (corresponding author), Shanxi Med Univ, Dept Physiol, Taiyuan 030001, Peoples R China.	fyanying6@hotmail.com; jiaoxyty@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81872854, 81773738, 81202520]; Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi [201802058]; Fund Program for "Sanjin Scholars" of Shanxi Province; Shanxi Province Natural Science FoundationNatural Science Foundation of Shanxi Province [201901D111198]; Key Laboratory of Cellular Physiology (Shanxi Medical University) [KLMEC/SXMU-201901]; Fund for Shanxi "1331 Project" Key Subjects Construction [1331]	This work was sponsored by the National Natural Science Foundation of China (81872854, 81773738, 81202520), the Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi (201802058), the Fund Program for "Sanjin Scholars" of Shanxi Province, the Shanxi Province Natural Science Foundation (201901D111198), the Open Fund from the Key Laboratory of Cellular Physiology (Shanxi Medical University, KLMEC/SXMU-201901) and the Fund for Shanxi "1331 Project" Key Subjects Construction.	Ashabi G, 2015, METAB BRAIN DIS, V30, P747, DOI 10.1007/s11011-014-9632-2; Carter R J, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0812s15; Dadwal P, 2015, STEM CELL REP, V5, P166, DOI 10.1016/j.stemcr.2015.06.011; Deng T, 2016, NEUROCHEM RES, V41, P2719, DOI 10.1007/s11064-016-1988-8; Fan YY, 2018, NEUROSCI LETT, V678, P68, DOI 10.1016/j.neulet.2018.05.002; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Ghadernezhad N, 2016, PHARM BIOL, V54, P2211, DOI 10.3109/13880209.2016.1150306; Harada S, 2010, BRAIN RES, V1351, P254, DOI 10.1016/j.brainres.2010.06.052; Hatakeyama M, 2020, NEURAL REGEN RES, V15, P16, DOI 10.4103/1673-5374.264442; Hill JL, 2016, J NEUROCHEM, V139, P106, DOI 10.1111/jnc.13726; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Jin Q, 2014, BRAIN BEHAV IMMUN, V40, P131, DOI 10.1016/j.bbi.2014.03.003; Krishna G, 2017, BBA-MOL BASIS DIS, V1863, P1204, DOI 10.1016/j.bbadis.2017.03.007; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Li HP, 2013, J NEUROTRAUM, V30, P413, DOI 10.1089/neu.2012.2513; Li J, 2010, STROKE, V41, P2645, DOI 10.1161/STROKEAHA.110.589697; Liao RJ, 2019, STEM CELL REP, V12, P532, DOI 10.1016/j.stemcr.2019.01.004; Liu YQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0177-4; Liu YQ, 2014, NEUROSCI LETT, V579, P46, DOI 10.1016/j.neulet.2014.07.006; Liu ZW, 2016, PROG NEUROBIOL, V144, P103, DOI 10.1016/j.pneurobio.2015.09.008; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Rotermund C, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00400; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Shen LH, 2008, GLIA, V56, P1747, DOI 10.1002/glia.20722; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Vallon M, 2014, CELL MOL LIFE SCI, V71, P3489, DOI 10.1007/s00018-014-1625-0; Venna VR, 2014, EUR J NEUROSCI, V39, P2129, DOI 10.1111/ejn.12556; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhao H, 2013, TRANSL STROKE RES, V4, P63, DOI 10.1007/s12975-012-0243-0	31	1	1	2	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	NOV	2020	164						146	156		10.1016/j.brainresbull.2020.08.021			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OH2JL	WOS:000582395500015	32858129				2022-02-06	
J	Fierain, A; McGonigal, A; Lagarde, S; Catenoix, H; Valton, L; Rheims, S; Nica, A; Trebuchon, A; Carron, R; Bartolomei, F				Fierain, Alexane; McGonigal, Aileen; Lagarde, Stanislas; Catenoix, Helene; Valton, Luc; Rheims, Sylvain; Nica, Anca; Trebuchon, Agnes; Carron, Romain; Bartolomei, Fabrice			Stereoelectroencephalography (SEEG) and epilepsy surgery in posttraumatic epilepsy: A multicenter retrospective study	EPILEPSY & BEHAVIOR			English	Article						Focal epilepsy; Epilepsy surgery; Traumatic brain injury; SEEG	EPILEPTOGENICITY	Purpose: Posttraumatic epilepsy (PTE) is a common cause of drug-resistant epilepsy, especially in young adults. Nevertheless, such patients are not common candidates for intracranial presurgical evaluation. We investigated the role of stereoelectroencephalography (SEEG) in defining epileptogenicity and surgical strategy in patients with PTE. Methods: We analyzed idal SEEG recordings from 18 patients. We determined the seizure onset zone (SOZ) by quantifying the epileptogenicity of the sampled structures, using the "epileptogenicity index" (El). We also identified seizure onset patterns (SOPS) through visual and frequency analysis. Postsurgical outcome was assessed by Engel's classification. Results: The SOZ in PTE was most often located in temporal lobes, followed by frontal lobes. The SOZ was networkorganized in the majority of the cases. Half of the SOP did not contain fast discharges. Half of the recordings showed SOZ that were less extensive than the posttraumatic lesions seen on brain magnetic resonance imaging (MRI). All but one operated patient benefited from tailored cortectomy. Only 3 patients were contraindicated for surgical resection due to bilateral epileptogenicity. The overall surgical outcome was good in majority of patients (67% Engel1). Conclusion: Despite the potential risk of bilateral or multifocal epilepsy, patients with PTE may benefit from presurgical assessment in well-selected cases. In this context. SEEG allows guidance of tailored resections adapted to the SOZ. (C) 2020 Published by Elsevier Inc.	[Fierain, Alexane; McGonigal, Aileen; Lagarde, Stanislas; Trebuchon, Agnes; Bartolomei, Fabrice] Timone Hosp, Epileptol Dept, AP HM, Marseille, France; [Fierain, Alexane] Catholic Univ Louvain, Reference Epilepsy Ctr, Clin Univ St Luc, Brussels, Belgium; [McGonigal, Aileen; Lagarde, Stanislas; Trebuchon, Agnes; Bartolomei, Fabrice] Aix Marseille Univ, Timone Hosp, Inst Neurosci Syst, Epileptol Dept,APHM,INSERM,INS, Marseille, France; [Carron, Romain] Aix Marseille Univ, Timone Hosp, Inst Neurosci Syst, Funct & Stereotact Neurosurg Dept,AP HM,INSERM,IN, Marseille, France; [Catenoix, Helene; Rheims, Sylvain] Univ Lyon 1, CNRS UMR5292, INSERM U1028, Translat & Integrat Grp Epilepsy Res TIGER,Lyon N, Lyon, France; [Catenoix, Helene; Rheims, Sylvain] Hosp Civils Lyon, Dept Funct Neurol & Epileptol, Lyon, France; [Catenoix, Helene; Rheims, Sylvain] Univ Lyon, Lyon, France; [Valton, Luc] Toulouse Univ Hosp, Hop Pierre Paul Riquet, Neurophysiol Invest, CHU Purpan, Toulouse, France; [Valton, Luc] Univ Toulouse 3, Ctr Rech Cerveau & Cognit CerCo, Toulouse Mind & Brain Inst, Univ Paul Sabatier,CNRS UMR 5549, Toulouse, France; [Nica, Anca] Rennes Univ Hosp, Neurol Dept, Inserm U1099, LTSI Lab Traitement Signal & Image,CIC 1414, Rennes, France		Bartolomei, F (corresponding author), Hop La Timone, Epileptol Dept, AP HM, 264 Rue St Pierre, F-13005 Marseille, France.	Fabrice.bartolomei@ap-hm.fr	McGonigal, Aileen/V-3292-2018; Lagarde, Stanislas/AAI-1330-2019	McGonigal, Aileen/0000-0001-6775-5318; Lagarde, Stanislas/0000-0003-2916-1302; Rheims, Sylvain/0000-0002-4663-8515			Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Aubert S, 2009, BRAIN, V132, P3072, DOI 10.1093/brain/awp242; Bartolomei F, 2008, BRAIN, V131, P1818, DOI 10.1093/brain/awn111; Blumcke I, 2017, NEW ENGL J MED, V377, P1648, DOI 10.1056/NEJMoa1703784; Brady RD, 2019, NEUROBIOL DIS, V123, P8, DOI 10.1016/j.nbd.2018.08.007; Cardinale F, 2016, J CLIN NEUROPHYSIOL, V33, P490, DOI 10.1097/WNP.0000000000000249; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; ENGEL J, 1993, NEUROLOGY, V43, P1612, DOI 10.1212/WNL.43.8.1612; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gonzalez-Martinez J, 2013, EPILEPSIA, V54, P323, DOI 10.1111/j.1528-1167.2012.03672.x; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; Hakimian S, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11329; Hartzfeld P, 2008, BRIT J NEUROSURG, V22, P224, DOI 10.1080/02688690701818901; Hitti FL, 2020, OPER NEUROSURG, V18, P12, DOI 10.1093/ons/opz043; Hung C, 2012, CURR TREAT OPTION NE, V14, P293, DOI 10.1007/s11940-012-0178-5; Isnard J, 2018, NEUROPHYSIOL CLIN, V48, P5, DOI 10.1016/j.neucli.2017.11.005; Kazemi NJ, 1997, EPILEPSIA, V38, P670, DOI 10.1111/j.1528-1157.1997.tb01236.x; Lagarde S, 2019, EPILEPSIA, V60, P85, DOI 10.1111/epi.14604; Lagarde S, 2018, BRAIN, V141, P2966, DOI 10.1093/brain/awy214; Lagarde S, 2016, EPILEPSIA, V57, P1426, DOI 10.1111/epi.13464; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; MATHERN GW, 1994, EPILEPSY RES, V19, P129, DOI 10.1016/0920-1211(94)90023-X; Neal A, 2020, EPILEPSIA, V61, P81, DOI 10.1111/epi.16410; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Schuh LA, 1998, ARCH NEUROL-CHICAGO, V55, P1325, DOI 10.1001/archneur.55.10.1325; Szaflarski JP, 2014, NEUROPSYCH DIS TREAT, V10, P1469, DOI 10.2147/NDT.S50421; Villalon SM, 2018, J NEUROSCI METH, V303, P7, DOI 10.1016/j.jneumeth.2018.03.018	28	1	1	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	NOV	2020	112								107378	10.1016/j.yebeh.2020.107378			7	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	OP3TK	WOS:000588004200048	32835959	Green Submitted			2022-02-06	
J	Furlan, JC; Kurban, D; Craven, BC				Furlan, Julio C.; Kurban, D.; Craven, B. C.			Traumatic spinal cord injury in military personnel versus civilians: a propensity score-matched cohort study	BMJ MILITARY HEALTH			English	Article						spinal cord injury; neurotrauma; military; civilian	UNITED-STATES; VETERANS; WAR	Introduction Military personnel are exposed to mechanisms of bodily injuries that may differ from civilians. A retrospective cohort study (RCS) and a propensity score-matched cohort study (PSMCS) were undertaken to examine the potential differences in injury epidemiology, management and outcomes after spinal cord injury (SCI) between military personnel and civilians. Methods Using a Canadian multicentre SCI database, data of all individuals with sufficient data from October 2013 to January 2017 were included in the RCS (n=1043). In the PSMCS, a group of 50 military personnel with SCI was compared with a group of 50 civilians with SCI who were matched regarding sex, age, and level, severity and mechanism of SCI. Results In the RCS, military personnel with SCI (n=61) were significantly older and predominantl males when compared with civilians with SCI (n=982). However, the study groups were not statistically different with regards to their: level, severity and mechanisms of SCI; frequency of associated bodily injuries; and need for mechanical ventilation after SCI. In the PSMCS, the group of military individuals with SCI (n=50) was similar to the group of civilians with SCI (n=50) regarding pre-existing medical comorbidities, degree of motor impairment at admission, initial treatment for SCI and clinical and neurological outcomes after SCI. Conclusions The results of these studies suggest that military SCI group has disproportionally older men at the time of injury compared with civilians with SCI. However, the military and civilian SCI groups had similar outcomes of alike initial treatment when both groups were matched regarding their demographic profile and injury characteristics.	[Furlan, Julio C.; Craven, B. C.] Toronto Rehabil Inst, Lyndhurst Ctr, Div Phys Med & Rehabil, Toronto, ON M4G 3V9, Canada; [Furlan, Julio C.; Craven, B. C.] Univ Toronto, Div Phys Med & Rehabil, Toronto, ON, Canada; [Kurban, D.] Rick Hansen Inst, Vancouver, BC, Canada		Furlan, JC (corresponding author), Toronto Rehabil Inst, Lyndhurst Ctr, Div Phys Med & Rehabil, Toronto, ON M4G 3V9, Canada.	jcfurlan@gmail.com	Furlan, Julio/Q-8290-2018; Craven, Beverley/D-5001-2015	Furlan, Julio/0000-0002-2038-0018; Craven, Beverley/0000-0001-8234-6803			Blackbourne LH, 2012, J TRAUMA ACUTE CARE, V73, pS372, DOI 10.1097/TA.0b013e3182755662; Blair JA, 2012, SPINE J, V12, P824, DOI 10.1016/j.spinee.2011.09.012; Blair JA, 2012, SPINE J, V12, P762, DOI 10.1016/j.spinee.2011.10.009; Burns SP, 2016, J SPINAL CORD MED, V39, P471, DOI 10.1080/10790268.2015.1114229; Butler FK, 2012, J TRAUMA ACUTE CARE, V73, pS395, DOI 10.1097/TA.0b013e3182754850; Chen YY, 2016, ARCH PHYS MED REHAB, V97, P1610, DOI 10.1016/j.apmr.2016.03.017; Creasey GH, 2015, J REHABIL RES DEV, V52, P669, DOI 10.1682/JRRD.2014.11.0291; Curtin CM, 2012, J REHABIL RES DEV, V49, P351, DOI 10.1682/JRRD.2010.11.0220; DeVivo MJ., 2011, TOP SPINAL CORD INJ, V16, P1, DOI DOI 10.1310/SCI1604-1; Dowdy J, 2014, J NEUROSURG, V120, P237, DOI 10.3171/2013.8.JNS122369; Eldar R, 2003, DISABIL REHABIL, V25, P1019, DOI 10.1080/0963828031000137739; Furlan JC, 2018, GLOB SPINE J, P1; Furlan JC, 2012, TRAUMATIC BRAIN SPIN, P360; Furlan JC, 2017, J SPINAL CORD MED, V40, P649, DOI 10.1080/10790268.2017.1368267; Grenier E.S., 2012, J BONE JOINT SURG AM, V94, pE135, DOI DOI 10.2106/JBJS.K.00502; Guzelkucuk U, 2016, SPINAL CORD, V54, P737, DOI 10.1038/sc.2016.29; Javadi M, 2014, ADV CLIN EXP MED, V23, P269, DOI 10.17219/acem/37075; Lanska DJ, 2009, ANN NEUROL, V66, P444, DOI 10.1002/ana.21822; Lehman RA, 2012, SPINE J, V12, P784, DOI 10.1016/j.spinee.2011.09.005; Noonan Vanessa K, 2013, Healthc Policy, V8, P87; Rabadi MH, 2013, SPINAL CORD, V51, P784, DOI 10.1038/sc.2013.77; Rivera Jessica C, 2014, J Surg Orthop Adv, V23, P136; SAMSA GP, 1993, ARCH NEUROL-CHICAGO, V50, P909, DOI 10.1001/archneur.1993.00540090018005; Samsa GP, 1996, ARCH PHYS MED REHAB, V77, P1037, DOI 10.1016/S0003-9993(96)90065-9; Schoenfeld AJ, 2013, SPINE, V38, P1770, DOI 10.1097/BRS.0b013e31829ef226; Schoenfeld AJ, 2012, SPINE J, V12, P777, DOI 10.1016/j.spinee.2011.01.029; Stroupe, 2011, TOP SPINAL CORD INJ, V16, P27, DOI DOI 10.1310/SCI1604-27; Yue JK, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17396	28	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2633-3767	2633-3775		BMJ MILITARY HEALTH	BMJ Military Health	NOV	2020	166	E					E57	E62		10.1136/jramc-2019-001197			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	OH8DZ	WOS:000582823700013	31154341				2022-02-06	
J	Grist, A; Bock, R; Knowles, TG; Wotton, SB				Grist, Andrew; Bock, Randall; Knowles, Toby G.; Wotton, Stephen B.			Further Examination of the Performance of Blank Cartridges Used in Captive Bolt Devices for the Pre-Slaughter Stunning of Animals	ANIMALS			English	Article						animal welfare; blank cartridges; cartridge variation; captive bolt devices; mechanical stunning; performance; stunning; velocity measurement		Simple Summary Since their advent in 1904, captive bolt devices have been used in abattoirs in Europe to produce an unconscious state in cattle prior to bleeding, to ensure that they suffer no pain during the process. These devices employ a single-use cartridge containing a propellant and no bullet (known as a blank cartridge) to rapidly provide a large quantity of gas through chemical combustion. This gas propels a piston (captive bolt) onto the head of the animal to produce a concussion that is severe enough to produce rapid brain dysfunction, preventing the brain from operating at a state where pain can be perceived by the animal. Subsequent penetration of the bolt is designed to prevent recovery from the stunned state by producing further mechanical damage to the brain. This paper examines and discusses variations in the performance of some blank cartridges in producing sufficient velocity and therefore energy to stun animals, thereby affecting animal welfare at slaughter. Blank cartridges produce gas through deflagration and are used as the main power source in captive bolt devices used within abattoirs and on farms in Europe. The European legislation recognises this and requires users to follow manufacturers' recommendations in terms of which power cartridge to use. Variation in cartridge performance of Eley (E) cartridges was found in previous research, which was published before Accles and Shelvoke (AS) started full production of their own cartridges. This work examined cartridge performance, structural integrity and dimensional tolerances, and found that the new AS cartridges that varied more greatly in performance in terms of velocity, kinetic energy and mechanical stability of casing than the more established E cartridges. In this study, 15% of the cartridges split at the primer flange on firing, resulting in less kinetic energy, which could impact the ability of the captive bolt to produce a successful stun. This, combined with the variation in performance in a primary component of a device that should have a uniform performance, could lead to animal welfare issues as this variation cannot be predetermined by examination of the cartridge pre firing.	[Grist, Andrew; Knowles, Toby G.; Wotton, Stephen B.] Univ Bristol, Sch Vet Sci, Langford House, Langford BS40 5DU, North Somerset, England; [Bock, Randall] Bock Ind Inc BI, 156 Bock Lane, Philipsburg, PA 16866 USA		Grist, A (corresponding author), Univ Bristol, Sch Vet Sci, Langford House, Langford BS40 5DU, North Somerset, England.	andy.grist@bristol.ac.uk; randall@bock-industries.com; toby.knowles@bristol.ac.uk; steve.wotton@bristol.ac.uk	Knowles, Toby G/A-2026-2008	Knowles, Toby G/0000-0002-3845-0942; Wotton, Stephen/0000-0002-9855-0267			[Anonymous], 2009, OFF J EUR UNION, V303, P1; Dorfler K, 2014, INT J LEGAL MED, V128, P641, DOI 10.1007/s00414-013-0961-1; Grist A, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9080552; Macnaughten L., 1932, HDB HUMANE SLAUGHTER, P7; Terlouw C, 2016, MEAT SCI, V118, P133, DOI 10.1016/j.meatsci.2016.03.011	5	1	1	1	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2076-2615			ANIMALS-BASEL	Animals	NOV	2020	10	11							2146	10.3390/ani10112146			12	Agriculture, Dairy & Animal Science; Veterinary Sciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture; Veterinary Sciences; Zoology	OX5RV	WOS:000593622500001	33218032	Green Published, gold			2022-02-06	
J	Gursoy, G; Gursoy, C; Kuscu, Y; Demirbilek, SG				Gursoy, Guven; Gursoy, Canan; Kuscu, Yagmur; Demirbilek, Semra Gumus			APACHE II or INCNS to predict mortality in traumatic brain injury: A retrospective cohort study	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Acute Physiology and Chronic Health Evaluation II (APACHE II); INCNS scoring system; intensive care unit mortality; scoring system; traumatic brain injury	ACUTE PHYSIOLOGY; SCORING SYSTEM; COMA SCALE; SEVERITY	BACKGROUND: Some scoring systems, such as Acute Physiology and Chronic Health Evaluation II (APACHE II), are used to predict mortality, but they are not specialized for traumatic brain injury. INCNS is a new scoring system for traumatic brain injury developed by Goa et al. INCNS score evaluates inflammation, nutrition, consciousness, neurological function and systemic condition. The present study aims to evaluate performances of Acute Physiology and Chronic Health Evaluation II (APACHE II) and INCNS to predict mortality in traumatic brain injuries. METHODS: In this study, 78 patients who were treated in anaesthesiology intensive care unit with the diagnosis of traumatic brain injury were included. Patients under the age of 18, foreigners, patients with incomplete data were excluded from this study. Medical records were examined retrospectively. APACHE II and INCNS scores in the first 24 hours were counted up. RESULTS: Of the 78 patients, 45 (57.7%) were males and 33 (42.3%) were females. The overall mortality was 34.6% (27/78). The mean APACHE II, INCNS score was 23.85 +/- 9.44 and 14.43 +/- 8.75, respectively. The area under the curve result of receiver operating characteristic curve analysis was 0.797 for the APACHE II and 0.847 for the INCNS. CONCLUSION: The INCNS scoring system had higher discriminatory power than the APACHE II in predicting the mortality of TBI in the ICU. INCNS can be considered as a usable prognostic model for Turkish people.	[Gursoy, Guven] Mugla Sitki Kocman Univ, Dept Neurosurg, Training & Res Hosp, Mugla, Turkey; [Gursoy, Canan] Mugla Sitki Kocman Univ, Dept Anesthesiol & Reanimat, Div Intens Care, Mugla, Turkey; [Kuscu, Yagmur; Demirbilek, Semra Gumus] Mugla Sitki Kocman Univ, Dept Anesthesiol & Reanimat, Fac Med, Mugla, Turkey		Gursoy, C (corresponding author), Mugla Sitki Kocman Univ, Egitim & Arastirma Hastanesi, Anesteziyol & Reanimasyon Klin, Mugla, Turkey.	gursoycanan@yahoo.com					Dalgic A, 2009, ULUS TRAVMA ACIL CER, V15, P453; Gao Q, 2020, CNS NEUROSCI THER, V26, P21, DOI 10.1111/cns.13134; Kim TK, 2012, J INT MED RES, V40, P777, DOI 10.1177/147323001204000244; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LEMESHOW S, 1994, JAMA-J AM MED ASSOC, V272, P1049, DOI 10.1001/jama.272.13.1049; Moskowitz Jesse, 2018, MDM Policy Pract, V3, p2381468318757987, DOI 10.1177/2381468318757987; Nyam TTE, 2017, NEUROCRIT CARE, V26, P225, DOI 10.1007/s12028-016-0326-y; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Potapov A A, 2016, Zh Vopr Neirokhir Im N N Burdenko, V80, P93, DOI 10.17116/neiro201680293-101; Talari HR, 2016, WORLD NEUROSURG, V87, P195, DOI 10.1016/j.wneu.2015.11.055; TEASDALE G, 1974, LANCET, V2, P81; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Yao S, 2017, WORLD NEUROSURG, V101, P528, DOI 10.1016/j.wneu.2017.02.072; Zou XJ, 2020, CRIT CARE MED, V48, pE657, DOI 10.1097/CCM.0000000000004411	14	1	1	0	2	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	NOV	2020	26	6					893	898		10.14744/tjtes.2020.22654			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	OH6NP	WOS:000582710000011	33107957				2022-02-06	
J	Hahn, EA; Boileau, NR; Hanks, RA; Sander, AM; Miner, JA; Carlozzi, NE				Hahn, Elizabeth A.; Boileau, Nicholas R.; Hanks, Robin A.; Sander, Angelle M.; Miner, Jennifer A.; Carlozzi, Noelle E.			Health Literacy, Health Outcomes, and the Caregiver Role in Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						caregivers; health literacy; caregiver appraisal; health-related quality of life; traumatic brain injury	QUALITY-OF-LIFE; MENTAL-HEALTH; TALKING TOUCHSCREEN; BEHAVIORAL-MODEL; SELF-EFFICACY; MEDICAL-CARE; INDIVIDUALS; VETERANS; BURDEN; PREPAREDNESS	Purpose/Objective: The purpose of this study is to estimate the occurrence of low health literacy among caregivers of people with traumatic brain injury (TBI), and to evaluate associations of health literacy with caregiver health-related quality of life (HRQOL) and perceptions of the caregiving role. Research Method/Design: The TBI-CareQOL measurement system assesses important self-reported outcomes for caregivers of civilians or service members/veterans (SMVs) with TBI. The validation phase included the Health Literacy Assessment Using Talking Touchscreen Technology (Health LiTT) measure. Multivariable regression evaluated the impact of low health literacy on generic and TBI-specific HRQOL and appraisals of the caregiving role, adjusted for caregiver gender, race/ethnicity and education, and the functional status of the TBI care recipient. Results: Among 131 caregivers, 28 (21%) had low health literacy. Compared with the high health literacy group, the group with low health literacy had fewer women, more racial/ethnic minorities, and lower education (all p < .05). The low health literacy group reported more subjective caregiving burden, less satisfaction with their relationship with the TBI recipient, less caregiving mastery, and poorer physical health (all p < .05). There were no differences between health literacy groups in caregiving ideology, caregiver-specific HRQOL or general mental health. Conclusions/Implications: A better understanding of the links between health literacy and caregiver HRQOL and the caregiving role can help identify strategies to meet the needs of this underserved population. Tailored interventions for caregivers with low health literacy could improve outcomes for both the caregiver and the care recipient.	[Hahn, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, 633 North St Clair St,Suite 1900, Evanston, IL 60611 USA; [Hahn, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Ctr Patient Ctr Outcomes, Evanston, IL 60611 USA; [Boileau, Nicholas R.; Miner, Jennifer A.; Carlozzi, Noelle E.] Univ Michigan, Ctr Clin Outcomes Dev & Applicat CODA, Dept Phys Med & Rehabil, Ann Arbor, MI USA; [Hanks, Robin A.] Wayne State Univ, Dept Phys Med & Rehabil, Sch Med, Detroit, MI USA; [Sander, Angelle M.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA		Hahn, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, 633 North St Clair St,Suite 1900, Evanston, IL 60611 USA.	e-hahn@northwestern.edu			National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01-NR013658]	Grant funding provided by the National Institute of Nursing Research (R01-NR013658) to Noelle E. Carlozzi.	Adams D, 2016, NEUROREHABILITATION, V39, P223, DOI 10.3233/NRE-161353; Adelman RD, 2014, JAMA-J AM MED ASSOC, V311, P1052, DOI 10.1001/jama.2014.304; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Andersen Ronald., 1968, BEHAV MODEL FAMILIES; [Anonymous], 2015, CAR US 2015; Bailey EK, 2017, J HEAD TRAUMA REHAB, V32, P245, DOI 10.1097/HTR.0000000000000317; Bandura A., 1992, SELF EFFICACY THOUGH, P355, DOI DOI 10.1080/10810730.2010.500713; Barutcu CD, 2019, P R HEALTH SCI J, V38, P163; Berkman N. D., 2011, USITC PUBL; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS43, DOI 10.1016/j.apmr.2018.06.025; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS13, DOI 10.1016/j.apmr.2018.05.033; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS31, DOI 10.1016/j.apmr.2018.05.026; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS22, DOI 10.1016/j.apmr.2018.05.027; Carlozzi NE, 2018, J HEAD TRAUMA REHAB, V33, P342, DOI 10.1097/HTR.0000000000000373; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Chan J, 2009, ADV MENT HEALTH, V8, P155, DOI 10.5172/jamh.8.2.155; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; Cianfrocca C, 2018, APPL NURS RES, V44, P100, DOI 10.1016/j.apnr.2018.10.004; Cohen J., 2013, STAT POWER ANAL BEHA; DeWalt DA, 2005, ARCH INTERN MED, V165, P1943, DOI 10.1001/archinte.165.17.1943; Dijkers MP, 2018, J HEAD TRAUMA REHAB, V33, P363, DOI 10.1097/HTR.0000000000000454; Family Caregiver Alliance, 2006, CAR ASS PRINC GUID S, VI; Family Caregiver Alliance, 2006, CAR ASS VOIC VIEWS F, VII; Fayers PM, 2007, QUALITY LIFE ASSESSM, VSecond, DOI [10.1002/9780470024522, DOI 10.1002/9780470024522]; Gelberg L, 2000, HEALTH SERV RES, V34, P1273; Gibson JT., 2012, CORRELATION HLTH LIT; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Hahn Elizabeth A, 2017, Health Lit Res Pract, V1, pe71, DOI 10.3928/24748307-20170427-02; Hahn EA, 2015, J HEALTH COMMUN, V20, P4, DOI 10.1080/10810730.2015.1061071; Hahn EA, 2014, J HEALTH COMMUN, V19, P285, DOI 10.1080/10810730.2014.936567; Hahn EA, 2011, J HEALTH COMMUN, V16, P150, DOI 10.1080/10810730.2011.605434; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hanauer DA, 2015, J BIOMED INFORM, V55, P290, DOI 10.1016/j.jbi.2015.05.003; Hart T, 2003, ARCH PHYS MED REHAB, V84, P221, DOI 10.1053/apmr.2003.50023; Hays RD, 1995, USERS MANUAL MED OUT; Hendrix CC, 2016, SUPPORT CARE CANCER, V24, P327, DOI 10.1007/s00520-015-2797-3; Jordan JE, 2011, J CLIN EPIDEMIOL, V64, P366, DOI 10.1016/j.jclinepi.2010.04.005; Karter AJ, 2000, DIABETES CARE, V23, P477, DOI 10.2337/diacare.23.4.477; Keatley E., 2018, PREDICTORS OUT UNPUB; Kratz A, 2014, ARCH PHYS MED REHAB, V95, pe50; Ladley A, 2018, ACAD PEDIATR, V18, P636, DOI 10.1016/j.acap.2018.02.003; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; Lester P, 2010, J AM ACAD CHILD PSY, V49, P310, DOI 10.1016/j.jaac.2010.01.003; Magasi S, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.117.004414; Malec J., 2005, MAYO PORTLAND ADAPTA; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Mansfield AJ, 2010, NEW ENGL J MED, V362, P101, DOI 10.1056/NEJMoa0900177; Montbleau Kara E, 1800, Cogent Med, V4, P1412121, DOI 10.1080/2331205X.2017.1412121; Moore M, 2017, BRAIN INJURY, V31, P1876, DOI 10.1080/02699052.2017.1346291; Nielsen-Bohlman L, 2004, HLTH LITERACY PRESCR; Parker RM, 1999, JAMA-J AM MED ASSOC, V281, P552; Phelan SM, 2011, DISABIL HEALTH J, V4, P177, DOI 10.1016/j.dhjo.2011.03.003; Piette JD, 2004, MED CARE, V42, P102, DOI 10.1097/01.mlr.0000108742.26446.17; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; Saban KL, 2016, J REHABIL RES DEV, V53, P681, DOI 10.1682/JRRD.2015.07.0143; Sarkar U, 2006, DIABETES CARE, V29, P823, DOI 10.2337/diacare.29.04.06.dc05-1615; Schorling JB, 2000, DIABETES CARE, V23, P330, DOI 10.2337/diacare.23.3.330; Slesinger N. C., VALIDATION SHORT FOR; Stellefson M, 2019, J MED INTERNET RES, V21, DOI 10.2196/12165; Stewart A., 1991, MEASURING FUNCTIONIN; Stone K, 2014, REHABIL NURS, V39, P76, DOI 10.1002/rnj.123; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Taft CT, 2008, J CONSULT CLIN PSYCH, V76, P648, DOI 10.1037/a0012576; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wang CL, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0190-5; Yost KJ, 2010, J HEALTH COMMUN, V15, P80, DOI 10.1080/10810730.2010.500713; Yost KJ, 2009, PATIENT EDUC COUNS, V75, P295, DOI 10.1016/j.pec.2009.02.020; Yuen EYN, 2018, HEALTH SOC CARE COMM, V26, pE191, DOI 10.1111/hsc.12368; Zhang XH, 2009, VALUE HEALTH, V12, pS106, DOI 10.1111/j.1524-4733.2009.00640.x; [No title captured]	73	1	1	2	6	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2020	65	4					401	408		10.1037/rep0000330			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	OW5SF	WOS:000592945400008	32463261	Bronze, Green Accepted			2022-02-06	
J	Herrold, AA; Siddiqi, SH; Livengood, SL; Pape, TLB; Higgins, JP; Adamson, MM; Leung, A; Raij, T				Herrold, Amy A.; Siddiqi, Shan H.; Livengood, Sherri L.; Pape, Theresa L. Bender; Higgins, James P.; Adamson, Maheen Mausoof; Leung, Albert; Raij, Tommi			Customizing TMS Applications in Traumatic Brain Injury Using Neuroimaging	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						MRI; neuroimaging; TBI; TMS; transcranial magnetic stimulation; traumatic brain injury	TRANSCRANIAL MAGNETIC STIMULATION; POSTTRAUMATIC-STRESS-DISORDER; WHITE-MATTER ABNORMALITIES; FUNCTIONAL CONNECTIVITY; SUBSTANCE-ABUSE; CONCUSSION; DEPRESSION; ATTENTION; NETWORKS; VETERANS	Optimizing transcranial magnetic stimulation (TMS) treatments in traumatic brain injury (TBI) and co-occurring conditions may benefit from neuroimaging-based customization. Participants: Our total sample (N = 97) included 58 individuals with TBI (49 mild, 8 moderate, and 1 severe in a state of disordered consciousness), of which 24 had co-occurring conditions (depression in 14 and alcohol use disorder in 10). Of those without TBI, 6 individuals had alcohol use disorder and 33 were healthy controls. Of our total sample, 54 were veterans and 43 were civilians. Design: Proof-of-concept study incorporating data from 5 analyses/studies that used multimodal approaches to integrate neuroimaging with TMS. Main Measures: Multimodal neuroimaging methods including structural magnetic resonance imaging (MRI), MRI-guided TMS navigation, functional MRI, diffusion MRI, and TMS-induced electric fields. Outcomes included symptom scales, neuropsychological tests, and physiological measures. Results: It is feasible to use multimodal neuroimaging data to customize TMS targets and understand brain-based changes in targeted networks among people with TBI. Conclusions: TBI is an anatomically heterogeneous disorder. Preliminary evidence from the 5 studies suggests that using multimodal neuroimaging approaches to customize TMS treatment is feasible. To test whether this will lead to increased clinical efficacy, studies that integrate neuroimaging and TMS targeting data with outcomes are needed.	[Herrold, Amy A.; Livengood, Sherri L.; Pape, Theresa L. Bender] Edward Hines Jr VA Hosp, Res Serv, 5000 S 5th Ave MC 151, Hines, IL 60141 USA; [Herrold, Amy A.] Northwestern Univ, Interdept Neurosci Program, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Livengood, Sherri L.; Pape, Theresa L. Bender; Raij, Tommi] Northwestern Univ, Interdept Neurosci Program, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Higgins, James P.] Northwestern Univ, Interdept Neurosci Program, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA; [Raij, Tommi] Northwestern Univ, Dept Neurobiol, Weinberg Coll Arts & Sci, Chicago, IL 60611 USA; [Siddiqi, Shan H.] Brigham & Womens Hosp, Ctr Brain Circuit Therapeut, 75 Francis St, Boston, MA 02115 USA; [Siddiqi, Shan H.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Adamson, Maheen Mausoof] VA Palo Alto Hlth Care Syst, Rehabil Serv, Palo Alto, CA USA; [Adamson, Maheen Mausoof] Stanford Univ, Sch Med, Dept Neurosurg, Palo Alto, CA 94304 USA; [Leung, Albert] UCSD Sch Med, Ctr Pain Med, Dept Anesthesiol, La Jolla, CA USA; [Raij, Tommi] Ctr Brain Stimulat, Shirley Ryan AbilityLab, 355 E Erie St, Chicago, IL 60611 USA		Herrold, AA (corresponding author), Edward Hines Jr VA Hosp, Res Serv, 5000 S 5th Ave MC 151, Hines, IL 60141 USA.; Raij, T (corresponding author), Ctr Brain Stimulat, Shirley Ryan AbilityLab, 355 E Erie St, Chicago, IL 60611 USA.	Amy.Herrold@va.gov; tommi.raij@northwestern.edu		Raij, Tommi/0000-0001-7439-7491; Higgins, James/0000-0002-7916-8468	VA RRD CDA-II [RX000949, RX002916]; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23-MH121657, DoD-CRMRP W81XWH-14-1-0568]; Marian Falk Medical Research Trust - Sidney R. Baer Foundation; Brain& Behavior Research FoundationNARSAD; Neuronetics Inc	The sources of funding are as follows: VA RR&D CDA-II RX000949 (A.A.H.), VA RR&D IIR RX002916 (A.A.H.), NIMH K23-MH121657 (S.H.S), VARehabilitation SPIRE (M.M.A.), DoD-CRMRP W81XWH-14-1-0568 (T.B.P.), and Dr Ralph and Marian Falk Medical Research Trust (T.R.). S.H.S. is funded by the Sidney R. Baer Foundation and the Brain& Behavior Research Foundation. S.H.S. has received investigatorinitiated grant funding from Neuronetics Inc unrelated to the present work.	Adamson MM, 2019, C P NEUR SCI NYC NEU; Beynel L, 2020, NEUROIMAGE, V211, DOI 10.1016/j.neuroimage.2020.116596; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Cash RFH, 2019, BIOL PSYCHIAT, V86, pE5, DOI 10.1016/j.biopsych.2018.12.002; Chong CD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0485-0; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; Delis DC., 2001, DELIS KAPLAN EXECUTI; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Deng ZD, 2013, BRAIN STIMUL, V6, P1, DOI 10.1016/j.brs.2012.02.005; Diana M, 2017, NAT REV NEUROSCI, V18, P685, DOI 10.1038/nrn.2017.113; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fox MD, 2012, BIOL PSYCHIAT, V72, P595, DOI 10.1016/j.biopsych.2012.04.028; Fox MD, 2012, NEUROIMAGE, V62, P2232, DOI 10.1016/j.neuroimage.2012.03.035; Gordon EM, 2017, NEURON, V95, P791, DOI 10.1016/j.neuron.2017.07.011; Gordon EM, 2017, CEREB CORTEX, V27, P386, DOI 10.1093/cercor/bhv239; Guenette JP, 2018, NEUROIMAG CLIN N AM, V28, P43, DOI 10.1016/j.nic.2017.09.004; Gugino LD, 2001, CLIN NEUROPHYSIOL, V112, P1781, DOI 10.1016/S1388-2457(01)00633-2; Hacker CD, 2013, NEUROIMAGE, V82, P616, DOI 10.1016/j.neuroimage.2013.05.108; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hanlon CA, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0220-9; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Herrold AA, 2014, NEURAL REGEN RES, V9, P1712, DOI 10.4103/1673-5374.143408; Hoffman JM, 2012, ARCH PHYS MED REHAB, V93, P287, DOI 10.1016/j.apmr.2011.08.041; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iraji A, 2016, NEUROIMAGE-CLIN, V12, P100, DOI 10.1016/j.nicl.2016.06.012; Joutsa J, 2018, ANN NEUROL, V84, P153, DOI 10.1002/ana.25285; Juengst SB, 2017, PSYCHOL RES BEHAV MA, V10, P175, DOI 10.2147/PRBM.S113264; Jurick SM, 2018, J HEAD TRAUMA REHAB, V33, pE41, DOI 10.1097/HTR.0000000000000313; Karlsen RH, 2019, J NEUROSCI RES, V97, P568, DOI 10.1002/jnr.24383; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; Klein MM, 2015, PAIN, V156, P1601, DOI 10.1097/j.pain.0000000000000210; Kletzel SL, J HEAD TRAUMA REHABI; Kulkarni P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125748; Lepage C, 2018, BRAIN IMAGING BEHAV, V12, P870, DOI 10.1007/s11682-017-9744-5; Leung A, 2020, NEUROMODULATION, V23, P267, DOI 10.1111/ner.13094; Leung A, 2016, NEUROMODULATION, V19, P133, DOI 10.1111/ner.12364; Loignon A, 2020, J HEAD TRAUMA REHAB, V35, pE21, DOI 10.1097/HTR.0000000000000514; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Makarov S., 2019, BRAIN HUMAN BODY MOD, P3, DOI [10.1007/978-3-030-21293-3_1, DOI 10.1007/978-3-030-21293-3_1]; Makarov SN, 2020, J NEURAL ENG, V17, DOI 10.1088/1741-2552/ab85b3; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Narayana Ponnada A, 2017, Concussion, V2, pCNC35, DOI 10.2217/cnc-2016-0028; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Nordhaug LH, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0838-2; Nummenmaa A, 2013, CLIN NEUROPHYSIOL, V124, P1995, DOI 10.1016/j.clinph.2013.04.019; O'Connell NE, 2018, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008208.pub4, 10.1002/14651858.CD008208.pub5]; Oberman LM, J HEAD TRAUMA REHABI; Ozdemir RA, 2020, P NATL ACAD SCI USA, V117, P8115, DOI 10.1073/pnas.1911240117; Padmanabhan JL, 2019, BIOL PSYCHIAT, V86, P749, DOI 10.1016/j.biopsych.2019.07.023; Pape TLB, 2006, J HEAD TRAUMA REHAB, V21, P437, DOI 10.1097/00001199-200609000-00063; Pink AE, 2021, NEUROPSYCHOL REHABIL, V31, P479, DOI 10.1080/09602011.2019.1706585; Ponsford J, 2018, J NEUROPSYCH CLIN N, V30, P262, DOI 10.1176/appi.neuropsych.18040093; Raij T, 2018, BIOL PSYCHIAT, V84, P129, DOI 10.1016/j.biopsych.2017.10.022; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sadaghiani S, 2015, CEREB CORTEX, V25, P2763, DOI 10.1093/cercor/bhu072; Setsompop K, 2012, NEUROIMAGE, V63, P569, DOI 10.1016/j.neuroimage.2012.06.033; Shaker M, 2017, MED IMAGE ANAL, V37, P56, DOI 10.1016/j.media.2017.01.005; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Siddiqi SH, 2020, AM J PSYCHIAT, V177, P435, DOI 10.1176/appi.ajp.2019.19090915; Siddiqi SH, 2019, J NEUROTRAUM, V36, P1361, DOI 10.1089/neu.2018.5889; Singh A., 2019, SCI REP, V9, P1; Strauss SB, 2016, AM J NEURORADIOL, V37, P1983, DOI 10.3174/ajnr.A4851; Terry DP, 2019, CLIN NEUROPSYCHOL, V33, P124, DOI 10.1080/13854046.2018.1459853; Vollstadt-Klein S, 2011, BIOL PSYCHIAT, V69, P1060, DOI 10.1016/j.biopsych.2010.12.016; Vollstadt-Klein S, 2010, ADDICTION, V105, P1741, DOI 10.1111/j.1360-0443.2010.03022.x; Wang DH, 2015, NAT NEUROSCI, V18, P1853, DOI 10.1038/nn.4164; Weigand A, 2018, BIOL PSYCHIAT, V84, P28, DOI 10.1016/j.biopsych.2017.10.028; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	74	1	1	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2020	35	6			SI		401	411		10.1097/HTR.0000000000000627			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OP5PJ	WOS:000588138300004	33165153				2022-02-06	
J	Howell, DR; Kirkwood, MW; Laker, S; Wilson, JC				Howell, David R.; Kirkwood, Michael W.; Laker, Scott; Wilson, Julie C.			Collision and Contact Sport Participation and Quality of Life Among Adolescent Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						youth athletes; pediatric athletes; anxiety; depression; pain	HIGH-SCHOOL FOOTBALL; EPIDEMIOLOGY; CONCUSSIONS; ANXIETY; INJURY; RISK	Context: Researchers investigating collision and contact sport participation during high school have found mixed results. Understanding the association between current contact and collision sport participation and quality-of-life outcomes can enhance our knowledge about the risks and benefits of sport participation. Objective: To examine quality-of-life outcomes among high school athletes who reported participation in collision and contact sports in the year preceding assessment compared with no- or limited-contact sport athletes. Design: Cross-sectional study. Setting: Preparticipation physical examination. Patients or Other Participants: High school athletes 13 to 18 years of age. Main Outcome Measure(s): We obtained sport participation and Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric-25 outcomes, which assess self-reported, quality-of-life domains in the preceding 7 days (ie, state assessment). Our grouping variable was collision and contact versus no- or limited-contact sport participation during the year preceding assessment. We used multivariable linear regression models to identify the associations between PROMIS scores and collision and contact sport participation and adjusted for sex; age; history of bone, muscle, ligament, or tendon injury; history of acute fracture or dislocation; and history of concussion. Results: A total of 143 (51%) athletes reported collision and contact sport participation (24% female, mean age = 15.1 +/- 1.7 years) and 138 (49%) reported no- or limited-contact sport participation (66% female, mean age = 15.4 +/- 1.2 years). A higher proportion of collision and contact sport athletes reported a history of time loss for bone, muscle, ligament, and tendon injuries (51% versus 29%, P < .001) and for acute fracture or dislocation (46% versus 26%, P < .001) than did no- or limited-contact athletes. After adjusting for covariates, we found that collision and contact sport participation was significantly associated with lower state anxiety (beta=-1.072, 95% confidence interval =-1.834, -0.310, P= .006) and depressive (beta=-0.807, 95% confidence interval = -1.484, -0.130, P = .020) symptom scores. Conclusions: Collision and contact sport athletes reported fewer anxiety and depressive symptoms in the week preceding evaluation than did no- or limited-contact sport athletes, but they had more extensive orthopaedic injury histories. Potential benefits and risks are associated with collision and contact sport participation. These data reinforce the need to examine the assumption that youth collision and contact sports are associated with negative quality of life.	[Howell, David R.; Wilson, Julie C.] Childrens Hosp Colorado, Sports Med Ctr, Dept Orthoped, Aurora, CO USA; [Howell, David R.; Wilson, Julie C.] Childrens Hosp Colorado, Rehabil Med, Aurora, CO USA; [Howell, David R.; Wilson, Julie C.] Univ Colorado, Dept Orthopaed, Sch Med, Aurora, CO 80045 USA; [Kirkwood, Michael W.; Laker, Scott] Univ Colorado, Dept Phys Med & Rehabil, Sch Med, Aurora, CO 80045 USA; [Wilson, Julie C.] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO 80045 USA		Howell, DR (corresponding author), Univ Colorado, Sch Med, Dept Orthoped, Sports Med Ctr,Childrens Hosp Colorado, 13123 East 16th Ave,B060, Aurora, CO 80045 USA.	David.Howell@CUanschutz.edu	Laker, Scott/ABE-7455-2021				Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Ashdown-Franks G, 2017, MENT HEALTH PHYS ACT, V12, P19, DOI 10.1016/j.mhpa.2016.12.001; Bailey R, 2006, J SCHOOL HEALTH, V76, P397, DOI 10.1111/j.1746-1561.2006.00132.x; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Caine D, 2008, CLIN SPORT MED, V27, P19, DOI 10.1016/j.csm.2007.10.008; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Fraser-Thomas J. L., 2005, Physical Education and Sport Pedagogy, V10, P19, DOI 10.1080/1740898042000334890; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hutchison MG, 2018, INT J PSYCHOPHYSIOL, V132, P55, DOI 10.1016/j.ijpsycho.2017.11.006; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kratz AL, 2013, QUAL LIFE RES, V22, P2865, DOI 10.1007/s11136-013-0397-6; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Meehan WP, 2016, J NEUROTRAUM, V33, P254, DOI 10.1089/neu.2015.3930; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Merkel DL, 2013, OPEN ACCESS J SPORTS, V4, P151, DOI 10.2147/OAJSM.S33556; National Federation of State High School Associations, 2018 19 HIGH SCH ATH, DOI [1020412/2018-19_participation_survey.pdf, DOI 1020412/2018-19_PARTICIPATION_SURVEY.PDF]; Pate RR, 2000, ARCH PEDIAT ADOL MED, V154, P904, DOI 10.1001/archpedi.154.9.904; Patel DR, 2010, J PEDIATR ADOL GYNEC, V23, P325, DOI 10.1016/j.jpag.2010.04.004; Pierpoint Lauren A, 2018, Inj Epidemiol, V5, P29, DOI 10.1186/s40621-018-0159-6; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Varni JW, 2014, QUAL LIFE RES, V23, P1233, DOI 10.1007/s11136-013-0544-0	26	1	1	2	3	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	NOV	2020	55	11					1174	1180		10.4085/1062-6050-0536.19			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	PA4OY	WOS:000595618400005	33112960	Green Published, gold			2022-02-06	
J	Irvine, KA; Sahbaie, P; Ferguson, AR; Clark, JD				Irvine, Karen-Amanda; Sahbaie, Peyman; Ferguson, Adam R.; Clark, J. David			Loss of diffuse noxious inhibitory control after traumatic brain injury in rats: A chronic issue	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Serotonin; Rat; Chronic pain; Locus Coeruleus; Noradrenalin	NERVE INJURY; DESCENDING CONTROL; NEUROPATHIC PAIN; PERSISTENT PAIN; MODULATION; SEROTONIN; MODEL; ANALGESIA; HYPERSENSITIVITY; MILNACIPRAN	Chronic pain is one of the most challenging and debilitating symptoms to manage after traumatic brain injury (TBI), yet the underlying mechanisms remain elusive. The disruption of normal endogenous pain control mechanisms has been linked to several forms of chronic pain and may play a role in pain after TBI. We hypothesized therefore that dysfunctional descending noradrenergic and serotonergic pain control circuits may contribute to the loss of diffuse noxious inhibitory control (DNIC), a critical endogenous pain control mechanism, weeks to months after TBI. For these studies, the rat lateral fluid percussion model of mild TBI was used along with a DNIC paradigm involving a capsaicin-conditioning stimulus. We observed sustained failure of the DNIC response up to 180-days post injury. We confirmed, that descending alpha(2) adrenoceptor-mediated noradrenergic signaling was critical for endogenous pain inhibition in uninjured rats. However, augmenting descending noradrenergic signaling using reboxetine, a selective noradrenaline reuptake inhibitor, failed to restore DNIC after TBI. Furthermore, blocking serotonin-mediated descending signaling using selective spinal serotonergic fiber depletion with 5, 7-dihydroxytryptamine was also unsuccessful at restoring endogenous pain modulation after TBI. Unexpectedly, increasing descending serotonergic signaling using the selective serotonin reuptake inhibitor escitalopram and the serotonin-norepinephrine reuptake inhibitor duloxetine restored the DNIC response in TBI rats at both 49- and 180- days post injury. Consistent with these observations, spinal serotonergic fiber depletion with 5, 7-dihydroxytryptamine eliminated the effects of escitalopram. Intact alpha(2) adrenoceptor signaling, however, was not required for the serotonin-mediated restoration of DNIC after TBI. These results suggest that TBI causes maladaptation of descending nociceptive signaling mechanisms and changes in the function of both adrenergic and serotonergic circuits. Such changes could predispose those with TBI to chronic pain.	[Irvine, Karen-Amanda; Sahbaie, Peyman; Clark, J. David] Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA; [Irvine, Karen-Amanda; Sahbaie, Peyman; Clark, J. David] Vet Affairs Palo Alto Hlth Care Syst, Anesthesiol Serv, 3801 Miranda Ave,E4-220, Palo Alto, CA 94304 USA; [Ferguson, Adam R.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, Dept Neurosurg, 1001 Potrero Ave, San Francisco, CA 94110 USA		Irvine, KA (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Anesthesiol Serv, 3801 Miranda Ave,E4-220, Palo Alto, CA 94304 USA.	kairvine@stanford.edu		Ferguson, Adam/0000-0001-7102-1608; Irvine, Karen-amanda/0000-0001-5259-1824	United States Department of DefenseUnited States Department of Defense [MR130295]; Department of Veterans AffairsUS Department of Veterans Affairs [RX002787, RX001776, 2 I01 RX001776-05]; National institutes of Health/National Institutes of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [UG3NS106899]	This work was supported by grants from the United States Department of Defense (MR130295) and the Department of Veterans Affairs (RX001776) and (2 I01 RX001776-05). Adam Ferguson was supported by a grant from the Department of Veterans Affairs (RX002787) and the National institutes of Health/National Institutes of Neurological Disorders and Stroke (UG3NS106899).	Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; Arora V, 2016, J PAIN, V17, P190, DOI 10.1016/j.jpain.2015.10.009; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bannister K, 2017, EUR J PAIN, V21, P750, DOI 10.1002/ejp.979; Bannister K, 2017, J PHYSIOL-LONDON, V595, P4159, DOI 10.1113/JP274165; Bannister K, 2015, PAIN, V156, P1803, DOI 10.1097/j.pain.0000000000000240; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bobinski F, 2015, PAIN, V156, P2595, DOI 10.1097/j.pain.0000000000000372; Burnham LJ, 2013, J PHARMACOL EXP THER, V344, P696, DOI 10.1124/jpet.112.199489; Da Silva JT, 2020, PAIN, V161, P1371, DOI 10.1097/j.pain.0000000000001810; Da Silva JT, 2018, BEHAV BRAIN RES, V349, P91, DOI 10.1016/j.bbr.2018.04.055; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Dogrul A, 2009, BRAIN RES, V1280, P52, DOI 10.1016/j.brainres.2009.05.001; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Fiorin FD, 2018, J NEUROSCI METH, V307, P23, DOI 10.1016/j.jneumeth.2018.06.004; Guo TZ, 2004, PAIN, V108, P95, DOI 10.1016/j.pain.2003.12.010; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Irvine KA, 2018, J NEUROTRAUM, V35, P1495, DOI 10.1089/neu.2017.5411; Irvine KA, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112976; Irvine KA, 2018, PAIN MED, V19, P1315, DOI 10.1093/pm/pnx153; Ito S, 2018, ANESTH ANALG, V126, P298, DOI 10.1213/ANE.0000000000002380; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004017; Khoury S, 2018, PROG NEURO-PSYCHOPH, V87, P224, DOI 10.1016/j.pnpbp.2017.06.007; Khouzam HR, 2016, POSTGRAD MED, V128, P323, DOI 10.1080/00325481.2016.1147925; Kimura M, 2015, ANESTHESIOLOGY, V123, P899, DOI 10.1097/ALN.0000000000000796; Kumar U, 2016, EPILEPSIA, V57, P506, DOI 10.1111/epi.13321; Lautenbacher S, 1997, CLIN J PAIN, V13, P189, DOI 10.1097/00002508-199709000-00003; Le Bars D, 2002, BRAIN RES REV, V40, P29, DOI 10.1016/S0165-0173(02)00186-8; LEBARS D, 1981, BRAIN RES, V215, P257, DOI 10.1016/0006-8993(81)90506-0; Leung A, 2016, MOL PAIN, V12, DOI 10.1177/1744806916662661; Liang DY, 2017, IBRO REP, V2, P14, DOI 10.1016/j.ibror.2016.12.001; Liang DY, 2017, MOL PAIN, V13, DOI 10.1177/1744806917730212; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Lockwood SM, 2019, J NEUROPHYSIOL, V121, P96, DOI 10.1152/jn.00613.2018; Meidahl AC, 2017, GENE THER, V24, P482, DOI 10.1038/gt.2017.55; Nakamura T, 2014, EUR J PHARMACOL, V738, P57, DOI 10.1016/j.ejphar.2014.05.022; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ofoghi Z, 2020, J NEUROTRAUM, V37, P907, DOI 10.1089/neu.2019.6750; Ossipov MH, 2014, CURR OPIN SUPPORT PA, V8, P143, DOI 10.1097/SPC.0000000000000055; Patetsos E, 2016, PAIN RES MANAG, V2016, DOI 10.1155/2016/2020915; Peters CM, 2015, ANESTHESIOLOGY, V122, P895, DOI 10.1097/ALN.0000000000000593; PICKLO MJ, 1994, BRAIN RES, V666, P195, DOI 10.1016/0006-8993(94)90772-2; Poree LR, 1998, ANESTH ANALG, V87, P941, DOI 10.1097/00000539-199810000-00037; Rahman W, 2008, J PAIN, V9, P350, DOI 10.1016/j.jpain.2007.11.010; Rahman Wahida, 2011, Rev Pain, V5, P21, DOI 10.1177/204946371100500204; Rohde DS, 1998, J NEUROSCI, V18, P4393; Sahbaie P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55739-x; Strigo IA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.116; Sun Y, 2013, ANESTHESIOLOGY, V119, P1198, DOI 10.1097/ALN.0b013e31829ce340; Thomas TC, 2015, BRAIN NEUROTRAUMA MO; Urban MO, 1999, P NATL ACAD SCI USA, V96, P7687, DOI 10.1073/pnas.96.14.7687; Vanegas H, 2004, BRAIN RES REV, V46, P295, DOI 10.1016/j.brainresrev.2004.07.004; Viisanen H, 2010, NEUROSCI LETT, V476, P133, DOI 10.1016/j.neulet.2010.04.014; Wrenn CC, 1996, BRAIN RES, V740, P175, DOI 10.1016/S0006-8993(96)00855-4; Yarnitsky D, 2012, PAIN, V153, P1193, DOI 10.1016/j.pain.2012.02.021	56	1	1	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	NOV	2020	333								113428	10.1016/j.expneurol.2020.113428			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NW2FV	WOS:000574826500002	32745472	Bronze			2022-02-06	
J	Jang, SH; Lee, HD				Jang, Sung Ho; Lee, Han Do			Injury of the dentatorubrothalamic tract in patients with post-traumatic tremor following mild traumatic brain injury: a case-control study	NEURAL REGENERATION RESEARCH			English	Article						dentatorubrothalamic tract; diffusion tensor imaging; diffusion tensor tractography; fiber number; fractional anisotropy; mild traumatic brain injury; post-traumatic tremor; region of interest	RUBRO-THALAMIC TRACT; MOVEMENT-DISORDERS; STIMULATION; TRACKING; LESIONS	Post-traumatic movement disorder is one of the sequelae of traumatic brain injury. The dentatorubrothalamic tract (DRTT) is reported to be involved in the control of movement. Therefore, injury of the DRTT can be accompanied by abnormal movements, including ataxia, tremor, or dystonia. We investigated DRTT injuries in 27 patients who showed post-traumatic tremor in at least one of four extremities following mild traumatic brain injury. We classified DRTT injuries based on diffusion tensor tractography parameters and configuration: type A: the DRTT showed narrowing, type B: the DRTT showed partial tearing, and type C: the DRTT showed discontinuation. Fractional anisotropy and fiber number of the DRTT were significantly decreased in patients compared with the healthy controls. Based on our DRTT injury classification, among the 54 hemispheres of the 27 patients, type A injury occurred in 22 hemispheres (40.7%) of 17 patients, type B injury was present in 15 hemispheres (27.7%) of 10 patients, and type C injury was observed in 8 hemispheres (14.8%) of 6 patients. Our results suggest that diffusion tensor tractography-based evaluation of the DRTT would be useful when determining cause of post-traumatic tremor in patients with mild traumatic brain injury. The study protocol was approved by the Institutional Review Board of Yeungnam University Hospital (YUMC-2018-09-007) on September 5, 2018.	[Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Daegu, South Korea; [Lee, Han Do] Ulsan Coll Univ, Coll Nat Sci, Dept Phys Med & Rehabil, Ulsan, South Korea		Lee, HD (corresponding author), Ulsan Coll Univ, Coll Nat Sci, Dept Phys Med & Rehabil, Ulsan, South Korea.	lhd890221@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2018R1A6A3A11043447]	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2018R1A6A3A11043447; to HDL).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; CARDOSO F, 1995, ARCH NEUROL-CHICAGO, V52, P263, DOI 10.1001/archneur.1995.00540270055019; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Coenen VA, 2014, NEUROSURGERY, V75, P657, DOI 10.1227/NEU.0000000000000540; Coenen VA, 2011, ACTA NEUROCHIR, V153, P1579, DOI 10.1007/s00701-011-1036-z; Jang SH, 2018, TRAUMATIC BRAIN INJU, P137, DOI DOI 10.5772/INTECHOPEN.70988; Jang SH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008253; Jang SH, 2015, BRAIN INJURY, V29, P1725, DOI 10.3109/02699052.2015.1075170; Krauss JK, 2002, NEUROSURGERY, V50, P927, DOI 10.1097/00006123-200205000-00003; Krauss JK, 1997, MOVEMENT DISORD, V12, P428, DOI 10.1002/mds.870120326; Kwon HG, 2011, NEURORADIOLOGY, V53, P787, DOI 10.1007/s00234-011-0878-7; Lehericy S, 2001, NEUROLOGY, V57, P1055, DOI 10.1212/WNL.57.6.1055; Marek M, 2015, J NEUROL, V262, P54, DOI 10.1007/s00415-014-7503-8; Marx JJ, 2008, NEUROIMAGE, V39, P1625, DOI 10.1016/j.neuroimage.2007.10.006; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schlaier J, 2015, NEUROMODULATION, V18, P105, DOI 10.1111/ner.12238; Yamada K, 2009, P NATL ACAD SCI USA, V106, pE14, DOI 10.1073/pnas.0812352106; Zasler N. D., 2012, BRAIN INJURY MED PRI	22	1	1	0	7	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	NOV	2020	15	11					2063	2066		10.4103/1673-5374.282259			4	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	MG0VP	WOS:000545753100020	32394963	Green Published, gold			2022-02-06	
J	Kim, H; Lee, JE; Yoo, HJ; Sung, JH; Yang, SH				Kim, Hoon; Lee, Jung Eun; Yoo, Hyun Ju; Sung, Jae Hoon; Yang, Seung Ho			Effect of Pioglitazone on Perihematomal Edema in Intracerebral Hemorrhage Mouse Model by Regulating NLRP3 Expression and Energy Metabolism	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Cerebral hemorrhage; Brain edema; Inflammasomes; Pioglitazone; Lactates	TXNIP/NLRP3 INFLAMMASOME ACTIVATION; ENDOPLASMIC-RETICULUM STRESS; TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; ACID CYCLE; LACTATE; PHOSPHORYLATION; MICRODIALYSIS; METABOLOMICS	Objective : Cerebral edema is the predominant mechanism of secondary inflammation after intracerebral hemorrhage (ICH). Pioglitazone, peroxisome proliferator-activated receptor gamma agonist has been shown to play a role in regulation of central nervous system inflammation. Here, we examined the pharmacological effects of pioglitazone in an ICH mouse model and investigated its regulation on NLRP3 inflammasome and glucose metabolism. Methods : The ICH model was established in C57 BL/6 mice by the stereotactical inoculation of blood (30 mu L) into the right frontal lobe. The treatment group was administered i.p. pioglitazone (20 mg/kg) for 1, 3, and 6 days. The control group was administered i.p. phosphate-buffered saline for 1, 3, and 6 days. We investigated brain water contents, NLRP3 expression, and changes in the metabolites in the ICH model using liquid chromatography-tandem mass spectrometry. Results : On day 3, brain edema in the mice treated with pioglitazone was decreased more than that in the control group. Expression levels of NLRP3 in the ICH model treated with pioglitazone were decreased more than those of the control mice on days 3 and 7. The pioglitazone group showed higher levels of glycolytic metabolites than those in the ICH mice. Lactate production was increased in the ICH mice treated with pioglitazone. Conclusion : Our results demonstrated less brain swelling following ICH in mice treated with pioglitazone. Pioglitazone decreased NLRP3-related brain edema and increased anaerobic glycolysis, resulting in the production of lactate in the ICH mice model. NLRP3 might be a therapeutic target for ICH recovery.	[Kim, Hoon] Catholic Univ Korea, Coll Med, Dept Neurosurg, Bucheon St Marys Hosp, Seoul, South Korea; [Lee, Jung Eun; Sung, Jae Hoon] Catholic Univ Korea, Coll Med, Dept Neurosurg, St Vincents Hosp, Seoul, South Korea; [Yoo, Hyun Ju] Univ Ulsan, Biomed Res Ctr, Asan Med Ctr, Coll Med, Seoul, South Korea; [Yang, Seung Ho] Catholic Univ Korea, Coll Med, Cell Death Dis Res Ctr, Dept Neurosurg,St Vincents Hosp, Seoul, South Korea		Yang, SH (corresponding author), Catholic Univ Korea, Coll Med, Cell Death Dis Res Ctr, Dept Neurosurg,St Vincents Hosp, 93 Jungbu Daero, Suwon 16247, South Korea.	72ysh@catholic.ac.kr		Lee, Jung Eun/0000-0002-8401-2839; Yang, Seung Ho/0000-0002-3490-1064; Yoo, Hyun Ju/0000-0003-2617-444X; Sung, Jae Hoon/0000-0003-3738-6413	National Research Foundation of Korea (NRF)National Research Foundation of Korea [2016R1D1A1A02937141]; St. Vincent' s Hospital Research Institute of Medical Science [SVHR-201703]	This study was supported by the National Research Foundation of Korea (NRF)-2016R1D1A1A02937141. The author would like to acknowledge financial support from St. Vincent' s Hospital Research Institute of Medical Science (SVHR-201703).	Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Alessandri B, 2012, J NEUROTRAUM, V29, P2181, DOI 10.1089/neu.2011.2067; Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Au A, 2018, ADV CLIN CHEM, V85, P31, DOI 10.1016/bs.acc.2018.02.002; Becatti M, 2012, CELL MOL LIFE SCI, V69, P2245, DOI 10.1007/s00018-012-0925-5; Berthet C, 2012, CEREBROVASC DIS, V34, P329, DOI 10.1159/000343657; Castro MA, 2009, J NEUROCHEM, V110, P423, DOI 10.1111/j.1471-4159.2009.06151.x; Chinopoulos C, 2013, J NEUROSCI RES, V91, P1030, DOI 10.1002/jnr.23196; Esen F, 2003, J NEUROSURG ANESTH, V15, P119, DOI 10.1097/00008506-200304000-00009; Fann DYW, 2013, AGEING RES REV, V12, P941, DOI 10.1016/j.arr.2013.09.004; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Helmy MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142303; Hsu CP, 2009, CIRC RES, V105, P481, DOI 10.1161/CIRCRESAHA.109.203703; Huang Q, 2018, MOL NEUROBIOL, V55, P6063, DOI 10.1007/s12035-017-0809-7; Irrera N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00459; Izawa Y, 2009, BRAIN RES, V1305, P64, DOI 10.1016/j.brainres.2009.09.098; Katsuki H, 2010, J PHARMACOL SCI, V114, P366, DOI 10.1254/jphs.10R05CR; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kim SJ, 2016, ENDOCRINOL METAB, V31, P7, DOI 10.3803/EnM.2016.31.1.7; Lebeaupin C, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.248; Li Y, 2015, PHARMACOL RES, V99, P101, DOI 10.1016/j.phrs.2015.05.012; Lu AG, 2006, J CEREBR BLOOD F MET, V26, P230, DOI 10.1038/sj.jcbfm.9600183; Mayer SA, 2005, LANCET NEUROL, V4, P662, DOI 10.1016/S1474-4422(05)70195-2; Ribo M, 2006, CURR NEUROL NEUROSCI, V6, P17, DOI 10.1007/s11910-996-0004-0; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rolland WB, 2011, ACTA NEUROCHIR SUPPL, V111, P213, DOI 10.1007/978-3-7091-0693-8_36; Rynkowski MA, 2008, NAT PROTOC, V3, P122, DOI 10.1038/nprot.2007.513; Sahuquillo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102540; Sanchez-Abarca LI, 2001, GLIA, V36, P321, DOI 10.1002/glia.1119; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Song N, 2017, MOL CELL, V68, P185, DOI 10.1016/j.molcel.2017.08.017; Strbian D, 2009, ANN MED, V41, P438, DOI 10.1080/07853890902887303; Stutz A, 2017, J EXP MED, V214, P1725, DOI 10.1084/jem.20160933; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Wang J, 2015, BIOCHEM BIOPH RES CO, V466, P300, DOI 10.1016/j.bbrc.2015.09.009; Wang Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181248; Yao ST, 2017, J MOL NEUROSCI, V61, P385, DOI 10.1007/s12031-016-0874-9; Ying WJ, 2007, FRONT BIOSCI-LANDMRK, V12, P2728, DOI 10.2741/2267; Zhao Y, 2015, J ETHNOPHARMACOL, V169, P210, DOI 10.1016/j.jep.2015.04.030; Zhu XX, 2012, STROKE, V43, P524, DOI 10.1161/STROKEAHA.111.635672	44	1	1	1	2	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	NOV	2020	63	6					689	697		10.3340/jkns.2020.0056			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OO5NF	WOS:000587424300003	33105536	gold, Green Published			2022-02-06	
J	Ko, Y; Lee, JS; Chae, MK; Ahn, JH; Kim, HH; Park, EJ; Kim, JH				Ko, Yura; Lee, Ji Sook; Chae, Minjung Kathy; Ahn, Jung Hwan; Kim, Hyuk-Hoon; Park, Eun Jung; Kim, Jung Heon			Risk Stratification of Intermediate-Risk Children With Minor Head Injury	PEDIATRIC EMERGENCY CARE			English	Article						craniocerebral trauma; decision support techniques; ionizing radiation; multidetector computed tomography; neoplasms; radiation-induced; risk assessment	TRAUMATIC BRAIN-INJURIES; EMERGENCY-DEPARTMENT OBSERVATION; COMPUTED-TOMOGRAPHY USE; DECISION RULES; PHYSICIANS; MILD; UTILITY; ASSOCIATION; MANAGEMENT; KNOWLEDGE	The Pediatric Emergency Care Applied Research Network rule helps emergency physicians identify very low-risk children with minor head injury who can forgo head computed tomography. This rule contributes to reduction in lifetime risk of radiation-induced cancers while minimizing missing clinically important traumatic brain injury. However, in intermediate-risk children, decisions on whether to perform computed tomography remain at the emergency physicians' discretion. To reduce this gray zone, this review summarizes evidence for risk stratification of intermediate-risk children with minor head injury.	[Ko, Yura; Lee, Ji Sook; Chae, Minjung Kathy; Ahn, Jung Hwan; Kim, Hyuk-Hoon; Park, Eun Jung; Kim, Jung Heon] Ajou Univ, Dept Emergency Med, Sch Med, 164 World Cup Ro, Suwon 16499, South Korea		Kim, JH (corresponding author), Ajou Univ, Dept Emergency Med, Sch Med, 164 World Cup Ro, Suwon 16499, South Korea.	medjh@daum.net		Kim, Jung Heon/0000-0001-7303-0241; Ahn, Jung Hwan/0000-0002-4676-1716			Aziz H, 2013, J TRAUMA ACUTE CARE, V75, P550, DOI 10.1097/TA.0b013e3182a53a77; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Ballard DW, 2013, ACAD EMERG MED, V20, P352, DOI 10.1111/acem.12109; Boutis K, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20160022; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bressan S, 2015, ACTA PAEDIATR, V104, P47, DOI 10.1111/apa.12797; Cheng CY, 2021, PEDIATR EMERG CARE, V37, pE129, DOI 10.1097/PEC.0000000000001540; Chern JJ, 2014, J NEUROSURG-PEDIATR, V14, P306, DOI 10.3171/2014.6.PEDS13682; Christian CW, 2015, PEDIATRICS, V135, pE1337, DOI 10.1542/peds.2015-0356; Conrad HB, 2019, PEDIATR EMERG CARE, V35, P506, DOI 10.1097/PEC.0000000000001870; Corwin DJ, 2021, PEDIATR EMERG CARE, V37, P437, DOI 10.1097/PEC.0000000000001728; Croskerry P, 2009, ADV HEALTH SCI EDUC, V14, P27, DOI 10.1007/s10459-009-9182-2; Dayan PS, 2015, PEDIATRICS, V135, P504, DOI 10.1542/peds.2014-2695; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Donaldson K, 2019, PEDIATR EMERG CARE, V35, P301, DOI 10.1097/PEC.0000000000001814; Eagles D, 2008, ACAD EMERG MED, V15, P1256, DOI 10.1111/j.1553-2712.2008.00265.x; Graham ID, 1998, ACAD EMERG MED, V5, P134, DOI 10.1111/j.1553-2712.1998.tb02598.x; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Hagiwara Y, 2020, PEDIATR EMERG CARE, V36, pE564, DOI 10.1097/PEC.0000000000001487; Hamilton M, 2010, PEDIATRICS, V126, pE33, DOI 10.1542/peds.2009-0692; Hartwig HDR, 2013, PEDIATR EMERG CARE, V29, P705, DOI 10.1097/PEC.0b013e3182949066; Hess ER, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2430; Homme JL, 2018, EMERG MED CLIN N AM, V36, P287, DOI 10.1016/j.emc.2017.12.015; Hull A, 2015, PEDIATR EMERG CARE, V31, P759, DOI 10.1097/PEC.0000000000000467; Jeong JH, 2015, CLIN EXP EMERG MED, V2, P226, DOI 10.15441/ceem.14.039; Karpas A, 2013, PEDIATR EMERG CARE, V29, P30, DOI 10.1097/PEC.0b013e31827b5090; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee LK, 2014, JAMA PEDIATR, V168, P837, DOI 10.1001/jamapediatrics.2014.361; Lefort R, 2017, PEDIATR EMERG CARE, V33, P161, DOI 10.1097/PEC.0000000000000863; Miescier MJ, 2017, PEDIATR EMERG CARE, V33, P156, DOI 10.1097/PEC.0000000000000500; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Nishijima DK, 2015, JAMA PEDIATR, V169, P1141, DOI 10.1001/jamapediatrics.2015.2743; Patel SK, 2018, J PEDIATR SURG, V53, P2048, DOI 10.1016/j.jpedsurg.2018.04.027; Rana KS, 2006, INDIAN PEDIATR, V43, P994; Reilly C, 2019, PEDIATR EMERG CARE, V35, P468, DOI 10.1097/PEC.0000000000001042; Schonfeld D, 2013, ANN EMERG MED, V62, P597, DOI 10.1016/j.annemergmed.2013.06.020; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Shaffer L, 2003, ARCH DIS CHILD, V88, P267, DOI 10.1136/adc.88.3.267; Shaw K, 2018, ADV PEDIAT EMERGENCY; Stein SC, 2008, PEDIATR NEUROSURG, V44, P448, DOI 10.1159/000172967; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Ukwuoma OI, 2021, PEDIATR EMERG CARE, V37, pE384, DOI 10.1097/PEC.0000000000001618; Varano P, 2015, J TRAUMA ACUTE CARE, V78, P1039, DOI 10.1097/TA.0000000000000604; Wylie MC, 2014, PEDIATR EMERG CARE, V30, P680, DOI 10.1097/PEC.0000000000000227	45	1	1	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	NOV	2020	36	11					E659	E664		10.1097/PEC.0000000000001938			6	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	OR4WE	WOS:000589471800027	31688704				2022-02-06	
J	Kratz, AL; Boileau, NR; Sander, AM; Nakase-Richardson, R; Hanks, RA; Massengale, JP; Miner, JA; Carlozzi, NE				Kratz, Anna L.; Boileau, Nicholas R.; Sander, Angelle M.; Nakase-Richardson, Risa; Hanks, Robin A.; Massengale, Jill P.; Miner, Jennifer A.; Carlozzi, Noelle E.			Do Emotional Distress and Functional Problems in Persons With Traumatic Brain Injury Contribute to Perceived Sleep-Related Impairment in Caregivers?	REHABILITATION PSYCHOLOGY			English	Article						caregivers; traumatic brain injury; military; sleep	QUALITY-OF-LIFE; PORTLAND ADAPTABILITY INVENTORY; METABOLIC CONSEQUENCES; HEAD-INJURY; TIME-COURSE; ITEM BANKS; FAMILY; HEALTH; RECOVERY; REHABILITATION	Objective: The goal of this study was to examine the association between characteristics of persons with traumatic brain injury (PwTBI) and perceived sleep-related impairment of the caregivers. Method: Fifty-two dyads (n = 23 civilians, n = 29 service members/veterans [SMVsJ) were enrolled. Caregivers completed the Patient-Reported Outcomes Measurement Information System Sleep-Related Impairment computer adaptive test, and PwTBI completed Quality of Life in Neurological Disorders measures of depression, anxiety, anger, cognitive functioning, and upper and lower extremity functioning. Hierarchical linear regression models, stratified by civilian/SMV group, were employed to assess prediction of caregiver-perceived sleep-related impairment from emotional distress of the PwTBI (anxiety, depressed mood, and anger) and perceived functional status of the PwTBI (cognitive, upper extremity, lower extremity functioning). Results: Compared with caregivers of civilians, caregivers of SMVs reported higher perceived sleep-related impairment. Regression results showed that characteristics of the PwTBI accounted for moderate amounts of variance in the sleep-related impairment of caregivers of both civilians and SMVs. Within-group analyses showed that the strongest predictor of sleep-related impairment of caregivers of civilians was self-reported cognitive function of the PwTBI (beta = -0.82, p = .08); the strongest predictor of sleep-related impairment of caregivers of SMVs was self-reported anger of the PwTBI (beta = 0.54, p = .07). Conclusions: In both caregivers of civilians and SMVs with 'FBI, characteristics of the PwTBI were related to perceived caregiver sleep-related impairment. These preliminary data can inform future research with larger samples that examine the impact of multiple characteristics of the caregiver and care recipient on caregiver sleep. Findings highlight the potential importance of considering the dynamics of the dyad in rehabilitation programming not only for the PwTBI but for caregivers as well.	[Kratz, Anna L.; Boileau, Nicholas R.; Miner, Jennifer A.; Carlozzi, Noelle E.] Univ Michigan, Dept Phys Med & Rehabil, NCRC B16-G031N,2800 Plymouth Rd, Ann Arbor, MI 48101 USA; [Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, MHBS, Def & Vet Brain Injury Ctr, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Morsani Coll Med, Tampa, FL 33620 USA; [Hanks, Robin A.] Rehabil Inst Michigan, Dept Psychol & Neuropsychol, Detroit, MI USA; [Hanks, Robin A.] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI 48202 USA; [Massengale, Jill P.] James A Haley Vet Hosp, MHBS, Tampa, FL 33612 USA		Kratz, AL (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, NCRC B16-G031N,2800 Plymouth Rd, Ann Arbor, MI 48101 USA.	alkratz@med.umich.edu		Kratz, Anna/0000-0002-3664-3898	National Institutes of Health, National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]; National Institute of Arthritis and Musculoskeletal and Skin DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [K01AR064275]	This article was supported by Grant R01NR013658 (PI: Noelle E. Carlozzi) from the National Institutes of Health, National Institute of Nursing Research. In addition, funding from the National Center for Advancing Translational Sciences (UL1TR000433) provided support for data collection. Anna L. Kratz's contribution to this article was supported in part by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (K01AR064275). We thank the investigators and research associates/coordinators who worked on the study, the study participants, and the organizations that supported recruitment efforts.	Amtmann D, 2018, DISABIL HEALTH J, V11, P99, DOI 10.1016/j.dhjo.2017.04.008; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; [Anonymous], 2009, SPRINGER TEXTS STAT, DOI DOI 10.1007/978-0-387-09608-7; Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Bajaj JS, 2011, ALIMENT PHARM THER, V34, P1123, DOI 10.1111/j.1365-2036.2011.04842.x; Bartlett SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138543; Bohac DL, 1997, BRAIN INJURY, V11, P469, DOI 10.1080/713802185; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Burns Anthony S, 2012, Handb Clin Neurol, V109, P47, DOI 10.1016/B978-0-444-52137-8.00003-6; Carlozzi N. E., 2018, ARCH PHYS MED REHAB, V99, pe80, DOI [10.1016/j.apmr.2018.07.286, DOI 10.1016/J.APMR.2018.07.286]; Carlozzi NE, 2020, REHABIL PSYCHOL, V65, P323, DOI 10.1037/rep0000295; Carlozzi NE, 2019, J HUNTINGTONS DIS, V8, P467, DOI 10.3233/JHD-190364; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS102, DOI 10.1016/j.apmr.2018.05.020; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Cella D, 2014, QUAL LIFE RES, V23, P2651, DOI 10.1007/s11136-014-0732-6; Cella D, 2011, ARCH PHYS MED REHAB, V92, pS28, DOI 10.1016/j.apmr.2011.01.025; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Comerci V, 2015, PURE APPL GEOPHYS, V172, P2997, DOI 10.1007/s00024-015-1066-1; Cook KF, 2015, QUAL LIFE RES, V24, P575, DOI 10.1007/s11136-014-0790-9; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Defense and Veterans Brain Injury Center, 2015, DOD WORLDW NUMB TBI; Depner CM, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0507-z; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; DITUNNO JF, 1992, ARCH PHYS MED REHAB, V73, P431; Duss SB, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0879-6; Farrell PC, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1211-y; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Fortune DG, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01368; Gershon Richard C, 2010, J Appl Meas, V11, P304; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Hair JF, 1995, MULTIVARIATE DATA AN; Hamidou Z, 2018, PSYCHO-ONCOLOGY, V27, P590, DOI 10.1002/pon.4553; Holcomb EM, 2016, J HEAD TRAUMA REHAB, V31, P82, DOI 10.1097/HTR.0000000000000230; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; HSU CY, 2012, CIRCULATION, V126; Javaheri S, 2017, CHEST, V152, P435, DOI 10.1016/j.chest.2017.01.026; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P406, DOI 10.1016/S0003-9993(95)80568-0; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P399, DOI 10.1016/S0003-9993(95)80567-2; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Jun J, 2009, ILAR J, V50, P289, DOI 10.1093/ilar.50.3.289; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kotronoulas G, 2013, J PAIN SYMPTOM MANAG, V45, P579, DOI 10.1016/j.jpainsymman.2012.03.013; Kozlowski AJ, 2016, ARCH PHYS MED REHAB, V97, P650, DOI 10.1016/j.apmr.2015.12.010; Kreutzer JS, 2010, J HEAD TRAUMA REHAB, V25, P113, DOI 10.1097/HTR.0b013e3181cf0712; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Levy P, 2009, EUR RESPIR J, V34, P243, DOI 10.1183/09031936.00166808; Li YP, 2014, CIRCULATION, V129, P737, DOI 10.1161/CIRCULATIONAHA.113.004500; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Malec J., 2005, MAYO PORTLAND ADAPTA; Malec JF, 2012, ARCH PHYS MED REHAB, V93, P2271, DOI 10.1016/j.apmr.2012.06.013; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Miller DM, 2016, MULT SCLER J, V22, P830, DOI 10.1177/1352458515599450; Montgomery P, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005169.pub2; MORIN CM, 1994, AM J PSYCHIAT, V151, P1172; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Nagaraja V, 2018, QUAL LIFE RES, V27, P755, DOI 10.1007/s11136-017-1709-z; Norup A, 2012, BRAIN INJURY, V26, P1192, DOI 10.3109/02699052.2012.672790; Novack T, 2000, ORIENTATION LOG; Nowinski CJ, 2016, MOVEMENT DISORD, V31, P725, DOI 10.1002/mds.26546; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Pakenham KI, 2002, AIDS CARE, V14, P731, DOI 10.1080/0954012021000081313; Panting A, 1972, REHABILITATION, V38, P33; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Potter GDM, 2016, ENDOCR REV, V37, P584, DOI 10.1210/er.2016-1083; Ramchand R., 2014, HIDDEN HEROES AM MIL, DOI DOI 10.7249/RR499.1; Ramkumar NA, 2010, NEUROREHABILITATION, V27, P105, DOI 10.3233/NRE-2010-0585; Saban KL, 2016, J REHABIL RES DEV, V53, P681, DOI 10.1682/JRRD.2015.07.0143; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Schalet BD, 2016, J CLIN EPIDEMIOL, V73, P119, DOI 10.1016/j.jclinepi.2015.08.036; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Smith A M, 1998, Rehabil Nurs, V23, P252; Sofi F, 2014, EUR J PREV CARDIOL, V21, P57, DOI 10.1177/2047487312460020; Stone AA, 2016, J CLIN EPIDEMIOL, V74, P194, DOI 10.1016/j.jclinepi.2015.08.029; Temple JL, 2016, BRAIN INJURY, V30, P1672, DOI 10.3109/02699052.2015.1113561; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Van Cauter E, 2008, SLEEP MED, V9, pS23, DOI 10.1016/S1389-9457(08)70013-3; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Victorson D, 2014, EPILEPSY BEHAV, V31, P77, DOI 10.1016/j.yebeh.2013.11.008; Waters R L, 1998, J Spinal Cord Med, V21, P195; WATERS RL, 1993, ARCH PHYS MED REHAB, V74, P242; WATERS RL, 1992, ARCH PHYS MED REHAB, V73, P784; WATERS RL, 1994, ARCH PHYS MED REHAB, V75, P67; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Wickwire EM, 2016, SLEEP MED REV, V30, P72, DOI 10.1016/j.smrv.2015.11.004; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; WMcCurry S. M., 2015, CURRENT OPINION PSYC, V28, P497, DOI [10.1097/YCO.0000000000000205, DOI 10.1097/YCO.0000000000000205]	110	1	1	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2020	65	4					432	442		10.1037/rep0000327			11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	OW5SF	WOS:000592945400011	32406737	Bronze, Green Accepted			2022-02-06	
J	Lee, KM; Khatri, TL; Fudge, ER				Lee, Katherine M.; Khatri, Trisha L.; Fudge, Elizabeth R.			US Department of Defense Warfighter Brain Health Initiative: Maximizing performance on and off the battlefield	JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS			English	Article						Brain exposures; brain health; cognitive performance; service member; traumatic brain injury		The US Department of Defense (DoD) recognizes the importance of warfighter brain health with the establishment of the Warfighter Brain Health Initiative and Strategy. For a warfighter, also known as a service member, to perform at their highest level, cognitive and physical capabilities must be optimized. This initiative addresses brain health, brain exposures, to include blast overpressure exposures from weapons and munitions, traumatic brain injury (TBI), and long-term or late effects of TBI. The DoD's pursuit of maximal strength hinges on the speed of decisions (neurocognitive) and detection of brain injury when it occurs. The strategy creates a framework for deliberate, prioritized, and rapid development of end-to-end solutions for warfighter brain health. Through this strategy, DoD is addressing the needs of our service members, their families, line leaders/commanders, and their communities at large. The implications of this initiative and strategy are noteworthy for practitioners because the DoD Warfighter Brain Health construct lends itself to nurse practitioner engagement in clinical practice, patient education, policy development, and emerging research.	[Lee, Katherine M.; Khatri, Trisha L.; Fudge, Elizabeth R.] Hlth Readiness Policy & Oversight, DoD Hlth Affairs, Falls Church, VA USA		Lee, KM (corresponding author), Def Hlth Headquarters, DoD Hlth Affairs, 7700 Arlington Blvd,3M609, Falls Church, VA 22042 USA.	katherine.m.lee34.civ@mail.mil					Belanger Heather G, 2020, J Spec Oper Med, V20, P87; Belding JN, 2020, MIL MED, V185, pE538, DOI 10.1093/milmed/usz289; Blacker KJ, 2021, HUM FACTORS, V63, P1141, DOI 10.1177/0018720820916975; Boutte AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221036; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Defense and Veterans Brain Injury Center, 2020, DOD WORLDW NUMB TBI DOD WORLDW NUMB TBI; Gill J, 2017, BRAIN BEHAV IMMUN, V65, P90, DOI 10.1016/j.bbi.2017.02.015; Gorelick PB, 2017, STROKE, V48, pE284, DOI 10.1161/STR.0000000000000148; Haran FJ, 2021, APPL NEUROPSYCH-ADUL, V28, P297, DOI 10.1080/23279095.2019.1630627; Kamimori Gary H, 2018, Mil Med, V183, P28, DOI 10.1093/milmed/usx186; LaValle CR, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00949; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Lumba-Brown A, 2020, NEUROSURGERY, V86, P2, DOI 10.1093/neuros/nyz332; Martinez Corina, 2020, Arch Physiother, V10, P10, DOI 10.1186/s40945-020-00081-z; Mattie CP, 2020, PSYCHOL SPORT EXERC, V50, DOI 10.1016/j.psychsport.2020.101720; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Presidential Executive Order, 2012, EX ORD 13625 IMPR AC; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Tschiffely AE, 2020, J NEUROTRAUM, V37, P1091, DOI 10.1089/neu.2019.6512	22	1	1	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2327-6886	2327-6924		J AM ASSOC NURSE PRA	J. Am. Assoc. Nurs. Pract.	NOV	2020	32	11					720	728		10.1097/JXX.0000000000000532			9	Health Care Sciences & Services; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Nursing	QI4MI	WOS:000618953000003	33177333				2022-02-06	
J	Makwana, B; Xu, XM				Makwana, Bindal; Xu, Xiaomeng (Mona)			C3Logix assessment of neuropsychological performance in athletes and nonathletes	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Athletes; C3Logix; neuropsychology; physical activity	TRAUMATIC BRAIN-INJURY; PHYSICAL-ACTIVITY; ADULTS; CONCUSSION; EXERCISE; DEMENTIA; MIDLIFE; DECLINE; RISK	Physical activity (PA) has been shown to enhance physical health, mental health, and cognitive functioning. Adult and older adult research shows that PA positively influences neuropsychological performance and protects against cognitive decline. This study investigated neuropsychological performance in uninjured athletes and nonathletes using an iPad-based neuropsychological battery called C3Logix. Since literature suggests that PA enhances cognitive functioning, athletes may perform better on neurocognitive measures than nonathletes due to athletes' assumed higher level of PA. We hypothesized that collegiate athletes would outperform nonathletes on all cognitive tasks. Ninety-five athletes and 92 nonathletes completed the neurocognitive assessments and results showed that athletes outperformed nonathletes on reaction time tasks, but not in other cognitive domains. The implications of this study included extending the work of previous research using C3Logix and added to our understanding of a possible difference in reaction time between healthy collegiate athletes and nonathletes.	[Makwana, Bindal; Xu, Xiaomeng (Mona)] Idaho State Univ, Dept Psychol, 921 S 8th Ave,Stop 8112, Pocatello, ID 83209 USA		Makwana, B; Xu, XM (corresponding author), Idaho State Univ, Dept Psychol, 921 S 8th Ave,Stop 8112, Pocatello, ID 83209 USA.	makwbind@isu.edu; xuxiao@isu.edu	Xu, Xiaomeng/H-3308-2019	Xu, Xiaomeng/0000-0003-3695-4845; Makwana Mehmel, Bindal/0000-0002-9316-8827			Alberts J, 2017, CLEVELAND CLIN CONCU; Andel R, 2008, J GERONTOL A-BIOL, V63, P62, DOI 10.1093/gerona/63.1.62; Auyeung TW, 2008, NEUROEPIDEMIOLOGY, V31, P167, DOI 10.1159/000154929; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Bernstein JP., 2018, APPL NEUROPSYCH-ADUL, V2018, P1, DOI [10.1080/23279095.2017.1416471, DOI 10.1080/23279095.2017.1416471]; Bherer L., 2013, J AGING RES, V2013, DOI 10.1155/2013/657508; Borges A, 2017, INT J SPORTS PHYS TH, V12, P381; Brown CN, 2007, J ATHL TRAINING, V42, P515; Chaddock L, 2011, MED SCI SPORT EXER, V43, P1920, DOI 10.1249/MSS.0b013e318218ca74; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Fedor A, 2013, OBESITY FACTS, V6, P185, DOI 10.1159/000351138; Gill SJ, 2015, J INT NEUROPSYCH SOC, V21, P816, DOI 10.1017/S1355617715000880; Hinton-Bayre AD, 2015, BRAIN IMPAIR, V16, P80, DOI 10.1017/BrImp.2015.14; Jacobson J, 2014, PSYCHOL SPORT EXERC, V15, P521, DOI 10.1016/j.psychsport.2014.05.005; Kiernan M, 2013, INT J OBESITY, V37, P1597, DOI 10.1038/ijo.2013.36; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M., 1997, STANDARDIZED ASSESSM; Oliver J, 2015, J EXP NEUROSCI, V9, P67, DOI 10.4137/JEN.S27921; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Simon M, 2017, DEV NEUROPSYCHOL, V42, P446, DOI 10.1080/87565641.2017.1383994; Smith A., 1968, LEARN DISORD, V3, P83, DOI 10.1080/13803390591004428; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588; Yaffe K, 2001, ARCH INTERN MED, V161, P1703, DOI 10.1001/archinte.161.14.1703; Zhao E, 2016, PHYSICIAN SPORTSMED, V44, P8, DOI 10.1080/00913847.2016.1103641	26	1	1	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	NOV 1	2020	27	6					490	496		10.1080/23279095.2019.1570927			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	NR9QH	WOS:000571896700001	30793975				2022-02-06	
J	Merritt, VC; Jurick, SM; Sakamoto, MS; Crocker, LD; Sullan, MJ; Hoffman, SN; Davey, DK; Jak, AJ				Merritt, Victoria C.; Jurick, Sarah M.; Sakamoto, McKenna S.; Crocker, Laura D.; Sullan, Molly J.; Hoffman, Samantha N.; Davey, Delaney K.; Jak, Amy J.			Post-concussive symptom endorsement and symptom attribution following remote mild traumatic brain injury in combat-exposed Veterans: An exploratory study	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						Mild traumatic brain injury; Combat exposure; Post-concussive symptoms; Military Veterans; Iatrogenic effects; Symptom attribution	PERSISTENT POSTCONCUSSION SYNDROME; SERVICE MEMBERS; RISK-FACTORS; DEPLOYMENT; PTSD; COMPLAINTS; TBI; PERCEPTIONS; PERSONNEL	The purpose of this study was to examine rates of and relationships between "post-concussive" symptom endorsement and symptom attribution in Veterans with a history of mild traumatic brain injury (mTBI). This cross-sectional, exploratory study included 48 combat-exposed Iraq/Afghanistan Veterans with remote history of mTBI. All Veterans completed clinical interviews and self-report questionnaires assessing sociodemographic factors, injury and combat-related variables, psychiatric distress, self-efficacy, and coping style. To assess symptom endorsement and symptom attribution, a modified version of the Neurobehavioral Symptom Inventory was administered. Results showed that the most commonly endorsed "post-concussive" symptoms were several non-specific symptoms, while the symptoms most frequently attributed to mTBI included forgetfulness, poor concentration, and headaches. Furthermore, although there were some overlapping correlates of both symptom endorsement and symptom attribution, unique variables were associated with each domain. Specifically, symptom endorsement was uniquely associated with measures of psychiatric distress, while symptom attribution was uniquely associated with having a history of loss of consciousness and a greater degree of combat exposure. Taken together, results suggest that endorsement of symptoms may be significantly impacted by the presence of mental health comorbidities, but that perceptions or beliefs as to why symptoms are occurring are related more to mTBI and combat-related characteristics. Findings offer potential avenues for therapeutic intervention, emphasize the importance of psychoeducation, and highlight the need to consider using alternate terminology for these symptoms that promotes recovery and minimizes misattribution of symptoms.	[Merritt, Victoria C.; Jurick, Sarah M.; Sakamoto, McKenna S.; Crocker, Laura D.; Sullan, Molly J.; Davey, Delaney K.; Jak, Amy J.] VA San Diego Healthcare Syst VASDHS, Res & Psychol Serv, San Diego, CA USA; [Jurick, Sarah M.; Crocker, Laura D.; Jak, Amy J.] VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Hoffman, Samantha N.] San Diego State Univ Univ Calif San Diego SDSU UC, San Diego, CA USA; [Jak, Amy J.] Univ Calif San Diego, Sch Med, Dept Psychiat, 9500 Gillman Dr, La Jolla, CA 92093 USA		Merritt, VC (corresponding author), VA San Diego Healthcare Syst, 3350 La Jolla Village Dr,MC 151B, San Diego, CA 92161 USA.	vmerritt@health.ucsd.edu; smjurick@gmail.com; msakamoto@sandiego.edu; laura.crocker@va.gov; snh.hoffman@gmail.com; delaney.davey@gmail.com; ajak@health.ucsd.edu		Hoffman, Samantha/0000-0002-2792-8576	Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) AwardUnited States Department of Defense [W81XWH-13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01 CX001135]; VA Clinical Science Research & Development Service [IK2 CX001952]; VA Rehabilitation Research & Development Service [IK2 RX002459]	This work was supported by grant funding from: Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award [W81XWH-13-2-0095] and Department of Veterans Affairs CENC Award [I01 CX001135]. Additionally, Victoria Merritt received salary support during this work from a Career Development Award [IK2 CX001952] from the VA Clinical Science Research & Development Service and Laura Crocker received salary support during this work from a Career Development Award [IK2 RX002459] from the VA Rehabilitation Research & Development Service. The authors report no conflicts of interest. The views, opinions and/or findings contained in this article are those of the authors and should not be construed as an official Veterans Affairs or Department of Defense position, policy, or decision unless so designated by other official documentation.	Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Andrews RJ, 2018, NEUROLOGY, V91, pE732, DOI 10.1212/WNL.0000000000006034; Avallone KM, 2019, MIL MED, V184, pE118, DOI 10.1093/milmed/usy225; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Block CK, 2016, PM&R, V8, P58, DOI 10.1016/j.pmrj.2015.05.022; Caplain S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00929; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; JAEGER RG, 1998, HERPETOLOGICA, V54, pS6; Jak AJ, 2020, CLIN NEUROPSYCHOL, V34, P1070, DOI 10.1080/13854046.2020.1730975; Jak AJ, 2019, J NEUROL NEUROSUR PS, V90, P333, DOI 10.1136/jnnp-2018-319315; Jurick SM, 2018, BRAIN INJURY, V32, P1256, DOI 10.1080/02699052.2018.1493225; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Larson EB, 2013, J INT NEUROPSYCH SOC, V19, P88, DOI 10.1017/S1355617712000999; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; Mah K, 2018, DISABIL REHABIL, V40, P960, DOI 10.1080/09638288.2016.1277402; Martindale SL, 2017, NEUROPSYCHOLOGY, V31, P93, DOI 10.1037/neu0000312; Merritt VC, 2019, J CLIN EXP NEUROPSYC, V41, P665, DOI 10.1080/13803395.2019.1610161; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Petrie KJ, 2007, CURR OPIN PSYCHIATR, V20, P163, DOI 10.1097/YCO.0b013e328014a871; Reid MW, 2018, J NEUROTRAUM, V35, P1146, DOI 10.1089/neu.2017.5424; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Roth R. S., 2013, INT J PHYS MED REHAB, V1, P1, DOI [10.4172/2329-9096.1000105, DOI 10.4172/2329-9096.1000105]; Sheehan D. V., 2014, MINIINTERNATIONAL NE; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Soble J.R., 2018, CURR PHYS MED REHABI, V6, P62, DOI [10.1007/s40141-018-0173-1., DOI 10.1007/S40141-018-0173-1]; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; The Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; Vanderploeg RD, 2019, REHABIL PSYCHOL, V64, P1, DOI 10.1037/rep0000255; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Weathers F.W., 2013, PTSD CHECKLIST DSM 5, DOI [10.1002/jts.22059, DOI 10.1002/JTS.22059]	43	1	1	1	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	NOV	2020	130						224	230		10.1016/j.jpsychires.2020.08.006			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	OC5DT	WOS:000579177600033	32846326				2022-02-06	
J	Morrissey, PJ; Maier, SP; Zhou, JJ; Sedaghatpour, D; Shah, NV; Torre, BB; Beaufort, A; Chatterjee, D; Doran, JP; Urban, WP				Morrissey, Patrick J.; Maier, Stephen P., II; Zhou, Jack J.; Sedaghatpour, Dillon; Shah, Neil V.; Torre, Barrett B.; Beaufort, Andrew; Chatterjee, Dipal; Doran, James P.; Urban, William P., Jr.			Epidemiology and trends of adult ice hockey injuries presenting to United States emergency departments: A ten-year analysis from 2007-2016	JOURNAL OF ORTHOPAEDICS			English	Article						Adult athletes; Ice hockey; Injury epidemiology; Injury trends; Concussion; National electronic injury surveillance system; Level of evidence; Level III; Retrospective study	CONCUSSION; IMPACT; RISK	Purpose: The adult population is under-represented in existing ice hockey injury studies, despite the number of United States (US) adult ice hockey players increasing from 103,533 in 2007 to 180,400 in 2016 (74%). This study establishes trends in demographics, injury location, and injury type for adult ice hockey players (>= 19 years old) in the United States. Methods: The National Electronic Injury Surveillance System (NEISS) was queried for all ice hockey injuries from January 1, 2007 to December 31, 2016. Cases under age 19 were excluded. Each injury's narrative text field was reviewed to determine mechanism of injury. Results: A total of 1,653 patients, representing an estimated 68,786 ice-hockey related injuries, presented to NEISS-participating US EDs. The most commonly injured body parts were the face (n = 12,432, 18.1%), head (n = 10,201, 14.8%), shoulder (n = 9,654, 14.0%) and ankle (n = 5,389, 7.8%). The most common diagnoses made were laceration (n = 18,153, 26.4%), strain/sprain (n = 12,202, 17.7%), fracture (n = 10,079, 14.7%), contusion (n = 9,283, 13.5%) and concussion (n = 4,794, 7.0%). The most common mechanisms of injury were falling (n = 11,786, 18.7%), puck contact (n = 10,544, 15.3%) and player contact (n = 9,449, 13.7%). Concussions increased from 46 in 2007 to 928 in 2016 (R-2 = 0.8, beta = 0.9, p < 0.001). Females (n = 1,852, 32%) had a higher proportion of head injuries than males (n = 8,349, 13.3%) (IPR = 2.4, p < 0.0001). The 50+ year old cohort showed a significant increase in injuries during the study period (n = 146 vs. 982, R-2 = 0.75, beta = 0.87, p = 0.001). Conclusions: Despite changing trends in age and sex-related demographics, the majority of injuries in this population may be preventable with adequate enforcement of protective gear use. Increased education amongst players, coaches, trainers, orthopaedic surgeons and primary care physicians should be encouraged to minimize injuries.	[Morrissey, Patrick J.; Zhou, Jack J.; Sedaghatpour, Dillon; Shah, Neil V.; Torre, Barrett B.; Beaufort, Andrew; Chatterjee, Dipal; Doran, James P.; Urban, William P., Jr.] Suny Downstate Med Ctr, Dept Orthopaed Surg & Rehabil Med, 450 Clarkson Ave,MSC 30, Brooklyn, NY 11203 USA; [Maier, Stephen P., II] Massachusetts Gen Hosp, Dept Orthopaed Surg, Harvard Combined Orthopaed Residency Program, Boston, MA 02114 USA		Morrissey, PJ (corresponding author), Suny Downstate Med Ctr, Dept Orthopaed Surg & Rehabil Med, 450 Clarkson Ave,MSC 30, Brooklyn, NY 11203 USA.	patmorrissey3@gmail.com		Beaufort, Andrew/0000-0002-2837-7171; Shah, Neil/0000-0002-3439-3071			CHEN JE, 2016, MATRIX BIOL, V25, P289, DOI DOI 10.1007/S11065-015-9294-9.FUNCTI0NAL; Clark JM, 2016, ANN BIOMED ENG, V44, P3693, DOI 10.1007/s10439-016-1686-3; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Cusimano MD., 2011, OPEN MED-WARSAW, V5, P57; Darling SR, 2011, BRIT J SPORT MED, V45, P492, DOI 10.1136/bjsm.2009.063693; Decker D., RISE AM COLL HOCKEY; Deits J, 2010, J ATHL TRAINING, V45, P467, DOI 10.4085/1062-6050-45.5.467; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Knowles SB, 2010, J ATHL TRAINING, V45, P475, DOI 10.4085/1062-6050-45.5.475; MacCormick L, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967113518181; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Micieli JA, 2014, CAN J OPHTHALMOL, V49, P243, DOI 10.1016/j.jcjo.2014.03.008; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Schroeder T., 2001, NEISS SAMPLE DESIGN; Smith A.C., 2010, P 2 ANN WORKSH SEC P, P1; Smith AM, 2017, CLIN J SPORT MED, V27, P503, DOI 10.1097/JSM.0000000000000412; Smith AM, 2011, CURR SPORT MED REP, V10, P233, DOI 10.1249/JSR.0b013e318224624a; Smith J., ACHA CELEBRATING NEA; Stead TS, 2016, CUREUS, V8, DOI 10.7759/cureus.755; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Trofa DP, 2017, ORTHOP J SPORT MED, V5, P4; Virani S, 2017, MED SCI SPORT EXER, V49, P573, DOI 10.1249/MSS.0000000000001136	26	1	1	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0972-978X			J ORTHOP	J. Orthop.	NOV-DEC	2020	22						231	236		10.1016/j.jor.2020.04.015			6	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	PH8RA	WOS:000600671400042	32425423	Green Published			2022-02-06	
J	Nael, K; Dagher, JC; Downs, ME; Fine, MS; Brokaw, E; Millward, D				Nael, K.; Dagher, J. C.; Downs, M. E.; Fine, M. S.; Brokaw, E.; Millward, D.			Maximum AmbiGuity Distance for Phase Imaging in Detection of Traumatic Cerebral Microbleeds: An Improvement over Current Imaging Practice	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							SUSCEPTIBILITY-WEIGHTED MRI; DIFFUSE AXONAL INJURY; BRAIN-INJURY; ECHO; FOCI	BACKGROUND AND PURPOSE: Developed using a rigorous mathematic framework, Maximum AmbiGuity distance for Phase Imaging (MAGPI) is a promising phase-imaging technique that provides optimal phase SNR and reduced susceptibility artifacts. We aimed to test the potential of MAGPI over routinely used SWI in the detection of traumatic cerebral microbleeds in athletes diagnosed with mild traumatic brain injury. MATERIALS AND METHODS: In this prospective study, 10 athletes (18-22 years of age, 3 women/7 men) diagnosed with mild traumatic brain injury were enrolled. Brain MRIs were performed using 3T MR imaging at 2 days, 2 weeks, and 2 months after head trauma. The imaging protocol included whole-brain T1 MPRAGE, T2 FLAIR, conventional SWI, and the MAGPI multiecho sequence. Phase images from MAGPI were put through a previously described SWI process to generate MAGPI-SWI. Conventional and MAGPI-SWI were assessed independently by a board-certified neuroradiologist for the presence of contusions and cerebral microbleeds. All participants had routine neuropsychological assessment and Visuo-Motor Tests. RESULTS: At initial assessment, 4 of the participants had visuo-motor performance indicative of mild traumatic brain injury, and 4 participants had a Post-Concussion Symptom Scale score of>21, a threshold that has been used to define moderate impairment. Cerebral microbleeds were identified in 6 participants on MAGPI-SWI, 4 of whom had evidence of concurrent contusions on FLAIR imaging. None of these cerebral microbleeds were identified confidently on conventional SWI due to substantial distortion and susceptibility artifacts. CONCLUSIONS: Optimal phase unwrapping with reduced susceptibility in MAGPI-SWI can clarify small microbleeds that can go undetected with routinely used conventional SWI.	[Nael, K.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Dagher, J. C.; Downs, M. E.; Fine, M. S.; Brokaw, E.] MITRE Corp, Emerging Technol, Mclean, VA USA; [Millward, D.] Univ Arizona, Athlet Dept, Tucson, AZ USA		Nael, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, 757 Westwood Plaza,Suite 1621, Los Angeles, CA 90095 USA.	Kambiznael@gmail.com		Dagher, Joseph/0000-0001-6956-7767; Fine, Michael/0000-0001-5717-179X; Downs, Matthew/0000-0001-6115-3156; Millward, David/0000-0002-2396-8861	MITER Corporation	This work was supported by internal funding from the MITER Corporation.	Ayaz M, 2010, J MAGN RESON IMAGING, V31, P142, DOI 10.1002/jmri.22001; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Cordonnier C, 2009, STROKE, V40, P94, DOI 10.1161/STROKEAHA.108.526996; Dagher J, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3523; Dagher J, 2016, MAGN RESON MED, V75, P1218, DOI 10.1002/mrm.25756; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Fine MS, 2016, EXP BRAIN RES, V234, P3173, DOI 10.1007/s00221-016-4714-5; Goos JDC, 2011, STROKE, V42, P1894, DOI 10.1161/STROKEAHA.110.599837; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Haller S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167743; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Keenan KE, 2019, P 5 INT WORKSH MRI P; Li NZ, 2014, J MAGN RESON IMAGING, V40, P1463, DOI 10.1002/jmri.24501; McPhee KC, 2011, MAGN RESON IMAGING, V29, P1023, DOI 10.1016/j.mri.2011.03.009; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schrag M, 2014, J STROKE CEREBROVASC, V23, P2489, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.006; Schweser F, 2012, NEUROIMAGE, V62, P2083, DOI 10.1016/j.neuroimage.2012.05.067; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Uetani H, 2013, AM J NEURORADIOL, V34, P984, DOI 10.3174/ajnr.A3332; Wang X, 2014, NEUROL SCI, V35, P1533, DOI 10.1007/s10072-014-1788-3; Wu B, 2012, NEUROIMAGE, V59, P297, DOI 10.1016/j.neuroimage.2011.07.019; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0	28	1	1	1	1	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	NOV	2020	41	11					2027	2033		10.3174/ajnr.A6774			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	OV0JH	WOS:000591906900020	33033046	Green Published, hybrid			2022-02-06	
J	Oberman, LM; Exley, S; Philip, NS; Siddiqi, SH; Adamson, MM; Brody, DL				Oberman, Lindsay M.; Exley, Shannon; Philip, Noah S.; Siddiqi, Shan H.; Adamson, Maheen M.; Brody, David L.			Use of Repetitive Transcranial Magnetic Stimulation in the Treatment of Neuropsychiatric and Neurocognitive Symptoms Associated With Concussion in Military Populations	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive symptoms; concussion; depression; posttraumatic stress disorder (PTSD); transcranial magnetic stimulation; traumatic brain injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; DORSOLATERAL PREFRONTAL CORTEX; COGNITIVE COMPLAINTS; CLINICAL PREDICTORS; MAJOR DEPRESSION; BLAST; PERFORMANCE; MECHANISMS; DISABILITY	Background: Since the year 2000, over 342 000 military service members have experienced a concussion, often associated with chronic neuropsychiatric and neurocognitive symptoms. Repetitive transcranial magnetic stimulation (rTMS) protocols have been developed for many of these symptoms in the general population. Objective: To conduct a scoping review of the literature on rTMS for neuropsychological and neurocognitive symptoms following concussion. Methods: PubMed and Google Scholar search engines identified 9 articles, written in English, corresponding to the search terms TBI or concussion; and TMS or rTMS; and depression, PTSD, or cognition. Studies that were not therapeutic trials or case reports, did not have neuropsychiatric or neurocognitive primary outcome measures, or described samples where 80% or more of the cohort did not have a TBI were excluded. Results: There were no reports of seizures nor difference in the frequency or quality of other adverse events as compared with the broader rTMS literature, supporting the safety of rTMS in this population. Support for the efficacy of rTMS for the treatment of neuropsychiatric and neurocognitive symptoms, in this population, is limited. Conclusions: Large-scale, innovative, neuroscience-informed protocols are recommended to elucidate the potential utility of rTMS for the complex neuropsychiatric and neurocognitive symptoms associated with military concussions.	[Oberman, Lindsay M.] Henry M Jackson Fdn Adv Mil Med, Ctr Neurosci & Regenerat Med, Rockville, MD USA; [Exley, Shannon] Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, Bethesda, MD 20814 USA; [Philip, Noah S.] Brown Univ, Ctr Neurorestorat & Neurotechnol, Providence VA Med Ctr, Alpert Med Sch, Providence, RI 02912 USA; [Philip, Noah S.] Brown Univ, Dept Psychiat & Human Behav, Alpert Med Sch, Providence, RI 02912 USA; [Siddiqi, Shan H.] Brigham & Womens Hosp, Ctr Brain Circuit Therapeut, 75 Francis St, Boston, MA 02115 USA; [Siddiqi, Shan H.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Adamson, Maheen M.] Stanford Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Adamson, Maheen M.] VA Palo Alto Healthcare Syst, Dept Rehabil, Palo Alto, CA USA; [Brody, David L.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Brody, David L.] NINDS, Brain MRI Mol Contrast Agent Unit, Lab Mol & Funct Imaging, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA		Brody, DL (corresponding author), 6720B Rockledge Dr,Suite 200, Bethesda, MD 20817 USA.	david.brody@usuhs.edu			US Veterans Affairs grant [I21RX002032, I01 RX002450]; VA Rehabilitation Research andDevelopment Service (RRAMP;D) Center for Neurorestoration and Neurotechnology at the Providence VA Medical Center; Neuronetics; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; DARPA, Department of Defense, National Football League, Cure Alzheimer's Fund; Thrasher Foundation; Burroughs WellcomeBurroughs Wellcome Fund; Kypha; Sage Therapeutics, St Louis Public Defenders Office; Avid Radiopharmaceuticals; Intellectual Ventures	L.M.O. is a paid scientific advisor to Achieve TMS and Neurowellness Centers of America. Effort by N.S.P. for this article was supported by US Veterans Affairs grant I21RX002032, I01 RX002450, and the VA Rehabilitation Research andDevelopment Service (RR&D) Center forNeurorestoration and Neurotechnology at the Providence VA Medical Center. In the past 3 years, N.S.P. has received grant support fromNeuronetics andNeosync through clinical trial contracts and has been an unpaid scientific advisory board member for Neuronetics. S.H.S. owns intellectual property involving connectivity-based TMS targeting, serves as a scientific consultant for SigNeuro LLC, and has received investigator-initiated grant support from Neuronetics. M.M.A. is a paid scientific advisor to neuroFit Inc and an unpaid scientific advisory board member for Trugenomix Inc. D.L.B. has received research support from NIH, DARPA, Department of Defense, National Football League, Cure Alzheimer's Fund, Bright Focus, Thrasher Foundation, and Burroughs Wellcome. D.L.B. has served as a consultant to Pfizer, Signum Nutralogix, Kypha, iPerian, Sage Therapeutics, St Louis Public Defenders Office, Avid Radiopharmaceuticals (Eli Lilly), and Intellectual Ventures. D.L.B. receives royalties from sales of Concussion Care Manual (Oxford University Press). D.L.B. owns equity in Inner Cosmos LLC. The funders had no role in the conduct of the study, paper preparation, or the decision to submit for publication.	Adamson MM, 2019, NEUR SCI NYC NEUR 20; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Avery DH, 2008, J CLIN PSYCHIAT, V69, P441, DOI 10.4088/JCP.v69n0315; Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Berry SM, 2004, J AM STAT ASSOC, V99, P36, DOI 10.1198/016214504000000052; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Brody DL, 2019, ANN NEUROL, V86, P329, DOI 10.1002/ana.25529; Brunoni AR, 2014, BRAIN COGNITION, V86, P1, DOI 10.1016/j.bandc.2014.01.008; Campbell G, 2016, J BIOPHARM STAT, V26, P3, DOI 10.1080/10543406.2015.1092037; Cole EJ, 2020, AM J PSYCHIAT, V177, P716, DOI 10.1176/appi.ajp.2019.19070720; Defense and Veterans Brain Injury Center, 2020, DOD WORLDW NUMB TBI DOD WORLDW NUMB TBI; Fann JR, 2017, J HEAD TRAUMA REHAB, V32, P332, DOI 10.1097/HTR.0000000000000322; Fitzgerald PB, 2011, J ECT, V27, P38, DOI 10.1097/YCT.0b013e3181eb30c6; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; George MS, 2014, BRAIN STIMUL, V7, P421, DOI 10.1016/j.brs.2014.03.006; Guse B, 2010, J NEURAL TRANSM, V117, P105, DOI 10.1007/s00702-009-0333-7; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoy KE, 2019, J NEUROTRAUM, V36, P2092, DOI 10.1089/neu.2018.6097; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Jones AE, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.6076; Kaster TS, 2019, AM J PSYCHIAT, V176, P367, DOI 10.1176/appi.ajp.2018.18091096; Kennedy JE, 2019, MIL MED, V184, P148, DOI 10.1093/milmed/usy321; Koek RJ, 2019, PROG NEURO-PSYCHOPH, V92, P148, DOI 10.1016/j.pnpbp.2019.01.004; Koski L, 2015, J NEUROTRAUM, V32, P38, DOI 10.1089/neu.2014.3449; Leung A, 2020, NEUROMODULATION, V23, P267, DOI 10.1111/ner.13094; Leung A, 2018, NEUROMODULATION, V21, P390, DOI 10.1111/ner.12615; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Lisanby SH, 2009, NEUROPSYCHOPHARMACOL, V34, P522, DOI 10.1038/npp.2008.118; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; McAlister FA, 2003, JAMA-J AM MED ASSOC, V289, P2545, DOI 10.1001/jama.289.19.2545; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Perera T, 2016, BRAIN STIMUL, V9, P336, DOI 10.1016/j.brs.2016.03.010; Philip NS, 2019, AM J PSYCHIAT, V176, P939, DOI 10.1176/appi.ajp.2019.18101160; Philip NS, 2018, BIOL PSYCHIAT, V83, P263, DOI 10.1016/j.biopsych.2017.07.021; Piantadosi S, 2005, WILEY SER PROBAB ST, P1, DOI 10.1002/0471740136; President's Commission on Care for America's Returning Wounded Warriors, 2007, SERV SUPP SIMPL REP; Rao V, 2019, J NEUROPSYCH CLIN N, V31, P306, DOI 10.1176/appi.neuropsych.17110338; Reeves RR, 2012, J PSYCHOSOC NURS MEN, V50, P32, DOI 10.3928/02793695-20120207-02; Sale MV, 2015, NEUROSCI BIOBEHAV R, V57, P187, DOI 10.1016/j.neubiorev.2015.09.010; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Siddiqi SH, 2020, AM J PSYCHIAT, V177, P435, DOI 10.1176/appi.ajp.2019.19090915; Siddiqi SH, 2019, J NEUROPSYCH CLIN N, V31, P254, DOI 10.1176/appi.neuropsych.18100230; Siddiqi SH, 2019, J NEUROTRAUM, V36, P1361, DOI 10.1089/neu.2018.5889; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Sydnor VJ, 2020, NEUROIMAGE-CLIN, V26, DOI 10.1016/j.nicl.2020.102190; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Trippa L, 2012, J CLIN ONCOL, V30, P3258, DOI 10.1200/JCO.2011.39.8420; US FDA (Center for Devices and Radiological Health), 2010, GUID US BAYES STAT M; US Food and Drug Administration, 2016, AD DES MED DEV CLIN; Vasterling JJ, 2018, J NEUROPSYCH CLIN N, V30, P91, DOI 10.1176/appi.neuropsych.17090180; Ventz S, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.6075; Wassmer G, 1999, J STAT PLAN INFER, V82, P69, DOI 10.1016/S0378-3758(99)00032-4; Yesavage JA, 2018, JAMA PSYCHIAT, V75, P884, DOI 10.1001/jamapsychiatry.2018.1483; Zhao Y, 2020, PHARM STAT, V19, P315, DOI 10.1002/pst.1993	63	1	1	3	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2020	35	6			SI		388	400		10.1097/HTR.0000000000000628			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OP5PJ	WOS:000588138300003	33165152	Green Accepted, Bronze			2022-02-06	
J	Prasetyo, E; Oley, MC; Faruk, M				Prasetyo, Eko; Oley, Maximillian Christian; Faruk, Muhammad			Split hypoglossal facial anastomosis for facial nerve palsy due to skull base fractures: A case report	ANNALS OF MEDICINE AND SURGERY			English	Article						Hypoglossal nerve; Facial nerve; Facial palsy; Traumatic brain injury; Case report	TEMPORAL BONE; PARALYZED FACE; MANAGEMENT; REANIMATION; CT; DIAGNOSIS; GRAFT	Introduction: Traumatic brain injury (TBI) is the most prevalent causes of morbidity and mortality worldwide. The biomechanics of primary TBI involve a direct impact, practically extended to the base of the skull, and most of the skull base fractures (SBF) are identified in anterior and medial cranial fossa. Furthermore, those predicted in the medial area are related to fissures from temporal bones. Presentation of case: We report two cases of right facial nerve palsy initiated by SBF's, which were diagnosed and treated at our institution. The 3D CT evaluation in our first case showed a longitudinal fracture of the right petrosal bone, which was longitudinal and transverse for the second case. Two cases of facial nerve palsy were managed with split hypoglossal facial anastomosis to restore functional reanimation. All patients were adequately achieved after the procedure, and the hypoglossal nerve function was preserved. Conclusion: Split hypoglossal facial anastomosis technique was used to treat patients with facial nerve paralysis resulting from SBF's. This was to achieve good recovery outcome, in terms of facial reanimation and preservation of tongue function.	[Prasetyo, Eko; Oley, Maximillian Christian] Univ Sam Ratulangi, Fac Med, Dept Surg, Div Neurosurg, Manado, Indonesia; [Prasetyo, Eko; Oley, Maximillian Christian] RD Kandou Hosp, Dept Surg, Div Neurosurg, Manado, Indonesia; [Faruk, Muhammad] Hasanuddin Univ, Fac Med, Dept Surg, Makassar, Indonesia		Prasetyo, E (corresponding author), Univ Sam Ratulangi, Fac Med, Dept Surg, Div Neurosurg, Manado, Indonesia.; Prasetyo, E (corresponding author), Jalan Malalayang Satu Barat, Manado City 95115, North Sulawesi, Indonesia.	ekoprasetyo@unsrat.ac.id; maxioley@yahoo.com; faroex8283@gmail.com		Oley, Maximillian Christian/0000-0001-8317-0790; Faruk, Muhammad/0000-0002-7079-4585			Agha RA, 2018, INT J SURG, V60, P132, DOI 10.1016/j.ijsu.2018.10.028; ARAI H, 1995, J NEUROSURG, V82, P51, DOI 10.3171/jns.1995.82.1.0051; Bello HR, 2019, RADIOGRAPHICS, V39, P1161, DOI 10.1148/rg.2019180118; BRAWLEY BW, 1967, J NEUROSURG, V26, P57, DOI 10.3171/jns.1967.26.1part1.0057; Brodie HA, 1997, AM J OTOL, V18, P188; Chang CYJ, 1999, AM J OTOL, V20, P96; CUSIMANO MD, 1994, NEUROSURGERY, V35, P532, DOI 10.1227/00006123-199409000-00027; Faried A, 2019, CHIN J TRAUMATOL, V22, P286, DOI 10.1016/j.cjtee.2019.05.006; Feldman JS, 2017, SEMIN PLAST SURG, V31, P177, DOI 10.1055/s-0037-1607275; FELIX H, 1991, ACTA OTO-LARYNGOL, V111, P332, DOI 10.3109/00016489109137396; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hammerschlag PE, 1999, LARYNGOSCOPE, V109, P1, DOI 10.1097/00005537-199902001-00001; Katzen JT, 2003, J TRAUMA, V54, P1026, DOI 10.1097/01.TA.0000066180.14666.8B; Kong K., 2017, OPERAT TECH OTOLARYN, V28, P277, DOI DOI 10.1016/J.0T0T.2017.08.014; Kral T, 1997, NEUROSURG REV, V20, P19, DOI 10.1007/BF01390521; Li J, 2004, BRAIN INJURY, V18, P315, DOI 10.1080/0269905031000149489; Manni JJ, 2001, AM J SURG, V182, P268, DOI 10.1016/S0002-9610(01)00715-2; MAY M, 1991, OTOLARYNG HEAD NECK, V104, P818, DOI 10.1177/019459989110400609; MCELHANEY JH, 1995, J NEUROTRAUM, V12, P669, DOI 10.1089/neu.1995.12.669; Mokolane NS, 2019, SA J RADIOL, V23, DOI 10.4102/sajr.v23i1.1677; Ozsoy U, 2011, ANN ANAT, V193, P304, DOI 10.1016/j.aanat.2011.01.009; PITTY LF, 1992, J NEUROSURG, V77, P724, DOI 10.3171/jns.1992.77.5.0724; Prasetyo E., 2020, CRIT CARE SHOCK, V23, P4; Reisser C, 1996, AM J OTOL, V17, P473; Ringl H, 2009, EUR RADIOL, V19, P2416, DOI 10.1007/s00330-009-1435-1; Samii M, 2015, WORLD NEUROSURG, V84, P368, DOI 10.1016/j.wneu.2015.03.029; Sanchez-Ocando M, 2019, EUR ARCH OTO-RHINO-L, V276, P3301, DOI 10.1007/s00405-019-05638-8; Schuknecht B, 2005, EUR RADIOL, V15, P560, DOI 10.1007/s00330-004-2631-7; Alonso MV, 2019, RADIOLOGIA-MADRID, V61, P204, DOI 10.1016/j.rx.2018.12.005; Wani AA, 2013, INDIAN J NEUROTRAUM, V10, P120, DOI 10.1016/j.ijnt.2013.05.009; Xu P, 2017, AM J OTOLARYNG, V38, P269, DOI 10.1016/j.amjoto.2017.01.002	31	1	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2049-0801			ANN MED SURG	Ann. Med. Surg.	NOV	2020	59						5	9		10.1016/j.amsu.2020.08.056			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	OH5NT	WOS:000582632200002	32983440	gold, Green Published			2022-02-06	
J	Qiu, SZ; Zheng, GR; Chen, B; Huang, JJ; Shen, J; Mao, W				Qiu, Shen-Zhong; Zheng, Guan-Rong; Chen, Bin; Huang, Jian-Jun; Shen, Jia; Mao, Wei			Prognostic value of admission serum glucose-phosphate ratio in predicting the 6-month outcome of patients with severe traumatic brain injury: A retrospective study	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; Biomarker; Severity; Glucose; Phosphate; Prognosis	HYPOPHOSPHATEMIA; HYPOMAGNESEMIA	Background: Serum glucose-phosphate ratio has been revealed to be associated with severity and prognosis of aneurysmal subarachnoid hemorrhage. Objective of this study was to investigate the relationship between serum glucose-phosphate ratio and severe traumatic brain injury outcome. Methods: Patients with severe traumatic brain injury were stratified in quartiles according to their serum glucose-phosphate ratio. Outcome parameters included mortality, overall survival and poor outcome defined as Glasgow outcome scale score of 1-3 at post-traumatic 6 months. Multiple logistic regression analysis was performed to evaluate the association between quartiles of serum glucose-phosphate ratio and outcome. Results: Data from 105 patients were retrospectively reviewed. Glasgow coma scale score declined, Glasgow outcome scale score decreased, Rotterdam computed tomography classification were raised, mortality increased, overall survival probability reduced and percentage of poor outcome rose significantly with each quartile of serum glucose-phosphate ratio. After adjusting for other confounding factors, serum glucose-phosphate ratio according to quartiles was substantially related to 6-month mortality, overall survival and poor outcome. Under receiver operating characteristic curve, serum glucose-phosphate ratio showed a significantly high prognostic predictive capability. Conclusions: Serum glucose-phosphate ratio might be a potential variable that can reflect trauma severity and prognosis in patients with severe traumatic brain injury.	[Qiu, Shen-Zhong; Zheng, Guan-Rong; Chen, Bin; Huang, Jian-Jun; Shen, Jia; Mao, Wei] First Peoples Hosp Fuyang Dist Hangzhou City, Dept Neurosurg, 429 Beihuan Rd, Hangzhou 311400, Peoples R China		Qiu, SZ (corresponding author), First Peoples Hosp Fuyang Dist Hangzhou City, Dept Neurosurg, 429 Beihuan Rd, Hangzhou 311400, Peoples R China.	weiaanggg@163.com			Medical and Health Science and Technology Project of Zhejiang Province [2019KY554]	This study was financially supported by Medical and Health Science and Technology Project of Zhejiang Province (2019KY554).	Chong SL, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/719476; Davanzo JR, 2017, SURG CLIN N AM, V97, P1237, DOI 10.1016/j.suc.2017.08.001; de Oliveira DV, 2017, ONCOTARGET, V8, P18622, DOI 10.18632/oncotarget.15740; Dolmans RGF, 2020, WORLD NEUROSURG, V136, pE60, DOI 10.1016/j.wneu.2019.10.086; Esnault P, 2019, NEUROCRIT CARE, V30, P405, DOI 10.1007/s12028-018-0639-0; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Geerse DA, 2010, CRIT CARE, V14, DOI 10.1186/cc9215; Haap M, 2006, EUR J CLIN NUTR, V60, P734, DOI 10.1038/sj.ejcn.1602375; Hermanides J, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1883-y; Junttila E, 2017, ACTA ANAESTH SCAND, V61, P641, DOI 10.1111/aas.12903; KNOCHEL JP, 1981, WESTERN J MED, V134, P15; Larsen VH, 1996, SCAND J CLIN LAB INV, V56, P83, DOI 10.3109/00365519609088626; Paiva WS, 2011, THER CLIN RISK MANAG, V7, P345, DOI 10.2147/TCRM.S17692; Pin-On P., 2019, MEDICINE, V97; Polderman KH, 2000, CRIT CARE MED, V28, P2022, DOI 10.1097/00003246-200006000-00057; Polderman KH, 2001, J NEUROSURG, V94, P697, DOI 10.3171/jns.2001.94.5.0697; Rau CS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111340; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Tudor RM, 2019, PITUITARY, V22, P296, DOI 10.1007/s11102-018-0917-z; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Zhang DD, 2019, WORLD NEUROSURG, V127, pE1145, DOI 10.1016/j.wneu.2019.04.071	21	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	NOV	2020	510						659	664		10.1016/j.cca.2020.08.038			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	OH3XC	WOS:000582504300102	32882225				2022-02-06	
J	Rabinowitz, AR; Chervoneva, I; Hart, T; O'Neil-Pirozzi, TM; Juengst, SB; Hoffman, JM				Rabinowitz, Amanda R.; Chervoneva, Inna; Hart, Tessa; O'Neil-Pirozzi, Therese M.; Juengst, Shannon B.; Hoffman, Jeanne M.			Heterogeneity in Temporal Ordering of Depression and Participation After Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Depression; Latent class analysis; Mental health; Rehabilitation	MINOR DEPRESSION; 1ST YEAR; TELEPHONE; SYMPTOMS; EXERCISE; MODERATE; THERAPY; ANXIETY; MOOD; LIFE	Objective: To examine heterogeneity in the temporal patterns of depression and participation over the first 2 years post traumatic brain injury (TBI). Design: Observational prospective longitudinal study. Setting: Inpatient rehabilitation centers, with 1- and 2-year follow-up conducted primarily by telephone. Participants: Persons with TBI (N=2307) enrolled in the Traumatic Brain Injury Model Systems database, followed at 1 and 2 years post injury. Interventions: Not applicable. Main Outcome Measure: Patient Health Questionnaire-9 (PHQ-9) and Participation Assessment With Recombined ToolseObjective (PART-O). Results: Using latent class modeling we examined heterogeneity in the longitudinal relationship between PHQ-9 and PART-O. The identified 6 classes were most distinct in terms of (1) level of PHQ-9 score and (2) association between the year 1 PART-O score and year 2 PHQ-9 score. For most participants, PART-O at year 1 predicted PHQ-9 at year 2 more than the reverse. However, there was a subgroup of participants that demonstrated the reverse pattern, PHQ-9 predicting later PART-O, who were on average, older and in the "other" employment category. Conclusions: Results suggest that links between participation and depression are stronger for some people living with TBI than for others and that variation in the temporal sequencing of these 2 constructs is associated with demographic characteristics. These findings illustrate the value in accounting for population heterogeneity when evaluating temporal among outcome domains. (C) 2020 by the American Congress of Rehabilitation Medicine	[Rabinowitz, Amanda R.; Hart, Tessa] Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA; [Chervoneva, Inna] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Jefferson Med Coll, Philadelphia, PA 19107 USA; [O'Neil-Pirozzi, Therese M.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Commun Sci & Disorders, Boston, MA 02115 USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Hoffman, Jeanne M.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA		Rabinowitz, AR (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	rabinowa@einstein.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R03HD093992]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DPTB0004, 90DPTB0011, 90DPTB0013, 90DPTB0008]	Supported in part by the National Institutes of Health (grant no. R03HD093992, PI: Rabinowitz) and the National Institute on Disability, Independent Living, and Rehabilitation Research (grant nos. 90DPTB0004, PI: Rabinowitz; 90DPTB0011, PI: Giacino; 90DPTB0013, PI: Bell; 90DPTB0008, PI: Hoffman).	Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Brasure M, 2013, ARCH PHYS MED REHAB, V94, P1398, DOI 10.1016/j.apmr.2012.12.019; Burg MM, 2017, ANN BEHAV MED, V51, P799, DOI 10.1007/s12160-017-9902-4; Cuijpers P, 2007, CLIN PSYCHOL REV, V27, P318, DOI 10.1016/j.cpr.2006.11.001; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Gertler P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009871.pub2; Hart T, 2019, ARCH REHABIL RES CLI, V1; Hart T, 2019, NEUROPSYCHOL REHABIL; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, pXI, DOI 10.1016/j.psc.2013.12.002; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; National Data and Statistical Center, TRAUM BRAIN INJ MOD; Nayak S, 2000, REHABIL PSYCHOL, V45, P274, DOI 10.1037/0090-5550.45.3.274; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Perrin PB, 2017, AM J PHYS MED REHAB, V96, P374, DOI 10.1097/PHM.0000000000000644; Pickles A, 2010, STAT METHODS MED RES, V19, P271, DOI 10.1177/0962280209105016; Proust-Lima C, 2015, ARXIV150300890; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Shinohara K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008696.pub2; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009	34	1	1	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2020	101	11					1973	1979		10.1016/j.apmr.2020.05.026			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	OH7DM	WOS:000582754600016	32653581				2022-02-06	
J	Rajesh, A; Daugherty, AM; Jain, S; Henry, D; Barbey, AK; Rubin, RD				Rajesh, Aishwarya; Daugherty, Ana M.; Jain, Sanjiv; Henry, Dawn; Barbey, Aron K.; Rubin, Rachael D.			Comorbid Conditions Differentiate Rehabilitation Profiles in Traumatic Versus Nontraumatic Brain Injury: A Retrospective Analysis Using a Medical Database	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						comorbid medical conditions; FIM-cognition; repeated measures; traumatic brain injury	LANGUAGE; RISK	Purpose: We examined the relationship between comorbid medical conditions and changes in cognition over the course of rehabilitation following acquired brain injury. In particular, we compared outcomes between traumatic brain injury (TBI) and non-TBI using a retrospective inpatient rehabilitation dataset. We hypothesized that differences by diagnosis would be minimized among subgroups of patients with common comorbid medical conditions. Materials and Methods: We used the Functional Independence Measure (FIM)-cognition subscale to index changes in cognition over rehabilitation. A decision tree classifier determined the top 10 comorbid conditions that maximally differentiated TBI and non-TBI. Ten subsets of patients were identified by matching on these conditions, in rank order. Data from these subsets were submitted to repeated-measures logistic regression to establish the minimum degree of commonality in comorbid conditions that would produce similar cognitive rehabilitation, regardless of etiology. Results: The TBI group demonstrated a greater increase in ordinal scores over time relative to non-TBI, across all subscales of the FIM-cognition. When both groups were matched on the top 3 symptoms, there were no significant group differences in rehabilitation trajectory in problem-solving and memory domains (Cohen's d range: 0.2-0.4). Conclusion: Comorbid medical conditions explain differences in cognitive rehabilitation trajectories following acquired brain injury beyond etiology.	[Rajesh, Aishwarya; Daugherty, Ana M.; Barbey, Aron K.; Rubin, Rachael D.] Univ Illinois, Beckman Inst Adv Sci & Technol, Champaign, IL 61801 USA; [Jain, Sanjiv; Henry, Dawn; Rubin, Rachael D.] Carle Fdn Hosp, Champaign, IL USA; [Daugherty, Ana M.] Wayne State Univ, Dept Psychol, Inst Gerontol, Detroit, MI USA; [Daugherty, Ana M.] Wayne State Univ, Dept Psychiat & Behav Neurosci, Inst Gerontol, Detroit, MI USA		Rajesh, A (corresponding author), Univ Illinois, 2147 Beckman Inst, Urbana, IL 61801 USA.	aishwar2@illinois.edu			Carle Foundation Hospital-Beckman Institute Fellowship	Supported in part by a Carle Foundation Hospital-Beckman Institute Fellowship to Rachael D. Rubin.	Barbey AK, 2015, CURR OPIN BEHAV SCI, V4, P92, DOI 10.1016/j.cobeha.2015.04.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Colantonio A, 2011, J REHABIL MED, V43, P311, DOI 10.2340/16501977-0783; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gardizi E, 2014, ARCH PHYS MED REHAB, V95, P2396, DOI 10.1016/j.apmr.2014.06.004; Gotts SJ, 2013, P NATL ACAD SCI USA, V110, pE3435, DOI 10.1073/pnas.1302581110; Hatcher RC, 2017, J PSYCHOEDUC ASSESS, V35, P57, DOI 10.1177/0734282916669019; Healey ML, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00491; Hopkins RO, 2005, NEUROPSYCHOLOGY, V19, P233, DOI 10.1037/0894-4105.19.2.233; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Khuu W, 2015, SYST REV-LONDON, V4, DOI 10.1186/2046-4053-4-14; Kirby KN, 2013, BEHAV RES METHODS, V45, P905, DOI 10.3758/s13428-013-0330-5; Li WQ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00074; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCullough KC, 2019, J SPEECH LANG HEAR R, V62, P706, DOI 10.1044/2018_JSLHR-L-18-0232; Menard S, 2002, APPL LOGISTIC REGRES, P106, DOI 10.4135/9781412983433; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Morganti-Kossmann C, 2010, ELSEV INSIGHT, P193, DOI 10.1016/B978-0-12-384691-4.00010-9; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Qureshi AW, 2018, PSYCHON B REV, V25, P1526, DOI 10.3758/s13423-018-1496-8; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Raymer AM, OXFORD HDB APHASIA L; Rendeki S, 2019, J THORAC DIS, V11, pS141, DOI 10.21037/jtd.2018.11.53; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Shoulson I, 2012, COGNITIVE REHABILITA; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Yuan P, 2014, NEUROSCI BIOBEHAV R, V42, P180, DOI 10.1016/j.neubiorev.2014.02.005; Zhang Y, 2011, J CLIN NEUROPHYSIOL, V28, P497, DOI 10.1097/WNP.0b013e318231c852	30	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2020	35	6			SI		E524	E534		10.1097/HTR.0000000000000578			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OP5PJ	WOS:000588138300015	32472835				2022-02-06	
J	Renaud, MI; van de Port, IGL; Catsman-Berrevoets, CE; Kohler, S; Lambregts, SAM; van Heugten, CM				Renaud, M. Irene; van de Port, Ingrid G. L.; Catsman-Berrevoets, Coriene E.; Kohler, Sebastian; Lambregts, Suzanne A. M.; van Heugten, Caroline M.			Effectiveness of the Brains Ahead! Intervention: 6 Months Results of a Randomized Controlled Trial in School-Aged Children With Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						activities and participation; children; intervention; mild traumatic brain injury; RCT	PSYCHOMETRIC PROPERTIES; HEAD-INJURY; PARTICIPATION; POPULATION; IMPACT; REHABILITATION; OUTCOMES; VERSION; YOUTH; LIFE	Objective:To examine the effectiveness of Brains Ahead!, a psychoeducational intervention aimed to prevent lon g-term problems with activities and participation in children after mild traumatic brain injury (mTBI). Participants: In total, 124 children, aged 6 to 18 years, diagnosed with mTBI and their caregivers.Method: After randomization, participants in the intervention group received a face-to-face psychoeducational session with written take-home information and follow-up telephone call(s). Participants in the control group received usual care, consisting of a concise information brochure. Primary Outcome Measures: Activities and participation (Child and Adolescent Scale of Participation [CASP]). Secondary outcomes: fatigue, postconcussive symptoms (PCSs), posttraumatic stress symptoms (PTSSs), and quality of life (QOL). Results: Generalized Estimated Equation analyses showed that both groups improved over the first 6 months post-mTBI, but the intervention group did not differ significantly on the CASP. Mann-Whitney U tests showed that the intervention group reported significantly less fatigue, PCSs, and PTSSs and better QOL compared with the control group at 6 months post-MTBI.Conclusions:The Brains Ahead! intervention resulted in significant improvements compared with usual care in reducing fatigue, PCSs, and PTSSs and improving QOL. Lack of an effect on activities and participation may be due to the ceiling effect of the CASP.	[Renaud, M. Irene; van de Port, Ingrid G. L.; Lambregts, Suzanne A. M.] Revant Rehabil Ctr, Breda, Netherlands; [Renaud, M. Irene; van Heugten, Caroline M.] Maastricht Univ, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands; [Renaud, M. Irene; van Heugten, Caroline M.] Limburg Brain Injury Ctr, Maastricht, Netherlands; [Catsman-Berrevoets, Coriene E.] Erasmus Univ Hosp, Sophia Childrens Hosp, Dept Paediat Neurol, Rotterdam, Netherlands; [Catsman-Berrevoets, Coriene E.] Erasmus Univ Hosp, Sophia Childrens Hosp, Dept Rehabil Med, Rotterdam, Netherlands; [Kohler, Sebastian; van Heugten, Caroline M.] Maastricht Univ, Dept Psychiat & Neuropsychol, Sch Mental Hlth & Neurosci, Med Ctr, Maastricht, Netherlands		van Heugten, CM (corresponding author), Maastricht Univ, Dept Neuropsychol & Psychopharmacol, Fac Psychol & Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands.	caroline.vanheugten@maastrichtuniversity.nl			Johanna Kinderfonds [2012/0040-1552]; Revalidatiefonds [R2012175]; Revant Rehabilitation Centre	The study was funded by the Johanna Kinderfonds (award no. 2012/0040-1552) and the Revalidatiefonds (award no. R2012175). The author acknowledge the following: fromMaastricht University, L. Bosma andW. A. C. M. IJpelaar; from Revant Rehabilitation Centre, N. Bovens; and from Amphia Hospital, J. F. de Rijk-van Andel.	Achenbach TM, 2008, J CHILD PSYCHOL PSYC, V49, P251, DOI 10.1111/j.1469-7610.2007.01867.x; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; CASEY R, 1987, PEDIATRICS, V80, P159; de Kloet AJ, 2015, DEV NEUROREHABIL, V18, P357, DOI 10.3109/17518423.2013.850749; Engelen V, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-68; Galvin J, 2010, AUST OCCUP THER J, V57, P118, DOI 10.1111/j.1440-1630.2009.00822.x; Gordijn MS, 2011, QUAL LIFE RES, V20, P1103, DOI 10.1007/s11136-010-9836-9; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Imms Christine, 2008, Phys Occup Ther Pediatr, V28, P389, DOI 10.1080/01942630802307135; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; LAMBREGTS SAM, 2014, KINDERARTS WETENSCHA, V11, P41; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Maillette de Buy Wenniger WF, 1995, TIJDSCHRIFT PSYCHIAT, V37; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McDougall J, 2013, CHILD CARE HLTH DEV, V39, P512, DOI 10.1111/cch.12050; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Renaud MI, 2018, CLIN REHABIL, V32, P1440, DOI 10.1177/0269215518785418; Renaud MI, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1357-6; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Sheese ALN, 2014, PROG NEUROL SURG, V28, P149, DOI 10.1159/000358775; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; van der Ploeg E, 2004, PSYCHOL ASSESSMENT, V16, P16, DOI 10.1037/1040-3590.16.1.16; van Heugten Caroline, 2017, Concussion, V2, pCNC38, DOI 10.2217/cnc-2016-0030; van Pelt ED, 2011, EUR J PAEDIATR NEURO, V15, P519, DOI 10.1016/j.ejpn.2011.05.005; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089	31	1	1	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2020	35	6			SI		E490	E500		10.1097/HTR.0000000000000583			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OP5PJ	WOS:000588138300012	32472840	Green Published, Bronze			2022-02-06	
J	Renaud, MI; van de Port, IGL; Catsman-Berrevoets, CE; Jellema, K; Lambregts, SAM; van Heugten, CM				Renaud, M. Irene; van de Port, Ingrid G. L.; Catsman-Berrevoets, Coriene E.; Jellema, Korne; Lambregts, Suzanne A. M.; van Heugten, Caroline M.			Activities and Participation in the First 6 Months After Mild Traumatic Brain Injury in Children and Adolescents	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						activities and participation; children; domains; mild traumatic brain injury; outcome; settings	CHILDHOOD; OUTCOMES; YOUTH; VALIDATION; SYMPTOMS; VERSION; SCALE; LIFE	Objective: To investigate the natural course of activities and participation of children up to 6 months after a mild traumatic brain injury (mTBI). Methods: A prospective longitudinal cohort study with complete data sets of 231 children diagnosed with mTBI and their caregivers. Main Measures: Activities and participation assessed with the Child and Adolescent Scale of Participation (CASP) and the Children's Assessment of Participation and Enjoyment (CAPE) measured at 2 weeks, 3 months, and 6 months post-mTBI. Because of a ceiling effect, the primary outcome measure (CASP) was divided into deviant (not maximum score) or full functioning. Results: Friedman's, Cochran's Q, and McNemar's tests (CASP) and repeated-measures analyses of variance (CAPE) showed significant increases in activities and participation between 2 weeks and 3 and 6 months after mTBI. Based on the parents' perspective, 67% of the children returned to full functioning at 6 months postinjury, with only 38% of the children describing themselves as functioning at their premorbid level. Discussion: Findings indicate that most children return to maximum level of activities and participation over time after mTBI. In a substantial number of children, however, the level of activities and participation at 6 months postinjury is evaluated as lower than that of peers. The importance of investigating predictors for child and caregiver perspectives is emphasized.	[Renaud, M. Irene; van de Port, Ingrid G. L.; Lambregts, Suzanne A. M.] Revant Rehabil Ctr, Breda, Netherlands; [Renaud, M. Irene; van Heugten, Caroline M.] Maastricht Univ, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands; [Renaud, M. Irene; van Heugten, Caroline M.] Limburg Brain Injury Ctr, Maastricht, Netherlands; [Catsman-Berrevoets, Coriene E.] Erasmus Univ Hosp, Sophia Childrens Hosp, Dept Paediat Neurol, Rotterdam, Netherlands; [Lambregts, Suzanne A. M.] Erasmus Univ Hosp, Sophia Childrens Hosp, Dept Rehabil Med, Rotterdam, Netherlands; [Jellema, Korne] Haaglanden Med Ctr, Dept Neurol, The Hague, Netherlands; [van Heugten, Caroline M.] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Maastricht, Netherlands		van Heugten, CM (corresponding author), Maastricht Univ, Dept Neuropsychol & Psychopharmacol, Fac Psychol & Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands.	caroline.vanheugten@maastrichtuniversity.nl			Johanna Kinderfonds [2012/0040-1552]; Revalidatiefonds [R2012175]	The study was funded by the Johanna Kinderfonds (award no. 2012/0040-1552) and the Revalidatiefonds (award No. R2012175). The authors acknowledge the following: Brains Ahead! Research group: N. Bovens from Maastricht University and Revant Rehabilitation Centre from Rijnstate Hospital; K. van Dijk, H. Hendricks, and D. Rijpsma from Hospital Gelderse Vallei; T. Oosterveld-Bonsma, B. Kievit, and E. Peeters from Medical Centre Haaglanden andHagaHospital; J. F. de Rijk-van Andel from AmphiaHospital, S. te Winkel from Groot-Klimmendaal Rehabilitation Centre, F. van Markus-Doornbosch from Sophia Rehabilitation Centre, and R. Pangalila from Rijndam Rehabilitation Centre.	Achenbach TM, 2008, J CHILD PSYCHOL PSYC, V49, P251, DOI 10.1111/j.1469-7610.2007.01867.x; Anaby D, 2012, DEV MED CHILD NEUROL, V54, P339, DOI 10.1111/j.1469-8749.2011.04204.x; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bedell G, 2009, DEV NEUROREHABIL, V12, P342, DOI 10.3109/17518420903087277; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Broers MC, 2018, BRAIN INJURY, V32, P1028, DOI 10.1080/02699052.2018.1469047; Bult MK, 2010, CLIN REHABIL, V24, P843, DOI 10.1177/0269215510367545; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; Cohen J., 2013, STAT POWER ANAL BEHA; Connell T, 2018, BRAIN INJURY, V32, P423, DOI 10.1080/02699052.2018.1429661; de Kloet AJ, 2015, BRAIN INJURY, V29, P1135, DOI 10.3109/02699052.2015.1034178; de Kloet AJ, 2015, DEV NEUROREHABIL, V18, P357, DOI 10.3109/17518423.2013.850749; Desha LN, 2007, AUST OCCUP THER J, V54, P4, DOI 10.1111/j.1440-1630.2006.00649.x; Foo WS, 2012, DEV NEUROREHABIL, V15, P1, DOI 10.3109/17518423.2011.623142; Galvin J, 2010, AUST OCCUP THER J, V57, P118, DOI 10.1111/j.1440-1630.2009.00822.x; Golos A, 2018, DEV NEUROREHABIL, V21, P431, DOI 10.1080/17518423.2017.1342711; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Imms Christine, 2008, Phys Occup Ther Pediatr, V28, P389, DOI 10.1080/01942630802307135; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Law M, 2011, BRAIN INJURY, V25, P587, DOI 10.3109/02699052.2011.572945; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McDougall J, 2013, CHILD CARE HLTH DEV, V39, P512, DOI 10.1111/cch.12050; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Moulaert VRM, 2017, NEUROREHAB NEURAL RE, V31, P530, DOI 10.1177/1545968317697032; Renaud MI, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1357-6; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Taylor HG, 2015, J HEAD TRAUMA REHAB, V30, P302, DOI 10.1097/HTR.0000000000000106; Thompson M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157951; van Heugten Caroline, 2017, Concussion, V2, pCNC38, DOI 10.2217/cnc-2016-0030; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; World Health Organization, 2007, INT CLASS FUNCT DIS	34	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2020	35	6			SI		E501	E512		10.1097/HTR.0000000000000584			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OP5PJ	WOS:000588138300013	32472841	Green Published			2022-02-06	
J	Rosinski, CL; Behbahani, M; Geever, B; Chaker, AN; Patel, S; Chiu, R; Zakrzewski, J; Rosenberg, D; Parola, R; Shah, K; Mehta, AI				Rosinski, Clayton L.; Behbahani, Mandana; Geever, Brett; Chaker, Anisse N.; Patel, Saavan; Chiu, Ryan; Zakrzewski, Jack; Rosenberg, David; Parola, Rown; Shah, Koral; Mehta, Ankit I.			Concurrent Versus Staged Procedures for Ventriculoperitoneal Shunt and Cranioplasty: A 10-Year Retrospective Comparative Analysis of Surgical Outcomes	WORLD NEUROSURGERY			English	Article						Concurrent; Craniectomy; Cranioplasty; Hydrocephalus; Staged; Timing; Ventriculoperitoneal shunt	REFRACTORY INTRACRANIAL HYPERTENSION; TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; COMPLICATIONS; RISK; HYDROCEPHALUS; MULTICENTER; INFECTIONS; RESORPTION; PLACEMENT	BACKGROUND: Many patients undergoing decompressive craniectomy will develop persistent hydrocephalus before cranioplasty. Therefore, surgeons must decide whether to perform ventriculoperitoneal shunt (VPS) placement and cranioplasty simultaneously or in staged procedures. With limited, conflicting data reported, this decision has often been made by personal preference. The objective of the present study was to compare the surgical outcomes between patients undergoing concurrent or staged VPS placement and cranioplasty. METHODS: We performed a 10-year retrospective comparative analysis of patients who had undergone either simultaneous or staged VPS placement and cranioplasty at a tertiary academic medical center. RESULTS: Of the 40 patients, 18 had undergone concurrent procedures and 22 had undergone VPS placement before a separate cranioplasty procedure. The concurrent group was significantly older, had more often had the VPS placed in the external ventricular drain site, and had had more patients taking aspirin at surgery. The rates of infection, resorption, and reoperation did not differ significantly, although reoperation showed a trend toward occurring less frequently in the concurrent group. Hospital acquired infection occurred significantly less frequently in the concurrent patients. The rate of VPS-associated outcomes did not differ significantly between the 2 groups. CONCLUSIONS: Because of the trend toward a reduced reoperation rate, the significantly reduced rate of hospital-acquired infection, and the reduction in the number of surgeries, we recommend that patients awaiting cranioplasty in the setting of persistent hydrocephalus undergo concurrent VPS placement and cranioplasty rather than staged procedures.	[Rosinski, Clayton L.; Behbahani, Mandana; Geever, Brett; Chaker, Anisse N.; Patel, Saavan; Chiu, Ryan; Zakrzewski, Jack; Rosenberg, David; Parola, Rown; Shah, Koral; Mehta, Ankit I.] Univ Illinois, Dept Neurosurg, Chicago, IL 60607 USA		Mehta, AI (corresponding author), Univ Illinois, Dept Neurosurg, Chicago, IL 60607 USA.	ankitm@uic.edu		Zakrzewski, Jack/0000-0002-9824-8148; Rosenberg, David/0000-0003-4914-3195; Chiu, Ryan/0000-0001-8666-9001			Abulhasan YB, 2018, AM J INFECT CONTROL, V46, P656, DOI 10.1016/j.ajic.2017.12.001; Akins PT, 2019, WORLD NEUROSURG, V130, pE941, DOI 10.1016/j.wneu.2019.07.041; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Behbahani M, 2019, WORLD NEUROSURG, V132, pE479, DOI 10.1016/j.wneu.2019.08.106; Chau CYC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091422; Cheng H, 2017, SURG INFECT, V18, P722, DOI 10.1089/sur.2017.089; Cho Yong Jun, 2017, Korean J Neurotrauma, V13, P9, DOI 10.13004/kjnt.2017.13.1.9; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Hanafusa H, 1986, Princess Takamatsu Symp, V17, P233; Heo J, 2014, J NEUROSURG, V121, P313, DOI 10.3171/2014.2.JNS131480; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2016, BRIT J NEUROSURG, V30, P523, DOI 10.1080/02688697.2016.1187259; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Lilja-Cyron A, 2020, J NEUROSURG, V133, P1548, DOI 10.3171/2019.7.JNS191077; Merkler AE, 2017, WORLD NEUROSURG, V98, P654, DOI 10.1016/j.wneu.2016.10.136; Meyer RM, 2017, WORLD NEUROSURG, V107, P830, DOI 10.1016/j.wneu.2017.08.034; Muralidharan Rajanandini, 2015, Surg Neurol Int, V6, pS271, DOI 10.4103/2152-7806.157620; Mustroph CM, 2017, WORLD NEUROSURG, V103, P686, DOI 10.1016/j.wneu.2017.04.066; Nasi D, 2018, WORLD NEUROSURG, V116, pE543, DOI 10.1016/j.wneu.2018.05.028; Pachatouridis D, 2014, TURK NEUROSURG, V24, P855, DOI 10.5137/1019-5149.JTN.8871-13.1; Park SP, 2017, J KOREAN NEUROSURG S, V60, P749, DOI 10.3340/jkns.2017.0203.002; Peraio S, 2017, J NEUROSURG SCI, V61, P673, DOI 10.23736/S0390-5616.16.03427-X; Rosinski CL, 2019, WORLD NEUROSURG, V131, pE312, DOI 10.1016/j.wneu.2019.07.139; Santana-Cabrera Luciano, 2012, Int J Crit Illn Inj Sci, V2, P186, DOI 10.4103/2229-5151.100937; Schuss P, 2015, WORLD NEUROSURG, V84, P1051, DOI 10.1016/j.wneu.2015.05.066; Smith M, 2017, ANESTH ANALG, V125, P1999, DOI 10.1213/ANE.0000000000002399; TESS BH, 1993, EUR J CLIN MICROBIOL, V12, P81, DOI 10.1007/BF01967579; Tsang ACO, 2015, J CLIN NEUROSCI, V22, P834, DOI 10.1016/j.jocn.2014.11.021; Wang QP, 2016, INT J NEUROSCI, V126, P707, DOI 10.3109/00207454.2015.1055357; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Zheng WJ, 2019, WORLD NEUROSURG, V127, pE1166, DOI 10.1016/j.wneu.2019.04.079	31	1	1	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2020	143						E648	E655		10.1016/j.wneu.2020.08.062			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OS1VO	WOS:000589953600028	32798784				2022-02-06	
J	Ruiter, KI; Boshra, R; DeMatteo, C; Noseworthy, M; Connolly, JF				Ruiter, Kyle, I; Boshra, Rober; DeMatteo, Carol; Noseworthy, Michael; Connolly, John F.			Neurophysiological markers of cognitive deficits and recovery in concussed adolescents	BRAIN RESEARCH			English	Article						Concussion; mTBI; Event-related potentials; EEG; Adolescence; Recovery	EVENT-RELATED POTENTIALS; COLLEGIATE FOOTBALL PLAYERS; ANTERIOR CINGULATE CORTEX; MISMATCH NEGATIVITY MMN; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; EXECUTIVE FUNCTION; REACTION-TIME; HEAD-INJURY; NOVELTY P3	Objective: The present study sought to determine: 1) whether concussed adolescents exhibited deficits in neurocognitive functioning as reflected by neurophysiological alterations; 2) if neurophysiological alterations could be linked to supplementary data such as the number of previous concussions and days since injury; and 3) if deficits in psychological health and behavioural tests increased during diagnosis duration. Methods: Twenty-six concussed adolescents were compared to twenty-eight healthy controls with no prior concussions. Self-report inventories evaluated depressive and concussive symptomatology, while behavioral tests evaluated cognitive ability qualitatively. To assess neurophysiological markers of cognitive function, two separate auditory oddball tasks were employed: 1) an active oddball task measuring executive control and attention as reflected by the N2b and P300, respectively; and 2) a passive oddball task assessing the early, automatic pre-conscious awareness processes as reflected by the MMN. Results: Concussed adolescents displayed delayed N2b and attenuated P300 responses relative to controls; showed elevated levels of depressive and concussive symptomatology; scored average-to- low-average in behavioral tests; and exhibited N2b response latencies that correlated with number of days since injury. Conclusion: These findings demonstrate that concussed adolescents exhibit clear deficiencies in neurocognitive function, and that N2b response latency may be a marker of concussion recovery.	[Ruiter, Kyle, I; Boshra, Rober; Connolly, John F.] McMaster Univ, ARiEAL Res Ctr, LR Wilson Hall,1280 Main St West, Hamilton, ON L8S 4M2, Canada; [Ruiter, Kyle, I; Connolly, John F.] McMaster Univ, Dept Linguist & Languages, Hamilton, ON, Canada; [Boshra, Rober; Noseworthy, Michael; Connolly, John F.] McMaster Univ, Sch Biomed Engn, ETB 406,1280 Main St, Hamilton, ON L8S 4K1, Canada; [Connolly, John F.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada; [DeMatteo, Carol] McMaster Univ, Sch Rehabil Sci, Fac Hlth Sci, Inst Appl Hlth Sci, Room 403,1400 Main St, Hamilton, ON L8S 1C7, Canada; [Boshra, Rober; Connolly, John F.] MaRS Ctr, Vector Inst, Hamilton, ON, Canada		Ruiter, KI (corresponding author), McMaster Univ, ARiEAL Res Ctr, LR Wilson Hall,1280 Main St West, Hamilton, ON L8S 4M2, Canada.	ruiterki@mcmaster.ca; boshrar@mcmaster.ca; dematteo@mcmaster.ca; nosewor@mcmaster.ca; jconnol@mcmaster.ca	Boshra, Rober/AAE-6466-2019	Boshra, Rober/0000-0003-2925-199X; Connolly, John/0000-0001-8869-5369; Ruiter, Kyle/0000-0002-7815-5980	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Canada Foundation for InnovationCanada Foundation for InnovationCGIAR; Senator William McMaster Chair in Cognitive Neuroscience of Language; Ontario Ministry of Research and InnovationMinistry of Research and Innovation, Ontario	The authors gratefully acknowledge the participants for their time, Ms. Chia-Yu Lin for coordinating and organizing this study, as well as the entire Back-2-Play team for their support. We would also like to thank Dr. Kiret Dhinsda for providing his consultation on statistical design. This work was supported by the Canadian Institutes of Health Research (CD, JFC, MN), Canada Foundation for Innovation (JFC), Senator William McMaster Chair in Cognitive Neuroscience of Language (JFC), and the Ontario Ministry of Research and Innovation (RB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO K, 1995, EAR HEARING, V16, P38, DOI 10.1097/00003446-199502000-00004; Allison BZ, 2008, BIOL PSYCHOL, V77, P277, DOI 10.1016/j.biopsycho.2007.10.014; Amenedo E, 1998, EVOKED POTENTIAL, V108, P361, DOI 10.1016/S0168-5597(98)00007-0; Amin HU, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0077-6; Arain M, 2013, NEUROPSYCH DIS TREAT, V9, P449, DOI 10.2147/NDT.S39776; Atienza M, 2002, INT J PSYCHOPHYSIOL, V46, P215, DOI 10.1016/S0167-8760(02)00113-7; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; BARR RE, 1978, INT J BIOMED COMPUT, V9, P465, DOI 10.1016/0020-7101(78)90053-3; Blain-Moraes S, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00248; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; Boshra R., 2019, IEEE T NEURAL SYST R; Boshra R., 2019, SCI REP, V22, P1; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Carter CS, 1999, REV NEUROSCIENCE, V10, P49; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Connolly JF, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029621; Covassin T, 2013, BRAIN INJURY, V27, P1589, DOI 10.3109/02699052.2013.823656; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Donchin E, 1978, EVENT RELATED BRAIN, P349, DOI DOI 10.1016/B978-0-12-155150-6.50019-5; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Dykstra AR, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500677; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finnigan S, 2002, NEUROPSYCHOLOGIA, V40, P2288, DOI 10.1016/S0028-3932(02)00113-6; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Garrido MI, 2008, NEUROIMAGE, V42, P936, DOI 10.1016/j.neuroimage.2008.05.018; Gosselin N, 2006, NEUROSCI LETT, V408, P73, DOI 10.1016/j.neulet.2006.08.046; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Gray HM, 2004, J EXP SOC PSYCHOL, V40, P216, DOI 10.1016/S0022-1031(03)00092-1; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Gronwall D, 1989, MILD HEAD INJURY, P153; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Heil M, 2000, J PSYCHOPHYSIOL, V14, P218, DOI 10.1027//0269-8803.14.4.218; Hinton-Bayre AD, 2012, CLIN J SPORT MED, V22, P105, DOI 10.1097/JSM.0b013e318248a526; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Huster RJ, 2010, HUM BRAIN MAPP, V31, P1260, DOI 10.1002/hbm.20933; Jemel B, 2002, BRAIN TOPOGR, V15, P13, DOI 10.1023/A:1019944805499; Johnston KM, 2001, J AM COLL SURGEONS, V192, P515, DOI 10.1016/S1072-7515(01)00797-9; Johnstone SJ, 1996, INT J PSYCHOPHYSIOL, V24, P223, DOI 10.1016/S0167-8760(96)00065-7; KENEMANS JL, 1993, ELECTROEN CLIN NEURO, V88, P51, DOI 10.1016/0168-5597(93)90028-N; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kovacs M., 1992, CHILDRENS DEPRESSION; Lamm C, 2006, NEUROPSYCHOLOGIA, V44, P2139, DOI 10.1016/j.neuropsychologia.2005.10.013; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Lewis MD, 2006, J COGNITIVE NEUROSCI, V18, P430, DOI 10.1162/jocn.2006.18.3.430; Lovell M.R.C.M., 2003, IMMEDIATE POSTCONCUS; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Luck SJ, 2017, PSYCHOPHYSIOLOGY, V54, P146, DOI 10.1111/psyp.12639; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Makeig S, 1999, J NEUROSCI, V19, P2665; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P., 2009, S AFR J SPORTS MED, V21; McKeon JMM, 2013, J ATHL TRAINING, V48, P836, DOI 10.4085/1062-6050-48.6.17; Morlet D, 2014, BRAIN TOPOGR, V27, P467, DOI 10.1007/s10548-013-0335-5; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Opitz B, 2002, NEUROIMAGE, V15, P167, DOI 10.1006/nimg.2001.0970; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Perri RL, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00556; POLICH J, 2012, OXFORD HDB EVENT REL, V159, P88; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; RUGG MD, 1988, J NEUROL NEUROSUR PS, V51, P691, DOI 10.1136/jnnp.51.5.691; Ruiter KI, 2019, CLIN NEUROPHYSIOL, V130, P111, DOI 10.1016/j.clinph.2018.10.013; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Stern R.A., 2019, NEW ENGLAND J MED; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Thompson-Schill SL, 2002, COGN AFFECT BEHAV NE, V2, P109, DOI 10.3758/CABN.2.2.109; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Williams LJ, 2010, ENCY RES DESIGN, V218, P840, DOI DOI 10.4135/9781412961288.N154; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	90	1	1	1	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 1	2020	1746								146998	10.1016/j.brainres.2020.146998			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NK4WQ	WOS:000566733300002	32574566	hybrid			2022-02-06	
J	Saenubol, P; Akatvipat, A; Pleumsamran, A; Chankrachang, S				Saenubol, Phitchaya; Akatvipat, Areerath; Pleumsamran, Apisate; Chankrachang, Siwaporn			Correlation between bispectral index value and modified Glasgow Coma Scale score in dogs with altered level of consciousness	JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE			English	Article						bifrontal pattern; bispectral index; consciousness; dog; modified Glasgow Coma Scale	PREVENT AWARENESS; ANESTHETIC DEPTH; HEAD TRAUMA; ISOFLURANE; ELECTROENCEPHALOGRAM; SEVOFLURANE; RECOVERY	Objective This study aims to identify the correlation between bispectral index (BIS) value and modified Glasgow Coma Scale (MGCS) score in dogs with altered level of consciousness (ALOC). Design This prospective, observational, clinical study was conducted from February 2016 to March 2017, and follow-up was conducted until the death of dogs or their discharge from the hospital. Setting This study was performed at the Small Animal Teaching Hospital. Animals A total of 31 client-owned dogs (males, 20; females, 11) with ALOC and MGCS score <18 with no restrictions for age, breed, sex, and body weight were included. Dogs that received neuromuscular blocking agents before MGCS score evaluation were excluded. Interventions BIS values were measured using the Covidien BIS Loc 2 Channel OEM module and a pediatric 4 sensor with a bifrontal application pattern. Measurements and Main Results Minimal databases of initial neurological assessment, blood profiles, and chest and skull radiographs were developed. In addition, MGCS scores and BIS values were recorded. The mean BIS values for mild, moderate, and severe brain injuries were 89.14 +/- 6.52, 77.21 +/- 9.82, and 50.58 +/- 27.04, respectively. Correlation analysis revealed a significantly positive relationship between BIS values and MGCS scores (r = 0.75; P < 0.001). Conclusions The significant correlation observed between MGCS scores and BIS values in dogs with ALOC demonstrated the usefulness of BIS as an alternative to MGCS for monitoring consciousness in patients with ALOC caused by traumatic brain injury, encephalitis, etc.	[Saenubol, Phitchaya] Chiang Mai Univ, Fac Vet Med, Masters Degree Programin Vet Sci, Chiang Mai, Thailand; [Akatvipat, Areerath] Chiang Mai Univ, Fac Vet Med, Dept Compan Anim, Chonlapratan Rd, Chiang Mai 50100, Thailand; [Akatvipat, Areerath] Chiang Mai Univ, Fac Vet Med, Wildlife Clin, Chonlapratan Rd, Chiang Mai 50100, Thailand; [Pleumsamran, Apisate] Chiang Mai Univ, Fac Med, Dept Physiol, Chiang Mai, Thailand; [Chankrachang, Siwaporn] Chiang Mai Univ, Fac Med, Dept Internal Med, Chiang Mai, Thailand		Akatvipat, A (corresponding author), Chiang Mai Univ, Fac Vet Med, Dept Compan Anim, Chonlapratan Rd, Chiang Mai 50100, Thailand.; Akatvipat, A (corresponding author), Chiang Mai Univ, Fac Vet Med, Wildlife Clin, Chonlapratan Rd, Chiang Mai 50100, Thailand.	areerath.a@cmu.ac.th		Akatvipat, Areerath/0000-0001-8442-4270	Small Animal Teaching Hospital, Faculty of Veterinary Medicine, Chiang Mai University	The authors would like to thank the Small Animal Teaching Hospital, Faculty of Veterinary Medicine, Chiang Mai University, for providing access to the medical databases, equipment, and support for this study.	Al-Kadi MI, 2013, SENSORS-BASEL, V13, P6605, DOI 10.3390/s130506605; Aprea F, 2014, J VET EMERG CRIT CAR, V24, P221, DOI 10.1111/vec.12123; Belda E, 2012, VET J, V192, P189, DOI 10.1016/j.tvjl.2011.05.021; Beldao E, 2010, VET ANAESTH ANALG, V37, P25, DOI 10.1111/j.1467-2995.2009.00507.x; Bleijenberg EH, 2011, VET ANAESTH ANALG, V38, P536, DOI 10.1111/j.1467-2995.2011.00651.x; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Campagnol D, 2007, AM J VET RES, V68, P1300, DOI 10.2460/ajvr.68.12.1300; de Araujo MA, 2015, ACTA CIR BRAS, V30, P67, DOI 10.1590/S0102-86502015001000009; Dou L, 2014, WORLD J EMERG MED, V5, P53, DOI [10.5847/wjem.j.issn.1920-8642.2014.01.009, 10.5847/wjem.j.1920-8642.2014.01.009]; Drews FA, 2008, ADV PATIENT SAFETY N, P1; Elliott Malcolm, 2012, Br J Nurs, V21, P621; Gardner RM, 2014, BIOMEDICAL INFORM, P561; Gill M, 2003, ACAD EMERG MED, V10, P175, DOI 10.1197/aemj.10.2.175; Haga H. A., 1999, Journal of Veterinary Anaesthesia, V26, P3, DOI 10.1111/j.1467-2995.1999.tb00175.x; Hatt J-M, 2012, DEPTH ANESTHESIA MON, V7, P147; Henao-Guerrero PN, 2009, VET ANAESTH ANALG, V36, P133, DOI 10.1111/j.1467-2995.2008.00440.x; Humm K, 2016, IN PRACTICE, V38, P12, DOI 10.1136/inp.i5503; Jaber SM, 2015, J AM ASSOC LAB ANIM, V54, P536; Joshi S, 2011, J NEUROSURG ANESTHES, V23, P425; Jung JY, 2013, KOREAN J ANESTHESIOL, V64, P246, DOI 10.4097/kjae.2013.64.3.246; Kung WM, 2011, INJURY, V42, P940, DOI 10.1016/j.injury.2010.09.019; Martin-Cancho MF, 2006, RES VET SCI, V81, P373, DOI 10.1016/j.rvsc.2006.01.003; Martin-Cancho MF, 2006, LAB ANIM-UK, V40, P28, DOI 10.1258/002367706775404462; Matis G, 2008, ACTA NEUROL BELG, V108, P75; Morgaz J, 2009, RES VET SCI, V86, P508, DOI 10.1016/j.rvsc.2008.09.005; Mortier E. P., 2001, BEST PRACTICE RES CL, V15, P83; Myles PS, 2004, LANCET, V363, P1757, DOI 10.1016/S0140-6736(04)16300-9; Nunes RR, 2012, REV BRAS ANESTESIOL, V62, P105, DOI 10.1016/S0034-7094(12)70109-5; O'Connor MF, 2001, ANESTHESIOLOGY, V94, P520, DOI 10.1097/00000542-200103000-00025; Ortolani O, 2002, BRIT J ANAESTH, V88, P644, DOI 10.1093/bja/88.5.644; Pachtinger G, 2013, VET CLIN N AM-SMALL, V43, P705, DOI 10.1016/j.cvsm.2013.03.014; Paul Danie B, 2006, J Clin Monit Comput, V20, P399, DOI 10.1007/s10877-006-9045-9; Platt S, 2014, VET CLIN N AM-SMALL, V44, P1039, DOI 10.1016/j.cvsm.2014.07.012; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2; Rampil IJ, 1998, ANESTHESIOLOGY, V89, P980, DOI 10.1097/00000542-199810000-00023; Ribeiro LM, 2009, RES VET SCI, V87, P287, DOI 10.1016/j.rvsc.2009.02.010; Saenubol P, 2016, P 17 KHON KAEN VET A, P113; Schnakers C, 2008, BRAIN INJURY, V22, P926, DOI 10.1080/02699050802530565; Senapathi TGA, 2017, OPEN ACCESS EMERG M, V9, P43, DOI 10.2147/OAEM.S130643; Sharma D, 2015, J VET EMERG CRIT CAR, V25, P631, DOI 10.1111/vec.12328; Szekely B, 2002, BRIT J ANAESTH, V88, P443, DOI 10.1093/bja/88.3.443; Tokushige Hirotaka, 2016, Journal of Equine Science, V27, P169; Van Soens I, 2009, VET J, V181, P163, DOI 10.1016/j.tvjl.2008.02.014	43	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1479-3261	1476-4431		J VET EMERG CRIT CAR	J. Vet. Emerg. Crit. Care	JAN	2021	31	1					52	58		10.1111/vec.13014		NOV 2020	7	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	QC6FD	WOS:000583227200001	33135305				2022-02-06	
J	Schwartz, J; Crandall, M; Hsu, A; Tepas, JJ; Joseph, B; Yorkgitis, BK				Schwartz, Jamie; Crandall, Marie; Hsu, Albert; Tepas, Joseph J.; Joseph, Bellal; Yorkgitis, Brian K.			Applying Pediatric Brain Injury Guidelines at a Level I Adult/Pediatric Safety-Net Trauma Center	JOURNAL OF SURGICAL RESEARCH			English	Article						Pediatric TBI; Brain injury guideline; Pediatric trauma; Intracranial hemorrhage	COMPUTED-TOMOGRAPHY; HEAD CT; CHILDREN; NEUROSURGERY; BIG	Background: Pediatric brain injuries are common, but current management of patients with mild traumatic intracranial hemorrhage (T-ICH) is suboptimal, often including unnecessary repeat head CT (RHCT) and neurosurgical consultation (NSC). Brain Injury Guidelines (BIG) have been developed to standardize the management of TBI, and recent work suggests they may be applied to children. The aim of this study was to apply BIG to a low-risk pediatric TBI population to further determine whether the framework can be safely applied to children in a way that reduces overutilization of RHCTs and NSC. Methods: A retrospective chart review of a Level I Adult and Pediatric Trauma Center's pediatric registry over 4 y was performed. BIG was applied to these patients to evaluate the utility of RHCT and need for neurosurgical intervention (NSG-I) in those meeting BIG-1 criteria. Those with minor skull fracture (mSFx) who otherwise met BIG-1 criteria were also included. Results: Twenty-eight patients with low-risk T-ICH met criteria for review. RHCT was performed in seven patients, with only two being prompted by clinical neurologic change/deterioration. NSC occurred in 21 of the cases. Ultimately, no patient identified by BIG-1 +/- mSFx required NSG-I. Conclusions: Application of BIG criteria to children with mild T-ICH appears capable of reducing RHCT and NSC safely. Additionally, those with mSFx that otherwise fulfill BIG-1 criteria can be managed similarly by acute care surgeons. Further prospective studies should evaluate the application of BIG-1 in larger patient populations to support the generalizability of these findings. (C) 2020 Elsevier Inc. All rights reserved.	[Schwartz, Jamie] Univ Florida, Coll Med, Gainesville, FL USA; [Crandall, Marie; Hsu, Albert; Yorkgitis, Brian K.] Univ Florida, Coll Med Jacksonville, Div Acute Care Surg, 655 W 8th St, Jacksonville, FL 32209 USA; [Tepas, Joseph J.] Univ Florida, Coll Med Jacksonville, Dept Surg, Jacksonville, FL 32209 USA; [Joseph, Bellal] Arizona Coll Med Tucson, Div Trauma Acute Care Burn & Emergency Surg, Jacksonville, FL USA		Yorkgitis, BK (corresponding author), Univ Florida, Coll Med Jacksonville, Div Acute Care Surg, 655 W 8th St, Jacksonville, FL 32209 USA.	Brian.Yorkgitis@jax.ufl.edu		Crandall, Marie/0000-0002-6536-3123	University of Florida College of Medicine's Medical Student Research Program	Jamie Schwartz was supported by the University of Florida College of Medicine's Medical Student Research Program.	American Association of Neurologic Surgeons, TRAUMATIC BRAIN INJU; Azim A, 2017, J TRAUMA ACUTE CARE, V83, P1200, DOI 10.1097/TA.0000000000001611; Durham SR, 2009, J NEUROSURG-PEDIATR, V3, P1, DOI 10.3171/2008.10.PEDS08255; Howe J, 2014, J TRAUMA ACUTE CARE, V76, P292, DOI 10.1097/TA.0000000000000119; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Kania K, 2016, J NEUROSURG-PEDIATR, V18, P224, DOI 10.3171/2016.1.PEDS15511; Kim WH, 2015, J KOREAN NEUROSURG S, V58, P125, DOI 10.3340/jkns.2015.58.2.125; Kommaraju K, 2019, PEDIATR NEUROSURG, V54, P21, DOI 10.1159/000495792; Kuhn EN, 2016, NEUROSURGERY, V79, P541, DOI 10.1227/NEU.0000000000001378; Michalska-Smith M., 2017, AMA J ETHICS, V19; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; National Resident Matching Program, MATCH RES STAT SURG; Patel SK, 2018, J PEDIATR SURG, V53, P2048, DOI 10.1016/j.jpedsurg.2018.04.027; Paul AB, 2015, J AM COLL RADIOL, V12, P453, DOI 10.1016/j.jacr.2014.12.016; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Puckett Y, 2016, AIMS PUBLIC HEALTH, V3, P49, DOI 10.3934/publichealth.2016.1.49; Snyder CW, 2019, J TRAUMA ACUTE CARE, V86, P92, DOI 10.1097/TA.0000000000002087; The American Association for the Surgery of Trauma, SURG CRIT CAR SPEC M; The American Association for the surgery of trauma acute care surgery, HIST TIM; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Zhao T, 2016, J TRAUMA ACUTE CARE, V81, P743, DOI 10.1097/TA.0000000000001088	21	1	1	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	NOV	2020	255						106	110		10.1016/j.jss.2020.05.042			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	OF3LU	WOS:000581114600015	32543374				2022-02-06	
J	Sonnay, S; Christinat, N; Thevenet, J; Wiederkehr, A; Chakrabarti, A; Masoodi, M				Sonnay, Sarah; Christinat, Nicolas; Thevenet, Jonathan; Wiederkehr, Andreas; Chakrabarti, Anirikh; Masoodi, Mojgan			Exploring Valine Metabolism in Astrocytic and Liver Cells: Lesson from Clinical Observation in TBI Patients for Nutritional Intervention	BIOMEDICINES			English	Article						valine; beta-hydroxyisobutyrate; 2-ketoisovaleric acid; traumatic brain injury; liver	AMINO-ACIDS; 3-HYDROXYISOBUTYRATE DEHYDROGENASE; BRAIN-INJURY; TRANSPORT; HINDQUARTER	The utilization of alternative energy substrates to glucose could be beneficial in traumatic brain injury (TBI). Recent clinical data obtained in TBI patients reported valine, beta-hydroxyisobutyrate (ibHB) and 2-ketoisovaleric acid (2-KIV) as three of the main predictors of TBI outcome. In particular, higher levels of ibHB, 2-KIV, and valine in cerebral microdialysis (CMD) were associated with better clinical outcome. In this study, we investigate the correlations between circulating and CMD levels of these metabolites. We hypothesized that the liver can metabolize valine and provide a significant amount of intermediate metabolites, which can be further metabolized in the brain. We aimed to assess the metabolism of valine in human-induced pluripotent stem cell (iPSC)-derived astrocytes and HepG2 cells using C-13-labeled substrate to investigate potential avenues for increasing the levels of downstream metabolites of valine via valine supplementation. We observed that 94 +/- 12% and 84 +/- 16% of ibHB, and 94 +/- 12% and 87 +/- 15% of 2-KIV, in the medium of HepG2 cells and in iPSC-derived astrocytes, respectively, came directly from valine. Overall, these findings suggest that both ibHB and 2-KIV are produced from valine to a large extent in both cell types, which could be of interest in the design of optimal nutritional interventions aiming at stimulating valine metabolism.	[Sonnay, Sarah; Christinat, Nicolas; Chakrabarti, Anirikh; Masoodi, Mojgan] Nestle Inst Hlth Sci, Lipid Metab, Nestle Res, CH-1015 Lausanne, Switzerland; [Thevenet, Jonathan; Wiederkehr, Andreas] Nestle Inst Hlth Sci, Nestle Res, Mitochondrial Funct, CH-1015 Lausanne, Switzerland; [Masoodi, Mojgan] Bern Univ Hosp, Inst Clin Chem, Inselspital, CH-3010 Bern, Switzerland		Masoodi, M (corresponding author), Nestle Inst Hlth Sci, Lipid Metab, Nestle Res, CH-1015 Lausanne, Switzerland.; Masoodi, M (corresponding author), Bern Univ Hosp, Inst Clin Chem, Inselspital, CH-3010 Bern, Switzerland.	sarah.sonnay@bluewin.ch; Nicolas.Christinat@rd.nestle.com; Jonathan.Thevenet@rd.nestle.com; andreas.wiederkehr@rd.nestle.com; Anirik@gmail.com; mojgan.masoodi@insel.ch		MASOODI, MOJGAN/0000-0001-9840-1731			Aquilani R, 2005, ARCH PHYS MED REHAB, V86, P1729, DOI 10.1016/j.apmr.2005.03.022; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; Dardevet D, 2006, NUTR RES REV, V19, P161, DOI 10.1017/S0954422407315175; Eghtesad Sareh, 2013, Middle East J Dig Dis, V5, P65; Eiden M, 2019, EBIOMEDICINE, V44, P607, DOI 10.1016/j.ebiom.2019.05.054; HU HY, 1992, ARCH BIOCHEM BIOPHYS, V299, P57, DOI 10.1016/0003-9861(92)90243-P; Jansen BCP, 1915, J BIOL CHEM, V21, P557; LAJTHA A, 1961, J NEUROCHEM, V8, P216, DOI 10.1111/j.1471-4159.1961.tb13545.x; LEE SHC, 1986, BIOCHEM J, V233, P621, DOI 10.1042/bj2330621; LETTO J, 1990, BIOCHEM CELL BIOL, V68, P260, DOI 10.1139/o90-036; LETTO J, 1986, BIOCHEM J, V240, P909, DOI 10.1042/bj2400909; Murin R, 2008, J NEUROCHEM, V105, P1176, DOI 10.1111/j.1471-4159.2008.05298.x; Murin R, 2009, NEUROCHEM RES, V34, P1195, DOI 10.1007/s11064-008-9895-2; OLDENDORF WH, 1971, AM J PHYSIOL, V221, P1629, DOI 10.1152/ajplegacy.1971.221.6.1629; Patet C, 2015, J NEUROTRAUM, V32, P1560, DOI 10.1089/neu.2014.3781; Pietz J, 1999, J CLIN INVEST, V103, P1169, DOI 10.1172/JCI5017; ROUGRAFF PM, 1988, J BIOL CHEM, V263, P327; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; SMITH QR, 1987, J NEUROCHEM, V49, P1651, DOI 10.1111/j.1471-4159.1987.tb01039.x; Sonnay S, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00288; SPYDEVOLD O, 1979, EUR J BIOCHEM, V97, P389, DOI 10.1111/j.1432-1033.1979.tb13125.x; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Wanders RJA, 2012, J INHERIT METAB DIS, V35, P5, DOI 10.1007/s10545-010-9236-x	25	1	1	0	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9059		BIOMEDICINES	Biomedicines	NOV	2020	8	11							487	10.3390/biomedicines8110487			12	Biochemistry & Molecular Biology; Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Research & Experimental Medicine; Pharmacology & Pharmacy	OW4MK	WOS:000592862700001	33182557	gold, Green Published			2022-02-06	
J	Sweeney, JE; Johnson, AM				Sweeney, James E.; Johnson, Andrew M.			Exploratory study of HRB signs, patterns, and right-left differences relating to spatial cognition following nonimpact mild traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Neuropsychology; Halstead-Reitan Battery; mTBI; Nonimpact	FRACTIONAL DISORDERS; RECENT MEMORY; VALIDITY	Sweeney and Johnson found that response time on the Tactile Form Recognition Test (TFR) of the Halstead-Reitan Test Battery (HRB) requiring speeded tactile- and visual-spatial recognition was deficient for Nonimpact mild traumatic brain injury (mTBI) individuals in comparison to Impact mTBI and No mTBI participants. A follow-up study by Sweeney and Slade noted that skills most sensitive to Deficient TFR performance of mTBI subjects involved tactile-spatial perception, with lateralization of inferior performances contralateral to cerebral regions known to specialize in the spatial skills required. The current study compared frequencies of HRB Pathognomonic Signs, atypical Score Patterns, and abnormal Right-Left Differences for Nonimpact mTBI groups that exhibited Deficient, Perfectly Normal, or Normal TFR performances. The only statistically significant finding was that the Deficient TFR group produced a disproportionately greater number of errors with the right hand relative to the left hand on Fingertip Number Writing Perception. Deficient TFR mTBI individuals were 5.29 times more likely to commit errors with the right hand on the Fingertip Number Writing Perception Test than Perfectly Normal and Normal TFR mTBI subjects. Tentative clinical markers of neuropsychological changes that appear to be associated with Nonimpact mTBI, based on a series of investigations, were provided.	[Johnson, Andrew M.] Univ Western Ontario, London, ON, Canada		Sweeney, JE (corresponding author), 242 Rideau St, Ottawa, ON K1N 0B7, Canada.	jsweeney@neuroinjury.com	Johnson, Andrew M/B-2048-2012	Johnson, Andrew M./0000-0002-7269-3016; Sweeney, James Ernest/0000-0001-7048-554X			ADAMS RL, 1981, J CONSULT CLIN PSYCH, V49, P298, DOI 10.1037/0022-006X.49.2.298; Beaudry M, 2003, CAN J NEUROL SCI, V30, P320, DOI 10.1017/S0317167100003024; Berryhill ME, 2008, NEUROPSYCHOLOGIA, V46, P1767, DOI 10.1016/j.neuropsychologia.2008.01.009; BOLL TJ, 1974, NEUROPSYCHOLOGIA, V12, P235, DOI 10.1016/0028-3932(74)90008-6; Carmon A., 1969, NEUROLOGY, V13, P449; De Renzi E, 1969, Cortex, V5, P53; DiCarlo MA, 2000, ARCH CLIN NEUROPSYCH, V15, P399, DOI 10.1016/S0887-6177(99)00031-1; HUMMEL TJ, 1971, PSYCHOL BULL, V76, P49, DOI 10.1037/h0031323; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; McCrea M., 2008, MILD TRAUMATIC BRAIN; Milner B, 1972, Clin Neurosurg, V19, P421; Reitan R. M., 1974, CLIN NEUROPSYCHOLOGY, P378; ROSS ED, 1980, ARCH NEUROL-CHICAGO, V37, P267, DOI 10.1001/archneur.1980.00500540045003; ROSS ED, 1980, ARCH NEUROL-CHICAGO, V37, P193, DOI 10.1001/archneur.1980.00500530031001; Sweeney JE, 2020, APPL NEUROPSYCH-ADUL, V27, P35, DOI 10.1080/23279095.2018.1476867; Sweeney JE, 2019, APPL NEUROPSYCH-ADUL, V26, P181, DOI 10.1080/23279095.2017.1392304; Sweeney JE, 2019, APPL NEUROPSYCH-ADUL, V26, P65, DOI 10.1080/23279095.2017.1359783; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wolfson, 1993, HALSTEAD REITAN NEUR; YATES AJ, 1954, PSYCHOL BULL, V51, P359, DOI 10.1037/h0059891	24	1	1	1	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	NOV 1	2020	27	6					532	539		10.1080/23279095.2019.1575220			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	NR9QH	WOS:000571896700006	30896307				2022-02-06	
J	Theadom, A; Reid, D; Hardaker, N; Lough, J; Hume, PA				Theadom, Alice; Reid, Duncan; Hardaker, Natalie; Lough, Jules; Hume, Patria A.			Concussion knowledge, attitudes and behaviour in equestrian athletes	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Brain injuries; Head trauma; Education; Habits; Horses; Survey	TRAUMATIC BRAIN-INJURY; SPORT; EPIDEMIOLOGY; POPULATION	Objective: To determine knowledge, attitudes and behaviour towards concussion in adult equestrian athletes. Design: Nationwide, cross-sectional, questionnaire. Methods: Participants were recruited via advertisements circulated through social media, community presentations and equestrian organisations. Participants were sent a web link to an online questionnaire previously designed for high school athletes and modified to ensure relevance to equestrian activities. The percentage of correct responses per item and a total knowledge score were calculated. Differences in concussion knowledge by age, sex, level of experience and previous history of concussion were explored using t-tests, 95% confidence intervals (CI) and effect sizes. Results: The questionnaire was completed by 1486 participants (Mean age = 39.1 +/- 15.4). Knowledge of what concussion was, how to recognise it and key symptoms (except poor sleep) was high (>80%). In contrast, awareness of guidelines was moderate (56%) and inability of helmets to prevent concussion was low (12%). Significantly higher levels of knowledge of concussion were identified in females compared with males (t=-6.55 p <0.001, 95%CI=-3.26 to -1.75). The majority (87%) of participants reported that a helmet should be replaced after a fall, yet 46% reported re-using a helmet following a hit to the head. Conclusions: Knowledge of and attitudes towards concussion were positive. However, there were knowledge gaps and discrepancies between some attitudes and behaviour on some aspects of concussion. Targeted campaigns to promote awareness of concussion and improve recognition and onward management are needed. Education related to equestrian activities such as helmet use and injury mechanisms is needed to change behaviour and minimise the risk of injury. (C) 2020 Sports Medicine Australia. Published by Elsevier Ltd.	[Theadom, Alice; Reid, Duncan; Hardaker, Natalie; Lough, Jules; Hume, Patria A.] Auckland Univ Technol, Fac Hlth & Environm Sci, Sch Clin Sci, TBI Network, Auckland, New Zealand; [Reid, Duncan; Hardaker, Natalie; Hume, Patria A.] Auckland Univ Technol, Fac Hlth & Environm Sci, Sports Performance Res Inst New Zealand, Auckland, New Zealand; [Hardaker, Natalie] Accid & Compensat Corp, Wellington, New Zealand		Theadom, A (corresponding author), Auckland Univ Technol, Fac Hlth & Environm Sci, Sch Clin Sci, TBI Network, Auckland, New Zealand.	alice.theadom@aut.ac.nz	Hume, Patria/AAN-5514-2021; Hume, Patria Anne/P-1084-2017	Hume, Patria/0000-0003-1847-8128; Hume, Patria Anne/0000-0003-1847-8128	Rutherford Discovery Fellowship	We thank Equine SuperGoo, HippoHealth and EquiBrew who kindly sponsored the study by offering products worth up to $250 for the prize draw for participants. The sponsors were not involved in the study design, data collection or analysis. Alice Theadom was supported by a Rutherford Discovery Fellowship, administered by The Royal Society of New Zealand.	Abdulkarim A, 2018, EMERG MED INT, V2018, DOI 10.1155/2018/7394390; ACC S RugbySmart, 2018, CONC REC GUID; Ahmed OH, 2017, PHYS THER SPORT, V23, P7, DOI 10.1016/j.ptsp.2016.07.003; Bodson J, 2016, HEALTH PROMOT PRACT, V17, P548, DOI 10.1177/1524839916640271; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Clark JM, 2020, J SCI MED SPORT, V23, P222, DOI 10.1016/j.jsams.2019.10.006; Clay MB, 2013, J CHIROPR MED, V12, P230, DOI 10.1016/j.jcm.2012.11.005; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Equestrian S., 2017, EQUESTRIAN SPORTS NZ; Griffin SA, 2017, BMJ OPEN SEM; IBM, 2017, IBM SPSS STAT WIND V; Kearney PE, 2017, J SCI MED SPORT, V20, P981, DOI 10.1016/j.jsams.2017.04.019; King D, 2014, J SCI MED SPORT, V17, P250, DOI 10.1016/j.jsams.2013.05.007; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Kuhl HN, 2014, SPORTS HEALTH, V6, P136, DOI 10.1177/1941738113508073; Lang J, 2014, J TRAUMA ACUTE CARE, V76, P205, DOI 10.1097/TA.0b013e3182a9007e; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McCrory P, 2005, MED SPORT SCI, V48, P8, DOI 10.1159/000084280; McCrory P, 2017, BR J SPORTS MED; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; O'Connor S, 2018, CLIN J SPORTS MED, V30; Patricios JS, 2018, BRIT J SPORT MED, V52, P635, DOI 10.1136/bjsports-2018-099079; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Sport. New Zealand, 2015, SPORT ACT RECR PROF; Theadom A, 2015, J NEUROTRAUMA; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Theadom A, 2014, J SCI MED SPORT, V17, P591, DOI 10.1016/j.jsams.2014.02.001	30	1	1	1	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	NOV	2020	23	11					1055	1061		10.1016/j.jsams.2020.05.008			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	OH3WD	WOS:000582501700009	32471785	Green Published, hybrid			2022-02-06	
J	Vega, M; Nabasny, A; Juengst, SB				Vega, Marlene; Nabasny, Andrew; Juengst, Shannon B.			"Descubriendo Soluciones Juntos"-An Argument for Adapting Problem-Solving Training for Latinx Care Partners After Traumatic Brain Injury (TBI)	REHABILITATION PSYCHOLOGY			English	Article						brain injuries; caregivers; cultural adaptation; problem solving; Latinx	NEWLY-DIAGNOSED CANCER; FAMILY CAREGIVERS; CULTURAL-ADAPTATION; MENTAL-HEALTH; STROKE CAREGIVERS; ETHNIC-MINORITIES; ACCULTURATION; REHABILITATION; INTERVENTION; CHILDREN	Purpose/Objective: This commentary demonstrates the need for culturally adapted interventions to support informal caregivers (care partners) of adults with traumatic brain injuries (TBI). proposes and supports an evidence-based intervention, Problem-Solving Training (PST), uniquely suitable for cultural adaptation for Latinx care partners, and describes several considerations and concrete suggestions for initial cultural adaption of PST for Latinx care partners of adults with TBI. Results: Caregiving among Latinxs is rooted in cultural values and norms that may facilitate or challenge family coping and adaptation after TBI in the United States. Evidence-based interventions to address emotional distress, health, and caregiver burden are needed for Latinx care partners, but must first be translated and adapted to address language and cultural values. Compared with other cognitive and behavioral evidence-based interventions, PST is ideal for cultural adaptation, as the problem-solving process is driven by, and therefore sensitive and responsive to, care partners and their individual values and situations. Conclusions/Implications: Adapting evidence-based problem-solving interventions like PST ("Descubriendo Soluciones Juntos") to be culturally tailored and culturally sensitive for Spanish-speaking Latinx care partners of adults with TBI could reduce existing health disparities and improve the health, well-being, and quality of life of these care partners.	[Vega, Marlene; Nabasny, Andrew] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Rehabil Counseling, Dallas, TX 75390 USA		Juengst, SB (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA.	shannon.juengst@utsouthwestern.edu		Juengst, Shannon/0000-0003-4709-545X			Abraido-Lanza AF, 2007, ETHNIC DIS, V17, P153; [Anonymous], 2015, CAREGIVING US 2015 R; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P801, DOI 10.3109/02699052.2012.655368; Askins MA, 2009, J PEDIATR PSYCHOL, V34, P551, DOI 10.1093/jpepsy/jsn124; Ayala GX, 2008, J AM DIET ASSOC, V108, P1330, DOI 10.1016/j.jada.2008.05.009; Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; Baker DW, 1998, MED CARE, V36, P1461, DOI 10.1097/00005650-199810000-00004; Barrera M, 2006, CLIN PSYCHOL-SCI PR, V13, P311, DOI 10.1111/j.1468-2850.2006.00043.x; Barrera M, 2013, J CONSULT CLIN PSYCH, V81, P196, DOI 10.1037/a0027085; Barrera M, 2012, HEALTH PSYCHOL, V31, P51, DOI 10.1037/a0025205; BERNAL G, 1995, J ABNORM CHILD PSYCH, V23, P67, DOI 10.1007/BF01447045; Bernal G, 2009, PROF PSYCHOL-RES PR, V40, P361, DOI 10.1037/a0016401; Buscemi J, 2011, J IMMIGR MINOR HEALT, V13, P149, DOI 10.1007/s10903-009-9263-6; Camacho A, 2015, SOC PSYCH PSYCH EPID, V50, P1669, DOI 10.1007/s00127-015-1120-4; Castillo LG, 2009, REHABIL PSYCHOL, V54, P351, DOI 10.1037/a0017801; Cianelli R, 2008, CULT HEALTH SEX, V10, P297, DOI 10.1080/13691050701861439; Cooper K. D, 1983, NEUROEPIDEMIOLOGY, V2, P79, DOI [10.1159/000110513, DOI 10.1159/000110513]; Cardoso EDS, 2007, J HEAD TRAUMA REHAB, V22, P85, DOI 10.1097/01.HTR.0000265096.44683.6b; Dillahunt-Aspillaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082896; Dunn DS, 2016, REHABIL PSYCHOL, V61, P1, DOI 10.1037/rep0000082; Dunn DS, 2005, REHABIL PSYCHOL, V50, P183, DOI 10.1037/0090-5550.50.2.183; Elliott TR, 2009, BEHAV RES THER, V47, P548, DOI 10.1016/j.brat.2009.03.006; Elliott TR, 2009, J CLIN PSYCHOL, V65, P406, DOI 10.1002/jclp.20527; Elliott TR, 2001, J COUNS PSYCHOL, V48, P223, DOI 10.1037//0022-0167.48.2.223; Field CA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1984-y; Flores YG, 2009, HEALTH CARE WOMEN IN, V30, P1055, DOI 10.1080/07399330903141252; Gao SY, 2018, J HEAD TRAUMA REHAB, V33, pE40, DOI 10.1097/HTR.0000000000000338; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Glover NM, 2007, J REHABIL, V73, P41; Grant JS, 2002, STROKE, V33, P2060, DOI 10.1161/01.STR.0000020711.38824.E3; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; IBARRA ML, 2003, AZTLAN J CHICANO STU, V28, P87; Jacobs EA, 2001, J GEN INTERN MED, V16, P468, DOI 10.1046/j.1525-1497.2001.016007468.x; Juengst Shannon B, 2019, Arch Rehabil Res Clin Transl, V1, P100009, DOI 10.1016/j.arrct.2019.100009; Juengst SB, 2019, CONTEMP CLIN TRIALS, V80, P9, DOI 10.1016/j.cct.2019.03.004; King RB, 2012, REHABIL NURS, V37, P231, DOI 10.1002/rnj.039; Knox L, 2015, BRAIN INJURY, V29, P745, DOI 10.3109/02699052.2015.1004753; Kondo KK, 2016, J ETHN SUBST ABUSE, V15, P46, DOI 10.1080/15332640.2014.1002878; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Kroshus E, 2019, HEALTH PROMOT PRACT, V20, P372, DOI 10.1177/1524839918790231; Kuhn JL, 2020, FAM PROCESS, V59, P477, DOI 10.1111/famp.12439; Kuo K., 2014, ILLEGAL UIGHUR IMMIG; Lee Christina S, 2013, J Ethn Subst Abuse, V12, P356, DOI 10.1080/15332640.2013.836730; Lee LJ, 2002, J GEN INTERN MED, V17, P640, DOI 10.1046/j.1525-1497.2002.10742.x; Linton KF, 2018, DISABIL HEALTH J, V11, P161, DOI 10.1016/j.dhjo.2017.04.009; Lorenzo-Blanco EI, 2012, J YOUTH ADOLESCENCE, V41, P1350, DOI 10.1007/s10964-012-9774-7; Lucke KT, 2013, QUAL HEALTH RES, V23, P218, DOI 10.1177/1049732312468062; Mainous AG, 2006, PUBLIC HEALTH REP, V121, P60, DOI 10.1177/003335490612100112; Mainous AG, 2008, ANN FAM MED, V6, P131, DOI 10.1370/afm.814; Malec JF, 2017, BRAIN INJURY, V31, P1235, DOI 10.1080/02699052.2016.1274778; Marsiglia FF, 2015, RES SOCIAL WORK PRAC, V25, P423, DOI 10.1177/1049731514535989; Masel MC, 2006, AM J HEALTH BEHAV, V30, P684, DOI 10.5993/AJHB.30.6.14; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; MENA FJ, 1987, HISPANIC J BEHAV SCI, V9, P207, DOI 10.1177/07399863870092006; Mendez JL, 2012, CULT DIVERS ETHN MIN, V18, P363, DOI 10.1037/a0029436; Mendez-Luck CA, 2016, J GERONTOL B-PSYCHOL, V71, P926, DOI 10.1093/geronb/gbv083; Metz MJ, 2018, SOC PSYCH PSYCH EPID, V53, P161, DOI 10.1007/s00127-017-1467-9; Moreira T, 2018, AM J LIFESTYLE MED, V12, P30, DOI 10.1177/1559827617736506; Nafradi L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186458; Nezu CM., 2007, SOLVING LIFES PROBLE; Niemeier J., 2015, MULTICULTURAL NEUROR; Norup A, 2015, BRAIN INJURY, V29, P822, DOI 10.3109/02699052.2015.1016451; Pappadis MR, 2017, ARCH PHYS MED REHAB, V98, P751, DOI 10.1016/j.apmr.2016.11.016; Pappadis MR, 2011, J HEAD TRAUMA REHAB, V26, P301, DOI 10.1097/HTR.0b013e3181e7832b; Perrin PB, 2010, REHABIL PSYCHOL, V55, P372, DOI 10.1037/a0021486; Perrin PB, 2009, REHABIL PSYCHOL, V54, P138, DOI 10.1037/a0015964; Pew Research Center, 2019, KEY FIND US IMM; Pfeiffer K, 2014, J CONSULT CLIN PSYCH, V82, P628, DOI 10.1037/a0036987; Pharr JR., 2014, ISRN PUBLIC HLTH, DOI [10.1155/2014/689826, DOI 10.1155/2014/689826]; Powell JM, 2016, J HEAD TRAUMA REHAB, V31, P180, DOI 10.1097/HTR.0000000000000167; Rayan-Gharra N, 2019, BMJ QUAL SAF, V28, P866, DOI 10.1136/bmjqs-2019-009317; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Rosales R, 2017, SOC WORK HEALTH CARE, V56, P748, DOI 10.1080/00981389.2017.1339760; Sahler OJZ, 2005, J CONSULT CLIN PSYCH, V73, P272, DOI 10.1037/0022-006X.73.2.272; Sahler OJZ, 2002, J DEV BEHAV PEDIATR, V23, P77, DOI 10.1097/00004703-200204000-00003; Sahler OJZ, 2013, J CLIN ONCOL, V31, P1329, DOI 10.1200/JCO.2011.39.1870; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Schofield TJ, 2008, DEV PSYCHOL, V44, P1190, DOI 10.1037/a0012529; Schwartz SJ, 2011, J COUNS PSYCHOL, V58, P27, DOI 10.1037/a0021356; Seid M, 2010, J PEDIATR PSYCHOL, V35, P1133, DOI 10.1093/jpepsy/jsp133; Shepherd-Banigan ME, 2018, J GEN INTERN MED, V33, P1177, DOI 10.1007/s11606-018-4417-7; Smokowski PR, 2008, FAM RELAT, V57, P295, DOI 10.1111/j.1741-3729.2008.00501.x; Sue D.W., 2012, COUNSELING CULTURALL; Suinn RM, 2010, ASIAN AM J PSYCHOL, V1, P5, DOI 10.1037/a0018798; Tederko P, 2017, INT J REHABIL RES, V40, P97, DOI 10.1097/MRR.0000000000000215; Toobert DJ, 2011, TRANSL BEHAV MED, V1, P416, DOI 10.1007/s13142-010-0011-1; Vaeth PAC, 2012, ADDICT BEHAV, V37, P1029, DOI 10.1016/j.addbeh.2012.04.015; Vazquez C. I., 2014, MARIA PARADOX LATINA; Wahl AMG, 2010, J IMMIGR MINOR HEALT, V12, P153, DOI 10.1007/s10903-008-9179-6	91	1	1	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2020	65	4					337	346		10.1037/rep0000310			10	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	OW5SF	WOS:000592945400003	31971433				2022-02-06	
J	Vita, SM; Redell, JB; Maynard, ME; Zhao, J; Grill, RJ; Dash, PK; Grayson, BE				Vita, Sydney M.; Redell, John B.; Maynard, Mark E.; Zhao, Jing; Grill, Raymond J.; Dash, Pramod K.; Grayson, Bernadette E.			P-glycoprotein Expression Is Upregulated in a Pre-Clinical Model of Traumatic Brain Injury	NEUROTRAUMA REPORTS			English	Article						blood-brain barrier; hippocampus; P-glycoprotein; traumatic brain injury	CANCER RESISTANCE PROTEIN; CROSS-REACTIVITY; HEAD-INJURY; EPIDEMIOLOGY; SYMPTOMS; BARRIER; BCRP; PENETRATION; ACTIVATION; INHIBITORS	Athletes participating in contact sports are at risk for sustaining repeat mild traumatic brain injury (rmTBI). Unfortunately, no pharmacological treatment to lessen the pathophysiology of brain injury has received U.S. Food and Drug Administration (FDA) approval. One hurdle to overcome for potential candidate agents to reach effective therapeutic concentrations in the brain is the blood-brain barrier (BBB). Adenosine triphosphate (ATP)-binding cassette (ABC) transporters, such as P-glycoprotein (Pgp), line the luminal membrane of the brain capillary endothelium facing the vascular space. Although these transporters serve to protect the central nervous system (CNS) from damage by effluxing neurotoxicants before they can reach the brain, they may also limit the accumulation of therapeutic drugs in the brain parenchyma. Thus, increased Pgp expression following brain injury may result in reduced brain availability of therapeutic agents. We therefore questioned if repeat concussive injury increases Pgp expression in the brain. To answer this question, we used a rodent model of repeat mild closed head injury (rmCHI) and examined the messenger RNA (mRN) and protein expression of both isoforms of rodent Pgp (Abcb1a and Abcb1b). Compared with sham-operated controls (n = 5), the mRNA levels of both Abcb1a and Abcb1b were found to be increased in the hippocampus at day 1 (n = 5) and at day 5 (n = 5) post-injury. Using a validated antibody, we show increased immunolabeling for Pgp in the dorsal cortex at day 5 and in the hippocampus at day 1 (n = 5) and at day 5 (n = 5) post-injury compared with sham controls (n = 6). Taken together, these results suggest that increased expression of Pgp after rmCHI may reduce the brain accumulation of therapeutic drugs that are Pgp substrates. It is plausible that including a Pgp inhibitor with a candidate therapeutic agent may be an effective approach to treat the pathophysiology of rmCHI.	[Vita, Sydney M.; Grill, Raymond J.; Grayson, Bernadette E.] Univ Mississippi, Med Ctr, Dept Neurobiol & Anat Sci, 2500 North State St, Jackson, MS 39216 USA; [Redell, John B.; Maynard, Mark E.; Zhao, Jing; Dash, Pramod K.] Univ Texas McGovern Med Sch, Dept Neurobiol & Anat, Houston, TX USA		Vita, SM (corresponding author), Univ Mississippi, Med Ctr, Dept Neurobiol & Anat Sci, 2500 North State St, Jackson, MS 39216 USA.	svita@umc.edu		Vita, Sydney/0000-0002-8413-1782	Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-16-1-0349, W81XWH-16-10387]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS087149, NS086301]	B.E.G. and R.J.G. have been supported by the Office of the Assistant Secretary of Defense for Health Affairs, awards W81XWH-16-1-0349 and W81XWH-16-10387. Aspects of the study were made possible by funds provided to P.K.D. by the National Institutes of Health (NS087149; NS086301).	Abdullahi W, 2017, AAPS J, V19, P931, DOI 10.1208/s12248-017-0081-9; Agarwal S, 2011, CURR PHARM DESIGN, V17, P2793, DOI 10.2174/138161211797440186; Agarwal S, 2010, J PHARMACOL EXP THER, V334, P147, DOI 10.1124/jpet.110.167601; Amin ML, 2013, DRUG TARGET INSIGHT, V7, P27, DOI 10.4137/DTI.S12519; Aronica E, 2005, EPILEPSIA, V46, P849, DOI 10.1111/j.1528-1167.2005.66604.x; Bardelmeijer HA, 2004, INVEST NEW DRUG, V22, P219, DOI 10.1023/B:DRUG.0000026248.45084.21; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; BEAULIEU E, 1995, BBA-BIOMEMBRANES, V1233, P27, DOI 10.1016/0005-2736(94)00239-L; Bihorel S, 2007, J NEUROCHEM, V102, P1749, DOI 10.1111/j.1471-4159.2007.04808.x; Boone DR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214741; Boyer-Di Ponio J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084179; Breedveld P, 2006, TRENDS PHARMACOL SCI, V27, P17, DOI 10.1016/j.tips.2005.11.009; Center for Drug Evaluation and Research, 2020, DRUG DEV DRUG INT TA; Centers for Disease Control and Prevention, 2020, REP C TRAUM BRAIN IN; Chan GNY, 2017, NEUROSCI LETT, V639, P103, DOI 10.1016/j.neulet.2016.12.049; Chan HSL, 1997, J NATL CANCER I, V89, P1473, DOI 10.1093/jnci/89.20.1473; Choo EF, 2014, MOL PHARMACEUT, V11, P4199, DOI 10.1021/mp500435s; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; de Klerk OL, 2010, PSYCHIAT RES-NEUROIM, V183, P151, DOI 10.1016/j.pscychresns.2010.05.002; Di Pietro A, 1999, BRAZ J MED BIOL RES, V32, P925, DOI 10.1590/S0100-879X1999000800001; Dulin JN, 2013, J NEUROTRAUM, V30, P211, DOI 10.1089/neu.2012.2587; Franklin K.B.J., 1997, MOUSE BRAIN STEREOTA, P186; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; GOLDSMITH ME, 1995, J BIOL CHEM, V270, P1894, DOI 10.1074/jbc.270.4.1894; Greco T, 2019, EXP NEUROL, V317, P206, DOI 10.1016/j.expneurol.2019.01.012; Hartz AMS, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00186; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Ikemura K, 2013, MOL PHARMACOL, V83, P399, DOI 10.1124/mol.112.081844; Jablonski MR, 2014, ANN CLIN TRANSL NEUR, V1, P996, DOI 10.1002/acn3.141; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; JETTE L, 1995, BIOCHEM J, V305, P761, DOI 10.1042/bj3050761; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1602/neurorx.2.1.86; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Ma D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25190-5; Maliepaard M, 2001, CLIN CANCER RES, V7, P935; Maynard ME, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113207; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Milane A, 2010, NEUROSCI LETT, V472, P166, DOI 10.1016/j.neulet.2010.01.078; Miller DS, 2010, TRENDS PHARMACOL SCI, V31, P246, DOI 10.1016/j.tips.2010.03.003; Numminen HJ, 2011, EUR J NEUROL, V18, P460, DOI 10.1111/j.1468-1331.2010.03179.x; Oyegbile TO, 2020, BEHAV SLEEP MED, V18, P241, DOI 10.1080/15402002.2019.1578223; Parikh I, 2016, AGING-US, V8, P2814, DOI 10.18632/aging.101094; PAVELIC ZP, 1993, ARCH OTOLARYNGOL, V119, P753; Planting AST, 2005, CANCER CHEMOTH PHARM, V55, P91, DOI 10.1007/s00280-004-0854-6; Qosa H, 2015, BRAIN RES, V1628, P298, DOI 10.1016/j.brainres.2015.07.005; RAO VV, 1995, J HISTOCHEM CYTOCHEM, V43, P1187, DOI 10.1177/43.12.8537634; Robinson S, 2017, J NEUROSCI RES, V95, P1025, DOI 10.1002/jnr.23848; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; Selwyn RG, 2016, J NEUROTRAUM, V33, P1479, DOI 10.1089/neu.2015.4129; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Walker PA, 2010, STEM CELLS DEV, V19, P867, DOI 10.1089/scd.2009.0188; Willyerd FA, 2016, J NEUROTRAUM, V33, P226, DOI 10.1089/neu.2015.3879; Yang JM, 2001, MOL PHARMACOL, V60, P674; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Zhang XP, 2006, J CEREBR BLOOD F MET, V26, P915, DOI 10.1038/sj.jcbfm.9600238; Zhang YK, 2017, ACTA PHARM SIN B, V7, P564, DOI 10.1016/j.apsb.2017.04.001; Zhou G, 1998, J BIOL CHEM, V273, P15387, DOI 10.1074/jbc.273.25.15387	62	1	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	NOV 1	2020	1	1					207	217		10.1089/neur.2020.0034			11	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WU7FW	WOS:000716708100007	33274346	hybrid, Green Published			2022-02-06	
J	Wallace, EJ; Mathias, JL; Ward, L; Pannek, K; Fripp, J; Rose, S				Wallace, Erica J.; Mathias, Jane L.; Ward, Lynn; Pannek, Kerstin; Fripp, Jurgen; Rose, Stephen			Chronic White Matter Changes Detected Using Diffusion Tensor Imaging Following Adult Traumatic Brain Injury and Their Relationship to Cognition	NEUROPSYCHOLOGY			English	Article						traumatic brain injury; diffusion tensor imaging; adults; outcomes	AXONAL INJURY; IMPAIRMENT; MRI; PERFORMANCE; INTEGRITY; MODERATE; DTI	Objective: White matter (WM) changes detected using diffusion tensor imaging (DTI) are reportedly related to cognitive outcomes following traumatic brain injury (TBI), but much existing research is underpowered or has only examined general outcomes, rather than cognitive functioning. Method: A large sample of adults who had sustained mild, moderate or severe TBIs seven months prior (N = 165) and a control group (N = 106) underwent DTI and cognitive testing. Fractional anisotropy and mean diffusivity were calculated for 5 regions (corpus callosum: genu, body, splenium; fornix; superior longitudinal fasciculus) that recent meta-analyses identified as being affected by TBI and related to cognition following TBI. Memory, attention and executive functioning, which are often affected by TBI, were assessed. Results: Overall, mild TBI did not show significant WM or cognitive changes, relative to controls, but moderate to severe TBI was associated with large WM alterations (all regions) and poorer cognitive performance. No significant correlations were found between DTI findings and cognition in the moderate to severe group. Conclusions: The findings have shown that moderate to severe TBI leads to considerable WM and cognitive changes. Early and ongoing examination of mild TBI is needed to determine whether WM and cognitive changes are initially present and, if so, when they resolve.	[Wallace, Erica J.; Mathias, Jane L.; Ward, Lynn] Univ Adelaide, Fac Hlth & Med Sci, Adelaide, SA 5005, Australia; [Pannek, Kerstin; Fripp, Jurgen; Rose, Stephen] CSIRO, Australian E Hlth Res Ctr, Brisbane, Qld, Australia		Wallace, EJ (corresponding author), Univ Adelaide, Fac Hlth & Med Sci, Adelaide, SA 5005, Australia.	erica.wallace@adelaide.edu.au	Fripp, Jurgen/A-8763-2011; Pannek, Kerstin/C-8059-2011	Fripp, Jurgen/0000-0001-9705-0079; Pannek, Kerstin/0000-0002-6512-7630; Rose, Stephen/0000-0003-1558-6297	National Health and Medical Research Foundation [519220]	This work was supported by the National Health and Medical Research Foundation (Project Grant 519220).	Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bigler Erin D, 2015, Handb Clin Neurol, V128, P691, DOI 10.1016/B978-0-444-63521-1.00043-1; Brandstack N, 2011, CLIN NEURORADIOL, V21, P75, DOI 10.1007/s00062-011-0058-5; Leon AMC, 2018, J NEUROTRAUM, V35, P2365, DOI 10.1089/neu.2018.5691; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; Dean PJA, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.292; Douglas DB, 2018, CURR OPIN NEUROL, V31, P362, DOI 10.1097/WCO.0000000000000567; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; HOLLAND BS, 1988, PSYCHOL BULL, V104, P145, DOI 10.1037/0033-2909.104.1.145; Huisman T A G M, 2010, Cancer Imaging, V10 Spec no A, pS163, DOI 10.1102/1470-7330.2010.9023; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jang SH, 2013, NEUROSCI LETT, V543, P47, DOI 10.1016/j.neulet.2013.02.058; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Koerte IK, 2016, TRANSLATIONAL RES TR, V2016; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oehr L, 2017, ARCH PHYS MED REHAB, V98, P2308, DOI 10.1016/j.apmr.2017.03.019; Pannek K., 2017, ISMRM 25 ANN M EXH H; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Raffelt DA, 2015, NEUROIMAGE, V117, P40, DOI 10.1016/j.neuroimage.2015.05.039; Rosenthal JA, 1996, J SOC SERV RES, V21, P37, DOI 10.1300/J079v21n04_02; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sherer M, 2015, ARCH PHYS MED REHAB, V96, P652, DOI 10.1016/j.apmr.2014.10.024; Shrout PE, 2018, ANNU REV PSYCHOL, V69, P487, DOI 10.1146/annurev-psych-122216-011845; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Strauss Sara, 2015, Top Magn Reson Imaging, V24, P353, DOI 10.1097/RMR.0000000000000071; Suri AK, 2018, HAND CLINIC, V158, P205, DOI 10.1016/B978-0-444-63954-7.00021-5; TOMARKEN AJ, 1986, PSYCHOL BULL, V99, P90, DOI 10.1037/0033-2909.99.1.90; Toothaker L.E., 1993, MULTIPLE COMP PROCED, DOI [10.4135/9781412985178, DOI 10.4135/9781412985178, 10. 4135/9781412985178]; Tukey JW., 1977, EXPLORATORY DATA ANA, V2; Ubukata S, 2016, J NEUROPSYCH CLIN N, V28, P97, DOI 10.1176/appi.neuropsych.15070159; Voelbel GT, 2012, NEUROREHABILITATION, V31, P281, DOI 10.3233/NRE-2012-0796; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wallace EJ, 2018, NEUROSCI BIOBEHAV R, V92, P93, DOI 10.1016/j.neubiorev.2018.05.023; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Wechsler D., 1997, WECHSLER MEMORY SCAL; WELCH BL, 1951, BIOMETRIKA, V38, P330, DOI 10.2307/2332579; Wilde EA, 2019, J NEUROTRAUM, V36, P239, DOI 10.1089/neu.2017.5513; Zhu YN, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/548392	64	1	1	0	1	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	NOV	2020	34	8					881	893		10.1037/neu0000690			13	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	OW2JR	WOS:000592720400006	33197200				2022-02-06	
J	Wang, XW; Tong, J; Han, XD; Qi, XM; Zhang, J; Wu, EX; Huang, J				Wang, Xiaowei; Tong, Jing; Han, Xiaodi; Qi, Xiaoming; Zhang, Jun; Wu, Erxi; Huang, Jason			Acute effects of human protein S administration after traumatic brain injury in mice	NEURAL REGENERATION RESEARCH			English	Article						apoptosis; aquaporin-4; controlled cortical impact; edema; inflammation; protein S; TBI therapy; traumatic brain injury	TAM RECEPTORS; INFLAMMATION; BLOOD; EXPRESSION; AQUAPORIN-4; INACTIVATION; APOPTOSIS; MODEL; GAS6	Despite years of effort, no effective acute phase treatment has been discovered for traumatic brain injury. One impediment to successful drug development is entangled secondary injury pathways. Here we show that protein S, a natural multifunctional protein that regulates coagulation, inflammation, and apoptosis, is able to reduce the extent of multiple secondary injuries in traumatic brain injury, and therefore improve prognosis. Mice subjected to controlled cortical impact were treated acutely (10-15 minutes post-injury) with a single dose of either protein S (1 mg/kg) or vehicle phosphate buffered saline via intravenous injection. At 24 hours post-injury, compared to the non-treated group, the protein S treated group showed substantial improvement of edema and fine motor coordination, as well as mitigation of progressive tissue loss. Immunohistochemistry and western blot targeting caspase-3, B-cell lymphoma 2 (Bcl-2) along with terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay revealed that apoptosis was suppressed in treated animals. Immunohistochemistry targeting CD11b showed limited leukocyte infiltration in the protein S-treated group. Moreover, protein S treatment increased the ipsilesional expression of aquaporin-4, which may be the underlying mechanism of its function in reducing edema. These results indicate that immediate intravenous protein S treatment after controlled cortical impact is beneficial to traumatic brain injury prognosis.	[Wang, Xiaowei] Univ Rochester, Ctr Translat Neuromed, Rochester, NY USA; [Tong, Jing] Hebei Med Univ, Dept Neurosurg, Affiliated Hosp 4, Shijiazhuang, Hebei, Peoples R China; [Han, Xiaodi] Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Qi, Xiaoming; Wu, Erxi; Huang, Jason] Baylor Scott & White Hlth, Dept Neurosurg, Temple, TX 76502 USA; [Zhang, Jun] Peoples Liberat Army Gen Hosp, Dept Neurosurg, Beijing, Peoples R China; [Wu, Erxi; Huang, Jason] Texas A&M Hlth Sci Ctr, Coll Med, Temple, TX 76508 USA		Huang, J (corresponding author), Baylor Scott & White Hlth, Dept Neurosurg, Temple, TX 76502 USA.; Huang, J (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Temple, TX 76508 USA.	Jason.Huang@BSWHealth.org		Reis, AlessanRSS/0000-0001-8486-7469	University of Rochester Institutional Grant [2011NSG-Huang]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH-R01-NS-067435]; Hellen Vosberg McCrillus Plummer and Robert Edward Lee Plummer, Jr, Endowment fund from Baylor Scott & White Medical Center	This work was supported in part by a University of Rochester Institutional Grant (2011NSG-Huang; to JHH), National Institute of Health (NIH-R01-NS-067435; to JHH), and the Hellen Vosberg McCrillus Plummer and Robert Edward Lee Plummer, Jr, Endowment fund from Baylor Scott & White Medical Center (to JHH).	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Chitnis T, 2017, J CLIN INVEST, V127, P3577, DOI 10.1172/JCI90609; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Fernandez JA, 2003, BLOOD CELL MOL DIS, V30, P271, DOI 10.1016/S1079-9796(03)00034-2; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Han XD, 2011, J NEUROTRAUM, V28, P995, DOI 10.1089/neu.2010.1563; Heeb MJ, 1999, J BIOL CHEM, V274, P36187, DOI 10.1074/jbc.274.51.36187; Heindl S, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00106; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Huang JH, 2013, NEUROL RES, V35, P221, DOI 10.1179/1743132813Y.0000000178; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Li XJ, 2013, NEURAL REGEN RES, V8, P338, DOI 10.3969/j.issn.1673-5374.2013.04.006; Liang BQ, 2017, NEURAL REGEN RES, V12, P401, DOI 10.4103/1673-5374.202939; Liu D, 2003, CIRCULATION, V107, P1791, DOI 10.1161/01.CIR.0000058460.34453.5A; Liu YWY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1173-x; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; LUNDWALL A, 1986, P NATL ACAD SCI USA, V83, P6716, DOI 10.1073/pnas.83.18.6716; MCINTOSH TK, 1990, ACT NEUR S, V51, P263; Mestre H, 2018, ELIFE, V7, DOI 10.7554/eLife.40070; Neal CJ, 2007, J NEUROTRAUM, V24, P1609, DOI 10.1089/neu.2007.0301; O'Brien LM, 2000, BLOOD, V95, P1714, DOI 10.1182/blood.V95.5.1714.005k40_1714_1720; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; ROSING J, 1995, J BIOL CHEM, V270, P27852, DOI 10.1074/jbc.270.46.27852; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Sulhan S, 2020, J NEUROSCI RES, V98, P19, DOI 10.1002/jnr.24331; Tait MJ, 2010, NEUROSCIENCE, V167, P60, DOI 10.1016/j.neuroscience.2010.01.053; Tong J, 2013, J NEUROTRAUM, V30, P247, DOI 10.1089/neu.2012.2493; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; van der Meer JHM, 2014, BLOOD, V123, P2460, DOI 10.1182/blood-2013-09-528752; WALKER FJ, 1980, J BIOL CHEM, V255, P5521; Wang FS, 2017, BRAIN STRUCT FUNCT, V222, P1543, DOI 10.1007/s00429-016-1292-z; Wofford KL, 2019, NEURAL REGEN RES, V14, P1481, DOI 10.4103/1673-5374.255958; Yu KW, 2014, J NEUROL SCI, V347, P275, DOI 10.1016/j.jns.2014.10.022; Zhang CC, 2015, MOL MED REP, V12, P7351, DOI 10.3892/mmr.2015.4372; Zhu DH, 2010, BLOOD, V115, P4963, DOI 10.1182/blood-2010-01-262386	45	1	1	0	7	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	NOV	2020	15	11					2073	2081		10.4103/1673-5374.282258			9	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	MG0VY	WOS:000545754000001	32394965	Green Published			2022-02-06	
J	Williams, KA				Williams, Karen A.			Headache management in a veteran population: First considerations	JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS			English	Article						Chronic daily headache management; chronic migraine management; veterans	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; CHRONIC MIGRAINE; BATTLEFIELD ACUPUNCTURE; CLINICAL-PRACTICE; AFGHANISTAN WARS; SERVICE MEMBERS; PREVALENCE; IMPACT; PAIN	It is estimated that almost half the general population has a headache disorder. The majority of these are considered tension-type headaches. Migraines and chronic daily headache (CDH) are not as common but are much more debilitating. Although CDH/chronic migraine (CM) occurs in about 3% of the population, it has been found to be 20% or higher in the post 9/11 combat Veteran population. Data from the Veterans Health Administration show that more than 380,000 Veterans, younger than 50 years, received care for a headache in 2017. Approximately 75% of the headache care was from a primary care provider. The purpose of the article is to review physical examination for the veteran with a history of a headache disorder, discuss contributing factors and comorbid conditions, as well as give an overview of current treatment options, with a focus on the post-9/11 combat Veteran who has CDH/CM.	[Williams, Karen A.] Cent Virginia VA Hlth Care Syst, Headache Ctr Excellence, 800 Semmes Ave,Apt 505, Richmond, VA 23224 USA		Williams, KA (corresponding author), Cent Virginia VA Hlth Care Syst, Headache Ctr Excellence, 800 Semmes Ave,Apt 505, Richmond, VA 23224 USA.	Karen.Williams1@va.gov					Allen SM, 2018, J AM BOARD FAM MED, V31, P211, DOI 10.3122/jabfm.2018.02.170188; Altalib HH, 2017, CEPHALALGIA, V37, P3, DOI 10.1177/0333102416631959; [Anonymous], 2020, PRIM CAR MAN AG HEAD; [Anonymous], 2016, MAN CONC MILD TRAUM; [Anonymous], 2017, MAN POSTTR STRESS DI; Blumenfeld AM, 2011, CEPHALALGIA, V31, P301, DOI 10.1177/0333102410381145; Blumenfeld A, 2015, HEADACHE, V55, P682, DOI 10.1111/head.12579; Burch R, 2018, HEADACHE, V58, P496, DOI 10.1111/head.13281; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Couch JR, 2016, HEADACHE, V56, P1004, DOI 10.1111/head.12837; Croop R, 2019, LANCET, V394, P737, DOI 10.1016/S0140-6736(19)31606-X; De Luca GC, 2010, SEMIN NEUROL, V30, P131, DOI 10.1055/s-0030-1249221; DoD, 2020, DOD WORLDW NUMB TBI; Dodick DW, 2019, NEW ENGL J MED, V381, P2230, DOI 10.1056/NEJMoa1813049; Dodick DW, 2006, NEW ENGL J MED, V354, P158, DOI 10.1056/NEJMcp042897; Dougherty C, 2015, PAIN PRACT, V15, P688, DOI 10.1111/papr.12243; Federman DG, 2018, MED ACUPUNCT, V30, P273, DOI 10.1089/acu.2018.1296; Finkel AG, 2017, CEPHALALGIA, V37, P548, DOI 10.1177/0333102416651285; Florencio LL, 2014, HEADACHE, V54, P1203, DOI 10.1111/head.12393; Grimsrud KW, 2018, CURR PAIN HEADACHE R, V22, DOI 10.1007/s11916-018-0716-2; Grinberg A, 2019, AM HEAD SOC 61 ANN S; Holtkamp MD, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0572-x; James A., 2018, HALEY VET HOSP TAMPA; Jaramillo CA, 2016, HEADACHE, V56, P528, DOI 10.1111/head.12726; Kelman L, 2007, CEPHALALGIA, V27, P394, DOI 10.1111/j.1468-2982.2007.01303.x; Kligler B, 2016, AM FAM PHYSICIAN, V94, P369; Levy CE, 2018, AM J PHYS MED REHAB, V97, pe18, DOI 10.1097/PHM.0000000000000766; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lipton RB, 2016, CEPHALALGIA, V36, P899, DOI 10.1177/0333102416652092; Loder E, 2012, HEADACHE, V52, P930, DOI 10.1111/j.1526-4610.2012.02185.x; Marmura MJ, 2015, HEADACHE, V55, P3, DOI 10.1111/head.12499; Moriarty M, 2019, JNP-J NURSE PRACT, V15, P717, DOI 10.1016/j.nurpra.2019.07.009; Moriarty M, 2016, NURSE PRACT, V41, P18, DOI 10.1097/01.NPR.0000483078.55590.b3; Munakata J, 2009, HEADACHE, V49, P498, DOI 10.1111/j.1526-4610.2009.01369.x; Murinova N, 2015, PHYS MED REH CLIN N, V26, P375, DOI 10.1016/j.pmr.2015.01.001; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; Rao AS, 2015, HEADACHE, V55, P1323, DOI 10.1111/head.12698; Sheeler RD, 2016, HEADACHE, V56, P1675, DOI 10.1111/head.12881; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; Theeler BJ, 2012, CURR TREAT OPTION NE, V14, P36, DOI 10.1007/s11940-011-0157-2; Tick H, 2018, EXPLORE-NY, V14, P177, DOI 10.1016/j.explore.2018.02.001; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Williams KA, 2019, MIL MED, V184, pE207, DOI 10.1093/milmed/usy405; Yerry JA, 2015, HEADACHE, V55, P395, DOI 10.1111/head.12495; Zhang NS, 2020, HEADACHE, V60, P309, DOI 10.1111/head.13723	47	1	1	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2327-6886	2327-6924		J AM ASSOC NURSE PRA	J. Am. Assoc. Nurs. Pract.	NOV	2020	32	11					758	763		10.1097/JXX.0000000000000539			6	Health Care Sciences & Services; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Nursing	QI4MI	WOS:000618953000007	33177336				2022-02-06	
J	Xu, BL; Chandrasekar, A; Heuvel, FO; Powerski, M; Nowak, A; Noack, L; Omari, J; Huber-Lang, M; Roselli, F; Relja, B				Xu, Baolin; Chandrasekar, Akila; Heuvel, Florian Olde; Powerski, Maciej; Nowak, Aleksander; Noack, Laurens; Omari, Jazan; Huber-Lang, Markus; Roselli, Francesco; Relja, Borna			Ethanol Intoxication Alleviates the Inflammatory Response of Remote Organs to Experimental Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						inflammation; TBI; alcohol; cytokines; lung; liver	TUMOR-NECROSIS-FACTOR; CLOSED-HEAD INJURY; NF-KAPPA-B; ALCOHOL EXPOSURE; SYSTEMIC INTERLEUKIN-6; ACUTE LUNG; CYTOKINE; MODEL; ACTIVATION; EXPRESSION	Traumatic brain injury (TBI) may cause damage to distant organs. Acute ethanol intoxication (EI) induces complex local and systemic anti-inflammatory effects and influences the early outcomes of traumatized patients. Here, we evaluated its effects on the BI-induced expression of local inflammatory mediators in the trauma-remote organs the lungs and liver. Male mice were exposed to ethanol as a single oral dose (5g center dot kg(-1), 32%) before inducing a moderate blunt TBI. Sham groups underwent the same procedures without TBI. Ether 3 or 6h after the TBI, the lung and liver were collected. The gene expression of HMGB1, IL-6, MMP9, IL-1 beta, and TNF as well as the homogenate protein levels of receptor for advanced glycation end products (RAGE), IL-6, IL-1 beta, and IL-10 were analyzed. Liver samples were immunohistologically stained for HMGB1. EI decreased the gene expressions of the proinflammatory markers HMGB1, IL-6, and MMP9 in the liver upon TBI. In line with the reduced gene expression, the TBI-induced protein expression of IL-6 in liver tissue homogenates was significantly reduced by EI at 3h after TBI. While the histological HMGB1 expression was enhanced by TBI, the RAGE protein expression in the liver tissue homogenates was diminished after TBI. EI reduced the histological HMGB1 expression and enhanced the hepatic RAGE protein expression at 6h post TBI. With regard to the lungs, EI significantly reduced the gene expressions of HMGB1, IL-6, IL-1 beta, and TNF upon TBI, without significantly affecting the protein expression levels of inflammatory markers (RAGE, IL-6, IL-1 beta, and IL-10). At the early stage of TBI-induced inflammation, the gene expression of inflammatory mediators in both the lungs and liver is susceptible to ethanol-induced remote effects. Taken together, EI may alleviate the TBI-induced pro-inflammatory response in the trauma-distant organs, the lungs and liver, via the HMGB1-RAGE axis.	[Xu, Baolin; Powerski, Maciej; Nowak, Aleksander; Noack, Laurens; Omari, Jazan; Relja, Borna] Otto Von Guericke Univ, Dept Radiol & Nucl Med, Expt Radiol, D-39120 Magdeburg, Germany; [Chandrasekar, Akila; Heuvel, Florian Olde] Ulm Univ, Dept Neurol, D-89081 Ulm, Germany; [Huber-Lang, Markus] Ulm Univ, Univ Hosp Ulm, Inst Clin & Expt Trauma Immunol, D-89081 Ulm, Germany; [Roselli, Francesco] German Ctr Neurodegenerat Dis DZNE Ulm, D-89081 Ulm, Germany		Relja, B (corresponding author), Otto Von Guericke Univ, Dept Radiol & Nucl Med, Expt Radiol, D-39120 Magdeburg, Germany.	xubaolin325@outlook.com; a.chandrasekar@tu-braunschweig.de; florian.oldeheuvel@gmail.com; maciej.powerski@med.ovgu.de; Aleksander.nowak@med.ovgu.de; laurens.noack@st.ovgu.de; jazan.omari@med.ovgu.de; mshuberlang2000@aol.com; francesco.roselli@dzne.de; info@bornarelja.com	Relja, Borna/B-6642-2016; roselli, francesco/O-8847-2019	Relja, Borna/0000-0002-5625-8823; roselli, francesco/0000-0001-9935-6899	German Research FoundationGerman Research Foundation (DFG) [DFG RE 3304/8-1, 361210922/RTG 2408]; Radala Foundation; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)German Research Foundation (DFG) [251293561, 431995586 (RO-5004/8-1), 443642953 (RO5004/9-1)]; Cellular and MolecularMechanisms in Aging (CEMMA) Research Training Group; BMBFFederal Ministry of Education & Research (BMBF) [FKZ 01EW1705A]; Thierry Latran Foundation (project "Trials"); Thierry Latran Foundation (project "Hypothals")	The work was supported by grants from the German Research Foundation DFG RE 3304/8-1 and 361210922/RTG 2408. FR is supported by the Thierry Latran Foundation (projects "Trials" and "Hypothals"), by the Radala Foundation, by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Project ID 251293561, Collaborative Research Center (CRC) 1149, and with the individual grant no. 431995586 (RO-5004/8-1) and no. 443642953 (RO5004/9-1), by the Cellular and MolecularMechanisms in Aging (CEMMA) Research Training Group and by BMBF (FKZ 01EW1705A, as a member of the ERANET-NEURON consortium "MICRONET").	Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Arredouani M, 2003, IMMUNOLOGY, V108, P144, DOI 10.1046/j.1365-2567.2003.01569.x; Au AK, 2012, J NEUROTRAUM, V29, P2013, DOI 10.1089/neu.2011.2171; BEUTLER B, 1986, IMMUNOL RES, V5, P281, DOI 10.1007/BF02935501; Bouchard JC, 2012, AM J PATHOL, V181, P845, DOI 10.1016/j.ajpath.2012.05.020; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Chandrasekar A, 2017, INT IMMUNOPHARMACOL, V51, P66, DOI 10.1016/j.intimp.2017.08.002; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Ding QP, 2017, ALCOHOL CLIN EXP RES, V41, P1532, DOI 10.1111/acer.13436; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; El-Guindy NBD, 2007, ALCOHOL, V41, P335, DOI 10.1016/j.alcohol.2007.07.002; Fang WH, 2002, SHOCK, V17, P329, DOI 10.1097/00024382-200204000-00016; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gasparotto J, 2017, BRAIN BEHAV IMMUN, V62, P124, DOI 10.1016/j.bbi.2017.01.008; Ge XD, 2014, J BIOL CHEM, V289, P22672, DOI 10.1074/jbc.M114.552141; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Harris B, 2019, ALCOHOL, V80, P45, DOI 10.1016/j.alcohol.2018.09.008; Harris HE, 2004, EUR J IMMUNOL, V34, P1503, DOI 10.1002/eji.200424916; Heuvel FO, 2019, BRAIN BEHAV IMMUN, V81, P228, DOI 10.1016/j.bbi.2019.06.019; Hoyt LR, 2017, REDOX BIOL, V12, P883, DOI 10.1016/j.redox.2017.04.020; Hoyt LR, 2016, J IMMUNOL, V197, P1322, DOI 10.4049/jimmunol.1600406; Huber-Lang M, 2018, NAT IMMUNOL, V19, P327, DOI 10.1038/s41590-018-0064-8; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Kany S, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111981; Kerr NA, 2018, J NEUROTRAUM, V35, P2067, DOI 10.1089/neu.2017.5430; KHORUTS A, 1991, HEPATOLOGY, V13, P267, DOI 10.1016/0270-9139(91)92439-F; Kobbe P, 2009, CYTOKINE, V45, P26, DOI 10.1016/j.cyto.2008.10.004; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Lowe PP, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1328-9; McDonald SJ, 2020, J NEUROTRAUM, V37, P770, DOI 10.1089/neu.2019.6885; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Nicolls MR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010259; Nurmi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078537; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Pang MY, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-55; Parker TM, 2017, BRAIN INJURY, V31, P2, DOI 10.1080/02699052.2016.1217045; Paudel YN, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00628; Relja B, 2016, INJURY, V47, P640, DOI 10.1016/j.injury.2016.01.016; Relja B, 2012, BRIT J PHARMACOL, V165, P1188, DOI 10.1111/j.1476-5381.2011.01595.x; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Sears BW, 2011, J BONE JOINT SURG AM, V93A, P739, DOI 10.2106/JBJS.J.00318; SHANLEY TP, 1995, J IMMUNOL, V154, P3454; Shao XF, 2020, INT IMMUNOPHARMACOL, V79, DOI 10.1016/j.intimp.2019.106175; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Szabo G, 1996, ALCOHOL CLIN EXP RES, V20, P900, DOI 10.1111/j.1530-0277.1996.tb05269.x; Teng SX, 2015, BRAIN BEHAV IMMUN, V45, P145, DOI 10.1016/j.bbi.2014.11.006; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Wagner N, 2016, SHOCK, V46, P261, DOI 10.1097/SHK.0000000000000620; Weber DJ, 2015, ANTIOXID REDOX SIGN, V23, P1316, DOI 10.1089/ars.2015.6299; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang SG, 2013, J NEUROSCI RES, V91, P230, DOI 10.1002/jnr.23159; Zhou CZ, 2015, INT J CLIN EXP PATHO, V8, P15879; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275	62	1	1	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	NOV	2020	21	21							8181	10.3390/ijms21218181			14	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	OQ6VS	WOS:000588919000001	33142949	Green Published, gold			2022-02-06	
J	Yao, ZF; Sligte, IG; Moreau, D; Hsieh, SL; Yang, CT; Ridderinkhof, KR; Muggleton, NG; Wang, CH				Yao, Zai-Fu; Sligte, Ilja G.; Moreau, David; Hsieh, Shulan; Yang, Cheng-Ta; Ridderinkhof, K. Richard; Muggleton, Neil G.; Wang, Chun-Hao			The brains of elite soccer players are subject to experience-dependent alterations in white matter connectivity	CORTEX			English	Article						Corpus callosum; Soccer training; Diffusion MRI; Sports; Brain injury; White matter	CORPUS-CALLOSUM; TRACT ABNORMALITIES; SPORTS; TRACTOGRAPHY; DIFFUSIVITY; INJURY; DEMYELINATION; MODULATION; FOOTBALL; SYSTEM	Soccer is the only major sport with voluntary unprotected head-to-ball contact. It is crucial to determine if head impact through long-term soccer training is manifested in brain structure and connectivity, and whether such alterations are due to sustained training per se. Using diffusion tensor imaging, we documented a comprehensive view of soccer players' brains in a sample of twenty-five right-handed male elite soccer players aged from 18 to 22 years and twenty-five non-athletic controls aged 19-24 years. Importantly, none had recalled a history of concussion. We performed a whole-brain tract-based spatial statistical analysis, and a tract-specific probabilistic tractography method to measure the differences of white matter properties between groups. Whole-brain integrity analysis showed stronger microstructural integrity within the corpus callosum tract in soccer players compared to controls. Further, tract-specific probabilistic tractography revealed that the anterior part of corpus callosum may be the brain structure most relevant to training experience, which may put into perspective prior evidence showing corpus callosum alteration in retired or concussed athletes practicing contact sports. Intriguingly, experience-related alterations showed left hemispheric lateralization of potential early signs of concussion-like effects. In sum, we concluded that the observed gains and losses may be due to a consequence of engagement in protracted soccer training that incurs prognostic hallmarks associated with minor injury-induced neural inflammation. (C) 2020 Elsevier Ltd. All rights reserved.	[Yao, Zai-Fu; Sligte, Ilja G.; Ridderinkhof, K. Richard] Univ Amsterdam, Dept Psychol, Brain & Cognit, Amsterdam, Netherlands; [Sligte, Ilja G.; Ridderinkhof, K. Richard] Univ Amsterdam, Amsterdam Brain & Cognit, Amsterdam, Netherlands; [Moreau, David] Univ Auckland, Ctr Brain Res, Sch Psychol, Auckland, New Zealand; [Hsieh, Shulan] Natl Cheng Kung Univ, Dept Psychol, Cognit Electrophysiol Lab Control Aging Sleep & E, Tainan, Taiwan; [Hsieh, Shulan; Yang, Cheng-Ta] Natl Cheng Kung Univ, Inst Allied Hlth Sci, Tainan, Taiwan; [Hsieh, Shulan] Natl Cheng Kung Univ, Dept & Inst Publ Hlth, Tainan, Taiwan; [Hsieh, Shulan; Yang, Cheng-Ta] Natl Cheng Kung Univ, Dept Psychol, Tainan, Taiwan; [Muggleton, Neil G.] Natl Cent Univ, Inst Cognit Neurosci, Taoyuan, Taiwan; [Muggleton, Neil G.] UCL, Inst Cognit Neurosci, London, England; [Muggleton, Neil G.] Goldsmiths Univ London, Dept Psychol, London, England; [Wang, Chun-Hao] Natl Cheng Kung Univ, Inst Phys Educ Hlth & Leisure Studies, Taipei, Taiwan		Wang, CH (corresponding author), Natl Cheng Kung Univ, Inst Phys Educ Hlth & Leisure Studies, Lab Sport & Behav Neurosci, 1 Univ Rd, Taipei 701, Taiwan.	kesawloq@gmail.com	Yao, Zai-Fu/AAG-3463-2021	Yao, Zai-Fu/0000-0002-9823-9110	Ministry of Science and Technology (MOST) in TaiwanMinistry of Science and Technology, Taiwan	We thank The Mind Research and Imaging Center at National Cheng Kung University for consultation and instrument availability. The Mind Research and Imaging Center is supported by the Ministry of Science and Technology (MOST) in Taiwan.	Alba-Ferrara LM, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00009; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Allen B, 2017, NEUROLOGY, V88, pE74, DOI 10.1212/WNL.0000000000003669; Andersson J., 2007, SD; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Bastiani M, 2019, NEUROIMAGE, V184, P801, DOI 10.1016/j.neuroimage.2018.09.073; Baum GL, 2018, NEUROIMAGE, V173, P275, DOI 10.1016/j.neuroimage.2018.02.041; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Berman JI, 2013, AM J NEURORADIOL, V34, P1573, DOI 10.3174/ajnr.A3471; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Camargo AV, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01729; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; CHAPMAN LJ, 1987, BRAIN COGNITION, V6, P175, DOI 10.1016/0278-2626(87)90118-7; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Corballis MC, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001767; Cox SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13629; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; de Groot M, 2013, NEUROIMAGE, V76, P400, DOI 10.1016/j.neuroimage.2013.03.015; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Eickhoff SB, 2010, J NEUROSCI, V30, P6409, DOI 10.1523/JNEUROSCI.5664-09.2010; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Giza CC, 2017, NEURON, V94, P1051, DOI 10.1016/j.neuron.2017.05.003; Hsieh SL, 2020, PERS INDIV DIFFER, V153, DOI 10.1016/j.paid.2019.109673; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jbabdi S, 2012, MAGN RESON MED, V68, P1846, DOI 10.1002/mrm.24204; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jones DK, 2013, NEUROPSYCHOLOGIA, V51, P67, DOI 10.1016/j.neuropsychologia.2012.11.018; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Li XR, 2016, J NEUROSCI METH, V264, P47, DOI 10.1016/j.jneumeth.2016.03.001; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Ludyga S, 2020, NAT HUM BEHAV, V4, P603, DOI 10.1038/s41562-020-0851-8; Mark L. P., 1993, AJNR AM J NEURORADIO; Martin JH, 2005, NEUROSCIENTIST, V11, P161, DOI 10.1177/1073858404270843; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Miller KL, 2011, NEUROIMAGE, V57, P167, DOI 10.1016/j.neuroimage.2011.03.070; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; Paus T, 2016, HAND CLINIC, V138, P17, DOI 10.1016/B978-0-12-802973-2.00002-1; Ruffini F, 2004, AM J PATHOL, V164, P1519, DOI 10.1016/S0002-9440(10)63709-1; Sainburg RL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01092; Scholz J, 2014, DIFFUSION MRI, P301, DOI DOI 10.1016/B978-0-12-396460-1.00014-7; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stewart WF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00240; Strain JF, 2017, J NEUROTRAUM, V34, P372, DOI 10.1089/neu.2016.4446; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wang CH, 2020, NAT HUM BEHAV, V4, P565, DOI 10.1038/s41562-020-0856-3; Wang CH, 2020, NEUROSCIENCE, V425, P267, DOI 10.1016/j.neuroscience.2019.11.003; Wang CH, 2017, NEUROIMAGE, V158, P260, DOI 10.1016/j.neuroimage.2017.07.009; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Winklewski PJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00092; Wylie SA, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00049; Yeh FC, 2011, NEUROIMAGE, V58, P91, DOI 10.1016/j.neuroimage.2011.06.021; Yozbatiran Nuray, 2017, Spinal Cord Ser Cases, V3, P17028, DOI 10.1038/scsandc.2017.28	67	1	1	1	3	ELSEVIER MASSON, CORP OFF	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex	NOV	2020	132						79	91		10.1016/j.cortex.2020.07.016			13	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	OP4NP	WOS:000588059000007	32956909	Green Published			2022-02-06	
J	Zhao, HY; Jin, TR; Cheng, X; Qin, JB; Zhang, L; He, H; Xue, JH; Jin, GH				Zhao, Heyan; Jin, Tianren; Cheng, Xiang; Qin, Jianbing; Zhang, Lei; He, Hui; Xue, Jianhua; Jin, Guohua			GAS5 which is regulated by Lhx8 promotes the recovery of learning and memory in rats with cholinergic nerve injury	LIFE SCIENCES			English	Article						GAS5; Lhx8; Hippocampus; Neuron; Differentiation; ChAT	NONCODING RNA GAS5; NEURAL STEM-CELLS; DEAFFERENTED HIPPOCAMPUS; NEURONAL DIFFERENTIATION; MAMMALIAN TARGET; SPATIAL MEMORY; RAPAMYCIN MTOR; GROWTH-ARREST; IN-VITRO; NEUROGENESIS	Damage to the cholinergic system in central nervous system injuries such as traumatic brain injury (FBI) and neurodegenerative diseases leads to impaired learning and cognition. Neural stem cells (NSCs) have self-renewal capacity and multi-directional differentiation potential and considered the best source of cells for cell replacement therapy. However, how to promote the differentiation of NSCs into neurons is a major challenge in current research. Lhx8 has a specific effect on the development of the cholinergic nervous system, but its exact function is unclear. In this study, we found that Lhx8 could regulate the expression of Growth arrest-specific (GAS)5 which has been implicated in cancer but was less studied in the nervous system. Additionally, results from PCR, fluorescence in situ hybridization, and immunocytochemical analyses showed that GAS5 is mainly expressed in the cytoplasm of hippocampal neural stems cells and promotes their differentiation into neurons; the Morris water maze test demonstrated that GAS5 overexpression restored learning and memory in rats with cholinergic injury. These findings indicate that GAS5, which is regulated by Lhx8, improve brain function following cholinergic nerve injury.	[Zhao, Heyan; Jin, Tianren; Cheng, Xiang; Qin, Jianbing; Zhang, Lei; He, Hui; Jin, Guohua] Nantong Univ, Med Sch, Dept Human Anat, Jiangsu Key Lab Neuroregenerat, Nantong, Jiangsu, Peoples R China; [Xue, Jianhua] Nantong Univ, Affiliated Hosp, Dept Emergency Surg, Nantong, Peoples R China		Jin, GH (corresponding author), Nantong Univ, Med Sch, Dept Human Anat, Jiangsu Key Lab Neuroregenerat, Nantong, Jiangsu, Peoples R China.; Jin, GH (corresponding author), Nantong Univ, Med Sch, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.	jguohua@ntu.edu.cn			Nantong Science and Technology Project of China [JC2018064, JCZ19116]; Scientific Research Fund Project of Nantong University Xinglin College [2018K131, 2018K132]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX17-1931]; Undergraduate Innovation and entrepreneurship training project of Nantong University [2018150, 2020141]	This research was funded by grants from the Nantong Science and Technology Project of China (Nos. JC2018064, JCZ19116), Scientific Research Fund Project of Nantong University Xinglin College (Nos. 2018K131, 2018K132), Postgraduate Research & Practice Innovation Program of Jiangsu Province (No. KYCX17-1931), and Undergraduate Innovation and entrepreneurship training project of Nantong University (Nos. 2018150, 2020141). The authors would like to thank International Science Editing (http://www.internationalscienceediting.com) for editing this manuscript.	[Anonymous], 2007, RAT BRAIN STEREOTAXI; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; BARRANTES GE, 1994, BIOCHEM SOC T, V22, pS294, DOI 10.1042/bst022294s; Berg DK, 2002, J NEUROBIOL, V53, P512, DOI 10.1002/neu.10116; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Chen FH, 2018, BIOCHEM BIOPH RES CO, V496, P184, DOI 10.1016/j.bbrc.2018.01.022; DALRYMPLEALFORD JC, 1994, BRAIN RES, V661, P243, DOI 10.1016/0006-8993(94)91201-7; Deng BY, 2017, BMC MOL BIOL, V18, DOI 10.1186/s12867-017-0091-2; Dong CM, 2012, NEUROSCI LETT, V520, P26, DOI 10.1016/j.neulet.2012.05.016; Emsley JG, 2003, EXP NEUROL, V183, P298, DOI 10.1016/S0014-4886(03)00129-8; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garcia JM, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00386; HEFTI F, 1986, J NEUROSCI, V6, P2155; Hironaka N, 2001, BRAIN RES, V901, P143, DOI 10.1016/S0006-8993(01)02338-1; Hlinak Z, 2002, BEHAV BRAIN RES, V133, P395, DOI 10.1016/S0166-4328(02)00028-1; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; Ladak AA, 2019, WORLD NEUROSURG, V131, P126, DOI 10.1016/j.wneu.2019.07.039; Leung LS, 2011, EXP NEUROL, V228, P259, DOI 10.1016/j.expneurol.2011.01.019; Li Jian-Wei, 2013, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V29, P298; Li J, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0510-6; Liu Y, 2013, NAT BIOTECHNOL, V31, P440, DOI 10.1038/nbt.2565; Lu SN, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20180789; Manabe T, 2007, CELL DEATH DIFFER, V14, P1080, DOI 10.1038/sj.cdd.4402106; Manabe T, 2005, J NEUROCHEM, V94, P723, DOI 10.1111/j.1471-4159.2005.03261.x; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Mourtada-Maarabouni M, 2010, MOL PHARMACOL, V78, P19, DOI 10.1124/mol.110.064055; Palmer TD, 1999, J NEUROSCI, V19, P8487; Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002; PENFIELD W, 1958, ARCH NEURO PSYCHIATR, V79, P475, DOI 10.1001/archneurpsyc.1958.02340050003001; Perry DC, 2002, J NEUROCHEM, V82, P468, DOI 10.1046/j.1471-4159.2002.00951.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramirez JJ, 1996, P NATL ACAD SCI USA, V93, P15512, DOI 10.1073/pnas.93.26.15512; Rozental R, 2000, BRAIN RES REV, V32, P57, DOI 10.1016/S0165-0173(99)00096-X; Rudy J.W., 1999, BEHAV NEUROSCI, V113; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Shapiro M, 2001, ARCH NEUROL-CHICAGO, V58, P874, DOI 10.1001/archneur.58.6.874; Shi JH, 2012, IN VITRO CELL DEV-AN, V48, P603, DOI 10.1007/s11626-012-9562-4; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; STENVERS KL, 1994, J COMP NEUROL, V339, P91, DOI 10.1002/cne.903390109; Tomaszewicz M, 2003, J NEUROCHEM, V87, P318, DOI 10.1046/j.1471-4159.2003.01983.x; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Williams GT, 2011, BIOCHEM SOC T, V39, P482, DOI 10.1042/BST0390482; Xu HY, 2020, BIOL PSYCHIAT, V88, P758, DOI 10.1016/j.biopsych.2020.05.004; Yang P, 2008, J NEUROSCI, V28, P2231, DOI 10.1523/JNEUROSCI.3574-07.2008; Zhang XH, 2007, NEUROSCI LETT, V414, P115, DOI 10.1016/j.neulet.2006.07.078; Zhang XH, 2009, HIPPOCAMPUS, V19, P176, DOI 10.1002/hipo.20498; Zhao HY, 2019, NEURAL REGEN RES, V14, P2118, DOI 10.4103/1673-5374.262592; Zhao HY, 2011, NEUROSCI LETT, V498, P93, DOI 10.1016/j.neulet.2011.04.070; Zheng W, 2004, DEV NEUROSCI-BASEL, V26, P181, DOI 10.1159/000082136; Zhu PP, 2013, IN VITRO CELL DEV-AN, V49, P103, DOI 10.1007/s11626-013-9582-8; ZOLAMORGAN S, 1986, BEHAV NEUROSCI, V100, P155, DOI 10.1037/0735-7044.100.2.155; Zong YY, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181859; Zou LQ, 2010, INT J NEUROSCI, V120, P192, DOI 10.3109/00207450903464579	59	1	1	1	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	NOV 1	2020	260								118388	10.1016/j.lfs.2020.118388			9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	OH5FK	WOS:000582605800039	32890602				2022-02-06	
J	Karlsen, RH; Saksvik, SB; Stenberg, J; Lundervold, AJ; Olsen, A; Rautio, I; Folvik, L; Haberg, AK; Vik, A; Karr, JE; Iverson, GL; Skandsen, T				Karlsen, Rune Hatlestad; Saksvik, Simen Berg; Stenberg, Jonas; Lundervold, Astri Johansen; Olsen, Alexander; Rautio, Ida; Folvik, Line; Haberg, Asta Kristine; Vik, Anne; Karr, Justin E.; Iverson, Grant L.; Skandsen, Toril			Examining the Subacute Effects of Mild Traumatic Brain Injury Using a Traditional and Computerized Neuropsychological Test Battery	JOURNAL OF NEUROTRAUMA			English	Article						brain concussion; cognition; neuropsychology	SPORTS-RELATED CONCUSSION; COGNITIVE IMPAIRMENT; CENTER-TBI; HEAD; OUTCOMES; METAANALYSES; PERFORMANCE; EDUCATION; DEFICITS; IMPACT	This study investigates subacute cognitive effects of mild traumatic brain injury (MTBI) in the Trondheim Mild TBI Study, as measured, in part, by the neuropsychological test battery of the Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) program, including computerized tests from the Cambridge Neuropsychological Test Automated Battery (CANTAB) and traditional paper-and-pencil tests. We investigated whether cognitive function was associated with injury severity: intracranial traumatic lesions on neuroimaging, witnessed loss of consciousness (LOC), or post-traumatic amnesia (PTA) >1 h. Further, we explored which of the tests in the CENTER-TBI battery might be associated with the largest subacute effects of MTBI (i.e., at 2 weeks post-injury). We recruited 177 patients with MTBI (16-59 years of age) from a regional trauma center and an outpatient clinic,79 trauma control participants, and 81 community control participants. The MTBI group differed from community controls only on one traditional test of processing speed (coding; p = 0.009, Cliff's delta [Delta] = 0.20). Patients with intracranial abnormalities performed worse than those without on a traditional test (phonemic verbal fluency; p = 0.043, Delta = 0.27), and patients with LOC performed differently on the Attention Switching Task from the CANTAB (p = 0.020, Delta = -0.20). Patients with PTA >1 h performed worse than those with <1 h on 10 measures, from traditional tests and the CANTAB (Delta = 0.33-0.20), likely attributable, at least in part, to pre-existing differences in intellectual functioning between groups. In general, those with MTBI had good neuropsychological outcome 2 weeks after injury and no particular CENTER-TBI computerized or traditional tests seemed to be more sensitive to subtle cognitive deficits.	[Karlsen, Rune Hatlestad; Stenberg, Jonas; Haberg, Asta Kristine; Vik, Anne; Skandsen, Toril] Norwegian Univ Sci & Technol, NTNU, Dept Neuromed & Movement Sci, Fac Med & Hlth Sci, N-7491 Trondheim, Norway; [Saksvik, Simen Berg; Olsen, Alexander; Rautio, Ida; Folvik, Line] Norwegian Univ Sci & Technol, NTNU, Dept Psychol, Fac Social & Educ Sci, Trondheim, Norway; [Saksvik, Simen Berg; Olsen, Alexander; Skandsen, Toril] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Haberg, Asta Kristine; Vik, Anne] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Lundervold, Astri Johansen] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Karr, Justin E.; Iverson, Grant L.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Karr, Justin E.; Iverson, Grant L.] Red Sox Fdn, Spaulding Res Inst, Home Base Program, Charlestown, MA USA; [Karr, Justin E.; Iverson, Grant L.] Massachusetts Gen Hosp, Charlestown, MA USA		Skandsen, T (corresponding author), Norwegian Univ Sci & Technol, NTNU, Dept Neuromed & Movement Sci, Fac Med & Hlth Sci, N-7491 Trondheim, Norway.	toril.skandsen@ntnu.no	Stenberg, Jonas/AAN-4552-2021	Stenberg, Jonas/0000-0002-5769-7959	Central Norway Regional Health Authority; Norwegian University of Science and Technology	This work was supported by the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology.	Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Barnett JH, 2016, CURR TOP BEHAV NEURO, V28, P449, DOI 10.1007/7854_2015_5001; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Burton Adrian, 2017, Lancet Neurol, V16, P958, DOI 10.1016/S1474-4422(17)30358-7; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chaban V, 2020, J NEUROTRAUM, V37, P2120, DOI 10.1089/neu.2019.6963; Cardoso MGD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00198; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P81, DOI 10.1017/S1355617713001288; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Einarsen CE, 2019, J NEUROTRAUM, V36, P3172, DOI 10.1089/neu.2018.6360; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Fowler KS, 2002, J INT NEUROPSYCH SOC, V8, P58, DOI 10.1017/S1355617701020069; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Iverson GL, 2000, ARCH CLIN NEUROPSYCH, V15, P643, DOI 10.1016/S0887-6177(99)00048-7; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Juncos-Rabadan O, 2014, INT J GERIATR PSYCH, V29, P602, DOI 10.1002/gps.4042; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lees J, 2017, PSYCHOL MED, V47, P2358, DOI 10.1017/S0033291717000885; Levi Y, 2013, J INT NEUROPSYCH SOC, V19, P664, DOI 10.1017/S1355617713000192; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2015, HUM BRAIN MAPP, V36, P4394, DOI 10.1002/hbm.22930; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Nelson LD, 2017, J INT NEUROPSYCH SOC, V23, P293, DOI 10.1017/S1355617717000157; Pearce AJ, 2018, BRAIN INJURY, V32, P498, DOI 10.1080/02699052.2018.1430376; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; QUADE D, 1967, J AM STAT ASSOC, V62, P1187, DOI 10.2307/2283769; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Schmidt M., 1996, REY AUDITORY VERBAL; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Stenberg J, 2020, ARCH PHYS MED REHAB, V101, P72, DOI 10.1016/j.apmr.2019.08.477; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stulemeijer M, 2010, J NEUROTRAUM, V27, P1585, DOI 10.1089/neu.2010.1298; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Vargha A, 2000, J EDUC BEHAV STAT, V25, P101, DOI 10.3102/10769986025002101; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Weschler D, 2008, WECHSLER ADULT INTEL; Weschler D., 2007, WECHSLER ABBREVIATED; Weschler D., 1999, WECHLSER ABBREVIATED; Weschler D, 2011, WECHSLER ADULT INTEL; Wheble JLC, 2016, J ROY ARMY MED CORPS, V162, P87, DOI 10.1136/jramc-2015-000472; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391	67	1	1	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2021	38	1					74	85		10.1089/neu.2019.6922		OCT 2020	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PN6IA	WOS:000586282700001	32948095	hybrid			2022-02-06	
J	Whiting, MD; Dengler, BA; Rodriguez, CL; Blodgett, D; Cohen, AB; Januszkiewicz, AJ; Rasmussen, TE; Brody, DL				Whiting, Mark D.; Dengler, Bradley A.; Rodriguez, Carissa L.; Blodgett, David; Cohen, Adam B.; Januszkiewicz, Adolph J.; Rasmussen, Todd E.; Brody, David L.			Prehospital Detection of Life-Threatening Intracranial Pathology: An Unmet Need for Severe TBI in Austere, Rural, and Remote Areas	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; ultrasound; near infrared spectroscopy; prehospital care; rural medicine	TRAUMATIC BRAIN-INJURY; NEAR-INFRARED SPECTROSCOPY; ACUTE SUBDURAL-HEMATOMA; NERVE SHEATH DIAMETER; TRANSCRANIAL DOPPLER; CEREBRAL AUTOREGULATION; NEUROCRITICAL CARE; PULSATILITY INDEX; PRESSURE; MANAGEMENT	Severe traumatic brain injury (TBI) is a leading cause of death and disability worldwide, especially in low- and middle-income countries, and in austere, rural, and remote settings. The purpose of this Perspective is to challenge the notion that accurate and actionable diagnosis of the most severe brain injuries should be limited to physicians and other highly-trained specialists located at hospitals. Further, we aim to demonstrate that the great opportunity to improve severe TBI care is in the prehospital setting. Here, we discuss potential applications of prehospital diagnostics, including ultrasound and near-infrared spectroscopy (NIRS) for detection of life-threatening subdural and epidural hemorrhage, as well as monitoring of cerebral hemodynamics following severe TBI. Ultrasound-based methods for assessment of cerebrovascular hemodynamics, vasospasm, and intracranial pressure have substantial promise, but have been mainly used in hospital settings; substantial development will be required for prehospital optimization. Compared to ultrasound, NIRS is better suited to assess certain aspects of intracranial pathology and has a smaller form factor. Thus, NIRS is potentially closer to becoming a reliable method for non-invasive intracranial assessment and cerebral monitoring in the prehospital setting. While one current continuous wave NIRS-based device has been FDA-approved for detection of subdural and epidural hemorrhage, NIRS methods using frequency domain technology have greater potential to improve diagnosis and monitoring in the prehospital setting. In addition to better technology, advances in large animal models, provider training, and implementation science represent opportunities to accelerate progress in prehospital care for severe TBI in austere, rural, and remote areas.	[Whiting, Mark D.; Rasmussen, Todd E.; Brody, David L.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Whiting, Mark D.; Rasmussen, Todd E.; Brody, David L.] NIH, Bldg 10, Bethesda, MD 20892 USA; [Whiting, Mark D.] Carle Fdn Hosp, Stephens Family Clin Res Inst, Urbana, IL USA; [Dengler, Bradley A.] Walter Reed Natl Mil Med Ctr, Dept Neurosurg, Bethesda, MD USA; [Rodriguez, Carissa L.; Blodgett, David; Cohen, Adam B.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA; [Cohen, Adam B.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Januszkiewicz, Adolph J.] Knowesis Inc, Gunpowder, MD USA; [Rasmussen, Todd E.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Brody, David L.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Brody, David L.] NINDS, Lab Funct & Mol Imaging, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA		Brody, DL (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA.; Brody, DL (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.; Brody, DL (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA.; Brody, DL (corresponding author), NINDS, Lab Funct & Mol Imaging, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	david.brody@usuhs.edu	Dengler, Bradley/AAN-7688-2021				Al-Mufti F, 2017, NEUROSURG CLIN N AM, V28, P267, DOI 10.1016/j.nec.2016.11.009; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Armstead WM, 2019, EXP NEUROL, V317, P291, DOI 10.1016/j.expneurol.2019.03.015; Armstead WM, 2020, J NEUROTRAUM, V37, P2372, DOI 10.1089/neu.2018.6119; Ayaz H, 2019, J BIOMED OPT, V24, DOI 10.1117/1.JBO.24.5.051411; Bellapart J, 2009, ULTRASOUND MED BIOL, V35, P883, DOI 10.1016/j.ultrasmedbio.2009.01.005; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Bossers SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141034; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P153, DOI 10.1097/MCC.0000000000000071; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Brogan RJ, 2017, BRAIN INJURY, V31, P581, DOI 10.1080/02699052.2017.1287956; Budohoski KP, 2012, NEUROCRIT CARE, V17, P211, DOI 10.1007/s12028-011-9572-1; Calviello LA, 2017, MINERVA ANESTESIOL, V83, P844, DOI 10.23736/S0375-9393.17.12043-2; Carlson, 2015, INJ EPIDEMIOL, V2, P32, DOI DOI 10.1186/s40621-015-0063-2; Chen SH, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01810-4; Crandall M, 2013, AM J PUBLIC HEALTH, V103, P1103, DOI 10.2105/AJPH.2013.301223; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; DeSoucy, 2017, J SPEC OPER MED, V17, P121; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Fandre M, 2020, MIL REV, P37; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; FierceBiotech, 2020, DOD AW NEUR AN 10000; Figaji AA, 2009, SURG NEUROL, V72, P389, DOI 10.1016/j.surneu.2009.02.012; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Gramer R, 2019, AANS ANN SCI M SAN D; Haltmeier T, 2017, EUR J TRAUMA EMERG S, V43, P731, DOI 10.1007/s00068-016-0718-x; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; Hawrysz DJ, 2000, NEOPLASIA, V2, P388, DOI 10.1038/sj.neo.7900118; Istfan R, 2019, PROC SPIE, V10874, DOI 10.1117/12.2509885; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kalanuria A, 2013, NEUROSURG CLIN N AM, V24, P441, DOI 10.1016/j.nec.2013.02.005; Keenan S, 2017, WILD ENVIRON MED, V28, pS135, DOI 10.1016/j.wem.2017.02.001; Kim SC, 2015, CLIN EXP EMERG MED, V2, P51, DOI 10.15441/ceem.14.023; Kinder HA, 2019, NEURAL REGEN RES, V14, P413, DOI 10.4103/1673-5374.245334; Kitsmiller VJ, 2019, PROC SPIE, V10874, DOI 10.1117/12.2508911; Knudson MM, 2008, J TRAUMA, V64, P255, DOI 10.1097/TA.0b013e31816275b0; Kramer DR, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/415813; Krauss S, 2020, MIL MED, V185, pE1787, DOI 10.1093/milmed/usaa069; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Leon-Carrion J, 2010, BRAIN INJURY, V24, P1193, DOI 10.3109/02699052.2010.506636; Liang CY, 2018, MIL MED, V183, pE318, DOI 10.1093/milmed/usx088; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Maissan IM, 2015, J NEUROSURG, V123, P743, DOI 10.3171/2014.10.JNS141197; Meairs S, 2015, FRONT NEUROL NEUROSC, V36, P57, DOI 10.1159/000366237; Meissner A, 2011, EUR SURG RES, V47, P141, DOI 10.1159/000330756; Moreno J, 2000, NEUROSURG FOCUS, V8, P1; Moretti R, 2009, NEUROCRIT CARE, V11, P406, DOI 10.1007/s12028-009-9250-8; O'Brien NF, 2015, J NEUROSURG-PEDIATR, V16, P420, DOI 10.3171/2015.3.PEDS14521; Panerai RB, 2009, CLIN AUTON RES, V19, P197, DOI 10.1007/s10286-009-0011-8; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pelekanos M, 2018, THERANOSTICS, V8, P2583, DOI 10.7150/thno.22852; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Peters J, 2017, PREHOSP DISASTER MED, V32, P414, DOI 10.1017/S1049023X17006367; PHAN TG, 2019, FRONT NEUROL, V0010; Potgieter DW, 2011, ANAESTH INTENS CARE, V39, P95, DOI 10.1177/0310057X1103900116; Preiksaitis A, 2016, NEUROSURGERY, V79, P75, DOI 10.1227/NEU.0000000000001192; Raffiz M, 2017, AM J EMERG MED, V35, P150, DOI 10.1016/j.ajem.2016.09.044; Ragauskas A, 2014, NEUROL RES, V36, P607, DOI 10.1179/1743132813Y.0000000308; Rasulo FA, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1632-2; Razumovsky A, 2013, ACTA NEUROCHIR SUPPL, V115, P87, DOI 10.1007/978-3-7091-1192-5_19; Robertson C S, 1997, J Biomed Opt, V2, P31, DOI 10.1117/12.261680; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Samuelsson T, 2013, J CONTEMP ETHNOGR, V42, P722, DOI 10.1177/0891241613488941; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Shin SS, 2018, J ULTRAS MED, V37, P1857, DOI 10.1002/jum.14547; Smith RM, 2009, INJURY, V40, pS23, DOI 10.1016/j.injury.2009.10.033; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Stein DM, 2011, J TRAUMA, V70, P1096, DOI 10.1097/TA.0b013e318216930d; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Strumwasser A, 2011, J SURG RES, V170, P265, DOI 10.1016/j.jss.2011.03.009; Tazarourte K, 2011, ACTA ANAESTH SCAND, V55, P422, DOI 10.1111/j.1399-6576.2010.02372.x; Timaru-Kast R, 2008, J NEUROTRAUM, V25, P1107, DOI 10.1089/neu.2008.0517; Tromberg BJ, 2000, NEOPLASIA, V2, P26, DOI 10.1038/sj.neo.7900082; Melo JRT, 2011, CHILD NERV SYST, V27, P979, DOI 10.1007/s00381-010-1367-8; Van Dillen CM, 2016, EMERG MED INT, V2016, DOI 10.1155/2016/5437490; van Santbrink H, 2002, ACTA NEUROCHIR, V144, P1141, DOI 10.1007/s00701-002-1012-8; von Wyl T, 2009, ACTA ANAESTH SCAND, V53, P121, DOI 10.1111/j.1399-6576.2008.01797.x; Voulgaris SG, 2005, MED SCI MONITOR, V11, pCR49; Xu L, 2017, J CLIN NEUROSCI, V40, P136, DOI 10.1016/j.jocn.2017.02.056; Xu ZNS, 2014, J ULTRAS MED, V33, P1763, DOI 10.7863/ultra.33.10.1763; Yilmaz I, 2019, ULUS TRAVMA ACIL CER, V25, P147, DOI 10.5505/tjtes.2018.48079; YOUNG HA, 1984, NEUROSURGERY, V14, P22, DOI 10.1227/00006123-198401000-00006; Yousefi A, 2009, IEEE T MED IMAGING, V28, P763, DOI 10.1109/TMI.2008.2012017	92	1	1	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 30	2020	11								599268	10.3389/fneur.2020.599268			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OQ4QY	WOS:000588771200001	33193067	Green Published, gold			2022-02-06	
J	Lambride, C; Christodoulou, N; Michail, A; Vavourakis, V; Stylianopoulos, T				Lambride, Chryso; Christodoulou, Nicolas; Michail, Anna; Vavourakis, Vasileios; Stylianopoulos, Triantafyllos			Decompressive craniectomy of post-traumatic brain injury: an in silico modelling approach for intracranial hypertension management	SCIENTIFIC REPORTS			English	Article							BIOMECHANICS; MECHANICS; PRESSURE; TISSUE; ICP	Traumatic brain injury (TBI) causes brain edema that induces increased intracranial pressure and decreased cerebral perfusion. Decompressive craniectomy has been recommended as a surgical procedure for the management of swollen brain and intracranial hypertension. Proper location and size of a decompressive craniectomy, however, remain controversial and no clinical guidelines are available. Mathematical and computational (in silico) models can predict the optimum geometric conditions and provide insights for the brain mechanical response following a decompressive craniectomy. In this work, we present a finite element model of post-traumatic brain injury and decompressive craniectomy that incorporates a biphasic, nonlinear biomechanical model of the brain. A homogenous pressure is applied in the brain to represent the intracranial pressure loading caused by the tissue swelling and the models calculate the deformations and stresses in the brain as well as the herniated volume of the brain tissue that exits the skull following craniectomy. Simulations for different craniectomy geometries (unilateral, bifrontal and bifrontal with midline bar) and sizes are employed to identify optimal clinical conditions of decompressive craniectomy. The reported results for the herniated volume of the brain tissue as a function of the intracranial pressure loading under a specific geometry and size of craniectomy are exceptionally relevant for decompressive craniectomy planning.	[Lambride, Chryso; Christodoulou, Nicolas; Michail, Anna; Vavourakis, Vasileios; Stylianopoulos, Triantafyllos] Univ Cyprus, Dept Mech & Mfg Engn, CY-1678 Nicosia, Cyprus; [Vavourakis, Vasileios] UCL, Dept Med Phys & Biomed Engn, London WC1E 6BT, England		Vavourakis, V; Stylianopoulos, T (corresponding author), Univ Cyprus, Dept Mech & Mfg Engn, CY-1678 Nicosia, Cyprus.	vasvav@ucy.ac.cy; tstylian@ucy.ac.cy		Vavourakis, Vasileios/0000-0002-4102-2084			Abode-Iyamah KO, 2018, WORLD NEUROSURG, V118, pE414, DOI 10.1016/j.wneu.2018.06.204; Alvis-Miranda Hernando, 2013, Bull Emerg Trauma, V1, P60; Angeli S, 2018, NEUROIMAGE-CLIN, V20, P664, DOI 10.1016/j.nicl.2018.08.032; Angeli S, 2017, J BIOMECH, V56, P42, DOI 10.1016/j.jbiomech.2017.02.028; Angeli S, 2016, J BIOMECH, V49, P1524, DOI 10.1016/j.jbiomech.2016.03.029; BASSER PJ, 1992, MICROVASC RES, V44, P143, DOI 10.1016/0026-2862(92)90077-3; Clatz O, 2005, IEEE T MED IMAGING, V24, P1334, DOI 10.1109/TMI.2005.857217; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; El Sayed T, 2008, J BIOMECH, V41, P1458, DOI 10.1016/j.jbiomech.2008.02.023; Fletcher TL, 2016, ANN BIOMED ENG, V44, P3495, DOI 10.1007/s10439-016-1666-7; Gao CP, 2008, ACTA NEUROCHIR SUPPL, V102, P279, DOI 10.1007/978-3-211-85578-2_52; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Jones H.R., 2013, NETTER COLLECTION 1, V2nd; Kaczmarek M, 1997, B MATH BIOL, V59, P295; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Li XG, 2013, COMPUT METHOD BIOMEC, V16, P1330, DOI 10.1080/10255842.2012.670853; Lilja-Cyron A, 2020, NEUROSURGERY, V86, P231, DOI 10.1093/neuros/nyz049; Lubarda VA, 2002, INT J SOLIDS STRUCT, V39, P4627, DOI 10.1016/S0020-7683(02)00352-9; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Saboori P, 2019, ANN BIOMED ENG, V47, P1982, DOI 10.1007/s10439-019-02199-z; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; von Holst H, 2014, ACTA NEUROCHIR, V156, P1961, DOI 10.1007/s00701-014-2195-5; von Holst H, 2012, ACTA NEUROCHIR, V154, P1583, DOI 10.1007/s00701-012-1393-2; Weickenmeier J, 2017, J ELASTICITY, V129, P197, DOI 10.1007/s10659-016-9606-1; Weickenmeier J, 2017, COMPUT METHOD APPL M, V314, P180, DOI 10.1016/j.cma.2016.08.011; Wittek A, 2019, BIOL MED PHYS BIOMED, P243, DOI 10.1007/978-3-030-04996-6_10	28	1	1	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	OCT 29	2020	10	1							18673	10.1038/s41598-020-75479-7			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OO9KN	WOS:000587692300070	33122800	Green Published, gold			2022-02-06	
J	Li, XX; Tan, XF; Wang, PY; Hu, XH; Dong, Y; Zhang, XT; Luo, BY				Li, Xiaoxia; Tan, Xufei; Wang, Pinyi; Hu, Xiaohua; Dong, Yan; Zhang, Xiaotong; Luo, Benyan			Chronic disorders of consciousness: a case report with longitudinal evaluation of disease progression using 7T magnetic resonance imaging	BMC NEUROLOGY			English	Article						Arcuate fasciculus; Connectome; Diffusion; Disorders of consciousness; Severe brain injury; Superior longitudinal fasciculus; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; WHITE-MATTER; DIFFUSION; RECOVERY; CONNECTOMETRY; CONNECTIVITY; TRACTOGRAPHY; FASCICULUS; NETWORKS; PATHWAYS	BackgroundOutcome prediction for patients with disorders of consciousness (DOC) is essential yet challenging. Evidence showed that patients with DOC lasting 1year or longer after a brain injury were less likely to recover. However, the reasons why outcomes of DOC patients differ greatly remain unclear. With a variety of analytical methods and through quantitative behavioral assessments, we aimed to track the progression of a patient with severe brain injury, in order to advance our understanding of the underlying mechanisms of DOC.Case presentationWe performed a longitudinal study for a 52-year-old male DOC patient who has remained in the state for 1.5years with comprehensive rehabilitative therapies. The patient underwent 3 times of assessments of Coma Recovery Scale-Revised (CRS-R) and ultra-high-field 7T magnetic resonance imaging (MRI). Both topologic properties and brain microstructure were analyzed to track disease progression. We observed dynamic increases of fiber densities with measurements at three time points (t1:1.5M, t2:7.5Mt3:17.5M). Specifically, fiber densities of the superior longitudinal fasciculus and arcuate fasciculus nerve fiber bundles improved mostly in the visual, verbal, and auditory subscales, which was consistent with the CRS-R scores. Moreover, the graph-theory analyses demonstrated that network topologic properties showed an improvement although the disease duration exceeded 1year.ConclusionsDOC patients with a course longer than 1year remain possible to improve, and including evaluation methods such as WM connectome analysis and graph theory could be potentially valuable for a more precise assessment of patients with a longer course of DOC.	[Li, Xiaoxia; Luo, Benyan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurol, Qingchun Rd, Hangzhou 310003, Peoples R China; [Li, Xiaoxia; Luo, Benyan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Brain Med Ctr, Qingchun Rd, Hangzhou 310003, Peoples R China; [Tan, Xufei] Zhejiang Univ City Coll, Sch Med, Dept Clin Med, Hangzhou, Peoples R China; [Wang, Pinyi; Zhang, Xiaotong] Zhejiang Univ, Interdisciplinary Inst Neurosci & Technol, Key Lab Biomed Engn, Minist Educ, Hangzhou, Peoples R China; [Hu, Xiaohua; Dong, Yan] Hangzhou Hosp Zhejiang CAPR, Dept Rehabil, Hangzhou, Peoples R China; [Zhang, Xiaotong] Zhejiang Univ, Sch Med, Hangzhou, Peoples R China		Luo, BY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurol, Qingchun Rd, Hangzhou 310003, Peoples R China.; Luo, BY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Brain Med Ctr, Qingchun Rd, Hangzhou 310003, Peoples R China.; Zhang, XT (corresponding author), Zhejiang Univ, Interdisciplinary Inst Neurosci & Technol, Key Lab Biomed Engn, Minist Educ, Hangzhou, Peoples R China.; Zhang, XT (corresponding author), Zhejiang Univ, Sch Med, Hangzhou, Peoples R China.	zhangxiaotong@zju.edu.cn; luobenyan@zju.edu.cn			National Key Research and Development Program of China [2018YFA0701400]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81870817, 81701774, 61771423]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2019-XZZX-001-01-02]; Key-Area Research and Development Program of Guangdong Province [2018B030333001]; Zhejiang Lab [2018EB0ZX01]	This work was supported in part by National Key Research and Development Program of China (2018YFA0701400), National Natural Science Foundation of China (81870817, 81701774, 61771423), Fundamental Research Funds for the Central Universities (2019-XZZX-001-01-02), Zhejiang Lab (2018EB0ZX01), and Key-Area Research and Development Program of Guangdong Province (2018B030333001). The funder had no role in study design, collection and analysis of the data, or preparation of the manuscript.	Ameis SH, 2013, ACTA NEUROPSYCHIATR, V25, P275, DOI 10.1017/neu.2013.2; Anderson JM, 1999, BRAIN LANG, V70, P1, DOI 10.1006/brln.1999.2135; Bucci W, 2002, PSYCHOANAL INQ, V22, P766, DOI 10.1080/07351692209349017; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chang MC, 2010, NEUROREHABILITATION, V26, P347, DOI 10.3233/NRE-2010-0572; Chechlacz M, 2015, J NEUROSCI, V35, P10647, DOI 10.1523/JNEUROSCI.0210-15.2015; Clark A, 2007, J MED PHILOS, V32, P263, DOI 10.1080/03605310701397024; Delaparte L, 2017, J PSYCHIATR RES, V89, P38, DOI 10.1016/j.jpsychires.2017.01.012; Edlow BL, 2013, NEUROCRIT CARE, V19, P364, DOI 10.1007/s12028-013-9870-x; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gu S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9414; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Thierry AGM, 2006, EUR RADIOL, V16, P1651, DOI 10.1007/s00330-006-0175-8; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; JENNETT B, 1975, LANCET, V1, P480; Kamali A, 2014, BRAIN STRUCT FUNCT, V219, P269, DOI 10.1007/s00429-012-0498-y; Kamali A, 2010, J NEUROSCI METH, V191, P249, DOI 10.1016/j.jneumeth.2010.06.026; Laureys S, 2006, J CLIN INVEST, V116, P1823, DOI 10.1172/JCI29172; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; McQuillen PS, 2003, J NEUROSCI, V23, P3308; Mennin D., 2009, EMOTION REGUL PSYCHO, P356; Olvet DM, 2016, DEPRESS ANXIETY, V33, P56, DOI 10.1002/da.22445; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Thengone DJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6113; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Williams S, 2001, ACTA NEUROPATHOL, V102, P581, DOI 10.1007/s004010100410; Yeh FC, 2016, NEUROIMAGE, V125, P162, DOI 10.1016/j.neuroimage.2015.10.053; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Yeh FC, 2013, NEUROIMAGE-CLIN, V2, P912, DOI 10.1016/j.nicl.2013.06.014	41	1	2	1	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	OCT 29	2020	20	1							396	10.1186/s12883-020-01973-0			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OS3NH	WOS:000590071500003	33121453	gold, Green Published			2022-02-06	
J	Rossato, E; Verzini, E; Scandola, M; Ferrari, F; Bonadiman, S				Rossato, Elena; Verzini, Elisabetta; Scandola, Michele; Ferrari, Federico; Bonadiman, Silvia			Role of LCF scale as an outcome prognostic index in patients with traumatic brain injury	NEUROLOGICAL SCIENCES			English	Article						Traumatic brain injury; Outcome scale; Level of cognitive functioning; Rehabilitation; Prognosis	DISABILITY RATING-SCALE; SEVERE HEAD-INJURY; COGNITIVE RESERVE; FUNCTIONAL OUTCOMES; REHABILITATION; RELIABILITY; RECOVERY; MODERATE; LIFE	The disabling effects of traumatic brain injuries (TBI) present a significant healthcare concern to developed countries. In order to achieve a reliable prognosis, validated assessment scales are used to monitor the cognitive outcome, like the Level of Cognitive Functioning Scale, or the overall functional outcome, namely the Functional Independence Measure and Glasgow Outcome Scale. The aim of our study was to evaluate the role of Level of Cognitive Functioning Scale (LCF) as an outcome prognostic index in patients with TBI. Materials and methods Fifty-four patients with TBI with a mean age of 44.9 years (SD 20.915) were enrolled in this retrospective study. Patients were evaluated at admission and at discharge using the Glasgow Outcome Scale, Functional Independence Measure, and Level of Cognitive Functioning Scale. The Glasgow Outcome Scale was also implemented at 6 months after discharge (OUTCOME.GOS), whereas the LCF was used twice a week throughout hospitalization. For our purpose, we named LCF at admission LCFa, whereas permanence in the same LCF value (number of days), LCFaL. Results Delta.GOS, Delta.FIM (Delta = difference between value at discharge and at admission), and OUTCOME.GOS were significantly affected by age, length of stay, LCFa, and LCFaL. Conclusion The LCF can give a valuable indication to the prognosis of patients with TBI besides monitoring changes in cognitive function. This allows for individual rehabilitation plan, and long-term management strategies could be developed more quickly upon patient's discharge. Consequently, valuable healthcare and social care resources could be assigned correctly.	[Rossato, Elena; Verzini, Elisabetta; Ferrari, Federico; Bonadiman, Silvia] IRCCS Sacro Cuore Don Calabria, Dept Rehabil Med, Via Don A Sempreboni 5, Negrar, VR, Italy; [Scandola, Michele] Univ Verona, Dept Human Sci, Verona, Italy		Rossato, E (corresponding author), IRCCS Sacro Cuore Don Calabria, Dept Rehabil Med, Via Don A Sempreboni 5, Negrar, VR, Italy.	elena.rossato@sacrocuore.it	Scandola, Michele/D-8107-2013	Scandola, Michele/0000-0003-0853-8975; rossato, elena/0000-0003-3078-8591			Al-Hassani A, 2018, J EMERG TRAUMA SHOCK, V11, P197, DOI 10.4103/JETS.JETS_6_18; Avesani R, 2011, EUR J PHYS REHAB MED, V47, P203; Baum J, 2016, WORLD NEUROSURG, V90, P525, DOI 10.1016/j.wneu.2015.12.012; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Conferenza Nazionale di Consenso, 2000, MOD TRATT RIAB TRAUM; Fortune DG, 2016, INT J REHABIL RES, V39, P234, DOI 10.1097/MRR.0000000000000175; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Hagen C, 1979, REHABILITATION HEAD; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Haller CS, 2017, BRAIN INJURY, V31, P1903, DOI 10.1080/02699052.2017.1346295; Handel SF, 2007, PSYCHOSOMATICS, V48, P67, DOI 10.1176/appi.psy.48.1.67; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Mehta R, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1296; Miles J., 2001, APPL REGRESSION CORR; Ludin SM, 2020, CLIN NURS RES, V29, P433, DOI 10.1177/1054773818792459; Nunnari D, 2014, NEUROL SCI, V35, P1513, DOI 10.1007/s10072-014-1897-z; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; R Core Team, 2021, R LANG ENV STAT COMP; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Roe CM, 2008, ARCH NEUROL-CHICAGO, V65, P1467, DOI 10.1001/archneur.65.11.1467; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x	28	1	1	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	JUL	2021	42	7					2747	2752		10.1007/s10072-020-04852-1		OCT 2020	6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TG4JV	WOS:000585045200002	33123923				2022-02-06	
J	Lei, K; Kunnel, A; Metzger-Smith, V; Golshan, S; Javors, J; Wei, JN; Lee, R; Vaninetti, M; Rutledge, T; Leung, A				Lei, Karen; Kunnel, Alphonsa; Metzger-Smith, Valerie; Golshan, Shahrokh; Javors, Jennifer; Wei, Jennie; Lee, Roland; Vaninetti, Michael; Rutledge, Thomas; Leung, Albert			Diminished corticomotor excitability in Gulf War Illness related chronic pain symptoms; evidence from TMS study	SCIENTIFIC REPORTS			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; TRAUMATIC BRAIN-INJURY; WHITE-MATTER LESIONS; CORTICAL EXCITABILITY; MOTOR CORTEX; DAILY SESSIONS; ACUTE STAGE; VETERANS; RTMS; PREVALENCE	Chronic diffuse body pain is unequivocally highly prevalent in Veterans who served in the 1990-91 Persian Gulf War and diagnosed with Gulf War Illness (GWI). Diminished motor cortical excitability, as a measurement of increased resting motor threshold (RMT) with transcranial magnetic stimulation (TMS), is known to be associated with chronic pain conditions. This study compared RMT in Veterans with GWI related diffuse body pain including headache, muscle and joint pain with their military counterparts without GWI related diffuse body pain. Single pulse TMS was administered over the left motor cortex, using anatomical scans of each subject to guide the TMS coil, starting at 25% of maximum stimulator output (MSO) and increasing in steps of 2% until a motor response with a 50 mu V peak to peak amplitude, defined as the RMT, was evoked at the contralateral flexor pollicis brevis muscle. RMT was then analyzed using Repeated Measures Analysis of Variance (RM-ANOVA). Veterans with GWI related chronic headaches and body pain (N=20, all males) had a significantly (P < 0.001) higher average RMT (%+/- SD) of 77.2%+/- 16.7% compared to age and gender matched military controls (N=20, all males), whose average was 55.6%+/- 8.8%. Veterans with GWI related diffuse body pain demonstrated a state of diminished corticomotor excitability, suggesting a maladaptive supraspinal pain modulatory state. The impact of this observed supraspinal functional impairment on other GWI related symptoms and the potential use of TMS in rectifying this abnormality and providing relief for pain and co-morbid symptoms requires further investigation. Trial registration: This study was registered on January 25, 2017, on ClinicalTrials.gov with the identifier: NCT03030794. Retrospectively registered. https://clinicaltrials.gov/ct2/show/NCT03030794.	[Lei, Karen; Golshan, Shahrokh; Leung, Albert] Vet Med Res Fdn, 3350 La Jolla Village Dr 151A,Bldg 13, San Diego, CA 92161 USA; [Lei, Karen] Calif Northstate Univ, Coll Med, 9700 W Taron Dr, Elk Grove, CA 95757 USA; [Kunnel, Alphonsa; Metzger-Smith, Valerie; Javors, Jennifer; Wei, Jennie; Lee, Roland; Vaninetti, Michael; Rutledge, Thomas; Leung, Albert] Vet Affairs San Diego Healthcare Syst, Ctr Pain & Headache Res, 3350 La Jolla Village Dr, San Diego, CA 92161 USA; [Leung, Albert] Univ Calif San Diego, Sch Med, Dept Anesthesiol, 9500 Gilman Dr, La Jolla, CA 92093 USA		Leung, A (corresponding author), Vet Med Res Fdn, 3350 La Jolla Village Dr 151A,Bldg 13, San Diego, CA 92161 USA.; Leung, A (corresponding author), Vet Affairs San Diego Healthcare Syst, Ctr Pain & Headache Res, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.; Leung, A (corresponding author), Univ Calif San Diego, Sch Med, Dept Anesthesiol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ayleung@health.ucsd.edu			Department of Defense Congressionally Directed Medical Research Program GrantUnited States Department of Defense [W81XWH-16-1-0754]	This study received funding support from the following agency: Department of Defense Congressionally Directed Medical Research Program Grant (W81XWH-16-1-0754).	Amourette C, 2009, BEHAV BRAIN RES, V203, P207, DOI 10.1016/j.bbr.2009.05.002; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Badawy RAB, 2012, FUNCT NEUROL, V27, P131; Bernabeu M, 2009, J NEUROTRAUM, V26, P2185, DOI 10.1089/neu.2008.0859; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Brighina F, 2010, CEPHALALGIA, V30, P46, DOI 10.1111/j.1468-2982.2009.01870.x; Bushnell MC, 2013, NAT REV NEUROSCI, V14, P502, DOI 10.1038/nrn3516; Caeyenberghs K, 2015, BRAIN CONNECT, V5, P423, DOI 10.1089/brain.2014.0293; Chistyakov AV, 2015, J AFFECT DISORDERS, V170, P225, DOI 10.1016/j.jad.2014.08.035; Cosentino G, 2014, PAIN, V155, P1070, DOI 10.1016/j.pain.2014.02.024; Coughlin Steven S, 2017, J Environ Health Sci, V3, DOI 10.15436/2378-6841.17.1551; Du J, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/1318093; Ferguson E, 2002, BEHAV NEUROL, V13, P133, DOI 10.1155/2002/418758; Fierro B, 2010, EXP BRAIN RES, V203, P31, DOI 10.1007/s00221-010-2206-6; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Fumal A, 2006, CEPHALALGIA, V26, P143, DOI 10.1111/j.1468-2982.2005.01013.x; Galhardoni R, 2019, CEPHALALGIA, V39, P219, DOI 10.1177/0333102418780426; George MS, 2013, CURR OPIN PSYCHIATR, V26, P13, DOI 10.1097/YCO.0b013e32835ab46d; Granovsky Y, 2019, PAIN REP, V4, DOI 10.1097/PR9.0000000000000725; Gu L, 2013, J TRAUMA ACUTE CARE, V74, P242, DOI 10.1097/TA.0b013e3182684fe8; Haskell SG, 2006, J WOMENS HEALTH, V15, P862, DOI 10.1089/jwh.2006.15.862; Hosomi K, 2013, PAIN, V154, P1352, DOI 10.1016/j.pain.2013.04.017; Khedr EM, 2005, J NEUROL NEUROSUR PS, V76, P833, DOI 10.1136/jnnp.2004.055806; King R, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00451; Kuzma John M, 2006, Curr Pain Headache Rep, V10, P85, DOI 10.1007/s11916-006-0017-z; Lefaucheur JP, 2012, EUR J PAIN, V16, P1403, DOI 10.1002/j.1532-2149.2012.00150.x; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Lei KR, 2019, SAGE OPEN MED, V7, DOI 10.1177/2050312119871418; Leung A, 2018, NEUROMODULATION, V21, P390, DOI 10.1111/ner.12615; Leung A, 2016, MOL PAIN, V12, DOI 10.1177/1744806916662661; Leung A, 2016, NEUROMODULATION, V19, P133, DOI 10.1111/ner.12364; Leung A, 2016, PAIN PHYSICIAN, V19, pE347; Levin HS, 2011, DEV NEUROPSYCHOL, V36, P273, DOI 10.1080/87565641.2010.549885; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Li MY, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3267-x; Lipton RB, 2010, NEUROTHERAPEUTICS, V7, P204, DOI 10.1016/j.nurt.2010.03.002; Ljubisavljevic M, 1996, ELECTROMYOGR MOTOR C, V101, P281, DOI 10.1016/0924-980X(96)95627-1; Ly JQM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11828; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Mhalla A, 2010, PAIN, V149, P495, DOI 10.1016/j.pain.2010.03.009; Moulton EA, 2012, J NEUROSCI, V32, P6024, DOI 10.1523/JNEUROSCI.0006-12.2012; Nahin RL, 2017, J PAIN, V18, P247, DOI 10.1016/j.jpain.2016.10.021; Neugebauer V, 2009, BRAIN RES REV, V60, P226, DOI 10.1016/j.brainresrev.2008.12.014; Pal D, 2012, CLIN NEUROL NEUROSUR, V114, P564, DOI 10.1016/j.clineuro.2011.12.002; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Pardini M, 2010, NEUROLOGY, V74, P749, DOI 10.1212/WNL.0b013e3181d25b6b; Parker RS, 2016, BRAIN STIMUL, V9, P488, DOI 10.1016/j.brs.2016.03.020; Rayhan RU, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00181; Rayhan RU, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058493, 10.1371/journal.pone.0063903]; Reijonen J, 2020, J NEUROSCI METH, V331, DOI 10.1016/j.jneumeth.2019.108521; Saavedra LC, 2014, MED HYPOTHESES, V83, P332, DOI 10.1016/j.mehy.2014.06.007; Schabrun SM, 2018, PAIN MED, V19, P1227, DOI 10.1093/pm/pnx168; Seifert F, 2010, NEUROSCIENCE, V170, P670, DOI 10.1016/j.neuroscience.2010.07.024; Sen CBA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186007; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Steele L, 2012, ENVIRON HEALTH PERSP, V120, P112, DOI 10.1289/ehp.1003399; Tajima S, 2010, NEUROL RES INT, V2010, DOI 10.1155/2010/671421; Tallus J, 2012, ACTA NEUROL SCAND, V126, P178, DOI 10.1111/j.1600-0404.2011.01623.x; Tallus J, 2013, J NEUROTRAUM, V30, P1270, DOI 10.1089/neu.2012.2760; Taylor Warren D, 2007, Neuropsychiatr Dis Treat, V3, P669; Thibaut A, 2017, PAIN REP, V2, DOI 10.1097/PR9.0000000000000594; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Tracey I, 2005, CURR OPIN NEUROBIOL, V15, P478, DOI 10.1016/j.conb.2005.06.010; Tracey Irene, 2007, Curr Opin Support Palliat Care, V1, P109, DOI 10.1097/SPC.0b013e3282efc58b; Van Riper SM, 2017, PAIN, V158, P2364, DOI 10.1097/j.pain.0000000000001038; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Weissman DH, 2012, NEUROIMAGE, V61, P798, DOI 10.1016/j.neuroimage.2012.03.032; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x; [No title captured]	71	1	1	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	OCT 28	2020	10	1							18520	10.1038/s41598-020-75006-8			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OO8XM	WOS:000587657600016	33116195	gold, Green Published			2022-02-06	
J	Chen, W; Gao, Z; Ma, LJ				Chen, Wei; Gao, Ze; Ma, Lijie			Failed reduction of posterior hip dislocation accompanied by femoral head fracture: causes and resolving strategy	INTERNATIONAL ORTHOPAEDICS			English	Article						Hip dislocation; Femoral head fracture; Closed reduction; Modified Allis manoeuvre	MANAGEMENT	Background We investigated the causes of failure of the Allis manoeuvre for posterior hip dislocations with an associated Pipkin type I femoral head fractures. The effectiveness of a modified Allis manoeuvre was also evaluated. Methods From January 2013 to December 2016, we enrolled five patients with a posterior hip dislocation associated by a Pipkin type I femoral head fracture who were treated initially with the Allis manoeuvre that subsequently failed. Radiographic evaluations were performed to determine the cause of failure, and then a modified Allis manoeuvre was performed. During this procedure, the hip and knee joints of the injured lower limb were both flexed to 90 degrees, and the leg was pulled posteriorly following an upward force to reduce the dislocation. Reduction was assessed by radiographic evaluation. Results In all patients, the fractured femoral head was incarcerated on the superior edge of the posterior rim of the acetabulum, resulting in failure of the conventional Allis manoeuvre. Satisfactory reduction was achieved with a modified Allis manoeuvre. The mean follow-up duration was 31 months. The femoral head fracture healed after four months on average. The mean Harris score was 91 at the final follow-up. Re-dislocation or femoral head necrosis was not observed. Conclusions For posterior hip dislocations associated with a Pipkin type I femoral head fracture, failed reduction is often caused by incarceration of the fractured femoral head on the superior edge of the posterior rim of the acetabulum. The modified Allis manoeuvre can effectively reduce the combined injury in a closed fashion.	[Chen, Wei; Gao, Ze; Ma, Lijie] Hebei Med Univ, Dept Orthopaed Surg, Hosp 3, 139 Ziqiang Rd, Shijiazhuang 050051, Hebei, Peoples R China		Ma, LJ (corresponding author), Hebei Med Univ, Dept Orthopaed Surg, Hosp 3, 139 Ziqiang Rd, Shijiazhuang 050051, Hebei, Peoples R China.	surgeonchenwei@126.com; drgaoze@126.com; 778013986@qq.com					Abdelazeem A, 2021, INT ORTHOP, V45, P1591, DOI 10.1007/s00264-020-04667-x; Ahmed Ghalib, 2017, Eur J Orthop Surg Traumatol, V27, P1109, DOI 10.1007/s00590-017-1988-7; Alhammoud Abduljabbar, 2016, J Orthop Case Rep, V6, P44, DOI 10.13107/jocr.2250-0685.624; Bakalakos M, 2019, EUR J ORTHOP SURG TR, V29, P231, DOI 10.1007/s00590-018-2241-8; Chen Zhi-wen, 2011, Orthopedics, V34, P350, DOI 10.3928/01477447-20110317-09; de Yoe LE, 1940, ANN SURG, V112, P127, DOI 10.1097/00000658-194007000-00014; Dilogo IH, 2020, INT J SURG CASE REP, V71, P85, DOI 10.1016/j.ijscr.2020.04.009; Dortaj H, 2015, Case Rep Orthop, V2015, P865786, DOI 10.1155/2015/865786; Foulk DM, 2010, J AM ACAD ORTHOP SUR, V18, P199, DOI 10.5435/00124635-201004000-00003; Kokubo Yasuo, 2013, Eur J Orthop Surg Traumatol, V23, P557, DOI 10.1007/s00590-012-1027-7; Mostafa MF, 2014, ARCH ORTHOP TRAUM SU, V134, P637, DOI 10.1007/s00402-014-1960-5; PIPKIN G, 1957, J BONE JOINT SURG AM, V39, P1027, DOI 10.2106/00004623-195739050-00004; Sanders S, 2010, BULL HOSP JT DIS, V68, P91; Tonetti J, 2010, ORTHOP TRAUMATOL-SUR, V96, P623, DOI 10.1016/j.otsr.2010.03.020; Uzel AP, 2010, ORTHOP TRAUMATOL-SUR, V96, P695, DOI 10.1016/j.otsr.2010.04.011; Wang SX, 2019, INT ORTHOP, V43, P2613, DOI 10.1007/s00264-019-04301-5; Yoon PW, 2011, CLIN ORTHOP SURG, V3, P336, DOI 10.4055/cios.2011.3.4.336; Yu X, 2017, PAK J MED SCI, V33, P650, DOI 10.12669/pjms.333.12633; Zaizi A, 2019, INT J SURG CASE REP, V61, P103, DOI 10.1016/j.ijscr.2019.07.017	19	1	1	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	JUN	2021	45	6					1609	1614		10.1007/s00264-020-04856-8		OCT 2020	6	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	SN4BQ	WOS:000582767400001	33108471				2022-02-06	
J	Erickson, SL; Killien, EY; Wainwright, M; Mills, B; Vavilala, MS				Erickson, Scott L.; Killien, Elizabeth Y.; Wainwright, Mark; Mills, Brianna; Vavilala, Monica S.			Mean Arterial Pressure and Discharge Outcomes in Severe Pediatric Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Pediatric intensive care unit; Blood pressure; physiology; Abbreviated Injury Scale; Patient discharge; Hypotension; Humans; Retrospective studies; Predictive value of tests	BLOOD-PRESSURE; HYPOTENSION; MANAGEMENT	Background and Objective Optimizing blood pressure is an important target for intervention following pediatric traumatic brain injury (TBI). The existing literature has examined the association between systolic blood pressure (SBP) and outcomes. Mean arterial pressure (MAP) is a better measure of organ perfusion than SBP and is used to determine cerebral perfusion pressure but has not been previously examined in relation to outcomes after pediatric TBI. We aimed to evaluate the strength of association between MAP-based hypotension early after hospital admission and discharge outcome and to contrast the relative strength of association of hypotension with outcome between MAP-based and SBP-based blood pressure percentiles. Methods We examined the association between lowest age-specific MAP percentile within 12 h after pediatric intensive care unit admission and poor discharge outcome (in-hospital death or transfer to a skilled nursing facility) in children with severe (Glasgow Coma Scale score < 9) TBI who survived at least 12 h. Poisson regression results were adjusted for maximum head Abbreviated Injury Scale (AIS) severity score, maximum nonhead AIS, and vasoactive medication use. We also examined the ability of lowest MAP percentile during the first 12 h to predict discharge outcomes using receiver operating curve characteristic analysis without adjustment for covariates. We contrasted the predictive ability and the relative strength of association of blood pressure with outcome between MAP and SBP percentiles. Results Data from 166 children aged < 18 years were examined, of whom 20.4% had a poor discharge outcome. Poor discharge outcome was most common among patients with lowest MAP < 5th percentile (42.9%; aRR 5.3 vs. 50-94th percentile, 95% CI 1.2, 23.0) and MAP 5-9th percentile (40%; aRR 8.5, 95% CI 1.9, 38.7). Without adjustment for injury severity or vasoactive medication use, lowest MAP percentile was moderately predictive of poor discharge outcome (AUC: 0.75, 95% CI 0.66, 0.85). In contrast, lowest SBP was associated with poor discharge outcome only for the < 5th percentile (50%; aRR 5.4, 95% CI 1.3, 22.2). Lowest SBP percentile was moderately predictive of poor discharge outcome (AUC: 0.82, 95% CI 0.74, 0.91). Conclusions In children with severe TBI, a single MAP < 10th percentile during the first 12 h after Pediatric Intensive Care Unit admission was associated with poor discharge outcome. Lowest MAP percentile during the first 12 h was moderately predictive of poor discharge outcome. Lowest MAP percentile was more strongly associated with outcome than lowest SBP percentile but had slightly lower predictive ability than SBP.	[Erickson, Scott L.; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Erickson, Scott L.; Killien, Elizabeth Y.; Mills, Brianna; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Erickson, Scott L.; Mills, Brianna] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Killien, Elizabeth Y.] Univ Washington, Dept Pediat, Div Pediat Crit Care Med, Seattle, WA 98195 USA; [Wainwright, Mark] Univ Washington, Dept Neurol, Div Pediat Neurol, Seattle, WA 98195 USA		Killien, EY (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA.; Killien, EY (corresponding author), Univ Washington, Dept Pediat, Div Pediat Crit Care Med, Seattle, WA 98195 USA.	elizabeth.killien@seattlechildrens.org		Erickson, Scott L/0000-0002-7694-6287	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01NS072308-06]	Funding was received from National Institutes of Health 5R01NS072308-06 (Vavilala).	Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Haque IU, 2007, PEDIATR CRIT CARE ME, V8, P138, DOI 10.1097/01.PCC.0000257039.32593.DC; Hazinsky M.F., 2002, PEDIAT ADV LIFE SUPP; Kannan N, 2018, PEDIATR EMERG CARE, V34, P325, DOI 10.1097/PEC.0000000000000803; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Krishnamoorthy V, 2017, J NEUROSURG ANESTH, V29, P382, DOI 10.1097/ANA.0000000000000370; Lehman LWH, 2013, CRIT CARE MED, V41, P34, DOI 10.1097/CCM.0b013e318265ea46; MAYER TA, 1985, ANN EMERG MED, V14, P1178, DOI 10.1016/S0196-0644(85)81025-8; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Pinsky MR, 2005, CRIT CARE, V9, P566, DOI 10.1186/cc3927; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Suttipongkaset P, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0594; Van Cleve W, 2013, NEUROSURGERY, V73, P746, DOI 10.1227/NEU.0000000000000097; Vavilala MS, 2019, LANCET CHILD ADOLESC, V3, P23, DOI 10.1016/S2352-4642(18)30341-9; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	21	1	1	1	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2021	34	3					1017	1025		10.1007/s12028-020-01121-z		OCT 2020	9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN4OZ	WOS:000584611100003	33108627				2022-02-06	
J	Miller, LE; Kaseda, ET; Koop, JI; Mau, KA; Heffelfinger, AK				Miller, Lauren E.; Kaseda, Erin T.; Koop, Jennifer, I; Mau, Katherine A.; Heffelfinger, Amy K.			Differential access to neuropsychological evaluation in children with perinatal complications or autism spectrum disorder: Impact of sociodemographic factors	CLINICAL NEUROPSYCHOLOGIST			English	Article						Early brain insult; perinatal complications; autism spectrum disorder; access to care; sociodemographic factors	TRAUMATIC BRAIN-INJURY; COGNITIVE-DEVELOPMENT; FUNCTIONAL RECOVERY; PRETERM BIRTH; CARE; LANGUAGE; DISPARITIES; PREDICTORS; RISK; AGE	Objective Early childhood evaluation can identify deficits related to disruptions in early brain development and facilitate interventions. Access to care may differ by race/ethnicity or socioeconomic status. We explored neuropsychological evaluation access patterns and examined potential sociodemographic disparities in evaluation timing. Method: Participants were 213 children (age: M = 46.4 months, SD = 15.3 months) with a history of disrupted neural development due to perinatal complications (PC; n = 109) or autism spectrum disorder (ASD; n = 104). We used chi square tests of independence and one-way ANOVAs to compare groups on sociodemographics, referral sources, and cognition. Clinical sample means for cognitive and adaptive variables were compared to normative means to determine the presence of developmental delays. Differences in age at evaluation by race/ethnicity, caregiver education, and referral source, accounting for cognition, were explored with ANCOVAs. Results: The ASD group included significantly more White children and the PC group relatively more Black/African Americans. Children with ASD were referred by primary care physicians and caregivers/school staff; those with PC were referred by other medical providers. All participants performed more poorly than expected across all intellectual and adaptive domains, with greater delays in the ASD group. Children of caregivers with lower education were evaluated earlier in the PC group. For ASD, participants referred by primary care physicians were evaluated earlier. Conclusions: Children with PC and ASD exhibit cognitive delays and require neuropsychological evaluation. Disparities in access to care exist, particularly for minority children with ASD. Ways to promote equal access are discussed.	[Miller, Lauren E.; Koop, Jennifer, I; Mau, Katherine A.; Heffelfinger, Amy K.] Med Coll Wisconsin, Dept Neurol, Div Neuropsychol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Kaseda, Erin T.] Rosalind Franklin Univ Med & Sci, Dept Psychol, N Chicago, IL USA		Miller, LE (corresponding author), Med Coll Wisconsin, Dept Neurol, Div Neuropsychol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	laurmiller@mcw.edu		Kaseda, Erin/0000-0001-8845-7459	Medical College of WisconsinGeneral Electric	This study was funded, in part, by a Vitality Award to Dr. Heffelfinger from the Medical College of Wisconsin.	Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Anderson VA, 2014, DEV MED CHILD NEUROL, V56, P329, DOI 10.1111/dmcn.12387; Bishop SL, 2011, AJIDD-AM J INTELLECT, V116, P331, DOI 10.1352/1944-7558-116.5.331; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Dall'Oglio AM, 2010, DEV MED CHILD NEUROL, V52, P955, DOI 10.1111/j.1469-8749.2010.03730.x; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P89; Elliott C.D., 2007, DIFFERENTIAL ABILITY; Elliott C. D., 1990, DIFFERENTIAL ABILITY; Farmer Cristan, 2016, Child Neuropsychol, V22, P556, DOI 10.1080/09297049.2015.1020775; Fu BQ, 2017, IMMUNITY, V47, P1100, DOI [10.15585/mmwr.ss6904a1, 10.1016/j.immuni.2017.11.018]; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Guarini A, 2010, J CHILD LANG, V37, P865, DOI 10.1017/S0305000909990109; Guilmette TJ, 2020, CLIN NEUROPSYCHOL, V34, P437, DOI 10.1080/13854046.2020.1722244; Hazlett HC, 2017, NATURE, V542, P348, DOI 10.1038/nature21369; Heffelfinger AK, 2009, CLIN NEUROPSYCHOL, V23, P51, DOI 10.1080/13854040801945052; Herlihy LE, 2014, J DEV BEHAV PEDIATR, V35, P85, DOI 10.1097/DBP.0000000000000014; Hessl, 2001, PEDIATRICS, V108, pE88; Howell EA, 2017, OBSTET GYN CLIN N AM, V44, P13, DOI 10.1016/j.ogc.2016.10.002; Hyman SL, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-3447; IBM Corp, 2019, IBM SPSS STAT WIND V; Lind A, 2020, CHILD NEUROPSYCHOL, V26, P312, DOI 10.1080/09297049.2019.1674267; Linsell L, 2015, JAMA PEDIATR, V169, P1162, DOI 10.1001/jamapediatrics.2015.2175; Mulder H, 2010, ARCH DIS CHILD-FETAL, V95, pF267, DOI 10.1136/adc.2009.167965; Mullen E.M., 1995, MULLEN SCALES EARLY; Newacheck PW, 2002, AMBUL PEDIATR, V2, P247, DOI 10.1367/1539-4409(2002)002<0247:RAEDIA>2.0.CO;2; Ngui EM, 2006, PEDIATRICS, V117, P1184, DOI 10.1542/peds.2005-1088; NSCH, 2007, DAT QUER CHILD AD HL; Orinstein AJ, 2014, J DEV BEHAV PEDIATR, V35, P247, DOI 10.1097/DBP.0000000000000037; Pike M, 2013, J INT NEUROPSYCH SOC, V19, P390, DOI 10.1017/S1355617712001579; Raz S, 2010, J INT NEUROPSYCH SOC, V16, P169, DOI 10.1017/S1355617709991147; Sansavini A, 2011, DEV DISABIL RES REV, V17, P102, DOI 10.1002/ddrr.1105; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Sparrow S.S., 2005, VINELAND ADAPTIVE BE; Swearingen C, 2020, J PERINATOL, V40, P790, DOI 10.1038/s41372-020-0659-4; Thomas KC, 2007, J AUTISM DEV DISORD, V37, P1902, DOI 10.1007/s10803-006-0323-7; Treble-Barna A, 2017, J NEUROTRAUM, V34, P353, DOI 10.1089/neu.2016.4476; U.S. Census Bureau, 2010, AM COMM SURV DEM HOU	39	1	1	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUL 4	2021	35	5			SI		988	1008		10.1080/13854046.2020.1837247		OCT 2020	21	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	SV7PS	WOS:000586077300001	33118866				2022-02-06	
J	Park, YS; Kogeichi, Y; Haku, T; Kim, TK; Yokota, H; Nakagawa, I; Motoyama, Y; Nakase, H				Park, Young-Soo; Kogeichi, Yohei; Haku, Takahide; Kim, Tae Kyun; Yokota, Hiroshi; Nakagawa, Ichiro; Motoyama, Yasushi; Nakase, Hiroyuki			Hinge and floating decompressive craniotomy for infantile acute subdural hematoma: technical note	CHILDS NERVOUS SYSTEM			English	Article						Infantile ASDH; Decompressive craniotomy; Hinge; Floating	TRAUMATIC BRAIN-INJURY; CRANIECTOMY	Cranioplasty complications after decompressive craniectomy (DC) in infants are not fully recognized. We aimed to devise and assess the efficacy of a hinge and floating DC (HFDC) technique for treating infantile acute subdural hematoma. Five infants, aged 2-20 months, were included. Intracranial pressure was controlled below 20 mmHg, no additional surgery was required, and there was no incidence of surgical site infection or bone graft resorption.	[Park, Young-Soo; Haku, Takahide; Kim, Tae Kyun; Yokota, Hiroshi; Nakagawa, Ichiro; Motoyama, Yasushi; Nakase, Hiroyuki] Nara Med Univ, Dept Neurosurg, 840 Shijo Cho, Kashihara, Nara, Japan; [Park, Young-Soo] Nara Med Univ Hosp, Childrens Med Ctr, Div Neurosurg, 840 Shijo Cho, Kashihara, Nara, Japan; [Kogeichi, Yohei] Nara Med Univ Hosp, Dept Emergency & Crit Care Med, 840 Shijo Cho, Kashihara, Nara, Japan		Park, YS (corresponding author), Nara Med Univ, Dept Neurosurg, 840 Shijo Cho, Kashihara, Nara, Japan.; Park, YS (corresponding author), Nara Med Univ Hosp, Childrens Med Ctr, Div Neurosurg, 840 Shijo Cho, Kashihara, Nara, Japan.	park-y-s@naramed-u.ac.jp		Park, Young-Soo/0000-0003-2271-1332			Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483; Brommeland T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0155-6; Frassanito P, 2019, CHILD NERV SYST, V35, P1499, DOI 10.1007/s00381-019-04251-8; Frassanito P, 2019, CHILD NERV SYST, V35, P1467, DOI 10.1007/s00381-019-04166-4; Frassanito P, 2017, CHILD NERV SYST, V33, P1759, DOI 10.1007/s00381-017-3541-8; Frassanito P, 2012, ACTA NEUROCHIR, V154, P927, DOI 10.1007/s00701-011-1253-5; Gutman Matthew J, 2017, Surg Neurol Int, V8, P130, DOI 10.4103/sni.sni_460_16; Horsfall HL, 2020, NEUROSURG REV, V43, P1493, DOI 10.1007/s10143-019-01180-7; Kenning TJ, 2012, J NEUROSURG, V116, P1289, DOI 10.3171/2012.2.JNS111772; Rocque BG, 2018, J NEUROSURG-PEDIATR, V22, P225, DOI 10.3171/2018.3.PEDS17234; Rocque BG, 2013, J NEUROSURG-PEDIATR, V12, P120, DOI 10.3171/2013.4.PEDS12605; Schmidt JH, 2007, J NEUROSURG, V107, P678, DOI 10.3171/JNS-07/09/0678; Yokota H, 2019, CHILD NERV SYST, V35, P1491, DOI 10.1007/s00381-019-04177-1	13	1	1	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JAN	2021	37	1					295	298		10.1007/s00381-020-04942-7		OCT 2020	4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	PR6TR	WOS:000584562100001	33108518				2022-02-06	
J	Hanell, A; Rostami, E				Hanell, Anders; Rostami, Elham			How Can a Punch Knock You Out?	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; concussion; boxing; mechanoporation; mechanosensitive (MS) ion channel	TRAUMATIC BRAIN-INJURY; CONCUSSIVE CONVULSIONS	Several hypotheses have been put forth over time to explain how consciousness can be so rapidly lost, and then spontaneously regained, following mechanical head trauma. The knockout punch in boxing is a relatively homogenous form of traumatic brain injury and can thus be used to test the predictions of these hypotheses. While none of the hypotheses put forth can be considered fully verified, pore formation following stretching of the axonal cell membrane, mechanoporation, is a strong contender. We here argue that the theoretical foundation of mechanoporation can be strengthened by a comparison with the experimental method electroporation.	[Hanell, Anders; Rostami, Elham] Uppsala Univ, Sect Neurosurg, Dept Neurosci, Uppsala, Sweden; [Rostami, Elham] Karolinska Inst KI, Dept Neurosci, Stockholm, Sweden		Hanell, A (corresponding author), Uppsala Univ, Sect Neurosurg, Dept Neurosci, Uppsala, Sweden.	anders.hanell@neuro.uu.se			Department of Neuroscience/Neurosurgery, Uppsala University, Sweden	The research was funded by the Department of Neuroscience/Neurosurgery, Uppsala University, Sweden.	Boothe DL, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00236; Choi JJ, 2010, ULTRASOUND MED BIOL, V36, P58, DOI 10.1016/j.ultrasmedbio.2009.08.006; Cournoyer J, 2019, CLIN BIOMECH, V67, P96, DOI 10.1016/j.clinbiomech.2019.05.003; Denny-Brown D E, 1941, Proc R Soc Med, V34, P691; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Gottlieb PA., CURRENT TOPICS MEMBR, P1; Gu YZ, 2017, J CELL BIOL, V216, P2179, DOI 10.1083/jcb.201606065; Hernandez ML, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01238; HEYBURN L, 2019, FRONT NEUROL, V0010; Heyman NS, 2008, BIOPHYS J, V94, P840, DOI 10.1529/biophysj.107.115634; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Jang SH, 2019, AM J PHYS MED REHAB, V98, P1067, DOI 10.1097/PHM.0000000000001243; Jang SH, 2018, TRANSL NEUROSCI, V9, P209, DOI 10.1515/tnsci-2018-0030; Kumar Priti, 2019, Cold Spring Harb Protoc, V2019, DOI 10.1101/pdb.top096271; Lafrenaye AD, 2014, J CEREBR BLOOD F MET, V34, P1628, DOI 10.1038/jcbfm.2014.122; LaPlaca MC, 2019, CLIN BIOMECH, V64, P2, DOI 10.1016/j.clinbiomech.2018.05.016; Maneshi MM, 2017, SCI REP-UK, V7, DOI 10.1038/srep39610; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory PR, 2001, NEUROLOGY, V57, P2283, DOI 10.1212/WNL.57.12.2283; McCrory PR, 1998, SPORTS MED, V25, P131, DOI 10.2165/00007256-199825020-00005; Montanino A, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00025; Morgan MH, 2013, J EXP BIOL, V216, P236, DOI 10.1242/jeb.075713; Murphy MA, 2016, MODEL SIMUL MATER SC, V24, DOI 10.1088/0965-0393/24/5/055008; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; RENNKE HG, 1978, KIDNEY INT, V13, P278, DOI 10.1038/ki.1978.41; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Sachs Frederick, 2015, World J Neurol, V5, P74, DOI 10.5316/wjn.v5.i3.74; SAULIS G, 1991, BIOELECTROCH BIOENER, V26, P1, DOI 10.1016/0302-4598(91)87029-G; Saulis G, 2012, BBA-BIOMEMBRANES, V1818, P3032, DOI 10.1016/j.bbamem.2012.06.018; Sengel JT, 2016, P NATL ACAD SCI USA, V113, P5281, DOI 10.1073/pnas.1517437113; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Tehse J, 2019, EUR J NEUROSCI, V49, P1157, DOI 10.1111/ejn.14307; Tenyi D, 2016, EPILEPSIA, V57, P1310, DOI 10.1111/epi.13432; Trotier W, 1924, BRIT MED J, V1924, P816, DOI 10.1136/bmj.1.3306.816; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103	40	1	1	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 26	2020	11								570566	10.3389/fneur.2020.570566			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OO4XS	WOS:000587384000001	33193016	Green Published, gold			2022-02-06	
J	Pappadis, MR; Sander, AM; Struchen, MA; Kurtz, DM				Pappadis, Monique R.; Sander, Angelle M.; Struchen, Margaret A.; Kurtz, Diana M.			Soy diferente: a qualitative study on the perceptions of recovery following traumatic brain injury among Spanish-speaking US immigrants	DISABILITY AND REHABILITATION			English	Article; Early Access						Emigrants and immigrants; Hispanic Americans; quality of life; self concept; social integration; traumatic brain injuries	ETHNIC DISPARITIES; HEALTH-CARE; RACIAL/ETHNIC DIFFERENCES; UNDOCUMENTED IMMIGRANTS; COMMUNITY INTEGRATION; OUTCOMES; REHABILITATION; INDIVIDUALS; SELF; DISCHARGE	Purpose To explore the impact of traumatic brain injury (TBI) on the quality of life (QoL) and self-concept of Spanish-speaking U.S. Hispanic immigrants with TBI. Materials and methods A prospective, qualitative study conducted in a county level I trauma center and community. Semi-structured interviews on QoL and self-concept following TBI were conducted with 24 Spanish-speaking U.S. Hispanic immigrants with TBI living in the community at least 6 months following injury. Results Perceived facilitators of QoL included faith, hopefulness in recovery, empathy for others, and support from others. Perceived barriers to QoL mentioned were symptoms/consequences of injury, employment/financial changes, loss of independence, fear/uncertainty, stigma/shame, lack of medical care, and decreased social integration. Participants described their self-concept after TBI as either a maintained self or loss of self. Those who viewed themselves differently reported physical and emotional changes, gender role conflict, loss of self-worth, and total loss due to the TBI. Conclusions Spanish-speaking U.S. Hispanic immigrants held a strong faith and positive outlook after TBI in spite of the significant barriers to recovery. A need exists for programs to support creatively the recovery of Spanish-speaking U.S. Hispanic immigrants with limited access to care and resources.	[Pappadis, Monique R.] Univ Texas Med Branch, Div Rehabil Sci, Galveston, TX 77555 USA; [Pappadis, Monique R.] Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA; [Pappadis, Monique R.; Sander, Angelle M.; Struchen, Margaret A.; Kurtz, Diana M.] TIRR Mem Hermann Brain Injury Res Ctr, Houston, TX USA; [Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA; [Struchen, Margaret A.] Ctr Rehabil Psychol & Neuropsychol, PC, Walnut Creek, CA USA; [Kurtz, Diana M.] Spring Branch Counseling Ctr, Houston, TX USA; [Struchen, Margaret A.] Rehab Without Walls, Bay Area, San Jose, CA USA; [Kurtz, Diana M.] Creek Wellness, Fulshear, TX USA		Pappadis, MR (corresponding author), Univ Texas Med Branch, Sch Hlth Profess, Div Rehabil Sci, 301 Univ Blvd, Galveston, TX 77555 USA.	mrpappad@utmb.edu		Pappadis, Monique R./0000-0003-4742-4380	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) for the Rehabilitation Research and Training Center on Community Integration of Persons with Traumatic Brain Injury [H133B03117]; NIDLRR [H133B031117, 90DPTB0016, 90DP0028, 90RT5007]; National Institute on Aging [NIA]United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01AG065492, P30AG024832, P30AG059301]; National Institute on Minority Health and Health Disparities [NIMHD]United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [L60 MD009326]	This work was supported by Grant [#H133B03117] from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) for the Rehabilitation Research and Training Center on Community Integration of Persons with Traumatic Brain Injury. The contents of this publication were developed under grants from NIDLRR [grant numbers H133B031117, 90DPTB0016, 90DP0028, 90RT5007]; National Institute on Aging [NIA grant numbers K01AG065492; P30AG024832; P30AG059301], and the National Institute on Minority Health and Health Disparities [NIMHD contract number L60 MD009326]. The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official institutional position or any other federal agency, policy, or decision unless so designated by other official documentation.	Alban RF, 2010, AM SURGEON, V76, P1108; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P801, DOI 10.3109/02699052.2012.655368; Arango-Lasprilla JC, 2011, PM&R, V3, P1083, DOI 10.1016/j.pmrj.2011.05.023; Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Attride-Stirling J., 2001, QUALITATIVE RES, V1, P385, DOI [10.1177/146879410100100307, DOI 10.1177/146879410100100307, https://doi.org/10.1177/146879410100100307]; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Beadle EJ, 2016, HEAD TRAUMA REHABIL, V31, pE12; Beck TL, 2017, PRIM CARE, V44, pe1; Bernard H., 2016, ANAL QUALITATIVE DAT, V2nd; Budnick HC, 2017, J SURG RES, V215, P231, DOI 10.1016/j.jss.2017.03.062; Callaghan T, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4167-1; Clark AN, 2010, NEUROREHABILITATION, V27, P95, DOI 10.3233/NRE-2010-0584; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Dijkers MP, 2004, ARCH PHYS MED REHABI, V85, pS21; Dismuke CE, 2015, AM J PUBLIC HEALTH, V105, P1696, DOI 10.2105/AJPH.2014.302545; Englum BR, 2011, J AM COLL SURGEONS, V213, P699, DOI 10.1016/j.jamcollsurg.2011.08.017; Fernandez A, 2017, JAMA INTERN MED, V177, P536, DOI 10.1001/jamainternmed.2016.9209; Fuentes A, 2019, REHABIL PSYCHOL, V64, P229, DOI 10.1037/rep0000260; Gao SY, 2018, J HEAD TRAUMA REHAB, V33, pE40, DOI 10.1097/HTR.0000000000000338; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Glaser B., 1967, DISCOVERY GROUNDED T; Jamison L, 2012, BRAIN INJURY, V26, P805, DOI 10.3109/02699052.2012.655367; Jm K, 2017, USE SPANISH DECLINES; Knowlton LM, 2018, J AM COLL SURGEONS, V227, P172, DOI 10.1016/j.jamcollsurg.2018.03.043; Kuruvilla R, 2014, TEXAS MED, V110, pe1; Lequerica AH, 2019, J HEAD TRAUMA REHAB, V34, pE46, DOI 10.1097/HTR.0000000000000398; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lincoln Y. S, 1986, NEW DIRECTIONS PROGR, V30, P73, DOI [DOI 10.1002/EV.1427, 10.1002/ev.1427]; de la Plata CM, 2007, J HEAD TRAUMA REHAB, V22, P113, DOI 10.1097/01.HTR.0000265099.29436.56; McColl MA, 2000, DISABIL REHABIL, V22, P555, DOI 10.1080/096382800416805; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Ortega AN, 2007, ARCH INTERN MED, V167, P2354, DOI 10.1001/archinte.167.21.2354; Pappadis MR, 2011, J HEAD TRAUMA REHAB, V26, P301, DOI 10.1097/HTR.0b013e3181e7832b; Pastorek NJ, 2004, J INT NEUROPSYCH SOC, V10, P807, DOI 10.1017/S1355617704106012; Philippus A, 2016, BRAIN INJURY, V30, P1605, DOI 10.1080/02699052.2016.1199903; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; QSR International Pty Ltd, 2012, NVIVO QUAL DAT AN SO; Ram P, 2020, CRIT CARE MED, V48, P31, DOI 10.1097/CCM.0000000000004043; Sander AM, 2011, J HEAD TRAUMA REHAB, V26, P158, DOI 10.1097/HTR.0b013e3181e7537e; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Shahin H, 2010, J TRAUMA, V69, P1176, DOI 10.1097/TA.0b013e3181edbd47; SMART JF, 1991, REHABIL COUNS BULL, V34, P357; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Taylor P., 2012, LABELS DONT FIT HISP; TEASDALE G, 1974, LANCET, V2, P81; Timmins CL, 2002, J MIDWIFERY WOM HEAL, V47, P80, DOI 10.1016/S1526-9523(02)00218-0; U.S. Census Bureau PD, 2019, ANN EST RES POP SEX; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218; Waldron-Perrine B, 2011, REHABIL PSYCHOL, V56, P107, DOI 10.1037/a0023552; Wyrick JM, 2017, J SURG RES, V214, P145, DOI 10.1016/j.jss.2017.02.006; Zuckerman S, 2011, HEALTH AFFAIR, V30, P1997, DOI 10.1377/hlthaff.2011.0604	54	1	1	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2020.1836045		OCT 2020	10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	OH9UH	WOS:000582933900001	33108224				2022-02-06	
J	Zhang, B; Bai, M; Xu, XJ; Yang, MS; Niu, F; Gao, F; Liu, BY				Zhang, Bin; Bai, Miao; Xu, Xiaojian; Yang, Mengshi; Niu, Fei; Gao, Fei; Liu, Baiyun			Corticosteroid receptor rebalancing alleviates critical illness-related corticosteroid insufficiency after traumatic brain injury by promoting paraventricular nuclear cell survival via Akt/CREB/BDNF signaling	JOURNAL OF NEUROINFLAMMATION			English	Article						Glucocorticoids; Corticosteroid receptor balance; Critical illness-related corticosteroid insufficiency; Apoptosis; Traumatic brain injury	SEVERE HEAD-INJURY; MINERALOCORTICOID RECEPTOR; NEUROTROPHIC FACTOR; PITUITARY-GLAND; CHRONIC STRESS; DEATH; GLUCOCORTICOIDS; HIPPOCAMPUS; EXPRESSION; APOPTOSIS	BackgroundWe previously found that high-dose methylprednisolone increased the incidence of critical illness-related corticosteroid insufficiency (CIRCI) and mortality in rats with traumatic brain injury (TBI), whereas low-dose hydrocortisone but not methylprednisolone exerted protective effects. However, the receptor-mediated mechanism remains unclear. This study investigated the receptor-mediated mechanism of the opposite effects of different glucocorticoids on the survival of paraventricular nucleus (PVN) cells and the incidence of CIRCI after TBI.MethodsBased on controlled cortical impact (CCI) and treatments, male SD rats (n = 300) were randomly divided into the sham, CCI, CCI + GCs (methylprednisolone 1 or 30mg/kg/day; corticosterone 1mg/kg/day), CCI + methylprednisolone+RU486 (RU486 50mg/kg/day), and CCI + corticosterone+spironolactone (spironolactone 50mg/kg/day) groups. Blood samples were collected 7days before and after CCI. Brain tissues were collected on postinjury day 7 and processed for histology and western blot analysis.ResultsWe examined the incidence of CIRCI, mortality, apoptosis in the PVN, the receptor-mediated mechanism, and downstream signaling pathways on postinjury day 7. We found that methylprednisolone and corticosterone exerted opposite effects on the survival of PVN cells and the incidence of CIRCI by activating different receptors. High-dose methylprednisolone increased the nuclear glucocorticoid receptor (GR) level and subsequently increased cell loss in the PVN and the incidence of CIRCI. In contrast, low-dose corticosterone but not methylprednisolone played a protective role by upregulating mineralocorticoid receptor (MR) activation. The possible downstream receptor signaling mechanism involved the differential effects of GR and MR on the activity of the Akt/CREB/BDNF pathway.ConclusionThe excessive activation of GR by high-dose methylprednisolone exacerbated apoptosis in the PVN and increased CIRCI. In contrast, refilling of MR by corticosterone protects PVN neurons and reduces the incidence of CIRCI by promoting GR/MR rebalancing after TBI.	[Zhang, Bin; Yang, Mengshi; Gao, Fei] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Bai, Miao] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurol, Xian, Peoples R China; [Xu, Xiaojian; Niu, Fei] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [Liu, Baiyun] Capital Med Univ, Beijing Key Lab Cent Nervous Syst Injury, 119 South Fourth Ring West Rd, Beijing 100070, Peoples R China; [Liu, Baiyun] Capital Med Univ, Dept Neurosurg, Beijing Neurosurg Inst, 119 South Fourth Ring West Rd, Beijing 100070, Peoples R China; [Liu, Baiyun] Capital Med Univ, Beijing Tiantan Hosp, 119 South Fourth Ring West Rd, Beijing 100070, Peoples R China; [Liu, Baiyun] Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China; [Liu, Baiyun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China		Liu, BY (corresponding author), Capital Med Univ, Beijing Key Lab Cent Nervous Syst Injury, 119 South Fourth Ring West Rd, Beijing 100070, Peoples R China.; Liu, BY (corresponding author), Capital Med Univ, Dept Neurosurg, Beijing Neurosurg Inst, 119 South Fourth Ring West Rd, Beijing 100070, Peoples R China.; Liu, BY (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, 119 South Fourth Ring West Rd, Beijing 100070, Peoples R China.; Liu, BY (corresponding author), Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China.	liubaiyun1212@163.com			Beijing municipal health commission [PXM2020_026280_000002]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771327]	This work was supported by research grants from the Beijing municipal health commission (No. PXM2020_026280_000002) and National Natural Science Foundation of China (No. 81771327).	Almeida OFX, 2000, FASEB J, V14, P779, DOI 10.1096/fasebj.14.5.779; Annane D, 2017, CRIT CARE MED, V45, P2089, DOI 10.1097/CCM.0000000000002724; Arango-Lievano M, 2015, P NATL ACAD SCI USA, V112, P15737, DOI 10.1073/pnas.1509045112; BRAAKMAN R, 1983, J NEUROSURG, V58, P326, DOI 10.3171/jns.1983.58.3.0326; Cardenas SP, 2002, NEUROSCI LETT, V331, P9, DOI 10.1016/S0304-3940(02)00744-9; Chen X, 2013, CRIT CARE, V17, DOI 10.1186/cc13067; Chen X, 2011, BRAIN RES, V1382, P298, DOI 10.1016/j.brainres.2011.01.045; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; de Kloet ER, 2018, FRONT NEUROENDOCRIN, V49, P124, DOI 10.1016/j.yfrne.2018.02.003; de Kloet ER, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12379; de Kloet ER, 2013, EUR J PHARMACOL, V719, P53, DOI 10.1016/j.ejphar.2013.04.053; Dixon CE, 2003, CRIT CARE MED, V31, P2222, DOI 10.1097/01.CCM.0000080493.04978.73; Farook JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.280; Gobiet W, 1976, INTRACRANIAL PRESSUR, P231; Gray JD, 2017, NAT REV ENDOCRINOL, V13, P661, DOI 10.1038/nrendo.2017.97; Han F, 2007, J NEUROENDOCRINOL, V19, P229, DOI 10.1111/j.1365-2826.2006.01519.x; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; Harris AP, 2013, PSYCHONEUROENDOCRINO, V38, P648, DOI 10.1016/j.psyneuen.2012.08.007; Joels M, 2017, J ENDOCRINOL, V234, pT49, DOI 10.1530/JOE-16-0660; Jung B, 2012, CRIT CARE, V16, DOI 10.1186/cc11871; Karssen AM, 2002, J ENDOCRINOL, V175, P251, DOI 10.1677/joe.0.1750251; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; MAXWELL RE, 1971, J NEUROSURG, V34, P477, DOI 10.3171/jns.1971.34.4.0477; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; MCEWEN BS, 1968, NATURE, V220, P911, DOI 10.1038/220911a0; Mifsud KR, 2016, P NATL ACAD SCI USA, V113, P11336, DOI 10.1073/pnas.1605246113; Murakami S, 2005, NEUROSCI RES, V53, P129, DOI 10.1016/j.neures.2005.06.008; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Numakawa T, 2013, NEUROSCIENCE, V239, P157, DOI 10.1016/j.neuroscience.2012.09.073; Olivecrona Z, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-33; Piao CS, 2012, NEUROBIOL DIS, V46, P745, DOI 10.1016/j.nbd.2012.03.018; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Sharshar T, 2004, BRAIN PATHOL, V14, P21, DOI 10.1111/j.1750-3639.2004.tb00494.x; Sharshar T, 2003, LANCET, V362, P1799, DOI 10.1016/S0140-6736(03)14899-4; Sheline YI, 2019, BIOL PSYCHIAT, V85, P436, DOI 10.1016/j.biopsych.2019.01.011; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tan CL, 2017, J NEUROL NEUROSUR PS, V88, P971, DOI 10.1136/jnnp-2016-315500; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wurzelmann M, 2017, NEURAL REGEN RES, V12, P7, DOI 10.4103/1673-5374.198964; Zhang B, 2020, NEUROSCIENCE, V424, P1, DOI 10.1016/j.neuroscience.2019.10.026; Zhang B, 2020, J NEUROTRAUM, V37, P262, DOI 10.1089/neu.2019.6556; Zhang XP, 2006, J CEREBR BLOOD F MET, V26, P915, DOI 10.1038/sj.jcbfm.9600238; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zuo DY, 2016, NEUROTOX RES, V30, P159, DOI 10.1007/s12640-016-9611-y; [No title captured]	50	1	1	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	OCT 25	2020	17	1							318	10.1186/s12974-020-02000-2			13	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	OP7XW	WOS:000588302600001	33100225	Green Published, gold			2022-02-06	
J	de Souza, NL; Parker, R; Gonzalez, CS; Ryan, JD; Esopenko, C				de Souza, Nicola L.; Parker, Rachel; Gonzalez, Christie S.; Ryan, Jennifer D.; Esopenko, Carrie			Effect of age at time of injury on long-term changes in intrinsic functional connectivity in traumatic brain injury	BRAIN INJURY			English	Article						Resting-state fMRI; functional connectivity; brain injury; aging	DEFAULT-MODE NETWORK; STRUCTURAL CONNECTIVITY; DISRUPTION; SCALE; COMPONENT; RELEVANT; ANTERIOR	Background: Alterations in resting-state functional connectivity (rsFC) occur in the acute and chronic phases following traumatic brain injury (TBI); however, few studies have assessed long-term (>1 year) changes in rsFC. Methods: Resting-state functional magnetic resonance imaging (rsfMRI) scans were obtained from the Federal Interagency Traumatic Brain Injury Research Informatics Systems. Patients with primarily mild TBI (n = 39) completed rsfMRI scans at the sub-acute (similar to 10 days) and long-term (similar to 18 months) phases. We examined changes in voxel-based rsFC from anterior medial prefrontal cortex (aMPFC) and posterior cingulate cortex (PCC) seeds in the default mode network (DMN) between both phases. The effect of age at the time of injury on long-term rsFC was also examined. Results: Increased rsFC from the aMPFC and the PCC to frontal and temporal regions was shown at similar to 18-months post-injury. Widespread increases in rsFC from the aMPFC and between the PCC and frontal regions were shown for younger patients at time of injury, but limited increases of rsFC were noted at similar to 18 months in older patients. Conclusion: Long-term increases in rsFC were found following TBI, but age at the time of injury was associated with distinct rsFC profiles suggesting that younger patients show greater increases in rsFC over time.	[de Souza, Nicola L.] Rutgers Biomed & Hlth Sci, Sch Grad Studies, Biomed Sci, Newark, NJ 07107 USA; [Parker, Rachel; Ryan, Jennifer D.] Rotman Res Inst Baycrest, Toronto, ON M6A 2E1, Canada; [Gonzalez, Christie S.; Esopenko, Carrie] Rutgers Biomed & Hlth Sci, Dept Rehabil & Movement Sci, Sch Hlth Profess, Newark, NJ 07107 USA; [Ryan, Jennifer D.] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Ryan, Jennifer D.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada		Ryan, JD (corresponding author), Rotman Res Inst Baycrest, Toronto, ON M6A 2E1, Canada.; Esopenko, C (corresponding author), Rutgers Biomed & Hlth Sci, Dept Rehabil & Movement Sci, Sch Hlth Profess, Newark, NJ 07107 USA.	jryan@research.baycrest.org; carrie.esopenko@rutgers.edu		de Souza, Nicola/0000-0003-2166-428X; Esopenko, Carrie/0000-0001-8607-5633	Rutgers University School of Health Professions; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-126003]	Financial support was provided to CE through Rutgers University School of Health Professions, and to JDR from the Canadian Institutes of Health Research (MOP-126003).	Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Centers for Disease Control and Prevention (CDC), 2019, SURV REP TRAUM BRAIN; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; De Simoni S, 2016, BRAIN, V139, P3137, DOI 10.1093/brain/aww241; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Esposito R, 2018, BRAIN IMAGING BEHAV, V12, P127, DOI 10.1007/s11682-017-9686-y; Fani N, 2015, CORTEX, V64, P249, DOI 10.1016/j.cortex.2014.11.006; Ferreira LK, 2013, NEUROSCI BIOBEHAV R, V37, P384, DOI 10.1016/j.neubiorev.2013.01.017; Grady C, 2013, NAT REV NEUROSCI, V123, P106, DOI [10.1016/j.clinph.2011.06.006.A, DOI 10.1016/J.CLINPH.2011.06.006.A]; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Jung WH, 2016, NEUROIMAGE, V141, P408, DOI 10.1016/j.neuroimage.2016.07.045; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Marstaller L, 2015, NEUROSCIENCE, V290, P369, DOI 10.1016/j.neuroscience.2015.01.049; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nieto-Castanon A., 2020, HDB FUNCTIONAL CONNE; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Qian T, 2017, BRAIN CONNECT, V7, P627, DOI 10.1089/brain.2017.0545; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Spreng RN, 2016, NEUROBIOL AGING, V45, P149, DOI 10.1016/j.neurobiolaging.2016.05.020; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wu JT, 2011, NEUROSCI LETT, V504, P62, DOI 10.1016/j.neulet.2011.08.059; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	53	1	1	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 14	2020	34	12					1646	1654		10.1080/02699052.2020.1832257		OCT 2020	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OU7LB	WOS:000581175400001	33090913				2022-02-06	
J	Beauchamp, MH; Seguin, M; Gagner, C; Lalonde, G; Bernier, A				Beauchamp, M. H.; Seguin, M.; Gagner, C.; Lalonde, G.; Bernier, A.			The PARENT model: a pathway approach for understanding parents' role after early childhood mild traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Traumatic brain injury; concussion; early childhood; parent; parent-child interactions; mental health; model; predictors; behavior; post-concussive symptoms	POST-CONCUSSIVE SYMPTOMS; BEHAVIOR PROBLEMS; PSYCHOLOGICAL DISTRESS; WARM RESPONSIVENESS; MISERABLE MINORITY; SKILLS PROGRAM; YOUNG-CHILDREN; FAMILY BURDEN; HEAD-INJURIES; MENTAL-HEALTH	Objective Mild traumatic brain injury (mTBI or "concussion") is a highly prevalent health condition in children, and those under the age of 6 years have the highest rate of Emergency Department presentation for suspected head injuries. The outcome of mTBI is determined by a range of child (injury, biological, functional) and environmental (socio-economic status, parent, family) factors. The aim of this work is to present evidence supporting the central role of parental and familial factors in pediatric mTBI recovery, and to illustrate ways in which parental factors can especially influence the outcome of early mTBI, defined as injuries sustained by infants, toddlers and preschoolers. Method The manuscript first presents a topical review of empirical studies providing evidence that family functioning and parental factors such as their mental or affective state, parenting style, and the quality of their interactions with their child, are affected by and determine the course of recovery after pediatric mTBI. Then, a pathway approach and conceptual model are proposed to illustrate probable scenarios associated with how parents detect and react to their child's post-concussive symptoms and changes in behavior after early mTBI. Conclusion The "Perception, Attribution, and Response after Early Non-inflicted Traumatic Brain Injury" (PARENT) model suggests that parental roles and factors are especially influential in the context of early brain injuries, and that parents' ability to perceive, attribute and respond to the symptoms experienced by their child in a well-adjusted and adaptive manner critically sets the direction and rhythm of the early mTBI recovery process.	[Beauchamp, M. H.; Seguin, M.; Gagner, C.; Lalonde, G.; Bernier, A.] Univ Montreal, Dept Psychol, CP Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Beauchamp, M. H.; Seguin, M.; Gagner, C.; Lalonde, G.] St Justine Hosp Res Ctr, Montreal, PQ, Canada		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca		Bernier, Annie/0000-0002-2359-9808; Beauchamp, Miriam/0000-0002-8637-6361	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	This work was supported by grants from the Canadian Institutes of Health Research.	Aksan N, 2006, DEV PSYCHOL, V42, P833, DOI 10.1037/0012-1649.42.5.833; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Atif N, 2015, SEMIN PERINATOL, V39, P345, DOI 10.1053/j.semperi.2015.06.007; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Barnes J, 2019, INFANT MENT HEALTH J, V40, P817, DOI 10.1002/imhj.21812; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Beauchamp MH, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040603; Beauchamp MH, 2017, J NEUROTRAUM, V34, P2545, DOI 10.1089/neu.2016.4868; Beaudoin C., 2017, BRAIN INJURY IBIA S; Bendikas EA, 2011, REHABIL PSYCHOL, V56, P374, DOI 10.1037/a0025634; Bernard C, 2017, BRAIN INJURY, V31, P1414, DOI 10.1080/02699052.2017.1350999; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Bigler ED, 2015, BRAIN INJURY, V29, P1062, DOI 10.3109/02699052.2015.1011234; Bramley H, 2017, CLIN PEDIATR, V56, P1280, DOI 10.1177/0009922816681603; Brown FL, 2013, BRAIN INJURY, V27, P1570, DOI 10.3109/02699052.2013.841996; Brown FL, 2013, J HEAD TRAUMA REHAB, V28, P349, DOI 10.1097/HTR.0b013e318245fed5; Cacucci F, 2019, P NATL ACAD SCI USA, V116, P26204, DOI 10.1073/pnas.1912952116; Chavez-Arana C, 2019, J INT NEUROPSYCH SOC, V25, P237, DOI 10.1017/S1355617718001236; Coghlin Craig J, 2009, J Can Chiropr Assoc, V53, P233; Cohen ML, 2012, J PEDIATR PSYCHOL, V37, P251, DOI 10.1093/jpepsy/jsr086; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe Louise M, 2015, Handb Clin Neurol, V128, P661, DOI 10.1016/B978-0-444-63521-1.00041-8; Davidov M, 2015, DEV PSYCHOPATHOL, V27, P947, DOI 10.1017/S0954579415000619; De Los Reyes A, 2015, PSYCHOL BULL, V141, P858, DOI 10.1037/a0038498; Degeilh F, 2018, DEV PSYCHOBIOL, V60, P1037, DOI 10.1002/dev.21786; Dennis M, 2013, NEUROSCI BIOBEHAV R, V37, P2760, DOI 10.1016/j.neubiorev.2013.09.010; Dennis M, 2010, CORTEX, V46, P1043, DOI 10.1016/j.cortex.2009.10.008; Durber CM, 2017, NEUROPSYCHOLOGY, V31, P499, DOI 10.1037/neu0000351; Durish CL, 2018, J INT NEUROPSYCH SOC, V24, P11, DOI 10.1017/S1355617717000595; Fairbanks JM, 2013, REHABIL PSYCHOL, V58, P223, DOI 10.1037/a0033119; Field T, 2018, INFANT BEHAV DEV, V51, P24, DOI 10.1016/j.infbeh.2018.02.005; Figaji AA, 2017, CHILD NERV SYST, V33, P1649, DOI 10.1007/s00381-017-3582-z; Gagner C, 2021, J NEUROTRAUM, V38, P102, DOI 10.1089/neu.2019.6936; Gagner C, 2020, J PEDIATR PSYCHOL, V45, P50, DOI 10.1093/jpepsy/jsz071; Gagner C, 2018, PSYCHOL MED, V48, P1551, DOI 10.1017/S0033291717003221; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Gilmore JH, 2018, NAT REV NEUROSCI, V19, P123, DOI 10.1038/nrn.2018.1; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Groh AM, 2014, ATTACH HUM DEV, V16, P103, DOI 10.1080/14616734.2014.883636; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; O'Meara AMI, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00118; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Lalonde G, 2020, J NEUROPSYCHOL, V14, P98, DOI 10.1111/jnp.12179; Lalonde G, 2018, J NEUROPSYCHOL, V12, P1, DOI 10.1111/jnp.12104; Landry-Roy C, 2018, J INT NEUROPSYCH SOC, V24, P769, DOI 10.1017/S1355617718000401; Lantagne A, 2018, J PEDIATR PSYCHOL, V43, P703, DOI 10.1093/jpepsy/jsy020; Le YY, 2017, J FAM PSYCHOL, V31, P679, DOI 10.1037/fam0000315; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; Narad ME, 2017, DIGIT HEALTH, V3, DOI 10.1177/2055207617719423; Narad ME, 2017, J PEDIATR PSYCHOL, V42, P304, DOI 10.1093/jpepsy/jsw079; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Peterson RL, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318263f5ba; Podolak OE, 2021, PEDIATR EMERG CARE, V37, pE1652, DOI 10.1097/PEC.0000000000002148; Potter JL, 2011, REHABIL PSYCHOL, V56, P351, DOI 10.1037/a0025445; Powell KA, 2020, COMMUN Q, V68, P243, DOI 10.1080/01463373.2020.1759112; Raby KL, 2015, CHILD DEV, V86, P695, DOI 10.1111/cdev.12325; Raj SP, 2015, J HEAD TRAUMA REHAB, V30, P347, DOI 10.1097/HTR.0000000000000052; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Rashid M, 2014, J PEDIATR REHAB MED, V7, P241, DOI 10.3233/PRM-140293; Rausa VC, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0881-z; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sambuco M, 2008, BRAIN INJURY, V22, P7, DOI 10.1080/02699050701822022; Schoppe-Sullivan SJ, 2020, J MARRIAGE FAM, V82, P175, DOI 10.1111/jomf.12645; Schorr E, 2020, DISABIL REHABIL, V42, P2437, DOI 10.1080/09638288.2019.1602676; Seguin M, 2020, NEUROPSYCHOLOGY, V34, P375, DOI 10.1037/neu0000618; Serbin LA, 2015, DEV PSYCHOPATHOL, V27, P969, DOI 10.1017/S0954579415000632; Sharp C, 2008, SOC DEV, V17, P737, DOI 10.1111/j.1467-9507.2007.00457.x; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Skreden M, 2012, SCAND J PUBLIC HEALT, V40, P596, DOI 10.1177/1403494812460347; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Stancin T, 2010, J DEV BEHAV PEDIATR, V31, P317, DOI 10.1097/DBP.0b013e3181dbaf32; Staudt M, 2010, SEMIN PERINATOL, V34, P87, DOI 10.1053/j.semperi.2009.10.009; Suskauer SJ, 2018, J PEDIATR REHAB MED, V11, P7, DOI 10.3233/PRM-160424; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Thompson RA, 2001, AM PSYCHOL, V56, P5, DOI 10.1037//0003-066X.56.1.5; Treble-Barna A, 2016, DEV PSYCHOL, V52, P1777, DOI 10.1037/dev0000208; van der Veen-Mulders L, 2017, EUR CHILD ADOLES PSY, V26, P365, DOI 10.1007/s00787-016-0897-3; Volling BL, 2019, MONOGR SOC RES CHILD, V84, P7, DOI 10.1111/mono.12404; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; Wade SL, 2017, J AM ACAD CHILD PSY, V56, P930, DOI 10.1016/j.jaac.2017.09.413; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2010, NEUROREHABILITATION, V27, P63, DOI 10.3233/NRE-2010-0581; Wade SL, 2003, J HEAD TRAUMA REHAB, V18, P164, DOI 10.1097/00001199-200303000-00007; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Webb R, 2018, J AFFECT DISORDERS, V225, P608, DOI 10.1016/j.jad.2017.08.063; Wilson ML, 2019, INJURY PREV, V25, P283, DOI 10.1136/injuryprev-2017-042624; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Woods DT, 2011, DEV NEUROREHABIL, V14, P274, DOI 10.3109/17518423.2011.586371; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; Zemek R, 2014, GUIDELINES DIAGNOSIN; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	108	1	1	1	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUN 13	2021	35	5					846	867		10.1080/13854046.2020.1834621		OCT 2020	22	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	SV7PN	WOS:000583800100001	33103594				2022-02-06	
J	Liu, Y; Zhang, XF; Gao, C; Zhang, H; Zhang, HT; Qu, J				Liu, Yan; Zhang, Xiaofu; Gao, Chao; Zhang, Hang; Zhang, Hongtao; Qu, Jing			MicroRNA124 and microRNA21-5p regulate migration, proliferation and differentiation of rat bone marrow mesenchymal stem cells	BIOSCIENCE REPORTS			English	Article							SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; STROMAL CELLS; IN-VITRO; INHIBITS PROLIFERATION; FUNCTIONAL RECOVERY; DOWN-REGULATION; GLIOMA-CELLS; MIR-124; PROMOTES	Mesenchymal stem cells (MSCs) are multipotent stromal cells that can be a useful source of cells for the treatment of many diseases, including neurologic diseases. The curative effect of MSCs relies mostly on cell's capacity of migration, proliferation and differentiation. MicroRNAs (miRNAs) are small non-coding RNAs that play important roles on regulating various cell behaviors. Here, we report that miRNA-124 (miR124) and miRNA-21-5p (miR21-5p) display different regulatory roles on migration, proliferation and neuron differentiation of MSCs. MiR124 was shown greatly promoting MSCs migration and neuronal differentiation. MiR21-5p could significantly enhance the proliferation and neuronal differentiation ability of MSCs. MiR124 and miR21-5p synergistically promote differentiation of MSCs into neurons. Collectively, miR124 and miR21-5p can functionally regulate cell migration, proliferation and neuronal differentiation of MSCs. Therefore, miR124 and miR21-5p may be promising tools to improve transplantation efficiency for neural injury.	[Liu, Yan; Gao, Chao; Zhang, Hang; Zhang, Hongtao] Soochow Univ, Affiliated Hosp 1, Dept Orthoped, Suzhou, Jiangsu, Peoples R China; [Zhang, Xiaofu; Qu, Jing] Soochow Univ, Med Coll, Jiangsu Key Lab Stem Cell Res, Dept Cell Biol, Ren Ai Rd 199,Suzhou Ind Pk, Suzhou 215123, Peoples R China		Zhang, HT (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Orthoped, Suzhou, Jiangsu, Peoples R China.; Qu, J (corresponding author), Soochow Univ, Med Coll, Jiangsu Key Lab Stem Cell Res, Dept Cell Biol, Ren Ai Rd 199,Suzhou Ind Pk, Suzhou 215123, Peoples R China.	htzhangsz@163.com; qujing@suda.edu.cn		Qu, Jing/0000-0003-2911-8777	Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20141198]; Jiangsu provincial Commission of Health and Family Planning [H201619]	This work was supported by the Natural Science Foundation of Jiangsu Province [grant number BK20141198] and the Jiangsu provincial Commission of Health and Family Planning [grant number H201619].	Abumaree MH, 2013, STEM CELL REV REP, V9, P16, DOI 10.1007/s12015-012-9385-4; An LW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069478; Bernardo ME, 2009, ANN NY ACAD SCI, V1176, P101, DOI 10.1111/j.1749-6632.2009.04607.x; Buller B, 2010, FEBS J, V277, P4299, DOI 10.1111/j.1742-4658.2010.07818.x; Cai WL, 2018, MOL CANCER, V17, DOI 10.1186/s12943-017-0746-0; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen R, 2017, NEUROSCI LETT, V661, P71, DOI 10.1016/j.neulet.2017.09.037; Chen WQ, 2016, MOL CELL BIOCHEM, V412, P173, DOI 10.1007/s11010-015-2624-7; Du SM, 2016, ONCOL REP, V36, P3259, DOI 10.3892/or.2016.5163; Fang FJ, 2016, J DERMATOL SCI, V83, P95, DOI 10.1016/j.jdermsci.2016.03.003; Forostyak S, 2013, BIOCHIMIE, V95, P2257, DOI 10.1016/j.biochi.2013.08.004; Gao Y, 2016, CLIN CHIM ACTA, V460, P164, DOI 10.1016/j.cca.2016.06.044; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Guo YB, 2018, MOL NEUROBIOL, V55, P2494, DOI 10.1007/s12035-017-0484-8; Huang S, 2018, FASEB J, V32, P512, DOI 10.1096/fj.201700673R; Huang SL, 2010, PROTEIN CELL, V1, P916, DOI 10.1007/s13238-010-0116-9; Ji WC, 2019, BIOCHIMIE, V167, P171, DOI 10.1016/j.biochi.2019.10.002; Jiao SJ, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0194-y; Kang J, 2019, GENE THER, V26, P491, DOI 10.1038/s41434-019-0101-8; Kharaziha P, 2009, EUR J GASTROEN HEPAT, V21, P1199, DOI 10.1097/MEG.0b013e32832a1f6c; Kim YJ, 2009, STEM CELLS, V27, P3093, DOI 10.1002/stem.235; Laine SK, 2012, J CELL BIOCHEM, V113, P2687, DOI 10.1002/jcb.24144; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee HK, 2014, STEM CELLS DEV, V23, P2851, DOI 10.1089/scd.2014.0146; Leiker M, 2008, CELL TRANSPLANT, V17, P911, DOI 10.3727/096368908786576444; Li LS, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-163; Li ZL, 2016, INT J CLIN PHARM TH, V54, P603, DOI 10.5414/CP202551; Liang YJ, 2013, CARCINOGENESIS, V34, P713, DOI 10.1093/carcin/bgs383; Liu WS, 2016, AM J TRANSL RES, V8, P3179; Liu XR, 2018, MOL MED REP, V17, P1970, DOI 10.3892/mmr.2017.8097; Lu J, 2006, NEUROSCI LETT, V398, P12, DOI 10.1016/j.neulet.2005.12.053; Luo GX, 2017, MOL MED REP, V15, P187, DOI 10.3892/mmr.2016.5971; Lv C, 2017, J CLIN NEUROSCI, V46, P156, DOI 10.1016/j.jocn.2017.07.040; Lv C, 2016, J CLIN NEUROSCI, V27, P154, DOI 10.1016/j.jocn.2015.07.029; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Men YQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11534-w; Ni YX, 2014, NEURAL REGEN RES, V9, P828, DOI 10.4103/1673-5374.131599; Qu J, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/5251313; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Reger Roxanne L., 2008, V449, P93, DOI 10.1007/978-1-60327-169-1_7; Sakai A, 2013, BIOCHEM BIOPH RES CO, V435, P176, DOI 10.1016/j.bbrc.2013.04.089; Salewski RP, 2015, STEM CELL TRANSL MED, V4, P743, DOI 10.5966/sctm.2014-0236; Sangani R, 2014, STEM CELL RES, V12, P354, DOI 10.1016/j.scr.2013.11.002; Siddiqui AM, 2015, PROG BRAIN RES, V218, P15, DOI 10.1016/bs.pbr.2014.12.007; Simeoli R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01841-5; Song JL, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.48; Strickland IT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023423; Taj SH, 2016, BIOMATERIALS, V91, P151, DOI 10.1016/j.biomaterials.2016.03.025; Twaroski DM, 2014, ANESTHESIOLOGY, V121, P786, DOI 10.1097/ALN.0000000000000345; Vaquero J, 2011, PROG NEUROBIOL, V93, P341, DOI 10.1016/j.pneurobio.2010.12.002; Wang JH, 2015, MOL MED REP, V12, P1810, DOI 10.3892/mmr.2015.3567; Wang P, 2014, ONCOGENE, V33, P514, DOI 10.1038/onc.2012.598; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Xu WW, 2012, NEUROSCI LETT, V529, P12, DOI 10.1016/j.neulet.2012.09.025; Xu XL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-276; Ye Y, 2018, NEUROSCI LETT, V666, P85, DOI 10.1016/j.neulet.2017.12.043; Yeh WL, 2015, ONCOTARGET, V6, P37770, DOI 10.18632/oncotarget.6092; Yu AY, 2017, IMMUNOL LETT, V182, P1, DOI 10.1016/j.imlet.2016.12.003; Yu B, 2018, MOL MED REP, V17, P6736, DOI 10.3892/mmr.2018.8637; Yu LD, 2018, MOL MED REP, V17, P3972, DOI 10.3892/mmr.2017.8348; Yuan QY, 2017, CANCER BIOMARK, V19, P93, DOI 10.3233/CBM-160427; Yue Q, 2016, EUR J CELL BIOL, V95, P342, DOI 10.1016/j.ejcb.2016.06.005; Zeng YL, 2017, ONCOTARGET, V8, P29161, DOI 10.18632/oncotarget.16254; Zhang C, 2015, ONCOL REP, V34, P2195, DOI 10.3892/or.2015.4186; Zhang GL, 2018, INT J CANCER, V143, P635, DOI 10.1002/ijc.31329; Zhang HY, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00931; Zhang X, 2016, ONCOL REP, V36, P2321, DOI 10.3892/or.2016.5025; Zhao Y, 2015, TISSUE CELL, V47, P140, DOI 10.1016/j.tice.2015.01.007; Zheng B, 2013, J CELL PHYSIOL, V228, P149, DOI 10.1002/jcp.24114; Zou DF, 2014, NEURAL REGEN RES, V9, P1241, DOI 10.4103/1673-5374.135333	70	1	1	4	12	PORTLAND PRESS LTD	LONDON	5TH FLR, 90 HIGH HOLBORN, LONDON WC1V 6LJ, ENGLAND	0144-8463	1573-4935		BIOSCIENCE REP	Biosci. Rep.	OCT 23	2020	40		10						BSR20193531	10.1042/BSR20193531			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ON8WW	WOS:000586974700001	33026076	Green Published, gold			2022-02-06	
J	Sayrs, LW; Ortiz, JB; Notrica, DM; Kirsch, L; Kelly, C; Stottlemyre, R; Cohen, A; Misra, S; Green, TR; Adelson, PD; Lifshitz, J; Rowe, RK				Sayrs, Lois W.; Ortiz, J. Bryce; Notrica, David M.; Kirsch, Lisa; Kelly, Cara; Stottlemyre, Rachael; Cohen, Aaron; Misra, Shivani; Green, Tabitha R.; Adelson, P. David; Lifshitz, Jonathan; Rowe, Rachel K.			Intimate Partner Violence, Clinical Indications, and Other Family Risk Factors Associated With Pediatric Abusive Head Trauma	JOURNAL OF INTERPERSONAL VIOLENCE			English	Article; Early Access						violence exposure; child abuse; physical abuse; child abuse; domestic violence; prevention of child abuse; child abuse	CHILD MALTREATMENT; YOUNG-CHILDREN; BRAIN-INJURY; DOMESTIC VIOLENCE; PHYSICAL ABUSE; COMA SCALE; INFANTS; DEATH; OPPORTUNITIES; CONSEQUENCES	Over half of fatal pediatric traumatic brain injuries are estimated to be the result of physical abuse, i.e., abusive head trauma (AHT). Although intimate partner violence (IPV) is a well-established risk for child maltreatment, little is known about IPV as an associated risk factor specifically for AHT. We performed a single-institution, retrospective review of all patients (0-17 years) diagnosed at a Level 1 pediatric trauma center with head trauma who had been referred to an in-hospital child protection team for suspicion of AHT between 2010 and 2016. Data on patient demographics, hospitalization, injury, family characteristics, sociobehavioral characteristics, physical examination, laboratory findings, imaging, discharge, and forensic determination of AHT were extracted from the institution's forensic registry. Descriptive statistics (mean, median), chi-square and Mann-Whitney U tests were used to compare patients with fatal head injuries to patients with nonfatal head injuries by clinical characteristics, family characteristics, and forensic determination. Multiple logistic regression was used to estimate adjusted odds ratios for the presence of IPV as an associated risk of AHT while controlling for other clinical and family factors. Of 804 patients with suspicion for AHT in the forensic registry, there were 240 patients with a forensic determination of AHT; 42 injuries were fatal. There were 101 families with a reported history of IPV; 64.4% of patients in families with reported IPV were <12 months of age. IPV was associated with a twofold increase in the risk of AHT (Exp(beta) = 2.3 [p = .02]). This study confirmed IPV was an associated risk factor for AHT in a single institution cohort of pediatric patients with both fatal and nonfatal injuries. Identifying IPV along with other family factors may improve detection and surveillance of AHT in medical settings and help reduce injury, disability, and death.	[Sayrs, Lois W.] Phoenix Childrens Hosp, Pediat Surg & Trauma Res, Phoenix, AZ 85003 USA; [Ortiz, J. Bryce; Adelson, P. David; Rowe, Rachel K.] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Notrica, David M.; Misra, Shivani; Green, Tabitha R.; Lifshitz, Jonathan] Phoenix Childrens Hosp, Phoenix, AZ USA; [Kirsch, Lisa] Phoenix Childrens Hosp, Child Protect Team, Phoenix, AZ USA; [Kelly, Cara] Phoenix Childrens Hosp, Trauma Res, Phoenix, AZ USA; [Stottlemyre, Rachael] Phoenix Childrens Hosp, Surg & Trauma, Phoenix, AZ USA; [Sayrs, Lois W.] Univ Arizona, Coll Med Phoenix, Child Hlth, Phoenix, AZ USA; [Ortiz, J. Bryce; Misra, Shivani; Adelson, P. David] Univ Arizona, Coll Med Phoenix, Phoenix, AZ USA; [Notrica, David M.] Univ Arizona, Child Hlth & Surg, Coll Med Phoenix, Phoenix, AZ USA; [Lifshitz, Jonathan] Univ Arizona, Child Hlth, Coll Med Phoenix, Phoenix, AZ USA; [Rowe, Rachel K.] Univ Arizona, Dept Child Hlth, Coll Med Phoenix, Phoenix, AZ USA; [Kelly, Cara] Arizona State Univ, Sch Social Work, Phoenix, AZ USA; [Lifshitz, Jonathan; Rowe, Rachel K.] Phoenix Vet Affairs Hlth Care Syst, Phoenix, AZ USA; [Cohen, Aaron] Valleywise Hlth Med Ctr, Phoenix, AZ USA		Sayrs, LW (corresponding author), Phoenix Childrens Hosp, Phoenix, AZ 85003 USA.	Lsayrs@phoenixchildrens.com		Rowe, Rachel/0000-0002-9034-3159			Abuse Office on Child Neglect Children's Bureau, 2003, Child protection in families experiencing domestic violence; Ali PA, 2016, AGGRESS VIOLENT BEH, V31, P16, DOI 10.1016/j.avb.2016.06.008; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Berger RP, 2011, PEDIATRICS, V128, P637, DOI 10.1542/peds.2010-2185; Berger RP, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.0429; Bonkowsky JL, 2008, PEDIATRICS, V122, P125, DOI 10.1542/peds.2007-3376; Chen CC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030390; Cherry R, 2016, CHILD YOUTH SERV REV, V66, P117, DOI 10.1016/j.childyouth.2016.05.008; Christian CW, 2015, PEDIATRICS, V135, pE1337, DOI 10.1542/peds.2015-0356; Christian CW, 2009, PEDIATRICS, V123, P1409, DOI 10.1542/peds.2009-0408; Currie J, 2010, CHILD MALTREATMENT, V15, P111, DOI 10.1177/1077559509355316; Damashek A, 2013, CHILD ABUSE NEGLECT, V37, P735, DOI 10.1016/j.chiabu.2013.04.014; Drake B, 2006, CHILD ABUSE NEGLECT, V30, P1201, DOI 10.1016/j.chiabu.2006.05.008; Dudley N, 2015, PEDIATRICS, V135, pE255, DOI 10.1542/peds.2014-3424; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Duhaime AC, 2019, J NEUROSURG-PEDIATR, V24, P481, DOI 10.3171/2019.7.PEDS18394; Eisele JA, 2006, J HEAD TRAUMA REHAB, V21, P537, DOI 10.1097/00001199-200611000-00008; Ellingson KD, 2008, AM J PREV MED, V34, pS157, DOI 10.1016/j.amepre.2007.12.021; Erickson SJ, 2005, ARCH PEDIAT ADOL MED, V159, P1173, DOI 10.1001/archpedi.159.12.1173; Evans SE, 2008, AGGRESS VIOLENT BEH, V13, P131, DOI 10.1016/j.avb.2008.02.005; Featherstone B, 2019, CHILD YOUTH SERV REV, V97, P127, DOI 10.1016/j.childyouth.2017.06.009; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Ferguson NM, 2016, PEDIATR CRIT CARE ME, V17, P444, DOI 10.1097/PCC.0000000000000709; Gencturk M, 2019, CLIN NEURORADIOL, V29, P253, DOI 10.1007/s00062-018-0663-7; Glaser D, 2000, J CHILD PSYCHOL PSYC, V41, P97, DOI 10.1111/1469-7610.00551; Hymel KP, 2019, CHILD ABUSE NEGLECT, V88, P266, DOI 10.1016/j.chiabu.2018.11.015; Hymel KP, 2014, PEDIATRICS, V134, pE1537, DOI 10.1542/peds.2014-1329; O'Meara AMI, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00118; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Jenny C, 2006, ARCH DIS CHILD, V91, P265, DOI 10.1136/adc.2004.066696; Jonson-Reid M, 2007, CHILD MALTREATMENT, V12, P86, DOI 10.1177/1077559506296722; Keenan HT, 2019, J NEUROTRAUM, V36, P282, DOI 10.1089/neu.2018.5687; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kelly P, 2015, ARCH DIS CHILD, V100, P1123, DOI 10.1136/archdischild-2014-306960; Kemp AM, 2011, ARCH DIS CHILD, V96, P1103, DOI 10.1136/archdischild-2011-300630; King WK, 2006, PEDIATR EMERG CARE, V22, P211, DOI 10.1097/01.pec.0000208180.94166.dd; Kitzmann KM, 2003, J CONSULT CLIN PSYCH, V71, P339, DOI 10.1037/0022-006X.71.2.339; Kochar A, 2020, EMERG MED J, V37, P127, DOI 10.1136/emermed-2018-208154; Letson MM, 2016, CHILD ABUSE NEGLECT, V60, P36, DOI 10.1016/j.chiabu.2016.09.001; Maguire SA, 2011, PEDIATRICS, V128, pE550, DOI 10.1542/peds.2010-2949; Miller TR, 2018, PREV SCI, V19, P695, DOI 10.1007/s11121-017-0815-z; Minns RA, 2008, AM J PREV MED, V34, pS126, DOI 10.1016/j.amepre.2008.01.016; Morad Y, 2010, CLIN EXP OPHTHALMOL, V38, P514, DOI 10.1111/j.1442-9071.2010.02291.x; Narang S, 2014, J CHILD NEUROL, V29, P1747, DOI 10.1177/0883073814549995; Niederkrotenthaler T, 2013, CHILD ABUSE NEGLECT, V37, P446, DOI 10.1016/j.chiabu.2013.02.002; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Notrica DM, 2020, J PEDIATR SURG, V55, P341, DOI 10.1016/j.jpedsurg.2019.10.010; Oral R, 2008, PEDIATR EMERG CARE, V24, P816, DOI 10.1097/PEC.0b013e31818e9f5d; Palusci VJ, 2014, CHILD ABUSE NEGLECT, V38, P25, DOI 10.1016/j.chiabu.2013.08.014; Paul AR, 2014, TRANSL PEDIATR, V3, P195, DOI 10.3978/j.issn.2224-4336.2014.06.01; Pears KC, 2001, CHILD ABUSE NEGLECT, V25, P1439, DOI 10.1016/S0145-2134(01)00286-1; Piteau SJ, 2012, PEDIATRICS, V130, P315, DOI 10.1542/peds.2011-1545; Rolfes MC, 2018, J PEDIATR NEUROL, V16, P39, DOI 10.1055/s-0037-1604212; Scott D, 2009, CHILD ABUSE NEGLECT, V33, P791, DOI 10.1016/j.chiabu.2009.08.005; Sheets LK, 2013, PEDIATRICS, V131, P701, DOI 10.1542/peds.2012-2780; Sieswerda-Hoogendoorn T, 2012, EUR J PEDIATR, V171, P415, DOI 10.1007/s00431-011-1598-z; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; Snyder Christopher W, 2014, Int J Circumpolar Health, V73, P25066, DOI 10.3402/ijch.v73.25066; Springer KW, 2007, CHILD ABUSE NEGLECT, V31, P517, DOI 10.1016/j.chiabu.2007.01.003; Stith SM, 2009, AGGRESS VIOLENT BEH, V14, P13, DOI 10.1016/j.avb.2006.03.006; Tiyyagura G, 2018, CHILD ABUSE NEGLECT, V79, P136, DOI 10.1016/j.chiabu.2018.02.003; van IJzendoorn MH, 2020, J CHILD PSYCHOL PSYC, V61, P272, DOI 10.1111/jcpp.13147; Wilson S.R., 2009, TRAUMATIC BRAIN INJU, P183	65	1	1	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0886-2605	1552-6518		J INTERPERS VIOLENCE	J. Interpers. Violence											0886260520967151	10.1177/0886260520967151		OCT 2020	28	Criminology & Penology; Family Studies; Psychology, Applied	Social Science Citation Index (SSCI)	Criminology & Penology; Family Studies; Psychology	SM9GY	WOS:000657906600001	33092447				2022-02-06	
J	Fong, AK; Allen, MD; Waltzman, D; Sarmiento, K; Yeates, KO; Suskauer, S; Wintermark, M; Lindberg, DM; Tate, DF; Wilde, EA; Loewen, JL				Fong, Alina K.; Allen, Mark D.; Waltzman, Dana; Sarmiento, Kelly; Yeates, Keith Owen; Suskauer, Stacy; Wintermark, Max; Lindberg, Daniel M.; Tate, David F.; Wilde, Elizabeth A.; Loewen, Jaycie L.			Neuroimaging in Pediatric Patients with Mild Traumatic Brain Injury: Relating the Current 2018 Centers for Disease Control Guideline and the Potential of Advanced Neuroimaging Modalities for Research and Clinical Biomarker Development	JOURNAL OF NEUROTRAUMA			English	Article						arterial spin labeling; Centers for Disease Control and Prevention; computed tomography; concussion; diffusion tensor imaging; diffusion-weighted imaging; functional magnetic resonance imaging; magnetic resonance spectroscopy imaging; mild traumatic brain injury; positron emission tomography; single-photon emission computerized tomography	SPORTS-RELATED CONCUSSION; TENSOR IMAGING FINDINGS; CEREBRAL-BLOOD-FLOW; DIFFUSION TENSOR; COMPUTED-TOMOGRAPHY; WORKING-MEMORY; HEAD-INJURY; UNITED-STATES; DECISION RULE; CHILDREN	The Center for Disease Control and Prevention (CDC)'s 2018 Guideline for current practices in pediatric mild traumatic brain injury (mTBI; also referred to as concussion herein) systematically identified the best up-to-date practices based on current evidence and, specifically, identified recommended practices regarding computed tomography (CT), magnetic resonance imaging (MRI), and skull radiograph imaging. In this article, we discuss types of neuroimaging not discussed in the guideline in terms of their safety for pediatric populations, their potential application, and the research investigating the future use of certain modalities to aid in the diagnosis and treatment of mTBI in children. The role of neuroimaging in pediatric mTBI cases should be considered for the potential contribution to children's neural and social development, in addition to the immediate clinical value (as in the case of acute structural findings). Selective use of specific neuroimaging modalities in research has already been shown to detect aspects of diffuse brain injury, disrupted cerebral blood flow, and correlate physiological factors with persistent symptoms, such as fatigue, cognitive decline, headache, and mood changes, following mTBI. However, these advanced neuroimaging modalities are currently limited to the research arena, and any future clinical application of advanced imaging modalities in pediatric mTBI will require robust evidence for each modality's ability to provide measurement of the subtle conditions of brain development, disease, damage, or degeneration, while accounting for variables at both non-injury and time-post-injury epochs. Continued collaboration and communication between researchers and healthcare providers is essential to investigate, develop, and validate the potential of advanced imaging modalities in pediatric mTBI diagnostics and management.	[Fong, Alina K.; Allen, Mark D.; Loewen, Jaycie L.] CognitiveFx, Provo, UT 84604 USA; [Waltzman, Dana; Sarmiento, Kelly] Ctr Dis Control & Prevent CDC, Natl Ctr Injury Prevent & Control, Div Injury Prevent, Atlanta, GA USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Suskauer, Stacy] Kennedy Krieger Inst, Baltimore, MD USA; [Wintermark, Max] Stanford Univ, Dept Neuroradiol, Stanford, CA 94305 USA; [Lindberg, Daniel M.] Univ Colorado, Emergency Med, Denver, CO 80202 USA; [Tate, David F.] Univ Missouri, Missouri Inst Mental Hlth, St Louis, MO 63121 USA; [Wilde, Elizabeth A.] Baylor Coll Med, Phys Med & Rehabil, Houston, TX 77030 USA		Loewen, JL (corresponding author), CognitiveFx, Provo, UT 84604 USA.	jaycie@cognitivefxusa.com	Yeates, Keith/AAJ-4223-2020		Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD083559]	A portion of Dr. Lindberg's effort was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (grant K23HD083559). Dr.'s Loewen, Fong, and Allen's contributions were fully or in part funded by Cognitive FX. All research and review was conducted free of bias. All other authors have nothing to disclose.	Abdel-Aziz K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105774; Ashwal S, 2014, J CHILD NEUROL, V29, P1704, DOI 10.1177/0883073814538504; Babcock L, 2015, J PEDIATR REHAB MED, V8, P285, DOI 10.3233/PRM-150347; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Barkovich MJ, 2019, NEUROIMAGE, V185, P793, DOI 10.1016/j.neuroimage.2018.04.044; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Berger RP, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-3756; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Burstein B, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0814; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Chamard E, 2018, BRAIN INJURY, V32, P816, DOI 10.1080/02699052.2018.1463106; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Friedman SD, 2017, NEUROLOGY, V89, P2151, DOI 10.1212/WNL.0000000000004666; Ghosh N, 2017, DEV NEUROSCI-BASEL, V39, P413, DOI 10.1159/000475545; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goodrich-Hunsaker NJ, 2018, J NEUROSCI RES, V96, P626, DOI 10.1002/jnr.24142; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Howell BR, 2019, NEUROIMAGE, V185, P891, DOI 10.1016/j.neuroimage.2018.03.049; Howell DR, 2019, CLIN PEDIATR, V58, P42, DOI 10.1177/0009922818806308; Iyer KK, 2019, ANN CLIN TRANSL NEUR, V6, P954, DOI 10.1002/acn3.764; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; King R, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101842; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Krivitzky LS, 2011, J INT NEUROPSYCH SOC, V17, P1143, DOI 10.1017/S1355617711001226; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langen CD, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1031; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Maruta J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01034; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meyer EJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00556; Munson S, 2006, PEDIATRICS, V117, P1372, DOI 10.1542/peds.2005-0826; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Raichle ME, 2009, TRENDS NEUROSCI, V32, P118, DOI 10.1016/j.tins.2008.11.001; Saluja RS, 2015, J NEUROTRAUM, V32, P712, DOI 10.1089/neu.2014.3470; Satchell EK, 2019, MUSCULOSKEL SCI PRAC, V42, P162, DOI 10.1016/j.msksp.2019.05.002; Satterthwaite TD, 2014, NEUROIMAGE, V86, P544, DOI 10.1016/j.neuroimage.2013.07.064; Scheinost D, 2015, HUM BRAIN MAPP, V36, P1524, DOI 10.1002/hbm.22720; Schmidt J, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3406; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Silverberg ND, 2016, JAMA PEDIATR, V170, P946, DOI 10.1001/jamapediatrics.2016.1187; Sinopoli KJ, 2014, J NEUROTRAUM, V31, P1843, DOI 10.1089/neu.2014.3326; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; Sun BC, 2007, ANN EMERG MED, V49, P325, DOI 10.1016/j.annemergmed.2006.08.032; Suskauer SJ, 2019, J HEAD TRAUMA REHAB, V34, P215, DOI 10.1097/HTR.0000000000000455; Thibeault CM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00200; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Westfall DR, 2015, J PEDIATR REHAB MED, V8, P297, DOI 10.3233/PRM-150348; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wing Benjamin H, 2017, Open Neuroimag J, V11, P58, DOI 10.2174/1874440001711010058; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yang Z, 2012, J NEUROTRAUM, V29, P2124, DOI 10.1089/neu.2012.2395; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	90	1	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2021	38	1					44	52		10.1089/neu.2020.7100		OCT 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PN6IA	WOS:000586272000001	32640874	Green Published			2022-02-06	
J	Lucca, LF; Lofaro, D; Leto, E; Ursino, M; Rogano, S; Pileggi, A; Vulcano, S; Conforti, D; Tonin, P; Cerasa, A				Lucca, Lucia Francesca; Lofaro, Danilo; Leto, Elio; Ursino, Maria; Rogano, Stefania; Pileggi, Antonio; Vulcano, Serafino; Conforti, Domenico; Tonin, Paolo; Cerasa, Antonio			The Impact of Medical Complications in Predicting the Rehabilitation Outcome of Patients With Disorders of Consciousness After Severe Traumatic Brain Injury	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						severe traumatic brain injury (sTBI); medical complications; neurorehabiliation; machine learning; predictor factors	RATING-SCALE; BILE-ACID; MORTALITY; MODEL; COMORBIDITIES; EPIDEMIOLOGY; ASSOCIATION; DEFINITION; DISABILITY; STATE	In this study, we sought to assess the predictors of outcome in patients with disorders of consciousness (DOC) after severe traumatic brain injury (TBI) during neurorehabilitation stay. In total, 96 patients with DOC (vegetative state, minimally conscious state, or emergence from minimally conscious state) were enrolled (69 males; mean age 43.6 +/- 20.8 years) and the improvement of the degree of disability, as assessed by the Disability Rating Scale, was considered the main outcome measure. To define the best predictor, a series of demographical and clinical factors were modeled using a twofold approach: (1) logistic regression to evaluate a possible causal effect among variables; and (2) machine learning algorithms (ML), to define the best predictive model. Univariate analysis demonstrated that disability in DOC patients statistically decreased at the discharge with respect to admission. Genitourinary was the most frequent medical complication (MC) emerging during the neurorehabilitation period. The logistic model revealed that the total amount of MCs is a risk factor for lack of functional improvement. ML discloses that the most important prognostic factors are the respiratory and hepatic complications together with the presence of the upper gastrointestinal comorbidities. Our study provides new evidence on the most adverse short-term factors predicting a functional recovery in DOC patients after severe TBI. The occurrence of medical complications during neurorehabilitation stay should be considered to avoid poor outcomes.	[Lucca, Lucia Francesca; Leto, Elio; Ursino, Maria; Rogano, Stefania; Pileggi, Antonio; Tonin, Paolo; Cerasa, Antonio] S Anna Inst, Crotone, Italy; [Lofaro, Danilo; Conforti, Domenico] UNICAL, Eng deHlth Lab, Arcavacata Di Rende, Italy; [Vulcano, Serafino] San Giovanni di Dio Hosp, Crotone, Italy; [Cerasa, Antonio] CNR, Inst Biomed Res & Innovat IRIB, Mangone, Italy		Cerasa, A (corresponding author), S Anna Inst, Crotone, Italy.; Cerasa, A (corresponding author), CNR, Inst Biomed Res & Innovat IRIB, Mangone, Italy.	antonio.cerasa76@gmail.com	cerasa, antonio/E-8614-2011; Lucca, Lucia Francesca/AAB-8558-2022; Tonin, Paolo/K-7483-2016	cerasa, antonio/0000-0002-8022-4770; Tonin, Paolo/0000-0002-4867-1378; LUCCA, LUCIA FRANCESCA/0000-0002-7602-2711			Chan Vincy, 2017, BMC Res Notes, V10, P371, DOI 10.1186/s13104-017-2682-x; Estraneo A, 2018, ARCH PHYS MED REHAB, V99, P2523, DOI 10.1016/j.apmr.2018.04.024; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Gaddam Samson Sujit Kumar, 2015, Handb Clin Neurol, V127, P205, DOI 10.1016/B978-0-444-52892-6.00014-3; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Glocker, 2020, HDB MED IMAGE COMPUT, P457, DOI DOI 10.1016/B978-0-12-816176-0.00024-7; Greenwald BD, 2015, J NEUROTRAUM, V32, P1883, DOI 10.1089/neu.2014.3454; Hamill V, 2015, J NEUROTRAUM, V32, P689, DOI 10.1089/neu.2014.3670; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P2114, DOI 10.1016/j.apmr.2008.04.013; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Hocomb EM, 2012, ARCH PHYS MED REHAB, V93, P1338, DOI 10.1016/j.apmr.2012.04.029; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lasry O, 2017, NEUROLOGY, V89, P2198, DOI 10.1212/WNL.0000000000004671; Lucca LF, 2019, J NEUROTRAUM, V36, P2430, DOI 10.1089/neu.2018.5963; Mathias JL, 2015, NEUROSCI BIOBEHAV R, V55, P573, DOI 10.1016/j.neubiorev.2015.06.001; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Merzo A, 2016, ACTA NEUROCHIR, V158, P125, DOI 10.1007/s00701-015-2639-6; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Nizamutdinov D, 2017, SCI REP-UK, V7, DOI 10.1038/srep40112; Pascarella A, 2016, J NEUROL, V263, P2048, DOI 10.1007/s00415-016-8232-y; Peters Matthew E, 2018, Concussion, V3, pCNC56, DOI 10.2217/cnc-2018-0001; Pisner DA., 2020, MACH LEARN, P101, DOI [10.1016/B978-0-12-815739-8.00006-7, DOI 10.1016/B978-0-12-815739-8.00006-7]; Pistoia F, 2015, J NEUROTRAUM, V32, P682, DOI 10.1089/neu.2014.3659; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Riganello F, 2016, J NEUROTRAUM, V33, P423, DOI 10.1089/neu.2015.3906; Riganello F, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-164; Rodrigues TMP, 2002, J CEREBR BLOOD F MET, V22, P463, DOI 10.1097/00004647-200204000-00010; Salvi F, 2008, J AM GERIATR SOC, V56, P1926, DOI 10.1111/j.1532-5415.2008.01935.x; Sara M, 2011, NEUROREHAB NEURAL RE, V25, P35, DOI 10.1177/1545968310378508; Scarponi F, 2019, EUR J PHYS REHAB MED, V55, P191, DOI 10.23736/S1973-9087.18.05342-X; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Victorino GP, 2003, ARCH SURG-CHICAGO, V138, P1093, DOI 10.1001/archsurg.138.10.1093; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027	42	1	1	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	OCT 21	2020	14								570544	10.3389/fnhum.2020.570544			9	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	OK2RV	WOS:000584499400001	33192402	Green Published, gold			2022-02-06	
J	Ghandour, E; Hould, LL; Fortier, FA; Gelinas, V; Melnick, ER; Hess, EP; Lang, ES; Gravel, J; Perry, JJ; Le Sage, N; Truchon, C; LeBlanc, A; Dubrovsky, AS; Gagnon, MP; Ouellet, MC; Gagnon, I; McKenna, S; Legare, F; Sauve, L; van de Belt, TH; Kavanagh, E; Paquette, L; Verrette, AC; Plante, P; Riopelle, RJ; Archambault, PM				Ghandour, El Kebir; Lelaidier Hould, Lania; Fortier, Felix-Antoine; Gelinas, Veronique; Melnick, Edward R.; Hess, Erik P.; Lang, Eddy S.; Gravel, Jocelyn; Perry, Jeffrey J.; Le Sage, Natalie; Truchon, Catherine; LeBlanc, Annie; Dubrovsky, Alexander Sasha; Gagnon, Marie-Pierre; Ouellet, Marie-Christine; Gagnon, Isabelle; McKenna, Suzanne; Legare, France; Sauve, Louise; van de Belt, Tom H.; Kavanagh, Eric; Paquette, Laurence; Verrette, Anne-Catherine; Plante, Patrick; Riopelle, Richard J.; Archambault, Patrick M.		Canadian Critical Care Trials Grp; Canadian Traumatic Brain Injury; Network Canadian Emergency	Adapting two American Decision Aids for Mild Traumatic Brain Injury to the Canadian Context Using the Nominal Group Technique	PATIENT-PATIENT CENTERED OUTCOMES RESEARCH			English	Article							CT HEAD RULE; RISK; MODEL	Background Decision aids are patient-focused tools that have the potential to reduce the overuse of head computed tomography (CT) scans. Objective The objective of this study was to create a consensus among Canadian mild traumatic brain injury and emergency medicine experts on modifications required to adapt two American decision aids about head CT use for adult and paediatric mild traumatic brain injury to the Canadian context. Methods We invited 21 Canadian stakeholders and the two authors of the American decision aids to a Nominal Group Technique consensus meeting to generate suggestions for adapting the decision aids. This method encourages idea generation and sharing between team members. Each idea was discussed and then prioritised using a voting system. We collected data using videotaping, writing material and online collaborative writing tools. The modifications proposed were analysed using a qualitative thematic content analysis. Results Twenty-one participants took part in the meeting, including researchers and clinician researchers (n = 9; 43%), patient partners (n = 3; 14%) and decision makers (n = 2; 10%). A total of 84 ideas were generated. Participants highlighted the need to clarify the purpose of the decision aids, the nature of the problem being addressed and the target population. The tools require sociocultural adaptations, better identification of their target population, better description of head CT utility, advantages and related risks, modification of the visual and written representation of the risk of brain injury and head CT use, and locally adapted, patient follow-up plans. Conclusions This study based on a Nominal Group Technique identified several adaptations for two American decision aids about head CT use for mild traumatic brain injury to support their use in Canada's different healthcare, social, cultural and legal context. These adaptations concerned the target users of the decision aids, the information presented, and how the benefits and risks were communicated in the decision aids. Future steps include prototyping the two adapted decision aids, conducting formative evaluations with actual emergency department patients and clinicians, and measuring the impact of the adapted tools on CT scan use. Plain Language Summary A mild traumatic brain injury (also called concussion) can happen when the brain moves around in the skull after an impact to the head. A concussion is not a brain bleed and you cannot see a concussion. Concussions do not show up on a computed tomography (CT) scan. Brain bleeds do. Computed tomography scans are specialised X-ray machines that can detect serious brain injuries. Unfortunately, CT scan use also exposes patients to radiation and a future increased risk of cancer. Shared decision making involves health professionals and patients making decisions together based on the best available evidence, health professionals' experience, and patients' values and preferences. Shared decision making improves appropriate diagnostic test use. Two decision aids created in the USA are available to facilitate shared decision making regarding the use of head CT scans for patients with concussion. These decision aids are not fully adapted for use in Canada because the healthcare, social and legal context is different. Our study brought together patients and experts in the field of concussion and shared decision making to analyse these decision aids and propose adaptations that would increase their acceptance in Canadian emergency departments. We used a technique called the Nominal Group Technique to create a consensus about the most important changes to make to both original decision aids. The main adaptations needed for the Canadian context concerned avoiding information about cost and removing any information that does not change clinical management. This project will help us adapt two decision aids for clinical use in Canada and support appropriate CT scan use for patients with concussion.	[Ghandour, El Kebir; Truchon, Catherine] Inst Natl Excellence Sante & Serv Sociaux INESSS, 2535 Blvd Laurier,5e Etage, Quebec City, PQ G1V 4M3, Canada; [Ghandour, El Kebir; Lelaidier Hould, Lania; Fortier, Felix-Antoine; Gelinas, Veronique; Archambault, Patrick M.] Ctr Integre Sante & Serv Sociaux Chaudiere Appala, Levis, PQ, Canada; [Melnick, Edward R.] Yale Univ, Sch Med, New Haven, CT USA; [Hess, Erik P.] Univ Alabama Birmingham, Dept Emergency Med, Birmingham, AL USA; [Lang, Eddy S.] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada; [Gravel, Jocelyn] Univ Montreal, Dept Pediat, Montreal, PQ, Canada; [Perry, Jeffrey J.] Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada; [Perry, Jeffrey J.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Le Sage, Natalie; LeBlanc, Annie; Legare, France; Archambault, Patrick M.] Univ Laval, Dept Family Med & Emergency Med, Quebec City, PQ, Canada; [Dubrovsky, Alexander Sasha] McGill Univ, Pediat & Pediat Emergency Med, Montreal, PQ, Canada; [Gagnon, Marie-Pierre] Univ Laval, Sch Nursing, Quebec City, PQ, Canada; [Ouellet, Marie-Christine] Univ Laval, Sch Psychol, Quebec City, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [McKenna, Suzanne] Brain Injury Canada, Ottawa, ON, Canada; [Sauve, Louise; Plante, Patrick] TELUQ, Quebec City, PQ, Canada; [van de Belt, Tom H.] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands; [Kavanagh, Eric; Paquette, Laurence; Verrette, Anne-Catherine] Univ Laval, Sch Design, Quebec City, PQ, Canada; [Riopelle, Richard J.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada		Ghandour, E (corresponding author), Inst Natl Excellence Sante & Serv Sociaux INESSS, 2535 Blvd Laurier,5e Etage, Quebec City, PQ G1V 4M3, Canada.; Ghandour, E (corresponding author), Ctr Integre Sante & Serv Sociaux Chaudiere Appala, Levis, PQ, Canada.	elkebir.ghandour@inesss.qc.ca	Ghandour, El Kebir/ABE-3147-2020; Le Sage, Natalie/G-7063-2016	Ghandour, El Kebir/0000-0002-5410-4265; Le Sage, Natalie/0000-0003-4762-8156; Gagnon, Isabelle/0000-0003-2043-1644; Plante, Patrick/0000-0002-0860-5798; Legare, France/0000-0002-2296-6696			Archambault PM, 2018, CAN J EMERG MED, V20, P435, DOI 10.1017/cem.2018.370; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brodersen J, 2018, BMJ EVID-BASED MED, V23, P1, DOI 10.1136/ebmed-2017-110886; Chenel V, 2018, PATIENT PREFER ADHER, V12, P321, DOI 10.2147/PPA.S151833; Cheng AHY, 2017, CAN J EMERG MED, V19, pS9, DOI 10.1017/cem.2017.1; Chernomas R, 2018, CHOOSE COMP US CANAD; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; DELBECQ AL, 1971, J APPL BEHAV SCI, V7, P466, DOI 10.1177/002188637100700404; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Elwyn G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004705; Flynn D, 2012, ACAD EMERG MED, V19, P959, DOI 10.1111/j.1553-2712.2012.01414.x; Harvey N, 2012, INT J NURS PRACT, V18, P188, DOI 10.1111/j.1440-172X.2012.02017.x; Hess EP, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-253; Hess ER, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2430; Huang WY, 2014, BRIT J CANCER, V110, P2354, DOI 10.1038/bjc.2014.103; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kuppermann N, 2008, PEDIATR RADIOL, V38, pS670, DOI 10.1007/s00247-008-0996-5; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Melnick Edward R, 2017, J Med Internet Res, V19, pe174, DOI 10.2196/jmir.7846; Melnick Edward R, 2015, EGEMS (Wash DC), V3, P1136, DOI 10.13063/2327-9214.1136; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Naik G, 2012, BRIT J GEN PRACT, V62, P213, DOI 10.3399/bjgp12X636236; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Parma C, 2014, AM SURGEON, V80, P664; Rao D., 2017, C OPEN, V5, pE301, DOI 10.9778/cmajo.20160115; Ridic Goran, 2012, Mater Sociomed, V24, P112, DOI 10.5455/msm.2012.24.112-120; Rootman I., 2008, VISION HLTH LITERATE; Schoenfeld EM, 2019, ANN EMERG MED, V74, P126, DOI 10.1016/j.annemergmed.2018.11.017; Schoenfeld EM, 2018, ACAD EMERG MED, V25, P1118, DOI 10.1111/acem.13499; Sharp AL, 2018, ANN EMERG MED, V71, P54, DOI 10.1016/j.annemergmed.2017.06.022; Singh N, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.8732; Skains RM, 2020, HEALTH EXPECT, V23, P63, DOI 10.1111/hex.12965; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Straus S, 2011, KNOWLEDGE TRANSLATIO	40	1	1	1	4	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1178-1653	1178-1661		PATIENT	Patient	DEC	2020	13	6			SI		729	743		10.1007/s40271-020-00459-y		OCT 2020	15	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	OP9UP	WOS:000579731800001	33078377	Green Accepted			2022-02-06	
J	Mundluru, J; Subhan, A; Lo, TWB; Churchill, N; Fornazzari, L; Munoz, DG; Schweizer, TA; Fischer, CE				Mundluru, Jahnavi; Subhan, Abdul; Lo, Tsz Wai Bentley; Churchill, Nathan; Fornazzari, Luis; Munoz, David G.; Schweizer, Tom A.; Fischer, Corinne E.			Neuropsychiatric Presentations due to Traumatic Brain Injury in Cognitively Normal Older Adults	JOURNAL OF NEUROTRAUMA			English	Article						neuropsychiatric symptoms (NPS); sex differences; traumatic brain injury (TBI)	SEX-DIFFERENCES; CONCUSSION; DISORDERS; DISINHIBITION; DISTURBANCES; TESTOSTERONE; SYMPTOMS	Neuropsychiatric symptoms (NPS) are common sequelae of traumatic brain injuries (TBI) among adults. However, little is known about NPS associated with a history of TBI in adults relative to adults without a history of TBI and to what extent NPS may be modulated by sex and other factors. Using the National Alzheimer's Coordinating Center Uniform Data Set, we examined the association between Neuropsychiatric Inventory-Questionnaire (NPI-Q) scores in cognitively normal older adults with and without a history of TBI. A binomial logistic regression model was used to examine NPI-Q domains in adults with a history of TBI (n = 266) versus without a history of TBI (n = 1508). History of TBI, sex, age, and body mass index were used as covariates. Adults with a history of TBI had a greater probability of exhibiting agitation, anxiety, apathy, disinhibition and aberrant motor behavior relative to adults without a history of TBI. In terms of sex differences, males with and without a history of TBI had an increased likelihood of agitation, apathy, disinhibition, and apnea, whereas femaleshad an increased likelihood of anxiety and insomnia relative to males. Our study confirms that history of TBI is associated with an increased prevalence of specific NPS, including agitation, anxiety, apathy, disinhibition, and aberrant motor behavior. Given that the aforementioned NPS are linked through different pathways, damage to any of them may cause an alteration in behavior. As well, NPS appear to be modulated by sex, with symptoms differing between males and females. Our research suggests future studies examining NPS sequelae of TBI should adjust for sex.	[Mundluru, Jahnavi; Subhan, Abdul; Lo, Tsz Wai Bentley; Churchill, Nathan; Fornazzari, Luis; Munoz, David G.; Schweizer, Tom A.; Fischer, Corinne E.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Churchill, Nathan; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada; [Munoz, David G.] St Michaels Hosp, Dept Pathol, Toronto, ON, Canada; [Fornazzari, Luis] Univ Toronto, Dept Med, Toronto, ON, Canada; [Munoz, David G.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Schweizer, Tom A.; Fischer, Corinne E.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Fischer, Corinne E.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada		Fischer, CE (corresponding author), St Michaels Hosp, Geriatr Psychiat, 30 Bond St, Toronto, ON M5B 1W8, Canada.	corinne.fischer@unityhealth.to			National Institute on Aging (NIA)/National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01 AG016976, P30 AG019610, P50 AG025688, P50 AG047266, P30 AG010133, P50 AG005146, P30 AG062421-01, P30 AG062422-01, P50 AG005138, P30 AG008051, P30 AG013854, P30 AG008017, P30 AG010161, P50 AG047366, P30 AG010129, P30 AG053760]	We would like to thank the NACC foundation for allowing us the use of their database. The NACC database is funded by National Institute on Aging (NIA)/National Institutes of Health Grant U01 AG016976. NACC data are contributed by the NIA-funded ADCs: P30 AG019610 (PI Eric Reiman, MD), P30 AG013846 (PI Neil Kowall, MD), P30 AG062428-01 (PI James Leverenz, MD) P50 AG008702 (PI Scott Small, MD), P50 AG025688 (PI Allan Levey, MD, PhD), P50 AG047266 (PI Todd Golde, MD, PhD), P30 AG010133 (PI Andrew Saykin, PsyD), P50 AG005146 (PI Marilyn Albert, PhD), P30 AG062421-01 (PI Bradley Hyman, MD, PhD), P30 AG062422-01 (PI Ronald Petersen, MD, PhD), P50 AG005138 (PI Mary Sano, PhD), P30 AG008051 (PI Thomas Wisniewski, MD), P30 AG013854 (PI Robert Vassar, PhD), P30 AG008017 (PI Jeffrey Kaye, MD), P30 AG010161 (PI David Bennett, MD), P50 AG047366 (PI Victor Henderson, MD, MS), P30 AG010129 (PI Charles DeCarli, MD), P50 AG016573 (PI Frank LaFerla, PhD), P30 AG062429-01(PI James Brewer, MD, PhD), P50 AG023501 (PI Bruce Miller, MD), P30 AG035982 (PI Russell Swerdlow, MD), P30 AG028383 (PI Linda Van Eldik, PhD), P30 AG053760 (PI Henry Paulson, MD, PhD), P30 AG010124 (PI John Trojanowski, MD, PhD), P50 AG005133 (PI Oscar Lopez, MD), P50 AG005142 (PI Helena Chui, MD), P30 AG012300 (PI Roger Rosenberg, MD), P30 AG049638 (PI Suzanne Craft, PhD), P50 AG005136 (PI Thomas Grabowski, MD), P30 AG062715-01 (PI Sanjay Asthana, MD, FRCP), P50 AG005681 (PI John Morris, MD), P50 AG047270 (PI Stephen Strittmatter, MD, PhD).	Alzeheimer's Association, 2019, WHAT IS DEM; Batrinos ML, 2012, INT J ENDOCRINOL MET, V10, P563, DOI 10.5812/ijem.3661; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Beekly DL, 2004, ALZ DIS ASSOC DIS, V18, P270; Besser L, 2018, ALZ DIS ASSOC DIS, V32, P351, DOI 10.1097/WAD.0000000000000279; Bewick V, 2004, CRIT CARE, V8, P46, DOI 10.1186/cc2428; Bors D., 2018, DATA ANAL SOCIAL SCI; Brodaty H, 2010, INT PSYCHOGERIATR, V22, P426, DOI 10.1017/S1041610209991335; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Canadian Institutes of Health Research, 2015, TRAUM BRAIN INJ DOES; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Cole W.R., 2016, TRANSLATIONAL RES TR, pFL; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Jaussent I, 2011, AM J GERIAT PSYCHIAT, V19, P88, DOI 10.1097/JGP.0b013e3181e049b6; Kahn H.A., 1989, STAT METHODS EPIDEMI; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/jnp.12.2.233; Knutson KM, 2014, HUM BRAIN MAPP, V35, P943, DOI 10.1002/hbm.22225; Kocka A, 2014, BEHAV SCI, V4, P352, DOI 10.3390/bs4040352; Kohnen RF, 2018, BRAIN INJURY, V32, P1591, DOI 10.1080/02699052.2018.1538537; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Ma Cheng, 2019, Chin Neurosurg J, V5, P24, DOI 10.1186/s41016-019-0173-8; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mayo Clinic, SLEEP APN SYMPT CAUS; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Oberholzer M., 2019, MED SCI BASEL SWITZ, P7; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Singh R, 2014, BRAIN INJURY, V28, P336, DOI 10.3109/02699052.2013.873142; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Sugarman MA, 2018, J ALZHEIMERS DIS, V62, P1841, DOI 10.3233/JAD-170527; Svensson AI, 2003, PHARMACOL BIOCHEM BE, V75, P481, DOI 10.1016/S0091-3057(03)00137-0; UCLA Institute for Digital Research and Education, 2020, LOG REGR SPSS ANN OU; van der Naalt J, 2000, BRAIN INJURY, V14, P781; Wald A, 1940, ANN MATH STAT, V11, P147, DOI 10.1214/aoms/1177731909; Williamson D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029604; Zar JH., 2014, SPEARMAN RANK CORREL	45	1	1	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2021	38	5					566	572		10.1089/neu.2020.7282		OCT 2020	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QP9GR	WOS:000582261700001	32977734				2022-02-06	
J	Stenberg, J; Karr, JE; Karlsen, RH; Skandsen, T; Silverberg, ND; Iverson, GL				Stenberg, Jonas; Karr, Justin E.; Karlsen, Rune H.; Skandsen, Toril; Silverberg, Noah D.; Iverson, Grant L.			Examining Test-Retest Reliability and Reliable Change for Cognition Endpoints for the CENTER-TBI Neuropsychological Test Battery	FRONTIERS IN NEUROLOGY			English	Article						brain concussion; brain injury; cognition; neuropsychology; psychometrics	TRAUMATIC BRAIN-INJURY; MULTIVARIATE BASE RATES; ADVANCED CLINICAL INTERPRETATION; LOW SCORES; INTERPRETING CHANGE; IMPAIRMENT; OUTCOMES; METAANALYSES; CANTAB; COMMON	Objective: Seven candidate cognition composite scores have been developed and evaluated as part of a research program designed to validate a cognition endpoint for traumatic brain injury (TBI) research and clinical trials, but these composites have yet to be examined longitudinally. This study examined test-retest reliability and methods for determining reliable change for these seven candidate composite scores, using the neuropsychological test battery from the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI). Methods: Participants (18-59 years-old) with mild TBI (n = 124), orthopedic trauma without head injury (n = 67), and healthy community controls (n = 63) from the Trondheim MTBI follow-up study completed the CENTER-TBI neuropsychological test battery at 2 weeks and 3 months after injury. The battery included both traditional paper-and-pencil tests and computerized tests from the Cambridge Neuropsychological Test Automated Battery (CANTAB). Seven composite scores were calculated for the paper-and-pencil tests, the CANTAB tests, and all tests combined (i.e., 21 composites in total on each assessment): the overall test battery mean (OTBM); global deficit score (GDS); neuropsychological deficit score-weighted (NDS-W); low score composite (LSC); and the number of scores <= 5th percentile, <= 16th percentile, or <50th percentile. The OTBM was calculated by averaging T scores for all tests. The other composite scores were deficit-based scores, assigning different weights to low scores. Results: All composites revealed better cognitive performance at the 3-month assessment compared to the 2-week assessment and the magnitude of improvement was similar across groups. Differences, in terms of effect sizes, were largest on the OTBMs. In the combined composites, the test-retest correlation was highest for the OTBM (Spearman's rho = 0.87, in the community control group) and lowest for the number of scores <= 5th percentile (rho = 0.41). Conclusion: The high test-retest reliability of the OTBM appears to favor its use in TBI research; however, future studies are needed to examine these candidate composite scores in participants with more severe TBIs and cognitive deficits and the association of the composites with functional outcomes.	[Stenberg, Jonas; Karlsen, Rune H.; Skandsen, Toril] Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway; [Stenberg, Jonas] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Karr, Justin E.; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Karr, Justin E.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Karr, Justin E.; Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Karr, Justin E.; Iverson, Grant L.] A Red Sox Fdn, Home Base, Charlestown, MA USA; [Karr, Justin E.; Iverson, Grant L.] Massachusetts Gen Hosp Program, Charlestown, MA USA; [Karr, Justin E.; Iverson, Grant L.] Spaulding Res Inst, Charlestown, MA USA; [Skandsen, Toril] Trondheim Reg & Univ Hosp, Dept Phys Med & Rehabil, St Olavs Hosp, Trondheim, Norway; [Silverberg, Noah D.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.] GF Strong Rehabil Ctr, Rehabil Res Program, Vancouver, BC, Canada		Stenberg, J (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway.; Stenberg, J (corresponding author), Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway.	jonas.stenberg@ntnu.no	Stenberg, Jonas/AAN-4552-2021	Stenberg, Jonas/0000-0002-5769-7959	U.S. Department of Defense, TBI Endpoints Development InitiativeUnited States Department of Defense [W81XWH-142-0176]; Central Norway Regional Health Authority (RHA) [90157700]; Norwegian University of Science and Technology (NTNU) [90157700]	Foundations for this work were funded in part by the U.S. Department of Defense as part of the TBI Endpoints Development Initiative with a grant entitled Development and Validation of a Cognition Endpoint for Traumatic Brain Injury Clinical Trials (subaward from W81XWH-142-0176). JS received funding from the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU) (project number 90157700). Unrestricted philanthropic support was provided by the Spaulding Research Institute.	Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Brooks BL, 2008, J INT NEUROPSYCH SOC, V14, P463, DOI 10.1017/S1355617708080521; Brooks BL, 2013, PRACT RESOUR MENT, P75, DOI 10.1016/B978-0-12-386934-0.00002-X; Brooks BL, 2011, ASSESSMENT, V18, P156, DOI 10.1177/1073191110385316; Brooks BL, 2009, ARCH CLIN NEUROPSYCH, V24, P647, DOI 10.1093/arclin/acp061; Burton Adrian, 2017, Lancet Neurol, V16, P958, DOI 10.1016/S1474-4422(17)30358-7; Cacciamani F, 2018, APPL NEUROPSYCH-ADUL, V25, P237, DOI 10.1080/23279095.2017.1286346; Calamia M, 2013, CLIN NEUROPSYCHOL, V27, P1077, DOI 10.1080/13854046.2013.809795; Cambridge Cognition, 2012, CANTABECLIPSE 5 TEST; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cohen J, 1998, STAT POWER ANAL BEHA; Cysique LA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0298-0; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Einarsen CE, 2019, J NEUROTRAUM, V36, P3172, DOI 10.1089/neu.2018.6360; Franzen M. D., 2000, RELIABILITY VALIDITY; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Goncalves MM, 2016, APPL NEUROPSYCH-ADUL, V23, P251, DOI 10.1080/23279095.2015.1053889; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Holdnack JA, 2017, ARCH CLIN NEUROPSYCH, V32, P574, DOI 10.1093/arclin/acx032; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; Iverson GL, 2020, ARCH CLIN NEUROPSYCH, V35, P312, DOI 10.1093/arclin/acz070; Iverson GL, 2020, ARCH CLIN NEUROPSYCH, V35, P56, DOI 10.1093/arclin/acz021; Ivins BJ, 2015, ARCH CLIN NEUROPSYCH, V30, P26, DOI 10.1093/arclin/acu072; Karlsen RH, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1722126; Karr JE, 2018, CLIN NEUROPSYCHOL, V32, P42, DOI 10.1080/13854046.2017.1334828; Karr JE, 2017, ARCH CLIN NEUROPSYCH, V32, P297, DOI 10.1093/arclin/acw105; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lemay S, 2004, CLIN NEUROPSYCHOL, V18, P284, DOI 10.1080/13854040490501718; Lowe C, 1998, NEUROPSYCHOLOGIA, V36, P915, DOI 10.1016/S0028-3932(98)00036-0; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; Miller LS, 2001, NEUROPSYCHOL REV, V11, P143, DOI 10.1023/A:1016602708066; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Pallant J.F., 2007, SPSS SURVIVAL MANUAL; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Schmidt M., 1996, REY AUDITORY VERBAL; Silverberg ND, 2017, J NEUROTRAUM, V34, P363, DOI 10.1089/neu.2016.4443; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; STENBERG J, 2020, FRONT NEUROL, V0011; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Wheble JLC, 2016, J ROY ARMY MED CORPS, V162, P87, DOI 10.1136/jramc-2015-000472; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7	47	1	1	2	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 20	2020	11								541533	10.3389/fneur.2020.541533			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OJ2OY	WOS:000583807400001	33192971	Green Published, gold			2022-02-06	
J	Salmon, DM; Sullivan, SJ; Murphy, I; Mihalik, JKR; Dougherty, B; McCrory, G				Salmon, Danielle M.; Sullivan, S. John; Murphy, Ian; Mihalik, Johna K. Regiser; Dougherty, Bret; McCrory, Graeme			Square peg round hole-Time to customise a concussion assessment tools for primary care: The New Zealand experience? A call for a GP-SCAT	BRAIN INJURY			English	Article						concussion; primary care; SCAT; primary care; rugby; childSCAT		In rugby union concussions are a player welfare concern, particularly in the community game where there is often minimal sideline medical support. New Zealand Rugby (NZR) has three primary goals around the management of concussions in the community game: (1) players with a suspected concussion are removed from the game or training; (2) players are referred into primary care for a diagnosis by a general practitioner(GPs) (doctor in primary care); (3) prior to returning to contact training that they are medically cleared by a doctor. Given their role in the diagnosis and medical clearance of players with a concussion, GPs are a key stakeholder in the concussion management pathway. Thus to ensure that players are safely returning to play, NZR acknowledged the need to better support and engage with GPs. This editorial is an opportunity for NZR to share our experience working collaboratively with GPs in New Zealand to support the diagnosis and medical clearance of players following a rugby-related concussion.	[Salmon, Danielle M.; Sullivan, S. John; Murphy, Ian] New Zealand Rugby, Injury Prevent, Wellington, New Zealand; [Mihalik, Johna K. Regiser] Univ N Carolina, Matthew Gfeller Sport Related TBI Res Ctr, Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Dougherty, Bret] Univ Otago, Student Hlth Ratoka Hauroa Akoka, Dunedin, New Zealand; [McCrory, Graeme] Hastings Hlth Ctr, Hastings, New Zealand		Salmon, DM (corresponding author), New Zealand Rugby, Wellington 6140, New Zealand.	Danielle.salmon@nzrugby.co.nz					[Anonymous], 2017, J PROSTHET DENT, V11, pe1; Arbogast KB, 2017, CLIN PEDIATR, V56, P854, DOI 10.1177/0009922817709555; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mrazik M, 2015, BRIT J SPORT MED; Patricios J, 2012, BRIT J SPORT MED, V46, P198, DOI 10.1136/bjsports-2011-090386; Quarrie K, 2020, SPORTS MED, V50, P227, DOI 10.1007/s40279-019-01177-8; Salmon D, 2020, BRIT J SPORT MED, V54, P300, DOI 10.1136/bjsports-2019-100949; SCAT3, 2013, BRIT J SPORT MED, V47, P259	9	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 5	2020	34	13-14					1794	1795		10.1080/02699052.2020.1831607		OCT 2020	2	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PH5MZ	WOS:000589545600001	33190545				2022-02-06	
J	Botchway, EN; Godfrey, C; Ryan, NP; Hearps, S; Nicholas, CL; Anderson, VA; Catroppa, C				Botchway, Edith N.; Godfrey, Celia; Ryan, Nicholas P.; Hearps, Stephen; Nicholas, Christian L.; Anderson, Vicki A.; Catroppa, Cathy			Sleep disturbances in young adults with childhood traumatic brain injury: relationship with fatigue, depression, and quality of life	BRAIN INJURY			English	Article						Sleep disturbances; childhood; traumatic brain injury; young adulthood	STRESS SCALES DASS; PSYCHOMETRIC PROPERTIES; OBJECTIVE ASSESSMENT; SEVERITY SCALE; RISK-FACTORS; WHOQOL-BREF; CHILDREN; ADOLESCENTS; INSOMNIA; HEALTH	Objective This study assessed the consequences of childhood traumatic brain injury (TBI) on sleep, fatigue, depression, and quality of life (QoL) outcomes and explored the relationships between these variables at 20 years following childhood TBI. Participants . We followed up 54 young adults with mild, moderate, and severe TBI, and 13 typically developing control (TDC) participants, recruited at the time of TBI. Methods . Sleep was assessed with the Pittsburgh Sleep Quality Index and actigraphy. Results . At 20 years postinjury, results showed no significant difference between whole TBI group and TDC participants on subjective sleep quality; however, the moderate TBI group reported significantly poorer subjective sleep quality compared to those with severe TBI. Poorer subjective sleep was associated with increased symptoms of fatigue, depression, and poorer perceptions of General Health in the TBI group. Actigraphic sleep efficiency, fatigue, depression, and QoL outcomes were not significantly different between TBI and TDC or among TBI severity groups. Conclusions . These preliminary findings underscore associations between subjective sleep disturbance, fatigue, depression, and QoL in this TBI sample, and mostly comparable outcomes in sleep, fatigue, depression, and QoL between the TBI and TDC groups. Further research is required to clarify these findings.	[Botchway, Edith N.; Godfrey, Celia; Ryan, Nicholas P.; Hearps, Stephen; Nicholas, Christian L.; Anderson, Vicki A.; Catroppa, Cathy] Murdoch Childrens Res Inst, Clin Sci, Parkville, Vic 3025, Australia; [Botchway, Edith N.; Godfrey, Celia; Ryan, Nicholas P.; Hearps, Stephen; Anderson, Vicki A.; Catroppa, Cathy] Royal Childrens Hosp, Dept Psychol, Parkville, Vic, Australia; [Botchway, Edith N.; Godfrey, Celia; Ryan, Nicholas P.; Anderson, Vicki A.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Ryan, Nicholas P.] Deakin Univ, Cognit Neurosci Unit, Geelong, Vic, Australia; [Nicholas, Christian L.; Anderson, Vicki A.; Catroppa, Cathy] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Nicholas, Christian L.] Austin Hlth, Inst Breathing & Sleep, Heidelberg, Vic, Australia		Botchway, EN (corresponding author), Murdoch Childrens Res Inst, Clin Sci, Parkville, Vic 3025, Australia.	edith.botchway@mcri.edu.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436; Ryan, Nicholas/0000-0002-0878-8889; Botchway, Edith N/0000-0002-0075-3382; Hearps, Stephen/0000-0003-2984-1172	Victorian Government's Operational Infrastructure Support Program	This work was supported by the Victorian Government's Operational Infrastructure Support Program. We thank our collaborators from the Sleep Research Laboratory, Melbourne School of Psychological Sciences, University of Melbourne (Victoria, Australia). We also appreciate all participating families for their dedication to this study, and generous participation in this follow-up.	Alvaro PK, 2013, SLEEP, V36, P1059, DOI 10.5665/sleep.2810; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Anderson VA, 2014, DEV MED CHILD NEUROL, V56, P329, DOI 10.1111/dmcn.12387; Blytt KM, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0653-7; Botchway EN, 2019, J HEAD TRAUMA REHAB, V34, P241, DOI 10.1097/HTR.0000000000000446; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Bruce ES, 2017, CLIN MED J R COLL PH, V17; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Chiu WT, 2006, J NEUROTRAUM, V23, P1609, DOI 10.1089/neu.2006.23.1609; Corwin EJ, 2002, BIOL RES NURS, V3, DOI [10.1177/109980040200300407, DOI 10.1177/109980040200300407.]; Crichton A, 2015, PEDIATRICS, V135, pE1015, DOI 10.1542/peds.2014-2440; Crichton AJ, 2017, J HEAD TRAUMA REHAB, V32, P107, DOI 10.1097/HTR.0000000000000248; Daniel A., 1983, POWER PRIVILEGE PRES; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Diaz-Roman A, 2018, NEUROSCI BIOBEHAV R, V89, P61, DOI 10.1016/j.neubiorev.2018.02.014; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Durish CL, 2018, J HEAD TRAUMA REHAB, V33, pE18, DOI 10.1097/HTR.0000000000000343; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ekinci O, 2017, INT J PSYCHIAT MED, V52, P72, DOI 10.1177/0091217417703288; El-Khatib H, 2019, SLEEP MED, V59, P67, DOI 10.1016/j.sleep.2018.11.012; Eren S, 2014, SOCIAL CARE NEURODIS, V5, P135, DOI [10.1108/SCN-06-2013-0022, DOI 10.1108/SCN-06-2013-0022]; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Fischer JT, 2018, NEUROPSYCHOLOGY, V32, P161, DOI 10.1037/neu0000420; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Goni M, 2018, DIAGNOSTICS, V8, DOI 10.3390/diagnostics8030042; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jain A, 2014, ASIAN J PSYCHIATR, V8, P99, DOI 10.1016/j.ajp.2013.12.017; Jonsson CCA, 2014, INT J REHABIL RES, V37, P317, DOI 10.1097/MRR.0000000000000073; Kalakoti P, 2016, WORLD NEUROSURG, V91, P635, DOI 10.1016/j.wneu.2016.04.053; Karimi M, 2016, PHARMACOECONOMICS, V34, P645, DOI 10.1007/s40273-016-0389-9; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Landry-Roy C, 2017, J HEAD TRAUMA REHAB, V32, pE13, DOI 10.1097/HTR.0000000000000303; Leger D, 2000, J SLEEP RES, V9, P35, DOI 10.1046/j.1365-2869.2000.00178.x; Lovato N, 2014, SLEEP MED REV, V18, P521, DOI 10.1016/j.smrv.2014.03.006; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; McCabe M, 2009, J ADV NURS, V65, P1735, DOI 10.1111/j.1365-2648.2009.05046.x; Milroy G, 2008, J PEDIATR PSYCHOL, V33, P242, DOI 10.1093/jpepsy/jsm099; Morse AM, 2018, MED SCI, V6; Muthen L. K., 2015, COMPREHENSIVE MODELL, V5; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rosenthal R., 1994, HDB RES SYNTHESIS, P231, DOI DOI 10.7758/9781610441377.20; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Seow SLE, 2018, SLEEP MED, V41, DOI [10.1016/j.sleep.2017.09.015, DOI 10.1016/J.SLEEP.2017.09.015.]; Shay N, 2014, J NEUROTRAUM, V31, P1305, DOI 10.1089/neu.2013.3275; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Shirley Ryan Ability Lab, 2018, FAT SEV SCAL; Shochat T, 2012, NAT SCI SLEEP, V4, P19, DOI 10.2147/NSS.S18891; Singareddy R, 2012, SLEEP MED, V13, P346, DOI 10.1016/j.sleep.2011.10.033; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Smith DJ, 2004, ADV PSYCHIAT TREAT, V10, DOI [10.1192/apt.10.1.4, DOI 10.1192/APT.10.1.4]; Stores G, 2013, DEV MED CHILD NEUROL, V55, P797, DOI 10.1111/dmcn.12163; Sumpter RE, 2013, J INT NEUROPSYCH SOC, V19, P829, DOI 10.1017/S1355617713000465; Tham SW, 2015, J NEUROTRAUM, V32, P847, DOI 10.1089/neu.2014.3559; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Valko PO, 2008, SLEEP, V31, P1601, DOI 10.1093/sleep/31.11.1601; van Markus-Doornbosch F, 2019, EUR J PAEDIATR NEURO, V23, P707, DOI 10.1016/j.ejpn.2019.08.003; Wilkinson J, 2018, NEUROPSYCHOL REV, V28, P73, DOI 10.1007/s11065-018-9370-z; Zhou ES, 2016, J PEDIATR PSYCHOL, V41, P623, DOI 10.1093/jpepsy/jsv071	80	1	1	2	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 14	2020	34	12					1579	1589		10.1080/02699052.2020.1832704		OCT 2020	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OU7LB	WOS:000578281500001	33054410				2022-02-06	
J	Farkhondeh, T; Azimi-Nezhad, M; Samini, F; Pourbagher-Shahri, AM; Samarghandian, S				Farkhondeh, Tahereh; Azimi-Nezhad, Mohsen; Samini, Fariborz; Pourbagher-Shahri, Ali Mohammad; Samarghandian, Saeed			Neuroprotective Effect of Alpinia galanga Against Middle Cerebral Artery Occlusion- Induced Ischemia in Rat	BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY			English	Article						Alpinia Galanga; Cerebral Ischemia; locomotor Functions; Middle Cerebral Artery Occlusion; Neuroprotection	TRAUMATIC BRAIN-INJURY; VOLATILE CONSTITUENTS; EXTRACT; OILS; L.	Alpinia galangal (A. galanga) is among the oldest traditional medications. A. galangal has important antioxidant characteristics. In the current research, we investigated the neuroprotective potential of ethanol extract of rhizomes of A. galanga in middle cerebral artery occlusion (MCAO)induced ischemia in rats. Rats were treated with A. galanga (10 and 20 mg/kg, i.p.) every 24 hours for 3 days after MCAO for 45 minutes. The behavioral impairments in rotarod performance, Angle board, and Grip test were decreased significantly in A. galanga treated rats compared to the sham- operated rats. The ischemic rats treated with A. galanga significantly improved neurobehavioral performance compared to the untreated ischemic rats. Furthermore, A. galangal treatment reduced the contralateral cortical infarct area in the MCAO rats. Our results indicated the neuroprotective properties of A. galanga in the rat model of cerebral ischemia.	[Farkhondeh, Tahereh] Birjand Univ Med Sci, Cardiovasc Dis Res Ctr, Birjand, Iran; [Azimi-Nezhad, Mohsen; Samarghandian, Saeed] Neyshabur Univ Med Sci, Noncommunicable Dis Res Ctr, Neyshabur, Iran; [Samini, Fariborz] Mashhad Univ Med Sci, Sch Med, Dept Neurosurg, Mashhad, Razavi Khorasan, Iran; [Pourbagher-Shahri, Ali Mohammad] Birjand Univ Med Sci, Fac Med, Birjand, Iran		Samarghandian, S (corresponding author), Neyshabur Univ Med Sci, Noncommunicable Dis Res Ctr, Neyshabur, Iran.	samarghandians1@nums.ac.ir	Pourbagher-Shahri, Ali Mohammad Mohammad/Y-5021-2018	Pourbagher-Shahri, Ali Mohammad Mohammad/0000-0003-4462-9890	Neyshabur University of Medical Sciences	The authors would like to thank the research affairs of the Neyshabur University of Medical Sciences for financially supporting this work.	Adwanikar H, 2011, NEUROMETHODS, V50, P237, DOI 10.1007/978-1-60761-883-6_10; Bavarsad K, 2019, MOL NEUROBIOL, V56, P1391, DOI 10.1007/s12035-018-1169-7; BELAYEV L, 1995, STROKE, V26, P2313, DOI 10.1161/01.STR.26.12.2313; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Callaway J.K., 1998, P ASCEPT; Duman A, 2018, BIOINTERFACE RES APP, V8, P3441; Gad H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213319; Gaire BP, 2018, CHIN J INTEGR MED, V24, P243, DOI 10.1007/s11655-018-2828-2; Georgakis MK, 2019, NEUROLOGY, V92, pE1298, DOI 10.1212/WNL.0000000000007142; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hermann DM, 2019, EXPERT OPIN DRUG DIS, V14, P315, DOI 10.1080/17460441.2019.1573984; Karbwang J, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/4935786; Kumar K., 2020, LETT APPL NANOBIOSCI, V9, P774, DOI [10.33263/LIANBS91.774778., DOI 10.33263/LIANBS91.774778]; L Lin, 2016, Biochem Pharmacol (Los Angel), V5, DOI 10.4172/2167-0501.1000213; Liu J, 2018, STROKE VASC NEUROL, V3, P222, DOI 10.1136/svn-2018-000152; Milot MR, 2009, BEHAV BRAIN RES, V200, P173, DOI 10.1016/j.bbr.2009.01.009; Mollaamin F., 2019, LETT APPL NANOBIOSCI, V8, P613; Mundugaru R, 2018, INDIAN J PHARM EDUC, V52, pS77, DOI 10.5530/ijper.52.4s.79; Pena-Bautista C, 2019, CLIN CHIM ACTA, V491, P85, DOI 10.1016/j.cca.2019.01.021; Peters O, 1998, J CEREBR BLOOD F MET, V18, P196, DOI 10.1097/00004647-199802000-00011; Piccardi B, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021183; Pierre S, 1999, NEUROREPORT, V10, P47, DOI 10.1097/00001756-199901180-00009; Powers WJ, 2019, STROKE, V50, pE344, DOI 10.1161/STR.0000000000000211; Raina AP, 2014, J ESSENT OIL RES, V26, P24, DOI 10.1080/10412905.2013.822430; Rana VS, 2010, J ESSENT OIL RES, V22, P521, DOI 10.1080/10412905.2010.9700388; Ritzel RM, 2017, P NATL ACAD SCI USA, V114, pE5673, DOI 10.1073/pnas.1607002114; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Si WH, 2018, FOOD CHEM, V239, P1117, DOI 10.1016/j.foodchem.2017.07.055; Verma R. K., 2011, Der Pharmacia Sinica, V2, P142; Yazgan B, 2018, BIOINTERFACE RES APP, V8, P3193; Zou P, 2018, MOL MED REP, V17, P3212, DOI 10.3892/mmr.2017.8241	32	1	1	1	3	BIOINTERFACE RESEARCH APPLIED CHEMISTRY	BUCURESTI	BIOINTERFACE RESEARCH APPLIED CHEMISTRY, BUCURESTI, 00000, ROMANIA	2069-5837			BIOINTERFACE RES APP	Biointerface Res. Appl. Chem.	OCT 15	2020	10	5					6185	6193		10.33263/BRIAC105.62736281			9	Chemistry, Applied	Emerging Sources Citation Index (ESCI)	Chemistry	LO5EN	WOS:000533651000015		gold			2022-02-06	
J	Liu, Y; Guo, CP; Ding, Y; Long, XB; Li, WS; Ke, D; Wang, Q; Liu, R; Wang, JZ; Zhang, HQ; Wang, XC				Liu, Yi; Guo, Cuiping; Ding, Yi; Long, Xiaobing; Li, Wensheng; Ke, Dan; Wang, Qun; Liu, Rong; Wang, Jian-Zhi; Zhang, Huaqiu; Wang, Xiaochuan			Blockage of AEP attenuates TBI-induced tau hyperphosphorylation and cognitive impairments in rats	AGING-US			English	Article						traumatic brain injury (TBI); asparaginyl endopeptidase (AEP); AEP inhibitor/AENK; tau pathology; cognitive impairment	TRAUMATIC BRAIN-INJURY; PROTEIN PHOSPHATASE-2A; ABNORMAL HYPERPHOSPHORYLATION; ALZHEIMER-DISEASE; ACTIVATION; IMPACT; INHIBITION; PATHOLOGY; PHOSPHORYLATION; I-2(PP2A)/SET	Traumatic brain injury (TBI) is regarded as a high-risk factor for Alzheimer's disease (AD). Asparaginyl endopeptidase (AEP), a lysosomal cysteine protease involved in AD pathogenesis, is normally activated under acidic conditions and also in TBI. However, both the molecular mechanism underlying AEP activation-mediated TBI-related AD pathologies, and the role of AEP as an AD therapeutic target, still remain unclear. Here, we report that TBI induces hippocampus dependent cognitive deficit and synaptic dysfunction, accompanied with AEP activation, I2PP2A (inhibitor 2 of PP2A, also called SET) mis-translocation from neuronal nucleus to cytoplasm, an obvious increase in AEP interaction with SET, and tau hyperphosphorylation in hippocampus of rats. Oxygen-glucose deprivation (OGD), mimicking an acidic condition, also leads to AEP activation, SET mis-translocation, PP2A inhibition, tau hyperphosphorylation, and a decrease in synaptic proteins, all of which are abrogated by AEP inhibitor AENK in primary neurons. Interestingly, AENK restores SET back to the nucleus, mitigates tau pathologies, rescuing TBI-induced cognitive deficit in rats. These findings highlight a novel etiopathogenic mechanism of TBI-related AD, which is initiated by AEP activation, accumulating SET in cytoplasm, and favoring tau pathology and cognitive impairments. Lowering AEP activity by AEP inhibitor would be beneficial to AD patients with TBI.	[Liu, Yi; Ding, Yi] Weifang Med Univ, Dept Pathophysiol, Weifang 261053, Peoples R China; [Liu, Yi; Guo, Cuiping; Li, Wensheng; Ke, Dan; Wang, Qun; Liu, Rong; Wang, Jian-Zhi; Wang, Xiaochuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Educ Minist China Neurol Disorders, Dept Pathophysiol,Sch Basic Med,Key Lab, Wuhan 430030, Peoples R China; [Long, Xiaobing; Zhang, Huaqiu] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Neurosurg, Tongji Med Coll, Wuhan 430030, Peoples R China; [Wang, Jian-Zhi; Wang, Xiaochuan] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong 226001, Peoples R China		Ding, Y (corresponding author), Weifang Med Univ, Dept Pathophysiol, Weifang 261053, Peoples R China.; Wang, XC (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Educ Minist China Neurol Disorders, Dept Pathophysiol,Sch Basic Med,Key Lab, Wuhan 430030, Peoples R China.; Zhang, HQ (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Neurosurg, Tongji Med Coll, Wuhan 430030, Peoples R China.; Wang, XC (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong 226001, Peoples R China.	dingy@wfmc.edu.cn; zhanghq_04@yahoo.com; wxch@mails.tjmu.edu.cn		zhang, huaqiu/0000-0003-3023-2040	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31771114, 31929002]; Innovative Research Groups of the National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81721005]; Ministry of Science and Technology of ChinaMinistry of Science and Technology, China [2016YFC1305800]; Academic Frontier Youth Team Project from Huazhong University of Science and Technology	This work was supported in parts by grants from National Natural Science Foundation of China (31771114 and 31929002), Innovative Research Groups of the National Natural Science Foundation of China (81721005), grant from the Ministry of Science and Technology of China (2016YFC1305800) and the Academic Frontier Youth Team Project to Xiaochuan Wang from Huazhong University of Science and Technology.	Arif M, 2014, J BIOL CHEM, V289, P27677, DOI 10.1074/jbc.M114.565358; Arnaud L, 2011, FEBS LETT, V585, P2653, DOI 10.1016/j.febslet.2011.07.020; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681, DOI 10.1212/WNL.42.9.1681; Bao J, 2018, P NATL ACAD SCI USA, V115, P3954, DOI 10.1073/pnas.1800498115; Bao WX, 2018, EXPERT REV MOL DIAGN, V18, P761, DOI 10.1080/14737159.2018.1471985; Basurto-Islas G, 2018, J ALZHEIMERS DIS, V63, P821, DOI 10.3233/JAD-170715; Basurto-Islas G, 2013, J BIOL CHEM, V288, P17495, DOI 10.1074/jbc.M112.446070; Cekic M, 2010, NEUROTHERAPEUTICS, V7, P81, DOI 10.1016/j.nurt.2009.10.017; Chan CB, 2009, P NATL ACAD SCI USA, V106, P468, DOI 10.1073/pnas.0809824105; Dekker SE, 2017, EUR J TRAUMA EMERG S, V43, P841, DOI 10.1007/s00068-016-0733-y; Evans CE, 2020, ACTA NEUROPATHOL, V139, P485, DOI 10.1007/s00401-019-02098-6; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fraser EE, 2019, J NEUROTRAUM, V36, P2753, DOI 10.1089/neu.2019.6430; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1989, P NATL ACAD SCI USA, V86, P2853, DOI 10.1073/pnas.86.8.2853; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Harrison JL, 2015, BRAIN BEHAV IMMUN, V47, P131, DOI 10.1016/j.bbi.2015.01.001; Hu W, 2018, J ALZHEIMERS DIS, V64, P709, DOI 10.3233/JAD-180177; Huang F, 2019, ALZHEIMERS DEMENT, V15, P217, DOI 10.1016/j.jalz.2018.08.013; Iqbal K, 2013, J ALZHEIMERS DIS, V37, P469, DOI 10.3233/JAD-130827; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Kowalski RG, 2017, STROKE, V48, P1802, DOI 10.1161/STROKEAHA.117.017327; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu ZX, 2008, MOL CELL, V29, P665, DOI 10.1016/j.molcel.2008.02.017; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Papp KV, 2020, ALZHEIMERS DEMENT, V16, P552, DOI 10.1016/j.jalz.2019.09.074; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Qin M, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0663-0; Ren YZ, 2020, J NEUROCHEM, V154, P530, DOI 10.1111/jnc.14962; Riley KP, 2002, ANN NEUROL, V51, P567, DOI 10.1002/ana.10161; Sanchez Jose J, 2013, Acta Neurochir Suppl, V118, P223, DOI 10.1007/978-3-7091-1434-6_42; Shimojo M, 2020, J NEUROSCI, V40, P3491, DOI 10.1523/JNEUROSCI.2880-19.2020; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Sugarman MA, 2019, ALZHEIMERS DEMENT, V15, P686, DOI 10.1016/j.jalz.2018.12.015; Sun Y, 2010, HUM MOL GENET, V19, P1088, DOI 10.1093/hmg/ddp580; Tanimukai H, 2005, AM J PATHOL, V166, P1761, DOI 10.1016/S0002-9440(10)62486-8; Tanimukai H, 2004, MOL BRAIN RES, V126, P146, DOI 10.1016/j.molbrainres.2004.04.003; Tsujio I, 2005, FEBS LETT, V579, P363, DOI 10.1016/j.febslet.2004.11.097; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang XC, 2014, ACTA NEUROPATHOL, V127, P243, DOI 10.1007/s00401-013-1175-9; Wu ZR, 2020, PROG NEUROBIOL, V185, DOI 10.1016/j.pneurobio.2019.101730; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Yu G, 2013, NEUROBIOL AGING, V34, P1748, DOI 10.1016/j.neurobiolaging.2012.12.025; Zetterberg H, 2019, J INTERN MED, V285, P624, DOI 10.1111/joim.12863; Zhang Q, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00146; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhang ZT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14740; Zhao LX, 2014, CELL RES, V24, P344, DOI 10.1038/cr.2014.4; Zhong YH, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00261	53	1	1	3	8	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1945-4589			AGING-US	Aging-US	OCT 15	2020	12	19					19421	19439		10.18632/aging.103841			19	Cell Biology; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Geriatrics & Gerontology	OF3EF	WOS:000581094800043	33040048	Green Published, gold			2022-02-06	
J	Remigio-Baker, RA; Kiser, S; Ferdosi, H; Gregory, E; Engel, S; Sebesta, S; Beauchamp, D; Malik, S; Scher, A; Hinds, II				Remigio-Baker, Rosemay A.; Kiser, Seth; Ferdosi, Hamid; Gregory, Emma; Engel, Scot; Sebesta, Sean; Beauchamp, Daniel; Malik, Saafan; Scher, Ann; Hinds, Sidney R., II			Provider Training in the Management of Headache Following Concussion Clinical Recommendation: Promoting a Standardized Means for Efficient Patient Recovery and Timely Return to Duty	FRONTIERS IN NEUROLOGY			English	Article						service member; military; concussion; mild traumatic brain injury; headache	TRAUMATIC BRAIN-INJURY; NATURAL-HISTORY; HIGH-SCHOOL; SOLDIERS; SPORT; PREVALENCE; DIAGNOSIS; COHORT; TRENDS	Background: Headache is a common symptom reported following concussion/mild traumatic brain injury. The Department of Defense's clinical recommendation (CR) describes guidance for primary care providers for the management of post-traumatic headache (PTH) in Service members. Objective: The objective of this study is to examine the association between training on the CR with provider clinical practice, patient behaviors, and symptom recovery. Methods: Participants were healthcare providers and two patient groups (one receiving care as usual [CAU] and another receiving care after provider training on PTH CR [CR+]). Providers were interviewed at three time points: (1) prior to CAU enrollment; (2) after CAU enrollment, but prior to training; and (3) after CR+ follow-up. Data from the second and third provider interview were used to evaluate a potential difference between provider practices pre- and post-training (n = 13). Patients were enrolled within 6 months of concussion. Patient outcomes (including neurobehavioral and headache symptoms) were assessed at three time-points: within 72 h (n = 35), at 1-week (n = 34) and at 1-month post-enrollment (n = 27). Results: Most follow-up care reported by providers were recommended within 72 h of initial visit post-training vs. >1 week pre-training. Additionally, providers reported a greater number of visits based on patient symptoms after training than before. Post-training, most providers reported referring patients to higher level of care "as needed," if not "very rarely," compared to 25% reported referrals prior to training. At 1-week post-enrollment the CR+ patient group reported more frequent medical provider visits compared to the CAU group. This trend was reversed at the 1-month follow-up whereby more CAU reported seeing a medical provider compared to CR+. By 1-week post-enrollment, fewer patients in the CR+ group reported being referred to any other providers or specialists compared to the CAU group. No differences in patient outcomes by provider training was found. Conclusion: The study results demonstrate the feasibility of training on the Management of Headache Following Concussion CR in order to change provider practices by promoting timely care, and promoting patient compliance as shown through improvement in follow-up visits and more monitoring within the primary care clinic.	[Remigio-Baker, Rosemay A.; Kiser, Seth; Ferdosi, Hamid; Gregory, Emma; Malik, Saafan] Def & Vet Brain Injury Ctr, Silver Spring, MD 20910 USA; [Remigio-Baker, Rosemay A.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Remigio-Baker, Rosemay A.] Naval Hosp Camp Pendleton, Camp Pendleton, CA 92055 USA; [Kiser, Seth; Ferdosi, Hamid] Gen Dynam Informat Technol, Falls Church, VA USA; [Engel, Scot] Ft Hood Intrepid Spirit Ctr, Ft Hood, TX USA; [Sebesta, Sean; Beauchamp, Daniel] Ft Bliss Intrepid Spirit Ctr, Ft Hood, TX USA; [Scher, Ann; Hinds, Sidney R., II] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA		Remigio-Baker, RA (corresponding author), Def & Vet Brain Injury Ctr, Silver Spring, MD 20910 USA.; Remigio-Baker, RA (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.; Remigio-Baker, RA (corresponding author), Naval Hosp Camp Pendleton, Camp Pendleton, CA 92055 USA.	rremigiobaker@gmail.com		Scher, Ann/0000-0003-4599-9834	Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; MRMC JPC-6 Neurotrauma [NT160002]	Defense and Veterans Brain Injury Center and MRMC JPC-6 Neurotrauma (Award Number NT160002).	Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; Bailie JM, 2019, AM J SPORT MED, V47, P3505, DOI 10.1177/0363546519883259; Baskin SM, 2006, HEADACHE, V46, pS76, DOI 10.1111/j.1526-4610.2006.00559.x; Brennan KC, 2009, SEMIN NEUROL, V29, P406, DOI 10.1055/s-0029-1237113; Chan TLH, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-1080-2; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen SP, 2012, CEPHALALGIA, V32, P94, DOI 10.1177/0333102411422382; Defense and Veterans Brain Injury Center, 2019, DOD TBI WORLDW NUMB; Defense and Veterans Brain Injury Center, 2016, MAN HEAD FOLL CONC M; Finkel AG, 2017, CEPHALALGIA, V37, P548, DOI 10.1177/0333102416651285; Finkel AG, 2017, HEADACHE, V57, P719, DOI 10.1111/head.13056; Gurr B, 2005, BRAIN INJURY, V19, P481, DOI 10.1080/02699050400005176; Hinds Ii Sidney R, 2016, US Army Med Dep J, P97; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S, 2018, HEADACHE, V58, P873, DOI 10.1111/head.13311; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKeon JMM, 2013, J ATHL TRAINING, V48, P836, DOI 10.4085/1062-6050-48.6.17; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Metti A, 2020, NEUROLOGY, V94, pE1137, DOI 10.1212/WNL.0000000000008935; Misky GJ, 2010, J HOSP MED, V5, P392, DOI 10.1002/jhm.666; O'Bryant SE, 2006, HEADACHE, V46, P1364, DOI 10.1111/j.1526-4610.2006.00579.x; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Remigio-Baker RA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236762; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Tfelt-Hansen P, 2012, CEPHALALGIA, V32, P6, DOI 10.1177/0333102411417901; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009	38	1	1	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 15	2020	11								559311	10.3389/fneur.2020.559311			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OK5XY	WOS:000584724400001	33178105	gold, Green Published			2022-02-06	
J	Jang, SH; Kwon, YH				Jang, Sung Ho; Kwon, Young Hyeon			The relationship between consciousness and the ascending reticular activating system in patients with traumatic brain injury	BMC NEUROLOGY			English	Article						Consciousness; Ascending reticular activating system; Traumatic brain injury; Diffusion tensor tractography; Glasgow coma scale	CONNECTIVITY; DISORDERS; MODERATE; AROUSAL; MILD; COMA	Background: We investigated the relationship between consciousness and the ascending reticular activating system (ARAS) by using diffusion tensor tractography (DTT) in patients with traumatic brain injury (TBI). Methods: Twenty-six patients with TBI and 13 healthy control subjects were recruited for this study. Glasgow Coma Scale (GCS) scores were used for evaluation of subject consciousness state at the chronic stage of TBI (at DTT scanning), According to the GCS score, the patient group was divided into two subgroups: A (14 patients;impaired consciousness: GCS score < 15, and B (12 patients;intact consciousness;GCS score = 15). Fractional anisotropy (FA) and tract volume (TV) values were assessed in the lower dorsal and upper ARAS. Results: The FA values of the lower dorsal ARAS and the upper ARAS in patient subgroup A were significantly lower than those in patient subgroup B and the control group(p < 0.05). However, the FA and TV values for the lower dorsal ARAS and the upper ARAS were not significantly different between patient subgroup B and the control group(p > 0.05). The FA value of the lower dorsal ARAS(r = 0.473,p < 0.05) and the TV of upper ARAS(r = 0.484,p < 0.05) had moderate positive correlations with the GCS score. The FA value of the upper ARAS had a strong positive correlation with the GCS score of the patient group(r = 0.780,p < 0.05). Conclusions: We detected a close relationship between consciousness at the chronic stage of TBI and injuries of the lower dorsal and upper ARAS (especially, the upper ARAS) in patients who showed impaired consciousness at the onset of TBI. We believe that our results can be useful during the development of therapeutic strategies for patients with impaired consciousness following TBI.	[Jang, Sung Ho; Kwon, Young Hyeon] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea		Kwon, YH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	kyh7648764@daum.net			National Research Foundation of Korea (NRF) - Korean Government (MSIP) [2018R1A2B6000996]	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP) (No. 2018R1A2B6000996). The sponsor had no role in the design or conduct of research.	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Cohen J., 2013, STAT POWER ANAL BEHA; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Godbolt AK, 2013, J REHABIL MED, V45, P741, DOI 10.2340/16501977-1167; Gosseries O, 2011, NEUROREHABILITATION, V28, P3, DOI 10.3233/NRE-2011-0625; Haberg AK, 2015, J NEUROSCI RES, V93, P1109, DOI 10.1002/jnr.23534; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jang SH, 2016, AM J PHYS MED REHAB, V95, P580, DOI 10.1097/PHM.0000000000000446; Jang SH, 2015, AM J PHYS MED REHAB, V94, P250, DOI 10.1097/PHM.0000000000000274; Jang SH, 2014, NEUROSCI LETT, V579, P140, DOI 10.1016/j.neulet.2014.07.024; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; Paus T, 2000, PROG BRAIN RES, V126, P65; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yeo SS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00416; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263	21	1	1	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	OCT 14	2020	20	1							375	10.1186/s12883-020-01942-7			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OC0EA	WOS:000578835000001	33054716	Green Submitted, Green Published, gold			2022-02-06	
J	Chan, V; Hurst, M; Petersen, T; Liu, JQ; Mollayeva, T; Colantonio, A; Sutton, M; Escobar, MD				Chan, Vincy; Hurst, Mackenzie; Petersen, Tierza; Liu, Jingqian; Mollayeva, Tatyana; Colantonio, Angela; Sutton, Mitchell; Escobar, Michael D.			A population-based sex-stratified study to understand how health status preceding traumatic brain injury affects direct medical cost	PLOS ONE			English	Article							OUTCOMES; GENDER; SERVICES; CARE; FACILITATORS; BARRIERS; SYSTEMS	Objective To understand how pre-injury health status present five-years preceding traumatic brain injury (TBI) affects direct medical cost two years post-injury. Methods Patients age >= 19 years in the emergency department (ED) or acute care for a TBI between April 1, 2007 and March 31, 2014 in Ontario, Canada (N = 55,669) were identified from population-based health administrative data. Forty-three factors of pre-injury health status (i.e., comorbidities and personal, social, and environmental factors) that were internally validated for the TBI population were assessed in this study. The outcome of interest was direct medical cost within two years of discharge. Sex-specific multivariable linear regressions were conducted to understand the associations between direct medical cost within two years of discharge and pre-injury health status. Results Patients who received care in the ED (81.9% of total sample) incurred a median cost of $2,492/male patient (average $12,342/patient) and $3,508/female patient (average $65,285/patient) within two years of injury; 37 pre-injury factors were significantly associated with increased direct medical costs. Patients who first received care for their TBI in acute care (18.1%) incurred a median cost of $25,081/male patient (average $63,060/patient) and $30,277/female patient (average $65,285/patient) within two years of injury; 21 factors were significantly associated with increased direct medical costs. Among more prevalent factors, those associated with increased medical cost by at least 50% included mental health disorders, substance abuse, disorders or medical conditions frequently observed among the elderly, cardiovascular disorders, stroke and emergencies involving the brain, metabolic disorders and abdominal symptoms, conditions and symptoms of abdomen and pelvis, genitourinary disorders and disorders of prostate, and pulmonary abdominal and other emergencies. Conclusions Direct medical costs two years post-TBI differed significantly between patients with and without adverse pre-existing health status. Interdisciplinary teams to promote early identification of pre-existing health conditions and appropriate management and integration of these conditions in TBI care across the continuum of healthcare may be opportunities to reduce direct medical costs post-injury.	[Chan, Vincy; Hurst, Mackenzie; Petersen, Tierza; Liu, Jingqian; Mollayeva, Tatyana; Colantonio, Angela; Sutton, Mitchell] Univ Hlth Network, KITE Toronto Rehab, Toronto, ON, Canada; [Colantonio, Angela; Escobar, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Colantonio, Angela] ICES, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Chan, V (corresponding author), Univ Hlth Network, KITE Toronto Rehab, Toronto, ON, Canada.	vincy.chan@uhn.ca	, Mollayeva/A-4522-2018	Mollayeva, Tatyana/0000-0002-2787-1848	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD089106]; Alzheimer's AssociationAlzheimer's Association [AARF-16-442937]; Canada's Strategy for Patient-Oriented Research (SPOR); Ontario SPOR Support Unit; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Government of Ontario	This study was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R21HD089106) to AC. A Postdoctoral research fellowship from the Alzheimer's Association (AARF-16-442937) was awarded to TM.; This study made use of de-identified data from the ICES Data Repository, which is managed by the Institute for Clinical Evaluative Sciences with support from its funders and partners: Canada's Strategy for Patient-Oriented Research (SPOR), the Ontario SPOR Support Unit, the Canadian Institutes of Health Research and the Government of Ontario. The opinions, results and conclusions reported are those of the authors. No endorsement by ICES or any of its funders or partners is intended or should be inferred. Parts of this material are based on data and information compiled and provided by CIHI. However, the analyses, conclusions, opinions and statements expressed herein are those of the author, and not necessarily those of CIHI.	[Anonymous], 2019, NACRS DAT EL 2018 20; [Anonymous], INT CHRON DIS PREV C; [Anonymous], 2019, DAD DAT EL 2018 2019; Association for the Advancement of Automotive Medicine, 2019, ABBR INJ SCAL ASS AD; Association of Public Health Epidemiologists in Ontario, 2019, REC ICD 10 CA COD IN; Atun R, 2010, HEALTH POLICY PLANN, V25, P104, DOI 10.1093/heapol/czp055; Balogh R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007492.pub2; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Centre for Disease Prevention and Control, 2019, ICD INJ MATR CTR DIS; Chan Vincy, 2017, BMC Res Notes, V10, P371, DOI 10.1186/s13104-017-2682-x; Chan V, 2016, ARCH PHYS MED REHAB, V97, P772, DOI 10.1016/j.apmr.2016.01.011; Chan V, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0259-7; Chan V, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-97; Chang VC, 2015, AM J IND MED, V58, P353, DOI 10.1002/ajim.22418; CHEN A, 2012, HEALTHC POLICY, V7, P41, DOI DOI 10.12927/hcpol.2013.22883; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Colantonio A, 2004, INT J REHABIL RES, V27, P209, DOI 10.1097/00004356-200409000-00006; Colantonio A, 2016, ARCH PHYS MED REHAB, V97, pS1, DOI 10.1016/j.apmr.2015.12.002; Croxford R., 2006, CANADIAN I HLTH INFO; Damian AJ, 2018, CHILD YOUTH SERV REV, V85, P273, DOI 10.1016/j.childyouth.2018.01.003; Haldane V, 2018, AIDS CARE, V30, P103, DOI 10.1080/09540121.2017.1344350; Haldane V, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21585; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Kantor V, 2017, CLIN PSYCHOL REV, V52, P52, DOI 10.1016/j.cpr.2016.12.001; Legido-Quigley H, 2013, TROP MED INT HEALTH, V18, P199, DOI 10.1111/tmi.12029; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marin JR, 2017, BRAIN INJURY, V31, P24, DOI 10.1080/02699052.2016.1217351; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Ministry of Health and Long-Term Care, 2019, ALT LEV CAR ALC DAYS; Mollayeva T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41916-5; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Munce SEP, 2014, BRAIN INJURY, V28, P1042, DOI 10.3109/02699052.2014.890744; Nations U, 2019, PROB POP PROJ BAS WO; Ng R., 2015, BRAIN DISORDERS ONTA; Raukar NP, 2014, ACAD EMERG MED, V21, P1370, DOI 10.1111/acem.12535; Roberts KC, 2015, HEALTH PROMOT CHRON, V35, DOI 10.24095/hpcdp.35.6.01; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016; Secretariat WHO, 2016, FRAM INT PEOPL CTR H; Shi HY, 2013, J NEUROSURG, V118, P732, DOI 10.3171/2012.12.JNS12693; Sigfrid L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181156; Statistics Canada, 2018, TABLE 17 10 0005 01; Sutton M, 2019, J WOMENS HEALTH, V28, P473, DOI 10.1089/jwh.2018.7282; Thompson AE, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0440-0; Toor GK, 2016, ARCH PHYS MED REHAB, V97, pS54, DOI 10.1016/j.apmr.2015.02.010; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; West LM, 2018, RES SOC ADMIN PHARM, V14, P1015, DOI 10.1016/j.sapharm.2017.12.003; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; Wodchis WP, 2013, GUIDELINES PERSON LE	52	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240208	10.1371/journal.pone.0240208			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UK	WOS:000581813300044	33048973	Green Published, gold			2022-02-06	
J	Yu, YM; Meng, FX; Zhang, L; Liu, XY; Wu, YH; Chen, SC; Tan, XF; Li, XX; Kuang, S; Sun, Y; Luo, BY				Yu, Yamei; Meng, Fanxia; Zhang, Li; Liu, Xiaoyan; Wu, Yuehao; Chen, Sicong; Tan, Xufei; Li, Xiaoxia; Kuang, Sheng; Sun, Yu; Luo, Benyan			A multi-domain prognostic model of disorder of consciousness using resting-state fMRI and laboratory parameters	BRAIN IMAGING AND BEHAVIOR			English	Article						Disorder of consciousness; Resting-state functional connectivity; Laboratory parameters; Machine learning	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; FUNCTIONAL CONNECTIVITY; NETWORKS; RECOVERY; LEVEL; REGISTRATION; PATTERNS; HUBS; MRI	Objectives Although laboratory parameters have long been recognized as indicators of outcome of traumatic brain injury (TBI), it remains a challenge to predict the recovery of disorder of consciousness (DOC) in severe brain injury including TBI. Recent advances have shown an association between alterations in brain connectivity and recovery from DOC. In the present study, we developed a prognostic model of DOC recovery via a combination of laboratory parameters and resting-state functional magnetic resonance imaging (fMRI). Methods Fifty-one patients with DOC (age = 52.3 +/- 15.2 y, male/female = 31/20) were recruited from Hangzhou Hospital of Zhejiang CAPR and were sub-grouped into conscious (n = 34) and unconscious (n = 17) groups based upon their Glasgow Outcome Scale-Extended (GOS-E) scores at 12-month follow-ups after injury. Resting-state functional connectivity, network nodal measures (centrality), and laboratory parameters were obtained from each patient and served as features for support vector machine (SVM) classifications. Results We found that functional connectivity was the most accurate single-domain model (ACC: 70.1% +/- 4.5%,P = 0.038, 1000 permutations), followed by degree centrality, betweenness centrality, and laboratory parameters. The stacked multi-domain prognostic model (ACC: 73.4% +/- 3.1%,P= 0.005, 1000 permutations) combining all single-domain models yielded a significantly higher accuracy compared to that of the best-performing single-domain model (P = 0.002). Conclusion Our results suggest that laboratory parameters only contribute to the outcome prediction of DOC patients, whereas combining information from neuroimaging and clinical parameters may represent a strategy to achieve a more accurate prognostic model, which may further provide better guidance for clinical management of DOC patients.	[Yu, Yamei; Meng, Fanxia; Liu, Xiaoyan; Wu, Yuehao; Tan, Xufei; Li, Xiaoxia; Luo, Benyan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurol, Hangzhou 310000, Peoples R China; [Yu, Yamei; Meng, Fanxia; Liu, Xiaoyan; Wu, Yuehao; Tan, Xufei; Li, Xiaoxia; Luo, Benyan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Brain Med Ctr, Hangzhou 310000, Peoples R China; [Zhang, Li] Hangzhou Med Coll, Peoples Hosp, Zhejiang Prov Peoples Hosp, Dept Rehabil Med, Hangzhou, Peoples R China; [Chen, Sicong] Huzhou Cent Hosp, Dept Neurol, Huzhou, Zhejiang, Peoples R China; [Kuang, Sheng] Ant Financial Hang Zhou Network Technol Co Ltd, Data Sci Grp, Hangzhou, Peoples R China; [Sun, Yu] Zhejiang Univ, Key Lab Biomed Engn, Minist Educ, Dept Biomed Engn, Hangzhou 310000, Zhejiang, Peoples R China; [Sun, Yu] Zhejiang Univ, Sch Med, Natl Clin Res Ctr Child Hlth, Childrens Hosp,Dept Radiol, Hangzhou, Zhejiang, Peoples R China		Luo, BY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurol, Hangzhou 310000, Peoples R China.; Luo, BY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Brain Med Ctr, Hangzhou 310000, Peoples R China.; Sun, Y (corresponding author), Zhejiang Univ, Key Lab Biomed Engn, Minist Educ, Dept Biomed Engn, Hangzhou 310000, Zhejiang, Peoples R China.; Sun, Y (corresponding author), Zhejiang Univ, Sch Med, Natl Clin Res Ctr Child Hlth, Childrens Hosp,Dept Radiol, Hangzhou, Zhejiang, Peoples R China.	yusun@zju.edu.cn; luobenyan@zju.edu.cn		SUN, Yu/0000-0002-6666-8586	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801785]; National Key R&D Program of China [2018YFA0701400]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2019FZJD005, 2020FZZX001-05]	This article was supported by grants from the National Natural Science Foundation of China (81870817), National Key R&D Program of China (2018YFA0701400), and the Fundamental Research Funds for the Central Universities +2019-XZZX-001-01-02. Y. S. was additionally supported by the National Natural Science Foundation of China (81801785) and the Fundamental Research Funds for the Central Universities (2019FZJD005, 2020FZZX001-05).	Achard S, 2012, P NATL ACAD SCI USA, V109, P20608, DOI 10.1073/pnas.1208933109; Al-Mufti F, 2019, J NEUROINTERV SURG, V11, P1135, DOI 10.1136/neurintsurg-2019-014759; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Chennu S, 2017, BRAIN, V140, P2120, DOI 10.1093/brain/awx163; Crone JS, 2014, NEUROIMAGE-CLIN, V4, P240, DOI 10.1016/j.nicl.2013.12.005; Dai ZJ, 2015, CEREB CORTEX, V25, P3723, DOI 10.1093/cercor/bhu246; Demertzi A, 2013, CURR OPIN NEUROBIOL, V23, P239, DOI 10.1016/j.conb.2012.12.003; Di Perri C, 2016, LANCET NEUROL, V15, P830, DOI 10.1016/S1474-4422(16)00111-3; Di Perri C, 2013, NEUROLOGY, V81, P1417, DOI 10.1212/WNL.0b013e3182a43b78; Dresler M, 2017, NEURON, V93, P1227, DOI 10.1016/j.neuron.2017.02.003; Edelman GM, 2003, P NATL ACAD SCI USA, V100, P5520, DOI 10.1073/pnas.0931349100; Fan LZ, 2016, CEREB CORTEX, V26, P3508, DOI 10.1093/cercor/bhw157; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kim J, 2016, CLIN CHIM ACTA, V456, P89, DOI 10.1016/j.cca.2016.02.030; Laureys S, 2007, CURR OPIN NEUROL, V20, P609, DOI 10.1097/WCO.0b013e3282f1d6dd; Liu XY, 2017, J CLIN NEUROSCI, V42, P160, DOI 10.1016/j.jocn.2017.04.015; Matsuo K, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6276; Montalcini T, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0660-4; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Nelson DW, 2012, J NEUROTRAUM, V29, P2613, DOI 10.1089/neu.2012.2468; Norton L, 2012, NEUROLOGY, V78, P175, DOI 10.1212/WNL.0b013e31823fcd61; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Pistoia F, 2015, J NEUROTRAUM, V32, P682, DOI 10.1089/neu.2014.3659; Pustina D, 2017, HUM BRAIN MAPP, V38, P5603, DOI 10.1002/hbm.23752; Qin PM, 2015, ANN NEUROL, V78, P594, DOI 10.1002/ana.24479; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Silva S, 2015, NEUROLOGY, V85, P2036, DOI 10.1212/WNL.0000000000002196; Siwicka-Gieroba D, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091453; Song M, 2018, ELIFE, V7, DOI 10.7554/eLife.36173; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; van den Heuvel MP, 2014, NEUROPSYCHOL REV, V24, P32, DOI 10.1007/s11065-014-9248-7; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Wang JH, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/fnhum.2015.00386, 10.3389/fnhum.2015.00458]; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Wu XH, 2015, J NEUROSCI, V35, P12932, DOI 10.1523/JNEUROSCI.0415-15.2015; Yan CG, 2016, NEUROINFORMATICS, V14, P339, DOI 10.1007/s12021-016-9299-4; Zhang J, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008624; Zhang L, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01024; Zheng JB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07636-4	50	1	1	0	9	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	AUG	2021	15	4					1966	1976		10.1007/s11682-020-00390-8		OCT 2020	11	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UO0EQ	WOS:000576846800001	33040258				2022-02-06	
J	Baig, MR; Beck, RD; Wilson, JL; Lemmer, JA; Meraj, A; Meyer, EC; Mintz, J; Peterson, AL; Roache, JD				Baig, Muhammad R.; Beck, Robert D.; Wilson, Jennifer L.; Lemmer, Jennifer A.; Meraj, Adeel; Meyer, Eric C.; Mintz, Jim; Peterson, Alan L.; Roache, John D.			Quetiapine augmentation of prolonged exposure therapy in veterans with PTSD and a history of mild traumatic brain injury: design and methodology of a pilot study	MILITARY MEDICAL RESEARCH			English	Article						Quetiapine; Trauma-focused psychotherapy; Posttraumatic stress disorder; Mild traumatic brain injury; Veterans	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE PROCESSING THERAPY; MAJOR DEPRESSIVE DISORDER; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; COMBAT VETERANS; INTRANASAL OXYTOCIN; EXTENDED-RELEASE; FEAR EXTINCTION; AFGHANISTAN	Background Selective serotonergic reuptake inhibitors (SSRIs) are first-line pharmacologic treatments for patients with posttraumatic stress disorder (PTSD), but must be given over extended period of time before the onset of action. The use of SSRIs in PTSD patients with mild traumatic brain injury (mTBI) is problematic since SSRIs could exacerbate post-concussion syndrome (PCS) symptoms. VA/DOD guidelines identify trauma-focused psychotherapy as the best evidence-based treatment for PTSD, but overall effectiveness is limited by reduced levels of patient engagement and retention. A previous study from this research group suggested that quetiapine monotherapy, but not risperidone or valproate, could increase engagement in trauma-focused psychotherapy. Methods We report the study protocol of a pilot study funded under the South-Central Mental Illness Research, Education, and Clinical Center pilot study program from the U.S. Department of Veterans Affairs. This randomized, open-label study was designed to evaluate the feasibility of completing a randomized trial of quetiapine vs. treatment as usual to promote patient engagement in PTSD patients with a history of mTBI. Discussion We expect that the success of this ongoing study should provide us with the preliminary data necessary to design a full-scale randomized trial. Positive efficacy results in a full- scale trial should inform new VA guidelines for clinical practice by showing that quetiapine-related improvements in patient engagement and retention may be the most effective approach to assure that VA resources achieve the best possible outcome for veterans.	[Baig, Muhammad R.; Beck, Robert D.; Wilson, Jennifer L.; Lemmer, Jennifer A.; Meraj, Adeel; Peterson, Alan L.] South Texas Vet Healthcare Syst, Mental Hlth, 116 A,7400 Merton Minter Blvd, San Antonio, TX 78229 USA; [Baig, Muhammad R.; Beck, Robert D.; Wilson, Jennifer L.; Lemmer, Jennifer A.] South Texas Vet Healthcare Syst, Polytrauma Rehabil Ctr, San Antonio, TX 78229 USA; [Baig, Muhammad R.; Mintz, Jim; Peterson, Alan L.; Roache, John D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat & Behav Sci, San Antonio, TX 78229 USA; [Meyer, Eric C.] VISN 17 Ctr Excellence Res Returning War Vet, Dept Vet Affairs, Waco, TX USA; [Meyer, Eric C.] Cent Texas Vet Healthcare Syst, Waco, TX USA; [Meyer, Eric C.] Baylor Univ, Dept Psychol & Neurosci, Waco, TX 76798 USA; [Mintz, Jim] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Peterson, Alan L.] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA; [Roache, John D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA		Baig, MR (corresponding author), South Texas Vet Healthcare Syst, Mental Hlth, 116 A,7400 Merton Minter Blvd, San Antonio, TX 78229 USA.; Baig, MR (corresponding author), South Texas Vet Healthcare Syst, Polytrauma Rehabil Ctr, San Antonio, TX 78229 USA.	Muhammad.baig@va.gov		Roache, John/0000-0002-7010-8119	South Central Mental Illness Research, Education, and Clinical Center (SC MIRECC)	This project is supported by the South Central Mental Illness Research, Education, and Clinical Center (SC MIRECC), which is a MIRECC for Veterans Integrated Service Network (VISN) 16 & 17.	Acheson D, 2013, PSYCHOPHARMACOLOGY, V229, P199, DOI 10.1007/s00213-013-3099-4; [Anonymous], 2017, MAN POSTTR STRESS DI; [Anonymous], 2020, DAT PRIV PUBL FUND C; [Anonymous], 2014, TREATMENT POSTTRAUMA; Asnis GM, 2004, DRUGS, V64, P383, DOI 10.2165/00003495-200464040-00004; Baig MR, 2019, PSYCHIAT QUART, V90, P815, DOI 10.1007/s11126-019-09668-7; Baig MR, 2019, PSYCHIAT QUART, V90, P431, DOI 10.1007/s11126-019-09638-z; Belleau EL, 2017, BEHAV RES THER, V91, P43, DOI 10.1016/j.brat.2017.01.011; Berger W, 2009, PROG NEURO-PSYCHOPH, V33, P169, DOI 10.1016/j.pnpbp.2008.12.004; Bernardy NC, 2012, J CLIN PSYCHIAT, V73, P297, DOI 10.4088/JCP.11m07311; Borison RL, 1996, J CLIN PSYCHOPHARM, V16, P158, DOI 10.1097/00004714-199604000-00008; Burghardt KJ, 2018, PROG NEURO-PSYCHOPH, V83, P55, DOI 10.1016/j.pnpbp.2018.01.004; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cohen J., 2013, STAT POWER ANAL BEHA; Cohrs S, 2004, PSYCHOPHARMACOLOGY, V174, P421, DOI 10.1007/s00213-003-1759-5; Collett Garen A, 2016, Drugs Real World Outcomes, V3, P45; Davidson J, 2006, ARCH GEN PSYCHIAT, V63, P1158, DOI 10.1001/archpsyc.63.10.1158; Davis LL, 2008, J CLIN PSYCHOPHARM, V28, P84, DOI [10.1097/jcp.0b013e318160f83b, 10.1097/JCP.0b013e318160f83b]; Deacon B, 2013, BEHAV RES THER, V51, P588, DOI 10.1016/j.brat.2013.06.006; Dold M, 2017, EUR NEUROPSYCHOPHARM, V27, P625, DOI 10.1016/j.euroneuro.2017.05.004; Duff J, 2011, WORLDV EVID-BASED NU, V8, P30, DOI 10.1111/j.1741-6787.2010.00209.x; Echiverri-Cohen A, 2016, J CONSULT CLIN PSYCH, V84, P415, DOI 10.1037/ccp0000080; El-Khalili N, 2010, INT J NEUROPSYCHOPH, V13, P917, DOI 10.1017/S1461145710000015; Flanagan JC, 2018, J PSYCHIATR RES, V98, P64, DOI 10.1016/j.jpsychires.2017.12.014; Foa E.B., 2007, PROLONGED EXPOSURE T; Foa EB, 2018, JAMA-J AM MED ASSOC, V319, P354, DOI 10.1001/jama.2017.21242; Foa EB, 2011, DEPRESS ANXIETY, V28, P1043, DOI 10.1002/da.20907; Friedman MJ, 2007, J CLIN PSYCHIAT, V68, P711, DOI 10.4088/JCP.v68n0508; Galovski TE, 2016, J CONSULT CLIN PSYCH, V84, P167, DOI 10.1037/ccp0000059; Gedge L, 2010, NEUROPSYCH DIS TREAT, V6, P501; Goodson JT, 2013, J TRAUMA STRESS, V26, P419, DOI 10.1002/jts.21830; Hertzog MA, 2008, RES NURS HEALTH, V31, P180, DOI 10.1002/nur.20247; Horacek J, 2006, CNS DRUGS, V20, P389, DOI 10.2165/00023210-200620050-00004; Hundt NE, 2020, PSYCHOL SERV, V17, P414, DOI 10.1037/ser0000316; Imel ZE, 2013, J CONSULT CLIN PSYCH, V81, P394, DOI 10.1037/a0031474; Ishibe N, 2009, J HEAD TRAUMA REHAB, V24, P424, DOI 10.1097/HTR.0b013e3181c13426; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Jaeger Jeff A, 2009, Int J Behav Consult Ther, V5, P294; Jeffreys MD, 2014, J ANXIETY DISORD, V28, P108, DOI 10.1016/j.janxdis.2013.04.010; Jerud AB, 2016, BEHAV RES THER, V77, P62, DOI 10.1016/j.brat.2015.12.002; Jun JJ, 2013, DEPRESS ANXIETY, V30, P607, DOI 10.1002/da.22119; Kaufmann CN, 2019, BEHAV SLEEP MED, V17, P12, DOI 10.1080/15402002.2016.1266490; KOSTEN TR, 1991, J NERV MENT DIS, V179, P366, DOI 10.1097/00005053-199106000-00011; Kraemer HC, 2006, ARCH GEN PSYCHIAT, V63, P484, DOI 10.1001/archpsyc.63.5.484; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Krystal JH, 2017, BIOL PSYCHIAT, V82, pE51, DOI 10.1016/j.biopsych.2017.03.007; Krystal JH, 2011, JAMA-J AM MED ASSOC, V306, P493, DOI 10.1001/jama.2011.1080; Leon AC, 2011, J PSYCHIATR RES, V45, P626, DOI 10.1016/j.jpsychires.2010.10.008; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Lund BC, 2012, J CLIN PSYCHIAT, V73, P292, DOI 10.4088/JCP.10m06775; Ma L, 2015, BRAIN RES, V1622, P443, DOI 10.1016/j.brainres.2015.07.012; Martin JL, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx079; Marx B.P., 2015, CLIN ADM PTSD SCALE; Matsumoto Y, 2013, PSYCHOPHARMACOLOGY, V229, P51, DOI 10.1007/s00213-013-3078-9; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; Mikolic A, 2019, CLIN PSYCHOL REV, V73, DOI 10.1016/j.cpr.2019.101776; Miles SR, 2015, J TRAUMA STRESS, V28, P475, DOI 10.1002/jts.22036; Mollayeva T, 2016, SLEEP MED REV, V25, P52, DOI 10.1016/j.smrv.2015.01.009; Murphy D, 2017, EUR J PSYCHOTRAUMATO, V8, DOI 10.1080/20008198.2017.1398001; Nikiforuk A, 2013, NEUROPHARMACOLOGY, V64, P357, DOI 10.1016/j.neuropharm.2012.06.042; Pelissier C, 2017, ACCIDENT ANAL PREV, V106, P411, DOI 10.1016/j.aap.2017.06.020; Peskind ER, 2003, J GERIATR PSYCH NEUR, V16, P165, DOI 10.1177/0891988703256050; Peterson A.L., 2019, TREATING PTSD MILITA, P46; Popiel A, 2015, J BEHAV THER EXP PSY, V48, P17, DOI 10.1016/j.jbtep.2015.01.002; Powers MB, 2010, CLIN PSYCHOL REV, V30, P635, DOI 10.1016/j.cpr.2010.04.007; Raskind MA, 2018, NEW ENGL J MED, V378, P507, DOI 10.1056/NEJMoa1507598; Raskind MA, 2003, AM J PSYCHIAT, V160, P371, DOI 10.1176/appi.ajp.160.2.371; Raskind MA, 2002, J CLIN PSYCHIAT, V63, P565, DOI 10.4088/JCP.v63n0705; Rauch SAM, 2004, J TRAUMA STRESS, V17, P461, DOI 10.1007/s10960-004-5794-8; Robert S, 2005, J CLIN PSYCHOPHARM, V25, P387, DOI 10.1097/01.jcp.0000169624.37819.60; Rothbaum BO, 2014, AM J PSYCHIAT, V171, P640, DOI 10.1176/appi.ajp.2014.13121625; Sachs G, 2004, BIPOLAR DISORD, V6, P213, DOI 10.1111/j.1399-5618.2004.00115.x; Schneier FR, 2012, AM J PSYCHIAT, V169, P80, DOI 10.1176/appi.ajp.2011.11020321; Schumm JA, 2017, J TRAUMA STRESS, V30, P704, DOI 10.1002/jts.22243; Simon NM, 2008, J CLIN PSYCHIAT, V69, P400, DOI 10.4088/JCP.v69n0309; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; Swanson TM, 2017, PUBLIC HEALTH REP, V132, P251, DOI 10.1177/0033354916687748; Tarrier N, 1999, J CONSULT CLIN PSYCH, V67, P13, DOI 10.1037/0022-006X.67.1.13; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Villarreal G, 2016, AM J PSYCHIAT, V173, P1205, DOI 10.1176/appi.ajp.2016.15070967; Viola J, 1997, MIL MED, V162, P616, DOI 10.1093/milmed/162.9.616; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Wiegand MH, 2008, PSYCHOPHARMACOLOGY, V196, P337, DOI 10.1007/s00213-007-0968-8	87	1	1	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2095-7467	2054-9369		MILITARY MED RES	MILITARY MED. RES.	OCT 8	2020	7	1							46	10.1186/s40779-020-00278-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NY1NB	WOS:000576164000001	33032657	gold, Green Published			2022-02-06	
J	Dietch, JR; Furst, AJ				Dietch, Jessica R.; Furst, Ansgar J.			Perspective: Cognitive Behavioral Therapy for Insomnia Is a Promising Intervention for Mild Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						CBT (cognitive-behavioral therapy); insomnia; traumatic brain injury; mild traumatic brain injury (mTBI); sleep; cognitive behavioral therapy for insomnia (CBT-I)	SLEEP DISTURBANCE; OLDER-ADULTS; DISORDERS; METAANALYSIS; INDIVIDUALS; PERFORMANCE; PREVALENCE; GUIDELINE; SYMPTOMS; RECOVERY	Mild traumatic brain injury (mTBI) is a significant public health problem. Insomnia is one of the most common symptoms of TBI, occurring in 30-50% of patients with TBI, and is more frequently reported in patients with mild as opposed to moderate or severe TBI. Although insomnia may be precipitated by mTBI, it is unlikely to subside on its own without specific treatment even after symptoms of mTBI reduce or remit. Insomnia is a novel, highly modifiable treatment target in mTBI, treatment of which has the potential to make broad positive impacts on the symptoms and recovery following brain injury. Cognitive-behavioral therapy for insomnia (CBT-I) is the front-line intervention for insomnia and has demonstrated effectiveness across clinical trials; between 70 and 80% of patients with insomnia experience enduring benefit from CBT-I and about 50% experience clinical remission. Examining an existing model of the development of insomnia in the context of mTBI suggests CBT-I may be effective for insomnia initiated or exacerbated by sustaining a mTBI, but this hypothesis has yet to be tested via clinical trial. Thus, more research supporting the use of CBT-I in special populations such as mTBI is warranted. The current paper provides a background on existing evidence for using CBT-I in the context of TBI, raises key challenges, and suggests considerations for future directions including need for increased screening and assessment of sleep disorders in the context of TBI, examining efficacy of CBT-I in TBI, and exploring factors that impact dissemination and delivery of CBT-I in TBI.	[Dietch, Jessica R.; Furst, Ansgar J.] VA Palo Alto Hlth Care Syst, War Related Illness & Injury Study Ctr WRIISC CA, Palo Alto, CA 94304 USA; [Dietch, Jessica R.; Furst, Ansgar J.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [Furst, Ansgar J.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA; [Furst, Ansgar J.] VA Palo Alto Hlth Care Syst, Polytrauma Syst Care PSC, Palo Alto, CA 94304 USA		Furst, AJ (corresponding author), VA Palo Alto Hlth Care Syst, War Related Illness & Injury Study Ctr WRIISC CA, Palo Alto, CA 94304 USA.; Furst, AJ (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA.; Furst, AJ (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA.; Furst, AJ (corresponding author), VA Palo Alto Hlth Care Syst, Polytrauma Syst Care PSC, Palo Alto, CA 94304 USA.	ajfurst@stanford.edu	Dietch, Jessica/AAG-2441-2020	Dietch, Jessica/0000-0001-9434-0791	War Related Illness and Injury Study Center (WRIISC) of the Palo Alto Veterans Affairs Health Care System, Department of Veterans Affairs Office of Academic Affiliations and VA Rehabilitation Research  Development (RRD) grant: Cognitive behavioral therap [1I01RX002319-01A2, NCT03261674]	This work was funded by the War Related Illness and Injury Study Center (WRIISC) of the Palo Alto Veterans Affairs Health Care System, Department of Veterans Affairs Office of Academic Affiliations and VA Rehabilitation Research & Development (RR&D) grant: Cognitive behavioral therapy for insomnia in chronic traumatic brain injury [1I01RX002319-01A2; PI: Furst; ClinicalTrials.gov identifier (NCT number): NCT03261674].	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Belleville G, 2011, CLIN PSYCHOL REV, V31, P638, DOI 10.1016/j.cpr.2011.02.004; Board of Behavioral Sleep Medicine, 2020, BEHAV SLEEP MED DIPL; Botchway EN, 2019, J NEUROTRAUM, V36, P669, DOI 10.1089/neu.2018.5743; Cassidy-Eagle E, 2018, CLIN GERONTOLOGIST, V41, P136, DOI 10.1080/07317115.2017.1384777; Centers for Disease Control and Prevention, 2016, RAT TBI REL EM DEP V; Chen PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049113; Chiu HY, 2015, EUR NEUROPSYCHOPHARM, V25, P2271, DOI 10.1016/j.euroneuro.2015.09.011; Chiu HY, 2014, INT J NURS STUD, V51, P892, DOI 10.1016/j.ijnurstu.2013.10.020; Daley M, 2009, SLEEP MED, V10, P427, DOI 10.1016/j.sleep.2008.04.005; DEGAGE SB, 2012, BMJ BRIT MED J, V0345; Dement, 2017, PRINCIPLES PRACTICE, P804, DOI [10.1016/C2012-0-03543-0, DOI 10.1016/C2012-0-03543-0]; Espie CA, 2018, SLEEP HEALTH, V4, P307, DOI 10.1016/j.sleh.2018.03.003; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Fields BG, 2013, J CLIN SLEEP MED, V9, P1093, DOI 10.5664/jcsm.3096; Fields BG, 2013, J SLEEP DISORD THER, V2, P2, DOI [10.4172/2167-0277.1000111, DOI 10.4172/2167-0277.1000111]; Flanagan SR, 2007, J HEAD TRAUMA REHAB, V22, P67, DOI 10.1097/00001199-200701000-00009; Ford ME, 2020, SLEEP MED REV, V50, DOI 10.1016/j.smrv.2019.101255; Gallacher J, 2012, J EPIDEMIOL COMMUN H, V66, P869, DOI 10.1136/jech-2011-200314; Gee B, 2019, SLEEP MED REV, V43, P118, DOI 10.1016/j.smrv.2018.09.004; Geiger-Brown JM, 2015, SLEEP MED REV, V23, P54, DOI 10.1016/j.smrv.2014.11.007; Gutner CA, 2018, PSYCHIAT RES, V263, P108, DOI 10.1016/j.psychres.2018.02.045; Harvey A. G., 2017, TREATING SLEEP PROBL; Herbert V, 2018, SLEEP MED REV, V39, P37, DOI 10.1016/j.smrv.2017.07.001; Ho FYY, 2016, CLIN PSYCHOL REV, V43, P90, DOI 10.1016/j.cpr.2015.09.005; Irwin MR, 2006, HEALTH PSYCHOL, V25, P3, DOI 10.1037/0278-6133.25.1.3; Jaussent I, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-212; Koffel E, 2018, J GEN INTERN MED, V33, P955, DOI 10.1007/s11606-018-4390-1; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Lichstein KL, 2006, SLEEP MED REV, V10, P3, DOI 10.1016/j.smrv.2005.10.001; Lowe A, 2020, DISABIL REHABIL, V42, P1041, DOI 10.1080/09638288.2018.1516819; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Manber R., 2016, CURR SLEEP MED REP, V2, P136, DOI [10.1007/s40675-016-0048-x, DOI 10.1007/S40675-016-0048-X]; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Miro E, 2011, J HEALTH PSYCHOL, V16, P770, DOI 10.1177/1359105310390544; Morgenthaler T, 2006, SLEEP, V29, P1415; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; MURTAGH DRR, 1995, J CONSULT CLIN PSYCH, V63, P79, DOI 10.1037/0022-006X.63.1.79; National Institutes of Health, 2005, Sleep, V28, P1049; Nguyen S, 2017, ARCH PHYS MED REHAB, V98, P1508, DOI 10.1016/j.apmr.2017.02.031; NIH Consensus, 2005, NIH CONSENS STATE SC, V22, P1; Ohayon MM, 1997, J PSYCHIATR RES, V31, P333, DOI 10.1016/S0022-3956(97)00002-2; Okajima I, 2011, SLEEP BIOL RHYTHMS, V9, P24, DOI 10.1111/j.1479-8425.2010.00481.x; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ong Jason C, 2017, Curr Sleep Med Rep, V3, P57, DOI 10.1007/s40675-017-0068-1; Ouellet M-C, 2019, INSOMNIA FATIGUE TRA; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Qaseem A, 2016, ANN INTERN MED, V165, P125, DOI 10.7326/M15-2175; Riemann D, 2017, J SLEEP RES, V26, P675, DOI 10.1111/jsr.12594; SAKSVIK SB, 2020, J NEUROTRAUM 0708; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Smith MT, 2004, SLEEP MED REV, V8, P119, DOI 10.1016/S1087-0792(03)00044-3; SPIELMAN AJ, 1987, PSYCHIAT CLIN N AM, V10, P541; Sullivan KA, 2018, J NEUROTRAUM, V35, P195, DOI 10.1089/neu.2016.4958; Sun JX, 2013, J CLIN NURS, V22, P1270, DOI 10.1111/jocn.12096; Suzuki Y, 2017, SLEEP MED, V33, P36, DOI 10.1016/j.sleep.2016.06.033; Taylor Daniel J, 2003, Behav Sleep Med, V1, P227, DOI 10.1207/S15402010BSM0104_5; The Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea Work Group, 2019, VA DOD CLIN PRACT GU; Theadom A, 2018, CLIN REHABIL, V32, P619, DOI 10.1177/0269215517736671; Trauer JM, 2015, ANN INTERN MED, V163, P191, DOI 10.7326/M14-2841; Wardle-Pinkston S, 2019, SLEEP MED REV, V48, DOI 10.1016/j.smrv.2019.07.008; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243; Wickwire EM, 2016, SLEEP MED REV, V30, P72, DOI 10.1016/j.smrv.2015.11.004; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; Worthington AD, 2006, BRAIN INJURY, V20, P327, DOI 10.1080/02699050500488249; Wu JQ, 2015, JAMA INTERN MED, V175, P1461, DOI 10.1001/jamainternmed.2015.3006; Wylie Glenn R, 2017, Concussion, V2, pCNC50, DOI 10.2217/cnc-2017-0003; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	72	1	1	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 7	2020	11								530273	10.3389/fneur.2020.530273			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OD4IS	WOS:000579816700001	33117253	Green Published, gold			2022-02-06	
J	Wilde, EA; Merkley, TL; Lindsey, HM; Bigler, ED; Hunter, JV; Ewing-Cobbs, L; Aitken, ME; MacLeod, MC; Hanten, G; Chu, ZLD; Abildskov, TJ; Noble-Haeusslein, LJ; Levin, HS				Wilde, Elisabeth A.; Merkley, Tricia L.; Lindsey, Hannah M.; Bigler, Erin D.; Hunter, Jill V.; Ewing-Cobbs, Linda; Aitken, Mary E.; MacLeod, Marianne C.; Hanten, Gerri; Chu, Zili D.; Abildskov, Tracy J.; Noble-Haeusslein, Linda J.; Levin, Harvey S.			Developmental Alterations in Cortical Organization and Socialization in Adolescents Who Sustained a Traumatic Brain Injury in Early Childhood	JOURNAL OF NEUROTRAUMA			English	Article						abnormal development; adaptive behavior; pediatric traumatic brain injury; structural neuroimaging	PREFRONTAL CORTEX; SOCIAL COGNITION; MEMORY DEFICITS; MICROGYRIA; RECOVERY; GYRIFICATION; NEUROSCIENCE; DISORDER; PATTERNS; ANTERIOR	This study investigated patterns of cortical organization in adolescents who had sustained a traumatic brain injury (TBI) during early childhood to determine ways in which early head injury may alter typical brain development. Increased gyrification in other patient populations is associated with polymicrogyria and aberrant development, but this has not been investigated in TBI. Seventeen adolescents (mean age = 14.1 +/- 2.4) who sustained a TBI between 1-8 years of age, and 17 demographically-matched typically developing children (TDC) underwent a high-resolution, T1-weighted 3-Tesla magnetic resonance imaging (MRI) at 6-15 years post-injury. Cortical white matter volume and organization was measured using FreeSurfer's Local Gyrification Index (LGI). Despite a lack of significant difference in white matter volume, participants with TBI demonstrated significantly increased LGI in several cortical regions that are among those latest to mature in normal development, including left parietal association areas, bilateral dorsolateral and medial frontal areas, and the right posterior temporal gyrus, relative to the TDC group. Additionally, there was no evidence of increased surface area in the regions that demonstrated increased LGI. Higher Vineland-II Socialization scores were associated with decreased LGI in right frontal and temporal regions. The present results suggest an altered pattern of expected development in cortical gyrification in the TBI group, with changes in late-developing frontal and parietal association areas. Such changes in brain structure may underlie cognitive and behavioral deficits associated with pediatric TBI. Alternatively, increased gyrification following TBI may represent a compensatory mechanism that allows for typical development of cortical surface area, despite reduced brain volume.	[Wilde, Elisabeth A.; Merkley, Tricia L.; Lindsey, Hannah M.; Bigler, Erin D.; Abildskov, Tracy J.] Univ Utah, Dept Neurol, 383 Colorow Way,Suite 302, Salt Lake City, UT 84108 USA; [Wilde, Elisabeth A.; MacLeod, Marianne C.; Hanten, Gerri; Levin, Harvey S.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Hunter, Jill V.; Chu, Zili D.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Merkley, Tricia L.; Lindsey, Hannah M.; Bigler, Erin D.; Abildskov, Tracy J.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Merkley, Tricia L.; Bigler, Erin D.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Hunter, Jill V.; Chu, Zili D.] Barrow Neurol Inst, Dept Clin Neuropsychol, Phoenix, AZ 85013 USA; [Hunter, Jill V.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, Dept Pediat, Houston, TX 77030 USA; [Aitken, Mary E.] Univ Arkansas Med Sci, Arkansas Childrens Res Inst, Little Rock, AZ USA; [Aitken, Mary E.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AZ USA; [Noble-Haeusslein, Linda J.] Univ Texas Austin, Dept Neurol, Austin, TX 78712 USA; [Noble-Haeusslein, Linda J.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Noble-Haeusslein, Linda J.] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA		Wilde, EA (corresponding author), Univ Utah, Dept Neurol, 383 Colorow Way,Suite 302, Salt Lake City, UT 84108 USA.	elisabeth.wilde@hsc.utah.edu	Aitken, Mary/ABG-6119-2021; Merkley, Tricia L./AAN-2989-2020	Aitken, Mary/0000-0002-8318-9755	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS065937]	The study was funded by the National Institutes of Health grant R21 NS065937 ("Trauma to Developing Brain: Model Refinement and Therapeutic Intervention''; Levin, PI and Noble, PI).	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Beauchamp MH, 2017, NEUROPSYCHOLOGY, V31, P981, DOI 10.1037/neu0000395; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Blanton RE, 2001, PSYCHIAT RES-NEUROIM, V107, P29, DOI 10.1016/S0925-4927(01)00091-9; Borrell V, 2018, J NEUROSCI, V38, P776, DOI 10.1523/JNEUROSCI.1106-17.2017; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Cohen J, 1998, STAT POWER ANAL BEHA; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Faber J, 2016, BRAIN INJURY, V30, P1635, DOI 10.1080/02699052.2016.1199910; Fine JG, 2014, J COUNS PSYCHOL, V61, P521, DOI 10.1037/cou0000033; Fitch RH, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-45; Garel C, 2001, AM J NEURORADIOL, V22, P184; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Herman AE, 1997, CEREB CORTEX, V7, P453, DOI 10.1093/cercor/7.5.453; Hiser J, 2018, BIOL PSYCHIAT, V83, P638, DOI 10.1016/j.biopsych.2017.10.030; Hofman MA, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00015; Hughes BL, 2012, CEREB CORTEX, V22, P1372, DOI 10.1093/cercor/bhr213; Jackson T, 1996, NEUROPSYCHOL REV, V6, P81, DOI 10.1007/BF01875369; Jenkins LM, 2014, PSYCHIAT RES-NEUROIM, V224, P192, DOI 10.1016/j.pscychresns.2014.08.007; Johansson Barbro B., 2004, Keio Journal of Medicine, V53, P231, DOI 10.2302/kjm.53.231; Johnson MH, 2009, DEV PSYCHOL, V45, P151, DOI 10.1037/a0014548; Kates WR, 2009, AUTISM RES, V2, P267, DOI 10.1002/aur.98; Keenan HT, 2019, J NEUROTRAUM, V36, P282, DOI 10.1089/neu.2018.5687; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Klein D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084914; Kline J.E., 2019, ARCH DIS CHILD FETAL, pprint; Kroenke CD, 2018, J NEUROSCI, V38, P767, DOI 10.1523/JNEUROSCI.1105-17.2017; Lindsey H.M., 2019, BRAIN IMAGING BEHAV; McCauley SR, 2010, DEV NEUROPSYCHOL, V35, P318, DOI 10.1080/87565641003696866; McIntosh AM, 2009, ACTA PSYCHIAT SCAND, V119, P192, DOI 10.1111/j.1600-0447.2008.01286.x; Oishi K, 2015, ANN NEUROL, V77, P68, DOI 10.1002/ana.24300; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oyegbile T, 2004, NEUROPSYCHOLOGY, V18, P729, DOI 10.1037/0894-4105.18.4.729; Pa J, 2010, J INT NEUROPSYCH SOC, V16, P640, DOI 10.1017/S1355617710000408; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Poirier K, 2013, NAT GENET, V45, P639, DOI 10.1038/ng.2613; Porcelli S, 2019, NEUROSCI BIOBEHAV R, V97, P10, DOI 10.1016/j.neubiorev.2018.09.012; Rakic P., 2000, Novartis Foundation Symposium, V228, P30; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Rial D, 2009, BRAIN RES BULL, V79, P177, DOI 10.1016/j.brainresbull.2009.02.003; Rosen GD, 2000, J COMP NEUROL, V418, P423; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Schaer M, 2008, IEEE T MED IMAGING, V27, P161, DOI 10.1109/TMI.2007.903576; Schmitt JE, 2002, DEV MED CHILD NEUROL, V44, P292; Sparrow S.S., 2005, VINELAND ADAPTIVE BE; Su S, 2013, HUM BRAIN MAPP, V34, P1230, DOI 10.1002/hbm.21510; TEASDALE G, 1974, LANCET, V2, P81; Threlkeld SW, 2006, BRAIN RES, V1109, P22, DOI 10.1016/j.brainres.2006.06.022; Threlkeld SW, 2012, BEHAV BRAIN RES, V235, P130, DOI 10.1016/j.bbr.2012.07.031; Violante IR, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-3; Welker W., 1990, Cerebral Cortex, V8B, P3; Xi CH, 2011, BEHAV BRAIN RES, V221, P587, DOI 10.1016/j.bbr.2010.09.031; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535	60	1	1	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2021	38	1					133	143		10.1089/neu.2019.6698		OCT 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PN6IA	WOS:000576983900001	32503385	Green Published			2022-02-06	
J	Biggs, A; Lovett, M; Moore-Clingenpeel, M; O'Brien, N				Biggs, Austin; Lovett, Marlina; Moore-Clingenpeel, Melissa; O'Brien, Nicole			Optic nerve sheath diameter does not correlate with intracranial pressure in pediatric neurocritical care patients	CHILDS NERVOUS SYSTEM			English	Article						Intracranial pressure; Optic nerve sheath diameter; Ultrasound; Critical care; PICU	TRAUMATIC BRAIN-INJURY; DOPPLER PULSATILITY INDEX; TRANSORBITAL SONOGRAPHIC EVALUATION; CEREBRAL PERFUSION-PRESSURE; TRANSBULBAR SONOGRAPHY; CHILDREN; HYPERTENSION; FUNDAMENTALS; GUIDELINES; MANAGEMENT	Purpose Intracranial pressure (ICP) > 20 mmHg is associated with worse outcomes in children. The gold standard for monitoring ICP is invasive, has complications such as bleeding and infection, and may not be available in resource limited areas. Ultrasound of the optic nerve sheath diameter (ONSD) has been studied as a noninvasive way to evaluate for elevated ICP in adults. Its utility in pediatrics remains unclear. Methods A prospective study was performed in a pediatric intensive care unit in children <= 18 years old. ONSD ultrasound was performed using a 13-6 MHz linear probe with the patient's invasively measured ICP simultaneously recorded. Linear mixed effects models were used to evaluate the association between ONSD and ICP. Results One hundred thirty-six measurements were obtained from 16 patients. ONSD was not significantly associated with ICP (p = 0.51). A ROC curve assessing ONSD to determine elevated ICP > 20 mmHg had an area under the curve of 0.52 (95%CI = 0.32-0.72). There was no difference in measurements obtained between the left and right ONSD at the same time (p = 0.82). Conclusions In conclusion, this study demonstrated no association between ONSD measurement and invasively monitored ICP in critically ill children.	[Biggs, Austin] Med Univ South Carolina, Div Pediat Crit Care, Charleston, SC 29425 USA; [Lovett, Marlina; Moore-Clingenpeel, Melissa; O'Brien, Nicole] Nationwide Childrens Hosp, Div Crit Care, Columbus, OH USA; [Lovett, Marlina; O'Brien, Nicole] Ohio State Univ, Coll Med, Columbus, OH 43210 USA		Biggs, A (corresponding author), Med Univ South Carolina, Div Pediat Crit Care, Charleston, SC 29425 USA.	Austin.Biggs@gmail.com					Agrawal A, 2019, CRIT CARE MED, V47, pE495, DOI 10.1097/CCM.0000000000003742; Alkhoury F, 2014, JAMA SURG, V149, P544, DOI 10.1001/jamasurg.2013.4329; Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; Ballantyne J, 1999, CLIN RADIOL, V54, P740, DOI 10.1016/S0009-9260(99)91176-5; Behrens A, 2010, NEUROSURGERY, V66, P1050, DOI 10.1227/01.NEU.0000369519.35932.F2; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Bennett TD, 2017, JAMA PEDIATR, V171, P965, DOI 10.1001/jamapediatrics.2017.2127; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; Figaji AA, 2009, SURG NEUROL, V72, P389, DOI 10.1016/j.surneu.2009.02.012; Fontanel L, 2019, AM J OPHTHALMOL, V208, P439, DOI 10.1016/j.ajo.2019.08.020; Grinkeviciute DE, 2008, MEDICINA-LITHUANIA, V44, P119, DOI 10.3390/medicina44020015; Helmke K, 1996, PEDIATR RADIOL, V26, P706, DOI 10.1007/BF01383384; Helmke K, 1996, PEDIATR RADIOL, V26, P701, DOI 10.1007/BF01383383; Kavi T, 2018, CUREUS, V10, DOI 10.7759/cureus.3546; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P280, DOI 10.1097/PCC.0000000000001736; Le A, 2009, ANN EMERG MED, V53, P785, DOI 10.1016/j.annemergmed.2008.11.025; Lee SH, 2020, J CRIT CARE, V56, P182, DOI 10.1016/j.jcrc.2020.01.006; Maissan IM, 2015, J NEUROSURG, V123, P743, DOI 10.3171/2014.10.JNS141197; Malayeri AA, 2005, J ULTRAS MED, V24, P143, DOI 10.7863/jum.2005.24.2.143; Newman WD, 2002, BRIT J OPHTHALMOL, V86, P1109, DOI 10.1136/bjo.86.10.1109; O'Brien NF, 2015, J NEUROSURG-PEDIATR, V16, P420, DOI 10.3171/2015.3.PEDS14521; Ohle R, 2015, J ULTRAS MED, V34, P1285, DOI 10.7863/ultra.34.7.1285; Padayachy LC, 2016, CHILD NERV SYST, V32, P1779, DOI 10.1007/s00381-016-3068-4; Rajajee V, 2012, CRIT CARE, V16, DOI [10.1186/cc11336, 10.1186/CC11336]; Raval R, 2020, NEUROCRIT CARE, V33, P173, DOI 10.1007/s12028-019-00881-7; Sekhon MS, 2015, INTENS CARE MED, V41, P177, DOI 10.1007/s00134-014-3560-9; Sekhon MS, 2014, NEUROCRIT CARE, V21, P245, DOI 10.1007/s12028-014-0003-y; Steinborn M, 2015, ULTRASCHALL MED, V36, P54, DOI 10.1055/s-0034-1385012; Steinborn M, 2016, CHILD NERV SYST, V32, P655, DOI 10.1007/s00381-015-3001-2; Tavakoli S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17450; Wang LJ, 2018, JAMA OPHTHALMOL, V136, P250, DOI 10.1001/jamaophthalmol.2017.6560; Young AMH, 2017, PEDIATR RES, V81, P443, DOI 10.1038/pr.2016.165	36	1	1	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAR	2021	37	3					951	957		10.1007/s00381-020-04910-1		OCT 2020	7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	QF4RG	WOS:000574803800001	33009927				2022-02-06	
J	Juengst, S; Rainey, E; Noorbakhsh, D; Driver, S				Juengst, Shannon; Rainey, Evan; Noorbakhsh, Donna; Driver, Simon			Providing equal attention: designing control groups for intensive lifestyle interventions after brain injury	BRAIN INJURY			English	Article						Traumatic brain injuries; clinical trials; intensive lifestyle intervention; weight-loss	DIABETES PREVENTION PROGRAM; WEIGHT-LOSS; OBESITY; OVERWEIGHT; COMMUNITY; DISEASE; RISK	Primary objective Interventions are needed to address chronic health conditions, such as obesity and diabetes, faced by adults with traumatic brain injury (TBI). The objective of this narrative is to present the justification for and an exemplar of an active attention control condition as a needed comparison group in clinical trials for intensive lifestyle interventions after TBI. Research Design Narrative review Methods and Procedures N/A Main Outcomes and Results Despite the historical use in scientific research, integration of appropriate control conditions to account for not only the placebo effect, but also to isolate the "active ingredients" of behavioural interventions, remains a challenge. This is particularly true for intensive lifestyle interventions, especially with the increasing use of mobile health (mHealth) to augment these interventions. Herein we describe the design, content, and implementation of a group-based, attention control condition, referred to as the Brain Health Group, as an exemplar active comparison to an intensive lifestyle intervention for weight-loss among individuals with TBI (GLB-TBI). Conclusions Intervention studies should incorporate strong scientific designs and active control conditions to assess effectiveness and aid in replication. Following recommended guidelines, we provide an active control condition for future group-based intensive lifestyle interventions post-TBI.	[Juengst, Shannon] Univ Texas Southwestern Med Ctr Dallas, North Texas TBI Model Syst, Dallas, TX 75390 USA; [Rainey, Evan; Driver, Simon] Baylor Scott & White Inst Rehabil, North Texas TBI Model Syst, Dallas, TX USA; [Noorbakhsh, Donna] Baylor Scott & White Inst Rehabil, Dallas, TX USA		Juengst, S (corresponding author), UT Southwestern Med Ctr, North Texas TBI Model Syst, Dallas, TX 75390 USA.	Shannon.Juengst@UTSouthwestern.edu		driver, simon/0000-0003-2356-432X; McShan, Evan Elizabeth/0000-0002-9250-3240; Juengst, Shannon/0000-0003-4709-545X	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DPTB0013]	The contents of this manuscript were developed under a grant from The National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant number 90DPTB0013). NIDILRR is a centre within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.	Ackermann RT, 2008, AM J PREV MED, V35, P357, DOI 10.1016/j.amepre.2008.06.035; Angus, 2019, STATPEARLS; [Anonymous], 2017, MOBILE FACT SHEET; Aycock DM, 2018, RES NURS HEALTH, V41, P320, DOI 10.1002/nur.21870; Byrd-Bredbenner C, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0546-3; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Davis-Smith YM, 2007, J NATL MED ASS, V99; Dicianno BE, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.7335; Dori YJ, 2005, J LEARN SCI, V14, P243, DOI 10.1207/s15327809jls1402_3; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Driver S, 2019, BRAIN INJURY, V33, P1299, DOI 10.1080/02699052.2019.1641623; Driver S, 2019, CONT CLIN TRIAL COMM, V14, DOI 10.1016/j.conctc.2019.100328; Driver S, 2018, J HEAD TRAUMA REHAB, V33, pE49, DOI 10.1097/HTR.0000000000000372; Driver S, 2017, BRAIN INJURY, V31, P1612, DOI 10.1080/02699052.2017.1346286; Hart T, 2018, BRAIN INJURY, V32, P1295, DOI 10.1080/02699052.2018.1493226; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Juengst SB, 2018, ARCH PHYS MED REHAB, V99, DOI [10.1016/j.apmr.2018.07.334, DOI 10.1016/J.APMR.2018.07.334]; Juengst SB, 2019, CURR PHYS MED REHAB, V7, P341, DOI 10.1007/s40141-019-00240-9; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kramer MK, 2015, J OCCUP ENVIRON MED, V57, P284, DOI 10.1097/JOM.0000000000000350; Kramer MK, 2011, DIABETES EDUCATOR, V37, P659, DOI 10.1177/0145721711411930; Kramer MK, 2009, AM J PREV MED, V37, P505, DOI 10.1016/j.amepre.2009.07.020; Lindquist R, 2007, J NURS SCHOLARSHIP, V39, P214, DOI 10.1111/j.1547-5069.2007.00171.x; Ma J, 2013, JAMA INTERN MED, V173, P113, DOI 10.1001/2013.jamainternmed.987; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mccoy L, 2015, J AM OSTEOPATH ASSOC, V115, P202, DOI 10.7556/jaoa.2015.042; Schippers M, 2017, OBES REV, V18, P450, DOI 10.1111/obr.12492; Vadheim LM, 2010, J RURAL HEALTH, V26, P266, DOI 10.1111/j.1748-0361.2010.00288.x; Waters L, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-120; Webb VL, 2017, GASTROENTEROLOGY, V152, P1752, DOI 10.1053/j.gastro.2017.01.045; Williamson DA, 2017, OBESITY, V25, P1867, DOI 10.1002/oby.21914	31	1	1	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 14	2020	34	12					1618	1624		10.1080/02699052.2020.1825807		OCT 2020	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OU7LB	WOS:000574205400001	33001707				2022-02-06	
J	Osiac, E; Mitran, SI; Manea, CN; Cojocaru, A; Rosu, GC; Osiac, M; Pirici, DN; Balseanu, AT; Catalin, B				Osiac, Eugen; Mitran, Smaranda Ioana; Manea, Catalin Nicolae; Cojocaru, Alexandru; Rosu, Gabriela-Camelia; Osiac, Mariana; Pirici, Daniel Nicolae; Balseanu, Adrian Tudor; Catalin, Bogdan			Optical coherence tomography microscopy in experimental traumatic brain injury	MICROSCOPY RESEARCH AND TECHNIQUE			English	Article						animal model; optical coherence tomography; traumatic brain injury	AGE; MORTALITY; STROKE; IMPACT; BURDEN	Worldwide elderly traumatic brain injury (TBI) patients tend to become an increasing burden to the society. Thus, a faster and less expensive way of evaluating TBI victims is needed. In the present study we investigated if optical coherence tomography (OCT) could be used as such a method. By using an animal model, we established if OCT can detect cortical changes in the acute phase of a penetrating TBI, in young (5-7 months) and old (20-22 months) rats. Due to the long-term evolution of TBI's, we wanted to investigate to what extent OCT could detect changes within the cortex in the chronic phase. Adult (7-12 months) male rats were used. Surprisingly, OCT imaging of the normal hemisphere was able to discriminate age-related differences in the mean gray values (MGV) of recorded pixels (p= .032). Furthermore, in the acute phase of TBI, OCT images recorded at 24 hr after the injury showed differences between the apparent damaged area of young and aged animals. Changes of MGV and skewness were only recorded 48 hr after injury. Monitoring the chronical evolution of the TBI with OCT revealed changes over time exceeding the normal range recorded for MGV, skewness and kurtosis, 14 and 21 days after TBI. Although in the present study we still used an extremely invasive approach, as technology improves, less invasive and non-harmful ways of recording OCT may allow for an objective way to detect changes within the brain structure after brain injuries.	[Osiac, Eugen; Mitran, Smaranda Ioana; Manea, Catalin Nicolae; Balseanu, Adrian Tudor; Catalin, Bogdan] Univ Med & Pharm Craiova, Ctr Normal & Pathol Aging, Expt Res, Petru Rares Str 2-4, Craiova 79106, Romania; [Osiac, Eugen] Univ Med & Pharm Craiova, Dept Biophys, Craiova, Romania; [Mitran, Smaranda Ioana; Cojocaru, Alexandru; Balseanu, Adrian Tudor; Catalin, Bogdan] Univ Med & Pharm Craiova, Dept Physiol, Craiova, Romania; [Manea, Catalin Nicolae] Univ Med & Pharm Craiova, Dept Informat Commun & Stat, Craiova, Romania; [Rosu, Gabriela-Camelia; Pirici, Daniel Nicolae] Univ Med & Pharm Craiova, Dept Res Methodol, Craiova, Romania; [Osiac, Mariana] Univ Craiova, Dept Phys, Fac Sci, Craiova, Romania		Manea, CN (corresponding author), Univ Med & Pharm Craiova, Ctr Normal & Pathol Aging, Expt Res, Petru Rares Str 2-4, Craiova 79106, Romania.	catalin.manea@umfcv.ro	Balseanu, Tudor Adrian/O-2289-2018; Catalin, Bogdan/G-2565-2013; Balseanu, Tudor Adrian/T-8118-2019; Osiac, Eugen/C-2910-2011	Balseanu, Tudor Adrian/0000-0002-0047-3436; Catalin, Bogdan/0000-0002-5706-8722; Balseanu, Tudor Adrian/0000-0002-0047-3436; Osiac, Eugen/0000-0001-9224-8000; Mitran, Smaranda Ioana/0000-0002-4458-2298	Consiliul Na.ional pentru Finantarea Invatamantului Superior [FDI-2020-0115]	Consiliul Na.ional pentru Finantarea Invatamantului Superior, Grant/Award Number: FDI-2020-0115	Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P201; Ayrapetyan S., 2012, BIOEQUIVALENCE BIOAV, V4, P9, DOI 10.4172/jbb.1000114; Beckmann L, 2019, BIOMED OPT EXPRESS, V10, P5235, DOI 10.1364/BOE.10.005235; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Boppart SA, 1998, NEUROSURGERY, V43, P834, DOI 10.1097/00006123-199810000-00068; Brickler T., 2018, TRAUMATIC BRAIN INJU; Cernak I, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00209; Chen Y, 2008, OPT EXPRESS, V16, P2469, DOI 10.1364/OE.16.002469; Coute RA, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005239; Deghoyan A, 2014, ELECTROMAGN BIOL MED, V33, P58, DOI 10.3109/15368378.2013.783852; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Dolezyczek H, 2020, NEUROPHOTONICS, V7; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Escobedo LVS, 2013, WORLD J EMERG MED, V4, P252, DOI [10.5847/wjem.j.issn.1920-8642.2013.04.002, 10.5847/wjem.j.1920-8642.2013.04.002]; Fenolland JR, 2013, J FR OPHTALMOL, V36, P378, DOI 10.1016/j.jfo.2013.01.006; FERCHER AF, 1993, AM J OPHTHALMOL, V116, P113, DOI 10.1016/S0002-9394(14)71762-3; Flanagan SR, 2006, CLIN GERIATR MED, V22, P449, DOI 10.1016/j.cger.2005.12.011; Fujimoto JG, 2000, NEOPLASIA, V2, P9, DOI 10.1038/sj.neo.7900071; Gerard I., 2017, TECH GASTROINTEST EN, V5, P8, DOI 10.1053/tgie.2003.50005; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; He DY, 2016, NAT NEUROSCI, V19, P678, DOI 10.1038/nn.4258; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Ker K, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a865; Kisser J, 2017, BRAIN INJURY, V31, P620, DOI 10.1080/02699052.2017.1283057; Krug E., 1999, INJURY LEADING CAUSE; Kuhne CA, 2005, WORLD J SURG, V29, P1476, DOI 10.1007/s00268-005-7796-y; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Mak CHK, 2012, CURR GERIATR REP, V1, P171, DOI 10.1007/s13670-012-0017-2; Marker Daniel F, 2010, J Vis Exp, DOI 10.3791/2059; McColl TJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00372; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Menzel JC, 2008, BRAIN INJURY, V22, P375, DOI 10.1080/02699050802001492; Mohan BM, 2008, INT J AUTOM CONTROL, V2, P5, DOI 10.1504/IJAAC.2008.020426; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Osiac E, 2014, ROM J MORPHOL EMBRYO, V55, P767; Osiac E, 2014, ROM J MORPHOL EMBRYO, V55, P507; Osiac E, 2011, WORLD J GASTROENTERO, V17, P15, DOI 10.3748/wjg.v17.i1.15; Petcu EB, 2008, GERONTOLOGY, V54, P6, DOI 10.1159/000112845; Popescu Dan P, 2011, Biophys Rev, V3, P155, DOI 10.1007/s12551-011-0054-7; Radhakrishnan H, 2013, BIOMED OPT EXPRESS, V4, P1255, DOI 10.1364/BOE.4.001255; Reaven Nancy L, 2009, J Intensive Care Med, V24, P131, DOI 10.1177/0885066608330211; Roe C, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/845491; Rosonke S, 2006, J EMERG MED, V31, P421, DOI 10.1016/j.jemermed.2006.08.003; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Rowe RK, 2016, DEV NEUROSCI-BASEL, V38, P195, DOI 10.1159/000446773; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Sato M, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9020216; Sfredel M. D., 2018, CURRENT HLTH SCI J, V44, P4, DOI 10.12865/CHSJ.44.02.04; Sharma B, 2020, SYST REV-LONDON, V9, DOI 10.1186/s13643-020-1281-4; Siddiq I, 2012, J NEUROTRAUM, V29, P2647, DOI 10.1089/neu.2012.2444; Srinivasan VJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071478; Srinivasan VJ, 2012, OPT EXPRESS, V20, P2220, DOI 10.1364/OE.20.002220; Stitzel Joel D, 2008, Ann Adv Automot Med, V52, P235; SWANSON EA, 1993, OPT LETT, V18, P1864, DOI 10.1364/OL.18.001864; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tearney GJ, 1996, CIRCULATION, V94, P3013, DOI 10.1161/01.CIR.94.11.3013; van Dijck JTJM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216743; Welzel J, 2001, SKIN RES TECHNOL, V7, P1, DOI 10.1034/j.1600-0846.2001.007001001.x; Westfall PH, 2014, AM STAT, V68, P191, DOI 10.1080/00031305.2014.917055; Witcher KG, 2018, GLIA, V66, P2719, DOI 10.1002/glia.23523; Wu FF, 2020, J CELL MOL MED, V24, P1220, DOI 10.1111/jcmm.14691; Xuan WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053454; Zhang Jun, 2009, Gastrointest Endosc Clin N Am, V19, P243, DOI 10.1016/j.giec.2009.02.003; Zhang K, 2011, PROC SPIE, V7883, DOI 10.1117/12.874190; Zhao S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25475-9	70	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-910X	1097-0029		MICROSC RES TECHNIQ	Microsc. Res. Tech.	MAR	2021	84	3					422	431		10.1002/jemt.23599		OCT 2020	10	Anatomy & Morphology; Biology; Microscopy	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics; Microscopy	QH1JI	WOS:000574552800001	33009699	hybrid, Green Published			2022-02-06	
J	Urban, K; Schudlo, L; Keightley, M; Alain, S; Reed, N; Chau, T				Urban, Karolina; Schudlo, Larissa; Keightley, Michelle; Alain, Sam; Reed, Nick; Chau, Tom			Altered Brain Activation in Youth following Concussion: Using a Dual-task Paradigm	DEVELOPMENTAL NEUROREHABILITATION			English	Article							NEAR-INFRARED SPECTROSCOPY; SPORTS-RELATED CONCUSSION; WORKING-MEMORY; FUNCTIONAL CONNECTIVITY; ATTENTION NETWORK; ATHLETES BRAIN; STROOP TASK; INJURY; BALANCE; PERFORMANCE	A concussion is known as a functional injury affecting brain communication, integration, and processing. There is a need to objectively measure how concussions disrupt brain activation while completing ecologically relevant tasks. The objective of this study was to compare brain activation patterns between concussion and comparison groups (non-concussed youth) during a cognitive-motor single and dual-task paradigm utilizing functional near-infrared spectroscopy (fNIRS) in regions of the frontal-parietal attention network and compared to task performance. Youth with concussion generally exhibited hyperactivation and recruitment of additional brain regions in the dorsal lateral prefrontal (DLPFC), superior (SPC) and inferior parietal cortices (IPC), which are associated with processing, information integration, and response selection. Additionally, hyper- or hypo-activation patterns were associated with slower processing speed on the cognitive task. Our findings corroborate the growing literature suggesting that neural recovery may be delayed compared to the restoration of behavioral performance post-concussion. Concussion, near-infrared spectroscopy, dual-task paradigm, cognitive, motor, brain activation	[Urban, Karolina; Schudlo, Larissa; Alain, Sam; Reed, Nick; Chau, Tom] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON M4G 1R8, Canada; [Urban, Karolina; Reed, Nick] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Schudlo, Larissa; Chau, Tom] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Schudlo, Larissa] Ryerson Univ, Elect Comp & Biomed Engn Dept, Toronto, ON, Canada; [Keightley, Michelle] Hosp Sick Children, Toronto, ON, Canada; [Reed, Nick] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Urban, K (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON M4G 1R8, Canada.	karolina.urban@mail.utoronto.ca			ONF-REPAR Grant; E & G Odette Foundation; ONF-REPAR	Funding for this study was provided by the ONF-REPAR Grant and the E & G Odette Foundation for funding Karolina Urban's Graduate Scholarship;E & G Odette Foundation;ONF-REPAR;	Aasted CM, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.2.020801; Astafiev SV, 2015, J NEUROTRAUM, V32, P1254, DOI 10.1089/neu.2014.3547; Barker JW, 2013, BIOMED OPT EXPRESS, V4, P1366, DOI 10.1364/BOE.4.001366; Beurskens R, 2014, INT J PSYCHOPHYSIOL, V92, P122, DOI 10.1016/j.ijpsycho.2014.03.005; Biodex Medical Systems Inc, BIOSW PORT BAL SYST, P6339; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Bryer EJ, 2013, J INT NEUROPSYCH SOC, V19, P751, DOI 10.1017/S1355617713000490; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; COHEN H, 1993, PHYS THER, V73, P346, DOI 10.1093/ptj/73.6.346; Conder RL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00890; Cook MJ, 2020, NEUROIMAGE-CLIN, V25, DOI 10.1016/j.nicl.2019.102129; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Doumas M, 2008, EXP BRAIN RES, V187, P275, DOI 10.1007/s00221-008-1302-3; Erickson KI, 2005, NEUROIMAGE, V28, P967, DOI 10.1016/j.neuroimage.2005.06.047; Ettenhofer ML, 2016, J NEUROPSYCH CLIN N, V28, P223, DOI 10.1176/appi.neuropsych.15100243; Fait PE, 2011, PERCEPT MOTOR SKILL, V112, P29, DOI 10.2466/05.10.23.25.PMS.112.1.29-43; Fujimoto H, 2014, NEUROIMAGE, V85, P547, DOI 10.1016/j.neuroimage.2013.05.014; Fujita H, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7053867; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Galea OA, 2018, NEUROREHAB NEURAL RE, V32, P115, DOI 10.1177/1545968318760728; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gardner A, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00141; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Guo ZP, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00072; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Havsteen I, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00232; Hawkins KA, 2018, HUM MOVEMENT SCI, V59, P46, DOI 10.1016/j.humov.2018.03.010; Helmich I, 2016, MED SCI SPORT EXER, V48, P2362, DOI 10.1249/MSS.0000000000001028; Hocke LM, 2018, J NEUROTRAUM, V35, P1224, DOI 10.1089/neu.2017.5365; Houston MN, 2016, BRAIN INJURY, V30, P891, DOI 10.3109/02699052.2016.1146960; Howell DR, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/ab3552; Howell DR, 2018, BRAIN INJURY, V32, P1129, DOI 10.1080/02699052.2018.1482424; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Intraub H, 1997, TRENDS COGN SCI, V1, P217, DOI 10.1016/S1364-6613(97)01067-X; Iraji A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4072402; Jahn K, 2008, PROG BRAIN RES, V171, P353, DOI 10.1016/S0079-6123(08)00652-3; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Karim H, 2013, NEUROIMAGE, V74, P318, DOI 10.1016/j.neuroimage.2013.02.010; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Kheradmand A, 2015, CEREB CORTEX, V25, P765, DOI 10.1093/cercor/bht267; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; Lague-Beauvais M, 2015, BRAIN COGNITION, V98, P1, DOI 10.1016/j.bandc.2015.05.001; Lax ID, 2015, BRAIN INJURY, V29, P1409, DOI 10.3109/02699052.2015.1043344; Lech RK, 2013, BEHAV BRAIN RES, V254, P45, DOI 10.1016/j.bbr.2013.06.009; Lee YM, 2013, J NEUROSURG-PEDIATR, V12, P537, DOI 10.3171/2013.7.PEDS12572; Leone C, 2017, NEUROSCI BIOBEHAV R, V75, P348, DOI 10.1016/j.neubiorev.2017.01.010; Levit-Binnun N, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-26; Lin T, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00038; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 2013, J PEDIATR-US, V163, P1192, DOI 10.1016/j.jpeds.2013.05.061; Marshall TR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002272; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moores KA, 2008, PSYCHIAT RES-NEUROIM, V163, P156, DOI 10.1016/j.pscychresns.2007.08.011; Morris T, 2010, HANDBOOK OF MEDICAL NEUROPSYCHOLOGY: APPLICATIONS OF COGNITIVE NEUROSCIENCE, P17, DOI 10.1007/978-1-4419-1364-7_2; Nakata H, 2010, BRAIN RES REV, V62, P197, DOI 10.1016/j.brainresrev.2009.11.006; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Niu HJ, 2013, CNS NEUROSCI THER, V19, P125, DOI 10.1111/cns.12046; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Peterka RJ, 2004, J NEUROPHYSIOL, V91, P410, DOI 10.1152/jn.00516.2003; Plenger P, 2016, BRAIN IMAGING BEHAV, V10, P357, DOI 10.1007/s11682-015-9401-9; Plummer P, 2013, ARCH PHYS MED REHAB, V94, P2565, DOI 10.1016/j.apmr.2013.08.002; Prime SL, 2011, PHILOS T R SOC B, V366, P540, DOI 10.1098/rstb.2010.0184; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Purcell L, 2016, CLIN PEDIATR, V55, P452, DOI 10.1177/0009922815589915; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Resch JE, 2011, J ATHL TRAINING, V46, P170, DOI 10.4085/1062-6050-46.2.170; Rivera RG, 2015, MCN-AM J MATERN-CHIL, V40, P76, DOI 10.1097/NMC.0000000000000114; Rosso AL, 2017, GAIT POSTURE, V57, P193, DOI 10.1016/j.gaitpost.2017.06.013; Santosa H, 2018, ALGORITHMS, V11, DOI 10.3390/a11050073; Schmithorst VJ, 2015, HUM BRAIN MAPP, V36, P1, DOI 10.1002/hbm.22608; Schroeter ML, 2002, HUM BRAIN MAPP, V17, P61, DOI 10.1002/hbm.10052; Schudlo LC, 2015, BEHAV BRAIN RES, V290, P131, DOI 10.1016/j.bbr.2015.04.053; SEAMAN MA, 1991, PSYCHOL BULL, V110, P577, DOI 10.1037/0033-2909.110.3.577; Shah-Basak PP, 2018, J NEUROTRAUM, V35, P267, DOI 10.1089/neu.2017.5117; Shomstein S, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00038; Singh-Curry V, 2009, NEUROPSYCHOLOGIA, V47, P1434, DOI 10.1016/j.neuropsychologia.2008.11.033; Sinopoli KJ, 2014, J NEUROTRAUM, V31, P1843, DOI 10.1089/neu.2014.3326; Sliwinska MW, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00161; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Surgent OJ, 2019, GAIT POSTURE, V71, P245, DOI 10.1016/j.gaitpost.2019.05.011; Sylvester CM, 2013, J AM ACAD CHILD PSY, V52, P1326, DOI 10.1016/j.jaac.2013.10.001; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Teel EF, 2013, J SCI MED SPORT, V16, P190, DOI 10.1016/j.jsams.2012.09.007; TREISMAN A, 1969, NATURE, V222, P437, DOI 10.1038/222437a0; Urban KJ, 2017, J NEUROTRAUM, V34, P816, DOI 10.1089/neu.2016.4502; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhang L., 2019, NAT COMMUN, V10, P566, DOI DOI 10.3389/fpsyg.2019.02752	101	1	1	6	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.	APR 3	2021	24	3					187	198		10.1080/17518423.2020.1825539		OCT 2020	12	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	QU9HM	WOS:000574972700001	33012188				2022-02-06	
J	Lu, WX; Jiang, C; Wang, ZN; Chen, Y; Bai, RB; Yan, GZ; Wang, G; Ren, HJ				Lu, Weixin; Jiang, Cheng; Wang, Zening; Chen, Yi; Bai, Ruobing; Yan, Guizhong; Wang, Gang; Ren, Haijun			Lactic acid, neuron-specific enolase, and blood-brain barrier index after a severe traumatic brain injury: a prospective study	BRITISH JOURNAL OF NEUROSURGERY			English	Article; Early Access						Severe traumatic brain injury; lactic acid; neuron-specific enolase; blood-brain barrier index; Glasgow coma score; Glasgow Outcome Scale-Extended; intracranial pressure	LACTATE; DISRUPTION; MECHANISMS; GLUTAMATE	Objective To explore the clinical significance of dynamic monitoring of cerebrospinal fluid (CSF) and serum Lactic acid(Lac), neuron-specific enolase (NSE), and the blood-brain barrier (BBB) index in evaluating the condition and prognosis after a severe traumatic brain injury (TBI). Methods A total of 52 severe TBI patients admitted to the Department of Neurosurgery within 24 hours after injury were dynamically monitored. CSF and serum samples were collected on the 1st, 3rd, and 7th day after a severe TBI to monitor the changes in Lac, NSE, and the BBB index. Intracranial pressure (ICP), Glasgow coma scale (GCS), and 6-month Glasgow outcome scale-extended (GOS-E) were tested. According to the results of GOS-E, the patients were divided into two groups (i.e. the poor prognosis group and good prognosis group). Statistical analysis was conducted to investigate the clinical significance of dynamic monitoring of CSF and serum Lac, NSE, and BBB index after a severe TBI. Results After a severe TBI, the levels of Lac, NSE, and BBB in CSF and serum were significantly higher than those in the normal range. Lac, NSE, and the BBB index did not correlate with ICP (except serum Lac) but had correlations with GCS and post-injury 6 months post-injury (except serum Lac). Moreover, the correlations between Lac, NSE, and BBB index were statistically significant (p < 0.05): CSF Lac and CSF NSE; CSF Lac and serum NSE; Lac and BBB index of CSF; Lac and BBB index of CSF; NSE and CSE of serum; CSF NSE and BBB index; and serum NSE and BBB index. Additionally, serum NSE is correlated with NSE in CSF (p < 0.05). Conclusion After a severe TBI, dynamic monitoring of CSF and serum Lac, NSE, and BBB index has the potential to assess the condition, predict the prognosis, and have clinical significance.	[Lu, Weixin; Jiang, Cheng; Wang, Zening; Chen, Yi; Bai, Ruobing; Yan, Guizhong; Wang, Gang; Ren, Haijun] Lanzhou Univ Second Hosp, Dept Neurosurg, Lanzhou, Peoples R China		Ren, HJ (corresponding author), Lanzhou Univ Second Hosp, Lanzhou 730000, Gansu, Peoples R China.	baiyunguan@hotmail.com			Science and technology plan project of Chengguan District, Lanzhou, Gansu, China [2018SHFZ0062]; Lanzhou University Second Hospital, Lanzhou, Gansu, China [SDKYJJ-16]	This study was supported by Science and technology plan project of Chengguan District, Lanzhou, Gansu, China (No. 2018SHFZ0062); Master and PhD Research Fund of Lanzhou University Second Hospital, Lanzhou, Gansu, China (No. SDKYJJ-16).	Adamides AA, 2009, J AM COLL SURGEONS, V209, P531, DOI 10.1016/j.jamcollsurg.2009.05.028; Bagnato S, 2020, J NEUROTRAUM, V37, P423, DOI 10.1089/neu.2019.6449; Bagnato S, 2013, NEUROSCI BIOBEHAV R, V37, P2721, DOI 10.1016/j.neubiorev.2013.09.007; Bisri Tatang, 2016, Asian J Neurosurg, V11, P151, DOI 10.4103/1793-5482.145375; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Chaves ML, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-6; Daoud H, 2014, NEUROCRIT CARE, V20, P427, DOI 10.1007/s12028-013-9879-1; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Lozano A, 2020, INT J NEURAL SYST, V30, DOI 10.1142/S0129065720500458; Lutkenhoff ES, 2015, ANN NEUROL, V78, P68, DOI 10.1002/ana.24423; MARAN A, 1994, LANCET, V343, P16, DOI 10.1016/S0140-6736(94)90876-1; Oresic M, 2016, EBIOMEDICINE, V12, P118, DOI 10.1016/j.ebiom.2016.07.015; Patet C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0638-5; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Saw MM, 2014, NEUROCRIT CARE, V20, P209, DOI 10.1007/s12028-013-9933-z; Sonnay S, 2017, NEUROSCIENCE, V346, P337, DOI 10.1016/j.neuroscience.2017.01.034; Stefani MA, 2017, ANN CLIN TRANSL NEUR, V4, P392, DOI 10.1002/acn3.416; VanItallie TB, 2019, METABOLISM, V100, DOI 10.1016/j.metabol.2019.07.007	22	1	1	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.												10.1080/02688697.2020.1823938		OCT 2020	5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NW7WR	WOS:000575229800001	33016150				2022-02-06	
J	Tiernan, S; Meagher, A; O'Sullivan, D; O'Kelly, E				Tiernan, Stephen; Meagher, Aidan; O'Sullivan, David; O'Kelly, Eoin			Finite element simulation of head impacts in mixed martial arts	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						Concussion; maximum principal strain; corpus callosum	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; LATERAL IMPACTS; CONCUSSION; THRESHOLD; RESPONSES	Thirteen MMA athletes were fitted with the MiG2.0 Stanford instrumented mouthguard. 451 video confirmed impacts were recoded during sparring sessions and competitive events. The competitive events resulted in five concussions. The impact with the highest angular acceleration from each event was simulated using the GHBMC head model. Average strain in the corpus callosum of concussed fighters was 0.27, which was 87.9% higher than uninjured fighters and was the best strain indicator of concussion. The best overall predictor of concussion found in this study was shear stress in the corpus callosum which differed by 111.4% between concussed and uninjured athletes.	[Tiernan, Stephen; Meagher, Aidan] Technol Univ Dublin, Dublin, Ireland; [O'Sullivan, David] Pusan Natl Univ, Div Sports Sci, Busan, South Korea; [O'Kelly, Eoin] St James Hosp, Hlth Care Ctr, Dept Neurol, Dublin, Ireland		Tiernan, S (corresponding author), Technol Univ Dublin, Dublin, Ireland.	stephen.tiernan@tudublin.ie		Tiernan, Stephen/0000-0002-0658-7557	CADFEM Ireland; UK Ltd.	This work was in part supported by CADFEM Ireland and UK Ltd.	Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Buse GJ, 2006, BRIT J SPORT MED, V40, P169, DOI 10.1136/bjsm.2005.021295; Elliott MR, 2015, J BIOMECH, V48, P3059, DOI 10.1016/j.jbiomech.2015.07.026; Giordano C., 2014, STAPP CAR CRASH J, V58, p14S; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Ho J, 2017, J BIOMECH, V60, P243, DOI 10.1016/j.jbiomech.2017.06.023; Holbourn AHS, 1943, LANCET, V2, P438; Hutchison MG, 2014, AM J SPORT MED, V42, P1352, DOI 10.1177/0363546514526151; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; King D, 2014, AM J SPORT MED, V43; Kleiven, 2005, P IRCOBI C PRAG CZEC, P21; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Laksari K, 2019, J NEUROTRAUM, V37, P1; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Newman KM, 2000, MINN REV, P223; O'Keeffe E, 2020, J NEUROTRAUM, V37, P347, DOI 10.1089/neu.2019.6483; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Patton D. U., 2013, COMPUTERS HUMAN BEHA, V29, pA54; Prasad P, 2008, STAPP CAR C, V52, P187; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Sawilowsky SS, 2009, J MOD APPL STAT METH, V8, P597, DOI 10.22237/jmasm/1257035100; Townsend DM, 2003, J AM SOC NEPHROL, V14, P1, DOI 10.1097/01.ASN.0000042803.28024.92; Trosseille X, 1992, SAE TECHNICAL PAPER; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Ward CC., 1977, INTRACRANIAL PRESSUR; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhou Z, 2018, SAE TECHNICAL PAPER	39	1	1	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.	FEB 17	2021	24	3					278	288		10.1080/10255842.2020.1826457		OCT 2020	11	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	SL1TQ	WOS:000575256200001	33017178	Green Submitted			2022-02-06	
J	Ajisebutu, A; Del Bigio, MR; Kazina, CJ; West, M; Serletis, D				Ajisebutu, Andrew; Del Bigio, Marc R.; Kazina, Colin J.; West, Michael; Serletis, Demitre			Dr. Dwight Parkinson: a Canadian neurosurgical pioneer	JOURNAL OF NEUROSURGERY			English	Article						parasellar plexus; neurosciences; carotid cavernous fistula; angiography; history; concussion; neuropathology; traumatic brain injury	CHYMOPAPAIN; CONCUSSION; HISTORY	In 1950, Dwight Parkinson was the first qualified neurosurgeon to arrive in Winnipeg, Manitoba. He played a monumental role in developing one of the earliest neurosurgical training programs in Western Canada. Parkinson was a pioneering neurosurgeon who served as the first president of the Canadian Neurosurgical Society in 1965. He was the epitome of the skull base neurosurgeon, which was not recognized as a distinct discipline at that time. He contributed to its development through detailed neuroanatomical study of the lateral sellar compartment (housing the parasellar venous plexus, a term he emphasized as more accurate than "cavernous sinus"). Parkinson also made seminal contributions to the management of cerebrovascular disease and offered new insights on cerebral concussion. Parkinson's dedication to clinical excellence and education laid a cornerstone for the development of neurosurgery and the neurosciences in Manitoba, making him a key figure in Canadian neurosurgery. Using published materials, online resources, hospital archives, and personal interviews, the authors conducted a systematic review of Parkinson's formative years, his development of the Section of Neurosurgery at the University of Manitoba, his achievements, and his legacy. This updated biography captures the exploits of this remarkable, and at times strictly disciplinarian, neurosurgeon-anatomist.	[Ajisebutu, Andrew; Kazina, Colin J.; West, Michael; Serletis, Demitre] Univ Manitoba, Sect Neurosurg, Dept Surg, Winnipeg, MB, Canada; [Del Bigio, Marc R.] Univ Manitoba, Dept Pathol, Winnipeg, MB, Canada; [Serletis, Demitre] Childrens Hosp Res Inst Manitoba, Manitoba Neurosurg Lab, Winnipeg, MB, Canada		Serletis, D (corresponding author), Univ Manitoba, Winnipeg, MB, Canada.	dserletis@hsc.mb.ca					Armstrong DD, 2017, J NEUROPATH EXP NEUR, V76, P917, DOI 10.1093/jnen/nlx069; BOWNESS JM, 1983, CLIN BIOCHEM, V16, P200, DOI 10.1016/S0009-9120(83)90291-6; Brown C, 1982, THESIS; CHILDE AE, 1953, ACTA RADIOL, V40, P211, DOI 10.3109/00016925309176583; Hay RK, 2003, NEUROSURGERY NEUROLO; Horoupian DS, 2017, J NEUROPATH EXP NEUR, V76, P480, DOI 10.1093/jnen/nlx033; Johnson C.C., 1980, THESIS; Lang M, 2017, J NEUROSURG, V126, P1995, DOI 10.3171/2016.5.JNS152372; LINDSAY JH, 1951, CAN MED ASSOC J, V65, P229; MACEWAN DW, 1979, RADIOLOGY, V130, P528, DOI 10.1148/130.2.528; McBeath J, 2016, DWIGHT PARKINSON INT; PARKINSON D, 1983, J NEUROSURG, V59, P990, DOI 10.3171/jns.1983.59.6.0990; PARKINSON D, 1983, SURG NEUROL, V20, P456, DOI 10.1016/0090-3019(83)90027-7; PARKINSON D, 1984, J NEUROSURG, V61, P993; Parkinson D, 1969, Clin Neurosurg, V16, P170; PARKINSON D, 1965, J NEUROSURG, V23, P474, DOI 10.3171/jns.1965.23.5.0474; PARKINSON D, 1958, Can J Surg, V1, P313; PARKINSON D, 1980, J NEUROSURG, V53, P285, DOI 10.3171/jns.1980.53.3.0285; Parkinson D, 1998, ANAT REC, V251, P486; PARKINSON D, 1981, SURG NEUROL, V16, P347, DOI 10.1016/0090-3019(81)90272-X; PARKINSON D, 1982, CLIN NEUR, V29, P131; PARKINSON D, 1988, J NEUROSURG, V68, P828; PARKINSON D, 1973, J NEUROSURG, V39, P203, DOI 10.3171/jns.1973.39.2.0203; PARKINSON D, 1973, J NEUROSURG, V38, P99, DOI 10.3171/jns.1973.38.1.0099; PARKINSON D, 1978, NEUROSURGERY, V3, P176, DOI 10.1227/00006123-197809000-00008; PARKINSON D, 1955, Can Med Assoc J, V72, P571; PARKINSON D, 1955, J NEUROSURG, V12, P565, DOI 10.3171/jns.1955.12.6.0565; PARKINSON D., 1967, J CAN ASS RADIOL, V18, P371; PARKINSON D, 1995, J NEUROSURG, V82, P900, DOI 10.3171/jns.1995.82.5.0900; PARKINSON DWIGHT, 1964, CANADIAN J SURG, V7, P251; Perneczky A, 2008, CONCEPT SURG TECHNIQ; Pool J L, 1975, J Neurosurg, V42, P625, DOI 10.3171/jns.1975.42.6.0625; Prolo DJ, 2014, DWIGHT PARKINSON GAV; Putnam H, 1939, SKATING; SHIELDS CB, 1985, SURG NEUROL, V23, P342, DOI 10.1016/0090-3019(85)90203-4; Vanderlinden RG, 2016, CAN J NEUROL SCI, V43, P434, DOI 10.1017/cjn.2015.346; WEST M, 1981, BRAIN RES, V225, P271, DOI 10.1016/0006-8993(81)90835-0	37	1	1	2	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2020	133	4					1092	1099		10.3171/2019.6.JNS19262			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OM5UM	WOS:000586089500020	31561217				2022-02-06	
J	Ajmera, S; Motiwala, M; Weeks, M; Oravec, CS; Hersh, DS; Fraser, BD; Vaughn, B; Klimo, P				Ajmera, Sonia; Motiwala, Mustafa; Weeks, Matt; Oravec, Chesney S.; Hersh, David S.; Fraser, Brittany D.; Vaughn, Brandy; Klimo, Paul, Jr.			What Variables Correlate With Different Clinical Outcomes of Abusive Head Injury?	NEUROSURGERY			English	Article						Abusive head trauma; Nonaccidental trauma; Predictors; Severe	ACUTE SUBDURAL-HEMATOMA; TRAUMATIC BRAIN-INJURY; SUSPECTED CHILD-ABUSE; NONACCIDENTAL TRAUMA; PREDICTIVE FACTORS; SEVERITY SCORE; RISK-FACTORS; MORTALITY; PERPETRATORS; MALTREATMENT	BACKGROUND: The spectrum of injury severity for abusive head trauma (AHT) severity is broad, but outcomes are unequivocally worse than accidental trauma. There are few publications that analyze different outcomes of AHT. OBJECTIVE: To determine variables associated with different outcomes of AHT. METHODS: Patients were identified using our AHT database. Three different, but not mutually exclusive, outcomes of AHT were modeled: (1) death or hemispheric stroke (diffuse loss of grey-white differentiation); (2) stroke(s) of any size; and (3) need for a neurosurgical operation. Demographic and clinical variables were collected and correlations to the 3 outcomes of interest were identified using bivariate and multivariable analysis. RESULTS: From January 2009 to December 2017, 305 children were identified through a prospectively maintained AHT database. These children were typically male (60%), African American (54%), and had public or no insurance (90%). A total of 29 children (9.5%) died or suffered a massive hemispheric stroke, 57 (18.7%) required a neurosurgical operation, and 91 (29.8%) sustained 1 or more stroke. Death or hemispheric stroke was statistically associated with the pupillary exam (odds ratio [OR] = 45.7) and admission international normalized ratio (INR) (OR = 17.3); stroke was associated with the pupillary exam (OR = 13.2), seizures (OR = 14.8), admission hematocrit (OR = 0.92), and INR (9.4), and need for surgery was associated with seizures (OR = 8.6). CONCLUSION: We have identified several demographic and clinical variables that correlate with 3 clinically applicable outcomes of abusive head injury.	[Ajmera, Sonia; Motiwala, Mustafa; Fraser, Brittany D.] Univ Tennessee, Coll Med, Hlth Sci Ctr, Memphis, TN USA; [Weeks, Matt] Rhodes Coll, Memphis, TN 38112 USA; [Oravec, Chesney S.] Wake Forest Sch Med, Dept Neurosurg, Winston Salem, NC 27101 USA; [Hersh, David S.; Klimo, Paul, Jr.] Univ Tennessee, Dept Neurosurg, Hlth Sci Ctr, Memphis, TN USA; [Vaughn, Brandy; Klimo, Paul, Jr.] Le Bonheur Childrens Hosp, Memphis, TN USA; [Klimo, Paul, Jr.] Semmes Murphey Clin, 6325 Humphreys Blvd, Memphis, TN 38120 USA		Klimo, P (corresponding author), Semmes Murphey Clin, 6325 Humphreys Blvd, Memphis, TN 38120 USA.	pklim@semmes-murphey.com			Jackson Fogelman Pediatric Neurosurgery Research Fund	The Jackson Fogelman Pediatric Neurosurgery Research Fund supported this project. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Acker SN, 2014, J PEDIATR SURG, V49, P338, DOI 10.1016/j.jpedsurg.2013.10.008; Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Boop S, 2016, J NEUROSURG-PEDIATR, V18, P542, DOI 10.3171/2016.1.PEDS15583; Brown JB, 2018, J TRAUMA ACUTE CARE, V85, P668, DOI 10.1097/TA.0000000000001841; Brown JB, 2017, J TRAUMA ACUTE CARE, V82, P995, DOI 10.1097/TA.0000000000001440; Choudhary AK, 2018, PEDIATR RADIOL, V48, P1048, DOI 10.1007/s00247-018-4149-1; Davies FC, 2017, EMERG MED J, V34, P562, DOI 10.1136/emermed-2016-206296; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; Diaz-Olavarrieta C, 2011, CHILD ABUSE NEGLECT, V35, P915, DOI 10.1016/j.chiabu.2011.05.017; Duhaime A.C., 1993, J NEUROTRAUM, V10, pS59; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1994, J NEUROTRAUM, V11, P669, DOI 10.1089/neu.1994.11.669; Esernio-Jenssen D, 2011, PEDIATRICS, V127, P649, DOI 10.1542/peds.2010-1770; Estroff JM, 2015, J EMERG MED, V48, P274, DOI 10.1016/j.jemermed.2014.07.030; Ettaro L, 2004, CHILD ABUSE NEGLECT, V28, P1099, DOI 10.1016/j.chiabu.2004.06.006; Falcone RA, 2007, J PEDIATR SURG, V42, P1031, DOI 10.1016/j.jpedsurg.2007.01.038; Fang XM, 2012, CHILD ABUSE NEGLECT, V36, P156, DOI 10.1016/j.chiabu.2011.10.006; Fortune PM, 2010, PEDIATR CRIT CARE ME, V11, P339, DOI 10.1097/PCC.0b013e3181c014ab; Foster KA, 2014, J NEUROTRAUM, V31, P1625, DOI 10.1089/neu.2014.3372; Fraser BD, 2019, NEUROSURGERY, V85, pE66, DOI 10.1093/neuros/nyy456; Ghahreman A, 2005, J NEUROSURG, V103, P213, DOI 10.3171/ped.2005.103.3.0213; Greeley CS, 2012, PEDIATRICS, V130, P347, DOI 10.1542/peds.2012-1442; Greenan K, 2019, J NEUROSURG-PEDIATR, V23, P670, DOI 10.3171/2019.1.PEDS18293; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; Johnson DL, 1995, PEDIATR NEUROSURG, V23, P305, DOI 10.1159/000120976; Khan NR, 2017, J NEUROSURG-PEDIATR, V20, P183, DOI 10.3171/2017.4.PEDS16650; King WJ, 2003, CAN MED ASSOC J, V168, P155; Labbe J, 2005, CHILD ABUSE NEGLECT, V29, P311, DOI 10.1016/j.chiabu.2005.03.002; Leeper CM, 2016, J TRAUMA ACUTE CARE, V80, P711, DOI 10.1097/TA.0000000000000954; Lind K, 2016, CHILD ABUSE NEGLECT, V51, P358, DOI 10.1016/j.chiabu.2015.08.001; Lopez ON, 2018, AM J SURG, V215, P1037, DOI 10.1016/j.amjsurg.2018.05.009; MINER ME, 1982, J PEDIATR-US, V100, P687, DOI 10.1016/S0022-3476(82)80565-9; Nuno M, 2018, CHILD ABUSE NEGLECT, V85, P39, DOI 10.1016/j.chiabu.2018.08.011; Orru' E, 2018, J NEUROIMAGING, V28, P608, DOI 10.1111/jon.12555; Parks SE, 2012, INJURY PREV, V18, P193, DOI 10.1136/injuryprev-2011-040128; Peterson C, 2014, PEDIATRICS, V134, P91, DOI 10.1542/peds.2014-0117; Pierre-Kahn V, 2003, OPHTHALMOLOGY, V110, P1718, DOI 10.1016/S0161-6420(03)00581-5; Rangel EL, 2010, J TRAUMA, V69, P20, DOI 10.1097/TA.0b013e3181bbd7c3; Roche AJ, 2005, CHILD ABUSE NEGLECT, V29, P325, DOI 10.1016/j.chiabu.2004.04.007; Scavarda D, 2010, CHILD NERV SYST, V26, P1555, DOI 10.1007/s00381-010-1150-x; Schnitzer PG, 2005, PEDIATRICS, V116, pE687, DOI 10.1542/peds.2005-0296; Scribano PV, 2013, CHILD ABUSE NEGLECT, V37, P771, DOI 10.1016/j.chiabu.2013.04.011; Shaver EG, 1996, PEDIATR NEUROSURG, V25, P123, DOI 10.1159/000121109; Shein SL, 2012, J PEDIATR-US, V161, P716, DOI 10.1016/j.jpeds.2012.03.046; Sonderman KA, 2018, J SURG RES, V231, P126, DOI 10.1016/j.jss.2018.05.033; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; Starling SP, 2000, SOUTHERN MED J, V93, P463; STARLING SP, 1995, PEDIATRICS, V95, P259; Stewart CL, 2013, J PEDIATR SURG, V48, P2106, DOI 10.1016/j.jpedsurg.2013.05.009; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Wittschieber D, 2019, AM J NEURORADIOL, V40, P388, DOI 10.3174/ajnr.A5855; Yilmazlar S, 1997, J Neurosurg Sci, V41, P379; Yu YYR, 2018, J PEDIATR SURG, V53, P1028, DOI 10.1016/j.jpedsurg.2018.02.043	56	1	1	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	OCT	2020	87	4					803	810		10.1093/neuros/nyaa058			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	OW8HR	WOS:000593121100046	32243538	Bronze			2022-02-06	
J	Aumen, AM; Oberg, KJ; Mingils, SM; Berkner, CB; Tracy, BL; Stephens, JA				Aumen, Allan M.; Oberg, Kelly J.; Mingils, Susan M.; Berkner, Cecelia B.; Tracy, Brian L.; Stephens, Jaclyn A.			Revised and Neuroimaging-Compatible Versions of the Dual Task Screen	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article							NEAR-INFRARED SPECTROSCOPY; SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; MOTION	Dual task paradigms simultaneously assess motor and cognitive abilities, and they can detect subtle, residual impairments in athletes with recent mild traumatic brain injury (mTBI). However, past dual task paradigms have focused solely on lower extremity skills and have relied on cumbersome, expensive laboratory equipment - thus limiting their practicality for everyday mTBI evaluation. Subsequently, we developed the Dual Task Screen (DTS), which takes <10 minutes to administer and score, uses low-cost portable equipment, and includes lower extremity (LE) and upper extremity (UE) subtasks. The purpose of this manuscript was twofold. First, we describe the administration protocol for the revised DTS, which we revised to address the limitations of the original DTS. Specifically, the revisions included additions of smart devices to acquire more detailed gait data and inclusion of single cognitive conditions to test for disrupted cognitive performance under dual task conditions. Importantly, the revised DTS is a measure intended for future clinical use, and we present representative results from three male athletes to illustrate the type of clinical data that can be acquired from the measure. Importantly, we have yet to evaluate the sensitivity and specificity of the revised DTS in athletes with mTBI, which is the next research initiative. The second purpose of this manuscript is to describe a neuroimaging-compatible version of the DTS. We developed this version so we could evaluate the neural underpinnings of single and dual task performance, for a better empirical understanding of the behavioral deficits associated with mTBI. Thus, this manuscript also describes the steps we took to enable simultaneous functional near-infrared spectroscopy (fNIRS) measurement during the DTS, along with how we acquired and completed first-level processing of the fNIRS data.	[Aumen, Allan M.; Oberg, Kelly J.; Stephens, Jaclyn A.] Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA; [Mingils, Susan M.; Stephens, Jaclyn A.] Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA; [Berkner, Cecelia B.; Tracy, Brian L.] Colorado State Univ, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA		Stephens, JA (corresponding author), Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA.; Stephens, JA (corresponding author), Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA.	Jaclyn.Stephens@colostate.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K12 HD055931, K01 HD096047-02]	We would like to thank Ms. Isabelle Booth, a Colorado State University honors student who assisted with accelerometry data analysis. We would also like to acknowledge funding from NIH K12 HD055931 and K01 HD096047-02 issued to author J.S.	Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Baker WB, 2014, BIOMED OPT EXPRESS, V5, P4053, DOI 10.1364/BOE.5.004053; Barker JW, 2013, BIOMED OPT EXPRESS, V4, P1366, DOI 10.1364/BOE.4.001366; Brigadoi S, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.2.025005; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, J ATHL TRAINING, V52, P160, DOI 10.4085/1062-6050-51.9.05; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Conway FN, 2020, CLIN J SPORT MED, V30, P203, DOI 10.1097/JSM.0000000000000557; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell David R, 2018, Concussion, V3, pCNC54, DOI 10.2217/cnc-2017-0014; Howell DR, 2019, ARCH PHYS MED REHAB, V100, P613, DOI 10.1016/j.apmr.2018.07.441; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Oyegbile TO, 2020, BEHAV SLEEP MED, V18, P241, DOI 10.1080/15402002.2019.1578223; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Sato T, 2016, NEUROIMAGE, V141, P120, DOI 10.1016/j.neuroimage.2016.06.054; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Scholkmann F, 2014, NEUROIMAGE, V85, P6, DOI 10.1016/j.neuroimage.2013.05.004; Solomito MJ, 2018, GAIT POSTURE, V64, P260, DOI 10.1016/j.gaitpost.2018.06.165; Stephens J, 2018, AM J OCCUP THER, V72, DOI 10.5014/ajot.2018.025361; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; Yrondi A, 2017, PRESSE MED, V46, P890, DOI 10.1016/j.lpm.2017.08.013	24	1	1	0	3	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	OCT	2020		164							e61678	10.3791/61678			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC2LI	WOS:000596838300031	33074251	Green Accepted			2022-02-06	
J	Balzano, RF; Popolizio, T; Izzo, R; Perri, M; Pennelli, AM; Al-Badayneh, B; Guglielmi, G				Balzano, Rosario Francesco; Popolizio, Teresa; Izzo, Roberto; Perri, Marco; Pennelli, Anna Maria; Al-Badayneh, Bilal; Guglielmi, Giuseppe			Traumatic Brain Injury: Radiological Findings and Clinical Outcome	CURRENT RADIOLOGY REPORTS			English	Article						TBI; CT; MRI; DTI; Outcome	DIFFUSE AXONAL INJURY; HEAD-INJURY; IMAGING FINDINGS; UNITED-STATES; CT; PATHOPHYSIOLOGY; CLASSIFICATION; DIAGNOSIS; NEURODEGENERATION; MECHANISMS	Purpose of the ReviewThis review talks about the principal imaging investigations in traumatic brain injury (TBI). Physiopathological mechanisms are briefly discussed. The article will focus on the major brain lesions and their imaging appearance with also reference to the most recent techniques that can correlate with prognosis.Recent FindingsNeuroimaging plays a principal role in the evaluation of TBI. CT and MRI are used for the evaluation of pathological findings after the trauma and for the follow-up. Several classification systems have been proposed to correlate neuroimaging findings and patients' outcome. Novel functional imaging techniques, such as diffusion tensor imaging, may provide further important information for the prediction of prognosis.SummaryCT is the best imaging tool for the acute evaluation of patients with TBI. MRI has higher sensibility in the detection of brain lesions, but currently is mostly used in the follow-up. Functional imaging techniques are very promising, but still are not currently included in the clinical evaluation.	[Balzano, Rosario Francesco] Dimiccoli Hosp, Dept Radiol, Viale Ippocrate 15, I-70051 Barletta, Italy; [Popolizio, Teresa; Izzo, Roberto; Pennelli, Anna Maria; Guglielmi, Giuseppe] Fdn IRCCS Casa Sollievo Sofferenza, Dept Radiol, Viale Cappuccini 1, I-71013 San Giovanni Rotondo, Italy; [Perri, Marco] Osped SS Filippo & Nicola, Dept Radiol, ASL 1 Avezzano, Via G Di Vittorio, I-67051 Laquila, Italy; [Al-Badayneh, Bilal] Hashemite Univ, Dept Radiol, Fac Med, Zarqa, Jordan; [Guglielmi, Giuseppe] Foggia Univ, Dept Clin & Expt Med, Sch Med, Viale L Pinto 1, I-71121 Foggia, Italy; [Guglielmi, Giuseppe] Dimiccoli Hosp, Univ Campus Barletta, Viale Ippocrate 15, I-70051 Barletta, Italy		Guglielmi, G (corresponding author), Fdn IRCCS Casa Sollievo Sofferenza, Dept Radiol, Viale Cappuccini 1, I-71013 San Giovanni Rotondo, Italy.; Guglielmi, G (corresponding author), Foggia Univ, Dept Clin & Expt Med, Sch Med, Viale L Pinto 1, I-71121 Foggia, Italy.; Guglielmi, G (corresponding author), Dimiccoli Hosp, Univ Campus Barletta, Viale Ippocrate 15, I-70051 Barletta, Italy.	giuseppe.guglielmi@unifg.it	Balzano, Rosario Francesco/R-5943-2018	Balzano, Rosario Francesco/0000-0001-5630-6760			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; BAYKANER K, 1988, SURG NEUROL, V30, P339, DOI 10.1016/0090-3019(88)90195-4; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Bodanapally UK, 2015, RADIOL CLIN N AM, V53, P695, DOI 10.1016/j.rcl.2015.02.011; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Callaghan P.T., 1991, PRINCIPLES NUCL MAGN; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; CDC, RAT TBI REL EM DEP V; Chen We-jian, 2006, Chin J Traumatol, V9, P59; Chieregato A, 2009, NEUROSURGERY, V64, P705, DOI 10.1227/01.NEU.0000341872.17024.44; Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; Coskun O, 2000, AM J NEURORADIOL, V21, P712; Croall Iain, 1800, Top Magn Reson Imaging, V24, P267, DOI 10.1097/RMR.0000000000000063; Currie S, 2016, POSTGRAD MED J, V92, P41, DOI 10.1136/postgradmedj-2014-133211; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Faul M., 2010, TRAUMATIC BRAIN INJU, DOI [10.15620/cdc.5571, DOI 10.15620/CDC.5571]; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gandhi D, 2012, AM J NEURORADIOL, V33, P1007, DOI 10.3174/ajnr.A2798; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; GENTRY LR, 1989, RADIOL CLIN N AM, V27, P435; GENTRY LR, 1994, RADIOLOGY, V191, P1; Grassi DC, 2018, ARQ NEURO-PSIQUIAT, V76, P189, DOI [10.1590/0004-282X20180007, 10.1590/0004-282x20180007]; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hellewell SC, 2016, METHODS MOL BIOL, V1462, P253, DOI 10.1007/978-1-4939-3816-2_15; Jacquard C, 2006, FASEB J, V20, P1021, DOI 10.1096/fj.05-5085fje; JAYAKUMAR PN, 1989, ACTA NEUROCHIR, V97, P114, DOI 10.1007/BF01772820; JENNETT B, 1976, LANCET, V1, P1031; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Le TH, 2006, SEMIN ROENTGENOL, V41, P177, DOI 10.1053/j.ro.2006.04.003; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Lloyd KM, 2008, RADIOLOGY, V248, P725, DOI 10.1148/radiol.2483070362; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lolli V, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150849; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Medina LS, 2000, AM J NEURORADIOL, V21, P1951; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Mohamed AZ, 2020, NEUROIMAGE-CLIN, V25, DOI 10.1016/j.nicl.2019.102136; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Mutch CA, 2016, NEUROSURG CLIN N AM, V27, P409, DOI 10.1016/j.nec.2016.05.011; Najem D, 2018, BIOCHEM CELL BIOL, V96, P391, DOI 10.1139/bcb-2016-0160; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Olney J W, 1990, Can Dis Wkly Rep, V16 Suppl 1E, P47; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Osborn AG., 2018, OSBORNS BRAIN; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Poon W, 2015, J NEUROTRAUM, V32, P571, DOI 10.1089/neu.2014.3558; Prasetyo E., 2020, CRIT CARE SHOCK, V23, P4; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Ranzenberger LR, 2020, STATPEARLS; Ricci B, 1997, NEURORADIOLOGY, V39, P313, DOI 10.1007/s002340050415; Ringl H, 2010, RADIOLOGY, V255, P553, DOI 10.1148/radiol.10091096; Gilardi BR, 2019, RADIOGRAPHICS, V39, P1598, DOI 10.1148/rg.2019190018; Rodallec MH, 2008, RADIOGRAPHICS, V28, P1711, DOI 10.1148/rg.286085512; Sandsmark DK, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0654-5; Schlosser Rodney J, 2002, J Otolaryngol, V31 Suppl 1, pS28, DOI 10.2310/7070.2002.21316; Schweitzer AD, 2019, RADIOGRAPHICS, V39, P1571, DOI 10.1148/rg.2019190076; Shetty VS, 2016, J AM COLL RADIOL, V13, P668, DOI 10.1016/j.jacr.2016.02.023; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Singh R, 2019, BRAIN INJURY, V33, P584, DOI 10.1080/02699052.2019.1566837; Singh R, 2018, BRAIN INJURY, V32, P84, DOI 10.1080/02699052.2017.1376756; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tehse J, 2019, EUR J NEUROSCI, V49, P1157, DOI 10.1111/ejn.14307; van Eijck Marleen Maria, 2020, Brain Inj, V34, P595, DOI 10.1080/02699052.2020.1741683; van Eijck MM, 2018, BRAIN INJURY, V32, P395, DOI 10.1080/02699052.2018.1429018; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Zayas JO, 2011, RADIOGRAPHICS, V31, P1741, DOI 10.1148/rg.316115506; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	84	1	1	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2167-4825		CURR RADIOL REP	Curr. Radiol. Rep.	OCT	2020	8	10							17	10.1007/s40134-020-00364-0			14	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	WA6KX	WOS:000702993800001					2022-02-06	
J	Bayram, JM; Hamilton, DF; Saunders, DH				Bayram, John M.; Hamilton, David F.; Saunders, David H.			Epidemiology of American Football Injuries at Universities in the United Kingdom	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						football (American); head injuries; concussion; general sports trauma; epidemiology	DATA-COLLECTION PROCEDURES; HIGH-SCHOOL; SURVEILLANCE SYSTEM; CONSENSUS STATEMENT; COLLEGIATE; DEFINITIONS; CONCUSSION; OBESITY; YOUTH	Background: College-level American football injury data are routinely collected; however, data relating to American football injuries at universities in the United Kingdom have never been reported. Purpose: To describe the epidemiology of UK university American football injuries. Study Design: Descriptive epidemiology study. Methods: An online survey tool was used to collect the injury data of 410 players from 56 UK university teams who participated in the 2014-2015 British Universities and College Sports American football season. Survey data were collected from January to February 2016 and were analyzed to determine the incidence and patterns of injury. Results: Overall, 710 injuries and 204 concussions were self-reported among the 410 participants, of which 334 (81.5%) were injured and 131 (32.0%) experienced concussion symptoms. The rate of injury per 100 athlete-seasons was greater in defensive players (195.3) than offensive players (155.1). The most common injuries were knee and ankle ligament injuries. Most injuries were classified as severe (time loss of >4 weeks). Conclusion: UK university American football injuries differ markedly from those reported for US colleges. UK university players appear to have less playing experience, greater concussion risks, more severe injuries, and a greater proportion of injuries in defensive players versus offensive players.	[Bayram, John M.; Hamilton, David F.] Univ Edinburgh, Dept Orthopaed & Trauma, Edinburgh, Midlothian, Scotland; [Saunders, David H.] Univ Edinburgh, Phys Act Hlth Res Ctr PAHRC, Edinburgh, Midlothian, Scotland		Bayram, JM (corresponding author), Univ Edinburgh, Dept Orthopaed & Trauma, Edinburgh, Midlothian, Scotland.	jmbayram@gmail.com	Hamilton, David/J-7186-2019	Hamilton, David/0000-0001-9060-9255			Badgeley MA, 2013, J PHYS ACT HEALTH, V10, P160, DOI 10.1123/jpah.10.2.160; Baruch Y, 2008, HUM RELAT, V61, P1139, DOI 10.1177/0018726708094863; Bazelmans C, 2004, EUR J EPIDEMIOL, V19, P1037, DOI 10.1007/s10654-004-0158-5; Bristol Online Surveys, 2020, BOS QUEST TOOL; British Universities and Colleges Sport, 2020, BUCS AM FOOTB; BUCS Rugby Injury Surveillance Project (CRISP) Steering Group, 2020, BUCS SUP RUGB INJ SU; Cheung CMK, 2011, COMPUT HUM BEHAV, V27, P1337, DOI 10.1016/j.chb.2010.07.028; Creative Research System, 2020, SAMPL SIZ CALC; Dick R, 2007, J ATHL TRAINING, V42, P221; Dick R, 2007, J ATHL TRAINING, V42, P173; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2006, CLIN J SPORT MED, V16, P97, DOI 10.1097/00042752-200603000-00003; Gabbe BJ, 2003, BRIT J SPORT MED, V37, P545, DOI 10.1136/bjsm.37.6.545; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Helgeson JG, 2002, PSYCHOL MARKET, V19, P303, DOI 10.1002/mar.1054; House of Commons Library, 8181 CBP HOUS COMM L; Iguchi J, 2013, J ATHL TRAINING, V48, P818, DOI 10.4085/1062-6050-48.4.15; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Kuzuhara K, 2009, J JPN SOC CLIN SPORT, V17, P542; Malina RM, 2007, J PEDIATR-US, V151, P378, DOI 10.1016/j.jpeds.2007.03.044; Marr D., 2014, International Journal of Sports Science, V4, P49; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Mostafavifar AM, 2013, BRIT J SPORT MED, V47, P1060, DOI 10.1136/bjsports-2012-092005; National Collegiate Athletic Association, 2020, 2014 NAT COLL FOOTB; National Collegiate Athletic Association, 2020, SPORTS SPONS PART RA; National Collegiate Athletic Association, 2020, INT CONS DIAGN MAN S; National Collegiate Athletic Association, 2020, EST PROB COMP COLL F; Sasakawa Sports Foundation, 2020, WHIT PAP SPORT JAP 2; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Sportscotland, 2020, SCOTT SPORTS CONC GU	34	1	1	1	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	OCT	2020	8	10							2325967120960206	10.1177/2325967120960206			10	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	OP4ID	WOS:000588043600001	33195720	Green Published, gold			2022-02-06	
J	Brett, BL; Savitz, J; Nitta, M; Espana, L; Teague, TK; Nelson, LD; McCrea, MA; Meier, TB				Brett, Benjamin L.; Savitz, Jonathan; Nitta, Morgan; Espana, Lezlie; Teague, T. Kent; Nelson, Lindsay D.; McCrea, Michael A.; Meier, Timothy B.			Systemic inflammation moderates the association of prior concussion with hippocampal volume and episodic memory in high school and collegiate athletes	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Concussion; Inflammation; Volumetrics; C-reactive protein	INTERLEUKIN-1 RECEPTOR ANTAGONIST; TRAUMATIC BRAIN-INJURY; C-REACTIVE PROTEIN; FOOTBALL PLAYERS; HISTORY; DYSFUNCTION; ACTIVATION; SYMPTOMS	Background: There is a need to determine why prior concussion has been associated with adverse outcomes in some retired and active athletes. We examined whether serum inflammatory markers moderate the associations of prior concussion with hippocampal volumes and neurobehavioral functioning in active high school and collegiate athletes. Methods: Athletes (N = 201) completed pre-season clinical testing and serum collection (C-reactive protein [CRP]; Interleukin-6 [IL]-6; IL-1 receptor antagonist [RA]) and in-season neuroimaging. Linear mixed-effects models examined associations of prior concussion with inflammatory markers, self-reported symptoms, neurocognitive function, and hippocampal volumes. Models examined whether inflammatory markers moderated associations of concussion history and hippocampal volume and/or clinical measures. Results: Concussion history was significantly associated with higher symptom severity, p = 0.012, but not hippocampal volume or inflammatory markers (ps > 0.05). A significant interaction of prior concussion and CRP was observed for hippocampal volume, p = 0.006. Follow-up analyses showed that at high levels of CRP, athletes with two or more prior concussions had smaller hippocampal volume compared to athletes without prior concussion, p = 0.008. There was a significant interaction between prior concussion and levels of IL-1RA on memory scores, p = 0.044, i.e., at low levels of IL-1RA, athletes with two or more concussions had worse memory performance than those without prior concussion (p = 0.014). Conclusion: Findings suggest that certain markers of systemic inflammation moderate the association between prior concussion and hippocampal volume and episodic memory performance. Current findings highlight potential markers for predicting at-risk individuals and identify therapeutic targets for mitigating the long-term adverse consequences of cumulative concussion.	[Brett, Benjamin L.; Nitta, Morgan; Espana, Lezlie; Nelson, Lindsay D.; McCrea, Michael A.; Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Brett, Benjamin L.; Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Savitz, Jonathan] Laureate Inst Brain Res, Tulsa, OK USA; [Savitz, Jonathan] Oxley Coll Hlth Sci, Tulsa, OK USA; [Nitta, Morgan] Marquette Univ, Dept Psychol, Milwaukee, WI 53233 USA; [Teague, T. Kent] Univ Oklahoma, Sch Community Med, Dept Surg, Norman, OK 73019 USA; [Teague, T. Kent] Univ Oklahoma, Sch Community Med, Dept Psychiat, Norman, OK 73019 USA; [Teague, T. Kent] Univ Oklahoma, Coll Pharm, Dept Pharmaceut Sci, Norman, OK 73019 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA		Meier, TB (corresponding author), Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA.	tmeier@mcw.edu	Teague, T. Kent/A-2527-2008; Savitz, Jonathan/C-3088-2009	Teague, T. Kent/0000-0002-4680-5440; Savitz, Jonathan/0000-0001-8143-182X; Espana, Lezlie/0000-0002-6466-4653	Department of Defense Broad Agency Announcement for Extramural Medical Research [W81XWH-14-1-0561]; National Institute of Neurological Disorders and Stroke of the NIH [R21NS099789, L301L30NS113158-01]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS102225]; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM121312]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH113871]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001436]	HSupported by the Department of Defense Broad Agency Announcement for Extramural Medical Research through award number W81XWH-14-1-0561, National Institute of Neurological Disorders and Stroke of the NIH under award number R21NS099789, and National Institute of Neurological Disorders and Stroke under award number R01NS102225. The National Institute of General Medical Sciences (P20GM121312) and the National Institute of Mental Health (R21MH113871) also provided support for this project. BLB acknowledges support from the National Institute of Neurological Disorders and Stroke of the NIH under the award NO L301L30NS113158-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The REDCap electronic database used for this project was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, Award Number UL1TR001436. This research was completed in part with computational resources and technical support provided by the Research Computing Center at the Medical College of Wisconsin.	Adler CM, 2018, CLIN J SPORT MED, V28, P100, DOI 10.1097/JSM.0000000000000391; Albrecht JS, 2019, J NEUROTRAUM, V36, P300, DOI 10.1089/neu.2017.5608; Alsalaheen B, 2017, SPORTS HEALTH, V9, P324, DOI 10.1177/1941738117713974; Asken B.M., 2019, CLIN NEUROPSYCHOL, P1; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Bettcher BM, 2012, BRAIN BEHAV IMMUN, V26, P103, DOI 10.1016/j.bbi.2011.07.240; Brett B.L., 2019, SPORTS HEALTH; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Cherry JD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185541; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Chesnokova V, 2016, BRAIN BEHAV IMMUN, V58, P1, DOI 10.1016/j.bbi.2016.01.017; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159929; Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108; Espana LY, 2017, J NEUROTRAUM, V34, P3143, DOI 10.1089/neu.2017.5002; Felger J.C., 2018, MOL PSYCHIAT; Green R.E., 2008, J CLIN EXP NEUROPSYC, V30, P163; Guedes VA, 2020, NEUROLOGY, V94, pE2412, DOI 10.1212/WNL.0000000000009577; Helmy A, 2016, J CEREBR BLOOD F MET, V36, P1434, DOI 10.1177/0271678X15620204; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jones NC, 2005, EUR J NEUROSCI, V22, P72, DOI 10.1111/j.1460-9568.2005.04221.x; Kao PC, 2006, ANN CLIN LAB SCI, V36, P163; Klein AP, 2019, J NEUROTRAUM, V36, P1776, DOI 10.1089/neu.2018.6055; Lassale C, 2019, J GERONTOL A-BIOL, V74, P195, DOI 10.1093/gerona/gly028; Marsland AL, 2015, BRAIN BEHAV IMMUN, V48, P195, DOI 10.1016/j.bbi.2015.03.015; Meier TB, 2020, ANN NEUROL, V87, P907, DOI 10.1002/ana.25725; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Misquitta K, 2018, NEUROIMAGE-CLIN, V19, P551, DOI 10.1016/j.nicl.2018.05.014; Montgomery S, 2017, ANN NEUROL, V82, P554, DOI 10.1002/ana.25036; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Muehlmann C., 2018, BRAIN IMAGING BEHAV; Nitta ME, 2019, NEUROLOGY, V93, pE497, DOI 10.1212/WNL.0000000000007864; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; Palomo J, 2015, CYTOKINE, V76, P25, DOI 10.1016/j.cyto.2015.06.017; Parivash SN, 2019, J NEUROTRAUM, V36, P2762, DOI 10.1089/neu.2018.6357; Parkin GM, 2019, J NEUROTRAUM, V36, P1768, DOI 10.1089/neu.2018.6042; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Pohlack ST, 2014, BRAIN STRUCT FUNCT, V219, P255, DOI 10.1007/s00429-012-0497-z; Reus GZ, 2015, NEUROSCIENCE, V300, P141, DOI 10.1016/j.neuroscience.2015.05.018; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Satizabal CL, 2012, NEUROLOGY, V78, P720, DOI 10.1212/WNL.0b013e318248e50f; Savitz J, 2018, BIOL PSYCHIAT-COGN N, V3, P514, DOI 10.1016/j.bpsc.2017.12.011; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Shetty T, 2019, J HEAD TRAUMA REHAB, V34, pE28, DOI 10.1097/HTR.0000000000000450; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Skelly DT, 2019, MOL PSYCHIATR, V24, P1533, DOI 10.1038/s41380-018-0075-8; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Su L, 2016, BRIT J PSYCHIAT, V209, P525, DOI 10.1192/bjp.bp.116.190165; Su SH, 2014, BRAIN BEHAV IMMUN, V38, P111, DOI 10.1016/j.bbi.2014.01.009; Sun MJ, 2017, BRAIN BEHAV IMMUN, V66, P359, DOI 10.1016/j.bbi.2017.08.005; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Terry D.P., 2017, BRAIN IMAGING BEHAV; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1394, DOI 10.1016/j.neuropsychologia.2004.04.006; Weissberg I, 2014, JAMA NEUROL, V71, P1453, DOI 10.1001/jamaneurol.2014.2682; Wojtowicz M, 2017, J NEUROTRAUM, V34, P322, DOI 10.1089/neu.2016.4412; Zivadinov R, 2018, J HEAD TRAUMA REHAB, V33, pE24, DOI 10.1097/HTR.0000000000000422	64	1	1	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	OCT	2020	89						380	388		10.1016/j.bbi.2020.07.024			9	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology; Neurosciences & Neurology; Psychiatry	OH9GJ	WOS:000582897600037	32717401	Green Accepted, Bronze			2022-02-06	
J	Courtes, AA; Goncalves, DF; Hartmann, DD; da Rosa, PC; Cassol, G; Royes, LFF; de Carvalho, NR; Soares, FAA				Courtes, Aline Alves; Goncalves, Debora Farina; Hartmann, Diane Duarte; da Rosa, Pamela Carvalho; Cassol, Gustavo; Freire Royes, Luiz Fernando; de Carvalho, Nelson Rodrigues; Antunes Soares, Felix Alexandre			Guanosine protects against behavioural and mitochondrial bioenergetic alterations after mild traumatic brain injury	BRAIN RESEARCH BULLETIN			English	Article						Nucleoside; Weight drop model; High-resolution respirometry; Mitochondrial functionality	FLUID PERCUSSION INJURY; HIPPOCAMPAL SLICES; OXIDATIVE STRESS; GLUTAMATE UPTAKE; DYSFUNCTION; MODEL; RATS; CELLS; IMPAIRMENTS; ISCHEMIA	Traumatic brain injury (TBI) constitutes a heterogeneous cerebral insult induced by traumatic biomechanical forces. Mitochondria play a critical role in brain bioenergetics, and TBI induces several consequences related with oxidative stress and excitotoxicity clearly demonstrated in different experimental model involving TBI. Mitochondrial bioenergetics alterations can present several targets for therapeutics which could help reduce secondary brain lesions such as neuropsychiatric problems, including memory loss and motor impairment. Guanosine (GUO), an endogenous neuroprotective nucleoside, affords the long-term benefits of controlling brain neurodegeneration, mainly due to its capacity to activate the antioxidant defense system and maintenance of the redox system. However, little is known about the exact protective mechanism exerted by GUO on mitochondrial bioenergetics disruption induced by TBI. Thus, the aim of this study was to investigate the effects of GUO in brain cortical and hippocampal mitochondrial bioenergetics in the mild TBI model. Additionally, we aimed to assess whether mitochondrial damage induced by TBI may be related to behavioral alterations in rats. Our findings showed that 24 h post-TBI, GUO treatment promotes an adaptive response of mitochondrial respiratory chain increasing oxygen flux which it was able to protect against the uncoupling of oxidative phosphorylation (OXPHOS) induced by TBI, restored the respiratory electron transfer system (ETS) established with an uncoupler. Guanosine treatment also increased respiratory control ratio (RCR), an indicator of the state of mitochondrial coupling, which is related to the mitochondrial functionality. In addition, mitochondrial bioenergetics failure was closely related with locomotor, exploratory and memory impairments. The present study suggests GUO treatment post mild TBI could increase GDP endogenous levels and consequently increasing ATP levels promotes an increase of RCR increasing OXPHOS and in substantial improve mitochondrial respiration in different brain regions, which, in turn, could promote an improvement in behavioral parameters associated to the mild TBI. These findings may contribute to the development of future therapies with a target on failure energetic metabolism induced by TBI.	[Courtes, Aline Alves; Goncalves, Debora Farina; Hartmann, Diane Duarte; da Rosa, Pamela Carvalho; Freire Royes, Luiz Fernando; Antunes Soares, Felix Alexandre] Univ Fed Santa Maria, Ctr Ciencias Nat & Exatas, Dept Bioquim & Biol Mol, Programa Posgrad Ciencias Biol Bioquim Toxicol, BR-97105900 Santa Maria, RS, Brazil; [Cassol, Gustavo; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Ctr Educ Fis & Desportos, Lab Bioquim Exercicio, BR-97105900 Santa Maria, RS, Brazil; [de Carvalho, Nelson Rodrigues] Inst Fed Farroupilha, Campus Santo Angelo, BR-98802705 Santo Angelo, RS, Brazil		Soares, FAA (corresponding author), Univ Fed Santa Maria, Dept Bioquim & Biol Mol CCNE, BR-97105900 Santa Maria, RS, Brazil.	felix@ufsm.br		Farina Goncalves, Debora/0000-0003-2356-2922; da Rosa, Pamela Carvalho/0000-0002-4827-7063; Cassol, Gustavo/0000-0003-1343-7001	Universidade Federal de Santa Maria (UFSM) [16/2551-0000248-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [16/2551-0000248-7, 88882.182135/2018-01, 0737/2018]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [16/2551-0000248-7]; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS) [16/2551-0000248-7]; Programa de Apoio a Nucleos Emergentes (PRONEM) [16/2551-0000248-7]; CNPQConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)	We gratefully acknowledged the Universidade Federal de Santa Maria (UFSM), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (PROEX Process Number: 88882.182135/2018-01 Furtherance Number: 0737/2018), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), and Programa de Apoio a Nucleos Emergentes (PRONEM) for the financial support [grant number 16/2551-0000248-7]. F.A.A.S and L.F.F.R express their gratitude to CNPQ by fellowship.	Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Bettio LEB, 2016, PURINERG SIGNAL, V12, P411, DOI 10.1007/s11302-016-9509-4; Chen H, 2016, CLIN EXP PHARMACOL P, V43, P1107, DOI 10.1111/1440-1681.12650; Collins-Praino LE, 2018, BEHAV BRAIN RES, V336, P22, DOI 10.1016/j.bbr.2017.08.035; Courtes AA, 2019, BIOMED PHARMACOTHER, V111, P1438, DOI 10.1016/j.biopha.2019.01.040; Dal-Cim T, 2012, NEUROCHEM INT, V61, P397, DOI 10.1016/j.neuint.2012.05.021; Darwish H, 2012, BRAIN INJURY, V26, P1763, DOI [10.3109/02699052.2012.741452, 10.3109/02699052.2011.635362]; de Carvalho NR, 2017, TOXICOL RES-UK, V6, P526, DOI 10.1039/c7tx00072c; Di Deo P, 2016, J NEUROTRAUM, V33, P2019, DOI 10.1089/neu.2015.4026; Dobrachinski F, 2019, MOL NEUROBIOL, V56, P3145, DOI 10.1007/s12035-018-1296-1; Dobrachinski F, 2017, J NEUROTRAUM, V34, P1318, DOI 10.1089/neu.2016.4563; Eckert A, 2008, J MOL MED, V86, P1255, DOI 10.1007/s00109-008-0391-6; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Frolova MS, 2014, J FLUORESC, V24, P1061, DOI 10.1007/s10895-014-1385-0; Gelfo F, 2018, NEUROSCIENCE, V370, P218, DOI 10.1016/j.neuroscience.2017.07.065; Gerbatin RD, 2017, MOL NEUROBIOL, V54, P7585, DOI 10.1007/s12035-016-0238-z; Gerbatin RR, 2019, NEUROSCI LETT, V704, P141, DOI 10.1016/j.neulet.2019.04.014; Giuliani P, 2012, J BIOL REG HOMEOS AG, V26, P51; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Goncalves DF, 2019, NEUROTOXICOLOGY, V70, P1, DOI 10.1016/j.neuro.2018.10.005; Gudkov S V, 2006, Dokl Biochem Biophys, V407, P47, DOI 10.1134/S1607672906020013; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Jin H, 2014, BBA-MOL BASIS DIS, V1842, P1282, DOI 10.1016/j.bbadis.2013.09.007; Khacho M, 2017, HUM MOL GENET, V26, P3327, DOI 10.1093/hmg/ddx217; Kilbaugh TJ, 2016, MITOCHONDRION, V26, P19, DOI 10.1016/j.mito.2015.11.001; Kilbaugh TJ, 2015, EXP NEUROL, V271, P136, DOI 10.1016/j.expneurol.2015.05.009; Lanznaster D, 2017, MOL NEUROBIOL, V54, P5482, DOI 10.1007/s12035-016-0082-1; Li DW, 2014, INT J MOL MED, V34, P1358, DOI 10.3892/ijmm.2014.1904; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Marques NF, 2019, NEUROTOX RES, V35, P475, DOI 10.1007/s12640-018-9976-1; McGee J, 2016, NEUROL CLIN, V34, P55, DOI 10.1016/j.ncl.2015.08.004; Mkrtchyan GV, 2018, BBA-BIOENERGETICS, V1859, P925, DOI 10.1016/j.bbabio.2018.05.005; Moretto MB, 2005, EXP NEUROL, V195, P400, DOI 10.1016/j.expneurol.2005.06.005; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Nita M, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3164734; Pecinova A, 2011, MITOCHONDRION, V11, P722, DOI 10.1016/j.mito.2011.05.006; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Quincozes-Santos A, 2014, J NEUROCHEM, V130, P61, DOI 10.1111/jnc.12694; Quincozes-Santos A, 2013, PURINERG SIGNAL, V9, P643, DOI 10.1007/s11302-013-9377-0; Ramos DB, 2016, PURINERG SIGNAL, V12, P149, DOI 10.1007/s11302-015-9489-9; Rhein V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012359; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; Scheff SW, 2017, J NEUROTRAUM, V34, P1491, DOI 10.1089/neu.2016.4718; Sharma A, 2018, THERANOSTICS, V8, P5529, DOI 10.7150/thno.29039; Soares FA, 2004, BRAIN RES, V1005, P182, DOI 10.1016/j.brainres.2004.01.053; Tavares RG, 2008, NEUROCHEM RES, V33, P97, DOI 10.1007/s11064-007-9421-y; Teixeira LV, 2018, NEUROCHEM RES, V43, P1476, DOI 10.1007/s11064-018-2562-3; Thomaz DT, 2016, PURINERG SIGNAL, V12, P707, DOI 10.1007/s11302-016-9534-3; Ucal M, 2017, J NEUROTRAUM, V34, P475, DOI 10.1089/neu.2016.4411; UEMURA Y, 1991, STROKE, V22, P1548, DOI 10.1161/01.STR.22.12.1548; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Watson William D, 2013, Front Neuroenergetics, V5, P12, DOI 10.3389/fnene.2013.00012; Whishaw IQ, 2003, J NEUROSCI METH, V126, P13, DOI 10.1016/S0165-0270(03)00049-9; Wirth C, 2016, BBA-BIOENERGETICS, V1857, P902, DOI 10.1016/j.bbabio.2016.02.013; Woyda-Ploszczyca AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098969	56	1	1	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	OCT	2020	163						31	39		10.1016/j.brainresbull.2020.07.003			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NK1BF	WOS:000566474100004	32681970	hybrid			2022-02-06	
J	Delaney, S; Fitzsimons, M; White, M; Power, K; O' Donoghue, S; Kilbride, R; Widdess-Walsh, P; El Naggar, H; Delanty, N				Delaney, S.; Fitzsimons, M.; White, M.; Power, K.; O' Donoghue, S.; Kilbride, R.; Widdess-Walsh, P.; El Naggar, H.; Delanty, N.			Analysis of the aetiology of epilepsy in 3,216 adult patients attending a tertiary referral center enabled by an electronic patient record	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Aetiology; Epilepsy; Electronic patient record	ILAE CLASSIFICATION; PREVALENCE; CARE; FEATURES; GENE	Purpose: The aim of this study was to review the causes of the epilepsies in our institution, an adult tertiary referral center for neurology and neurosurgery in Dublin, Ireland. Data was obtained from a bespoke epilepsy electronic patient record (EPR). Methods: Predetermined search parameters of well-established broad categories of epilepsy aetiology were used to identify patients with a diagnosis of epilepsy attending Beaumont Hospital, Dublin. There were 3216 patients that met the inclusion criteria for this study. We included living patients with epilepsy attending our institution. We then excluded patients with a diagnosis of pure non-epileptic attack disorder and patients found to have idiopathic generalised epilepsy (IGE) (n = 382) from our final cohort. We excluded IGE due to the complex polygenic basis underlying this patient group. Results: An aetiology was identified in 54.3 % (n = 1747) of the total number of patients studied. Of the symptomatic epilepsies, 41.08 % (n = 1321) were acquired and 13.3 % (n = 426) were predominantly of genetic or developmental aetiology. The most common causes of the acquired epilepsies were hippocampal sclerosis (n = 380; 28.75 %), cerebral tumor (n = 279; 21.06 %), traumatic brain injury (n = 248; 18.77 %), stroke and cerebrovascular disease (n = 151; 11.43 %) and perinatal causes (n = 138; 10.45 %). The leading causes in the genetic / developmental category included cavernous haemangiomas (n = 62, 22.22 %), arteriovenous malformations (n = 59; 21.15 %) and cortical dysplasia (n = 55; 19.71 %). The aetiology of a patient's epilepsy was undetermined in 45.68 % (n = 1469) of individuals. Conclusion: This study emphasizes the clinical utility of the ILAE's 2017 revised classification of the epilepsies and highlights the evolving dynamic nature of attributing causality in epilepsy. This is the largest single centre analysis of the aetiology of the epilepsies described in the literature. It is also the first large scale study examining aetiology utilising a bespoke electronic patient record in epilepsy.	[Delaney, S.; White, M.; Kilbride, R.; Widdess-Walsh, P.; El Naggar, H.; Delanty, N.] Beaumont Hosp, Epilepsy Programme, Dublin, Ireland; [Fitzsimons, M.; White, M.; Power, K.; Widdess-Walsh, P.; El Naggar, H.; Delanty, N.] SFI FutureNeuro Res Ctr, Dublin, Ireland; [O' Donoghue, S.] Ergo Grp, Digital Practice, Dublin, Ireland; [Delanty, N.] Royal Coll Surg, Sch Pharm & Biomed Sci, Dublin, Ireland		Delanty, N (corresponding author), Beaumont Hosp, Beaumont Rd, Dublin 9, Ireland.	normandelanty@beaumont.ie		Power, Kevin/0000-0001-5621-3660; Widdess-Walsh, Peter/0000-0003-4217-2575; Delaney, Siobhan/0000-0002-2629-7127			Andermann E, 2009, GENETICS EPILEPSY GE, P1; Banerjee PN, 1997, EPILEPSY COMPREHENSI, P47, DOI 10.1007/978-88-470-2903-3_81; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x; Fiest KM, 2017, NEUROLOGY, V88, P296, DOI 10.1212/WNL.0000000000003509; Fitzsimons M, 2013, SEIZURE-EUR J EPILEP, V22, P604, DOI 10.1016/j.seizure.2013.03.002; FORSGREN L, 1992, EPILEPSIA, V33, P450, DOI 10.1111/j.1528-1157.1992.tb01690.x; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Goldberg EM, 2013, NAT REV NEUROSCI, V14, P337, DOI 10.1038/nrn3482; Kariuki SM, 2014, EPILEPSIA, V55, P76, DOI 10.1111/epi.12392; Lennox WG, 1960, EPILEPSY RELATED DIS; Linehan C, 2010, EPILEPSIA, V51, P845, DOI 10.1111/j.1528-1167.2009.02417.x; Mbuba CK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000162; Pardoe H, 2014, EPILEPSY CURR, V14, P121, DOI 10.5698/1535-7597-14.3.121; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Shorvon SD, 2011, EPILEPSIA, V52, P1052, DOI 10.1111/j.1528-1167.2011.03041.x; Si Y, 2012, SEIZURE-EUR J EPILEP, V21, P40, DOI 10.1016/j.seizure.2011.09.008; Uttam AK, 2013, EPILEPSIA, V54, P751, DOI 10.1111/epi.12086; Wolf P, 2003, EPILEPSIA, V44, P1, DOI 10.1046/j.1528-1157.2003.09202_2.x	20	1	1	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	OCT	2020	81						332	337		10.1016/j.seizure.2020.08.005			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OJ1EK	WOS:000583710200055	32883563	Bronze, Green Published			2022-02-06	
J	Dell'Acqua, S; Massardi, E; Monzani, E; Di Natale, G; Rizzarelli, E; Casella, L				Dell'Acqua, Simone; Massardi, Elisa; Monzani, Enrico; Di Natale, Giuseppe; Rizzarelli, Enrico; Casella, Luigi			Interaction between Hemin and Prion Peptides: Binding, Oxidative Reactivity and Aggregation	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						hemin; prion peptides; prion diseases; oxidative stress; neurodegeneration; peroxidase	AMYLOID-BETA PEPTIDES; A-BETA; OCTAREPEAT DOMAIN; ALZHEIMERS-DISEASE; PROTEIN BINDS; COPPER; PEROXIDASE; MICROPEROXIDASES; DIMERIZATION; SPECIATION	We investigate the interaction of hemin with four fragments of prion protein (PrP) containing from one to four histidines (PrP106-114, PrP95-114, PrP84-114, PrP76-114) for its potential relevance to prion diseases and possibly traumatic brain injury. The binding properties of hemin-PrP complexes have been evaluated by UV-visible spectrophotometric titration. PrP peptides form a 1:1 adduct with hemin with affinity that increases with the number of histidines and length of the peptide; the following log K-1 binding constants have been calculated: 6.48 for PrP76-114, 6.1 for PrP84-114, 4.80 for PrP95-114, whereas for PrP106-114, the interaction is too weak to allow a reliable binding constant calculation. These constants are similar to that of amyloid-beta (A beta) for hemin, and similarly to hemin-A beta, PrP peptides tend to form a six-coordinated low-spin complex. However, the concomitant aggregation of PrP induced by hemin prevents calculation of the K-2 binding constant. The turbidimetry analysis of [hemin-PrP76-114] shows that, once aggregated, this complex is scarcely soluble and undergoes precipitation. Finally, a detailed study of the peroxidase-like activity of [hemin-(PrP)] shows a moderate increase of the reactivity with respect to free hemin, but considering the activity over long time, as for neurodegenerative pathologies, it might contribute to neuronal oxidative stress.	[Dell'Acqua, Simone; Massardi, Elisa; Monzani, Enrico; Casella, Luigi] Univ Pavia, Dipartimento Chim, Via Taramelli 12, I-27100 Pavia, Italy; [Di Natale, Giuseppe; Rizzarelli, Enrico] CNR, Ist Cristallog, SS Catania, Via Paolo Gaifami 18, I-95126 Catania, Italy		Dell'Acqua, S; Casella, L (corresponding author), Univ Pavia, Dipartimento Chim, Via Taramelli 12, I-27100 Pavia, Italy.	simone.dellacqua@unipv.it; elisamassardi@gmail.com; enrico.monzani@unipv.it; peppedinatale@yahoo.it; erizza@unict.it; luigi.casella@unipv.it		MONZANI, ENRICO/0000-0002-8791-6446; Dell'Acqua, Simone/0000-0002-1231-4045	Italian Ministry of Education, University, and Research (MIUR)-Research Projects of National Interest (PRIN)Ministry of Education, Universities and Research (MIUR) [2015T778JW]	This research was funded by the Italian Ministry of Education, University, and Research (MIUR)-Research Projects of National Interest (PRIN) 2015 prot. 2015T778JW.	ADAMS PA, 1990, J CHEM SOC PERK T 2, P1407, DOI 10.1039/p29900001407; Asher C, 2009, INORG CHEM, V48, P7994, DOI 10.1021/ic900647y; Atamna H, 2006, P NATL ACAD SCI USA, V103, P3381, DOI 10.1073/pnas.0600134103; Atamna H, 2004, P NATL ACAD SCI USA, V101, P11153, DOI 10.1073/pnas.0404349101; Atamna H, 2009, ARCH BIOCHEM BIOPHYS, V487, P59, DOI 10.1016/j.abb.2009.05.003; Bacchella C, 2020, INORG CHEM, V59, P900, DOI 10.1021/acs.inorgchem.9b03153; Casella L, 1996, INORG CHEM, V35, P439, DOI 10.1021/ic950148x; Chattopadhyay M, 2005, J AM CHEM SOC, V127, P12647, DOI 10.1021/ja053254z; Chiabrando D, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00712; Daglas M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00981; Dallacosta C, 2004, CHEMBIOCHEM, V5, P1692, DOI 10.1002/cbic.200400175; de Villiers KA, 2007, J BIOL INORG CHEM, V12, P101, DOI 10.1007/s00775-006-0170-1; Dell'Acqua S, 2017, INORG CHEM, V56, P11317, DOI 10.1021/acs.inorgchem.7b01757; Di Natale G, 2015, CHEM-EUR J, V21, P4071, DOI 10.1002/chem.201405502; Di Natale G, 2009, INORG CHEM, V48, P4239, DOI 10.1021/ic802190v; Dunford H. B., 1991, PEROXIDASES CHEM BIO, VII, P1; DUNFORD HB, 1976, COORDIN CHEM REV, V19, P187, DOI 10.1016/S0010-8545(00)80316-1; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Farina M, 2013, NEUROCHEM INT, V62, P575, DOI 10.1016/j.neuint.2012.12.006; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Frey PA, 2012, ACS CHEM BIOL, V7, P1477, DOI 10.1021/cb300323q; Fuhrhop J.H, 1977, LAB METHODS PORPHYRI; Gasperini L, 2015, ANTIOXID REDOX SIGN, V22, P772, DOI 10.1089/ars.2014.6032; Ghosh C, 2015, ACCOUNTS CHEM RES, V48, P2556, DOI 10.1021/acs.accounts.5b00102; Gozzelino R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010130; Harrathi C, 2019, MOL NEUROBIOL, V56, P5287, DOI 10.1007/s12035-018-1443-8; Honda R, 2018, FASEB J, V32, P3641, DOI 10.1096/fj.201701183RR; Hou SW, 2006, ACCOUNTS CHEM RES, V39, P918, DOI 10.1021/ar040020w; Huang XY, 2018, CHEM REV, V118, P2491, DOI 10.1021/acs.chemrev.7b00373; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Johnstone D, 2010, J NEUROCHEM, V113, P1387, DOI 10.1111/j.1471-4159.2010.06697.x; Khodarahmi R, 2017, INT J BIOL MACROMOL, V100, P18, DOI 10.1016/j.ijbiomac.2016.09.074; Kuhl T, 2014, CHEMBIOCHEM, V15, P2024, DOI 10.1002/cbic.201402218; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee KS, 2007, J BIOL CHEM, V282, P36525, DOI 10.1074/jbc.M705620200; Legname G, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006458; Magri A, 2018, INORG CHIM ACTA, V472, P93, DOI 10.1016/j.ica.2017.10.032; Monzani E, 1998, INORG CHIM ACTA, V273, P339, DOI 10.1016/S0020-1693(97)06029-5; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; Osz K, 2007, CHEM-EUR J, V13, P7129, DOI 10.1002/chem.200601568; Pato C, 2004, PROTEIN SCI, V13, P1100, DOI 10.1110/ps.03409304; Pirota V, 2016, DALTON T, V45, P14343, DOI 10.1039/c6dt02183b; Pramanik D, 2013, COORDIN CHEM REV, V257, P81, DOI 10.1016/j.ccr.2012.02.025; Priola SA, 2000, SCIENCE, V287, P1503, DOI 10.1126/science.287.5457.1503; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Resenberger UK, 2012, NEURODEGENER DIS, V10, P298, DOI 10.1159/000332596; Ryabova ES, 2004, J BIOL INORG CHEM, V9, P385, DOI 10.1007/s00775-004-0532-5; Sanchez-Lopez C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010018; Smith AG, 2011, METALLOMICS, V3, P955, DOI 10.1039/c1mt00085c; Soutyrine A, 2015, RES VET SCI, V101, P168, DOI 10.1016/j.rvsc.2015.05.008; Stanyon HF, 2014, BIOCHEMISTRY-US, V53, P3934, DOI 10.1021/bi500643b; Thiabaud G, 2013, ANGEW CHEM INT EDIT, V52, P8041, DOI 10.1002/anie.201302989; Tripathi AK, 2016, J ALZHEIMERS DIS, V51, P107, DOI 10.3233/JAD-151039; Velasquez CD, 2020, J BIOL CHEM, V295, P4985, DOI 10.1074/jbc.RA120.012546; Wong BX, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00081; Wulf MA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0375-5; Yamaguchi Kei-Ichi, 2018, Biophys Rev, V10, P517, DOI 10.1007/s12551-017-0377-0; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Younan ND, 2013, FASEB J, V27, P1847, DOI 10.1096/fj.12-222588; Zhou YL, 2013, ACS CHEM NEUROSCI, V4, P535, DOI 10.1021/cn300231q	62	1	1	2	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	OCT	2020	21	20							7553	10.3390/ijms21207553			17	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	OL8ST	WOS:000585603000001	33066163	Green Published, gold			2022-02-06	
J	Farzaneh, N; Williamson, CA; Jiang, C; Srinivasan, A; Bapuraj, JR; Gryak, J; Najarian, K; Soroushmehr, SMR				Farzaneh, Negar; Williamson, Craig A.; Jiang, Cheng; Srinivasan, Ashok; Bapuraj, Jayapalli R.; Gryak, Jonathan; Najarian, Kayvan; Soroushmehr, S. M. Reza			Automated Segmentation and Severity Analysis of Subdural Hematoma for Patients with Traumatic Brain Injuries	DIAGNOSTICS			English	Article						clinical decision support system; subdural hematoma; medical image processing; machine learning; deep learning	INTRACRANIAL HEMATOMA; HEMORRHAGE SEGMENTATION; CLASSIFICATION; TOMOGRAPHY; DIAGNOSIS; CT	Detection and severity assessment of subdural hematoma is a major step in the evaluation of traumatic brain injuries. This is a retrospective study of 110 computed tomography (CT) scans from patients admitted to the Michigan Medicine Neurological Intensive Care Unit or Emergency Department. A machine learning pipeline was developed to segment and assess the severity of subdural hematoma. First, the probability of each point belonging to the hematoma region was determined using a combination of hand-crafted and deep features. This probability provided the initial state of the segmentation. Next, a 3D post-processing model was applied to evolve the initial state and delineate the hematoma. The recall, precision, and Dice similarity coefficient of the proposed segmentation method were 78.61%, 76.12%, and 75.35%, respectively, for the entire population. The Dice similarity coefficient was 79.97% for clinically significant hematomas, which compared favorably to an inter-rater Dice similarity coefficient. In volume-based severity analysis, the proposed model yielded an F1, recall, and specificity of 98.22%, 98.81%, and 92.31%, respectively, in detecting moderate and severe subdural hematomas based on hematoma volume. These results show that the combination of classical image processing and deep learning can outperform deep learning only methods to achieve greater average performance and robustness. Such a system can aid critical care physicians in reducing time to intervention and thereby improve long-term patient outcomes.	[Farzaneh, Negar; Gryak, Jonathan; Najarian, Kayvan; Soroushmehr, S. M. Reza] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Williamson, Craig A.; Najarian, Kayvan; Soroushmehr, S. M. Reza] Univ Michigan, Michigan Ctr Integrat Res Crit Care MCIRCC, Ann Arbor, MI 48109 USA; [Williamson, Craig A.] Univ Michigan, Dept Neurol Surg & Neurol, Ann Arbor, MI 48109 USA; [Williamson, Craig A.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Jiang, Cheng; Najarian, Kayvan] Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA; [Srinivasan, Ashok; Bapuraj, Jayapalli R.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA; [Gryak, Jonathan; Najarian, Kayvan] Univ Michigan, Michigan Inst Data Sci MIDAS, Ann Arbor, MI 48109 USA; [Najarian, Kayvan] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA		Farzaneh, N (corresponding author), Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.	negarf@umich.edu; craigaw@med.umich.edu; gryakj@umich.edu; ashoks@med.umich.edu; jrajiv@med.umich.edu; gryakj@umich.edu; kayvan@umich.edu; ssoroush@umich.edu	Bapuraj, Jayapalli Rajiv/P-2279-2017	Bapuraj, Jayapalli Rajiv/0000-0003-3933-203X; Gryak, Jonathan/0000-0002-5125-7741	National Science Foundation (NSF)National Science Foundation (NSF) [1500124]; Massey Foundation; University of Michigan National Institute of Health (NIH) NIGMS Bioinformatics Training Grant (T32) [GM070499]; National Institute of Health (NIH) Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (F31)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [LM012946-01]	This material is based upon work supported by the National Science Foundation (NSF) under Grant No.1500124 and the Massey Foundation. Negar Farzaneh was supported by the University of Michigan National Institute of Health (NIH) NIGMS Bioinformatics Training Grant (T32) No. GM070499 during this research. Negar Farzaneh is supported by National Institute of Health (NIH) Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (F31) No. LM012946-01 during this research.	Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; [Anonymous], **NON-TRADITIONAL**; Bardera A, 2009, COMPUT MED IMAG GRAP, V33, P304, DOI 10.1016/j.compmedimag.2009.02.001; Bhadauria HS, 2013, COMPUT ELECTR ENG, V39, P1527, DOI 10.1016/j.compeleceng.2013.04.010; Chan T, 2007, COMPUT MED IMAG GRAP, V31, P285, DOI 10.1016/j.compmedimag.2007.02.010; Chilamkurthy S, 2018, LANCET, V392, P2388, DOI 10.1016/S0140-6736(18)31645-3; Farzaneh Negar, 2017, Annu Int Conf IEEE Eng Med Biol Soc, V2017, P3069, DOI 10.1109/EMBC.2017.8037505; Faul M, 2010, TRAUMATIC BRAIN INJU; Gennarelli TA., 2008, ABBREVIATED INJURY S; Grewal M, 2018, I S BIOMED IMAGING, P281, DOI 10.1109/ISBI.2018.8363574; JAIN AK, 1991, PATTERN RECOGN, V24, P1167, DOI 10.1016/0031-3203(91)90143-S; Liao CC, 2010, COMPUT MED IMAG GRAP, V34, P563, DOI 10.1016/j.compmedimag.2010.03.003; Liao CC, 2009, COMPUT MED IMAG GRAP, V33, P423, DOI 10.1016/j.compmedimag.2009.04.001; Liu BQ, 2008, IEEE ENG MED BIO, P1214, DOI 10.1109/IEMBS.2008.4649381; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shahangian B, 2013, IRAN CONF MACH, P467, DOI 10.1109/IranianMVIP.2013.6780031; Shahangian B, 2016, BIOCYBERN BIOMED ENG, V36, P217, DOI 10.1016/j.bbe.2015.12.001; Yuh EL, 2008, J NEUROTRAUM, V25, P1163, DOI 10.1089/neu.2008.0590	23	1	1	3	7	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4418		DIAGNOSTICS	Diagnostics	OCT	2020	10	10							773	10.3390/diagnostics10100773			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OL4LN	WOS:000585313800001	33007929	gold, Green Published			2022-02-06	
J	Garcia-Rudolph, A; Garcia-Molina, A; Opisso, E; Munoz, JT				Garcia-Rudolph, Alejandro; Garcia-Molina, Alberto; Opisso, Eloy; Munoz, Jose Tormos			Personalized Web-Based Cognitive Rehabilitation Treatments for Patients with Traumatic Brain Injury: Cluster Analysis	JMIR MEDICAL INFORMATICS			English	Article						cluster analysis; traumatic brain injury; web-based rehabilitation	VERBAL-LEARNING TEST; EDITION CVLT-II; TEST-PERFORMANCE; PROFILES; SUBTYPES; PATTERNS; CLASSIFICATION; VALIDATION; VALIDITY; PEOPLE	Background: Traumatic brain injury (TBI) is a leading cause of disability worldwide. TBI is a highly heterogeneous disease, which makes it complex for effective therapeutic interventions. Cluster analysis has been extensively applied in previous research studies to identify homogeneous subgroups based on performance in neuropsychological baseline tests. Nevertheless, most analyzed samples are rarely larger than a size of 100, and different cluster analysis approaches and cluster validity indices have been scarcely compared or applied in web based rehabilitation treatments. Objective: The aims of our study were as follows: (1) to apply state-of-the-art cluster validity indices to different cluster strategies: hierarchical, partitional, and model-based, (2) to apply combined strategies of dimensionality reduction by using principal component analysis and random forests and perform stability assessment of the final profiles, (3) to characterize the identified profiles by using demographic and clinically relevant variables, and (4) to study the external validity of the obtained clusters by considering 3 relevant aspects of TBI rehabilitation: Glasgow Coma Scale, functional independence measure, and execution of web-based cognitive tasks. Methods: This study was performed from August 2008 to July 2019. Different cluster strategies were executed with Mclust, factoextra, and cluster R packages. For combined strategies, we used the FactoMineR and random forest R packages. Stability analysis was performed with the fpc R package. Between-group comparisons for external validation were performed using 2-tailed t test, chi-square test, or Mann-Whitney U test, as appropriate. Results: We analyzed 574 adult patients with TBI (mostly severe) who were undergoing web-based rehabilitation. We identified and characterized 3 clusters with strong internal validation: (1) moderate attentional impairment and moderate dysexecutive syndrome with mild memory impairment and normal spatiotemporal perception, with almost 66% (111/170) of the patients being highly educated (P<.05); (2) severe dysexecutive syndrome with severe attentional and memory impairments and normal spatiotemporal perception, with 49.2% (153/311) of the patients being highly educated (P<.05); (3) very severe cognitive impairment, with 45.2% (42/93) of the patients being highly educated (P<.05). We externally validated them with severity of injury (P=.006) and functional independence assessments: cognitive (P<.001), motor (P<.001), and total (P<.001). We mapped 151,763 web-based cognitive rehabilitation tasks during the whole period to the 3 obtained clusters (P<.001) and confirmed the identified patterns. Stability analysis indicated that clusters 1 and 2 were respectively rated as 0.60 and 0.75; therefore, they were measuring a pattern and cluster 3 was rated as highly stable. Conclusions: Cluster analysis in web-based cognitive rehabilitation treatments enables the identification and characterization of strong response patterns to neuropsychological tests, external validation of the obtained clusters, tailoring of cognitive web-based tasks executed in the web platform to the identified profiles, thereby providing clinicians a tool for treatment personalization, and the extension of a similar approach to other medical conditions.	[Garcia-Rudolph, Alejandro; Garcia-Molina, Alberto; Opisso, Eloy; Munoz, Jose Tormos] Inst Guttmann Hosp Neurorehabil, Cami Can Ruti S-N, Badalona, Spain; [Garcia-Rudolph, Alejandro; Garcia-Molina, Alberto; Opisso, Eloy; Munoz, Jose Tormos] Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain; [Garcia-Rudolph, Alejandro; Garcia-Molina, Alberto; Opisso, Eloy; Munoz, Jose Tormos] Fundacio Inst Invest Ciencies Salut Germans Trias, Badalona, Spain		Garcia-Rudolph, A (corresponding author), Inst Guttmann Hosp Neurorehabil, Cami Can Ruti S-N, Badalona, Spain.	alejandropablogarcia@gmail.com		Opisso, Eloy/0000-0002-6868-6737; Tormos Munoz, Jose Maria/0000-0002-8764-2289; Garcia-Molina, Alberto/0000-0002-5014-7591	INNOBRAIN project: New Technologies for Innovation in Cognitive Stimulation and Rehabilitation [COMRDI15-1-0017]; FEDER Catalonia 2014-2020 Operational Program [COM15-1-0004]	This study was partially funded by the INNOBRAIN project: New Technologies for Innovation in Cognitive Stimulation and Rehabilitation (COMRDI15-1-0017). ACCIO-Comunitat RIS3CAT d'innovacio en salut NEXTHEALTH (COM15-1-0004) cofinanced this project under the FEDER Catalonia 2014-2020 Operational Program.	Allen DN, 2013, CLUSTER ANAL NEUROPS; [Anonymous], STATS V3 6 1; Arbelaitz O, 2013, PATTERN RECOGN, V46, P243, DOI 10.1016/j.patcog.2012.07.021; Cha YJ, 2013, NEUROREHABILITATION, V32, P359, DOI 10.3233/NRE-130856; Chan RCK, 2003, BRAIN INJURY, V17, P131, DOI 10.1080/0269905021000010168; Chimge NO, 2012, CLIN CANCER RES, V18, P901, DOI 10.1158/1078-0432.CCR-11-1530; Conrad DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122705; Crosson B., 1990, CLIN NEUROPSYCHOL, V4, P253, DOI 10.1080/13854049008401908; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; de Assis CS, 2015, REV ESC ENFERM USP, V49, P753, DOI 10.1590/S0080-623420150000500007; DeJong J, 2010, J CLIN EXP NEUROPSYC, V32, P953, DOI 10.1080/13803391003645640; Demery JA, 2002, J CLIN EXP NEUROPSYC, V24, P818, DOI 10.1076/jcen.24.6.818.8400; Deshpande SA, 1996, J CLIN EXP NEUROPSYC, V18, P836, DOI 10.1080/01688639608408306; Donders J, 1995, CHILD NEUROPSYCHOL, V1, P19, DOI 10.1080/09297049508401339; Donders J, 2008, ASSESSMENT, V15, P123, DOI 10.1177/1073191107310926; Flynt A, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0017-5; Garcia-Rudolph A, 2016, ENG APPL ARTIF INTEL, V55, P165, DOI 10.1016/j.engappai.2016.06.007; Garcia-Rudolph A, 2014, EXPERT SYST APPL, V41, P5238, DOI 10.1016/j.eswa.2014.03.001; Gates NJ, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-55; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; Han J, 2019, MORGAN KAUFMANN SERI; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Harman-Smith YE, 2013, J CLIN EXP NEUROPSYC, V35, P785, DOI 10.1080/13803395.2013.824554; Haut M., 1992, NEUROPSYCHOLOGY, V6, P51; Hennig C., FPC V2 2 3 FLEXIBLE; Husson F., FACTOMINER V1 42 MUL; Husson F, 2019, EXPLORATORY MULTIVAR; Jaeggi SM, 2010, INTELLIGENCE, V38, P625, DOI 10.1016/j.intell.2010.09.001; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Kassambara A., FACTOEXTRA V1 0 5 EX; Kueider AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040588; Liaw A., RANDOMFOREST V4 6 14; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maechle M., CLUSTER V2 1 0 FINDI; MALEC JF, 1993, CLIN NEUROPSYCHOL, V7, P48, DOI DOI 10.1080/13854049308401887; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Messaris P, 2006, DIGITAL MEDIA TRANSF, V2018, P8147; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Mottram L, 2006, DEV NEUROPSYCHOL, V30, P865, DOI 10.1207/s15326942dn3003_6; Plant SE, 2016, CLIN REHABIL, V30, P921, DOI 10.1177/0269215516655856; Ringdahl EN, 2019, DEV NEUROPSYCHOL, V44, P172, DOI 10.1080/87565641.2018.1557190; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sansonetti D, 2018, AUST OCCUP THER J, V65, P512, DOI 10.1111/1440-1630.12492; Scrucca L., MCLUST V5 4 5 GAUSSI; Scrucca L, 2016, R J, V8, P289; Sherer M, 2015, CLIN NEUROPSYCHOL, V29, P522, DOI 10.1080/13854046.2015.1052763; Sohlberg MM, 2018, COGNITIVE REHABILITA, P8147; Solana J, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-58; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Stuss T. D, 2008, COGNITIVE NEUROREHAB; Subirats L, 2015, INT J ENV RES PUB HE, V12, P9832, DOI 10.3390/ijerph120809832; Thaler NS, 2013, ARCH CLIN NEUROPSYCH, V28, P798, DOI 10.1093/arclin/act080; Thompson G, 2005, EDUC GERONTOL, V31, P603, DOI 10.1080/03601270591003364; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; van der Heijden P, 2003, ASSESSMENT, V10, P115, DOI 10.1177/1073191103010002001; Wei T., CORRPLOT V0 84 VISUA; Whitmer AJ, 2012, J ABNORM PSYCHOL, V121, P570, DOI 10.1037/a0027474; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Wolfson, 1993, HALSTEAD REITAN NEUR; World Health Organization, 2020, INT CLASS FUNCT DIS; Zimmermann N, 2015, BRAIN INJURY, V29, P1071, DOI 10.3109/02699052.2015.1015613; Zumel N., 2014, PRACTICAL DATA SCI R	64	1	1	0	0	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA		2291-9694		JMIR MED INF	JMIR Med. Inf.	OCT	2020	8	10							e16077	10.2196/16077			16	Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Medical Informatics	OO6FW	WOS:000587474400002	33021482	gold, Green Published			2022-02-06	
J	Jayawarden, SK; Sandarage, R; Farag, J; Ganzert, C; Winston, P; Mills, P; Reebye, R				Jayawarden, Supun Kotteduwa; Sandarage, Ryan; Farag, Jordan; Ganzert, Carl; Winston, Paul; Mills, Patricia; Reebye, Rajiv			EFFECT OF TREATING ELBOW FLEXOR SPASTICITY WITH BOTULINUM TOXIN INJECTION AND ADJUNCTIVE CASTING ON HEMIPARETIC GAIT PARAMETERS: A PROSPECTIVE CASE SERIES	JOURNAL OF REHABILITATION MEDICINE			English	Article						botulinum; spasticity; casting; gait	RANDOMIZED CONTROLLED-TRIAL; LIMB SPASTICITY; STROKE; ADULTS; CHILDREN	Objective: To investigate changes in hemiparetic gait parameters after treatment of elbow flexor spasticity with botulinum neurotoxin (BoNT) injection and adjunctive casting. Design: Prospective case series. Subjects: Ten participants with spasticity secondary to acquired brain injury ( 8 stroke, 2 traumatic brain injury). Interventions: Participants received BoNT injections for their spastic elbow flexors under ultrasound guid-ance. Two weeks post-injection, an elbow stretching cast was applied for 1 week. Outcome measures: Assessments using the Modified Ashworth Scale (MAS), Tardieu scale V1 angle of arrest at slow speed and V3 angle of catch at fast speed, 2-min walk test (2MWT), Edinburgh Gait Score scale (EGS) and video gait analysis for step-length symmetry were conducted pre-BoNT injection (t(0)) and at cast removal (t(1)). Goal attainment scale (GAS) was used to assess changes in spasticity and gait 3 months post-injection (t(2)). Results: At t(1), participants showed a mean increase of 16.7 degrees (p< 0.01) on the Tardieu Scale V3 and a mean reduction of 0.5 points on the MAS (p < 0.05). There was also a mean reduction on EGS of 2.7 points (p < 0.05), and a mean increase on 2MWT of 3.1 m (p < 0.05). On the GAS, all participants report-ed improved gait at t(2) and 80% reported a decrease in spasticity. Conclusion: Combining BoNT injection with casting for treatment of elbow flexor spasticity without treat-ing the lower limb may improve hemiparetic gait parameters.	[Jayawarden, Supun Kotteduwa; Sandarage, Ryan; Farag, Jordan; Mills, Patricia; Reebye, Rajiv] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Farag, Jordan; Winston, Paul; Mills, Patricia; Reebye, Rajiv] GF Strong Rehabil Ctr, Vancouver, BC, Canada; [Ganzert, Carl] Hodgson Orthoped Grp, Coquitlam, BC, Canada; [Winston, Paul] Vancouver Isl Hlth Author, Vancouver, BC, Canada; [Mills, Patricia; Reebye, Rajiv] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada; [Mills, Patricia] Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada; [Ganzert, Carl; Winston, Paul; Mills, Patricia; Reebye, Rajiv] New Westminster Rehabil Med, Study Locat, Canadian Adv Neuro Orthoped Spastic Congress, 304-250 Keary St, New Westminster, BC, Canada		Jayawarden, SK (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC, Canada.		Reebye, Rajiv/AAK-5882-2021	Sandarage, Ryan/0000-0002-7998-5505; Winston, Paul/0000-0002-8403-6988			Bakheit AMO, 2002, DISABIL REHABIL, V24, P519, DOI 10.1080/09638280110112891; Carda S, 2011, CLIN REHABIL, V25, P1119, DOI 10.1177/0269215511405080; Chu Wing Hong, 2016, JBI Database System Rev Implement Rep, V14, P23, DOI 10.11124/JBISRIR-2016-002472; Esquenazi A, 2010, EUR J NEUROL, V17, P1, DOI 10.1111/j.1468-1331.2010.03125.x; Esquenazi A., 2011, J CLIN OUTCOMES MANA, V18, P34; Esquenazi A, 2008, AM J PHYS MED REHAB, V87, P305, DOI 10.1097/PHM.0b013e318168d36c; Farag J, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2629; Lannin N, 2007, CLIN REHABIL, V21, P963, DOI 10.1177/0269215507079141; Leung J, 2019, CLIN REHABIL, V33, P1035, DOI 10.1177/0269215519831337; Leung J, 2018, PHYSIOTHER CAN, V70, P152, DOI 10.3138/ptc.2016-76; Li SP, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00346; Lizama LEC, 2019, GAIT POSTURE, V70, P389, DOI 10.1016/j.gaitpost.2019.03.035; Mayer NH, 1997, MUSCLE NERVE, pS21; McAllister PJ, 2019, J REHABIL MED, V51, P813, DOI 10.2340/16501977-2604; McGlothlin AE, 2014, JAMA-J AM MED ASSOC, V312, P1342, DOI 10.1001/jama.2014.13128; Milinis K, 2016, DISABIL REHABIL, V38, P1431, DOI 10.3109/09638288.2015.1106592; Mills PB, 2016, CLIN REHABIL, V30, P537, DOI 10.1177/0269215515593783; O'Neill D, 2014, LANCET, V383, P1205, DOI 10.1016/S0140-6736(14)60595-X; Ridao-Fernandez C, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/2085039; Robinson LW, 2017, GAIT POSTURE, V53, P25, DOI 10.1016/j.gaitpost.2016.12.030; Shaw L, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14260; Singer BJ, 2003, ARCH PHYS MED REHAB, V84, P483, DOI 10.1053/apmr.2003.50041; Stoeckmann T, 2005, TOP STROKE REHABIL, V8, P27; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; TurnerStokes L, 2013, BMJ OPEN, P1; Verplancke D, 2005, CLIN REHABIL, V19, P117, DOI 10.1191/0269215505cr827oa; Yasar E, 2010, BRAIN INJURY, V24, P736, DOI 10.3109/02699051003610524	27	1	1	1	2	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	OCT	2020	52	10							jrm00110	10.2340/16501977-2743			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	OH3VP	WOS:000582500300001	32939558	gold			2022-02-06	
J	Le, DT; Barhorst, KA; Castiglione, J; Yang, GL; Shah, SJ; Harlan, SS; Keegan, SP; Jandarov, RA; Ngwenya, LB; Prestigiacomo, CJ				Le, Diana T.; Barhorst, Kinsey A.; Castiglione, James; Yang, George L.; Shah, Sanjit J.; Harlan, Sarah S.; Keegan, Shaun P.; Jandarov, Roman A.; Ngwenya, Laura B.; Prestigiacomo, Charles J.			Blunt cerebrovascular injury in the geriatric population	NEUROSURGICAL FOCUS			English	Article						BCVI; blunt cerebrovascular injury; geriatrics	TRAUMA PATIENTS; PREDICTORS; MORTALITY	OBJECTIVE Blunt cerebrovascular injury (BCVI) is associated with high rates of neurological morbidity and mortality. The detection and management of BCVI has improved with advances in imaging and sensitive screening protocols. Few studies have explored how these injuries specifically affect the geriatric population. The purpose of this retrospective analysis was to investigate the presentation and prognosis of BCVI in the elderly population and to assess its clinical implications in the management of these patients. METHODS All patients presenting to the University of Cincinnati (UC) level I trauma center between February 2017 and December 2019 were screened for BCVI and entered into the prospectively maintained UC Neurotrauma Registry. Patients with BCVI confirmed by CT angiography underwent retrospective chart reviews to collect information regarding demographics, positive screening criteria, cause of injury, antithrombotic agent, injury location, Denver Grading Scale, hospital and ICU length of stay, and discharge disposition. Patients were divided into geriatric (age >= 65 years) and adult (age < 65 years) subgroups. Continuous variables were analyzed using the Student t-test and categorical variables with the Pearson chi-square test. RESULTS Of 124 patients with BCVI, stratification by age yielded 23 geriatric and 101 adult patients. Injury in the geriatric group was associated with significantly higher mortality (p = 0.0194). The most common cause of injury in the elderly was falls (74%, 17/23; p < 0.0001), whereas motor vehicle accidents were most common in the adult group (38%, 38/100; p = 0.0642). With respect to the location of injury, carotid (p = 0.1171) and vertebral artery (p = 0.6981) injuries did not differ significantly for the geriatric group. The adult population presented more often with Denver grade I injuries (p < 0.0001), whereas the geriatric population presented with grade IV injuries (p = 0.0247). Elderly patients were more likely to be discharged to skilled nursing facilities (p = 0.0403) and adults to home or self-care (p = 0.0148). CONCLUSIONS This study is the first to characterize BCVI to all cervical and intracranial vessels in the geriatric population. Older age at presentation is significantly associated with greater severity, morbidity, and mortality from injury, with no preference for the particular artery injured. These findings carry important clinical implications for adapting practice in an aging population.	[Le, Diana T.; Barhorst, Kinsey A.; Castiglione, James; Prestigiacomo, Charles J.] Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA; [Yang, George L.; Shah, Sanjit J.; Ngwenya, Laura B.; Prestigiacomo, Charles J.] Univ Cincinnati, Coll Med, Dept Neurol Surg, Cincinnati, OH USA; [Harlan, Sarah S.; Keegan, Shaun P.] Univ Cincinnati, James L Winkle Coll Pharm, Div Pharmaceut Sci, Cincinnati, OH USA; [Jandarov, Roman A.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Div Biostat & Bioinformat, Cincinnati, OH 45267 USA		Prestigiacomo, CJ (corresponding author), Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA.	presticj@uc.edu					Adams SD, 2012, J TRAUMA ACUTE CARE, V72, P112, DOI 10.1097/TA.0b013e318241f073; Alvis Bret D, 2015, Anesthesiol Clin, V33, P447, DOI 10.1016/j.anclin.2015.05.003; [Anonymous], FACTS AND STAT, VInternational Osteoporosis Foundation; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Bromberg WJ, 2010, J TRAUMA, V68, P471, DOI 10.1097/TA.0b013e3181cb43da; Burlew CC, 2012, J TRAUMA ACUTE CARE, V72, P330, DOI 10.1097/TA.0b013e31823de8a0; Centers for Disease Control and Prevention, PERC US AD 55 OV CHR; Cothren CC, 2009, ARCH SURG-CHICAGO, V144, P685, DOI 10.1001/archsurg.2009.111; Desai M, 2017, CLIN SURG, V2, P1551; Esnault P, 2017, J NEUROSURG, V127, P16, DOI 10.3171/2016.4.JNS152600; Flashburg E, 2019, J TRAUMA ACUTE CARE, V86, P1010, DOI 10.1097/TA.0000000000002241; Foreman PM, 2017, CEREBROVASC DIS EXTR, V7, P72, DOI 10.1159/000455391; George B, 2009, PATHOLOGY SURG VERTE; Golemati S, 2014, 2014 IEEE-EMBS INTERNATIONAL CONFERENCE ON BIOMEDICAL AND HEALTH INFORMATICS (BHI), P680, DOI 10.1109/BHI.2014.6864455; Grossman A, 2018, U CINCINNATI MED CTR; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hashmi A, 2014, J TRAUMA ACUTE CARE, V76, P894, DOI 10.1097/TA.0b013e3182ab0763; Heron Melonie, 2019, Natl Vital Stat Rep, V68, P1; Ho AL, 2020, WORLD NEUROSURG, V137, pE315, DOI 10.1016/j.wneu.2020.01.191; Kopelman TR, 2011, AM J SURG, V202, P684, DOI 10.1016/j.amjsurg.2011.06.033; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; National Council on Aging, FALLS PREV FACTS; Nunes BP, 2016, ARCH GERONTOL GERIAT, V67, P130, DOI 10.1016/j.archger.2016.07.008; Page PS, 2020, J NEUROSURG-SPINE, V32, P657, DOI 10.3171/2019.11.SPINE191055; Schrag SP, 2008, AM J SURG, V195, P170, DOI 10.1016/j.amjsurg.2007.09.029; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; Tso MK, 2017, J NEUROSURG, V126, P1033, DOI 10.3171/2016.1.JNS151545; US Census Bureau, OLD PEOPL PROJ OUTN	29	1	1	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	OCT	2020	49	4							E10	10.3171/2020.7.FOCUS20499			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OG2DX	WOS:000581702500010	33002862	gold			2022-02-06	
J	Lee, YL; Lim, SW; Zheng, HX; Chang, WT; Nyam, TTE; Chio, CC; Kuo, JR; Wang, CC				Lee, Yao-Lin; Lim, Sher-Wei; Zheng, Hong-Xiang; Chang, Wei-Ting; Nyam, Tee-Tau Eric; Chio, Chung-Ching; Kuo, Jinn-Rung; Wang, Che-Chuan			The Short-Term Effects of Isolated Traumatic Brain Injury on the Heart in Experimental Healthy Rats	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Intracranial pressure; Infarction volume; BNP; Troponin I; Cardiac echo	CARDIAC DYSFUNCTION; IMPACT; APNEA	Background To date, cardiac dysfunction after traumatic brain injury (TBI) has not been consistent. In this study, we hypothesized that TBI may play a role in the development of new-onset cardiac dysfunction in healthy experimental rats. Materials and Methods Anesthetized healthy male Sprague-Dawley rats were divided into two groups: a sham-operated control group and a TBI group. The brain was injured with 2.4 atm percussion via a fluid percussion injury model. During the 120 min after TBI, we continuously measured brain parameters, including intracranial pressure (ICP) and cerebral perfusion pressure (CPP), and cardiac parameters, such as heart rate (HR), inter-ventricular septum dimension (IVSD), left ventricular internal dimension diastole (LVIDd), end-diastolic volume (EDV), ejection fraction (EF), fractional shortening (FS), and LV mass diastole (LVd mass) by cardiac echo. On days 1, 3, 7, and 14 after TBI, the brain damage volume was evaluated with triphenyltetrazolium chloride; the physiological parameters of the heart, including HR, IVSd, LVIDd, EDV, EF, FS, and LVd mass, were evaluated with cardiac echo; the morphology of cardiomyocytes was examined by hematoxylin and eosin (HE) and Masson trichrome staining; and the biomarkers of cardiac injury troponin I and B-type natriuretic peptide (BNP) were also examined. Results Compared to sham-operated controls, the TBI groups had higher ICP, lower CPP, and higher brain neuronal apoptosis and infarction contusion volume. The impact of TBI on heart function showed hyperdynamic response trends in IVSd, LVIDd, EDV, EF, FS, and LVd mass within 30 min after TBI; however, EF and FS exhibited eventual decreasing trends. Simultaneously, the values of the biomarkers troponin I and BNP were within normal limits, and HE and Mass trichrome staining revealed no significant differences between the sham-operated control group and the TBI group. Conclusions Our results suggest that TBI due to 2.4 atm fluid percussion injury in healthy experimental rats may cause significant damage to the brain and affect the heart function as investigated by cardiac echo but not as investigated by HE and Masson trichrome stainings or troponin I and BNP evaluation.	[Lee, Yao-Lin; Lim, Sher-Wei; Zheng, Hong-Xiang; Nyam, Tee-Tau Eric; Chio, Chung-Ching; Kuo, Jinn-Rung; Wang, Che-Chuan] Chi Mei Med Ctr, Dept Neurosurg, 901 Chung Hwa Rd, Tainan, Taiwan; [Chang, Wei-Ting] Chi Mei Med Ctr, Dept Cardiol, Tainan, Taiwan; [Kuo, Jinn-Rung; Wang, Che-Chuan] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Lim, Sher-Wei] Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan; [Wang, Che-Chuan] Southern Taiwan Univ Sci & Technol, Ctr Gen Educ, Tainan, Taiwan		Kuo, JR; Wang, CC (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, 901 Chung Hwa Rd, Tainan, Taiwan.	kuojinnrung@gmail.com; wangchechuan@gmail.com		Lee, Yaolin/0000-0001-7443-1514			Arellano-Orden V, 2011, NEUROCRIT CARE, V14, P18, DOI 10.1007/s12028-010-9441-3; Armstead WM, 2019, NEUROCRIT CARE, V31, P476, DOI 10.1007/s12028-019-00735-2; Armstead William M, 2016, Anesthesiol Clin, V34, P465, DOI 10.1016/j.anclin.2016.04.002; Atkinson JLD, 2000, MAYO CLIN PROC, V75, P37, DOI 10.4065/75.1.37; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Borbely XI, 2015, NEUROCRIT CARE, V23, P66, DOI 10.1007/s12028-014-0101-x; Chandramouli C, 2019, EUR J HEART FAIL, V21, P297, DOI 10.1002/ejhf.1358; Cheng CY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001468; Cuisinier A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0323-3; Dobbing J., 1981, SCI F PAEDIATRICS, P744; Dombrowski Keith, 2014, Handb Clin Neurol, V119, P3, DOI 10.1016/B978-0-7020-4086-3.00001-1; El Hajj MC, 2017, AM J PHYSIOL-HEART C, V312, pH98, DOI 10.1152/ajpheart.00348.2016; Eric Nyam TT, 2019, WORLD NEUROSURG, V122, P740; Hasanin A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0246-z; Hsieh TH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178186; Kerro A, 2017, J CRIT CARE, V38, P27, DOI 10.1016/j.jcrc.2016.10.010; Khechinashvili G, 2002, CEREBROVASC DIS, V14, P67, DOI 10.1159/000064733; Kokubo Y, 2017, ADV EXP MED BIOL, V956, P419, DOI 10.1007/5584_2016_99; KOLIN A, 1984, STROKE, V15, P990, DOI 10.1161/01.STR.15.6.990; Komamura K, 2014, WORLD J CARDIOL, V6, P602, DOI 10.4330/wjc.v6.i7.602; Krishnamoorthy V, 2013, CASE REP ANESTHESIOL, V2013; Krishnamoorthy V, 2016, CHEST, V149, P1325, DOI 10.1016/j.chest.2015.12.014; Krishnamoorthy Vijay, 2015, Int J Crit Illn Inj Sci, V5, P103, DOI 10.4103/2229-5151.158409; Krishnamoorthy V, 2014, INDIAN J CRIT CARE M, V18, P570, DOI 10.4103/0972-5229.140144; Liao JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093956; Lim SW, 2018, WORLD NEUROSURG, V112, pE278, DOI 10.1016/j.wneu.2018.01.036; Lim SW, 2017, NEUROCRIT CARE, V26, P122, DOI 10.1007/s12028-016-0290-6; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; Lockey DJ, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-21; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Najafipour Hamid, 2014, Iranian Biomedical Journal, V18, P225, DOI 10.6091/ibj.13222.2014; Nordestgaard BG, 2016, CIRC RES, V118, P547, DOI 10.1161/CIRCRESAHA.115.306249; Ozisik K, 2004, AM J TRANSPLANT, V4, P900, DOI 10.1111/j.1600-6143.2004.00448.x; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Ruggieri F, 2014, AM J EMERG MED, V32, DOI 10.1016/j.ajem.2013.08.047; Serri K, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0217-4; SHIVALKAR B, 1993, CIRCULATION, V87, P230, DOI 10.1161/01.CIR.87.1.230; Tang WC, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1457-6; The Brain Trauma Foundation The American Association of Neurological Surgeons, 2007, J NEUROTRAUMA S1, V24, pS59; Tsai YT, 2014, J SURG RES, V189, P106, DOI 10.1016/j.jss.2014.02.009; Wang CC, 2013, J SURG RES, V184, P1045, DOI 10.1016/j.jss.2013.04.059; Wang Y, 1997, J NEUROSCI, V17, P4341; Watson LE, 2004, J AM SOC ECHOCARDIOG, V17, P161, DOI 10.1016/j.echo.2003.10.010; Wee HY, 2015, J SURG RES, V197, P382, DOI 10.1016/j.jss.2015.04.052; Wilson MH, 2016, RESUSCITATION, V105, P52, DOI 10.1016/j.resuscitation.2016.05.007	48	1	1	1	8	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2020	33	2					438	448		10.1007/s12028-019-00902-5			11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NS0NU	WOS:000571957800015	31907801				2022-02-06	
J	Lentz, S; Grossman, A; Koyfman, A; Long, B				Lentz, Skyler; Grossman, Alexandra; Koyfman, Alex; Long, Brit			HIGH-RISK AIRWAY MANAGEMENT IN THE EMERGENCY DEPARTMENT: DISEASES AND APPROACHES, PART II	JOURNAL OF EMERGENCY MEDICINE			English	Article						airway; aortic stenosis; cardiac tamponade; elevated intracranial pressure; morbid obesity; postintubation cardiac arrest; pregnancy; trauma; upper gastrointestinal bleed	RAPID-SEQUENCE INTUBATION; FAILED TRACHEAL INTUBATION; TRAUMATIC BRAIN-INJURY; LARYNGEAL MASK AIRWAY; ENDOTRACHEAL INTUBATION; INTRACRANIAL-PRESSURE; MORBIDLY OBESE; GENERAL-ANESTHESIA; DIFFICULT AIRWAY; HEAD-INJURY	Background: Successful airway management is critical to the practice of emergency medicine. Thus, emergency physicians must be ready to optimize and prepare for airway management in critically ill patients with a wide range of physiologic challenges. Challenges in airway management commonly encountered in the emergency department are discussed using a pearl and pitfall discussion in this second part of a 2-part series. Objective: This narrative review presents an evidence-based approach to airway and patient management during endotracheal intubation in challenging cases commonly encountered in the emergency department. Discussion: Adverse events during emergent airway management are common with postintubation cardiac arrest, reported in as many as 1 in 25 intubations. Many of these adverse events can be avoided by proper identification and understanding the underlying physiology, preparation, and postintubation management. Those with high-risk features including trauma, elevated intracranial pressure, upper gastrointestinal bleed, cardiac tamponade, aortic stenosis, morbid obesity, and pregnancy must be managed with airway expertise. Conclusions: This narrative review discusses the pearls and pitfalls of commonly encountered physiologic high-risk intubations with a focus on the emergency clinician. Published by Elsevier Inc.	[Lentz, Skyler] Univ Vermont, Dept Surg, Div Emergency Med, Larner Coll Med, Burlington, VT 05405 USA; [Grossman, Alexandra] Harbor Univ Calif Los Angeles Med Ctr, Dept Emergency Med, Torrance, CA USA; [Koyfman, Alex] Univ Texas Southwestern Med Ctr Dallas, Dept Emergency Med, Dallas, TX 75390 USA; [Long, Brit] Brooke Army Med Ctr, Dept Emergency Med, 3841 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA		Long, B (corresponding author), Brooke Army Med Ctr, Dept Emergency Med, 3841 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.			Lentz, Skyler/0000-0003-1288-3261			Abdi W, 2009, OBES SURG, V19, P1624, DOI 10.1007/s11695-009-9953-0; Abir G, 2017, BEST PRAC RES-CL ANA, V31, P91, DOI 10.1016/j.bpa.2017.01.005; Aceto P, 2013, SURG OBES RELAT DIS, V9, P809, DOI 10.1016/j.soard.2013.04.013; Ahmad I, 2020, ANAESTHESIA, V75, P509, DOI 10.1111/anae.14904; Almashhrawi AA, 2015, WORLD J META-ANAL, V3, P4, DOI 10.13105/wjma.v3.i1.4; Altermatt FR, 2005, BRIT J ANAESTH, V95, P706, DOI 10.1093/bja/aei231; Amer Soc Anesthesiologists, 2013, ANESTHESIOLOGY, V118, P251, DOI 10.1097/ALN.0b013e31827773b2; [Anonymous], 2007, CURR PROB SURG, V44, P778, DOI 10.1067/j.cpsurg.2007.09.006; Appleton C, 2017, CARDIOL CLIN, V35, P525, DOI 10.1016/j.ccl.2017.07.006; Aye T, 2002, CAN J ANAESTH, V49, P283, DOI 10.1007/BF03020528; Baekgaard JS, 2019, ANESTH ANALG, V128, P504, DOI 10.1213/ANE.0000000000003568; Baird CRW, 2009, EMERG MED J, V26, P576, DOI 10.1136/emj.2008.067801; Ballow SL, 2012, J TRAUMA ACUTE CARE, V73, P1401, DOI 10.1097/TA.0b013e318270dcf5; Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; Basaranoglu G, 2010, EUR J ANAESTH, V27, P947, DOI 10.1097/EJA.0b013e32833e2656; Bedford R. F., 1980, INTRACRANIAL PRESSUR, P595; Ben-Dor I, 2012, CARDIOVASC REVASCULA, V13, P207, DOI 10.1016/j.carrev.2012.02.002; Bourgoin A, 2003, CRIT CARE MED, V31, P711, DOI 10.1097/01.CCM.0000044505.24727.16; Bozeman WP, 2005, J TRAUMA, V58, P278, DOI 10.1097/01.TA.0000152536.71932.85; Brown CA, 2015, ANN EMERG MED, V65, P363, DOI 10.1016/j.annemergmed.2014.10.036; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carron M, 2012, ANESTHESIOLOGY, V117, P309, DOI 10.1097/ALN.0b013ef31825b6a80; Castillo J, 2004, STROKE, V35, P520, DOI 10.1161/01.STR.0000109769.22917.B0; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clancy M, 2001, EMERG MED J, V18, P373, DOI 10.1136/emj.18.5.373; Collins JS, 2004, OBES SURG, V14, P1171, DOI 10.1381/0960892042386869; Combes X, 2005, ANESTHESIOLOGY, V102, P1106, DOI 10.1097/00000542-200506000-00008; Curley JM, 2020, NEUROCRIT CARE, V32, P880, DOI 10.1007/s12028-019-00901-6; Dahl JS, 2020, CARDIOL CLIN, V38, P139, DOI 10.1016/j.ccl.2019.09.009; Davis DP, 2004, J TRAUMA, V56, P808, DOI 10.1097/01.TA.0000100217.05066.87; de Raaff CAL, 2018, CURR OPIN ANESTHESIO, V31, P104, DOI 10.1097/ACO.0000000000000542; Delay JM, 2008, ANESTH ANALG, V107, P1707, DOI 10.1213/ane.0b013e318183909b; Dixon BJ, 2005, ANESTHESIOLOGY, V102, P1110, DOI 10.1097/00000542-200506000-00009; DuCanto J, 2017, WEST J EMERG MED, V18, DOI [10.5811/WESTJEM.2016.9.30891, 10.5811/westjem.2016.9.30891]; El-Orbany M, 2011, ANESTH ANALG, V113, P103, DOI 10.1213/ANE.0b013e31821c7e9c; Ezri T, 2001, OBSTET GYNECOL SURV, V56, P631, DOI 10.1097/00006254-200110000-00022; Fei M, 2017, BRIT J ANAESTH, V118, P618, DOI 10.1093/bja/aex035; Frappier J, 2003, ANESTH ANALG, V96, P1510, DOI 10.1213/01.ANE.0000057003.91393.3C; Frogel Jonathan, 2010, Anesthesiol Clin, V28, P67, DOI 10.1016/j.anclin.2010.01.008; Gander S, 2005, ANESTH ANALG, V100, P580, DOI 10.1213/01.ANE.0000143339.40385.1B; Gerstein NS, 2013, J CLIN ANESTH, V25, P193, DOI 10.1016/j.jclinane.2012.10.009; GOERTZ AW, 1994, ANESTHESIOLOGY, V81, P49, DOI 10.1097/00000542-199407000-00009; Gondek S, 2017, SURG CLIN N AM, V97, P985, DOI 10.1016/j.suc.2017.06.001; Gottlieb M, 2018, J EMERG MED, V55, P34, DOI 10.1016/j.jemermed.2018.01.026; Green RS, 2012, CAN J EMERG MED, V14, P74, DOI 10.2310/8000.2012.110548; Griesdale DEG, 2008, INTENS CARE MED, V34, P1835, DOI 10.1007/s00134-008-1205-6; Grocott HP, 2011, CAN J ANESTH, V58, P952, DOI 10.1007/s12630-011-9557-8; Hales Craig M, 2017, NCHS Data Brief, P1; Hart D, 2013, J EMERG MED, V44, P1028, DOI 10.1016/j.jemermed.2012.11.005; Hayat U, 2017, GASTROINTEST ENDOSC, V86, P500, DOI 10.1016/j.gie.2016.12.008; HEATH KJ, 1994, ANAESTHESIA, V49, P843, DOI 10.1111/j.1365-2044.1994.tb04254.x; Heffner AC, 2013, RESUSCITATION, V84, P1500, DOI 10.1016/j.resuscitation.2013.07.022; Heffner AC, 2012, J CRIT CARE, V27, P587, DOI 10.1016/j.jcrc.2012.04.022; Ho AMH, 2009, RESUSCITATION, V80, P272, DOI 10.1016/j.resuscitation.2008.09.021; Ho AMH, 2019, J CRIT CARE, V54, P256, DOI 10.1016/j.jcrc.2019.09.015; Jaber S, 2006, CRIT CARE MED, V34, P2355, DOI 10.1097/01.CCM.0000233879.58720.87; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Jain U, 2016, ANESTHESIOLOGY, V124, P199, DOI 10.1097/ALN.0000000000000903; Joffe AM, 2010, ANESTHESIOLOGY, V113, P873, DOI 10.1097/ALN.0b013e3181ec6414; Jung JY, 2015, KOREAN J ANESTHESIOL, V68, P213, DOI 10.4097/kjae.2015.68.3.213; Kerr M E, 1998, Am J Crit Care, V7, P205; Kinsella SM, 2015, INT J OBSTET ANESTH, V24, P356, DOI 10.1016/j.ijoa.2015.06.008; Kovacs G, 2018, EMERG MED CLIN N AM, V36, P61, DOI 10.1016/j.emc.2017.08.006; KOVARIK WD, 1994, ANESTH ANALG, V78, P469; Kramer N, 2018, CUREUS, V10, DOI 10.7759/cureus.2530; Kristensen MS, 2010, EUR J ANAESTH, V27, P923, DOI 10.1097/EJA.0b013e32833d91aa; Langeron O, 2000, ANESTHESIOLOGY, V92, P1229, DOI 10.1097/00000542-200005000-00009; Lapinsky SE, 2015, OBSTET MED, V8, P126, DOI 10.1177/1753495X15589223; Lee SW, 2009, J TRAUMA, V67, P526, DOI 10.1097/TA.0b013e3181866432; Lev Roneet, 1994, Journal of Emergency Medicine, V12, P499, DOI 10.1016/0736-4679(94)90347-6; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; McConkey HZR, 2019, CIRC-CARDIOVASC INTE, V12, DOI 10.1161/CIRCINTERVENTIONS.118.007547; Miller M, 2016, ANN EMERG MED, V68, P181, DOI 10.1016/j.annemergmed.2016.03.041; Moon TS, 2019, J ANESTH, V33, P96, DOI 10.1007/s00540-018-2592-7; Mosier JM, 2015, W J EMERG MED INTEGR, V16; MOSS E, 1979, BRIT J ANAESTH, V51, P347, DOI 10.1093/bja/51.4.347; Munnur Uma, 2005, Crit Care Med, V33, pS259, DOI 10.1097/01.CCM.0000183502.45419.C9; Murphy C, 2013, CAN J ANESTH, V60, P929, DOI 10.1007/s12630-013-9991-x; Murphy David L, 2018, Air Med J, V37, P380, DOI 10.1016/j.amj.2018.07.004; Mushambi MC, 2015, ANAESTHESIA, V70, P1286, DOI 10.1111/anae.13260; Mushambi MC, 2016, CURR OPIN ANESTHESIO, V29, P261, DOI 10.1097/ACO.0000000000000309; Nickson C., INTUBATION UPPER GAS; Otten D, 2014, ANN EMERG MED, V63, P6, DOI 10.1016/j.annemergmed.2013.07.014; Otto CM, 2014, NEW ENGL J MED, V371, P744, DOI 10.1056/NEJMra1313875; Patanwala AE, 2016, PHARMACOTHERAPY, V36, P57, DOI 10.1002/phar.1683; PILKINGTON S, 1995, BRIT J ANAESTH, V74, P638, DOI 10.1093/bja/74.6.638; Price B, 2013, AM J EMERG MED, V31, P1124, DOI 10.1016/j.ajem.2013.03.041; Ramakrishna H, 2017, KAPLANS CARDIAC ANES, P770; Rao S, 2007, INT J ANESTHESIOL, V18, P3; Reynolds SF, 2005, CHEST, V127, P1397, DOI 10.1378/chest.127.4.1397; Rudolph SJ, 2003, GASTROINTEST ENDOSC, V57, P58, DOI 10.1067/mge.2003.46; Sagarin MJ, 2005, ANN EMERG MED, V46, P328, DOI 10.1016/j.annemergmed.2005.01.009; Sakles JC, 1998, ANN EMERG MED, V31, P325, DOI 10.1016/S0196-0644(98)70342-7; Sakles JC, 2013, ACAD EMERG MED, V20, P71, DOI 10.1111/acem.12055; Salhi B, 2007, ANN EMERG MED, V49, P84, DOI 10.1016/j.annemergmed.2006.09.003; Schneider AC, 2018, J ANESTH CRIT CARE O, V10, P262; SCHWARTZ DE, 1995, ANESTHESIOLOGY, V82, P367, DOI 10.1097/00000542-199502000-00007; Seder DB, 2012, NEUROCRIT CARE, V17, P4, DOI 10.1007/s12028-012-9753-6; Sehdev Rajesh S, 2006, Emerg Med Australas, V18, P37; Semler MW, 2017, CHEST, V152, P712, DOI 10.1016/j.chest.2017.03.061; Shah U, 2016, CURR OPIN ANESTHESIO, V29, P109, DOI 10.1097/ACO.0000000000000267; Singh V, 2014, EUR HEART J-ACUTE CA, V3, P158, DOI 10.1177/2048872613516017; Sinha A, 2019, J ANAESTH CLIN PHARM, V35, P540, DOI 10.4103/joacp.JOACP_159_19; Smischney NJ, 2019, J INTENSIVE CARE MED, V34, P480, DOI 10.1177/0885066617736256; Soleimanpour H., 2012, EMERGEN MED, V2, pe123, DOI DOI 10.4172/2165-7548.1000E123; STANLEY TH, 1973, ANESTH ANALG, V52, P110; Stoecklein HH, 2019, ACAD EMERG MED, V26, P1144, DOI 10.1111/acem.13805; Suppan L, 2016, BRIT J ANAESTH, V116, P27, DOI 10.1093/bja/aev205; Tanoubi I, 2009, CAN J ANAESTH, V56, P449, DOI 10.1007/s12630-009-9084-z; Thomsen JLD, 2019, ANAESTHESIA, V74, P151, DOI 10.1111/anae.14443; Tyagaraj Kalpana, 2015, Case Rep Anesthesiol, V2015, P489157, DOI 10.1155/2015/489157; Vaillancourt C, 2007, ANN EMERG MED, V49, P86, DOI 10.1016/j.annemergmed.2006.09.002; Vourc'h M, 2019, ECLINICALMEDICINE, V13, P112, DOI 10.1016/j.eclinm.2019.05.014; Walls RM, 2011, J EMERG MED, V41, P347, DOI 10.1016/j.jemermed.2010.02.024; Wardi G, 2017, RESUSCITATION, V121, P76, DOI 10.1016/j.resuscitation.2017.09.020; Webster JA, 2003, CAN J ANAESTH, V50, P815, DOI 10.1007/BF03019378; Weingart SD, 2015, ANN EMERG MED, V65, P349, DOI 10.1016/j.annemergmed.2014.09.025; Yumul R, 2016, J CLIN ANESTH, V31, P46, DOI 10.1016/j.jclinane.2015.12.045; Zeiler FA, 2014, NEUROCRIT CARE, V21, P163, DOI 10.1007/s12028-013-9950-y; Zigelman Charles Z, 2009, Anesthesiol Clin, V27, P519, DOI 10.1016/j.anclin.2009.07.012	120	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	OCT	2020	59	4					573	585		10.1016/j.jemermed.2020.05.009			13	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	OT0VP	WOS:000590573200024	32591298				2022-02-06	
J	Lumba-Brown, A; Tang, K; Yeates, KO; Zemek, R				Lumba-Brown, Angela; Tang, Ken; Yeates, Keith Owen; Zemek, Roger		Pediat Emergency Res Canada PERC	Post-concussion symptom burden in children following motor vehicle collisions	JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN			English	Article						concussion; motor vehicle collision; post-concussive symptoms; traumatic brain injury	TRAUMATIC BRAIN-INJURY; EMERGENCY-DEPARTMENT VISITS; UNITED-STATES	ObjectiveMotor vehicle collisions generate considerable transmitted forces resulting in traumatic brain injury in children presenting to emergency departments (EDs). To date, no large study has examined post-concussive symptoms in children sustaining concussions in motor vehicle collisions. This study aimed to compare trends in acute post-concussive symptom burden in children with concussion following motor vehicle collisions as compared to other injury mechanisms. MethodsThe study is a secondary analysis of the Predicting Persistent Post-concussive Problems in Pediatrics study, which prospectively recruited a multicenter cohort of 3029 children 5-17 years of age presenting to the ED with concussion from 2013-2015. Post-concussive symptom ratings were obtained at pre-specified time points for 12 weeks post-injury, using the validated Post-Concussion Symptom Inventory (PCSI). Symptom severity and recovery trajectories were measured using delta scores on the PCSI (mean post-injury symptom score minus perceived pre-injury score). A multivariable, longitudinal model evaluated the adjusted effect of mechanism of injury (motor vehicle collisions vs other mechanisms) on mean symptom scores, compared to perceived pre-injury reports, and the temporal change in mean scores over during recovery. ResultsOf 3029 study participants, 56 (1.8%) sustained concussion from motor vehicle collisions. Children sustaining concussion in a motor vehicle collision had lower post-concussive symptom scores upon ED presentation, measured as differences from their perceived pre-injury reports, as compared to other injury mechanisms (-0.36 [95% confidence interval (CI) = -0.58, -0.15]). However, the motor vehicle collisions group showed the smallest decline in symptom burden over 1 month following injury (-0.54 [95% CI = -0.81, -0.27]). ConclusionsChildren sustaining concussions in motor vehicle collisions may have lower initial symptom burdens but slower symptom recovery at 1 month compared to other mechanisms of injury and may represent a distinct population for prognostic counseling in the ED requiring further research.	[Lumba-Brown, Angela; Pediat Emergency Res Canada PERC] Stanford Univ, Dept Emergency Med, Palo Alto, CA 94304 USA; [Tang, Ken; Zemek, Roger] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Zemek, Roger] Univ Ottawa, Dept Pediat & Emergency Med, Ottawa, ON, Canada		Lumba-Brown, A (corresponding author), Stanford Univ, Dept Emergency Med, Palo Alto, CA 94304 USA.	alumba@stanford.edu		Lumba-Brown, Angela/0000-0002-9102-8791	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [TM1127047]	Canadian Institutes of Health Research, Grant/Award Number: TM1127047	Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Ganti L, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0031-6; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gioia GA, 2009, TOP LANG DISORD, V29, P266, DOI 10.1097/TLD.0b013e3181b5322b; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Hanna R., 2010, CHILDREN INJURED MOT; Harrell FE, 2015, SPRINGER SER STAT, P1, DOI 10.1007/978-3-319-19425-7_1; Hillary FG, 2002, BRAIN INJURY, V16, P729, DOI 10.1080/02699050110119844; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Lumba-Brown A, 2018, ANN EMERG MED, V72, P581, DOI 10.1016/j.annemergmed.2018.03.045; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKay MP, 2010, ANN EMERG MED, V56, P688, DOI 10.1016/j.annemergmed.2010.09.007; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Perno JF, 2005, PEDIATR EMERG CARE, V21, P367, DOI 10.1097/01.pec.0000166726.84308.cf; R Core Team, 2016, R LANG ENV STAT COMP; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Stuart B, 2012, J EMERG NURS, V38, P435, DOI 10.1016/j.jen.2011.04.006; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Viano DC, 2017, TRAFFIC INJ PREV, V18, P616, DOI 10.1080/15389588.2017.1285023; Zemek R, 2013, BMJ OPEN, V3, P8; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	26	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2688-1152		JACEP OPEN	J. Am. Coll. Emerg. Phys. Open	OCT	2020	1	5					938	946		10.1002/emp2.12056			9	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	RZ6GP	WOS:000648695300038	33145544	gold, Green Published			2022-02-06	
J	Maragkos, GA; Nelton, EB; Richter, S; Stippler, M				Maragkos, Georgios A.; Nelton, Emmalin B.; Richter, Sven; Stippler, Martina			Low Risk of Traumatic Intracranial Hematoma Expansion with Factor Xa Inhibitors without Andexanet Reversal	WORLD NEUROSURGERY			English	Article						Andexanet alpha; Anticoagulation; Intracranial hemorrhage	PROTHROMBIN COMPLEX CONCENTRATE; INTRACEREBRAL HEMORRHAGE; ORAL ANTICOAGULANTS; ATRIAL-FIBRILLATION; BRAIN-INJURY; ASSOCIATION; RIVAROXABAN; DABIGATRAN; MANAGEMENT; WARFARIN	BACKGROUND: Andexanet alfa, a novel anticoagulation reversal agent for factor Xa inhibitors, was recently approved. Traumatic intracranial hemorrhage presents a prime target for this drug. The Novel Antidote to the Anticoagulation Effects of Factor Xa Inhibitors study established the efficacy of andexanet alfa in reversing factor Xa inhibitors. However, the association between anticoagulation reversal and traumatic intracranial hemorrhage progression is not well understood. The objective of this study was to determine progression rates of patients with traumatic intracranial hemorrhage on factor Xa inhibitors prior to hospitalization who were managed without the use of andexanet alfa. METHODS: A retrospective cohort study was performed between 2016 and 2019 at a single institution. An institutional traumatic brain injury (TBI) registry was queried. Patients with recorded use of apixaban or rivaroxaban <18 hours before injury were included. The primary study outcome was <35% increase in hemorrhage volume or thickness on repeated head computed tomography (CT) scans. RESULTS: We identified 25 patients meeting the inclusion criteria. Two patients were excluded because of a lack of necessary CT data. Twelve patients (52%) were receiving apixaban, and 11 were (48%) on rivaroxaban. On admission CT scan, 14 patients had subdural hematoma, 6 had traumatic intraparenchymal hemorrhage, and 3 had subarachnoid hemorrhage. Anticoagulation reversal was attempted in 17 patients (74%), primarily using 4-factor prothrombin complex concentrate. Twenty patients (87%) were adjudicated as having excellent or good hemostasis on repeat imaging. CONCLUSIONS: Our results indicate that patients on factor Xa inhibitors with complicated mild TBI have a similar intracranial hemorrhage progression rate to patients who are not anticoagulated or anticoagulated with a reversible agent. The hemostatic outcomes in our cohort were similar to those reported after andexanet alfa administration.	[Maragkos, Georgios A.; Nelton, Emmalin B.; Richter, Sven; Stippler, Martina] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Neurosurg, Boston, MA 02115 USA		Stippler, M (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Neurosurg, Boston, MA 02115 USA.	mstipple@bidmc.harvard.edu		Maragkos, Georgios/0000-0003-2156-7391			Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Connolly SJ, 2019, NEW ENGL J MED, V380, P1326, DOI 10.1056/NEJMoa1814051; Connolly SJ, 2016, NEW ENGL J MED, V375, P1131, DOI 10.1056/NEJMoa1607887; Do MT, 2015, HEALTH PROMOT CHRON, V35, P99, DOI 10.24095/hpcdp.35.7.01; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Hankey GJ, 2014, STROKE, V45, P1304, DOI 10.1161/STROKEAHA.113.004506; Hart RG, 2012, STROKE, V43, P1511, DOI 10.1161/STROKEAHA.112.650614; Inohara T, 2018, JAMA-J AM MED ASSOC, V319, P463, DOI 10.1001/jama.2017.21917; Karni A, 2001, AM SURGEON, V67, P1098; Kobayashi L, 2017, J TRAUMA ACUTE CARE, V82, P827, DOI 10.1097/TA.0000000000001414; Lombardo S, 2018, TRAUMA SURG ACUTE CA, V3; Majeed A, 2017, BLOOD, V130, P1706, DOI 10.1182/blood-2017-05-782060; Maung AA, 2016, J TRAUMA ACUTE CARE, V81, P652, DOI 10.1097/TA.0000000000001189; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Modi NJ, 2016, NEUROL INDIA, V64, P8, DOI 10.4103/0028-3886.178030; Piran S, 2019, BLOOD ADV, V3, P158, DOI 10.1182/bloodadvances.2018024133; Pozzessere A, 2015, AM SURGEON, V81, P1039; Rau CS, 2014, INT J ENV RES PUB HE; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Schulman S, 2018, THROMB HAEMOSTASIS, V118, P842, DOI 10.1055/s-0038-1636541; Scotti P, 2020, J NEUROSURG, V133, P486, DOI 10.3171/2019.4.JNS19252; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Siegal DM, 2015, NEW ENGL J MED, V373, P2413, DOI 10.1056/NEJMoa1510991; Stippler M, 2017, WORLD NEUROSURG, V105, P265, DOI 10.1016/j.wneu.2017.05.008; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Webb AJS, 2015, STROKE, V46, P2470, DOI 10.1161/STROKEAHA.114.007343; Zeeshan M, 2018, J TRAUMA ACUTE CARE, V85, P915, DOI 10.1097/TA.0000000000001995	27	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2020	142						E95	E100		10.1016/j.wneu.2020.06.069			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NY5WL	WOS:000576459300011	32561488				2022-02-06	
J	Mason, SJ; Davidson, BS; Lehto, M; Ledreux, A; Granholm, AC; Gorgens, KA				Mason, Sara J.; Davidson, Bradley S.; Lehto, Marybeth; Ledreux, Aurelie; Granholm, Ann-Charlotte; Gorgens, Kim A.			A Cohort Study of the Temporal Stability of ImPACT Scores Among NCAA Division I Collegiate Athletes: Clinical Implications of Test-Retest Reliability for Enhancing Student Athlete Safety	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Concussion; Assessment; Traumatic Brain Injury; Reliability; ImPACT; Baseline Screening; Neuropsychological Testing	POST-CONCUSSION ASSESSMENT; SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; BASE-LINE; NORMATIVE DATA; INTERPRETING CHANGE; VALIDITY; PERFORMANCE; STATEMENT; UTILITY	Objective: In this study we examined the temporal stability of the Immediate Post-Concussion Assessment and Cognitive Test (ImPACT) within NCAA Division I athletes across various timepoints using an exhaustive series of statistical models. Methods: Within a cohort design, 48 athletes completed repeated baseline ImPACT assessments at various timepoints. Intraclass correlation coefficients (ICC) were calculated using a two-way mixed effects model with absolute agreement. Results: Four ImPACT composite scores (Verbal Memory, Visual Memory, Visual Motor Speed, and Reaction Time) demonstrated moderate reliability (ICC = 0.51-0.66) across the span of a typical Division I athlete's career, which is below previous reliability recommendations (0.90) for measures used in individual decision-making. No evidence of fixed bias was detected within Verbal Memory, Visual Motor Speed, or Reaction Time composite scores, and minimal detectable change values exceeded the limits of agreement. Conclusions: The demonstrated temporal stability of the ImPACT falls below the published recommendations, and as such, fails to provide robust support for the NCAA's recommendation to obtain a single preparticipation cognitive baseline for use in sports-related concussion management throughout an athlete's career. Clinical interpretation guidelines are provided for clinicians who utilize baseline ImPACT scores for later performance comparisons.	[Mason, Sara J.; Lehto, Marybeth; Gorgens, Kim A.] Univ Denver, Grad Sch Profess Psychol, Denver, CO 80208 USA; [Davidson, Bradley S.] Univ Denver, Mech & Mat Engn, Denver, CO 80208 USA; [Ledreux, Aurelie; Granholm, Ann-Charlotte] Univ Denver, Knoebel Inst Hlth Aging, Denver, CO 80208 USA		Mason, SJ (corresponding author), Univ Denver, Grad Sch Profess Psychol, Denver, CO 80208 USA.	drsaramason@gmail.com		Mason, Sara/0000-0002-3310-774X	Knoebel Institute for Health Aging Pilot Award	This work was supported in part by a Knoebel Institute for Health Aging Pilot Award.	Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Bartels C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-118; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bland JM, 2003, ULTRASOUND OBST GYN, V22, P85, DOI 10.1002/uog.122; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brett BL, 2017, J CLIN EXP NEUROPSYC, V39, P286, DOI 10.1080/13803395.2016.1224322; Brett BL, 2016, ARCH CLIN NEUROPSYCH, V31, P904, DOI 10.1093/arclin/acw055; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Carlson MDA, 2009, J PALLIAT MED, V12, P77, DOI 10.1089/jpm.2008.9690; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Cohen J, 1998, STAT POWER ANAL BEHA; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Davidson AC, 1997, BOOTSTRAP METHODS TH; De Marco AP, 2016, J CHILD NEUROL, V31, P68, DOI 10.1177/0883073814559645; DuPaul GJ, 2009, J ATTEN DISORD, V13, P234, DOI 10.1177/1087054709340650; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2016, CLIN NEUROPSYCHOL, V30, P311, DOI 10.1080/13854046.2016.1158320; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Fernandez-Marcos T, 2018, APPL NEUROPSYCH-ADUL, V25, P464, DOI 10.1080/23279095.2017.1329145; Fukata K, 2019, ATTEN PERCEPT PSYCHO, V81, P590, DOI 10.3758/s13414-018-1627-3; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Haley SM, 2006, PHYS THER, V86, P735, DOI 10.1093/ptj/86.5.735; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Higgins KL, 2018, ARCH CLIN NEUROPSYCH, V33, P437, DOI 10.1093/arclin/acx071; Huang SL, 2011, PHYS THER, V91, P114, DOI 10.2522/ptj.20090126; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2001, LUPUS, V10, P266, DOI 10.1191/096120301680416959; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jager J, 2017, MONOGR SOC RES CHILD, V82, P13, DOI 10.1111/mono.12296; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kerr ZY, 2015, J ATHL TRAINING, V50, P1174, DOI 10.4085/1062-6050-50.11.11; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Lovell M, 2000, IMPACT IMMEDIATE POS; Lovell M. R., 2016, IMPACT ADM INTERPRET; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Maerlender AC, 2016, J CLIN EXP NEUROPSYC, V38, P869, DOI 10.1080/13803395.2016.1168781; Mann CJ, 2003, EMERG MED J, V20, P54, DOI 10.1136/emj.20.1.54; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Miller ET, 2002, PSYCHOL ADDICT BEHAV, V16, P56, DOI 10.1037//0893-164X.16.1.56; National Collegiate Athletic Association, 2018, NCAA DEM DAT DAT VIS; National Collegiate Athletic Association (NCAA), 2015, TRANSF TERMS EL TIM; National Collegiate Athletic Association (NCAA) Sports Science Institute, 2017, INT CONS DIAGN MAN S; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Rai SK, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0658-6; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Rebchuk AD, 2020, J NEUROTRAUM, V37, P1521, DOI 10.1089/neu.2019.6829; Schatz P., 2011, HDB SPORT NEUROPSYCH, P173; Schatz P, 2017, SPORT EXERC PERFORM, V6, P243, DOI 10.1037/spy0000100; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1630; Tsushima WT, 2016, ARCH CLIN NEUROPSYCH, V31, P105, DOI 10.1093/arclin/acv066; Varian H., 2005, Mathematica Journal, V9, P768; Vaz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073990; White N, 2019, J CLIN EXP NEUROPSYC, V41, P179, DOI 10.1080/13803395.2018.1526888; Wilk CM, 2002, AM J PSYCHIAT, V159, P838, DOI 10.1176/appi.ajp.159.5.838	75	1	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	OCT	2020	35	7					1131	1144		10.1093/arclin/acaa047			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	PA2TQ	WOS:000595486600007	32853329	Bronze			2022-02-06	
J	McGuine, TA; Pfaller, A; Hetzel, S; Broglio, SP; Hammer, E				McGuine, Timothy A.; Pfaller, Adam; Hetzel, Scott; Broglio, Steven P.; Hammer, Erin			A Prospective Study of Concussions and Health Outcomes in High School Football Players	JOURNAL OF ATHLETIC TRAINING			English	Article						traumatic brain injuries; longitudinal studies; psychosocial outcomes	QUALITY-OF-LIFE; SYMPTOMS; DEPRESSION; ASSOCIATION; RELIABILITY; PREVALENCE; COGNITION; RECOVERY; VALIDITY; HISTORY	Context: Football is the most popular sport among US high school students and among the highest for sport-related concussion (SRC) incidence. Limited data detail how SRCs affect high school football players' psychosocial and health status beyond short-term injury recovery. Objective: To longitudinally assess how SRCs affected symptoms, depression, and health-related quality of life (HRQoL) in high school football players up to 12 months after SRC. Design: Prospective cohort study. Setting: Thirty-one Wisconsin high schools. Patients or Other Participants: A total of 1176 interscholastic football players (age = 16.0 +/- 1.2 years). Main Outcome Measure(s): Participants completed the Post-concussion Symptom Scale ( PCSS) from the Sport Concussion Assessment Tool 3 (SCAT3), Patient Health Questionnaire-9 (PHQ-9) for depression, and Pediatric Quality of Life Inventory 4.0 (PedsQL) for HRQoL at enrollment. Participants who sustained an SRC repeated each measure within 72 hours of their injury (onset) and at 7 days (D7), return to play (RTP), and 3 months (M3), 6 months (M6), and 12 months (M12) after SRC. Scores at each time point were compared with each participant's baseline using linear mixed models for repeated measures while controlling for age and previous SRC with participant as a random effect. Results: Sixty-two participants sustained an SRC. Participants reported a higher number of PCSS symptoms, greater symptom severity, and lower PedsQL physical summary scores at onset and D7. From RTP through M12, PCSS symptoms, PCSS severity scores, PedsQL total scores, physical summary, and psychosocial summary were unchanged or improved relative to baseline. The PHQ-9 scores were not higher than baseline at any post-SRC interval. Conclusions: High school football players in this study who sustained an SRC described no sustained adverse health outcomes (increased PCSS symptoms or symptom severity, increased depression symptoms, or lower HRQoL) after their RTP through M12 after injury.	[McGuine, Timothy A.; Pfaller, Adam; Hetzel, Scott; Hammer, Erin] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI 53705 USA; [Broglio, Steven P.] Univ Michigan, Ann Arbor, MI 48109 USA		McGuine, TA (corresponding author), Univ Wisconsin, Dept Orthoped, Sports Med & Rehabil Program, Med Fdn Centennial Bldg,1685 Highland Ave, Madison, WI 53705 USA.	mcguine@ortho.wisc.edu			National Athletic Trainers' Association Research and Education Foundation [15OUT003]; Department of Orthopedics and Rehabilitation at the University of Wisconsin School of Medicine and Public Health	We thank Allie Wiedman for her assistance in collecting data for this study. We also thank all of the participating high school coaches, athletic trainers, interscholastic athletes, and athletes' parents for their willingness to take part in this study. This study was funded by the National Athletic Trainers' Association Research and Education Foundation (Award No. 15OUT003) and the Department of Orthopedics and Rehabilitation at the University of Wisconsin School of Medicine and Public Health.	[Anonymous], 1997, REPORT QUALITY STAND, V48, P581; Baugh CM, 2017, J NEUROTRAUM, V34, P790, DOI 10.1089/neu.2016.4585; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Corbin-Berrigan LA, 2017, CLIN J SPORT MED, V27, P325, DOI 10.1097/JSM.0000000000000355; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Fehr SD, 2019, CLIN J SPORT MED, V29, P11, DOI 10.1097/JSM.0000000000000494; Feudtner C, 2018, JAMA PEDIATR, V172, P492, DOI 10.1001/jamapediatrics.2017.5242; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; High School Particiaption Statistics, NAT FED STAT HIGH SC; Houston MN, 2016, BRAIN INJURY, V30, P891, DOI 10.3109/02699052.2016.1146960; Howell DR, 2018, AM J SPORT MED, V46, P3254, DOI 10.1177/0363546518796830; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Janssen PHH, 2017, MAYO CLIN PROC, V92, P66, DOI 10.1016/j.mayocp.2016.09.004; Kerr ZY, 2018, AM J SPORT MED, V46, P1733, DOI 10.1177/0363546518765121; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V201751, P838; McGuine TA, 2018, J ATHL TRAINING, V53, P1017, DOI 10.4085/1062-6050-209-18; McLeod TV, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000394; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Richardson LP, 2010, PEDIATRICS, V126, P1117, DOI 10.1542/peds.2010-0852; Snedden TR, 2017, CLIN J SPORT MED, V27, P462, DOI 10.1097/JSM.0000000000000389; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Vos BC, 2018, CLIN J SPORT MED, V28, P91, DOI 10.1097/JSM.0000000000000432; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	29	1	1	0	3	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	OCT	2020	55	10					1013	1019		10.4085/1062-6050-141-19			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	OH5SX	WOS:000582645900001	32946575	gold, Green Published			2022-02-06	
J	Mollayeva, T; Hurst, M; Chan, V; Escobar, M; Sutton, M; Colantonio, A				Mollayeva, Tatyana; Hurst, Mackenzie; Chan, Vincy; Escobar, Michael; Sutton, Mitchell; Colantonio, Angela			Pre-injury health status and excess mortality in persons with traumatic brain injury: A decade-long historical cohort study	PREVENTIVE MEDICINE			English	Article						Age; Comorbidity; Environmental exposures; Injury severity; Health services; Mortality; Life tables; Risk; Sex differences; Traumatic brain injury	AFTER-DISCHARGE; HEAD-INJURY; EPIDEMIOLOGY; CARE; AGE; SEVERITY; CLASSIFICATION; CONSEQUENCES; MORBIDITY; ALCOHOL	An increasing number of patients are able to survive traumatic brain injuries (TBIs) with advanced resuscitation. However, the role of their pre-injury health status in mortality in the following years is not known. Here, we followed 77,088 consecutive patients (59% male) who survived the TBI event in Ontario, Canada for more than a decade, and examined the relationships between their pre-injury health status and mortality rates in excess to the expected mortality calculated using sexand age-specific life tables. There were 5792 deaths over the studied period, 3163 (6.95%) deaths in male and 2629 (8.33%) in female patients. The average excess mortality rate over the follow-up period of 14 years was 1.81 (95% confidence interval = 1.76-1.86). Analyses of follow-up time windows showed different patterns for the average excess rate of mortality following TBI, with the greatest rates observed in year one after injury. Among identified pre-injury comorbidity factors, 33 were associated with excess mortality rates. These rates were comparable between sexes. Additional analyses in the validation dataset confirmed that these findings were unlikely a result of TBI misclassification or unmeasured confounding. Thus, detection and subsequent management of pre-injury health status should be an integral component of any strategy to reduce excess mortality in TBI patients. The complexity of pre-injury comorbidity calls for integration of multidisciplinary health services to meet TBI patients' needs and prevent adverse outcomes.	[Mollayeva, Tatyana; Hurst, Mackenzie; Chan, Vincy; Sutton, Mitchell; Colantonio, Angela] Univ Hlth Network, KITE Toronto Rehabil Inst, 550 Univ Ave,Rm 11-183, Toronto, ON M5G 2A2, Canada; [Mollayeva, Tatyana; Hurst, Mackenzie; Chan, Vincy; Sutton, Mitchell; Colantonio, Angela] Univ Toronto, Acquired Brain Injury Res Lab, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Fac Med, Rehabil Sci Inst, Toronto, ON, Canada; [Escobar, Michael; Colantonio, Angela] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Colantonio, Angela] ICES Inst Clin Evaluat Sci, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Mollayeva, T (corresponding author), Univ Hlth Network, KITE Toronto Rehabil Inst, 550 Univ Ave,Rm 11-183, Toronto, ON M5G 2A2, Canada.	tatyana.mollayeva@uhn.ca	, Mollayeva/A-4522-2018		Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [R21HD089106]; Gender and Health grant [CGW-126580]; Alzheimer's AssociationAlzheimer's Association [AARF-16-442937]	This work was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number R21HD089106. AC was funded by the Gender and Health grant #CGW-126580. TM was supported by the postdoctoral research grant from the Alzheimer's Association (AARF-16-442937). The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Albrecht JS, 2018, AM J EPIDEMIOL, V187, P233, DOI 10.1093/aje/kwx254; Allison PaulD., 1982, SOCIOLOGICAL METHODO, V13, P61, DOI [10.2307/270718, DOI 10.2307/270718]; Baan CA, 1999, EPIDEMIOLOGY, V10, P184, DOI 10.1097/00001648-199903000-00018; Beck Alexander, 2005, Oper Orthop Traumatol, V17, P569, DOI 10.1007/s00064-005-1152-0; Bisson EJ, 2017, CLIN REHABIL, V31, P1305, DOI 10.1177/0269215517698734; Brain Injury Association of America, 2011, BIAA ADOPTS NEW TBI; Catapano JS, 2017, AM J SURG, V213, P1104, DOI 10.1016/j.amjsurg.2016.07.010; Centers for Disease Control and Prevention, TOOLS CAT INJ US ICD; Chan Vincy, 2017, BMC Res Notes, V10, P371, DOI 10.1186/s13104-017-2682-x; Cheng CY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001468; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Collett Garen A, 2016, Drugs Real World Outcomes, V3, P45; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; Fazel S, 2014, LANCET, V384, P1529, DOI 10.1016/S0140-6736(14)61132-6; FEINSTEIN AR, 1970, J CHRON DIS, V23, P455, DOI 10.1016/0021-9681(70)90054-8; Forster AJ, 2004, CAN MED ASSOC J, V170, P345; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Fuller GW, 2016, NEUROEPIDEMIOLOGY, V47, P1, DOI 10.1159/000445997; Gagne M, 2017, J TRAUMA ACUTE CARE, V82, P374, DOI 10.1097/TA.0000000000001319; Gedeborg R, 2014, J TRAUMA ACUTE CARE, V76, P358, DOI 10.1097/TA.0b013e3182a9cd31; Gilthorpe MS, 1999, BRIT J ORAL MAX SURG, V37, P294, DOI 10.1054/bjom.1998.0039; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI [10.1007/978-0-387-84858-7_7, DOI 10.1007/978-0-387-84858-7_7]; Isetts BJ, 2012, MED CARE, V50, P997, DOI 10.1097/MLR.0b013e31826ecf9a; Jamoulle M, 2015, INT J HEALTH POLICY, V4, P61, DOI 10.15171/ijhpm.2015.24; Jonsdottir GM, 2017, ACTA ANAESTH SCAND, V61, P408, DOI 10.1111/aas.12869; Kiiskinen T, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-019-0676-2; LAIRD N, 1981, J AM STAT ASSOC, V76, P231, DOI 10.2307/2287816; Lalonde M., 1974, NEW PERSPECTIVE HLTH; Lane K, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040632; Leijdesdorff HA, 2021, EUR J TRAUMA EMERG S, V47, P2065, DOI 10.1007/s00068-020-01381-6; Leo P, 2016, TRANSLATIONAL RES TR; Leppin AL, 2015, HEALTHCARE-BASEL, V3, P50, DOI 10.3390/healthcare3010050; Lewandowski-Romps L, 2018, PREV MED, V111, P299, DOI 10.1016/j.ypmed.2017.11.016; Lin WJ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16040589; Marincowitz C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-028912; Mollayeva T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41916-5; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Nicholson K, 2019, J CLIN EPIDEMIOL, V105, P142, DOI 10.1016/j.jclinepi.2018.09.008; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Public Health Agency of Canada Steering Committee on Health-Adjusted Life Expectancy, 2012, HLTH ADJUSTED LIFE E; Quaglio G, 2017, LANCET NEUROL, V16, P951, DOI 10.1016/S1474-4422(17)30370-8; Raj R, 2016, J NEUROSURG, V124, P1684, DOI 10.3171/2015.4.JNS141746; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Roberts S, 2006, AM J EPIDEMIOL, V164, P1242, DOI 10.1093/aje/kwj335; Shibahashi K, 2017, WORLD NEUROSURG, V107, P82, DOI [10.1016/J.WNEU.2017.07.117, 10.1016/j.wneu.2017.07.117]; Spaite DW, 2019, JAMA SURG, V154, DOI 10.1001/jamasurg.2019.1152; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Spitz G, 2015, J NEUROTRAUM, V32, P1272, DOI 10.1089/neu.2014.3814; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Taylor A.N., 2015, BRAIN NEUROTRAUMA MO; Uccella L, 2020, NEUROL SCI, V41, P2127, DOI 10.1007/s10072-020-04313-9; van der Ploeg T, 2016, J CLIN EPIDEMIOL, V78, P83, DOI 10.1016/j.jclinepi.2016.03.002; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; Wang ZC, 2017, J BIOMED INFORM, V76, P59, DOI 10.1016/j.jbi.2017.11.003; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wolff ML, 2012, J AM GERIATR SOC, V60, P987, DOI 10.1111/j.1532-5415.2012.03913.x; Xiong C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029072	64	1	1	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0091-7435	1096-0260		PREV MED	Prev. Med.	OCT	2020	139								106213	10.1016/j.ypmed.2020.106213			10	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; General & Internal Medicine	NR3PO	WOS:000571475500037	32693173	Green Accepted			2022-02-06	
J	Nakase-Richardson, R; Schwartz, DJ; Ketchum, JM; Drasher-Phillips, L; Dahdah, MN; Monden, KR; Bell, K; Hoffman, J; Whyte, J; Bogner, J; Calero, K; Magalang, U				Nakase-Richardson, Risa; Schwartz, Daniel J.; Ketchum, Jessica M.; Drasher-Phillips, Leah; Dahdah, Marie N.; Monden, Kimberley R.; Bell, Kathleen; Hoffman, Jeanne; Whyte, John; Bogner, Jennifer; Calero, Karel; Magalang, Ulysses			Comparison of Diagnostic Sleep Studies in Hospitalized Neurorehabilitation Patients With Moderate to Severe Traumatic Brain Injury	CHEST			English	Article						brain injury; rehabilitation; sleep apnea; sleep-disordered breathing	POSTTRAUMATIC AMNESIA; APNEA SYNDROME; REHABILITATION; SCALE; INDIVIDUALS; DEPRIVATION; ORIENTATION; ACTIGRAPHY; HYPOPNEA; RECOVERY	BACKGROUND: OSA is prevalent during a time of critical neural repair after traumatic brain injury (TBI). The diagnostic utility of existing sleep studies is needed to inform clinical management during acute recovery from TBI. RESEARCH QUESTION: This study aimed to evaluate the non-inferiority and diagnostic accuracy of a portable level 3 sleep study relative to level 1 polysomnography in hospitalized neurorehabilitation patients with TBI. STUDY DESIGN AND METHODS: This is a prospective clinical trial conducted at six TBI Model System study sites between May 2017 and February 2019. Of 896 admissions, 449 were screened and eligible for the trial, with 345 consented. Additional screening left 263 eligible for and completing simultaneous administration of both level 1 and level 3 sleep studies, with final analyses completed on 214 (median age = 42 years; ED Glasgow Coma Scale = 6; time to polysomnography [PSG] = 52 days). RESULTS Agreement was moderate to strong (weighted kappa = 0.78, 95% CI, 0.72-0.83) with the misclassification commonly occurring with mild sleep apnea due to underestimation of apnea hypopnea index (AHI). Most of those with moderate to severe sleep apnea were correctly classified (n = 54/72). Non-inferiority was not demonstrated: the minimum tolerable specificity of 0.5 was achieved across all AHI cutoff scores (lower confidence limits [LCL] range, 0.807-0.943), but the minimum tolerable sensitivity of 0.8 was not (LCL range, 0.665-0.764). INTERPRETATION: Although the non-inferiority of level 3 portable diagnostic testing relative to level 1 was not established, strong agreement was seen across sleep apnea indexes. Most of those with moderate to severe sleep apnea were correctly identified; however, there was risk of misclassification with level 3 sleep studies underestimating disease severity for those with moderate to severe AHI and disease presence for those with mild AHI during early TBI neurorehabilitation.	[Nakase-Richardson, Risa] Univ S Florida, Mental Hlth & Behav Sci, Def & Vet Brain Injury Ctr, Tampa, FL 33620 USA; [Schwartz, Daniel J.] Univ S Florida, Med Serv, Tampa, FL 33620 USA; [Nakase-Richardson, Risa; Schwartz, Daniel J.] Univ S Florida, James A Haley Vet Hosp, Morsani Coll Med, Div Pulm & Sleep Med, Tampa, FL 33620 USA; [Ketchum, Jessica M.] Craig Hosp, Res Dept, Englewood, CO USA; [Ketchum, Jessica M.] Traumat Brain Injury Model Syst Natl Data & Stat, Englewood, CO USA; [Drasher-Phillips, Leah] Baylor Scott & White Inst Rehabil, James A Haley Vet Hosp, Res & Dev Serv, Dallas, TX USA; [Dahdah, Marie N.] Baylor Scott & White Med Ctr, Plano, TX USA; [Monden, Kimberley R.] Craig Hosp, Englewood, CO USA; [Monden, Kimberley R.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA; [Bell, Kathleen] UT Southwestern Med Ctr, Dept Phys Med & Rehabil, Dallas, TX USA; [Hoffman, Jeanne] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; [Whyte, John] Albert Einstein Healthcare Network, Moss Rehabil Res Inst, Elkins Pk, PA USA; [Bogner, Jennifer] Ohio State Univ, Div Rehabil Psychol, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Calero, Karel] Univ S Florida, Med Serv, James A Haley Vet Hosp, Morsani Coll Med,Div Pulm & Sleep Med, Tampa, FL 33620 USA; [Magalang, Ulysses] Ohio State Univ, Wexner Med Ctr, Div Pulm Crit Care & Sleep Med, Columbus, OH 43210 USA; [Magalang, Ulysses] Ohio State Univ, Wexner Med Ctr, Neurosci Res Inst, Columbus, OH 43210 USA		Nakase-Richardson, R (corresponding author), James A Haley Vet Hosp, Polytrauma TBI Rehabil Mail Code 117, Tampa, FL 33612 USA.	Risa.Richardson@va.gov	Monden, Kimberley/AAE-9831-2020	Monden, Kimberley/0000-0002-5207-0452	Patient-Centered Outcomes Research Institute (PCORI) AwardPatient-Centered Outcomes Research Institute - PCORI [CER-1511-33005]; VHA Central Office VA TBI Model Systems Program of Research; General Dynamics Information Technology from the Defense and Veterans Brain Injury Center [W9 lYTZ13-C-0015, HT0014-19-C-0004]; National Institute on Disability, Independent Living, and Rehabilitation Research (NSDC)United States Department of Health & Human Services [90DPTB00070, 90DP0084, 90DPTB0013-01-00, 90DPTB0008, 90DPT80004-02]	Research reported in this article was funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (CER-1511-33005). This research was sponsored by VHA Central Office VA TBI Model Systems Program of Research; Subcontract from General Dynamics Information Technology (W9 lYTZ13-C-0015; HT0014-19-C-0004) from the Defense and Veterans Brain Injury Center and National Institute on Disability, Independent Living, and Rehabilitation Research (NSDC Grant #90DPTB00070, #90DP0084, 90DPTB0013-01-00, 90DPTB0008, 90DPT80004-02). Clinicaltrial.gov Registration Number: NCT03033901.	Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Alkan A, 2013, CLIN IMAG, V37, P989, DOI 10.1016/j.clinimag.2013.07.010; [Anonymous], 2016, SLEEPW G3 COMP PROGR; [Anonymous], 2016, NOXT COMP PROGR VERS; Arzt M, 2005, AM J RESP CRIT CARE, V172, P1447, DOI 10.1164/rccm.200505-702OC; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; Bogner J, 2020, J HEAD TRAUMA REHAB, V35, pE43, DOI 10.1097/HTR.0000000000000488; Bosi M, 2017, EUR ARCH OTO-RHINO-L, V274, P3251, DOI 10.1007/s00405-017-4578-8; Brown RM, 2018, BRAIN INJURY, V32, P986, DOI 10.1080/02699052.2018.1468575; Chao LL, 2014, SLEEP, V37, P445, DOI 10.5665/sleep.3472; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Dijkers MP, 2018, J HEAD TRAUMA REHAB, V33, P363, DOI 10.1097/HTR.0000000000000454; Dreer LE, 2018, J HEAD TRAUMA REHAB, V33, P246, DOI 10.1097/HTR.0000000000000408; Flanagan SR, 2015, BRAIN INJ PROF, V12, P8; Gamaldo C, 2018, J CLIN SLEEP MED, V14, P1239, DOI 10.5664/jcsm.7232; Gjevre JA, 2011, CAN RESPIR J, V18, P271, DOI 10.1155/2011/408091; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Holcomb EM, 2016, J HEAD TRAUMA REHAB, V31, P82, DOI 10.1097/HTR.0000000000000230; Huynh NT, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00058; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kamper JE, 2016, J HEAD TRAUMA REHAB, V31, P117, DOI 10.1097/HTR.0000000000000215; Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Longordo F, 2009, EUR J NEUROSCI, V29, P1810, DOI 10.1111/j.1460-9568.2009.06719.x; Masa JF, 2011, THORAX, V66, P567, DOI 10.1136/thx.2010.152272; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McDermott CM, 2003, J NEUROSCI, V23, P9687; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2009, NEUROLOGY, V73, P1120, DOI 10.1212/WNL.0b013e3181bacf34; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; OConnor K, 2018, BRAIN INJURY, V32, P994; Pepe M S, 2003, STAT EVALUATION MED; Polese JF, 2013, SLEEP BREATH, V17, P679, DOI 10.1007/s11325-012-0742-y; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Santos-Silva R, 2009, SLEEP, V32, P629, DOI 10.1093/sleep/32.5.629; Shayeb EM, 2014, CMAJ, V186, pE25 ; Silva MA, 2012, AM J PHYS MED REHAB, V91, P890, DOI 10.1097/PHM.0b013e31825a1648; Sivertsen B, 2008, EUR RESPIR J, V32, P1497, DOI 10.1183/09031936.00044908; Sjosten N, 2009, RESP MED, V103, P1047, DOI 10.1016/j.rmed.2009.01.014; TEASDALE G, 1974, LANCET, V2, P81; Towns SJ, 2016, PM&R, V8, P1046, DOI 10.1016/j.pmrj.2016.04.005; Veasey Sigrid C, 2012, Front Neurol, V3, P139, DOI 10.3389/fneur.2012.00139; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Young T, 1997, ARCH INTERN MED, V157, P1746, DOI 10.1001/archinte.157.15.1746; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Zunzunegui C, 2011, SLEEP, V34, P1261, DOI 10.5665/SLEEP.1252	54	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0012-3692	1931-3543		CHEST	Chest	OCT	2020	158	4					1689	1700		10.1016/j.chest.2020.03.083			12	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Respiratory System	OC7JF	WOS:000579331500074	32387522	hybrid			2022-02-06	
J	Picinich, C; Kennedy, J; Thind, H; Foreman, C; Martin, RM; Zimmermann, LL				Picinich, Christine; Kennedy, Jeffrey; Thind, Harjot; Foreman, Christine; Martin, Ryan M.; Zimmermann, Lara L.			Continuous Electroencephalographic Training for Neuroscience Intensive Care Unit Nurses: A Feasibility Study	JOURNAL OF NEUROSCIENCE NURSING			English	Article						adult; brain injuries; brain injury; traumatic; cEEG; critical care; methods; critical care nursing; electroencephalography; intensive care units; intracranial hypertension; monitoring; physiologic; nursing; neurocritical care; neuroscience nursing; nursing evaluation research; nursing staff; hospital; education; status epilepticus	CRITICALLY-ILL ADULTS; CONTINUOUS EEG; SEIZURE IDENTIFICATION; CONSENSUS STATEMENT; NEUROCRITICAL CARE; NEUROPHYSIOLOGISTS; CHILDREN; STAFF	BACKGROUND:Use of continuous electroencephalographic (cEEG) monitoring has more than doubled at our institution for the last 4 years. Although intensive care unit cEEG is reviewed remotely by board-certified epileptologists every 4 to 6 hours, there are inherent delays between occurrence, recognition, and treatment of epileptiform activity. Neuroscience intensive care unit (NSICU) nurses are uniquely positioned to monitor cEEG in real time yet do not receive formal training. The purpose of this study was to evaluate the effectiveness of an education program to teach nurses to monitor cEEG, identify a burst suppression pattern, and measure the duration of suppression.METHODS:We performed a retrospective analysis of pretest and posttest data. All NSICU nurses (40) were invited to complete the pretest (PT-0), with 25 participating. Learning style/preference, demographics, comfort with cEEG, and knowledge of EEG fundamentals were assessed. A convenience cohort of NSICU nurses (13) were selected to undergo EEG training. Posttests evaluating EEG fundamental knowledge were completed immediately after training (PT-1), at 3 months (PT-3), and at 6 months (PT-6). The cohort also completed a burst suppression module after the training, which assessed ability to quantify the duration of suppression.RESULTS:Mean cohort test scores significantly improved after the training (P< .001). All nurses showed improvement in test scores, and 76.9% passed PT-1 (a score of 80% or higher). Reported mean comfort level with EEG also significantly improved after the training (P= .001). There was no significant difference between mean cohort scores between PT-1, PT-3, and PT-6 (all 88.6%;P= 1.000). Mean cohort score from the bust suppression module was 73%, with test scores ranging from 31% to 93%.CONCLUSIONS:NSICU nurses can be taught fundamentals of cEEG, to identify a burst suppression pattern, and to quantify the duration of suppression. Further research is needed to determine whether this knowledge can be translated into clinical competency and affect patient care.	[Picinich, Christine] Univ Calif Davis, Med Ctr, Dept Neurol Surg, Sacramento, CA 95817 USA; [Kennedy, Jeffrey] Univ Calif Davis, Sch Med, Dept Neurol, Div Epilepsy & Clin Neurophysiol, Sacramento, CA USA; [Thind, Harjot; Foreman, Christine] Univ Calif Davis, Med Ctr, Sacramento, CA USA; [Martin, Ryan M.] Univ Calif Davis, Med Ctr, Dept Neurol Surg, Sacramento, CA USA; [Martin, Ryan M.] Univ Calif Davis, Med Ctr, Dept Neurol, Sacramento, CA USA; [Zimmermann, Lara L.] Univ Calif Davis, Med Ctr, Neurol Surg, Sacramento, CA USA; [Zimmermann, Lara L.] Univ Calif Davis, Med Ctr, Neurocrit Care Serv, Sacramento, CA USA		Picinich, C (corresponding author), Univ Calif Davis, Med Ctr, Dept Neurol Surg, Sacramento, CA 95817 USA.	Cpicinich@ucdavis.edu			National Center for Advancing Translational Sciences, National Institutes of Health (NIH) [UL1 TR001860]	Statistical analysis for this project was partially supported by the National Center for Advancing Translational Sciences, National Institutes of Health (NIH), through grant number UL1 TR001860. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Amorim E, 2017, J CLIN NEUROPHYSIOL, V34, P359, DOI 10.1097/WNP.0000000000000368; Arbour RB, 2015, J NEUROSCI NURS, V47, P113, DOI 10.1097/JNN.0000000000000124; Claassen J, 2002, EPILEPSIA, V43, P146, DOI 10.1046/j.1528-1157.2002.28501.x; Dericioglu N, 2015, EPILEPSY RES, V109, P48, DOI 10.1016/j.eplepsyres.2014.10.013; Ganesan SL, 2018, CRIT CARE MED, V46, pE1105, DOI 10.1097/CCM.0000000000003385; Gavvala J, 2014, EPILEPSIA, V55, P1864, DOI 10.1111/epi.12809; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P96, DOI 10.1097/WNP.0000000000000165; Kang JH, 2019, NEUROCRIT CARE, V31, P312, DOI 10.1007/s12028-019-00673-z; Kennedy JD, 2012, CURR NEUROL NEUROSCI, V12, P419, DOI 10.1007/s11910-012-0289-0; Kramer AH, 2019, NEUROCRIT CARE, V30, P499, DOI 10.1007/s12028-019-00694-8; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Olson DM, 2012, NEUROCRIT CARE, V16, P55, DOI 10.1007/s12028-011-9613-9; Parvizi J, 2018, EPILEPSIA, V59, P877, DOI 10.1111/epi.14043; Schomer AC, 2015, INT ANESTHESIOL CLIN, V53, P107, DOI 10.1097/AIA.0000000000000042; Seiler L, 2012, J NEUROSCI NURS, V44, pE1, DOI 10.1097/JNN.0b013e3182478c7c; Swisher CB, 2015, J CLIN NEUROPHYSIOL, V32, P324, DOI 10.1097/WNP.0000000000000144; Topjian AA, 2015, PEDIATR CRIT CARE ME, V16, P461, DOI 10.1097/PCC.0000000000000352; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Whitelaw A, 2006, CLIN PERINATOL, V33, P667, DOI 10.1016/j.clp.2006.06.006; WINER JW, 1991, NEUROSURGERY, V29, P739, DOI 10.1227/00006123-199111000-00016; Yazbeck M, 2019, J NEUROSCI NURS, V51, P308, DOI 10.1097/JNN.0000000000000476; Young GB, 2017, HAND CLINIC, V140, P107, DOI 10.1016/B978-0-444-63600-3.00007-6	23	1	1	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	OCT	2020	52	5					245	250		10.1097/JNN.0000000000000535			6	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	NS7DV	WOS:000572418900012	32740316				2022-02-06	
J	Portnova, G; Girzhova, I; Filatova, D; Podlepich, V; Tetereva, A; Martynova, O				Portnova, Galina; Girzhova, Irina; Filatova, Daria; Podlepich, Vitaliy; Tetereva, Alina; Martynova, Olga			Brain Oscillatory Activity during Tactile Stimulation Correlates with Cortical Thickness of Intact Areas and Predicts Outcome in Post-Traumatic Comatose Patients	BRAIN SCIENCES			English	Article						coma; unconsciousness; EEG; brain morphometry; TBI; tactile stimulation	SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; GEOMETRICALLY ACCURATE; BASAL GANGLIA; CONSCIOUSNESS; DISORDERS; SEGMENTATION; CONNECTIVITY; SYSTEM; INJURY	In this study, we have reported a correlation between structural brain changes and electroencephalography (EEG) in response to tactile stimulation in ten comatose patients after severe traumatic brain injury (TBI). Structural morphometry showed a decrease in whole-brain cortical thickness, cortical gray matter volume, and subcortical structures in ten comatose patients compared to fifteen healthy controls. The observed decrease in gray matter volume indicated brain atrophy in coma patients induced by TBI. In resting-state EEG, the power of slow-wave activity was significantly higher (2-6 Hz), and the power of alpha and beta rhythms was lower in coma patients than in controls. During tactile stimulation, coma patients' theta rhythm power significantly decreased compared to that in the resting state. This decrease was not observed in the control group and correlated positively with better coma outcome and the volume of whole-brain gray matter, the right putamen, and the insula. It correlated negatively with the volume of damaged brain tissue. During tactile stimulation, an increase in beta rhythm power correlated with the thickness of patients' somatosensory cortex. Our results showed that slow-wave desynchronization, as a nonspecific response to tactile stimulation, may serve as a sensitive index of coma outcome and morphometric changes after brain injury.	[Portnova, Galina; Tetereva, Alina; Martynova, Olga] Russian Acad Sci, Human High Nervous Act Lab, Inst Higher Nervous Act & Neurophysiol, 5A Butlerova Str, Moscow 117485, Russia; [Girzhova, Irina; Filatova, Daria] Lomonosov Moscow State Univ, Fac Med, 27 Lomonosovsky Pr T, Moscow 119991, Russia; [Podlepich, Vitaliy] Minist Hlth Russian Federat, Fed State Autonomous Inst, NN Burdenko Natl Med Res Ctr Neurosurg, 16 4 Ya Tverskaya Yamskaya Str, Moscow 125047, Russia		Portnova, G (corresponding author), Russian Acad Sci, Human High Nervous Act Lab, Inst Higher Nervous Act & Neurophysiol, 5A Butlerova Str, Moscow 117485, Russia.	caviter@list.ru; girzhova.irina-103@yandex.ru; dariafilatova.msu@mail.ru; podlepichv@gmail.com; alina.tao@mail.ru; omartynova@ihna.ru	Подлепич, Виталий/ABD-5527-2020; Martynova, Olga V/K-3900-2012	Martynova, Olga V/0000-0001-9047-2893	Russian Foundation for Basic Research (RFBR)Russian Foundation for Basic Research (RFBR) [18-00-01670, 18-00-01511]	The study was carried out within the state assignment of Ministry of Education and Science of the Russian Federation for the Institute of Higher Nervous Activity and Neurophysiology of the Russian Academy of Science and supported in part by the Russian Foundation for Basic Research (RFBR project No 18-00-01670 (18-00-01511).	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Ackerley R, 2013, NEUROSCI LETT, V535, P62, DOI 10.1016/j.neulet.2013.01.004; Andre-Obadia N, 2018, NEUROPHYSIOL CLIN, V48, P143, DOI 10.1016/j.neucli.2018.05.038; Ardeshna Nikesh I, 2016, Neurodiagn J, V56, P1; Bjornsdotter M, 2009, J NEUROSCI, V29, P9314, DOI 10.1523/JNEUROSCI.0400-09.2009; Brenner RP, 2005, NEUROLOGIST, V11, P271, DOI 10.1097/01.nrl.0000178756.44055.f6; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Di Perri C, 2014, EPILEPSY BEHAV, V30, P28, DOI 10.1016/j.yebeh.2013.09.014; Emidio A.C., 2019, EUR J CASE REP INTER, V6, P001316, DOI 10.12890/2019_001316; Fernandez-Torre JL, 2018, RESUSCITATION, V124, P118, DOI 10.1016/j.resuscitation.2017.12.022; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; GOODWIN AW, 2008, SENSES COMPREHENSIVE, V6, P39; Gordon I, 2013, HUM BRAIN MAPP, V34, P914, DOI 10.1002/hbm.21480; Hannawi Y, 2015, NEUROLOGY, V84, P1272, DOI 10.1212/WNL.0000000000001404; Hawryluk GWJ, 2017, NEUROSURGERY, V81, pE3, DOI 10.1093/neuros/nyx087; He JH, 2014, NMR BIOMED, V27, P880, DOI 10.1002/nbm.3130; Husain AM, 2006, J CLIN NEUROPHYSIOL, V23, P208, DOI 10.1097/01.wnp.0000220094.60482.b5; Jeffry J, 2011, PHYSIOLOGY, V26, P286, DOI 10.1152/physiol.00007.2011; Kitada R, 2019, NEUROIMAGE, V197, P156, DOI 10.1016/j.neuroimage.2019.04.044; 장성호, 2017, [The Journal of Korean Society of Physical Therapy, 대한물리치료학회지], V29, P109; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Lazarus M, 2013, CURR OPIN NEUROBIOL, V23, P780, DOI 10.1016/j.conb.2013.02.001; Lazarus M, 2012, TRENDS NEUROSCI, V35, P723, DOI 10.1016/j.tins.2012.07.001; Lutkenhoff ES, 2015, ANN NEUROL, V78, P68, DOI 10.1002/ana.24423; Mitchell DJ, 2008, PROG NEUROBIOL, V86, P156, DOI 10.1016/j.pneurobio.2008.09.005; Morrison I, 2012, CURR BIOL, V22, pR77, DOI 10.1016/j.cub.2011.11.032; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Potapov A.A., 2014, VOPR NEIROKHIRURGII, V78; Qi H-X, 2008, SENSES COMPREHENSIVE, P143, DOI DOI 10.1016/B978-012370880-9.00350-9; Schaer M, 2012, JOVE-J VIS EXP, DOI 10.3791/3417; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Trinka E, 2015, EPILEPSY BEHAV, V49, P203, DOI 10.1016/j.yebeh.2015.05.005; Tristan Bekinschtein, 2015, Handb Clin Neurol, V127, P195, DOI 10.1016/B978-0-444-52892-6.00013-1; Tshibanda L, 2009, PROG BRAIN RES, V177, P215, DOI 10.1016/S0079-6123(09)17715-4; VALLBO A, 1993, BRAIN RES, V628, P301, DOI 10.1016/0006-8993(93)90968-S; Vanhaudenhuyse A, 2011, J COGNITIVE NEUROSCI, V23, P570, DOI 10.1162/jocn.2010.21488; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Weiss N, 2008, J NEUROL, V255, P217, DOI 10.1007/s00415-008-0658-4; Xie QY, 2017, EXP THER MED, V14, P1277, DOI 10.3892/etm.2017.4639; YOUNG GB, 1994, ELECTROEN CLIN NEURO, V91, P93, DOI 10.1016/0013-4694(94)90030-2	57	1	1	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	OCT	2020	10	10							720	10.3390/brainsci10100720			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OJ6XV	WOS:000584102400001	33053681	gold, Green Published			2022-02-06	
J	Qiao, M; Yang, F				Qiao, Mu; Yang, Feng			Leg Joint Stiffness Affects Dynamics of Backward Falling From Standing Height: A Simulation Work	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							PREDICTED THRESHOLD; OLDER-ADULTS; BALANCE LOSS; PATIENT; SLIP; IDENTIFICATION; SYNCOPE; IMPACT	Falling backward can lead to injuries including hip fracture, back injury, and traumatic brain impact among older adults. A loss of consciousness is associated with falling backward and accounts for about 13% of all falls among older adults. Little is known about the dynamics of backward falls, such as the falling duration, the impact severity, and how the fall dynamics are affected by the biomechanical properties of the lower limb joints, particularly the rotational stiffness. The purpose of this study was to investigate the influence of the stiffness of individual leg joints on the dynamics of backward falls after losing consciousness in terms of the falling duration and impact velocities. Based on a 15-segment human model, we simulated the process of falling backward by sweeping the parameter space of ankle, knee, and hip's stiffnesses varying from 0 to 8.73 N.m.deg(-1) (or 500 N.m.rad(-1)). The results revealed that the falling duration and impact speeds of the head and hip ranged from 0.27 to 0.63s, 2.65 to 7.88m.s(-1), and 0.35 to 3.36m.s(-1), respectively, when the stiffness of the leg joints changed within their limits. Overall, the influence of the joint stiffness on the falling dynamics (falling duration and impact speed) is comparable between hip and knee joints, whereas ankle stiffness showed little influence on the backward falling dynamics. Our findings could provide references for designing protective devices to prevent impact-induced injuries after a backward fall.	[Qiao, Mu] Louisiana Tech Univ, Dept Kinesiol, Scotty Robertson Mem Gym, Rm-236, Ruston, LA 71272 USA; [Yang, Feng] Georgia State Univ, Dept Kinesiol & Hlth, 125 Decatur St SE,Suite 137, Atlanta, GA 30303 USA		Yang, F (corresponding author), Georgia State Univ, Dept Kinesiol & Hlth, 125 Decatur St SE,Suite 137, Atlanta, GA 30303 USA.	mqiao@latech.edu; fyang@gsu.edu	Qiao, Mu/H-6877-2019	Qiao, Mu/0000-0002-7110-4830			Aerts P., 1993, Journal of Sports Sciences, V11, P449, DOI 10.1080/02640419308730011; Berry Sarah D, 2008, Curr Osteoporos Rep, V6, P149, DOI 10.1007/s11914-008-0026-4; Gilchrist S, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025390; Gunther M, 2002, J BIOMECH, V35, P1459, DOI 10.1016/S0021-9290(02)00183-5; Hoffman GJ, 2017, HEALTH SERV RES, V52, P1794, DOI 10.1111/1475-6773.12554; Kenny RA, 2013, PROG CARDIOVASC DIS, V55, P357, DOI 10.1016/j.pcad.2012.11.006; Maladen RD, 2011, J R SOC INTERFACE, V8, P1332, DOI 10.1098/rsif.2010.0678; Migliore SA, 2010, AUTON ROBOT, V29, P119, DOI 10.1007/s10514-010-9186-z; Pirozzi G, 2013, J CLIN GERONTOL GERI, V4, P69, DOI 10.1016/j.jcgg.2013.07.001; Qiao M, 2017, BIOINSPIR BIOMIM, V12, P1, DOI 10.1088/1748-3190/aa50b0; Qiao M, 2016, J BIOMECH, V49, P66, DOI 10.1016/j.jbiomech.2015.11.022; Qiao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051888; Riener R, 1999, J BIOMECH, V32, P539, DOI 10.1016/S0021-9290(99)00009-3; Robinovitch SN, 1997, ANN BIOMED ENG, V25, P499, DOI 10.1007/BF02684190; Saftari LN, 2018, J PHYSIOL ANTHROPOL, V37, DOI 10.1186/s40101-018-0170-1; Sandler R, 2001, J BIOMECH ENG-T ASME, V123, P590, DOI 10.1115/1.1408940; Serpen G, 2018, PROCEDIA COMPUT SCI, V140, P238, DOI 10.1016/j.procs.2018.10.324; Shamaei K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059935; Shaw FE, 1997, POSTGRAD MED J, V73, P635, DOI 10.1136/pgmj.73.864.635; Shi GY, 2009, IEEE SENS J, V9, P495, DOI 10.1109/JSEN.2008.2012212; Silder A, 2007, J BIOMECH, V40, P2628, DOI 10.1016/j.jbiomech.2006.12.017; Song S, 2017, FRONT COMPUT NEUROSC, V11, DOI 10.3389/fncom.2017.00015; Stevens Judy A, 2014, Inj Epidemiol, V1, P5, DOI 10.1186/2197-1714-1-5; Tamura T, 2009, IEEE T INF TECHNOL B, V13, P910, DOI 10.1109/TITB.2009.2033673; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; Tricco AC, 2017, JAMA-J AM MED ASSOC, V318, P1687, DOI 10.1001/jama.2017.15006; vandenKroonenberg AJ, 1996, J BIOMECH, V29, P807, DOI 10.1016/0021-9290(95)00134-4; WAMPLER C, 1985, J APPL MECH-T ASME, V52, P465, DOI 10.1115/1.3169070; Yang F, 2008, J BIOMECH, V41, P1823, DOI 10.1016/j.jbiomech.2008.04.005; Yang F, 2007, J BIOMECH, V40, P804, DOI 10.1016/j.jbiomech.2006.03.015; Yang F, 2011, J BIOMECH, V44, P2607, DOI 10.1016/j.jbiomech.2011.08.018; Yang F, 2010, J BIOMECH, V43, P397, DOI 10.1016/j.jbiomech.2009.10.003	32	1	1	1	6	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	OCT 1	2020	142	10							101007	10.1115/1.4047077			8	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	QA2RN	WOS:000613295700013	32346720				2022-02-06	
J	Riemann, L; Beqiri, E; Younsi, A; Czosnyka, M; Smielewski, P				Riemann, Lennart; Beqiri, Erta; Younsi, Alexander; Czosnyka, Marek; Smielewski, Peter			Predictive and Discriminative Power of Pressure Reactivity Indices in Traumatic Brain Injury	NEUROSURGERY			English	Article						Cerebral autoregulation; Cerebrovascular reactivity; Pressure reactivity index; Outcome; Traumatic brain injury	DYNAMIC CEREBRAL AUTOREGULATION; STATIC AUTOREGULATION; MANAGEMENT; HUMANS	BACKGROUND: Dysfunctional cerebral blood flow autoregulation plays a crucial role in the secondary damage after traumatic brain injury. The pressure reactivity index (PRx) can be used to monitor dynamic cerebral blood flow autoregulation indirectly. OBJECTIVE: To test different versions of the long pressure reactivity index (LPRx), which is based on minute-by-minute data and calculated over extended time windows, and to study their predictive ability and examine whether "long" and "short" pressure reactivity indices could improve predictive power. METHODS: PRx and 3 versions of the LPRx calculated over 20-, 60-, and 240-min time windows were assessed in relation to outcome at 6 mo in 855 patients with traumatic brain injury. Predictive power and discriminative ability of indices were evaluated using area under the operator curves and determination of critical thresholds. PRx and LPR indices were combined to evaluate whether LPR indices could improve outcome prediction by adding information about static components of autoregulation. RESULTS: Correlation of each LPRx with the PRx decreased with increased time windows. LPR indices performed successively worse in their predictive and discriminative ability from 20-min to 240-min time frames. PRx had a significantly higher predictive ability compared to each LPRx. Combining LPRx and PRx did not lead to an improvement of predictive power compared to the PRx alone. CONCLUSION: The critical threshold and predictive value of the PRx for unfavorable outcome and mortality have been confirmed in one of the largest so far published patient cohorts. LPRx performed significantly worse, and its discriminative and predictive abilities decreased with an increasing calculation window.	[Riemann, Lennart; Younsi, Alexander] Heidelberg Univ Hosp, Dept Neurosurg, Neuenheimer Feld 400, D-69120 Heidelberg, Germany; [Riemann, Lennart; Beqiri, Erta; Czosnyka, Marek; Smielewski, Peter] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Brain Phys Lab, Cambridge, England; [Beqiri, Erta] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Riemann, L (corresponding author), Heidelberg Univ Hosp, Dept Neurosurg, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	l.riemann@stud.uni-heidelberg.de		Riemann, Lennart/0000-0002-7188-5227	NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); CENTER-TBI scholarship	Dr Czosnyka and Dr Smielewski receive part of the licensing fee for the ICM+ software. The other authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article. Mr Riemann received a CENTER-TBI scholarship to visit the Brain Physics Laboratory in Cambridge. Dr Marek Czosnyka is supported by the NIHR Cambridge Biomedical Research Centre.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2017, ACTA NEUROCHIR, V159, P2063, DOI 10.1007/s00701-017-3310-1; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; Fraser CD, 2013, J APPL PHYSIOL, V115, P52, DOI 10.1152/japplphysiol.00068.2013; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; ICM, 2019, PRESSURE REACTIVITY; Johnson U, 2014, NEUROCRIT CARE, V21, P259, DOI 10.1007/s12028-014-9954-2; Lang EW, 2015, J NEUROSURG, V122, P588, DOI 10.3171/2014.10.JNS14602; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Numan T, 2014, MED ENG PHYS, V36, P1487, DOI 10.1016/j.medengphy.2014.08.001; Panerai RB, 2004, BRIT J NEUROSURG, V18, P471, DOI 10.1080/02688690400012343; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Puppo C, 2008, NEUROCRIT CARE, V8, P344, DOI 10.1007/s12028-008-9069-8; R Core Team, 2018, STATS PACK LANG ENV; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Sanchez-Porras R, 2012, ACTA NEUROCHIR, V154, P1575, DOI 10.1007/s00701-012-1423-0; Santos E, 2011, ACTA NEUROCHIR, V153, P2189, DOI 10.1007/s00701-011-1148-5; Schramm P, 2011, J NEUROSURG ANESTH, V23, P41, DOI 10.1097/ANA.0b013e3181f35854; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Toth P, 2016, AM J PHYSIOL-HEART C, V311, pH1118, DOI 10.1152/ajpheart.00267.2016; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	25	1	1	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	OCT	2020	87	4					655	663		10.1093/neuros/nyaa039			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OW8HR	WOS:000593121100029	32171019				2022-02-06	
J	Robinson, LK; McFadden, SL				Robinson, Lindsey K.; McFadden, Sandra L.			Distinguishing TBI Malingering and Fatigue Using Event-Related Potentials	JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						concussion; electrophysiology; evoked potentials; head injury; malingering; old-new task	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; MEMORY IMPAIRMENT; MENTAL FATIGUE; REACTION-TIME; DIGIT SPAN; MILD; P300; MODERATE; MOTIVATION	Poorer-than-expected performance on cognitive-behavioral tasks may indicate malingering, or it could be an outcome of fatigue, resulting in false positives when suboptimal task performance is used to flag individuals feigning or exaggerating symptoms of traumatic brain injury (TBI). The primary goal of this study was to examine the P3 event-related potentials (ERP) and behavioral outcomes associated with TBI malingering and fatigue, in order to distinguish between them. A secondary goal was to determine if history of TBI (hTBI) is associated with differences in fatigue, ERPs, or performance on a short-term memory task. Participants completed the Mental Fatigue and Related Symptoms (SR-MF) questionnaire and were interviewed to assess TBI history, then they completed a computerized "old/new" (match-mismatch) task while ERPs were recorded, under three conditions: Normal, Malinger, and Fatigue. Participants reported mild fatigue at the end of study, with no difference between individuals reporting a history of TBI (n = 32) and healthy controls (n = 47). Fatigue was associated with prolonged P3 latency but was otherwise indistinguishable from Normal. In contrast, Malinger was clearly distinguished from Normal by significantly lower accuracy, longer reaction times, reduced P3 amplitude on Match trials, and a smaller old/new ERP effect. Individuals with a history of TBI reported clinical levels of fatigue at baseline but did not differ significantly from healthy controls on any behavioral or ERP measure. The results support the use of behavioral and ERP measures to identify malingering, without concern over confounding effects of mild subjective fatigue, including mild fatigue induced by testing.	[Robinson, Lindsey K.; McFadden, Sandra L.] Western Illinois Univ, Dept Psychol, 1 Univ Circle, Macomb, IL 61455 USA		McFadden, SL (corresponding author), Western Illinois Univ, Dept Psychol, 1 Univ Circle, Macomb, IL 61455 USA.	sl-mcfadden@wiu.edu			School of Graduate Studies at Western Illinois University; College of Arts and Sciences at Western Illinois University	This research was supported by a Graduate Student Research and Professional Development Award to Lindsey K. Robinson from the School of Graduate Studies and the College of Arts and Sciences at Western Illinois University.	Aaronson L S, 1999, Image J Nurs Sch, V31, P45; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Bay E, 2009, WESTERN J NURS RES, V31, P731, DOI 10.1177/0193945909334856; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Binder LM, 2003, J CLIN EXP NEUROPSYC, V25, P420, DOI 10.1076/jcen.25.3.420.13806; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Browndyke J. N., 2013, MILD TRAUMATIC BRAIN, P303; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Centers for Disease Control and Prevention, 2015, TRAUMATIC BRAIN INJU; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Elting JW, 2008, BRAIN INJURY, V22, P870, DOI 10.1080/02699050802403581; Fabiano R. J., 1999, J REHABIL, V64, P9; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; Guo ZZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163360; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Johnson R., 1995, HDB NEUROPSYCHOLOGY, VVol. 10, P135; Johnson S K, 1997, Appl Neuropsychol, V4, P145, DOI 10.1207/s15324826an0403_1; KARIS D, 1984, COGNITIVE PSYCHOL, V16, P177, DOI 10.1016/0010-0285(84)90007-0; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Kraus JF, 2005, TXB TRAUMATIC BRAIN, P3; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; MILLIS SR, 1994, J CLIN PSYCHOL, V50, P601, DOI 10.1002/1097-4679(199407)50:4<601::AID-JCLP2270500417>3.0.CO;2-9; Millis SR., 2001, J FORENSIC NEUROPSYC, V2, P1, DOI [10.1300/J151v02n01_01, DOI 10.1300/J151V02N01_]; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; National Institute of Child Health and Human Development, 2013, DO HEALTHC PROV DIAG; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; PALLER KA, 1992, J COGNITIVE NEUROSCI, V4, P375, DOI 10.1162/jocn.1992.4.4.375; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Robinson L. K., 2016, 88 ANN MIDW PSYCH AS; Rosenfeld JP, 1999, INT J PSYCHOPHYSIOL, V33, P3, DOI 10.1016/S0167-8760(99)00021-5; Rosenfeld JP, 1998, INT J PSYCHOPHYSIOL, V28, P233; RUGG MD, 1988, J NEUROL NEUROSUR PS, V51, P691, DOI 10.1136/jnnp.51.5.691; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; SMITH ME, 1993, J COGNITIVE NEUROSCI, V5, P1, DOI 10.1162/jocn.1993.5.1.1; SMITH ME, 1989, J EXP PSYCHOL LEARN, V15, P50, DOI 10.1037/0278-7393.15.1.50; Solbakk AK, 2002, CLIN ELECTROENCEPHAL, V33, P102, DOI 10.1177/155005940203300306; STRAUSS E, 1994, ARCH CLIN NEUROPSYCH, V9, P483, DOI 10.1016/0887-6177(94)90039-6; Suhr JA, 2003, J PSYCHOSOM RES, V55, P321, DOI 10.1016/S0022-3999(02)00628-1; Tardif HP, 2000, INT J PSYCHOPHYSIOL, V36, P1, DOI 10.1016/S0167-8760(00)00083-0; Tardif HP, 2002, INT J PSYCHOPHYSIOL, V46, P147, DOI 10.1016/S0167-8760(02)00090-9; Vagnini VL, 2008, J CLIN EXP NEUROPSYC, V30, P766, DOI 10.1080/13803390701754746; van Hooff JC, 2009, INT J PSYCHOPHYSIOL, V73, P246, DOI 10.1016/j.ijpsycho.2009.04.002; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Woodman GF, 2010, ATTEN PERCEPT PSYCHO, V72, P2031, DOI 10.3758/APP.72.8.2031; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P101, DOI 10.1080/13803395.2010.493149	58	1	1	0	2	HOGREFE & HUBER PUBLISHERS	GOTTINGEN	MERKELSTR 3, D-37085 GOTTINGEN, GERMANY	0269-8803	2151-2124		J PSYCHOPHYSIOL	J. Psychophysiol.	OCT	2020	34	4					203	213		10.1027/0269-8803/a000248			11	Psychology, Biological; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	OF4VH	WOS:000581206900001					2022-02-06	
J	St Hilaire, C; Johnson, A; Loseth, C; Alipour, H; Faunce, N; Kaminski, S; Sharma, R				St Hilaire, Cameron; Johnson, Arianne; Loseth, Caitlin; Alipour, Hamid; Faunce, Nick; Kaminski, Stephen; Sharma, Rohit			Facial Fractures After Geriatric Ground-Level Falls Are a Marker of Functional Decline and Warrant Trauma Center Admission	AMERICAN SURGEON			English	Article						facial fractures; ground-level falls; geriatric		Ground-level falls (GLFs) are a frequent source of injury in the geriatric population. Facial fractures (FFs) are one subsequent injury that can occur and may be an important marker of functional decline. We conducted a retrospective analysis over a 6-year period of patients 65 years and older sustaining one or more FFs due to a GLF (n = 28). Demographics, comorbidities, FF patterns, concomitant injuries, procedures, and outcomes were analyzed. The mean age was 80.0 +/- 8.2 years, 64% were male, 12 patients (43%) were on oral anticoagulants prior to injury, and mean injury severity score was 8.3 +/- 7.0. Five patients (18%) had LeFort fractures (1 with LeFort I, 4 with LeFort II), and 5 (18%) had isolated mandible fractures (2 were bilateral). Nearly half of all patients suffered neurological injury (concussion: 18%, intracranial hemorrhage: 29%). Average hospital length of stay (LOS) was 4.0 +/- 2.9 days. Eight patients (29%) required intensive care unit (ICU) admission with an average ICU-LOS of 2.8 +/- 1.2 days. Surgical management was required in 4 patients (14%). More than half of the patients returned home (54%), 25% were discharged to a skilled nursing facility, 4% to rehabilitation, 7% to hospice, and 7% expired. Nearly one-third of patients required discharge to a higher level of care facility than their location prior to injury. GLF-induced FFs are often associated with significant injuries and serve as an indicator of functional decline. These injuries warrant trauma center admission for comprehensive evaluation and management.	[St Hilaire, Cameron; Johnson, Arianne; Loseth, Caitlin; Alipour, Hamid; Faunce, Nick; Kaminski, Stephen; Sharma, Rohit] Santa Barbara Cottage Hosp, 400 W Pueblo St, Santa Barbara, CA 93105 USA		Sharma, R (corresponding author), Santa Barbara Cottage Hosp, 400 W Pueblo St, Santa Barbara, CA 93105 USA.	rsharma@sbch.org		St. Hilaire, Cameron/0000-0002-6190-2804			American College of Surgeons, 2016, NATL TRAUMA DATA BAN; Atisha DM, 2016, PLAST RECONSTR SURG, V137, P587, DOI 10.1097/01.prs.0000475791.31361.9a; Bergen G, 2016, MMWR-MORBID MORTAL W, V65, P993, DOI 10.15585/mmwr.mm6537a2; Grimmer K, 2013, PATIENT-RELAT OUTCOM, V4, P37, DOI 10.2147/PROM.S42474; Grimmer K, 2013, AUST HEALTH REV, V37, P341, DOI 10.1071/AH12034; Ortman J. M., 2014, P251140 US CENS BUR; Peden M., 2002, INJURY CHART BOOK GR; R Core Team, 2021, R LANG ENV STAT COMP	8	1	1	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	OCT	2020	86	10					1302	1306		10.1177/0003134820964228			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	QA9YU	WOS:000613801200014	33074742				2022-02-06	
J	Takoukam, R; Kanmounye, US; Robertson, FC; Zimmerman, K; Nguembu, S; Lartigue, JW; Park, KB; Figuim, B; Esene, I				Takoukam, Regis; Kanmounye, Ulrick Sidney; Robertson, Faith C.; Zimmerman, Kathrin; Nguembu, Stephane; Lartigue, Jean W.; Park, Kee B.; Figuim, Bello; Esene, Ignatius			Prehospital Conditions and Outcomes After Craniotomy for Traumatic Brain Injury Performed Within 72 Hours in Central Cameroon: A Cross-Sectional Study	WORLD NEUROSURGERY			English	Article						Cameroon; Craniectomy; Cranioplasty; Craniotomy; Global neurosurgery; Neurosurgery; Neurotrauma; Traumatic brain injury	GOLDEN HOUR; HEAD; MANAGEMENT	BACKGROUND: Traumatic brain injury (TBI) is the most common neurosurgical condition globally. In Cameroon, there are 572 cases of TBI per 100,000 people, but <40% of Cameroonians live within 4 hours of a neurosurgical facility. We sought to understand the clinical outcomes at a neurosurgical center in Central Cameroon. METHODS: This cross-sectional study was conducted at the largest neurosurgical center of Cameroon, the Yaounde Central Hospital. Data included 100 consecutive patients undergoing an intervention 72 hours after their injury from February 1, 2015 to February 1, 2019. Patients with missing data or undergoing surgery >72 hours after injury were excluded. Analyses of covariance were performed, and a P value >0.05 was considered significant. A Kaplan-Meier survival curve was computed. RESULTS: The patients had a mean age of 31.3 +/- 17.4 years, with a male predominance of 91.0%, and the principal mechanism of injury was road traffic accidents (68.0%). Only 11% arrived via ambulance, and 36.0% were admitted <3 hours after the traumatic event. The postoperative mortality was 15.0%, mean survival was 25.0 postoperative days (95% confidence interval, 23.42-26.52), and the mean Glasgow Outcome Scale score at 28 days was 3.9 +/- 1.4. CONCLUSIONS: Most patients with TBI undergoing neurosurgery 72 hours after injury in Cameroon arrive at the hospital late and have a high mortality risk during the first postoperative week. Investments in prehospital care should be made to improve surgical outcomes.	[Takoukam, Regis; Nguembu, Stephane] Univ Montagnes, Fac Med, Higher Inst Hlth Sci, Bangangte, Cameroon; [Takoukam, Regis] Univ Felix Houphouet Boigny, Dept Neurosurg, Abidjan, Cote Ivoire; [Takoukam, Regis; Kanmounye, Ulrick Sidney; Nguembu, Stephane] Assoc Future African Neurosurg, Dept Res, Yaounde, Cameroon; [Kanmounye, Ulrick Sidney; Zimmerman, Kathrin; Lartigue, Jean W.; Park, Kee B.] Harvard Med Sch, Global Neurosurg Initiat, Program Global Neurosurg & Social Change, Boston, MA 02115 USA; [Robertson, Faith C.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Zimmerman, Kathrin] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Figuim, Bello] Yaounde Cent Hosp, Dept Neurosurg, Yaounde, Cameroon; [Esene, Ignatius] Univ Bamenda, Fac Hlth Sci, Bamenda, Cameroon; [Esene, Ignatius] Garoua Reg Hosp, Dept Neurosurg, Garoua, Cameroon		Kanmounye, US (corresponding author), Assoc Future African Neurosurg, Dept Res, Yaounde, Cameroon.; Kanmounye, US (corresponding author), Harvard Med Sch, Global Neurosurg Initiat, Program Global Neurosurg & Social Change, Boston, MA 02115 USA.	ulricksidney@gmail.com	Robertson, Faith/AAO-9914-2020; Kanmounye, Ulrick Sidney/AAY-6123-2020; Nguembu, Stephane/AAY-6575-2020; ESENE, IGNATIUS/AAX-8716-2020	Kanmounye, Ulrick Sidney/0000-0001-6791-1018; Nguembu, Stephane/0000-0003-3601-663X; ESENE, IGNATIUS/0000-0001-8785-8875; Lartigue, Jean Wilguens/0000-0001-9889-7976			Abdelgadir J, 2017, WORLD NEUROSURG, V102, P526, DOI 10.1016/j.wneu.2017.03.019; Barthelemy EJ, 2019, WORLD NEUROSURG, V126, pE232, DOI 10.1016/j.wneu.2019.02.019; Beavogui K, 2012, NEUROCHIRURGIE, V58, P287, DOI 10.1016/j.neuchi.2012.05.006; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chichom-Mefire A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180784; Corley J, 2019, WORLD NEUROSURG, V132, P434, DOI 10.1016/j.wneu.2019.08.240; Corley J, 2019, WORLD NEUROSURG, V123, P295, DOI 10.1016/j.wneu.2018.12.042; De Vloo P, 2018, WORLD NEUROSURG, V114, pE546, DOI 10.1016/j.wneu.2018.03.032; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dhandapani SS, 2012, J NEUROSCI RURAL PRA, V3, P131, DOI 10.4103/0976-3147.98208; Dinh MM, 2013, INJURY, V44, P606, DOI 10.1016/j.injury.2012.01.011; Djientcheu V, 2016, J NEUROL SCI, V371, P100, DOI 10.1016/j.jns.2016.10.016; Edu PBN, 2018, OPEN J MOD NEUROSURG, V8, P720; Esquivel MM, 2015, J AM COLL SURGEONS, V221, pS86, DOI 10.1016/j.jamcollsurg.2015.07.196; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Goldstein LN, 2017, AFR J EMERG MED, V7, P100, DOI 10.1016/j.afjem.2017.04.012; Gupta S, 2020, J NEUROSURG, V132, P289, DOI 10.3171/2018.8.JNS182182; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Juillard C, 2011, WORLD J SURG, V35, P1, DOI 10.1007/s00268-010-0825-5; Karekezi C, 2019, WORLD NEUROSURG, V126, P576, DOI 10.1016/j.wneu.2019.03.141; Mhando S, 2008, PEDIATR SURG INT, V24, P219, DOI 10.1007/s00383-007-2072-x; Moran D, 2017, WORLD J SURG, V41, P2215, DOI 10.1007/s00268-017-4022-7; Motah M, 2010, AFR J NEUROL SCI, V29, P51; Motah M, 2013, HLTH SCI DIS, V12, P3; Mukhopadhyay S, 2019, J NEUROSURG, V130, P1142, DOI 10.3171/2018.10.JNS171723; Ndoumbe A, 2019, OPEN J MOD NEUROSURG, V9, P49; Newgard CD, 2015, ANN EMERG MED, V66, P30, DOI 10.1016/j.annemergmed.2014.12.004; Nguembu S, 2020, WORLD NEUROSURG, V139, pE774, DOI 10.1016/j.wneu.2020.04.162; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Puvanachandra P, 2008, SALUD PUBLICA MEXICO, V50, pS3; Rabiu TB, 2016, J NEUROSCI RURAL PRA, V7, P485, DOI 10.4103/0976-3147.188624; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; Vaca SD, 2019, NEUROSURGERY, V84, P95, DOI 10.1093/neuros/nyy004; WHO. World Health Organization, 2018, GLOBAL STATUS REPORT; Winkler AS, 2010, WORLD NEUROSURG, V73, P264, DOI 10.1016/j.wneu.2010.03.037; World Bank Group, CAM DAT; World Federation of Neurosurgical Societies, AFR 2016 NEUR CAP AC; World Health Organization, NEUROTRAUMA; World Health Organization, 2013, GLOB STAT REP ROAD S	40	1	1	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2020	142						E238	E244		10.1016/j.wneu.2020.06.182			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NY5WL	WOS:000576459300029	32599210				2022-02-06	
J	Tiwari, D; Yorke, A; Goldberg, A; Marchetti, GF; Alsalaheen, B				Tiwari, Devashish; Yorke, Amy; Goldberg, Allon; Marchetti, Gregory F.; Alsalaheen, Bara			Measurement Properties of the Dizziness Handicap Inventory-Children and Adolescents for Children and Adolescents Postconcussion	PEDIATRIC PHYSICAL THERAPY			English	Article						assessment; child; dizziness; traumatic brain injury	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; RELIABILITY; VALIDITY; REHABILITATION; ADAPTATION; VERSION	Purpose: The purpose of this study was to examine and report the construct validity, internal consistency, and item structure of the Dizziness Handicap Inventory-Children and Adolescents (DHI-CA) in postconcussion children and adolescents. Methods: A retrospective chart review was conducted for 132 participants. Data were extracted on the DHI-CA, Sports Concussion Assessment Tool-III symptom inventory, and Vestibulo-ocular Motor Screening. The DHI-CA was examined for validity, internal consistency, and factor structure. Results: The DHI-CA had fair convergent validity (r(s)= 0.30-0.40), but discriminant validity findings were inconclusive. The functional subscale demonstrated least consistent loadings and 4 items had cross-loading. Reliability analysis indicated possible item redundancy given that the overall Cronbach alpha was higher than the subscales. Conclusion: Despite demonstrating convergent validity, structural inconsistencies and possible item redundancy warrant further exploration and restructuring of the DHI-CA. Caution is recommended while making clinical decisions based on the DHI-CA results alone.	[Tiwari, Devashish] Simmons Univ, Dept Phys Therapy, 300 Fenway, Boston, MA 02115 USA; [Yorke, Amy; Goldberg, Allon; Alsalaheen, Bara] Univ Michigan, Sch Hlth Profess & Studies, Phys Therapy Dept, Flint, MI USA; [Marchetti, Gregory F.] Duquesne Univ, Rangos Sch Hlth Sci, Phys Therapy Dept, Pittsburgh, PA 15219 USA; [Alsalaheen, Bara] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Alsalaheen, Bara] Michigan Med, Michigan NeuroSport, Ann Arbor, MI USA		Tiwari, D (corresponding author), Simmons Univ, Dept Phys Therapy, 300 Fenway, Boston, MA 02115 USA.	tiwari@simmons.edu					Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Anthoine Emmanuelle, 2014, Health Qual Life Outcomes, V12, P176, DOI 10.1186/s12955-014-0176-2; Faul M, 2010, TRAUMATIC BRAIN INJU; Gilchrist J, 2011, JAMA-J AM MED ASSOC, V306, P2318; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jafarzadeh S, 2014, J RES MED SCI, V19, P769; Jarlsater S., 2003, ADV PHYSIOTHER, V5, P137, DOI [10.1080/14038190310004385, DOI 10.1080/14038190310004385]; Kaiser-Meyer-Olkin value (KMO value), 2007, DICT PSYCH TEST ASS; Kurre A, 2009, OTOL NEUROTOL, V30, P359, DOI 10.1097/MAO.0b013e3181977e09; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Mutlu B, 2013, J VESTIBUL RES-EQUIL, V23, P271, DOI 10.3233/VES-130488; Nola G, 2010, ACTA OTORHINOLARYNGO, V30, P190; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Perez N, 2001, ACTA OTO-LARYNGOL, P145; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Sousa Maria da Glória Canto de, 2015, Audiol., Commun. Res., V20, P327, DOI 10.1590/2317-6431-2015-1595; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Tamber AL, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-101; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	30	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-5669	1538-005X		PEDIATR PHYS THER	Pediatr. Phys. Ther.	OCT	2020	32	4					382	388		10.1097/PEP.0000000000000741			7	Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Rehabilitation	OC5LR	WOS:000579198200022	32925816				2022-02-06	
J	Wang, C; Jia, QB; Sun, CJ; Jing, CH				Wang, Chun; Jia, Qingbin; Sun, Chenjun; Jing, Chaohui			Calcium sensing receptor contribute to early brain injury through the CaMKII/NLRP3 pathway after subarachnoid hemorrhage in mice	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Subarachnoid hemorrhage; Early brain injury; Calcium sensing receptor; GdCI3; NPS-2143	NLRP3 INFLAMMASOME; CA2+; ACTIVATION; APOPTOSIS	The subversive role of Calcium sensing receptor (CaSR) in cerebral ischemia and traumatic brain injury has been recently reported. Nevertheless, the role of CaSR in early brain injury (EBI) after subarachnoid hemorrhage (SAH) remains unexplored. Using the endovascular perforation model in mice, this study was aimed at investigating the role and potential mechanism of CaSR in EBI after SAH. Gadolinium trichloride (GdCI3), an agonist of CaSR, and NPS-2143, an inhibitor of CaSR, were administered intra-peritoneally. The CaMKII inhibitor KN-93 was injected to intracerebroventricular. We found that CaSR expression was increased and widely expressed in neurons, astrocytes, and microglia after SAH. GdCI3 further deteriorated neurological function, brain edema, neurodegeneration, which were alleviated by NPS-2143. Also, GdCI3 increased the level of CaMKII phosphorylation, and upregulated expression of NLRP3, cleaved caspase-1, and IL-1 beta, which were attenuated by NPS-2143. Besides, CaMKII inhibitor KN-93 down-regulated the upregulated expression of NLRP3, cleaved caspase-1, and IL-1 beta induced by GdCI3. In conclusion, CaSR activation promotes early brain injury, which may be related to the CaMKII/NLRP3 signaling pathway. (c) 2020 Elsevier Inc. All rights reserved.	[Wang, Chun] Zhejiang Univ, Dept Neurosurg, Affiliated Hosp 2, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Jia, Qingbin] Liaocheng Peoples Hosp, Dept Neurosurg, Liaocheng, Shandong, Peoples R China; [Sun, Chenjun] Shaoxing Cent Hosp, Dept Neurosurg, Shaoxing, Zhejiang, Peoples R China; [Jing, Chaohui] Shanghai Jiao Tong Univ, Dept Neurosurg, Sch Med, Xinhua Hosp, Shanghai, Peoples R China		Jing, CH (corresponding author), Shanghai Jiao Tong Univ, Dept Neurosurg, Sch Med, Xinhua Hosp, Shanghai, Peoples R China.	jingchaohui@xinhuamed.com.cn			Shanghai Pujiang ProgramShanghai Pujiang Program [2019PJD031]; Zhejiang Administration of Traditional Chinese Medicine [2020ZB269]	This work was sponsored by Shanghai Pujiang Program (NO. 2019PJD031) and Program from Zhejiang Administration of Traditional Chinese Medicine (NO. 2020ZB269).	Bagur R, 2017, MOL CELL, V66, P780, DOI 10.1016/j.molcel.2017.05.028; Bhattacharyya M, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a035147; Chen S, 2013, NEUROBIOL DIS, V58, P296, DOI 10.1016/j.nbd.2013.06.011; Coultrap SJ, 2014, CELL REP, V6, P431, DOI 10.1016/j.celrep.2014.01.005; Edvinsson L, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0207-2; Fujii M, 2013, TRANSL STROKE RES, V4, P432, DOI 10.1007/s12975-013-0257-2; Fujimoto M, 2016, J NEUROSURG, V124, P1693, DOI 10.3171/2015.4.JNS15484; Gaberel T, 2019, STROKE, V50, P520, DOI 10.1161/STROKEAHA.118.022325; Geng Y, 2016, ELIFE, V5, DOI 10.7554/eLife.13662; Hannan FM, 2018, NAT REV ENDOCRINOL, V15, P33, DOI 10.1038/s41574-018-0115-0; Kelley N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133328; Kim JY, 2013, J NEUROTRAUM, V30, P1170, DOI 10.1089/neu.2012.2691; Kim W, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00440; Klein GL, 2016, SEMIN CELL DEV BIOL, V49, P52, DOI 10.1016/j.semcdb.2015.08.006; Lai NS, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01745-0; Larsson SC, 2017, JAMA-J AM MED ASSOC, V318, P371, DOI 10.1001/jama.2017.8981; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Li JR, 2016, MOL NEUROBIOL, V53, P2668, DOI 10.1007/s12035-015-9318-8; Liu L, 2018, MOL NEUROBIOL, V55, P8346, DOI 10.1007/s12035-018-1006-z; Liu WX, 2015, CELL PHYSIOL BIOCHEM, V35, P2483, DOI 10.1159/000374048; Luo YJ, 2019, BRAIN RES BULL, V146, P320, DOI 10.1016/j.brainresbull.2019.01.027; Macdonald RL, 2017, LANCET, V389, P655, DOI 10.1016/S0140-6736(16)30668-7; Nishikawa H, 2018, STROKE, V49, P2743, DOI 10.1161/STROKEAHA.118.021757; Rossol M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2339; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Tennakoon S, 2016, BBA-MOL CELL RES, V1863, P1398, DOI 10.1016/j.bbamcr.2015.11.017; Yano S, 2004, CELL CALCIUM, V35, P257, DOI 10.1016/j.ceca.2003.10.008; Yarova PL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0282; Zhang XH, 2019, J ALZHEIMERS DIS, V67, P1109, DOI 10.3233/JAD-181084; Zhang X, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/6847087; Zhang ZY, 2018, EXP NEUROL, V301, P13, DOI 10.1016/j.expneurol.2017.12.005; Zhen YL, 2016, AM J TRANSL RES, V8, P911; Zhou KR, 2018, STROKE, V49, P175, DOI 10.1161/STROKEAHA.117.018593	34	1	2	1	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	OCT 1	2020	530	4					651	657		10.1016/j.bbrc.2020.07.081			7	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	NI9DP	WOS:000565646300006	32768195				2022-02-06	
J	Warmath, D; Winterstein, AP				Warmath, Dee; Winterstein, Andrew P.			A Social-Marketing Intervention and Concussion-Reporting Beliefs	JOURNAL OF ATHLETIC TRAINING			English	Article						concussion education; expectancy value theory; sport-related concussion; help seeking	COLLEGIATE FOOTBALL PLAYERS; HEAD-INJURY; SPORT; PERFORMANCE; EDUCATION; HEALTH	Context: Concussion-symptom education remains the primary approach used by athletic trainers to address underreporting of possible sport-related concussions. Social marketing represents an untapped approach to promote concussion reporting by communicating the benefits or consequences of reporting or not reporting, respectively. Objective: To apply expectancy value theory and identify how marketing the possible consequences of concealing concussion symptoms influenced young adults' concussion-reporting beliefs to increase the likelihood of reporting. Design: Randomized controlled clinical trial. Setting: Laboratory. Patients or Other Participants: A total of 468 competitive collegiate club sport athletes at a large US university who engaged in 1 of 46 sports with various levels of concussion risk. Intervention(s): Participants were randomly assigned by team to 1 of 3 conditions. The treatment condition was a social-marketing program focused on the possible consequences of the reporting decision. The control condition was traditional concussion-symptom education based on the National Collegiate Athletic Association's publication, "Concussion: A Fact Sheet for Student-Athletes." An additional condition mirrored the traditional symptom education but included a less clinical delivery. Main Outcome Measure(s): Positive and negative beliefs regarding concussion reporting were assessed. We applied expectancy value theory, which posits that changing beliefs in the short term will produce greater reporting intentions in the long term. Results: Club sport athletes exposed to consequence-based social marketing showed higher levels of positive reporting beliefs and lower levels of negative reporting beliefs than athletes exposed to traditional or revised symptom education. We observed no differences between the traditional and revised symptom-education programs. Exposure to consequence-based marketing decreased negative beliefs about reporting (B = -0.165, P =.01) and increased positive beliefs about reporting (B = 0.165, P =.01). Conclusions: Social marketing offers athletic trainers another strategic tool for motivating athletes to report concussion symptoms by translating scientific findings into marketable statements and then communicating the benefits of reporting or the negative consequences of concealing concussion symptoms.	[Warmath, Dee] Univ Georgia, Coll Family & Consumer Sci, Dept Financial Planning Housing & Consumer Econ, Dawson Hall,305 Sanford Dr, Athens, GA 30602 USA; [Winterstein, Andrew P.] Univ Wisconsin, Dept Kinesiol, Madison, WI 53706 USA		Warmath, D (corresponding author), Univ Georgia, Coll Family & Consumer Sci, Dept Financial Planning Housing & Consumer Econ, Dawson Hall,305 Sanford Dr, Athens, GA 30602 USA.	warmath@uga.edu	Warmath, Dee/AAK-5148-2021	Warmath, Dee/0000-0001-8301-1386	NCAA Mind Matters Challenge; National Collegiate Athletic Association; US Department of DefenseUnited States Department of Defense; University of Wisconsin-Madison Recreational Sports Department	This research was funded by a grant from the NCAA Mind Matters Challenge. We thank the National Collegiate Athletic Association, US Department of Defense, and University of Wisconsin-Madison Recreational Sports Department for their support.	[Anonymous], 2012, CONC FACT SHEET STUD; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Chinn NR, 2016, BMJ OPEN SPORT EXERC, V2; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Fishbein M., 1975, BELIEF ATTITUDE INTE; Gordon R, 2006, PUBLIC HEALTH, V120, P1133, DOI 10.1016/j.puhe.2006.10.008; Grier S, 2005, ANNU REV PUBL HEALTH, V26, P319, DOI 10.1146/annurev.publhealth.26.021304.144610; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Henderson J., 2015, 2015 ATHLETIC TRAINE; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hulleman CS, 2009, SCIENCE, V326, P1410, DOI 10.1126/science.1177067; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; KOTLER P, 1971, J MARKETING, V35, P3, DOI 10.2307/1249783; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, HEALTH EDUC RES, V30, P1004, DOI 10.1093/her/cyv047; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Rothschild ML, 1999, J MARKETING, V63, P24, DOI 10.2307/1251972; Warmath D, 2019, SPORTS HEALTH, V11, P416, DOI 10.1177/1941738119856609; Yeager DS, 2016, J EDUC PSYCHOL, V108, P374, DOI 10.1037/edu0000098	30	1	1	2	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	OCT	2020	55	10					1035	1045		10.4085/1062-6050-242-19			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	OH5SX	WOS:000582645900004	32966568	gold, Green Published			2022-02-06	
J	Bi, FF; Ma, HF; Ji, C; Chang, CC; Liu, WB; Xie, KL				Bi, Fangfang; Ma, Huaifen; Ji, Chen; Chang, Cuicui; Liu, Wenbo; Xie, Keliang			Rhein Protects Against Neurological Deficits After Traumatic Brain Injury in MiceviaInhibiting Neuronal Pyroptosis	FRONTIERS IN PHARMACOLOGY			English	Article						Rhein; traumatic brain injury; inflammatory cytokines; pyroptosis; neurological deficits	NF-KAPPA-B; INFLAMMATORY CASPASES; CELLS; EXPRESSION; KIDNEY; RATS; MICE	Neurological dysfunction provoked by traumatic brain injury (TBI) makes a huge impact on individual learning ability, memory level, social participation, and quality of life. Pyroptosis, the caspase-1-dependent cell death, which is associated with the release of numerous pro-inflammatory factors, plays a major role in the pathological process after TBI. Inhibition of pyroptosis has been shown to be an attractive strategy for the treatment of various neurological disorders. Here, we found that Rhein, an anthraquinone derived from the medicinal plant rhubarb, attenuated TBI-induced upregulation of pro-inflammatory cytokines, blood lactate dehydrogenase (LDH), and pyroptosis-related proteins, as well as reduced neurological dysfunction in a mouse TBI model. Consistently, Rhein inhibitd equiaxial stretch-induced neuron pyroptosis, LDH release, and upregulation of pro-inflammatory factorsin vitro. Thus, our study suggested that Rhein protected against neurological deficits after TBIviainhibiting neuronal pyroptosis.	[Bi, Fangfang; Ma, Huaifen; Ji, Chen; Chang, Cuicui] Xian Peihua Univ, Dept Med, Xian, Peoples R China; [Liu, Wenbo; Xie, Keliang] Weifang Med Univ, Coll Anesthesiol, Weifang, Peoples R China		Liu, WB; Xie, KL (corresponding author), Weifang Med Univ, Coll Anesthesiol, Weifang, Peoples R China.	boboliucn@126.com; xiekeliang2009@hotmail.com			Natural Science Basic Research Program of Shaanxi [2018JM7140]	This study was supported by a grant from the Natural Science Basic Research Program of Shaanxi (program no. 2018JM7140).	Angeloni C, 2015, CHEM RES TOXICOL, V28, P1234, DOI 10.1021/acs.chemrestox.5b00067; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Chen W, 2018, J NEUROPHYSIOL, V119, P305, DOI 10.1152/jn.00654.2017; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Dong WW, 2018, TOXICOL APPL PHARM, V346, P28, DOI 10.1016/j.taap.2018.03.020; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Fernand VE, 2011, CHEM-BIOL INTERACT, V192, P220, DOI 10.1016/j.cbi.2011.03.013; Guo Mei-zi, 2003, Zhonghua Gan Zang Bing Za Zhi, V11, P26; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hu G, 2013, AM J CHINESE MED, V41, P473, DOI 10.1142/S0192415X13500341; Irrera N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00459; Li H, 2011, MED HYPOTHESES, V77, P1105, DOI 10.1016/j.mehy.2011.09.013; Li R, 2017, BRAIN RES BULL, V130, P236, DOI 10.1016/j.brainresbull.2017.01.016; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Martin G, 2003, INFLAMMATION, V27, P233, DOI 10.1023/A:1025040631514; Mawhinney LJ, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-123; Meng XF, 2014, MOL NEUROBIOL, V49, P673, DOI 10.1007/s12035-013-8551-2; Meng Z, 2013, ACTA PHARMACOL SIN, V34, P901, DOI 10.1038/aps.2013.24; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Shi H, 2015, CNS NEUROSCI THER, V21, P374, DOI 10.1111/cns.12366; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Su J, 2013, TRANSPL P, V45, P2546, DOI 10.1016/j.transproceed.2013.03.030; Suneela Dhaneshwar, 2013, Inflammation & Allergy Drug Targets, V12, P288; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00351; Tsang SW, 2015, PHYTOTHER RES, V29, P407, DOI 10.1002/ptr.5266; Wei J, 2016, ARCH PHARM RES, V39, P960, DOI 10.1007/s12272-016-0770-4; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Ye YQ, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/5841814; Yu C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11822; YU HS, 2016, J TISSUE ENG, V0007; Zeng CC, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/487097; Zeng ZJ, 2013, PLANTA MED, V79, P102, DOI 10.1055/s-0032-1328057; Zhang K, 2015, MOL MED REP, V12, P4415, DOI 10.3892/mmr.2015.3925; Zhang Q, 2017, KIDNEY INT, V91, P144, DOI 10.1016/j.kint.2016.07.040; Zhang Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep34597; Zhao L, 2011, NUTR REV, V69, P310, DOI 10.1111/j.1753-4887.2011.00394.x	39	1	1	2	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	SEP 30	2020	11								564367	10.3389/fphar.2020.564367			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	OC5WW	WOS:000579227300001	33101024	gold, Green Published			2022-02-06	
J	Champigny, CM; Rawana, J; Iverson, GL; Maxwell, B; Berkner, PD; Wojtowicz, M				Champigny, Claire M.; Rawana, Jennine; Iverson, Grant L.; Maxwell, Bruce; Berkner, Paul D.; Wojtowicz, Magdalena			Influence of Anxiety on Baseline Cognitive Testing and Symptom Reporting in Adolescent Student Athletes	JOURNAL OF NEUROTRAUMA			English	Article						anxiety; athletes; concussion; postconcussional syndrome	POSTCONCUSSION-LIKE SYMPTOMS; POST-CONCUSSION SYMPTOMS; TRAUMATIC BRAIN-INJURY; LIFE-STYLE FACTORS; CLINICAL RECOVERY; MENTAL-HEALTH; DISORDER; PREDICTORS; DEPRESSION; STRESS	Anxiety symptoms are commonly endorsed by student athletes. This study examined the possible influence of anxiety on baseline cognitive testing and symptom reporting in a large sample of adolescent student athletes. Participants were 37,945 adolescent student athletes from the state of Maine who completed baseline testing using ImPACT(R). ImPACT includes an evaluation of cognitive functioning and a questionnaire assessing the presence and severity of common post-concussion symptoms. Participants were divided into high and low anxiety groups based on endorsement of anxiety-like symptoms. Student athletes in the high anxiety group were more likely to be girls and to have a greater lifetime history of treatment for mental health problems and headaches (ps < 0.001). The high anxiety group scored slightly lower on cognitive tests (Cohends = 0.15-0.26) and reported a much greater amount of baseline pre-season symptoms (Cohend = 3.38). More than eight of 10 youth in the high anxiety group (82.7%) metInternational Statistical Classification of Diseases and Related Health Problems-10th Revision(ICD-10) symptom criteria for at least a mild form of the postconcussional syndrome compared with less than two of 10 (18.4%) in the low anxiety group. Students in the high anxiety group had slightly lower scores on neurocognitive testing, but the differences were not practically meaningful; however, they endorsed dramatically more physical, cognitive, and emotional symptoms. Anxiety can mimic the ICD-10 postconcussional syndrome in adolescent student athletes at baseline, when they have not been injured.	[Champigny, Claire M.; Rawana, Jennine; Wojtowicz, Magdalena] York Univ, Dept Psychol, Behav Sci Bldg,4700 Keele St, Toronto, ON M3J 1P3, Canada; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Charlestown, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp & Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Program, Charlestown, MA USA; [Iverson, Grant L.] Red Sox Fdn, Charlestown, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Charlestown, MA USA; [Maxwell, Bruce] Colby Coll, Dept Comp Sci, Waterville, ME 04901 USA; [Berkner, Paul D.] Univ New England, Coll Osteopath Med, Biddeford, ME USA		Wojtowicz, M (corresponding author), York Univ, Dept Psychol, Behav Sci Bldg,4700 Keele St, Toronto, ON M3J 1P3, Canada.	magdawoj@yorku.ca			Goldfarb Center for Public Policy and Civic Engagement/Colby College; Bill and Joan Alfond Foundation; ImPACT Applications, Inc.; CNS Vital Signs; Psychological Assessment Resources (PAR, Inc.); National Football League	Dr. Berkner acknowledges funding for the Maine Concussion Management Initiative from the Goldfarb Center for Public Policy and Civic Engagement/Colby College and the Bill and Joan Alfond Foundation. Grant Iverson, PhD, acknowledges unrestricted philanthropic support from ImPACT Applications, Inc., the MooneyReed Charitable Foundation, Boston Bolts, Heinz Family Foundation, and the Spaulding Research Institute.; Grant Iverson, Ph.D. has been reimbursed by the government, professional scientific bodies, and commercial organizations for discussing or presenting research relating to mild TBI and sportrelated concussion at meetings, scientific conferences, and symposiums. He has a clinical and consulting practice in forensic neuropsychology, including expert testimony, involving individuals who have sustained mild traumatic brain injuries (including athletes). He has received research funding from several test publishing companies, including ImPACT Applications, Inc., CNS Vital Signs, and Psychological Assessment Resources (PAR, Inc.), and the National Football League. He serves as a scientific advisor for Sway Operations, LLC, Highmark, Inc., and BioDirection, Inc. He has received salary support from the Harvard Integrated Program to Protect and Improve the Health of National Football League Players Association Members. None of the authors nor their family members have a commercial or proprietary interest in ImPACT.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Arnett P.A., 2019, NEUROPSYCHOLOGY SPOR, DOI DOI 10.1037/0000114-004; Bar KJ, 2013, EUR ARCH PSY CLIN N, V263, pS205, DOI 10.1007/s00406-013-0458-4; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Balasundaram AP, 2016, ARCH CLIN NEUROPSYCH, V31, P197, DOI 10.1093/arclin/acw001; Balasundaram AP, 2017, PM&R, V9, P866, DOI 10.1016/j.pmrj.2017.01.004; Barker-Collo S, 2015, BRAIN INJURY, V29, P859, DOI 10.3109/02699052.2015.1004759; Castaneda AE, 2011, EUR PSYCHIAT, V26, P346, DOI 10.1016/j.eurpsy.2009.11.006; Castaneda AE, 2008, J AFFECT DISORDERS, V106, P1, DOI 10.1016/j.jad.2007.06.006; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; Foskett RL, 2018, J SCI MED SPORT, V21, P765, DOI 10.1016/j.jsams.2017.11.016; Fujii Y, 2013, NEUROSCI LETT, V543, P42, DOI 10.1016/j.neulet.2013.02.059; Gouttebarge V, 2015, OCCUP MED-OXFORD, V65, P190, DOI 10.1093/occmed/kqu202; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Gulliver A, 2015, J SCI MED SPORT, V18, P255, DOI 10.1016/j.jsams.2014.04.006; Hixson KM, 2017, J SPORT REHABIL, V26, P588, DOI 10.1123/jsr.2016-0122; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kontos A.P., 2018, CONCUSSION CLIN PROF, P59, DOI DOI 10.1037/0000087-004; Leonard K, 2019, EUR PSYCHIAT, V56, P1, DOI 10.1016/j.eurpsy.2018.10.008; Ludewig S, 2003, J AFFECT DISORDERS, V76, P183, DOI 10.1016/S0165-0327(02)00089-7; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McNally RJ, 2006, TRENDS COGN SCI, V10, P271, DOI 10.1016/j.tics.2006.04.007; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Neal TL, 2015, J ATHL TRAINING, V50, P231, DOI 10.4085/1062-6050-50.3.03; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; O'Toole MS, 2011, NORD J PSYCHIAT, V65, P147, DOI 10.3109/08039488.2011.565801; Polak AR, 2012, J AFFECT DISORDERS, V141, P11, DOI 10.1016/j.jad.2012.01.001; Reardon CL, 2010, SPORTS MED, V40, P961, DOI 10.2165/11536580-000000000-00000; Rice SM, 2016, SPORTS MED, V46, P1333, DOI 10.1007/s40279-016-0492-2; Shin NY, 2014, PSYCHOL MED, V44, P1121, DOI 10.1017/S0033291713001803; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Tempesta D, 2013, PROG NEURO-PSYCHOPH, V45, P236, DOI 10.1016/j.pnpbp.2013.06.006; Toren P, 2000, J ANXIETY DISORD, V14, P239, DOI 10.1016/S0887-6185(99)00036-5; Vytal KE, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00093; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wood RL, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/HTR.0b013e31827eabba; World Health Organization, 2004, ICD 10 INT STAT CLAS; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	45	1	1	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 15	2020	37	24					2632	2638		10.1089/neu.2020.7079		SEP 2020	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PF0CR	WOS:000575391600001	32772792				2022-02-06	
J	Hirsch, Y; Geraghty, JR; Katz, EA; Testai, FD				Hirsch, Yonatan; Geraghty, Joseph R.; Katz, Eitan A.; Testai, Fernando D.			Inflammasome Caspase-1 Activity is Elevated in Cerebrospinal Fluid After Aneurysmal Subarachnoid Hemorrhage and Predicts Functional Outcome	NEUROCRITICAL CARE			English	Article						Subarachnoid hemorrhage; Inflammasome; Caspase-1; Neuroinflammation; Cerebrospinal fluid; Functional outcome	TRAUMATIC BRAIN-INJURY; CEREBRAL VASOSPASM; BIOMARKERS; ACTIVATION; PROTEINS; SCALE	Background/Objective Subarachnoid hemorrhage (SAH) is a devastating neurological injury, further complicated by few available methods to objectively predict outcomes. With the recent shift in focus to neuroinflammation as a potential cause of adverse outcomes following SAH, we investigated the inflammasome-derived enzyme, caspase-1, as a potential biomarker for poor functional outcome. Methods SAH patients were recruited from a regional stroke referral center. Cerebrospinal fluid (CSF) samples from 18 SAH subjects were collected via an external ventricular drain and obtained as close as possible to admission (within 72 h). For control subjects, we collected CSF from 9 patients undergoing lumbar puncture with normal CSF. Caspase-1 activity was measured using commercially available luminescence assays. SAH subjects were categorized at hospital discharge into those with good outcomes (Glasgow Outcome Scale, GOS, of 4-5) and poor outcomes (GOS of 1-3). Results CSF analysis demonstrated a nearly seven-fold increase in caspase-1 activity in SAH patients compared to controls (p < 0.0001). Within the SAH group, 10 patients (55.6%) had good outcomes and 8 patients (44.4%) had poor outcomes. Mean caspase-1 activity in the poor outcome group was approximately three-times higher than the good outcome group (p = 0.001). Caspase-1 activity was significantly correlated with GOS score (r = - 0.705,p = 0.001). Receiver operating characteristic curve analysis showed that caspase-1 activity can accurately differentiate between patients with good versus poor functional outcome (area under the curve 0.944,p = 0.002). Conclusions Inflammasome-derived caspase-1 activity is elevated in the CSF of SAH patients compared to controls and higher levels correlate with worse functional outcome.	[Hirsch, Yonatan; Geraghty, Joseph R.; Katz, Eitan A.; Testai, Fernando D.] Univ Illinois, Dept Neurol & Rehabil, Coll Med, 912 S Wood St Suite 174 N, Chicago, IL 60612 USA; [Geraghty, Joseph R.] Univ Illinois, Med Scientist Training Program, Chicago, IL USA		Geraghty, JR (corresponding author), Univ Illinois, Dept Neurol & Rehabil, Coll Med, 912 S Wood St Suite 174 N, Chicago, IL 60612 USA.	jgerag2@uic.edu			American Heart AssociationAmerican Heart Association; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1F31NS105525-01A1]	Mr. Hirsch received a Student Scholarship in Cerebrovascular Disease and Stroke from the American Heart Association. Mr. Geraghty receives grant support from the National Institute of Neurological Disorders and Stroke (Grant No. 1F31NS105525-01A1). Dr. Testai receives private donations from Louis and Christine Friedrich.	Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Akamatsu Y, 2020, J NEUROSCI RES, V98, P549, DOI 10.1002/jnr.24515; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bialer M, 2013, EPILEPSY RES, V103, P2, DOI 10.1016/j.eplepsyres.2012.10.001; Cahill J, 2009, STROKE, V40, pS86, DOI 10.1161/STROKEAHA.108.533315; Canesin G, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00066; Chaudhry SR, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072035; Chen JM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16851-z; Chen S, 2018, TRANSL STROKE RES, V9, P555, DOI 10.1007/s12975-018-0666-3; Manoel ALD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00292; Di Napoli M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01921; Dinarello CA, 2013, SEMIN IMMUNOL, V25, P469, DOI 10.1016/j.smim.2013.10.008; Fang YJ, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00068; Flores J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06449-x; Freeman LC, 2016, J NEUROCHEM, V136, P29, DOI 10.1111/jnc.13217; Geraghty JR, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.105027; Geraghty JR, 2019, NEUROCRIT CARE, V31, P373, DOI 10.1007/s12028-019-00710-x; Geraghty JR, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0690-x; Golanov EV, 2018, J CEREBR BLOOD F MET, V38, P793, DOI 10.1177/0271678X17701157; Goulay R, 2017, STROKE, V48, P2301, DOI 10.1161/STROKEAHA.117.017014; Hoffman HM, 2010, CURR ALLERGY ASTHM R, V10, P229, DOI 10.1007/s11882-010-0109-z; Hong CM, 2014, BIOMARKERS, V19, P95, DOI 10.3109/1354750X.2014.881418; Iliff Jeffrey J, 2012, Sci Transl Med, V4, p147ra111, DOI 10.1126/scitranslmed.3003748; Jaja BNR, 2013, NEUROCRIT CARE, V18, P143, DOI 10.1007/s12028-012-9792-z; Jo EK, 2016, CELL MOL IMMUNOL, V13, P148, DOI 10.1038/cmi.2015.95; Kapapa T, 2013, WORLD NEUROSURG, V80, P853, DOI 10.1016/j.wneu.2012.08.021; Kerr N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210128; Lackner P, 2010, STROKE, V41, P2353, DOI 10.1161/STROKEAHA.110.584995; Lantigua H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1036-0; Lattanzi S, 2020, NEUROTHERAPEUTICS, V17, P484, DOI 10.1007/s13311-020-00839-0; Lattanzi S, 2017, ONCOTARGET, V8, P57489, DOI 10.18632/oncotarget.15423; Lu J, 2008, J NEUROTRAUM, V25, P641, DOI 10.1089/neu.2007.0510; Lucke-Wold BP, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040497; Luo C, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.63; Macdonald RL, 2011, LANCET NEUROL, V10, P618, DOI 10.1016/S1474-4422(11)70108-9; Maestrini I, 2020, NEUROLOGY, V95, pE97, DOI 10.1212/WNL.0000000000009179; Maragkos GA, 2019, WORLD NEUROSURG, V121, pE500, DOI 10.1016/j.wneu.2018.09.148; Maslanik T, 2013, BRAIN BEHAV IMMUN, V28, P54, DOI 10.1016/j.bbi.2012.10.014; McKenzie BA, 2018, P NATL ACAD SCI USA, V115, pE6065, DOI 10.1073/pnas.1722041115; Monteleone M, 2015, CYTOKINE, V74, P213, DOI 10.1016/j.cyto.2015.03.022; Nadkarni NA, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2019.104605; Nowarski R, 2015, CELL, V163, P1444, DOI 10.1016/j.cell.2015.10.072; O'Brien M, 2017, J IMMUNOL METHODS, V447, P1, DOI 10.1016/j.jim.2017.03.004; Perez-Barcena J, 2021, J NEUROSURG, V134, P1644, DOI 10.3171/2020.2.JNS193079; Pu TL, 2019, EXP NEUROBIOL, V28, P104, DOI 10.5607/en.2019.28.1.104; Pyne-Geithman GJ, 2005, J CEREBR BLOOD F MET, V25, P1070, DOI 10.1038/sj.jcbfm.9600101; Reiter CR, 2020, NEUROCHEM RES, V45, P620, DOI 10.1007/s11064-019-02913-2; Vaccari JPD, 2016, J NEUROCHEM, V136, P39, DOI 10.1111/jnc.13036; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Vertex P, 2011, VERTEX ANNOUNCES COM; Wu Q, 2016, WORLD NEUROSURG, V94, P472, DOI 10.1016/j.wneu.2016.07.039; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; Yong-Lin L, 2020, INT J HYPERTENS, V2020, P1; Zahid A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02538	57	1	1	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2021	34	3					889	898		10.1007/s12028-020-01113-z		SEP 2020	10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN4OZ	WOS:000573752900001	32996055				2022-02-06	
J	Pandit, VA; Sharma, RK; Bhaskar, S; Kindra, AS; Choudhary, A; Gupta, LN				Pandit, Vir Abhimanyu; Sharma, Rajesh Kumar; Bhaskar, Suryanarayanan; Kindra, Amanjeet Singh; Choudhary, Ajay; Gupta, L. N.			A Randomised Interventional Study to Compare Autologous and Nonautologous Dural Substitutes Among Traumatic Brain Injury (TBI) Patients	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						dural substitutes; galea-pericranium; traumatic brain injury	DECOMPRESSIVE CRANIECTOMY; DURAPLASTY; GRAFT; RATES	Objectives To determine and compare the effectiveness and safety of galea-pericranium autologous dural graft with nonautologous polypropylene (G-patch) dural substitute among traumatic brain injury (TBI) patients. Methods A prospective interventional randomized comparative study was conducted at the Department of Neurosurgery from November 2013 to March 2015 after obtaining approval from the Institutional Ethical Committee. The study population included 50 cases of TBI which were divided into two groups of 25 each by the randomization technique and were treated either with autologous duraplasty (galea-pericranium) or nonautologous polypropylene (G-patch) dural substitute. The outcomes measured were time to duraplasty, blood loss, hospital stay, and the incidence of complications with the two techniques. The data were entered in a MS Excel spreadsheet and analysis was done using Statistical Package for Social Sciences (SPSS) version 21.0. A p value of < 0.05 was considered statistically significant. Results The average time to harvest galea-pericranium was 5 minutes. Compared with the patients undergoing G-patch, the patients in group pericranium had comparable duraplasty time (minutes) (34.32 vs. 27.80, p = 0.44), significantly lower drain output (54.8 vs. 74.5, p = 0.017), comparable blood loss (322 vs. 308, p = 0.545), comparable blood transfusion (24% vs. 16%, p = 0.48), significantly lesser duration of hospital stay (8.6 vs. 10.44, p = 0.028), comparable wound infection (8% vs. 16%, p = 0.384), and comparable cerebrospinal fluid (CSF) leak (0% vs. 8%, p = 0.149). Conclusion The study showed that galea-pericranium and polypropylene dural patch are equally effective and safe dural substitutes in providing a dural seal to minimize the CSF leaks and infections among posttraumatic brain injury patients.	[Pandit, Vir Abhimanyu] Narayan Med Coll & Hosp, Dept Neurosurg, Rohtas, Bihar, India; [Sharma, Rajesh Kumar; Choudhary, Ajay; Gupta, L. N.] Atal Bihari Vajpayee Inst Med Sci ABVIMS, Dept Neurosurg, Dr RML Hosp, PGIMER, New Delhi 110001, India; [Bhaskar, Suryanarayanan] All Indian Inst Med Sci AIIMS, Dept Neurosurg, Jodhpur, Rajasthan, India; [Kindra, Amanjeet Singh] Shah Neuro & Trauma Ctr Kaithal, Kaithal, Haryana, India		Sharma, RK (corresponding author), Atal Bihari Vajpayee Inst Med Sci ABVIMS, Dept Neurosurg, Dr RML Hosp, PGIMER, New Delhi 110001, India.	drsrk22@gmail.com					Ammar A S, 2016, MENOUFIA MED J, V29, P637; Azzam D, 2018, WORLD NEUROSURG, V113, P244, DOI 10.1016/j.wneu.2018.01.115; Bangash M, 2016, INT J CONT MED RES, V3, P1522; Bonda DJ, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.5.FOCUS15126; Centonze Roberto, 2016, Asian J Neurosurg, V11, P201, DOI 10.4103/1793-5482.179645; Ha B, 2016, NERVE, V2, P22; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Kamalabai RP, 2018, WORLD NEUROSURG, V111, pE105, DOI 10.1016/j.wneu.2017.12.005; Kharal IA, 2017, PAKISTAN J NEUROLOGI, V21; Kinaci A, 2018, WORLD NEUROSURG, V118, P368, DOI 10.1016/j.wneu.2018.06.196; Kizmazoglu C, 2019, J KOREAN NEUROSURG S, V62, P635, DOI 10.3340/jkns.2019.0122; Malliti M, 2004, NEUROSURGERY, V54, P599, DOI 10.1227/01.NEU.0000108640.45371.1A; Pogorielov M, 2017, J MATER SCI-MATER M, V28, DOI 10.1007/s10856-017-5845-3; Sabatino G, 2014, CLIN NEUROL NEUROSUR, V116, P20, DOI 10.1016/j.clineuro.2013.11.010; Sinha S, 2015, NEUROL INDIA, V63, P175, DOI 10.4103/0028-3886.156277; Stendel R, 2008, J NEUROSURG, V109, P215, DOI 10.3171/JNS/2008/109/8/0215; Sun HT, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.907; Turchan A, 2018, J CLIN NEUROSCI, V50, P272, DOI 10.1016/j.jocn.2018.01.069; Zhang GL, 2010, CHIN J TRAUMATOL, V13, P259, DOI 10.3760/cma.j.issn.1008-1275.2010.05.001	19	1	1	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2021	18	01					26	31		10.1055/s-0040-1717216		SEP 2020	6	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RL6LW	WOS:000573521900001		hybrid			2022-02-06	
J	Wright, MJ; Monti, MM; Lutkenhoff, ES; Hardy, DJ; Litvin, PY; Kelly, DF; Guskiewicz, K; Cantu, RC; Vespa, PM; Hovda, DA; Lopez, WD; Wang, CA; Swerdloff, R; Fuster, JM				Wright, Matthew J.; Monti, Martin M.; Lutkenhoff, Evan S.; Hardy, David J.; Litvin, Pavel Y.; Kelly, Daniel F.; Guskiewicz, Kevin; Cantu, Robert C.; Vespa, Paul M.; Hovda, David A.; Lopez, Walter D.; Wang, Christina; Swerdloff, Ronald; Fuster, Joaquin M.			Memory in repeat sports-related concussive injury and single-impact traumatic brain injury	BRAIN INJURY			English	Article						Concussion; traumatic brain injury; memory; sport	WHITE-MATTER INTEGRITY; CLOSED-HEAD INJURY; VERBAL MEMORY; HIPPOCAMPAL; MECHANISMS; RETRIEVAL; PATHOLOGY; COGNITION; RECOVERY; DEFICITS	Background:Repeat sports-related concussive/subconcussive injury (RC/SCI) is related to memory impairment. Objective & Methods: We sought to determine memory differences between persons with RC/SCI, moderate-to-severe single-impact traumatic brain injury (SI-TBI), and healthy controls. MRI scans from a subsample of participants with SI-TBI were used to identify the neuroanatomical correlates of observed memory process differences between the brain injury groups. Results: Both brain injury groups evidenced worse learning and recall in contrast to controls, although SI-TBI group had poorer memory than the RC/SCI group. Regarding memory process differences, in contrast to controls, the SI-TBI group evidenced difficulties with encoding, consolidation, and retrieval, while the RC/SCI group showed deficits in consolidation and retrieval. Delayed recall was predicted by encoding, with consolidation as a secondary predictor in the SI-TBI group. In the RC/SCI group, delayed recall was only predicted by consolidation. MRI data showed that the consolidation index we used mapped onto hippocampal atrophy. Conclusions: RC/SCI is primarily associated with consolidation deficits, which differs from SI-TBI. Given the role of the hippocampus in memory consolidation and the fact that hyperphosphorylated tau tends to accumulate in the medial temporal lobe in RC/SCI, consolidation deficits may be a cognitive marker of chronic traumatic encephalopathy in athletes.	[Wright, Matthew J.; Litvin, Pavel Y.; Lopez, Walter D.; Wang, Christina; Swerdloff, Ronald] Harbor UCLA Med Ctr, Lundquist Inst, Torrance, CA 90509 USA; [Wright, Matthew J.; Hardy, David J.; Fuster, Joaquin M.] Univ Calif Los Angeles, Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA USA; [Monti, Martin M.; Lutkenhoff, Evan S.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Monti, Martin M.; Lutkenhoff, Evan S.; Vespa, Paul M.; Hovda, David A.] Univ Calif Los Angeles, Sch Med, Dept Neurosurg, Los Angeles, CA USA; [Hardy, David J.] Loyola Marymount Univ, Dept Psychol, Los Angeles, CA 90045 USA; [Kelly, Daniel F.] John Wayne Canc Inst, St Johns Hlth Ctr, Brain Tumor Ctr, Dept Neurosurg, Santa Monica, CA USA; [Kelly, Daniel F.] John Wayne Canc Inst, St Johns Hlth Ctr, Pituitary Disorders Program, Santa Monica, CA USA; [Guskiewicz, Kevin] Univ N Carolina, Ctr Study Retired Athletes, Dept Exercise & Sports Sci, Chapel Hill, NC 27515 USA; [Cantu, Robert C.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Vespa, Paul M.] Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90024 USA		Wright, MJ (corresponding author), Harbor UCLA, Lundquist Inst, Torrance, CA 90502 USA.	mwright@lundquist.org			National Operating Committee on Standards for Athletic Equipment; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR 19975]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS049471, NS02089]; California State Neurotrauma Initiative; Los Angeles Biomedical Research InstituteUniversity of California System	This research was supported by National Operating Committee on Standards for Athletic Equipment, the National Center for Research Resources (M01 RR 19975), the National Institutes of Health (NS049471 & NS02089), the California State Neurotrauma Initiative, and the Los Angeles Biomedical Research Institute.	Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Brooks BL, 2011, LITTLE BLACK BOOK NE; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Buffalo EA, 1998, HIPPOCAMPUS, V8, P330, DOI 10.1002/(SICI)1098-1063(1998)8:4<330::AID-HIPO3>3.0.CO;2-L; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Clark MD, 2018, RADIOLOGY, V286, P975, DOI 10.1148/radiol.2017170539; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Delis D.C., 2000, CALIFORNIA VERBAL LE; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Dolan RJ, 1999, HIPPOCAMPUS, V9, P25, DOI 10.1002/(SICI)1098-1063(1999)9:1<25::AID-HIPO3>3.3.CO;2-W; Fitzpatrick J, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967116675272; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Habib R, 2003, TRENDS COGN SCI, V7, P241, DOI 10.1016/S1364-6613(03)00110-4; Hillary FG, 2003, J CLIN EXP NEUROPSYC, V25, P49, DOI 10.1076/jcen.25.1.49.13631; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lengenfelder J, 2007, REHABIL PSYCHOL, V52, P290, DOI 10.1037/0090-5550.52.3.290; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lutkenhoff ES, 2015, ANN NEUROL, V78, P68, DOI 10.1002/ana.24423; Mannino C, 2018, J NEUROSCI RES, V96, P696, DOI 10.1002/jnr.24097; Martin RM, 2017, J NEUROSURG, V126, P796, DOI 10.3171/2016.3.JNS151781; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, DOI 10.1093/brain/awt051; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Meyers JE, 2009, APPL NEUROPSYCHOL, V16, P237, DOI 10.1080/09084280903098752; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; NIELSENBOHLMAN L, 1994, NEUROREPORT, V5, P1517, DOI 10.1097/00001756-199407000-00027; Nyberg L, 2002, COGNITIVE BRAIN RES, V13, P281, DOI 10.1016/S0926-6410(02)00052-6; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; REDWOOD E, 2016, J CLIN ONCOL S, V34; Richardson MP, 2003, NEUROIMAGE, V20, pS112, DOI 10.1016/j.neuroimage.2003.09.008; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Strange BA, 2002, J NEUROSCI, V22, P523, DOI 10.1523/JNEUROSCI.22-02-00523.2002; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Tayim FM, 2016, J CLIN EXP NEUROPSYC, V38, P1005, DOI 10.1080/13803395.2016.1182968; Tulving E, 1997, CURR OPIN NEUROBIOL, V7, P209, DOI 10.1016/S0959-4388(97)80009-8; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Vingerhoets G, 2006, EPILEPSY BEHAV, V8, P422, DOI 10.1016/j.yebeh.2005.11.013; Williamson DJG, 1996, NEUROPSYCHOLOGY CLIN; Wright MJ, 2013, BRAIN IMAGING BEHAV, V7, P307, DOI 10.1007/s11682-013-9231-6; Wright MJ, 2011, J HEAD TRAUMA REHAB, V26, P182, DOI 10.1097/HTR.0b013e318218dcf9; Wright MJ, 2010, J CLIN EXP NEUROPSYC, V32, P728, DOI 10.1080/13803390903512652; Wright MJ, 2009, J CLIN EXP NEUROPSYC, V31, P790, DOI 10.1080/13803390802508918; Wright MJ, 2011, WORKING MEMORY CAPAC; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110	51	1	1	5	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 14	2020	34	12					1666	1673		10.1080/02699052.2020.1825806		SEP 2020	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OU7LB	WOS:000573318100001	32990043				2022-02-06	
J	Zahedi, H; Hosseinzadeh-Attar, MJ; Sahebkar, A; Ranjbar, SH; Najafi, A; Hosseini, S; Qorbani, M; Ahmadi, A; Ardehali, SH; Moravvej, H; Pourmand, G; Norouzy, A; Shadnoush, M				Zahedi, Hoda; Hosseinzadeh-Attar, Mohammad-Javad; Sahebkar, Amirhossein; Ranjbar, Shirin Hasani; Najafi, Atabak; Hosseini, Saeed; Qorbani, Mostafa; Ahmadi, Arezoo; Ardehali, Seyed Hossein; Moravvej, Hamideh; Pourmand, Gholamreza; Norouzy, Abdolreza; Shadnoush, Mahdi			Therapeutic effects of supplementation with Curcuminoids in critically ill patients receiving enteral nutrition: a randomized controlled trial protocol	JOURNAL OF DIABETES AND METABOLIC DISORDERS			English	Article						Clinical trial protocol; Intensive care unit; Curcumin	TRAUMATIC BRAIN-INJURY; OSTEOARTHRITIS; INFLAMMATION; ANTIOXIDANT; STRESS	Background Curcuminoids are dietary polyphenols that can improve health indices through different mechanisms such as anti-inflammatory, antioxidant and immunoregulatory properties. Due to the lack of evidences on the efficacy of curcuminoids in critically ill patients, this study was designed to investigate the effects of short-term curcuminoids supplementation on inflammatory, oxidative stress and adipokine indices as well as nutritional and clinical status in Traumatic Brain Injury (TBI) patients admitted in the Intensive Care Unit (ICU). Methods The present trial will be performed in the ICU of Sina and Shohadaye Tajrish hospitals of Tehran, Iran. Sixty-two critically ill patients with TBI will be enrolled based on the eligibility criteria. The patients will be randomly assigned into two groups. For 7 days, they will received either 500 mg curcuminoids in combination with 5 mg piperine or matched placebo. A general questionnaire, consent form as well as NUTRIC, SOFA and APACHEII scoring system and anthropometrics will be assessed at baseline. The inflammatory markers including TNF-alpha, IL-6, MCP-1 and CRP, oxidative stress indices (GPx and SOD) and adipokines (leptin and adiponetctin) will be measured at baseline and at the end of the study. In addition, dietary intake, concomitant drugs and laboratory tests will be recorded daily. Discussion To the best of our knowledge, this is the first clinical trial investigating the effect of curcuminoids supplementation in critically ill patient with TBI. The findings of the present study will provide evidence on the efficacy and safety of curcuminoids in these patients.	[Zahedi, Hoda; Hosseinzadeh-Attar, Mohammad-Javad; Hosseini, Saeed; Norouzy, Abdolreza] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Clin Nutr, 44 Hojjat Dost Alley,Naderi St,Keshavarz Blvd, Tehran, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran; [Ranjbar, Shirin Hasani] Univ Tehran Med Sci, Obes & Eating Habits Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran; [Ranjbar, Shirin Hasani] Thran Univ Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran; [Najafi, Atabak; Ahmadi, Arezoo] Univ Tehran Med Sci, Sina Hosp, Dept Anesthesiol & Crit Care Med, Fac Med, Tehran, Iran; [Qorbani, Mostafa] Alborz Univ Med Sci, Noncommunicable Dis Res Ctr, Karaj, Iran; [Ardehali, Seyed Hossein] Shahid Beheshti Univ Med Sci, Dept Anesthesiol & Crit Care, Shohadaye Tajrish Hosp, Tehran, Iran; [Moravvej, Hamideh] Shahid Beheshti Univ Med Sci, Skin Res Ctr, Tehran, Iran; [Pourmand, Gholamreza] Univ Tehran Med Sci, Urol Res Ctr, Tehran, Iran; [Shadnoush, Mahdi] Semnan Univ Med Sci, Fac Med, Semnan, Iran; [Shadnoush, Mahdi] Shahid Beheshti Univ Med Sci, Fac Nutr & Food Technol, Dept Clin Nutr, Velenjak St,Shahid Chamran High Way, Tehran, Iran		Norouzy, A (corresponding author), Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Clin Nutr, 44 Hojjat Dost Alley,Naderi St,Keshavarz Blvd, Tehran, Iran.; Shadnoush, M (corresponding author), Semnan Univ Med Sci, Fac Med, Semnan, Iran.; Shadnoush, M (corresponding author), Shahid Beheshti Univ Med Sci, Fac Nutr & Food Technol, Dept Clin Nutr, Velenjak St,Shahid Chamran High Way, Tehran, Iran.	arnorouzy@sina.tums.ac.ir; mshadnoush@gmail.com	Zahedi, Hoda/AAO-9339-2021; Shadnoush/U-5147-2017; Sahebkar, Amirhossein/B-5124-2018; moravvej, hamideh/AAU-5072-2021	Zahedi, Hoda/0000-0003-4431-7459; Shadnoush/0000-0002-3716-0994; 	Tehran University of Medical SciencesTehran University of Medical Sciences; Semnan University of Medical sciences and Health Services [96-04-161-37823]	The present research has been supported by Tehran University of Medical Sciences and Semnan University of Medical sciences and Health Services grant no. 96-04-161-37823.	Aggarwal B. B., 2013, British Journal of Pharmacology, V169, P1672, DOI 10.1111/bph.12131; Basnet P, 2011, MOLECULES, V16, P4567, DOI 10.3390/molecules16064567; Calabrese V, 2008, MOL NUTR FOOD RES, V52, P1062, DOI 10.1002/mnfr.200700316; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Deguchi A, 2015, ENDOCR METAB IMMUNE, V15, P88, DOI 10.2174/1871530315666150316120458; Fakharian E, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.23869; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Goel A, 2008, MOL NUTR FOOD RES, V52, P1010, DOI 10.1002/mnfr.200700354; Gupta SC, 2013, BIOFACTORS, V39, P2, DOI 10.1002/biof.1079; Heyland DK, 2011, CRIT CARE, V15, DOI 10.1186/cc10546; Liu XQ, 2018, BRIT J SPORT MED, V52, P167, DOI 10.1136/bjsports-2016-097333; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Motterlini R, 2000, FREE RADICAL BIO MED, V28, P1303, DOI 10.1016/S0891-5849(00)00294-X; Panahi Y, 2016, NUTRITION, V32, P1116, DOI 10.1016/j.nut.2016.03.018; Panahi Y, 2015, CLIN NUTR, V34, P1101, DOI 10.1016/j.clnu.2014.12.019; Panahi Yunes, 2016, Journal of Dietary Supplements, V13, P209, DOI 10.3109/19390211.2015.1008611; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Polinder S, 2007, B WORLD HEALTH ORGAN, V85, P27, DOI 10.2471/BLT.06.030973; Rahimnia AR, 2015, DRUG RES, V65, P521, DOI 10.1055/s-0034-1384536; Rahmani S, 2016, PHYTOTHER RES, V30, P1540, DOI 10.1002/ptr.5659; Raj R, 2014, CRIT CARE, V18, DOI 10.1186/cc13814; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sahebkar A, 2014, NAT REV CARDIOL, V11, P12, DOI 10.1038/nrcardio.2013.139-c1; Young LA, 2015, SEMIN NEUROL, V35, P5, DOI 10.1055/s-0035-1544242	25	1	1	0	2	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND		2251-6581		J DIABETES METAB DIS	J. Diabetes Metab. Disord.	DEC	2020	19	2					1609	1614		10.1007/s40200-019-00451-w		SEP 2020	6	Endocrinology & Metabolism	Emerging Sources Citation Index (ESCI)	Endocrinology & Metabolism	QC8UX	WOS:000574338100001	33553039	Green Published, Bronze			2022-02-06	
J	Li, T; Hu, E; Li, PF; Yang, ZY; Wu, Y; Ding, RQ; Zhu, XF; Tang, T; Wang, Y				Li, Teng; Hu, En; Li, Pengfei; Yang, Zhaoyu; Wu, Yao; Ding, Ruoqi; Zhu, Xiaofei; Tang, Tao; Wang, Yang			Metabolomics Deciphers Potential Targets of Xuefu Zhuyu Decoction Against Traumatic Brain Injury in Rat	FRONTIERS IN PHARMACOLOGY			English	Article						metabolomics; traumatic brain injury; Xuefu Zhuyu decoction; neuroprotective effects; traditional Chinese medicine	ROLES; ACID	Xuefu Zhuyu decoction (XFZYD) performs multiple functions for traumatic brain injury (TBI) treatment. However, its clinical application is limited by the incomplete exploration of targets and inadequate discussion of mechanisms. We aimed to investigate the metabolic alterations of XFZYD in acute and chronic stages of TBI. Sprague-Dawley rats were randomly divided into the sham, controlled cortical impact (CCI) and XFZYD group. Behavioral and histopathological tests were used to evaluate the neuroprotective effects. Coagulation assays were performed to assess safety. Moreover, we analyzed the metabolomic profiling of hippocampal samples with different time intervals after CCI by high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). Differential metabolites were screened by multivariate data analysis. To further uncover the association between candidate metabolites and biological interaction networks, we applied bioinformatics analysis using MetaboAnalyst 4.0, STITCH 5.0 and TCMSP. The potential mechanism was verified by ELISA and Western blot. XFZYD ameliorated neurological deficiencies post-CCI without impairing blood coagulation in the rat's model. Seventeen and fourteen metabolites were filtered on d 3 and 21, respectively. Eleven of potential metabolites were common at these time points, involving two significant pathways (arginine and proline metabolism, phenylalanine, tyrosine and tryptophan biosynthesis). Gamma-aminobutyric acid (GABA) and the related pathways were specifically affected by XFZYD at the acute phase of TBI, while biosynthesis of amino acids was the major pathway influenced at the chronic phase. This study provides broad insights into the therapeutic effects of XFZYD in treating TBI through the whole phases.	[Li, Teng; Hu, En; Yang, Zhaoyu; Wu, Yao; Ding, Ruoqi; Zhu, Xiaofei; Tang, Tao; Wang, Yang] Cent South Univ, Xiangya Hosp, Inst Integrat Med, Dept Integrated Tradit Chinese & Western Med, Changsha, Peoples R China; [Li, Pengfei] Zhengzhou Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Zhengzhou, Peoples R China		Wang, Y (corresponding author), Cent South Univ, Xiangya Hosp, Inst Integrat Med, Dept Integrated Tradit Chinese & Western Med, Changsha, Peoples R China.	wangyang_xy87@csu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81673719, 81973665]; Hunan Provincial Natural Science Foundation of ChinaNatural Science Foundation of Hunan Province [2019JJ30042]; Innovation-Driven Project of Central South University [2020CX047]	This work was supported by the National Natural Science Foundation of China (No. 81673719 and No. 81973665), Hunan Provincial Natural Science Foundation of China (No. 2019JJ30042) and Innovation-Driven Project of Central South University (No. 2020CX047).	Amorini AM, 2017, J CELL MOL MED, V21, P530, DOI 10.1111/jcmm.12998; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Brown AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186656; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Chen YY, 2019, J PHARM ANAL, V9, P312, DOI 10.1016/j.jpha.2019.05.005; Costa ED, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00206; Covarrubias-Pinto A, 2015, INT J MOL SCI, V16, P28194, DOI 10.3390/ijms161226095; Dauncey MJ, 2014, EUR J CLIN NUTR, V68, P1179, DOI 10.1038/ejcn.2014.173; Durham WJ, 2017, J NEUROTRAUM, V34, P385, DOI 10.1089/neu.2015.4350; Feng DD, 2017, ONCOTARGET, V8, P94692, DOI 10.18632/oncotarget.21876; Fernstrom JD, 2007, J NUTR, V137, p1539S, DOI 10.1093/jn/137.6.1539S; Fu CY, 2019, J ETHNOPHARMACOL, V245, DOI 10.1016/j.jep.2019.112149; Fung FY, 2017, PHYTOMEDICINE, V32, P88, DOI 10.1016/j.phymed.2017.04.004; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; Han YQ, 2016, J PHARMACEUT BIOMED, V129, P339, DOI 10.1016/j.jpba.2016.07.021; Hartings JA, 2020, JAMA NEUROL, V77, P489, DOI 10.1001/jamaneurol.2019.4476; He XY, 2020, J ETHNOPHARMACOL, V254, DOI 10.1016/j.jep.2020.112717; Huang J, 2001, P NATL ACAD SCI USA, V98, P11720, DOI 10.1073/pnas.171325998; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Lan YL, 2019, AM J TRANSL RES, V11, P2616; Leiser SC, 2015, ACS CHEM NEUROSCI, V6, P970, DOI 10.1021/cn500340j; Li P, 2018, AMINO ACIDS, V50, P29, DOI 10.1007/s00726-017-2490-6; Li PF, 2019, INT J BIOL SCI, V15, P895, DOI 10.7150/ijbs.29744; Luo ML, 2019, NEUROCHEM RES, V44, P2765, DOI 10.1007/s11064-019-02897-z; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Madan S, 2018, MOL GENET METAB, V125, P112, DOI 10.1016/j.ymgme.2018.07.007; Mink R, 2007, BRAIN RES, V1147, P256, DOI 10.1016/j.brainres.2007.02.004; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; NISHIDA Y, 1991, J PHARM PHARMACOL, V43, P885, DOI 10.1111/j.2042-7158.1991.tb03204.x; Qian WJ, 2019, METABOLITES, V9, DOI 10.3390/metabo9010006; Rami H., 2018, J XIANGYA MED, V3, P25, DOI [10.21037/jxym.2018.05.01, DOI 10.21037/JXYM.2018.05.01]; Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13; Shen H, 2005, STROKE, V36, P654, DOI 10.1161/01.STR.0000155747.15679.04; Somayaji MR, 2018, CURR NEUROPHARMACOL, V16, P484, DOI 10.2174/1570159X15666170828165711; Sun M, 2008, CHIN J INTEGR MED, V14, P137, DOI 10.1007/s11655-008-0137-x; Tao TQ, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00985; Thau-Zuchman O, 2019, J NEUROTRAUM, V36, P25, DOI 10.1089/neu.2017.5579; Wang JJ, 2018, NEUROCHEM RES, V43, P1736, DOI 10.1007/s11064-018-2589-5; Wang M, 2017, CHEM-BIOL INTERACT, V273, P133, DOI 10.1016/j.cbi.2017.06.011; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Wang XJ, 2019, MASS SPECTROM REV, V38, P380, DOI 10.1002/mas.21589; Wesley UV, 2019, NEUROCHEM INT, V127, P113, DOI 10.1016/j.neuint.2019.01.025; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Yan H, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6353845; Yang B, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1076-2; Yang MX, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00158; Yoshikawa T, 2014, J NUTR, V144, P1637, DOI 10.3945/jn.114.196105; Zhang Q, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00165; Zhao YH, 2019, J ETHNOPHARMACOL, V241, DOI 10.1016/j.jep.2019.111908; Zheng F, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1520; Zhou J, 2017, ONCOTARGET, V8, P72069, DOI 10.18632/oncotarget.18895; Zhou SH, 2020, NEUROPEPTIDES, V81, DOI 10.1016/j.npep.2020.102006	53	1	1	12	22	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	SEP 25	2020	11								559618	10.3389/fphar.2020.559618			15	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	NY5ZH	WOS:000576466700001	33101022	gold, Green Published			2022-02-06	
J	Lv, K; Yuan, Q; Fu, PF; Wu, G; Wu, X; Du, ZY; Yu, J; Li, ZQ; Hu, J				Lv, Ke; Yuan, Qiang; Fu, Pengfei; Wu, Gang; Wu, Xing; Du, Zhuoying; Yu, Jian; Li, Zhiqi; Hu, Jin			Impact of fibrinogen level on the prognosis of patients with traumatic brain injury: a single-center analysis of 2570 patients	WORLD JOURNAL OF EMERGENCY SURGERY			English	Article						Traumatic brain injury; Fibrinogen; Coagulopathy; Mortality; Outcomes	HEMORRHAGIC PROGRESSION; COAGULOPATHY; COAGULATION; MANAGEMENT; DIAGNOSIS; PROTEIN; SUPPORT; MODEL	Background Fibrinogen may play an important role in the survival of trauma patients; however, its role in traumatic brain injury (TBI) and its correlation with disease prognosis remain poorly understood. The aims of this study were to determine the incidence of TBI-associated hypofibrinogenemia in patients with TBI and to evaluate the prognostic value of fibrinogen level with respect to mortality and clinical outcomes. Methods A total of 2570 consecutive TBI patients were retrospectively studied. Prognostic evaluations were determined using the Glasgow Outcome Score (GOS) assessment 3 months after injury. The shape of the relationship between fibrinogen level and mortality or outcome was examined using cubic spline functions. Logistic regression analyses were conducted to identify the association between fibrinogen level and 3-month functional outcomes. Results Fibrinogen concentrations < 2 g/L were observed in 992 (38.6%) patients at the time of admission. Multivariate analyses showed that for patients with fibrinogen levels < 2.0 g/L, those levels were an independent prognostic factor for 3-month mortality (odds ratio [OR], 0.91; 95% confidence interval [CI], 0.89-0.93;P< .001). By contrast, for patients with fibrinogen levels < 2.5 g/L, the levels were an independent prognostic factor for favorable outcomes at 3 months (OR, 1.654; 95% CI, 1.186-2.306;P= .003). Similar results were also seen for patients with fibrinogen levels > 3.0 g/L, with the levels being an independent prognostic factor for favorable outcomes at 3 months (OR, 0.771; 95% CI, 0.607-0.979;P= .033). Conclusions Fibrinogen is an independent prognostic factor for clinical outcomes in TBI patients. Maintaining the level of fibrinogen between 2.5 and 3 g/L may improve clinical outcomes in patients with TBI.	[Lv, Ke; Yuan, Qiang; Fu, Pengfei; Wu, Gang; Wu, Xing; Du, Zhuoying; Yu, Jian; Li, Zhiqi; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Middle Rd, Shanghai, Peoples R China		Hu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Middle Rd, Shanghai, Peoples R China.	hujindn@126.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81701206, 81471241, 81870968, 81671200]	The funding was provided by the National Natural Science Foundation of China (NSFC Grants 81701206 to Q.Y. and 81471241 to X.W.) and the National Natural Science Foundation of China (NSFC Grants 81870968 and 81671200 to J.H.).	Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Charbit B, 2007, J THROMB HAEMOST, V5, P266, DOI 10.1111/j.1538-7836.2007.02297.x; Corrado E, 2010, J ATHEROSCLER THROMB, V17, P1, DOI 10.5551/jat.2600; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; FAGON JY, 1993, INTENS CARE MED, V19, P137, DOI 10.1007/BF01720528; Fair K, 2019, J NEUROTRAUMA; Floccard B, 2012, INJURY, V43, P26, DOI 10.1016/j.injury.2010.11.003; Hagemo JS, 2014, CRIT CARE, V18, DOI 10.1186/cc13798; Hunt BJ, 1998, BRIT MED J, V316, P1328, DOI 10.1136/bmj.316.7141.1328; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Kiyohira Miwa, 2019, No Shinkei Geka, V47, P753, DOI 10.11477/mf.1436204019; Kobayashi T, 2001, SEMIN THROMB HEMOST, V27, P161, DOI 10.1055/s-2001-14076; Lissitchkov T, 2018, TRANSFUSION, V58, P413, DOI 10.1111/trf.14421; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Martini WZ, 2007, ANN SURG, V246, P831, DOI 10.1097/SLA.0b013e3180cc2e94; Martini WJZ, 2005, AM J PHYSIOL-ENDOC M, V289, pE930, DOI 10.1152/ajpendo.00137.2005; Merlini M, 2019, NEURON, V101, P1099, DOI 10.1016/j.neuron.2019.01.014; Roberts HR, 2006, SEMIN THROMB HEMOST, V32, P32, DOI 10.1055/s-2006-939552; Ryu JK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9164; Sarani B, 2008, CRIT CARE MED, V36, P1114, DOI 10.1097/CCM.0b013e318168f89d; Scheraga HA, 2004, BIOPHYS CHEM, V112, P117, DOI 10.1016/j.bpc.2004.07.011; Schlimp CJ, 2013, CRIT CARE, V17, DOI 10.1186/cc12816; SCHULTZ DR, 1990, SEMIN ARTHRITIS RHEU, V20, P129, DOI 10.1016/0049-0172(90)90055-K; Sorensen B, 2012, SEMIN THROMB HEMOST, V38, P268, DOI 10.1055/s-0032-1309287; Spahn DR, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2347-3; Spahn DR, 2016, SEMIN THROMB HEMOST, V42, P147, DOI 10.1055/s-0035-1564841; Stinger HK, 2008, J TRAUMA, V64, pS79, DOI 10.1097/TA.0b013e318160a57b; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089	31	1	1	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-7922			WORLD J EMERG SURG	World J. Emerg. Surg.	SEP 25	2020	15	1							54	10.1186/s13017-020-00332-1			9	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	NX3VZ	WOS:000575641100001	32977824	Green Submitted, gold, Green Published			2022-02-06	
J	Bernstein, JE; Ghanchi, H; Kashyap, S; Podkovik, S; Miulli, DE; Wacker, MR; Sweiss, R				Bernstein, Jacob E.; Ghanchi, Hammad; Kashyap, Samir; Podkovik, Stacey; Miulli, Dan E.; Wacker, Margaret Rose; Sweiss, Raed			Pentobarbital Coma With Therapeutic Hypothermia for Treatment of Refractory Intracranial Hypertension in Traumatic Brain Injury Patients: A Single Institution Experience	CUREUS			English	Article						pentobarbital; traumatic brain injury; hypothermia	DECOMPRESSIVE CRANIECTOMY; BARBITURATE COMA; MANAGEMENT; PRESSURE	Introduction Traumatic brain injury (TBI) results in primary and secondary brain injuries. Secondary brain injury can lead to cerebral edema resulting in increased intracranial pressure (ICP) secondary to the rigid encasement of the skull. Increased ICP leads to decreased cerebral perfusion pressure which leads to cerebral ischemia. Refractory intracranial hypertension (RICH) occurs when ICP remains elevated despite first-tier therapies such as head elevation, straightening of the neck, analgesia, sedation, paralytics, cerebrospinal fluid (CSF) drainage, mannitol and/or hypertonic saline administration. If unresponsive to these measures, second-tier therapies such as hypothermia, barbiturate infusion, and/or surgery are employed. Methods This was a retrospective review of patients admitted at Arrowhead Regional Medical Center from 2008 to 2019 for severe TBI who developed RICH requiring placement into a pentobarbital-induced coma with therapeutic hypothermia. Primary endpoints included mortality, good recovery which was designated al Glasgow outcome scale (GOS) of 4 or 5, and improvement in ICP (goal is <20 mmHg). Secondary endpoints included complications, length of intensive care unit (ICU) stay, length of hospital stay, length of pentobarbital coma, length of hypothermia, need for vasopressors, and decompressive surgery versus no decompressive surgery. Results Our study included 18 patients placed in pentobarbital coma with hypothermia for RICH. The overall mortality rate in our study was 50%; with 60% mortality in pentobarbital/hypothermia only group, and 46% mortality in surgery plus pentobarbital/hypothermia group. Maximum ICP prior to pentobarbital/hypothermia was significantly lower in patients who had a prior decompressive craniectomy than in patients who were placed into pentobarbital/hypothermia protocol first (28.3 vs 35.4, p<0.0238). ICP was significantly reduced at 4 hours, 8 hours, 12 hours, 24 hours, and 48 hours after pentobarbital and hypothermia treatment. Initial ICP and maximum ICP prior to pentobarbital/hypothermia was significantly correlated with mortality (p=0.022 and p=0.026). Patients with an ICP>25 mmHg prior to pentobarbital/hypothermia initiation had an increased risk of mortality (p=0.0455). There was no statistically significant difference in mean ICP after 24 hours after pentobarbital/hypothermia protocol in survivors vs non-survivors. Increased time to reach 33 degrees C was associated with increased mortality (r=0.47, p=0.047); with a 10.5-fold increase in mortality for >7 hours (OR 10.5, p=0.039). Conclusion Prolonged cooling time >7 hours was associated with a 10.5-fold increase in mortality and ICP>25 mmHg prior to initiation of pentobarbital and hypothermia is suggestive of a poor response to treatment. We recommend patients with severe TBI who develop RICH should first undergo a 12 x 15 cm decompressive hemicraniectomy because they have better survival and are more likely to have ICP <25 mmHg as the highest elevation of ICP if the ICP were to become and stay elevated again. Pentobarbital and hypothermia should be initiated if the ICP becomes elevated and sustained above 20 mmHg with a prior decompressive hemicraniectomy and refractory to other medical therapies. However, our data suggests that patients are unlikely to survive if there ICP does not decrease to less than 15mmHg at 8 and 12 hours after pentobarbital/hypothermia and remain less than 20 mmHg within first 48 hours.	[Bernstein, Jacob E.; Ghanchi, Hammad; Kashyap, Samir; Podkovik, Stacey] Riverside Univ, Hlth Syst Med Ctr, Neurosurg, Moreno Valley, CA 92555 USA; [Miulli, Dan E.; Wacker, Margaret Rose] Arrowhead Reg Med Ctr, Neurosurg, Colton, CA USA; [Sweiss, Raed] Riverside Univ, Hlth Syst Med Ctr, Neurol Surg, Moreno Valley, CA USA		Bernstein, JE (corresponding author), Riverside Univ, Hlth Syst Med Ctr, Neurosurg, Moreno Valley, CA 92555 USA.	jacobebernstein@gmail.com					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Eskandari R, 2013, J NEUROSURG, V119, P338, DOI 10.3171/2013.4.JNS121541; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Iida K, 2003, J NEUROSURG, V98, P793, DOI 10.3171/jns.2003.98.4.0793; Kim YI, 2008, J KOREAN NEUROSURG S, V44, P141, DOI 10.3340/jkns.2008.44.3.141; Marion DW, 2006, NEUROSURGERY, V58, P655; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marshall GT, 2010, J TRAUMA, V69, P275, DOI 10.1097/TA.0b013e3181de74c7; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; Vaity C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0804-1; Vincent JL, 2005, CRIT CARE MED, V33, P1392, DOI 10.1097/01.CCM.0000166890.93559.2D; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383	24	1	1	0	1	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	SEP 22	2020	12	9							e10591	10.7759/cureus.10591			10	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	NR6HD	WOS:000571662400011	33110727	Green Published, gold			2022-02-06	
J	Javdani, M; Ghorbani, R; Hashemnia, M				Javdani, Moosa; Ghorbani, Roya; Hashemnia, Mohammad			Histopathological Evaluation of Spinal Cord with Experimental Traumatic Injury Following Implantation of a Controlled Released Drug Delivery System of Chitosan Hydrogel Loaded with Selenium Nanoparticle	BIOLOGICAL TRACE ELEMENT RESEARCH			English	Article						SCI; Chitosan hydrogel; Selenium nanoparticle; Rat	ACIDIC PROTEIN GFAP; IN-VITRO; REGENERATION; INFLAMMATION; SCAFFOLDS; BRAIN; CELLS; AXON; CNS	The purpose of this study was to evaluate the neuroprotective effect of local implantation of a controlled delivery system of chitosan hydrogel loaded with selenium nanoparticles in rats with spinal cord injury (SCI). For this purpose, 60 adult female rats were randomly divided into three equal groups. In all three groups, SCI was induced by aneurysm clamping at the level of thoracic vertebrae under inhaled anesthesia with isoflurane. In one group after spinal cord injury, chitosan hydrogels loaded with selenium nanoparticles (treatment group), and in the other group, only chitosan hydrogels (positive control group) were placed at the site of injury. In the last group (negative control), no material was placed in the injury site. Hematoxylin-eosin and glial fibrillary acidic protein (GFAP) staining evaluated histological changes at the site of injury on days 3, 7, 21, and 28 after surgery. Evaluations show that hemorrhage and inflammation also have a marked decrease in inflammatory cells at different times in the treatment group. This decrease was also seen in the chitosan group but was less severe than in the treatment group. The formation of nerve fibers was also observed in the treatment group over time of injury. Immunohistochemical studies of damaged tissue showed higher expression of GFAP protein in the astrocytes of the treatment group than in the other two groups and the chitosan group compared with the negative control group. A controlled drug delivery system containing selenium nanoparticles seems to play a role in the protection of nerve cells through its anti-inflammatory effect.	[Javdani, Moosa; Ghorbani, Roya] Shahrekord Univ, Dept Clin Sci, Fac Vet Med, Shahrekord 115, Iran; [Hashemnia, Mohammad] Razi Univ, Dept Pathobiol, Fac Vet Med, Kermanshah, Iran		Javdani, M (corresponding author), Shahrekord Univ, Dept Clin Sci, Fac Vet Med, Shahrekord 115, Iran.	javdani59@gmail.com					Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Bach Leon A, 2004, Clin Biochem Rev, V25, P155; Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019; Brown K M, 2001, Public Health Nutr, V4, P593; Chedly J, 2017, BIOMATERIALS, V138, P91, DOI 10.1016/j.biomaterials.2017.05.024; Chen MQ, 2018, ADV THER-GERMANY, V1, DOI 10.1002/adtp.201800074; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fehlings MG, 2011, J NEUROTRAUM, V28, P1329, DOI 10.1089/neu.2011.1955; Furuike T, 2017, INT J BIOL MACROMOL, V104, P1620, DOI 10.1016/j.ijbiomac.2017.02.099; Gnavi S, 2013, INT REV NEUROBIOL, V109, P1, DOI 10.1016/B978-0-12-420045-6.00001-8; Heller RA, 2019, J TRACE ELEM MED BIO, V51, P141, DOI 10.1016/j.jtemb.2018.10.006; Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Holmes GM, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.113009; Horn KP, 2008, J NEUROSCI, V28, P9330, DOI 10.1523/JNEUROSCI.2488-08.2008; Javdani M, 2019, BIOL TRACE ELEM RES, V187, P202, DOI 10.1007/s12011-018-1371-5; Kizilay Z, 2017, J INSTANB FAC MED, V80, P138; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; Natarajan JV, 2014, J CONTROL RELEASE, V193, P122, DOI 10.1016/j.jconrel.2014.05.029; Nguyen T, 2017, NEURAL REGEN RES, V12, P1885, DOI 10.4103/1673-5374.219051; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Rao SY, 2019, J MATER CHEM B, V7, P2648, DOI 10.1039/c8tb02520g; Ren YJ, 2009, BIOMATERIALS, V30, P1036, DOI 10.1016/j.biomaterials.2008.10.028; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Ruppert KA, 2019, ROADMAP TO NONHEMATOPOIETIC STEM CELL-BASED THERAPEUTICS: FROM THE BENCH TO THE CLINIC, P321, DOI 10.1016/B978-0-12-811920-4.00013-6; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sun X, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0736-y; Tardy M, 1990, ADV EXPT MED BIOL, P41; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; Tian RJ, 2010, J NEUROPATH EXP NEUR, V69, P335, DOI 10.1097/NEN.0b013e3181d3cb52; Tinggi U, 2003, TOXICOL LETT, V137, P103, DOI 10.1016/S0378-4274(02)00384-3; Tykhomyrov AA, 2016, NEUROPHYSIOLOGY+, V48, P54, DOI 10.1007/s11062-016-9568-8; Verma Poonam, 2018, J Microsc Ultrastruct, V6, P182, DOI 10.4103/JMAU.JMAU_3_18; Yang YM, 2009, CELL BIOL INT, V33, P352, DOI 10.1016/j.cellbi.2009.01.005; Yeo JE, 2007, BBA-MOL BASIS DIS, V1772, P1199, DOI 10.1016/j.bbadis.2007.09.004; Yip PK, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-6; Yoshizawa T, 2015, SPINAL CORD, V53, P190, DOI 10.1038/sc.2014.233; Zhang N, 2012, INDIAN J MED RES, V135, P287	39	1	1	8	20	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0163-4984	1559-0720		BIOL TRACE ELEM RES	Biol. Trace Elem. Res.	JUL	2021	199	7					2677	2686		10.1007/s12011-020-02395-2		SEP 2020	10	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	SU8CK	WOS:000571713200003	32959339				2022-02-06	
J	Loomis, AM; Sonsteng-Person, M; Jaggers, J; Osteen, P				Loomis, Alysse M.; Sonsteng-Person, Melanie; Jaggers, Jeremiah; Osteen, Philip			School Discipline as a Consequence of Violent Victimization in Adolescence: Understanding the Mediating Roles of Head Injury and Behavior	JOURNAL OF INTERPERSONAL VIOLENCE			English	Article; Early Access						violence exposure; youth violence; community violence; treatment; intervention; child abuse; intervention; treatment; domestic violence	TRAUMATIC BRAIN-INJURY; INTIMATE PARTNER VIOLENCE; RACIAL DISPARITIES; AFRICAN-AMERICAN; EXCLUSIONARY DISCIPLINE; ALLOSTATIC LOAD; MENTAL-HEALTH; RACE; SUSPENSION; EXPOSURE	Pathways from violence to head injury and poor long-term outcomes have been found among numerous populations, however, have not yet been widely examined with youth exposed to violence. Traumatic brain injuries (TBIs) are linked to a range of consequences salient to adolescent development and well-being, such as impulsivity, academic abilities, and emotional processing. This gap in research has led to a missed opportunity to understand the consequences of youth victimization, particularly within the academic setting. The current study examined whether head injury and problem behaviors mediate the relationships between victimization and suspension/expulsion using data from the Pathways to Desistance Study, a multi-site, longitudinal study of serious adolescent offenders age 14-18. A sample of male youth who had witnessed violence (n= 1,094) reported a total score of victimization, number of early behavior problems (i.e., cheating, fighting, etc.), ever having a head injury (32.9%), and number of times suspended (adjustedM= 13.13;SD= 19.31) or expelled (adjustedM= 0.65;SD= 0.99). Structural equation modeling was used to examine direct and indirect pathways from victimization to suspension and expulsion through head injury and behavior. Direct pathways from victimization to school discipline were significant; indirect pathways mediated by only head injury were not significant, but indirect pathways through only problem behavior and through TBI and problem behavior were significant for both expulsion and suspension. Results suggest that youth who have been victimized are at higher risk for both suspension and expulsion and that this risk may be, in part, explained through increased head injury and problem behaviors. TBI screenings/services for violence-exposed youth and trauma-informed school-based services may help to deter trajectories toward suspension and expulsion but should be developed with attention to the influence of racial bias on pathways to school discipline.	[Loomis, Alysse M.; Jaggers, Jeremiah; Osteen, Philip] Univ Utah, Coll Social Work, 395 South 1500 East 111, Salt Lake City, UT 84112 USA; [Osteen, Philip] Univ Utah, Inst Social Res, Salt Lake City, UT USA; [Sonsteng-Person, Melanie] Univ Calif Los Angeles, Los Angeles, CA USA		Loomis, AM (corresponding author), Univ Utah, Coll Social Work, 395 South 1500 East 111, Salt Lake City, UT 84112 USA.	Alysse.loomis@utah.edu		Sonsteng-Person, Melanie/0000-0002-7395-4193			Alvarez A, 2020, REV EDUC RES, V90, P583, DOI 10.3102/0034654320938131; Anyon Y, 2016, AM EDUC RES J, V53, P1663, DOI 10.3102/0002831216675719; Anyon Y, 2014, CHILD YOUTH SERV REV, V44, P379, DOI 10.1016/j.childyouth.2014.06.025; Banks ME, 2007, TRAUMA VIOLENCE ABUS, V8, P290, DOI 10.1177/1524838007303503; Barnes JC, 2018, DEV PSYCHOL, V54, P2328, DOI 10.1037/dev0000613; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Beauchaine TP, 2011, DEV PSYCHOPATHOL, V23, P975, DOI 10.1017/S0954579411000459; Bevans K, 2009, PSYCHONEUROENDOCRINO, V34, P1582, DOI 10.1016/j.psyneuen.2009.04.010; Bottiani JH, 2017, J EDUC PSYCHOL, V109, P532, DOI 10.1037/edu0000155; Boynton-Jarrett R, 2013, SOC SCI MED, V95, P77, DOI 10.1016/j.socscimed.2012.09.007; Brady SS, 2008, J ABNORM CHILD PSYCH, V36, P105, DOI 10.1007/s10802-007-9164-x; Brame Robert, 2004, Youth Violence Juv Justice, V2, P256, DOI 10.1177/1541204004265877; Carrion VG, 2012, J ADOLESCENT HEALTH, V51, pS23, DOI 10.1016/j.jadohealth.2012.04.010; Chafouleas SM, 2016, SCH MENT HEALTH, V8, P144, DOI 10.1007/s12310-015-9166-8; Coxe K, 2018, J ADOLESCENT HEALTH, V62, P255, DOI 10.1016/j.jadohealth.2017.07.003; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; Dorado JS, 2016, SCH MENT HEALTH, V8, P163, DOI 10.1007/s12310-016-9177-0; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Ford JD, 2010, J ADOLESCENT HEALTH, V46, P545, DOI 10.1016/j.jadohealth.2009.11.212; Gilliam WS, 2018, INFANT YOUNG CHILD, V31, P93, DOI 10.1097/IYC.0000000000000113; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Hemphill SA, 2014, CHILD YOUTH SERV REV, V36, P187, DOI 10.1016/j.childyouth.2013.11.022; Hoyle R.H., 1995, STRUCTURAL EQUATION; Hughes T., 2020, POLICY INSIGHTS BEHA, V7, P72, DOI [10.1177/2372732219897093, DOI 10.1177/2372732219897093]; Hunnicutt G, 2017, J FAM VIOLENCE, V32, P471, DOI 10.1007/s10896-016-9854-7; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108167; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Jimenez N, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2462; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Kaba F, 2014, J ADOLESCENT HEALTH, V54, P615, DOI 10.1016/j.jadohealth.2013.12.013; Kennedy AC, 2006, J INTERPERS VIOLENCE, V21, P750, DOI 10.1177/0886260506287314; Kernic MA, 2002, ARCH PEDIAT ADOL MED, V156, P549, DOI 10.1001/archpedi.156.6.549; Krezmien MP, 2006, J EMOT BEHAV DISORD, V14, P217, DOI 10.1177/10634266060140040501; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Like-Haislip TZ, 2011, RACE JUSTICE, V1, P254, DOI 10.1177/2153368711409059; Loomis A. M., 2020, J FAMILY TRAUMA CHIL, V17, P21; Luukkainen S, 2012, PSYCHIAT RES, V200, P767, DOI 10.1016/j.psychres.2012.04.018; Mendez Linda M, 2003, New Dir Youth Dev, P17; Mizel ML, 2016, CHILD YOUTH SERV REV, V70, P102, DOI 10.1016/j.childyouth.2016.09.009; Muthen L. K., 2018, MPLUS USERS GUIDE; Noltemeyer AL, 2015, SCHOOL PSYCHOL REV, V44, P224, DOI 10.17105/spr-14-0008.1; Okonofua JA, 2015, PSYCHOL SCI, V26, P617, DOI 10.1177/0956797615570365; Raykov T., 2006, 1 COURSE STRUCTURAL, V2nd; Riddle T, 2019, P NATL ACAD SCI USA, V116, P8255, DOI 10.1073/pnas.1808307116; Robles-Ramamurthy B, 2019, J AM ACAD PSYCHIATRY, V47, P48, DOI 10.29158/JAAPL.003828-19; Rogosch FA, 2011, DEV PSYCHOPATHOL, V23, P1107, DOI 10.1017/S0954579411000587; Sanders-Phillips K, 2009, CLIN CHILD FAM PSYCH, V12, P174, DOI 10.1007/s10567-009-0053-4; Selner-O'Hagan MB, 1998, J CHILD PSYCHOL PSYC, V39, P215, DOI 10.1017/S002196309700187X; Skiba RJ, 2014, EQUITY EXCELL EDUC, V47, P546, DOI 10.1080/10665684.2014.958965; Skiba RJ, 2011, SCHOOL PSYCHOL REV, V40, P85; Smolkowski K, 2016, BEHAV DISORDERS, V41, P178, DOI 10.17988/bedi-41-04-178-195.1; St Ivany A, 2019, J AGGRESS MALTREAT T, V28, P785, DOI 10.1080/10926771.2019.1632400; Stoddard SA, 2011, PEDIATRICS, V127, P1074, DOI 10.1542/peds.2010-2453; Sullivan AL, 2014, REM SPEC EDUC, V35, P199, DOI 10.1177/0741932513519825; Theriot MT, 2010, CHILD YOUTH SERV REV, V32, P13, DOI 10.1016/j.childyouth.2009.06.009; Tillyer MS, 2016, J YOUTH ADOLESCENCE, V45, P1497, DOI 10.1007/s10964-016-0416-3; Treble-Barna A, 2017, NEUROPSYCHOLOGY, V31, P486, DOI 10.1037/neu0000325; Turner HA, 2016, J ADOLESCENT HEALTH, V58, P208, DOI 10.1016/j.jadohealth.2015.09.021; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wald Johanna, 2003, New Dir Youth Dev, P9, DOI 10.1002/yd.51; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Yehuda R, 2006, ANN NY ACAD SCI, V1071, P137, DOI 10.1196/annals.1364.012; Zeng ST, 2019, CHILD ABUSE NEGLECT, V97, DOI 10.1016/j.chiabu.2019.104149	66	1	1	1	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0886-2605	1552-6518		J INTERPERS VIOLENCE	J. Interpers. Violence											0886260520959635	10.1177/0886260520959635		SEP 2020	29	Criminology & Penology; Family Studies; Psychology, Applied	Social Science Citation Index (SSCI)	Criminology & Penology; Family Studies; Psychology	NT2GN	WOS:000572766000001	32960124				2022-02-06	
J	Tritos, NA; Biller, BMK				Tritos, Nicholas A.; Biller, Beverly M. K.			Current concepts of the diagnosis of adult growth hormone deficiency	REVIEWS IN ENDOCRINE & METABOLIC DISORDERS			English	Article						Glucagon; Growth hormone deficiency; Growth hormone releasing hormone; Insulin; Insulin-like growth factor I; Macimorelin	GLUCAGON STIMULATION TEST; FACTOR-I; CLINICAL ENDOCRINOLOGISTS; AMERICAN ASSOCIATION; ENDOCRINE-SOCIETY; GH-DEFICIENCY; ARGININE TEST; SECRETION; VALIDATION; PEPTIDE	In adults, growth hormone (GH) deficiency is associated with increased visceral adiposity, decreased lean body mass, bone mineral density and exercise capacity, dyslipidemia, insulin resistance, increased cardiometabolic and fracture risk, and impaired quality of life. The aim of the present article is to review the diagnosis of GH deficiency in adults. To avoid overdiagnosis of GH deficiency, it is critical to evaluate only patients at risk for pituitary dysfunction, including those who have had sellar masses, pituitary surgery, radiation therapy, traumatic brain injury, subarachnoid hemorrhage or childhood onset GH deficiency. Evaluation for GH deficiency should be undertaken after testing and replacement of other pituitary hormone deficits. Since GH secretion is pulsatile, measuring serum GH levels randomly is not helpful in establishing the diagnosis of GH deficiency. Serum insulin-like growth factor I (IGF-I) levels lack substantial diurnal variation but also lack sufficient sensitivity and specificity in the diagnosis of GH deficiency in adults. However, adults with multiple (>= 3) additional pituitary hormone deficiencies, risk factors for hypopituitarism and low serum IGF-I levels are very likely to be GH deficient. In most cases, the diagnosis of GH deficiency requires stimulation testing. These tests involve the administration of a pharmacologic agent that normally stimulates GH release from pituitary somatotrophs, including insulin, glucagon, growth hormone releasing hormone-arginine or macimorelin, followed by sampling of serum specimens at regular intervals for GH assay. Patients with a peak GH level that is below a predetermined cutpoint are classified as GH deficient. A systematic approach to the diagnosis of GH deficiency is essential in order to accurately identify adults who may benefit from GH replacement.	[Tritos, Nicholas A.; Biller, Beverly M. K.] Massachusetts Gen Hosp, Neuroendocrine Unit, 100 Blossom St,Suite 140, Boston, MA 02114 USA; [Tritos, Nicholas A.; Biller, Beverly M. K.] Massachusetts Gen Hosp, Neuroendocrine & Pituitary Tumor Clin Ctr, 100 Blossom St,Suite 140, Boston, MA 02114 USA; [Tritos, Nicholas A.; Biller, Beverly M. K.] Harvard Med Sch, Boston, MA 02115 USA		Tritos, NA (corresponding author), Massachusetts Gen Hosp, Neuroendocrine Unit, 100 Blossom St,Suite 140, Boston, MA 02114 USA.; Tritos, NA (corresponding author), Massachusetts Gen Hosp, Neuroendocrine & Pituitary Tumor Clin Ctr, 100 Blossom St,Suite 140, Boston, MA 02114 USA.; Tritos, NA (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	ntritos@mgh.havard.edu	Tritos, Nicholas/W-1594-2019	Tritos, Nicholas/0000-0001-8867-607X			ALBAROTH J, 1988, J CLIN ENDOCR METAB, V67, P1186, DOI 10.1210/jcem-67-6-1186; Attanasio AF, 2004, J CLIN ENDOCR METAB, V89, P4857, DOI 10.1210/jc.2004-0551; Berg C, 2010, EUR J ENDOCRINOL, V162, P477, DOI 10.1530/EJE-09-0824; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Bowers CY, 2008, NAT CLIN PRACT ENDOC, V4, P68, DOI 10.1038/ncpendmet0679; Chanson P, 2010, J CLIN ENDOCR METAB, V95, P3684, DOI 10.1210/jc.2010-0295; Chihara K, 2007, EUR J ENDOCRINOL, V157, P19, DOI 10.1530/EJE-07-0066; Clemmons DR, 2014, J CLIN ENDOCR METAB, V99, P409, DOI 10.1210/jc.2013-4187; Clemmons DR, 2011, CLIN CHEM, V57, P555, DOI 10.1373/clinchem.2010.150631; Conceicao FL, 2003, J ENDOCRINOL INVEST, V26, P1065, DOI 10.1007/BF03345251; Conway GS, 2009, EUR J ENDOCRINOL, V160, P899, DOI 10.1530/EJE-08-0436; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Dichtel LE, 2014, J CLIN ENDOCR METAB, V99, P4712, DOI 10.1210/jc.2014-2830; Fleseriu M, 2016, J CLIN ENDOCR METAB, V101, P3888, DOI 10.1210/jc.2016-2118; Garcia JM, 2013, J CLIN ENDOCR METAB, V98, P2422, DOI 10.1210/jc.2013-1157; Garcia JM, 2018, J CLIN ENDOCR METAB, V103, P3083, DOI 10.1210/jc.2018-00665; Giustina A, 1998, ENDOCR REV, V19, P717, DOI 10.1210/er.19.6.717; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; Hamrahian AH, 2016, PITUITARY, V19, P332, DOI 10.1007/s11102-016-0712-7; HARTMAN ML, 1992, J CLIN ENDOCR METAB, V74, P757, DOI 10.1210/jc.74.4.757; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; HARTMAN ML, 1993, AM J HUM BIOL, V5, P603, DOI 10.1002/ajhb.1310050603; Higham CE, 2016, LANCET, V388, P2403, DOI 10.1016/S0140-6736(16)30053-8; Hilding A, 1999, J CLIN ENDOCR METAB, V84, P2013, DOI 10.1210/jc.84.6.2013; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; HOFFMAN DM, 1994, LANCET, V343, P1064, DOI 10.1016/S0140-6736(94)90181-3; Hokken-Koelega A, 2016, ENDOCR CONNECT, V5, pR44, DOI 10.1530/EC-16-0028; Irwig MS, 2020, ENDOCR PRACT, V26, P340, DOI 10.4158/PS-2019-0540; JORGENSEN JOL, 1989, LANCET, V1, P1221; Junnila RK, 2015, ENDOCRIN METAB CLIN, V44, P27, DOI 10.1016/j.ecl.2014.10.003; JUUL A, 1994, J CLIN ENDOCR METAB, V78, P744, DOI 10.1210/jc.78.3.744; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Leal A, 2002, CLIN ENDOCRINOL, V57, P377, DOI 10.1046/j.1365-2265.2002.01623.x; Leung KC, 1996, ENDOCRINOLOGY, V137, P2694, DOI 10.1210/en.137.7.2694; Makimura H, 2008, J CLIN ENDOCR METAB, V93, P4254, DOI 10.1210/jc.2008-1333; Mekala KC, 2009, J CLIN ENDOCR METAB, V94, P130, DOI 10.1210/jc.2008-1357; Melmed S, 2019, NEW ENGL J MED, V380, P2551, DOI 10.1056/NEJMra1817346; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Murray PG, 2015, J ENDOCRINOL, V226, pT123, DOI 10.1530/JOE-15-0120; PLUMPTON FS, 1969, BRIT J SURG, V56, P216, DOI 10.1002/bjs.1800560315; SALOMON F, 1989, NEW ENGL J MED, V321, P1797, DOI 10.1056/NEJM198912283212605; Shalet SM, 2003, J CLIN ENDOCR METAB, V88, P4124, DOI 10.1210/jc.2003-030126; Sklar CA, 2018, J CLIN ENDOCR METAB, V103, P2761, DOI 10.1210/jc.2018-01175; Takaya K, 2000, J CLIN ENDOCR METAB, V85, P4908, DOI 10.1210/jc.85.12.4908; Tritos NA, 2006, MAYO CLIN PROC, V81, P653, DOI 10.4065/81.5.653; Tritos NA, 2015, ENDOCR PRACT, V21, P823, DOI 10.4158/EP14567.DSCR; Weltman A, 2008, J CLIN ENDOCR METAB, V93, P4711, DOI 10.1210/jc.2008-0998; Yuen KCJ, 2019, ENDOCR PRACT, V25, P1191, DOI 10.4158/GL-2019-0405; Yuen KCJ, 2016, ENDOCR PRACT, V22, P1235, DOI 10.4158/EP161407.DSCR; Yuen KCJ, 2013, PITUITARY, V16, P220, DOI 10.1007/s11102-012-0407-7	50	1	1	1	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1389-9155	1573-2606		REV ENDOCR METAB DIS	Rev. Endocr. Metab. Disord.	MAR	2021	22	1			SI		109	116		10.1007/s11154-020-09594-1		SEP 2020	8	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	QZ5AP	WOS:000571705900001	32959175				2022-02-06	
J	Creed, J; Cantillana-Riquelme, V; Yan, BH; Ma, S; Chu, DM; Wang, HC; Turner, DA; Laskowitz, DT; Hoffmann, U				Creed, Jennifer; Cantillana-Riquelme, Viviana; Yan, Bai Hui; Ma, Shuang; Chu, Dongmei; Wang, Haichen; Turner, Dennis A.; Laskowitz, Daniel T.; Hoffmann, Ulrike			Argon Inhalation for 24 h After Closed-Head Injury Does not Improve Recovery, Neuroinflammation, or Neurologic Outcome in Mice	NEUROCRITICAL CARE			English	Article						Argon; Noble gases; TBI; Neuroprotection; Mice	TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; NEUROPROTECTION; PATHOPHYSIOLOGY; INFLAMMATION; SIMVASTATIN; NEURONS	Background/Objective In recent years, the noble gas argon (Ar) has been extensively studied for its organ protection properties. While mounting in vitro and in vivo evidence indicates that argon provides neuroprotection in ischemic brain injury, its neuroprotective potential in traumatic brain injury (TBI) has not been evaluated in vivo. We tested the hypothesis that prolonged inhalation of 70% or 79% argon for 24 h after closed-head injury (CHI) improves neurologic outcome and overall recovery at 36 days post-injury. We also compared effects of the 30% or 21% residual oxygen on argon's potential neuroprotective capacity. Methods Adult male C57/black mice (n = 240) were subjected to closed-head traumatic brain injury, followed by inhalation of 70% argon or nitrogen (30% oxygen), or 79% argon or nitrogen (21% oxygen) for 24 h. Neurologic outcome (rotarod, neuroscore, and Morris water maze) was evaluated for up to 36 days post-injury. Histologic parameters of neurologic degeneration (Fluoro-Jade staining) and inflammation (F4/80 microglia immunostaining) were assessed in subgroups at 24 h and on post-injury day 7. Results Our CHI protocol consistently resulted in significant brain injury. After argon inhalation for 24 h at either concentration, mice did not show significant improvement with regard to neuroscores, rotarod performance, Morris water maze performance, or overall recovery (body weight), compared to nitrogen controls, up to 36 days. At 7 days post-injury, histologic markers of neurodegeneration and inflammation, particularly in the hippocampus, consistently demonstrated significant injury. Notably, recovery was reduced in mice treated with the higher oxygen concentration (30%) after CHI compared to 21%. Conclusions Prolonged argon treatment did not improve neurologic outcome, overall recovery (weight), nor markers of neurodegeneration or neuroinflammation after significant CHI compared to nitrogen. While neuroprotective in predominately ischemic injury, argon did not provide protection after TBI in this model, highlighting the crucial importance of assessing argon's strengths and weaknesses in preclinical models to fully understand its organ protective potential in different pathologies and gas mixtures.	[Creed, Jennifer; Cantillana-Riquelme, Viviana; Wang, Haichen; Laskowitz, Daniel T.] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA; [Yan, Bai Hui; Ma, Shuang; Chu, Dongmei; Turner, Dennis A.; Laskowitz, Daniel T.; Hoffmann, Ulrike] Duke Univ, Med Ctr, Dept Anesthesiol, Ctr Perioperat Organ Protect CPOP, Box 3094, Durham, NC 27710 USA; [Turner, Dennis A.] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC USA; [Turner, Dennis A.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Turner, Dennis A.] Duke Univ, Dept Biomed Engn, Med Ctr, Durham, NC 27706 USA; [Yan, Bai Hui] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Anesthesiol, Xian, Shaanxi, Peoples R China; [Ma, Shuang] China Med Univ, Shengjing Hosp, Dept Neurol, Shenyang, Liaoning, Peoples R China; [Chu, Dongmei] Fifth Cent Hosp Tianjin, Dept Pediat, Tianjin, Peoples R China		Hoffmann, U (corresponding author), Duke Univ, Med Ctr, Dept Anesthesiol, Ctr Perioperat Organ Protect CPOP, Box 3094, Durham, NC 27710 USA.	ulrike.hoffmann@duke.edu			DREAM Award, Duke Anesthesiology; Donald B. Sanders Fund for Residents and Fellows, Duke University	DREAM Award, Duke Anesthesiology to UH; Donald B. Sanders Fund for Residents and Fellows, Duke University to JC.	Abdul-Muneer PM, 2017, MOL NEUROBIOL, V54, P3964, DOI 10.1007/s12035-016-9949-4; Abdul-Muneer PM, 2017, BRAIN BEHAV IMMUN, V59, P190, DOI 10.1016/j.bbi.2016.09.002; Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Bhowmick S, 2019, MOL NEUROBIOL, V56, P1124, DOI 10.1007/s12035-018-1132-7; Brucken A, 2015, NEUROCRIT CARE, V22, P112, DOI 10.1007/s12028-014-0029-1; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; da Silva EB, 2017, VERBO MINAS, V18, P5; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Donati G, 2008, ACTA OPHTHALMOL, V86, P302, DOI [10.1111/j.1600-0420.2007.01044.x, 10.1111/j.600-0420.2007.01044.x]; Fahlenkamp AV, 2012, EUR J PHARMACOL, V674, P104, DOI 10.1016/j.ejphar.2011.10.045; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Faure A, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0795-y; Fumagalli S, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00081; Grusser L, 2017, MED GAS RES, V7, P93, DOI 10.4103/2045-9912.208512; Grune F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171962; Haelewyn B, 2011, ANESTHESIOLOGY, V115, P1044, DOI 10.1097/ALN.0b013e3182342860; Hafner C, 2016, EUR SURG RES, V57, P252, DOI 10.1159/000448682; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Hollig A, 2016, CRIT CARE MED, V44, pE520, DOI 10.1097/CCM.0000000000001561; Lamade AM, 2020, EXP NEUROL, V329, DOI 10.1016/j.expneurol.2020.113307; Lemoine S, 2017, J CARDIOVASC PHARM T, V22, P564, DOI 10.1177/1074248417702891; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Lynch JR, 2005, STROKE, V36, P2024, DOI 10.1161/01.STR.0000177879.11607.10; Ma S, 2019, CRIT CARE MED, V47, pE693, DOI 10.1097/CCM.0000000000003809; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Nespoli F, 2019, ANN CARD ANAESTH, V22, P122, DOI 10.4103/aca.ACA_111_18; Rizvi M, 2010, EXP BIOL MED, V235, P886, DOI 10.1258/ebm.2010.009366; Ryang YM, 2011, CRIT CARE MED, V39, P1448, DOI 10.1097/CCM.0b013e31821209be; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shi HJ, 2019, NEUROPHARMACOLOGY, V145, P259, DOI 10.1016/j.neuropharm.2018.07.022; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Thorek DLJ, 2011, MOL IMAGING, V10, P206, DOI 10.2310/7290.2010.00042; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Ulbrich F, 2016, J NEUROCHEM, V138, P859, DOI 10.1111/jnc.13662; Ulbrich F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143887; Ulbrich F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115984; Wang H, 2007, NEUROSCIENCE, V144, P1324, DOI 10.1016/j.neuroscience.2006.11.017; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wu X, 2018, EXP THER MED, V15, P2015, DOI 10.3892/etm.2017.5596; Zhao HL, 2016, ONCOTARGET, V7, P25640, DOI 10.18632/oncotarget.8241; Zhao HL, 2016, ANESTHESIOLOGY, V125, P180, DOI 10.1097/ALN.0000000000001128	44	1	1	2	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2021	34	3					833	843		10.1007/s12028-020-01104-0		SEP 2020	11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN4OZ	WOS:000571706800003	32959200				2022-02-06	
J	Mulcahy, LT; O'Halloran, PJ; O'Rourke, C; Corr, P; Nolan, D; O'Brien, DP				Mulcahy, Liam T.; O'Halloran, Philip J.; O'Rourke, Ciara; Corr, Paula; Nolan, Deirdre; O'Brien, David P.			Traumatic brain injury in the Republic of Ireland twenty-five years on: a comparison of two cohorts from a neurosurgical unit	BRAIN INJURY			English	Article						'head injury'; 'road traffic collisions'; 'sports injuries'; 'falls'; 'Ireland'; 'traumatic brain injury'		Objective We assessed for change in the number of admissions, demographics, mechanism, severity, operative management, length of stay, and in-hospital mortality of Traumatic Brain Injury (TBI) in patients admitted to a Neurosurgical Unit (NSU) in the Republic of Ireland in 2017 compared to 25 years previously. Method We performed a retrospective cohort study of TBI admissions during 2017 and compared the results with a prospective cohort study covering a one-year period across 1992 and 1993. Results In 2017, 184 patients (5.78 per 100,000) were admitted, compared to 225 in 1992/1993 (7.31 per 100,000). Mean age increased by 8.5 years. The contribution of road traffic collisions (RTCs) decreased by 62% while sports injuries increased by 300%, led by soccer. Falls replaced RTCs as the leading mechanism of injury. We report a decrease in severe injuries (GCS <= 8) of 52% while mild injuries (GCS >= 13) increased by 58%. The number undergoing neurosurgery remained comparable (2017: 55%, 1992/1993: 48%), as did in-hospital mortality (13%, 16%). Mean length of stay decreased by four days. Conclusion There has been a sizable change in the landscape of TBI as seen in the Republic of Ireland's national NSU including in demographics, mechanism of injury, and injury severity.	[Mulcahy, Liam T.; O'Halloran, Philip J.] Royal Coll Surg Ireland RCSI, Sch Med, Dublin, Ireland; [O'Halloran, Philip J.; O'Rourke, Ciara; Corr, Paula; Nolan, Deirdre; O'Brien, David P.] Beaumont Hosp, Natl Ctr Neurosurg, Dublin, Ireland		O'Halloran, PJ (corresponding author), Royal Coll Surg Ireland RCSI, Sch Med, Dublin, Ireland.	phiohalloran@rcsi.ie		Mulcahy, Liam/0000-0002-2847-7527			Avila-Palencia I, 2018, ENVIRON INT, P120; Beaumont Hospital, 2017, ANN REP 2017; Beaumont Hospital, 1992, BIENN REP 1991 1992; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Central Statistics Office Ireland, 1997, 1991 CENS, V11; Central Statistics Office Ireland, 2016, 2016 CENS POP CHANG; Central Statistics Office Ireland, 1993, 1991 CENS, V1; Central Statistics Office Ireland, 2016, 2016 CENS PROF 6 COM; Conway R, 2019, IRAN MED J, P112; Department of the Environment and Local Government, 1999, ROAD SAF GOV STRAT R; Department of Transport, 2009, NAT CYCL POL FRAM; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; European Transport Safety Council, 2019, RANK EU PROGR ROAD S; European Transport Safety Council, 2011, RAIS COMPL ROAD SAF; European Transport Safety Council, 2018, RANK EU PROGR ROAD S; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; National Institute for Health and Care Excellence (NICE), 2017, HEAD INJ ASS EARL MA; National Office of Clinical Audit (NOCA), 2017, MAJ TRAUM AUD NAT RE; O'Brien DP, 1996, IRAN MED J, P89; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Phillips J, 2008, PHILIPS REPORT NATL; Ponsford JL, 2013, J NEUROTRAUM, V30, P1498, DOI 10.1089/neu.2012.2843; Road Safety Authority, 2007, ROAD SAF STRAT 2007; Road Safety Authority, 2013, ROAD SAF STRAT 2013; Road Safety Authority, 2019, PROV REV FAT COLL 20; Teasdale G, 1974, LANCET, P304; Teschke K, 2012, AM J PUBLIC HEALTH, P102	29	1	1	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 14	2020	34	12					1610	1617		10.1080/02699052.2020.1824299		SEP 2020	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OU7LB	WOS:000571302800001	32954840				2022-02-06	
J	Acar, N; Canakci, ME; Bilge, U				Acar, Nurdan; Canakci, Mustafa Emin; Bilge, Ugur			Early and Ultraearly Administration of Tranexamic Acid in Traumatic Brain Injury: Our 8-Year-Long Clinical Experience	EMERGENCY MEDICINE INTERNATIONAL			English	Article							VASCULAR OCCLUSIVE EVENTS; PROPHYLAXIS PROTOCOLS; TRANSFUSION; HEMORRHAGE; CRASH-2; DEATH; RISK	Introduction. The most important result of head trauma, which can develop with a blunt or penetrating mechanism, is traumatic brain injury. Tranexamic acid (TXA) can be used safely in multiple trauma. Recent studies showed that TXA can be useful in management of intracerebral hemorrhage, especially in reducing the amount of bleeding. The TXA given in the first 3 hours has been shown to reduce mortality. The aim of our study was to evaluate the effectiveness of tranexamic acid used in patients with traumatic brain injury.Method. Patients with trauma in the emergency room between January 2012 and January 2020 were screened in this retrospective study. The inclusion criteria were being over the age of 18 years, tranexamic acid administration in the emergency department, and traumatic brain injury on brain computerized tomography (CT) and control CT imaging after 6 hours.Results. The number of study patients was 51. The median score of GCS was 12.00 (8.00-15.00). Subdural hemorrhage and subarachnoid hemorrhage were the most common findings on brain CT scans. In the group TXA treatment for less than 1 hour, the arrival MAP was low and the pulse was high (p=0.022andp=0.030, respectively). All the patients were admitted with multiple trauma. None of the 51 patients had thrombotic complications and died due to head injury.Conclusion. TXA appears to be a safe drug with few side effects in the short term in head injuries. According to our experience, it comes to mind earlier in multiple trauma, especially in head trauma with pelvic trauma.	[Acar, Nurdan; Canakci, Mustafa Emin] Eskisehir Osmangazi Univ, Sch Med, Emergency Dept, Eskisehir, Turkey; [Bilge, Ugur] Eskisehir Osmangazi Univ, Sch Med, Family Med Dept, Eskisehir, Turkey		Acar, N (corresponding author), Eskisehir Osmangazi Univ, Sch Med, Emergency Dept, Eskisehir, Turkey.	nurdanergun@gmail.com	Ergun, Nurdan/AAX-2677-2020	Ergun, Nurdan/0000-0002-3532-1803; Canakci, Mustafa Emin/0000-0001-9015-1782			Baksaas-Aasen K, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2224-9; Chibbaro S, 2018, WORLD NEUROSURG, V109, pE510, DOI 10.1016/j.wneu.2017.10.012; Cole E., 2019, ANN SURG; Solla DJF, 2021, NEUROCRIT CARE, V34, P130, DOI 10.1007/s12028-020-00991-7; Ganau M, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.08.44; Ganau M, 2017, J CLIN NEUROSCI, V45, P60, DOI 10.1016/j.jocn.2017.08.008; Ganetsky M, 2017, ACAD EMERG MED, V24, P1258, DOI 10.1111/acem.13217; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; HENRY D, 2011, COCHRANE DB SYST REV; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McLaughlin DF, 2008, J TRAUMA, V64, pS57, DOI 10.1097/TA.0b013e318160a566; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; OSTBERG HO, 1977, ACTA CHIR SCAND, V143, P463; Roberts I, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI [10.3310/HTA17100, 10.3310/hta17100]; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Roberts I, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-450; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Sprigg N, 2018, LANCET, V391, P2107, DOI 10.1016/S0140-6736(18)31033-X; Stollings JL, 2018, J CRIT CARE, V43, P128, DOI 10.1016/j.jcrc.2017.08.035; Wan YZ, 2019, EMERG MED INT, V2019, DOI 10.1155/2019/4680184; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20	24	1	1	2	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-2840	2090-2859		EMERG MED INT	Emerg. Med. Int.	SEP 18	2020	2020								6593172	10.1155/2020/6593172			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	NY0VB	WOS:000576116500001	33014471	gold, Green Published			2022-02-06	
J	Morse, H; Biggart, L; Pomeroy, V; Rossit, S				Morse, Helen; Biggart, Laura; Pomeroy, Valerie; Rossit, Stephanie			Exploring perspectives from stroke survivors, carers and clinicians on virtual reality as a precursor to using telerehabilitation for spatial neglect post-stroke	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Spatial neglect; Virtual reality; Telerehabilitation; Stroke; Qualitative	TRAUMATIC BRAIN-INJURY; UNILATERAL NEGLECT; REHABILITATION; TECHNOLOGY; OUTCOMES; SYSTEM; HOME; FEASIBILITY; PERCEPTIONS; ACCEPTANCE	Spatial neglect is a common and severe cognitive consequence of stroke, yet there is currently no effective rehabilitation tool. Virtual Reality (VR) telerehabilitation tools have the potential to provide multisensory and enjoyable therapies and remotely monitor adherence without the presence of a therapist at all times. Researchers and industry need to better understand end-user perspectives about these technologies to ensure these are acceptable and, ultimately, optimize adherence and efficacy. This study aims to explore end-user perspectives on the use of self-administered VR for spatial neglect in a university environment to identify barriers and facilitators prior to extending its use remotely as a telerehabilitation tool. We used a mixed-method design including focus groups, self-administered questionnaires and interviews with stroke survivors (N = 7), their carers (N = 3) and stroke clinicians (N = 6). End-user perspectives identified clarity of instructions, equipment (cost, available resources) and for some, level of experience with technology as barriers of use. Perceived facilitators were performance feedback, engagement and enjoyment, and psychological benefits associated with self-administered VR telerehabilitation. Overall, end-users were positive and interested in using VR telerehabilitation for spatial neglect. These perspectives enabled us to produce practical recommendations to inform development, enhance engagement and uptake of VR telerehabilitation and inform future studies.	[Morse, Helen; Biggart, Laura; Rossit, Stephanie] Univ East Anglia, Sch Psychol, Lawrence Stenhouse Bldg,Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Morse, Helen; Pomeroy, Valerie; Rossit, Stephanie] Univ East Anglia, Acquired Brain Injury Rehabil Alliance, Norwich, Norfolk, England; [Pomeroy, Valerie] Univ East Anglia, Sch Hlth Sci, Norwich, Norfolk, England; [Pomeroy, Valerie] Natl Inst Hlth Res NIHR Brain Injury MedTech Coop, Cambridge, England		Rossit, S (corresponding author), Univ East Anglia, Sch Psychol, Lawrence Stenhouse Bldg,Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	s.rossit@uea.ac.uk	Rossit, Stephanie/ABH-4911-2020	Rossit, Stephanie/0000-0001-6640-2289; Biggart, Laura/0000-0002-1233-9787; Morse, Helen/0000-0002-8856-0453; Pomeroy, Valerie/0000-0003-4487-823X	University of East Anglia [Innovation Proof-of-Concept Fund 2017-2018]; National Institute for Health Research (NIHR) Brain Injury MedTechNational Institute for Health Research (NIHR); University of CambridgeUniversity of Cambridge; Stroke Association [19\100016]	This research was supported by the University of East Anglia [Innovation Proof-of-Concept Fund 2017-2018]. C-SIGHT developments were also funded by a grant to SR and VP from the National Institute for Health Research (NIHR) Brain Injury MedTech Co-operative based at Cambridge University Hospital NHS Foundation Trust and University of Cambridge. HM is currently funded by a grant from The Stroke Association to SR, HM and VP (grant 19\100016).	Nguyen AV, 2019, DISABIL REHABIL-ASSI, V14, P317, DOI 10.1080/17483107.2018.1447608; Appleby E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225150; Association S, 2018, STAT NAT STROK STAT; Azouvi P, 2017, ANN PHYS REHABIL MED, V60, P191, DOI 10.1016/j.rehab.2016.10.006; Bangor A, 2008, INT J HUM-COMPUT INT, V24, P574, DOI 10.1080/10447310802205776; Bangor A, 2009, J USABILITY STUD, V4, P114; Bini SA, 2017, J TELEMED TELECARE, V23, P239, DOI 10.1177/1357633X16634518; Bowen A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003586.pub3; Braun V., 2016, J POSIT PSYCHOL, DOI [10.1080/17439760.2016.1262613, DOI 10.1080/17439760.2016.1262613]; Brennan DM, 2009, STUD HEALTH TECHNOL, V145, P231, DOI 10.3233/978-1-60750-018-6-231; Brooke J., 1996, USABILITY EVALUATION, P189, DOI DOI 10.1002/HBM.20701; Brouns B, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0827-5; Burdea GC, 2003, METHOD INFORM MED, V42, P519; Burdea GC, 2020, TOP STROKE REHABIL, V27, P321, DOI 10.1080/10749357.2019.1701178; Canada's Strategy for Patient-Oriented Research, 2011, IMPR HLTH OUTC EV IN; Castelvecchi D, 2016, NATURE, V533, P153, DOI 10.1038/533153a; Chen P, 2018, DISABIL REHABIL, V40, P2677, DOI 10.1080/09638288.2017.1347720; Cipresso Pietro, 2014, Stud Health Technol Inform, V196, P66; Creswell J. W., 2008, MIXED METHODREADER, P159; Creswell JW., 2015, CONCISE INTRO MIXED; Demeyere N, 2015, PSYCHOL ASSESSMENT, V27, P883, DOI 10.1037/pas0000082; Dickey L, 2010, ARCH PHYS MED REHAB, V91, P196, DOI 10.1016/j.apmr.2009.09.020; Dockx K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010760.pub2; Farrow S., 2004, TECHNOL DISABIL, V16, P69, DOI [10.3233/TAD-2004-16201, DOI 10.3233/TAD-2004-16201]; Fasotti L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00780; Finley M, 2013, PHYSIOTHER THEOR PR, V29, P195, DOI 10.3109/09593985.2012.717591; FOLCHLYON E, 1981, STUD FAMILY PLANN, V12, P443, DOI 10.2307/1965656; Galletta EE, 2014, TOP STROKE REHABIL, V21, P75, DOI 10.1310/tsr2101-75; Gammeri R, 2020, NEUROPSYCH DIS TREAT, V16, P131, DOI 10.2147/NDT.S171461; Gillen R, 2005, ARCH PHYS MED REHAB, V86, P763, DOI 10.1016/j.apmr.2004.10.029; Hackett ML, 2014, LANCET NEUROL, V13, P525, DOI [10.1016/S1474-4422(14)70016-X, 10.1016/s1474-4422(14)70016-X]; Hill AJ, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00640; Huijgen BCH, 2008, J TELEMED TELECARE, V14, P249, DOI 10.1258/jtt.2008.080104; Katz N, 2005, DISABIL REHABIL, V27, P1235, DOI 10.1080/09638280500076079; Kim YM, 2011, ANN REHABIL MED-ARM, V35, P309, DOI 10.5535/arm.2011.35.3.309; Klinke ME, 2016, DISABIL REHABIL, V38, P2429, DOI 10.3109/09638288.2015.1130176; Lane K, 2020, PHYSIOTHERAPY, V107, P36, DOI 10.1016/j.physio.2019.08.008; Lange B, 2010, TOP STROKE REHABIL, V17, P345, DOI 10.1310/tsr1705-345; Laver KE, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010255.pub3; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4, 10.1002/14651858.CD008349.pub2]; Liu LL, 2015, DISABIL REHABIL, V37, P447, DOI 10.3109/09638288.2014.923529; Maggio MG, 2019, J CLIN NEUROSCI, V61, P1, DOI 10.1016/j.jocn.2018.12.020; Meldrum D, 2012, DISABIL REHABIL-ASSI, V7, P205, DOI 10.3109/17483107.2011.616922; MORSE JM, 1991, NURS RES, V40, P120; Mountain G, 2010, J ENG DESIGN, V21, P223, DOI 10.1080/09544820903333792; Nijboer TCW, 2013, CORTEX, V49, P2021, DOI 10.1016/j.cortex.2012.11.006; Niraj S, 2020, NEUROPSYCHOL REHABIL, V30, P731, DOI 10.1080/09602011.2018.1515086; Ogourtsova T, 2019, DISABIL REHABIL, V41, P284, DOI 10.1080/09638288.2017.1387292; Ogourtsova T, 2018, NEUROREHAB NEURAL RE, V32, P46, DOI 10.1177/1545968317751677; Ogourtsova T, 2017, NEUROPSYCHOL REHABIL, V27, P409, DOI 10.1080/09602011.2015.1113187; Pallesen H, 2018, REHABIL RES PRACT, V2018, DOI 10.1155/2018/4318678; Pei YC, 2017, FRONT NEUROROBOTICS, V11, DOI 10.3389/fnbot.2017.00036; Peretti A., 2017, JMIR REHABIL ASSIST, V4; Pietrzak E, 2014, GAMES HEALTH J, V3, P202, DOI 10.1089/g4h.2014.0013; Pollock A, 2014, INT J STROKE, V9, P313, DOI 10.1111/j.1747-4949.2012.00942.x; Proffitt R, 2019, J ENABLING TECHNOL, V13, P92, DOI 10.1108/JET-10-2018-0050; Proffitt R, 2015, INT J TELEREHABILITA, V7, P23, DOI 10.5195/ijt.2015.6177; Puig-Pijoan A, 2018, ACTA NEUROL SCAND, V138, P441, DOI 10.1111/ane.12998; Richmond T, 2017, INT J TELEREHABILITA, V9, P63, DOI 10.5195/ijt.2017.6232; Ringman JM, 2004, NEUROLOGY, V63, P468, DOI 10.1212/01.WNL.0000133011.10689.CE; Rossit S, 2019, NEUROPSYCHOL REHABIL, V29, P251, DOI 10.1080/09602011.2016.1273119; Rowe FJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213035; Santana MJ, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-031187; Sarfo FS, 2018, J STROKE CEREBROVASC, V27, P2306, DOI 10.1016/j.jstrokecerebrovasdis.2018.05.013; Schmid L, 2016, STROKE RES TREAT, V2016, DOI 10.1155/2016/6210508; Sedda A, 2013, BEHAV NEUROL, V26, P183, DOI [10.3233/BEN-2012-129006, 10.1155/2013/810279]; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; Threapleton K, 2016, DIGIT HEALTH, V2, DOI 10.1177/2055207616641302; Tindall LR, 2009, INT J TELEREHABILITA, V1, P3, DOI 10.5195/IJT.2009.5559; Tobler-Ammann BC, 2017, JMIR SERIOUS GAMES, V5, DOI 10.2196/games.8013; Vaughn S., 1996, FOCUS GROUP INTERVIE, DOI [https://doi.org/10.4135/9781452243641, DOI 10.4135/9781452243641]; Vekiri I, 2008, COMPUT EDUC, V51, P1392, DOI 10.1016/j.compedu.2008.01.003; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540; Warland A, 2019, DISABIL REHABIL, V41, P2119, DOI 10.1080/09638288.2018.1459881; Webster JS, 2001, ARCH PHYS MED REHAB, V82, P769, DOI 10.1053/apmr.2001.23201; Wentink M, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0871-3; WILSON B, 1987, ARCH PHYS MED REHAB, V68, P98; Yasuda K, 2017, TOP STROKE REHABIL, V24, P533, DOI 10.1080/10749357.2017.1351069	78	1	1	1	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2020.1819827		SEP 2020	25	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	NP6JO	WOS:000570280700001	32942950	Green Accepted, Green Submitted			2022-02-06	
J	Pettyjohn, EW; Donlan, RM; Breck, J; Clugston, JR				Pettyjohn, Eric W.; Donlan, Robert M.; Breck, John; Clugston, James R.			Intracranial Hypotension in the Setting of Post-Concussion Headache: A Case Series	CUREUS			English	Article						intracranial hypotension; csf leak; csf hypovolemia; concussion; post-concussion headache; american football; post-traumatic headache; autologous blood patch	LEAKS	Intracranial hypotension can be a common sequela of a cerebrospinal fluid (CSF) leak. However, evidence of such a condition related to an injury in American football is currently lacking in the literature. While a positional or orthostatic headache is the most classic symptom of headaches due to intracranial hypotension, a variety of nonspecific symptoms such as neck pain, nausea, vomiting, photophobia, phonophobia, and visual changes can also be present. We present two cases where collegiate American football players developed protracted headaches after a concussive injury and were subsequently diagnosed with intracranial hypotension thought secondary to spinal CSF leaks. Both players underwent multiple procedures of fluoroscopic-guided autologous blood patching, with improvement in their headaches. Recovery varied between the athletes. Case 1 achieved full resolution of his headaches and returned to full activity. Case 2 continued to have intermittent headaches after blood patching, but the positional nature had resolved and he was cleared for full participation in football and was closely followed during the remainder of his collegiate career. Both these cases emphasize the importance of including CSF leak as a cause of post-traumatic headache in an American football player.	[Pettyjohn, Eric W.] Univ Florida Hlth, Family Med, Gainesville, FL 32610 USA; [Donlan, Robert M.] DCH Ctr Occupat Hlth, Sports Med, Tuscaloosa, AL USA; [Breck, John] Univ Colorado, Sports Med, Boulder, CO 80309 USA; [Clugston, James R.] Univ Florida Hlth, Sports Med, Gainesville, FL USA		Pettyjohn, EW (corresponding author), Univ Florida Hlth, Family Med, Gainesville, FL 32610 USA.	epettyjohn@ufl.edu					Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Mokri B, 2013, HEADACHE, V53, P1034, DOI 10.1111/head.12149; Sakka L, 2011, EUR ANN OTORHINOLARY, V128, P309, DOI 10.1016/j.anorl.2011.03.002; Schievink WI, 2008, AM J NEURORADIOL, V29, P853, DOI 10.3174/ajnr.A0956; Schievink WI, 2006, JAMA-J AM MED ASSOC, V295, P2286, DOI 10.1001/jama.295.19.2286; Siavoshi S, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010003; Spears RC, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0425-4; Takagi K, 2007, EUR J MED RES, V12, P249; Yilmazlar S, 2006, NEUROSURG REV, V29, P64, DOI 10.1007/s10143-005-0396-3; Zaremski JL, 2015, CURR SPORT MED REP, V14, P16, DOI 10.1249/JSR.0000000000000121	11	1	1	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	SEP 18	2020	12	9							e10526	10.7759/cureus.10526			9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	NQ3TC	WOS:000570786000007	33094067	Green Published, gold			2022-02-06	
J	Roby, PR; DeCicco, JP; Chandran, A; Barczak-Scarboro, N; DeLellis, SM; Ford, CB; Healy, ML; Means, GE; Kane, SF; Lynch, JH; Mihalik, JP				Roby, Patricia R.; DeCicco, Jamie P.; Chandran, Avinash; Barczak-Scarboro, Nikki; DeLellis, Stephen M.; Ford, Cassie B.; Healy, Marshall L.; Means, Gary E.; Kane, Shawn F.; Lynch, James H.; Mihalik, Jason P.			Neurovascular Coupling in Special Operations Forces Combat Soldiers	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Blast injury; Cerebrovascular function; Mild traumatic brain injury; Military; Neurophysiology	TRAUMATIC BRAIN-INJURY; TRANSCRANIAL DOPPLER ULTRASOUND; VISUAL SCREENING TOOL; CEREBRAL-BLOOD-FLOW; RECURRENT CONCUSSION; IRAQI FREEDOM; KING-DEVICK; MECHANISMS; PLASTICITY; MILITARY	The purpose of this study was to investigate how concussion history affects neurovascular coupling in Special Operations Forces (SOF) combat Soldiers. We studied 100 SOF combat Soldiers [age = 33.5 +/- 4.3 years; height = 180.4 +/- 6.0 cm; 55 (55.0%) with self-reported concussion history]. We employed transcranial Doppler (TCD) ultrasound to assess neurovascular coupling (NVC) via changes in posterior cerebral artery (PCA) velocity in response to a reading and a visual search task. Baseline TCD data were collected for 2 min. NVC was quantified by the percent change in overall PCA response curves. We employed linear mixed effect models using a linear spline with one knot to assess group differences in percent change observed in the PCA velocity response curves between SOF combat Soldiers with and without a concussion history. Baseline PCA velocity did not significantly differ (t(98)= 1.28,p= 0.20) between those with and without concussion history. Relative PCA velocity response curves did not differ between those with and without a concussion history during the reading task (F-1,F-98= 0.80,p= 0.37) or the visual search task (F-1,F-98= 0.52,p= 0.47). When assessing only SOF combat Soldiers with a concussion history, differential response to task was significantly greater in those with 3 or more concussions (F-1,F-4341= 27.24,p< 0.0001) relative to those with 1-2 concussions. Despite no main effect of concussion history on neurovascular coupling response in SOF combat Soldiers, we observed a dose-response based on lifetime concussion incidence. While long-term neurophysiological effects associated with head impact and blast-related injury are currently unknown, assessing NVC response may provide further insight into cerebrovascular function and overall physiological health.	[Roby, Patricia R.; DeCicco, Jamie P.; Chandran, Avinash; Barczak-Scarboro, Nikki; Ford, Cassie B.; Kane, Shawn F.; Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, 2207 Stallings Evans Sports Med Ctr, Chapel Hill, NC 27515 USA; [Roby, Patricia R.; Barczak-Scarboro, Nikki; Mihalik, Jason P.] Univ N Carolina, Sch Med, Dept Allied Hlth Sci, Curriculum Human Movement Sci, Chapel Hill, NC 27515 USA; [Chandran, Avinash] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [DeLellis, Stephen M.] Def Med Strategies LLC, Fayetteville, NC USA; [Ford, Cassie B.] Duke Univ, Sch Med, Dept Populat Hlth Sci, Durham, NC USA; [Healy, Marshall L.; Means, Gary E.; Lynch, James H.] US Army, Special Operat Command, Ft Bragg, NC USA; [Kane, Shawn F.] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27515 USA		Mihalik, JP (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, 2207 Stallings Evans Sports Med Ctr, Chapel Hill, NC 27515 USA.	jmihalik@email.unc.edu		Roby, Patricia/0000-0003-0166-4274; Barczak-Scarboro, Nikki/0000-0003-4877-6732	United States Army Special Operations Command (USASOC); Preservation of the Force and Family Program at US Special Operations Command; Henry M. Jackson Foundation; Uniformed Services University	This project was funded with contract grant support from the United States Army Special Operations Command (USASOC) to the University of North Carolina at Chapel Hill (Chapel Hill, NC, USA). This work was also supported by funding secured by the Preservation of the Force and Family Program at US Special Operations Command and executed as a subaward issued to the University of North Carolina at Chapel Hill by the Henry M. Jackson Foundation under a cooperative agreement with the Uniformed Services University. Co-authors DeLellis, Healy, Kane, Lynch, and Means were employed by USASOC for part or all of the study period. The results of the study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation. We would like to thank the research team at the Matthew Gfeller Sport-Related Traumatic Brain Injury Research Center for assistance with data collection. We would also like to thank LTC Shane Larson, LTC Kane Morgan, MSG Zac Prengler, SGM John Sims, MSG Daniel Carver, and SGM Lance Doody for assistance with the study and dissemination.	AASLID R, 1987, STROKE, V18, P771, DOI 10.1161/01.STR.18.4.771; Aaslid R., 2018, VISUALLY EVOKED DYNA; Albalawi T, 2017, J NEUROTRAUM, V34, P2700, DOI 10.1089/neu.2017.5060; Belmont PJ, 2010, J TRAUMA, V68, P204, DOI 10.1097/TA.0b013e3181bdcf95; Buchweitz Augusto, 2009, Psychol. Neurosci., V2, P111, DOI 10.3922/j.psns.2009.2.003; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Churchill NW, 2017, NEUROIMAGE-CLIN, V16, P234, DOI 10.1016/j.nicl.2017.07.019; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Forsten R. D., 2008, J SPECIAL OPERATIONS, V8, P74; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Lin AL, 2010, P NATL ACAD SCI USA, V107, P8446, DOI 10.1073/pnas.0909711107; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Phillips AA, 2016, J CEREBR BLOOD F MET, V36, P647, DOI 10.1177/0271678X15617954; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Robinson ME, 2017, J NEUROTRAUM, V34, pS53, DOI 10.1089/neu.2016.4709; Roby PR, 2020, ANN BIOMED ENG, V48, P1651, DOI 10.1007/s10439-020-02514-z; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Smirl JD, 2016, J NEUROSCI METH, V270, P92, DOI 10.1016/j.jneumeth.2016.06.007; Tannen B, 2015, VIS DEV REHAB, V1, P206; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Willie CK, 2011, J NEUROSCI METH, V196, P221, DOI 10.1016/j.jneumeth.2011.01.011; Wright AD, 2020, CLIN J SPORT MED, V30, pS53, DOI 10.1097/JSM.0000000000000578; Wright AD, 2017, J NEUROTRAUM, V34, P3097, DOI 10.1089/neu.2017.5020	39	1	1	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	FEB	2021	49	2					793	801		10.1007/s10439-020-02604-y		SEP 2020	9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	QB0NF	WOS:000570478700002	32944852				2022-02-06	
J	Sawaya, RD; Wakil, C; Wazir, A; Shayya, S; Berbari, I; Safa, R; Makki, M; Hamade, M; Tamim, H				Sawaya, Rasha D.; Wakil, Cynthia; Wazir, Adonis; Shayya, Sami; Berbari, Iskandar; Safa, Rawan; Makki, Maha; Hamade, Mahdi; Tamim, Hani			Does implementation of the PECARN rules for minor head trauma improve patient-centered outcomes in a lower resource emergency department: a retrospective cohort study	BMC PEDIATRICS			English	Article						Minor head trauma; Clinically important traumatic brain injury; PECARN prediction rules; CT imaging; Pediatric patients	COMPUTED-TOMOGRAPHY; BRAIN-INJURY; DECISION RULES; UNITED-STATES; CHILDREN; EPIDEMIOLOGY; ACCURACY; OVERUSE	Background Managing children with minor head trauma remains challenging for physicians who evaluate for the need for computed tomography (CT) imaging for clinically important traumatic brain injury (ciTBI) identification. The Pediatric Emergency Care Applied Research Network (PECARN) prediction rules were adopted in our pediatric emergency department (PED) in December 2013 to identify children at low risk for ciTBI. This study aimed to evaluate this implementation's impact on CT rates and clinical outcomes. Methods Retrospective cohort study on pediatric patients with head trauma presenting to the PED of the American University of Beirut Medical Center in Lebanon. Participants were divided into pre- (December 2012 to December 2013) and post-PECARN (January 2014 to December 2016) groups. Patients were further divided into < 2 and >= 2 years and stratified into groups of low, intermediate and high risk for ciTBI. Bivariate analysis was conducted to determine differences between both groups. Results We included 1362 children of which 425 (31.2%) presented pre- and 937 (68.8%) presented post-PECARN rules implementation with 1090 (80.0%) of low, 214 (15.7%) of intermediate and 58 (4.3%) of high risk for ciTBI. CTs were ordered on 92 (21.6%) pre- versus 174 (18.6%) patients post-PECARN (p = 0.18). Among patients < 2 years, CT rates significantly decreased from 25.2% (34/135) to 16.5% (51/309) post-PECARN (p = 0.03), and dropped in all risk groups but only significantly for low risk patients from 20.7% (24/116) to 11.4% (30/264) (p = 0.02). There was no significant decrease in CT rates in patients >= 2 years (20% pre (58/290) vs 19.6% post (123/628),p = 0.88). There was no increase in bounce back numbers, nor in admission rates or positive CT findings among bounce backs. Conclusions PECARN rules implementation did not significantly change the overall CT scan rate but reduced the CT scan rate in patients aged < 2 years at low risk of ciTBI. The implementation did not increase the number of missed ciTBI.	[Sawaya, Rasha D.; Wakil, Cynthia; Wazir, Adonis; Shayya, Sami; Berbari, Iskandar; Safa, Rawan; Makki, Maha] Amer Univ Beirut, Dept Emergency Med, Med Ctr, Beirut, Lebanon; [Hamade, Mahdi] Amer Univ Beirut, Fac Med, Beirut, Lebanon; [Tamim, Hani] Amer Univ Beirut, Clin Res Inst, Fac Med, Beirut, Lebanon; [Tamim, Hani] Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon		Tamim, H (corresponding author), Amer Univ Beirut, Clin Res Inst, Fac Med, Beirut, Lebanon.; Tamim, H (corresponding author), Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon.	hani_t@hotmail.com		WAZIR, ADONIS/0000-0001-5755-2250; Sawaya, Rasha/0000-0003-3699-4505			Abou-Abbass H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005342; Ahmed S, 2017, INDIAN J PSYCHOL MED, V39, P114, DOI 10.4103/0253-7176.203129; Armao Diane, 2014, N C Med J, V75, P128; Atabaki SM, 2017, PEDIAT QUAL SAF, V2; Babl FE, 2018, ANN EMERG MED, V71, P703, DOI 10.1016/j.annemergmed.2018.01.015; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Brehaut JC, 2005, ACAD EMERG MED, V12, P948, DOI 10.1197/j.aem.2005.04.024; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Cellina M, 2018, RADIOL MED, V123, P507, DOI 10.1007/s11547-018-0871-x; Chumpitazi CE, 2011, CLIN PEDIATR EMERG M, V12, P113, DOI 10.1016/j.cpem.2011.05.001; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; El-Menyar A, 2017, WORLD NEUROSURG, V107, P6, DOI [10.1016/J.WNEU.2017.07.070, 10.1016/j.wneu.2017.07.070]; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferrara P, 2016, PEDIATR NEUROSURG, V51, P249, DOI 10.1159/000445904; Gagliardi AR, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-26; Gerber N, 2019, EMERG RADIOL, V26, P45, DOI 10.1007/s10140-018-1645-4; Ishida Y, 2013, JAMA PEDIATR, V167, P491, DOI 10.1001/jamapediatrics.2013.1448; Jolley DL, 2019, PEDIATR EMERG CARE, V35, P199, DOI 10.1097/PEC.0000000000001757; Klang E, 2017, J AM COLL RADIOL, V14, P171, DOI 10.1016/j.jacr.2016.08.032; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; Lorton F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0287-3; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Mannix R, 2010, ACAD EMERG MED, V17, P694, DOI 10.1111/j.1553-2712.2010.00797.x; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Mutch CA, 2016, NEUROSURG CLIN N AM, V27, P409, DOI 10.1016/j.nec.2016.05.011; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Oakley E, 2017, EMERG MED AUSTRALAS, V29, P192, DOI 10.1111/1742-6723.12732; Pathman DE, 1996, MED CARE, V34, P873, DOI 10.1097/00005650-199609000-00002; Sawaya RD, 2013, J EMERG MED, V44, P1180, DOI 10.1016/j.jemermed.2012.12.017; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Trivedi MH, 2002, METHOD INFORM MED, V41, P435, DOI 10.1055/s-0038-1634216	42	1	1	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2431		BMC PEDIATR	BMC Pediatr.	SEP 17	2020	20	1							439	10.1186/s12887-020-02328-x			11	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	NU3VF	WOS:000573570200003	32943022	gold, Green Published, Green Submitted			2022-02-06	
J	Giordano, V; Santos, FSE; Prata, C; do Amaral, NP				Giordano, Vincenzo; Santos, Fabricio Santos e; Prata, Celso; do Amaral, Ney Pecegueiro			Patterns and management of musculoskeletal injuries in attempted suicide by jumping from a height: a single, regional level I trauma center experience	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						Suicide risk; Suicidal; Jumpers; Trauma; Fractures; Vertical jump height	FRACTURES; SEVERITY; JUMPERS	Background Suicide is a common cause of death in Brazil, with an overall increase of 62.5% during the last 30-year period. The study aims to determine overall patient characteristics and symptomatic indicators of complications among survivors. Methods In this retrospective cross-sectional study, we collected and analyzed clinical information of all patients aged > 10 years who presented to our hospital with a history of attempted suicide by jumping from a height in a 7-year period. Records were searched for primary demographic data, radiographs and CT scans were reviewed to determine injury characteristics, and records and operative notes were searched to look for symptomatic indicators of complications among survivors. Baseline demographics and the distribution on skeletal injuries were compared between the survivor and non-survivor patients using the Chi-squared for categorical variables and the Student's t-test for continuous variables. Among survivors, univariate and multivariate analysis were performed to investigate independent risk factors of attempted suicide and complications. Results A total of 222 patients attempted suicide by jumping from a height. At multivariate analysis, the middle-aged patient was the unique identified risk factor for suicide by jumping from a height. Overall mortality was 67.6%. The main independent cause for death was traumatic brain injury. Among survivors, there was a higher incidence of foot and ankle fractures, and pelvic ring injuries. The overall complication rate for survivor patients was 51.4%, with acute infection being the most prevalent complication. At multivariate analysis, middle-aged men, foot and ankle injuries, open pelvic injuries, and open fractures were identified as risk factors for acute complications. Conclusion Middle-aged people are at significant risk for attempting suicide by jumping from a height in Brazil, independently of gender, with 67.6% deaths. Traumatic brain injury, higher ISS, and more than 3 skeletal injuries are independent variables related to this fatal outcome. Acute complications occur in approximately 50% of survivors. Middle-aged men, foot and ankle injuries, open pelvic injuries, and open fractures are risk factors for complications.	[Giordano, Vincenzo; Santos, Fabricio Santos e; Prata, Celso; do Amaral, Ney Pecegueiro] Hosp Municipal Miguel Couto, Serv Ortoped & Traumatol Prof Nova Monteiro, Rua Mario Ribeiro 117-2 Ander, BR-22430160 Rio De Janeiro, RJ, Brazil; [Giordano, Vincenzo] Clin Sao Vicente, Rio De Janeiro, RJ, Brazil		Giordano, V (corresponding author), Hosp Municipal Miguel Couto, Serv Ortoped & Traumatol Prof Nova Monteiro, Rua Mario Ribeiro 117-2 Ander, BR-22430160 Rio De Janeiro, RJ, Brazil.; Giordano, V (corresponding author), Clin Sao Vicente, Rio De Janeiro, RJ, Brazil.	v_giordano@me.com	Giordano, Vincenzo/B-6285-2018	Giordano, Vincenzo/0000-0002-4429-312X			Abel SM, 2013, FORENSIC SCI INT, V231, DOI 10.1016/j.forsciint.2013.05.034; Atanasijevic TC, 2005, J FORENSIC SCI, V50, P608; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Borg T, 2010, SCAND J SURG, V99, P180, DOI 10.1177/145749691009900314; Camm AJ, 2018, OPEN HEART, V5, DOI 10.1136/openhrt-2018-000788; Chang CE, 2018, BONE JOINT J, V100B, P780, DOI 10.1302/0301-620X.100B6.BJJ-2017-1183.R2; Choi JH, 2014, AM J EMERG MED, V32, P529, DOI 10.1016/j.ajem.2014.01.053; Dickinson A, 2012, J ROY ARMY MED CORPS, V158, P123, DOI 10.1136/jramc-158-02-11; Gore-Jones V, 2012, AUSTRALAS PSYCHIATRY, V20, P309, DOI 10.1177/1039856212449672; GUSTILO RB, 1984, J TRAUMA, V24, P742, DOI 10.1097/00005373-198408000-00009; Hayashi N, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-109; Kellam JF, 2018, J ORTHOP TRAUMA, V32, pS1, DOI [10.1097/BOT.0000000000001063, 10.1097/BOT.0000000000001062]; Kim Do Young, 2014, Korean J Neurotrauma, V10, P70, DOI 10.13004/kjnt.2014.10.2.70; Leite Chilan Bou Ghosson, 2018, Rev. bras. ortop., V53, P472, DOI 10.1016/j.rboe.2018.05.014; Light TD, 2011, J SURG RES, V167, P121, DOI 10.1016/j.jss.2009.07.009; Mascayano Franco, 2015, Rev Fac Cien Med Univ Nac Cordoba, V72, P295; Nielssen O, 2010, AUST NZ J PSYCHIAT, V44, P568, DOI 10.3109/00048671003606086; Papadakis SA, 2020, INJURY, V51, P230, DOI 10.1016/j.injury.2019.12.029; Petaros A, 2013, FORENSIC SCI INT, V226, P290, DOI 10.1016/j.forsciint.2013.01.044; Piazzalunga D, 2020, EUR J TRAUMA EMERG S, V46, P383, DOI 10.1007/s00068-019-01110-8; Rapeli Claudemir Benedito, 2005, Sao Paulo Med. J., V123, P43, DOI 10.1590/S1516-31802005000100011; Rocos B, 2015, Open Orthop J, V9, P395, DOI 10.2174/1874325001509010395; Rocos B, 2016, WORLD J ORTHOP, V7, P182, DOI 10.5312/wjo.v7.i3.182; Rodrigues CD, 2019, BRAZ J PSYCHIAT, V41, P380, DOI 10.1590/1516-4446-2018-0230; Silva Bráulio Figueiredo Alves da, 2018, Soc. estado., V33, P565, DOI 10.1590/s0102-699220183302014; Souza Edinilsa Ramos de, 2002, Cad. Saúde Pública, V18, P673, DOI 10.1590/S0102-311X2002000300011; TEASDALE G, 1974, LANCET, V2, P81; Teh J, 2003, CLIN RADIOL, V58, P482, DOI 10.1016/S0009-9260(03)00064-3; Turk EE, 2004, AM J FOREN MED PATH, V25, P194, DOI 10.1097/01.paf.0000136441.53868.a4; Willenegger H, 1986, Unfallchirurgie, V12, P241, DOI 10.1007/BF02586085	30	1	1	0	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-020-01499-7		SEP 2020	6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	NP2TX	WOS:000570034800001	32936309				2022-02-06	
J	Bretzin, AC; Anderson, M; Moran, RN; Covassin, T				Bretzin, Abigail C.; Anderson, Morgan; Moran, Ryan N.; Covassin, Tracey			Long-term test-retest evaluation of the King-Devick test in youth soccer athletes	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Concussion; Youth sport; Baseline	CONCUSSION-ASSESSMENT; HIGH-SCHOOL; RELIABILITY; PERFORMANCE; FOOTBALL; TOOL	Despite the clinical utility of baseline comparisons during concussion assessments, little evidence exists on longterm test-retest reliability of baseline tests in youth athletes. In addition, sex differences in baseline performance are inconsistent in youth athletes, warranting further research. The purpose was to examine sex differences, prevalence of false-positive scores, and long-term test-retest reliability of the King-Devick (KD) test. Healthy youth athletes (23 males, 28 females) completed the KD test prior to the Spring 2016 and Fall 2017 seasons. Two-way random-effects intraclass correlation coefficients (ICCs) were utilized to determine test-retest reliability. A mixed between-within ANOVA with post-hoc t-tests were used to identify the interaction between sex and season, and frequencies were used to determine abnormal test score prevalence. The KD test demonstrated good test-retest reliability (0.77[95% CI, 0.43-0.89]), with 11.8% of youth athletes having clinically meaningful improvements between Season 1 to Season 2. There was a significant sex*season interaction (F(1,49) = 4.67, p = .04), with significantly greater improvements between seasons in male youth athletes compared to female youth athletes. However, 33-35% of youth athletes displayed abnormal test scores in Season 2 relative to Season 1. The KD test demonstrated good reliability and only a small percentage had clinically meaningful changes, however a high prevalence of false-positive scores were observed in this sample.	[Bretzin, Abigail C.] Univ Penn, Penn Injury Sci Ctr, 423 Blockley Hall,Room 937, Philadelphia, PA 19104 USA; [Anderson, Morgan; Covassin, Tracey] Michigan State Univ, 308 W Circle Dr,Room 134, E Lansing, MI 48823 USA; [Moran, Ryan N.] Univ Alabama, 478 Russell Hall,Box 873011, Tuscaloosa, AL 35487 USA		Bretzin, AC (corresponding author), Univ Penn, Penn Injury Sci Ctr, 423 Blockley Hall,Room 937, Philadelphia, PA 19104 USA.	abigail.bretzin@pennmedicine.edu; ande1997@msu.edu; rnmoran@ches.ua.edu; covassin@msu.edu		Bretzin, Abigail/0000-0003-3730-2849; Anderson, Morgan/0000-0001-9170-6663			Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; Breedlove KM, 2019, J ATHL TRAINING, V54, P1241, DOI 10.4085/1062-6050-219-18; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Clugston J.R., 2018, CLIN J SPORT MED; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Dessy AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1922; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Halpern DF, 1997, AM PSYCHOL, V52, P1091, DOI 10.1037/0003-066X.52.10.1091; Hecimoyich M, 2018, J SCI MED SPORT, V21, P1004, DOI 10.1016/j.jsams.2018.03.011; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kulp M T, 1997, J Am Optom Assoc, V68, P589; Lempke LB, 2020, J ATHL TRAINING, V55, P17, DOI 10.4085/1062-6050-322-18; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moran R, 2017, J NEUROL SCI, V383, P101, DOI 10.1016/j.jns.2017.10.039; Moran RN, 2018, SCAND J MED SCI SPOR, V28, P2686, DOI 10.1111/sms.13286; Morrison R, 2020, J SPORT REHABIL, V29, P134, DOI 10.1123/jsr.2018-0304; Moser RS, 2019, ARCH CLIN NEUROPSYCH, V34, P50, DOI 10.1093/arclin/acy007; Naidu D, 2018, J NEUROTRAUM, V35, P2283, DOI 10.1089/neu.2017.5490; Oberlander TJ, 2017, J ATHL TRAINING, V52, P439, DOI 10.4085/1062-6050-52.2.12; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Ozinga SJ, 2018, J ATHL TRAINING, V53, P636, DOI 10.4085/1062-6050-129-17; Smolyansky  V., 2016, OPTOM VIS PERFORM, V4, P147; Subotic A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183092; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Weise KK, 2017, OPTOMETRY VISION SCI, V94, P89, DOI 10.1097/OPX.0000000000000938; Worts PR, 2018, AM J SPORT MED, V46, P2004, DOI 10.1177/0363546518768750	30	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	SEP 15	2020	416								116951	10.1016/j.jns.2020.116951			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PB7DD	WOS:000596476500052	32554153				2022-02-06	
J	Hong, ZJ; Firek, M; Zachary, B; Mors, K; Schindler, C; Marzi, I; Yu, JC; Coimbra, R				Hong, Zhi-Jie; Firek, Matthew; Zachary, Bishoy; Moers, Katharina; Schindler, Cora; Marzi, Ingo; Yu, Jyh-Cherng; Coimbra, Raul			The effect of age and sex on outcomes following isolated moderate to severe traumatic brain injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						Traumatic brain injury; Gender; Outcome; Estrogen; Mortality	GENDER-DIFFERENCES; MORTALITY; PROGESTERONE; ESTROGEN; DIFFERENCE; MENOPAUSE; IMPACT	Purpose The impact of female sex on traumatic brain injury (TBI) outcomes remains controversial. The combined impact of age and sex on TBI outcomes must be clarified. We hypothesized that females have better outcomes than males in the premenopausal age group. Methods Data from the 2007-2016 National Trauma Data Bank of the Committee on Trauma-American College of Surgeons were used. Of a total of 686,549 patients with moderate to severe TBI (AIS >= 3), 251,491 were female. Comparison analyses of clinical characteristics and outcomes between females and males were conducted at different age groups: < 45 years, 45-55, and > 55 years. Logistic regressions were performed to assess the impact of age and female sex on mortality and complications. Results Mortality rate between females and males aged < 45 and 45-55 years was similar, but significantly reduced in the > 55 years group. After multivariate logistic regression analysis controlling for multiple confounding factors, we found that females aged > 55 years had markedly decreased risk of mortality (AOR: 0.857, 95% CI 0.835-0.879,p < 0.001) and complications. Conclusion Female patients in the postmenopausal stage have better outcomes following TBI than males, but pre- and perimenopausal females do not, suggesting that female sexual hormones may not provide a significant protective effect on clinical outcomes following isolated moderate to severe TBI.	[Hong, Zhi-Jie; Firek, Matthew; Zachary, Bishoy; Coimbra, Raul] Riverside Univ Hlth Syst, Comparat Effectiveness & Clin Outcomes Res Ctr, Med Ctr, 26520 Cactus Ave,CPC Bldg,Suite 102-5, Moreno Valley, CA 92555 USA; [Hong, Zhi-Jie] Triserv Gen Hosp, Div Traumatol, Dept Surg, Natl Def Med Ctr, Taipei, Taiwan; [Hong, Zhi-Jie; Yu, Jyh-Cherng] Triserv Gen Hosp, Div Gen Surg, Dept Surg, Natl Def Med Ctr, Taipei, Taiwan; [Hong, Zhi-Jie; Yu, Jyh-Cherng] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Moers, Katharina; Schindler, Cora; Marzi, Ingo] Goethe Univ Frankfurt, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany; [Coimbra, Raul] Loma Linda Univ, Sch Med, Dept Surg, Loma Linda, CA 92350 USA		Coimbra, R (corresponding author), Riverside Univ Hlth Syst, Comparat Effectiveness & Clin Outcomes Res Ctr, Med Ctr, 26520 Cactus Ave,CPC Bldg,Suite 102-5, Moreno Valley, CA 92555 USA.; Coimbra, R (corresponding author), Loma Linda Univ, Sch Med, Dept Surg, Loma Linda, CA 92350 USA.	r.coimbra@ruhealth.org	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851			Albrecht JS, 2016, J TRAUMA ACUTE CARE, V81, P486, DOI 10.1097/TA.0000000000001118; Bell TM, 2015, NICOTINE TOB RES, V17, P1499, DOI 10.1093/ntr/ntv027; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Brown CVR, 2006, J TRAUMA, V61, P572, DOI 10.1097/01.ta.0000200842.19740.38; Cardozo Júnior Luis Carlos Maia, 2014, Rev. bras. ter. intensiva, V26, P148, DOI 10.5935/0103-507X.20140022; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; Czorlich P, 2017, WORLD NEUROSURG, V107, P515, DOI 10.1016/j.wneu.2017.08.010; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Gold EB, 2011, OBSTET GYN CLIN N AM, V38, P425, DOI 10.1016/j.ogc.2011.05.002; Goldstein FC, 2017, J NEUROTRAUM, V34, P115, DOI 10.1089/neu.2015.4313; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Ho CH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190683; Hsiao KY, 2008, EMERG MED J, V25, P670, DOI 10.1136/emj.2007.053405; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Krishnamoorthy V, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0113-4; Lee IN, 2012, METAB BRAIN DIS, V27, P197, DOI 10.1007/s11011-012-9294-x; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Lin C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13442; Ma JP, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub4; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Meltser I, 2008, J CLIN INVEST, V118, P1563, DOI 10.1172/JCI32796; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; Neese SL, 2010, BRAIN RES, V1362, P93, DOI 10.1016/j.brainres.2010.09.055; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Prin I., 2013, INJ EPIDEMIOL, V3, P18, DOI DOI 10.1186/S40621-016-0084-5; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Saadat S, 2012, ULUS TRAVMA ACIL CER, V18, P219, DOI [10.5505/tjtes.2012.03453, 10.5505/tjtes.2012. 03453]; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Steinkellner AR, 2012, MENOPAUSE, V19, P616, DOI 10.1097/gme.0b013e31824bb039; TREVOUX R, 1986, MATURITAS, V8, P309, DOI 10.1016/0378-5122(86)90039-3; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yeung JHH, 2011, ARCH SURG-CHICAGO, V146, P436, DOI 10.1001/archsurg.2011.46	42	1	1	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-020-01491-1		SEP 2020	10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	NO1XL	WOS:000569279600001	32929551				2022-02-06	
J	Liu, KL; Yu, XJ; Sun, TZ; Wang, YC; Chen, MX; Su, YW; Zhang, HC; Chen, YM; Gao, HL; Shi, XL; Qi, J; Li, Y; Li, HB; Dong, WJ; He, JK; Kang, YM				Liu, Kai-Li; Yu, Xiao-Jing; Sun, Tian-Ze; Wang, Yi-Chang; Chen, Meng-Xuan; Su, Yan-Wen; Zhang, Hao-Chen; Chen, Yan-Mei; Gao, Hong-Li; Shi, Xiao-Lian; Qi, Jie; Li, Ying; Li, Hong-Bao; Dong, Wei-Jiang; He, Jian-Kang; Kang, Yu-Ming			Effects of seawater immersion on open traumatic brain injury in rabbit model	BRAIN RESEARCH			English	Article						Open Traumatic Brain Injury; Seawater; Blood-brain barrier; Pathophysiology; Apoptosis	OXIDATIVE STRESS	We emulated instances of open traumatic brain injuries (FBI) in a maritime disaster. New Zealand rabbit animal models were used to evaluate the pathophysiological changes in open TBI with and without the influence of artificial seawater. New Zealand rabbits were randomly divided into 3 groups. Control group consisted of only normal animals. Animals in TBI and TBI + Seawater groups underwent craniotomy with dura mater incised and brain tissue exposed to free-fall impact. Afterward, only TBI + Seawater group received on-site artificial seawater infusion. Brain water content (BWC) and permeability of blood-brain barrier (BBB) were assessed. Reactive oxygen species levels were measured. Western blotting and immunofluorescence were employed to detect: apoptosis-related factors Caspase-3, Bax and Bcl-2; angiogenesis-related factors CD31 and CD34; astrogliosis-related factor glial fibrillary acidic protein (GFAP); potential neuron injury indicator neuron-specific enolase (NSE). Hematoxylin & eosin, Masson-trichrome and Nissl stainings were performed for pathological observations. Comparing to Control group, TBI group manifested abnormal neuronal morphology; increased BWC; compromised BBB integrity; increased ROS, Bax, CD31, CD34, Caspase-3 and GFAP expressions; decreased Bcl-2 and NSE expression. Seawater immersion caused all changes, except BWC, to become more significant. Seawater immersion worsens the damage inflicted to brain tissue by open TBI. It aggravates hypoxia in brain tissue, upregulates ROS expression, increases neuron sensitivity to apoptosis-inducing factors, and promotes angiogenesis as well as astrogliosis.	[Liu, Kai-Li; Yu, Xiao-Jing; Chen, Yan-Mei; Gao, Hong-Li; Qi, Jie; Li, Ying; Li, Hong-Bao; Kang, Yu-Ming] Xi An Jiao Tong Univ, Dept Physiol & Pathophysiol, Key Lab Environm & Genes Related Dis, Educ Minist China,Sch Basic Med Sci, Xian 710061, Peoples R China; [Sun, Tian-Ze; Dong, Wei-Jiang] Xi An Jiao Tong Univ, Dept Human Anat & Histol & Embryol, Sch Basic Med Sci, Xian 710061, Peoples R China; [Wang, Yi-Chang] Xi An Jiao Tong Univ, Dept Neurosurg, Affiliated Hosp 1, Xian 710061, Shaanxi, Peoples R China; [Chen, Meng-Xuan] Xi An Jiao Tong Univ, Coll Stomatol, Key Lab Shaanxi Prov Craniofacial Precis Med Res, 98 XiWu Rd, Xian 710004, Shaanxi, Peoples R China; [Su, Yan-Wen; He, Jian-Kang] Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian 710049, Peoples R China; [Zhang, Hao-Chen] Xi An Jiao Tong Univ, Sch Clin Med, Xian 710061, Peoples R China; [Shi, Xiao-Lian] Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Pharmacol, Hlth Sci Ctr, Xian 710061, Peoples R China		Kang, YM (corresponding author), Xi An Jiao Tong Univ, Dept Physiol & Pathophysiol, Key Lab Environm & Genes Related Dis, Educ Minist China,Sch Basic Med Sci, Xian 710061, Peoples R China.; Dong, WJ (corresponding author), Xi An Jiao Tong Univ, Dept Human Anat & Histol & Embryol, Sch Basic Med Sci, Xian 710061, Peoples R China.; He, JK (corresponding author), Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian 710049, Peoples R China.	dongwj@xjtu.edu.cn; jiankanghe@mail.xjtu.edu.cn; ykang@mail.xjtu.edu.cn			OPEN Project [BHJ17C019]; National Natural Science Foundation of China, ChinaNational Natural Science Foundation of China (NSFC) [81770426, 81600333]; China Postdoctoral Science Foundation, ChinaChina Postdoctoral Science Foundation [2019M663750]; Fundamental Research Funds of Xi'an Jiaotong University [zrzd2017006]; Natural Science Basic Research Program of Shaanxi [2020JM-079]	We thank Xin'ai Song for technical assistance. This work was funded by OPEN Project (BHJ17C019), National Natural Science Foundation of China, China (Nos. 81770426, 81600333), China Postdoctoral Science Foundation, China (No. 2019M663750), Fundamental Research Funds of Xi'an Jiaotong University (No. zrzd2017006) and Natural Science Basic Research Program of Shaanxi (No. 2020JM-079).	Abbasloo E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31866; Assis-Nascimento P, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0016-5; Aubrecht TG, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1156-y; Bai J, 2017, TOXICOL LETT, V281, P1, DOI 10.1016/j.toxlet.2017.08.018; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Booker J, 2019, BRAIN INJURY, V33, P1158, DOI 10.1080/02699052.2019.1629626; Bylicky MA, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/6501031; Chi RF, 2017, CELL PHYSIOL BIOCHEM, V44, P2439, DOI 10.1159/000486167; Goelzer JG, 2010, J CRANIOFAC SURG, V21, P513, DOI 10.1097/SCS.0b013e3181d023bd; Guo SW, 2019, LIFE SCI, V235, DOI 10.1016/j.lfs.2019.116819; Hu Y, 2016, CLIN LAB, V62, P1193, DOI 10.7754/Clin.Lab.2015.150929; Jiang Q, 2020, INT IMMUNOPHARMACOL, V79, DOI 10.1016/j.intimp.2019.106083; Kaptigau WM, 2007, PAPUA NEW GUINEA MED, V50, P58; Kendirli MT, 2014, EPILEPSIA, V55, P1969, DOI 10.1111/epi.12854; Krohn M, 2015, J NEUROTRAUM, V32, P430, DOI 10.1089/neu.2014.3524; Lertkiatmongkol P, 2016, CURR OPIN HEMATOL, V23, P253, DOI 10.1097/MOH.0000000000000239; Li HB, 2020, HYPERTENSION, V75, P1315, DOI 10.1161/HYPERTENSIONAHA.120.14736; Liu Y, 2020, CELL MOL NEUROBIOL, V40, P447, DOI 10.1007/s10571-019-00747-8; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Pirmoradi Z, 2019, IRAN J BASIC MED SCI, V22, P154, DOI 10.22038/ijbms.2018.31225.7534; Rai A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.514; Rashad A, 2015, J CRANIO MAXILL SURG, V43, P1072, DOI 10.1016/j.jcms.2015.05.018; Rashno M, 2019, LIFE SCI, V228, P285, DOI 10.1016/j.lfs.2019.05.007; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Wang ML, 2018, AM J HYPERTENS, V31, P1013, DOI 10.1093/ajh/hpy074; Wang ML, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1131-7; Warren MW, 2005, LIFE SCI, V78, P301, DOI 10.1016/j.lfs.2005.04.058; Wu GF, 2017, J STROKE CEREBROVASC, V26, P701, DOI 10.1016/j.jstrokecerebrovasdis.2014.12.013; Wu GF, 2011, NEUROL RES, V33, P300, DOI 10.1179/016164110X12759951866993; Wu M.Y., 2019, BRAIN RES; Yang JX, 2015, J NEUROSCI, V35, P36, DOI 10.1523/JNEUROSCI.1161-14.2015	33	1	1	2	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 15	2020	1743								146903	10.1016/j.brainres.2020.146903			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LZ5HS	WOS:000541255600004	32445716				2022-02-06	
J	Patch, CS; Hill-Yardin, EL; Ryan, L; Daly, E; Pearce, AJ				Patch, C. S.; Hill-Yardin, E. L.; Ryan, L.; Daly, E.; Pearce, Alan J.			Long Chain Omega-3 Fatty Acid Intervention in Ageing Adults at Risk of Dementia Following Repeated Head Trauma. Low-Level Support or an Opportunity for an Unanswered Question?	JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE			English	Article						Omega-3 fatty acids; concussion; cognition; depression	DIETARY SUPPLEMENTATION; DHA	Emerging evidence of brain injury on risk of neurodegenerative diseases such as Alzheimer's disease (AD) and chronic traumatic encephalopathy (CTE) have resulted in interest in therapeutic potential of omega-3 fatty acids (n-3FA). We conducted a systematic review of n-3FA therapeutic efficacy for ageing adults at risk of AD/CTE following a history of repeated head trauma. Databases for articles between 1980-June 2020 were examined for studies reporting on n-3 FAs in adults (>= 45 years) with a history of repeated brain injury. Following an initial screen of 175 articles, 12 studies were considered but were eventually rejected, as they did not meet inclusion criteria. Our review could find no evidence to support, or disprove, effectiveness of n-3FA intervention in older adults with a history of head trauma. With animal studies showing neuro-restorative potential of n-3FA following brain injury, this review highlights the urgent need for human research in this area.	[Patch, C. S.; Pearce, Alan J.] La Trobe Univ, Coll Sci Hlth & Engn, Melbourne, Vic, Australia; [Hill-Yardin, E. L.] RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia; [Ryan, L.; Daly, E.] Galway Mayo Inst Technol, Sch Sci & Comp, Dublin, Ireland		Pearce, AJ (corresponding author), La Trobe Univ, Coll Sci Hlth & Engn, Melbourne, Vic, Australia.	alan.pearce@latrobe.edu.au					Alosco ML, 2020, NEUROLOGY, V95, pE793, DOI 10.1212/WNL.0000000000010040; Avallone R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174256; Bailes JE, 2020, J NEUROSURG, V133, P598, DOI 10.3171/2020.3.JNS20183; Bailes JE, 2014, MIL MED, V179, P112, DOI 10.7205/MILMED-D-14-00139; Cardoso C, 2016, NUTR RES REV, V29, P281, DOI 10.1017/S0954422416000184; Eckert GP, 2013, PROSTAG LEUKOTR ESS, V88, P105, DOI 10.1016/j.plefa.2012.05.006; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hasadsri L, 2013, J NEUROTRAUM, V30, P897, DOI 10.1089/neu.2012.2672; Hicks AJ, 2019, J NEUROTRAUM, V36, P3191, DOI 10.1089/neu.2018.6346; Kotani S, 2006, NEUROSCI RES, V56, P159, DOI 10.1016/j.neures.2006.06.010; Kouchaki E, 2018, J NUTR, V148, P1380, DOI 10.1093/jn/nxy116; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Pearce, BRAIN IMAGING BEHAV; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Yaffe J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036626	18	1	1	0	6	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	2274-5807	2426-0266		JPAD-J PREV ALZHEIM	JPAD-J. Prev. Alzheimers Dis.	JAN	2021	8	1					29	32		10.14283/jpad.2020.49		SEP 2020	4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PO1TJ	WOS:000568638000001	33336221				2022-02-06	
J	Kim, NY; Lim, J; Lee, S; Kim, K; Hong, JH; Chun, DH				Kim, Na Young; Lim, Jaejoon; Lee, Seunghoon; Kim, Koeun; Hong, Jung Hwa; Chun, Duk-Hee			Hematological factors predicting mortality in patients with traumatic epidural or subdural hematoma undergoing emergency surgical evacuation A retrospective cohort study	MEDICINE			English	Article						epidural hematoma; emergency surgery; mortality; prognostic factor; subdural hematoma	TO-LYMPHOCYTE RATIO; BRAIN-INJURY; INDEPENDENT PREDICTOR; NEUTROPHIL; PLATELET	Hematological abnormalities at admission are common after traumatic brain injuries and are associated with poor outcomes. The objective of this study was to identify the predictive factors of mortality among patients who underwent emergency surgery for the evacuation of epidural hematoma (EDH) or subdural hematoma (SDH). This was a single-center retrospective cohort study of 200 patients who underwent emergency surgical evacuation of EDH or SDH between September 2010 and December 2018. Data on hematological parameters and clinical and intraoperative features were collected. The primary end-point was 1-year mortality after surgery. Univariate and multivariate analysis were performed, and the receiver operating characteristic (ROC) curves were assessed. Of the 200 patients included in this study, 102 (51%) patients died within 1 year of emergency surgery. Lymphocyte count at admission, creatinine levels, activated partial thromboplastin time (aPTT), age, intraoperative epinephrine use, and Glasgow Coma Scale (GCS) score were significantly associated with mortality in the multivariate analysis. The areas under the ROC curve for the GCS score, aPTT, and lymphocyte counts were 0.677 (95% confidence interval [CI] 0.602-0.753), 0.644 (95% CI 0.567-0.721), and 0.576 (95% CI 0.496-0.656), respectively. Patients with elevated lymphocyte counts on admission showed a higher rate of 1-year mortality following emergency craniectomy for EDH or SDH. In addition, prolonged aPTT and a lower GCS score were also related to poor survival.	[Kim, Na Young] Yonsei Univ, Anesthesia & Pain Res Inst, Dept Anesthesiol & Pain Med, Coll Med, 50-1 Yonsei Ro, Seoul, South Korea; [Lim, Jaejoon] CHA Univ, CHA Bundang Med Ctr, Dept Neurosurg, Sch Med, 59 Yatap Ro, Seongnam, South Korea; [Lee, Seunghoon; Kim, Koeun; Chun, Duk-Hee] CHA Univ, CHA Bundang Med Ctr, Dept Anesthesiol & Pain Med, Sch Med, 59 Yatap Ro, Seongnam 13496, South Korea; [Hong, Jung Hwa] Ilsan Hosp, Dept Policy Res Affairs, Natl Hlth Insurance Serv, 100 Ilsan Ro, Goyang, Gyeonggi Do, South Korea		Chun, DH (corresponding author), CHA Univ, CHA Bundang Med Ctr, Dept Anesthesiol & Pain Med, Sch Med, 59 Yatap Ro, Seongnam 13496, South Korea.	leah1013@chamc.co.kr		Kim, Na Young/0000-0003-3685-2005			Alexiou GA, 2014, BRAIN INJURY, V28, P438, DOI 10.3109/02699052.2014.888769; Benarroch EE, 2013, NEUROLOGY, V81, P1079, DOI 10.1212/WNL.0b013e3182a4a577; Bhat T, 2013, EXPERT REV CARDIOVAS, V11, P55, DOI [10.1586/ERC.12.159, 10.1586/erc.12.159]; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Chen JG, 2019, NEUROCRIT CARE, V30, P334, DOI 10.1007/s12028-018-0622-9; Corbett JM, 2020, J NEUROSURG, V132, P545, DOI 10.3171/2018.10.JNS182293; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Giede-Jeppe A, 2017, CEREBROVASC DIS, V44, P26, DOI 10.1159/000468996; Giede-Jeppe A, 2016, STROKE, V47, P1239, DOI 10.1161/STROKEAHA.116.013003; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; Kim NY, 2019, J CLIN MED, V8; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Morotti A, 2017, NEUROCRIT CARE, V26, P160, DOI 10.1007/s12028-016-0367-2; Nguyen HX, 2007, J NEUROCHEM, V102, P900, DOI 10.1111/j.1471-4159.2007.04643.x; Petrone AB, 2017, NEUROREHABILITATION, V40, P501, DOI 10.3233/NRE-171437; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; Sun YM, 2017, AM J EMERG MED, V35, P429, DOI 10.1016/j.ajem.2016.11.037; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Tao CY, 2017, NEUROCRIT CARE, V26, P393, DOI 10.1007/s12028-016-0332-0; TEASDALE G, 1974, LANCET, V2, P81; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wang F, 2016, J STROKE CEREBROVASC, V25, P182, DOI 10.1016/j.jstrokecerebrovasdis.2015.09.013; Weller RO, 1996, BRAIN PATHOL, V6, P275, DOI 10.1111/j.1750-3639.1996.tb00855.x; West KL, 2011, J NEUROSURG, V114, P9, DOI 10.3171/2010.7.JNS091857; Ying HQ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0305-0; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac; Yuan Q, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-017-0471-0; Zhang F, 2018, WORLD NEUROSURG, V119, pE956, DOI 10.1016/j.wneu.2018.08.010; Zheng J, 2017, CELL PHYSIOL BIOCHEM, V44, P967, DOI 10.1159/000485396	33	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	SEP 11	2020	99	37								10.1097/MD.0000000000022074			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OC5EX	WOS:000579180600037	32925745	Green Published			2022-02-06	
J	Liem, NT; Chinh, VD; Phuong, DTM; Doan, NV; Forsyth, NR; Heke, M; Thi, PAN; Nguyen, XH				Liem, Nguyen Thanh; Chinh, Vu Duy; Phuong, Dam Thi Minh; Van Doan, Ngo; Forsyth, Nicholas R.; Heke, Michael; Thi, Phuong Anh Nguyen; Nguyen, Xuan-Hung			Outcomes of Bone Marrow-Derived Mononuclear Cell Transplantation for Patients in Persistent Vegetative State After Drowning: Report of Five Cases	FRONTIERS IN PEDIATRICS			English	Article						drowning; persistent vegetative state; bone marrow mononuclear cells; autologous; cell therapy	TRAUMATIC BRAIN-INJURY; ISCHEMIC-STROKE; STROMAL CELLS; STEM-CELLS; DIFFERENTIATION; RAT; PROLIFERATION; RELIABILITY; CHILDREN; SEQUELAE	Aim:Anoxic brain injury (ABI) due to non-fatal drowning may cause persistent vegetative state (VS) that is currently incurable. The aim of this paper is to present the safety and feasibility of autologous bone marrow-derived mononuclear cell (BMMNC) transplantation in five drowning children surviving in persistent VS. Methods:We used BMMNC as a novel candidate therapeutic tool in a pilot phase-I study for five patients affected by neurological sequelae after near-death drowning. Autologous BMMNCs were freshly isolated using Ficoll gradient centrifugation then infused intrathecally to five patients. The number of transplantation varied from two to four times depending on the motor function improvement of patient after transplantation. Clinical therapeutic effects were evaluated using gross motor function measure and muscle spasticity rating scales, cognitive assessments, and brain MRI before and after cell administrations. Results:Six months after BMMNC transplantation, no serious complications or adverse events were reported. All five patients displayed improvement across the major parameters of gross motor function, cognition, and muscle spasticity. Three patients displayed improved communication including the expression of words. In particular, one patient remarkably reduced cerebral atrophy, with nearly normal cerebral parenchyma after BMMNC transplantation. Conclusions:Autologous BMMNC transplantation for the treatment of children in persistent VS after drowning is safe, feasible, and can potentially improve motor function and cognition and reduce muscle spasticity. These results pave the way for a future phase II clinical trial to evaluate the efficacy of the therapy.	[Liem, Nguyen Thanh; Phuong, Dam Thi Minh; Nguyen, Xuan-Hung] Vinmec Hlth Care Syst, Vinmec Res Inst Stem Cell & Gene Technol VRISG, Hanoi, Vietnam; [Liem, Nguyen Thanh; Phuong, Dam Thi Minh; Nguyen, Xuan-Hung] VinUniversity, Coll Hlth Sci, Hanoi, Vietnam; [Chinh, Vu Duy; Van Doan, Ngo; Thi, Phuong Anh Nguyen] Vinmec Healthcare Syst, Vinmec Times City Int Hosp, Hanoi, Vietnam; [Forsyth, Nicholas R.] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England; [Heke, Michael] Stanford Univ, Dept Biol, Stanford, CA 94305 USA		Liem, NT (corresponding author), Vinmec Hlth Care Syst, Vinmec Res Inst Stem Cell & Gene Technol VRISG, Hanoi, Vietnam.; Liem, NT (corresponding author), VinUniversity, Coll Hlth Sci, Hanoi, Vietnam.	liemnhp@hotmail.com					An YH, 2003, BIOMED ENVIRON SCI, V16, P90; Andrews EM, 2008, EXP NEUROL, V211, P588, DOI 10.1016/j.expneurol.2008.02.027; Bae KS, 2011, YONSEI MED J, V52, P401, DOI 10.3349/ymj.2011.52.3.401; da Fonseca LMB, 2010, EXP NEUROL, V221, P122, DOI 10.1016/j.expneurol.2009.10.010; Battistella V, 2011, REGEN MED, V6, P45, DOI [10.2217/rme.10.97, 10.2217/RME.10.97]; BELL TS, 1985, NEUROSURGERY, V17, P604, DOI 10.1227/00006123-198510000-00012; Bhasin A, 2013, CLIN NEUROL NEUROSUR, V115, P1003, DOI 10.1016/j.clineuro.2012.10.015; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Busl KM, 2010, NEUROREHABILITATION, V26, P5, DOI 10.3233/NRE-2010-0531; Chang ZT, 2016, EXP THER MED, V12, P3535, DOI 10.3892/etm.2016.3811; Cox CS, 2017, STEM CELLS, V35, P1065, DOI 10.1002/stem.2538; FRANKENBURG WK, 1992, PEDIATRICS, V89, P91; Ishaque M, 2017, HUM BRAIN MAPP, V38, P4813, DOI 10.1002/hbm.23745; Jang DK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/238409; Keimpema E, 2009, NEUROPATH APPL NEURO, V35, P89, DOI 10.1111/j.1365-2990.2008.00961.x; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liao GP, 2015, PEDIATR CRIT CARE ME, V16, P245, DOI 10.1097/PCC.0000000000000324; Thanh LN, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1669-2; Nguyen LT, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0859-z; Lu-Emerson C, 2010, NEUROREHABILITATION, V26, P35, DOI 10.3233/NRE-2010-0534; Moniche F, 2012, STROKE, V43, P2242, DOI 10.1161/STROKEAHA.112.659409; Mori T, 2005, MOL CELL BIOL, V25, P5183, DOI 10.1128/MCB.25.12.5183-5195.2005; Liem NT, 2020, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00543; Nguyen TL, 2018, ANN STEM CELLS REGEN, V1, P1006; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Park HC, 2005, TISSUE ENG, V11, P913, DOI 10.1089/ten.2005.11.913; Pavlichenko N, 2008, BRAIN RES, V1233, P203, DOI 10.1016/j.brainres.2008.06.123; Prabhakar S, 2010, BRAIN INJURY, V24, P1485, DOI 10.3109/02699052.2010.520298; Sharma A, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/623875; Suzuki H, 2004, BIOCHEM BIOPH RES CO, V322, P918, DOI 10.1016/j.bbrc.2004.07.201; Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381; Topjian AA, 2012, NEUROCRIT CARE, V17, P441, DOI 10.1007/s12028-012-9747-4; von Wild Klaus, 2008, J Med Life, V1, P443; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Weiss J, 2010, PEDIATRICS, V126, pE253, DOI 10.1542/peds.2010-1265; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; World Health Organisation, 2008, WORLD REPORT CHILD I; World Health Organization, 2014, GLOB REP DROWN PREV; Yoo SW, 2008, EXP MOL MED, V40, P387, DOI 10.3858/emm.2008.40.4.387	39	1	1	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-2360			FRONT PEDIATR	Front. Pediatr.	SEP 10	2020	8								564	10.3389/fped.2020.00564			10	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	NV9NX	WOS:000574639700001	33014944	gold, Green Published, Green Accepted			2022-02-06	
J	Rippee, MA; Chen, J; Taylor, MK				Rippee, Michael A.; Chen, Jamie; Taylor, Matthew K.			The Ketogenic Diet in the Treatment of Post-concussion Syndrome-A Feasibility Study	FRONTIERS IN NUTRITION			English	Article						mTBI; post-concussion syndrome; ketogenic diet; ketones; cognition	TRAUMATIC BRAIN-INJURY; CORTICAL IMPACT INJURY; CEREBRAL-BLOOD-FLOW; BETA-HYDROXYBUTYRATE; KETONE-BODIES; ALZHEIMERS-DISEASE; CELL-DEATH; METABOLISM; JUVENILE; HYPOXIA	Concussion is the most common form of mild traumatic brain injury (mTBI). Although most patients' symptoms resolve within a month, patients with post-concussion syndrome (PCS) may continue to experience symptoms for years and have limited treatment options. This pilot study assessed the feasibility and symptom-related effects of a ketogenic diet (KD) in patients with PCS symptoms. The Ketogenic Diet in Post-Concussion Syndrome (KD-PCS) was a single-arm trial of a 2-month KD high in non-starchy vegetables and supplemented with medium-chain triglyceride (MCT) oil. Macronutrient targets were >= 70% fat, <= 10% carbohydrate, and the remainder as protein as energy. We assessed feasibility by daily self-reported measure of urine acetoacetate and collection of 3-day food records and serum beta-hydroxybutyrate at multiple timepoints. We assessed symptoms by administering the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) and Modified Balance Error Scoring System (M-BESS) at baseline and month 2 and the Post-Concussion Symptom Scale (PCSS) at baseline, month 1, and month 2. Fourteen participants enrolled in the KD-PCS. Twelve participants completed the study and 11 implemented the KD (73% fat, 9% carbohydrate, and 18% protein) and achieved ketosis. One participant complained of MCT-related diarrhea that resolved and another reported nausea and fatigue that resulted in withdrawal from the study. Among compliant participants, the visual memory domain of the ImPACT improved by 12 points (p= 0.02) and PCSS scores improved by 9 points, although not statistically significant. This pilot trial suggests that the KD is a feasible experimental treatment for PCS and justifies further study of its efficacy.	[Rippee, Michael A.] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA; [Rippee, Michael A.; Chen, Jamie] Univ Kansas Hlth Syst, Ctr Concuss Management, Kansas City, KS 66160 USA; [Taylor, Matthew K.] Univ Kansas, Med Ctr, Dept Dietet & Nutr, Kansas City, KS 66103 USA; [Taylor, Matthew K.] Univ Kansas, Alzheimers Dis Ctr, Fairway, KS USA		Rippee, MA (corresponding author), Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA.; Rippee, MA (corresponding author), Univ Kansas Hlth Syst, Ctr Concuss Management, Kansas City, KS 66160 USA.	mrippee@kumc.edu			Center for Concussion Management at the University of Kansas Health System; Heads Up Foundation for PCS; University of Kansas Medical Center Department of Dietetics and Nutrition; University of Kansas CTSA grant [UL1TR002366]; University of Kansas (KU) One University Open Access Author Fund - KU Provost; University of Kansas (KU) One University Open Access Author Fund - KU Vice Chancellor for Research & Graduate Studies; University of Kansas (KU) One University Open Access Author Fund - KUMC Vice Chancellor for Research	This study was supported by the Center for Concussion Management at the University of Kansas Health System, the Heads Up Foundation for PCS, and the University of Kansas Medical Center Department of Dietetics and Nutrition. This study was also conducted with the technological support of the University of Kansas CTSA grant #UL1TR002366. The article processing charges related to the publication of this article were supported by The University of Kansas (KU) One University Open Access Author Fund sponsored jointly by the KU Provost, KU Vice Chancellor for Research & Graduate Studies, and KUMC Vice Chancellor for Research and managed jointly by the Libraries at the Medical Center and KU - Lawrence.	Appelberg KS, 2009, J NEUROTRAUM, V26, P497, DOI 10.1089/neu.2008.0664; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Bernini A, 2020, J CEREBR BLOOD F MET, V40, P177, DOI 10.1177/0271678X18808947; Brandt J, 2019, J ALZHEIMERS DIS, V68, P969, DOI 10.3233/JAD-180995; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; CDC, INJ PREV CONTR TRAUM; Chung S, 2019, AM J NEURORADIOL, V40, P1438, DOI 10.3174/ajnr.A6146; Churchill NW, 2017, NEUROIMAGE-CLIN, V16, P234, DOI 10.1016/j.nicl.2017.07.019; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Courchesne-Loyer A, 2017, CURR DEV NUTR, V1, DOI 10.3945/cdn.117.000851; Croteau E, 2018, EXP GERONTOL, V107, P18, DOI 10.1016/j.exger.2017.07.004; Croteau E, 2018, J ALZHEIMERS DIS, V64, P551, DOI 10.3233/JAD-180202; Cunnane SC, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00053; DAHLQUIST G, 1976, PEDIATR RES, V10, P910, DOI 10.1203/00006450-197611000-00002; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; Donders J, 2017, ARCH PHYS MED REHAB, V98, P2514, DOI 10.1016/j.apmr.2017.05.019; Eun SH, 2006, BRAIN DEV-JPN, V28, P566, DOI 10.1016/j.braindev.2006.03.011; FEE CRA, 1988, ARCH EMERG MED, V5, P12; FERRIS SH, 1980, NEUROBIOL AGING, V1, P127, DOI 10.1016/0197-4580(80)90005-6; Fortier M, 2019, ALZHEIMERS DEMENT, V15, P625, DOI 10.1016/j.jalz.2018.12.017; FOSTER NL, 1983, NEUROLOGY, V33, P961, DOI 10.1212/WNL.33.8.961; Gilbert DL, 2000, J CHILD NEUROL, V15, P787, DOI 10.1177/088307380001501203; Giza CC, 2001, J ATHL TRAINING, V36, P228; Greco T, 2016, J CEREBR BLOOD F MET, V36, P1603, DOI 10.1177/0271678X15610584; Haces ML, 2008, EXP NEUROL, V211, P85, DOI 10.1016/j.expneurol.2007.12.029; HAWKINS RA, 1979, SCIENCE, V205, P325, DOI 10.1126/science.451608; Hu ZG, 2009, ANN CLIN LAB SCI, V39, P76; Hu ZG, 2009, BRAIN INJURY, V23, P459, DOI 10.1080/02699050902788469; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Keene DL, 2006, PEDIATR NEUROL, V35, P1, DOI 10.1016/j.pediatrneurol.2006.01.005; Kim DY, 2015, ANN NEUROL, V78, P77, DOI 10.1002/ana.24424; Koppel SJ, 2018, NEUROCHEM INT, V117, P114, DOI 10.1016/j.neuint.2017.05.019; Kossoff EH, 2006, EPILEPSIA, V47, P421, DOI 10.1111/j.1528-1167.2006.00438.x; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; Masuda R, 2005, J NEUROSCI RES, V80, P501, DOI 10.1002/jnr.20464; Merritt VC, 2018, J CLIN EXP NEUROPSYC, V40, P377, DOI 10.1080/13803395.2017.1353590; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; Musa-Veloso K, 2002, AM J CLIN NUTR, V76, P65, DOI 10.1093/ajcn/76.1.65; Newman JC, 2017, ANNU REV NUTR, V37, P51, DOI 10.1146/annurev-nutr-071816-064916; Noh HS, 2003, EPILEPSY RES, V53, P119, DOI 10.1016/S0920-1211(02)00262-0; Ostergaard L, 2014, J CEREBR BLOOD F MET, V34, P1585, DOI 10.1038/jcbfm.2014.131; Papandreou D, 2006, BRIT J NUTR, V95, P5, DOI 10.1079/BJN20051591; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; Prins ML, 2012, EPILEPSY RES, V100, P218, DOI 10.1016/j.eplepsyres.2011.09.027; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Salberg S, 2019, BEHAV BRAIN RES, V376, DOI 10.1016/j.bbr.2019.112225; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sinnott AM, 2019, J SCI MED SPORT, V22, P1292, DOI 10.1016/j.jsams.2019.08.004; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Suzuki M, 2001, JPN J PHARMACOL, V87, P143, DOI 10.1254/jjp.87.143; Taylor MK, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081910; Taylor MK, 2019, CURR DEV NUTR, V3, DOI 10.1093/cdn/nzz003; Taylor Matthew K, 2018, Alzheimers Dement (N Y), V4, P28, DOI 10.1016/j.trci.2017.11.002; Wang Y, 2019, BRAIN IMAGING BEHAV, V13, P1375, DOI 10.1007/s11682-018-9946-5	62	1	1	1	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-861X			FRONT NUTR	Front. Nutr.	SEP 10	2020	7								160	10.3389/fnut.2020.00160			12	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	NV8ZB	WOS:000574601100001	33015129	Green Published, gold			2022-02-06	
J	Crespy, T; Durost, M; Fricault, P; Lemasson, B; Bouzat, P; Barbier, EL; Payen, JF				Crespy, Thibaud; Durost, Maxime; Fricault, Pierre; Lemasson, Benjamin; Bouzat, Pierre; Barbier, Emmanuel L.; Payen, Jean-Francois			Hypertonic Sodium Lactate to Alleviate Functional Deficits Following Diffuse Traumatic Brain Injury: An Osmotic or a Lactate-Related Effect?	NEUROCRITICAL CARE			English	Article						Hypertonic solutions; sodium lactate; traumatic brain injury; cognition	INTRACRANIAL HYPERTENSIVE EPISODES; COGNITIVE DEFICITS; TISSUE OXYGENATION; MODEL; MEMORY; RATS; DYSFUNCTION; MANNITOL; GLUCOSE; IMPACT	Background There has been growing interest in the use of hypertonic sodium lactate (HSL) solution following traumatic brain injury (TBI) in humans. However, little is known about the effects of HSL on functional deficits with respect to the hyperosmotic nature of HSL. Methods We have compared the effects of HSL solution and isotonic saline solution using sensorimotor and cognitive tests for 14 days post-trauma in animals. Thirty minutes after trauma (impact-acceleration model), anesthetized rats were randomly allocated to receive a 2-h infusion of isotonic saline solution (TBI-saline group) or HSL (TBI-HSL group) (n = 10 rats per group). In another series of experiments using a similar protocol, the effects of equiosmolar doses of HSL and hypertonic saline solution (HSS) were compared in TBI rats (n = 10 rats per group). Blood lactate and ion concentrations were measured during the 2-h infusions. Results Compared to the TBI-saline group, the TBI-HSL group had a reduced latency to complete the adhesive removal test: 6 s (5-9) (median [25-75th centiles]) versus 13 s (8-17) on day 7, and 5 s (5-9) versus 11 s (8-26) on day 14 (P < 0.05), respectively, and a shorter delay to complete the radial arm maze test on day 7: 99 s (73-134) versus 176 s (127-300), respectively (P < 0.05). However, no differences were found between the TBI-HSL and TBI-HSS groups in neurocognitive tests performance. Compared to the TBI-saline group, the HSL and HSS groups had higher serum osmolality: 318 mOsm/Kg (315-321) and 315 mOsm/Kg (313-316) versus 307 mOsm/Kg (305-309), respectively (P < 0.05), and the HSL group had a higher serum lactate concentration: 6.4 mmol/L (5.3-7.2) versus 1.5 mmol/L (1.1-1.9) and 1.6 mmol/L (1.5-1.7), respectively (P < 0.05). Conclusions These results indicate that improvements in cognitive and sensorimotor tests with HSL infusion post-TBI could be related to elevation of serum osmolality, not to exogenous administration of lactate.	[Crespy, Thibaud; Durost, Maxime; Fricault, Pierre; Bouzat, Pierre; Payen, Jean-Francois] Univ Grenoble Alpes, CHU Grenoble Alpes, Grenoble Inst Neurosci, Inserm,U1216,Dept Anesthesia & Crit Care, Grenoble, France; [Lemasson, Benjamin; Barbier, Emmanuel L.] Univ Grenoble, Grenoble Inst Neurosci, INSERM, U1216, Grenoble, France		Payen, JF (corresponding author), Univ Grenoble Alpes, CHU Grenoble Alpes, Grenoble Inst Neurosci, Inserm,U1216,Dept Anesthesia & Crit Care, Grenoble, France.	jfpayen@univ-grenoble-alpes.fr	Barbier, Emmanuel/E-6302-2011; Lemasson, Benjamin/AAC-4092-2019	Barbier, Emmanuel/0000-0002-4952-1240; Lemasson, Benjamin/0000-0003-0446-3531; payen, jean-francois/0000-0001-8400-3839	"Fondation des Gueules Cassees" (Paris, France); French program "Investissement d'Avenir" (Agence Nationale de la Recherche, Grant Infrastructure d'Avenir en Biologie Sante)French National Research Agency (ANR) [ANR-11-INBS-0006]	This study was conducted at the INSERM U1216/Grenoble Institut des Neurosciences and was partly funded by the "Fondation des Gueules Cassees" (Paris, France). Brain MRI was performed at the Grenoble MRI Facility (IRMaGe) that is partly funded by the French program "Investissement d'Avenir" (Agence Nationale de la Recherche, Grant Infrastructure d'Avenir en Biologie Sante ANR-11-INBS-0006).	Alessandri B, 2012, J NEUROTRAUM, V29, P2181, DOI 10.1089/neu.2011.2067; Barzo P, 1997, ACT NEUR S, V70, P119; Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; Berthet C, 2009, J CEREBR BLOOD F MET, V29, P1780, DOI 10.1038/jcbfm.2009.97; Bisri Tatang, 2016, Asian J Neurosurg, V11, P151, DOI 10.4103/1793-5482.145375; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P133, DOI 10.1097/MCC.0000000000000072; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Bouzat P, 2013, CRIT CARE MED, V41, P1316, DOI 10.1097/CCM.0b013e31827ca64e; Bouzier-Sore AK, 2003, J CEREBR BLOOD F MET, V23, P1298, DOI 10.1097/01.WCB.0000091761.61714.25; Christen T, 2014, J CEREBR BLOOD F MET, V34, P1550, DOI 10.1038/jcbfm.2014.116; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Greco T, 2020, EXP NEUROL, V329, DOI 10.1016/j.expneurol.2020.113289; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Ichai C, 2013, INTENS CARE MED, V39, P1413, DOI 10.1007/s00134-013-2978-9; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Mannino C, 2018, J NEUROSCI RES, V96, P696, DOI 10.1002/jnr.24097; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Meierhans R, 2012, MINERVA ANESTESIOL, V78, P185; Millet A, 2018, BRIT J ANAESTH, V120, P1295, DOI 10.1016/j.bja.2018.01.025; Millet A, 2016, J NEUROTRAUM, V33, P1625, DOI 10.1089/neu.2015.4160; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; Schilte C, 2015, CRIT CARE MED, V43, P2212, DOI 10.1097/CCM.0000000000001137; Schreibman DL, 2018, NEUROCRIT CARE, V29, P253, DOI 10.1007/s12028-018-0535-7; SCHURR A, 1988, SCIENCE, V240, P1326, DOI 10.1126/science.3375817; Sebastian V, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00038; Sell SL, 2008, ANESTHESIOLOGY, V108, P873, DOI 10.1097/ALN.0b013e31816c8a15; Soblosky JS, 1996, BEHAV BRAIN RES, V80, P185, DOI 10.1016/0166-4328(96)00034-4; Tanino M, 2016, ACTA MED OKAYAMA, V70, P455; Thompson HJ, 2006, EUR J NEUROSCI, V24, P3063, DOI 10.1111/j.1460-9568.2006.05197.x; Tropres I, 2015, MAGN RESON MED, V73, P325, DOI 10.1002/mrm.25396; van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35; Wenk Gary L, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0805as26; White H, 2011, CRIT CARE, V15, DOI 10.1186/cc10020; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	40	1	1	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2021	34	3					795	803		10.1007/s12028-020-01090-3		SEP 2020	9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN4OZ	WOS:000567786200001	32901380				2022-02-06	
J	Wang, RY; Qi, Y; Wang, YX; Wang, YS				Wang, Renying; Qi, Yang; Wang, Yunxing; Wang, Yisha			Characteristics of Injury Patients in the Emergency Department in Shanghai, China: A Retrospective Observational Study	MEDICAL SCIENCE MONITOR			English	Article						Emergency Service, Hospital; Epidemiology; Multiple Trauma	TRAUMATIC BRAIN-INJURY; SEVERITY SCORE; EPIDEMIOLOGY; FATALITIES	Background: This study analyzed the epidemiological characteristics and trends of trauma injuries in Ruijin Hospital North, Shanghai, China, and the feasibility of methods to prevent trauma. Material/Methods: In this retrospective cross-sectional study, the electronic databases of Ruijin Hospital North were searched for patients who experienced severe trauma from 2013 to 2016. Characteristics of severe trauma were analyzed, including trauma mechanism, gender, reasons for injury, and injury-associated causes of death. Results: Of the 17,093 patients who experienced trauma during the study period, 11,165 (65.3%) were male and 5,928 (34.7%) were female. Analysis by age showed that the highest incidence of traumatic injuries was in subjects aged 25-34 years, whereas analysis by occupation showed the highest incidence of injury in migrant workers without higher education. Classification by Injury Severity Score (ISS) showed that 12,563 (73.5%) subjects had minor injuries, 4,273 (25.0%) had serious injuries, and 256 (1.5%) had severe injuries. In addition, 256 (1.5%) subjects died, with traffic accidents and falling injuries being the main causes of death. The incidence of injury peaked at 9-11 am and 2-4 pm and was significantly higher in autumn and winter than in spring and summer. Conclusions: Most trauma patients were young adults. Injuries due to traffic accidents and falling were the main causes of death, with disregard of driving regulations and other health and safety regulations being the main cause of trauma. Trauma injuries may be prevented by strengthening education and by obeying traffic laws and construction site safety regulations.	[Wang, Yisha] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Emergency, Sch Med, Shanghai, Peoples R China; Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp North, Shanghai, Peoples R China		Wang, YS (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Emergency, Sch Med, Shanghai, Peoples R China.	wysdoctor123@163.com			Ruijin Hospital North [2014-07-8]	This study was supported by a grant from Ruijin Hospital North (No. 2014-07-8). Establishment of trauma monitoring system and epidemiological study in a third-class hospital (2017ZY09)	Alghnam Suliman, 2016, Inj Epidemiol, V3, P5; Armstrong GW, 2014, WEST J EMERG MED, V15, P693, DOI 10.5811/westjem.2014.5.20623; Association for the Advancement of Automotive Medicine, 2016, ABBR INJ SCAL AIS; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balogh ZJ, 2003, J ORTHOP TRAUMA, V17, P508, DOI 10.1097/00005131-200308000-00006; Chang VC, 2015, AM J IND MED, V58, P353, DOI 10.1002/ajim.22418; Colantonio A, 2009, BRAIN INJURY, V23, P873, DOI 10.1080/02699050903036033; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Finkelstein E, 2006, INCIDENCE EC BURDEN, Vxiii, P187; Florence C, 2015, MMWR-MORBID MORTAL W, V64, P1074, DOI 10.15585/mmwr.mm6438a4; Gargett S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-270; Grivna M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0051-5; Gyekye SA, 2010, INT J OCCUP SAF ERGO, V16, P431; Leidman E, 2016, CONFL HEALTH, V10, DOI 10.1186/s13031-016-0070-0; Lombardi DA, 2010, CHRONOBIOL INT, V27, P1013, DOI 10.3109/07420528.2010.489466; Mack KA, 2012, J SAFETY RES, V43, P229, DOI 10.1016/j.jsr.2012.08.015; Mikkelsen KL, 2010, AM J IND MED, V53, P601, DOI 10.1002/ajim.20803; Mock C, 2005, B WORLD HEALTH ORGAN, V83, P294; Siddiqui Arshad A, 2004, J Coll Physicians Surg Pak, V14, P173; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007; Toroyan T, 2013, INJURY PREV, V19, P150, DOI 10.1136/injuryprev-2013-040775; Verma SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150939; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; Zhang XJ, 2013, IRAN J PUBLIC HEALTH, V42, P7; Zuraik C, 2017, WORLD J SURG, V41, P2674, DOI 10.1007/s00268-017-4088-2	25	1	1	3	5	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	SEP 9	2020	26								e922726	10.12659/MSM.922726			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	NL2YJ	WOS:000567287000001	32900987	Green Published			2022-02-06	
J	Chen, H; Jing, Y; Xu, ZM; Yang, DX; Ju, SM; Guo, Y; Tian, HL; Xue, LX				Chen, Hao; Jing, Yao; Xu, Zhiming; Yang, Dianxu; Ju, Shiming; Guo, Yan; Tian, Hengli; Xue, Lixia			Upregulation of C Terminus of Hsc70-Interacting Protein Attenuates Apoptosis and Procoagulant Activity and Facilitates Brain Repair After Traumatic Brain Injury	FRONTIERS IN NEUROSCIENCE			English	Article						traumatic brain injury; coagulopathy; phosphatase and tensin homolog deleted on chromosome 10; C terminus of Hsc70-interacting protein; apoptosis; procoagulant activity	POSTTRAUMATIC CEREBRAL INFARCTION; PROGRESSIVE HEMORRHAGIC INJURY; STRETCH-INDUCED INJURY; BARRIER DISRUPTION; RISK-FACTORS; PTEN; COAGULOPATHY; BLOOD; ISCHEMIA; MODERATE	Traumatic brain injury (TBI) could highly induce coagulopathy through breaking the dynamic balance between coagulation and fibrinolysis systems, which may be a major contributor to the progressive secondary injury cascade that occurs after TBI. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) inhibition is reported to exert neuroprotection in TBI, making it a potential regulatory target involved in TBI-induced coagulation disorder. PTEN level is controlled in a major way by E3 ligase-mediated degradation through the ubiquitin-proteasome system. The C terminus of Hsc70-interacting protein (CHIP) has been shown to regulate proteasomal degradation and ubiquitination level of PTEN. In the present study, CHIP was overexpressed and knocked down in mouse brain microvascular endothelial cells (bEnd.3) and tissues during the early phase of TBI.In vitrocell proliferation, cell apoptosis, migration capacity, and invasion capacity were determined. The changes of procoagulant and apoptosis molecules after TBI were also detected as well as the micrangium density and blood-brain barrier permeability afterin vivoTBI.In vitroresults demonstrated that CHIP overexpression facilitated bEnd.3 cell proliferation, migration, and invasion and downregulated cell apoptosis and the expressions of procoagulant molecules through promoting PTEN ubiquitination in a simulated TBI model with stretch-induced injury treatment.In vivoexperiments also demonstrated that CHIP overexpression suppressed post-TBI apoptosis and procoagulant protein expressions, as well as increased microvessel density, reduced hemorrhagic injury, and blood-brain barrier permeability. These findings suggested that the upregulation of CHIP may attenuate apoptosis and procoagulant activity, facilitate brain repair, and thus exerts neuroprotective effects in TBI.	[Chen, Hao; Jing, Yao; Xu, Zhiming; Yang, Dianxu; Ju, Shiming; Guo, Yan; Tian, Hengli] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Neurosurg, Shanghai, Peoples R China; [Xue, Lixia] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Neurol, Shanghai, Peoples R China		Xue, LX (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Neurol, Shanghai, Peoples R China.	dr.xue@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81501657, 81801169]; Shanghai Pujiang ProgramShanghai Pujiang Program [18PJD034]	This study was supported by the National Natural Science Foundation of China (81501657 and 81801169) and was sponsored by the Shanghai Pujiang Program (18PJD034).	Ahmed SF, 2012, J BIOL CHEM, V287, P15996, DOI 10.1074/jbc.M111.321083; Barklin A, 2009, ANESTHESIOLOGY, V110, P1287, DOI 10.1097/ALN.0b013e3181a10352; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Chen H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/685174; Condron M, 2018, J TRAUMA ACUTE CARE, V85, P888, DOI 10.1097/TA.0000000000002040; De Luca C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102128; De Oliveira CO, 2007, J NEUROTRAUM, V24, P1331, DOI 10.1089/neu.2006.0159; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Ding J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080429; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Guo JY, 2013, INT J MOL SCI, V14, P12013, DOI 10.3390/ijms140612013; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Hasegawa Y, 2012, J NEUROSCI RES, V90, P691, DOI 10.1002/jnr.22801; He LQ, 2019, THERANOSTICS, V9, P8206, DOI 10.7150/thno.37455; Hori Y, 2005, INT J MOL MED, V15, P265; Kao SH, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0470-0; Kilic U, 2017, REDOX BIOL, V12, P657, DOI 10.1016/j.redox.2017.04.006; Kitagishi Y, 2013, ALZHEIMERS RES THER, V5, DOI [10.1186/alzrt208, 10.1186/1758-9193-5-42]; Liu C, 2010, J NEUROCHEM, V112, P1500, DOI 10.1111/j.1471-4159.2009.06561.x; Liu J, 2016, CHIN J TRAUMATOL, V19, P172, DOI 10.1016/j.cjtee.2016.01.011; Liu SW, 2015, ACTA NEUROCHIR, V157, P1697, DOI 10.1007/s00701-015-2559-5; Liu YL, 2018, J NEUROTRAUM, V35, P2850, DOI 10.1089/neu.2017.5397; Lv YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083312; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Marino R, 2006, NEUROLOGY, V67, P1165, DOI 10.1212/01.wnl.0000238081.35281.b5; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Schabbauer G, 2004, ARTERIOSCL THROM VAS, V24, P1963, DOI 10.1161/01.ATV.0000143096.15099.ce; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Server A, 2001, ACTA RADIOL, V42, P254; Shao C, 2017, CELL CYCLE, V16, P957, DOI 10.1080/15384101.2017.1310351; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; Voutsadakis IA, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-67; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Xu T, 2017, AM J CANCER RES, V7, P289; Xu ZM, 2017, J NEUROTRAUM, V34, P925, DOI 10.1089/neu.2016.4491; Xue LX, 2018, METAB BRAIN DIS, V33, P1679, DOI 10.1007/s11011-018-0276-5; Yang DX, 2019, J NEUROTRAUM, V36, P1279, DOI 10.1089/neu.2018.5942; Yang DB, 2014, PEPTIDES, V58, P26, DOI 10.1016/j.peptides.2014.05.015; Yuan F, 2016, J NEUROCHEM, V136, P581, DOI 10.1111/jnc.13423; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	50	1	1	3	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	SEP 8	2020	14								925	10.3389/fnins.2020.00925			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NV4GB	WOS:000574281200001	33013306	Green Published, gold			2022-02-06	
J	Fagan, BT; Satapathy, SS; Rutledge, JN; Kornguth, SE				Fagan, Brian T.; Satapathy, Sikhanda S.; Rutledge, J. Neal; Kornguth, Steven E.			Simulation of the Strain Amplification in Sulci Due to Blunt Impact to the Head	FRONTIERS IN NEUROLOGY			English	Article						injury biomechanics; finite element analysis; computational biomechanics; traumatic brain injury; blunt impact to head	TRAUMATIC BRAIN-INJURY; FINITE-ELEMENT MODEL; CAVITATION	Traumatic brain injury (TBI) has become a concern in sports, automobile accidents and combat operations. A better understanding of the mechanics leading to a TBI is required to cope with both the short-term life-threatening effects and long-term effects of TBIs, such as the development chronic traumatic encephalopathy (CTE). Kornguth et al. (1) proposed that an inflammatory and autoimmune process initiated by a water hammer effect at the bases of the sulci of the brain is a mechanism of TBI leading to CTE. A major objective of this study is to investigate whether the water hammer effect is present due to blunt impacts through the use of computational models. Frontal blunt impacts were simulated with 2D finite element models developed to capture the biofidelic geometry of a human head. The models utilized the Arbitrary Lagrangian Eulerian (ALE) method to model a layer of cerebrospinal fluid (CSF) as a deforming fluid allowing for CSF to move in and out of sulci. During the simulated impacts, CSF was not observed to be driven into the sulci during the transient response. However, elevated shear strain levels near the base of the sulci were exhibited. Further, increased shear strain was present when differentiation between white and gray matter was taken into account. Both of the results support clinical observations of (1).	[Fagan, Brian T.; Satapathy, Sikhanda S.] US Army Combat Capabil Dev Command, Army Res Lab, Aberdeen Proving Ground, MD 21005 USA; [Rutledge, J. Neal] Austin Radiol Assoc, Austin, TX USA; [Kornguth, Steven E.] Univ Texas Austin, Dell Med Sch, Austin, TX 78712 USA; [Kornguth, Steven E.] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA		Fagan, BT (corresponding author), US Army Combat Capabil Dev Command, Army Res Lab, Aberdeen Proving Ground, MD 21005 USA.	brian.t.fagan2.civ@mail.mil			U.S. Army Combat Capabilities Development Command (CCDC) Army Research Laboratory [W911NF-16-2-0008]	Research was sponsored by the U.S. Army Combat Capabilities Development Command (CCDC) Army Research Laboratory and was accomplished under Cooperative Agreement Number W911NF-16-2-0008. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the CCDC Army Research Laboratory or the U.S. Government. The U.S. Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation herein.	Alexander SL, 2018, MICROSTRUCTURAL DEPE; Bandak F.A., 1994, SAE T, V103, P1708, DOI DOI 10.4271/942215; Bargerstock E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101477; Brennen CE, 2014, CAVITATION AND BUBBLE DYNAMICS, P1; Caupin F, 2006, CR PHYS, V7, P1000, DOI 10.1016/j.crhy.2006.10.015; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; DeKosky, 1998, Semin Clin Neuropsychiatry, V3, P176; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; FALLENSTEIN GT, 1969, J BIOMECH, V2, P217, DOI 10.1016/0021-9290(69)90079-7; Ferro A, 2014, J HUM KINET, V44, P143, DOI 10.2478/hukin-2014-0120; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Herbert E, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041603; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kochunov P, 2005, HUM BRAIN MAPP, V26, P210, DOI 10.1002/hbm.20198; Kornguth S, 2018, BIOMARK INSIGHTS, V13, DOI 10.1177/1177271918808216; Kornguth S, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120164; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; Kurosawa Y, 2009, IEEE ENG MED BIO, P7224, DOI 10.1109/IEMBS.2009.5335260; Mansell JL, 2010, BRAIN INJURY, V24, P1070, DOI 10.3109/02699052.2010.494589; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Nenno PT, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/12/125019; NUSHOLTZ GS, 1995, J NEUROTRAUM, V12, P707, DOI 10.1089/neu.1995.12.707; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Wardlaw A., 2010, 26 SO BIOM ENG C, DOI [10.1007/978-3-642-14998-6_9, DOI 10.1007/978-3-642-14998-6_9]; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Yun HJ, 2013, RADIOLOGY, V267, P880, DOI DOI 10.1148/radiol.13122542; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhang Timothy G, 2013, P ASME 2013 INT MECH; Zygote Media Group Inc, 2015, ZYG SOL 3D MAL AN CO	41	1	1	2	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 8	2020	11								998	10.3389/fneur.2020.00998			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NV7DH	WOS:000574476800001	33013659	gold, Green Published			2022-02-06	
J	Qubty, D; Rubovitch, V; Benromano, T; Ovadia, M; Pick, CG				Qubty, Doaa; Rubovitch, Vardit; Benromano, Tali; Ovadia, Michael; Pick, Chaim G.			Orally Administered Cinnamon Extract Attenuates Cognitive and Neuronal Deficits Following Traumatic Brain Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Traumatic brain injury (TBI); Cognitive impairments; Cinnamon extract (CE); Neurodegenerative disease; Neuronal survival; Spatial memory; Visual memory	ALZHEIMERS-DISEASE; ESSENTIAL OIL; HEAD-INJURY; PATHOPHYSIOLOGY; CONSEQUENCES; INHIBITION; BEHAVIOR; RISK; MICE	The present paper shows how cinnamon extract (CE) consumption mitigates neuronal loss and memory impairment following traumatic brain injury (TBI), one of the world's most common neurodegenerative diseases. TBI patients suffer short- and long-term behavioral, cognitive, and emotional impairments, including difficulties in concentration, memory loss, and depression. Research shows that CE application can mitigate cognitive and behavioral impairments in animal models for Alzheimer's and Parkinson's disease, whose pathophysiology is similar to that of TBI. This study builds on prior research by showing similar results in TBI mice models. After drinking CE for a week, mice were injured using our 70-g weight drop TBI device. For 2 weeks thereafter, the mice continued drinking CE alongside standard lab nutrition. Subsequently, the mice underwent behavioral tests to assess their memory, motor activity, and anxiety. The mice brains were harvested for immunohistochemistry staining to evaluate overall neuronal survival. Our results show that CE consumption almost completely mitigates memory impairment and decreases neuronal loss after TBI. Mice that did not consume CE demonstrated impaired memory. Our results also show that CE consumption attenuated neuronal loss in the temporal cortex and the dentate gyrus. Mice that did not consume CE suffered a significant neuronal loss. There were no significant differences in anxiety levels and motor activity between all groups. These findings show a new therapeutic approach to improve cognitive function and decrease memory loss after TBI.	[Qubty, Doaa; Rubovitch, Vardit; Benromano, Tali; Pick, Chaim G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, Tel Aviv, Israel; [Ovadia, Michael] Tel Aviv Univ, Dept Zool, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Dr Miriam & Sheldon G Adelson Chair, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Ctr Biol Addict Dis, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Sylvan Adams Sports Inst, Tel Aviv, Israel		Pick, CG (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, Tel Aviv, Israel.; Pick, CG (corresponding author), Tel Aviv Univ, Dr Miriam & Sheldon G Adelson Chair, Tel Aviv, Israel.; Pick, CG (corresponding author), Tel Aviv Univ, Ctr Biol Addict Dis, Tel Aviv, Israel.; Pick, CG (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.; Pick, CG (corresponding author), Tel Aviv Univ, Sylvan Adams Sports Inst, Tel Aviv, Israel.	pickc@tauex.tau.ac.il			Ari and Regine Aprijaskis Fund at Tel-Aviv University; Dr. Miriam and Sheldon G. Adelson Chair for the Biology of Addictive Diseases in Tel-Aviv University, Tel-Aviv, Israel	This research was supported in part by the Ari and Regine Aprijaskis Fund at Tel-Aviv University and the Dr. Miriam and Sheldon G. Adelson Chair for the Biology of Addictive Diseases in Tel-Aviv University, Tel-Aviv, Israel.	Anderson RA, 2004, J AGR FOOD CHEM, V52, P65, DOI 10.1021/jf034916b; Anderson RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083243; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Brahmachari S, 2009, J IMMUNOL, V183, P5917, DOI 10.4049/jimmunol.0803336; Gende LB, 2008, B INSECTOL, V61, P1; Chen YF, 2016, NEUROMOL MED, V18, P322, DOI 10.1007/s12017-016-8395-9; Choe MC, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0573-9; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Dugoua JJ, 2007, CAN J PHYSIOL PHARM, V85, P837, DOI 10.1139/Y07-080; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; Espejo EF, 1997, BEHAV BRAIN RES, V86, P105, DOI 10.1016/S0166-4328(96)02245-0; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Frydman-Marom A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016564; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Khan A, 2003, DIABETES CARE, V26, P3215, DOI 10.2337/diacare.26.12.3215; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lin LC, 2007, J AGR FOOD CHEM, V55, P1517, DOI 10.1021/jf062816a; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Momtaz S, 2018, PHARMACOL RES, V130, P241, DOI 10.1016/j.phrs.2017.12.011; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Ouattara B, 1997, INT J FOOD MICROBIOL, V37, P155, DOI 10.1016/S0168-1605(97)00070-6; Paiva SAR, 1999, J AM COLL NUTR, V18, P426, DOI 10.1080/07315724.1999.10718880; Peterson DW, 2009, J ALZHEIMERS DIS, V17, P585, DOI 10.3233/JAD-2009-1083; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Rao PV, 2014, EVIDENCE BASED COMPL; Schaffer S, 2012, GENES NUTR, V7, P99, DOI 10.1007/s12263-011-0255-5; Shaltiel-Karyo R, 2012, BBA-GEN SUBJECTS, V1820, P1628, DOI 10.1016/j.bbagen.2012.04.021; SIMIAND J, 1984, PSYCHOPHARMACOLOGY, V84, P48, DOI 10.1007/BF00432023; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Yulug B, 2018, CNS NEUROL DISORD-DR, V17, P439, DOI 10.2174/1871527317666180501110918; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	44	1	1	1	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	JAN	2021	71	1					178	186		10.1007/s12031-020-01688-4		SEP 2020	9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	PI6HN	WOS:000568086000004	32901372				2022-02-06	
J	Rao, HM; Talkar, T; Ciccarelli, G; Nolan, M; O'Brien, A; Vergara-Diaz, G; Sherrill, D; Zafonte, R; Palmer, JS; Quatieri, TF; McKindles, RJ; Bonato, P; Lammert, AC				Rao, Hrishikesh M.; Talkar, Tanya; Ciccarelli, Gregory; Nolan, Michael; O'Brien, Anne; Vergara-Diaz, Gloria; Sherrill, Delsey; Zafonte, Ross; Palmer, Jeffrey S.; Quatieri, Thomas F.; McKindles, Ryan J.; Bonato, Paolo; Lammert, Adam C.			Sensorimotor conflict tests in an immersive virtual environment reveal subclinical impairments in mild traumatic brain injury	SCIENTIFIC REPORTS			English	Article							BERG BALANCE SCALE; MONTREAL COGNITIVE ASSESSMENT; MINOR HEAD-INJURY; CONCUSSION; REHABILITATION; WALKING; COMMUNITY; POSITION; SPEED; MOCA	Current clinical tests lack the sensitivity needed for detecting subtle balance impairments associated with mild traumatic brain injury (mTBI). Patient-reported symptoms can be significant and have a huge impact on daily life, but impairments may remain undetected or poorly quantified using clinical measures. Our central hypothesis was that provocative sensorimotor perturbations, delivered in a highly instrumented, immersive virtual environment, would challenge sensory subsystems recruited for balance through conflicting multi-sensory evidence, and therefore reveal that not all subsystems are performing optimally. The results show that, as compared to standard clinical tests, the provocative perturbations illuminate balance impairments in subjects who have had mild traumatic brain injuries. Perturbations delivered while subjects were walking provided greater discriminability (average accuracy approximate to 0.90) than those delivered during standing (average accuracy approximate to 0.65) between mTBI subjects and healthy controls. Of the categories of features extracted to characterize balance, the lower limb accelerometry-based metrics proved to be most informative. Further, in response to perturbations, subjects with an mTBI utilized hip strategies more than ankle strategies to prevent loss of balance and also showed less variability in gait patterns. We have shown that sensorimotor conflicts illuminate otherwise-hidden balance impairments, which can be used to increase the sensitivity of current clinical procedures. This augmentation is vital in order to robustly detect the presence of balance impairments after mTBI and potentially define a phenotype of balance dysfunction that enhances risk of injury.	[Rao, Hrishikesh M.; Talkar, Tanya; Ciccarelli, Gregory; Nolan, Michael; Sherrill, Delsey; Palmer, Jeffrey S.; Quatieri, Thomas F.; McKindles, Ryan J.] MIT, Lincoln Lab, Human Hlth & Performance Syst, 244 Wood St, Lexington, MA 02173 USA; [O'Brien, Anne; Vergara-Diaz, Gloria; Bonato, Paolo] Spaulding Rehabil Hosp, Mot Anal Lab, Boston, MA USA; [Vergara-Diaz, Gloria; Zafonte, Ross; Bonato, Paolo] Massachusetts Gen Hosp, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Zafonte, Ross] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; [Lammert, Adam C.] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [Talkar, Tanya; Quatieri, Thomas F.] Harvard Med Sch, Speech & Hearing Biosci & Technol, Boston, MA 02115 USA		Rao, HM (corresponding author), MIT, Lincoln Lab, Human Hlth & Performance Syst, 244 Wood St, Lexington, MA 02173 USA.	Hrishikesh.Rao@LL.mit.edu	Bonato, Paolo/AAH-6111-2019; Palmer, Jeffrey/AAB-6622-2022	Bonato, Paolo/0000-0002-1818-1714; 	Under Secretary of Defense for Research and Engineering under Air Force [FA8702-15-D-0001]	A. Approved for public release. Distribution is unlimited. This material is based upon work supported by the Under Secretary of Defense for Research and Engineering under Air Force Contract No. FA8702-15-D-0001. Any opinions, findings, conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the Under Secretary of Defense for Research and Engineering. (c) 2020 Massachusetts Institute of Technology. Delivered to the U.S. Government with Unlimited Rights, as defined in DFARS Part 252.227-7013 or 7014 (Feb 2014). Notwithstanding any copyright notice, U.S. Government rights in this work are defined by DFARS 252.227-7013 or DFARS 252.227-7014 as detailed above. Use of this work other than as specifically authorized by the U.S. Government may violate any copyrights that exist in this work.	Barkan A, 2014, IEEE INT CONF ROBOT, P2838, DOI 10.1109/ICRA.2014.6907266; Blenkinsop GM, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.161018; Collins JD, 2015, WORK, V50, P121, DOI 10.3233/WOR-141927; Dvorkin AY, 2013, BRAIN INJURY, V27, P957, DOI 10.3109/02699052.2013.793399; Faul M, 2010, CDC TBI US REPORT TR; Finkelstein E., 2006, INCIDENCE EC BURDEN; Godi M, 2013, PHYS THER, V93, P158, DOI 10.2522/ptj.20120171; Haran F J, 2008, J Neurol Phys Ther, V32, P186, DOI 10.1097/NPT.0b013e31818dee39; Helm-Estabrooks N., 2001, COGNITIVE LINGUISTIC; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Horak FB, 2009, PHYS THER, V89, P484, DOI 10.2522/ptj.20080071; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Jin X, 2015, IEEE INT CONF ROBOT, P5578, DOI 10.1109/ICRA.2015.7139979; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Keshner E., 2016, NEUROPHYSIOL CLIN CL, V46, P264; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; Lei-Rivera L, 2013, NEUROREHABILITATION, V32, P463, DOI 10.3233/NRE-130869; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; MUELLER MJ, 1994, ARCH PHYS MED REHAB, V75, P1196, DOI 10.1016/0003-9993(94)90004-3; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Peterson Michelle, 2015, Arch Phys Med Rehabil, V96, P379, DOI 10.1016/j.apmr.2013.06.012; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Quatman-Yates C, 2014, PHYSICIAN SPORTSMED, V42, P32, DOI 10.3810/psm.2014.09.2073; Rabago CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142083; Rabago CA, 2011, J NEUROL PHYS THER, V35, P185, DOI 10.1097/NPT.0b013e318235d7e6; Rossetti HC, 2011, NEUROLOGY, V77, P1272, DOI 10.1212/WNL.0b013e318230208a; Sessoms PH, 2015, MIL MED, V180, P143, DOI 10.7205/MILMED-D-14-00385; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Stanney KM, 2014, HDB VIRTUAL ENV DESI; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Vazquez A, 2015, J NEUROPHYSIOL, V114, P3255, DOI 10.1152/jn.00302.2015; Williams GP, 2009, INT J THER REHABIL, V16, P370, DOI 10.12968/ijtr.2009.16.7.43046; Yokoyama H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194875; Young PMM, 2012, J BIOMECH, V45, P1053, DOI 10.1016/j.jbiomech.2011.12.027; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	39	1	1	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	SEP 8	2020	10	1							14773	10.1038/s41598-020-71611-9			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NT9JG	WOS:000573254600008	32901067	gold, Green Published			2022-02-06	
J	Merz, ZC; Flashman, LA; Ford, JC; McDonald, BC; McAllister, TW				Merz, Zachary C.; Flashman, Laura A.; Ford, James C.; McDonald, Brenna C.; McAllister, Thomas W.			Comparison of season-long diffusivity measures in a cohort of non-concussed contact and non-contact athletes	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Sport-related concussion; diffusion tensor imaging; TRACULA; white matter integrity	TRAUMATIC BRAIN-INJURY; WHITE-MATTER INTEGRITY; UNCINATE FASCICULUS; FRONTOTEMPORAL DEMENTIA; CORPUS-CALLOSUM; DAMAGE; ENCEPHALOPATHY; DEGENERATION; DEFICITS; DISEASE	Introduction Concern surrounding short- and long-term consequences of participation in contact sports has become a significant public health topic. Previous literature utilizing diffusion tensor imaging in sports-related concussion has exhibited notable variety of analysis methods and analyzed regions of interest, and largely focuses on acute effects of concussion. The current study aimed to compare diffusivity metrics across a single season within athlete cohorts with no history of concussion. Methods A prospective cohort of 75 contact and 79 non-contact division I athletes were compared across diffusion tensor imaging metrics (i.e. TRACULA); examinations were also performed assessing the relationship between neuroimaging metrics, head impact exposure metrics (in-helmet accelerometer), and neurocognitive variables. Assessment occurred at pre-and post-season time points. Results Seasonal changes in fractional anisotropy and mean diffusivity values did not differ between athlete cohorts, nor did they differ within cohort groups, across pre- and post-season scans. Specific to contact athletes, positive associations were found between uncinate fasciculus mean diffusivity values and season linear acceleration (p =.018), season rotational acceleration (p =.017), and season hit severity (p =.021). Conclusions Results suggest an influence of impact frequency, type, and severity on white matter integrity in select brain regions in contact athletes. Current findings expand our knowledge of anatomical changes over the course of a single season, and underscore the importance of considering methodology when interpreting findings in this population, as differing image analysis techniques may lead to different conclusions regarding significant effects.	[Merz, Zachary C.] Moses Cone Mem Hosp, LeBauer Dept Neurol, Greensboro, NC 27401 USA; [Flashman, Laura A.] Wake Forest Univ, Dept Neurol, Wake Forest Baptist Hlth, Winston Salem, NC USA; [Ford, James C.] Dartmouth Hitchcock Med Ctr, Dept Psychiat, Hanover, NH USA; [Ford, James C.] Geisel Sch Med Dartmouth, Hanover, NH USA; [McDonald, Brenna C.] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA		Merz, ZC (corresponding author), Moses Cone Mem Hosp, LeBauer Dept Neurol, Greensboro, NC 27401 USA.	zachary.merz@conehealth.com			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD048638, R01NS055020]; National Operating Committee on Standards for Athletic Equipment [NOCSAE 04-07]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD048638, R01NS055020]	This study was funded via grants NIH R01HD048638 and R01NS055020 and the National Operating Committee on Standards for Athletic Equipment [NOCSAE 04-07]; National Institutes of Health [R01HD048638,R01NS055020]	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Agosta F, 2012, CEREB CORTEX, V22, P2705, DOI 10.1093/cercor/bhr288; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Aylward, 1996, GORDON DIAGNOSTIC SY; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behen ME, 2008, CHILD NEUROPSYCHOL, V14, P453, DOI 10.1080/09297040802244136; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Delis DC., 2001, DELIS KAPLAN EXECUTI; Ewing-Cobbs L., 2011, OUTCOME ABUSIVE HEAD, P451; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Golden CJ, 1978, STROOP COLOR WORD TE; Goodrich-Hunsaker NJ, 2018, J NEUROSCI RES, V96, P626, DOI 10.1002/jnr.24142; Gou JH, 2003, POLYM COMPOSITE, V24, P1, DOI 10.1002/pc.10000; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Johnson CP, 2011, J INT NEUROPSYCH SOC, V17, P663, DOI 10.1017/S1355617711000464; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lao Y, 2015, PROC SPIE, V9287, DOI 10.1117/12.2072600; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Mahoney C, 2012, J NEUROL NEUROSUR PS, V83, DOI 10.1136/jnnp-2011-301993.61; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayinger MC, 2018, BRAIN IMAGING BEHAV, V12, P44, DOI 10.1007/s11682-017-9672-4; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Metzler-Baddeley C, 2012, J NEUROSCI, V32, P17612, DOI 10.1523/JNEUROSCI.3299-12.2012; Neuroimaging Tools and Resources Collaboratory (NITRC), 2007, WFU PICKATLAS TOOL R; Oishi K, 2015, ANN NEUROL, V77, P68, DOI 10.1002/ana.24300; Olson IR, 2015, DEV COGN NEUROS-NETH, V14, P50, DOI 10.1016/j.dcn.2015.06.003; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Piguet O, 2011, LANCET NEUROL, V10, P162, DOI 10.1016/S1474-4422(10)70299-4; R Development Core Team, 2012, R LANG ENV STAT COMP; Reitan RM, 1992, TRAIL MAKING TEST MA; Schoenberg MR, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P357, DOI 10.1007/978-0-387-76978-3_14; Seo JP, 2012, NEUROREHABILITATION, V30, P323, DOI 10.3233/NRE-2012-0762; Solomon GS, 2015, BRAIN INJURY, V29, P164, DOI 10.3109/02699052.2014.965205; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tartaglia MC, 2012, J NEUROL, V259, P1071, DOI 10.1007/s00415-011-6300-x; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weder Natalie D, 2007, Ann Gen Psychiatry, V6, P15, DOI 10.1186/1744-859X-6-15; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wilcox B. J., 2014, THESIS; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Yeh PH, 2017, HUM BRAIN MAPP, V38, P352, DOI 10.1002/hbm.23365; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhang L, 2006, AM J NEURORADIOL, V27, P2000; Zhang Y, 2009, BRAIN, V132, P2579, DOI 10.1093/brain/awp071	64	1	1	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	SEP 13	2020	42	8					811	821		10.1080/13803395.2020.1813257		SEP 2020	11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	OA2EN	WOS:000566998500001	32893734	Green Accepted			2022-02-06	
J	Celi, F; Saal-Zapata, G				Celi, Fernando; Saal-Zapata, Giancarlo			Decompressive Craniectomy for Traumatic Brain Injury: In-hospital Mortality-Associated Factors	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						decompressive craniectomy; intracranial pressure; intracranial hypertension; traumatic brain injury	MANAGEMENT	Objective Determine predictors of in-hospital mortality in patients with severe traumatic brain injury (TBI) who underwent decompressive craniectomy. Materials and Methods This retrospective study reviewed consecutive patients who underwent a decompressive craniectomy between March 2017 and March 2020 at our institution, and analyzed clinical characteristics, brain tomographic images, surgical details and morbimortality associated with this procedure. Results Thirty-three (30 unilateral and 3 bifrontal) decompressive craniectomies were performed, of which 27 patients were male (81.8%). The mean age was 52.18 years, the mean Glasgow coma scale (GCS) score at admission was 9, and 24 patients had anisocoria (72.7%). Falls were the principal cause of the trauma (51.5%), the mean anterior-posterior diameter (APD) of the bone flap in unilateral cases was 106.81 mm (standard deviation [SD] 20.42) and 16 patients (53.3%) underwent a right-sided hemicraniectomy. The temporal bone enlargement was done in 20 cases (66.7%), the mean time of surgery was 2 hours and 27 minutes, the skull flap was preserved in the subcutaneous layer in 29 cases (87.8%), the mean of blood loss was 636.36 mL,and in-hospital mortality was 12%. Univariate analysis found differences between the APD diameter (120.3 mm vs. 85.3 mm; p = 0.003) and the presence of midline shift > 5 mm (p = 0.033). Conclusion The size of the skull flap and the presence of midline shift > 5 mm were predictors of mortality. In the absence of intercranial pressure (ICP) monitoring, clinical and radiological criteria are mandatory to perform a decompressive craniectomy.	[Celi, Fernando] Hosp Emergencias Jose Casimiro Ulloa, Dept Neurosurg, Lima, Peru; [Saal-Zapata, Giancarlo] Hosp Nacl Guillermo Almenara Irigoyen EsSalud, Dept Neurosurg, Lima, Peru; [Saal-Zapata, Giancarlo] Clin Angloamer, Lima, Peru		Saal-Zapata, G (corresponding author), Grau Ave 800, Lima 13, Peru.	gian_carlo1987@hotmail.com	Saal, Giancarlo/A-2281-2019	Saal, Giancarlo/0000-0002-4622-7118			Cam Páucar Juan Luís, 2011, Acta méd. peruana, V28, P39; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Flores J, 2010, REV PERU NEUROCIR, V5, P5; Gopalakrishnan MS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00977; Gouello G, 2014, SCI WORLD J, DOI 10.1155/2014/207585; Guillén-Pinto Daniel, 2013, Rev. perú. med. exp. salud publica, V30, P630; Ho MY, 2018, INT J BIOMED IMAGING, V2018, DOI 10.1155/2018/5237693; Honeybul S, 2013, WORLD NEUROSURG, V79, P159, DOI 10.1016/j.wneu.2012.08.012; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Huang X, 2010, INT J MED SCI, V7, P385; Huang YH, 2013, J NEUROSURG, V118, P1329, DOI 10.3171/2013.1.JNS121775; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Khalili Hosseinali, 2017, Bull Emerg Trauma, V5, P190; Kolias AG, 2018, CURR TRAUMA REP, V4, P326, DOI 10.1007/s40719-018-0147-x; Laghari Altaf Ali, 2018, Asian J Neurosurg, V13, P1053, DOI 10.4103/ajns.AJNS_195_17; Moon Ji Won, 2017, Korean J Neurotrauma, V13, P1, DOI 10.13004/kjnt.2017.13.1.1; Ogunlade J, 2018, CUREUS, V10, DOI 10.7759/cureus.3042; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Robinson JD, 2016, CRIT CARE NURS CLIN, V28, P67, DOI 10.1016/j.cnc.2015.09.004; Sahuquillo J, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub3; Sedney CL, 2014, J NEUROSCI RURAL PRA, V5, P212, DOI 10.4103/0976-3147.133555; Smith M, 2020, INTENS CARE MED, V46, P1023, DOI 10.1007/s00134-020-05933-7; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4	27	1	1	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	OCT	2020	11	04					601	608		10.1055/s-0040-1715998		SEP 2020	8	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	OI1FX	WOS:000565888500002	33144798	Green Published, gold			2022-02-06	
J	Coslick, AM; Chin, KE; Kalb, LG; Slomine, BS; Suskauer, SJ				Coslick, Alexis M.; Chin, Kaitlyn E.; Kalb, Luther G.; Slomine, Beth S.; Suskauer, Stacy J.			Participation in Physical Activity at Time of Presentation to a Specialty Concussion Clinic Is Associated With Shorter Time to Recovery	PM&R			English	Article							SPORTS; CHILDREN; SYMPTOMS; OUTCOMES; INJURY; REST; REHABILITATION; EPIDEMIOLOGY; STATEMENT; TRENDS	IntroductionNovel research suggests that children engaging in physical activity during recovery from concussion may recover more rapidly. ObjectiveTo determine if level of physical activity at presentation to a rehabilitation-based concussion specialty clinic predicted days from injury to recovery. DesignRetrospective cohort. SettingA concussion sub-specialty clinic at an academic institution. PatientsRetrospective review of medical records between September 2015 and February 2017 identified 178 children ages 6-17years (mean age=13.7years; standard deviation [SD]=2.7years) who presented within 60days of concussion and were ultimately deemed recovered and cleared to progress to full return to high-risk activities. InterventionsNot applicable. Main Outcome MeasuresPhysical activity at initial visit was classified as none-to-light (79%) versus moderate-to-heavy (21%). A doubly robust, inverse probability of exposure weighted linear regression model was used to examine the relationship between physical activity level and days to recovery, while adjusting for 10 demographic and clinical variables. ResultsChildren participating in moderate-to-heavy activity at initial evaluation in concussion clinic averaged recovery 21days quicker (95% confidence interval [CI] -27.1, -15.5, P<.001) than children who were engaging in none-to-light activity. This finding did not change when removing children who were deemed recovered at the first visit (who may have initiated physical activity after becoming asymptomatic). ConclusionsThese data add to growing evidence that progressive physical activity during recovery from concussion does not appear to be harmful. Physical activity represents a modifiable variable in recovery, and physicians can potentially expedite symptomatic recovery by recommending noncontact physical activity as tolerated during concussion recovery.	[Coslick, Alexis M.; Slomine, Beth S.; Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21205 USA; [Chin, Kaitlyn E.] Univ New England, Coll Osteopath Med, Biddeford, ME USA; [Kalb, Luther G.; Slomine, Beth S.; Suskauer, Stacy J.] Kennedy Krieger Inst, Biddeford, ME 04005 USA; [Kalb, Luther G.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Slomine, Beth S.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Slomine, Beth S.; Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA		Suskauer, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21205 USA.; Suskauer, SJ (corresponding author), Kennedy Krieger Inst, Biddeford, ME 04005 USA.; Suskauer, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.	suskauer@kennedykrieger.org		Suskauer, Stacy/0000-0002-5009-5584	Peter Morgane Student Research Fellowship University of New England College of Osteopathic Medicine; IDDRC from the NICHD [U54 HD079123]	Supported by the Peter Morgane Student Research Fellowship University of New England College of Osteopathic Medicine 2017-2018 [to KEC]; IDDRC from the NICHD (Grant #: U54 HD079123) [to LGK].	Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Davis-Hayes C, 2017, J AM ACAD ORTHOP SUR, V25, P818, DOI 10.5435/JAAOS-D-17-00276; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Dobney DM, 2018, J HEAD TRAUMA REHAB, V33, pE11, DOI 10.1097/HTR.0000000000000339; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gioia G, 2007, ACUTE CONCUSSION EVA; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Joffe MM, 2004, AM STAT, V58, P272, DOI 10.1198/000313004X5824; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lennon A, 2018, J NEUROL PHYS THER, V42, P123, DOI 10.1097/NPT.0000000000000227; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Pfaller AY, 2016, AM J SPORT MED, V44, P2941, DOI 10.1177/0363546516651821; Risen SR, 2017, PM&R, V9, P874, DOI 10.1016/j.pmrj.2016.12.005; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Wells EM, 2016, J CHILD NEUROL, V31, P86, DOI 10.1177/0883073815570152; Willer BS, 2019, ARCH PHYS MED REHAB, V100, P2267, DOI 10.1016/j.apmr.2019.07.003; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	41	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	DEC	2020	12	12					1195	1204		10.1002/pmrj.12443		SEP 2020	10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	PD9ET	WOS:000568370900001	32578944	Green Accepted			2022-02-06	
J	Sigler, A; He, XL; Bose, M; Cristea, A; Liu, WY; Nam, PKS; James, D; Burton, C; Shi, HL				Sigler, Austin; He, Xiaolong; Bose, Mousumi; Cristea, Alexandre; Liu, Wenyan; Nam, Paul Ki-souk; James, Donald; Burton, Casey; Shi, Honglan			Simultaneous Determination of Eight Urinary Metabolites by HPLC-MS/MS for Noninvasive Assessment of Traumatic Brain Injury	JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY			English	Article						traumatic brain injury (TBI); biomarkers; HPLC-MS/MS; urine analysis; noninvasive assessment	NEURON-SPECIFIC ENOLASE; C-TERMINAL HYDROLASE; CEREBROSPINAL-FLUID; AMINO-ACIDS; MILD; SERUM; BIOMARKERS; QUANTIFICATION; LACTATE; PROTEIN	Traumatic brain injury (TBI) is a serious public health concern for which sensitive and objective diagnostic methods remain lacking. While advances in neuroimaging have improved diagnostic capabilities, the complementary use of molecular biomarkers can provide clinicians with additional insight into the nature and severity of TBI. In this study, a panel of eight metabolites involved in distinct pathophysiological processes related to concussion was quantified using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). Specifically, the newly developed method can simultaneously determine urinary concentrations of glutamic acid, homovanillic acid, 5-hydroxyindoleacetic acid, methionine sulfoxide, lactic acid, pyruvic acid, N-acetylaspartic acid, and F-2 alpha-isoprostane without intensive sample preparation or preconcentration. The method was systematically validated to assess sensitivity (method detection limits: 1-20 mu g/L), accuracy (81-124% spike recoveries in urine), and reproducibility (relative standard deviation: 4-12%). The method was ultimately applied to a small cohort of urine specimens obtained from healthy college student volunteers. The method presented here provides a new technique to facilitate future work aiming to assess the clinical efficacy of these putative biomarkers for noninvasive assessment of TBI.	[Sigler, Austin; He, Xiaolong; Bose, Mousumi; Cristea, Alexandre; Liu, Wenyan; Nam, Paul Ki-souk; Burton, Casey; Shi, Honglan] Missouri Univ Sci & Technol, Dept Chem, Rolla, MO 65409 USA; [James, Donald; Burton, Casey] Phelps Hlth, Rolla, MO 65401 USA		Burton, C; Shi, HL (corresponding author), Missouri Univ Sci & Technol, Dept Chem, Rolla, MO 65409 USA.; Burton, C (corresponding author), Phelps Hlth, Rolla, MO 65401 USA.	c.f.burton@mst.edu; honglan@mst.edu		Nam, Paul/0000-0002-6064-3257; , Casey/0000-0002-0729-6743	Leonard Wood Institute; U.S. Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL) [W911NF-14-2-0034]	This study was sponsored by the Leonard Wood Institute in cooperation with the U.S. Army Research Laboratory and was accomplished under Cooperative Agreement Number W911NF-14-2-0034. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Leonard Wood Institute, the Army Research Laboratory or the U.S. Government. The U.S. Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation herein.	Achaintre D, 2016, ANAL CHEM, V88, P2637, DOI 10.1021/acs.analchem.5b03609; Aquilani R, 2003, ARCH PHYS MED REHAB, V84, P1258, DOI 10.1016/S0003-9993(03)00148-5; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Basu S, 1998, PROSTAG LEUKOTR ESS, V58, P319, DOI 10.1016/S0952-3278(98)90042-4; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Bulut M, 2006, ADV THER, V23, P12, DOI 10.1007/BF02850342; Burton C, 2014, CLIN CHIM ACTA, V435, P42, DOI 10.1016/j.cca.2014.04.022; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Guo K, 2009, ANAL CHEM, V81, P3919, DOI 10.1021/ac900166a; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; INAO S, 1988, J NEUROSURG, V69, P736, DOI 10.3171/jns.1988.69.5.0736; Jones MG, 2005, CLIN CHIM ACTA, V361, P150, DOI 10.1016/j.cccn.2005.05.023; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kvitvang HFN, 2011, ANAL CHEM, V83, P2705, DOI 10.1021/ac103245b; Luan HM, 2015, J PROTEOME RES, V14, P467, DOI 10.1021/pr500807t; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Narayanan S, 2001, J NEUROL, V248, P979, DOI 10.1007/s004150170052; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Sanchez-Rabaneda F, 2003, J MASS SPECTROM, V38, P35, DOI 10.1002/jms.395; Sharma R, 2012, CURR NEUROL NEUROSCI, V12, P560, DOI 10.1007/s11910-012-0301-8; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Singh B, 2013, BRAIN INJURY, V27, P293, DOI 10.3109/02699052.2012.743182; STROOMER AEM, 1990, CLIN CHEM, V36, P1834; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wu ZR, 2004, ANAL CHEM, V76, P839, DOI 10.1021/ac0351670; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; Yeo RA, 2006, J NEUROTRAUM, V23, P1427, DOI 10.1089/neu.2006.23.1427; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	37	1	1	1	6	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1044-0305	1879-1123		J AM SOC MASS SPECTR	J. Am. Soc. Mass Spectrom.	SEP 2	2020	31	9					1910	1917		10.1021/jasms.0c00181			8	Biochemical Research Methods; Chemistry, Analytical; Chemistry, Physical; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry; Spectroscopy	NO1VV	WOS:000569275300015	32700913				2022-02-06	
J	Song, J; Li, J; Chen, LX; Lu, XQ; Zheng, SN; Yang, Y; Cao, BL; Weng, YH; Chen, QY; Ding, JP; Huang, RW				Song, Jie; Li, Jie; Chen, Lixiang; Lu, Xingqi; Zheng, Senning; Yang, Ying; Cao, Bolin; Weng, Yihe; Chen, Qinyuan; Ding, Jianping; Huang, Ruiwang			Altered gray matter structural covariance networks at both acute and chronic stages of mild traumatic brain injury	BRAIN IMAGING AND BEHAVIOR			English	Article						Mild traumatic brain injury (mTBI); Structural covariance (SC); Gray matter volume (GMV)	DEFAULT MODE NETWORK; RESTING-STATE NETWORKS; FUNCTIONAL CONNECTIVITY; CORTICAL THICKNESS; PSYCHIATRIC-SYMPTOMS; POSTTRAUMATIC-STRESS; SUSTAINED ATTENTION; OEF/OIF VETERANS; SERVICE MEMBERS; MOTOR NETWORK	Cognitive and emotional impairments observed in mild traumatic brain injury (mTBI) patients may reflect variances of brain connectivity within specific networks. Although previous studies found altered functional connectivity (FC) in mTBI patients, the alterations of brain structural properties remain unclear. In the present study, we analyzed structural covariance (SC) for the acute stages of mTBI (amTBI) patients, the chronic stages of mTBI (cmTBI) patients, and healthy controls. We first extracted the mean gray matter volume (GMV) of seed regions that are located in the default-mode network (DMN), executive control network (ECN), salience network (SN), sensorimotor network (SMN), and the visual network (VN). Then we determined and compared the SC for each seed region among the amTBI, the cmTBI and the healthy controls. Compared with healthy controls, the amTBI patients showed lower SC for the ECN, and the cmTBI patients showed higher SC for the both DMN and SN but lower SC for the SMN. The results revealed disrupted ECN in the amTBI patients and disrupted DMN, SN and SMN in the cmTBI patients. These alterations suggest that early disruptions in SC between bilateral insula and the bilateral prefrontal cortices may appear in amTBI and persist into cmTBI, which might be potentially related to the cognitive and emotional impairments.	[Song, Jie; Chen, Lixiang; Zheng, Senning; Cao, Bolin; Weng, Yihe; Chen, Qinyuan; Huang, Ruiwang] South China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou 510631, Peoples R China; [Song, Jie; Chen, Lixiang; Zheng, Senning; Cao, Bolin; Weng, Yihe; Huang, Ruiwang] South China Normal Univ, Sch Psychol, Guangzhou 510631, Peoples R China; [Song, Jie; Chen, Lixiang; Zheng, Senning; Cao, Bolin; Weng, Yihe; Chen, Qinyuan; Huang, Ruiwang] South China Normal Univ, Guangdong Key Lab Mental Hlth & Cognit Sci, Guangzhou 510631, Peoples R China; [Li, Jie; Lu, Xingqi; Yang, Ying; Ding, Jianping] Hangzhou Normal Univ, Dept Radiol, Affiliated Hosp, Hangzhou 310015, Peoples R China; [Chen, Qinyuan] South China Normal Univ, Inst Brain Res & Rehabil, Guangzhou 510631, Peoples R China; [Ding, Jianping] Hangzhou Normal Univ, Sch Med, Hangzhou 310015, Peoples R China		Huang, RW (corresponding author), South China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou 510631, Peoples R China.; Huang, RW (corresponding author), South China Normal Univ, Sch Psychol, Guangzhou 510631, Peoples R China.; Huang, RW (corresponding author), South China Normal Univ, Guangdong Key Lab Mental Hlth & Cognit Sci, Guangzhou 510631, Peoples R China.; Ding, JP (corresponding author), Hangzhou Normal Univ, Dept Radiol, Affiliated Hosp, Hangzhou 310015, Peoples R China.; Ding, JP (corresponding author), Hangzhou Normal Univ, Sch Med, Hangzhou 310015, Peoples R China.	jpding@vip.sina.com; ruiwang.huang@gmail.com		Chen, Qinyuan/0000-0002-8567-0374; Chen, Lixiang/0000-0002-8154-7168	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81871338, 81371535, 81271548]; National Key R&D Program of China [2018YFC1705006]; Key Specialty Disease Specialist Project of Hangzhou City [20150733Q19]	This study was funded by the National Natural Science Foundation of China (Grant numbers: 81871338, 81371535, and 81271548), the National Key R&D Program of China (Grant number: 2018YFC1705006), and the Key Specialty Disease Specialist Project of Hangzhou City (Grant number: 20150733Q19). The funding organizations played no further role in study design, data collection, analysis and interpretation, or paper writing.	Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Aoki Y, 2016, NEUROSCI BIOBEHAV R, V66, P119, DOI 10.1016/j.neubiorev.2016.04.021; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bailie JM, 2016, J HEAD TRAUMA REHAB, V31, P2, DOI 10.1097/HTR.0000000000000142; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bernier RA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00297; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Cauda F, 2018, BRAIN, V141, P3211, DOI 10.1093/brain/awy252; Cauda F, 2018, HUM BRAIN MAPP, V39, P1898, DOI 10.1002/hbm.23952; Chang CY, 2018, ADV MECH ENG, V10, DOI 10.1177/1687814018798531; Chen Z, 2014, PSYCHOL MED, V44, P2489, DOI 10.1017/S003329171300319X; Chiong W, 2013, BRAIN, V136, P1929, DOI 10.1093/brain/awt066; Chou KH, 2015, HUM BRAIN MAPP, V36, P1567, DOI 10.1002/hbm.22724; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Dall'Acqua P, 2017, J NEUROTRAUM, V34, P3270, DOI 10.1089/neu.2017.5124; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Simoni S, 2018, BRAIN, V141, P148, DOI 10.1093/brain/awx309; Di Perri C, 2013, NEUROLOGY, V81, P1417, DOI 10.1212/WNL.0b013e3182a43b78; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Duning T, 2005, NEUROLOGY, V64, P548, DOI 10.1212/01.WNL.0000150542.16969.CC; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Evans AC, 2013, NEUROIMAGE, V80, P489, DOI 10.1016/j.neuroimage.2013.05.054; FERRER I, 1995, NEUROSCIENCE, V66, P189, DOI 10.1016/0306-4522(94)00584-R; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Fortenbaugh FC, 2018, NEUROIMAGE, V171, P148, DOI 10.1016/j.neuroimage.2018.01.002; Geng XJ, 2017, CEREB CORTEX, V27, P1795, DOI 10.1093/cercor/bhw022; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hamblin MR, 2018, J NEUROSCI RES, V96, P731, DOI 10.1002/jnr.24190; Heinze K, 2015, BIOL PSYCHIAT, V77, P989, DOI 10.1016/j.biopsych.2014.10.023; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Lee PL, 2018, EUR RADIOL, V28, P3296, DOI 10.1007/s00330-018-5342-1; Li F., 2019, BRAIN IMAGING BEHAV; Lindemer ER, 2013, NEUROIMAGE-CLIN, V2, P601, DOI 10.1016/j.nicl.2013.04.009; Manoliu A, 2014, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00930; Matsuo K, 2012, MOL PSYCHIATR, V17, P412, DOI 10.1038/mp.2011.3; Mayer AR, 2015, HUM BRAIN MAPP, V36, P4394, DOI 10.1002/hbm.22930; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mechelli A, 2005, J NEUROSCI, V25, P8303, DOI 10.1523/JNEUROSCI.0357-05.2005; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Montembeault M, 2016, CEREB CORTEX, V26, P2650, DOI 10.1093/cercor/bhv105; Montembeault M, 2012, NEUROIMAGE, V63, P754, DOI 10.1016/j.neuroimage.2012.06.052; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nelson C, 2011, MIL MED, V176, P156, DOI 10.7205/MILMED-D-10-00252; Newsome MR, 2015, NEUROIMAGE-CLIN, V8, P543, DOI 10.1016/j.nicl.2015.04.024; O'Neil M E., 2013, COMPLICATIONS MILD T, P1; Pagani M, 2016, NEUROIMAGE, V129, P55, DOI 10.1016/j.neuroimage.2016.01.025; Qi T, 2019, NEUROIMAGE, V191, P36, DOI 10.1016/j.neuroimage.2019.02.014; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rigon A, 2016, J NEUROTRAUM, V33, P977, DOI 10.1089/neu.2014.3847; Risen SR, 2015, J PEDIATR REHAB MED, V8, P309, DOI 10.3233/PRM-150349; Santhanam P, 2019, BRAIN RES, V1711, P77, DOI 10.1016/j.brainres.2019.01.015; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2017, EXP BRAIN RES, V235, P799, DOI 10.1007/s00221-016-4841-z; Smith LGF, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.9.FOCUS19652; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Sripada RK, 2012, PSYCHOSOM MED, V74, P904, DOI 10.1097/PSY.0b013e318273bf33; Stephens JA, 2017, J NEUROTRAUM, V34, P3117, DOI 10.1089/neu.2017.5081; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; TEASDALE G, 1974, LANCET, V2, P81; van der Horn HJ, 2017, J NEUROTRAUM, V34, P3262, DOI 10.1089/neu.2017.5185; van der Horn HJ, 2016, HUM BRAIN MAPP, V37, P1645, DOI 10.1002/hbm.23126; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; Ware AL, 2019, J NEUROTRAUM, V36, P686, DOI 10.1089/neu.2018.5725; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Xu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14867-y; Zhou R, 2019, DIGESTION, V99, P247, DOI 10.1159/000492861; Zielinski BA, 2010, P NATL ACAD SCI USA, V107, P18191, DOI 10.1073/pnas.1003109107	90	1	1	5	9	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	AUG	2021	15	4					1840	1854		10.1007/s11682-020-00378-4		SEP 2020	15	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	UO0EQ	WOS:000565498900001	32880075				2022-02-06	
J	Abulwerdi, G; Stoica, BA; Loane, DJ; Faden, AI				Abulwerdi, Gelareh; Stoica, Bogdan A.; Loane, David J.; Faden, Alan, I			Putative mGluR4 positive allosteric modulators activate G(i)-independent anti-inflammatory mechanisms in microglia	NEUROCHEMISTRY INTERNATIONAL			English	Article						mGluR4; Microglia; Neuroinflammation; Metabotropic receptor; Lipopolysaccharide	METABOTROPIC GLUTAMATE RECEPTORS; IMPROVES FUNCTIONAL RECOVERY; TRAUMATIC BRAIN-INJURY; KAPPA-B ACTIVATION; RODENT MODELS; NITRIC-OXIDE; GROUP-II; ADENOSINE A2A; NEURODEGENERATION; NEUROTOXICITY	Chronic dysregulated microglial activation may lead to persistent inflammation and progressive neurodegeneration. A previous study reported that ADX88178, a putative metabotropic glutamate receptor 4 (mGluR4) positive allosteric modulator (PAM), exerts anti-inflammatory effects in microglia by activating mGluR4. We employed in vitro models of immortalized microglia cell lines and primary microglia to elucidate the molecular mechanisms responsible for the regulation of inflammatory pathways by ADX88178 and other mGluR4 PAMs. ADX88178 downregulated lipopolysaccharide (LPS)-induced expression of pro-inflammatory mediators, including TNF-alpha, IL-1 beta, CCL-2, IL-6, NOS2, and miR-155, as well as NO levels, in BV2 cells and primary microglia. Other mGluR4 modulators had divergent activities; VU0361737 (PAM) showed anti-inflammatory effects, whereas the orthosteric group III agonist, L-AP4, and VU0155041 (PAM) displayed no anti-inflammatory actions. In contrast to the earlier report, ADX88178 anti-inflammatory effects appeared to be mGluR4-independent as mGluR4 expression in our in vitro models was very low and its actions were not altered by pharmacological or molecular inhibition of mGluR4. Moreover, we showed that ADX88178 activated G(i)-independent, alternative signaling pathways as indicated by the absence of pertussis toxin-mediated inhibition and by increased phosphorylation of cAMP-response element binding protein (CREB), an inhibitor of the NF kappa B pro-inflammatory pathway. ADX88178 also attenuated NF kappa B activation by reducing the degradation of I kappa B and the associated translocation of NF kappa B-p65 to the nucleus. ADX88178 did not exert its anti-inflammatory effects through adenosine receptors, reported as mGluR4 heteromerization partners. Thus, our results indicate that in microglia, putative mGluR4 PAMs activate mGluR4/G(i)-independent mechanisms to attenuate pro-inflammatory pathways.	[Abulwerdi, Gelareh; Stoica, Bogdan A.; Loane, David J.; Faden, Alan, I] Univ Maryland, Trauma & Anesthesiol Res STAR Ctr, Dept Anesthesiol & Shock, Sch Med, Baltimore, MD 21201 USA		Faden, AI (corresponding author), Univ Maryland, Ctr Shock Trauma & Anesthesiol Res STAR, Dept Anesthesiol, Sch Med, 685 West Baltimore St,Room 6-02, Baltimore, MD 21201 USA.; Faden, AI (corresponding author), Univ Maryland, Ctr Shock Trauma & Anesthesiol Res STAR, Dept Anat & Neurobiol, Sch Med, 685 West Baltimore St,Room 6-02, Baltimore, MD 21201 USA.; Faden, AI (corresponding author), Univ Maryland, Ctr Shock Trauma & Anesthesiol Res STAR, Dept Neurosurg, Sch Med, 685 West Baltimore St,Room 6-02, Baltimore, MD 21201 USA.; Faden, AI (corresponding author), Univ Maryland, Ctr Shock Trauma & Anesthesiol Res STAR, Dept Psychiat, Sch Med, 685 West Baltimore St,Room 6-02, Baltimore, MD 21201 USA.; Faden, AI (corresponding author), Univ Maryland, Ctr Shock Trauma & Anesthesiol Res STAR, Dept Neurol, Sch Med, 685 West Baltimore St,Room 6-02, Baltimore, MD 21201 USA.	gabulwerdi@som.umaryland.edu; bstoica@som.umaryland.edu; dloane@som.umaryland.edu; afaden@som.umaryland.edu	Loane, David/ABD-5177-2021	Loane, David/0000-0003-0393-3503; Faden, Alan I./0000-0003-0128-2348; Vinueza, Gelareh/0000-0002-1036-6378	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS037313]	This work was supported by the National Institutes of Health grant R01NS037313 (A.I.F).	Barger SW, 2007, J NEUROCHEM, V101, P1205, DOI 10.1111/j.1471-4159.2007.04487.x; Barger SW, 2001, J NEUROCHEM, V76, P846, DOI 10.1046/j.1471-4159.2001.00075.x; Besong G, 2002, J NEUROSCI, V22, P5403; Betts MJ, 2012, BRIT J PHARMACOL, V166, P2317, DOI 10.1111/j.1476-5381.2012.01943.x; Bhat SA, 2021, J NEUROCHEM, V156, P225, DOI 10.1111/jnc.14954; Bollinger SR, 2019, J MED CHEM, V62, P342, DOI 10.1021/acs.jmedchem.8b00994; Byrnes KR, 2009, NEUROTHERAPEUTICS, V6, P94, DOI 10.1016/j.nurt.2008.10.038; Byrnes KR, 2009, GLIA, V57, P550, DOI 10.1002/glia.20783; Canudas AM, 2004, J NEUROSCI, V24, P10343, DOI 10.1523/JNEUROSCI.3229-04.2004; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Colella M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00605; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Engers DW, 2009, J MED CHEM, V52, P4115, DOI 10.1021/jm9005065; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fallarino F, 2010, NAT MED, V16, P897, DOI 10.1038/nm.2183; Foster DJ, 2017, NEURON, V94, P431, DOI 10.1016/j.neuron.2017.03.016; Geurts JJG, 2005, J NEUROIMMUNOL, V158, P182, DOI 10.1016/j.jneuroim.2004.08.012; Gross TJ, 2014, J IMMUNOL, V192, P2326, DOI 10.4049/jimmunol.1301758; Jin Y, 2009, NEUROSCI RES, V65, P141, DOI 10.1016/j.neures.2009.06.006; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Jones CK, 2012, J PHARMACOL EXP THER, V340, P404, DOI 10.1124/jpet.111.187443; Kalinichev M, 2014, J PHARMACOL EXP THER, V350, P495, DOI 10.1124/jpet.114.214437; Kew JNC, 2004, PHARMACOL THERAPEUT, V104, P233, DOI 10.1016/j.pharmthera.2004.08.010; Kingston AE, 1998, NEUROPHARMACOLOGY, V37, P1, DOI 10.1016/S0028-3908(97)00191-3; Klyuch BP, 2012, NEUROPHARMACOLOGY, V62, P815, DOI 10.1016/j.neuropharm.2011.09.007; Knoflach F, 2001, P NATL ACAD SCI USA, V98, P13402, DOI 10.1073/pnas.231358298; Kopitar-Jerata N, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00073; Le Poul E, 2012, J PHARMACOL EXP THER, V343, P167, DOI 10.1124/jpet.112.196063; Lee JY, 2006, NEUROSCI LETT, V396, P1, DOI 10.1016/j.neulet.2005.11.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2013, J NEUROTRAUM, V30, P403, DOI 10.1089/neu.2012.2589; Loane DJ, 2009, J BIOL CHEM, V284, P15629, DOI 10.1074/jbc.M806139200; Lopez S, 2008, NEUROPHARMACOLOGY, V55, P483, DOI 10.1016/j.neuropharm.2008.06.038; Maj M, 2003, NEUROPHARMACOLOGY, V45, P895, DOI 10.1016/S0028-3908(03)00271-5; Marino MJ, 2003, P NATL ACAD SCI USA, V100, P13668, DOI 10.1073/pnas.1835724100; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mennicken F, 1999, TRENDS PHARMACOL SCI, V20, P73, DOI 10.1016/S0165-6147(99)01308-5; Moon EY, 2005, J NEUROSCI RES, V81, P38, DOI 10.1002/jnr.20535; Movsesyan VA, 2004, J NEUROCHEM, V89, P1528, DOI 10.1111/j.1471-4159.2004.02451.x; Nicoletti E, 2011, NEUROPHARMACOLOGY, V60, P1017, DOI 10.1016/j.neuropharm.2010.10.022; Nicoletti F, 1996, TRENDS NEUROSCI, V19, P267, DOI 10.1016/S0166-2236(96)20019-0; Niswender CM, 2008, MOL PHARMACOL, V74, P1345, DOI 10.1124/mol.108.049551; Niswender CM, 2016, ACS CHEM NEUROSCI, V7, P1201, DOI 10.1021/acschemneuro.6b00036; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Ollivier V, 1996, J BIOL CHEM, V271, P20828, DOI 10.1074/jbc.271.34.20828; Park T, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0751-z; Parker LC, 2002, BRIT J PHARMACOL, V136, P312, DOI 10.1038/sj.bjp.0704715; Parry GCN, 1997, J IMMUNOL, V159, P5450; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Petrova TV, 1999, J BIOL CHEM, V274, P28823, DOI 10.1074/jbc.274.40.28823; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Ponnazhagan R, 2016, J NEUROIMMUNE PHARM, V11, P231, DOI 10.1007/s11481-016-9655-z; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Qiu JL, 2015, NEUROCHEM INT, V85-86, P46, DOI 10.1016/j.neuint.2015.04.007; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Stansley BJ, 2019, TRENDS PHARMACOL SCI, V40, P240, DOI 10.1016/j.tips.2019.02.006; Tang FR, 2001, J NEUROCYTOL, V30, P137, DOI 10.1023/A:1011939223872; Taylor DL, 2002, J NEUROCHEM, V82, P1179, DOI 10.1046/j.1471-4159.2002.01062.x; Taylor DL, 2003, J NEUROSCI, V23, P2150; Volpi C, 2016, NEUROPHARMACOLOGY, V102, P59, DOI 10.1016/j.neuropharm.2015.10.036; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Williams R, 2009, BIOORG MED CHEM LETT, V19, P4967, DOI 10.1016/j.bmcl.2009.07.072; Xue FT, 2014, CNS NEUROL DISORD-DR, V13, P558, DOI 10.2174/18715273113126660199; Ye RD, 2001, J LEUKOCYTE BIOL, V70, P839; Zhang ZY, 2015, NEUROCHEM RES, V40, P1121, DOI 10.1007/s11064-015-1572-7; Zhou F, 2006, J NEUROSCI RES, V84, P268, DOI 10.1002/jnr.20897; Zou ZQ, 2017, J PHARMACOL EXP THER, V362, P67, DOI 10.1124/jpet.116.239608	72	1	1	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	SEP	2020	138								104770	10.1016/j.neuint.2020.104770			15	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	MR1WA	WOS:000553380800010	32454165	Green Accepted			2022-02-06	
J	Bastien, C; Neal-Sturgess, C; Davies, H; Cheng, X				Bastien, Christophe; Neal-Sturgess, Clive; Davies, Huw; Cheng, Xiang			Computing Brain White and Grey Matter Injury Severity in a Traumatic Fall	MATHEMATICAL AND COMPUTATIONAL APPLICATIONS			English	Article						brain trauma modelling; organ trauma model; peak virtual power; fall; trauma modelling		In the real world, the severity of traumatic injuries is measured using the Abbreviated Injury Scale (AIS). However, the AIS scale cannot currently be computed by using the output from finite element human computer models, which currently rely on maximum principal strains (MPS) to capture serious and fatal injuries. In order to overcome these limitations, a unique Organ Trauma Model (OTM) able to calculate the threat to the life of a brain model at all AIS levels is introduced. The OTM uses a power method, named Peak Virtual Power (PVP), and defines brain white and grey matter trauma responses as a function of impact location and impact speed. This research has considered ageing in the injury severity computation by including soft tissue material degradation, as well as brain volume changes due to ageing. Further, to account for the limitations of the Lagrangian formulation of the brain model in representing hemorrhage, an approach to include the effects of subdural hematoma is proposed and included as part of the predictions. The OTM model was tested against two real-life falls and has proven to correctly predict the post-mortem outcomes. This paper is a proof of concept, and pending more testing, could support forensic studies.	[Bastien, Christophe; Davies, Huw; Cheng, Xiang] Coventry Univ, Inst Future Transport & Cities, Priory St, Coventry CV1 5FB, W Midlands, England; [Neal-Sturgess, Clive] Univ Birmingham, Dept Mech Engn, Birmingham B15 2TT, W Midlands, England		Bastien, C (corresponding author), Coventry Univ, Inst Future Transport & Cities, Priory St, Coventry CV1 5FB, W Midlands, England.	aa3425@coventry.ac.uk; c.e.n.sturgess@bham.ac.uk; ac2616@coventry.ac.uk; chengx4@uni.coventry.ac.uk		davies, huw/0000-0002-6250-8497; Bastien, Christophe/0000-0001-6194-4548; Neal-Sturgess, Clive Edward/0000-0003-2113-545X			Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Association for the Advancement of Automotive Medicine (AAAAM), 2020, ABBR INJ SCAL; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bastien C, 2020, J MECH MED BIOL, V20, DOI 10.1142/S0219519420500347; Bastien C., 2019, P 2 ANN AUT SAF SUMM; Cheng X., THESIS; Debasis S., 2013, P CARHS SAF WEEK HUM; Desmorat R., 2012, P SUMM SCH HARD DAM; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly MC, 2009, INT J CRASHWORTHINES, V14, P503, DOI 10.1080/13588260902826554; Fenner H., 2005, WORKSH CRIT HEAD INJ; Fernandes F., NUMERICAL MODELLING; Fernandes FAO, 2020, MATH COMPUT APPL, V25, DOI 10.3390/mca25010012; Hosseini-Farid M, 2020, MATH COMPUT APPL, V25, DOI 10.3390/mca25020021; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Klug C., 2018, P IRC C 2018 ATH GRE; Koncan D, 2020, COMPUT METHOD BIOMEC, V23, P500, DOI 10.1080/10255842.2020.1741555; Lamy Michael, 2011, Ann Adv Automot Med, V55, P125; Li X., 2020, KTH ROYAL I TECHNOLO, V141, P52; Lynnerup Niels, 2005, Head Face Med, V1, P13, DOI 10.1186/1746-160X-1-13; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao HJ, 2011, INT J NUMER METH BIO, V27, P357, DOI 10.1002/cnm.1403; Marjoux D., 2006, P INT IRCOBI C 2006; Murray JL, 1996, GLOBAL BURDEN DIS; Neal-Sturgess CE, 2002, P I MECH ENG D-J AUT, V216, P883, DOI 10.1243/095440702321031432; Newman J., 1986, P INT IRCOBI C ZUR S; NHTSA, 2020, FED MOT VEH SAF STAN; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; Paden M., 2002, INJURY LEADING CAUSE; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Post A, 2019, TRAUMA, V21, P27, DOI 10.1177/1460408617721564; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Raul JS, 2006, INT J LEGAL MED, V120, P212, DOI 10.1007/s00414-005-0018-1; Sack I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023451; Schrodinger I., 1944, WHAT IS LIFE PHYS AS; Sturgess C.E.N., 2001, P PASS SAF NETW WORK; Sturgess C.E.N., ARXIV10083695; Svennerholm L, 1997, ACTA NEUROPATHOL, V94, P345, DOI 10.1007/s004010050717; Tagliaferri F., 2005, SYSTEMATIC REV BRAIN; Toma M, 2020, MATH COMPUT APPL, V25, DOI 10.3390/mca25020022; UNECE, 2020, R94 UN PROV APPR VEH; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; Wen L., 2019, THESIS; Yamada H., 1970, STRENGTH BIOL MAT	45	1	1	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1300-686X	2297-8747		MATH COMPUT APPL	Math. Comput. Appl.	SEP	2020	25	3							61	10.3390/mca25030061			18	Mathematics, Interdisciplinary Applications	Emerging Sources Citation Index (ESCI)	Mathematics	OB2DY	WOS:000578285000001		gold			2022-02-06	
J	Brenner, LA; Stamper, CE; Hoisington, AJ; Stearns-Yoder, KA; Stanislawksi, MA; Brostow, DP; Hoffmire, CA; Forster, JE; Schneider, AL; Postolache, TT; Lowry, CA				Brenner, Lisa A.; Stamper, Christopher E.; Hoisington, Andrew J.; Stearns-Yoder, Kelly A.; Stanislawksi, Maggie A.; Brostow, Diana P.; Hoffmire, Claire A.; Forster, Jeri E.; Schneider, Alexandra L.; Postolache, Teodor T.; Lowry, Christopher A.			Microbial Diversity and Community Structures Among Those With Moderate to Severe TBI: A United States-Veteran Microbiome Project Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						inflammation; microbiome; traumatic brain injury; Veterans; Veterans Health Administration	TRAUMATIC BRAIN-INJURY; INDIVIDUALS; INFLAMMATION; VALIDITY	Objective: To evaluate the association between distal moderate/severe traumatic brain injury (TBI) history and the human gut microbiome. Setting: Veterans Affairs Medical Center. Participants: Veterans from the United States-Veteran Microbiome Project (US-VMP). Veterans with moderate/severe TBI (n= 34) were compared with (1) Veterans with a history of no TBI (n= 79) and (2) Veterans with a history of no TBI or mild TBI only (n= 297). Design: Microbiome analyses from 16S rRNA gene sequencing with gut microbiota function inferred using PICRUSt2. Main Measures: alpha-Diversity and beta-diversity of the gut microbiome, as well as taxonomic and functional signatures associated with moderate/severe TBI. Results: There were no significant differences in gut bacterial alpha- and beta-diversity associated with moderate/severe TBI status. No differentially abundant taxa were identified when comparing samples from moderate/severe TBI to those with no TBI or no TBI/mild TBI. Conclusion: Results suggest that moderate/severe TBI-related changes to the gut microbiome do not persist for years postinjury.	[Brenner, Lisa A.; Stamper, Christopher E.; Hoisington, Andrew J.; Stearns-Yoder, Kelly A.; Stanislawksi, Maggie A.; Brostow, Diana P.; Hoffmire, Claire A.; Forster, Jeri E.; Schneider, Alexandra L.; Postolache, Teodor T.; Lowry, Christopher A.] Rocky Mt Reg VA Med Ctr, Rocky Mt Mental Illness Res Educ & Clin Ctr, Aurora, CO USA; [Brenner, Lisa A.; Stamper, Christopher E.; Hoisington, Andrew J.; Stearns-Yoder, Kelly A.; Brostow, Diana P.; Hoffmire, Claire A.; Forster, Jeri E.; Lowry, Christopher A.] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Dept Psychiat, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Dept Neurol, Anschutz Med Campus, Aurora, CO USA; [Stanislawksi, Maggie A.] Univ Colorado, Div Biomed Informat & Personalized Med, Anschutz Med Campus, Aurora, CO USA; [Lowry, Christopher A.] Univ Colorado, Ctr Neurosci, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.; Stamper, Christopher E.; Hoisington, Andrew J.; Stearns-Yoder, Kelly A.; Brostow, Diana P.; Hoffmire, Claire A.; Forster, Jeri E.; Schneider, Alexandra L.; Postolache, Teodor T.; Lowry, Christopher A.] Mil & Vet Microbiome Consortium Res & Educ, Aurora, CO USA; [Hoisington, Andrew J.] Air Force Inst Technol, Dept Syst Engn & Management, Wright Patterson AFB, OH USA; [Postolache, Teodor T.] Univ Maryland, Sch Med, Mood & Anxiety Program, Baltimore, MD 21201 USA; [Postolache, Teodor T.] VISN 5 MIRECC, Dept Vet Affairs, Baltimore, MD 21201 USA; [Lowry, Christopher A.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Lowry, Christopher A.] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA		Brenner, LA (corresponding author), VA Rocky Mt MIRECC, 1700 N Wheeling St, Aurora, CO 80045 USA.	lisa.brenner@va.gov		Postolache, Teodor/0000-0001-6056-4244; Stanislawski, Maggie/0000-0001-7768-8868	Department of Veterans Affairs, Rocky Mountain Mental Illness Research Education and Clinical CenterUS Department of Veterans Affairs	This study was funded by the Department of Veterans Affairs, Rocky Mountain Mental Illness Research Education and Clinical Center.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Amir A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00199-16; Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Brenner LA, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00400; Brenner LA, 2017, BRAIN BEHAV IMMUN, V65, P57, DOI 10.1016/j.bbi.2017.06.003; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Cassidy J.D., 2014, ARCH PHYS MED REHAB, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Davis Cindy D, 2016, Nutr Today, V51, P167, DOI 10.1097/NT.0000000000000167; Douglas G.M., 2019, 672295 BIORXIV; Dreer LE, 2018, J HEAD TRAUMA REHAB, V33, P246, DOI 10.1097/HTR.0000000000000408; Earley ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129996; First M., 2015, STRUCTURED CLIN INTE, P1; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Garcia FD, 2009, P IEEE S SECUR PRIV, P3, DOI 10.1109/SP.2009.6; Genuer R, 2015, R J, V7, P19; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Howard Benjamin M, 2017, Trauma Surg Acute Care Open, V2, pe000108, DOI 10.1136/tsaco-2017-000108; Ivins BJ, 2008, MIL MED, V173, P1168, DOI 10.7205/MILMED.173.12.1168; Jackson M. A., 2018, NAT COMMUN, V9, P1, DOI DOI 10.1038/S41467-018-05184-7.; Janssen S, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00021-18; Kigerl KA, 2016, J EXP MED, V213, P2603, DOI 10.1084/jem.20151345; Lewis CT, 2019, J CLIN NEUROSCI, V70, P37, DOI 10.1016/j.jocn.2019.09.004; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Maier L, 2018, NATURE, V555, P623, DOI 10.1038/nature25979; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; Matharu D, 2019, J BIOSCIENCES, V44, DOI 10.1007/s12038-019-9940-0; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Morin CM, 1993, INSOMNIA PSYCHOL ASS; Nicholson SE, 2019, SHOCK, V52, P240, DOI 10.1097/SHK.0000000000001211; Oksanen J, 2019, R VEGAN COMMUNITY EC; Postolache TT, 2020, J ALZHEIMERS DIS, V74, P1, DOI 10.3233/JAD-191150; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2020, R LANG ENV STAT COMP; Ruel MT, 2003, J NUTR, V133, p3911S, DOI 10.1093/jn/133.11.3911S; Su SH, 2014, BRAIN BEHAV IMMUN, V38, P111, DOI 10.1016/j.bbi.2014.01.009; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tiew KF, 2014, J HEALTH POPUL NUTR, V32, P665; Urban RJ, 2020, J NEUROTRAUM, V37, P1037, DOI 10.1089/neu.2019.6688; VA/DoD Clinical Practice Guidelines, 2016, MAN CONC MILD TRAUM; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Zhu CS, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060113	52	1	1	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2020	35	5			SI		332	341		10.1097/HTR.0000000000000615			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NP5SO	WOS:000570236100006	32881767				2022-02-06	
J	Paiva, ALC; Araujo, JLV; Lovato, RM; Veiga, JCE				Campos Paiva, Aline Lariessy; Vitorino Araujo, Joao Luiz; Lovato, Renan Maximilian; Veiga, Jose Carlos Esteves			Microsurgical Cisternostomy for Treating Critical Patients with Traumatic Brain Injury-An alternative Therapeutic Approach	BRAZILIAN NEUROSURGERY-ARQUIVOS BRASILEIROS DE NEUROCIRURGIA			English	Article						cisternostomy; traumatic brain injury; decompressive craniectomy; hydrodynamics	DECOMPRESSIVE CRANIECTOMY; COSTS	Introduction Traumatic brain injury (TBI) is a major cause of mortality around the world. Few advances regarding surgical approaches have been made in the past few years to improve its outcomes. Microsurgical cisternostomy is a well-established technique used in vascular and skull base surgery and recently emerges as a suitable procedure with lesser costs and morbidity when compared with decompressive craniectomy in patients with diffuse TBI. This study aims to describe the technique, indications, and limitations of cisternostomy and to compare it with decompressive craniectomy (DC). Methods A prospective study is being conducted after obtaining approval of the local human ethics research committee. Once the inclusion and exclusion criteria are applied, the patients are submitted to microsurgical cisternostomy, pre and postoperative neurological status and brain computed tomography (CT) evaluation. A detailed review was also performed, which discusses diffuse TBI, DC, and cisternostomy for the treatment of TBI. Results Two patients were submitted to cisternostomy after TBI and the presence of acute subdural hematoma and hugemidline shift at admission computed tomography. The surgery was authorized by the family (the informed consent form was signed). Both patients evolved with a good recovery after the procedure, and had a satisfactory control brain CT. No further surgeries were required after the initial cisternostomy. Conclusions Cisternostomy is an adequate technique for the treatment of selected patients affected by diffuse TBI, and it is a proper alternative to DC with lesser costs and morbidity, since a single neurosurgical procedure is performed. A prospective study is being conducted for a better evaluation and these were the initial cases of this new protocol.	[Campos Paiva, Aline Lariessy; Vitorino Araujo, Joao Luiz; Lovato, Renan Maximilian; Veiga, Jose Carlos Esteves] Fac Ciencias Med Santa Casa Sao Paulo FCMSCSP, Dept Neurosurg, Sao Paulo, SP, Brazil		Paiva, ALC (corresponding author), Irmandade Santa Casa Misericordia Sao Paulo, Sao Paulo, SP, Brazil.	lariessy@hotmail.com		Lovato, Renan/0000-0002-9239-008X; Paiva, Aline/0000-0002-1228-531X; Vitorino Araujo, Joao Luiz/0000-0002-6539-6718			Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; Badke GL, 2018, ARQ NEURO-PSIQUIAT, V76, P257, DOI [10.1590/0004-282x20180016, 10.1590/0004-282X20180016]; Cherian Iype, 2016, Surg Neurol Int, V7, pS711; Cherian I, 2016, WORLD NEUROSURG, V89, P51, DOI 10.1016/j.wneu.2016.01.072; Cherian I, 2016, CHIN J TRAUMATOL, V19, P7, DOI 10.1016/j.cjtee.2016.01.003; Cherian Iype, 2013, Asian J Neurosurg, V8, P132, DOI 10.4103/1793-5482.121684; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Li A, 2017, WORLD NEUROSURG, V102, P209, DOI 10.1016/j.wneu.2017.03.022; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Masoudi Mohammad Sadegh, 2016, Bull Emerg Trauma, V4, P161; PICKARD JD, 1990, BRIT MED J, V301, P629, DOI 10.1136/bmj.301.6753.629; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Timofeev I, 1800, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962	16	1	1	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0103-5355	2359-5922		BRAZ NEUROSURG	Braz. Neurosurg.	SEP	2020	39	03					155	160		10.1055/s-0040-1701279			6	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	NS6UQ	WOS:000572394900001		gold			2022-02-06	
J	Chandran, A; Kerr, ZY; Roby, PR; Nedimyer, AK; Arakkal, A; Pierpoint, LA; Zuckerman, SL				Chandran, Avinash; Kerr, Zachary Y.; Roby, Patricia R.; Nedimyer, Aliza K.; Arakkal, Alan; Pierpoint, Lauren A.; Zuckerman, Scott L.			Concussion Symptom Characteristics and Resolution in 20 United States High School Sports, 2013/14-2017/18 Academic Years	NEUROSURGERY			English	Article						Concussion; Symptoms; Head injuries; Youth sports	PROFESSIONAL FOOTBALL; RECURRENT CONCUSSION; POSITION STATEMENT; GENDER-DIFFERENCES; ATHLETIC TRAINERS; SEX-DIFFERENCES; EPIDEMIOLOGY; COLLEGIATE; ASSOCIATION; INJURIES	BACKGROUND: High school (HS) sport-related concussions (SRCs) remain a public health concern in the United States. OBJECTIVE: To describe patterns in symptom prevalence, symptom resolution time (SRT), and return-to-play time (RTP) for SRCs sustained in 20 HS sports during the 2013/14-2017/18 academic years. METHODS: A convenience sample of athletic trainers reported concussion information to the HS RIO (TM) surveillance system. Symptom prevalence, average number of symptoms, and SRT and RTP distributions were examined and compared by event type (practice, competition), injury mechanism (person contact, nonperson contact), sex, and contact level (collision, high contact, and low contact) with chi-square tests and Wilcoxon rank-sum tests. RESULTS: Among all SRCs (n = 9542), headache (94.5%), dizziness (73.8%), and difficulty concentrating (56.0%) were commonly reported symptoms. On average, 4.7 +/- 2.4 symptoms were reported per SRC. Overall, 51.3% had symptoms resolve in <:7 d, yet only 7.9% had RTP < 7 d. Differential prevalence of amnesia was seen between practice and competition-related SRCs (8.8% vs 13.0%; P < .001); nonperson-contact and person-contact SRCs (9.3% vs 12.7%; P < .001); and female and male SRCs in low-contact sports (5.8% vs 17.5%; P < .001). Differential prevalence of loss of consciousness was seen between practice and game-related SRCs (1.3% vs 3.2%; P <.001); and female and male SRCs in high contact sports (1.2% vs 4.0%; P < .001). Differential longer SRT ( >21 d) was seen between new and recurrent SRCs (9.4% vs 15.9%; P < .001). CONCLUSION: Headache was the most commonly reported symptom. Notable group differences in the prevalence of amnesia, loss of consciousness, and SRT may be associated with more severe SRCs, warranting further attention.	[Chandran, Avinash; Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Chandran, Avinash; Kerr, Zachary Y.; Roby, Patricia R.; Nedimyer, Aliza K.] Univ N Carolina, Matthew Gfeller Sport Related Trauma Brain Injury, Chapel Hill, NC 27515 USA; [Chandran, Avinash] Datalys Ctr Sports Injury Res & Prevent Inc, Indianapolis, IN 46202 USA; [Roby, Patricia R.; Nedimyer, Aliza K.] Univ N Carolina, Human Movement Sci Curriculum, Chapel Hill, NC 27515 USA; [Arakkal, Alan] Univ Colorado Anschutz, Dept Epidemiol, Aurora, CO USA; [Pierpoint, Lauren A.] Steadman Philippon Res Inst, Vail, CO USA; [Zuckerman, Scott L.] Vanderbilt Univ, Vanderbilt Sports Concuss Ctr, Sch Med, Nashville, TN USA; [Zuckerman, Scott L.] Vanderbilt Univ, Dept Neurol Surg, Sch Med, Nashville, TN USA		Chandran, A (corresponding author), Datalys Ctr Sports Injury Res & Prevent Inc, Indianapolis, IN 46202 USA.; Chandran, A (corresponding author), Datalys Ctr Sports Injury Res & Prevent Inc, NCAA Injury Surveillance Program, 401 W Michigan St 500, Indianapolis, IN 46202 USA.	avinashc@datalyscenter.org		Zuckerman, Scott/0000-0003-2951-2942; Roby, Patricia/0000-0003-0166-4274	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR025754] Funding Source: Medline; NCIPC CDC HHS [R49 CE001172, R49 CE000674] Funding Source: Medline		Aubry Mark, 2002, Phys Sportsmed, V30, P57, DOI 10.3810/psm.2002.02.176; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Chandran A, 2020, RES SPORTS MED, V28, P42, DOI 10.1080/15438627.2019.1590834; Comstock RD, 2018, CONVENIENCE SAMPLE S; Currie DW, 2017, AM J SPORT MED, V45, P3368, DOI 10.1177/0363546517725068; de Courten-Myers GM, 1999, J NEUROPATH EXP NEUR, V58, P217; Esposito G, 1996, J NUCL MED, V37, P559; Ferrara Michael S., 2001, J Athl Train, V36, P145; Giza CC, 2017, J NEUROTRAUM, V35, P681; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Howell DR, 2019, CLIN J SPORT MED, V29, P391, DOI 10.1097/JSM.0000000000000629; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Hurtubise JM, 2018, BMJ OPEN SPORT EXERC, V4, P1; IBRAHIM A, 2017, INJ EPIDEMIOL, V8, DOI DOI 10.3390/MI8020032; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Krolikowski MP, 2017, AM J SPORT MED, V45, P468, DOI 10.1177/0363546516669701; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Lee Green J., 2014, LEGAL PERSPECTIVES R; Lombardi NJ, 2016, ORTHOPEDICS, V39, pE944, DOI 10.3928/01477447-20160623-10; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lowrey KM., 2015, J BUS TECHNOL LAW, V10, P61; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2019, BRIT J SPORT MED; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McGuine TA, 2019, AM J SPORT MED, V47, P3514, DOI 10.1177/0363546519880175; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Neidecker JM, 2017, J AM OSTEOPATH ASSOC, V117, P635, DOI 10.7556/jaoa.2017.120; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Register-Mihalik JK, 2019, J ATHL TRAINING, V54, P12, DOI 10.4085/1062-6050-451-18; Rose SC, 2016, SPORTS HEALTH, V8, P37, DOI 10.1177/1941738115591948; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Weissman B, 2019, NEUROL-CLIN PRACT, V9, P241, DOI 10.1212/CPJ.0000000000000624; Wiebe DJ, 2018, JAMA-J AM MED ASSOC, V320, P2035, DOI 10.1001/jama.2018.14165; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047; Yard EE, 2009, J ATHL TRAINING, V44, P645, DOI 10.4085/1062-6050-44.6.645	51	1	1	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	SEP	2020	87	3					573	583		10.1093/neuros/nyaa091			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OW8HM	WOS:000593120600066	32294184	Green Published			2022-02-06	
J	Charney, MF; Howell, DR; Lanois, C; Starr, TC; Liao, HJ; Coello, E; Breedlove, KM; Meehan, WP; Koerte, I; Lin, AP				Charney, Molly F.; Howell, David R.; Lanois, Corey; Starr, Tyler C.; Liao, Huijun; Coello, Eduardo; Breedlove, Katherine M.; Meehan, William P., III; Koerte, Inga; Lin, Alexander P.			Associations Between Neurochemistry and Gait Performance Following Concussion in Collegiate Athletes	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						biochemistry; brain injury; concussion; gait; magnetic resonance spectroscopy	DUAL-TASK GAIT; TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; POSTERIOR CINGULATE CORTEX; MILD COGNITIVE IMPAIRMENT; BALANCE CONTROL; SINGLE-TASK; ACUTE-PHASE; ADOLESCENTS; METABOLITE	Objective: To evaluate the strength of associations between single-task and dual-task gait measures and posterior cingulate gyrus (PCG) neurochemicals in acutely concussed collegiate athletes. Setting: Participants were recruited from an NCAA Division 1 University. Participants: Nineteen collegiate athletes acutely (<4 days) following sports-related concussion. Design: We acquired magnetic resonance spectroscopy (MRS) in the PCG and gait performance measurements in the participants, acutely following concussion. Linear mixed-effects models were constructed to measure the effect of gait performance, in the single- and dual-task settings, and sex on the 6 neurochemicals quantified with MRS in mmol. Correlation coefficients were also calculated to determine the direction and strength of the relationship between MRS neurochemicals and gait performance, postconcussion symptom score, and number of previous concussions. Main Measures: Average gait speed, average cadence,N-acetyl aspartate, choline, myo-inositol, glutathione, glutamate plus glutamine, and creatine. Results: Single-task gait speed (P= .0056) and cadence (P= .0065) had significant effects on myo-inositol concentrations in the PCG, independent of sex, in concussed collegiate athletes. Single-task cadence (P= .047) also had a significant effect on glutathione in the PCG. No significant effects were observed between dual-task gait performance and PCG neurochemistry. Conclusions: These findings indicate that increased concentrations of neuroinflammatory markers in the PCG are associated with slower single-task gait performance within 4 days of sports-related concussion.	[Charney, Molly F.; Starr, Tyler C.; Liao, Huijun; Coello, Eduardo; Breedlove, Katherine M.; Lin, Alexander P.] Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA; [Koerte, Inga] Brigham & Womens Hosp, Dept Psychiat, 75 Francis St, Boston, MA 02115 USA; [Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Howell, David R.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO USA; [Howell, David R.; Lanois, Corey; Meehan, William P., III] Michell Ctr Sports Injury Prevent, Waltham, MA USA; [Lanois, Corey; Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Koerte, Inga] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany		Lin, AP (corresponding author), Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA.	aplin@bwh.harvard.edu	Koerte, Inga Katharina/AAW-3031-2021		National Institute of Neurological Disorder and Stroke of the National Institutes ofHealth [R01NS100952]	Research reported in this publication was supported by the National Institute of Neurological Disorder and Stroke of the National Institutes ofHealth under Award Number R01NS100952. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albrecht DS, 2016, ACS CHEM NEUROSCI, V7, P470, DOI 10.1021/acschemneuro.6b00056; Alosco ML, 2020, BRAIN IMAGING BEHAV, V14, P1419, DOI 10.1007/s11682-019-00060-4; Annweiler C, 2013, BRAIN, V136, P859, DOI 10.1093/brain/aws373; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Brennan Brian P, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P116; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Brown PJ, 2016, J GERONTOL A-BIOL, V71, P221, DOI 10.1093/gerona/glv156; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Chang LD, 2013, J NEUROIMMUNE PHARM, V8, P576, DOI 10.1007/s11481-013-9460-x; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Fayed N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058476; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Giza CC, 2001, J ATHL TRAINING, V36, P228; Glodzik L, 2012, PSYCHIAT RES-NEUROIM, V204, P49, DOI 10.1016/j.pscychresns.2012.04.013; Goel A, 2015, WORLD NEUROSURG, V84, DOI 10.1016/j.wneu.2015.05.017; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Howel DR, 2017, J APPL BIOMECH, V33, P24, DOI 10.1123/jab.2015-0323; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Howell DR, 2021, CLIN J SPORT MED, V31, P133, DOI 10.1097/JSM.0000000000000722; Howell DR, 2019, J SCI MED SPORT, V22, P521, DOI 10.1016/j.jsams.2018.11.014; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Howell DR, 2018, J SCI MED SPORT, V21, P358, DOI 10.1016/j.jsams.2017.08.004; Howell DR, 2017, J NEUROTRAUM, V34, P3288, DOI 10.1089/neu.2017.5191; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Johnson B, 2012, NEUROSCI LETT, V509, P5, DOI 10.1016/j.neulet.2011.11.013; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405; Kubas B, 2010, POL J RADIOL, V75, P7; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Lin Alexander, 2005, NeuroRx, V2, P197, DOI 10.1602/neurorx.2.2.197; Lin A, 2012, SEMIN NEUROL, V32, P432, DOI 10.1055/s-0032-1331814; Lin AP, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0094-5; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mannix R, 2014, J NEUROTRAUM, V31, P1072, DOI 10.1089/neu.2013.3265; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Montero-Odasso M, 2012, ARCH PHYS MED REHAB, V93, P293, DOI 10.1016/j.apmr.2011.08.026; Morris R, 2016, NEUROSCI BIOBEHAV R, V64, P326, DOI 10.1016/j.neubiorev.2016.02.012; Mukaka MM, 2012, MALAWI MED J, V24, P69; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Panchal H, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00616; Parrington L, 2019, J ATHL TRAINING, V54, P429, DOI 10.4085/1062-6050-46-18; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Pizzorno Joseph, 2014, Integr Med (Encinitas), V13, P8; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Reyngoudt H, 2012, EUR J RADIOL, V81, pE223, DOI 10.1016/j.ejrad.2011.01.106; Rowland BC, 2017, J NEUROIMAGING, V27, P23, DOI 10.1111/jon.12388; Schranz AL, 2018, HUM BRAIN MAPP, V39, P1489, DOI 10.1002/hbm.23919; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shukla D, 2019, HUM BRAIN MAPP, V41, P194; Stenberg J, 2020, ARCH PHYS MED REHAB, V101, P72, DOI 10.1016/j.apmr.2019.08.477; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Verghese J, 2011, J GERONTOL A-BIOL, V66, P1083, DOI 10.1093/gerona/glr099; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Yu CH, 2011, J VET SCI, V12, P299, DOI 10.4142/jvs.2011.12.3.299; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	72	1	1	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2020	35	5			SI		342	353		10.1097/HTR.0000000000000616			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NP5SO	WOS:000570236100007	32881768	Green Accepted			2022-02-06	
J	Cook, N; Hunt, TN				Cook, Natalie; Hunt, Tamerah N.			Factors Influencing Concussion Reporting Intention in Adolescent Athletes	JOURNAL OF SPORT REHABILITATION			English	Article						young adult; reporting behaviors; mild traumatic brain injury	KNOWLEDGE	Clinical Scenario: Concussions are severely underreported, with only 47.3% of high school athletes reporting their concussion. The belief was that athletes who were better educated on the signs and symptoms and potential dangers of concussion would be more likely to report. However, literature has shown inconsistent evidence on the efficacy of concussion education, improving reporting behaviors. Factors such as an athlete's attitude, subjective norms, and perceived behavioral control have shown promise in predicting intention to report concussions in athletes. Focused Clinical Question: Do attitudes, subjective norms, and perceived behavioral control influence adolescent athletes' intention to report? Summary of Key Findings: Three studies (1 randomized control and 2 cross-sectional surveys) were included. Across the 3 studies, attitudes, subjective norms, and perceived behavioral control positively influenced athletes' reporting intention. The studies found that attitude toward concussion reporting and perceived behavioral control were the most influential predictors of reporting intention. Clinical Bottom Line: There is moderate evidence to suggest that positive attitudes, supportive subjective norms, and increased perceived behavioral control influence reporting intention in secondary school athletes. Strength of Recommendation: Grade B evidence exists that positive attitudes, supportive subjective norms, and increased perceived behavioral control positively influence concussion reporting intention in secondary school athletes.	[Cook, Natalie] Georgia Southern Univ, Statesboro, GA USA; [Hunt, Tamerah N.] Georgia Southern Univ, Dept Hlth Sci & Kinesiol, Statesboro, GA 30458 USA		Hunt, TN (corresponding author), Georgia Southern Univ, Dept Hlth Sci & Kinesiol, Statesboro, GA 30458 USA.	thunt@georgiasouthern.edu			Centers for Disease ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [CE17-002]	This research was supported by the Centers for Disease Control (grant: CE17-002).	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Beakey M, 2016, EUR J SPORTS MED, V4, P65; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; Phillips B, 1998, LEVELS EVIDENCE GRAD; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Sullivan L, 2018, HEALTH EDUC RES, V33, P492, DOI 10.1093/her/cyy034; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07	11	1	1	0	3	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	SEP	2020	29	7					1019	1023		10.1123/jsr.2019-0419			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	ND6BX	WOS:000561984100022	32109886	Bronze			2022-02-06	
J	Cremonini, C; Lewis, M; Wong, MD; Benjamin, ER; Inaba, K; Demetriades, D				Cremonini, Camilla; Lewis, Meghan; Wong, Monica Darlene; Benjamin, Elizabeth R.; Inaba, Kenji; Demetriades, Demetrios			Traumatic epidural hematomas in the pediatric population: clinical characteristics and diagnostic pitfalls	JOURNAL OF PEDIATRIC SURGERY			English	Article						Traumatic epidural hematoma; Pediatric patients; Clinical presentation; Diagnosis; Radiographic findings	CONSERVATIVE MANAGEMENT; EXTRADURAL HEMATOMAS; COMPUTED-TOMOGRAPHY; HEAD-INJURY; CT-SCAN; PREDICTION; RISK	Background/Purpose: The purpose of this study was to review the initial clinical presentation of EDH, identify potential clinical markers and highlight diagnostic pitfalls. Methods: Retrospective review of all pediatric patients admitted to a Level I Trauma Center diagnosed with blunt traumatic EDH from 2008 to 2018. Results: A total of 699 pediatric patients were identified with blunt traumatic brain injury (TBI); 106 with EDH made up the study population. A skull fracture was present in 84%. Overall, the most common clinical finding was a scalp hematoma (86%), followed by loss of consciousness (66%), emesis (34%), headache (27%), amnesia (18%), and seizures (12%). Importantly, 40% of patients with EDH presented with GCS 15. Four children (4%) had GCS 15 and were completely asymptomatic on admission. In three children (3%) the only symptom was a scalp hematoma. 50% of all EDH required craniotomy, and this was not significantly different if GCS was 15 on presentation (45%, p = 0.192). Mortality was 2%. Fourteen patients (13%) were discharged with cognitive/motor deficits. Conclusions: Pediatric EDH frequently present with subtle clinical signs, including a normal GCS half the time. Irrespective of asymptomatic presentation, threshold for CT scan or an observation period should be low after head injuries in children. (C) 2020 Elsevier Inc. All rights reserved.	[Cremonini, Camilla; Lewis, Meghan; Wong, Monica Darlene; Benjamin, Elizabeth R.; Inaba, Kenji; Demetriades, Demetrios] Univ Southern Calif, LAC USC Med Ctr, Div Trauma Emergency Surg Care, 2051 Marengo St,IPT,C5L100, Los Angeles, CA 90033 USA		Lewis, M (corresponding author), Univ Southern Calif, LAC USC Med Ctr, Div Trauma & Crit Care, 2051 Marengo St,IPT,C5L100, Los Angeles, CA 90033 USA.	meghan.lewis@med.usc.edu	Wong, Monica D/D-9016-2017	Wong, Monica D/0000-0001-7041-9518; Cremonini, Camilla/0000-0003-1503-7087			Balmer B, 2006, CHILD NERV SYST, V22, P363, DOI 10.1007/s00381-005-1254-x; Bejjani GK, 1996, PEDIATR NEUROSURG, V25, P302, DOI 10.1159/000121144; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Champagne PO, 2017, PEDIATR NEUROSURG, V52, P168, DOI 10.1159/000455925; CHAN KH, 1990, J NEUROSURG, V72, P189, DOI 10.3171/jns.1990.72.2.0189; CHOUX M, 1975, CHILD BRAIN, V1, P337; Ciurea A V, 2009, J Med Life, V2, P191; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; ERICSON K, 1981, ACTA RADIOL DIAGN, V22, P513, DOI 10.1177/028418518102200501; Faul M, 2010, TRAUMATIC BRAIN INJU; Flaherty BF, 2017, J PEDIATR SURG, V52, P334, DOI 10.1016/j.jpedsurg.2016.09.005; Flaherty BF, 2013, PEDIATR NEUROSURG, V49, P208, DOI 10.1159/000363143; FORD LE, 1963, J NEUROSURG, V20, P760, DOI 10.3171/jns.1963.20.9.0760; Fundaro C, 2012, CHILD NERV SYST, V28, P1063, DOI 10.1007/s00381-012-1717-9; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Gutierrez FA, 1981, CONCEPTS PEDIAT NEUR, V188; Guzel A, 2009, PEDIATR NEUROSURG, V45, P262, DOI 10.1159/000228984; HOOPER R, 1959, BRIT J SURG, V47, P71, DOI 10.1002/bjs.18004720114; INGRAHAM FD, 1949, JAMA-J AM MED ASSOC, V140, P1010, DOI 10.1001/jama.1949.02900470014004; Jamous MA, 2009, PEDIATR NEUROSURG, V45, P181, DOI 10.1159/000218200; Khan MB, 2014, CHILD NERV SYST, V30, P1249, DOI 10.1007/s00381-014-2391-x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Maggi G, 1998, J Neurosurg Sci, V42, P95; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; PANG D, 1983, J NEUROSURG, V59, P958, DOI 10.3171/jns.1983.59.6.0958; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Rocchi G, 2005, J CHILD NEUROL, V20, P569, DOI 10.1177/08830738050200070501; SCHUTZMAN SA, 1993, ANN EMERG MED, V22, P535, DOI 10.1016/S0196-0644(05)81938-9; Singh N, 2017, CHILD NERV SYST, V33, P1677, DOI 10.1007/s00381-017-3535-6; Teasdale G, 1981, CRANIOCEREBRAL TRAUM, P252	31	1	1	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	SEP	2020	55	9					1773	1778		10.1016/j.jpedsurg.2020.05.011			6	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	NK7SO	WOS:000566932900016	32553454				2022-02-06	
J	Dalecki, M; Usand, J; Van Gemmert, AWA; Sergio, LE				Dalecki, Marc; Usand, Jessica; Van Gemmert, Arend W. A.; Sergio, Lauren E.			Motor Deficits in Youth with Concussion History: Issues with Task Novelty or Task Demand?	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						mild traumatic brain injury; children; performance; cognitive-motor integration; skill	FOOTBALL PLAYERS; STRUCTURAL MRI; RISK; EPIDEMIOLOGY; ADOLESCENTS; ATTENTION; INJURIES; RETURN	The present study expands previous work on eye-hand decoupling deficits in youth with concussion history. It examines whether deficits can be linked to difficulties adapting to new task constraints or meeting ongoing task demands. Data from 59 youth with concussion history (M=11 months post-concussion) and 55 no history controls were analyzed. All 114 participants (M=12.5 yrs.) performed two touchscreen-based eye-hand coordination tasks: A standard task with vision and motor action in alignment, and an eye-hand decoupling task with both spatially decoupled, with twenty trials per task condition. First (trial 1-4), middle (trial 9-12), and last (trial 17-20) trial blocks were analyzed in each condition across groups, as well as first and last blocks only. The latter analysis showed in the first block longer response times in the concussion history group in the eye-hand decoupling condition due to a general slowdown of the reaction times across blocks and a trend for higher movement times. Our findings suggest that youth with concussion history have difficulty to adapt to new task constraints associated with complex skill performance during a short series of trials. These results are relevant for athletic trainers, therapists and coaches who work with youth with concussion history.	[Dalecki, Marc; Usand, Jessica; Van Gemmert, Arend W. A.] Louisiana State Univ, Sch Kinesiol, 71 Huey P Long Field House, Baton Rouge, LA 70803 USA; [Sergio, Lauren E.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada		Dalecki, M (corresponding author), Louisiana State Univ, Sch Kinesiol, 71 Huey P Long Field House, Baton Rouge, LA 70803 USA.	mdalecki@lsu.edu			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [125915]; Donald Sanderson Memorial Trust; Initiative for Minority Student Development from Louisiana State University	Funding provided by the Canadian Institutes of Health Research operating grant #125915(LS), and the Donald Sanderson Memorial Trust. JU was funded by the Initiative for Minority Student Development from Louisiana State University.	Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Beilock SL, 2002, Q J EXP PSYCHOL-A, V55, P1211, DOI 10.1080/02724980244000170; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Cancelliere C, 2014, ARCH PHYS MED REHAB, V95, P210; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Dalecki M, 2019, EUR J SPORT SCI, V19, P1257, DOI 10.1080/17461391.2019.1584249; Dalecki Marc, 2016, Concussion, V1, pCNC14, DOI 10.2217/cnc-2016-0001; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Fernandez WG, 2007, ACAD EMERG MED, V14, P641, DOI [10.1197/j.aem.2007.03.1354, 10.1111/j.1553-2712.2007.tb01851.x]; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Gorbet DJ, 2016, BEHAV BRAIN RES, V298, P229, DOI 10.1016/j.bbr.2015.11.012; Gorbet DJ, 2004, NEUROIMAGE, V23, P1100, DOI 10.1016/j.neuroimage.2004.07.043; Grunwald M, 2001, COGNITIVE BRAIN RES, V11, P33, DOI 10.1016/S0926-6410(00)00061-6; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harriss DJ, 2019, INT J SPORTS MED, V40, P813, DOI 10.1055/a-1015-3123; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Hurtubise Johanna, 2016, Concussion, V1, pCNC17, DOI 10.2217/cnc-2016-0006; KARLIN AM, 2011, PM&R, V3, P369; Kissick J, 2005, CLIN J SPORT MED, V15, P426, DOI 10.1097/01.jsm.0000186683.59158.8b; Locklin J, 2010, SPORTS MED, V40, P183, DOI 10.2165/11319440-000000000-00000; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McGuine T, 2006, CLIN J SPORT MED, V16, P488, DOI 10.1097/01.jsm.0000248848.62368.43; Mrazik M, 2013, J ATHL TRAINING, V48, P654, DOI 10.4085/1062-6050-48.3.19; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Sergio L.E., 2017, BRIT J SPORT MED, V51, pA41; Thompson PM, 2005, INT REV NEUROBIOL, V67, P285, DOI 10.1016/S0074-7742(05)67009-2	28	1	1	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	SEP	2020	41	10					688	695		10.1055/a-1144-3217			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	NI8XK	WOS:000565630000008	32485775				2022-02-06	
J	Daugherty, J; DePadilla, L; Sarmiento, K				Daugherty, Jill; DePadilla, Lara; Sarmiento, Kelly			Assessment of HEADS UP online training as an educational intervention for sports officials/athletic trainers	JOURNAL OF SAFETY RESEARCH			English	Article						Concussion; Youth athletes; Sports officials; Athletic trainers; Concussion education	TRAUMATIC BRAIN-INJURIES; FOR-DISEASE-CONTROL; CONCUSSION KNOWLEDGE; ATHLETIC TRAINERS; YOUTH; MANAGEMENT; ATTITUDES; COACHES	Background: Sports- and recreation-related concussions are a common injury among children. Sports officials (SOs) and athletic trainers (ATs) are integral to setting the stage for safe play and managing concussions when they occur, and significant numbers of both groups have completed the Centers for Disease Control and Prevention's HEADS UP online concussion training course. However, the utility of the course for these audiences has not been assessed. We hypothesized that sports officials' and athletic trainers' concussion-related knowledge, attitudes, and behavioral intentions will improve from pre- and posttest after completing CDC's HEADS UP online concussion training course. Method: Respondents' concussion-related knowledge, attitudes, and behavioral intentions were assessed both before and after taking the training course. Differences between pre- and post-test scores were calculated based on the Wilcoxon Signed Rank Test Z-score or McNemar's test. Effect sizes were interpreted. Results: The SOs and ATs who participated in the HEADS UP online training had a high level of concussion knowledge before taking the course: 90% or more of respondents could identify the correct response for at least seven of the 13 knowledge questions in the pre-test. Still, the course was effective at improving the respondents' knowledge about return-to-play protocols and concussion reporting. Further, SOs and ATs demonstrated improvement in their concussion-related attitudes and behavioral intentions between the pre- and post-test. Conclusion: SOs' and ATs' concussion knowledge, attitudes, and behavioral intentions improved immediately following completion of the CDC HEADS UP online training. Future research could also focus on the long-term retention of this type of training. Practical Applications: This study provides insight into how to better focus concussion-related educational programs to fit SOs' and ATs' needs. (C) 2020 National Safety Council and Elsevier Ltd. All rights reserved.	[Daugherty, Jill; Sarmiento, Kelly] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Injury Prevent, 4770 Buford Highway, Atlanta, GA 30341 USA; [DePadilla, Lara] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Overdose Prevent, 4770 Buford Highway, Atlanta, GA 30341 USA		Daugherty, J (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Injury Prevent, 4770 Buford Highway, Atlanta, GA 30341 USA.	jdaugherty@cdc.gov; LDepadilla@cdc.gov; KSarmiento@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline		Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bureau of Labor Statistics, 2019, UMP REF OTH SPORTS O; Centers for Disease Control and Prevention, 2017, HEADS YOUTH SPORTS O; Cohen J., 2013, STAT POWER ANAL BEHA; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Daugherty J, 2019, HEALTH EDUC J, V78, P784, DOI 10.1177/0017896919846185; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Kerr Zachary Y, 2018, Inj Epidemiol, V5, P28, DOI 10.1186/s40621-018-0158-7; Kroshus E, 2017, J ATHL TRAINING, V52, P1041, DOI 10.4085/1062-6050-52.11.17; Kroshus E, 2017, CLIN J SPORT MED, V27, P542, DOI 10.1097/JSM.0000000000000409; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; McGrath S. P., 2017, AMIA ANN S P; McGuine T. A., 2018, J ATHLETIC TRAINING; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; Naftel KG, 2014, SOUTH MED J, V107, P418, DOI 10.14423/SMJ.0000000000000136; National Conference of State Legislatures, 2018, TRAUM BRAIN INJ LEG; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rice T, 2019, J SAFETY RES, V69, P85, DOI 10.1016/j.jsr.2019.02.007; Sarmiento K, 2019, J SAFETY RES, V69, P217, DOI 10.1016/j.jsr.2019.01.005; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Sarmiento K, 2017, J SCHOOL HEALTH, V87, P790, DOI 10.1111/josh.12552; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Seattle Pediatric Concussion Research Collaborative, 2019, HUDDL CONC SAF; Sheeran P, 2016, HEALTH PSYCHOL, V35, P1178, DOI 10.1037/hea0000387; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1	29	1	1	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	SEP	2020	74						133	141		10.1016/j.jsr.2020.04.015			9	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	NW7AP	WOS:000575169200016	32951774	Green Accepted			2022-02-06	
J	Duyu, M; Karakaya, Z				Duyu, Muhterem; Karakaya, Zeynep			Evaluation of Patients Diagnosed with Brain Death in Paediatric Critical Care	JOURNAL OF PEDIATRIC RESEARCH			English	Article						Brain death; paediatric intensive care; organ donation	ORGAN DONATION; EPIDEMIOLOGY	Aim: We aimed to investigate the rate of brain death (BD) determinations and organ donations in our tertiary pediatric intensive care unit (PICU), and to report the data on demographic pattern and supplementary descriptive data on the BD declarations. Materials and Methods: Age and gender of the cases were recorded, and also clinical conditions causing BD were grouped and recorded under six headings including; traumatic brain injury (TBI), brain neoplasm, cardiac arrest, intracranial haemorrhage, central nervous system infection and other causes. The time from the PICU admission to the diagnosis of BD, the time from suspicion of BD to final diagnosis, duration of survival after diagnosis of BD, confirmatory tests used, whether apnea test is performed, and inherent alterations (diabetes insipidus, hyperglycaemia, hypothermia) that occurred following diagnosis of BD were recorded. Organ donation rate, the name and number of organs harvested were determined. Results: Twenty-three patients were diagnosed with BD. The mean age of the patients diagnosed with BD was 5.5 +/- 4.9 years. The causative mechanism leading to BD was classified into six groups, out of which the most common diagnosis was TBI with a rate of 39.3%. The meantime from PICU admission to BD diagnosis was 5.7 +/- 5.5 days. The time period from suspicion of BD to the final diagnosis was 1.6 +/- 0.7 days and the meantime to develop cardiac arrest after diagnosis of BD was 13.1 +/- 21.6 days in non-donor cases. The most commonly used confirmation test was brain computed tomography angiography with 82.6%. The most common alteration that follow BD was diabetes insipidus (56.5%). Four patients became organ donors (17.4%). Conclusion: Patients with severe TBI are the most likely candidates for BD declaration and suitable for organ donation for children in need. Early diagnosis and good donor care are of great importance, especially for paediatric patients waiting for organ transplants.	[Duyu, Muhterem] Medeniyet Univ, Goztepe Training & Res Hosp, Pediat Intens Care Unit, Clin Pediat, Istanbul, Turkey; [Karakaya, Zeynep] Medeniyet Univ, Goztepe Training & Res Hosp, Clin Pediat, Istanbul, Turkey		Duyu, M (corresponding author), Medeniyet Univ, Goztepe Training & Res Hosp, Pediat Intens Care Unit, Clin Pediat, Istanbul, Turkey.	drmuhteremduyu@gmail.com	Duyu, Muhterem/M-8366-2018	Karakaya, Zeynep/0000-0002-1412-0068; DUYU, MUHTEREM/0000-0001-7892-2927			ABBUD M, 1995, TRANSPLANT P, V27, P1835; Ashwal S, 2001, BRAIN DEATH, P91; Bonetto G, 2018, ARCH ARGENT PEDIATR, V116, pE54, DOI 10.5546/aap.2018.eng.e54; Burns JP, 2014, CRIT CARE MED, V42, P2101, DOI 10.1097/CCM.0000000000000498; Drake M, 2017, SURG CLIN N AM, V97, P1255, DOI 10.1016/j.suc.2017.07.001; Frutos MA, 2005, TRANSPLANT P, V37, P1557, DOI 10.1016/j.transproceed.2005.02.048; Golchet G, 2000, Optometry, V71, P318; Gomez MP, 2012, TRANSPL P, V44, P1592, DOI 10.1016/j.transproceed.2012.04.005; Heron M, 2010, PEDIATRICS, V125, P4, DOI 10.1542/peds.2009-2416; Joffe AR, 2013, PEDIATR CRIT CARE ME, V14, P1, DOI 10.1097/PCC.0b013e31825b5485; Karasu D, 2015, J MED SURG INTENSIVE, V6, P23, DOI 10.5152/dcbybd.2015.595; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kirikli C, 2011, YOGUN BAKIM DERG, V1, P8; Mascia L, 2009, MINERVA ANESTESIOL, V75, P125; Ozmert S, 2019, TURK J ANAESTHESIOL, V47, P55, DOI 10.5152/TJAR.2019.43726; Ozturk NY, 2016, J PEDIAT EMERG INTEN, V3, P11; POWER BM, 1995, ANAESTH INTENS CARE, V23, P26, DOI 10.1177/0310057X9502300107; Sari MY, 2019, J PEDIAT EMERG INTEN, V6, P156; Sucu A, 2018, J PEDIAT EMERG INTEN, V5, P59; Todres D, 2006, PEDIATR CRIT CARE ME, P790	20	1	1	0	6	GALENOS YAYINCILIK	FINDIKZADE	MOLLA GURANI MAHALLESI KACAMAK SOKAK NO 21, FINDIKZADE, ISTANBUL 34093, TURKEY	2147-9445			J PEDIATR RES	J. Pediatr. Res.	SEP	2020	7	3					250	256		10.4274/jpr.galenos.2020.82474			7	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	ME7MI	WOS:000544838900012		gold			2022-02-06	
J	Flanagan, G; Velez, T; Gu, WD; Singman, E				Flanagan, Gerald; Velez, Tom; Gu, Weidong; Singman, Eric			The Relationship Between Severe Visual Acuity Loss, Traumatic Brain Injuries, and Ocular Injuries in American Service Members From 2001 to 2015	MILITARY MEDICINE			English	Article							PRIMARY BLAST; INTERNATIONAL-CLASSIFICATION; MILITARY; GLOBE; TBI; CONSEQUENCES; DYSFUNCTION; IMPAIRMENT; MECHANISMS; ACCURACY	Introduction Although traumatic brain injury (TBI) is known to cause many visual problems, the correlation between the extent of severe visual acuity loss (SVAL) and severity of TBI has not been widely explored. In this retrospective analysis, combined information from Department of Defense (DoD)/Veterans Affairs ocular injury and TBI repositories were used to evaluate the relationship between chronic SVAL, TBI, ocular injuries, and associated ocular sequelae for U.S. service members serving between 2001 and 2015. Materials and Methods The Defense and Veterans Eye Injury and Vision Registry (DVEIVR) is an initiative led by the DoD and Veterans Affairs that consists of clinical and related data for service members serving in theater since 2001. The Defense and Veterans Brain Injury Center (DVBIC) is the DoD's office for tracking TBI data in the military and maintains data on active-duty service members with a TBI diagnosis since 2000. Longitudinal data from these 2 resources for encounters between February 2001 and October 2015 were analyzed to understand the relation between SVAL, and TBI while adjusting for ocular covariates such as open globe injury (OGI), disorders of the anterior segment and disorders of the posterior segment in a logistic regression model. TBI cases in DVEIVR were identified using DVBIC data and classified according to International Statistical Classification of Diseases criteria established by DVBIC. Head trauma and other open head wounds (OOHW) were also included. SVAL cases in DVEIVR were identified using both International Statistical Classification of Diseases criteria for blindness and low vision as well as visual acuity test data recorded in DVEIVR. Results Data for a total of 25,193 unique patients with 88,996 encounters were recorded in DVEIVR from February, 2001 to November, 2015. Of these, 7,217 TBI and 1,367 low vision cases were identified, with 638 patients experiencing both. In a full logistic model, neither UTBI nor differentiated TBI (DTBI, ie, mild, moderate, severe, penetrating, or unclassified) were significant risk factors for SVAL although ocular injuries (disorders of the anterior segment, disorders of the posterior segment, and OGI) and OOHW were significant. Conclusion Any direct injury to the eye or head risks SVAL but the location and severity will modify that risk. After adjusting for OGIs, OOHW and their sequelae, TBI was found to not be a significant risk factor for SVAL in patients recorded in DVEIVR. Further research is needed to explore whether TBI is associated with more moderate levels of vision acuity loss.	[Flanagan, Gerald; Velez, Tom] Comp Technol Associates Inc, 543 W Graaf Ave, Ridgecrest, CA 93555 USA; [Gu, Weidong] Directorate Def Hlth Agcy, Vis Ctr Excellence Def Hlth Agcy Res & Dev, 1335 East West Highway,SSMC1 Suite 9-100, Silver Spring, MD 20910 USA; [Singman, Eric] Johns Hopkins Univ Hosp, Wilmer Eye Inst Johns Hopkins Hosp Wilmer B29, 600 N Wolfe St, Baltimore, MD 21287 USA		Flanagan, G (corresponding author), Comp Technol Associates Inc, 543 W Graaf Ave, Ridgecrest, CA 93555 USA.				DHA J-9 Vision Center of Excellence Vendor: Knowesis, Inc. [W81XWH18F0486]	This work was supported/funded by the DHA J-9 Vision Center of Excellence Vendor: Knowesis, Inc. Contract #: W81XWH18F0486.	Allen RS, 2018, J NEUROTRAUM, V35, P2104, DOI 10.1089/neu.2017.5394; Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Armstrong RA, 2017, OPTOMETRY VISION SCI, V94, P33, DOI 10.1097/OPX.0000000000000911; Atkins Edward J, 2008, Rev Neurol Dis, V5, P73; Barker-Collo S, 2016, NEUROEPIDEMIOLOGY, V47, P46, DOI 10.1159/000448403; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Berthold Lindstedt M, 2019, J REHABIL MED, V51, P499, DOI 10.2340/16501977-2570; Biehl JW, 1999, MIL MED, V164, P780, DOI 10.1093/milmed/164.11.780; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Bricker-Anthony C, 2016, J OCUL PHARMACOL TH, V32, P286, DOI 10.1089/jop.2015.0104; Bricker-Anthony C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131921; Cairelli MJ, 2015, J BIOMED SEMANT, V6, DOI 10.1186/s13326-015-0022-4; Chaitanya K, 2018, CHILD NERV SYST, V34, P1119, DOI 10.1007/s00381-018-3784-z; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Cockerham GC, 2014, OPHTHALMOLOGY, V121, P2165, DOI 10.1016/j.ophtha.2014.06.009; Corrigan JD, 2014, J NEUROTRAUM, V31, P1000, DOI 10.1089/neu.2013.3145; Dandona L, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-7; Debacker J, 2018, HAND CLINIC, V158, P145, DOI 10.1016/B978-0-444-63954-7.00015-X; Defense Health Agency (DHA), 2018, 18016 DHA; Defense & Veterans Brain Injury Center (DVBIC), 2000, DOD WORLDW NUMB TRAU; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; Doble JE, 2010, PM&R, V2, P244, DOI 10.1016/j.pmrj.2010.01.011; DoD Vision Center of Excellence (VCE), 2014, EYE INJ REG PROM ADV; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Du T, 2005, BRAIN INJURY, V19, P1125, DOI 10.1080/02699050500149817; DVBIC, 2018, DOD WORLDW NUMB TRAU; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Frick KD, 2019, MIL MED, V184, pE338, DOI 10.1093/milmed/usy420; Garner Jeff, 2007, Anesthesiol Clin, V25, P147; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Greer N, 2016, 09009 VA ESP DEP VET; Greer N, 2018, J HEAD TRAUMA REHAB, V33, pE16, DOI 10.1097/HTR.0000000000000304; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Health Mil, 2016, AFHSB SURV CAS DEF F; Health Mil, 2019, DOD STAND SURV CAS D; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Jang SH, 2015, J NEURO-OPHTHALMOL, V35, P270, DOI 10.1097/WNO.0000000000000249; Khalifa M, 2019, BMC EMERG MED, V19, DOI 10.1186/s12873-019-0249-y; Kong GYX, 2015, CLIN EXP OPHTHALMOL, V43, P508, DOI 10.1111/ceo.12511; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Kuhn Ferenc, 2002, Ophthalmol Clin North Am, V15, P139, DOI 10.1016/S0896-1549(02)00004-4; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Lew HL, 2010, NEUROREHABILITATION, V26, P213, DOI 10.3233/NRE-2010-0557; Licona NE, 2017, ARCH PHYS MED REHAB, V98, P391, DOI 10.1016/j.apmr.2016.09.131; Ling G, 2015, Handb Clin Neurol, V127, P173, DOI 10.1016/B978-0-444-52892-6.00011-8; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Muir KW, 2013, JAMA OPHTHALMOL, V131, P119, DOI 10.1001/jamaophthalmol.2013.577; Peacock WF, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00641; Pourhoseingholi Mohamad Amin, 2012, Gastroenterol Hepatol Bed Bench, V5, P79; Ray PL, 2016, J BIOMED SEMANT, V7, DOI 10.1186/s13326-016-0058-0; Rex TS, 2015, CLIN EXP OPHTHALMOL, V43, P197, DOI 10.1111/ceo.12502; Robertson IH, 2008, ARCH PHYS MED REHAB, V89, pS1, DOI 10.1016/j.apmr.2008.10.001; Schulz KF, 2002, LANCET, V359, P431, DOI 10.1016/S0140-6736(02)07605-5; Scott R, 2011, PHILOS T R SOC B, V366, P251, DOI 10.1098/rstb.2010.0234; Sen N, 2017, NEUROCHEM INT, V111, P103, DOI 10.1016/j.neuint.2017.01.019; Sherwood D, 2014, INVEST OPHTH VIS SCI, V55, P1124, DOI 10.1167/iovs.13-13295; Singman EL, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0069-2; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Thakker MM, 2006, CAN J OPHTHALMOL, V41, P86, DOI 10.1016/S0008-4182(06)80074-8; Vlasov Anton, 2015, J Trauma Acute Care Surg, V79, pS210, DOI 10.1097/TA.0000000000000666; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weichel EA, 2009, J HEAD TRAUMA REHAB, V24, P41, DOI 10.1097/HTR.0b013e3181956ffd; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X	68	1	1	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	SEP-OCT	2020	185	9-10					E1576	E1583		10.1093/milmed/usaa154			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NV3WN	WOS:000574256400047	32627822	Bronze			2022-02-06	
J	Gabrieli, D; Vigilante, NF; Scheinfeld, R; Rifkin, JA; Schumm, S; Wu, TT; Gabler, L; Panzer, M; Meaney, DF				Gabrieli, David; Vigilante, Nicholas F.; Scheinfeld, Rich; Rifkin, Jared A.; Schumm, Samantha N.; Wu, Taotao; Gabler, Lee F.; Panzer, Matthew B.; Meaney, David F.			A Multibody Model for Predicting Spatial Distribution of Human Brain Deformation Following Impact Loading	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							UNITED-STATES; PROFESSIONAL FOOTBALL; STRAIN RESPONSES; HEAD IMPACTS; INJURY; BIOMECHANICS; CONCUSSION; ACCELERATIONS; SPORT	With an increasing focus on long-term consequences of concussive brain injuries, there is a new emphasis on developing tools that can accurately predict the mechanical response of the brain to impact loading. Although finite element models (FEM) estimate the brain response under dynamic loading, these models are not capable of delivering rapid (similar to seconds) estimates of the brain's mechanical response. In this study, we develop a multibody spring-mass-damper model that estimates the regional motion of the brain to rotational accelerations delivered either about one anatomic axis or across three orthogonal axes simultaneously. In total, we estimated the deformation across 120 locations within a 50th percentile human brain. We found the multibody model (MBM) correlated, but did not precisely predict, the computed finite element response (average relative error: 18.4 +/- 13.1%). We used machine learning (ML) to combine the prediction from the MBM and the loading kinematics (peak rotational acceleration, peak rotational velocity) and significantly reduced the discrepancy between the MBM and FEM (average relative error: 9.8 +/- 7.7%). Using an independent sports injury testing set, we found the hybrid ML model also correlated well with predictions from a FEM (average relative error: 16.4 +/- 10.2%). Finally, we used this hybrid MBM-ML approach to predict strains appearing in different locations throughout the brain, with average relative error estimates ranging from 8.6% to 25.2% for complex, multi-axial acceleration loading. Together, these results show a rapid and reasonably accurate method for predicting the mechanical response of the brain for single and multiplanar inputs, and provide a new tool for quickly assessing the consequences of impact loading throughout the brain.	[Gabrieli, David; Vigilante, Nicholas F.; Scheinfeld, Rich; Rifkin, Jared A.; Schumm, Samantha N.; Meaney, David F.] Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA; [Wu, Taotao; Gabler, Lee F.; Panzer, Matthew B.] Univ Virginia, Ctr Appl Biomech, Dept Mech & Aerosp Engn, POB 400237, Charlottesville, VA 22904 USA; [Panzer, Matthew B.] Univ Virginia, Ctr Appl Biomech, Dept Biomed Engn, POB 400237, Charlottesville, VA 22904 USA; [Meaney, David F.] Univ Penn, Dept Neurosurg, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA		Meaney, DF (corresponding author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.; Meaney, DF (corresponding author), Univ Penn, Dept Neurosurg, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.	davidgab@seas.upenn.edu; nvig@seas.upenn.edu; rharry@seas.upenn.edu; jarifkin@seas.upenn.edu; schumms@seas.upenn.edu; tw2dx@virginia.edu; lgabler@biocorellc.com; mbp2q@virginia.edu; dmeaney@seas.upenn.edu		Vigilante, Nicholas/0000-0003-0540-4816; Schumm, Samantha/0000-0003-4399-5362	Football Research, Inc. (FRI); Paul G. Allen Family Foundation	The research presented in this paper was made possible in part by a grant from Football Research, Inc. (FRI) and the Paul G. Allen Family Foundation. The views expressed are solely those of the authors and do not represent those of FRI or any of its affiliates or funding sources.	Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Bailly N, 2018, MED SCI SPORT EXER, V50, P2322, DOI 10.1249/MSS.0000000000001701; Brinn J., 1970, 14 STAPP CAR CRASH C, P700902, DOI 10.4271/700902; Cai YL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197992; Cancelliere C, 2017, J HEAD TRAUMA REHAB, V32, pE37, DOI 10.1097/HTR.0000000000000260; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Cui ZY, 2017, COMPUT METHOD BIOMEC, V20, P530, DOI 10.1080/10255842.2016.1255942; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Dormand JR., 1980, J COMPUT APPL MATH, V6, P19, DOI 10.1016/0771-050x(80)90013-3; Elliott MR, 2015, J BIOMECH, V48, P3059, DOI 10.1016/j.jbiomech.2015.07.026; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Gabler LF, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038357; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giudice JS, 2019, ANN BIOMED ENG, V47, P464, DOI 10.1007/s10439-018-02155-3; Goldsmith W., 2001, CRITICAL REV BIOMEDI, V29; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Hastie T., 2008, ELEMENTS STAT LEARNI, VSecond; Hedin DS, 2016, IEEE ENG MED BIO, P2007, DOI 10.1109/EMBC.2016.7591119; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; KING AI, 1995, J NEUROTRAUM, V12, P651, DOI 10.1089/neu.1995.12.651; Knowles BM, 2017, J BIOMECH, V59, P59, DOI 10.1016/j.jbiomech.2017.05.016; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; Kuo C, 2018, BIOMECH MODEL MECHAN, V17, P235, DOI 10.1007/s10237-017-0957-8; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; LEUNG K, 1988, NATURE, V333, P776, DOI 10.1038/333776a0; Lu YC, 2019, ANN BIOMED ENG, V47, P1923, DOI 10.1007/s10439-019-02226-z; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; McElhaney L. E., 1976, HDB HUMAN TOLERANCE; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Nishimoto T, 1998, J BIOMECH ENG-T ASME, V120, P140, DOI 10.1115/1.2834294; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson B, 2018, HAND CLINIC, V158, P235, DOI 10.1016/B978-0-444-63954-7.00023-9; Sanchez E. J., 2018, CLIN BIOMECH; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Slattenschek A., 1968, 700426 SAE, DOI [10.4271/700426, DOI 10.4271/700426]; Spaethling JM, 2007, PROG BRAIN RES, V161, P27, DOI 10.1016/S0079-6123(06)61003-0; Stalnaker R., 1985, APPL NEW MEAN STRAIN, P191; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Voo L, 1996, MED BIOL ENG COMPUT, V34, P375, DOI 10.1007/BF02520009; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Wu LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17864-3; Zhang Jiangyue, 2006, Annu Proc Assoc Adv Automot Med, V50, P1; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501; Zhao W, 2017, ANN BIOMED ENG, V45, P2437, DOI 10.1007/s10439-017-1888-3	60	1	1	2	3	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	SEP 1	2020	142	9							091015	10.1115/1.4046866			11	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	NC7YR	WOS:000561431000015	32266930	Green Published			2022-02-06	
J	Garavito, DMN; Reyna, VF; DeTello, JE; Landow, BR; Tarpinian, LM				Garavito, David M. N.; Reyna, Valerie F.; DeTello, Joseph E.; Landow, Bailey R.; Tarpinian, Lindsey M.			Intentions to report concussion symptoms in nonprofessional athletes: A fuzzy-trace theory approach	APPLIED COGNITIVE PSYCHOLOGY			English	Article						adolescence; athletes; concussions; risky decision making; sports psychology	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; FOOTBALL PLAYERS; RISK-TAKING; KNOWLEDGE; ADOLESCENTS; BEHAVIORS; EPIDEMIOLOGY; UNDERSTAND; DECISIONS	Reducing concussion risks in athletes depends on self-reporting. Often, athletes decide whether to report concussions or continue playing and risk serious health consequences. Fuzzy-trace theory (FTT) predicts that reliance on gisty, categorical representations of risky decisions, not amounts of risk/reward, encourages risk avoidance and application of bottom-line values, or gist principles, thus promoting healthy decisions. Applying FTT, we test whether intentions to report are predicted by gist-based thinking about risks and values. High school and college students (N= 1,366) were assessed for concussion knowledge, social pressures to not report (by coaches/parents/teammates), categorical gist-based thinking, endorsement of gist principles expressing values, and intentions to report. As expected, the older group scored higher on gist measures. For young adults, categorical thinking, and gist principles predicted intentions, controlling for sex, knowledge, and social pressures. For adolescents, categorical thinking again predicted intentions. For both age groups, adding FTT's predictors accounted for significantly more variance than baseline models.	[Garavito, David M. N.; Reyna, Valerie F.; DeTello, Joseph E.; Landow, Bailey R.; Tarpinian, Lindsey M.] Cornell Univ, Dept Human Dev, Ithaca, NY 14853 USA		Garavito, DMN (corresponding author), Cornell Univ, Dept Human Dev, Ithaca, NY 14853 USA.	dmg345@cornell.edu		Garavito, David/0000-0003-4903-9486	Engaged Cornell -Office of Engagement Initiatives; National Institute of Food and AgricultureUnited States Department of Agriculture (USDA)National Institute of Food and Agriculture [NYC-321407]; National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR014368, R21NR016905]	Engaged Cornell -Office of Engagement Initiatives, Grant/Award Numbers: Engaged Graduate Student Grant, Engaged Undergraduate Grant; National Institute of Food and Agriculture, Grant/Award Number: NYC-321407; National Institute of Nursing Research, Grant/Award Numbers: R01NR014368, R21NR016905	Blalock SJ, 2016, HEALTH PSYCHOL, V35, P781, DOI 10.1037/hea0000384; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Byard RW, 2009, FORENSIC SCI MED PAT, V5, P36, DOI 10.1007/s12024-008-9063-7; Celorrio-Navarro M, 2019, J NEUROTRAUM, V36, pA2; Centers for Disease Control and Prevention, 2014, SURV REP TRAUM BRAIN; Cina S. J., 2014, FORENSIC PATHOLOGY I, P711, DOI [10.1007/978-1-61779-403-2, DOI 10.1007/978-1-61779-403-2]; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Defoe IN, 2015, PSYCHOL BULL, V141, P48, DOI 10.1037/a0038088; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Fishbein M, 2008, MED DECIS MAKING, V28, P834, DOI 10.1177/0272989X08326092; Foster CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215030; Fraenkel L, 2015, ARTHRIT CARE RES, V67, P1496, DOI 10.1002/acr.22659; Fraenkel L, 2012, ARTHRIT CARE RES, V64, P977, DOI 10.1002/acr.21657; Garavito D. M. N., 2018, CAMBRIDGE HDB PSYCHO, P713; Garavito DMN, 2019, APPL COGNITIVE PSYCH, V33, P646, DOI 10.1002/acp.3481; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hair JF, 1995, MULTIVARIATE DATA AN; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kahneman D., 2012, THINKING FAST SLOW; Kerr ZY, 2018, AM J SPORT MED, V46, P1733, DOI 10.1177/0363546518765121; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Mills B, 2008, PSYCHOL SCI, V19, P429, DOI 10.1111/j.1467-9280.2008.02104.x; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Reyna VF, 2006, PSYCHOL SCI, P1, DOI 10.1111/j.1529-1006.2006.00026.x; Reyna VF, 2015, CHILD DEV PERSPECT, V9, P122, DOI 10.1111/cdep.12117; Reyna VF, 2014, J EXP PSYCHOL GEN, V143, P1627, DOI 10.1037/a0036717; Reyna VF, 2011, DEV REV, V31, P180, DOI 10.1016/j.dr.2011.07.004; Reyna VF, 2011, J EXP PSYCHOL LEARN, V37, P1125, DOI 10.1037/a0023943; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; TVERSKY A, 1986, J BUS, V59, pS251, DOI 10.1086/296365; Wallace J., 2017, J ATHL TRAINING, V52, P422, DOI [10.4085/1062-6050-52.3.05, DOI 10.4085/1062-6050-52.3.05]; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Warmath D, 2019, SPORTS HEALTH, V11, P416, DOI 10.1177/1941738119856609; White CM, 2015, RISK ANAL, V35, P1407, DOI 10.1111/risa.12369; Wilhelms EA, 2013, J MED PHILOS, V38, P268, DOI 10.1093/jmp/jht018; Wolfe CR, 2015, MED DECIS MAKING, V35, P46, DOI 10.1177/0272989X14535983; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	49	1	1	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0888-4080	1099-0720		APPL COGNITIVE PSYCH	Appl. Cogn. Psychol.	JAN	2021	35	1					26	38		10.1002/acp.3734		SEP 2020	13	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	PS7QD	WOS:000564232600001		Bronze			2022-02-06	
J	Giorgianni, A; Agosti, E; Terrana, AV; Vinacci, G; Nativo, L; Valvassori, L; Locatelli, D; Lanzino, G				Giorgianni, Andrea; Agosti, Edoardo; Terrana, Alberto Vito; Vinacci, Gabriele; Nativo, Luca; Valvassori, Luca; Locatelli, Davide; Lanzino, Giuseppe			Comaneci-Assisted Coiling Embolization of a Posttraumatic Carotid-Cavernous Fistula	WORLD NEUROSURGERY			English	Article						Carotid-cavernous; Coiling; Comaneci-assisted; Embolization; Endovascular; Fistula; Selective microcatheterization	ARTERIOVENOUS-FISTULAS; ENDOVASCULAR TREATMENT; SINUS FISTULA; COVERED STENT	BACKGROUND: A direct carotid-cavernous fistula (CCF) is a rare complication that typically occurs in closed head injuries. The balloon-assisted occlusion is the most used treatment. However, this technique requires multiple inflation/deflations, which could be problematic in a vessel with acute vessel injury. CASE DESCRIPTION: In this study we reported a case of 72-year-old male patient with posttraumatic CCF, treated endovascularly with a transarterial Comaneci-assisted coiling embolization, highlighting the advantages and pitfalls of this innovative endovascular treatment. CONCLUSIONS: The Comaneci-assisted coiling technique has proven to be advantageous both in the microcatheterization of the CCF and during coiling with remodeling technique. In addition, this device does not interrupt the vascular flow compared to balloon-assisted coiling and does not require long-term antiaggregation therapy with respect to the stent placement.	[Giorgianni, Andrea; Terrana, Alberto Vito] Univ Insubria, Dept Neuroradiol, ASST Sette Laghi, Varese, Italy; [Agosti, Edoardo; Locatelli, Davide] Univ Insubria, Dept Biotechnol & Life Sci, Div Neurosurg, Varese, Italy; [Vinacci, Gabriele; Nativo, Luca] Univ Insubria, Dept Radiol, Varese, Italy; [Valvassori, Luca] ASST Monza, Dept Neuroradiol, Monza, Italy; [Locatelli, Davide] Univ Insubria, Dept Biotechnol & Life Sci, Head & Neck Surg & Forens Dissect Res Ctr HNS&FDR, Varese, Italy; [Lanzino, Giuseppe] Mayo Clin, Dept Neurosurg, Rochester, MN USA		Agosti, E (corresponding author), Univ Insubria, Dept Biotechnol & Life Sci, Div Neurosurg, Varese, Italy.	edoardo_agosti@libero.it	giorgianni, andrea/AAI-7238-2021; valvassori, luca/AAC-5772-2022; Locatelli, Davide/AAH-5844-2020	giorgianni, andrea/0000-0002-4035-3172; Locatelli, Davide/0000-0003-1163-9611; Valvassori, Luca Piero/0000-0002-0519-775X			Baranoski JF, 2019, J NEUROINTERV SURG, V11, P1129, DOI 10.1136/neurintsurg-2019-014731; Barranco Pons Roger, 2019, Radiol Case Rep, V14, P1554, DOI 10.1016/j.radcr.2019.09.001; Ducruet AF, 2013, WORLD NEUROSURG, V80, P538, DOI 10.1016/j.wneu.2013.02.033; Felber S, 2004, NEUROSURGERY, V55, P631, DOI 10.1227/01.NEU.0000134455.02947.1F; Fischer S, 2017, J NEUROINTERV SURG, V9, P1093, DOI 10.1136/neurintsurg-2016-012664; Gemmete JJ, 2009, NEUROIMAG CLIN N AM, V19, P241, DOI 10.1016/j.nic.2009.01.006; Gemmete JJ, 2009, J NEURO-OPHTHALMOL, V29, P62, DOI 10.1097/WNO.0b013e3181989fc0; Gomez F, 2007, AM J NEURORADIOL, V28, P1762, DOI 10.3174/ajnr.A0636; Goto K, 1986, Acta Radiol Suppl, V369, P576; Gupta R, 2016, J NEUROINTERV SURG, V8, P181, DOI 10.1136/neurintsurg-2014-011518; HALBACH VV, 1991, AM J NEURORADIOL, V12, P429; Hassan T, 2015, J STROKE CEREBROVASC, V24, P2824, DOI 10.1016/j.jstrokecerebrovasdis.2015.08.016; Henkes H, 2015, CLIN NEURORADIOL, V25, P317, DOI 10.1007/s00062-015-0403-1; Klisch J, 2003, NEUROSURGERY, V53, P836, DOI 10.1227/01.NEU.0000083551.26295.AB; Lawson ALD, 2015, BMJ CASE REP, V2015, P1; Luo CB, 2006, AM J NEURORADIOL, V27, P1535; Lv XL, 2008, J NEUROSURG, V108, P588, DOI 10.3171/JNS/2008/108/3/0588; Madan A, 2006, J NEUROSURG, V104, P969, DOI 10.3171/jns.2006.104.6.969; Marin-Fernandez Ana-Belen, 2016, J Clin Exp Dent, V8, pe226, DOI 10.4317/jced.52913; Miller Neil R, 2007, Neurosurg Focus, V23, pE13, DOI 10.3171/FOC-07/11/E13; Moron FE, 2005, AM J NEURORADIOL, V26, P1399; Niu Y, 2016, INTERV NEURORADIOL, V22, P201, DOI 10.1177/1591019915609779; Sirakov S, 2018, Radiol Case Rep, V13, P1036, DOI 10.1016/j.radcr.2018.04.011; Sirakov SS, 2018, BMJ CASE REP, V2018, P2; Teng MMH, 2000, AM J NEURORADIOL, V21, P1753; Tjoumakaris SI, 2009, NEUROSURG CLIN N AM, V20, P447, DOI 10.1016/j.nec.2009.07.013	26	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2020	141						166	170		10.1016/j.wneu.2020.05.185			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NG9NF	WOS:000564307700015	32474096				2022-02-06	
J	Jaksha, AF; Justin, GA; Brooks, DI; Elward, CJ; Ryan, DS; Weichel, ED; Colyer, MH				Jaksha, Alexandria F.; Justin, Grant A.; Brooks, Daniel I.; Elward, Cameron J.; Ryan, Denise S.; Weichel, Eric D.; Colyer, Marcus H.			Neuro-Ophthalmic Injuries With Systemic Neurologic Injury or Traumatic Brain Injury in Operation Iraqi Freedom and Operation Enduring Freedom	JOURNAL OF NEURO-OPHTHALMOLOGY			English	Article							INTRAOCULAR FOREIGN-BODIES; OCULAR TRAUMA; VISUAL DYSFUNCTION; EYE INJURIES; MOUSE MODEL; BLAST INJURY; GLOBE; WAR; EPIDEMIOLOGY; POPULATION	Background: To analyze the final visual acuity (VA) of neuro-ophthalmologic injuries (NOI) in combat ocular trauma and to study the association of NOI with systemic neurologic injury (SNI) and traumatic brain injury (TBI). Methods: The Walter Reed Ocular Trauma Database was reviewed. Inclusion criteria were any US service member and Department of Defense civilians who suffered NOI, SNI, or TBI in Operation Iraqi Freedom or Operation Enduring Freedom. The primary outcome measure was the rate of poor final VA in patients with an NOI with secondary outcome measures the rate of SNI and TBI. in patients with NOI. Results: One hundred seventy-eight (20.00%) of 890 eyes had an NOI. Optic nerve injury was observed in 79 (44.38%) eyes, other cranial nerve injury in 68 (38.20%), Horner syndrome in 4 (2.25%), diplopia in 45 (25.28%), and ptosis in 13 (7.30%). In patients with NOI, 76 (42.69%) eyes had a final VA less than 20/200. In injured eyes (n = 359) of patients (n = 251) with TBI, 154 eyes (34.26%) had a final VA less than 20/200. In multivariate analysis, optic nerve injury (P< 0.001), unlike TBI (P= 0.47), was associated with final VA less than 20/200. SNI (n = 229) had a statistically significant association (odds ratio 29.8, 95% confidence interval 19.2-47.8,P< 0.001) with NOI. Optic nerve injury and cranial nerve injury were associated with TBI and SNI (all,P< 0.001). Conclusion: Optic nerve injury and cranial nerve injury are associated with TBI and SNI. Optic nerve injury, but not TBI or cranial nerve injury, is associated with a poor final VA.	[Jaksha, Alexandria F.] Landstuhl Reg Med Ctr, Baumholder Army Hlth Clin, Landstuhl, Germany; [Justin, Grant A.] Brooke Army Med Ctr, Dept Ophthalmol, San Antonio, TX USA; [Justin, Grant A.; Colyer, Marcus H.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Brooks, Daniel I.] Walter Reed Natl Mil Med Ctr, Dept Res Programs, Bethesda, MD USA; [Elward, Cameron J.] Uniformed Serv Univ Hlth Sci, Sch Med, Bethesda, MD 20814 USA; [Ryan, Denise S.] Warfighter Refract Eye Surg Program & Res Ctr, Ft Belvoir, VA USA; [Weichel, Eric D.] Retina Grp Washington DC, Greenbelt, MD USA; [Colyer, Marcus H.] Walter Reed Natl Mil Med Ctr, Dept Ophthalmol, Bethesda, MD USA		Justin, GA (corresponding author), Brooke Army Med Ctr, 3551 Roger Brooke Dr, San Antonio, TX 78219 USA.	grant.a.justin@gmail.com			Office of the Assistant Secretary of Defense for Health Affairs under the Broad Agency Announcement for Extramural Medical Research [BAA-16-R-BAA1, W81XWH-17-2-0007]	` Supported by the Office of the Assistant Secretary of Defense for Health Affairs under the Broad Agency Announcement for Extramural Medical Research, BAA-16-R-BAA1 under Award No. W81XWH-17-2-0007.	Aghadoost D, 2013, CHIN J TRAUMATOL, V16, P347, DOI 10.3760/cma.j.issn.1008-1275.2013.06.006; Al-Mahrouqi Haitham H, 2017, Oman J Ophthalmol, V10, P63, DOI 10.4103/ojo.OJO_117_2016; Batur M, 2016, J CRANIOFAC SURG, V27, P1636, DOI 10.1097/SCS.0000000000003001; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Bricker-Anthony C, 2016, J OCUL PHARMACOL TH, V32, P286, DOI 10.1089/jop.2015.0104; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Caceres V, 2007, OCULAR TRAUMA RATES; Cao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048377; Centers for Disease Control and Prevention DHHS, EXPL BLAST INJ PRIM; Chauhan N, 2017, GUOJI YANKE ZAZHI, V17, P2207; Cho RI, 2009, J TRAUMA, V67, P516, DOI 10.1097/TA.0b013e3181a5f08d; Cillino S, 2008, BMC OPHTHALMOL, V8, DOI 10.1186/1471-2415-8-6; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Colyer MH, 2008, OPHTHALMOLOGY, V115, P2087, DOI 10.1016/j.ophtha.2008.05.013; Dandona L, 2000, CLIN EXP OPHTHALMOL, V28, P350, DOI 10.1046/j.1442-9071.2000.00334.x; DeWalt GJ, 2017, J COMP NEUROL, V525, P2955, DOI 10.1002/cne.24252; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Elhesy AE., 2016, J EGYPT OPHTHALMOL, V109, P153; Fox J, 2010, R COMPANION APPL REG; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Kelts EA, 2010, NEUROREHABILITATION, V27, P223, DOI 10.3233/NRE-2010-0601; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kuhn F, 2004, J FR OPHTALMOL, V27, P206, DOI 10.1016/S0181-5512(04)96122-0; Kuhn Ferenc, 2002, Ophthalmol Clin North Am, V15, P163, DOI 10.1016/S0896-1549(02)00007-X; Leivo T, 2015, ACTA OPHTHALMOL, V93, P224, DOI 10.1111/aos.12633; Lemke S, 2016, OPHTHALMOLOGY, V123, P415, DOI 10.1016/j.ophtha.2015.10.003; Lemke S, 2013, JAMA OPHTHALMOL, V131, P1602, DOI 10.1001/jamaophthalmol.2013.5028; Liu CCH, 2017, INT OPHTHALMOL, V37, P55, DOI 10.1007/s10792-016-0225-4; Mader TH, 2006, OPHTHALMOLOGY, V113, P97, DOI 10.1016/j.ophtha.2005.07.018; Pradhan E, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0429-z; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; Sahraravand A, 2017, ACTA OPHTHALMOL, V95, P288, DOI 10.1111/aos.13313; Scott RAH, 2015, TRAUMA, V17, P83, DOI 10.1177/1460408614539621; Shashikala P, 2013, Indian J Occup Environ Med, V17, P66, DOI 10.4103/0019-5278.123168; Singh S, 2017, INDIAN J OPHTHALMOL, V65, P1192, DOI 10.4103/ijo.IJO_375_17; Soliman MM, 2008, GRAEF ARCH CLIN EXP, V246, P205, DOI 10.1007/s00417-007-0720-4; Soong TKW, 2011, GRAEF ARCH CLIN EXP, V249, P1755, DOI 10.1007/s00417-010-1444-4; Thach AB, 2008, OPHTHALMOLOGY, V115, P377, DOI 10.1016/j.ophtha.2007.04.032; Vlasov Anton, 2015, J Trauma Acute Care Surg, V79, pS210, DOI 10.1097/TA.0000000000000666; Wang JD, 2012, ACTA OPHTHALMOL, V90, pE61, DOI 10.1111/j.1755-3768.2011.02230.x; Weichel EA, 2009, J HEAD TRAUMA REHAB, V24, P41, DOI 10.1097/HTR.0b013e3181956ffd; Weichel ED, 2009, RETINA-J RET VIT DIS, V29, P349, DOI 10.1097/IAE.0b013e31818d4b82; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033; Wong TY, 1999, AM J OPHTHALMOL, V128, P345, DOI 10.1016/S0002-9394(99)00167-1; Wong TY, 1997, SURV OPHTHALMOL, V41, P433, DOI 10.1016/S0039-6257(97)00022-2; Wong TY, 2000, AM J OPHTHALMOL, V129, P645, DOI 10.1016/S0002-9394(99)00448-1; Zhang Y, 2011, AM J OPHTHALMOL, V152, P66, DOI 10.1016/j.ajo.2011.01.014	49	1	1	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1070-8022	1536-5166		J NEURO-OPHTHALMOL	J. Neuro-Ophthal.	SEP	2020	40	3					322	327		10.1097/WNO.0000000000000913			6	Clinical Neurology; Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Ophthalmology	NQ9CC	WOS:000571163200014	32108667				2022-02-06	
J	Kazazian, K; Norton, L; Gofton, TE; Debicki, D; Owen, AM				Kazazian, Karnig; Norton, Loretta; Gofton, Teneille E.; Debicki, Derek; Owen, Adrian M.			Cortical Function in Acute Severe Traumatic Brain Injury and at Recovery: A Longitudinal fMRI Case Study	BRAIN SCIENCES			English	Article						coma; consciousness; awareness; disorders of consciousness; traumatic brain injury	DEFAULT MODE NETWORK; COMATOSE SURVIVORS; SPOKEN LANGUAGE; CONSCIOUSNESS; DISORDERS; STATE; CONNECTIVITY; SPEECH; ACTIVATION; SCALE	Differences in the functional integrity of the brain from acute severe brain injury to subsequent recovery of consciousness have not been well documented. Functional magnetic resonance imaging (fMRI) may elucidate this issue as it allows for the objective measurement of brain function both at rest and in response to stimuli. Here, we report the cortical function of a patient with a severe traumatic brain injury (TBI) in a critically ill state and at subsequent functional recovery 9-months post injury. A series of fMRI paradigms were employed to assess sound and speech perception, command following, and resting state connectivity. The patient retained sound perception and speech perception acutely, as indexed by his fMRI responses. Command following was absent acutely, but was present at recovery. Increases in functional connectivity across multiple resting state networks were observed at recovery. We demonstrate the clinical utility of fMRI in assessing cortical function in a patient with severe TBI. We suggest that hallmarks of the recovery of consciousness are associated with neural activity to higher-order cognitive tasks and increased resting state connectivity.	[Kazazian, Karnig; Owen, Adrian M.] Western Univ, Brain & Mind Inst, London, ON N6A 3K7, Canada; [Kazazian, Karnig] Western Univ, Grad Program Neurosci, London, ON N6A 3K7, Canada; [Norton, Loretta] Western Univ, Kings Univ Coll, Dept Psychol, London, ON N6A 3K7, Canada; [Gofton, Teneille E.; Debicki, Derek] Western Univ, Dept Clin Neurol Sci, London, ON N6A 3K7, Canada; [Owen, Adrian M.] Western Univ, Dept Physiol & Pharmacol, London, ON N6A 3K7, Canada; [Owen, Adrian M.] Western Univ, Dept Psychol, London, ON N6A 3K7, Canada		Kazazian, K (corresponding author), Western Univ, Brain & Mind Inst, London, ON N6A 3K7, Canada.; Kazazian, K (corresponding author), Western Univ, Grad Program Neurosci, London, ON N6A 3K7, Canada.	kkazazia@uwo.ca; lnorton5@uwo.ca; teneille.gofton@lhsc.on.ca; derek.debicki@lhsc.on.ca; uwocerc@uwo.ca		Norton, Loretta/0000-0002-6651-1837; Kazazian, Karnig/0000-0001-6157-601X; Owen, Adrian/0000-0002-5738-3765	Canada Excellence Research Chairs (CERC) program [215063]; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [408004]; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR [RGPIN-2018-05878]	This research was funded by the Canada Excellence Research Chairs (CERC) program (#215063), the Canadian Institutes of Health Research (CIHR, #408004), and the Natural Sciences and Engineering Research Council of Canada (RGPIN-2018-05878).	Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; Baars BJ, 2005, PROG BRAIN RES, V150, P45, DOI 10.1016/S0079-6123(05)50004-9; Bateman DE, 2001, J NEUROL NEUROSUR PS, V71, P13; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Bodien YG, 2016, ARCH PHYS MED REHAB, V97, P490, DOI 10.1016/j.apmr.2015.08.422; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Cooksley T, 2018, CLIN MED, V18, P88, DOI 10.7861/clinmedicine.18-1-88; D'Arcy RCN, 2016, J HEAD TRAUMA REHAB, V31, pE50, DOI 10.1097/HTR.0000000000000185; Davis MH, 2003, J NEUROSCI, V23, P3423; Demertzi A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aat7603; Edlow BL, 2018, J HEAD TRAUMA REHAB, V33, P424, DOI 10.1097/HTR.0000000000000448; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Fernandez-Espejo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095082; Gofton TE, 2009, EXP NEUROL, V217, P320, DOI 10.1016/j.expneurol.2009.03.011; Green SM, 2011, ANN EMERG MED, V58, P427, DOI 10.1016/j.annemergmed.2011.06.009; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Kirsch M, 2017, ANESTH ANALG, V124, P588, DOI 10.1213/ANE.0000000000001721; Koenig MA, 2014, NEUROCRIT CARE, V20, P348, DOI 10.1007/s12028-014-9953-3; Leunissen I, 2013, HUM BRAIN MAPP, V34, P1254, DOI 10.1002/hbm.21508; Madhavan R, 2019, J NEUROTRAUM, V36, P650, DOI 10.1089/neu.2018.5739; Mayor SA, 1999, NEUROLOGY, V52, P1602, DOI 10.1212/WNL.52.8.1602; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Moritz CH, 2001, MAGN RESON IMAGING, V19, P1129, DOI 10.1016/S0730-725X(01)00432-5; Norton L, 2012, NEUROLOGY, V78, P175, DOI 10.1212/WNL.0b013e31823fcd61; Norton L., FUNCTIONAL NEUROIMAG; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Rodd JM, 2005, CEREB CORTEX, V15, P1261, DOI 10.1093/cercor/bhi009; Rohaut B, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2370-4; Sair HI, 2018, RADIOLOGY, V287, P247, DOI 10.1148/radiol.2017162161; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Soddu A, 2011, FUNCT NEUROL, V26, P37; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tomaiuolo F, 2016, J INT NEUROPSYCH SOC, V22, P620, DOI 10.1017/S1355617716000485; Weijer C, 2016, BRAIN, V139, P292, DOI 10.1093/brain/awv272; Wijdicks Eelco F M, 2010, Pract Neurol, V10, P51, DOI 10.1136/jnnp.2009.200097	40	1	1	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	SEP	2020	10	9							604	10.3390/brainsci10090604			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OG2OZ	WOS:000581731300001	32899145	gold, Green Published			2022-02-06	
J	Kent, M; Brilliant, A; Erickson, K; Meehan, W; Howell, D				Kent, Matthew; Brilliant, Anna; Erickson, Kirk; Meehan, William; Howell, David			Symptom Presentation After Concussion and Pre-existing Anxiety Among Youth Athletes	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						adolescent; mild traumatic brain injury; anxiety; mental health; sports	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYMPTOMS; UNITED-STATES; DISORDERS; RECOVERY; CHILDREN; SCHOOL; RISK; PREDICTORS	Our purpose was to evaluate the effect of self-reported pre-injury anxiety diagnosis on persistent symptom development, vestibular symptom severity, and balance control among youth who sustained a concussion. We performed a retrospective study of patients seen at a specialty pediatric concussion clinic. Patients were 18 years of age or younger, examined within 10 days of concussion, and received care until full recovery. A questionnaire was used to assess pre-existing medical and psychiatric conditions, including anxiety. Our main outcomes were prolonged symptom recovery defined as persistent symptoms for >28 days after concussion) and severity of vestibular symptoms. Patients who reported pre-injury anxiety (n=43; median age=14.9 years; 37% female) were more likely to experience symptoms>28 days post-injury (76 vs. 54%; p=0.04) than those without pre-existing anxiety (n=241; median age=14.9 years; 53% female). After adjusting for sex, history of migraine, depression and ADHD, however, there was no independent association between pre-existing anxiety and prolonged symptom duration (adjusted odds ratio=2.34; 95% CI=0.083-6.63; p=0.11). Pre-existing anxiety was independently associated with self-reported nausea/vomiting severity (beta coefficient=0.59, 95% CI=0.07-1.11). A pre-existing anxiety diagnosis does not appear to be associated with persistent symptoms after concussion, although it may be associated with post-injury nausea.	[Kent, Matthew; Erickson, Kirk] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Brilliant, Anna] Childrens Hosp Boston, Dept Sports Med, Boston, MA USA; [Meehan, William] Micheli Ctr Sports Injury Prevent, Dept Sports Med, Waltham, MA USA; [Howell, David] Univ Colorado Denver, Dept Orthoped, Sch Med, 13123 E 16th Ave,B060, Aurora, CO 80045 USA; [Howell, David] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA		Howell, D (corresponding author), Univ Colorado Denver, Dept Orthoped, Sch Med, 13123 E 16th Ave,B060, Aurora, CO 80045 USA.	David.Howell@CUAnschutz.edu			Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560]; National Institute of Neurological Disorders And StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03HD094560, R01NS100952, R43NS108823]; MIND-SOURCE Brain Injury Network; National Hockey League Alumni Association; National Football League	There was no funding provided for this study. Dr. Howell has received research support from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (R03HD094560), the National Institute of Neurological Disorders And Stroke (R01NS100952, R03HD094560, and R43NS108823), and MIND-SOURCE Brain Injury Network. Dr. Meehan receives royalties from 1) ABC-Clio publishing for the sale of his books, Kids, Sports, and Concussion: A guide for coaches and parents, and Concussions; 2) Springer International for the book Head and Neck Injuries in the Young Athlete and 3) Wolters Kluwer for working as an author for UpToDate. His research is funded, in part, by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament and a grant from the National Football League. The remaining authors have conflicts to disclose.	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Balabann CD, 2011, EXPERT REV NEUROTHER, V11, P379, DOI [10.1586/ern.11.19, 10.1586/ERN.11.19]; Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Brainard A, 2014, AM FAM PHYSICIAN, V90, P41; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Goes FS, 2012, PSYCHOL MED, V42, P1449, DOI 10.1017/S0033291711002637; Guerriero RM, 2018, J CHILD NEUROL, V33, P168, DOI 10.1177/0883073817749655; Harriss DJ, 2019, INT J SPORTS MED, V40, P813, DOI 10.1055/a-1015-3123; Harter MC, 2003, EUR ARCH PSY CLIN N, V253, P313, DOI 10.1007/s00406-003-0449-y; Howell DR, 2018, AM J SPORT MED, V46, P3254, DOI 10.1177/0363546518796830; Howell DR, 2019, CLIN J SPORT MED, V29, P391, DOI 10.1097/JSM.0000000000000629; Howell DR, 2017, CLIN J SPORT MED, V27, P444, DOI 10.1097/JSM.0000000000000374; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Legarreta AD, 2018, J NEUROSURG-PEDIATR, V22, P238, DOI 10.3171/2018.3.PEDS1850; Lumba-Brown A, 2019, NEUROSURGERY, V0, P1; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P764, DOI 10.1080/13803395.2015.1060950; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Paillard AC, 2013, J VESTIBUL RES-EQUIL, V23, P203, DOI 10.3233/VES-130501; Redfern MS, 2007, J ANXIETY DISORD, V21, P704, DOI 10.1016/j.janxdis.2006.09.002; Reynolds E, 2014, NEUROSURGERY S4, V75, P71; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Souza I, 2005, ARQ NEURO-PSIQUIAT, V63, P407, DOI 10.1590/S0004-282X2005000300008; Staab JP, 2013, SEMIN NEUROL, V33, P297, DOI 10.1055/s-0033-1356462; Sufrinko AM, 2019, CLIN J SPORT MED, V29, P318, DOI 10.1097/JSM.0000000000000528; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Viaud-Delmon I, 2011, PROG NEURO-PSYCHOPH, V35, P1391, DOI 10.1016/j.pnpbp.2010.09.016; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhang LL, 2016, CNS NEUROSCI THER, V22, P15, DOI 10.1111/cns.12468; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	40	1	1	0	4	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	SEP	2020	41	10					682	687		10.1055/a-1107-3025			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	NI8XK	WOS:000565630000007	32492729				2022-02-06	
J	Kim, SH; Lee, N; Martin, B; Suh, J; Walters, D; Silverman, DH; Berenji, GR				Kim, Seong-Hyeon; Lee, Narae; Martin, Bess; Suh, Joy; Walters, Darrell; Silverman, Daniel H.; Berenji, Gholam R.			Examining Posttraumatic Stress Disorder as a Key Postinjury Risk Factor in OIF/OEF Veterans With Blast-Induced Mild Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						mild traumatic brain injury; PTSD; veterans; blast; processing speed	NEUROPSYCHOLOGICAL OUTCOMES; OEF/OIF VETERANS; COGNITIVE SEQUELAE; PROCESSING SPEED; MENTAL-HEALTH; FIT INDEXES; SYMPTOMS; PERFORMANCE; CONCUSSION; AFGHANISTAN	Objective: To explore the neuropsychological sequelae of blast-induced mild traumatic brain injury (mTBI) and posttraumatic stress disorder (PTSD), several neuropsychological tests and self-reported measures of cognitive and emotional functioning were administered to 138 Operation Iraqi Freedom (OIF)/Operation Enduring Freedom (OEF) veterans. We hypothesized that veterans affected by mTBI and PTSD would manifest differences in neuropsychological testing and self-report measures compared to a group of healthy veteran controls and to veterans with only PTSD. Method: Participants included 3 groups of veterans: (a) healthy controls (n = 43); (b) PTSD only (n = 48); and (c) comorbid blast-induced mTBI and PTSD (n = 47). An exploratory factor analysis (EFA) was used to extract a smaller number of latent dimensions for group comparison. Results: The EFA suppo, ted an 8-factor model. A multivariate analysis of variance on the 8 factor scores demonstrated 3 significant factor mean differences: (a) perceived cognitive complications (PCC), (b) perceived emotional distress (PED), and (c) processing speed (PS). Post hoc analyses showed significant group mean difference in PS between the comorbid and the control groups. In addition, the comerbid group presented with the highest levels of PCC and PED. Conclusions: Results suggest that among OIF/OEF veterans with blast-induced mTBI, PTSD with its accompanying emotional distress may be a significant determinant of subjective sense of well-being both cognitively and emotionally. The objective discrepancy in PS between the comorbid group and the healthy controls also appears largely due to PTSD more so than the remote blast-induced mTBI, as the group mean difference in PS became negligible after controlling for PTSD levels.	[Kim, Seong-Hyeon; Suh, Joy; Walters, Darrell] Fuller Theol Seminary, Dept Clin Psychol, 180 North Oakland Ave, Pasadena, CA 91101 USA; [Lee, Narae] Patton State Hosp, Dept Psychol, Patton, CA USA; [Martin, Bess] Rehabil Inst Michigan, Dept Neuropsychol, Detroit, MI USA; [Silverman, Daniel H.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Berenji, Gholam R.] VA Greater Los Angeles Healthcare Syst, Dept Nucl Med, Los Angeles, CA 90073 USA		Kim, SH (corresponding author), Fuller Theol Seminary, Dept Clin Psychol, 180 North Oakland Ave, Pasadena, CA 91101 USA.; Berenji, GR (corresponding author), VA Greater Los Angeles Healthcare Syst, Dept Nucl Med, West Los Angeles Med Ctr, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	shkim@fuller.edu; gholam.berenji@va.gov		Lee, Narae/0000-0002-7018-2239; Walters, Darrell/0000-0002-5598-3572	Department of Veterans AffairsUS Department of Veterans Affairs [1I01CX000622-01]	This research was supported by a Merit Review Award (1I01CX000622-01) for Clinical Science Research and Development from the Department of Veterans Affairs.	AASE DM, 2018, PSYCHIAT RES, V0268, P00460, DOI DOI 10.1016/J.PSYCHRES.2018.08.019; ALOSCO ML, 2016, J HEAD TRAUMA REHAB, V0031, P00360, DOI DOI 10.1097/HTR.0000000000000201; Beck A. T., 1996, Manual for the Beck Depression Inventory, V2nd; BECK AT, 1988, J CONSULT CLIN PSYCH, V0056, P00893; BELANGER HG, 2005, J INT NEUROPSYCH SOC, V0011, P00215, DOI DOI 10.1017/S1355617705050277; BELANGER HG, 2010, J INT NEUROPSYCH SOC, V0016, P00194, DOI DOI 10.1017/S1355617709990841; BELANGER HG, 2009, J INT NEUROPSYCH SOC, V0015, P00001, DOI DOI 10.1017/S1355617708090036; Benedict R. H., 1997, BRIEF VISUOSPATIAL M; BOONE KB, 2002, ARCH CLIN NEUROPSYCH, V0017, P00625, DOI DOI 10.1093/ARCLIN/17.7.625; Brandt J., 2001, HOPKINS VERBAL LEARN; BRENNER LA, 2009, REHABIL PSYCHOL, V0054, P00239, DOI DOI 10.1037/A0016908; BRENNER LA, 2010, NEUROPSYCHOLOGY, V0024, P00160, DOI DOI 10.1037/A0017966; Chelune G. J., 1986, ADV CLIN NEUROPSYCHO, P95, DOI [10.1007/978-1-4613-2211-5_4, DOI 10.1007/978-1-4613-2211-5_4]; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd Edn; COMBS HL, 2015, J NEUROTRAUM, V0032, P00956, DOI DOI 10.1089/NEU.2014.3585; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI; Delis D. C., 2001, DELIS KAPLAN EXECUTI; DEPALMA RG, 2005, NEW ENGL J MED, V0352, P01335, DOI DOI 10.1056/NEJMRA042083; DEPUE BE, 2014, BIOMED RES INT, V2014; DONNELLY K, 2018, CLIN NEUROPSYCHOL, V0032, P00436, DOI DOI 10.1080/13854046.2017.1390163; DRAG LL, 2012, J INT NEUROPSYCH SOC, V0018, P00576, DOI DOI 10.1017/S1355617712000203; ELDER GA, 2010, PSYCHIAT CLIN N AM, V0033, P00757, DOI DOI 10.1016/J.PSC.2010.08.001; FABRIGAR LR, 1999, PSYCHOL METHODS, V0004, P00272; Finch H., 2005, METHODOLOGY, V1, P27, DOI DOI 10.1027/1614-1881.1.1.27; First M. B., 2002, STRUCTURED CLIN INTE; GOULD KR, 2014, J CLIN EXP NEUROPSYC, V0036, P00001, DOI DOI 10.1080/13803395.2013.863832; Green P., 1995, MANUAL ORAL WORD MEM; Greiffenstein M. F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3]; GREVE KW, 2008, CLIN NEUROPSYCHOL, V0022, P00896, DOI DOI 10.1080/13854040; Halstead W. C., 1947, BRAIN INTELLIGENCE; Hayes J. P., 2019, PTSD RES Q, V30, P2; HOGE CW, 2009, NEW ENGL J MED, V0360, P01588, DOI DOI 10.1056/NEJMP0810606; HOGE CW, 2008, NEW ENGL J MED, V0358, P00453; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; IVERSON GL, 2005, CURR OPIN PSYCHIATR, V0018, P00301; KARR JE, 2014, NEUROPSYCHOLOGY, V0028, P00321, DOI DOI 10.1037/NEU0000037; Katz DI, 2015, HDB CLIN NEUROLOGY, V127, P131, DOI DOI 10.1016/B978-0-444-52892-6.00009-X; KING NS, 2003, BRIT J PSYCHIAT, V0183, P00276, DOI DOI 10.1192/BJP.183.4.276; KORKMAZ S, 2014, R J, V0006, P00151, DOI DOI 10.32614/RJ-2014-031; LARRABEE GJ, 2003, CLIN NEUROPSYCHOL, V0017, P00410, DOI DOI 10.1076/CLIN.17.3.410.18089; LARRABEE GJ, 2003, J INT NEUROPSYCH SOC, V0009, P00947, DOI DOI 10.1017/S1355617703960140; LITTLE RJA, 1988, J AM STAT ASSOC, V0083, P01198, DOI DOI 10.1080/01621459; LOSOI H, 2016, J NEUROTRAUM, V0033, P00766, DOI DOI 10.1089/NEU.2015.4070; MACERA CA, 2013, SLEEP, V0036, P00083, DOI DOI 10.5665/SLEEP.2306; MARDIA KV, 1970, BIOMETRIKA, V0057, P00519, DOI DOI 10.1093/BI0MET/57.3.519; MARSH HW, 2004, STRUCT EQU MODELING, V0011, P00320, DOI DOI 10.1207/S15328007SEM1103_2; MATTSON EK, 2019, NEUROPSYCHOLOGY, V0033, P00913, DOI DOI 10.1037/NEU0000560; MCCREA M, 2008, CLIN NEUROPSYCHOL, V0022, P00010, DOI DOI 10.1080/13854040701760981; MCDERMOTT LM, 2009, J AFFECT DISORDERS, V0119, P00001, DOI DOI 10.1016/J.JAD.2009.04.022; MERRITT VC, 2019, J CLIN EXP NEUROPSYC, V0041, P00665, DOI DOI 10.1080/13803395; Meyers J. E., 1995, REY COMPLEX FIGURE T; NEIPERT L, 2014, BRAIN INJURY, V0028, P01667, DOI DOI 10.3109/02699052.2014.947623; NELSON LA, 2009, J HEAD TRAUMA REHAB, V0024, P00032, DOI DOI 10.1097/HTR.0B013E3181957016; NELSON NW, 2020, NEUROPSYCHOLOGY, V0034, P00116, DOI DOI 10.1037/NEU0000594; OKIE S, 2005, NEW ENGL J MED, V0352, P02043, DOI DOI 10.1056/NEJMP058102; ONEIL ME, 2014, J INT NEUROPSYCH SOC, V0020, P00249, DOI DOI 10.1017/S135561771300146X; OWENS BD, 2008, J TRAUMA, V0064, P00295, DOI DOI 10.1097/TA; PAGULAYAN KF, 2018, J INT NEUROPSYCH SOC, V0024, P00324, DOI DOI 10.1017/S1355617717001217; PATT VM, 2018, ARCH CLIN NEUROPSYCH, V0033, P00079, DOI DOI 10.1093/ARCLIN/ACX043; PESKIND ER, 2011, NEUROIMAGE, V0054, pS 7, DOI DOI 10.1016/J.NEUROIMAGE.2010.04.008; PETRIE EC, 2014, J NEUROTRAUM, V0031, P00425, DOI DOI 10.1089/NEU.2013.2952; Raykov T., 2006, 1 COURSE STRUCTURAL; Revelle W., 2018, R PACKAGE VERSION, V1, P4; ROHLING ML, 2012, CLIN NEUROPSYCHOL, V0026, P00197, DOI DOI 10.1080/13854046.2011.647085; RUSSO AC, 2017, ARCH CLIN NEUROPSYCH, V0032, P00184, DOI DOI 10.1093/ARCLIN/ACW093; RYAN LM, 2003, INT REV PSYCHIATR, V0015, P00310, DOI DOI 10.1080/; SCHNEIDERMAN AI, 2008, AM J EPIDEMIOL, V0167, P01446, DOI DOI 10.1093/AJE/KWN068; SCHWAB K, 2017, NEUROLOGY, V0088, P01571, DOI DOI 10.1212/WNL.0000000000; SCOTT JC, 2015, PSYCHOL BULL, V0141, P00105, DOI DOI 10.1037/A0038039; SHANDERAOCHSNER AL, 2013, CLIN NEUROPSYCHOL, V0027, P00881, DOI DOI 10.1080/13854046.2013.802017; SHIVELY SB, 2016, LANCET NEUROL, V0015, P00944, DOI DOI 10.1016/S1474-4422(16)30057-6; SPENCER RJ, 2010, J REHABIL RES DEV, V0047, P00521, DOI DOI 10.1682/JRRD.2009.11.0181; STEIN MB, 2009, AM J PSYCHIAT, V0166, P00768, DOI DOI 10.1176/APPI.AJP; Tabachnick B. G., 2001, USING MULTIVARIATE S; TABER KH, 2006, J NEUROPSYCH CLIN N, V0018, P00141, DOI DOI 10.1176/JNP; TAYLOR BC, 2012, MED CARE, V0050, P00342; TENBERGE JMF, 1999, LINEAR ALGEBRA APPL, V0289, P00311, DOI DOI 10.1016/S0024-3795(97)10007-6; TSOURTOS G, 2002, PSYCHOL MED, V0032, P00259, DOI DOI 10.1017/S0033291701005001; VASTERLING JJ, 2018, J INT NEUROPSYCH SOC, V0024, P00311, DOI DOI 10.1017/S1355617717001059; VERFAELLIE M, 2014, NEUROPSYCHOLOGY, V0028, P00337, DOI DOI 10.1037/NEU0000027; VICTOR T, 2009, CLIN NEUROPSYCHOL, V0023, P00297, DOI DOI 10.1080/13854040802232682; WALJAS M, 2015, J NEUROTRAUM, V0032, P00534, DOI DOI 10.1089/NEU.2014.3339; Weathers F., 1993; Wechsler D., 2008, WECHSLER AD INT SCAL, V4th; Wechsler D., 2009, WECHSLER INDIVIDUAL	85	1	1	0	5	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	SEP	2020	34	6					713	725		10.1037/neu0000678			13	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	NG2GH	WOS:000563802900010	32614198	Bronze			2022-02-06	
J	Kinney, AR; Graham, JE; Eakman, AM				Kinney, Adam R.; Graham, James E.; Eakman, Aaron M.			Participation Is Associated With Well-Being Among Community-Based Veterans: An Investigation of Coping Ability, Meaningful Activity, and Social Support as Mediating Mechanisms	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; DISABILITY-AND-HEALTH; INTERNATIONAL-CLASSIFICATION; MILITARY PERSONNEL; LIFE SATISFACTION; REINTEGRATION; EXPERIENCES; DEPRESSION; SEVERITY	Importance: Occupational therapy practitioners can use therapeutic activity to promote veterans' well-being, but the mechanisms through which participation promotes well-being are poorly understood. Objective: To examine whether coping ability, meaningful activity, and social support mediate the relationship between participation and two indicators of veterans' overall well-being: life meaning (psychological well-being) and life satisfaction (subjective well-being). Design: Explanatory cross-sectional design. We used two multiple mediation models to test whether coping ability, meaningful activity, and social support explained the relationship between participation and both life meaning and life satisfaction. Models were adjusted for demographic characteristics and service-related health conditions (e.g., posttraumatic stress disorder). Setting: Community. Participants: Three hundred eighty-nine community-based veterans attending college. Intervention: None. Outcomes and Measures: Measures of participation, coping ability, meaningful activity, social support, life meaning, life satisfaction, and service-related health conditions. Results: Meaningfulness of activity partially explained the relationship between participation and both psychological well-being (B = 0.16, standard error [SE] = 0.04, 99% confidence interval [CI] [0.07, 0.27]) and subjective well-being (B = 0.14, SE= 0.03, 99% CI [0.07, 0.24]). Social support partially explained the relationship between participation and subjective well-being (B= 0.05, SE= 0.02, 99% CI [0.01, 0.11]). These findings persisted when symptoms of service-related health conditions were accounted for. Conclusions and Relevance: Veterans' participation is associated with a greater sense of meaningful activity and social support, which in turn promotes psychological and subjective well-being. Occupational therapy practitioners may promote veterans' well-being by supporting engagement in activities that elicit meaning and enable social interaction, although further study is needed. What This Article Adds: This is among the first studies to test mechanisms underlying the relationship between veterans' engagement in activities and their overall well-being. Results may inform treatment theories for activity-based interventions in the veteran population. For example, results indicate that occupational therapy interventions that facilitate engagement in meaningful and shared activities could be developed to promote veterans' well-being.	[Kinney, Adam R.] Dept Vet Affairs, Rocky Mt Mental Illness Res Educ & Clin Ctr, Aurora, CO 80012 USA; [Kinney, Adam R.] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO 80045 USA; [Kinney, Adam R.; Graham, James E.; Eakman, Aaron M.] Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA		Kinney, AR (corresponding author), Dept Vet Affairs, Rocky Mt Mental Illness Res Educ & Clin Ctr, Aurora, CO 80012 USA.; Kinney, AR (corresponding author), Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO 80045 USA.	Adam.Kinney@va.gov			NSSV program	We thank the participating service members and veterans for expending valuable time and effort to share their experiences with us. We also thank past and present NSSV student veteran coordinators for their assistance with the dissemination of our online survey: Erica Billingsley, Joshua E. Burns, Holly Darnell, Natalie R. Rolle, Cathy Schelly, and Erica Tohtz. Funding for this study was provided through philanthropic support of the NSSV program by a private donor. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of Defense, the Department of Veterans Affairs, or the U.S. government.	BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bauer A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190144; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brenner L.A., 2008, J MENTAL HEALTH COUN, V30, P211, DOI [10.17744/mehc.30.3.n6418tm72231j606, DOI 10.17744/MEHC.30.3.N6418TM72231J606]; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Chang FH, 2013, ARCH PHYS MED REHAB, V94, P771, DOI 10.1016/j.apmr.2012.10.031; Church AT, 2013, J CROSS CULT PSYCHOL, V44, P507, DOI 10.1177/0022022112466590; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Eakman AM, 2019, OTJR-OCCUP PART HEAL, V39, P222, DOI 10.1177/1539449219833351; Eakman AM, 2018, J OCCUP SCI, V25, P346, DOI 10.1080/14427591.2018.1492958; Eakman AM, 2017, BRIT J OCCUP THER, V80, P697, DOI 10.1177/0308022617712198; Eakman AM, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.016519; Eakman AM, 2012, J OCCUP SCI, V19, P165, DOI 10.1080/14427591.2012.671762; Eakman AM, 2013, OTJR-OCCUP PART HEAL, V33, P100, DOI 10.3928/15394492-20130222-02; Eakman Aaron M, 2012, Am J Occup Ther, V66, pe20, DOI 10.5014/ajot.2012.001867; Fritz HA, 2015, DISABIL REHABIL, V37, P1501, DOI 10.3109/09638288.2014.967415; Goldberg B., 2002, OCCUP THER MENT HEAL, V18, P17, DOI [10.1300/J004v18n02_03, DOI 10.1300/J004V18N02_03, DOI 10.1300/J004V18N02_]; Gregg BT, 2016, OCCUP THER MENT HEAL, V32, P86, DOI 10.1080/0164212X.2015.1082081; Hamarat E, 2001, EXP AGING RES, V27, P181, DOI 10.1080/036107301750074051; Hanel PHP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168354; Hawkins BL, 2015, J REHABIL RES DEV, V52, P527, DOI 10.1682/JRRD.2014.08.0196; Hayes, 2018, INTRO MEDIATION MODE; Hemmingsson H, 2005, AM J OCCUP THER, V59, P569, DOI 10.5014/ajot.59.5.569; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Keyes CLM, 2002, J PERS SOC PSYCHOL, V82, P1007, DOI 10.1037//0022-3514.82.6.1007; King GA, 2004, AM J ORTHOPSYCHIAT, V74, P72, DOI 10.1037/0002-9432.74.1.72; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Leclair S., 1998, OCCUP THER J RES, V65, P81, DOI [10.1177/000841749806500204, DOI 10.1177/000841749806500204]; Levasseur M, 2010, SOC SCI MED, V71, P2141, DOI 10.1016/j.socscimed.2010.09.041; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Park CL, 2008, QUAL LIFE RES, V17, P21, DOI 10.1007/s11136-007-9279-0; REILLY M, 1962, Am J Occup Ther, V16, P1; Resnik L, 2012, J REHABIL RES DEV, V49, P87, DOI 10.1682/JRRD.2010.06.0107; Resnik L, 2011, J REHABIL RES DEV, V48, P89, DOI 10.1682/JRRD.2010.04.0070; Resnik LJ, 2007, J REHABIL RES DEV, V44, P991, DOI 10.1682/JRRD.2007.05.0071; Rogers CM, 2014, AM J OCCUP THER, V68, P395, DOI 10.5014/ajot.2014.011221; Seligowski AV, 2012, APPL PSYCHOL-HLTH WE, V4, P261, DOI 10.1111/j.1758-0854.2012.01073.x; Sheldon KM, 2001, J PERS SOC PSYCHOL, V80, P325, DOI 10.1037/0022-3514.80.2.325; Sinclair S, 2016, INT J COGN THER, V9, P87; Sinclair VG, 2004, ASSESSMENT, V11, P94, DOI 10.1177/1073191103258144; Slade M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-26; Southwick S, 2015, PTSD RES Q, V25, P1; Speicher SM, 2014, AM J OCCUP THER, V68, P412, DOI 10.5014/ajot.2014.011304; Steger MF, 2006, J COUNS PSYCHOL, V53, P80, DOI 10.1037/0022-0167.53.1.80; Stoller CC, 2012, AM J OCCUP THER, V66, P59, DOI 10.5014/ajot.2012.001230; Tanielian T., 2008, INVISIBLE WOUNDS WAR, DOI [10.7249/MG720.1, DOI 10.7249/MG720.1]; U.S. Department of Veterans Affairs, 2020, VA DIS RAT; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Whyte J, 2012, ARCH PHYS MED REHAB, V93, pS101, DOI 10.1016/j.apmr.2011.11.040; World Health Organization, 2007, INT CLASS FUNCT DIS; World Health Organization, 2004, PROMOTING MENTAL HLT	54	1	1	0	7	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	SEP-OCT	2020	74	5							7405205010	10.5014/ajot.2020.037119			11	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	NH7OP	WOS:000564855600002	32804619				2022-02-06	
J	Knutson, KM; Gotts, SJ; Wassermann, EM; Lewis, JD				Knutson, Kristine M.; Gotts, Stephen J.; Wassermann, Eric M.; Lewis, Jeffrey D.			Testosterone and Resting State Connectivity of the Parahippocampal Gyrus in Men With History of Deployment-Related Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article							HORMONE PROFILES; SLEEP; STRESS; ASSOCIATION; MEMORY; FMRI; HYPOGONADISM; DYSFUNCTION; DEPRESSION; SYMPTOMS	Introduction The purpose of this study was to explore the effect of low testosterone level on whole-brain resting state (RS) connectivity in male veterans with symptoms such as sleep disturbance, fatiguability, pain, anxiety, irritability, or aggressiveness persisting after mild traumatic brain injury (mTBI). Follow-up analyses were performed to determine if sleep scores affected the results. Materials and Methods In our cross-sectional design study, RS magnetic resonance imaging scans on 28 veterans were performed, and testosterone, sleep quality, mood, and post-traumatic stress symptoms were measured. For each participant, we computed the average correlation of each voxel's time-series with the rest of the voxels in the brain, then used AFNI's 3dttest++ on the group data to determine whether the effects of testosterone level on whole-brain connectivity were significant. We then performed follow-up region of interest-based RS analyses of testosterone, with and without sleep quality as a covariate. The study protocol was approved by the National Institute of Health's Combined Neuroscience Institutional Review Board. Results Sixteen participants reported repeated blast exposure in theater, leading to symptoms; the rest reported exposure to a single blast or a nonblast TBI. Thirty-three percent had testosterone levels <300 ng/dL. Testosterone level was lower in participants who screened positive for post-traumatic stress disorder compared to those who screened negative, but it did not reach statistical significance. Whole-brain connectivity and testosterone level were positively correlated in the left parahippocampal gyrus (LPhG), especially in its connectivity with frontal areas, the lingual gyrus, cingulate, insula, caudate, and right parahippocampal gyrus. Further analysis revealed that the effect of testosterone on LPhG connectivity is only partially mediated by sleep quality. Sleep quality by itself had an effect on connectivity of the thalamus, cerebellum, precuneus, and posterior cingulate. Conclusion Lower testosterone levels were correlated with lower connectivity of the LPhG. Weaknesses of this study include a retrospective design based on self-report of mTBI and the lack of a control group without TBI. Without a control group or pre-injury testosterone measures, we were not able to attribute the rate of low testosterone in our participants to TBI per se. Also testosterone levels were checked only once. The high rate of low testosterone level that we found suggests there may be an association between low testosterone level and greater post-traumatic stress disorder symptoms following deployment, but the causality of the relationships between TBI and deployment stress, testosterone level, behavioral symptomatology, and LPhG connectivity remains to be determined. Our study on men with persistent symptoms postdeployment and post-mTBI may help us understand the role of low testosterone and sleep quality in persistent symptoms and may be important in developing therapeutic interventions. Our results highlight the role of the LPhG, as we found that whole-brain connectivity in that region was positively associated with testosterone level, with only a limited portion of that effect attributable to sleep quality.	[Knutson, Kristine M.; Wassermann, Eric M.; Lewis, Jeffrey D.] NINDS, Behav Neurol Unit, NIH, Room 7D41,MSC 1440,10 Ctr Dr, Bethesda, MD 20892 USA; [Gotts, Stephen J.] NIMH, Sect Cognit Neuropsychol, Lab Brain & Cognit, NIH, Room 4C217,10 Ctr Dr, Bethesda, MD 20814 USA; [Lewis, Jeffrey D.] Wright Patterson Med Ctr, Mental Hlth Clin, 88th Med Grp,4881 Sugar Maple Dr, Wright Patterson AFB, OH 45433 USA		Knutson, KM (corresponding author), NINDS, Behav Neurol Unit, NIH, Room 7D41,MSC 1440,10 Ctr Dr, Bethesda, MD 20892 USA.				Intramural NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [ZIA MH002588, ZIA NS002977] Funding Source: Medline		[Anonymous], 2018, EVALUATION MANAGEMEN; Barton DJ, 2016, J HEAD TRAUMA REHAB, V31, P277, DOI 10.1097/HTR.0000000000000188; Bassil Nazem, 2009, Ther Clin Risk Manag, V5, P427; Bercea RM, 2015, CLIN RESPIR J, V9, P342, DOI 10.1111/crj.12150; Bernton E, 1995, ANN NY ACAD SCI, V774, P217; Birn RM, 2008, HUM BRAIN MAPP, V29, P740, DOI 10.1002/hbm.20577; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Carteri RB, 2019, J NEUROTRAUM, V36, P2246, DOI 10.1089/neu.2018.6266; Casto KV, 2016, HORM BEHAV, V82, P21, DOI 10.1016/j.yhbeh.2016.04.004; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gaser C., 2016, CAT COMPUTATIONAL AN; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.3.CO;2-5; Gomez-Merino D, 2005, NEUROIMMUNOMODULAT, V12, P164, DOI 10.1159/000084849; Gotts SJ, 2012, BRAIN, V135, P2711, DOI 10.1093/brain/aws160; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Heany SJ, 2016, METAB BRAIN DIS, V31, P157, DOI 10.1007/s11011-015-9692-y; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kopczak A, 2014, J NEUROTRAUM, V31, P99, DOI 10.1089/neu.2013.3002; Lei K, 2019, SAGE OPEN MED, V7, P1; Lentini E, 2013, CEREB CORTEX, V23, P2322, DOI 10.1093/cercor/bhs222; Maki PM, 2007, J CLIN ENDOCR METAB, V92, P4107, DOI 10.1210/jc.2006-1805; Morgan CA, 2000, BIOL PSYCHIAT, V47, P891, DOI 10.1016/S0006-3223(99)00307-8; Mueller SC, 2011, INT J NEUROPSYCHOPH, V14, P445, DOI 10.1017/S1461145710001136; Murty VP, 2010, NEUROPSYCHOLOGIA, V48, P3459, DOI 10.1016/j.neuropsychologia.2010.07.030; Patel P, 2019, WORLD J UROL, V37, P1449, DOI 10.1007/s00345-018-2485-2; Petering RC, 2017, AM FAM PHYSICIAN, V96, P441; Plumb TR, 2014, PSYCHOL SERV, V11, P209, DOI 10.1037/a0034958; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reijnen A, 2015, PSYCHONEUROENDOCRINO, V51, P525, DOI 10.1016/j.psyneuen.2014.07.017; Rosario ER, 2013, J HEAD TRAUMA REHAB, V28, P390, DOI 10.1097/HTR.0b013e318250eac6; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Spivak B, 2003, NEUROPSYCHOBIOLOGY, V47, P57, DOI 10.1159/000070009; Steel A, 2016, CORTEX, V74, P134, DOI 10.1016/j.cortex.2015.10.004; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Wagner AK, 2012, BRAIN INJURY, V26, P1226, DOI 10.3109/02699052.2012.667594; Wang C, 2004, J CLIN ENDOCR METAB, V89, P2085, DOI 10.1210/jc.2003-032006; Ward AM, 2014, HUM BRAIN MAPP, V35, P1061, DOI 10.1002/hbm.22234; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wilkinson CW, 2012, FRONT NEUROL, V3, P1; Zarrour FA, 2009, J PSYCHIATR PRACT, V15, P289, DOI 10.1097/01.pra.0000358315.88931.fc	50	1	1	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	SEP-OCT	2020	185	9-10					E1750	E1758		10.1093/milmed/usaa142			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NV3WN	WOS:000574256400070	32776114	Green Published, hybrid			2022-02-06	
J	Koch, PF; Cottone, C; Adam, CD; Ulyanova, AV; Russo, RJ; Weber, MT; Arena, JD; Johnson, VE; Wolf, JA				Koch, Paul F.; Cottone, Carlo; Adam, Christopher D.; Ulyanova, Alexandra, V; Russo, Robin J.; Weber, Maura T.; Arena, John D.; Johnson, Victoria E.; Wolf, John A.			Traumatic Brain Injury Preserves Firing Rates But Disrupts Laminar Oscillatory Coupling and Neuronal Entrainment in Hippocampal CA1	ENEURO			English	Article						hippocampus; medial septum; oscillations rodents; synchronization; TBI	AMYLOID PRECURSOR PROTEIN; SEPTUM DIAGONAL BAND; MEDIAL SEPTUM; SHARP WAVES; AXONAL INJURY; PLACE CELLS; MEMORY; MILD; DENTATE; DEATH	While hippocampal-dependent learning and memory are particularly vulnerable to traumatic brain injury (TBI), the functional status of individual hippocampal neurons and their interactions with oscillations are unknown following injury. Using the most common rodent TBI model and laminar recordings in CA1, we found a significant reduction in oscillatory input into the radiatum layer of CA1 after TBI. Surprisingly, CA1 neurons maintained normal firing rates despite attenuated input, but did not maintain appropriate synchronization with this oscillatory input or with local high-frequency oscillations. Normal synchronization between these coordinating oscillations was also impaired. Simultaneous recordings of medial septal neurons known to participate in theta oscillations revealed increased GABAergic/glutamatergic firing rates postinjury under anesthesia, potentially because of a loss of modulating feedback from the hippocampus. These results suggest that TBI leads to a profound disruption of connectivity and oscillatory interactions, potentially disrupting the timing of CA1 neuronal ensembles that underlie aspects of learning and memory.	[Koch, Paul F.; Cottone, Carlo; Adam, Christopher D.; Ulyanova, Alexandra, V; Russo, Robin J.; Weber, Maura T.; Arena, John D.; Johnson, Victoria E.; Wolf, John A.] Univ Penn, Ctr Brain Injury & Repair, Dept Neurosurg, Philadelphia, PA 19104 USA; [Wolf, John A.] Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Koch, Paul F.] Virginia Commonwealth Univ, Dept Neurosurg, Sch Med, Richmond, VA 23298 USA; [Koch, Paul F.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA 23249 USA		Wolf, JA (corresponding author), Univ Penn, Ctr Brain Injury & Repair, Dept Neurosurg, Philadelphia, PA 19104 USA.; Wolf, JA (corresponding author), Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA 19104 USA.	wolfjo@pennmedicine.upenn.edu		Adam, Christopher/0000-0002-6520-5301; Arena, John/0000-0002-4322-4472; Ulyanova, Alexandra/0000-0002-1319-5279; Russo, Robin/0000-0002-2208-073X	Department of Veterans AffairsUS Department of Veterans Affairs [IK2-RX001479, RX002705]; National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS-101108-01, T32-NS-043126]; Codman Neurotrauma Award	This research was supported by The Department of Veterans Affairs (Grants IK2-RX001479 and RX002705 to J.A.W.), National Institutes of Health/National Institute of Neurological Disorders and Stroke [Grants R01-NS-101108-01 (to J.A.W.) and T32-NS-043126 (to A.V.U.)] and the Codman Neurotrauma Award (P.F.K.).	Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Berens P, 2009, J STAT SOFT, DOI 10.18637/jss.v031.i10; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bokil H., 2008, OBSERVED BRAIN DYNAM; Borhegyi Z, 2004, J NEUROSCI, V24, P8470, DOI 10.1523/JNEUROSCI.1413-04.2004; Bragin A, 1999, EPILEPSIA, V40, P127, DOI 10.1111/j.1528-1157.1999.tb02065.x; Broussard JI, 2020, J NEUROTRAUM, V37, P227, DOI 10.1089/neu.2019.6766; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Chen ZM, 2005, NEUROSCI LETT, V376, P166, DOI 10.1016/j.neulet.2004.11.051; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Dinocourt C, 2011, EPILEPSIA, V52, P1656, DOI 10.1111/j.1528-1167.2011.03113.x; Dragoi G, 1999, J NEUROSCI, V19, P6191, DOI 10.1523/JNEUROSCI.19-14-06191.1999; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Ezzyat Y, 2017, CURR BIOL, V27, P1251, DOI 10.1016/j.cub.2017.03.028; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Heck CN, 2014, EPILEPSIA, V55, P432, DOI 10.1111/epi.12534; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howard AL, 2007, J NEUROPHYSIOL, V97, P2394, DOI 10.1152/jn.00509.2006; Jia XX, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001045; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; King C, 1998, EUR J NEUROSCI, V10, P464, DOI 10.1046/j.1460-9568.1998.00026.x; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lee DJ, 2015, J NEUROTRAUM, V32, P1822, DOI 10.1089/neu.2014.3744; Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; Lustig B, 2016, HIPPOCAMPUS, V26, P102, DOI 10.1002/hipo.22494; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MATTHEWS RT, 1991, NEUROSCIENCE, V42, P451, DOI 10.1016/0306-4522(91)90388-5; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; McNaughton N, 2006, HIPPOCAMPUS, V16, P1102, DOI 10.1002/hipo.20235; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Muller C, 2018, CELL TISSUE RES, V373, P565, DOI 10.1007/s00441-017-2745-2; Munyon C, 2014, BRAIN RES, V1582, P220, DOI 10.1016/j.brainres.2014.07.036; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Oo TF, 2002, EXP NEUROL, V175, P1, DOI 10.1006/exnr.2002.7881; Paterno R, 2016, J NEUROTRAUM, V33, P1645, DOI 10.1089/neu.2015.4107; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Pettersen KH, 2006, J NEUROSCI METH, V154, P116, DOI 10.1016/j.jneumeth.2005.12.005; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Rossant C, 2016, NAT NEUROSCI, V19, P634, DOI 10.1038/nn.4268; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schomburg EW, 2012, J NEUROSCI, V32, P11798, DOI 10.1523/JNEUROSCI.0656-12.2012; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Sullivan D, 2011, J NEUROSCI, V31, P8605, DOI 10.1523/JNEUROSCI.0294-11.2011; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; TOTH K, 1993, J NEUROSCI, V13, P3712; Toth Z, 1997, J NEUROSCI, V17, P8106; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Weber MT, 2019, BRAIN PATHOL, V29, P437, DOI 10.1111/bpa.12677; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wolf JA, 2017, J NEUROTRAUM, V34, P2303, DOI 10.1089/neu.2016.4848; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; YLINEN A, 1995, J NEUROSCI, V15, P30	79	1	1	0	0	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	SEP-OCT	2020	7	5							0495-19.2020	10.1523/ENEURO.0495-19.2020			23	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OG9OL	WOS:000582204000034	32737188	gold, Green Published			2022-02-06	
J	Komoltsev, IG; Sinkin, MV; Volkova, AA; Smirnova, EA; Novikova, MR; Kordonskaya, OO; Talypov, AE; Guekht, AB; Krylov, VV; Gulyaeva, NV				Komoltsev, Ilia G.; Sinkin, Mikhail V.; Volkova, Aleksandra A.; Smirnova, Elizaveta A.; Novikova, Margarita R.; Kordonskaya, Olga O.; Talypov, Alexander E.; Guekht, Alla B.; Krylov, Vladimir V.; Gulyaeva, Natalia V.			A Translational Study on Acute Traumatic Brain Injury: High Incidence of Epileptiform Activity on Human and Rat Electrocorticograms and Histological Correlates in Rats	BRAIN SCIENCES			English	Article						traumatic brain injury; post-traumatic epilepsy; epileptiform discharges; electrocorticograms; local field potentials; neocortex; hippocampus; microglia; neurodegeneration	DELTA BRUSH; EEG; SEIZURE; HIPPOCAMPAL; MECHANISMS; EPILEPSY; NEUROINFLAMMATION; EPIDEMIOLOGY; FREQUENCY; SOCIETY	Background: In humans, early pathological activity on invasive electrocorticograms (ECoGs) and its putative association with pathomorphology in the early period of traumatic brain injury (TBI) remains obscure. Methods: We assessed pathological activity on scalp electroencephalograms (EEGs) and ECoGs in patients with acute TBI, early electrophysiological changes after lateral fluid percussion brain injury (FPI), and electrophysiological correlates of hippocampal damage (microgliosis and neuronal loss), a week after TBI in rats. Results: Epileptiform activity on ECoGs was evident in 86% of patients during the acute period of TBI, ECoGs being more sensitive to epileptiform and periodic discharges. A "brush-like" ECoG pattern superimposed over rhythmic delta activity and periodic discharge was described for the first time in acute TBI. In rats, FPI increased high-amplitude spike incidence in the neocortex and, most expressed, in the ipsilateral hippocampus, induced hippocampal microgliosis and neuronal loss, ipsilateral dentate gyrus being most vulnerable, a week after TBI. Epileptiform spike incidence correlated with microglial cell density and neuronal loss in the ipsilateral hippocampus. Conclusion: Epileptiform activity is frequent in the acute period of TBI period and is associated with distant hippocampal damage on a microscopic level. This damage is probably involved in late consequences of TBI. The FPI model is suitable for exploring pathogenetic mechanisms of post-traumatic disorders.	[Komoltsev, Ilia G.; Volkova, Aleksandra A.; Smirnova, Elizaveta A.; Novikova, Margarita R.; Gulyaeva, Natalia V.] Russian Acad Sci, Lab Funct Biochem Nervous Syst, Inst Higher Nervous Act & Neurophysiol, 5A Butlerov Str, Moscow 117485, Russia; [Komoltsev, Ilia G.; Guekht, Alla B.; Gulyaeva, Natalia V.] Res & Clin Ctr Neuropsychiat Moscow Healthcare De, 43 Donskaya Str, Moscow 115419, Russia; [Sinkin, Mikhail V.; Kordonskaya, Olga O.; Talypov, Alexander E.; Krylov, Vladimir V.] Sklifosovsky Res Inst Emergency Care, 3 Bolshaya Sucharevskaya Sq, Moscow 129010, Russia; [Sinkin, Mikhail V.; Krylov, Vladimir V.] Moscow State Univ Med & Dent, Dept Neurosurg & Neuroresuscitat, 20-1 Delegatskaya Str, Moscow 127473, Russia		Gulyaeva, NV (corresponding author), Russian Acad Sci, Lab Funct Biochem Nervous Syst, Inst Higher Nervous Act & Neurophysiol, 5A Butlerov Str, Moscow 117485, Russia.; Gulyaeva, NV (corresponding author), Res & Clin Ctr Neuropsychiat Moscow Healthcare De, 43 Donskaya Str, Moscow 115419, Russia.	komoltsev.ilia@gmail.com; mvsinkin@gmail.com; aleksandra.al.volkova@gmail.com; liz0nka@mail.ru; mrnovikova.ihna@mail.ru; dr.kochetkova@mail.ru; dr.talypov@mail.ru; guekht@mail.ru; manuscript@inbox.ru; nata_gul@mail.ru	Novikova, Margarita/AAC-2331-2022; Guekht, Alla/N-3422-2019; Sinkin, Mikhail/AAJ-3157-2021; Komoltsev, Ilia/V-1327-2018	Guekht, Alla/0000-0002-1170-6127; Sinkin, Mikhail/0000-0001-5026-0060; Krylov, Vladimir/0000-0001-7206-8926; Komoltsev, Ilia/0000-0002-4918-6411	Russian Foundation for Basic ResearchRussian Foundation for Basic Research (RFBR) [19-015-00258, 18-29-02035]	This research was funded by the Russian Foundation for Basic Research grant numbers 19-015-00258 (animal study) and 18-29-02035 (human electrophysiology).	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Aniol VA, 2011, EPILEPSY BEHAV, V22, P433, DOI 10.1016/j.yebeh.2011.08.002; Aniol VA, 2013, EPILEPSY BEHAV, V26, P196, DOI 10.1016/j.yebeh.2012.12.006; Aronica E, 2017, MODELS OF SEIZURES AND EPILEPSY, 2ND EDITION, P139, DOI 10.1016/B978-0-12-804066-9.00011-0; Bagetta G, 1996, NEUROSCIENCE, V71, P613, DOI 10.1016/0306-4522(95)00502-1; Baykan B, 2018, CLIN EEG NEUROSCI, V49, P278, DOI 10.1177/1550059417693168; Becker A, 1997, PHARMACOL RES, V35, P27, DOI 10.1006/phrs.1996.0116; BENARI Y, 1980, BRAIN RES, V191, P79, DOI 10.1016/0006-8993(80)90316-9; Bragin A, 2016, EPILEPSIA, V57, P735, DOI 10.1111/epi.13359; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Christensen J, 2015, SEMIN NEUROL, V35, P218, DOI 10.1055/s-0035-1552923; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; Dumoulin SO, 2018, NEUROIMAGE, V168, P345, DOI 10.1016/j.neuroimage.2017.01.028; Ferrari-Marinho T, 2016, EPILEPSY RES, V127, P200, DOI 10.1016/j.eplepsyres.2016.09.009; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Gulyaeva NV, 2015, NEUROCHEM J+, V9, P85, DOI 10.1134/S1819712415020075; Gulyaeva NV, 2010, NEUROCHEM J+, V4, P84, DOI 10.1134/S1819712410020029; Gulyaeva NV, 2019, NEUROCHEM RES, V44, P1306, DOI 10.1007/s11064-018-2662-0; Gurkoff GG, 2013, J NEUROTRAUM, V30, P292, DOI 10.1089/neu.2012.2463; Hashiguchi K, 2007, SEIZURE-EUR J EPILEP, V16, P238, DOI 10.1016/j.seizure.2006.12.010; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Hester MS, 2013, J NEUROSCI, V33, P8926, DOI 10.1523/JNEUROSCI.5161-12.2013; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; JENNETT B, 1975, EPILEPSIA, V16, P251, DOI 10.1111/j.1528-1157.1975.tb06055.x; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kim JA, 2018, ANN NEUROL, V83, P858, DOI 10.1002/ana.25211; Komoltsev IG, 2021, NEUROSCI RES, V166, P42, DOI 10.1016/j.neures.2020.05.005; Lagarde S, 2019, EPILEPSIA, V60, P85, DOI 10.1111/epi.14604; LERNERNATOLI M, 1991, NEUROSCI LETT, V122, P174, DOI 10.1016/0304-3940(91)90851-J; Lowenstein DH, 1999, EPILEPSIA, V40, P120, DOI 10.1111/j.1528-1157.1999.tb02000.x; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MELDRUM BS, 1973, ARCH NEUROL-CHICAGO, V28, P10, DOI 10.1001/archneur.1973.00490190028002; Ovsepian SV, 2019, TRENDS BIOTECHNOL, V37, P1315, DOI 10.1016/j.tibtech.2019.07.012; Ovsepian SV, 2017, NEURON, V96, P966, DOI 10.1016/j.neuron.2017.10.022; Perucca P, 2019, NEUROBIOL DIS, V123, P69, DOI 10.1016/j.nbd.2018.06.002; Perucca P, 2014, BRAIN, V137, P183, DOI 10.1093/brain/awt299; Piccenna Loretta, 2017, Epilepsia Open, V2, P123, DOI 10.1002/epi4.12049; Pitkanen A, 2017, MODELS OF SEIZURES AND EPILEPSY, 2ND EDITION, P661, DOI 10.1016/B978-0-12-804066-9.00046-8; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Rink A., 1995, AM J PATHOL, V63, P305, DOI [10.1111/j.1365-2265.2005.02342.x, DOI 10.1111/J.1365-2265.2005.02342.X]; Rodriguez Ruiz A, 2017, JAMA NEUROL, V74, P181, DOI DOI 10.1001/jamaneurol.2016.4990; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; RUTH RE, 1982, EXP NEUROL, V76, P508, DOI 10.1016/0014-4886(82)90120-0; Santana-Gomez C, 2019, EPILEPSY RES, V156, DOI 10.1016/j.eplepsyres.2019.03.008; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Tao JX, 2005, EPILEPSIA, V46, P669, DOI 10.1111/j.1528-1167.2005.11404.x; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Trinka E, 2015, EPILEPSIA, V56, P1515, DOI 10.1111/epi.13121; Veciana M, 2015, EPILEPSY BEHAV, V49, P280, DOI 10.1016/j.yebeh.2015.04.032; Vezzani A., 2012, JASPERS BASIC MECH E, P1	59	1	1	1	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	SEP	2020	10	9							570	10.3390/brainsci10090570			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OG2JJ	WOS:000581716700001	32825101	Green Published, gold			2022-02-06	
J	Lequerica, AH; Arango-Lasprilla, JC; Krch, D				Lequerica, Anthony H.; Arango-Lasprilla, Juan Carlos; Krch, Denise			Factor analysis of the Neurobehavioral Symptom Inventory among a sample of Spanish-speakers	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Neurobehavioral; factor analysis; Spanish-speakers; construct validity; psychometrics	TRAUMATIC BRAIN-INJURY; POSTCONCUSSIVE SYMPTOMS	A study was conducted to examine the factor structure of the Neurobehavioral Symptom Inventory (NSI) among a large community sample of 729 Spanish-speakers from the Continental United States (n = 174, 23.9%), Latin America (n = 465, 63.8%), and Spain (n = 90, 12.3%) The sample was 62.1% female, had at least 10 years of formal education, and ranged in age from 18 to 65 years (M = 36.7, SD = 12.5). The sample was randomly split into two groups with comparable demographics for a sequential analysis that consisted of an exploratory factor analysis on the first subsample followed by a confirmatory factor analysis within a second validation subsample. Results demonstrated a high internal consistency reliability for the Spanish version of the NSI, and a three-factor solution was supported with somatic, affective, and cognitive factors. Findings were comparable to prior studies with the English version of the NSI providing preliminary support for the construct validity of this measure among a large sample of Spanish-speakers. Further study is needed to determine the criterion-related validity of the individual factors as separate subscales and to examine the appropriateness of this measure for individuals with lower levels of education.	[Lequerica, Anthony H.; Krch, Denise] Kessler Fdn, Ctr Traumat Brain Injury Res, 120 Eagle Rock Ave,Suite 100, E Hanover, NJ 07936 USA; [Lequerica, Anthony H.; Krch, Denise] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Arango-Lasprilla, Juan Carlos] BioCruces Bizkaia Hlth Res Inst, Baracaldo, Bizkaia, Spain; [Arango-Lasprilla, Juan Carlos] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Arango-Lasprilla, Juan Carlos] Univ Basque Country, UPV EHU, Dept Cell Biol & Histol, Leioa, Spain		Lequerica, AH (corresponding author), Kessler Fdn, Ctr Traumat Brain Injury Res, 120 Eagle Rock Ave,Suite 100, E Hanover, NJ 07936 USA.	alequerica@kesslerfoundation.org					Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Bahraini NH, 2018, PSYCHOL ASSESSMENT, V30, P1013, DOI 10.1037/pas0000555; Brown M.W., 1993, SOCIOL METHOD RES, P136; Brown T.A., 2006, CONFIRMATORY FACTOR; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chalmers RP, 2012, J STAT SOFTW, V48, P1; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cox C., 2011, GROWING GAPS ED INEQ, P33, DOI [10.1093/acprof:oso/9780199732180.003.0002, DOI 10.1093/ACPROF:OSO/9780199732180.003.0002]; Dismuke CE, 2015, AM J PUBLIC HEALTH, V105, P1696, DOI 10.2105/AJPH.2014.302545; Dretsch M, 2016, J HEAD TRAUMA REHAB, V31, P23, DOI 10.1097/HTR.0000000000000109; Flores A., 2019, US HISPANIC POPULATI; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Galperin H, 2017, INT J COMMUN-US, V11, P3332; Hair JF., 2014, MULTIVARIATE DATA AN, V7; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iacobucci D, 2010, J CONSUM PSYCHOL, V20, P90, DOI 10.1016/j.jcps.2009.09.003; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; JASP Team, 2019, JASP VERS 0 10 2; Juengst SB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01210; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; MacCallum RC, 2001, MULTIVAR BEHAV RES, V36, P611, DOI 10.1207/S15327906MBR3604_06; Marteleto L, 2012, RES SOC STRAT MOBIL, V30, P352, DOI 10.1016/j.rssm.2011.12.003; McCrea M., 2008, MILD TRAUMATIC BRAIN; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Raykov T, 1997, APPL PSYCH MEAS, V21, P173, DOI 10.1177/01466216970212006; Schermelleh-Engel K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00181; Sullivan KA, 2017, APPL NEUROPSYCH-ADUL, V24, P522, DOI 10.1080/23279095.2016.1216433; U.S. Census Bureau, 2017, AM COMM SURV 1 YEAR; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; World Health Organization, 1993, ICD 10 CLASS MENT BE	34	1	1	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2020.1809464		SEP 2020	14	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	NI7IG	WOS:000565522200001	32867569				2022-02-06	
J	MacGregor, AJ; Joseph, AR; Dougherty, AL				MacGregor, Andrew J.; Joseph, Antony R.; Dougherty, Amber L.			Prevalence of Tinnitus and Association with Self-Rated Health among Military Personnel Injured on Combat Deployment	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; BLAST INJURY; HEARING-LOSS; SEVERITY SCORE; LONG-TERM; VETERANS; IRAQ; OUTCOMES; SERVICE; MECHANISMS	Introduction Tinnitus is an auditory problem frequently reported by military personnel and is currently responsible for 1 billion dollars annually in disability compensation. Recent military conflicts in Iraq and Afghanistan saw high levels of combat exposure coupled with a surge in blast weaponry, both of which can adversely affect hearing. The present study explored the prevalence of tinnitus and the association with self-rated health among military personnel injured during combat deployment. Materials and Methods A total of 1,026 U.S. military personnel who sustained an injury during operations (592 battle blast, 73 battle nonblast, 361 nonbattle) in Iraq were identified from clinical records. Post-Deployment Health Assessments administered at two separate points in time were used to identify self-reported tinnitus symptoms and self-rated health within 1 year of injury. Results Those with a battle blast injury had the highest prevalence of tinnitus with 19.1% and 31.3% on the first and second health assessments, respectively. In a multivariate model adjusting for combat exposure, concussion, posttraumatic stress disorder, and other covariates, tinnitus was associated with lower self-rated health for both the first (odds ratio [OR] = 3.31, 95% confidence interval [CI] = 2.07-5.30, P < 0.001) and second assessments (OR = 2.52, 95% CI = 1.76-3.61, P < 0.001). Conclusions Tinnitus is a common source of impairment among military personnel injured during combat deployment and is associated with poorer self-rated health. Future research should determine whether timing of assessment is linked to symptom recognition or reporting, and what interventions are best suited for ameliorating the negative impact of tinnitus.	[MacGregor, Andrew J.; Dougherty, Amber L.] Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, San Diego, CA 92106 USA; [Joseph, Antony R.] Illinois State Univ, Commun Sci & Disorders Dept, Hearing Loss Prevent Lab, Normal, IL 61761 USA; [Joseph, Antony R.; Dougherty, Amber L.] Leidos Inc, San Diego, CA 92106 USA		MacGregor, AJ (corresponding author), Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, San Diego, CA 92106 USA.			MacGregor, Andrew/0000-0003-1020-7390	U.S. Navy Bureau of Medicine and Surgery [60808]	I am a military service member or employee of the U.S. Government. This work was prepared as part of my official duties. Title 17, U.S.C. 105 provides that copyright protection under this title is not available for any work of the U.S. Government. Title 17, U.S.C. 101 defines a U.S. Government work as work prepared by a military service member or employee of the U.S. Government as part of that person's official duties. Report No. 19-76 was supported by the U.S. Navy Bureau of Medicine and Surgery under work unit no. 60808. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the U.S. Government. The study protocol was approved by the Naval Health Research Center Institutional Review Board in compliance with all applicable Federal regulations governing the protection of human subjects. Research data were derived from an approved Naval Health Research Center, Institutional Review Board protocol number NHRC.2003.0025.	ADAMS PF, 1999, VITAL HLTH STAT, V10, P200; Alamgir H, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0082-5; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Benyamini Y, 2009, PSYCHOSOM MED, V71, P345, DOI 10.1097/PSY.0b013e31819ccd10; Bhatt JM, 2017, LARYNGOSCOPE, V127, P466, DOI 10.1002/lary.26107; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Cantley LF, 2015, INT J AUDIOL, V54, pS30, DOI 10.3109/14992027.2014.981305; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Clifford RE, 2019, MIL MED, V184, P839, DOI 10.1093/milmed/usz016; Commission on Professional Hospital Activities, 1977, INT CLASS DIS; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Dougherty AL, 2013, J REHABIL RES DEV, V50, P893, DOI 10.1682/JRRD.2012.02.0024; Fagelson Marc A, 2007, Am J Audiol, V16, P107, DOI 10.1044/1059-0889(2007/015); Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Greer N, 2016, PREVALENCE EPIDEMIOL; Haddock CK, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-57; Han BI, 2009, J CLIN NEUROL, V5, P11, DOI 10.3988/jcn.2009.5.1.11; Hasson D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-130; Helfer TM, 2004, AM J AUDIOL, V14, P161; Helling ER, 2004, MIL MED, V169, P872, DOI 10.7205/MILMED.169.11.872; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Henry JA, 2016, HEARING RES, V334, P58, DOI 10.1016/j.heares.2015.06.004; Hiller W, 2004, INT J AUDIOL, V43, P600, DOI 10.1080/14992020400050077; Hinton DE, 2006, J TRAUMA STRESS, V19, P541, DOI 10.1002/jts.20138; HIRSCH FG, 1968, ANN NY ACAD SCI, V152, P147, DOI 10.1111/j.1749-6632.1968.tb11972.x; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Jalilvand H, 2015, AUDIOL NEURO-OTOL, V20, P195, DOI 10.1159/000377617; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Joseph AR, 2018, AM J EPIDEMIOL, V187, P7, DOI 10.1093/aje/kwx199; Kreuzer PM, 2014, J HEAD TRAUMA REHAB, V29, P432, DOI 10.1097/HTR.0b013e31829d3129; Larsson D, 2002, SCAND J PUBLIC HEALT, V30, P259, DOI 10.1080/14034940210133997; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; Manor O, 2000, INT J EPIDEMIOL, V29, P149, DOI 10.1093/ije/29.1.149; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Miura M, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00722; Muhr P, 2011, NOISE HEALTH, V13, P320, DOI 10.4103/1463-1741.82965; Nageris Ben I., 2008, Journal of Basic and Clinical Physiology and Pharmacology, V19, P185; National Institute for Occupational Safety and Health (NIOSH), PUTT EAR GROUND NIOS; National Institute of Deafness and Other Communication Disor- ders (NIDCD), TINNITUS; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Phillips JS, 2018, LARYNGOSCOPE, V128, P217, DOI 10.1002/lary.26607; Prins A, 2004, PRIMARY CARE PSYCHIA, V9, P151, DOI 10.1185/135525703125002360; Remenschneider AK, 2014, OTOL NEUROTOL, V35, P1825, DOI 10.1097/MAO.0000000000000616; Ritenour AE, 2008, J TRAUMA, V64, pS174, DOI 10.1097/TA.0b013e318160773e; Rubak T, 2008, INT J AUDIOL, V47, P109, DOI 10.1080/14992020701581430; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Sharkey JM, 2011, MIL MED, V176, P915, DOI 10.7205/MILMED-D-10-00366; Shi YB, 2014, J AM ACAD AUDIOL, V25, P23, DOI 10.3766/jaaa.25.1.3; Singh-Manoux A, 2006, J EPIDEMIOL COMMUN H, V60, P364, DOI 10.1136/jech.2005.039883; Singh-Manoux A, 2007, PSYCHOSOM MED, V69, P138, DOI 10.1097/PSY.0b013e318030483a; Swan AA, 2017, HEARING RES, V349, P4, DOI 10.1016/j.heares.2017.01.013; Theodoroff SM, 2015, EPIDEMIOL REV, V37, P71, DOI 10.1093/epirev/mxu005; Trump DH, 2006, MIL MED, V171, P662, DOI 10.7205/MILMED.171.7.662; Tsao JW, 2017, NEUROLOGY, V89, P2010, DOI 10.1212/WNL.0000000000004616; U.S. Department of Veterans Affairs, VBA ANN BEN REP FISC; Van Campen L E, 1999, J Am Acad Audiol, V10, P231; Van Haesendonck G, 2018, OTOL NEUROTOL, V39, P1250, DOI 10.1097/MAO.0000000000002012; Wallhausser-Franke E, 2013, SLEEP MED REV, V17, P65, DOI 10.1016/j.smrv.2012.04.003; Wang JJ, 2006, ANN ACAD MED SINGAP, V35, P190; Weidt S, 2016, PSYCHIAT RES, V237, P114, DOI 10.1016/j.psychres.2016.01.065	61	1	1	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	SEP-OCT	2020	185	9-10					E1608	E1614		10.1093/milmed/usaa103			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NV3WN	WOS:000574256400052	32592390	hybrid			2022-02-06	
J	Macheda, T; Snider, HC; Watson, JB; Roberts, KN; Bachstetter, AD				Macheda, Teresa; Snider, Henry C.; Watson, James B.; Roberts, Kelly N.; Bachstetter, Adam D.			An active avoidance behavioral paradigm for use in a mild closed head model of traumatic brain injury in mice	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Concussion; Traumatic brain injury; Mouse; Behavioral testing; Animal behavior; Learning and memory; Visual acuity test	SEX-DIFFERENCES; RATS; SENSITIVITY; ACQUISITION; RETENTION; RESPONSES; STRAINS; ANXIETY; STRESS; REFLEX	Background: A mild traumatic brain injury (TBI) occurs to millions of people each year. Translational approaches to understanding the pathogenesis of neurological diseases and the testing of the effectiveness of interventions typically require cognitive function assays in rodents. New methods: Our goal was to validate the active avoidance task using the GEMINI avoidance system in a mouse model of mild closed head injury (CHI). Results: We found that shock intensity had only a marginal effect on the test. We found that sex was an important biological variable, as female mice learned the task better than male mice. We demonstrate that a single mild CHI in mice caused deficits in the task at four weeks post-injury. Comparison with existing methods: Active avoidance is a classical conditioning test in which mice must pair the presence of a conditioned stimulus with moving between two chambers to avoid an electric shock. External conditions (i.e., apparatus), as well as inherent differences in the mice, which may not be directly linked to the model of the disease (i.e., sensory differences), can affect the reproducibility of a behavioral assay. Before our study, there was a lack of standard operating procedures and validated methods for the active avoidance behavior for phenotyping mouse models of injury and disease. Conclusion: We offer a method for validating the active avoidance test, and a standard operating procedure, which will be useful in other models of neurological injury and disease.	[Macheda, Teresa; Snider, Henry C.; Watson, James B.; Roberts, Kelly N.; Bachstetter, Adam D.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Macheda, Teresa; Snider, Henry C.; Watson, James B.; Roberts, Kelly N.; Bachstetter, Adam D.] Univ Kentucky, Dept Neurosci, Lexington, KY USA; [Bachstetter, Adam D.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA		Bachstetter, AD (corresponding author), 741 S Limestone St, Lexington, KY 40536 USA.	adam.bachstetter@uky.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R00 AG044445, R01 NS103785, R21 AG059123]	Research reported in this publication was supported by National Institutes of Health under award numbers R00 AG044445 (ADB), R01 NS103785 (ADB), R21 AG059123 (ADB). Fig. 3 and 4 were created with BioRender.com	Aguilar R, 2003, PHYSIOL BEHAV, V78, P723, DOI 10.1016/S0031-9384(03)00043-X; Barrot M, 2012, NEUROSCIENCE, V211, P39, DOI 10.1016/j.neuroscience.2011.12.041; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Cain CK, 2019, CURR OPIN BEHAV SCI, V26, P9, DOI 10.1016/j.cobeha.2018.09.002; Chang HP, 1999, LEARN MEMORY, V6, P448, DOI 10.1101/lm.6.5.448; Dalla C, 2009, PHYSIOL BEHAV, V97, P229, DOI 10.1016/j.physbeh.2009.02.035; DENTI A, 1972, PHYSIOL BEHAV, V8, P611, DOI 10.1016/0031-9384(72)90083-2; Diehl MM, 2019, NEUROSCI BIOBEHAV R, V107, P229, DOI 10.1016/j.neubiorev.2019.09.010; El-Ghundi M, 2001, BRAIN RES, V892, P86, DOI 10.1016/S0006-8993(00)03234-0; Fernandes C, 1999, PHARMACOL BIOCHEM BE, V64, P731, DOI 10.1016/S0091-3057(99)00139-2; FOX WM, 1965, ANIM BEHAV, V13, P234, DOI 10.1016/0003-3472(65)90041-2; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; Hormigo S, 2019, J NEUROSCI, V39, P4576, DOI 10.1523/JNEUROSCI.0049-19.2019; Kazdoba TM, 2007, BEHAV PHARMACOL, V18, P89, DOI 10.1097/FBP.0b013e3280ae6c7c; LeDoux JE, 2017, MOL PSYCHIATR, V22, P24, DOI 10.1038/mp.2016.166; Lehner M, 2006, BEHAV BRAIN RES, V171, P189, DOI 10.1016/j.bbr.2006.03.044; Lehner M, 2010, ACTA NEUROBIOL EXP, V70, P56; Lyons DN, 2018, J NEUROTRAUM, V35, P2435, DOI 10.1089/neu.2018.5663; Mandillo S, 2008, PHYSIOL GENOMICS, V34, P243, DOI 10.1152/physiolgenomics.90207.2008; Metz GA, 2004, NEUROSCIENCE, V129, P563, DOI 10.1016/j.neuroscience.2004.07.053; Mowrer OH, 1939, PSYCHOL REV, V46, P553, DOI 10.1037/h0054288; Paylor R, 2006, PHYSIOL BEHAV, V87, P95, DOI 10.1016/j.physbeh.2005.09.002; ROSIC N, 1980, PHARMACOL BIOCHEM BE, V13, P183, DOI 10.1016/0091-3057(80)90070-2; Rowe RK, 2016, MOL PAIN, V12, DOI 10.1177/1744806916647055; SAAVEDRA MA, 1990, PHYSIOL BEHAV, V47, P107, DOI 10.1016/0031-9384(90)90047-8; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/NMETH.2935, 10.1038/nmeth.2935]; Sprowitz A, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00143; Sukoff Rizzo Stacey J, 2018, Curr Protoc Mouse Biol, V8, pe45, DOI 10.1002/cpmo.45; Sukoff Rizzo Stacey J, 2016, Curr Protoc Mouse Biol, V6, P364, DOI 10.1002/cpmo.17; VANHAAREN F, 1990, NEUROSCI BIOBEHAV R, V14, P23, DOI 10.1016/S0149-7634(05)80157-5; VANOYEN HG, 1980, PHYSIOL BEHAV, V25, P859, DOI 10.1016/0031-9384(80)90305-4; VinaderCaerols C, 1996, NEUROBIOL LEARN MEM, V66, P246, DOI 10.1006/nlme.1996.0066; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; Wahlsten D, 2003, J NEUROBIOL, V54, P283, DOI 10.1002/neu.10173; Wahlsten D, 2003, TRENDS NEUROSCI, V26, P132, DOI 10.1016/S0166-2236(03)00033-X; Wahlsten D, 2001, PHYSIOL BEHAV, V73, P695, DOI 10.1016/S0031-9384(01)00527-3; WERKA T, 1980, ACTA NEUROBIOL EXP, V40, P433; Wong AA, 2006, GENES BRAIN BEHAV, V5, P389, DOI 10.1111/j.1601-183X.2005.00173.x	38	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	SEP 1	2020	343								108831	10.1016/j.jneumeth.2020.108831			9	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	MX5KT	WOS:000557762600002	32592717	hybrid, Green Accepted			2022-02-06	
J	Martin, R; Taylor, S; Palmieri, TL				Martin, Ryan; Taylor, Sandra; Palmieri, Tina L.			Mortality following combined burn and traumatic brain injuries: An analysis of the national trauma data bank of the American College of Surgeons	BURNS			English	Article						Traumatic brain injury; Burn; Mortality	SURVIVAL PROBABILITY; RESUSCITATION; ALBUMIN; DEATH	Background: Severe burn and traumatic brain injuries (TBI) lead to significant mortality, and combined burn-TBI injuries may predispose towards even worse outcomes. The purpose of this study was to investigate the mortality of patients with burn, burn with non-TBI trauma, and combined burn/TBI to determine if combined injury portends a worse outcome. Methods: We obtained the National Trauma Data Bank from 2007 to 2012, identifying 32,334 patients with burn related injuries, dividing this cohort into three injury types: BURN ONLY, BURN with TRAUMA/NO TBI, and BURN with TBI. For each patient, demographic data was obtained, including age, gender, presence of trauma, TBI, or inhalation injury, burn total body surface area (TBSA), Glasgow Coma Scale, Injury Severity Score, and mortality. Multivariable logistic regression was performed. Results: Age, gender, and TBSA were similar across the three injury groups, but the incidence of inhalation injury was doubled in the BURN with TRAUMA/NO TBI (15.4 %) and BURN with TBI (15.3 %) groups when compared to the BURN ONLY (7.2 %) group. Mortality differed across injury categories after adjusting for age, TBSA, and inhalation injury. Increased mortality was seen in BURN with TRAUMA/NO TBI versus BURN ONLY (OR = 1.27 [1.06, 1.53]) and was higher when comparing BURN with TBI versus BURN ONLY (OR = 4.22 [2.85, 6.18]). BURN with TBI also had higher mortality when compared to BURN with TRAUMA/NO TBI (OR = 3.33 [2.30, 4.82]). The logs odds of mortality also increased with increasing age, TBSA and presence of inhalation injury. Discussion: This analysis of the NTDB suggests that mortality following burn-related injuries may be higher when burn injury is combined with TBI when compared to burns with other trauma, even after correcting for age, TBSA, and inhalation injury. Further clinical and laboratory research is needed to validate these findings and better understand how to optimize combined TBI and burn injury treatment. (C) 2020 Elsevier Ltd and ISBI. All rights reserved.	[Martin, Ryan] Univ Calif Davis, Dept Neurol Surg, 4860 Y St,Suite 3740, Sacramento, CA 95817 USA; [Martin, Ryan] Univ Calif Davis, Dept Neurol, 4860 Y St,Suite 3740, Sacramento, CA 95817 USA; [Taylor, Sandra] Univ Calif Davis, Dept Publ Hlth Sci, Div Biostat, 2921 Stockton Blvd,Suite 1400, Sacramento, CA 95817 USA; [Palmieri, Tina L.] Univ Calif Davis, Dept Surg, Sacramento, CA 95817 USA; [Palmieri, Tina L.] Shriners Hosp Children Northern Calif, Burn Surg, Sacramento, CA 95817 USA		Palmieri, TL (corresponding author), Univ Calif Davis, Dept Surg, Sacramento, CA 95817 USA.; Palmieri, TL (corresponding author), Shriners Hosp Children Northern Calif, Burn Surg, Sacramento, CA 95817 USA.	tlpalmieri@ucdavis.edu			National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [U L1 TR001860]; USAMRMC Award [W81XWH-10-1-0527, W81XWH1820071]	The project described was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant number U L1 TR001860 and by USAMRMC Award #W81XWH-10-1-0527 and #W81XWH1820071. The funding source was not involved in study design; in the collection, analysis and interpretation of data; in the writing of the report; nor in the decision to submit the article for publication.	Cancio LC, 2017, NEUROTRAUMA MANAGEME, P329; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Champion HR, 2010, J TRAUMA, V68, P1139, DOI 10.1097/TA.0b013e3181d86a0d; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Concannon E, 2020, BURNS, V46, P552, DOI 10.1016/j.burns.2019.08.018; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Flierl MA, 2009, CRIT CARE, V13, DOI 10.1186/cc7794; Gantner D, 2014, CURR OPIN CRIT CARE, V20, P385, DOI 10.1097/MCC.0000000000000114; Graybill MAJMJC, 2016, J AM COLL SURGEONS, V223, pE217; Greenhalgh DG, 2010, BURNS, V36, P176, DOI 10.1016/j.burns.2009.09.004; Grigorian A, 2018, BURNS, V44, P1989, DOI 10.1016/j.burns.2018.07.003; Hawkins A, 2005, J TRAUMA, V58, P284, DOI 10.1097/01.TA.0000130610.19361.BD; Janak JC, 2018, BURNS, V44, P1920, DOI 10.1016/j.burns.2018.03.012; Jeschke MG, 2015, CRIT CARE MED, V43, P808, DOI 10.1097/CCM.0000000000000790; Kauvar DS, 2006, BURNS, V32, P853, DOI 10.1016/j.burns.2006.03.008; Kraft R, 2012, LANCET, V379, P1013, DOI 10.1016/S0140-6736(11)61345-7; Lawrence A, 2010, J BURN CARE RES, V31, P40, DOI 10.1097/BCR.0b013e3181cb8c72; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Namdar Thomas, 2010, Ger Med Sci, V8, pDoc11, DOI 10.3205/000100; Randolph AC, 2019, SHOCK, V51, P634, DOI 10.1097/SHK.0000000000001196; Ryan CM, 1998, NEW ENGL J MED, V338, P362, DOI 10.1056/NEJM199802053380604; Santaniello JM, 2004, J TRAUMA, V57, P696, DOI 10.1097/01.TA.0000140480.50079.A8; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Sen S, 2017, BURNS TRAUMA, V5, DOI 10.1186/s41038-017-0098-4; Stanojcic M, 2016, ANN SURG, V264, P195, DOI 10.1097/SLA.0000000000001408; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Swann K, 2007, BRAIN RES, V1129, P26, DOI 10.1016/j.brainres.2006.10.061; Zhao ZL, 2016, J NEUROL SCI, V364, P12, DOI 10.1016/j.jns.2016.03.007	29	1	1	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0305-4179	1879-1409		BURNS	Burns	SEP	2020	46	6					1289	1296		10.1016/j.burns.2020.06.022			8	Critical Care Medicine; Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Dermatology; Surgery	NW6ZA	WOS:000575164400005	32680663	Green Accepted			2022-02-06	
J	Mirzaeva, L; Lobzin, S; Tcinzerling, N; Sarana, A; Gilhus, NE; Rekand, T				Mirzaeva, Liudmila; Lobzin, Sergey; Tcinzerling, Natalya; Sarana, Andrey; Gilhus, Nils Erik; Rekand, Tiina			Complications and mortality after acute traumatic spinal cord injury in Saint Petersburg, Russia	SPINAL CORD			English	Article							PRESSURE ULCERS; BRAIN-INJURY; RISK-FACTORS	Study design Retrospective cohort study. Objectives We studied complications during early rehabilitation and their relation to length of stay (LOS) in the hospital as well as to survival in people with traumatic spinal cord injury (TSCI). Setting All specialized hospitals of Saint Petersburg. Methods We analysed all charts of patients admitted with acute TSCI to the city hospitals, 2012-2016. Patient characteristics, complications, time and cause of death, and LOS were recorded. Mean values with standard deviations andt-tests were used. We analysed mortality rate using the Kaplan-Meier method and calculated relative risks (RRs). Results A total of 311 patients with TSCI were included. Complications occurred in 34% of patients; most were respiratory complications and pressure ulcers. Complications occurred more often in those with concomitant traumatic brain injury (TBI) (RR = 1.4, 95% CI: 1.2-1.8). All complications prolonged LOS (median, 11 days) and increased mortality in the acute phase (p < 0.001). In the early phase, 15% died, with a median time to death of 13 days. Respiratory complications markedly increased the death rate (RR = 18, 95% CI: 15-22). Mortality rate correlated also with age, TSCI severity and level, and concomitant TBI. Alcohol/drug consumption before TSCI increased the likelihood for complications (RR = 1.7, 95% CI: 1.3-2.1) and mortality (RR = 2.2, 95% CI: 1.6-3.1). Conclusion Focus on prevention as well as early and optimal treatment of complications, together with no or low alcohol/drug consumption may reduce mortality in the early phase after TSCI and at the same time shorten LOS.	[Mirzaeva, Liudmila; Lobzin, Sergey; Tcinzerling, Natalya] Northwestern State Med Univ, Dept Neurol, St Petersburg, Russia; [Sarana, Andrey] Hlth Care Comm, St Petersburg, Russia; [Sarana, Andrey] St Petersburg State Univ, Med Fac, St Petersburg, Russia; [Gilhus, Nils Erik] Univ Bergen, Dept Clin Med, Bergen, Norway; [Gilhus, Nils Erik; Rekand, Tiina] Haukeland Hosp, Dept Neurol, Bergen, Norway; [Rekand, Tiina] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Neurosci & Physiol, Gothenburg, Sweden		Rekand, T (corresponding author), Haukeland Hosp, Dept Neurol, Bergen, Norway.; Rekand, T (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Neurosci & Physiol, Gothenburg, Sweden.	tiina.rekand@helse-bergen.no	Sarana, Andrei/J-4297-2015; Rekand, Tiina/A-6201-2008	Sarana, Andrei/0000-0003-3198-8990; Rekand, Tiina/0000-0002-2506-9501; Mirzaeva, Liudmila/0000-0001-9392-1789			Ahn H, 2015, CAN MED ASSOC J, V187, P873, DOI 10.1503/cmaj.150085; Azarhomayoun Amir, 2018, Bull Emerg Trauma, V6, P181, DOI 10.29252/beat-060301; Barinov A, 2011, HUM ECOL, V8, P51; Biering-Sorensen F, 2017, SPINAL CORD, V55, P759, DOI 10.1038/sc.2017.59; Boakye M, 2008, J NEUROTRAUM, V25, P173, DOI 10.1089/neu.2007.0395; Bombardier CH, 2016, ARCH PHYS MED REHAB, V97, P1628, DOI 10.1016/j.apmr.2016.03.008; Brienza D, 2018, SPINAL CORD, V56, P28, DOI 10.1038/sc.2017.96; Crutcher CL, 2014, J NEUROTRAUM, V31, P798, DOI 10.1089/neu.2014.3329; Eichinger S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193735; Ekeke ON, 2017, PAN AFR MED J, V28, DOI 10.11604/pamj.2017.28.6.10690; Ferro S, 2017, SPINAL CORD, V55, P1103, DOI 10.1038/sc.2017.88; Garshick E, 2005, SPINAL CORD, V43, P408, DOI 10.1038/sj.sc.3101729; [Гринь Андрей Анатольевич Grin Andrey Anatolyevich], 2012, [Хирургия позвоночника, Khirurgiya pozvonochnika], P8; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Hagen EM, 2010, SPINAL CORD, V48, P313, DOI 10.1038/sc.2009.133; Haisma JA, 2007, J REHABIL MED, V39, P393, DOI 10.2340/16501977-0067; Iuldashev S M, 2007, Vestn Khir Im I I Grek, V166, P39; Joseph C, 2016, SPINAL CORD, V54, P535, DOI 10.1038/sc.2015.189; Kahl JE, 2013, J TRAUMA ACUTE CARE, V75, P195, DOI 10.1097/TA.0b013e3182997865; Kopp MA, 2017, NEUROLOGY, V88, P892, DOI [10.1212/WNL.0000000000003652, 10.1212/wnl.0000000000003652]; Krause JS, 2008, ARCH PHYS MED REHAB, V89, P1482, DOI 10.1016/j.apmr.2007.11.062; Lidal IB, 2007, J REHABIL MED, V39, P145, DOI 10.2340/16501977-0017; Marion TE, 2017, J NEUROTRAUM, V34, P2883, DOI 10.1089/neu.2016.4933; Maung AA, 2011, J TRAUMA, V71, P1241, DOI 10.1097/TA.0b013e318235ded0; McCaughey EJ, 2016, SPINAL CORD, V54, P270, DOI 10.1038/sc.2015.167; Mirzaeva L, 2019, SPINAL CORD, V57, P692, DOI 10.1038/s41393-019-0266-4; Moshi H, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1355604; Nulle Anda, 2017, Spinal Cord Ser Cases, V3, P17088, DOI 10.1038/s41394-017-0002-2; Schedrenok V, 2010, NEUROCHIR RUSS, V11, P458; Thietje R, 2011, J SPINAL CORD MED, V34, P482, DOI 10.1179/2045772311Y.0000000022; van Weert KCM, 2014, J REHABIL MED, V46, P882, DOI 10.2340/16501977-1858; Wahman K, 2019, J REHABIL MED, V51, P513, DOI 10.2340/16501977-2568; Zakrasek EC, 2015, SPINAL CORD, V53, P7, DOI 10.1038/sc.2014.179	33	1	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	SEP	2020	58	9					970	979		10.1038/s41393-020-0458-y			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	NJ1AS	WOS:000565775500004	32286529	Bronze			2022-02-06	
J	Morris, MC; John, D; Singer, KE; Moran, R; McGlone, E; Veile, R; Goetzman, HS; Makley, AT; Caldwell, CC; Goodman, MD				Morris, Mackenzie C.; John, Devin; Singer, Kathleen E.; Moran, Ryan; McGlone, Emily; Veile, Rosalie; Goetzman, Holly S.; Makley, Amy T.; Caldwell, Charles C.; Goodman, Michael D.			Post-TBI splenectomy may exacerbate coagulopathy and platelet activation in a murine model	THROMBOSIS RESEARCH			English	Article						Traumatic brain injury; Splenectomy; Coagulopathy; Platelets; Rotational thromboelastometry	TRAUMATIC BRAIN-INJURY; VENOUS THROMBOEMBOLISM; SPLEEN CONTRIBUTES; SURGEONS PRACTICE; 1602 EPISODES; NTDB STORY; DATA-BANK; MICROPARTICLES; COAGULATION; TRANSFUSION	Introduction: Traumatic brain injury (TBI) induces acute hypocoagulability, subacute hypercoagulability, and persistently elevated risk for thromboembolic events. Splenectomy is associated with increased mortality in patients with moderate or severe TBI. We hypothesized that the adverse effects of splenectomy in TBI patients may be secondary to the exacerbation of pathologic coagulation and platelet activation changes. Methods: An established murine weight-drop TBI model was utilized and a splenectomy was performed immediately following TBI. Sham as well as TBI and splenectomy alone mice were used as injury controls. Mice were sacrificed for blood draws at 1, 6, and 24 h, as well as 7 days post-TBI. Viscoelastic coagulation parameters were assessed by rotational thromboelastometry (ROTEM) and platelet activation was measured by expression of P-selectin via flow cytometry analysis of platelet rich plasma samples. Results: At 6 h following injury, TBI/splenectomy demonstrated hypocoagulability with prolonged clot formation time (CFT) compared to TBI alone. By 24 h following injury, TBI/splenectomy and splenectomy mice were hypercoagulable with a shorter CFT, a higher alpha angle, and increased MCF, despite a lower percentage of platelet contribution to clot compared to TBI alone. However, only the TBI/splenectomy continued to display this hypercoagulable state at 7 days. While TBI/splenectomy had greater P-selectin expression at 1-h post-injury, TBI alone had significantly greater P-selectin expression at 24 h post-injury compared to TBI/splenectomy. Interestingly, P-selectin expression remained elevated only in TBI/splenectomy at 7 days post-injury. Conclusion: Splenectomy following TBI exacerbates changes in the post-injury coagulation state. The combination of TBI and splenectomy induces an acute hypocoagulable state that could contribute to an increase in intracranial bleeding. Subacutely, the addition of splenectomy to TBI exacerbates post-injury hypercoagulability and induces persistent platelet activation. These polytrauma effects on coagulation may contribute to the increased mortality observed in patients with combined brain and splenic injuries.	[Morris, Mackenzie C.; John, Devin; Singer, Kathleen E.; Moran, Ryan; McGlone, Emily; Veile, Rosalie; Goetzman, Holly S.; Makley, Amy T.; Caldwell, Charles C.; Goodman, Michael D.] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA; [Goetzman, Holly S.; Caldwell, Charles C.] Shriners Hosp Children, Div Res, Cincinnati, OH USA		Goodman, MD (corresponding author), Univ Cincinnati, Dept Surg, Sect Gen Surg, 231 Albert Sabin Way,ML 0558, Cincinnati, OH 45267 USA.	goodmamd@ucmail.uc.edu		Goodman, Michael/0000-0001-7218-4855	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 GM124156-01A1]	This work was supported by the National Institutes of Health R01 GM124156-01A1 (MDG).	Abdelfattah K, 2016, INT J SURG, V33, P196, DOI 10.1016/j.ijsu.2015.09.036; Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Chu WH, 2013, J TRAUMA ACUTE CARE, V74, P1446, DOI 10.1097/TA.0b013e31829246ad; Friedrich V, 2010, BRAIN RES, V1354, P179, DOI 10.1016/j.brainres.2010.07.040; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Hans GA, 2016, BRIT J HAEMATOL, V173, P37, DOI 10.1111/bjh.13930; Harbrecht BG, 2006, J TRAUMA, V61, P254; Hurtuk M, 2006, J TRAUMA, V61, P243, DOI 10.1097/01.ta.0000231353.06095.8d; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Martin G, 2018, NEUROCRIT CARE, V28, P330, DOI 10.1007/s12028-017-0485-5; Martin GE, 2019, J TRAUMA ACUTE CARE, V86, P592, DOI 10.1097/TA.0000000000002171; Massaro AM, 2015, NEUROCRIT CARE, V22, P45, DOI 10.1007/s12028-014-0051-3; Midura EF, 2015, J SURG RES, V197, P25, DOI 10.1016/j.jss.2015.02.064; Mohseni Shahin, 2012, J Emerg Trauma Shock, V5, P11, DOI 10.4103/0974-2700.93102; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Morris MC, 2019, J SURG RES, V244, P63, DOI 10.1016/j.jss.2019.06.023; Morris MC, 2019, J SURG RES, V244, P1, DOI 10.1016/j.jss.2019.06.022; National Comprehensive Cancer Network, BREAST CANC VERS 3 2; Nekludov M, 2014, J NEUROTRAUM, V31, P1927, DOI 10.1089/neu.2013.3168; Peitzman AB, 2000, J TRAUMA, V49, P177, DOI 10.1097/00005373-200008000-00002; Pommerening MJ, 2015, SURGERY, V158, P618, DOI 10.1016/j.surg.2015.06.014; Prakash PS, 2012, J TRAUMA ACUTE CARE, V73, P401, DOI 10.1097/TA.0b013e31825a776d; Rogers FB, 2001, SURGERY, V130, P1, DOI 10.1067/msy.2001.114558; Seifert HA, 2012, METAB BRAIN DIS, V27, P131, DOI 10.1007/s11011-012-9283-0; Shackford SR, 2004, ANN SURG, V240, P496; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Teixeira PG, 2013, J TRAUMA ACUTE CARE, V75, P596, DOI 10.1097/TA.0b013e31829bb976; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1	39	1	1	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848	1879-2472		THROMB RES	Thromb. Res.	SEP	2020	193						211	217		10.1016/j.thromres.2020.08.002			7	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	NM8CO	WOS:000568321000006	32798961	Green Accepted			2022-02-06	
J	Nayeri, ND; Esmaeili, M; Farsi, Z; Chenari, HA				Nayeri, Nahid Dehghan; Esmaeili, Maryam; Farsi, Zahra; Chenari, Hadi Ahmadi			Taking care experiences of improved comatose patients with traumatic brain injury and their families	JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE			English	Article						Care experiences; comatose patients; traumatic brain injury		Introduction: The most prominent causes of coma are traumatic brain injuries (TBIs), which have high incidence. However, little research about the caring aspects of these patients has been done, and the notion of caring experiences is unknown. Therefore, this study was conducted to describe the care-taking experiences of coma patients and their families during and after treatment. Methods: This study is a qualitative content analysis. Participants in this study were improved TBI patients and their families. Participants were selected purposefully. The method of data collection was 16 interviews that were held with 14 of the participants. Data were analyzed using Elo and Kyngas conventional content analysis guidelines with MAXQDA software, version 10. Results: The results showed four main themes and eight categories. Themes included "crisis," "comprehensive support," communication," and "unprofessional care." Conclusion: Patients and families experience a crisis during hospitalization and after discharge. Therefore, patients and families need psychological support. Informing families and communication decrease the conflicts between healthcare personnel and the family. Medical staff must be careful about their statements and behaviors during comatose patients' care because they understand the care process.	[Nayeri, Nahid Dehghan; Esmaeili, Maryam] Univ Tehran Med Sci, Nursing & Midwifery Care Res Ctr, Sch Nursing & Midwifery, Tehran, Iran; [Farsi, Zahra] Aja Univ Med Sci, Fac Nursing, Dept Res & Community Hlth, Tehran, Iran; [Chenari, Hadi Ahmadi] Univ Tehran Med Sci, Sch Nursing & Midwifery, Dept Crit Care Nursing, Tehran, Iran		Chenari, HA (corresponding author), Sch Nursing & Midwifery, Dept Crit Care Nursing, Western Nosrat St,Tohid Sq, Tehran 1419733171, Iran.	ahmadi.h@bums.ac.ir			Tehran University of Medical Sciences, Tehran, IranTehran University of Medical Sciences	This research was funded by the Tehran University of Medical Sciences, Tehran, Iran.	Ahmadi Chenari H, 2016, IRAN J REHABIL RES N, V2, P68; Azami-Aghdash S, 2017, IRAN RED CRESCENT ME, V19, DOI 10.5812/ircmj.38743; Buchini S, 2014, J NURS MANAGE, V22, P140, DOI 10.1111/jonm.12004; Cain C, 2020, CRIT CARE NURSE, V40, P87, DOI 10.4037/ccn2020273; Coco K, 2013, J CLIN NURS, V22, P1467, DOI 10.1111/jocn.12136; Elo S, 2014, SAGE OPEN, V4, DOI 10.1177/2158244014522633; Guba EG, 1994, HDB QUALITATIVE RES, P105; Hofman M, 2020, EUR J TRAUMA EMERG S, V46, P11, DOI 10.1007/s00068-019-01179-1; Imam SZ, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-161; Lee HY, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01758-5; Motaghi M., 2017, J CLIN NURS MIDWIFER, V5, P90; Oyesanya TO, 2018, J CLIN NURS, V27, P1408, DOI 10.1111/jocn.14298; Pashaeypoor S, 2019, NURS SCI QUART, V32, P239, DOI 10.1177/0894318419845396; Robertson K, 2015, BRAIN INJURY, V29, P848, DOI 10.3109/02699052.2015.1005135; Schindler CR, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061667; Shokati Ahmad Abad M, 2012, J QUALITATIVE RES HL, V1, P182	16	1	1	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2249-4863	2278-7135		J FAM MED PRIM CARE	J. Fam. Med. Prim. Care	SEP	2020	9	9					4815	4820		10.4103/jfmpc.jfmpc_878_20			6	Primary Health Care	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	RZ2PH	WOS:000648440600056	33209806	gold, Green Published			2022-02-06	
J	Neumann, D; Sander, AM; Perkins, SM; Bhamidipalli, SS; Witwer, N; Combs, D; Hammond, FM				Neumann, Dawn; Sander, Angelle M.; Perkins, Susan M.; Bhamidipalli, Surya Sruthi; Witwer, Noelle; Combs, Dennis; Hammond, Flora M.			Assessing Negative Attributions After Brain Injury With the Ambiguous Intentions Hostility Questionnaire	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anger; attributions; blame; brain injury; hostility; intent	WORKING-MEMORY; BIAS; MIND; ASSOCIATION; AGGRESSION; STYLE; ANGER	Objectives: (1) To explore the construct validity of the Ambiguous Intentions Hostility Questionnaire (AIHQ) in participants with traumatic brain injury (TBI) (ie, confirm negative attributions are associated with anger and aggression); and (2) use the AIHQ to examine negative attribution differences between participants with and without TBI. Setting: Two rehabilitation hospitals. Participants: Eighty-five adults with TBI and 86 healthy controls (HCs). Design: Cross-sectional survey. Main Measures: The AIHQ, a measure of negative attributions (intent, hostility, and blame), anger, and aggressive responses to hypothetical scenarios. Results: Attributions were significantly correlated with anticipated anger and aggressive responses to AIHQ scenarios. Compared with HCs, participants with TBI reported stronger negative attributions (P <= .001), anger (P= .021), and aggressive responses (P= .002) to the scenarios. Conclusion: Negative attributions were associated with anger and aggression responses, demonstrating construct validity of the AIHQ in the TBI population. Participants with TBI judged others' behaviors more severely than HCs, similar to prior research using a different attribution measure. The AIHQ has promise as a practical instrument for assessing negative attributions after TBI.	[Neumann, Dawn; Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Perkins, Susan M.; Bhamidipalli, Surya Sruthi] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA; [Neumann, Dawn; Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Sander, Angelle M.] Baylor Coll Med, Div Clin Neuropsychol & Rehabil Psychol, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Witwer, Noelle] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Combs, Dennis] Univ Texas Tyler, Dept Psychol, Tyler, TX 75799 USA		Neumann, D (corresponding author), Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA.	dneumann73@gmail.com			National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90IF00-95-01-00]	This study was funded by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), award #90IF00-95-01-00.	An SK, 2010, SCHIZOPHR RES, V118, P54, DOI 10.1016/j.schres.2010.01.025; Bailey CA, 2008, J YOUTH ADOLESCENCE, V37, P713, DOI 10.1007/s10964-007-9211-5; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Brookshire R, 1993, DISCOURSE COMPREHENS, P105; Buck B, 2017, J PSYCHIATR RES, V89, P48, DOI 10.1016/j.jpsychires.2017.01.004; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Combs Dennis R, 2007, Cogn Neuropsychiatry, V12, P128, DOI 10.1080/13546800600787854; Combs Dennis R, 2009, Cogn Neuropsychiatry, V14, P30, DOI 10.1080/13546800902732970; Ellsworth PC, 2003, SER AFFECTIVE SCI, P572; EPPS J, 1995, COGNITIVE THER RES, V19, P159, DOI 10.1007/BF02229692; Evans JD, 1996, STRAIGHTFORWARD STAT; Gross J., 2007, HDB EMOTION REGULATI, V2nd, P1; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Jeon IH, 2013, PSYCHIAT INVEST, V10, P34, DOI 10.4306/pi.2013.10.1.34; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Neumann D, 2017, J HEAD TRAUMA REHAB, V32, P205, DOI 10.1097/HTR.0000000000000261; Neumann D, 2017, J HEAD TRAUMA REHAB, V32, P197, DOI 10.1097/HTR.0000000000000259; Neumann D, 2015, REHABIL PSYCHOL, V60, P155, DOI 10.1037/rep0000036; Pinkham AE, 2014, SCHIZOPHRENIA BULL, V40, P813, DOI 10.1093/schbul/sbt081; Steinberg M. S., 1983, J SOC CLIN PSYCHOL, V1, P312, DOI [10.1521/jscp.1983.1.4.312, DOI 10.1521/JSCP.1983.1.4.312]; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993	26	1	1	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2020	35	5			SI		E450	E457		10.1097/HTR.0000000000000581			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NP5SO	WOS:000570236100016	32472838				2022-02-06	
J	Okusanya, DO; Basson, WJ				Okusanya, D. O.; Basson, W. J.			Symptom profile following cumulative mild traumatic brain injury in early adolescent rugby union players in South Africa	SOUTH AFRICAN JOURNAL OF CHILD HEALTH			English	Article							SPORT-RELATED CONCUSSION; IMPACT; HEAD	Background. The symptom profiles of young adolescent rugby and non-contact sports were investigated over one sport season. Objectives. To compare the concussion symptom profiles of rugby players with those of non-contact sport players over a sport season. Methods. In a non-equivalent quasi-experimental design, a group of rugby players (n=99) were compared with a demographically equivalent group of non-contact sport participants (n=74). The computerised Immediate Post-concussion Assessment and Cognitive Testing (IMPACT) symptom scale was employed to evaluate and compare pre-season and post-season assessment of both groups. Results. Independent comparative analyses revealed that the damaging effects owing to exposure to concussive and sub-concussive incidents appear to be more pronounced in the rugby group in terms of symptomatic presentation compared with the controls. Conclusion. The damaging effects are compounded during a rugby season as a result of sub-concussive and concussive events.	[Okusanya, D. O.; Basson, W. J.] Sefako Makgatho Hlth Sci Univ, Dept Psychol, Pretoria, South Africa		Okusanya, DO (corresponding author), Sefako Makgatho Hlth Sci Univ, Dept Psychol, Pretoria, South Africa.	201209408@swave.smu.ac.za					Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Baron IS, 2008, NEUROPSYCHOLOGY COUR, P66; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Brooks J, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5629; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Centers for Disease Control and Prevention (CDC), 2015, GUID WRIT TRAUM BRAI; Clark SB, 2011, THESIS; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Collie A, 2005, MED SCI SPORT EXER, V37, pS276, DOI 10.1097/00005768-200505001-01419; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, NORMATIVE DATA FOXPR; Kearney PE, 2017, J SCI MED SPORT, V20, P981, DOI 10.1016/j.jsams.2017.04.019; Kontos AP, 2004, J APPL SPORT PSYCHOL, V16, P220, DOI 10.1080/10413200490485568; Legome E, 2009, POSTCONCUSSIVE SYNDR; Luna B, 2004, ANN NY ACAD SCI, V1021, P296, DOI 10.1196/annals.1308.035; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Matheson GO, 2011, CLIN J SPORT MED, V21, P25, DOI 10.1097/JSM.0b013e3182095f92; Mc Fie S, 2016, CLIN J SPORT MED, V26, P398, DOI 10.1097/JSM.0000000000000276; McIntosh AS, 2010, BRIT J SPORT MED, V44, P188, DOI 10.1136/bjsm.2007.041400; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Ramalho Joana, 2015, Dement. neuropsychol., V9, P356, DOI 10.1590/1980-57642015DN94000356; Rios JS, 2014, THESIS; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schunk JE, 2012, PEDIATR REV, V33, P398, DOI 10.1542/pir.33-9-398; Semrud-Clikeman M., 2016, J PEDIATR NEUROPSYCH, V2, P58, DOI [10.1007/s40817-015-0010-8, DOI 10.1007/S40817-015-0010-8, https://doi.org/10.1007/s40817-015-0010-8]; Shuttleworth-Edwards AB, 2004, J CLIN EXP NEUROPSYC, V26, P903, DOI 10.1080/13803390490510824; Shuttleworth-Edwards Ann B, 2009, Phys Sportsmed, V37, P45, DOI 10.3810/psm.2009.12.1741; Webbe FM, 2004, ARCH CLIN NEUROPSYCH, V19, P1111, DOI 10.1016/j.acn.2004.05.002	39	1	1	0	0	HEALTH & MEDICAL PUBLISHING GROUP	CAPE TOWN	PRIVATE BAG X1, PINELANDS, CAPE TOWN, 7430, SOUTH AFRICA	1994-3032	1999-7671		S AFR J CHILD HEALTH	S. Afr. J. Child Health	SEP	2020	14	3					133	138					6	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	OF3IO	WOS:000581106100007					2022-02-06	
J	Olivares, M; Pigot, H; Bottari, C; Lavoie, M; Zayani, T; Bier, N; Le Dorze, G; Pinard, S; Le Pevedic, B; Swaine, B; Therriault, PY; Thepaut, A; Giroux, S				Olivares, Marisnel; Pigot, Helene; Bottari, Carolina; Lavoie, Monica; Zayani, Taoufik; Bier, Nathalie; Le Dorze, Guylaine; Pinard, Stephanie; Le Pevedic, Brigitte; Swaine, Bonnie; Therriault, Pierre-Yves; Thepaut, Andre; Giroux, Sylvain			Use of a Persona to Support the Interdisciplinary Design of an Assistive Technology for Meal Preparation in Traumatic Brain Injury	INTERACTING WITH COMPUTERS			English	Article						persona; scenario; assistive technology; traumatic brain injury (TBI); instrumental activities of daily living (IADL); meal preparation	IADL PROFILE; HEALTH; THERAPISTS; DISABILITY; VALIDITY; FATIGUE	User-centered design (UCD) facilitates the creation of technologies that are specifically designed to answer users' needs. This paper presents the first step of a UCD using a persona, a fictitious character representing the targeted population, which in this case is people having sustained a traumatic brain injury (TBI). The persona is used to better understand the possible interactions of a TBI population with a prototype of a technology that we wish to develop, namely the Cognitive Orthosis for coOKing (COOK). COOK is meant to be an assistive technology that will be designed to promote independence for cooking within a supported-living residence. More specifically, this paper presents the persona's creation methodology based on the first four phases of the persona's lifecycle. It also describes how the persona methodology served as a facilitator to initiate an interdisciplinary collaboration between a clinical team and a computer science team. Creation of personas relied on a clinical model (Disability Creation Process) that contextualized the needs of this population and an evaluation tool [Instrumental Activities of Daily Living (IADL) Profile] that presented a wide range of cognitive assistance needs found in this same population. This paper provides an in-depth description of some of the most frequent everyday difficulties experienced by individuals with TBI as well as the persona's abilities, limitations and social participation during the realization of IADL, and an evaluation of the manifestations of these difficulties during IADL performance as represented through scenarios. The interdisciplinary team used the persona to complete a first description of the interactions of a persona with TBI with COOK. This work is an attempt at offering a communication tool, the persona, to facilitate interdisciplinary research among diverse disciplines who wish to learn to develop a common language, models and methodologies at the beginning of the design process. RESEARCH HIGHLIGHTS Personas as a communication tool to facilitate interdisciplinary design research. The use of personas as a means of developing common knowledge and vocabulary among interdisciplinary team members. Personas as a UCD representation of the common characteristics of a population with complex cognitive needs. Use of personas as a means of representing how deficits experienced by persons with traumatic brain injury can impact independence in instrumental activities of daily living. A scenario as a means of establishing the main functionalities and user interactions of an assistive technology named COOK, based on a persona's assistance needs.	[Olivares, Marisnel; Pigot, Helene; Zayani, Taoufik; Giroux, Sylvain] Univ Sherbrooke, DOMUS, 2500 Boul Univ, Sherbrooke, PQ J1K 2R1, Canada; [Olivares, Marisnel; Thepaut, Andre] IMT Atlantique Bretagne, Lab STIC, 655 Av Technopole, F-29200 Brest, France; [Pigot, Helene; Giroux, Sylvain] Ctr Rech Vieillissernent, 1036 Rue Belvedere Sud, Sherbrooke, PQ J1H 4C4, Canada; [Pigot, Helene; Bottari, Carolina; Le Dorze, Guylaine; Swaine, Bonnie] Inst Univ Readaptat Deficience Phys Montreal, Ctr Interdisciplinary Res Rehabil Greater Montrea, 6363 Chemin Hudson, Montreal, PQ H3S 1M9, Canada; [Bottari, Carolina; Bier, Nathalie; Pinard, Stephanie; Swaine, Bonnie] Univ Montreal, Sch Rehabil, 7077 Av Parc, Montreal, PQ H3N 1X7, Canada; [Lavoie, Monica] Univ Laval, Dept Readaptat, Quebec City, PQ, Canada; [Lavoie, Monica] Ctr Rech CERVO, Quebec City, PQ, Canada; [Bier, Nathalie] Inst Univ Geriatrie Montreal, CIUSSS Ctr Sud Lile Montreal, Site Ctr Rech, 4545 Chemin Queen Mary, Montreal, PQ H3W 1W4, Canada; [Le Dorze, Guylaine] Univ Montreal, Ecole Orthophonie & Audiol, 7077 Av Parc, Montreal, PQ H3N 1X7, Canada; [Le Pevedic, Brigitte] Univ Bretagne Sud, Lab STICC, IUT Vannes, 8 Rue Michel, F-56000 Montaigne, France; [Therriault, Pierre-Yves] Univ Quebec Trois Rivieres, Dept Ergotherapie, 3351 Boul Forges, Trois Rivieres, PQ G9A 5H7, Canada		Olivares, M (corresponding author), Univ Sherbrooke, DOMUS, 2500 Boul Univ, Sherbrooke, PQ J1K 2R1, Canada.; Olivares, M (corresponding author), IMT Atlantique Bretagne, Lab STIC, 655 Av Technopole, F-29200 Brest, France.	marisnel.olivares@usherbrooke.ca					Abras C., 2004, ENCY HUMAN COMPUTER, P445; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Baguena N., 2006, Annales de Readaptation et de Medecine Physique, V49, P234, DOI 10.1016/j.annrmp.2006.02.007; Bittner RM, 2007, BRAIN INJURY, V21, P709, DOI 10.1080/02699050701468917; Blomquist A., 2002, P CHI 2002 P 2 NORD C HUM COMP, P197; Boger J, 2017, DISABIL REHABIL-ASSI, V12, P480, DOI 10.3109/17483107.2016.1151953; Bornet C., 2013, B PSYCHOL, V524, P115; Bottari C, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0000000000000029; Bottari C, 2011, BRAIN INJURY, V25, P1306, DOI 10.3109/02699052.2011.624570; Bottari C, 2010, ARCH PHYS MED REHAB, V91, P734, DOI 10.1016/j.apmr.2009.12.023; Bottari C, 2009, NEUROPSYCHOL REHABIL, V19, P177, DOI 10.1080/09602010802188435; Bottari C, 2009, BRAIN INJURY, V23, P322, DOI 10.1080/02699050902788436; Bottari CL, 2010, CAN J OCCUP THER, V77, P90, DOI 10.2182/cjot.2010.77.2.5; Brangier E, 2011, ERGON DES MANAG THEO, P37; Cooper A, 2004, INMATES ARE RUNNING, V2; Dabbs AD, 2009, CIN-COMPUT INFORM NU, V27, P175, DOI 10.1097/NCN.0b013e31819f7c7c; Duclos C, 2015, AUST OCCUP THER J, V62, P2, DOI 10.1111/1440-1630.12164; Fougeyrollas P, 1998, INT J REHABIL RES, V21, P127, DOI 10.1097/00004356-199806000-00002; Hadorn G. H., 2010, OXFORD HDB INTERDISC, P431; Heim Steven, 2007, RESONANT INTERFACE H; JAMESON A, 2008, HUMAN COMPUTER INTER, P433; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Klein J., 1997, HDB UNDERGRADUATE CU, P393; LeRouge C, 2013, INT J MED INFORM, V82, pE251, DOI 10.1016/j.ijmedinf.2011.03.006; Levasseur M, 2016, DISABIL REHABIL-ASSI, V11, P636, DOI 10.3109/17483107.2015.1029536; Mollo V, 2008, THEOR ISS ERGON SCI, V9, P223, DOI 10.1080/14639220701195186; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nielsen L., 2019, PERSONAS USER FOCUSE, P55; Nielsen L., 2002, P 4 C DES INT SYST P, P99; Pigot H, 2005, ASSIST TECHNOL RES S, V15, P25; Pinard S, 2021, DISABIL REHABIL-ASSI, V16, P687, DOI 10.1080/17483107.2019.1696898; Pruitt J, 2006, PERSONA LIFECYCLE KE; Robert JM, 2012, WORK, V41, P5235, DOI 10.3233/WOR-2012-0012-5235; Rochat L, 2013, J INT NEUROPSYCH SOC, V19, P890, DOI 10.1017/S1355617713000672; Rode G., 2005, Annales de Readaptation et de Medecine Physique, V48, P376, DOI 10.1016/j.annrmp.2005.04.006; SCHERZER BP, 1993, BRAIN INJURY, V7, P411, DOI 10.3109/02699059309029684; Schulz R, 2015, GERONTOLOGIST, V55, P724, DOI 10.1093/geront/gnu071; Song H., 2009, INT J DESIGN INNOV R, V4, P59; TEASDALE G, 1974, LANCET, V2, P81; Toglia JP, 2012, CAN J OCCUP THER, V79, P225, DOI 10.2182/cjot.2012.79.4.4; Turner AM, 2013, J BIOMED INFORM, V46, P575, DOI 10.1016/j.jbi.2013.04.006; Ustun TB, 2003, DISABIL REHABIL, V25, P565, DOI 10.1080/0963828031000137063; Vas AK, 2015, J CLIN EXP NEUROPSYC, V37, P152, DOI 10.1080/13803395.2014.994478; World Health Organization, 2007, INT CLASS FUNCT DIS	44	1	1	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-5438	1873-7951		INTERACT COMPUT	Interact. Comput.	SEP-NOV	2020	32	5-6					435	456		10.1093/iwcomp/iwab002			22	Computer Science, Cybernetics; Ergonomics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Engineering	TL1SO	WOS:000674635200001					2022-02-06	
J	Pan, J; Barros, G; Greil, ME; Meyer, RM; Ene, CI; Chesnut, RM				Pan, James; Barros, Guilherme; Greil, Madeline E.; Meyer, R. Michael; Ene, Chibawanye, I; Chesnut, Randall M.			Pseudoaneurysm of the Superficial Temporal Artery After Intracranial Pressure Monitoring Device Placement: Case Report of a Rare Complication	OPERATIVE NEUROSURGERY			English	Article						Superficial temporal artery; Pseudoaneurysm; Trauma; ICP monitor; Neurocritical care; Critical care	ARTERIOVENOUS-FISTULA; TRAUMATIC PSEUDOANEURYSM	BACKGROUND AND IMPORTANCE: Pseudoaneurysms involving the superficial temporal artery (STA), either iatrogenic or caused by direct trauma, are rare. The STA is prone to injury due to its long course throughout the scalp. Injuries can cause cosmetic defects and/or skin breakdown leading to further complications. CLINICAL PRESENTATIONS: We report a case of delayed iatrogenic pseudoaneurysm of the STA after placement of an intracranial pressure monitor in the setting of acute traumatic brain injury. The patient had a delayed development of a pulsatile mass over his right frontal region, with computed tomography angiography concerning for a pseudoaneurysm of the STA. This was managed with surgical resection with complete resolution of symptoms at follow-up. CONCLUSIONS: We review the literature regarding the etiology, pathogenesis, and management of these lesions. While iatrogenic injuries to the STA have been previously reported, this is a curious case related to placement of an intracranial pressure monitor. We recommend direct surgical resection of the pseudoaneurysm for cosmetic effect and prevention of further wound breakdown.	[Pan, James; Barros, Guilherme; Greil, Madeline E.; Meyer, R. Michael; Ene, Chibawanye, I; Chesnut, Randall M.] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA		Chesnut, RM (corresponding author), Univ Washington, Dept Neurol Surg, Neurol Surg Publicat, 325 Ninth Ave,Box 359924, Seattle, WA 98104 USA.	respub4@uw.edu					Fard Mahmoud Omrani, 2017, Adv Biomed Res, V6, P82, DOI 10.4103/2277-9175.210663; Field M, 2002, J NEUROSURG, V97, P227, DOI 10.3171/jns.2002.97.1.0227; Kim SW, 2013, J CRANIOFAC SURG, V24, P295, DOI 10.1097/SCS.0b013e31827136f6; Lee HS, 2010, J KOREAN NEUROSURG S, V48, P291, DOI 10.3340/jkns.2010.48.3.291; Li F, 2007, J CLIN NEUROSCI, V14, P595, DOI 10.1016/j.jocn.2006.04.011; Martin-Granizo R, 2004, INT J ORAL MAX SURG, V33, P301, DOI 10.1006/ijom.2003.0488; Pourdanesh F, 2013, J CRANIOFAC SURG, V24, pE334, DOI 10.1097/SCS.0b013e31828a7ab0; Seferi Arsen, 2016, Surg Neurol Int, V7, P66, DOI 10.4103/2152-7806.184264; Shah Kushal J, 2014, BMJ Case Rep, V2014, DOI 10.1136/bcr-2014-011410; Sloane J, 2013, INT J SURG CASE REP, V4, P852, DOI 10.1016/j.ijscr.2013.05.001; Takeuchi S, 2011, J CRANIOFAC SURG, V22, P1959, DOI 10.1097/SCS.0b013e31822ea814; Tavakoli S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17450	12	1	1	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2332-4252	2332-4260		OPER NEUROSURG	Oper. Neurosurg.	SEP	2020	19	3					288	291		10.1093/ons/opaa151			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OW8KB	WOS:000593127700064	32503046				2022-02-06	
J	Partiali, B; Oska, S; Barbat, A; Sneij, J; Folbe, A				Partiali, Benjamin; Oska, Sandra; Barbat, Antonio; Sneij, Joseph; Folbe, Adam			Injuries to the Head and Face From Skateboarding: A 10-Year Analysis From National Electronic Injury Surveillance System Hospitals	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							TRAUMATIC BRAIN-INJURY; RISK; ADOLESCENTS; ASSOCIATION; FRACTURES; OUTCOMES	Purpose: To estimate the incidence of patients presenting to emergency departments (EDs) as a result of facial trauma sustained from skateboarding. Patients and Methods: The National Electronic Injury Surveillance System (NEISS) database was queried for skateboard-related head and face fractures, contusions, abrasions, and lacerations from 2009 through 2018. We identified 2,519 reported injuries, extrapolating to a national incidence of 100,201 injuries. Fractures accounted for 14.1% of these visits. There were 355 ED visits for fractures, extrapolating to an estimated 11,893 visits nationally. Entries were tabulated for demographic information, fracture type, mechanism of injury, and disposition. Results: Patients sustaining injury to the head and face were aged 16 years, on average, and predominantly male patients (85.9%). Most patients sustaining fractures were male patients (87.9%), with a mean age of 18 years. The most common fracture types included unspecified skull fractures (31%), nasal fractures (29%), and mandibular fractures (18%). The most common mechanism of injury was falling off the skateboard while riding (76.9%). Collisions with motor vehicles also accounted for a substantial proportion of the injuries (7.3%). Conclusions: A substantial number of ED visits were a result of skateboarding-related facial trauma. Given the neurologic outcomes of head trauma and functional consequences of facial fractures, especially among adolescents, our findings suggest that injury prevention programs and more aggressive helmet use may be necessary to reduce morbidity and hospitalization. (C) 2020 American Association of Oral and Maxillofacial Surgeons	[Partiali, Benjamin; Oska, Sandra; Barbat, Antonio] Oakland Univ, William Beaumont Sch Med, Rochester, MI 48063 USA; [Folbe, Adam] William Beaumont Hosp, Dept Otolaryngol, Div Otolaryngol Head & Neck Surg, Royal Oak, MI 48072 USA		Partiali, B (corresponding author), William Beaumont Hosp, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA.	partiali@oakland.edu		Partiali, Benjamin/0000-0003-2244-5302; Barbat, Antonio/0000-0003-1077-5371			Bandzar S, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-1253; Bull MJ, 2002, PEDIATRICS, V109, P542; Consumer Product Safety Commission, NEISS FREQ ASK QUEST; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Kraus JF, 2003, ANN EMERG MED, V41, P18, DOI 10.1067/mem.2003.1; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Munoz-Sanchez MA, 2009, BRAIN INJURY, V23, P39, DOI 10.1080/02699050802590346; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Rethnam Ulfin, 2008, BMC Res Notes, V1, P59, DOI 10.1186/1756-0500-1-59; Sadeghian Homa, 2017, Perm J, V21, P16, DOI 10.7812/TPP/16-161; Saunders LL, 2009, BRAIN INJURY, V23, P866, DOI 10.1080/02699050903283213; Schleimer Jonathan A, 2002, Curr Sports Med Rep, V1, P323; Shuman KM, 2015, PHYSICIAN SPORTSMED, V43, P317, DOI 10.1080/00913847.2015.1050953; The Tokyo Organising Committee of the Olympic and Paralympic Games, SKAT; Tominaga GT, 2015, BRAIN INJURY, V29, P1044, DOI 10.3109/02699052.2014.989404; Tseng WC, 2011, J TRAUMA, V71, P1611, DOI 10.1097/TA.0b013e31823a8a60; Tuckel PS, 2019, CLIN PEDIATR, V58, P417, DOI 10.1177/0009922818821872; Wang HW, 2018, INJURY, V49, P219, DOI 10.1016/j.injury.2017.11.039	19	1	1	2	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	SEP	2020	78	9					1590	1594		10.1016/j.joms.2020.04.039			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	NK9HA	WOS:000567038500023	32504565				2022-02-06	
J	Ren, LH; Wang, DD; Jiang, CY; Hu, YZ				Ren, Lihai; Wang, Dangdang; Jiang, Chengyue; Hu, Yuanzhi			Influence of Foramen Magnum Boundary Condition on Intracranial Dynamic Response Under Forehead Impact Using Human Body Finite Element Model	INTERNATIONAL JOURNAL OF COMPUTATIONAL METHODS			English	Article						Head impact; traumatic brain injury; finite element method; human body model	DIFFUSE AXONAL INJURY	The biofidelity is an essential requirement of the application of human head finite element (FE) models to investigate head injuries under mechanical loadings. However, the influence of the foramen magnum boundary condition (FM BC) on intracranial dynamic responses under head impacts has yet to be fully identified until now. This study aimed to investigate the effect of different modeling methods of the FMBC on intracranial dynamic responses induced by forehead impact, especially the axonal injury associated dynamic responses. The total human model for safety (THUMS) was applied in this study. Two FE models with different PM BC modeling methods were developed from the THUMS model. Then, three forehead impact FE models were established respectively, including the original THUMS model. Further FE simulations were conducted to investigate the influence of FMBC modeling methods on intracranial dynamic responses. Though, difference between the intracranial dynamic responses (relative skull-brain motion and strain responses) at areas far from the foramen magnum were slightly, the corresponding difference at the brain stem area were distinctly. Meanwhile, the predicted axonal injury risk of the brain stem white matter was varying among each other. Different modeling methods of FMBC could result in different intracranial dynamic responses of the brain stem, and affect the axonal injury prediction. Therefore, the modeling of the FMBC should be further evaluated for the study of brain stem injury using human head FE models.	[Ren, Lihai; Wang, Dangdang; Jiang, Chengyue; Hu, Yuanzhi] Chongqing Univ Technol, Minist Educ, Key Lab Adv Mfg Technol Automobile Parts, Chongqing 400054, Peoples R China		Jiang, CY (corresponding author), Chongqing Univ Technol, Minist Educ, Key Lab Adv Mfg Technol Automobile Parts, Chongqing 400054, Peoples R China.	jiangchengyue@cqut.edu.cn	Wang, Dangdang/AAE-4553-2021	ren, lihai/0000-0003-0477-8699	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51405050]; Scientific and Technological Research Program of Chongqing Municipal Education Commission [KJQN201801107]	This work was supported by the National Natural Science Foundation of China (Grant No. 51405050), Scientific and Technological Research Program of Chongqing Municipal Education Commission (Grant No. KJQN201801107).	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Alvarez V. S., 2017, UNDERSTANDING BOUNDA; Alvarez Victor S, 2014, Stapp Car Crash J, V58, P63; Bandak F. A., 1994, 942215 SAE; Coronado VG, 2011, SURVEILLANCE TRAUMAT; Fahlstedt M, 2016, ACCIDENT ANAL PREV, V91, P135, DOI 10.1016/j.aap.2016.02.025; Ghosh P., 2016, HEAD INJURY RISK ASS; Hardy W N, 2001, Stapp Car Crash J, V45, P337; [胡远志 Hu Yuanzhi], 2018, [哈尔滨工业大学学报, Journal of Harbin Institute of Technology], V50, P154; Huang J, 2018, ACCIDENT ANAL PREV, V119, P91, DOI 10.1016/j.aap.2018.07.012; Ji Songbai, 2004, Stapp Car Crash J, V48, P227; Ji SB, 2007, J BIOMECH, V40, P92, DOI 10.1016/j.jbiomech.2005.11.009; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Lamy M, 2013, MED BIOL ENG COMPUT, V51, P353, DOI 10.1007/s11517-012-1004-7; Li GB, 2015, ACCIDENT ANAL PREV, V85, P83, DOI 10.1016/j.aap.2015.07.012; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Nahum A, 1977, 770922 SAE; National Bureau of Statistics, 2017, CHIN STAT YB; Ren LH, 2015, INT J CRASHWORTHINES, V20, P602, DOI 10.1080/13588265.2015.1073132; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Takhounts EG, 2008, STAPP CAR C, V52, P1; Wang Fang, 2018, Br J Neurosurg, P1, DOI 10.1080/02688697.2018.1523367; [王方 Wang Fang], 2018, [中国公路学报, China Journal of Highway and Transport], V31, P231; World Health Organization, 2015, GLOB STAT REP ROAD S; Yang JK, 2008, CHIN J MECH ENG-EN, V21, P81, DOI 10.3901/CJME.2008.04.081; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5; Zhou Z, 2016, COMPUT METH PROG BIO, V131, P13, DOI 10.1016/j.cmpb.2016.04.013	27	1	1	3	6	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-8762	1793-6969		INT J COMP METH-SING	Int. J. Comput. Methods	SEP	2020	17	7							1950029	10.1142/S0219876219500294			12	Engineering, Multidisciplinary; Mathematics, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mathematics	NE9YF	WOS:000562959100007					2022-02-06	
J	Rudkovskii, MV; Fedorenko, AG; Khaitin, AM; Pitinova, MA; Uzdensky, AB				Rudkovskii, M., V; Fedorenko, A. G.; Khaitin, A. M.; Pitinova, M. A.; Uzdensky, A. B.			The effect of axotomy on firing and ultrastructure of the crayfish mechanoreceptor neurons and satellite glial cells	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						Axotomy; Neuron activity; Ca2+; Glia; Microtubules; Mitochondria	INDUCED NECROSIS; GIANT-AXONS; GROWTH CONE; CUT ENDS; APOPTOSIS; REPAIR; PROTECTION; MECHANISMS; BARRIER; REMOTE	Neurotrauma is among main causes of human disability and death. We studied effects of axotomy on ultrastructure and neuronal activity of a simple model object - an isolated crayfish stretch receptor that consists of single mechanoreceptor neurons (MRN) enwrapped by multilayer glial envelope. After isolation, MRN regularly fired until spontaneous activity cessation. Axotomy did not change significantly MRN spike amplitude and firing rate. However, the duration of neuron activity from MRN isolation to its spontaneous cessation decreased in axotomized MRN relative to intact neuron. [Ca2+] in MRN axon and soma increased 3-10 min after axotomy. Ca2+ entry through ion channels in the axolemma accelerated axotomy-stimulated firing cessation. MRN incubation with Ca2+ ionophore ionomycin accelerated MRN inactivation, whereas Ca2+-channel blocker Cd2+ prolonged firing. Activity duration of either intact, or axotomized MRN did not change in the presence of ryanodine or dantrolene, inhibitors of ryanodin-sensitive Ca2+ channels in endoplasmic reticulum. Thapsigargin, inhibitor of endoplasmic reticulum Ca2+-ATPase, or its activator ochratoxin were ineffective. Ultrastructural study showed that the defect in the axon transected by thin scissors is sealed by fused axolemma, glial and collagen layers. Only the 30-50 mu m long segment completely lost microtubules and contained swelled mitochondria. The microtubular bundle remained undamaged at 300 mu m away from the axotomy site. However, mitochondria within the 200-300 mu m segment were strongly condensed and lost matrix and cristae. Glial and collagen layers exhibited greater damage. Swelling and edema of glial layers, collagen disorganization and rupture occurred within this segment. Thus, axotomy stronger damages glia/collagen envelope, axonal microtubules and mitochondria.	[Rudkovskii, M., V; Fedorenko, A. G.; Khaitin, A. M.; Pitinova, M. A.; Uzdensky, A. B.] Southern Fed Univ, Lab Mol Neurobiol, 194-1 Stachky Ave, Rostov Na Donu 344090, Russia		Uzdensky, AB (corresponding author), Southern Fed Univ, Lab Mol Neurobiol, 194-1 Stachky Ave, Rostov Na Donu 344090, Russia.	auzd@yandex.ru		Khaitin, Andrey/0000-0003-0413-7656	Ministry of Science and Higher Education of the Russian Federation [0852-2020-0028]	The work was supported by the grand of the Ministry of Science and Higher Education of the Russian Federation #0852-2020-0028. The authors thank Dr. A.N. Ivanova (The Center for Development of Molecular and Cellular Technologies from The Saint-Petersburg State University) for the valuable help in the preparation of serial slices.	Aldskogius H, 1998, PROG NEUROBIOL, V55, P1, DOI 10.1016/S0301-0082(97)00093-2; Ashery U, 1996, NEURON, V16, P641, DOI 10.1016/S0896-6273(00)80083-5; Barres BA, 2000, CURR OPIN NEUROBIOL, V10, P642, DOI 10.1016/S0959-4388(00)00134-3; Berezhnaya EV, 2017, MOL CELL NEUROSCI, V83, P1, DOI 10.1016/j.mcn.2017.06.003; Bittner GD, 2016, NEURAL REGEN RES, V11, P1033, DOI 10.4103/1673-5374.187019; Bloom OE, 2011, MOL CELL NEUROSCI, V48, P339, DOI 10.1016/j.mcn.2011.04.003; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Burov YV, 2000, B EXP BIOL MED+, V129, P362, DOI 10.1007/BF02439271; CHONG X, 1992, BIOCHEM PHARMACOL, V44, P1401, DOI 10.1016/0006-2952(92)90542-Q; Eddleman CS, 1998, NEUROSCI LETT, V256, P123, DOI 10.1016/S0304-3940(98)00709-5; Egawa N, 2017, TRANSL STROKE RES, V8, P14, DOI 10.1007/s12975-016-0495-1; Erez H, 2007, J CELL BIOL, V176, P497, DOI 10.1083/jcb.200607098; Fedorenko GM, 2008, J NEUROSCI RES, V86, P1409, DOI 10.1002/jnr.21587; Fedorenko GM, 2009, CELL TISSUE RES, V337, P477, DOI 10.1007/s00441-009-0825-7; Fishman HM, 2003, NEWS PHYSIOL SCI, V18, P115, DOI 10.1152/nips.01429.2002; Godell CM, 1997, P NATL ACAD SCI USA, V94, P4751, DOI 10.1073/pnas.94.9.4751; GU XN, 1989, J NEUROBIOL, V20, P422, DOI 10.1002/neu.480200512; Hendricks BK, 2014, NEUROSCI BULL, V30, P627, DOI 10.1007/s12264-013-1446-4; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Horn A, 2018, CELL MOL LIFE SCI, V75, P3751, DOI 10.1007/s00018-018-2888-7; Khaitin AM, 2015, INVERTEBR NEUROSCI, V15, DOI 10.1007/s10158-014-0176-2; Khaitin A, 2018, MOL CELL NEUROSCI, V88, P7, DOI 10.1016/j.mcn.2017.12.004; Kobeissy F. H, 2015, BRAIN NEUROTRAUMA MO; Kolosov M, 2006, BRAIN RES BULL, V69, P495, DOI 10.1016/j.brainresbull.2006.02.018; Koopmans G, 2009, INT REV NEUROBIOL, V87, P363, DOI 10.1016/S0074-7742(09)87019-0; Kopp DM, 1997, J NEUROSCI, V17, P6697; Krause T, 2004, ANAESTHESIA, V59, P364, DOI 10.1111/j.1365-2044.2004.03658.x; KRAUSE TL, 1994, J NEUROSCI, V14, P6638; Largo C, 1996, NEUROL RES, V18, P445; Laskowitz D, 2016, TRANSLATIONAL RES TR, DOI [10.1201/b18959., DOI 10.1201/B18959, 10.1201/b18959]; Lichstein JW, 2000, J COMP NEUROL, V416, P143, DOI 10.1002/(SICI)1096-9861(20000110)416:2<143::AID-CNE2>3.0.CO;2-3; McGill CH, 2016, EXP NEUROL, V279, P149, DOI 10.1016/j.expneurol.2016.02.001; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; NORDLANDER RH, 1972, Z ZELLFORSCH MIK ANA, V126, P157, DOI 10.1007/BF00307214; Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609; ROUSSEAU E, 1987, AM J PHYSIOL, V253, pC364, DOI 10.1152/ajpcell.1987.253.3.C364; Rydqvist B, 2007, PHYSIOL BEHAV, V92, P21, DOI 10.1016/j.physbeh.2007.05.055; Spaeth CS, 2012, J NEUROSCI RES, V90, P945, DOI 10.1002/jnr.22823; SPIRA ME, 1993, J NEUROBIOL, V24, P300, DOI 10.1002/neu.480240304; Spira ME, 2003, J COMP NEUROL, V457, P293, DOI 10.1002/cne.10569; THEVENOD F, 1992, BIOPHYS J, V63, P162, DOI 10.1016/S0006-3495(92)81575-8; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Uzdensky AB, 1997, J PHOTOCH PHOTOBIO B, V39, P224, DOI 10.1016/S1011-1344(97)00013-4; Uzdensky A, 2015, MOL NEUROBIOL, V52, P811, DOI 10.1007/s12035-015-9237-8; Uzdensky A, 2013, J MOL NEUROSCI, V49, P480, DOI 10.1007/s12031-012-9858-6; Whiteside G, 1998, EUR J NEUROSCI, V10, P3400, DOI 10.1046/j.1460-9568.1998.00346.x; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a; Yoo S, 2003, J NEUROSCI RES, V74, P541, DOI 10.1002/jnr.10771	48	1	1	1	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	SEP	2020	107								103534	10.1016/j.mcn.2020.103534			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NP4OR	WOS:000570157600001	32717316				2022-02-06	
J	Samitinjay, A; Karri, SR; Khairkar, P; Biswas, R				Samitinjay, Aditya; Karri, Satya Revanth; Khairkar, Praveen; Biswas, Rakesh			Traumatic subdural haematoma: integrating case-based clinical judgement with guidelines	BMJ CASE REPORTS			English	Article						trauma; adult intensive care; coma and raised intracranial pressure; neurosurgery; psychiatry	DECOMPRESSIVE CRANIECTOMY; NEUROPSYCHIATRIC SEQUELAE; BRAIN-INJURY; DOUBLE-BLIND	Traumatic brain injury (TBI) is one of the leading causes of mortality and morbidity with a significant loss of functional capacity and a huge socioeconomic burden. Road traffic accidents are the most common (60%) cause followed by falls and violence in India and worldwide. This case discusses the story of a 23-year-old man with severe TBI-subdural haematoma, who presented in a comatose state. The patient was a purported candidate for emergency decompressive surgery as per Brain Trauma Foundation (BTF) guidelines but was managed conservatively. This case questions the plausibility of the BTF guidelines for severe TBI, particularly in rural hospitals in India and how such cases are often managed with clinical judgement based on the review of literature. The patient recovered well with a perfect 8/8 on Glasgow Outcome Scale Extended Score.	[Samitinjay, Aditya; Biswas, Rakesh] Kamineni Inst Med Sci, Dept Gen Med, Narketpally, Telangana, India; [Karri, Satya Revanth; Khairkar, Praveen] Kamineni Inst Med Sci, Dept Psychiat, Narketpally, Telangana, India		Biswas, R (corresponding author), Kamineni Inst Med Sci, Dept Gen Med, Narketpally, Telangana, India.	rakesh7biswas@gmail.com		Khairkar, Praveen/0000-0003-3166-3547; Karri, Satya Revanth/0000-0003-3715-6976			Agrawal Amit, 2016, Int J Crit Illn Inj Sci, V6, P65, DOI 10.4103/2229-5151.183025; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chaudhury S, 2005, INDIAN J NEUROTRAUM, V2, P13, DOI 10.1016/S0973-0508(05)80005-X; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fatima Nida, 2019, Asian J Neurosurg, V14, P371, DOI 10.4103/ajns.AJNS_289_18; Ganapathy K, 2013, WORLD NEUROSURG, V79, P621, DOI 10.1016/j.wneu.2013.02.071; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Nicholl J, 2009, SEMIN NEUROL, V29, P247, DOI 10.1055/s-0029-1223878; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Shekhar Chandra, 2015, J Emerg Trauma Shock, V8, P131, DOI 10.4103/0974-2700.160700; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Wilcock G, 2002, INT CLIN PSYCHOPHARM, V17, P297, DOI 10.1097/00004850-200211000-00005; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson MH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-24	18	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		1757-790X		BMJ CASE REP	BMJ Case Rep.	SEP	2020	13	9							e233197	10.1136/bcr-2019-233197			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	SS1ZA	WOS:000661540300016	32895250	Bronze			2022-02-06	
J	Schindler, CR; Woschek, M; Verboket, RD; Sturm, R; Sohling, N; Marzi, I; Stormann, P				Schindler, Cora Rebecca; Woschek, Mathias; Verboket, Rene Danilo; Sturm, Ramona; Soehling, Nicolas; Marzi, Ingo; Stoermann, Philipp			Registry-Based Mortality Analysis Reveals a High Proportion of Patient Decrees and Presumed Limitation of Therapy in Severe Geriatric Trauma	JOURNAL OF CLINICAL MEDICINE			English	Article						polytrauma; trauma registry; geriatric patients; quality of life; severely injured; patient's decree; mortality analysis	INJURY	Background: The treatment of severely injured patients, especially in older age, is complex, and based on strict guidelines. Methods: We conducted a retrospective study by analyzing our internal registry for mortality risk factors in deceased trauma patients. All patients that were admitted to the trauma bay of our level-1-trauma center from 2014 to 2018, and that died during the in-hospital treatment, were included. The aim of this study was to carry out a quality assurance concerning the initial care of severely injured patients. Results: In the 5-year period, 135 trauma patients died. The median (IQR) age was 69 (38-83) years, 71% were male, and the median (IQR) Injury Severity Score (ISS) was 25 (17-34) points. Overall, 41% of the patients suffered from severe traumatic brain injuries (TBI) (AIS(head)>= 4 points). For 12.7%, therapy was finally limited owing to an existing patient's decree; in 64.9% with an uncertain prognosis, a 'therapia minima' was established in consensus with the relatives. Conclusion: Although the mortality rate was primarily related to the severity of the injury, a significant number of deaths were not exclusively due to medical reasons, but also to a self-determined limitation of therapy for severely injured geriatric patients. The conscientious documentation concerning the will of the patient is increasingly important in supporting medical decisions.	[Schindler, Cora Rebecca; Woschek, Mathias; Verboket, Rene Danilo; Sturm, Ramona; Soehling, Nicolas; Marzi, Ingo; Stoermann, Philipp] Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, D-60590 Frankfurt, Germany		Schindler, CR (corresponding author), Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, D-60590 Frankfurt, Germany.	cora.schindler@kgu.de; mathias.woschek@kgu.de; rene.verboket@kgu.de; ramona.sturm@kgu.de; nicolas.soehling@kgu.de; marzi@trauma.uni-frankfurt.de; philipp.stoermann@kgu.de	Verboket, Rene Danilo/ABA-3870-2020	Verboket, Rene Danilo/0000-0003-1086-4016; Stormann, Philipp/0000-0003-3584-2518			Backstrom D, 2018, EUR J TRAUMA EMERG S, V44, P589, DOI 10.1007/s00068-017-0827-1; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Benchimol EI, 2016, Z EVIDENZ FORTBILD Q, V115, P33, DOI [10.1016/j.zefq.2016.07.010, 10.1371/journal.pmed.1001885]; Bouillon B, 2004, UNFALLCHIRURG, V107, P844, DOI 10.1007/s00113-004-0847-2; DAVIS RA, 1984, SURG GYNECOL OBSTET, V159, P597; Faid M., 2010, WHO EUR, V80, P1; Haasper C, 2010, UNFALLCHIRURG, V113, P366, DOI 10.1007/s00113-010-1778-8; Hack J, 2016, Z GERONTOL GERIATR, V49, P721, DOI 10.1007/s00391-015-0981-1; Klauber J., 2014, KRANKENHAUS REPORT S; Konesky KL, 2018, EUR J TRAUMA EMERG S, V44, P903, DOI 10.1007/s00068-017-0875-6; Kuhn-Regnier S, 2019, EUR J TRAUMA EMERG S, V45, P309, DOI 10.1007/s00068-017-0894-3; Lansink KWW, 2013, EUR J TRAUMA EMERG S, V39, P375, DOI 10.1007/s00068-013-0278-2; Lefering R., 2003, ZURUCK ZUK, V2003, P256, DOI [10.1007/978-3-642-55611-1_71, DOI 10.1007/978-3-642-55611-1_71]; Lefering R., 2019, AUC AKAD UNFALLCHIRU, V2, P1; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Malkomes P, 2019, EUR J TRAUMA EMERG S, V45, P315, DOI 10.1007/s00068-018-0911-1; Malone DL, 2003, J TRAUMA, V54, P898, DOI 10.1097/01.TA.0000060261.10597.5C; Marzi I.R.S., 2012, PRAXISBUCH POLYTRAUM; Marzi I, 2013, EUR J TRAUMA EMERG S, V39, P1, DOI 10.1007/s00068-013-0252-z; Nast-Kolb D, 1999, UNFALLCHIRURG, V102, P337, DOI 10.1007/s001130050414; Nolan J.P., 1997, RESUSCITATION, V33, P283, DOI [10.1016/S0300-9572(96)01049-0, DOI 10.1016/S0300-9572(96)01049-0]; Oder W., 2013, J NEUROL NEUROCHIR P, V14, P55; Ohrn A., 2012, MEASURES PATIENT SAF; Oyeniyi BT, 2017, INJURY, V48, P5, DOI 10.1016/j.injury.2016.10.037; Pape H.C., 2018, MANAGEMENT SCHWERVER; Schmidt BR, 2019, EUR J TRAUMA EMERG S, V45, P191, DOI 10.1007/s00068-018-1029-1; Stormann P, 2020, EUR J TRAUMA EMERG S, V46, P31, DOI 10.1007/s00068-019-01098-1; Tosic B., 2018, P 3 INT C QUAL LIF K, P1; von Elm E, 2008, INTERNIST, V49, P688, DOI 10.1007/s00108-008-2138-4; Wegscheider K, 2004, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V47, P416, DOI 10.1007/s00103-004-0828-1; Workman TA, 2013, ENGAGING PATIENTS IN; World Health Organization, 2010, TECHNICAL REPORT, V53, P1689, DOI [DOI 10.1017/CBO9781107415324.004, 10.1017/CBO9781107415324.004]; Yogi RR, 2018, EUR J TRAUMA EMERG S, V44, P567, DOI 10.1007/s00068-017-0818-2; Yoong S, 2019, EUR J TRAUMA EMERG S, V45, P489, DOI 10.1007/s00068-018-0926-7; Zwingmann J, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1463-6	35	1	1	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	SEP	2020	9	9							2686	10.3390/jcm9092686			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OE0YI	WOS:000580266800001	32825084	Green Published, gold			2022-02-06	
J	Schroeppel, TJ; Sharpe, JP; Melendez, CI; Jepson, B; Dunn, R; Clement, LP; Khan, AD; Croce, MA; Fabian, TC				Schroeppel, Thomas J.; Sharpe, John P.; Melendez, Claudia I.; Jepson, Brian; Dunn, Rebekah; Paige Clement, L.; Khan, Abid D.; Croce, Martin A.; Fabian, Timothy C.			Long-Term Analysis of Functional Outcomes in Traumatic Brain Injury Patients	AMERICAN SURGEON			English	Article; Proceedings Paper	Annual Scientific Meeting of the Southeastern-Surgical-Congress (SESC)	FEB 07-11, 2020	New Orleans, LA	SE Surg Congress		traumatic brain injury; beta-blockade; outcomes		Introduction Traumatic brain injury (TBI) remains a significant cause of morbidity and mortality. The purpose of this study is to examine outcomes after discharge and identify factors from the index admission that may contribute to long-term mortality. Methods The study population is composed of patients who survived to discharge from a previously published study examining TBI. Demographics, injury severity, and length of stay were abstracted from the index study. Phone surveys of surviving patients were performed to evaluate each patient's Glasgow Outcome Scale-Extended (GOSE). Patients who were deceased at the time of the survey were compared with those who were alive. Results 1615 patients were alive at the end of the first study period and 211 (13%) comprised the study population. Overall, the median age was 54 years, and the majority were male (74%). The median time to follow-up was 80 months. The population was severely injured, with a median injury severity score (ISS) of 25 and a median head abbreviated injury score (AIS) of 4. Overall mortality was 57%. The group that survived at the time of the survey was younger, more injured, less likely to have received beta-blockers (BB) during the index admission, and had a longer time to follow-up. After adjusting for ISS, age, base deficit, and BB, age was the only variable predictive of mortality (HR 1.03; HL 1.02-1.04). Conclusion Despite being more severely injured, younger patients were more likely to survive to follow-up. Further investigation is needed to determine if aggressive care in older TBI patients in the acute phase leads to good long-term outcomes.	[Schroeppel, Thomas J.; Melendez, Claudia I.; Jepson, Brian; Dunn, Rebekah; Khan, Abid D.] Univ Colorado, Hlth Mem Hosp, Dept Surg, 1400 E Boulder St, Colorado Springs, CO 80909 USA; [Sharpe, John P.] Covenant Healthcare, Dept Surg, Saginaw, MI USA; [Paige Clement, L.] Univ Colorado, Hlth Mem Hosp, Dept Pharm, Colorado Springs, CO USA; [Croce, Martin A.; Fabian, Timothy C.] Univ Tennessee, Hlth Sci Ctr, Dept Surg, Memphis, TN USA		Schroeppel, TJ (corresponding author), Univ Colorado, Hlth Mem Hosp, Dept Surg, 1400 E Boulder St, Colorado Springs, CO 80909 USA.	thomas.schroeppel@uchealth.org		Schroeppel, Thomas/0000-0001-9164-5004			Alali AS, 2017, ANN SURG, V266, P952, DOI 10.1097/SLA.0000000000002286; Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; Beck B, 2018, J NEUROTRAUM, V35, P1021, DOI 10.1089/neu.2017.5287; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Dunn MS, 2019, INJURY, V50, P1534, DOI 10.1016/j.injury.2019.06.012; Gross T, 2018, ARCH ORTHOP TRAUM SU, V138, P1375, DOI 10.1007/s00402-018-2974-1; JENNETT B, 1975, LANCET, V1, P480; Kelly ML, 2015, J TRAUMA ACUTE CARE, V79, P372, DOI 10.1097/TA.0000000000000762; Ley EJ, 2018, J TRAUMA ACUTE CARE, V84, P234, DOI 10.1097/TA.0000000000001747; Lu J, 2018, J NEUROTRAUM, V35, P1596, DOI 10.1089/neu.2017.5299; Maiden MJ, 2020, AM J RESP CRIT CARE, V201, P167, DOI 10.1164/rccm.201903-0673OC; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Ruet A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00120; Schroeppel TJ, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2019-000307; Schroeppel TJ, 2014, J TRAUMA ACUTE CARE, V76, P504, DOI 10.1097/TA.0000000000000104; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Wabl R, 2019, J NEUROSURG, V131, P114, DOI 10.3171/2018.2.JNS173247; Wilkins TE, 2019, J NEUROTRAUM, V36, P3158, DOI 10.1089/neu.2018.6153	20	1	1	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	SEP	2020	86	9					1124	1128		10.1177/0003134820943648			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	QA9XR	WOS:000613798300015	32841047				2022-02-06	
J	Seeger, TA; Tabor, J; Sick, S; Schneider, KJ; Jenne, C; La, P; Talai, AS; Rajashekar, D; Mouches, P; Forkert, ND; Emery, C; Debert, CT				Seeger, Trevor A.; Tabor, Jason; Sick, Stacy; Schneider, Kathryn J.; Jenne, Craig; La, Parker; Talai, Aron Sahand; Rajashekar, Deepthi; Mouches, Pauline; Forkert, Nils D.; Emery, Carolyn; Debert, Chantel T.			The Association of Saliva Cytokines and Pediatric Sports-Related Concussion Outcomes	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adolescents; concussion; cytokines; inflammation; sports-related concussion	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; NEURONAL DEATH; CELL; NEUROINFLAMMATION; MICROGLIA; SERUM; PERSPECTIVES; INFLAMMATION; MODEL	Objectives: This study aimed to explore cytokine alterations following pediatric sports-related concussion (SRC) and whether a specific cytokine profile could predict symptom burden and time to return to sports (RTS). Setting: Sports Medicine Clinic. Participants: Youth ice hockey participants (aged 12-17 years) were recruited prior to the 2013-2016 hockey season. Design: Prospective exploratory cohort study. Main Measure: Following SRC, saliva samples were collected and a Sport Concussion Assessment Tool version 3 (SCAT3) was administered within 72 hours of injury and analyzed for cytokines. Additive regression of decision stumps was used to model symptom burden and length to RTS based on cytokine and clinical features. RRelieFF feature selection was used to determine the predictive value of each cytokine and clinical feature, as well as to identify the optimal cytokine profile for the symptom burden and RTS. Results: Thirty-six participants provided samples post-SRC (81% male; age 14.4 +/- 1.3 years). Of these, 10 features, sex, number of previous concussions, and 8 cytokines, were identified to lead to the best prediction of symptom severity (r= 0.505,P= .002), while 12 cytokines, age, and history of previous concussions predicted the number of symptoms best (r= 0.637,P< .001). The prediction of RTS led to the worst results, requiring 21 cytokines, age, sex, and number of previous concussions as features (r= -0.320,P= .076). Conclusions: In pediatric ice hockey participants following SRC, there is evidence of saliva cytokine profiles that are associated with increased symptom burden. However, further studies are needed.	[Seeger, Trevor A.; Tabor, Jason; La, Parker; Forkert, Nils D.; Debert, Chantel T.] Univ Calgary, Dept Clin Neurosci, Div Phys Med & Rehabil, Calgary, AB, Canada; [Seeger, Trevor A.; Tabor, Jason; Schneider, Kathryn J.; Talai, Aron Sahand; Rajashekar, Deepthi; Mouches, Pauline; Forkert, Nils D.; Debert, Chantel T.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Tabor, Jason; Sick, Stacy; Schneider, Kathryn J.; Emery, Carolyn; Debert, Chantel T.] Univ Calgary, Dept Kinesiol, Calgary, AB, Canada; [Jenne, Craig] Univ Calgary, Dept Microbiol Immunol & Infect Dis MIID, Calgary, AB, Canada; [Jenne, Craig] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Talai, Aron Sahand; Rajashekar, Deepthi; Mouches, Pauline; Forkert, Nils D.] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Schneider, Kathryn J.; Forkert, Nils D.; Emery, Carolyn; Debert, Chantel T.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada		Debert, CT (corresponding author), Foothills Med Ctr, Special Serv Bldg,Main Floor Room AC144, Calgary, AB T2N 2T9, Canada.	chantel.debert@ahs.ca		Debert, Chantel/0000-0002-2704-0438	Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR); Alberta Innovates Health Solutions; Hotchkiss Brain Institute, University of Calgary	This study was funded by the Canadian Institute of Health Research, Alberta Innovates Health Solutions, and Hotchkiss Brain Institute, University of Calgary. The authors thank all the students and research assistants who have worked extremely hard on the Safe to Play study. The authors also thank Hockey Canada, parents, players, and coaches for their support in this study, as this research would not have happened without them. The Sport Injury Prevention Research Centre is one of 11 International Olympic Committee Centers focused on injury prevention and protection of athlete health. The authors give special thanks to Matthew Machan for his hard work and help in editing the manuscript.	Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bertani I, 2017, J NEUROSCI, V37, P10278, DOI 10.1523/JNEUROSCI.1301-17.2017; Bjartmar C, 2001, NEUROLOGY, V57, P1248, DOI 10.1212/WNL.57.7.1248; Blank T, 2013, GLIA, V61, P62, DOI 10.1002/glia.22372; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cruikshank WW, 2000, J LEUKOCYTE BIOL, V67, P757, DOI 10.1002/jlb.67.6.757; Daley M, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1131-5; Di Battista AP, 2020, BMC IMMUNOL, V21, DOI 10.1186/s12865-020-0339-3; Di Battista AP, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1402-y; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Friedman J, 1999, STOCHASTIC GRADIENT; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Lai AY, 2006, J NEUROIMMUNOL, V175, P97, DOI 10.1016/j.jneuroim.2006.03.001; Liu XL, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/564750; Mandolesi G, 2013, J NEUROSCI, V33, P12105, DOI 10.1523/JNEUROSCI.5369-12.2013; McCrea M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19771; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Miura Y, 2003, P NATL ACAD SCI USA, V100, P2777, DOI 10.1073/pnas.2628048100; Morales J, 1999, P NATL ACAD SCI USA, V96, P14470, DOI 10.1073/pnas.96.25.14470; Mori M, 2015, INT J MOL SCI, V16, P18018, DOI 10.3390/ijms160818018; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Neidecker JM, 2017, J AM OSTEOPATH ASSOC, V117, P635, DOI 10.7556/jaoa.2017.120; Nishanian P, 1998, CLIN DIAGN LAB IMMUN, V5, P507, DOI 10.1128/CDLI.5.4.507-512.1998; Nitta ME, 2019, NEUROLOGY, V93, pE497, DOI 10.1212/WNL.0000000000007864; Niven Daniel J, 2012, BMC Res Notes, V5, P147, DOI 10.1186/1756-0500-5-147; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; Riis JL, 2014, DEV PSYCHOBIOL, V56, P797, DOI 10.1002/dev.21149; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Sukowati CHC, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6435482; Sun YX, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01120; Szalay G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11499; Tisato V, 2016, CELL MOL LIFE SCI, V73, P2017, DOI 10.1007/s00018-016-2164-7; Ueki R, 2016, ANGEW CHEM INT EDIT, V55, P579, DOI 10.1002/anie.201508572; Viviani B, 2003, J NEUROSCI, V23, P8692; Viviani B, 2014, NEUROTOXICOLOGY, V43, P10, DOI 10.1016/j.neuro.2014.03.004; Wen TC, 1998, J EXP MED, V188, P635, DOI 10.1084/jem.188.4.635; Williamson S, 2012, NURS RES PRACT, V2012, DOI 10.1155/2012/246178; Wohleb ES, 2014, J NEUROSCI, V34, P2583, DOI 10.1523/JNEUROSCI.3723-13.2014; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Yirmiya R, 2015, TRENDS NEUROSCI, V38, P637, DOI 10.1016/j.tins.2015.08.001; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641	50	1	1	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2020	35	5			SI		354	362		10.1097/HTR.0000000000000605			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NP5SO	WOS:000570236100008	32881769				2022-02-06	
J	Seifert, KD; Wu, X; Malhotra, A				Seifert, Kimberly D.; Wu, Xiao; Malhotra, Ajay			Utility of routine follow-up imaging in patients with small paraflacine and/ or paratentorial hemorrhages	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Subdural; Parafalcine; Paratentorial; Trauma	TRAUMATIC BRAIN-INJURY; SUBDURAL HEMATOMAS; INTRACRANIAL HEMORRHAGE; HEAD CT; TENTORIAL; MANAGEMENT; FALCINE; ADULTS	Objective: Imaging follow-up for acute intracranial hemorrhage has followed the same protocols despite differences in clinical progression and outcome associated with bleed in different compartments. We evaluated isolated, small parafalcine and paratentorial subdural hemorrhages to determine the necessity of routine imaging follow up. Methods: We conducted a retrospective review of all patients presenting to the Emergency Department who were found to have an isolated parafalcine and/or paratentorial subdural hemorrhage, and obtained follow up imaging over the course of 3 years. Subsequent imaging was reviewed to assess for changes in hemorrhage size and the average number of studies performed; clinical data was reviewed for changes in patient status and any intervention if performed. Results: 95 patients were identified with isolated parafalcine and/or paratentorial hemorrhage that were evaluated with multiple follow-up imaging studies. The average initial subdural hemorrhage thickness was 3.5 mm, with all smaller than 1 cm. The average number of subsequent imaging studies performed was 2.7. All patients received follow up imaging despite remaining neurologically stable. 96 % of the patients had stable to decreased size off hemorrhage on follow up exams. The remaining 4% had a slight increase on the second imaging study but, stabilized without any intervention. Anticoagulation use had no correlation with increase on subsequent imaging. Conclusion: Small isolated parafalcine and/or paratentorial hemorrhage in a neurologically stable patient and absence of anticoagulation does not require scheduled routine follow-up imaging.	[Seifert, Kimberly D.; Wu, Xiao; Malhotra, Ajay] Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06510 USA		Malhotra, A (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06510 USA.	Kimberly.seifert@yale.edu; xiao.wu@yale.edu; ajay.malhotra@yale.edu	wu, xiao/L-1421-2019; Malhotra, Ajay/ABC-2951-2020	Malhotra, Ajay/0000-0001-9223-6640			AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Bajsarowicz P, 2015, J NEUROSURG, V123, P1176, DOI 10.3171/2014.10.JNS141728; BARTELS RHMA, 1995, NEUROSURGERY, V36, P1210, DOI 10.1227/00006123-199506000-00026; Devulapalli KK, 2018, AM J NEURORADIOL, V39, P654, DOI 10.3174/ajnr.A5557; Howard BM, 2017, J NEUROTRAUM, V34, P128, DOI 10.1089/neu.2015.4270; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Kreitzer N, 2014, ACAD EMERG MED, V21, P1084, DOI 10.1111/acem.12479; Orlando A, 2019, J NEUROSURG, V130, P1626, DOI 10.3171/2018.1.JNS171906; Pruitt P, 2017, AM J EMERG MED, V35, P255, DOI 10.1016/j.ajem.2016.10.064; Rosen Claire B, 2018, Trauma Surg Acute Care Open, V3, pe000129, DOI 10.1136/tsaco-2017-000129; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Sweis RT, 2015, J EMERG MED, V49, P679, DOI 10.1016/j.jemermed.2015.06.055	13	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	SEP	2020	196								105956	10.1016/j.clineuro.2020.105956			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NR3RZ	WOS:000571482200033	32526488				2022-02-06	
J	Shigemura, T; Miura, M; Murata, Y; Yamamoto, Y; Maruyama, J; Wada, Y				Shigemura, Tomonori; Miura, Masataka; Murata, Yasuaki; Yamamoto, Yohei; Maruyama, Juntaro; Wada, Yuichi			A new closed reduction technique using a traction table to treat a traumatic posterior dislocation of the hip joint	ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH			English	Article						Trauma; Posterior; Dislocation; Hip; Closed reduction	FRACTURE-DISLOCATION; FEMORAL-HEAD	Traumatic hip dislocations should be reduced gently and promptly to prevent complications such as osteonecrosis of the femoral head, heterotopic ossification, incomplete recovery of sciatic nerve injury, and fractures of the femoral neck. Many closed reduction manoeuvres have been reported; however, these manoeuvres require forceful and sustained traction, which places an enormous physical burden on surgeons. The aim of the present technical note is to describe a new reduction manoeuvre that uses a traction table to decrease the physical burden experienced by surgeons. (C) 2020 Elsevier Masson SAS. All rights reserved.	[Shigemura, Tomonori; Miura, Masataka; Murata, Yasuaki; Yamamoto, Yohei; Maruyama, Juntaro; Wada, Yuichi] Teikyo Univ, Dept Orthopaed Surg, Chiba Med Ctr, 3426-3 Anesaki, Ichihara, Chiba 2990111, Japan		Shigemura, T (corresponding author), Teikyo Univ, Dept Orthopaed Surg, Chiba Med Ctr, 3426-3 Anesaki, Ichihara, Chiba 2990111, Japan.	tshigepon@yahoo.co.jp					Dwyer AJ, 2006, INT ORTHOP, V30, P224, DOI 10.1007/s00264-005-0056-9; Gedouin JE, 2010, ORTHOP TRAUMATOL-SUR, V96, pS59, DOI 10.1016/j.otsr.2010.08.002; HOUGAARD K, 1988, J BONE JOINT SURG AM, V70A, P233, DOI 10.2106/00004623-198870020-00011; Nordt WE, 1999, CLIN ORTHOP RELAT R, P260; Park KH, 2016, ARCH ORTHOP TRAUM SU, V136, P1107, DOI 10.1007/s00402-016-2481-1; PIETRAFESA CA, 1983, JAMA-J AM MED ASSOC, V249, P3342; Sahin V, 2003, J TRAUMA, V54, P520, DOI 10.1097/01.TA.0000020394.32496.52; THOMPSON VP, 1951, J BONE JOINT SURG AM, V33-A, P746, DOI 10.2106/00004623-195133030-00023; YANG RS, 1991, CLIN ORTHOP RELAT R, P218	9	1	1	0	2	ELSEVIER MASSON, CORP OFF	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	1877-0568			ORTHOP TRAUMATOL-SUR	Orthop. Traumatol.-Surg. Res.	SEP	2020	106	5					881	884		10.1016/j.otsr.2020.03.015			4	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	ND8OE	WOS:000562161300016	32386842	Bronze			2022-02-06	
J	Smigielski, W; Gajda, R; Malek, L; Drygas, W				Smigielski, Witold; Gajda, Robert; Malek, Lukasz; Drygas, Wojciech			Goalkeepers Live Longer than Field Players: A Retrospective Cohort Analysis Based on World-Class Football Players	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						football goalkeepers; football field players; football; life expectancy; longevity; playing position	PHYSICAL-ACTIVITY; SOCCER PLAYERS; TERM MORTALITY; ALL-CAUSE; POLYMORPHISM; PERFORMANCE; CONCUSSIONS; ACCOUNT; FITNESS	The purpose of this article is to study whether the position occupied by footballers on the pitch influences their life duration. It is known that various types of sporting activity (endurance, resistance, or mixed) may influence lifespan in different ways. However, there is a paucity of data regarding the role of different positions played in team sports such as football. Our research was based on elite international football players born before 1923 who took part in the first three football World Cups (n= 443) or played in the 1946/1947 season in the leading clubs of the main European leagues (n= 280). Goalkeepers were characterized by a 5-8-year longer life duration compared to their colleagues playing in other positions (World Cup: 82.0 +/- 7.0 vs. 74.0 +/- 8.0, p= 0.0047; European leagues: 83.0 +/- 7.5 vs. 78.0 +/- 8.0,p= 0.0023), with an absence of differences between defenders, midfielders, and forwards. Moreover, in both of the analyzed subgroups, the rate of survival until the 85th birthday was significantly higher among goalkeepers than among field players (p= 0.0102 and p= 0.0048, for both studied groups, respectively).	[Smigielski, Witold] Univ Lodz, Dept Demog, PL-90131 Lodz, Poland; [Gajda, Robert] Gajda Med Med Ctr Pultusk, Ctr Sports Cardiol, PL-06100 Pultusk, Poland; [Malek, Lukasz; Drygas, Wojciech] Cardinal Stefan Wyszynski Natl Inst Cardiol, Dept Epidemiol Cardiovasc Dis Prevent & Hlth Prom, PL-04628 Warsaw, Poland; [Drygas, Wojciech] Med Univ Lodz, Dept Prevent & Social Med, PL-90131 Lodz, Poland		Smigielski, W (corresponding author), Univ Lodz, Dept Demog, PL-90131 Lodz, Poland.	witold.smigielski@uni.lodz.pl; gajda@gajdamed.pl; lmalek@ikard.pl; wdrygas@ikard.pl	Gajda, Robert/AAL-3361-2020	Gajda, Robert/0000-0002-8305-8130; Malek, Lukasz/0000-0002-9586-0163; Smigielski, Witold/0000-0002-5239-2988; Drygas, Wojciech/0000-0002-4351-6459			[Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; Aoki H, 2012, AM J SPORT MED, V40, P1006, DOI 10.1177/0363546512438695; Bauman A E, 2004, J Sci Med Sport, V7, P6, DOI 10.1016/S1440-2440(04)80273-1; Bujnovky D, 2019, SPORTS, V7, DOI 10.3390/sports7020046; Caley M., WANT HAVE LONG CAREE; Chandra N, 2013, J AM COLL CARDIOL, V61, P1027, DOI 10.1016/j.jacc.2012.08.1032; Coakley JJ, 1983, QUEST, V35, P1, DOI DOI 10.1080/00336297.1983.10483777; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Della Villa Francesco, 2018, Am J Orthop (Belle Mead NJ), V47, DOI 10.12788/ajo.2018.0092; Egorova ES, 2014, J SPORT SCI, V32, P1286, DOI 10.1080/02640414.2014.898853; Evequoz D, 1996, Praxis (Bern 1994), V85, P188; Fortunato V, 1999, J PERS INTERPERS LOS, V4, P269, DOI 10.1080/10811449908409735; Gajda A, 2018, KARDIOL POL, V76, P1705, DOI 10.5603/KP.a2018.0173; Harmon KG, 2011, CIRCULATION, V123, P1594, DOI 10.1161/CIRCULATIONAHA.110.004622; Higgins John P, 2013, J Sports Med (Hindawi Publ Corp), V2013, P967183, DOI 10.1155/2013/967183; Jae SY, 2019, MAYO CLIN PROC, V94, P545, DOI 10.1016/j.mayocp.2018.11.023; Jones A, 2002, EXERC SPORT SCI REV, V30, P184, DOI 10.1097/00003677-200210000-00008; Koning RH, 2012, ECON LABOUR RELAT RE, V23, P55, DOI 10.1177/103530461202300205; Kujala UM, 1998, JAMA-J AM MED ASSOC, V279, P440, DOI 10.1001/jama.279.6.440; Kuss O, 2011, SCAND J MED SCI SPOR, V21, pE260, DOI 10.1111/j.1600-0838.2010.01269.x; Lee DC, 2014, J AM COLL CARDIOL, V64, P472, DOI 10.1016/j.jacc.2014.04.058; Lee IM, 1997, AGING CLIN EXP RES, V9, P2, DOI 10.1007/BF03340123; Lemez S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185617; Lemez S, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0024-x; Lewis SF, 2016, AM J MED, V129, P137, DOI 10.1016/j.amjmed.2015.07.016; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Lollgen H, 2009, INT J SPORTS MED, V30, P213, DOI 10.1055/s-0028-1128150; Mandsager K, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.3605; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Merghani A, 2016, TRENDS CARDIOVAS MED, V26, P232, DOI 10.1016/j.tcm.2015.06.005; Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335; Moreno-Perez V, 2020, INT J PERF ANAL SPOR, V20, P19, DOI 10.1080/24748668.2019.1699386; Nirengi S, 2016, ENDOCR PRACT, V22, P786, DOI 10.4158/EP15963.OR; Nitrini Ricardo, 2017, Dement. neuropsychol., V11, P218, DOI 10.1590/1980-57642016dn11-030002; Petranovic MZ, 2012, AGE, V34, P583, DOI 10.1007/s11357-011-9270-0; Pickering C, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00015; Riedl I, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12314; Sayed-Tabatabaei FA, 2005, J MED GENET, V42, P26, DOI 10.1136/jmg.2004.022756; Schnohr P, 2015, J AM COLL CARDIOL, V65, P411, DOI 10.1016/j.jacc.2014.11.023; Slimani M, 2019, J HUM KINET, V66, P233, DOI 10.2478/hukin-2018-0060; Slimani M, 2019, J SPORT MED PHYS FIT, V59, P141, DOI 10.23736/S0022-4707.17.07950-6; Smigielski W., FOOTBALL PLAYERS DIE; Smigielski W., 2019, P INT CARD RES M ICV; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Stolen T, 2005, SPORTS MED, V35, P501; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Taioli E, 2007, EUR J PUBLIC HEALTH, V17, P600, DOI 10.1093/eurpub/ckm035; White A, 2018, SPORTS MED, V48, P2497, DOI 10.1007/s40279-018-0977-2; Wik EH, 2019, SPORTS, V7, DOI 10.3390/sports7010009; Ziv G, 2011, INT J SPORT PHYSIOL, V6, P509, DOI 10.1123/ijspp.6.4.509	51	1	1	0	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	SEP	2020	17	17							6297	10.3390/ijerph17176297			10	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	NO6LS	WOS:000569601600001	32872456	gold, Green Published			2022-02-06	
J	Song, K; Wang, CP; McGeary, DD; Jaramillo, CA; Eapen, BC; Amuan, M; McGeary, CA; Potter, JS; Pugh, MJ				Song, Kangwon; Wang, Chen-Pin; McGeary, Donald D.; Jaramillo, Carlos A.; Eapen, Blessen C.; Amuan, Megan; McGeary, Cindy A.; Potter, Jennifer S.; Pugh, Mary Jo			Five-year Pain Intensity and Treatment Trajectories of Post-9/11 Veterans With Mild Traumatic Brain Injury	JOURNAL OF PAIN			English	Article						TBI (traumatic brain injury); chronic pain/therapy; pain measurement; veterans; longitudinal study	LOW-BACK-PAIN; OEF/OIF VETERANS; ASSOCIATION; COMORBIDITY; PHYSICIANS; MODERATE; COLLEGE; RATINGS; IMPACT; RISK	Pain is a pervasive problem that affects nearly half of the U.S. Veterans deployed in sup-port of the Global War on Terror (Post-9/11 Veterans) and over half of the Post-9/11 Veterans with diagnosed traumatic brain injury (TBI). The goal of the current study was to identify pain phenotypes based on distinct longitudinal patterns of pain scores in light of pain treatment among Post-9/11 Veterans over 5 years of care using latent growth mixture analysis stratified by TBI status. Five pain phenotypes emerged: 1) simple low impact stable pain, 2) complex low impact stable pain, 3) complex low impact worsening pain, 4) complex moderate impact worsening pain, and 5) complex high impact stable pain. Baseline pain scores and slopes were significantly higher in Veterans with mild TBI for some phenotypes. The mild TBI cohort was younger, had more men, more whites, less blacks, less education, more unmarried, more Marines and Army, more active duty in comparison to the no TBI cohort. Distinct trajectories in pain treatment were apparent among the pain intensity subgroups. Perspective: The complexity of pain in patients with mTBI is categorically different than those with no TBI. Pain in patients with mTBI is heterogeneous with distinct phenotypes which may explain poor outcomes in this group. Identification of the individual differences may have a significant impact on the success of interventions. (c) Published by Elsevier Inc. on behalf of United States Association for the Study of Pain, Inc.	[Song, Kangwon; Wang, Chen-Pin; Jaramillo, Carlos A.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Wang, Chen-Pin; McGeary, Donald D.; Jaramillo, Carlos A.; McGeary, Cindy A.; Potter, Jennifer S.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Eapen, Blessen C.; Amuan, Megan] VA Greater Los Angeles Hlth Care Syst, Los Angeles, CA USA; [Eapen, Blessen C.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Pugh, Mary Jo] VA Salt Lake City Hlth Care Syst, 500 Foothill Dr, Salt Lake City, UT 84148 USA; [Pugh, Mary Jo] Univ Utah, Sch Med, Salt Lake City, UT USA		Pugh, MJ (corresponding author), VA Salt Lake City Hlth Care Syst, 500 Foothill Dr, Salt Lake City, UT 84148 USA.	Maryjo.pugh2@va.gov			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21HD089098-01]	This work was supported by the National Institutes of Health [1R21HD089098-01].	Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; [Anonymous], DEF MED SURV SYST SU; Bandeen-Roche K, 1997, J AM STAT ASSOC, V92, P1375, DOI 10.2307/2965407; Bennett AS, 2013, SUBST USE MISUSE, V48, P894, DOI 10.3109/10826084.2013.796991; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Byrne BM, 2008, J PERS ASSESS, V90, P536, DOI 10.1080/00223890802388350; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cook AJ, 2015, BEHAV RES THER, V73, P25, DOI 10.1016/j.brat.2015.07.003; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Farmer CM, 2017, RAND HLTH Q, V6; Food and Drug Administration, DRUG SAF AV FDA DRUG; Goulet JL, 2013, MED CARE, V51, P245, DOI 10.1097/MLR.0b013e318277f1ad; Heapy A, 2014, J PAIN, V15, P1360, DOI 10.1016/j.jpain.2014.09.012; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Jensen MP, 2017, CLIN J PAIN, V33, P414, DOI 10.1097/AJP.0000000000000429; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McGeary DD, 2006, J BONE JOINT SURG AM, V88A, P317, DOI 10.2106/JBJS.D.02968; Morone NE, 2013, CLIN THER, V35, P1728, DOI 10.1016/j.clinthera.2013.10.001; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Office of Inspector General, 2014, 1400895163 DEP VET A; Preacher K.J., 2008, LATENT GROWTH CURVE; Pugh MJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222674; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Ram N, 2009, INT J BEHAV DEV, V33, P565, DOI 10.1177/0165025409343765; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; SERLIN RC, 1995, PAIN, V61, P277, DOI 10.1016/0304-3959(94)00178-H; The Diagnosis and Treatment of Low Back Pain Work Group, 2017, DIAGN TREATM LOW BAC; The Opioid Therapy for Chronic Pain Work Group: Management of Opioid Therapy (OT) for Chronic Pain, 2017, MAN OP THER CHRON PA; Von Korff M, 2016, J PAIN, V17, P1068, DOI 10.1016/j.jpain.2016.06.009; Wang CP, 2005, J AM STAT ASSOC, V100, P1054, DOI 10.1198/016214505000000501	34	1	1	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1526-5900	1528-8447		J PAIN	J. Pain	SEP-OCT	2020	21	9-10					1005	1017		10.1016/j.jpain.2019.12.009			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OT2HA	WOS:000590671800007	31981717	Green Accepted			2022-02-06	
J	Stranjalis, G; Komaitis, S; Kalyvas, AV; Drosos, E; Stavrinou, LC; Koutsarnakis, C; Kalamatianos, T				Stranjalis, George; Komaitis, Spyridon; Kalyvas, Aristotelis V.; Drosos, Evangelos; Stavrinou, Lampis C.; Koutsarnakis, Christos; Kalamatianos, Theodosis			Recent trends (2010-2018) in traumatic brain injury in Greece: Results on 2042 patients	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Greece; Epidemiology; Falls; Road traffic accidents; Mortality; Length of hospital stay	HOSPITAL ADMISSIONS; FINANCIAL CRISIS; OLDER PATIENTS; RISK-FACTORS; HEAD-INJURY; CARE; EPIDEMIOLOGY; OUTCOMES; PATTERNS; IMPACT	Background: Recent analysis on the epidemiology of traumatic brain injury (TBI) within Europe indicates an increase in fall-related injuries and in the incidence of hospitalization among older adults as well as a decrease in contribution of road traffic accidents (RTA). Given the paucity of recent national data, we analyzed TBI-related admissions from the Athens Head Trauma Registry during the largest part of the past decade (2010-2018), a period marked by a profound national socioeconomic crisis. Methods: Demographic and clinical data of admitted TBI patients were collected and analyzed statistically. Results: The mean age of patients (N=2042, 68% men) was 59 years (median 64 years). Patient age showed an upward trend across the study period. Most cases were mild, while moderate and severe injuries were indicated in, 11% and 20%, respectively. Falls were the predominant cause of injury (46% of cases), followed by RTA (38%). An upward trend in the frequency of fall-related injury was apparent across the study period; RTA-related injury frequency displayed a downward trend during the second part of the study period. Assault-related injury accounted for 6%. Surgery took place in 11% of cases. In-hospital mortality (IHM) was 21%. Fall-related mortality contributed to 56% of total IHM; RTA-related mortality contributed to 30%. The mean length of hospital stay was 13 days (median: 5 days). Conclusions: The present findings suggest a shift in the epidemiologic profile of TBI patients in Greece with a rise in the proportion of elderly patients, a concomitant increase in fall-related injuries and a reduction in RTA-related injury. They also highlight fall-related injury as the predominant cause of IHM. Our results point towards the urgent need for the intensification of fall prevention strategies, continuing medical education as well as public information campaigns on the risks of geriatric fall-related injury. (C) 2020 Elsevier Ltd. All rights reserved.	[Stranjalis, George; Komaitis, Spyridon; Kalyvas, Aristotelis V.; Drosos, Evangelos; Stavrinou, Lampis C.; Koutsarnakis, Christos; Kalamatianos, Theodosis] Natl & Kapodistrian Univ Athens, Evangelismos Hosp, Dept Neurosurg, Ypsilantou 45-47, Athens 10676, Greece		Kalamatianos, T (corresponding author), Natl & Kapodistrian Univ Athens, Evangelismos Hosp, Dept Neurosurg, Ypsilantou 45-47, Athens 10676, Greece.	tkalamatian@med.uoa.gr					Avesani R, 2013, EUR J PHYS REHAB MED, V49, P611; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Cuevas-Trisan R, 2019, CLIN GERIATR MED, V35, P173, DOI 10.1016/j.cger.2019.01.008; Dias C, 2014, ACTA MEDICA PORT, V27, P349, DOI 10.20344/amp.4892; Dunn L, 2003, J NEUROL NEUROSUR PS, V74, P1060, DOI 10.1136/jnnp.74.8.1060; Dunn MS, 2019, INJURY, V50, P1534, DOI 10.1016/j.injury.2019.06.012; European Commission, 2018, ANN ACC REP ANN ACC REP; Franse CB, 2019, J ADV NURS, V75, P3689, DOI 10.1111/jan.14181; Franse CB, 2018, INT J NURS STUD, V88, P153, DOI 10.1016/j.ijnurstu.2018.09.006; Fu WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175868; Gabbe BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020545; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Hawley C, 2017, EMERG MED J, V34, P509, DOI 10.1136/emermed-2016-206506; Hwang HF, 2015, J HEAD TRAUMA REHAB, V30, pE9, DOI 10.1097/HTR.0000000000000093; Ifanti AA, 2013, HEALTH POLICY, V113, P8, DOI 10.1016/j.healthpol.2013.05.017; Ioannis D, 2013, SURG CHRON, V18, P190; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kannus P, 2020, ARCH GERONTOL GERIAT, V86, DOI 10.1016/j.archger.2019.103958; Karidis NP, 2011, WORLD J SURG, V35, P2377, DOI 10.1007/s00268-011-1228-y; Katsaragakis S, 2010, BRAIN INJURY, V24, P871, DOI 10.3109/02699051003789237; Kyriacou DN, 1999, NEW ENGL J MED, V341, P1892, DOI 10.1056/NEJM199912163412505; Lilley EJ, 2016, J TRAUMA ACUTE CARE, V80, P998, DOI 10.1097/TA.0000000000001028; Long SJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011169; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Michas G, 2013, J EPIDEMIOL COMMUN H, V67, P894, DOI 10.1136/jech-2013-202827; Odgaard L, 2015, CLIN EPIDEMIOL, V7, P225, DOI 10.2147/CLEP.S78141; Owens PW, 2018, BRAIN INJURY, V32, P900, DOI 10.1080/02699052.2018.1466366; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Peeters W, 2017, NEUROEPIDEMIOLOGY, V48, P63, DOI 10.1159/000471877; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Roe C, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/845491; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Stranjalis G, 2008, J TRAUMA, V65, P789, DOI 10.1097/TA.0b013e3181469e26; Stylianidis Stelios, 2019, BJPsych Int, V16, P16, DOI 10.1192/bji.2017.31; Teo DB, 2018, INTERN MED J, V48, P1048, DOI 10.1111/imj.13794; Tyrovolas S, 2018, LANCET PUBLIC HEALTH, V3, pE395, DOI 10.1016/S2468-2667(18)30130-0; Yokobori S, 2016, WORLD NEUROSURG, V86, P127, DOI 10.1016/j.wneu.2015.09.105	38	1	2	1	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2020	51	9					2033	2039		10.1016/j.injury.2020.05.045			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	NL7XH	WOS:000567623100014	32536530				2022-02-06	
J	Takayama, W; Endo, A; Koguchi, H; Murata, K; Otomo, Y				Takayama, Wataru; Endo, Akira; Koguchi, Hazuki; Murata, Kiyoshi; Otomo, Yasuhiro			Age-related differences in the impact of coagulopathy in patients with isolated traumatic brain injury: An observational cohort study	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Coagulopathy; traumatic brain injury; trauma-induced coagulopathy; Glasgow Outcome Scale-Extended; age-related differences	HEMORRHAGIC PROGRESSION; COAGULATION DISORDERS; MECHANISMS; FIBRINOGEN; PLASMA; SHOCK	BACKGROUND Although age and coagulopathy are well-known predictors of poor outcome after traumatic brain injury (TBI), the interaction effect of these two predictors remains unclear. OBJECTIVES We assessed age-related differences in the impact of coagulopathy on the outcome following isolated TBI. METHODS We conducted a retrospective observational study in two tertiary emergency critical care medical centers in Japan from 2013 to 2018. A total of 1036 patients with isolated TBI (head Abbreviated Injury Scale >= 3 and other Abbreviated Injury Scale < 3) were selected and divided into the nonelderly (n = 501, 16-64 years) and elderly group (n = 535, age >= 65 years). We further evaluated the impact of coagulopathy (international normalized ratio, >1.2) on the outcomes (Glasgow Outcome Scale-Extended [GOS-E] scores, in-hospital mortality, and ventilation-free days) in both groups using univariate and multivariate models. Further, we conducted an age-based assessment of the impact of TBI-associated coagulopathy on GOS-E using a generalized additive model. RESULTS The multivariate model showed a significant association of age and TBI-associated coagulopathy with lower GOS-E scores, in-hospital mortality, and shorter ventilation-free days in the nonelderly group; however, significant impact of coagulopathy was not observed for all the outcomes in the elderly group. There was a decrease in the correlation degree between coagulopathy and GOS-E scores decreased with those older than 65 years. CONCLUSION There was a low impact of coagulopathy on functional and survival outcomes in geriatric patients with isolated TBI.	[Takayama, Wataru; Endo, Akira; Koguchi, Hazuki; Otomo, Yasuhiro] Tokyo Med & Dent Univ, Trauma & Acute Crit Care Ctr, Tokyo, Japan; [Takayama, Wataru; Endo, Akira; Otomo, Yasuhiro] Tokyo Med & Dent Univ, Grad Sch, Dept Acute Crit Care & Disaster Med, Tokyo, Japan; [Murata, Kiyoshi] Matsudo City Gen Hosp, Shock Trauma & Emergency Med Ctr, Matsudo, Chiba, Japan		Takayama, W (corresponding author), Tokyo Med & Dent Univ, Dept Emergency & Disaster Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1130034, Japan.	tak2accm@tmd.ac.jp	Endo, Akira/AAL-8535-2021				Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Brown CVR, 2016, AM SURGEON, V82, P1055; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Endo A, 2018, BRIT J SURG, V105, P1426, DOI 10.1002/bjs.10905; Epstein DS, 2015, BRIT J NEUROSURG, V29, P118, DOI 10.3109/02688697.2014.950632; Epstein DS, 2016, J CLIN NEUROSCI, V29, P64, DOI 10.1016/j.jocn.2015.11.024; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Etemadrezaie H, 2007, CLIN NEUROL NEUROSUR, V109, P166, DOI 10.1016/j.clineuro.2006.09.001; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Franschman G, 2012, BRAIN INJURY, V26, P1464, DOI 10.3109/02699052.2012.694566; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; HAMILTON PJ, 1974, J CLIN PATHOL, V27, P980, DOI 10.1136/jcp.27.12.980; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Harr JN, 2013, SHOCK, V39, P45, DOI 10.1097/SHK.0b013e3182787122; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Keller JM, 2012, J ORTHOP TRAUMA, V26, pE161, DOI 10.1097/BOT.0b013e3182324460; Kocuvan S, 2016, WIEN KLIN WOCHENSCHR, V128, P535, DOI 10.1007/s00508-016-1140-4; Kojima M, 2019, ANN EMERG MED, V73, P281, DOI 10.1016/j.annemergmed.2018.09.034; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; MARI D, 1995, BLOOD, V85, P3144, DOI 10.1182/blood.V85.11.3144.bloodjournal85113144; Martini WZ, 2008, J TRAUMA, V65, P535, DOI 10.1097/TA.0b013e31818379a6; MEADE TW, 1979, BMJ-BRIT MED J, V1, P153, DOI 10.1136/bmj.1.6157.153; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Rating the severity of tissue damage. I, 1971, JAMA-J AM MED ASSOC, V215, P277; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Statistics Bureau Ministry of Internal Affairs and Communications, PORT SIT OFF STAT JA PORT SIT OFF STAT JA; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tong WS, 2012, BRAIN INJURY, V26, P1136, DOI 10.3109/02699052.2012.666437; Wada T, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1808-9; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137	39	1	1	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2020	89	3					523	528		10.1097/TA.0000000000002796			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	NQ7RJ	WOS:000571066500027	32502089	Green Submitted			2022-02-06	
J	Tau, T; Kelly, A; Lekgwara, P				Tau, Tshepang; Kelly, Adrian; Lekgwara, Patrick			Predicting outcome in patients with traumatic brain injury who undergo a decompressive craniectomy at a single academic center in Pretoria, South Africa	INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT			English	Article								Aim: South Africa ranks as a global epicenter for traumatic brain injury, a proportion of which results in raised intra-cranial pressure of various degree requiring neurosurgical intervention. We aimed to determine the significance of demographic, pre-operative, operative, and post-operative variables in predicting outcome in 62 patients admitted over a 5-year period with traumatic brain injury and raised intra-cranial pressure who underwent decompressive craniectomy. Methods: Retrospective chart review of 62 patients admitted with traumatic brain injury and raised intra-cranial pressure who underwent decompressive craniectomy from January 2014 to December 2018 was performed. Medical records were analyzed for Age; Gender; Mechanism of injury; Hours between injury and admission; Severity of head injury; Hours between admission and surgery; Type of decompressive craniectomy performed; and Glasgow Outcome Score at discharge. Results: Considering all variables, significance was demonstrated between Mechanism of injury, namely being assaulted which was favorable rather than having fallen or being involved in a motor vehicle or pedestrian vehicle accident which was unfavorable (p = 0.015); Time from injury to neurosurgical admission (p = 0.007), and especially Severity of head injury at admission (p < 0.001) in predicting outcome. Neither Age (p = 0.84); Gender (p = 0.88); CT finding (p = 0.34) or Time from admission to surgery (p = 0.39) demonstrated significance. Conclusion: Considering patients with traumatic brain injury who underwent a decompressive craniectomy, our study noted that all of the variables that demonstrated significance in determining outcome were determined prior to the patient being admitted to our unit. Our study highlights the need for primary prevention of falls, motor vehicle, and pedestrian vehicle accidents as well as early presentation as the major determinants of outcome.	[Tau, Tshepang; Kelly, Adrian; Lekgwara, Patrick] Sefako Makgatho Hlth Sci Univ, Dr George Mukhari Acad Hosp, Dept Neurosurg, Pretoria, South Africa		Kelly, A (corresponding author), POB Medunsa, Pretoria, South Africa.	adriankelly1000@yahoo.co.uk					Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Grande PO, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00315; Honeybul S, 2013, WORLD NEUROSURG, V79, P159, DOI 10.1016/j.wneu.2012.08.012; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson P.J., 2016, NEW ENGL J MED, V375, P12; Kapapa T, 2016, WORLD NEUROSURG, V93, P389, DOI 10.1016/j.wneu.2016.06.075; Khalili Hosseinali, 2017, Bull Emerg Trauma, V5, P190; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Marion DW, 2006, NEUROSURGERY, V58, P655; Matthew B.Potts, 2012, SCHMIDEK SWEET OPERA, P1551, DOI [10.1016/B978-1-4160-6839-6.10135-2., DOI 10.1016/B978-1-4160-6839-6.10135-2]; Miller K, 2016, WORLD NEUROSURG, V95, P441, DOI 10.1016/j.wneu.2016.08.061; Norman R, 2007, B WORLD HEALTH ORGAN, V85, P695, DOI 10.2471/BLT.06.037184; Ogunlade J, 2018, CUREUS, V10, DOI 10.7759/cureus.3042; Tian RF, 2019, WORLD NEUROSURG, V126, pE101, DOI 10.1016/j.wneu.2019.01.246	16	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2214-7519		INTERDISCIP NEUROSUR	Interdiscip. Neurosurg.	SEP	2020	21								100753	10.1016/j.inat.2020.100753			6	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	LZ3ZV	WOS:000541167500005		gold			2022-02-06	
J	Thone-Otto, A				Thoene-Otto, Angelika			Summary of the S2e Guideline "Diagnosis and Therapy of Memory Disorders in Neurological Diseases" (AWMF-030/124)	ZEITSCHRIFT FUR NEUROPSYCHOLOGIE			German	Article							TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; TREAT LEARNING IMPAIRMENT; COGNITIVE ASSESSMENT MOCA; MENTAL-STATE-EXAMINATION; TEMPORAL-LOBE EPILEPSY; MULTIPLE-SCLEROSIS; KORSAKOFFS-SYNDROME; VIRTUAL-REALITY; AUTOBIOGRAPHICAL MEMORY		[Thoene-Otto, Angelika] Univ Klinikum Leipzig, Tagesklin Kognit Neurol, Liebigstr 16, D-04103 Leipzig, Germany		Thone-Otto, A (corresponding author), Univ Klinikum Leipzig, Tagesklin Kognit Neurol, Liebigstr 16, D-04103 Leipzig, Germany.	angelika.thoene@medizin.uni-leipzig.de					Aida J, 2018, NEUROREHABILITATION, V42, P441, DOI 10.3233/NRE-172361; Alle MC, 2017, NEUROPSYCHOL REV, V27, P81, DOI 10.1007/s11065-016-9337-x; Andriessen TMJC, 2009, BRAIN INJURY, V23, P345, DOI 10.1080/02699050902791414; Ballard C, 2008, CURR MED RES OPIN, V24, P2561, DOI 10.1185/03007990802328142 ; Bikson M, 2016, BRAIN STIMUL, V9, P641, DOI 10.1016/j.brs.2016.06.004; Birks J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004744.pub3; Boringa JB, 2001, MULT SCLER, V7, P263, DOI 10.1177/135245850100700409; Brown PD, 2013, NEURO-ONCOLOGY, V15, P1429, DOI 10.1093/neuonc/not114; Browne G, 2011, MEMORY, V19, P713, DOI 10.1080/09658211.2011.614622; Butler JM, 2007, INT J RADIAT ONCOL, V69, P1496, DOI 10.1016/j.ijrobp.2007.05.076; Chan E, 2014, J NEUROL SCI, V343, P176, DOI 10.1016/j.jns.2014.05.005; Charters E, 2015, NEUROPSYCHOL REHABIL, V25, P82, DOI 10.1080/09602011.2014.942672; Chiaravalloti ND, 2016, NEUROREHAB NEURAL RE, V30, P539, DOI 10.1177/1545968315604395; Chiaravalloti ND, 2015, J HEAD TRAUMA REHAB, V30, P261, DOI 10.1097/HTR.0000000000000164; Chiaravalloti ND, 2013, NEUROLOGY, V81, P2066, DOI 10.1212/01.wnl.0000437295.97946.a8; Chiaravalloti ND, 2012, J NEUROL, V259, P1337, DOI 10.1007/s00415-011-6353-x; Chouliara N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011225; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Dardiotis E, 2018, MULT SCLER RELAT DIS, V20, P58, DOI 10.1016/j.msard.2017.12.017; das Nair R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002293.pub3; das Nair R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008754.pub3; das Nair R, 2015, NEUROPSYCHOL REHABIL, V25, P479, DOI 10.1080/09602011.2014.971820; Day J, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011335.pub2; de Joode EA, 2013, SCAND J OCCUP THER, V20, P446, DOI 10.3109/11038128.2013.821161; De Joode EA, 2013, NEUROPSYCHOL REHABIL, V23, P133, DOI 10.1080/09602011.2012.726632; Del Felice A, 2015, BRAIN STIMUL, V8, P567, DOI 10.1016/j.brs.2015.01.410; Dougall D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009221.pub2; Drake AI, 2006, BRAIN INJURY, V20, P469, DOI 10.1080/02699050600676370; Evald L, 2018, DISABIL REHABIL, V40, P2250, DOI 10.1080/09638288.2017.1333633; Ferland MB, 2013, BRAIN INJURY, V27, P1461, DOI 10.3109/02699052.2013.823661; Fetta J, 2017, J NEUROSCI NURS, V49, P235, DOI 10.1097/JNN.0000000000000298; Foley Frederick W, 2012, Int J MS Care, V14, P58, DOI 10.7224/1537-2073-14.2.58; Gehring K, 2012, J NEURO-ONCOL, V107, P165, DOI 10.1007/s11060-011-0723-1; Gess JL, 2014, APPL NEUROPSYCH-ADUL, V21, P231, DOI 10.1080/09084282.2013.791826; Geurts S, 2019, CORTEX, V110, P150, DOI 10.1016/j.cortex.2018.04.002; Goodwin RA, 2020, NEUROPSYCHOL REHABIL, V30, P15, DOI 10.1080/09602011.2018.1447973; Grewe P, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-42; Gromisch ES, 2020, NEUROPSYCHOL REHABIL, V30, P767, DOI 10.1080/09602011.2018.1491408; Hayes SM, 2012, NEUROPSYCHOL REV, V22, P132, DOI 10.1007/s11065-012-9204-3; Helmstaedter C, 2009, EPILEPSY RES, V87, P203, DOI 10.1016/j.eplepsyres.2009.09.002; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Iodice R, 2017, RESTOR NEUROL NEUROS, V35, P497, DOI 10.3233/RNN-170735; Jamieson M, 2017, NEUROPSYCHOL REHABIL, V27, P919, DOI 10.1080/09602011.2015.1103760; Jamieson M, 2014, NEUROPSYCHOL REHABIL, V24, P419, DOI 10.1080/09602011.2013.825632; Jonker C, 2000, INT J GERIATR PSYCH, V15, P983, DOI 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5; Joplin S, 2018, NEUROPSYCHOL REV, V28, P88, DOI 10.1007/s11065-018-9367-7; Kaleita TA, 2006, J CLIN ONCOL, V24, p58S; Kober SE, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-17; Kopelman MD, 2002, CORTEX, V38, P655, DOI 10.1016/S0010-9452(08)70031-5; Koski L, 2015, J NEUROTRAUM, V32, P38, DOI 10.1089/neu.2014.3449; Krohn S., 2019, MULTIDIMENSIONAL EVA, DOI [10.31219/osf.io/zsqbe, DOI 10.31219/OSF.IO/ZSQBE]; Kumar KS, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007935.pub2; Langdon DW, 2011, CURR OPIN NEUROL, V24, P244, DOI 10.1097/WCO.0b013e328346a43b; Leavitt VM, 2014, NEUROCASE, V20, P695, DOI 10.1080/13554794.2013.841951; Leavitt VM, 2014, BRAIN IMAGING BEHAV, V8, P394, DOI 10.1007/s11682-012-9183-2; Lesniak M, 2014, J HEAD TRAUMA REHAB, V29, pE20, DOI 10.1097/HTR.0b013e318292a4c2; Liu AL, 2016, EPILEPSY BEHAV, V55, P11, DOI 10.1016/j.yebeh.2015.10.032; Locke Dona E C, 2008, J Support Oncol, V6, P383; Luck Tobias, 2018, BMC Psychol, V6, P23, DOI 10.1186/s40359-018-0236-1; Maier W, 2014, NERVENARZT, V85, P564, DOI 10.1007/s00115-013-3984-4; Mansouri A, 2018, J NEUROSURG, V128, P1199, DOI 10.3171/2016.11.JNS16715; Markowitsch H.J., 2017, GEDACHTNIS SPUR ERIN; Markowitsch HJ, 2012, LANCET, V380, P1429, DOI 10.1016/S0140-6736(11)61304-4; Meares S, 2011, BRAIN INJURY, V25, P1198, DOI 10.3109/02699052.2011.608213; Meisenhelter S, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0837-3; Merten T, 2011, FORTSCHR NEUROL PSYC, V79, P102, DOI 10.1055/s-0029-1245731; Middleton EL, 2012, NEUROPSYCHOL REHABIL, V22, P138, DOI 10.1080/09602011.2011.639619; Mok Vincent, 2007, Neuropsychiatr Dis Treat, V3, P943; Momsen AM, 2012, J REHABIL MED, V44, P901, DOI 10.2340/16501977-1040; Muller S.V., 2019, LEITLINIEN DIAGNOSTI; Narasimhalu K, 2010, ACTA NEUROL SCAND, V121, P217, DOI 10.1111/j.1600-0404.2009.01263.x; National Institute for Health and Care Excellence, 2013, STROK REH AD CLIN GU; Negut A., 2015, TRANSYLVANIAN J PSYC, V16; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; O'Neill B, 2018, J HEAD TRAUMA REHAB, V33, pE33, DOI 10.1097/HTR.0000000000000358; Oudman E, 2015, NEUROPSYCHOL REV, V25, P134, DOI 10.1007/s11065-015-9288-7; Oudman E, 2014, CLIN NEUROPSYCHOL, V28, P1123, DOI 10.1080/13854046.2014.960005; Oudman E, 2013, NEUROPSYCHOL REHABIL, V23, P888, DOI 10.1080/09602011.2013.835738; Ownsworth T, 2017, NEUROREHAB NEURAL RE, V31, P1072, DOI 10.1177/1545968317740635; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Radford K, 2011, EPILEPSY BEHAV, V22, P272, DOI 10.1016/j.yebeh.2011.06.021; Radomski MV, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020776; Rapp SR, 2013, J CLIN ONCOL, V31; Rayner G, 2015, EPILEPSIA, V56, P225, DOI 10.1111/epi.12902; Rensen YCM, 2019, NEUROPSYCHOL REHABIL, V29, P1211, DOI 10.1080/09602011.2017.1379419; Richter KM, 2018, NEUROPSYCHOLOGY, V32, P586, DOI 10.1037/neu0000445; Richter KM, 2015, NEUROREHAB NEURAL RE, V29, P33, DOI 10.1177/1545968314527352; Rizzo AA, 1997, ST HEAL T, V44, P123; Rosti-Otajarvi EM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009131.pub3; Ryan SM, 2016, NEUROSCI BIOBEHAV R, V61, P121, DOI 10.1016/j.neubiorev.2015.12.004; Sandry J, 2016, ARCH PHYS MED REHAB, V97, P1026, DOI 10.1016/j.apmr.2015.10.109; Schellig D., 2009, HDB NEUROPSYCHOLOGIS; Shin H, 2015, J PHYS THER SCI, V27, P2999, DOI 10.1589/jpts.27.2999; Silva AR, 2018, NEUROPSYCHOL REHABIL, V28, P117, DOI 10.1080/09602011.2015.1128450; Spreij LA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00993; Stringer AY, 2011, BRAIN INJURY, V25, P169, DOI 10.3109/02699052.2010.541894; Suthana N, 2014, NEUROIMAGE, V85, P996, DOI 10.1016/j.neuroimage.2013.07.066; Thone-Otto A, 2010, Z NEUROPSYCHOL, V21, P271, DOI 10.1024/1016-264X/a000020; Thone-Otto A., 2017, NEUROL REHABIL, V23, P9; Trevena-Peters J, 2018, J HEAD TRAUMA REHAB, V33, P317, DOI 10.1097/HTR.0000000000000363; Trevena-Peters J, 2019, NEUROPSYCHOL REHABIL, V29, P1655, DOI 10.1080/09602011.2018.1441033; van der Werf SP, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00605; Van Heugten CM, 2015, CLIN REHABIL, V29, P694, DOI 10.1177/0269215514553012; Visser M, 2019, CORTEX, V110, P80, DOI 10.1016/j.cortex.2018.02.017; Weicker J, 2020, BRAIN INJURY, V34, P1051, DOI 10.1080/02699052.2020.1773536; Wong D, 2017, DISABIL REHABIL, V39, P2387, DOI 10.1080/09638288.2016.1226434; Yip BCB, 2013, NEUROREHABILITATION, V32, P103, DOI [10.3233/NRE-130827, 10.3233/NRE-30827]	107	1	1	1	4	VERLAG HANS HUBER	BERN 9	LANGGASS-STRASSE 76, CH-3000 BERN 9, SWITZERLAND	1016-264X	1664-2902		Z NEUROPSYCHOL	Z. Neuropsychol.	SEP	2020	31	3					107	128		10.1024/1016-264X/a000298			22	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	NI1NS	WOS:000565125200002					2022-02-06	
J	Vadlamani, A; Albrecht, JS				Vadlamani, Aparna; Albrecht, Jennifer S.			Severity of Traumatic Brain Injury in Older Adults and Risk of Ischemic Stroke and Depression	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						depression; older adults; stroke; TBI	HEAD-INJURY	Objective: Risk of ischemic stroke and depression is elevated among older adults following traumatic brain injury (TBI), yet little is known about how the severity of TBI influences risk. Thus, our objective was to assess the association between severity of the index TBI and risk of ischemic stroke and depression in a sample of older adults treated for TBI. Design: Retrospective cohort study. Setting: R Adams Cowley Shock Trauma Center. Participants: Adults 65 years and older treated for TBI between 2006 and 2010 who survived to hospital discharge and could be linked to their Medicare administrative claims data with continuous enrollment for at least 6 months pre-TBI and 12 months post-TBI. Main Measures: First dates of ischemic stroke and depression available in Medicare claims were used to exclude individuals with a history. Next, we separately assessed the association between TBI severity and time to first stroke and depression using Cox proportional hazards models. Results: Among 132 patients without preexisting history of stroke, high TBI severity was associated with increased risk of stroke compared with low TBI severity (adjusted hazard ratio 6.68, 95% confidence interval 2.49-17.94). Among 163 patients without preexisting history of depression, high TBI severity was not significantly associated with increased risk of depression compared with low TBI severity (adjusted hazard ratio 1.90, 95% confidence interval 0.94-3.84). Conclusion: In this group of older adults with TBI, higher TBI severity was associated with increased risk of ischemic stroke, but not depression. These results suggest that increased monitoring of older adults with moderate-severe TBI for stroke may be warranted.	[Vadlamani, Aparna; Albrecht, Jennifer S.] Univ Maryland, Dept Epidemiol & Publ Hlth, Sch Med, MSTF 360,10 South Pine St, Baltimore, MD 21201 USA		Vadlamani, A (corresponding author), Univ Maryland, Dept Epidemiol & Publ Hlth, Sch Med, MSTF 360,10 South Pine St, Baltimore, MD 21201 USA.	avadlamani@som.umaryland.edu		Albrecht, Jennifer/0000-0003-4838-2274	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32AG000262]; AHRQUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01HS024560]	Ms. Vadlamani is supported by the National Institutes of Health grant T32AG000262 (Magaziner, PI). Dr Albrecht was supported by AHRQ grant K01HS024560.	Albrecht JS, 2019, J NEUROTRAUM, V36, P300, DOI 10.1089/neu.2017.5608; Albrecht JS, 2015, AM J GERIAT PSYCHIAT, V23, P607, DOI 10.1016/j.jagp.2014.07.006; [Anonymous], 1971, JAMA, V215, P277; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Chen GS, 2016, J NEUROTRAUM, V33, P1263, DOI 10.1089/neu.2015.4063; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Chronic Conditions Warehouse, CHRON COND DAT WAR; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Kowalski RG, 2017, STROKE, V48, P1802, DOI 10.1161/STROKEAHA.117.017327; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MIEMSS, MIEMSS ANN REP 2015; Miller AP, 2016, J GERIATR CARDIOL, V13, P373, DOI 10.11909/j.issn.1671-5411.2016.05.001; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	21	1	1	3	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2020	35	5			SI		E436	E440		10.1097/HTR.0000000000000561			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NP5SO	WOS:000570236100014	32108711	Green Accepted			2022-02-06	
J	Wallesch, CW				Wallesch, Claus-W			Summary of the S2k guideline "medicolegal evaluation of adults with closed head injuries" (AWMF 094/002)	ZEITSCHRIFT FUR NEUROPSYCHOLOGIE			German	Article						medicolegal evaluation; closed head injury; clinical signs and symptoms; CT; MRT	DIFFUSE AXONAL INJURY; BRAIN-INJURY	In 2005 and 2013, the German Society for Neurocientific Medicolegal Evaluations (DGNR) developed and consented together with other learned societies, among them the Society for Neu ropsychology (GNP), guidelines for the medicolegal evaluation of adults with closed head injuries. The new revision was developed on the higher S2k level of consent through a Delphi Conferebce concerning the crucial statements. The guideline describes which radiological and cliniceal features allow the assumption of structural brain damage and therefore remaining deficits.	[Wallesch, Claus-W] BDH Klin Elzach, Tannwald 1-3, D-79215 Elzach, Germany		Wallesch, CW (corresponding author), BDH Klin Elzach, Tannwald 1-3, D-79215 Elzach, Germany.	claus.wallesch@bdh-klinik-elzach.de					Deb S, 1999, AM J PSYCHIAT, V156, P374; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; Neumann-Zielke L, 2016, AKTUEL NEUROL, V43, P158, DOI 10.1055/s-0042-100805; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Wallesch CW, 2018, FORTSCHR NEUROL PSYC, V86, P635, DOI 10.1055/a-0677-7068; Widder B, 2018, NEUROWISSENSCHAFTLIC	7	1	1	0	1	VERLAG HANS HUBER	BERN 9	LANGGASS-STRASSE 76, CH-3000 BERN 9, SWITZERLAND	1016-264X	1664-2902		Z NEUROPSYCHOL	Z. Neuropsychol.	SEP	2020	31	3					149	156		10.1024/1016-264X/a000301			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	NI1NS	WOS:000565125200005					2022-02-06	
J	Wang, WT; Canavese, F; Lin, R; Pan, YC; Huang, DH; Xiong, Z; Chen, SY				Wang, Wentao; Canavese, Federico; Lin, Ran; Pan, Yuancheng; Huang, Dianhua; Xiong, Zhu; Chen, Shunyou			Clinical, radiographic and pedobarographic analysis of skeletally immature patients with surgically treated distal metaphyseal fractures of the tibia: is concomitant fixation of the fibula necessary?	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						children; distal tibia metaphysis; elastic stable intramedullary nailing; fibula; fracture; pedobarography	FEMORAL VALGUS; PLATE FIXATION; CHILDREN	This study evaluated the outcomes of distal tibia metaphyseal fractures (DTMFs) managed surgically and compared the outcomes of patients with and without associated fibula fracture fixation. Thirty-two consecutive patients (14 males; mean age at the time of injury: 7.8 years) with closed displaced DTMFs, with (22 patients; group A) or without associated fibula fractures fixation (10 patients; group B), were included. Besides standard radiographic measurements, the following static and dynamic pedobarographic parameters were evaluated: foot total static plantar pressure percentage (PP%(tot)), static plantar pressure percentage of the forefoot (PP%(ff)) and of the rear foot (PP%(rf)), landing sequence of the metatarsals during contact with the ground (MTland), and impulse percentage of the metatarsal heads (MT%(imp)) and the medial and lateral heel (MH%(imp)and LH%(imp)). All patients were followed for at least 2 years (range: 2-4.5 years). Functional outcomes were excellent to good in all but two patients (93.8%) at the last follow-up visit using the Johner-Wruths criteria'. Radiographic measurements, PP%(tot), PP%(ff), PP%(rf), MT%(imp), MH%(imp)and LH%(imp)were not significantly different between two groups as well as between injured and uninjured side of patients within the same group (P> 0.05). Abnormal MT(land)sequence was found in 40.9% of group A (9/22) and in 40% of group B patients (4/10) (P> 0.05). Stabilization of associated fibula fractures did not significantly impact the clinical, radiographic and pedobarographic outcomes of the children with displaced DTMFs who were surgically treated. Level of evidence: Level III.	[Wang, Wentao; Lin, Ran; Pan, Yuancheng; Huang, Dianhua; Chen, Shunyou] Xiamen Univ, Dept Pediat Orthoped, FuZhou Hosp 2, 47th Shang Teng Rd, Fuzhou 350007, Fujian, Peoples R China; [Canavese, Federico] Univ Hosp Estaing, Dept Pediat Surg, Clermont Ferrand, France; [Xiong, Zhu] ShenZhen Childrens Hosp, Dept Pediat Orthoped, Shenzhen, Peoples R China		Chen, SY (corresponding author), Xiamen Univ, Dept Pediat Orthoped, FuZhou Hosp 2, 47th Shang Teng Rd, Fuzhou 350007, Fujian, Peoples R China.	csy508@163.com		CANAVESE, Federico/0000-0002-6114-5372			Alvarez C, 2008, GAIT POSTURE, V28, P309, DOI 10.1016/j.gaitpost.2008.01.017; Bauer J, 2017, J PEDIATR ORTHOPED, V37, pE100, DOI 10.1097/BPO.0000000000000705; Beekman F, 1991, AM J SURG, V51, P722; Brantley Justin, 2016, Iowa Orthop J, V36, P133; Bryant A, 1999, FOOT ANKLE INT, V20, P646, DOI 10.1177/107110079902001006; Cravino Mattia, 2014, Eur J Orthop Surg Traumatol, V24, P1603, DOI 10.1007/s00590-013-1402-z; Domzalski ME, 2006, J PEDIATR ORTHOPED, V26, P171, DOI 10.1097/01.bpo.0000218523.82996.76; EVANOFF M, 1993, J PEDIATR ORTHOPED, V13, P98, DOI 10.1097/01241398-199301000-00020; Ezzat A, 2016, J PEDIATR ORTHOP B, V25, P381, DOI 10.1097/BPB.0000000000000289; Griffet J, 2011, J CHILD ORTHOP, V5, P297, DOI 10.1007/s11832-011-0343-5; HANLON CR, 1954, AM J SURG, V87, P312, DOI 10.1016/S0002-9610(54)90128-2; Heyworth BE, 2013, J BONE JOINT SURG AM, V95A, P526, DOI 10.2106/JBJS.K.01190; Hunter JB, 2005, INJURY, V36, pA20, DOI 10.1016/j.injury.2004.12.009; Joeris A, 2017, ACTA ORTHOP, V88, P129, DOI 10.1080/17453674.2016.1258533; JOHNER R, 1983, CLIN ORTHOP RELAT R, P7; Joo S, 2012, J PEDIATR ORTHOPED, V32, P605, DOI 10.1097/BPO.0b013e318263a245; Masquijo JJ, 2014, J PEDIATR ORTHOP B, V23, P207, DOI 10.1097/BPB.0000000000000036; O'Brien T, 2004, J PEDIATR ORTHOPED, V24, P601, DOI 10.1097/01241398-200411000-00001; Shen KY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004980; Sinclair MF, 2009, CLIN ORTHOP RELAT R, V467, P1223, DOI 10.1007/s11999-009-0746-5; Strauss EJ, 2007, J ORTHOP TRAUMA, V21, P172, DOI 10.1097/BOT.0b013e3180332dd2; Wallace J, 2016, J PEDIATR ORTHOP B, V25, P89, DOI 10.1097/BPB.0000000000000258; Xu C, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000932; Zelle BA, 2006, J ORTHOP TRAUMA, V20, P76, DOI 10.1097/01.bot.0000202997.45274.a1	24	1	1	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	SEP	2020	29	5					490	498		10.1097/BPB.0000000000000684			9	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	MZ8NM	WOS:000559381700013	31651749				2022-02-06	
J	Yeole, U; Krishnakumar, M; Gopalakrishna, KN; Sekar, A; Sadashiva, N; Shukla, D				Yeole, Ujwal; Krishnakumar, Mathangi; Gopalakrishna, Kadarapura Nanjundaiah; Sekar, Arunkumar; Sadashiva, Nishanth; Shukla, Dhaval			Surgical outcomes in traumatic brain injuries with bilateral mass occupying lesions. Analysis of prognostic factors	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Traumatic brain injury; Glasgow coma scale; Rotterdam CT score; Severe head injury; Intracranial hematoma	SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; PREDICTION; MANAGEMENT; HEMATOMAS; CARE; AGE	Introduction: Traumatic brain injury is a silent epidemic with major impacts on national productivity as it affects the economically productive age group. Bilateral injuries are usually severe with no clearly defined predictors of outcome as per current available literature. Methods: We retrospectively assessed 102 consecutive cases of post traumatic intracranial mass lesions operated bilaterally, either simultaneously or sequentially, between January 2011 and April 2019. The primary and secondary end points of the study were to assess mortality and GCS at discharge respectively. Results: The cohort included 102 patients. 91(89.2 %) were males, mean age was 40( +/- 13.6) years. Median GCS at presentation was 9 with 47(46.07 %) having moderate head injury. EDH with contusion was seen in 38(37.3 %), SDH with contusion in 24(23.5 %) and 4 patients (3.9 %) had EDH, SDH and contusion. On univariate analysis, female gender(p = 0.001), poor GCS at presentation(p < 0.001), higher Rotterdam grade on initial CT scan(p < 0.001), need for blood transfusions(p = 0.026) and intraoperative hypotension (p = 0.007) were associated with significantly higher mortality. On multivariate analysis female gender (p = 0.034), poor GCS(p = 0.026) and worse Rotterdam score(p = 0.038) were associated with mortality. Among the subgroup of survivors, GCS at presentation(p < 0.001), Rotterdam grading(p = 0.003), time to surgery after trauma(p = 0.032), duration of hospital stay(< 0.001), intraoperative brain bulge(p=.003) and craniotomy instead of craniectomy(p = 0.001) were associated with clinical outcome at discharge. Conclusion: Traumatic brain injuries with bilateral mass lesions requiring surgery have been rarely reported. In this study we have elucidated management strategies and have further studied the factors influencing mortality and clinical outcome. Careful considerations are required in decision making in such cases. Larger multicentric studies would throw more light on outcomes of this rare variety of traumatic brain injury.	[Yeole, Ujwal] Tata Mem Hosp, Dept Neurosurg, Neurosurg Oncol, Mumbai 400012, Maharashtra, India; [Sadashiva, Nishanth; Shukla, Dhaval] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bengaluru 560029, Karnataka, India; [Krishnakumar, Mathangi; Gopalakrishna, Kadarapura Nanjundaiah] Natl Inst Mental Hlth & Neurosci, Dept Neuroanaesthesia, Bengaluru 560029, Karnataka, India; [Sekar, Arunkumar] Amrita Inst Med Sci, Dept Pediat Neurosurg, Kochi 682041, Kerala, India		Sadashiva, N (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bengaluru 560029, Karnataka, India.	ujwalyeole@yahoo.com; mathz89@gmail.com; gops868@gmail.com; arunkumar3002@gmail.com; nishanth46@gmail.com; neurodhaval@rediffmail.com	Krishnakumar, Mathangi/AAM-8343-2020; Sadashiva, Nishanth/J-9587-2015	Shukla, Dhaval/0000-0001-7613-1929; Sadashiva, Nishanth/0000-0003-0509-4993; krishnakumar, Mathangi/0000-0002-9225-3165; Sekar, Arunkumar/0000-0001-9664-6620			Agrawal Amit, 2016, Int J Crit Illn Inj Sci, V6, P65, DOI 10.4103/2229-5151.183025; Akyuz M, 2010, TURK NEUROSURG, V20, P382, DOI 10.5137/1019-5149.JTN.2785-09.1; Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Caroli M, 2001, SURG NEUROL, V56, P82, DOI 10.1016/S0090-3019(01)00540-7; Choi Young Hwan, 2017, Korean J Neurotrauma, V13, P108, DOI 10.13004/kjnt.2017.13.2.108; East JM, 2018, CURR OPIN ANESTHESIO, V31, P219, DOI 10.1097/ACO.0000000000000566; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Hu Y, 2015, BMC SURG, V15, DOI 10.1186/1471-2482-15-6; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Leitgeb J, 2013, EUR J TRAUMA EMERG S, V39, P285, DOI 10.1007/s00068-013-0269-3; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Majdan M, 2017, J NEUROSCI RURAL PRA, V8, P20, DOI 10.4103/0976-3147.193543; Majdan M, 2013, EUR J PUBLIC HEALTH, V23, P682, DOI 10.1093/eurpub/cks074; MEIER U, 1994, UNFALLCHIRURG, V97, P406; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Pandey S, 2017, INDIAN J SURG, V79, P19, DOI 10.1007/s12262-015-1416-3; Prusty G.K., 2012, TRAUMATIC SPINAL COR, P17, DOI 10.1017/CBO9781139030564.003.; Razack N, 1997, J TRAUMA, V43, P840, DOI 10.1097/00005373-199711000-00017; Sinha S, 2015, NEUROL INDIA, V63, P175, DOI 10.4103/0028-3886.156277; Taw BBT, 2012, ASIAN J SURG, V35, P117, DOI 10.1016/j.asjsur.2012.04.027; Walcott BP, 2012, J NEUROTRAUM, V29, P1879, DOI 10.1089/neu.2012.2382; Waqas M, 2016, BRIT J NEUROSURG, V30, P258, DOI 10.3109/02688697.2016.1139047; Wester K, 1999, NEUROSURGERY, V44, P495, DOI 10.1097/00006123-199903000-00034; Yatsushige H, 2010, ACTA NEUROCHIR SUPPL, V106, P265, DOI 10.1007/978-3-211-98811-4_50	29	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	SEP	2020	196								106017	10.1016/j.clineuro.2020.106017			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NR3FQ	WOS:000571448600020	32619900				2022-02-06	
J	Yuceli, S; Yazici, GN; Mammadov, R; Suleyman, H; Kaya, M; Ozdogan, S				Yuceli, Sahin; Yazici, Gulce Naz; Mammadov, Renad; Suleyman, Halis; Kaya, Mustafa; Ozdogan, Selcuk			The Effect of Rutin on Experimental Traumatic Brain Injury and Edema in Rats	IN VIVO			English	Article						Traumatic brain injury; rutin; brain edema	OXIDATIVE STRESS; KAPPA-B; INFLAMMATION; ACTIVATION	Background/Aim: The aim of the study was to evaluate the effect of rutin, which is a vitamin P1 flavonoid with anti-inflammatory and anti-edema effects, on traumatic brain injury (TBI) and edema in rats. Materials and Methods: Rats were divided into 3 groups as sham group without brain trauma (SG), brain trauma without medication (BT) group and Rutin treated brain trauma (RBT) group. Fifty mg/kg rutin was administered to the RBT group once a day for three days. On the fourth day, rats were sacrificed. Extracted brain tissues were examined biochemically and histopathologically. Results: We found that the levels of malondialdehyde, nuclear factor-kappa B and tumor necrosis factor-alpha decreased, and those of total glutathione increased signcantly. Furthermore, rutin administration reduced pyramidal neuron degeneration and poly-morpho-nuclear-leucocyte accumulation due to trauma in brain tissue, while eliminating edema. Conclusion: Rutin might be effective in the treatment of TBI and TBI-related brain edema.	[Yuceli, Sahin] Neon Hosp, Dept Neurosurg, Erzincan, Turkey; [Yazici, Gulce Naz] Erzincan Binali Yildirim Univ, Dept Histol & Embryol, Sch Med, Erzincan, Turkey; [Mammadov, Renad; Suleyman, Halis] Erzincan Binali Yildirim Univ, Dept Pharmacol, Sch Med, Erzincan, Turkey; [Kaya, Mustafa] Sakarya Training & Res Hosp, Dept Neurosurg, Sakarya, Turkey; [Ozdogan, Selcuk] Beykent Univ, Dept Neurosurg, Sch Med, Istanbul, Turkey		Ozdogan, S (corresponding author), Beykent Univ, Dept Neurosurg, Sch Med, Tip Fak, TR-34000 Beylikduzu Istanbul, Turkey.	selcukozdogan@beykent.edu.tr					Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Batsaikhan B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030502; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Chen Wen-mei, 2002, Zhongguo Zhong Xi Yi Jie He Za Zhi, V22, P283; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dilmen OK, 2015, TURK J ANAESTHESIOL, V43, P1, DOI 10.5152/TJAR.2014.26680; Gugliandolo E, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00590; Harborne J B, 1986, Prog Clin Biol Res, V213, P15; Hu YC, 2014, INFLAMM RES, V63, P109, DOI 10.1007/s00011-013-0677-1; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Khan MM, 2009, BRAIN RES, V1292, P123, DOI 10.1016/j.brainres.2009.07.026; Kim JM, 2021, EUR J TRAUMA EMERG S, V47, P1437, DOI 10.1007/s00068-019-01095-4; Lee W, 2012, FOOD CHEM TOXICOL, V50, P3048, DOI 10.1016/j.fct.2012.06.013; Moutinho MSS, 2018, ANTICANCER RES, V38, P1461, DOI 10.21873/anticanres.12371; Nafees S, 2015, CHEM-BIOL INTERACT, V231, P98, DOI 10.1016/j.cbi.2015.02.021; Niu XL, 2018, MOL MED REP, V18, P4516, DOI 10.3892/mmr.2018.9465; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Suleyman H, 2018, ERZINCAN MED J, V1, P4; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Urso ML, 2003, TOXICOLOGY, V189, P41, DOI 10.1016/S0300-483X(03)00151-3; Xiao Guo-min, 2005, J Zhejiang Univ Sci B, V6, P28, DOI 10.1631/jzus.2005.B0028; Yattoo Gh, 2008, J Trauma Manag Outcomes, V2, P5, DOI 10.1186/1752-2897-2-5; Zhai XF, 2016, NEUROIMMUNOMODULAT, V23, P179, DOI 10.1159/000448716; Zou P, 2018, MOL MED REP, V17, P3212, DOI 10.3892/mmr.2017.8241	28	1	1	2	3	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0258-851X	1791-7549		IN VIVO	In Vivo	SEP-OCT	2020	34	5					2453	2460		10.21873/invivo.12060			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	NW4LM	WOS:000574979900002	32871772	Green Published, gold			2022-02-06	
J	Zaman, S; Arouj, K; Irfan, S				Zaman, Sabir; Arouj, Kehkashan; Irfan, Shahid			The relationship between post-traumatic stress disorder and acquired brain injury among civilian patients	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Post-traumatic stress disorder symptoms and severity; Acquired brain injury; Civilian patients; Traumatic vs non traumatic brain injury	PSYCHIATRIC-DISORDERS; EPIDEMIOLOGY; DEPRESSION; ADULTS	Purpose: Patients with acquired brain injury are a vulnerable group in Pakistan with limited psychosocial ser-vices available to them. The current study sought to determine the incidence of post-traumatic stress disorder (PTSD) in ABI patients with traumatic and non-traumatic injury. Patients and Methods: A cross-sectional research design was used. The assessment of PTSD was carried out by using the Clinician Administered PTSD Scale (CAPS-5). In the study, there were 132 adults older than 18 years who have ABI-either traumatic or non-traumatic. The study was conducted in a public hospital in Islamabad, Pakistan, and the data was collected one-month post brain injury. Results: The results showed that traumatic brain injury (TBI) patients have more PTSD symptoms as compared to non-TBI patients (p = 0.00). Intrusive (p = 0.00) and hyper arousal symptoms (p = 0.04) of PTSD were higher in TBI than in non-TBI patients. There was statically non-significant mean difference in symptoms of PTSD among male and female patients (p = 0.34). The moderately brain injury patients have high PTSD symptoms as compared to mild brain injury patients (p = 0.04). Further, the frequency of severe and extreme PTSD symptoms was high in TBI patient as compared to non TBI patients (p = .05) Conclusion: PTSD severity and PTSD symptoms such as intrusive and avoidance symptoms were higher in TBI patients than in non-TBI patients. This study contributed to the literature by assessing the onset of PTSD in patients with acquired brain injury. This study also provided knowledge to plan psychosocial interventions for patients with acquired brain injury having PTSD symptoms.	[Zaman, Sabir; Arouj, Kehkashan] Int Islamic Univ Islamabad, Dept Psychol, Islamabad, Pakistan; [Irfan, Shahid] Fdn Univ Islamabad, Dept Psychol, Islamabad, Pakistan		Zaman, S (corresponding author), Int Islamic Univ Islamabad, Dept Psychol, Islamabad, Pakistan.	sabir.zaman@iiu.edu.pk; kehkashan.arouj@iiu.edu.pk; shahid.irfan@fui.edu.pk	Shahid, Irfan/X-2405-2019; zaman, Sabir/AAF-4309-2020	Shahid, Irfan/0000-0002-2848-2297; 			APA, 2013, ACAD PSYCHIAT; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Ciuffreda K, 2001, VISUAL VESTIBULAR CO, P1; Cohen J M, 1993, J Am Optom Assoc, V64, P60; Corrigan JD, 2008, BRAIN INJURY, V22, P223, DOI 10.1080/02699050801938967; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Finnerty F, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-36; Grigsby J.P., 1986, INT J CLIN NEUROPSYC; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; Koponen S, 2011, BRAIN INJURY, V25, P1029, DOI 10.3109/02699052.2011.607783; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lannoo E, 2004, BRAIN INJURY, V18, P203, DOI 10.1080/02699050310001596905; McDermott GL, 2014, BRAIN INJURY, V28, P81, DOI 10.3109/02699052.2013.857790; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Weathers F., 2013, CLINICIAN ADMINISTER; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Zost M., 1995, DIAGNOSIS MANAGEMENT	21	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	SEP	2020	196								105981	10.1016/j.clineuro.2020.105981			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	NR3FQ	WOS:000571448600013	32599423				2022-02-06	
J	Zangbar, HS; Ghadiri, T; Vafaee, MS; Kalan, AE; Karimipour, M; Fallahi, S; Ghorbani, M; Shahabi, P				Zangbar, Hamid Soltani; Ghadiri, Tahereh; Vafaee, Manuchehr Seyedi; Kalan, Abbas Ebrahimi; Karimipour, Mohammad; Fallahi, Solmaz; Ghorbani, Meysam; Shahabi, Parviz			A potential entanglement between the spinal cord and hippocampus: Theta rhythm correlates with neurogenesis deficiency following spinal cord injury in male rats	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						hippocampus; neurogenesis; RRID; AB_10847359; RRID; AB_10988210; RRID; AB_2714189; RRID; AB_2858256; RRID; AB_305426; RRID; AB_626803; RRID; AB_732011; spatial memory; spinal cord injury; theta rhythm	PERFORANT PATH INPUTS; SPATIAL MEMORY; COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN; OSCILLATIONS; RECEPTORS; NEURONS; CORTEX; REPRESENTATIONS; PROJECTIONS	Cognitive deficits due to spinal cord injury (SCI) have been elucidated in both animals and humans with SCI. Such disorders may cause concomitant oscillatory changes in regions of the brain involving in cognition; a subject that has not been directed mechanistically. One of the crucial oscillations, having a prominent role in cognition, particularly spatial memory, is hippocampal theta rhythm. Our research revealed that SCI could induce changes not only in the neurogenesis and apoptosis rate of the hippocampus but also in theta power as well as receptors involving in the generation of this rhythm. Herein we used 24 male Wistar rats (Sham/SCI = 12) and examined the effect of spinal cord contusion on hippocampal theta rhythm, spatial memory, and neurodegeneration. We proved that SCI eliminates hippocampus-dependent theta power through spatial working memory, and correlates significantly with neurodegeneration and expression of receptors (NMDA, GABAA, Muscarinic1/M1), which are in turn essential in generation of theta rhythm. The immunohistochemistry analysis also demonstrated a significant decrease in DCX+ and BrdU+ cells; however, according to TUNEL assay, apoptosis is significantly higher in SCI-induced animals. The western blotting analysis further showed a significant reduction of the abovementioned receptors in the hippocampus. We also verified that SCI impairs the spatial memory, proved by poor performance in the Y-maze task. As well as, based on the local field potential recordings analysis, SCI decreases the power of theta rhythm. Eventually, this study demonstrated that chronic brain neurodegeneration occurs after SCI accompanied by theta rhythm and cognitive deficiency.	[Zangbar, Hamid Soltani; Ghadiri, Tahereh; Kalan, Abbas Ebrahimi] Tabriz Univ Med Sci, Fac Adv Med Sci, Dept Neurosci & Cognit, Tabriz, Iran; [Zangbar, Hamid Soltani; Shahabi, Parviz] Tabriz Univ Med Sci, Aging Res Inst, Tabriz, Iran; [Zangbar, Hamid Soltani; Shahabi, Parviz] Tabriz Univ Med Sci, Neurosci Res Ctr NSRC, Tabriz, Iran; [Vafaee, Manuchehr Seyedi] Odense Univ Hosp, Dept Nucl Med, Odense, Denmark; [Karimipour, Mohammad] Tabriz Univ Med Sci, Fac Adv Med Sci, Dept Appl Cell Sci, Tabriz, Iran; [Fallahi, Solmaz; Ghorbani, Meysam] Tabriz Univ Med Sci, Fac Med, Dept Physiol, Tabriz, Iran		Shahabi, P (corresponding author), Tabriz Univ Med Sci, Aging Res Inst, Golgasht St, East Azarbayjan, Tabriz, Iran.	shahabip@tbzmed.ac.ir	Karimipour, Mohammad/AAZ-9243-2020; Ebrahimi-Kalan, Abbas/G-9595-2017; Ghadiri, Tahereh/AAU-7811-2020; shahabi, parviz/D-9690-2017	Karimipour, Mohammad/0000-0002-6975-4308; Ghadiri, Tahereh/0000-0002-3568-8699; shahabi, parviz/0000-0001-5594-5544	Iran National Science FoundationIran National Science Foundation (INSF) [97017102]	Iran National Science Foundation, Grant/Award Number: 97017102	Abu-Qare AW, 2001, J TOXICOL ENV HEAL B, V4, P313, DOI 10.1080/109374001301419737; Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Arrigoni E, 2004, BRIT J PHARMACOL, V142, P317, DOI 10.1038/sj.bjp.0705744; Boord P, 2008, SPINAL CORD, V46, P118, DOI 10.1038/sj.sc.3102077; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Chang CM, 2009, NEUROREPORT, V20, P968, DOI 10.1097/WNR.0b013e32832d0a28; Chauviere L, 2009, J NEUROSCI, V29, P5402, DOI 10.1523/JNEUROSCI.4699-08.2009; Colgin LL, 2016, NAT REV NEUROSCI, V17, P239, DOI 10.1038/nrn.2016.21; Colgin LL, 2013, ANNU REV NEUROSCI, V36, P295, DOI 10.1146/annurev-neuro-062012-170330; Dannenberg H, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00102; de Oliveira Cabral H., 2014, NMDA RECEPTOR DEPEND; Dennis SH, 2016, CEREB CORTEX, V26, P414, DOI 10.1093/cercor/bhv227; Drieu C, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00232; Endo T, 2009, NEUROSCIENTIST, V15, P291, DOI 10.1177/1073858408329508; Fallahi S, 2019, NEUROSCI LETT, V707, DOI 10.1016/j.neulet.2019.134304; Felix MS, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00045; Frost SB, 2015, J NEUROTRAUM, V32, P1666, DOI 10.1089/neu.2015.3961; Ghorbani M, 2020, J CELL PHYSIOL, V235, P9795, DOI 10.1002/jcp.29793; Ghorbani M, 2018, PHYSIOL PHARMACOL, V22, P228; Griffin AL, 2007, J NEUROSCI, V27, P2416, DOI 10.1523/JNEUROSCI.4083-06.2007; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Hirase H, 1999, EUR J NEUROSCI, V11, P4373, DOI 10.1046/j.1460-9568.1999.00853.x; HJORTHSIMONSEN A, 1972, J COMP NEUROL, V144, P215, DOI 10.1002/cne.901440206; Hosseini M, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1576; Humanes-Valera D, 2017, CEREB CORTEX, V27, P2926, DOI 10.1093/cercor/bhw142; Humanes-Valera D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069655; Hunt MJ, 2013, J PSYCHOPHARMACOL, V27, P972, DOI 10.1177/0269881113495117; Jensen MP, 2013, SPINAL CORD, V51, P55, DOI 10.1038/sc.2012.84; Hernandez-Perez JJ, 2016, NEUROSCIENCE, V337, P224, DOI 10.1016/j.neuroscience.2016.09.003; Jure I, 2017, NEUROCHEM RES, V42, P2178, DOI 10.1007/s11064-017-2225-9; Kandel E. R., 2000, PRINCIPLES NEURAL SC, V4; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Leaderbrand K, 2016, LEARN MEMORY, V23, P631, DOI 10.1101/lm.043133.116; Lee DJ, 2015, J NEUROTRAUM, V32, P1822, DOI 10.1089/neu.2014.3744; Lee I, 2004, HIPPOCAMPUS, V14, P66, DOI 10.1002/hipo.10167; Liu JB, 2011, INJURY, V42, P742, DOI 10.1016/j.injury.2010.08.028; Ma S, 2009, LEARN MEMORY, V16, P730, DOI 10.1101/lm.1438109; Maldonado-Bouchard S, 2016, BRAIN BEHAV IMMUN, V51, P176, DOI 10.1016/j.bbi.2015.08.009; MIZUMORI SJY, 1989, J NEUROSCI, V9, P3915; Montgomery SM, 2009, J NEUROSCI, V29, P1381, DOI 10.1523/JNEUROSCI.4339-08.2009; Nardone R, 2013, BRAIN RES, V1504, P58, DOI 10.1016/j.brainres.2012.12.034; Obernier K, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.156059; Olvera-Cortes E, 2004, BRAIN RES BULL, V62, P379, DOI 10.1016/j.brainresbull.2003.10.003; Paxinos G, 2006, RAT BRAIN STEREOTAXI; Perez-Cordova M. G., 2010, BMC NEUROSCIENCE S1, V11, DOI [10.1186/1471-2202-11-S1-P125, DOI 10.1186/1471-2202-11-S1-P125]; Rodriguez A, 2018, METHODS ECOL EVOL, V9, P460, DOI 10.1111/2041-210X.12874; Rogers RD, 2004, BIOL PSYCHIAT, V55, P594, DOI 10.1016/j.biopsych.2003.11.012; Roth TC, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1904; Sachdeva R, 2018, NEUROLOGY, V91, P611, DOI 10.1212/WNL.0000000000006244; Zangbar HS, 2020, BRAIN CONNECT, V10, P157, DOI 10.1089/brain.2019.0733; Sun MK, 2001, J NEUROPHYSIOL, V85, P269, DOI 10.1152/jn.2001.85.1.269; Unal G, 2015, J NEUROSCI, V35, P15812, DOI 10.1523/JNEUROSCI.2639-15.2015; Watrous AJ, 2013, HIPPOCAMPUS, V23, P656, DOI 10.1002/hipo.22124; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Wirt RA, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7040043; Witter MP, 2007, PROG BRAIN RES, V163, P43, DOI 10.1016/S0079-6123(07)63003-9; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072; Wu JF, 2016, J NEUROTRAUM, V33, P1919, DOI 10.1089/neu.2015.4348; Wu JF, 2014, CELL CYCLE, V13, P2446, DOI 10.4161/cc.29420; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014	63	1	1	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	DEC	2020	98	12					2451	2467		10.1002/jnr.24719		SEP 2020	17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OD2AS	WOS:000564544300001	32875652	Green Published			2022-02-06	
J	Black, CE; Zhou, E; DeAngelo, CM; Asante, I; Louie, SG; Petasis, NA; Humayun, MS				Black, Caroline E.; Zhou, Eugene; DeAngelo, Caitlin M.; Asante, Isaac; Louie, Stan G.; Petasis, Nicos A.; Humayun, Mark S.			Cyanine Nanocages Activated by Near-Infrared Light for the Targeted Treatment of Traumatic Brain Injury	FRONTIERS IN CHEMISTRY			English	Article						cyanine dye; near-infrared; light-activated; traumatic brain injury (TBI); gabapentin	HUMAN SERUM-ALBUMIN; HEPTAMETHINE CYANINE; DYES; BIOMOLECULES; BINDING; AGENTS	Traumatic brain injury (TBI) is a common and prevalent condition that affects large numbers of people across a range of ages. Individuals engaging in physical activities and victims of accidents are at a higher risk for TBI. There is a lack of available treatment specifically for TBI. Given the difficulty to determine its precise location in the brain, TBI remains difficult to fully diagnose or treat. Herein, we disclose a novel strategy for directing therapeutic agents to TBI sites, without the need to determine the precise location of the TBI activity in the brain. This novel approach is based on the use of a cyanine dye nanocage carrying Gabapentin, a known TBI therapeutic agent. Upon exposure of the cyanine nanocage to near-infrared light, the local release of Gabapentin is triggered, selectively at the TBI-affected site.	[Black, Caroline E.; DeAngelo, Caitlin M.; Petasis, Nicos A.] Univ Southern Calif, Dept Chem, Los Angeles, CA 90007 USA; [Zhou, Eugene; Asante, Isaac; Louie, Stan G.; Petasis, Nicos A.] Univ Southern Calif, Sch Pharm, Los Angeles, CA 90007 USA; [Louie, Stan G.; Petasis, Nicos A.; Humayun, Mark S.] Univ Southern Calif, Ginsburg Inst Biomed Therapeut, Los Angeles, CA 90007 USA; [Humayun, Mark S.] Univ Southern Calif, Keck Sch Med, Viterbi Sch Engn, Los Angeles, CA 90007 USA; [Humayun, Mark S.] Univ Southern Calif, Roski Eye Inst, Los Angeles, CA 90007 USA		Petasis, NA (corresponding author), Univ Southern Calif, Dept Chem, Los Angeles, CA 90007 USA.; Louie, SG; Petasis, NA (corresponding author), Univ Southern Calif, Sch Pharm, Los Angeles, CA 90007 USA.; Louie, SG; Petasis, NA; Humayun, MS (corresponding author), Univ Southern Calif, Ginsburg Inst Biomed Therapeut, Los Angeles, CA 90007 USA.; Humayun, MS (corresponding author), Univ Southern Calif, Keck Sch Med, Viterbi Sch Engn, Los Angeles, CA 90007 USA.; Humayun, MS (corresponding author), Univ Southern Calif, Roski Eye Inst, Los Angeles, CA 90007 USA.	slouie@usc.edu; petasis@usc.edu; humayun@med.usc.edu		Black, Caroline/0000-0002-5523-4387	William M. Keck FoundationW.M. Keck Foundation; USC Ginsburg Institute for Biomedical Therapeutics and Research to Prevent Blindness	Financial support of this work by the William M. Keck Foundation, unrestricted funds from USC Ginsburg Institute for Biomedical Therapeutics and Research to Prevent Blindness Unrestricted Grant to USC Roski Eye Institute was gratefully acknowledged.	Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Ghosh AK, 2015, J MED CHEM, V58, P2895, DOI 10.1021/jm501371s; Gorka AP, 2018, ACCOUNTS CHEM RES, V51, P3226, DOI 10.1021/acs.accounts.8b00384; Gorka AP, 2018, CHEMBIOCHEM, V19, P1239, DOI 10.1002/cbic.201800061; Gorka AP, 2016, CURR OPIN CHEM BIOL, V33, P117, DOI 10.1016/j.cbpa.2016.05.022; Gorka AP, 2015, ORG BIOMOL CHEM, V13, P7584, DOI 10.1039/c5ob00788g; Gorka AP, 2014, J AM CHEM SOC, V136, P14153, DOI 10.1021/ja5065203; Henary M, 2009, J HETEROCYCLIC CHEM, V46, P84, DOI 10.1002/jhet.39; Kukkar A, 2013, ARCH PHARM RES, V36, P237, DOI 10.1007/s12272-013-0057-y; LIPOWSKA M, 1993, SYNTHETIC COMMUN, V23, P3087, DOI 10.1080/00397919308011153; Luciano MP, 2019, ACS CHEM BIOL, V14, P934, DOI 10.1021/acschembio.9b00122; Luo SL, 2011, BIOMATERIALS, V32, P7127, DOI 10.1016/j.biomaterials.2011.06.024; Ma XM, 2008, TETRAHEDRON, V64, P345, DOI 10.1016/j.tet.2007.10.094; Marshall Milton V, 2010, Open Surg Oncol J, V2, P12; Mason JC, 1997, HETEROCYCL COMMUN, V3, P409; Mohammad I, 2013, DYES PIGMENTS, V99, P275, DOI 10.1016/j.dyepig.2013.05.001; Naeser MA, 2016, PHOTOMED LASER SURG, V34, P610, DOI 10.1089/pho.2015.4037; Nagao Y, 2007, DYES PIGMENTS, V73, P344, DOI 10.1016/j.dyepig.2006.01.039; Nani RR, 2017, ACS CENTRAL SCI, V3, P329, DOI 10.1021/acscentsci.7b00026; Nani RR, 2015, ANGEW CHEM INT EDIT, V54, P13635, DOI 10.1002/anie.201507391; Nani RR, 2015, CHEM SCI, V6, P6556, DOI 10.1039/c5sc02396c; Nani RR, 2015, ORG LETT, V17, P302, DOI 10.1021/ol503398f; Nolting DD, 2011, CURR ORG SYNTH, V8, P521, DOI 10.2174/157017911796117223; Offord J, 2016, CRIT REV BIOCHEM MOL, V51, P246, DOI 10.3109/10409238.2016.1173010; Owens EA, 2015, J MED CHEM, V58, P4348, DOI 10.1021/acs.jmedchem.5b00475; Patel NJ, 2016, BIOCONJUGATE CHEM, V27, P667, DOI 10.1021/acs.bioconjchem.5b00656; Patonay G, 2004, MOLECULES, V9, P40, DOI 10.3390/90300040; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Sato K, 2016, BIOCONJUGATE CHEM, V27, P404, DOI 10.1021/acs.bioconjchem.5b00492; Sato K, 2015, MOL PHARMACEUT, V12, P3303, DOI 10.1021/acs.molpharmaceut.5b00472; SHEALY DB, 1995, ANAL CHEM, V67, P247, DOI 10.1021/ac00098a002; Sowell J, 2001, ELECTROPHORESIS, V22, P2512, DOI 10.1002/1522-2683(200107)22:12<2512::AID-ELPS2512>3.0.CO;2-9; Sowell J, 2001, J CHROMATOGR B, V755, P91, DOI 10.1016/S0378-4347(01)00035-4; Strekowski L, 2001, HETEROCYCL COMMUN, V7, P117; Tran LV, 2014, J TRAUMA NURS, V21, P30, DOI 10.1097/JTN.0000000000000026; WILLIAMS RJ, 1993, ANAL CHEM, V65, P601, DOI 10.1021/ac00053a019; Williams RJ, 1997, APPL SPECTROSC, V51, P836, DOI 10.1366/0003702971941115; Wu JB, 2015, J AM CHEM SOC, V137, P2366, DOI 10.1021/ja512613j; Yamamoto T, 2019, PHOTOCHEM PHOTOBIOL, V95, P951, DOI 10.1111/php.13090; Yue L, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.8.088001	40	1	1	1	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-2646			FRONT CHEM	Front. Chem.	AUG 31	2020	8								769	10.3389/fchem.2020.00769			11	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	NQ2CH	WOS:000570672700001	33062635	Green Published, gold			2022-02-06	
J	Daglas, M; Galle, A; Draxler, DF; Ho, HD; Liu, ZK; Sashindranath, M; Medcalf, RL				Daglas, Maria; Galle, Adam; Draxler, Dominik F.; Ho, Heidi; Liu, Zikou; Sashindranath, Maithili; Medcalf, Robert L.			Sex-dependent effects of tranexamic acid on blood-brain barrier permeability and the immune response following traumatic brain injury in mice	JOURNAL OF THROMBOSIS AND HAEMOSTASIS			English	Article						blood-brain barrier; fibrinolysis; intracerebral hemorrhage; tranexamic acid; traumatic brain injury	VASCULAR OCCLUSIVE EVENTS; INTRACEREBRAL HEMORRHAGE; PROVIDES NEUROPROTECTION; PLASMINOGEN; GENDER; FIBRINOLYSIS; INFLAMMATION; ACTIVATION; CRASH-2; TRANSFUSION	Background Tranexamic acid (TXA) is an anti-fibrinolytic agent used to reduce bleeding in various conditions including traumatic brain injury (TBI). As the fibrinolytic system also influences the central nervous system and the immune response, TXA may also modulate these parameters following TBI. Objectives To determine the effect of TXA on blood-brain barrier (BBB) integrity and changes in immune and motor function in male and female mice subjected to TBI. Methods Wild-type and plasminogen deficient (plg-/-) mice were subjected to TBI then administered either TXA/vehicle. The degree of BBB breakdown, intracerebral hemorrhage (ICH), motor dysfunction, and changes in inflammatory subsets in blood and brain were determined. Results and conclusions Tranexamic acid significantly reduced BBB breakdown, and increased blood neutrophils in male mice 3 hours post-TBI. In contrast, TXA treatment of female mice increased BBB permeability and ICH but had no effect on blood neutrophils at the same time-point. TXA improved motor function in male mice but still increased BBB breakdown in female mice 24 hours post-TBI. Brain urokinase-type plasminogen activator (u-PA) antigen and activity levels were significantly higher in injured females compared to males. Because TXA can promote a pro-fibrinolytic effect via u-PA, these sex differences may be related to brain u-PA levels. TXA also increased monocyte subsets and dendritic cells in the injured brain of wild-type male mice 1 week post-TBI. Plg(-/-)mice of both sexes had reduced BBB damage and were protected from TBI irrespective of treatment indicating that TXA modulation of the BBB is plasmin-dependent. In conclusion, TXA is protective post-TBI but only in male mice.	[Daglas, Maria; Galle, Adam; Draxler, Dominik F.; Ho, Heidi; Liu, Zikou; Sashindranath, Maithili; Medcalf, Robert L.] Monash Univ, Australian Ctr Blood Dis, Mol Neurotrauma & Haemostasis, Cent Clin Sch, Melbourne, Vic, Australia		Sashindranath, M; Medcalf, RL (corresponding author), Australian Ctr Blood Dis, Mol Neurotrauma & Haemostasis, Monash AMREP Bldg,Level 1 Walkway,Via Alfred Ctr, Melbourne, Vic 3004, Australia.	maithili.sashindranath@monash.edu; robert.medcalf@monash.edu	Sashindranath, Maithili/AAI-7408-2021	Sashindranath, Maithili/0000-0002-9712-4784; Medcalf, Robert/0000-0001-6885-3892; Daglas, Maria/0000-0002-9356-4061; Liu, Zikou/0000-0002-0787-5083	NHMRC (Australia)National Health and Medical Research Council of Australia; NH&MRC Principal Research FellowshipNational Health and Medical Research Council of Australia	The authors acknowledge the facilities and technical assistance provided by members of the AMREP Flow Cytometry Core Facility at Monash University, Victoria, Australia. The presented study was supported by a NH&MRC (Australia) grant and by a NH&MRC Principal Research Fellowship, awarded to the corresponding author RLM.	Alhelaly MM, 2019, TRAUMA, V21, P167, DOI 10.1177/1460408619842736; Barrett CD, 2019, J TRAUMA ACUTE CARE, V86, P101, DOI 10.1097/TA.0000000000002092; Barthel D, 2012, J BIOL CHEM, V287, P18831, DOI 10.1074/jbc.M111.323287; Borg RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131216; Boudreau RM, 2017, J SURG RES, V215, P47, DOI 10.1016/j.jss.2017.03.031; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Cap AP, 2011, J TRAUMA, V71, pS9, DOI 10.1097/TA.0b013e31822114af; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; Daglas M, 2019, CELL REP, V29, P1178, DOI 10.1016/j.celrep.2019.09.046; Draxler DF, 2017, SEMIN THROMB HEMOST, V43, P143, DOI 10.1055/s-0036-1586227; Draxler DF, 2019, J THROMB HAEMOST, V17, P2174, DOI 10.1111/jth.14603; Draxler DF, 2019, J NEUROTRAUM, V36, P3297, DOI 10.1089/neu.2018.6030; Draxler DF, 2019, BLOOD ADV, V3, P1598, DOI 10.1182/bloodadvances.2019000092; Draxler DF, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00591; Elhasade AS, 1998, MED SCI MONITOR, V4, pRA555; Engler-Chiurazzi EB, 2017, PROG NEUROBIOL, V157, P188, DOI 10.1016/j.pneurobio.2015.12.008; Foley JH, 2017, SEMIN THROMB HEMOST, V43, P135, DOI 10.1055/s-0036-1592302; Gaddam SSK, 2015, HDB CLIN NEUROLOGY, P205; GEBARA OCE, 1995, CIRCULATION, V91, P1952, DOI 10.1161/01.CIR.91.7.1952; Grant AL, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0855-5; GRANT PJ, 1990, CLIN SCI, V78, P3, DOI 10.1042/cs0780003; Griemert EV, 2019, ANN NEUROL, V85, P667, DOI 10.1002/ana.25458; Griemert EV, 2019, J NEUROTRAUM, V36, P2272, DOI 10.1089/neu.2018.6126; Hald A, 2012, FASEB J, V26, P4445, DOI 10.1096/fj.12-208025; Hamer J, 2020, J NEUROTRAUM, V37, P1197, DOI 10.1089/neu.2019.6800; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Hiramoto K, 2016, BIOMED PHARMACOTHER, V83, P283, DOI 10.1016/j.biopha.2016.06.043; Hiramoto K, 2016, PHOTODERMATOL PHOTO, V32, P136, DOI 10.1111/phpp.12231; Itsekson-Hayosh Z, 2016, J NEUROTRAUM, V33, P1848, DOI 10.1089/neu.2015.4146; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Komanapalli ES, 2016, ACTA NEUROCHIR SUPPL, V121, P311, DOI 10.1007/978-3-319-18497-5_54; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Leminen H, 2012, INT J WOMENS HEALTH, V4, P413, DOI 10.2147/IJWH.S13840; Longstaff C, 2019, J THROMB HAEMOST, V17, P195, DOI 10.1111/jth.14338; MARKUS G, 1979, J BIOL CHEM, V254, P1211; Medcalf RL, 2007, J THROMB HAEMOST, V5, P132, DOI 10.1111/j.1538-7836.2007.02464.x; Medcalf RL, 2017, J THROMB HAEMOST, V15, P2089, DOI 10.1111/jth.13849; Medcalf RL, 2015, BLOOD, V125, P2457, DOI 10.1182/blood-2015-02-629808; Mehra A, 2016, BBA-MOL BASIS DIS, V1862, P395, DOI 10.1016/j.bbadis.2015.10.011; Miles LA, 2013, SEMIN THROMB HEMOST, V39, P329, DOI 10.1055/s-0033-1334483; Morte D, 2019, J TRAUMA ACUTE CARE, V87, P125, DOI 10.1097/TA.0000000000002269; MULLINS ES, 2013, BLOOD, V122; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; Naderi V, 2015, IRAN J BASIC MED SCI, V18, P138; Nakamura T, 2005, J NEUROSURG, V103, P97, DOI 10.3171/jns.2005.103.1.0097; Niego B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177332; Niego B, 2014, J CEREBR BLOOD F MET, V34, P1283, DOI 10.1038/jcbfm.2014.99; Niego B, 2012, BLOOD, V119, P4752, DOI 10.1182/blood-2011-07-369512; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; PETERSON J, 1988, J ORAL MAXIL SURG, V46, P176, DOI 10.1016/0278-2391(88)90076-6; Roberts I, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI [10.3310/HTA17100, 10.3310/hta17100]; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Sashindranath M, 2015, BEHAV BRAIN RES, V286, P33, DOI 10.1016/j.bbr.2015.02.038; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Secher JJ, 2018, J ORAL MAXIL SURG, V76, P1327, DOI 10.1016/j.joms.2017.11.015; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shen Y, 2012, BLOOD, V119, P5879, DOI 10.1182/blood-2012-01-407825; Shiraishi Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52621-8; SMOKOVITIS A, 1993, THROMB RES, V69, P425, DOI 10.1016/0049-3848(93)90231-C; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Sulniute R, 2016, THROMB HAEMOSTASIS, V115, P1001, DOI 10.1160/TH15-08-0653; Suzuki S, 2009, FRONT NEUROENDOCRIN, V30, P201, DOI 10.1016/j.yfrne.2009.04.007; Syrovets T, 2012, J LEUKOCYTE BIOL, V92, P509, DOI 10.1189/jlb.0212056; Teng Y, 2018, EXP ANIM TOKYO, V67, P313, DOI 10.1538/expanim.17-0143; Vandromme M, 2008, CRIT CARE, V12, DOI 10.1186/cc6899; Vanek T, 2013, COR VASA, V55, pE184, DOI 10.1016/j.crvasa.2012.10.002; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Weng ST, 2019, WORLD NEUROSURG, V123, P128, DOI 10.1016/j.wneu.2018.11.214; Wilson AC, 2008, BBA-MOL BASIS DIS, V1782, P401, DOI 10.1016/j.bbadis.2008.02.011; WINKLER UH, 1992, FIBRINOLYSIS, V6, P5, DOI 10.1016/0268-9499(92)90004-2; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108	74	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1538-7933	1538-7836		J THROMB HAEMOST	J. Thromb. Haemost.	OCT	2020	18	10					2658	2671		10.1111/jth.15015		AUG 2020	14	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	NU9GL	WOS:000563757300001	32668057	Bronze			2022-02-06	
J	Patton, MP; Moore, L; Farhat, I; Tardif, PA; Gonthier, C; Belcaid, A; Lauzier, F; Turgeon, A; Clement, J				Patton, Marie-Pier; Moore, Lynne; Farhat, Imen; Tardif, Pier-Alexandre; Gonthier, Catherine; Belcaid, Amina; Lauzier, Francois; Turgeon, Alexis; Clement, Julien			Inter-hospital variation in surgical intensity for trauma admissions: A multicentre cohort study	INTERNATIONAL JOURNAL OF CLINICAL PRACTICE			English	Article							LENGTH-OF-STAY; EASTERN ASSOCIATION; NONOPERATIVE MANAGEMENT; MULTIPLE IMPUTATION; HOSPITAL QUALITY; BRAIN-INJURY; GUIDELINES; SURGERY; CARE; COMPLICATIONS	Background Guidelines for injury care are increasingly moving away from surgical management towards less invasive procedures but there is a knowledge gap on how these recommendations are influencing practice. We aimed to assess inter-hospital variation in surgical intensity for injury admissions and evaluate the correlation between hospital surgical intensity and mortality/complications. Methods We included adults admitted for major trauma between 2006 and 2016 in a Canadian provincial trauma system. Analyses were stratified for orthopaedic (n = 16 887), neurological (n = 12 888) and torso injuries (n = 9816). Surgical intensity was quantified with the number of surgical procedures <72 hours. Inter-hospital variation was assessed with the intra-class correlation coefficient (ICC). We assessed the correlation between the risk-adjusted mean number of surgical procedures and risk-adjusted incidence of mortality and complications using Pearson correlation coefficients (r). Results Moderate inter-hospital variation was observed for orthopaedic surgery (ICC = 14.0%) whereas variation was low for torso surgery (ICC = 2.7%) and neurosurgery (ICC = 0.8%). Surgical intensity was negatively correlated with hospital mortality for torso injury (r = -.32,P = .02) and neurotrauma (r = -.65,P = .08). A strong positive correlation was observed with hospital complications for orthopaedic injuries (r = .36,P = .006) whereas the opposite was observed for neurotrauma (r = -.71,P = .05). Conclusions Results should be interpreted with caution as they may be a result of residual confounding. However, they may suggest that there are opportunities for quality improvement in surgical care for injury admissions, particularly for orthopaedic injuries. Moving forward, we should aim to prospectively evaluate adherence to guidelines on non-operative management and their impact on mortality and morbidity.	[Patton, Marie-Pier; Moore, Lynne; Farhat, Imen; Tardif, Pier-Alexandre] Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada; [Patton, Marie-Pier; Moore, Lynne; Farhat, Imen; Tardif, Pier-Alexandre; Lauzier, Francois; Turgeon, Alexis] Univ Laval, Traumatol Urgence Soins Intensifs Trauma Emergenc, Axe Sante Populat & Prat Optimales Sante Populat, Ctr Rech,CHU Quebec,Hop Enfant Jesus, Quebec City, PQ, Canada; [Gonthier, Catherine; Belcaid, Amina] Inst Natl Excellence Sante & Serv Sociaux INESSS, Quebec City, PQ, Canada; [Lauzier, Francois; Turgeon, Alexis] Univ Laval, Dept Med, Quebec City, PQ, Canada; [Lauzier, Francois] Univ Laval, Dept Anesthesiol & Crit Care, Div Crit Care, Quebec City, PQ, Canada; [Clement, Julien] Univ Laval, Dept Surg, Quebec City, PQ, Canada		Moore, L (corresponding author), CHU Quebec, Traumatol Urgence Soins Intensifs Trauma Emergenc, Axe Sante Populat & Prat Optimales Sante Populat, Enfant Jesus Hosp,Res Ctr, 1401,18e Rue,Local H-012a, Quebec City, PQ G1J 1Z4, Canada.	lynne.moore@fmed.ulaval.ca	; Lauzier, Francois/B-9237-2015	Moore, Lynne/0000-0002-6143-8888; Lauzier, Francois/0000-0002-6530-5513	Fonds de Recherche du Quebec - SanteFonds de la Recherche en Sante du Quebec [112775]; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [358052]	Fonds de Recherche du Quebec - Sante, Grant/Award Number: 112775; Canadian Institutes of Health Research, Grant/Award Number: 358052	American Academy of Orthopaedic Surgeons, 2020, GUID SUMM; American College of Surgeons, 2015, ACS TQIP BEST PRACT; American College of Surgeons - Committee on Trauma, 2014, RESOURCES OPTIMAL CA; Anderson GF, 2008, JAMA-J AM MED ASSOC, V299, P2444, DOI 10.1001/jama.299.20.2444; Austin PC, 2017, STAT MED, V36, P3257, DOI 10.1002/sim.7336; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Canadian Institute for Health Information (CIHI), 2018, CCI GUID INT COD ASS; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Choosing Wisely, CLIN LISTS ABIM FDN; Choosing Wisely Canada, 2016, 5 THINGS NOT DO ICU; Choudhary Niraj Kumar, 2018, Asian J Neurosurg, V13, P314, DOI 10.4103/ajns.AJNS_281_16; Coccolini F, 2017, WORLD J EMERG SURG, V12, DOI 10.1186/s13017-017-0117-6; Coccolini F, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0105-2; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Glance LG, 2010, ANN SURG, V252, P217, DOI 10.1097/SLA.0b013e3181e623f6; Graham, 2012, MISSING DATA ANAL DE; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Hayat MJ, 2014, J NURS EDUC, V53, P208, DOI 10.3928/01484834-20140325-04; Hicks LK, 2015, J ONCOL PRACT, V11, P168, DOI 10.1200/JOP.2015.004283; Ho VP, 2017, J TRAUMA ACUTE CARE, V82, P185, DOI 10.1097/TA.0000000000001300; Holena DN, 2020, J TRAUMA ACUTE CARE, V88, P42, DOI 10.1097/TA.0000000000002491; Jamous M, 2010, EUR J TRAUMA EMERG S, V36, P465, DOI 10.1007/s00068-010-0002-4; Jha AK, 2009, HEALTH AFFAIR, V28, P897, DOI 10.1377/hlthaff.28.3.897; Kalayci M, 2013, J PAK MED ASSOC, V63, P38; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Krogstad U, 2005, QUAL SAF HEALTH CARE, V14, P438, DOI 10.1136/qshc.2005.014233; Kuimi BLB, 2015, INJURY, V46, P595, DOI 10.1016/j.injury.2015.01.006; Liu W., 2008, COUNT DATA MODELS SA; Luta X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123764; Menendez ME, 2014, CLIN ORTHOP RELAT R, V472, P2878, DOI 10.1007/s11999-014-3686-7; Missios S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092057; Moore L, 2005, J TRAUMA, V59, P698, DOI 10.1097/01.ta.0000177700.54943.ee; Moore L, 2016, JAMA SURG, V151, P622, DOI 10.1001/jamasurg.2015.5484; Moore L, 2014, J TRAUMA ACUTE CARE, V77, P322, DOI 10.1097/TA.0000000000000366; Moore L, 2014, ANN SURG, V260, P179, DOI 10.1097/SLA.0000000000000624; Moore L, 2012, CRIT CARE, V16, DOI 10.1186/cc11680; Moore L, 2010, J TRAUMA, V69, P1132, DOI 10.1097/TA.0b013e3181cc8449; Moore Lynne, 2009, J Emerg Trauma Shock, V2, P73, DOI 10.4103/0974-2700.44774; Moore L, 2009, J AM COLL SURGEONS, V209, P572, DOI 10.1016/j.jamcollsurg.2009.07.004; Mukaka MM, 2012, MALAWI MED J, V24, P69; Palmer CS, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-1; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rysavy MA, 2015, NEW ENGL J MED, V372, P1801, DOI 10.1056/NEJMoa1410689; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Schomaker M, 2018, STAT MED, V37, P2252, DOI 10.1002/sim.7654; Shafi S, 2009, ARCH SURG-CHICAGO, V144, P64, DOI 10.1001/archsurg.2008.509; Sperandei S, 2014, BIOCHEM MEDICA, V24, P12, DOI 10.11613/BM.2014.003; Stassen NA, 2012, J TRAUMA ACUTE CARE, V73, pS294, DOI 10.1097/TA.0b013e3182702afc; Stassen NA, 2012, J TRAUMA ACUTE CARE, V73, pS288, DOI 10.1097/TA.0b013e318270160d; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Tardif PA, 2017, INJURY, V48, P94, DOI 10.1016/j.injury.2016.10.042; Thomas JW, 2004, INT J QUAL HEALTH C, V16, P181, DOI 10.1093/intqhc/mzh035; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Tohira H, 2011, J TRAUMA, V71, P1829, DOI 10.1097/TA.0b013e31823cc5c5; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wennberg JE, 2008, TRACKING CARE PATIEN; WHO, 2010, STRENGTHENING CARE FOR THE INJURED: SUCCESS STORIES AND LESSONS LEARNED FROM AROUND THE WORLD, P1; World Health Organization, 2010, VIOL INJ PREV; Yasaitis L, 2009, HEALTH AFFAIR, V28, pW566, DOI 10.1377/hlthaff.28.4.w566; Yuan Y, 2011, J STAT SOFTW, V45, P1; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	62	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-5031	1742-1241		INT J CLIN PRACT	Int. J. Clin. Pract.	NOV	2020	74	11							e13613	10.1111/ijcp.13613		AUG 2020	12	Medicine, General & Internal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pharmacology & Pharmacy	OI5GB	WOS:000562869800001	32683730				2022-02-06	
J	Usmani, S; Balcer, L; Galetta, S; Minen, M				Usmani, Saima; Balcer, Laura; Galetta, Steven; Minen, Mia			Feasibility of Smartphone-Delivered Progressive Muscle Relaxation in Persistent Post-Traumatic Headache Patients	JOURNAL OF NEUROTRAUMA			English	Article						behavior therapy; persistent headache attributed to traumatic injury to the head; post-concussion syndrome; telemedicine; traumatic brain injury	MIND-BODY INTERVENTIONS; TRAUMATIC BRAIN-INJURY; BEHAVIORAL INTERVENTIONS; NATURAL-HISTORY; ANXIETY; SYMPTOMS; QUALITY; OLDER	Persistent post-traumatic headache (PPTH) is often the most common injury after mild traumatic brain injury (mTBI), reported by 47-95% of patients. Progressive muscle relaxation (PMR) has level A evidence in preventing migraine and tension headaches. However, research on this behavioral therapy for PPTH, let alone smartphone delivered, is limited. We performed a single-arm study of prospective patients calling our Concussion Center between June 2017 and July 2018. Inclusion criteria were that subjects had to meet International Classification of Headache Disorders, 3rd Edition criteria for PPTH secondary to mTBI, have four or more headache days a month, be age 18-85 years and 3-12 months post-injury, own a smartphone, and not tried headache behavioral therapy within the year. We recorded baseline headache and neuropsychiatric data. Using the RELAXaHEAD smartphone application, which has a headache diary and PMR audio files, participants were instructed to record headache symptoms and practice 20 min of PMR daily. There were three monthly follow-up assessments. There were 49 subjects enrolled. Basic demographics were: 33 (67%) female with mean age 40.1 +/- 14.6 [20, 75] years. Of the 49 subjects, 15 (31%) had pre-existing headaches. In 11 (22%) subjects, mTBI was sports related. Subjects reported 17.7 +/- 9.3 [4, 31] headache days in the month before enrollment, and 49 (100%) experienced over three concussion symptoms. Participants inputted data in the RELAXaHEAD app on average 18.3 +/- 12.0 days [0, 31] the first month. Number of participants who did PMR over four times per week was 12 (24.5%) the first month, 9 (22.5%) the second month, and 6 (15%) the third month. After 3 months, 17 (42.5 %) participants continued doing PMR. Participants cited time constraints, forgetfulness, application glitches, and repetitiveness as obstacles to practicing PMR. It is feasible to get PPTH subjects to practice behavioral therapy through low-cost smartphone-based PMR two times weekly. Future work will assess efficacy and examine how to optimize barriers to PMR.	[Usmani, Saima; Balcer, Laura; Galetta, Steven; Minen, Mia] NYU, Dept Neurol, Langone Med Ctr, New York, NY 10016 USA		Usmani, S (corresponding author), NYU, Langone Med Ctr, 35 Revere Court, West Windsor, NJ 08550 USA.	paperclip137@gmail.com			NYU Clinical and Translational Science Institute (CTSI) [UL1TR 001445]; National Center for Complementary and Integrative Health (NCCIH) [K23AT009706-01]; Center for Healthcare Innovation and Delivery (CHIDS) Empire Clinical Research Investigator Program American Academy of Neurology-American Brain Foundation Practice Research Training Fellowship	NYU Clinical and Translational Science Institute (CTSI): UL1TR 001445; National Center for Complementary and Integrative Health (NCCIH): K23AT009706-01; Center for Healthcare Innovation and Delivery (CHIDS) Empire Clinical Research Investigator Program American Academy of Neurology-American Brain Foundation Practice Research Training Fellowship.	Andrasik F, 2003, NEUROL SCI, V24, pS80; [Anonymous], 2018, Cephalalgia, V38, P1, DOI 10.1177/0333102417738202; [Anonymous], 2013, Br J Sports Med, V47, P259; Bomyea J, 2016, HEADACHE, V56, P699, DOI 10.1111/head.12799; DALY EJ, 1983, BIOFEEDBACK SELF-REG, V8, P135, DOI 10.1007/BF01000544; De Benedittis G, 1983, J Neurosurg Sci, V27, P177; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Fraser F, 2017, CURR PAIN HEADACHE R, V21, DOI 10.1007/s11916-017-0624-x; Ghafari S, 2009, J CLIN NURS, V18, P2171, DOI 10.1111/j.1365-2702.2009.02787.x; GUSTAFSON R, 1992, PSYCHOL REP, V70, P124, DOI 10.2466/PR0.70.1.124-126; Haut SR, 2018, NEUROLOGY, V90, pE963, DOI 10.1212/WNL.0000000000005109; HEIDE FJ, 1983, J CONSULT CLIN PSYCH, V51, P171, DOI 10.1037/0022-006X.51.2.171; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; HOLLAND JC, 1991, J CLIN ONCOL, V9, P1004, DOI 10.1200/JCO.1991.9.6.1004; JANSSEN K, 1986, BEHAV RES THER, V24, P199, DOI 10.1016/0005-7967(86)90091-4; Kjeldgaard D, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-81; Klainin-Yobas P, 2015, AGING MENT HEALTH, V19, P1043, DOI 10.1080/13607863.2014.997191; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Matsuzawa Y, 2019, HEADACHE, V59, P19, DOI 10.1111/head.13429; Minen M, 2019, HEADACHE, V59, P151, DOI 10.1111/head.13455; Minen MT, 2018, PAIN MED, V19, P2274, DOI 10.1093/pm/pny028; Minen MT, 2019, PAIN MED, V20, P369, DOI 10.1093/pm/pny080; Minen MT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0697-7; Minen MT, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0608-y; Olesen J., 2006, HEADACHES; Penzien DB, 2002, APPL PSYCHOPHYS BIOF, V27, P163, DOI 10.1023/A:1016247811416; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; Sun JX, 2013, J CLIN NURS, V22, P1270, DOI 10.1111/jocn.12096; Tassorelli C, 2018, CEPHALALGIA, V38, P815, DOI 10.1177/0333102418758283; Tatrow K, 2003, APPL PSYCHOPHYS BIOF, V28, P267, DOI 10.1023/A:1027326808356; Wahbeh H, 2008, NEUROLOGY, V70, P2321, DOI 10.1212/01.wnl.0000314667.16386.5e	34	1	1	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2021	38	1					94	101		10.1089/neu.2019.6601		AUG 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PN6IA	WOS:000566010900001	32484070	Green Published			2022-02-06	
J	Crichton, T; Singh, R; Abosi-Appeadu, K; Dennis, G				Crichton, Thomas; Singh, Rajiv; Abosi-Appeadu, Kessewa; Dennis, Gary			Excessive daytime sleepiness after traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; excessive daytime sleepiness; anxiety; epworth sleepiness scale	WAKE DISTURBANCES; RATING-SCALE; LATENCY TEST; HEAD-INJURY; DEPRESSION; DISORDERS; ANXIETY; NEED; QUESTIONNAIRE; ASSOCIATION	Study Objectives To identify the prevalence of excessive daytime sleepiness (EDS) in a prospectively recruited patient population with traumatic brain injury (TBI) of mixed severity. Furthermore, the study aimed to assess the relationship between patient factors and EDS. Method One-hundred and eighteen patients with TBI were assessed in a neurorehabilitation clinic after discharge from the emergency department. Enrolled participants were evaluated using several TBI-related outcome measures, 6-8 weeks after injury. Results EDS (defined using the Epworth Sleepiness Scale >= 10) occurred in 48 of 118 (41.7%) patients in this study. Anxiety; depression; change in ability to work; employment status; global outcome (GOSE); social and functional outcome (RHFUQ); and symptom severity (RPCS) were associated with EDS in a univariate analysis. Anxiety was the only factor associated with EDS in the multivariate analysis (OR: 0.28 [95% CI: 0.09-0.90],P= .032). Conclusion EDS is common after TBI in a community setting and is associated with several factors, which likely interact to contribute toward worse outcome. Anxiety is a factor that, if routinely assessed and considered during patient care choices, may assist in favorable sleep-related outcome during and after post-TBI recovery.	[Crichton, Thomas; Singh, Rajiv; Dennis, Gary] Univ Sheffield, Dept Neurosci, Sheffield, S Yorkshire, England; [Singh, Rajiv] Sheffield Teaching Hosp, Dept Rehabil Med, Osborn Neurorehabil Unit, Sheffield, S Yorkshire, England; [Abosi-Appeadu, Kessewa] Univ Ghent, Fac Med & Hlth Sci, Ghent, Belgium; [Dennis, Gary] Sheffield Teaching Hosp, Dept Neurol, Sheffield, S Yorkshire, England		Crichton, T (corresponding author), Univ Sheffield, Sheffield Inst Translat Neurosci Sitran, Dept Neurosci, Sheffield S10 2HQ, S Yorkshire, England.	tcrichton9@googlemail.com			Sheffield Institute for Translational Neuroscience (SITraN)	We would like to thank the study participants for their contribution to the study. We also thank the Sheffield Institute for Translational Neuroscience (SITraN) for their support.	Aurora RN, 2011, SLEEP, V34, P1707, DOI 10.5665/sleep.1442; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Benbadis SR, 1999, ANN INTERN MED, V130, P289, DOI 10.7326/0003-4819-130-4-199902160-00014; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Connor J, 2001, ACCIDENT ANAL PREV, V33, P31, DOI 10.1016/S0001-4575(00)00013-0; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Guilleminault C, 2001, BRAIN, V124, P1482, DOI 10.1093/brain/124.8.1482; Guilleminault C, 2000, NEUROLOGY, V54, P653, DOI 10.1212/WNL.54.3.653; Hocomb EM, 2012, ARCH PHYS MED REHAB, V93, P1338, DOI 10.1016/j.apmr.2012.04.029; Hudon C, 2005, J CLIN EPIDEMIOL, V58, P603, DOI 10.1016/j.jclinepi.2004.10.017; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Jang SH, 2016, J NEUROL NEUROSUR PS, V87, P1260, DOI 10.1136/jnnp-2016-313093; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; Masel BE, 2001, ARCH PHYS MED REHAB, V82, P1526, DOI 10.1053/apmr.2001.26093; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nutt D, 2008, DIALOGUES CLIN NEURO, V10; Nutt DJ, 2001, J CLIN PSYCHIAT, V62, P22; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Singh R, 2018, BRAIN INJURY, V32, P84, DOI 10.1080/02699052.2017.1376756; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; Tsaousides T, 2008, REHABIL PSYCHOL, V53, P456, DOI 10.1037/a0012579; Valko PO, 2015, ANN NEUROL, V77, P177, DOI 10.1002/ana.24298; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wu SQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-849; Wulfing C, 2009, J CLIN ONCOL, V27; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	43	1	2	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 18	2020	34	11					1525	1531		10.1080/02699052.2020.1810316		AUG 2020	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NR9QK	WOS:000562201900001	32835526				2022-02-06	
J	Reyes, LD; Haight, T; Desai, A; Chen, HZ; Bosomtwi, A; Korotcov, A; Dardzinski, B; Kim, HY; Pierpaoli, C				Reyes, Laura D.; Haight, Thaddeus; Desai, Abhishek; Chen, Huazhen; Bosomtwi, Asamoah; Korotcov, Alexandru; Dardzinski, Bernard; Kim, Hee-Yong; Pierpaoli, Carlo			Investigation of the effect of dietary intake of omega-3 polyunsaturated fatty acids on trauma-induced white matter injury with quantitative diffusion MRI in mice	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						closed-head injury; diffusion tensor imaging; mouse; MRI; omega-3 fatty acids; traumatic brain injury	DOCOSAHEXAENOIC ACID; BRAIN-INJURY; DIFFEOMORPHIC REGISTRATION; AXONAL INJURY; HEAD-INJURY; ISCHEMIA; SUPPLEMENTATION; NEUROPROTECTION; TRANSIENT; OMEGA-3-FATTY-ACIDS	Previous studies suggest that long-term supplementation and dietary intake of omega-3 polyunsaturated fatty acids (PUFAs) may have neuroprotective effects following brain injury. The objective of this study was to investigate potential neuroprotective effects of omega-3 PUFAs on white matter following closed-head trauma. The closed-head injury model of engineered rotational acceleration (CHIMERA) produces a reproducible injury in the optic tract and brachium of the superior colliculus in mice. Damage is detectable using diffusion tensor imaging (DTI) metrics, particularly fractional anisotropy (FA), with sensitivity comparable to histology. We acquiredin vivo(n = 38) andex vivo(n = 41) DTI data in mice divided into sham and CHIMERA groups with two dietary groups: one deficient in omega-3 PUFAs and one adequate in omega-3 PUFAs. We examined injury effects (reduction in FA) and neuroprotection (FA reduction modulated by diet) in the optic tract and brachium. We verified that diet did not affect FA in sham animals. In injured animals, we found significantly reduced FA in the optic tract and brachium (similar to 10% reduction,p < 0.001), and Bayes factor analysis showed strong evidence to reject the null hypothesis. However, Bayes factor analysis showed substantial evidence to accept the null hypothesis of no diet-related FA differences in injured animals in thein vivoandex vivosamples. Our results indicate no neuroprotective effect from adequate dietary omega-3 PUFA intake on white matter damage following traumatic brain injury. Since damage from CHIMERA mainly affects white matter, our results do not necessarily contradict previous findings showing omega-3 PUFA-mediated neuroprotection in gray matter.	[Reyes, Laura D.; Pierpaoli, Carlo] Natl Inst Biomed Imaging & Bioengn, Quantitat Med Imaging Sect, NIH, 13 South Dr,Bldg 13 Room 3W43, Bethesda, MD 20852 USA; [Reyes, Laura D.; Haight, Thaddeus; Bosomtwi, Asamoah; Korotcov, Alexandru] Adv Mil Med Inc, Henry M Jackson Fdn, Bethesda, MD USA; [Haight, Thaddeus; Kim, Hee-Yong] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Desai, Abhishek; Chen, Huazhen] NIAAA, Lab Mol Signaling, NIH, Bethesda, MD USA; [Bosomtwi, Asamoah] Augusta Univ, Georgia Canc Ctr, Augusta, GA USA; [Bosomtwi, Asamoah; Korotcov, Alexandru; Dardzinski, Bernard] Uniformed Serv Univ Hlth Sci, Dept Radiol & Radiol Sci, Bethesda, MD USA		Reyes, LD (corresponding author), Natl Inst Biomed Imaging & Bioengn, Quantitat Med Imaging Sect, NIH, 13 South Dr,Bldg 13 Room 3W43, Bethesda, MD 20852 USA.	laura.reyes@nih.gov	Pierpaoli, Carlo/E-1672-2011	Pierpaoli, Carlo/0000-0001-8558-4428; Reyes, Laura/0000-0002-0404-1817	CNRM HJF Award [307513-3.01-60855]	CNRM HJF Award Number 307513-3.01-60855	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Avants B., 2017, ANTSR ANTS R QUANTIF; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; BAZAN NG, 1970, BIOCHIM BIOPHYS ACTA, V218, P1, DOI 10.1016/0005-2760(70)90086-X; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Belayev L, 2011, TRANSL STROKE RES, V2, P33, DOI 10.1007/s12975-010-0046-0; Belayev L, 2009, STROKE, V40, P3121, DOI 10.1161/STROKEAHA.109.555979; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Cai MF, 2017, AGING DIS, V8, P531, DOI 10.14336/AD.2017.0520; Cao DH, 2007, J NUTR BIOCHEM, V18, P297, DOI 10.1016/j.jnutbio.2006.05.005; Cao DH, 2006, J NUTR BIOCHEM, V17, P234, DOI 10.1016/j.jnutbio.2005.04.006; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Desai A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0714-4; Desai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086472; Faulkenberry Thomas J, 2018, J Undergrad Neurosci Educ, V16, pA126; Fernandes JS, 2008, NUTR RES, V28, P798, DOI 10.1016/j.nutres.2008.09.004; Haber M, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0164-17.2017; Hedges LV., 1981, J EDUC STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.2307/1164588]; Hong SH, 2014, J NEUROL SCI, V338, P135, DOI 10.1016/j.jns.2013.12.033; Irfanoglu M.O., 2017, ISMRM ANN M HAW, P3540; Irfanoglu MO, 2016, NEUROIMAGE, V132, P439, DOI 10.1016/j.neuroimage.2016.02.066; Irfanoglu MO, 2015, NEUROIMAGE, V106, P284, DOI 10.1016/j.neuroimage.2014.11.042; Jeffreys H., 1961, THEORY PROBABILITY, V3; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jiang XY, 2016, TRANSL STROKE RES, V7, P548, DOI 10.1007/s12975-016-0502-6; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Krzywinski M, 2013, NAT METHODS, V10, P1041, DOI 10.1038/nmeth.2698; Lalancette-Hebert M, 2011, STROKE, V42, P2903, DOI 10.1161/STROKEAHA.111.620856; Laye S, 2018, PHARMACOL REV, V70, P12, DOI 10.1124/pr.117.014092; Laye S, 2010, PROSTAG LEUKOTR ESS, V82, P295, DOI 10.1016/j.plefa.2010.02.006; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Okada M, 1996, NEUROSCIENCE, V71, P17, DOI 10.1016/0306-4522(95)00427-0; Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.3.CO;2-A; Pan HC, 2009, J NUTR BIOCHEM, V20, P715, DOI 10.1016/j.jnutbio.2008.06.014; Pernet C., 2016, F1000RESEARCH, V4, DOI [10.12688/f1000research.6963.3, DOI 10.12688/F1000RESEARCH.6963.3]; Pierpaoli C., 2010, ISMRM 18 ANN M, P1597; Pu HJ, 2017, CELL TRANSPLANT, V26, P555, DOI [10.3727/096368916x693842, 10.3727/096368916X693842]; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; R Core Team, 2017, R LANG ENV STAT COMP; REHNCRONA S, 1982, J NEUROCHEM, V38, P84, DOI 10.1111/j.1471-4159.1982.tb10857.x; Saadani-Makki F, 2009, J CHILD NEUROL, V24, P1179, DOI 10.1177/0883073809338213; Sadeghi N, 2015, NEUROIMAGE, V109, P480, DOI 10.1016/j.neuroimage.2014.12.084; Simopoulos AP, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030128; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Surette ME, 2008, CAN MED ASSOC J, V178, P177, DOI 10.1503/cmaj.071356; Trepanier MO, 2016, EUR J PHARMACOL, V785, P187, DOI 10.1016/j.ejphar.2015.05.045; Walker L, 2011, NEUROIMAGE, V54, P1168, DOI 10.1016/j.neuroimage.2010.08.048; YOSHIDA S, 1986, J NEUROCHEM, V47, P744; Zhang MJ, 2014, J NEUROSCI, V34, P1903, DOI 10.1523/JNEUROSCI.4043-13.2014; Zhang WT, 2010, STROKE, V41, P2341, DOI 10.1161/STROKEAHA.110.586081	57	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	NOV	2020	98	11					2232	2244		10.1002/jnr.24705		AUG 2020	13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NV4CZ	WOS:000563979700001	32840025	Green Published, hybrid			2022-02-06	
J	Shobeirian, F; Ghomi, Z; Soleimani, R; Mirshahi, R; Taheri, MS				Shobeirian, Farzaneh; Ghomi, Zahra; Soleimani, Reza; Mirshahi, Reza; Taheri, Morteza Sanei			Overuse of brain CT scan for evaluating mild head trauma in adults	EMERGENCY RADIOLOGY			English	Article						Minor head injury; CT scan; Indication; Traumatic brain injury	COMPUTED-TOMOGRAPHY USE; INJURY; EPIDEMIOLOGY; RULE	Introduction CT scan is crucial in evaluating head trauma. However, its inappropriate use will cause unnecessary radiation exposure to patient and financial burden to health systems. Our aim is appraising amount of brain CT scans performed in our Emergency Department (ED) for evaluating mild head trauma which are not indicated according to four standardized guidelines as well as analyzing contributing factors. Methods This was a descriptive prospective study. We included randomly selected adult patients under 75 years old with minor head trauma evaluated by brain CT scan at our ED. For all patients, we completed a checklist including demographic data, mechanism of trauma, specialty of the requesting physician, and whether the patient meets the brain CT guidelines criteria. Brain CT overuse was defined as scans performed for patients without criteria of any of the standardized guidelines. Results We evaluated 170 patients. The mean age of patients was 38.38 +/- 19.73 years old. The most common mechanism of trauma was falling (37.6%). The overall brain CT scan overuse was 15.3%. Most of the overused scans were performed in younger patients, and patient's age was inversely correlated to overuse. There was no significant difference based on the mechanism of trauma and the specialty of requesting physician. Discussion Our study accentuates the high frequency of brain CT scan overuse, leading to unnecessary radiation exposure and financial burden on healthcare systems. We emphasize that using a guideline for requesting brain CT scan can eliminate unnecessary scans along with detecting patients with important decisive damages.	[Shobeirian, Farzaneh] Guilan Univ Med Sci, Razi Hosp, Dept Radiol, Rasht, Iran; [Ghomi, Zahra; Taheri, Morteza Sanei] Shahid Beheshti Univ Med Sci, Shohada E Tajrish Hosp, Dept Radiol, Tehran, Iran; [Soleimani, Reza] Kerman Univ Med Sci, Dept Radiol, Kerman, Iran; [Mirshahi, Reza] Iran Univ Med Sci, Eye Res Ctr, Five Senses Inst, Tehran, Iran		Ghomi, Z (corresponding author), Shahid Beheshti Univ Med Sci, Shohada E Tajrish Hosp, Dept Radiol, Tehran, Iran.	zgh1881@gmail.com	Mirshahi, Reza/D-1377-2019; ghomi, zahra/AAD-4229-2022	Mirshahi, Reza/0000-0002-5997-6417; ghomi, zahra/0000-0003-3113-2375; Soleimani, Reza/0000-0001-9277-8466			ACEP, MILD TRAUM BRAIN INJ; Bhalla K, 2009, INJURY PREV, V15, P150, DOI 10.1136/ip.2008.020826; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Brenner DJ, 2012, CANC RISKS CT SCANS; Campiglio L, 2017, NEUROL-CLIN PRACT, V7, P296, DOI 10.1212/CPJ.0000000000000375; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cellina M, 2018, RADIOL MED, V123, P507, DOI 10.1007/s11547-018-0871-x; Fortin EM, 2016, EMERG RADIOL, V23, P597, DOI 10.1007/s10140-016-1424-z; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Gerritsen H, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020364; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Haydon NB, 2013, J MED IMAG RADIAT ON, V57, P161, DOI 10.1111/1754-9485.12007; Ip IK, 2015, AM J EMERG MED, V33, P320, DOI 10.1016/j.ajem.2014.11.005; Jame SZB, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.13067; Klang E, 2017, J AM COLL RADIOL, V14, P171, DOI 10.1016/j.jacr.2016.08.032; Landes M, 2017, AFR J EMERG MED, V7, P130, DOI 10.1016/j.afjem.2017.04.001; Melnick ER, 2015, ACAD EMERG MED, V22, P1474, DOI 10.1111/acem.12824; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Natale JE, 2012, ARCH PEDIAT ADOL MED, V166, P732, DOI 10.1001/archpediatrics.2012.307; Nayebaghayee Hossein, 2016, Asian J Neurosurg, V11, P46, DOI 10.4103/1793-5482.165780; NICE, HEAD INJ NICE; Orlando A, 2017, WORLD NEUROSURG, V107, P94, DOI [10.1016/j.wneu.2017.07.130, 10.1016/J.WNEU.2017.07.130]; Owlia M, 2014, AM J MED, V127, P406, DOI 10.1016/j.amjmed.2014.01.023; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Saboori M, 2007, CLIN NEUROL NEUROSUR, V109, P399, DOI 10.1016/j.clineuro.2007.01.013; Salerno S, 2016, RADIOL MED, V121, P144, DOI 10.1007/s11547-015-0584-3; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Walsh L, 2014, J RADIOL PROT, V34, pE1, DOI 10.1088/0952-4746/34/1/E1; Webster NJ, 2017, ADV EMERG NURS J, V39, P300, DOI 10.1097/TME.0000000000000169	30	1	1	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1070-3004	1438-1435		EMERG RADIOL	Emerg. Radiol.	APR	2021	28	2					251	257		10.1007/s10140-020-01846-6		AUG 2020	7	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	QV8OY	WOS:000562697700001	32844320				2022-02-06	
J	Evans, RW; Strutt, AM				Evans, Randolph W.; Strutt, Adriana M.			Medico-Legal Aspects of Concussion	HEADACHE			English	Article						concussion; mild traumatic brain injury; post-concussion syndrome; post-traumatic headache; cognitive impairment; cognitive rehabilitation	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSION SYNDROME; CHRONIC PAIN; NEUROPSYCHOLOGICAL OUTCOMES; COGNITIVE SEQUELAE; TEST-PERFORMANCE; HEAD-INJURY; SYMPTOMS	Concussion and the sequelae have been controversial medico-legal issues for over 150 years. The following topics which are also important in clinical practice are discussed: definitions of concussion, neuroimaging, onset and prognosis of headaches, cognitive impairment, cognitive rehabilitation, post-traumatic stress disorder, and risk of later development of dementia.	[Evans, Randolph W.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Strutt, Adriana M.] BCM Med Ctr, Dept Neurol, Houston, TX USA; [Strutt, Adriana M.] BCM Med Ctr, Dept Psychiat & Behav Sci, Houston, TX USA		Evans, RW (corresponding author), 1200 Binz 1370, Houston, TX 77004 USA.	revansmd@gmail.com					American Association of Neurological Surgeons, NEUR COND TREAT CONC; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Andrikopoulos J, 2003, HEADACHE, V43, P553; [Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Barker MJ, 2004, CNS DRUGS, V18, P37, DOI 10.2165/00023210-200418010-00004; Barr WB, 2020, ARCH CLIN NEUROPSYCH, V35, P128, DOI 10.1093/arclin/acz075; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bhowmick S, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8010011; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Boirel A, 1674, TRITE PLAYES TESTE; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chepenik LG, 2007, EMOTION, V7, P802, DOI 10.1037/1528-3542.7.4.802; Choi MS, 2014, J KOREAN NEUROSURG S, V55, P190, DOI 10.3340/jkns.2014.55.4.190; CHOW TW, 1999, SCI PRACT NEUROPSYCH, P3; Cook NE, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00002; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Custer A, 2016, J ATHL TRAINING, V51, P136, DOI 10.4085/1062-6050-51.2.12; de Koning ME, 2017, NEUROLOGY, V89, P1908, DOI 10.1212/WNL.0000000000004604; DEGAGE SB, 2012, BMJ-BRIT MED J, V345, DOI DOI 10.1136/BMJ.E6231; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Delis D.C., 2001, CALIFORNIA VERBAL LE; Doose-Grunefeld S, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00003; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P81, DOI 10.1017/S1355617713001288; Douglas DB, 2018, CURR OPIN NEUROL, V31, P362, DOI 10.1097/WCO.0000000000000567; Duenas M, 2016, J PAIN RES, V9, P457, DOI 10.2147/JPR.S105892; Dumke HA, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000244; Dwyer B, 2018, HAND CLINIC, V158, P163, DOI 10.1016/B978-0-444-63954-7.00017-3; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Evans RW, 2018, HEADACHE, V58, P836, DOI 10.1111/head.13272; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; EVANS RW, 1994, SEMIN NEUROL, V14, P32, DOI 10.1055/s-2008-1041056; Evans RW, UPTODATE; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Gates MA, 2012, PSYCHOL SERV, V9, P361, DOI 10.1037/a0027649; Gil-Gouveia R, 2016, PAIN PHYSICIAN, V19, pE137; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; GOLDBERG E, 2001, EXECUTIVE BRAIN; Gould Thomas J, 2010, Addict Sci Clin Pract, V5, P4; Greve KW, 2009, ARCH PHYS MED REHAB, V90, P1117, DOI 10.1016/j.apmr.2009.01.018; Hannay HJ., 2004, NEUROPSYCHOLOGICAL A, V4, P157; Headache Classification Committee of the International Headache Society (IHS), 2018, CEPHALALGIA, V38, P64; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; IVERSON G, 2014, BRAIN INJURY, V28, P667; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218997; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kaufman NK, 2019, PSYCHOL INJ LAW, V12, P91, DOI 10.1007/s12207-019-09355-9; Kontos AP, 2018, MIL MED, V183, P333, DOI 10.1093/milmed/usx172; Larrabee GJ, 2013, BEHAV SCI LAW, V31, P686, DOI 10.1002/bsl.2087; Loring DW, 2011, NEUROLOGY, V76, P131, DOI 10.1212/WNL.0b013e318206ca02; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Manzanero S., 2017, J CONCUSSION, DOI [10.1177/2059700217726874, DOI 10.1177/2059700217726874]; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McCrory PR, 2001, NEUROLOGY, V57, P2283, DOI 10.1212/WNL.57.12.2283; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Morris T, 2019, HDB MED NEUROPSYCHOL, P19; Mullally WJ, 2017, AM J MED, V130, P885, DOI 10.1016/j.amjmed.2017.04.016; Nelson NW, 2020, NEUROPSYCHOLOGY, V34, P116, DOI 10.1037/neu0000594; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Powell GE, 2008, J NEUROL NEUROSUR PS, V79, P237, DOI 10.1136/jnnp.2007.131722; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Pozzato I, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034494; Quinn DK, 2018, AM J PSYCHIAT, V175, P103, DOI 10.1176/appi.ajp.2017.17020235; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Riegler KE, 2020, NEUROPSYCHOLOGY, V34, P63, DOI 10.1037/neu0000582; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Roth R. S., 2013, INT J PHYS MED REHAB, V1, P1, DOI [10.4172/2329-9096.1000105, DOI 10.4172/2329-9096.1000105]; Rowe BH, 2018, AM J EMERG MED, V36, P2144, DOI 10.1016/j.ajem.2018.03.040; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Schrader Harald, 2009, BMC Med Imaging, V9, P11, DOI 10.1186/1471-2342-9-11; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stewart WF, 2008, CEPHALALGIA, V28, P1170, DOI 10.1111/j.1468-2982.2008.01666.x; Strutt AM, USE PERFORMANCE VALI; Stucky KJ, 2014, NEUROPSYCHOLOGY STUD, P432; Sussman ES, 2018, HAND CLINIC, V158, P21, DOI 10.1016/B978-0-444-63954-7.00003-3; Vanderploeg RD, 2019, REHABIL PSYCHOL, V64, P1, DOI 10.1037/rep0000255; Vasterling JJ, 2012, PTSD MILD TRAUMATIC; Victoroff J, 2019, CONCUSSION AND TRAUMATIC ENCEPHALOPATHY: CAUSES, DIAGNOSIS, AND MANAGEMENT, P33; Vikane E, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/8026414; Walia HK, 2019, CLEV CLIN J MED, V86, P19, DOI 10.3949/ccjm.86.s1.04; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Weathers F., 2013, CLINICIAN ADMINISTER; Yilmaz T, 2017, EMERG MED J, V34, P800, DOI 10.1136/emermed-2015-205429; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	108	1	1	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	SEP	2020	60	8					1749	1760		10.1111/head.13926		AUG 2020	12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NI5QV	WOS:000561434900001	32827445				2022-02-06	
J	Tageldeen, MK; Gowers, SAN; Leong, CL; Boutelle, MG; Drakakis, EM				Tageldeen, Momen K.; Gowers, Sally A. N.; Leong, Chi L.; Boutelle, Martyn G.; Drakakis, Emmanuel M.			Traumatic brain injury neuroelectrochemical monitoring: behind-the-ear micro-instrument and cloud application	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article						Traumatic brain injury (TBI); Flexible PCB; Wireless brain monitoring; Cloud processing; Microdialysis	SPREADING DEPOLARIZATION; METABOLIC CRISIS; WIRELESS; GLUCOSE; MICRODIALYSIS; LACTATE	Background Traumatic Brain Injury (TBI) is a leading cause of fatality and disability worldwide, partly due to the occurrence of secondary injury and late interventions. Correct diagnosis and timely monitoring ensure effective medical intervention aimed at improving clinical outcome. However, due to the limitations in size and cost of current ambulatory bioinstruments, they cannot be used to monitor patients who may still be at risk of secondary injury outside the ICU. Methods We propose a complete system consisting of a wearable wireless bioinstrument and a cloud-based application for real-time TBI monitoring. The bioinstrument can simultaneously record up to ten channels including both ECoG biopotential and neurochemicals (e.g. potassium, glucose and lactate), and supports various electrochemical methods including potentiometry, amperometry and cyclic voltammetry. All channels support variable gain programming to automatically tune the input dynamic range and address biosensors' falling sensitivity. The instrument is flexible and can be folded to occupy a small space behind the ear. A Bluetooth Low-Energy (BLE) receiver is used to wirelessly connect the instrument to a cloud application where the recorded data is stored, processed and visualised in real-time. Bench testing has been used to validate device performance. Results The instrument successfully monitored spreading depolarisations (SDs) - reproduced using a signal generator - with an SNR of 29.07 dB and NF of 0.26 dB. The potentiostat generates a wide voltage range from -1.65V to +1.65V with a resolution of 0.8mV and the sensitivity of the amperometric AFE was verified by recording 5 pA currents. Different potassium, glucose and lactate concentrations prepared in lab were accurately measured and their respective working curves were constructed. Finally,the instrument achieved a maximum sampling rate of 1.25 ksps/channel with a throughput of 105 kbps. All measurements were successfully received at the cloud. Conclusion The proposed instrument uniquely positions itself by presenting an aggressive optimisation of size and cost while maintaining high measurement accuracy. The system can effectively extend neuroelectrochemical monitoring to all TBI patients including those who are mobile and those who are outside the ICU. Finally, data recorded in the cloud application could be used to help diagnosis and guide rehabilitation.	[Tageldeen, Momen K.; Drakakis, Emmanuel M.] Imperial Coll London, Dept Bioengn, Bioinspired VLSI Circuits & Syst Grp, Exhibit Rd, London SW7 2AZ, England; [Gowers, Sally A. N.; Leong, Chi L.; Boutelle, Martyn G.] Imperial Coll London, Dept Bioengn, Biomed Sensors Grp, Exhibit Rd, London SW7 2AZ, England		Drakakis, EM (corresponding author), Imperial Coll London, Dept Bioengn, Bioinspired VLSI Circuits & Syst Grp, Exhibit Rd, London SW7 2AZ, England.	e.drakakis@imperial.ac.uk					Brooks GA, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00408; Cass Stephen, 2017, 2017 TOP PROGRAMMING; Cesarini KG, 2002, ACTA NEUROCHIR, V144, P1121, DOI 10.1007/s00701-002-1011-9; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Dementyev A, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON RFID (RFID), P1, DOI 10.1109/RFID.2013.6548128; Dizdarevic K, 2012, CLIN NEUROL NEUROSUR, V114, P142, DOI 10.1016/j.clineuro.2011.10.005; Django, 2013, DJANGO VERSION 1 5 D; Glaros KN, 2013, IEEE T BIOMED CIRC S, V7, P363, DOI 10.1109/TBCAS.2012.2200677; Gowers SAN, 2019, LAB CHIP, V19, P2537, DOI 10.1039/c9lc00400a; Gowers SAN, 2015, ANAL CHEM, V87, P7763, DOI 10.1021/acs.analchem.5b01353; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; He F, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1933; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jeffcote T, 2014, NEUROCRIT CARE, V20, P21, DOI 10.1007/s12028-013-9938-7; Kasasbeh A, 2013, STEREOT FUNCT NEUROS, V91, P141, DOI 10.1159/000345111; Li CY, 2016, BIOSENS BIOELECTRON, V77, P62, DOI 10.1016/j.bios.2015.09.021; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Nielsen TH, 2013, ACTA ANAESTH SCAND, V57, P793, DOI 10.1111/aas.12092; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Pagkalos I, 2018, CHEMPHYSCHEM, V19, P1215, DOI 10.1002/cphc.201701119; Papadimitriou KI, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00212; Piangerelli M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00156; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Purins K, 2012, NEUROCRIT CARE, V16, P462, DOI 10.1007/s12028-012-9675-3; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rogers ML, 2017, J CEREBR BLOOD F MET, V37, P1883, DOI 10.1177/0271678X16674486; Rogers ML, 2013, ANNU REV ANAL CHEM, V6, P427, DOI 10.1146/annurev.anchem.111808.073648; Roham M, 2008, IEEE T BIOMED CIRC S, V2, P3, DOI 10.1109/TBCAS.2008.918282; Samper IC, 2019, LAB CHIP, V19, P2038, DOI 10.1039/c9lc00044e; Schmidt JM, 2011, STROKE, V42, P1351, DOI 10.1161/STROKEAHA.110.596874; Siekkinen M, 2012, 2012 IEEE WIRELESS COMMUNICATIONS AND NETWORKING CONFERENCE WORKSHOPS (WCNCW), P232, DOI 10.1109/WCNCW.2012.6215496; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Texas Instruments, 2010, CC2640 CC2650 SIMPLE; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Viggiano A, 2012, J NEUROSCI METH, V206, P1, DOI 10.1016/j.jneumeth.2012.01.013; Wirtz H, 2015, 2015 12 ANN IEEE INT; Zafeiropoulos GC, 2018, MEASUREMENT, V129, P128, DOI 10.1016/j.measurement.2018.05.115; Zeiler FA, 2020, J NEUROTRAUM, V37, P1854, DOI 10.1089/neu.2020.7024; [No title captured]	40	1	1	2	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1743-0003		J NEUROENG REHABIL	J. NeuroEng. Rehabil.	AUG 21	2020	17	1							114	10.1186/s12984-020-00742-x			16	Engineering, Biomedical; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology; Rehabilitation	NI9SX	WOS:000565686800001	32825829	gold, Green Published			2022-02-06	
J	Fisher, LB; Bomyea, J; Thomas, G; Cheung, JC; He, F; Jain, S; Flashman, LA; Andaluz, N; Coimbra, R; George, MS; Grant, GA; Marx, CE; McAllister, TW; Shutter, L; Lang, AJ; Stein, MB; Zafonte, RD				Fisher, Lauren B.; Bomyea, Jessica; Thomas, Garrett; Cheung, Joey C.; He, Feng; Jain, Sonia; Flashman, Laura A.; Andaluz, Norberto; Coimbra, Raul; George, Mark S.; Grant, Gerald A.; Marx, Christine E.; McAllister, Thomas W.; Shutter, Lori; Lang, Ariel J.; Stein, Murray B.; Zafonte, Ross D.			Contributions of posttraumatic stress disorder (PTSD) and mild TBI (mTBI) history to suicidality in the INTRuST consortium	BRAIN INJURY			English	Article						Mild brain injury; posttraumatic stress disorder; suicide risk	TRAUMATIC BRAIN-INJURY; US VETERANS; PSYCHOMETRIC PROPERTIES; NATIONAL-HEALTH; UNITED-STATES; RISK; IDEATION; BEHAVIOR; IRAQ; DEPRESSION	Objective Mild TBI (mTBI) and posttraumatic stress disorder (PTSD) are independent risk factors for suicidal behaviour (SB). Further, co-occurring mTBI and PTSD increase one's risk for negative health and psychiatric outcomes. However, little research has examined the role of comorbid mTBI and PTSD on suicide risk. Methods The present study utilized data from the Injury and TRaUmatic STress (INTRuST) Consortium to examine the prevalence of suicidal ideation (SI) and behaviours among four groups: 1) comorbid mTBI+PTSD, 2) PTSD only, 3) mTBI only, and 4) healthy controls. Results Prevalence of lifetime SI, current SI, and lifetime SB for individuals with mTBI+PTSD was 40%, 25%, and 19%, respectively. Prevalence of lifetime SI, current SI, and lifetime SB for individuals with PTSD only was 29%, 11%, and 11%, respectively. Prevalence of lifetime SI, current SI, and lifetime SB for individuals with mTBI only was 14%, 1%, and 2%, respectively. Group comparisons showed that individuals with mTBI alone experienced elevated rates of lifetime SI compared to healthy controls. History of mTBI did not add significantly to risk for suicidal ideation and behaviour beyond what is accounted for by PTSD. Conclusion Findings suggest that PTSD seems to be driving risk for suicidal behaviour.	[Fisher, Lauren B.] Harvard Med Sch, Dept Psychiat, Boston, MA 02114 USA; [Fisher, Lauren B.; Thomas, Garrett; Cheung, Joey C.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Bomyea, Jessica; Lang, Ariel J.] VA San Diego Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Bomyea, Jessica; Lang, Ariel J.; Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [He, Feng; Jain, Sonia] Univ Calif San Diego, Dept Family Med & Publ Hlth, Biostat Res Ctr, La Jolla, CA 92093 USA; [Flashman, Laura A.; McAllister, Thomas W.] Dartmouth Geisel Sch Med Dartmouth, Dept Psychiat, Dartmouth Hitchcock Med Ctr, Hanover, NH USA; [Andaluz, Norberto] Univ Louisville, Dept Neurol Surg, Louisville, KY 40292 USA; [Coimbra, Raul] Riverside Univ Hlth Syst, Dept Surg, Moreno Valley, CA USA; [George, Mark S.] Ralph H Johnson VA Med Ctr, Psychiat Div, Charleston, SC USA; [George, Mark S.] Med Univ South Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA; [Grant, Gerald A.] Stanford Univ, Med Ctr, Dept Neurol & Neurosci, Stanford, CA 94305 USA; [Marx, Christine E.] Durham VA Med Ctr, Durham, NC USA; [Marx, Christine E.] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Shutter, Lori] Univ Pittsburgh, Dept Crit Care Med Neurol & Neurosurg, Pittsburgh, PA USA; [Shutter, Lori; Lang, Ariel J.; Stein, Murray B.] Univ Pittsburgh, Dept Crit Care Med Neurol & Neurosurg, Pittsburgh, PA USA; [Zafonte, Ross D.] Massachusetts Gen Hosp, Brigham & Womens Hosp, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Zafonte, Ross D.] Harvard Med Sch, Boston, MA 02115 USA; [Zafonte, Ross D.] Massachusetts Gen Hosp, Children Sports Concuss Program, Boston, MA 02114 USA; [Zafonte, Ross D.] MGH Red Sox Fdn, Home Base Program, Boston, MA USA		Fisher, LB (corresponding author), Harvard Med Sch, Dept Psychiat, Boston, MA 02114 USA.	fisher.lauren@mgh.harvard.edu	Shutter, Lori A/G-2957-2013; Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851; George, Mark/0000-0003-1767-1815	Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-08-2-0159]	This work was supported by the Medical Research and Materiel Command [Contract #W81XWH-08-2-0159 (Stein et al.), DOD INT].	Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bethune A, 2017, ARCH SUICIDE RES, V21, P392, DOI 10.1080/13811118.2016.1199990; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Bryan CJ, 2013, J AFFECT DISORDERS, V150, P1226, DOI 10.1016/j.jad.2013.05.087; Bryant J, 2011, LEVIATHAN-J MELVILLE, V13, P3, DOI 10.1111/j.1750-1849.2011.01527.x; Bryant RA, 2000, J ABNORM PSYCHOL, V109, P341, DOI 10.1037/0021-843X.109.2.341; BULLMAN TA, 1994, J NERV MENT DIS, V182, P604, DOI 10.1097/00005053-199411000-00002; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA, V45; Coronado VG, 2002, MMWR-MORBID MORTAL W, V60, P1; DAVIDSON JRT, 1991, PSYCHOL MED, V21, P713, DOI 10.1017/S0033291700022352; Deb S, 1999, AM J PSYCHIAT, V156, P374; Derogatis LR, 2000, HANDBOOK OF PSYCHOLOGICAL ASSESSMENT IN PRIMARY CARE SETTINGS, P297; Dreer LE, 2018, CURR OPIN PSYCHOL, V22, P73, DOI 10.1016/j.copsyc.2017.08.030; Eber S, 2013, MIL MED, V178, P966, DOI 10.7205/MILMED-D-13-00175; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Ferrada-Noli M, 1998, J TRAUMA STRESS, V11, P103, DOI 10.1023/A:1024461216994; Finley EP, 2015, AM J PUBLIC HEALTH, V105, P380, DOI 10.2105/AJPH.2014.301957; Fisher LB, 2016, BRAIN INJURY, V30, P1311, DOI 10.1080/02699052.2016.1195517; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Gradus JL, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0965-0; Gradus JL, 2015, AM J EPIDEMIOL, V182, P451, DOI 10.1093/aje/kwv066; Gradus JL, 2013, DEPRESS ANXIETY, V30, P1046, DOI 10.1002/da.22117; Gros DF, 2012, PSYCHIAT RES, V196, P267, DOI 10.1016/j.psychres.2011.10.022; Haarbauer-Krupa J, 2017, J NEUROTRAUM, V34, P50, DOI 10.1089/neu.2015.4158; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Hawton K, 2000, BRIT J PSYCHIAT, V177, P484, DOI 10.1192/bjp.177.6.484; Hickling EJ, 1999, J TRAUMA STRESS, V12, P345, DOI 10.1023/A:1024784711484; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hostetter TA, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000489; Jakupcak M, 2009, J TRAUMA STRESS, V22, P303, DOI 10.1002/jts.20423; Kang HK, 2008, JAMA-J AM MED ASSOC, V300, P652, DOI 10.1001/jama.300.6.652; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; KLONOFF PS, 1995, J HEAD TRAUMA REHAB, V10, P16, DOI 10.1097/00001199-199512000-00005; Kposowa AJ, 2001, PSYCHOL MED, V31, P127, DOI 10.1017/S0033291799002925; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Krysinska K, 2010, ARCH SUICIDE RES, V14, P1, DOI 10.1080/13811110903478997; Louzon SA, 2016, PSYCHIAT SERV, V67, P517, DOI 10.1176/appi.ps.201500149; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Nazem S, 2014, SUICIDE PHENOMENOLOG, P101; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Nock MK, 2014, JAMA PSYCHIAT, V71, P514, DOI 10.1001/jamapsychiatry.2014.30; Nock MK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000123; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Pernin C.G., 2011, WAR PREVENTING SUICI; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Rossom RC, 2017, J AFFECT DISORDERS, V215, P77, DOI 10.1016/j.jad.2017.03.037; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shen YC, 2016, LANCET PSYCHIAT, V3, P1039, DOI 10.1016/S2215-0366(16)30304-2; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Stein MB, 2019, JAMA PSYCHIAT, V76; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Sundin J, 2010, PSYCHOL MED, V40, P367, DOI 10.1017/S0033291709990791; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tarrier N, 2004, SOC PSYCH PSYCH EPID, V39, P927, DOI 10.1007/s00127-004-0828-3; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Uebelacker LA, 2011, PRIM CARE COMPANION, V13; Vasterling JJ, 2012, J INT NEUROPSYCH SOC, V18, P390, DOI 10.1017/S1355617712000367; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Weathers F.W., 1993, 9 ANN C ISTSS; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wingate LR, 2004, BEHAV SCI LAW, V22, P651, DOI 10.1002/bsl.612; Wisco BE, 2014, J CLIN PSYCHIAT, V75, P1338, DOI 10.4088/JCP.14m09328; Xu J, 2016, NATL VITAL STAT REP, V67, P1; Zivin K, 2007, AM J PUBLIC HEALTH, V97, P2193, DOI 10.2105/AJPH.2007.115477	88	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 23	2020	34	10					1339	1349		10.1080/02699052.2020.1807054		AUG 2020	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NI5TJ	WOS:000561980700001	32811203				2022-02-06	
J	Lazaridis, C				Lazaridis, Christos			Deciding Under Uncertainty: The Case of Refractory Intracranial Hypertension	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; shared decision making; intracranial hypertension; intracranial pressure; decompressive craniectomy; expected utility	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; DECISION-MAKING; DISABILITY; IMPACT; MANAGEMENT; SURVIVAL; PRESSURE; LIFE	A challenging clinical conundrum arises in severe traumatic brain injury patients who develop intractable intracranial hypertension. For these patients, high morbidity interventions such as surgical decompression and barbiturate coma have to be considered against a backdrop of uncertain outcomes including prolonged states of disordered consciousness and severe disability. The clinical evidence available to guide shared decision-making is mainly limited to one randomized controlled trial, the RESCUEicp. However, since the publication of this trial significant controversy has been ongoing over the interpretation of the results. Is the mortality benefit from surgery merely a trade off for unacceptable long-term disability? How should treatment options, possible outcomes, and results from the trial be communicated to surrogates? How do we incorporate patient values into forming plans of care? The aim of this article is to sketch an approach based on insights fromDecision Theory, and specificallydeciding under uncertainty. The mainstream normative decision theory, Expected Utility (EU) theory, essentially says that,in situations of uncertainty, one should prefer the option with greatest expected desirability or value. The steps required to compute expected utilities include listing the possible outcomes of available interventions, assigning each outcome a utility ranking representing an individual patient's preferences, and a conditional probability given each intervention. This is a conceptual framework meant to supplement, and enhance shared decision making by assuring that patient values are elicited and incorporated, the possible range and nature of outcomes is discussed, and finally by attempting to connect best available means to patient-individualized ends.	[Lazaridis, Christos] Univ Chicago, Med Ctr, Dept Neurol, Neurocrit Care Unit, Chicago, IL 60637 USA; [Lazaridis, Christos] Univ Chicago, Med Ctr, Dept Surg, Neurosurg Sect, Chicago, IL 60637 USA		Lazaridis, C (corresponding author), Univ Chicago, Med Ctr, Dept Neurol, Neurocrit Care Unit, Chicago, IL 60637 USA.; Lazaridis, C (corresponding author), Univ Chicago, Med Ctr, Dept Surg, Neurosurg Sect, Chicago, IL 60637 USA.	lazaridis@uchicago.edu			Stevanovich Institute on the Formation of Knowledge (SIFK) at the University of Chicago; SIFK Faculty Research Grant on Shared Decision Making in Neurocritical Care	CL acknowledges support from the Stevanovich Institute on the Formation of Knowledge (SIFK) at the University of Chicago; this manuscript is part of work based on a SIFK Faculty Research Grant on Shared Decision Making in Neurocritical Care.	Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bareham CA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00676; Blumenthal-Barby JS, 2016, AM J BIOETHICS, V16, P5, DOI 10.1080/15265161.2016.1159750; Blumenthal-Barby JS, 2015, MED DECIS MAKING, V35, P539, DOI 10.1177/0272989X14547740; Briggs RA, 2019, STANFORD ENCY PHILOS; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cotte J, 2014, NEW ENGL J MED, V371, P971, DOI 10.1056/NEJMc1407775; Hansson SO, 2018, STANFORD ENCY PHILOS; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Honeybul S, 2018, CURR OPIN CRIT CARE, V24, P97, DOI 10.1097/MCC.0000000000000481; Honeybul S, 2016, ACTA NEUROCHIR, V158, P1251, DOI 10.1007/s00701-016-2818-0; Honeybul S, 2015, J MED ETHICS, V41, P963, DOI 10.1136/medethics-2013-101960; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P2403, DOI 10.1056/NEJMc1613479; Katie S, 2016, STANFORD ENCY PHILOS; Klein A, 2012, NEUROCRIT CARE, V16, P456, DOI 10.1007/s12028-012-9677-1; Kon AA, 2016, CRIT CARE MED, V44, P188, DOI 10.1097/CCM.0000000000001396; Lazaridis Christos, 2018, Continuum (Minneap Minn), V24, P1794, DOI 10.1212/CON.0000000000000673; Lazaridis C, 2019, NEUROCRIT CARE, V30, P33, DOI 10.1007/s12028-018-0595-8; Lonnqvist PA, 2017, BRIT J ANAESTH, V118, P286, DOI 10.1093/bja/aew474; Menon DK, 2017, BRIT J ANAESTH, V119, P1062, DOI 10.1093/bja/aex374; Rohaut B, 2018, BRIT J ANAESTH, V120, P5, DOI 10.1016/j.bja.2017.11.007; Shutter LA, 2016, NEW ENGL J MED, V375, P1183, DOI 10.1056/NEJMe1609722; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Tung J, 2020, QUAL LIFE RES, V29, P1217, DOI 10.1007/s11136-019-02390-8; Ubel PA, 2005, HEALTH PSYCHOL, V24, pS57, DOI 10.1037/0278-6133.24.4.S57; Wilkins TE, 2019, J NEUROTRAUM, V36, P3158, DOI 10.1089/neu.2018.6153; Wilkinson D, 2018, MONASH BIOETH REV, V35, P2, DOI 10.1007/s40592-017-0075-5	32	1	1	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 20	2020	11								908	10.3389/fneur.2020.00908			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NJ7QY	WOS:000566238900001	32973664	Green Published, gold			2022-02-06	
J	Brett, BL; Kramer, MD; McCrea, MA; Broglio, SP; McAllister, TW; Nelson, LD; Hazzard, JB; Kelly, LA; Ortega, J; Port, N; Pasquina, PF; Jackson, J; Cameron, KL; Houston, MN; Goldman, JT; Giza, C; Buckley, T; Clugston, JR; Schmidt, JD; Feigenbaum, LA; Eckner, JT; Master, CL; Collins, MW; Kontos, AP; Chrisman, SPD; Duma, SM; Miles, CM; Susmarski, A				Brett, Benjamin L.; Kramer, Mark D.; McCrea, Michael A.; Broglio, Steven P.; McAllister, Thomas W.; Nelson, Lindsay D.; Hazzard, Joseph B., Jr.; Kelly, Louise A.; Ortega, Justus; Port, Nicholas; Pasquina, Paul F.; Jackson, Jonathan; Cameron, Kenneth L.; Houston, Megan N.; Goldman, Joshua T.; Giza, Christopher; Buckley, Thomas; Clugston, James R.; Schmidt, Julianne D.; Feigenbaum, Luis A.; Eckner, James T.; Master, Christina L.; Collins, Michael W.; Kontos, Anthony P.; Chrisman, Sara P. D.; Duma, Stefan M.; Miles, Christopher M.; Susmarski, Adam		CARE Consortium Investigators	Bifactor Model of the Sport Concussion Assessment Tool Symptom Checklist: Replication and Invariance Across Time in the CARE Consortium Sample	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						clinical phenotypes; invariance modeling; sport-related concussion; CARE Consortium; bifactor model; blood biomarkers	OF-FIT INDEXES; HIGH-SCHOOL; POSTCONCUSSION SYMPTOMS; INTERNATIONAL-CONFERENCE; POSTTRAUMATIC MIGRAINE; CONSENSUS STATEMENT; NORMATIVE VALUES; BASE-LINE; CHILDREN; VALIDITY	Background: Identifying separate dimensions of concussion symptoms may inform a precision medicine approach to treatment. It was previously reported that a bifactor model identified distinct acute postconcussion symptom dimensions. Purpose: To replicate previous findings of a bifactor structure of concussion symptoms in the Concussion Assessment Research and Education (CARE) Consortium sample, examine measurement invariance from pre- to postinjury, and evaluate whether factors are associated with other clinical and biomarker measures. Study Design: Cohort study (Diagnosis); Level of evidence, 2. Methods: Collegiate athletes were prospectively evaluated using the Sport Concussion Assessment Tool-3 (SCAT-3) during preseason (N = 31,557); 2789 were followed at <6 hours and 24 to 48 hours after concussion. Item-level SCAT-3 ratings were analyzed using exploratory and confirmatory factor analyses. Bifactor and higher-order models were compared for their fit and interpretability. Measurement invariance tested the stability of the identified factor structure across time. The association between factors and criterion measures (clinical and blood-based markers of concussion severity, symptom duration) was evaluated. Results: The optimal structure for each time point was a 7-factor bifactor model: a General factor, on which all items loaded, and 6 specific factors-Vestibulo-ocular, Headache, Sensory, Fatigue, Cognitive, and Emotional. The model manifested strict invariance across the 2 postinjury time points but only configural invariance from baseline to postinjury. From <6 to 24-48 hours, some dimensions increased in severity (Sensory, Fatigue, Emotional), while others decreased (General, Headache, Vestibulo-ocular). The factors correlated with differing clinical and biomarker criterion measures and showed differing patterns of association with symptom duration at different time points. Conclusion: Bifactor modeling supported the predominant unidimensionality of concussion symptoms while revealing multidimensional properties, including a large dominant General factor and 6 independent factors: Headache, Vestibulo-ocular, Sensory, Cognitive, Fatigue, and Emotional. Unlike the widely used SCAT-3 symptom severity score, which declines gradually after injury, the bifactor model revealed separable symptom dimensions that have distinct trajectories in the acute postinjury period and different patterns of association with other markers of injury severity and outcome.	[Brett, Benjamin L.; McCrea, Michael A.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA; [Brett, Benjamin L.; McCrea, Michael A.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurol, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [McAllister, Thomas W.] Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Hazzard, Joseph B., Jr.] Bloomsburg Univ, Bloomsburg, PA USA; [Kelly, Louise A.] Calif Lutheran Univ, Thousand Oaks, CA USA; [Ortega, Justus] Humboldt State Univ, Arcata, CA 95521 USA; [Port, Nicholas] Indiana Univ, Bloomington, IN USA; [Pasquina, Paul F.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Jackson, Jonathan] Air Force Acad, Colorado Springs, CO USA; [Houston, Megan N.] US Mil Acad, West Point, NY USA; [Goldman, Joshua T.; Giza, Christopher] Univ Calif Los Angeles, Los Angeles, CA USA; [Buckley, Thomas] Univ Delaware, Newark, DC USA; [Eckner, James T.] Univ Florida, Gainesville, FL USA; [Schmidt, Julianne D.] Univ Georgia, Athens, GA USA; [Feigenbaum, Luis A.] Univ Miami, Coral Gables, FL 33124 USA; [Eckner, James T.] Univ Michigan, Ann Arbor, MI 48109 USA; [Master, Christina L.] Univ Penn, Philadelphia, PA 19104 USA; [Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Pittsburgh, PA USA; [Chrisman, Sara P. D.] Univ Washington, Seattle, WA 98195 USA; [Duma, Stefan M.] Virginia Tech, Blacksburg, VA USA; [Miles, Christopher M.] Wake Forest Univ, Raleigh, NC USA; [Susmarski, Adam] US Naval Acad, Annapolis, MD 21402 USA			linelson@mcw.edu		Chrisman, Sara/0000-0001-5373-7223; Susmarski, Adam/0000-0003-3698-4163	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R03NS100691, R01NS110856]; Department of DefenseUnited States Department of Defense; National Collegiate Athletic Association; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; National Institute of Neurological Disorders and Stroke, under the National Institutes of Health [L301L30NS113158-01]	This secondary analysis project was funded by the National Institutes of Health (grants R03NS100691 and R01NS110856). The Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium study was funded by the Department of Defense and National Collegiate Athletic Association. The US Army Medical Research Acquisition Activity is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program (award W81XWH-14-2-0151), and B.L.B. received support from the National Institute of Neurological Disorders and Stroke, under the National Institutes of Health (award L301L30NS113158-01). AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	[Anonymous], 2006, IMM POSTC ASS COGN T; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Biderman MD, 2011, J RES PERS, V45, P417, DOI 10.1016/j.jrp.2011.05.001; Brett BL, 2020, AM J SPORT MED, V48, P1476, DOI 10.1177/0363546520913252; Brett BL, 2018, J INT NEUROPSYCH SOC, V24, P476, DOI 10.1017/S1355617717001321; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Brooks MA, 2017, JAMA PEDIATR, V171, P670, DOI 10.1001/jamapediatrics.2017.0592; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Galenkamp H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203483; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guty E, 2018, J INT NEUROPSYCH SOC, V24, P684, DOI 10.1017/S135561771800036X; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Liu Y, 2017, PSYCHOL METHODS, V22, P486, DOI 10.1037/met0000075; Lumba-Brown A, 2020, NEUROSURGERY, V86, P2, DOI 10.1093/neuros/nyz332; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19771; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P764, DOI 10.1080/13803395.2015.1060950; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P265, DOI 10.1080/13803395.2015.1004303; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Nelson LD, 2018, J INT NEUROPSYCH SOC, V24, P793, DOI 10.1017/S1355617718000462; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Piland SG, 2003, J ATHL TRAINING, V38, P104; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Putnick DL, 2016, DEV REV, V41, P71, DOI 10.1016/j.dr.2016.06.004; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Reise SP, 2013, J PERS ASSESS, V95, P129, DOI 10.1080/00223891.2012.725437; Resch JE, 2015, J ATHL TRAINING, V50, P1292, DOI 10.4085/1062-6050-50.12.03; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Snedden TR, 2017, CLIN J SPORT MED, V27, P462, DOI 10.1097/JSM.0000000000000389; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Waljas M, 2012, BRAIN INJURY, V26, P972, DOI 10.3109/02699052.2012.660511; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	55	1	1	1	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	SEP	2020	48	11					2783	2795	0363546520946056	10.1177/0363546520946056		AUG 2020	13	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	NI3RK	WOS:000561913500001	32809856	Green Accepted			2022-02-06	
J	Macheda, T; Roberts, KN; Morganti, JM; Braun, DJ; Bachstetter, AD				Macheda, Teresa; Roberts, Kelly N.; Morganti, Josh M.; Braun, David J.; Bachstetter, Adam D.			Optimization and validation of a modified radial-arm water maze protocol using a murine model of mild closed head traumatic brain injury	PLOS ONE			English	Article							LONG-TERM-MEMORY; MOUSE BEHAVIOR; DEFICITS; STRESS; MECHANISMS; MICE; TASK; AGE	Cognitive impairments can be a significant problem after a traumatic brain injury (TBI), which affects millions worldwide each year. There is a need for establish reproducible cognitive assays in rodents to better understand disease mechanisms and to develop therapeutic interventions towards treating TBI-induced impairments. Our goal was to validate and standardize the radial arm water maze (RAWM) test as an assay to screen for cognitive impairments caused by TBI. RAWM is a visuo-spatial learning test, originally designed for use with rats, and later adapted for mice. The present study investigates whether test procedures, such us the presence of extra-maze cues influences learning and memory performance. C57BL/6 mice were tested in an 8-arm RAWM using a four-day protocol. We demonstrated that two days of training, exposing the mice to extra-maze cues and a visible platform, influenced learning and memory performance. Mice that did not receive training performed poorer compared to mice trained. To further validate our RAWM protocol, we used scopolamine. We, also, demonstrated that a single mild closed head injury (CHI) caused deficits in this task at two weeks post-CHI. Our data supported the use of 7 trials per day and a spaced training protocol as key factor to unmask memory impairment following CHI. Here, we provide a detailed standard operating procedure for RAWM test, which can be applied to a variety of mouse models including neurodegenerative diseases and pathology, as well as when pharmacological approaches are used.	[Macheda, Teresa; Roberts, Kelly N.; Morganti, Josh M.; Bachstetter, Adam D.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40506 USA; [Macheda, Teresa; Roberts, Kelly N.; Morganti, Josh M.; Bachstetter, Adam D.] Univ Kentucky, Dept Neurosci, Lexington, KY 40506 USA; [Morganti, Josh M.; Braun, David J.; Bachstetter, Adam D.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA		Bachstetter, AD (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40506 USA.; Bachstetter, AD (corresponding author), Univ Kentucky, Dept Neurosci, Lexington, KY 40506 USA.; Bachstetter, AD (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA.	adam.bachstetter@uky.edu	Braun, David/AAJ-5829-2021		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R00 AG044445, R01 NS103785, R21 AG059123]	Research reported in this publication was supported by National Institutes of Health under award numbers R00 AG044445 (ADB), R01 NS103785 (ADB), R21 AG059123 (ADB). The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health.	Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Anderson MJ, 2008, BEHAV PROCESS, V78, P481, DOI 10.1016/j.beproc.2008.02.005; Bachstetter AD, 2020, EXP NEUROL, V326, DOI 10.1016/j.expneurol.2020.113180; Bachstetter AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0289-5; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Beck CDO, 2000, J NEUROSCI, V20, P2944; Bello-Medina PC, 2013, BEHAV BRAIN RES, V250, P102, DOI 10.1016/j.bbr.2013.04.047; Bellush LL, 1996, PHYSIOL BEHAV, V60, P541, DOI 10.1016/S0031-9384(96)80029-1; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; BURESOVA O, 1985, PHYSIOL BEHAV, V34, P1003, DOI 10.1016/0031-9384(85)90028-9; Chiarotti Flavia, 2005, Curr Protoc Toxicol, VChapter 13, DOI 10.1002/0471140856.tx1308s25; Chou A, 2017, P NATL ACAD SCI USA, V114, pE6420, DOI 10.1073/pnas.1707661114; Corser-Jensen CE, 2014, EXP NEUROL, V256, P7, DOI 10.1016/j.expneurol.2014.03.008; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Hyde LA, 1998, BRAIN RES, V785, P236, DOI 10.1016/S0006-8993(97)01417-0; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kelley P, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00589; Klinkenberg I, 2010, NEUROSCI BIOBEHAV R, V34, P1307, DOI 10.1016/j.neubiorev.2010.04.001; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; Kramar EA, 2012, P NATL ACAD SCI USA, V109, P5121, DOI 10.1073/pnas.1120700109; Lee JY, 2019, THERANOSTICS, V9, P1029, DOI 10.7150/thno.29868; Light KR, 2010, CURR BIOL, V20, P777, DOI 10.1016/j.cub.2010.02.034; Littlejohn EL, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00925-6; Lyons DN, 2018, J NEUROTRAUM, V35, P2435, DOI 10.1089/neu.2018.5663; Malikowska-Racia N, 2018, NEUROTOX RES, V34, P431, DOI 10.1007/s12640-018-9901-7; MANDEL RJ, 1989, BEHAV BRAIN RES, V31, P221, DOI 10.1016/0166-4328(89)90004-1; Mandillo S, 2008, PHYSIOL GENOMICS, V34, P243, DOI 10.1152/physiolgenomics.90207.2008; Mauelshagen J, 1998, LEARN MEMORY, V5, P246; MEDIN DL, 1974, J HUM EVOL, V3, P455, DOI 10.1016/0047-2484(74)90005-0; Menzel R, 2001, LEARN MEMORY, V8, P198, DOI 10.1101/lm.40001; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Novais A, 2017, NEUROBIOL STRESS, V6, P44, DOI 10.1016/j.ynstr.2016.11.004; Philips GT, 2013, NEUROBIOL LEARN MEM, V105, P117, DOI 10.1016/j.nlm.2013.05.003; Philips GT, 2013, J NEUROSCI, V33, P7565, DOI 10.1523/JNEUROSCI.5561-12.2013; Salat K, 2015, PHARMACOL REP, V67, P1155, DOI 10.1016/j.pharep.2015.04.018; Seese RR, 2014, P NATL ACAD SCI USA, V111, P16907, DOI 10.1073/pnas.1413335111; Smolen P, 2016, NAT REV NEUROSCI, V17, P77, DOI 10.1038/nrn.2015.18; Song SJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071418; Song SJ, 2016, RESTOR NEUROL NEUROS, V34, P415, DOI 10.3233/RNN-150607; Song SJ, 2016, J NEUROSCI RES, V94, P409, DOI 10.1002/jnr.23714; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/NMETH.2935, 10.1038/nmeth.2935]; Sukoff Rizzo Stacey J, 2018, Curr Protoc Mouse Biol, V8, pe45, DOI 10.1002/cpmo.45; Sukoff Rizzo Stacey J, 2016, Curr Protoc Mouse Biol, V6, P364, DOI 10.1002/cpmo.17; Wahlsten D, 2003, J NEUROBIOL, V54, P283, DOI 10.1002/neu.10173; Wahlsten D, 2003, TRENDS NEUROSCI, V26, P132, DOI 10.1016/S0166-2236(03)00033-X; Wahlsten D, 2001, PHYSIOL BEHAV, V73, P695, DOI 10.1016/S0031-9384(01)00527-3; Wainwright ML, 2002, J NEUROSCI, V22, P4132, DOI 10.1523/JNEUROSCI.22-10-04132.2002; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Whiting MD, 2016, METHODS MOL BIOL, V1462, P553, DOI 10.1007/978-1-4939-3816-2_30; Xiong XD, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/8728415; Zhang YL, 2012, NAT NEUROSCI, V15, P294, DOI 10.1038/nn.2990	52	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2020	15	8							e0232862	10.1371/journal.pone.0232862			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NF7CD	WOS:000563451300025	32810143	Green Submitted, Green Published, gold			2022-02-06	
J	Nakhjiri, E; Vafaee, MS; Hojjati, SMM; Shahabi, P; Shahpasand, K				Nakhjiri, Elnaz; Vafaee, Manuchehr S.; Hojjati, Seyed Mohammad Massod; Shahabi, Parviz; Shahpasand, Koorosh			Tau Pathology Triggered by Spinal Cord Injury Can Play a Critical Role in the Neurotrauma Development	MOLECULAR NEUROBIOLOGY			English	Article						Spinal cord injury; Traumatic brain injury; Biomarker; cisP-tau; Hyperphosphorylation; Pin1	TRAUMATIC BRAIN-INJURY; FLUID PERCUSSION INJURY; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; PHOSPHORYLATED TAU; OXIDATIVE STRESS; HYPERPHOSPHORYLATED TAU; INFLAMMATORY RESPONSE; PROTEIN PHOSPHATASES; COGNITIVE IMPAIRMENT	Traumatic spinal cord injury (SCI) can result in substantial neurological impairment along with significant emotional and psychological distress. It is clear that there is profound neurodegeneration upon SCI, gradually spread to other spinal cord regions and brain areas. Despite extensive considerations, it remains uncertain how pathogenicity diffuses in the cord. It has been reported that tau protein abnormal hyperphosphorylation plays a central role in neurodegeneration triggered by traumatic brain injury (TBI). Tau is a microtubule-associated protein, heavily implicated in neurodegenerative diseases. Importantly, tau pathology spreads in a traumatic brain in a timely manner. In particular, we have recently demonstrated that phosphorylated tau at Thr231 exists in two distinctcisandtransconformations, in which thatcisP-tau is extremely neurotoxic, has a prion nature, and spreads to various brain areas and cerebrospinal fluid (CSF) upon trauma. On the other hand, tau pathology, in particular hyperphosphorylation at Thr231, has been observed upon SCI. Taken these together, we conclude thatcispT231-tau may accumulate and spread in the spinal cord as well as CSF and diffuse tau pathology in the central nervous system (CNS). Moreover, antibody againstcisP-tau can target intracellularcisP-tau and protect pathology spreading. Thus, consideringcisP-tau as a driver of tau pathology and neurodegeneration upon SCI would open new windows toward understanding the disease development and early biomarkers. Furthermore, it would help us develop effective therapies for SCI patients.	[Nakhjiri, Elnaz] Tabriz Univ Med Sci, Fac Med, Neurosci Res Ctr, Tabriz, Iran; [Vafaee, Manuchehr S.] Odense Univ Hosp, Dept Nucl Med, Odense, Denmark; [Hojjati, Seyed Mohammad Massod] Babol Univ Med Sci, Dept Neurol, Babol, Iran; [Shahabi, Parviz] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran; [Shahpasand, Koorosh] ACECR, Royan Inst Stem Cell Biol & Technol, Dept Brain & Cognit Sci, Cell Sci Res Ctr, Tehran, Iran		Shahabi, P (corresponding author), Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran.; Shahpasand, K (corresponding author), ACECR, Royan Inst Stem Cell Biol & Technol, Dept Brain & Cognit Sci, Cell Sci Res Ctr, Tehran, Iran.	shahabip@tbzmed.ac.ir; shahpasand@royaninstitute.org			Neurosciences Research Center of Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran [IR.TBZMED.VCR.REC.1398.067]; Council for Stem Cell Sciences and Technologies, Tehran, Iran [11/35721]	The grant of this study was provided by the Neurosciences Research Center of Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran (code of ethics: IR.TBZMED.VCR.REC.1398.067) and Council for Stem Cell Sciences and Technologies, Tehran, Iran (grant number: 11/35721).	Albayram O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01068-4; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Banik NL, 1997, BRAIN RES, V752, P301, DOI 10.1016/S0006-8993(96)01488-6; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Bethea JR, 2002, CURR OPIN NEUROL, V15, P355, DOI 10.1097/00019052-200206000-00021; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Biglari B, 2015, SPINAL CORD, V53, P510, DOI 10.1038/sc.2015.28; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bonatz H, 2000, J NEUROSCI METH, V100, P105, DOI 10.1016/S0165-0270(00)00238-7; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; Burns AS, 2003, J NEUROTRAUM, V20, P477, DOI 10.1089/089771503765355540; Caprelli MT, 2018, J NEUROTRAUM, V35, P1929, DOI 10.1089/neu.2017.5495; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Castillo-Carranza DL, 2017, AGING DIS, V8, P257, DOI 10.14336/AD.2017.0112; Cavdar S, 2008, J ANAT, V212, P249, DOI 10.1111/j.1469-7580.2008.00858.x; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chen LJ, 2010, J NEUROTRAUM, V27, P1657, DOI 10.1089/neu.2010.1308; Cheng CM, 2003, J NEUROSCI RES, V73, P1, DOI 10.1002/jnr.10634; Cheng CM, 2000, P NATL ACAD SCI USA, V97, P10236, DOI 10.1073/pnas.170008497; Cohen ML, 2017, REHABIL PSYCHOL, V62, P425, DOI 10.1037/rep0000140; Collins-Praino LE, 2017, BRAIN BEHAV IMMUN, V60, P369, DOI 10.1016/j.bbi.2016.09.027; Coulthart MB, 2016, CAN MED ASSOC J, V188, pE210, DOI 10.1503/cmaj.151257; Craig A, 2017, J NEUROTRAUM, V34, P1156, DOI 10.1089/neu.2016.4632; Crawley AP, 2004, BRAIN RES, V1028, P19, DOI 10.1016/j.brainres.2004.08.060; Davies SJA, 1996, EXP NEUROL, V142, P203, DOI 10.1006/exnr.1996.0192; Davis DR, 1997, J NEUROCHEM, V68, P1590; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; Dumont M, 2011, FASEB J, V25, P4063, DOI 10.1096/fj.11-186650; Farhadi A, 2019, TRENDS ENDOCRIN MET, V30, P692, DOI 10.1016/j.tem.2019.07.012; FERINGA ER, 1985, NEUROSCI LETT, V58, P283, DOI 10.1016/0304-3940(85)90067-9; Fontaine SN, 2015, CELL MOL LIFE SCI, V72, P1863, DOI 10.1007/s00018-015-1839-9; Frankel H L, 1969, Paraplegia, V7, P179; Galas MC, 2006, J BIOL CHEM, V281, P19296, DOI 10.1074/jbc.M601849200; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Gendron TF, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-13; Gerson JE, 2016, CRIT REV BIOCHEM MOL, V51, P482, DOI 10.1080/10409238.2016.1226251; Gerson JE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00093; Geschwind DH, 2003, NEURON, V40, P457, DOI 10.1016/S0896-6273(03)00681-0; Giehl KM, 1996, EUR J NEUROSCI, V8, P1167, DOI 10.1111/j.1460-9568.1996.tb01284.x; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goedert M, 2017, ANNU REV NEUROSCI, V40, P189, DOI 10.1146/annurev-neuro-072116-031153; Hains BC, 2005, BRAIN, V128, P2359, DOI 10.1093/brain/awh623; Hains BC, 2003, J COMP NEUROL, V462, P328, DOI 10.1002/cne.10733; Hammond ENL, 1999, NEUROREPORT, V10, P2671, DOI 10.1097/00001756-199908200-00043; HAPPEL RD, 1981, BRAIN RES, V211, P476, DOI 10.1016/0006-8993(81)90976-8; Hayes KC, 2002, J NEUROTRAUM, V19, P753, DOI 10.1089/08977150260139129; Hong M, 1997, J BIOL CHEM, V272, P19547, DOI 10.1074/jbc.272.31.19547; Hoshino S, 1998, NEUROREPORT, V9, P1879, DOI 10.1097/00001756-199806010-00039; Hubscher CH, 2006, EXP NEUROL, V197, P177, DOI 10.1016/j.expneurol.2005.09.007; Hulsebosch CE, 2009, BRAIN RES REV, V60, P202, DOI 10.1016/j.brainresrev.2008.12.010; Hung KS, 2005, J NEUROPATH EXP NEUR, V64, P15, DOI 10.1093/jnen/64.1.15; Hung KS, 2007, J NEUROSURG-SPINE, V6, P35, DOI 10.3171/spi.2007.6.1.7; Hyman BT, 2014, NEURON, V82, P1189, DOI 10.1016/j.neuron.2014.06.004; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Janssen O, 2003, CELL DEATH DIFFER, V10, P1215, DOI 10.1038/sj.cdd.4401305; Jure I, 2017, NEURAL REGEN RES, V12, P1044, DOI 10.4103/1673-5374.211177; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kirshblum S, 2014, PHYS MED REH CLIN N, V25, P505, DOI 10.1016/j.pmr.2014.04.001; Klapka N, 2005, EUR J NEUROSCI, V22, P3047, DOI 10.1111/j.1460-9568.2005.04495.x; Knerlich-Lukoschus F, 2011, J NEUROTRAUM, V28, P619, DOI 10.1089/neu.2010.1652; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kopeikina KJ, 2011, AM J PATHOL, V179, P2071, DOI 10.1016/j.ajpath.2011.07.004; Krueger H, 2013, CHRON DIS INJ CAN, V33, P113; Kwon BK, 2017, J NEUROTRAUM, V34, P567, DOI 10.1089/neu.2016.4435; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lee RS, 2012, J CLIN NEUROSCI, V19, P1338, DOI 10.1016/j.jocn.2012.02.015; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Lu KP, 1996, NATURE, V380, P544; Lv QS, 2014, J NEUROL SCI, V345, P48, DOI 10.1016/j.jns.2014.06.037; Maccioni RB, 2001, EUR J BIOCHEM, V268, P1518, DOI 10.1046/j.1432-1033.2001.02024.x; Marino RJ, 2003, J SPINAL CORD MED S1, V26, pS50; Martin L, 2013, AGEING RES REV, V12, P39, DOI 10.1016/j.arr.2012.06.008; Mason MRJ, 2003, EUR J NEUROSCI, V18, P789, DOI 10.1046/j.1460-9568.2003.02809.x; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MORI H, 1995, NEUROSCI LETT, V186, P181, DOI 10.1016/0304-3940(95)11291-4; MORIYA T, 1994, J NEUROTRAUM, V11, P255, DOI 10.1089/neu.1994.11.255; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Nakamura K, 2013, CURR MOL MED, V13, P1098; Nakamura K, 2013, PRION, V7, P117, DOI 10.4161/pri.22849; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; Nardone R, 2013, BRAIN RES, V1504, P58, DOI 10.1016/j.brainres.2012.12.034; Niblock MM, 2000, J NEUROSCI, V20, P4165; Nielson JL, 2010, J NEUROSCI, V30, P11516, DOI 10.1523/JNEUROSCI.1433-10.2010; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; Noonan VK, 2012, NEUROEPIDEMIOLOGY, V38, P219, DOI 10.1159/000336014; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Pei JJ, 1998, BRAIN RES, V797, P267, DOI 10.1016/S0006-8993(98)00296-0; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Pouw MH, 2014, SPINAL CORD, V52, P428, DOI 10.1038/sc.2014.26; Priebe MM, 2007, ARCH PHYS MED REHAB, V88, pS84, DOI 10.1016/j.apmr.2006.12.005; Qi ZP, 2016, NEURAL REGEN RES, V11, P332, DOI 10.4103/1673-5374.177744; Qian W, 2010, J ALZHEIMERS DIS, V19, P1221, DOI [10.3233/JAD-2009-1317, 10.3233/JAD-2010-1317]; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Roerig A, 2013, VET J, V197, P253, DOI 10.1016/j.tvjl.2013.02.005; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Schmitt AB, 2000, ACTA NEUROPATHOL, V100, P528, DOI 10.1007/s004010000221; Schneider L, 2020, J NEUROSURG, V132, P933, DOI 10.3171/2018.10.JNS181517; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Spittaels K, 1999, AM J PATHOL, V155, P2153, DOI 10.1016/S0002-9440(10)65533-2; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Su B, 2010, NEUROSCI LETT, V468, P267, DOI 10.1016/j.neulet.2009.11.010; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Tang Y, 2019, NEURAL REGEN RES, V14, P896, DOI 10.4103/1673-5374.249238; Taoka Y, 1998, PROG NEUROBIOL, V56, P341, DOI 10.1016/S0301-0082(98)00049-5; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tran HT, 2012, J NEUROPATH EXP NEUR, V71, P116, DOI 10.1097/NEN.0b013e3182456aed; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Trivedi A, 2006, CLIN NEUROSCI RES, V6, P283, DOI 10.1016/j.cnr.2006.09.007; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wingrave JM, 2003, J NEUROSCI RES, V73, P95, DOI 10.1002/jnr.10607; Wolf H, 2014, SPINE J, V14, P2918, DOI 10.1016/j.spinee.2014.04.027; Wu JF, 2014, CELL CYCLE, V13, P2446, DOI 10.4161/cc.29420; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014; Wu JF, 2013, NEUROTHERAPEUTICS, V10, P520, DOI 10.1007/s13311-013-0198-1; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yang WJ, 2017, ACTA NEUROL SCAND, V135, P622, DOI 10.1111/ane.12644; Yoon EJ, 2013, BRAIN RES, V1540, P64, DOI 10.1016/j.brainres.2013.10.007; YOUNG W, 1992, J NEUROTRAUM, V9, pS9; Young Wise, 1993, Journal of Emergency Medicine, V11, P13; Zambrano CA, 2004, FREE RADICAL BIO MED, V36, P1393, DOI 10.1016/j.freeradbiomed.2004.03.007; Zhang SX, 2000, J NEUROPATH EXP NEUR, V59, P287, DOI 10.1093/jnen/59.4.287; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zhao P, 2007, J NEUROSCI, V27, P8893, DOI 10.1523/JNEUROSCI.2209-07.2007	132	1	1	1	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	NOV	2020	57	11					4845	4855		10.1007/s12035-020-02061-7		AUG 2020	11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NS9CD	WOS:000560278800002	32808121				2022-02-06	
J	Schmidt, M; Cheng, L; Raj, S; Wade, S				Schmidt, Matthew; Cheng, Li; Raj, Stacey; Wade, Shari			Formative Design and Evaluation of a Responsive eHealth/mHealth Intervention for Positive Family Adaptation Following Pediatric Traumatic Brain Injury	JOURNAL OF FORMATIVE DESIGN IN LEARNING			English	Article						eHealth; Intervention; User experience design; Traumatic brain injury; Positive family adaptation	BEHAVIOR PROBLEMS; CHILD; EXPERIENCES; OUTCOMES; BURDEN; PREDICTORS; MODERATORS; PARENTS; STIGMA; SKILLS	This paper describes the formative design and evaluation of a self-guided online program called "Road to Recovery" to provide education, support, and skills training for parents and caregivers of children with traumatic brain injury (TBI) in the acute phase following injury. TBI is a leading cause of death and disability in childhood and can lead to substantial family stress and burden, particularly during the initial months post-injury. Road to Recovery directly addresses the need for resources to support families while adapting to this "new normal." This online program was designed and developed using the Successive Approximation Model of instructional design. Formative evaluation was conducted across three phases of design, with improvements implemented following each phase. The result is a highly usable online program that is responsive to identified parent and caregiver needs.	[Schmidt, Matthew; Cheng, Li] Univ Florida, Gainesville, FL 32611 USA; [Raj, Stacey] Xavier Univ, Cincinnati, OH 45207 USA; [Wade, Shari] Cincinnati Childrens Hosp, Cincinnati, OH 45229 USA		Schmidt, M (corresponding author), Univ Florida, Gainesville, FL 32611 USA.	matthew.schmidt@coe.ufl.edu		Schmidt, Matthew/0000-0002-8110-4367	Ohio Emergency Medical Services (EMS) Grant (2017-2018)	This study received financial support from the Ohio Emergency Medical Services (EMS) Grant (2017-2018).	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Allen Michael, 2012, LEAVING ADDIE SAM AG; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Andersson K, 2016, BRAIN INJURY, V30, P829, DOI 10.3109/02699052.2016.1146963; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Bangor A, 2008, INT J HUM-COMPUT INT, V24, P574, DOI 10.1080/10447310802205776; Bangor A, 2009, J USABILITY STUD, V4, P114; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Brooke J., 1986, SYSTEM USABILITY SCA, P1; Brown FL, 2013, BRAIN INJURY, V27, P1570, DOI 10.3109/02699052.2013.841996; Brown FL, 2013, J HEAD TRAUMA REHAB, V28, P349, DOI 10.1097/HTR.0b013e318245fed5; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Cohen-Zimerman S, 2019, NEUROPSYCHOLOGIA, V124, P1, DOI 10.1016/j.neuropsychologia.2019.01.001; Corrigan P, 2004, AM PSYCHOL, V59, P614, DOI 10.1037/0003-066X.59.7.614; Corrigan PW, 2012, CAN J PSYCHIAT, V57, P464, DOI 10.1177/070674371205700804; Hagen M, 2016, EUR J TRAIN DEV, V40, P171, DOI 10.1108/EJTD-10-2015-0081; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; International Organization for Standardization, 2011, SYST SOFTW ENG SYST; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Kennedy E, 2017, J HEAD TRAUMA REHAB, V32, P425, DOI 10.1097/HTR.0000000000000289; Kim KH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002344; Lajiness-O'Neill R, 2010, APPL NEUROPSYCHOL, V17, P83, DOI 10.1080/09084281003708837; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; McLaughlin KA, 2013, J HEAD TRAUMA REHAB, V28, P341, DOI 10.1097/HTR.0b013e31824e1d43; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; Nielsen J., 2000, WHY YOU ONLY NEED TE; Nielsen J., 1999, DESIGNING WEB USABIL; Nielsen J., 1994, SEVERITY RATINGS USA; Ozuah P. O., 2016, EINSTEIN J BIOL MED, V21, P83, DOI DOI 10.23861/EJBM20052190; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Pew Research Center, 2015, US SMARTPHONE USE 20; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Ryan NP, 2015, J HEAD TRAUMA REHAB, V30, P75, DOI 10.1097/HTR.0000000000000123; Schmidt M, 2020, J FORMATIVE DES LEAR, V4, P51, DOI 10.1007/s41686-019-00038-x; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Treble-Barna A, 2016, DEV PSYCHOL, V52, P1777, DOI 10.1037/dev0000208; Tyerman E, 2017, BRAIN INJURY, V31, P1553, DOI 10.1080/02699052.2017.1341999; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; Wade SL, 2017, J AM ACAD CHILD PSY, V56, P930, DOI 10.1016/j.jaac.2017.09.413; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Wharewera-Mika J, 2016, CLIN CHILD PSYCHOL P, V21, P268, DOI 10.1177/1359104515589636	48	1	1	0	0	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND		2509-8039		J FORMATIVE DES LEAR	J. Formative Des. Learn.	DEC	2020	4	2					88	106		10.1007/s41686-020-00049-z		AUG 2020	19	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	PD4CQ	WOS:000560943100001					2022-02-06	
J	Dahan, N; Moehringer, N; Hasanaj, L; Serrano, L; Joseph, B; Wu, S; Nolan-Kenney, R; Rizzo, JR; Rucker, JC; Galetta, SL; Balcer, LJ				Dahan, Natalie; Moehringer, Nicholas; Hasanaj, Lisena; Serrano, Liliana; Joseph, Binu; Wu, Shirley; Nolan-Kenney, Rachel; Rizzo, John-Ross; Rucker, Janet C.; Galetta, Steven L.; Balcer, Laura J.			The SUN test of vision: Investigation in healthy volunteers and comparison to the mobile universal lexicon evaluation system (MULES)	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Concussion; Staggered uneven number (SUN); Picture naming; Mobile universal lexicon evaluation system (MULES); Vision	AUTOMATIZED NAMING RAN; DISCRIMINATION; RELIABILITY; IMPAIRMENT	Objective: Tests of rapid automatized naming (RAN) have been used for decades to evaluate neurological conditions. RAN tests require extensive brain pathways involving visual perception, memory, eye movements and language. To the extent that different naming tasks capture varied visual pathways and related networks, we developed the Staggered Uneven Number (SUN) test of rapid number naming to complement existing RAN tests, such as the Mobile Universal Lexicon Evaluation System (MULES). The purpose of this investigation was to determine values for time scores for SUN, and to compare test characteristics between SUN and MULES. Methods: We administered the SUN and MULES tests to healthy adult volunteers in a research office setting. MULES consists of 54 color photographs; the SUN includes 145 single- and multi-digit numbers. Participants are asked to name each number or picture aloud. Results: Among 54 healthy participants, aged 33 +/- 13 years (range 20-66), the average SUN time score was 45.2 +/- 8.3 s (range 30-66). MULES test times were 37.4 +/- 9.9 s (range 20-68). SUN and MULES time scores did not differ by gender, but were greater (worse) among older participants for MULES (r(s) = 0.43, P =.001). Learning effects between first and second trials were greater for the MULES; participants improved (reduced) their time scores between trials by 5% on SUN and 16% for MULES (P <.0001, Wilcoxon signed-rank test). Conclusion: The SUN is a new vision-based test that complements presently available picture- and number-based RAN tests. These assessments may require different brain pathways and networks for visual processing, visual memory, language and eye movements.	[Dahan, Natalie; Moehringer, Nicholas; Hasanaj, Lisena; Serrano, Liliana; Joseph, Binu; Wu, Shirley; Nolan-Kenney, Rachel; Rizzo, John-Ross; Rucker, Janet C.; Galetta, Steven L.; Balcer, Laura J.] NYU, Dept Neurol, Grossman Sch Med, New York, NY 10016 USA; [Balcer, Laura J.] NYU, Dept Populat Hlth, Grossman Sch Med, New York, NY USA; [Rucker, Janet C.; Galetta, Steven L.; Balcer, Laura J.] NYU, Dept Ophthalmol, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA; [Rizzo, John-Ross] NYU, Grossman Sch Med, Dept Phys Med & Rehabil, New York, NY USA		Balcer, LJ (corresponding author), NYU Grossman Sch Med, Dept Neurol, 222 E 41st St,14th Floor, New York, NY 10017 USA.	nicholas.moehringer@nyulangone.org; lisena.hasanaj@nyulangone.org; liliana.serrano@nyulangone.org; binu.joseph@nyulangone.org; shirley.wu@nyulangone.org; rachel.kenney@nyulangone.org; johnross.rizzo@nyulangone.org; janet.rucker@nyulangone.org; steven.galetta@nyulangone.org; laura.balcer@nyulangone.org		Rucker, Janet/0000-0002-0397-0999; Rizzo, John-Ross/0000-0002-4084-0085; Dahan, Natalie/0000-0002-3834-2693	NYU Grossman School of Medicine	This study was supported in part by the NYU Grossman School of Medicine.	Aggleton JP, 2010, BEHAV NEUROSCI, V124, P55, DOI 10.1037/a0018320; Akhand O, 2019, CURR OPIN NEUROL, V32, P68, DOI 10.1097/WCO.0000000000000654; Akhand O, 2019, J NEURO-OPHTHALMOL, V39, P68, DOI 10.1097/WNO.0000000000000726; Akhand O, 2018, J NEUROL SCI, V387, P199, DOI 10.1016/j.jns.2018.02.031; Cobbs L, 2017, J NEUROL SCI, V372, P393, DOI 10.1016/j.jns.2016.10.044; Conway J, 2020, J NEUROL SCI, V410, DOI 10.1016/j.jns.2020.116680; Cummine J, 2014, BEHAV BRAIN RES, V275, P157, DOI 10.1016/j.bbr.2014.08.038; Denckla M.B., 1974, CORTEX, V10, P185; DENCKLA MB, 1976, BRAIN LANG, V3, P1, DOI 10.1016/0093-934X(76)90001-8; Denckla MB, 1999, ANN DYSLEXIA, V49, P29, DOI 10.1007/s11881-999-0018-9; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; DiFabio M., 2016, NEUROLOGY, V86, ps16; Fallon S, 2019, J NEUROL SCI, V402, P52, DOI 10.1016/j.jns.2019.04.036; GESCHWIND N, 1966, ARCH NEUROL-CHICAGO, V15, P137, DOI 10.1001/archneur.1966.00470140027004; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Heick JD, 2016, ATHLETIC TRAINING SP, V8, P222, DOI DOI 10.3928/19425864-20160509-01; Kandel Eric R, 2012, THE AGE OF INSIGHT; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Norman Geschwind, 1967, CORTEX, V3, P97; Norton ES, 2012, ANNU REV PSYCHOL, V63, P427, DOI 10.1146/annurev-psych-120710-100431; Oberlander TJ, 2017, J ATHL TRAINING, V52, P439, DOI 10.4085/1062-6050-52.2.12; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Ryan L, 2012, HIPPOCAMPUS, V22, P1978, DOI 10.1002/hipo.22069; Seay M, 2018, J NEUROL SCI, V394, P1, DOI 10.1016/j.jns.2018.08.019; Wells F.L., 1945, MENTAL EXAMINERS HDB; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004	28	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	AUG 15	2020	415								116953	10.1016/j.jns.2020.116953			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	ML3SO	WOS:000549390100045	32554181				2022-02-06	
J	VanderEnde, J; Bateman, EA; MacKenzie, HM; Sequeira, K				VanderEnde, Jordan; Bateman, Emma A.; MacKenzie, Heather M.; Sequeira, Keith			Use of CGRP receptor blocker erenumab in the management of post-traumatic headache: a case series of 5 women	BRAIN INJURY			English	Article						Post-traumatic headache; mild traumatic brain injury; secondary headache disorders; monoclonal antibody	TRAUMATIC BRAIN-INJURY; TRIGEMINOVASCULAR PATHWAY; MIGRAINE	Context: Post-traumatic headache (PTH) is a disabling headache disorder and the most common sequela of mild traumatic brain injury. The pathophysiology of PTH is poorly understood and there is limited available evidence to guide prophylactic medication selection. Emerging understanding of the pathophysiology of migraine headaches has led to the development of monoclonal antibodies, including erenumab. Erenumab has shown promise for the prevention of primary migraine headache; however, it has not yet been studied in PTH. Case Series: five women (average age 43.0 +/- 17.9y) received treatment with erenumab for PTH secondary to mTBI. The average duration of PTH prior to starting erenumab was 32.0 +/- 18.2 months. All patients were taking at least one daily headache prophylactic therapy prior to erenumab. The average pre-erenumab headache intensity was 86/100. On erenumab, the average reported reduction in headache intensity was 51.1%. After starting erenumab, all five patients were able to discontinue one or more medication(s). The most common side effect was constipation (three patients). There were no serious adverse events after an average follow-up of 3.4 +/- 1.5 months. One patient discontinued erenumab during this period of follow-up after the resolution of her headaches. Conclusion: Erenumab appears to be safe and effective for the management of PTH.	[VanderEnde, Jordan; Bateman, Emma A.; MacKenzie, Heather M.; Sequeira, Keith] Western Univ, Dept Phys Med & Rehabil, London, ON, Canada		VanderEnde, J (corresponding author), St Josephs Hlth Care London, Dept Phys Med & Rehabil, London, ON N6A 4V2, Canada.	vanderende.jordan@gmail.com		VanderEnde, Jordan/0000-0002-6463-7145; Bateman, E. Ali/0000-0002-5069-3058			Conidi FX, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0570-z; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Edvinsson L, 2017, HEADACHE, V57, P47, DOI 10.1111/head.13081; Gagnier JJ, 2014, J CLIN EPIDEMIOL, V67, P46, DOI 10.1016/j.jclinepi.2013.08.003; Goadsby PJ, 2017, NEW ENGL J MED, V377, P2123, DOI 10.1056/NEJMoa1705848; He AJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0720-7; Hepp Z, 2014, J MANAGE CARE PHARM, V20, P22, DOI 10.18553/jmcp.2014.20.1.22; Kobeissy FH, 2015, BRAIN NEUROTRAUMA MO, P725; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Marshall S, 2018, GUIDELINES CONCUSSIO; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Noseda R, 2013, PAIN, V154, pS44, DOI 10.1016/j.pain.2013.07.021; Plantier D, 2016, ANN PHYS REHABIL MED, V59, P42, DOI 10.1016/j.rehab.2015.10.003; Russo AF, 2015, ANNU REV PHARMACOL, V55, P533, DOI 10.1146/annurev-pharmtox-010814-124701; Tepper S, 2017, LANCET NEUROL, V16, P425, DOI 10.1016/S1474-4422(17)30083-2; Thompson J., PERSISTENT SYMPTOMS	17	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 23	2020	34	10					1431	1434		10.1080/02699052.2020.1807052		AUG 2020	4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NI5TJ	WOS:000559543400001	32790533				2022-02-06	
J	Mansi, IA; English, JL; Alvarez, CA; Mortensen, EM; Pugh, MJ				Mansi, Ishak A.; English, Jenny L.; Alvarez, Carlos A.; Mortensen, Eric M.; Pugh, M. J.			Statins in survivors of traumatic brain injury: a propensity score-matched analysis	BRAIN INJURY			English	Article						Statins; traumatic brain injury; post-concussion syndrome; neurological disorders; substance dependence or abuse; psychiatric disorders	ROSUVASTATIN; ANGIOGENESIS; SIMVASTATIN; RISK	Background Several in-vitro and animal studies suggest that statins may have beneficial effects on clinical outcomes of traumatic brain injury (TBI), however, clinical data are scarce. Objectives To examine the association of statin use with TBI clinical outcomes among patients with TBI. Methods A retrospective cohort study of Tricare beneficiaries who had a TBI diagnosis, as defined by the Barbell injury diagnosis matrix. Outcomes were defined using ICD-9 codes and included: post-concussion syndrome, neurological disorders, substance dependence or abuse, and psychiatric disorders. Statin-users and non-users were propensity score (PS)-matched using 103 baseline characteristics. Results Out of 1187 adult patients with a TBI diagnosis (172 statin-users and 1015 nonusers), we PS-matched 70 statin-users to 70 non-users. There were no statistically significant differences in the PS-matched cohort of statin-users in comparison to nonusers for post-concussion syndrome (odds ratio [OR]: 0.24, 95% confidence interval [CI]: 0.03-2.20), neurological disorders (OR: 0.60, CI: 0.31-1.16); substance dependence or abuse (OR: 0.80, CI: 0.40-1.60), or psychiatric disorders (OR 0.80, CI: 0.41-1.55). Conclusion This study did not show benefit or harm for statins among survivors of TBI. Our findings do not support the evidence from some animal studies and small randomized controlled trials. Further studies utilizing larger sample sizes are warranted.	[Mansi, Ishak A.; Alvarez, Carlos A.; Mortensen, Eric M.] VA North Texas Hlth Syst, Med Serv, Dallas, TX 75216 USA; [Mansi, Ishak A.] Univ Texas Southwestern, Dept Internal Med, Dallas, TX 75216 USA; [Mansi, Ishak A.] Univ Texas Southwestern, Dept Populat & Data Sci, Dallas, TX 75216 USA; [Alvarez, Carlos A.] Texas Tech Univ, Hlth Sci Ctr, Dept Pharm Practice, Dallas, TX USA; [Mortensen, Eric M.] Univ Connecticut, Sch Med, Farmington, CT USA; [Pugh, M. J.] VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Analyt Sci Ctr, Salt Lake City, UT USA; [Pugh, M. J.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA		Mansi, IA (corresponding author), VA North Texas Hlth Syst, Dallas, TX 75216 USA.; Mansi, IA (corresponding author), Univ Texas Southwestern, Med, Dallas, TX 75216 USA.	Ishak.mansi@va.gov			North Texas VA Healthcare System, University of Texas Southwestern Medical Center, Dallas, TX; UT Southwestern Center for Patient-Centered Outcomes Research [AHRQ] [R24 HS022418]; VA Health Services Research and Development ServiceUS Department of Veterans Affairs [IK6 HX002608-01]	No funding was provided for this work, but this work was supported in part by resources from the North Texas VA Healthcare System, University of Texas Southwestern Medical Center, Dallas, TX, the UT Southwestern Center for Patient-Centered Outcomes Research [AHRQ R24 HS022418] and VA Health Services Research and Development Service [IK6 HX002608-01].	[Anonymous], TRAUM BRAIN INJ CONC; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Beziaud T, 2011, CRIT CARE MED, V39, P2300, DOI 10.1097/CCM.0b013e3182227e4a; Chan Carmen C M, 2008, Recent Pat CNS Drug Discov, V3, P189, DOI 10.2174/157488908786242434; Chauhan NB, 2011, RESTOR NEUROL NEUROS, V29, P23, DOI 10.3233/RNN-2011-0573; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dormuth CR, 2009, CIRCULATION, V119, P2051, DOI 10.1161/CIRCULATIONAHA.108.824151; Elixhauser A, 2012, CLIN CLASSIFICATIONS; FDA, 2011, DRUG SAF COMM NEW RE; Han XG, 2011, NEUROSCI LETT, V487, P255, DOI 10.1016/j.neulet.2010.09.007; Hansen BB, 2004, J AM STAT ASSOC, V99, P609, DOI 10.1198/016214504000000647; Hansen BB, 2008, STAT SCI, V23, P219, DOI 10.1214/08-STS254; Hazer DB, 2010, CLIN HEMORHEOL MICRO, V46, P1, DOI 10.3233/CH-2010-1328; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Ho DE, 2011, J STAT SOFTW, V42; Lilly SM, 2014, AM J CARDIOL, V114, P1035, DOI 10.1016/j.amjcard.2014.07.010; Luhrman S, 2008, ICD1300622001; Mann DM, 2010, ANN PHARMACOTHER, V44, P1410, DOI 10.1345/aph.1P150; Mansi I, 2015, AM J MED SCI, V350, P330, DOI 10.1097/MAJ.0000000000000527; Mansi I, 2013, EXPERT OPIN DRUG SAF, V12, P327, DOI 10.1517/14740338.2013.779667; Mashkouri S, 2016, NEURAL REGEN RES, V11, P1379, DOI 10.4103/1673-5374.191197; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; MDR, MDR M2 ICDS FUNCT RE; Neilson SJ, 2016, BRAIN INJURY, V30, P993, DOI 10.3109/02699052.2016.1147599; Redelmeier DA, 2019, JAMA NEUROL, V76, P887, DOI 10.1001/jamaneurol.2019.1148; Schneider EB, 2011, J TRAUMA, V71, P815, DOI 10.1097/TA.0b013e3182319de5; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8; Tapia-Perez JH, 2008, J NEUROTRAUM, V25, P1011, DOI 10.1089/neu.2008.0554; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thoemmes F., PROPENSITY SCORE MAT; Ucak A, 2011, ANN VASC SURG, V25, P686, DOI 10.1016/j.avsg.2011.02.024; Wang B, 2012, J NEUROL SCI, V319, P117, DOI 10.1016/j.jns.2012.04.015; Whyte J, 2019, J NEUROTRAUM, V36, P118, DOI 10.1089/neu.2017.5545; Wible EF, 2010, NEUROTHERAPEUTICS, V7, P62, DOI 10.1016/j.nurt.2009.11.003; Wu HT, 2011, NEUROSURGERY, V68, P1363, DOI 10.1227/NEU.0b013e31820c06b9	36	1	1	2	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 23	2020	34	10					1367	1374		10.1080/02699052.2020.1802663		AUG 2020	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NI5TJ	WOS:000559564000001	32790503				2022-02-06	
J	Botchway, EN; Godfrey, C; Nicholas, CL; Hearps, S; Anderson, V; Catroppa, C				Botchway, Edith N.; Godfrey, Celia; Nicholas, Christian L.; Hearps, Stephen; Anderson, Vicki; Catroppa, Cathy			Objective sleep outcomes 20 years after traumatic brain injury in childhood	DISABILITY AND REHABILITATION			English	Article						Young adults; childhood; objective sleep disturbance; traumatic brain injury; actigraphy	PAIN QUESTIONNAIRE-2 SF-MPQ-2; STRESS SCALES DASS; PSYCHOMETRIC PROPERTIES; ADULT SURVIVORS; DISTURBANCES; ADOLESCENTS; INSOMNIA; ACTIGRAPHY; DEPRESSION; CHILDREN	Purpose:To assess objective sleep outcomes and correlates in young adults with a history of childhood traumatic brain injury. Materials and methods:Participants included 45 young adults who sustained brain injury in childhood (mild = 12, moderate = 22, and severe = 11) and 13 typically developing control participants. Sleep was assessed with actigraphy and sleep diaries recorded over 14 consecutive days. Rates of good sleep (sleep efficiency >= 85%) and poor sleep (sleep efficiency < 85%) were also evaluated. Results:At 20-years postinjury, participants with traumatic brain injury and controls presented with similar outcomes across the objective sleep parameters (allp > 0.050) and rates of poor sleepers were also similar between these groups (p = 0.735): 67% and 77%, respectively. However, moderate and severe traumatic brain injury and female sex were associated with longer sleep duration. Conclusions:These findings provide preliminary insights into objective sleep outcome and associated factors in the very-long-term after childhood brain injuries. They also indicate the need to monitor sleep outcomes in young adults with and without traumatic brain injury.Implication for rehabilitation Sustaining traumatic brain injury in childhood can impact on several functional domains including sleep. Sleep disturbances, particularly insomnia-related symptoms, are common in this population, with evidence of poor outcomes reported until adolescence postinjury, while outcomes beyond adolescence remain unexplored. In this first investigation of objective sleep outcomes in young adults with a history of childhood traumatic brain injury, we showed that insomnia-related symptoms are highly prevalent in both young adults with traumatic brain injury (67%) and healthy controls (77%). These findings suggest the need to routinely evaluate and treat sleep problem in young adults in general, irrespective of history of childhood traumatic brain injury.	[Botchway, Edith N.; Godfrey, Celia; Nicholas, Christian L.; Hearps, Stephen; Anderson, Vicki; Catroppa, Cathy] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Botchway, Edith N.; Godfrey, Celia; Hearps, Stephen; Anderson, Vicki; Catroppa, Cathy] Royal Childrens Hosp, Melbourne, Vic, Australia; [Botchway, Edith N.; Godfrey, Celia; Anderson, Vicki] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Nicholas, Christian L.; Anderson, Vicki; Catroppa, Cathy] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Nicholas, Christian L.] Austin Hlth, Inst Breathing & Sleep, Heidelberg, Vic, Australia		Botchway, EN (corresponding author), Murdoch Childrens Res Inst, Clin Sci, 50 Flemington Rd, Parkville, Vic 3052, Australia.	edith.botchway@mcri.edu.au	Catroppa, Cathy/AAX-9458-2021; Hearps, Stephen/L-6853-2016	Catroppa, Cathy/0000-0002-9750-0436; Botchway, Edith N/0000-0002-0075-3382; Hearps, Stephen/0000-0003-2984-1172			Albicini M, 2018, J HEAD TRAUMA REHAB, V33, P191, DOI 10.1097/HTR.0000000000000312; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Beebe DW, 2010, J ADOLESCENT HEALTH, V47, P523, DOI 10.1016/j.jadohealth.2010.03.005; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bei B, 2014, J SLEEP RES, V23, P107, DOI 10.1111/jsr.12080; Biggs SN, 2013, SLEEP MED, V14, P1304, DOI 10.1016/j.sleep.2013.06.014; Blackwell T, 2008, SLEEP, V31, P283, DOI 10.1093/sleep/31.2.283; Blytt KM, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0653-7; Boccabella A, 2017, J CLIN SLEEP MED, V13, P685, DOI 10.5664/jcsm.6584; Botchway EN, 2018, J HEAD TRUAMA REHABI; Botchway EN, 2018, J NEUROTRAUM, V35, P1; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Buysse DJ, 2008, SLEEP, V31, P473, DOI 10.1093/sleep/31.4.473; Cantor Z, 2016, AM J EMERG MED, V34, P2048, DOI 10.1016/j.ajem.2016.08.013; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Chan JKM, 2013, ALCOHOL CLIN EXP RES, V37, P1720, DOI 10.1111/acer.12141; Colrain Ian M, 2014, Handb Clin Neurol, V125, P415, DOI 10.1016/B978-0-444-62619-6.00024-0; Cortesi F, 2012, J SLEEP RES, V21, P700, DOI 10.1111/j.1365-2869.2012.01021.x; Daniel A., 1983, POWER PRIVILEGE PRES; Decker C, 2000, CALCULATING NONPARAM; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Driver H S, 1998, Sleep Med Rev, V2, P213, DOI 10.1016/S1087-0792(98)90009-0; Dworkin RH, 2015, J PAIN, V16, P357, DOI 10.1016/j.jpain.2015.01.012; Eren S, 2014, SOCIAL CARE NEURODIS, V5, P135, DOI [10.1108/SCN-06-2013-0022, DOI 10.1108/SCN-06-2013-0022]; Fetveit A, 2002, INT J GERIATR PSYCH, V17, P604, DOI 10.1002/gps.639; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Grima NA, 2017, CURR OPIN PULM MED, V23, P493, DOI 10.1097/MCP.0000000000000429; Hale L, 2015, SLEEP MED REV, V21, P50, DOI 10.1016/j.smrv.2014.07.007; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Jang SH., 2016, MEDICINE, V95, P1; Jonsson CCA, 2014, INT J REHABIL RES, V37, P317, DOI 10.1097/MRR.0000000000000073; Kachooei AR, 2015, ARCH BONE JT SURG-AB, V3, P45; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kim CW, 2012, J SLEEP RES, V21, P546, DOI 10.1111/j.1365-2869.2012.01013.x; Landry-Roy C, 2018, J INT NEUROPSYCH SOC, V24, P769, DOI 10.1017/S1355617718000401; Landry-Roy C, 2017, J HEAD TRAUMA REHAB, V32, pE13, DOI 10.1097/HTR.0000000000000303; Lovejoy TI, 2012, J PAIN, V13, P1250, DOI 10.1016/j.jpain.2012.09.011; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Milroy G, 2008, J PEDIATR PSYCHOL, V33, P242, DOI 10.1093/jpepsy/jsm099; Mouthon AL, 2017, NEUROREHAB NEURAL RE, V31, P462, DOI 10.1177/1545968316688794; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Ophoff D, 2018, EUR J PEDIATR, V177, P641, DOI 10.1007/s00431-018-3116-z; Osorio MB, 2013, PM&R, V5, P554, DOI 10.1016/j.pmrj.2012.11.006; Owens J, 2014, PEDIATRICS, V134, pE921, DOI 10.1542/peds.2014-1696; Oyegbile TO, 2017, SLEEP MED, V40, P110, DOI 10.1016/j.sleep.2017.09.026; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Roth T., 2007, J CLIN SLEEP MED, V3, pS7, DOI DOI 10.5664/JCSM.26929; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; SPIELMAN AJ, 1987, SLEEP, V10, P45; Sumpter RE, 2013, J INT NEUROPSYCH SOC, V19, P829, DOI 10.1017/S1355617713000465; Tang J, 2017, SCI REP, V7, P1; Tang NKY, 2004, BEHAV RES THER, V42, P27, DOI 10.1016/S0005-7967(03)00068-8; Tham SW, 2015, J NEUROTRAUM, V32, P847, DOI 10.1089/neu.2014.3559; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Van Der Werf YD, 2009, NAT NEUROSCI, V12, P122, DOI 10.1038/nn.2253; Waters KA, 2013, MED J AUSTRALIA, V199, pS31, DOI 10.5694/mja13.10621; Zhou ES, 2016, J PEDIATR PSYCHOL, V41, P623, DOI 10.1093/jpepsy/jsv071	74	1	1	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	AUG 13	2020	42	17			SI		2393	2401		10.1080/09638288.2019.1578422			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	NE7PD	WOS:000562793500002	30945574				2022-02-06	
J	Cheng, ZQ; Yang, W; Li, BJ; Cui, RJ				Cheng, Ziqian; Yang, Wei; Li, Bingjin; Cui, Ranji			KLF4 Exerts Sedative Effects in Pentobarbital-Treated Mice	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						KLF4; Sedation; Pentobarbital; Lateral hypothalamic	AGOUTI-RELATED PROTEIN; GABA-A RECEPTOR; SIGNALING PATHWAYS; OREXIN NEURONS; SLEEP; INSOMNIA; MECHANISMS; RAT; P53; IDENTIFICATION	KLF4 is a zinc-finger transcription factor that plays an essential role in many biological processes, including neuroinflammation, neuron regeneration, cell proliferation, and apoptosis. Through effects on these processes, KLF4 has likely roles in Alzheimer's disease, Parkinson's disease, and traumatic brain injury. However, little is known about the role of KLF4 in more immediate behavioral processes that similarly depend upon broad changes in brain excitability, such as the sleep process. Here, behavioral approaches, western blot, and immunohistochemical experiments were used to explore the role of KLF4 on sedation and the potential mechanisms of those effects. The results showed that overexpression of KLF4 prolonged loss of righting reflex (LORR) duration in pentobarbital-treated mice and increased c-Fos expression in the lateral hypothalamus (LH) and the ventrolateral preoptic nucleus (VLPO), while it decreased c-Fos expression in the tuberomammillary nucleus (TMN). Moreover, overexpression of KLF4 reduced the expression of p53 in the hypothalamus and increased the expression of STAT3 in the hypothalamus. Therefore, these results suggest that KLF4 exerts sedative effects through the regulation of p53 and STAT3 expression, and it indicates a role of KLF4 ligands in the treatment of sleep disorders.	[Cheng, Ziqian; Yang, Wei; Li, Bingjin; Cui, Ranji] Second Hosp Jilin Univ, Jilin Prov Key Lab Mol & Chem Genet, 218 Ziqiang St, Changchun 130041, Peoples R China		Li, BJ; Cui, RJ (corresponding author), Second Hosp Jilin Univ, Jilin Prov Key Lab Mol & Chem Genet, 218 Ziqiang St, Changchun 130041, Peoples R China.	libingjin@jlu.edu.cn; cuiranji@jlu.edu.cn	cui, ranji/AAV-6234-2021		Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81871070, 31971078, 81971276]; National Key Research and Development Program of China [2018YFC1311603]; Jilin Science and Technology Agency funds in China [20200301005RQ, 20190701078GH, 20200201465JC, 20180101114JC]; Jilin Province Medical and Health Talents [2019SCZT013, 20170414034GH, 20190504, 2017F012]	This work was supported by the Natural Science Foundation of China (Grant numbers: 81871070, 31971078 and 81971276), the National Key Research and Development Program of China (2018YFC1311603) and Jilin Science and Technology Agency funds in China (Grant numbers: 20200301005RQ; 20190701078GH; 20200201465JC; 20180101114JC) and Jilin Province Medical and Health Talents (Grant numbers: 2019SCZT013; 20170414034GH; 20190504; 2017F012).	Ahnaou A, 2008, EUR J PHARMACOL, V579, P177, DOI 10.1016/j.ejphar.2007.10.017; Alvaro-Bartolome M, 2015, EUR NEUROPSYCHOPHARM, V25, P2131, DOI 10.1016/j.euroneuro.2015.07.019; Arrigoni E, 2019, NEUROPHARMACOLOGY, V154, P34, DOI 10.1016/j.neuropharm.2018.11.017; Artamokhina I V, 2011, Zh Evol Biokhim Fiziol, V47, P391; Azdad K, 2003, J NEUROPHYSIOL, V90, P559, DOI 10.1152/jn.00226.2003; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Beland FA, 1999, TOXIC REP SER, V1-66; Bonnavion P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7266; BORBELY AA, 1977, BRAIN RES, V124, P457, DOI 10.1016/0006-8993(77)90947-7; Buysse DJ, 2013, JAMA-J AM MED ASSOC, V309, P706, DOI 10.1001/jama.2013.193; Cheng ZQ, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00325; Chou TC, 2002, J NEUROSCI, V22, P977, DOI 10.1523/JNEUROSCI.22-03-00977.2002; Ciriello J, 2016, NEUROSCI LETT, V626, P112, DOI 10.1016/j.neulet.2016.05.029; Cronlein T, 2016, CURR OPIN PSYCHIATR, V29, P409, DOI 10.1097/YCO.0000000000000284; Cui DM, 2017, CNS NEUROSCI THER, V23, P106, DOI 10.1111/cns.12633; Cutler Andrew J, 2016, J Clin Psychiatry, V77, pe1010, DOI 10.4088/JCP.14076tx3c; DeBardeleben HK, 2017, GENETICS, V207, P571, DOI 10.1534/genetics.117.300070; DEWASMES G, 1989, PHYSIOL BEHAV, V46, P179, DOI 10.1016/0031-9384(89)90252-7; Franklin KBJ, 2013, PAXINOS FRANKLINS MO; Friedman J, 2016, J CLIN INVEST, V126, P4727, DOI 10.1172/JCI91578; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Ghaleb AM, 2017, GENE, V611, P27, DOI 10.1016/j.gene.2017.02.025; Goldstein N, 2018, CURR BIOL, V28, P3736, DOI 10.1016/j.cub.2018.09.055; Gottesmann C, 2004, BRAIN RES REV, V45, P230, DOI 10.1016/j.brainresrev.2004.04.003; Guesdon B, 2005, BEHAV BRAIN RES, V164, P156, DOI 10.1016/j.bbr.2005.06.006; Hakim F, 2015, SLEEP, V38, P31, DOI 10.5665/sleep.4320; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Herring WJ, 2019, J SLEEP RES, V28, DOI 10.1111/jsr.12782; Ilnytska O, 2011, DIABETES, V60, P97, DOI 10.2337/db10-0172; Imbernon M, 2014, MOL METAB, V3, P441, DOI 10.1016/j.molmet.2014.04.001; Jego S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052525; Jones BE, 2013, SLEEP, V36, P1769, DOI 10.5665/sleep.3188; Kwon O, 2016, CELL MOL LIFE SCI, V73, P1457, DOI 10.1007/s00018-016-2133-1; Lanni C, 2008, MOL PSYCHIATR, V13, P641, DOI 10.1038/sj.mp.4002060; Laque A, 2015, MOL METAB, V4, P706, DOI 10.1016/j.molmet.2015.07.002; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li BJ, 2013, J BIOCHEM MOL TOXIC, V27, P486, DOI 10.1002/jbt.21510; Li H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00969-0; Li LH, 2017, NEUROSCI LETT, V643, P131, DOI 10.1016/j.neulet.2017.02.017; Li ZD, 2010, CELL STRESS CHAPERON, V15, P905, DOI 10.1007/s12192-010-0199-5; Ma X, 2011, MOL PSYCHIATR, V16, P1105, DOI 10.1038/mp.2011.43; Mamonkin M, 2013, IMMUNOL LETT, V156, P94, DOI 10.1016/j.imlet.2013.09.008; Miki T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3444; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; Park MJ, 2009, PEPTIDES, V30, P181, DOI 10.1016/j.peptides.2008.11.005; Perez-Monter C, 2011, MOL CELL ENDOCRINOL, V333, P127, DOI 10.1016/j.mce.2010.12.020; Perron IJ, 2015, SLEEP, V38, P1893, DOI 10.5665/sleep.5236; Peter-Derex L, 2015, SLEEP MED REV, V19, P29, DOI 10.1016/j.smrv.2014.03.007; Qin S, 2012, MOL CELL BIOL, V32, P4297, DOI 10.1128/MCB.00838-12; Qu WM, 2012, BRIT J PHARMACOL, V167, P587, DOI 10.1111/j.1476-5381.2012.02010.x; Riemann D, 2015, LANCET NEUROL, V14, P547, DOI 10.1016/S1474-4422(15)00021-6; Roky R, 1999, PHYSIOL BEHAV, V67, P697, DOI 10.1016/S0031-9384(99)00137-7; Roth T, 2007, SLEEP MED, V8, pS1, DOI 10.1016/S1389-9457(08)70001-7; SAHA N, 1990, METHOD FIND EXP CLIN, V12, P507; Sahin GS, 2020, MOL CELL NEUROSCI, V106, DOI 10.1016/j.mcn.2020.103500; Salort G, 2019, NEUROCHEM INT, V122, P59, DOI 10.1016/j.neuint.2018.11.008; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Sharma R, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12498; Sharma R, 2014, SLEEP, V37, P525, DOI 10.5665/sleep.3490; Sherin JE, 1998, J NEUROSCI, V18, P4705; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; St-Onge MP, 2016, ADV NUTR, V7, P938, DOI 10.3945/an.116.012336; Stino FKR, 1998, PHARMACOLOGY, V56, P92, DOI 10.1159/000028186; Szymusiak R, 2008, ANN NY ACAD SCI, V1129, P275, DOI 10.1196/annals.1417.027; Tholfsen LK, 2017, NEUROLOGY, V88, P352, DOI 10.1212/WNL.0000000000003540; Venner A, 2016, CURR BIOL, V26, P2137, DOI 10.1016/j.cub.2016.05.078; Vgontzas AN, 2013, SLEEP MED REV, V17, P241, DOI 10.1016/j.smrv.2012.09.005; Weber F, 2016, NATURE, V538, P51, DOI 10.1038/nature19773; Williams RH, 2014, J NEUROSCI, V34, P6023, DOI 10.1523/JNEUROSCI.4838-13.2014; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang Y, 2012, PHARMACOL BIOCHEM BE, V102, P450, DOI 10.1016/j.pbb.2012.06.002; Zhu SS, 2009, BRAIN RES, V1250, P49, DOI 10.1016/j.brainres.2008.11.013	74	1	1	5	10	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	MAR	2021	71	3					596	606		10.1007/s12031-020-01680-y		AUG 2020	11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	QA9UW	WOS:000559317100001	32789565				2022-02-06	
J	Kheyrkhah, H; Zangbar, HS; Salimi, O; Shahabi, P; Alaei, H				Kheyrkhah, Hasan; Zangbar, Hamid Soltani; Salimi, Omid; Shahabi, Parviz; Alaei, HojjatAllah			Prefrontal dopaminergic system and its role in working memory and cognition in spinal cord-injured rats	EXPERIMENTAL PHYSIOLOGY			English	Article						cognition; dopamine; spatial working memory; spinal cord injury	TRAUMATIC BRAIN-INJURY; OBJECT RECOGNITION MEMORY; LONG-TERM DEPRESSION; FRONTAL-CORTEX; D-1 RECEPTOR; INVOLVEMENT; MODULATION; EXPRESSION; D1; PERFORMANCE	New Findings What is the central question of this study?How does spinal cord injury affect prefrontal cortex function and the expression of dopamine receptors? What is the main finding and its importance?Spinal cord injury impaired cognitive function, which was associated with reduced dopamine receptor expression in the prefrontal cortex. The effect of spinal cord injury (SCI) has been studied widely in paraplegia and motor areas of the brain, but its mechanisms in memory and cognitive impairment remain controversial. Here, we focused on the impact of SCI on prefrontal performance via dopamine levels and receptors. We divided 18 male rats into three groups, i.e. control, laminectomy and SCI groups. Laminectomy and SCI were induced at T10 of the spinal cord. One week later, after locomotor recovery, the novel object recognition and T-maze (spontaneous alternation) tests were applied. After behavioural assessments, the rats were killed and their brain tissues harvested. According to the behavioural findings, cognitive function was impaired in the SCI group (P < 0.05). Also, SCI significantly increased the dopamine level and decreased the expression of dopamine receptors in the prefrontal cortex 2 weeks after injury (P < 0.05). Given the role of dopamine in cognition, SCI could impair novel object recognition and spatial working memory via dopaminergic systems.	[Kheyrkhah, Hasan; Alaei, HojjatAllah] Isfahan Univ Med Sci, Fac Med, Dept Physiol, Esfahan, Iran; [Zangbar, Hamid Soltani] Tabriz Univ Med Sci, Fac Adv Med Sci, Dept Neurosci & Cognit, Tabriz, Iran; [Salimi, Omid; Shahabi, Parviz] Tabriz Univ Med Sci, Neurosci Res Ctr, Tabriz, Iran		Alaei, H (corresponding author), Isfahan Univ Med Sci, Fac Med, Dept Physiol, Esfahan, Iran.; Shahabi, P (corresponding author), Tabriz Univ Med Sci, Neurosci Res Ctr, Tabriz, Iran.	shahabip@tbzmed.ac.ir; alaei@med.mui.ac.ir	shahabi, parviz/D-9690-2017	shahabi, parviz/0000-0001-5594-5544	Isfahan University of Medical Sciences [396748]	Isfahan University of Medical Sciences, Grant/Award Number: 396748	Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bales James W, 2010, Open Drug Discov J, V2, P119; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Barraud Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013306; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BATUEV AS, 1990, BEHAV BRAIN RES, V41, P95, DOI 10.1016/0166-4328(90)90145-5; Besheer J, 1999, BEHAV BRAIN RES, V103, P35, DOI 10.1016/S0166-4328(99)00021-2; Bezu M, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00196; Chen Q, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00211; de Lima MNM, 2005, BEHAV BRAIN RES, V156, P139, DOI 10.1016/j.bbr.2004.05.016; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster J. M., 1999, MEMORY CEREBRAL CORT; GASPAR P, 1995, EUR J NEUROSCI, V7, P1050, DOI 10.1111/j.1460-9568.1995.tb01092.x; GLOWINSKI J, 1984, TRENDS NEUROSCI, V7, P414; Goldman-Rakic P.S., 2011, COMPR PHYSIOL, P373, DOI DOI 10.1002/CPHY.CP010509; Goldman-Rakic P. S., 1994, MOTOR COGNITIVE FUNC, P112; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GOLDMANRAKIC PS, 1990, PROG BRAIN RES, V85, P325; GOLDMANRAKIC PS, 1992, SEMIN NEUROSCI, V4, P149; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; HEDEMAN LS, 1974, J NEUROSURG, V40, P37, DOI 10.3171/jns.1974.40.1.0037; Hotte M, 2005, NEUROBIOL LEARN MEM, V84, P85, DOI 10.1016/j.nlm.2005.04.002; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; KAHN RS, 1994, SCHIZOPHR RES, V11, P217, DOI 10.1016/0920-9964(94)90015-9; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Krimchansky BZ, 2004, BRAIN INJURY, V18, P1099, DOI 10.1080/02699050310001646206; Kuppers E, 2000, J NEUROCYTOL, V29, P375, DOI 10.1023/A:1007165307652; LAWTHO D, 1995, NEUROSCI LETT, V188, P125, DOI 10.1016/0304-3940(95)11414-R; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Murphy BL, 1996, P NATL ACAD SCI USA, V93, P1325, DOI 10.1073/pnas.93.3.1325; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Otani S, 1998, NEUROSCIENCE, V85, P669, DOI 10.1016/S0306-4522(97)00677-5; PENITSORIA J, 1987, BRAIN RES, V425, P263, DOI 10.1016/0006-8993(87)90509-9; PETRIDES M, 1995, J NEUROSCI, V15, P359; Peyron C, 1995, NEUROREPORT, V6, P2527, DOI 10.1097/00001756-199512150-00019; Pezze MA, 2015, EUR NEUROPSYCHOPHARM, V25, P2145, DOI 10.1016/j.euroneuro.2015.07.018; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Rossato JI, 2013, NEUROBIOL LEARN MEM, V106, P66, DOI 10.1016/j.nlm.2013.07.012; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; SAWAGUCHI T, 1990, J NEUROPHYSIOL, V63, P1401, DOI 10.1152/jn.1990.63.6.1401; SAWAGUCHI T, 1994, J NEUROPHYSIOL, V71, P515, DOI 10.1152/jn.1994.71.2.515; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seamans JK, 1998, J NEUROSCI, V18, P1613; SEEMAN P, 1994, TRENDS PHARMACOL SCI, V15, P264, DOI 10.1016/0165-6147(94)90323-9; Spijker S., 2011, NEUROPROTEOMICS, V13; VINCENT SL, 1993, J NEUROSCI, V13, P2551, DOI 10.1523/JNEUROSCI.13-06-02551.1993; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Wang DY, 2007, NEUROPSYCHOPHARMACOL, V32, P1261, DOI 10.1038/sj.npp.1301256; Wiesenfeld-Hallin Zsuzsanna, 2005, Gend Med, V2, P137, DOI 10.1016/S1550-8579(05)80042-7; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Wu JF, 2014, CELL CYCLE, V13, P2446, DOI 10.4161/cc.29420; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009; Yang C., 1997, J NEUROSCI, V18, P9139, DOI [10.1523/JNEUROSCI.18-21-09139.1998, DOI 10.1523/JNEUROSCI.18-21-09139.1998]; Zahrt J, 1997, J NEUROSCI, V17, P8528; Zhu H, 2007, NEUROSCIENCE, V149, P885, DOI 10.1016/j.neuroscience.2007.07.052	65	1	1	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0958-0670	1469-445X		EXP PHYSIOL	Exp. Physiol.	SEP 1	2020	105	9					1579	1587		10.1113/EP088537		AUG 2020	9	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	OY0EU	WOS:000559391600001	32654245				2022-02-06	
J	Pyndiura, KL; Di Battista, AP; Hutchison, MG				Pyndiura, Kyla L.; Di Battista, Alex P.; Hutchison, Michael G.			A history of concussion is associated with minimal perturbations to heart rate variability in athletes	BRAIN INJURY			English	Article						Autonomic nervous system; sport concussion; mTBI; electrophysiology	STRESS; GENDER; IMPACT; YOUNG; RISK; SEX; AGE	Purpose To compare heart rate variability (HRV) in healthy male and female athletes with versus without a history of concussion. Methods A cross-sectional study of 113 healthy interuniversity athletes (n = 62 female; n = 51 male) across nine sports from a single institution, participating within the first half of their respective athletic seasons. Concussion history was determined by self-report (males: yes = 20, no = 31; females: yes = 21, no = 41). HRV was measured over five-minute time intervals in both seated and supine positions. All analyses were adjusted for age. Results No differences in HRV were observed in female athletes with versus without a history of concussion; male athletes with a history of concussion displayed a significantly lower mean RR in the seated position compared to athletes with no history of concussion. Conclusion In the months-to-years following a concussion, HRV does not appear to be significantly perturbed. However, males with a history of concussion may have a slightly lower mean RR. Future studies evaluating HRV and concussion history should be mindful of the confounding influence of sex and age.	[Pyndiura, Kyla L.; Di Battista, Alex P.; Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, 100 Devonshire Pl, Toronto, ON M5S 2C9, Canada; [Hutchison, Michael G.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Neurosci Res Program, Toronto, ON, Canada		Di Battista, AP (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, 100 Devonshire Pl, Toronto, ON M5S 2C9, Canada.	dibattista.alex@gmail.com			Canadian Institute of Military and Veteran Health Research (CIMVHR, Task 7)	This work was supported by the Canadian Institute of Military and Veteran Health Research (CIMVHR, Task 7).	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Billman GE, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00055; Bishop S, 2017, BRAIN INJURY, V31, P247, DOI 10.1080/02699052.2016.1226385; Bruce JM, 2017, CLIN NEUROPSYCHOL, V31, P1329, DOI 10.1080/13854046.2017.1311375; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Di Battista AP, 2018, BRAIN INJURY, V32, P575, DOI 10.1080/02699052.2018.1432892; Dobney DM, 2018, J SPORT REHABIL, V27, P312, DOI 10.1123/jsr.2017-0038; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Emery CF, 2018, J PSYCHOSOM RES, V110, P54, DOI 10.1016/j.jpsychores.2018.04.011; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Estevez-Baez M, 2019, ADV EXP MED BIOL, V1133, P19, DOI 10.1007/5584_2018_292; Fyfe-Johnson AL, 2016, STROKE, V47, P1452, DOI 10.1161/STROKEAHA.116.012662; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Koenig J, 2016, NEUROSCI BIOBEHAV R, V64, P288, DOI 10.1016/j.neubiorev.2016.03.007; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Monda M, 2009, NUTR NEUROSCI, V12, P43, DOI 10.1179/147683009X388841; Paniccia M, 2018, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00753; Rauh R, 2006, CLIN PHYSIOL FUNCT I, V26, DOI [10.1111/j.1475-097X.2006.00663, DOI 10.1111/J.1475-097X.2006.00663]; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Senthinathan A, 2017, CLIN J SPORT MED, V27, P288, DOI 10.1097/JSM.0000000000000337; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; Umetani K, 1998, J AM COLL CARDIOL, V31, P593, DOI 10.1016/S0735-1097(97)00554-8; Videira G, 2016, J NEUROL SCI, V367, P133, DOI 10.1016/j.jns.2016.05.049; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413; Zimmermann-Viehoff F, 2016, NUTR NEUROSCI, V19, P169, DOI 10.1179/1476830515Y.0000000018	37	1	1	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 23	2020	34	10					1416	1421		10.1080/02699052.2020.1802661		AUG 2020	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NI5TJ	WOS:000558511700001	32780666				2022-02-06	
J	Sweeny, M; Inness, EL; Singer, J; Perez, OH; Danells, C; Chandra, T; Foster, E; Comper, P; Bayley, M; Mochizuki, G				Sweeny, Michelle; Inness, Elizabeth L.; Singer, Jonathan; Habib Perez, Olinda; Danells, Cynthia; Chandra, Tharshini; Foster, Evan; Comper, Paul; Bayley, Mark; Mochizuki, George			The Toronto Concussion Study: a longitudinal analysis of balance deficits following concussion in community-dwelling adults	BRAIN INJURY			English	Article						Balance; concussion; adult; community-dwelling; BESS; forceplate	ERROR SCORING SYSTEM; LINEAR MIXED MODELS; POSTURAL-CONTROL; CEREBRAL CONCUSSION; QUIET STANCE; RELIABILITY; STABILITY; RECOVERY; SYMPTOMS; ATHLETE	Objective To characterize recovery of balance deficits in community-dwelling adults with concussion. Hypothesis Balance measures will improve 2 weeks after injury and persist over 12 weeks. Design Prospective longitudinal observational study. Methods Assessments included the Balance Error Scoring System (BESS) and quiet standing during eyes open, eyes closed, and a cognitive dual task. Recovery was determined using a Hierarchical Growth Curve Model (HGCM) at Week1 (n = 61), Week2 (n = 58), Week4 (n = 53), Week8 (n = 51), and Week12 (n = 39) post-injury. Within-individual follow-up analysis was conducted using the coefficient of variation (quiet standing measures) and a reliable change index (BESS) on 28 individuals with concussion assessed at all 5 time points. Results Self-reported symptom score recovered between Week 4-8. Anteroposterior COP velocity (eyes closed) was the only variable to show statistically significant (p< .05) recovery in the HGCM. The within-individual analysis identified fewer than 43% (12/28) of participants recovered by Week 12, relative to their own Week 1 assessment. Conclusions While recovery of balance deficits was observed in 1 variable over 12 weeks, less than half of the participants included in all assessments demonstrated improvement in balance outcomes. Future research and clinical practice should focus on the unique characteristics of community-dwelling adults with concussion to optimize recovery in this cohort.	[Sweeny, Michelle; Inness, Elizabeth L.; Habib Perez, Olinda; Danells, Cynthia; Chandra, Tharshini; Foster, Evan; Comper, Paul; Bayley, Mark; Mochizuki, George] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Sweeny, Michelle; Comper, Paul; Mochizuki, George] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Inness, Elizabeth L.; Danells, Cynthia] Univ Toronto, Dept Phys Therapy, Fac Med, Toronto, ON, Canada; [Singer, Jonathan] Univ Manitoba, Fac Kinesiol & Recreat Management, Winnipeg, MB, Canada; [Comper, Paul] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Bayley, Mark] Univ Toronto, Div Phys Med & Rehabil, Fac Med, Toronto, ON, Canada; [Mochizuki, George] York Univ, Fac Hlth, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada		Mochizuki, G (corresponding author), York Univ, Bethune Coll, Rm 363, Toronto, ON M3J1P3, Canada.	gmochizu@yorku.ca		Inness, Elizabeth L./0000-0002-9217-4619; Bayley, Mark/0000-0001-7860-9463	Hull-Ellis Concussion and Research Clinic; TorontoRehab Foundation	The authors acknowledge funding from the Hull-Ellis Concussion and Research Clinic and the TorontoRehab Foundation.	Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Brauer SG, 2008, AGING CLIN EXP RES, V20, P406; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Carpenter MG, 2010, NEUROSCIENCE, V171, P196, DOI 10.1016/j.neuroscience.2010.08.030; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Cotman CW, 2002, EXERC SPORT SCI REV, V30, P75, DOI 10.1097/00003677-200204000-00006; Curran PJ, 2010, J COGN DEV, V11, P121, DOI 10.1080/15248371003699969; Degani AM, 2017, BRAIN INJURY, V31, P49, DOI 10.1080/02699052.2016.1225982; DeLucia C, 2006, J PEDIATR PSYCHOL, V31, P1002, DOI 10.1093/jpepsy/jsj074; Duarte M., 2010, REV BRAS FISIOTER, V14, DOI DOI 10.1590/S1413-35552010000300003; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Gasq D, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-39; Gatev P, 1999, J PHYSIOL-LONDON, V514, P915, DOI 10.1111/j.1469-7793.1999.915ad.x; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Inness EL, 2019, J HEAD TRAUMA REHAB, V34, pE37, DOI 10.1097/HTR.0000000000000431; Kaplan D, 2004, SAGE HDB QUANTITATIV; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrea M, 2003, J AM MED ASS, V290; McIlroy WE, 1997, CLIN BIOMECH, V12, P66, DOI 10.1016/S0268-0033(96)00040-X; Meeuwisse W, 2017, BR J SPORTS MED, V51; Meeuwisse WH, 2013, BR J SPORTS MED, V47; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Nakata H, 2010, BRAIN RES REV, V62, P197, DOI 10.1016/j.brainresrev.2009.11.006; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Rhine TD, 2016, CLIN J SPORT MED, V26, P221, DOI 10.1097/JSM.0000000000000234; Riemann BL, 2000, J ATHL TRAIN, V35; Rochefort C, 2017, J SCI MED SPORT, V20, P970, DOI 10.1016/j.jsams.2017.04.008; Ruhe A, 2014, SPORTS HEALTH, V6, P427, DOI 10.1177/1941738114541238; Schinkel-Ivy A, 2016, CLIN NEUROPHYSIOL, V127, P2463, DOI 10.1016/j.clinph.2016.02.021; Sheehan DP, 2011, MEAS PHYS EDUC EXERC, V15, P234, DOI 10.1080/1091367X.2011.568368; Shek DTL, 2011, THESCIENTIFICWORLDJO, V11, P42, DOI 10.1100/tsw.2011.2; Singer JC, 2015, IEEE TRANSNEURAL SYS, V23; Singer JC, 2016, NEUROREHAB NEURAL RE, V30, P626, DOI 10.1177/1545968315613862; Slobounov S, 2005, CLIN NEUROPHYSIOL, V116, P315, DOI 10.1016/j.clinph.2004.09.007; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Valovich Mcleod TC, 2006, J ATHL TRAIN, V41; West BT, 2009, EVAL HEALTH PROF, V32, P207, DOI 10.1177/0163278709338554	44	1	1	2	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 23	2020	34	10					1384	1394		10.1080/02699052.2020.1802665		AUG 2020	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NI5TJ	WOS:000558491400001	32780656				2022-02-06	
J	Asselin, PD; Gu, Y; Merchant-Borna, K; Abar, B; Wright, DW; Qiu, X; Bazarian, JJ				Asselin, Patrick D.; Gu, Yu; Merchant-Borna, Kian; Abar, Beau; Wright, David W.; Qiu, Xing; Bazarian, Jeff J.			Spatial regression analysis of MR diffusion reveals subject-specific white matter changes associated with repetitive head impacts in contact sports	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; LONGITUDINAL CHANGES; AXONAL DAMAGE; TENSOR; CONCUSSION; SEASON; EXPOSURE; MODEL	Repetitive head impacts (RHI) are a growing concern due to their possible neurocognitive effects, with research showing a season of RHI produce white matter (WM) changes seen on neuroimaging. We conducted a secondary analysis of diffusion tensor imaging (DTI) data for 28 contact athletes to compare WM changes. We collected pre-season and post-season DTI scans for each subject, approximately 3 months apart. We collected helmet data for the athletes, which we correlated with DTI data. We adapted the SPatial REgression Analysis of DTI (SPREAD) algorithm to conduct subject-specific longitudinal DTI analysis, and developed global inferential tools using functional norms and a novel robust p value combination test. At the individual level, most detected injured regions (93.3%) were associated with decreased FA values. Using meta-analysis techniques to combine injured regions across subjects, we found the combined injured region at the group level occupied the entire WM skeleton, suggesting the WM damage location is subject-specific. Several subject-specific functional summaries of SPREAD-detected WM change, e.g., the L infinity norm, significantly correlated with helmet impact measures, e.g. cumulative unweighted rotational acceleration (adjusted p=0.0049), time between hits rotational acceleration (adjusted p value 0.0101), and time until DTI rotational acceleration (adjusted p=0.0084), suggesting RHIs lead to WM changes.	[Asselin, Patrick D.] Boston Childrens Hosp, Dept Pediat, 300 Longwood Ave, Boston, MA 02115 USA; [Gu, Yu; Qiu, Xing] Univ Rochester, Dept Biostat & Computat Biol, 265 Crittenden Blvd,CU 420630, Rochester, NY 14642 USA; [Merchant-Borna, Kian; Abar, Beau; Bazarian, Jeff J.] Univ Rochester, Sch Med & Dent, Dept Emergency Med, 265 Crittenden Blvd,Box 655C, Rochester, NY 14642 USA; [Wright, David W.] Emory Univ, Dept Emergency Med, 49 Jesse Hill Jr Dr, Atlanta, GA 30303 USA		Qiu, X (corresponding author), Univ Rochester, Dept Biostat & Computat Biol, 265 Crittenden Blvd,CU 420630, Rochester, NY 14642 USA.	Xing_Qiu@URMC.Rochester.edu			US Army Rapid Innovation Fund [W911NF-11-R0017]; University of Rochester Center for AIDS Research [NIH 5 P30 AI078498-08]; University of Rochester CTSA award from the National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR002001]; Offices for Medical Education at the University of Rochester School of Medicine and Dentistry	We thank Adnan Hirad, PhD, for providing support and expertise during the pre-processing steps of the DTI data. This work is supported in part by the US Army Rapid Innovation Fund (W911NF-11-R0017); the University of Rochester Center for AIDS Research (NIH 5 P30 AI078498-08); and the University of Rochester CTSA award number UL1 TR002001 from the National Center for Advancing Translational Sciences of the National Institutes of Health; and the Offices for Medical Education at the University of Rochester School of Medicine and Dentistry.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andersson JLR, 2007, NONLINEAR REGISTRATI; Asken BM, 2018, NEUROLOGY, V91, pE2123, DOI 10.1212/WNL.0000000000006616; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bankman I.N., 2000, HDB MED IMAGING; BAZARIAN J, 2014, PLOS ONE, V0009, P00001; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; di Battista AP, 2016, PLOS ONE, V11, P1; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Gajawelli N, 2013, WORLD NEUROSURG, V80, P824, DOI 10.1016/j.wneu.2013.10.020; Hall A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151778; Li C, 2007, ISSN INT J MAGNETIC, V01, P1749; Liu BL, 2016, NEUROIMAGE-CLIN, V11, P291, DOI 10.1016/j.nicl.2016.02.009; Liu BL, 2016, PHYS MED BIOL, V61, P2497, DOI 10.1088/0031-9155/61/6/2497; Mayinger MC, 2018, BRAIN IMAGING BEHAV, V12, P44, DOI 10.1007/s11682-017-9672-4; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Merchant-Borna K, 2016, ANN BIOMED ENG, V44, P3679, DOI 10.1007/s10439-016-1680-9; Montenigro PH, 2017, J NEUROTRAUMA, V340, P1; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; R Core Team, 2021, R LANG ENV STAT COMP; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rose SC, 2019, J HEAD TRAUMA REHAB, V34, P87, DOI 10.1097/HTR.0000000000000441; Saigal Rajiv, 2014, Neurosurgery, V75 Suppl 4, pS149, DOI 10.1227/NEU.0000000000000497; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Slemmer JE, 2005, NEUROBIOL DIS, V18, P421, DOI 10.1016/j.nbd.2004.09.022; Snook L, 2007, NEUROIMAGE, V34, P243, DOI 10.1016/j.neuroimage.2006.07.021; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Watts R, 2014, RADIOLOGY, V272, P217, DOI 10.1148/radiol.14131856; WESTFALL PH, 1993, BIOMETRICS, V49, P941, DOI 10.2307/2532216; Whitcher B, 2011, J STAT SOFTW, V44, P1; Zhu T, 2013, MAGN RESON IMAGING, V31, P1657, DOI 10.1016/j.mri.2013.07.016	47	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 12	2020	10	1							13606	10.1038/s41598-020-70604-y			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NF8HT	WOS:000563534600028	32788605	gold, Green Published			2022-02-06	
J	Hu, YC; Wang, XJ; Ye, L; Li, C; Chen, WW; Cheng, HW				Hu, Yangchun; Wang, Xiaojian; Ye, Lei; Li, Chao; Chen, Weiwei; Cheng, Hongwei			Rosuvastatin Alleviates Intestinal Injury by Down-Regulating the CD40 Pathway in the Intestines of Rats Following Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						rosuvastatin; CD40; NF-kappa B; intestinal injury; traumatic brain injury	NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; ISCHEMIA-REPERFUSION INJURY; TNF-ALPHA; EXPRESSION; ATORVASTATIN; INHIBITION; MODERATE; COLITIS	Statins have been reported to suppress CD40 expression and nuclear factor (NF)-kappa B activation, which are both up-regulated in the intestines following traumatic brain injury (TBI)-induced intestinal injury. In this study, we aimed to investigate the effects of the statin rosuvastatin on post-TBI jejunal injury in rats, focusing on potential mechanisms involving the CD40/NF-kappa B signaling pathway. The jejunal CD40 expression was determined by western blotting. The DNA-binding activity of NF-kappa B was assessed by electrophoretic mobility shift assays (EMSAs). The tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 beta levels were assessed by enzyme-linked immunosorbent assays (ELISAs). The severity of the jejunal mucosal injury was assessed by hematoxylin and eosin (HE) staining and histopathological evaluation. We found that the post-TBI upregulation of both CD40 expression and NF-kappa B activity in the jejunal tissues were significantly inhibited by rosuvastatin, while the post-TBI expression of TNF-alpha and IL-1 beta was significantly suppressed by rosuvastatin. In addition, rosuvastatin significantly ameliorated TBI-induced effects on the villus height, crypt depth, and villous surface area. Rosuvastatin suppressed TBI-induced intestinal injury in rats, which may be associated with the blockade of the CD40/NF-kappa B pathway.	[Hu, Yangchun; Wang, Xiaojian; Ye, Lei; Li, Chao; Chen, Weiwei; Cheng, Hongwei] Anhui Med Univ, Dept Neurosurg, Affiliated Hosp 1, Hefei, Peoples R China		Hu, YC; Ye, L (corresponding author), Anhui Med Univ, Dept Neurosurg, Affiliated Hosp 1, Hefei, Peoples R China.	hycdoc@sohu.com; yelei8778@sina.cn					Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Beauparlant Pierre, 1996, Cytokine and Growth Factor Reviews, V7, P175, DOI 10.1016/1359-6101(96)00020-2; Chen G, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/93431; Chong AJ, 2019, WORLD NEUROSURG, V132, pE99, DOI 10.1016/j.wneu.2019.08.250; Danese S, 2004, GUT, V53, P1035, DOI 10.1136/gut.2003.026278; Di Napoli P, 2005, CARDIOVASC RES, V66, P462, DOI 10.1016/j.cardiores.2005.02.008; Grotz MRW, 1999, ANN SURG, V229, P478, DOI 10.1097/00000658-199904000-00005; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hilgendorff A, 2003, INT J CLIN PHARM TH, V41, P397; Hu YC, 2013, J SURG RES, V184, P1022, DOI 10.1016/j.jss.2013.04.005; Inoue I, 2002, BIOCHEM BIOPH RES CO, V290, P131, DOI 10.1006/bbrc.2001.6141; Kigerl KA, 2016, J EXP MED, V213, P2603, DOI 10.1084/jem.20151345; Kumai T., 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P195, DOI 10.2174/1568016054368223; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Ling HP, 2013, J SURG RES, V179, pE227, DOI 10.1016/j.jss.2012.03.030; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Liu YL, 2017, J NEUROTRAUM, V34, P2119, DOI 10.1089/neu.2016.4764; Lopez-Canales JS, 2011, BRAZ J MED BIOL RES, V44, P438, DOI 10.1590/S0100-879X2011007500032; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Martin G, 2001, J CLIN INVEST, V107, P1423, DOI 10.1172/JCI10852; Mulhaupt F, 2003, CARDIOVASC RES, V59, P755, DOI 10.1016/S0008-6363(03)00515-7; Naito Y, 2006, WORLD J GASTROENTERO, V12, P2024, DOI 10.3748/wjg.v12.i13.2024; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Olsen AB, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12121; Senhaji N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00529; Spies M, 2002, AM J PHYSIOL-GASTR L, V283, pG703, DOI 10.1152/ajpgi.00149.2001; Tabrizi R, 2019, PHARMACOL RES, V141, P85, DOI 10.1016/j.phrs.2018.12.010; Tu J, 2017, INFLAMMATION, V40, P725, DOI 10.1007/s10753-017-0516-6; Wagner AH, 2002, ARTERIOSCL THROM VAS, V22, P1784, DOI 10.1161/01.ATV.0000037098.20829.31; Wang L, 2018, MOL MED REP, V18, P789, DOI 10.3892/mmr.2018.9062; Wu X, 2008, AM J PHYSIOL-GASTR L, V294, pG295, DOI 10.1152/ajpgi.00173.2007; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2	34	1	1	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 11	2020	11								816	10.3389/fneur.2020.00816			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NI4FW	WOS:000565310800001	32849246	gold, Green Published			2022-02-06	
J	Bartnik-Olson, B; Holshouser, B; Ghosh, N; Oyoyo, UE; Nichols, JG; Pivonka-Jones, J; Tong, KR; Ashwal, S				Bartnik-Olson, Brenda; Holshouser, Barbara; Ghosh, Nirmalya; Oyoyo, Udochukwu E.; Nichols, Joy G.; Pivonka-Jones, Jamie-; Tong, Karen; Ashwal, Stephen			Evolving White Matter Injury following Pediatric Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						diffusion tensor imaging; factor analysis; longitudinal; neurocognitive outcome; pediatric	IMAGING DTI FINDINGS; DIFFUSION-TENSOR; CORPUS-CALLOSUM; WORKING-MEMORY; AXONAL INJURY; SPATIAL STATISTICS; KEY ROLE; MILD; INTELLIGENCE; CHILDREN	This study is unique in that it examines the evolution of white matter injury very early and at 12 months post-injury in pediatric patients following traumatic brain injury (TBI). Diffusion tensor imaging (DTI) was acquired at two time-points: acutely at 6-17 days and 12 months following a complicated mild (cMild)/moderate (mod) or severe TBI. Regional measures of anisotropy and diffusivity were compared between TBI groups and against a group of age-matched healthy controls and used to predict performance on measures of attention, memory, and intellectual functioning at 12-months post-injury. Analysis of the acute DTI data using tract based spatial statistics revealed a small number of regional decreases in fractional anisotropy (FA) in both the cMild/mod and severe TBI groups compared with controls. These changes were observed in the occipital white matter, anterior limb of the internal capsule (ALIC)/basal ganglia, and corpus callosum. The severe TBI group showed regional differences in axial diffusivity (AD) in the brainstem and corpus callosum that were not seen in the cMild/mod TBI group. By 12-months, widespread decreases in FA and increases in apparent diffusion coefficient (ADC) and radial diffusivity (RD) were observed in both TBI groups compared with controls, with the overall number of regions with abnormal DTI metrics increasing over time. The early changes in regional DTI metrics were associated with 12-month performance IQ scores. These findings suggest that there may be regional differences in the brain's reparative processes or that mechanisms associated with the brain's plasticity to recover may also be region based.	[Bartnik-Olson, Brenda; Holshouser, Barbara; Oyoyo, Udochukwu E.; Tong, Karen] Loma Linda Univ Hlth, Dept Radiol, 11234 Anderson St,B616, Loma Linda, CA 92354 USA; [Ghosh, Nirmalya; Nichols, Joy G.; Pivonka-Jones, Jamie-; Ashwal, Stephen] Loma Linda Univ Hlth, Dept Pediat, Loma Linda, CA USA		Bartnik-Olson, B (corresponding author), Loma Linda Univ Hlth, Dept Radiol, 11234 Anderson St,B616, Loma Linda, CA 92354 USA.	bbartnik@llu.edu		Bartnik-Olson, Brenda/0000-0002-1137-9437	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS 5R01NS05400]	This work was supported by the National Institutes of Health [NINDS 5R01NS05400].	Adamson C, 2013, BRAIN INJURY, V27, P454, DOI 10.3109/02699052.2012.750756; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Bergemann TL, 2012, J BIOMET BIOSTAT, P7310; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; CATTELL RB, 1978, J EDUC MEAS, V15, P139, DOI 10.1111/j.1745-3984.1978.tb00065.x; Colom R, 2013, INTELLIGENCE, V41, P129, DOI 10.1016/j.intell.2013.01.002; Colom R, 2013, NEUROIMAGE, V72, P143, DOI 10.1016/j.neuroimage.2013.01.032; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Dyrby TB, 2014, NEUROIMAGE, V103, P202, DOI 10.1016/j.neuroimage.2014.09.005; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Ewing-Cobbs L, 2016, HUM BRAIN MAPP, V37, P3929, DOI 10.1002/hbm.23286; Faber J, 2016, BRAIN INJURY, V30, P1635, DOI 10.1080/02699052.2016.1199910; Faul M., 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.1089/NEU.2006.0119; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Genc S, 2017, J NEUROTRAUM, V34, P798, DOI 10.1089/neu.2016.4584; Ghosh N, 2017, DEV NEUROSCI-BASEL, V39, P413, DOI 10.1159/000475545; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Holshouser B, 2019, J NEUROTRAUM, V36, P1352, DOI 10.1089/neu.2018.5919; Koliatsos VE, 2019, CURR OPIN NEUROL, V32, P786, DOI 10.1097/WCO.0000000000000763; Kurowski B, 2009, J PEDIATR REHAB MED, V2, P273, DOI 10.3233/PRM-2009-0093; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; Mohamed MA, 2010, RADIOLOGY, V254, P577, DOI 10.1148/radiol.09081867; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Roberts RM, 2016, DEV NEUROPSYCHOL, V41, P176, DOI 10.1080/87565641.2016.1186167; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Soul JS, 2001, PEDIATRICS, V108, P1211, DOI 10.1542/peds.108.5.1211; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Villegas R, 2014, J NEUROSCI, V34, P7179, DOI 10.1523/JNEUROSCI.4784-13.2014; Volpe DSJ, 2017, BRAIN INJURY, V31, P1689, DOI 10.1080/02699052.2017.1358398; Westerhausen R, 2018, BRAIN STRUCT FUNCT, V223, P285, DOI 10.1007/s00429-017-1493-0; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yoon YB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02304-z; Yuh Esther L, 2014, Neurosurgery, V75 Suppl 4, pS50, DOI 10.1227/NEU.0000000000000491; Zalesky A, 2011, MAGN RESON IMAGING, V29, P111, DOI 10.1016/j.mri.2010.06.027; Ziogas NK, 2018, J NEUROSCI, V38, P4031, DOI 10.1523/JNEUROSCI.2343-17.2018	61	1	1	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2021	38	1					111	121		10.1089/neu.2019.6574		AUG 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PN6IA	WOS:000558943000001	32515269	Green Published			2022-02-06	
J	Berk, T; Halvachizadeh, S; Bellmann, F; Busser, L; Pape, HC; Allemann, F				Berk, Till; Halvachizadeh, Sascha; Bellmann, Frederik; Busser, Lucas; Pape, Hans-Christoph; Allemann, Florin			Does the magnitude of injuries affect the outcome of proximal humerus fractures treated by locked plating (PHILOS)?	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						PHILOS; DASH; Outcome after PHILOS; Proximal humerus fracture; ISS; Multiple injured; EQ-5D-3L; EQ-VAS	QUALITY-OF-LIFE; PATIENT-REPORTED OUTCOMES; FOLLOW-UP; TRAUMA; SEVERITY; VALUES; EQ-5D; STATE	Purpose Health-related quality of life (HRQoL) becomes increasingly relevant in an aging society. Functional outcome (FO) and the patient-reported outcome (PRO) after surgical treatment of proximal humerus fractures (PHF) depends on numerous factors, including patient- and injury-specific factors. There is little evidence on how the FO and the PRO vary in different settings such as monotrauma or multiple injuries, even though the PHF is one of the more frequent fractures. In addition, to a previous study, on multiple injured patients and upper extremity injuries, the aim of the current study was to investigate the impact of multiple injuries, quantified by the ISS, on the FO and PRO after surgically treated PHF by PHILOS. Methods A retrospective cohort-study was conducted with an additional follow-up by a questionnaire. HRQoL tools such as range of motion (ROM), the Quick-Disability of Arm Shoulder and Hand score (DASH), EuroQol Five Dimension Three Levels (EQ-5D-3L), and EuroQol VAS (EQ-VAS) were used. The study-population was stratified according to ISS obtained based on information at discharge into Group I/M-H (ISS < 16 points) and Group PT-H (ISS >= 16). Median outcome scores were calculated and presented. Inclusion criteria: adult patients (> 18 years) with PHF treated at one academic Level 1 trauma center between 2007 and 2017 with Proximal Humeral Inter-Locking System (PHILOS) and preoperative CT-scan. Group stratification according Injury Severity Score (ISS): Group PT-H (ISS >= 16 points) and Group I/M-H (ISS < 16 points). Exclusion criteria: oncology patients, genetic disorders affecting the musculoskeletal system, paralysis or inability to move upper extremity prior or after injury, additional ipsilateral upper limb fractures, open injuries, associated vascular injuries as well brachial plexus injuries and nerve damages. Follow-up 5-10 years including PRO: EQ-5D-3L and EQ-VAS. FO, including DASH and ROM. The ROM was measured 1 year after PHILOS. Results Inclusion of 75 patients, mean age at injury was 49.9 (+/- 17.6) years. The average follow-up period in Group I/M-H was 6.18 years (+/- 3.5), and in Group PT-H 5.58 years (+/- 3.1). The ISS in the Group I/M-H was 6.89 (+/- 2.5) points, compared to 21.7 (+/- 5.3) points in Group PT-H (p <= 0.001). The DASH-score in Group I/M-H was 9.86 (+/- 13.12 and in Group PT-H 12.43 (+/- 15.51, n.s.). The EQ-VAS in Group I/M-H was 78.13 (+/- 19.77) points compared with 74.13 (+/- 19.43, n.s.) in Group PT-H. DASH, EQ-VAS as well as ROM were comparable in Groups I/M-H and PT-H (9.9 +/- 13.1 versus 12.4 +/- 15.5, n.s.). The EQ-5D-3L in Group I/M-H was 0.86 (+/- 0.23) points compared to Group PT-H 0.72 (+/- 0.26,p <= 0.017). No significant differences could be found in Group I/M-H and PT-H in the severity of traumatic brain injury (TBI). A multivariable regression analyses was performed for DASH, EQ-5D-3L and EQ-VAS. All three outcome metrics were correlated. There was a significant difference between the EQ-5D-3L and the ISS (Beta-Coefficient was 0.86, 95% low was 0.75, 95% high was 0.99,p <= 0.041). No significant correlation could be found comparing DASH, EQ-5D-3L and EQ-VAS to age, gender and TBIs. Conclusion Multiple injuries did not affect the DASH, ROM or EQ-VAS after PHILOS; but a higher ISS negatively affected the EQ-5D-EL. While the ROM and DASH aim to be objective measurements of functionality, EQ-5D-3L and EQ-VAS represent the patients' PRO. The FO and PRO outcomes are not substitutable, and both should be taken into consideration during follow-up visits of multiple injured patients. Future research should prospectively explore whether the findings of this study can be recreated using a larger study population and investigate if different FO and PRO parameters come to similar conclusions. The gained information could be used for an enhanced long-term evaluation of patients who suffered a PHF from multiple injuries to meet their multifarious conditions.	[Berk, Till; Halvachizadeh, Sascha; Pape, Hans-Christoph; Allemann, Florin] Univ Hosp Zurich, Dept Trauma, Raemistr 100, CH-8091 Zurich, Switzerland; [Halvachizadeh, Sascha; Bellmann, Frederik; Busser, Lucas; Pape, Hans-Christoph] Univ Zurich, Harald Tscherne Lab Orthoped & Trauma Res, Sternwartstr 14, CH-8091 Zurich, Switzerland		Berk, T (corresponding author), Univ Hosp Zurich, Dept Trauma, Raemistr 100, CH-8091 Zurich, Switzerland.	Till.Berk@usz.ch; Sascha.Halvachizadeh@usz.ch; bellmann91@web.de; lucas.buesser@uzh.ch; Hans-Christoph.Pape@usz.ch; Florin.Allemann@usz.ch		Pape, Hans-Christoph/0000-0002-2059-4980	University of Zurich	Open access funding provided by University of Zurich.	Allemann F, 2019, PATIENT SAF SURG, V13, DOI 10.1186/s13037-019-0187-3; Banerjee M, 2013, INJURY, V44, P1015, DOI 10.1016/j.injury.2012.12.007; Beaton DE, 2005, J BONE JOINT SURG AM, V87A, P1038, DOI 10.2106/JBJS.D.02060; Beeres FJP, 2017, ARCH ORTHOP TRAUM SU, V137, P1685, DOI 10.1007/s00402-017-2790-z; Bhayana H, 2019, INDIAN J ORTHOP, V53, P190, DOI 10.4103/ortho.IJOrtho_298_18; Biermann N, 2019, ARCH ORTHOP TRAUM SU, V139, P1075, DOI 10.1007/s00402-019-03162-2; Borgstrom F, 2006, OSTEOPOROSIS INT, V17, P1781, DOI 10.1007/s00198-006-0193-z; Briese T, 2021, EUR J TRAUMA EMERG S, V47, P1921, DOI 10.1007/s00068-020-01340-1; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Currens JAB, 2000, INJURY, V31, P93, DOI 10.1016/S0020-1383(99)00244-2; Ferree S, 2018, INJURY, V49, P630, DOI 10.1016/j.injury.2018.02.003; Flanagan CD, 2018, J ORTHOP TRAUMA, V32, P433, DOI 10.1097/BOT.0000000000001192; Frima H, 2019, ARCH ORTHOP TRAUM SU, V139, P203, DOI 10.1007/s00402-018-3063-1; Gabbe BJ, 2013, ANN SURG, V257, P166, DOI 10.1097/SLA.0b013e31825d7422; Gagnier JJ, 2017, J ORTHOP RES, V35, P2098, DOI 10.1002/jor.23604; Greiner W, 2012, GESUNDHEITSOKONOMISC, V4, P411; Grobet C, 2018, ARCH ORTHOP TRAUM SU, V138, P953, DOI 10.1007/s00402-018-2933-x; Haddad SL, 2007, J BONE JOINT SURG AM, V89A, P1899, DOI 10.2106/JBJS.F.01149; Hengg C, 2019, ARCH ORTHOP TRAUM SU, V139, P927, DOI 10.1007/s00402-019-03142-6; Hinz A, 2014, QUAL LIFE RES, V23, P443, DOI 10.1007/s11136-013-0498-2; Inauen C, 2013, J ORTHOP TRAUMA, V27, pE74, DOI 10.1097/BOT.0b013e3182693cac; Launonen AP, 2015, ARCH OSTEOPOROS, V10, DOI 10.1007/s11657-015-0209-4; Ramos-Goni JM, 2011, STATA J, V11, P120, DOI 10.1177/1536867X1101100108; McPherson K, 2004, MED CARE, V42, P1143, DOI 10.1097/00005650-200411000-00014; Neer CS, 2002, J SHOULDER ELB SURG, V11, P389, DOI 10.1067/mse.2002.124346; Olerud P, 2010, J SHOULDER ELB SURG, V19, P814, DOI 10.1016/j.jse.2009.11.046; Pape HC, 2010, J TRAUMA, V69, P1243, DOI 10.1097/TA.0b013e3181ce1fa1; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Rios-Diaz AJ, 2017, J TRAUMA ACUTE CARE, V83, P97, DOI 10.1097/TA.0000000000001490; Russo R, 2015, ARCH ORTHOP TRAUM SU, V135, P905, DOI 10.1007/s00402-015-2221-y; Scharplatz D, 2003, Swiss Surg, V9, P263, DOI 10.1024/1023-9332.9.6.263; Spross C, 2019, J SHOULDER ELB SURG, V28, P1022, DOI 10.1016/j.jse.2019.02.015; Sutherland AG, 2005, J TRAUMA, V59, P213, DOI 10.1097/01.TA.0000162730.86809.61; TEASDALE G, 1974, LANCET, V2, P81; Tejwani NC, 2010, CLIN ORTHOP RELAT R, V468, P599, DOI 10.1007/s11999-009-0968-6; Trikha V, 2017, J SHOULDER ELB SURG, V26, pE293, DOI 10.1016/j.jse.2017.03.035; van der Vliet QMJ, 2019, CLIN ORTHOP RELAT R, V477, P2267, DOI 10.1097/CORR.0000000000000757; Zelle BA, 2005, INJURY, V36, P169, DOI 10.1016/j.injury.2004.06.004	39	1	1	0	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-020-01451-9		AUG 2020	8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	MZ1LG	WOS:000558883200001	32778927	Green Accepted, hybrid			2022-02-06	
J	Flashman, LA; McDonald, BC; Ford, JC; Kenny, RM; Andrews, KD; Saykin, AJ; McAllister, TW				Flashman, Laura A.; McDonald, Brenna C.; Ford, James C.; Kenny, Rachel M.; Andrews, Katharine D.; Saykin, Andrew J.; McAllister, Thomas W.			Differential Effects of Pergolide and Bromocriptine on Working Memory Performance and Brain Activation after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						dopamine agonists; functional magnetic resonance imaging; mild traumatic brain injury; working memory	DOPAMINE-RECEPTOR AGONIST; PREFRONTAL CORTEX; ATTENTION; DEFICITS; D2; POLYMORPHISMS; DYSFUNCTION; MODULATION; MECHANISMS; CHALLENGE	Dopamine D1 and D2 receptors differ with respect to patterns of regional brain distribution and behavioral effects. Pre-clinical work suggests that D1 agonists enhance working memory, but the absence of selective D1 agonists has constrained using this approach in humans. This study examines working memory performance in mild traumatic brain injury (mTBI) patients when given pergolide, a mixed D1/D2 agonist, compared with bromocriptine, a selective D2 agonist. Fifteen individuals were studied 1 month after mTBI and compared with 17 healthy controls. At separate visits, participants were administered 1.25 mg bromocriptine or 0.05 mg pergolide prior to functional magnetic resonance imaging (MRI) using a working memory task (visual-verbal n-back). Results indicated a significant group-by-drug interaction for mean performance across n-back task conditions, where the mTBI group showed better performance on pergolide relative to bromocriptine, whereas controls showed the opposite pattern. There was also a significant effect of diagnosis, where mTBI patients performed worse than controls, particularly while on bromocriptine, as shown in our prior work. Functional MRI activation during the most challenging task condition (3-back > 0-back contrast) showed a significant group-by-drug interaction, with the mTBI group showing increased activation relative to controls in working memory circuitry while on pergolide, including in the left inferior frontal gyrus. Across participants there was a positive correlation between change in activation in this region and change in performance between drug conditions. Results suggest that activation of the D1 receptor may improve working memory performance after mTBI. This has implications for the development of pharmacological strategies to treat cognitive deficits after mTBI.	[Flashman, Laura A.] Wake Forest Med Sch, Dept Neurol, Winston Salem, NC USA; [Flashman, Laura A.] Wake Forest Baptist Med Ctr, Winston Salem, NC USA; [McDonald, Brenna C.; Saykin, Andrew J.] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA; [Ford, James C.] Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH USA; [Ford, James C.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Kenny, Rachel M.; Andrews, Katharine D.; McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA		Flashman, LA (corresponding author), WFBMC, Dept Neurol, Neuropsychol Program, Janeway 9th Floor,Med Ctr Blvd, Winston Salem, NC 27157 USA.	lflashma@wakehealth.edu			National Institute on Disability and Rehabilitation Research (NIDRR) [H133G70031, H133G000136]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS040472]	This research was supported in part by National Institute on Disability and Rehabilitation Research (NIDRR) Grants H133G70031 and H133G000136 and National Institutes of Health (NIH) Grant R01NS040472.	Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; Arnsten A F, 1998, Adv Pharmacol, V42, P764; Arnsten AFT, 2015, PHARMACOL REV, V67, P681, DOI 10.1124/pr.115.010512; Arnsten AFT, 2012, J AM ACAD CHILD PSY, V51, P356, DOI 10.1016/j.jaac.2012.01.008; Arnsten AFT, 2011, BIOL PSYCHIAT, V69, pE89, DOI 10.1016/j.biopsych.2011.01.027; Aylward, 1996, GORDON DIAGNOSTIC SY; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Bartholomeusz CF, 2003, J PSYCHOPHARMACOL, V17, P9, DOI 10.1177/0269881103017001688; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Costa A, 2009, NEUROPSYCHOLOGIA, V47, P1374, DOI 10.1016/j.neuropsychologia.2009.01.039; Dash PK, 2007, LEARN MEMORY, V14, P554, DOI 10.1101/lm.558707; Delis D., 2001, DELIS KAPLAN EXECUTI, DOI DOI 10.1037/T15082-000; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; Ellis KA, 2005, PSYCHOPHARMACOLOGY, V181, P771, DOI 10.1007/s00213-005-0019-2; First M., 1997, STRUCTURED CLIN INTE; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Gibbs SEB, 2006, NEUROSCIENCE, V139, P359, DOI 10.1016/j.neuroscience.2005.11.055; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kimberg DY, 2003, NEUROPSYCHOLOGIA, V41, P1020, DOI 10.1016/S0028-3932(02)00317-2; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Lan YL, 2019, AM J TRANSL RES, V11, P2616; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; McAllister, 2004, J NEUROPSYCHIATRY CL, V16, P238; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2011, INT J PSYCHOPHYSIOL, V82, P107, DOI 10.1016/j.ijpsycho.2011.06.022; McAllister TW, 2011, J NEUROPSYCH CLIN N, V23, P277, DOI 10.1176/appi.neuropsych.23.3.277; McAllister TW, 2009, J HEAD TRAUMA REHAB, V24, P65, DOI 10.1097/HTR.0b013e3181996e6b; McAllister TW, 2005, AM J PSYCHIAT, V162, P1749, DOI 10.1176/appi.ajp.162.9.1749; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McClure MM, 2010, NEUROPSYCHOPHARMACOL, V35, P1356, DOI 10.1038/npp.2010.5; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McDonald B, 2017, BRAIN INJURY, V31, P950; McDonald BC, 2017, NEUROPSYCHOPHARMACOL, V42, P1766, DOI 10.1038/npp.2016.261; McHenry M, 2001, J COMMUN DISORD, V34, P397; Muller U, 1998, J NEUROSCI, V18, P2720; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; Palomero-Gallagher N., 2015, BRAIN MAPPING ENCY R, P261, DOI [10.1016/B978-0-12-397025-1.00221-9, DOI 10.1016/B978-0-12-397025-1.00221-9]; Perreault ML, 2014, NEUROPSYCHOPHARMACOL, V39, P156, DOI 10.1038/npp.2013.148; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Redell JB, 2007, NEUROSCI LETT, V413, P36, DOI 10.1016/j.neulet.2006.11.060; Roesch-Ely D, 2005, PSYCHOPHARMACOLOGY, V178, P420, DOI 10.1007/s00213-004-2027-z; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Talsky A., 2011, BRIT COLOMBIA MED J, V53, P26; Tarantino IS, 2011, BEHAV BRAIN RES, V219, P181, DOI 10.1016/j.bbr.2010.12.037; The Psychological Corporation, 1997, WAIS 3 WECHSL AD INT; Veenith Tonny, 2009, World J Emerg Surg, V4, P7, DOI 10.1186/1749-7922-4-7; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Vogelsang DA, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00242; Wang M, 2019, NEUROPHARMACOLOGY, V150, P46, DOI 10.1016/j.neuropharm.2019.03.001; Whyte J, 2008, AM J PHYS MED REHAB, V87, P85, DOI 10.1097/PHM.0b013e3181619609; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; Winterer G, 2004, TRENDS NEUROSCI, V27, P683, DOI 10.1016/j.tins.2004.08.002; Wolfson, 1993, HALSTEAD REITAN NEUR; Yousif N, 2016, J NEUROSCI, V36, P9303, DOI 10.1523/JNEUROSCI.4452-15.2016	61	1	1	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2021	38	2					225	234		10.1089/neu.2020.7087		AUG 2020	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PP0TL	WOS:000560235600001	32635808	Green Published, Green Submitted			2022-02-06	
J	Li, D; Jatana, KR; Kistamgari, S; Smith, GA				Li, Daniel; Jatana, Kris R.; Kistamgari, Sandhya; Smith, Gary A.			Nonfatal All-Terrain Vehicle-Related Head and Neck Injuries to Children Treated in US Emergency Departments	CLINICAL PEDIATRICS			English	Article						all-terrain vehicle; trauma; injury; traumatic brain injury; concussion	FATALITIES; ROADWAY; RIDERS	This study investigates children <18 years old with nonfatal all-terrain vehicle (ATV)-related head and neck injuries treated in United States emergency departments by analyzing data from the National Electronic Injury Surveillance System from 1990 to 2014. An estimated 279 391 children received emergency treatment during the 25-year study period. The number of injuries remained relatively constant from 1990 to 1997, increased by 142.9% from 1997 to 2007, and then decreased by 37.4% from 2007 to 2014. The most common diagnoses were concussion/closed head injury (32.6%) and fracture (32.6%); 15.4% of children were admitted. The most common injury mechanisms include ejection (30.0%), crash (18.8%), and rollover (15.8%). Patients who were injured on a street/highway were 1.49 times (95% confidence interval = 1.11-1.99) more likely to be admitted than patients injured at other locations. Although the number of nonfatal ATV-related head and neck injuries decreased during the latter part of the study period, they remain common and can have serious medical outcomes.	[Li, Daniel; Jatana, Kris R.; Kistamgari, Sandhya; Smith, Gary A.] Nationwide Childrens Hosp, Columbus, OH USA; [Li, Daniel; Jatana, Kris R.; Smith, Gary A.] Ohio State Univ, Columbus, OH 43210 USA; [Smith, Gary A.] Child Injury Prevent Alliance, Columbus, OH USA		Smith, GA (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	gary.smith@nationwidechildrens.org			Bennett Medical Student Research Scholarship of The Ohio State University College of Medicine	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Stipend support for Mr Li was provided by the Bennett Medical Student Research Scholarship of The Ohio State University College of Medicine while he worked on this study.	Aitken ME, 2004, INJURY PREV, V10, P303, DOI 10.1136/ip.2003.004176; Anfuso A, 2012, INT J PEDIATR OTORHI, V76, P202, DOI 10.1016/j.ijporl.2011.11.003; Bowman SM, 2010, J TRAUMA, V69, P1344, DOI 10.1097/TA.0b013e3181ea283d; Bull MJ, 2000, PEDIATRICS, V105, P1352, DOI 10.1542/peds.105.6.1352; Denning GM, 2018, RES SPORTS MED, V26, P38, DOI 10.1080/15438627.2018.1438279; Denning GM, 2016, TRAFFIC INJ PREV, V17, P406, DOI 10.1080/15389588.2015.1057280; Denning GM, 2013, INJURY PREV, V19, P250, DOI 10.1136/injuryprev-2012-040548; Doud AN, 2017, J EMERG MED, V53, P222, DOI 10.1016/j.jemermed.2016.12.035; Hanseen J, 2013, NCSL TRANSPORTATION; Howell RJ, 2008, 2007 ANN REPORT ATV; ImmediateClinic, FUT URG CAR MED; Jennissen CA, 2015, INJURY PREV, V21, P166, DOI 10.1136/injuryprev-2014-041408; Jennissen CA, 2014, ANN FAM MED, V12, P310, DOI 10.1370/afm.1663; Kleiner JE, 2018, J AM ACAD ORTHOP SUR, V26, P663, DOI 10.5435/JAAOS-D-17-00041; Krauss EM, 2010, J TRAUMA, V69, P1338, DOI 10.1097/TA.0b013e3181fc5e7b; Mazotas I, 2014, J TRAUMA ACUTE CARE, V77, P103, DOI 10.1097/TA.0000000000000266; Schroeder T., 2001, NEISS SAMPLE DESIGN; Shults RA, 2015, INJURY PREV, V21, P10, DOI 10.1136/injuryprev-2013-041138; Shults RA, 2013, PEDIATRICS, V132, P282, DOI 10.1542/peds.2013-0751; Specialty Vehicle Institute of America, POS OPP ROAD OP ATVS; Topping J, 2019, 2017 ANN REPORT ATV; Topping J, 2015, 2013 ANN REPORT ATV; United States Consumer Product Safety Commission, NAT EL INJ SURV SYST; *US BUR CENS, NAT STAT POP EST; US Census Bureau, INT EST US RES POP A; US Census Bureau, NAT INT TABL 2000 20; US Customer Product Safety Commission, 2000, NEISS NAT EL INJ SUR; Wang BS, 2007, OTOLARYNG HEAD NECK, V137, P201, DOI 10.1016/j.otohns.2007.01.033; Williams AF, 2014, J SAFETY RES, V50, P117, DOI 10.1016/j.jsr.2014.05.001	29	1	1	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	NOV	2020	59	13					1141	1149	0009922819901011	10.1177/0009922819901011		AUG 2020	9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	NC6XA	WOS:000558315200001	32772567				2022-02-06	
J	Oliveira, TG; Ifrah, C; Fleysher, R; Stockman, M; Lipton, ML				Oliveira, Tiago Gil; Ifrah, Chloe; Fleysher, Roman; Stockman, Michael; Lipton, Michael L.			Soccer heading and concussion are not associated with reduced brain volume or cortical thickness	PLOS ONE			English	Article							MATTER; VALIDATION; FOOTBALL; NEUROPLASTICITY; EXPOSURE; PLAYERS	Soccer is the most popular sport in the world and, since it is a contact sport, players are at risk for head injury, including concussion. Here, we proposed to investigate the association of heading and concussion with macroscopic brain structure among adult amateur soccer players. For this study, 375 amateur soccer players (median age 23 years) completed HeadCount-12m to estimate heading over the 12 months prior to MRI and lifetime concussion. T1-weighted 3D magnetization prepared rapid acquisition gradient echo (MP-RAGE) MRI was performed at 3 Tesla. Parcellation was performed using Freesurfer to extract regional gray and white matter volumes as well as regional cortical thickness and total intracranial volume. Regional cortical brain volumes were normalized by total intracranial volume. We categorized heading into quartiles and concussion as 0, 1 or 2 or more. Generalized linear regressions were used to test the association of heading or concussion with each brain morphometry metric, including age and sex, as covariates. Neither heading nor concussion were associated with reduced brain volume or cortical thickness. We observed that greater heading was associated with greater gray matter volume in the left inferior parietal area, which may reflect effects related to training.	[Oliveira, Tiago Gil] Univ Minho, Sch Med, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Oliveira, Tiago Gil] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Ifrah, Chloe; Fleysher, Roman; Stockman, Michael; Lipton, Michael L.] Albert Einstein Coll Med, Gruss Magnet Resonance Imaging Ctr, Bronx, NY 10467 USA; [Ifrah, Chloe; Fleysher, Roman; Stockman, Michael; Lipton, Michael L.] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA; [Fleysher, Roman; Lipton, Michael L.] Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA		Lipton, ML (corresponding author), Albert Einstein Coll Med, Gruss Magnet Resonance Imaging Ctr, Bronx, NY 10467 USA.; Lipton, ML (corresponding author), Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA.; Lipton, ML (corresponding author), Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA.; Lipton, ML (corresponding author), Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA.; Lipton, ML (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA.	michael.lipton@einstein.yu.edu	Oliveira, Tiago Gil/AAL-2147-2021	Oliveira, Tiago Gil/0000-0003-0509-0562; Lipton, Michael/0000-0001-5421-8441	National Institutes of Health, National Institute of Neurologic Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS082432]; Dana Foundation David Mahoney Neuroimaging Program (MLL)	Supported by the National Institutes of Health, National Institute of Neurologic Disorders and Stroke (R01 NS082432) (MLL) (www.nih.gov) and The Dana Foundation David Mahoney Neuroimaging Program (MLL) (www.dana.org).	Bermudez P, 2009, CEREB CORTEX, V19, P1583, DOI 10.1093/cercor/bhn196; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Catenaccio E, 2016, RES SPORTS MED, V24, P416, DOI 10.1080/15438627.2016.1234472; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Erickson KI, 2014, NEUROBIOL AGING, V35, pS20, DOI 10.1016/j.neurobiolaging.2014.03.034; Hales C, 2014, NEUROLOGY, V83, P2307, DOI 10.1212/WNL.0000000000001081; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kunz M., 2007, FIFA MAGAZINE, V7, P11, DOI DOI 10.1080/13673882.2007.9680857; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Lipton ML, 2018, J SCI MED SPORT, V21, P363, DOI 10.1016/j.jsams.2017.08.008; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rodrigues AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00038; Rubin TG, 2018, RADIOLOGY, V289, P478, DOI 10.1148/radiol.2018180217; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; Stewart WF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00240; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Valkanova V, 2014, INT PSYCHOGERIATR, V26, P891, DOI 10.1017/S1041610213002482; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910	23	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2020	15	8							e0235609	10.1371/journal.pone.0235609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NC7KJ	WOS:000561393800013	32776940	gold, Green Published			2022-02-06	
J	van Velzen, JM; van Bennekom, CAM; Frings-Dresen, MHW				van Velzen, Judith M.; van Bennekom, Coen A. M.; Frings-Dresen, Monique H. W.			Availability of vocational rehabilitation services for people with acquired brain injury in Dutch rehabilitation institutions	BRAIN INJURY			English	Article						Vocational rehabilitation; return to work; brain injury; stroke; traumatic brain injury	RETURN; WORK	Objective To provide an overview of the availability of and process involved in vocational rehabilitation (VR) services for people with acquired brain injury (ABI) provided in Dutch rehabilitation institutions. Methods A survey on the availability and characteristics of the VR intervention process for people with ABI was conducted in all Dutch rehabilitation centers and rehabilitation departments of general and academic hospitals (n = 120). Different domains of the VR intervention process were included in the questionnaire, the number (and percentage) of respondents giving a certain answer within a domain was reported. Results Fifty-five institutions replied (response rate 46%). VR services for ABI were provided in 34 (62%) of these, of which 20 (59%) used a VR protocol. The main similarities found among different organizations providing VR services were the involvement of different disciplines, determination of the gap between job requirements and the patient's abilities, goal-setting for VR, involvement of external partners, timing, and source of funding. The main differences found concerned start and stop criteria, and coordination of the VR process. Conclusions Currently, at least 30% of the Dutch rehabilitation institutions offer VR services for people with ABI; there is variation in processes.	[van Velzen, Judith M.; van Bennekom, Coen A. M.] Heliomare Rehabil Ctr, Dept Res & Dev, Wijk Aan Zee, Netherlands; [van Velzen, Judith M.; van Bennekom, Coen A. M.; Frings-Dresen, Monique H. W.] Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Coronel Inst Occupat Hlth, Amsterdam UMC, Amsterdam, Netherlands		van Velzen, JM (corresponding author), Heliomare Res & Dev, NL-1949 EC Wijk Aan Zee, Netherlands.	j.van.velzen@heliomare.nl			Heliomare	We hereby certify that the research was internally funded by Heliomare. This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The execution and results of the study were coordinated and controlled by an independent academic department.	Donker-Cools BHPM, 2012, ACQUIRED BRAIN INJUR; Donker-Cools BHPM, 2016, BRAIN INJURY, V30, P113, DOI 10.3109/02699052.2015.1090014; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Graham CW., 2016, CAMPBELL SYST REV, V12, DOI [10.4073/csr.2016.6, DOI 10.4073/CSR.2016.6]; Groeneveld IF, 2016, J REHABIL MED, V48, P287, DOI 10.2340/16501977-2054; Ministerie van Volksgezondheid, 2005, WELZ SPORT; Playford ED, 2011, MAPPING VOCATIONAL R; Revalidatie Nederland, 2016, BRANCH DAT REH 2014; Ribbers GM, 2007, J HEAD TRAUMA REHAB, V22, P234, DOI 10.1097/01.HTR.0000281839.07968.32; van Dongen CH, 2018, J OCCUP REHABIL, V28, P523, DOI 10.1007/s10926-017-9738-6; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2015, J VOCAT REHABIL, V42, P31, DOI 10.3233/JVR-140725; VanVelzen JM, 2017, NED TIJDSCHR REVALID, V39; VanVelzen JM, 2014, RETURN WORK ACQUIRED; Wehman P, 2012, J VOCAT REHABIL, V37, P139, DOI 10.3233/JVR-2012-0607; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047	16	1	1	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 23	2020	34	10					1401	1407		10.1080/02699052.2020.1802778		AUG 2020	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NI5TJ	WOS:000559541300001	32791017	hybrid			2022-02-06	
J	Xia, XH; Zhou, CL; Sun, XC; He, XN; Liu, C; Wang, GY				Xia, Xiaohui; Zhou, Changlong; Sun, Xiaochuan; He, Xuenong; Liu, Chang; Wang, Guanyu			Estrogen improved the regeneration of axons after subcortical axon injury via regulation of PI3K/Akt/CDK5/Tau pathway	BRAIN AND BEHAVIOR			English	Article						CDK5; estrogen; PI3K; Akt; subcortical axonal injury; Tau	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; CYCLIN-DEPENDENT KINASE-5; RAT; ACTIVATION; EXPRESSION; PLASTICITY; TAMOXIFEN; NEURONS; TAU	Aim To investigate the effect of estrogen on axon regeneration and neurological recovery after subcortical axon injury, and further explore its underlying molecular mechanisms. Method Subcortical axonal fiber injury model was used in this study. Morris water maze was conducted to detect the learning and memory ability of the rats; modified neurological severity score (mNSS) and beam walking test were performed to evaluate the behavioral; and diffusion tensor imaging (DTI) was used for the determination of recovery after subcortical axonal injury, while Western blotting was performed to detect the expression of p-Akt, CDK5, p-Ser262, p-Ser404, and p-Thr205. Results Compared with the Sham group, the injury of subcortical axonal fiber resulted in higher mNSS, higher beam walking scores, longer time of escape latency, less number, time and shorter distance of crossing the quadrant, and less FA values. After ovariectomy, the mNSS, beam walking scores, and escape latency reached the peak; inversely, the others reached a minimum. High estrogen treatment reduced the mNSS, beam walking score, and escape latency; improved the number, time, and distance of crossing the quadrant; and increased the FA value. Western blotting results showed that estrogen increased the expression of p-Akt and decreased the expression of CDK5, p-Ser262, p-Ser404, and p-Thr205. All the changes were counteracted to some extent by Akt inhibitor LY294002. Conclusion After subcortical axonal injury, estrogen could improve the regeneration of axons and improve their functions via regulating the PI3K/Akt/CDK5/Tau pathway.	[Xia, Xiaohui; Zhou, Changlong; He, Xuenong; Liu, Chang; Wang, Guanyu] Chongqing Med Univ, Yongchuan Hosp, Dept Neurosurg, 439 Xuanhua Load, Chongqing 400000, Peoples R China; [Sun, Xiaochuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing, Peoples R China		Zhou, CL (corresponding author), Chongqing Med Univ, Yongchuan Hosp, Dept Neurosurg, 439 Xuanhua Load, Chongqing 400000, Peoples R China.	zhouchanglong88@163.com					Acosta MC, 2017, DEV NEUROBIOL, V77, P1133, DOI 10.1002/dneu.22501; Adams C, 2018, THERANOSTICS, V8, P4824, DOI 10.7150/thno.24747; Barbara Mostacci, 2018, SEIZURE; Bhatta S, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00544; Bogush A, 2007, J BIOL CHEM, V282, P7352, DOI 10.1074/jbc.M606508200; Chakrabarti M, 2014, BRAIN RES BULL, V109, P22, DOI 10.1016/j.brainresbull.2014.09.004; Colon JM, 2016, NEURAL REGEN RES, V11, P1208, DOI 10.4103/1673-5374.189164; Colon JM, 2016, J NEUROTRAUM, V33, P1696, DOI 10.1089/neu.2015.4111; DALE SM, 1995, EXP NEUROL, V135, P67, DOI 10.1006/exnr.1995.1066; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; de Oliveira TS, 2018, VASC PHARMACOL, V110, P42, DOI 10.1016/j.vph.2018.07.003; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Feinstein SC, 2005, BBA-MOL BASIS DIS, V1739, P268, DOI 10.1016/j.bbadis.2004.07.002; Hsieh TH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182300; Huang YN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19654-x; Katsuki H, 2017, BIOL PHARM BULL, V40, P564, DOI 10.1248/bpb.b16-01013; Kim CS, 2019, BIOL CELL, V111, P18, DOI 10.1111/boc.201800040; Kim H, 2017, J NEUROSURG, V127, P23, DOI 10.3171/2016.7.JNS161263; Lee CH, 2016, EXP THER MED, V11, P2240, DOI 10.3892/etm.2016.3216; Lescot T, 2010, J NEUROTRAUM, V27, P463, DOI 10.1089/neu.2009.0982-C; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Lopes S, 2016, AGING CELL, V15, P208, DOI 10.1111/acel.12391; Namgung U, 2004, MOL CELL NEUROSCI, V25, P422, DOI 10.1016/j.mcn.2003.11.005; Neri-Gomez T, 2017, NEURAL REGEN RES, V12, P588, DOI 10.4103/1673-5374.205098; Raghava Narayan, 2017, Neurosci Neuroecon, V6, P15, DOI 10.2147/NAN.S105134; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Stokowska A, 2017, BRAIN, V140, P353, DOI 10.1093/brain/aww314; Tu L, 2018, NEUROCHEM RES, V43, P1210, DOI 10.1007/s11064-018-2538-3; Wang Z, 2007, NEUROSCIENCE, V145, P911, DOI 10.1016/j.neuroscience.2006.12.059; Wang ZF, 2017, BIOCHEM BIOPH RES CO, V482, P948, DOI 10.1016/j.bbrc.2016.11.138; Xiao JY, 2017, NEUROL RES, V39, P1022, DOI 10.1080/01616412.2017.1367077; Xiao N, 2018, TOXICOL LETT, V292, P97, DOI 10.1016/j.toxlet.2018.04.027; Yang JT, 2018, NEUROSCI BULL, V34, P736, DOI 10.1007/s12264-018-0268-9; Ye T, 2012, INT REV NEUROBIOL, V105, P91, DOI 10.1016/B978-0-12-398309-1.00006-8; Yin XS, 2015, J CARDIOVASC PHARM T, V20, P428, DOI 10.1177/1074248414568196; Yu T, 2019, BRAZ J MED BIOL RES, V52, DOI [10.1590/1414-431X20198735, 10.1590/1414-431x20198735]	36	1	1	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	SEP	2020	10	9							e01777	10.1002/brb3.1777		AUG 2020	10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	NU8NS	WOS:000555438900001	32755041	gold, Green Published			2022-02-06	
J	Madaan, P; Agrawal, D; Gupta, D; Kumar, A; Jauhari, P; Chakrabarty, B; Pandey, RM; Paul, VK; Misra, MC; Gulati, S				Madaan, Priyanka; Agrawal, Deepak; Gupta, Deepak; Kumar, Atin; Jauhari, Prashant; Chakrabarty, Biswaroop; Pandey, R. M.; Paul, Vinod Kumar; Misra, M. C.; Gulati, Sheffali			Clinicoepidemiologic Profile of Pediatric Traumatic Brain Injury: Experience of a Tertiary Care Hospital From Northern India	JOURNAL OF CHILD NEUROLOGY			English	Article						traumatic brain injury; head injury; children; road traffic accidents	HEAD-INJURY; EPIDEMIOLOGY; MORTALITY	Traumatic brain injury is an important cause of acquired brain injury. The current study brings to light the clinicoepidemiologic profile of pediatric traumatic brain injury in India. Retrospective record analysis of children (aged <= 16 years) with traumatic brain injury presenting to an apex-trauma-center in North India over 4 years was done. Of more than 15 000 patients with a suspected head injury, 4833 were children <= 16 years old. Of these, 1074 were admitted to the inpatient department; 65% were boys with a mean age at presentation being 6.6 years. Most patients (85%) had a Glasgow Coma Scale score of 13 to 15 at presentation while Glasgow Coma Scale scores of <= 8 was seen in 10% of patients. Neuroimaging (computed tomography [CT]) abnormalities were seen in 12% of patients, with the commonest abnormality being skull fracture, followed by contusions, and extradural hemorrhage. Around 2% of patients required decompressive craniotomy whereas 3% of patients succumbed to their illness. Among the inpatients with pediatric traumatic brain injury, two-thirds were boys with a mean age at presentation of 7.6 years. Severity of traumatic brain injury varied as mild (64%), moderate (11%), and severe (25%). The most common mode of injury was accidental falls (59%) followed by road traffic and rail accidents (34%). Neuroimaging abnormalities were seen in half of inpatients with pediatric traumatic brain injury, with the commonest abnormality being skull fracture. Pediatric head injuries are an important public health problem and constitute a third of all head injuries. They are more common in boys, and the most common modes of injury are accidental falls, followed by road traffic accidents.	[Madaan, Priyanka; Jauhari, Prashant; Chakrabarty, Biswaroop; Gulati, Sheffali] All India Inst Med Sci AIIMS, Dept Pediat, Child Neurol Div, New Delhi, India; [Madaan, Priyanka] Post Grad Inst Med Educ & Res PGIMER, Dept Pediat, Pediat Neurol Unit, Chandigarh, India; [Agrawal, Deepak; Gupta, Deepak] AIIMS, Dept Neurosurg, New Delhi, India; [Kumar, Atin] AIIMS, Dept Radiodiag, New Delhi, India; [Pandey, R. M.] AIIMS, Dept Biostat, New Delhi, India; [Paul, Vinod Kumar] AIIMS, Dept Pediat, New Delhi, India; [Misra, M. C.] AIIMS, Dept Gen Surg, New Delhi, India		Gulati, S (corresponding author), All India Inst Med Sci AIIMS, Dept Pediat, Child Neurol Div, New Delhi, India.	sheffaligulati@gmail.com	/AAG-3032-2021	/0000-0002-5499-0746			Agrawal A, 2012, INDIAN J NEUROTRAUM, V9, P87, DOI 10.1016/j.ijnt.2012.11.001; Agrawal Amit, 2012, Int J Crit Illn Inj Sci, V2, P167, DOI 10.4103/2229-5151.100915; Agrawal Deepak, 2016, Asian J Neurosurg, V11, P143, DOI 10.4103/1793-5482.145081; Bhargava P, 2011, J PEDIATR NEUROSCI, V6, P97, DOI 10.4103/1817-1745.84428; Channabasavanna S, 1993, EPIDEMIOLOGY HEAD IN; Gomes M, 2017, HEALTH AFFAIR, V36, P1887, DOI 10.1377/hlthaff.2017.0635; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Gururaj G., 1995, NEUROL INDIA, V43, P95; Hsiao M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002621; Jagnoor J, 2011, B WORLD HEALTH ORGAN, V89, P733, DOI 10.2471/BLT.11.086306; Kamal VK, 2016, J NEUROSCI RURAL PRA, V7, P515, DOI 10.4103/0976-3147.188637; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mahapatra AK, 2012, TXB HEAD INJURY, P80; Nath Haradhan Deb, 2015, Asian J Neurosurg, V10, P149, DOI 10.4103/1793-5482.161183; Roy TK, 2000, NATL FAMILY HLTH SUR, P1998; Satapathy Mani Charan, 2016, Int J Crit Illn Inj Sci, V6, P16, DOI 10.4103/2229-5151.177359; Sharma Mukesh, 2011, J Indian Assoc Pediatr Surg, V16, P88, DOI 10.4103/0971-9261.83484; Shekhar Chandra, 2015, J Emerg Trauma Shock, V8, P131, DOI 10.4103/0974-2700.160700; Tabish A, 2006, INJURY, V37, P410, DOI 10.1016/j.injury.2006.01.039; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Vaghani Gaurang, 2013, J Pediatr Neurosci, V8, P104, DOI 10.4103/1817-1745.117836; Yattoo GH, 2009, INT J HEALTH SCI-IJH, V3, P59	22	1	1	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	DEC	2020	35	14					970	974	0883073820944040	10.1177/0883073820944040		AUG 2020	5	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	OS5FA	WOS:000556308100001	32748676				2022-02-06	
J	Mojgani, P; Jalali, M; Keramatfar, A				Mojgani, Parviz; Jalali, Maryam; Keramatfar, Abdalsamad			Bibliometric study of traumatic brain injury rehabilitation	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; TBI; Rehabilitation; Keyword analysis; Bibliometrics; Scientometrics	EPIDEMIOLOGY	Purpose:This paper aims to present a bibliometric analysis of scientific documents in the field of traumatic brain injury rehabilitation. Methods:Web of Science was used to collect bibliographic data of traumatic brain injury rehabilitation documents from 1983 until the end of 2017. Results:Of a total of 6069 documents retrieved, 78.2% were journal articles. The average annual growth of the documents as of the year 2000 was 9.4%. The most frequent subject categories in this field were Rehabilitation, Neurosciences and Neurology, Sport Sciences, Psychology, and General and Internal Medicine. The most active journal was Brain Injury. More than 50% of the documents were published in 10 journals. The most prolific and impactful institutions were from the USA, Australia and Canada. Traumatic brain injury, rehabilitation, brain injury, stroke and outcome were the most commonly used keywords. Mild traumatic brain injury and concussion were the topics receiving attention in recent years. Conclusion:Traumatic brain injury rehabilitation is a young and constantly growing field. Since the late 1990s, traumatic brain injury rehabilitation documents published yearly comprised about 3-4% of all rehabilitation documents. It was shown that review papers and proceedings have more impact than journal articles, and collaborative papers receive more citations. It was also revealed that knowledge does not become obsolete rapidly in this field.	[Mojgani, Parviz] Iranian Red Crescent Soc, Rehabil & Med Educ Dept, Iran Helal Inst Appl Sci & Technol, Tehran, Iran; [Jalali, Maryam] Iran Univ Med Sci, Sch Rehabil Sci, Orthot & Prosthet Dept, Tehran, Iran; [Keramatfar, Abdalsamad] Sci Informat Database, Data Analyt, Tehran, Iran		Keramatfar, A (corresponding author), Sci Informat Database, Data Analyt, Tehran, Iran.	samad@sid.ir	Keramatfar, Abdalsamad/AAH-7414-2019; Keramatfar, Abdalsamad/D-7117-2015	Keramatfar, Abdalsamad/0000-0001-6826-4692; 			Annalingam A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-140; Bohannon R W, 1991, Int J Rehabil Res, V14, P333, DOI 10.1097/00004356-199112000-00006; Brett BL, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-018-0121-8; CAMPBELL FM, 1990, B MED LIBR ASSOC, V78, P376; CDC, 2019, TBI GET THE FACTS; Cernak I, 2017, BRAIN INJURY, V31, P1168, DOI 10.1080/02699052.2016.1274779; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Heimerl F, 2014, P ANN HICSS, P1833, DOI 10.1109/HICSS.2014.231; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Igoumenou A, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0332-6; Ioannidis JPA, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002542; Keramatfar A., 2015, CASPIAN J SCIENTOMET, V2, DOI [10.22088/acadpub.BUMS.2.1.33, DOI 10.22088/ACADPUB.BUMS.2.1.33]; Keramatfar A, 2019, J INF SCI, V45, P3, DOI 10.1177/0165551518761013; Kiduk Y., 2006, P AM SOC INF SCI TEC, V43, P1, DOI [10.1002/MEET.14504301185, DOI 10.1002/MEET.14504301185]; Kreutzer JS, 2017, NEUROREHABILITATION, V40, P163, DOI 10.3233/NRE-161415; KUHLEMEIER KV, 1992, ARCH PHYS MED REHAB, V73, P126; Kumar KS, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007935.pub2; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu XX, 2019, THER CLIN RISK MANAG, V15, P1, DOI 10.2147/TCRM.S163881; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Oberholzer Michael, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030047; Persson I, 2009, TLS-TIMES LIT SUPPL, P9; Popovic V, 2005, GROWTH HORM IGF RES, V15, P177, DOI 10.1016/j.ghir.2005.02.003; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Shadgan B, 2010, ARCH PHYS MED REHAB, V91, P806, DOI 10.1016/j.apmr.2010.01.011; TORKELSON RM, 1983, REHABIL PSYCHOL, V28, P169, DOI 10.1037/h0090992; Ugolini D, 2012, SUPPORT CARE CANCER, V20, P1629, DOI 10.1007/s00520-011-1253-2; Vanderploeg R, 2016, ARCH CLIN NEUROPSYCH, V31, P628, DOI 10.1093/arclin/acw043.116; White K. E., 2017, SCI ENG PUBLICATION, P1; Wright CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156826; Yuen J, 2018, WORLD NEUROSURG, V119, pE328, DOI 10.1016/j.wneu.2018.07.144; Zasler N. D., 2012, BRAIN INJURY MED PRI	37	1	1	3	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN 2	2022	32	1					51	68		10.1080/09602011.2020.1796714		AUG 2020	18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	XW1CD	WOS:000555172100001	32744132				2022-02-06	
J	Simma, L; Palmer, CS; Ngo, A; Jowett, HE; Teague, WJ				Simma, Leopold; Palmer, Cameron S.; Ngo, Alan; Jowett, Helen E.; Teague, Warwick J.			An evaluation of the presentation and severity of Australian football injury in children	TRAUMA-ENGLAND			English	Article						Child; injuries; sports; Australian football; Australian rules football; injury burden	REFERRAL CENTER; TRAUMA CARE; VICTORIA; AGE; SPORTS; PREVENTION; CONCUSSION; ACTIVATION; RISK	Introduction Child participation in sport is important for physical, cognitive and psychosocial wellbeing. Australian rules football has high participation, but also carries a high risk of injury due to the contact nature of the sport. This study aimed to evaluate changes in the presentation and hospital admission of paediatric Australian rules football-related injuries, and to compare the severity of these injuries with those from other team ball sports. Materials and methods At an Australian paediatric major trauma service, ED and hospital trauma registry data relating to Australian rules football injury between 2009 and 2015 were obtained. Data from other common team ball sports with a shared field of play were also identified. Results During the study period, there were 10,003 ED presentations, and 1110 admissions resulting from team ball sports. With 4751 ED presentations and 616 admissions, Australian rules football accounted for almost one-third of all sports-related presentations and admissions, and around half of the team ball sports cohort. Compared to other team ball sports patients, Australian rules football-related patients were 40% more likely to be admitted, and nearly twice as likely to be classified as severe injury. Australian rules football players presented with different injury patterns were compared to other team ball sports players; admitted players were significantly more likely to have sustained head or neck injuries, and were more than twice as likely to sustain truncal injury. Conclusions Australian rules football is a common cause of ED presentations and results in substantial morbidity, both overall and when compared with other team ball sports. Australian rules football should remain a focus for ongoing and active research into strategies which reduce injury risk.	[Simma, Leopold; Palmer, Cameron S.; Ngo, Alan; Jowett, Helen E.; Teague, Warwick J.] Royal Childrens Hosp, Trauma Serv, Melbourne, Vic, Australia; [Simma, Leopold; Ngo, Alan] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Simma, Leopold] Childrens Hosp Lucerne, Luzern, Switzerland; [Palmer, Cameron S.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Teague, Warwick J.] Murdoch Childrens Res Inst, Surg Res Grp, Melbourne, Vic, Australia; [Teague, Warwick J.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia		Palmer, CS (corresponding author), Royal Childrens Hosp Melbourne, 50 Flemington Rd, Parkville, Vic 3052, Australia.	cameron.palmer@rch.org.au	Teague, Warwick J/AAY-7260-2020	Teague, Warwick J/0000-0003-4747-6025; Simma, Leopold/0000-0003-3032-2759	Royal Children's Hospital Foundation	Associate Professor Teague's position as an Academic Paediatric Surgeon and Director of The Royal Children's Hospital Trauma Service is generously supported by The Royal Children's Hospital Foundation.	Adult Retrieval Victoria, 2014, VICT STAT TRAUM SYST; Australian Football League, 2019, AFL KIDS AUSK FAQ 20; Australian Sports Commission, 2018, AUSPLAY VIC DAT TABL; Australian Sports Commission, 2016, AUSPLAY PART DAT SPO; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Braham R, 2004, J SCI MED SPORT, V7, P96, DOI 10.1016/S1440-2440(04)80048-3; Bressan S, 2015, EMERG MED J, V32, P716, DOI 10.1136/emermed-2014-203998; Burton P, 2007, EMERG MED AUSTRALAS, V19, P160, DOI 10.1111/j.1742-6723.2007.00947.x; Cameron PA, 2008, MED J AUSTRALIA, V189, P546, DOI 10.5694/j.1326-5377.2008.tb02176.x; Cassell E, 2007, HAZARD VISU, V65, P1; Cassell E, 2012, HAZARD, V74, P1; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2010, EMERG MED AUSTRALAS, V22, P56, DOI 10.1111/j.1742-6723.2009.01249.x; Davis G.A., 2017, MANAGEMENT CONCUSSIO; Deasy C, 2012, INJURY, V43, P2006, DOI 10.1016/j.injury.2011.08.032; Ekegren CL, 2015, CLIN J SPORT MED, V25, P162, DOI 10.1097/JSM.0000000000000108; Falcone RA, 2012, J TRAUMA ACUTE CARE, V73, P377, DOI 10.1097/TA.0b013e318259ca84; Finch C, 1998, BRIT J SPORT MED, V32, P220, DOI 10.1136/bjsm.32.3.220; Finch CF, 2013, CLIN J SPORT MED, V23, P430, DOI 10.1097/JSM.0b013e31829aa3e8; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Freitag A, 2015, BRIT J SPORT MED, V49, P511, DOI 10.1136/bjsports-2014-093684; Gennarelli TA., 2008, ABBREVIATED INJURY S; Grimmer K, 2003, J SCI MED SPORT, V6, P328, DOI 10.1016/S1440-2440(03)80026-9; Haran HP, 2016, J SCI MED SPORT, V19, P194, DOI 10.1016/j.jsams.2015.02.009; Hrysomallis C, 2013, SPORTS MED, V43, P339, DOI 10.1007/s40279-013-0034-0; McKenzie K, 2010, ACCIDENT ANAL PREV, V42, P354, DOI 10.1016/j.aap.2009.09.020; MCMAHON KA, 1993, MED J AUSTRALIA, V159, P301, DOI 10.5694/j.1326-5377.1993.tb137864.x; Orchard J, 1998, J Sci Med Sport, V1, P83, DOI 10.1016/S1440-2440(98)80016-9; Palmer CS, 2016, INJURY, V47, P109, DOI 10.1016/j.injury.2015.07.003; Romiti M, 2008, BRIT J SPORT MED, V42, P441, DOI 10.1136/bjsm.2007.042721; Sheskin D, 2004, HDB PARAMETRIC NONPA; Spinks AB, 2006, INJURY PREV, V12, P390, DOI 10.1136/ip.2006.011502; Stevenson MR, 2000, BRIT J SPORT MED, V34, P188, DOI 10.1136/bjsm.34.3.188	33	1	1	0	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1460-4086	1477-0350		TRAUMA	Trauma	JUL	2021	23	3					206	217	1460408620941335	10.1177/1460408620941335		AUG 2020	12	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	SS7OE	WOS:000556256900001					2022-02-06	
J	Sullivan, L; Newton, A; Shi, JX; Chang, TJ; Yang, JZ				Sullivan, Lindsay; Newton, Alison; Shi, Junxin; Chang, Teng-Jen; Yang, Jingzhen			Concussion-Related Health Care Utilization Among Medicaid Insured Children in Ohio: Rural and Urban Differences	JOURNAL OF RURAL HEALTH			English	Article						children; concussion laws; health care utilization; location of residence; Medicaid	TRAUMATIC BRAIN-INJURY; UNITED-STATES; LYSTEDT LAW; ALL-CAUSE; VISITS; SPORTS; ACCESS; TRENDS; US; DISPARITIES	Purpose The current study examines rural-urban differences in trends in rates and type of concussion-related health care utilization over time from 2008 to 2016 among Medicaid insured children in Ohio. Methods We analyzed Medicaid claims for health care utilization for diagnosed concussions among children aged <= 18 years between April 1, 2008, and December 31, 2016. We compared the trends in rates of concussion-related health care utilization between children who lived in rural and urban areas using Poisson regressions. We examined trends in the type of concussion-related health care utilization by location of residence using linear regressions. Findings We found a significant increase in health care utilization for concussion over time, with rates of treated concussion consistently higher in rural children compared to urban children (P< .0001) throughout the study period. Although initial care at the Emergency Department (ED) remained the most common type of initial concussion-related health care utilization for rural children throughout the study period, the most common type of initial care sought by urban children shifted over time from the ED to primary care providers (PCPs). For both rural and urban children, PCPs remained the most common type of follow-up care sought throughout the study period, with no significant rural-urban differences in the trends of follow-up care sought through PCPs over time. Conclusions We observed significant rural-urban differences in the trends in rates and types of concussion-related health care utilization over time from 2008 to 2016. Future studies are needed to further our understanding of the effect of these observed rural-urban differences on concussion recovery.	[Sullivan, Lindsay; Newton, Alison; Shi, Junxin; Chang, Teng-Jen; Yang, Jingzhen] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH USA; [Yang, Jingzhen] Ohio State Univ, Coll Med, Dept Pediat, 700 Childrens Dr,RB3-WB5403, Columbus, OH 43205 USA		Yang, JZ (corresponding author), Ohio State Univ, Coll Med, Dept Pediat, 700 Childrens Dr,RB3-WB5403, Columbus, OH 43205 USA.; Yang, JZ (corresponding author), Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr,RB3-WB5403, Columbus, OH 43205 USA.	Ginger.Yang@nationwidechildrens.org		Sullivan, Lindsay/0000-0001-8079-0388	Centers for Disease Control and Prevention National Center for Injury Prevention and ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [3 R49 CE002106-05S1]	This research work was supported by funding from the Centers for Disease Control and Prevention National Center for Injury Prevention and Control (Grant 3 R49 CE002106-05S1 to Dr Yang).	Baker DR, 2018, AM J SPORT MED, V46, P396, DOI 10.1177/0363546517738742; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Carlson, 2015, INJ EPIDEMIOL, V2, P32, DOI DOI 10.1186/s40621-015-0063-2; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, TRAUM BRAIN INJ CONC; Chan L, 2006, J RURAL HEALTH, V22, P140, DOI 10.1111/j.1748-0361.2006.00022.x; Chapital Alyssa D, 2007, Hawaii Med J, V66, P318; Coben JH, 2009, AM J PREV MED, V36, P49, DOI 10.1016/j.amepre.2008.10.001; Concannon LG, 2016, PHYS MED REH CLIN N, V27, P513, DOI 10.1016/j.pmr.2015.12.006; DeVoe JE, 2009, J RURAL HEALTH, V25, P1, DOI 10.1111/j.1748-0361.2009.00192.x; Douthit N, 2015, PUBLIC HEALTH, V129, P611, DOI 10.1016/j.puhe.2015.04.001; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Haggerty Jeannie L, 2007, Healthc Policy, V3, P72; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Health Resources & Services Administration, FED OFF RUR HLTH POL; Kaye AJ, 2010, J TRAUMA, V68, P1396, DOI 10.1097/TA.0b013e3181cf7d1b; Keenan HT, 2017, J HEAD TRAUMA REHAB, V32, P385, DOI 10.1097/HTR.0000000000000265; Kim K, 2012, INJURY PREV, V18, P264, DOI 10.1136/injuryprev-2011-040306; Mackenzie B, 2015, PEDIATR EMERG CARE, V31, P25, DOI 10.1097/PEC.0000000000000325; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Moy E, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6601a1; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Singh GK, 2014, J URBAN HEALTH, V91, P272, DOI 10.1007/s11524-013-9847-2; Singh GK, 2013, J URBAN HEALTH, V90, P388, DOI 10.1007/s11524-012-9744-0; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Tarimala A, 2019, J PEDIATR-US, V206, P178, DOI 10.1016/j.jpeds.2018.10.021; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Trojian Thomas, 2015, Inj Epidemiol, V2, P2; United States Census Bureau, URB RUR; Yang YT, 2016, JAMA PEDIATR, V170, P413, DOI 10.1001/jamapediatrics.2016.0338; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067	32	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0890-765X	1748-0361		J RURAL HEALTH	J. Rural Health	JUN	2021	37	3					479	486		10.1111/jrh.12484		AUG 2020	8	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	TA1XK	WOS:000554763700001	32744752				2022-02-06	
J	de-Lima-Oliveira, M; Ferreira, AA; Belon, AR; Salinet, AM; Nogueira, RC; Ping, BC; Paiva, WS; Teixeira, MJ; Bor-Seng-Shu, E				de-Lima-Oliveira, Marcelo; Ferreira, Almir Andrade; Belon, Alessandro Rodrigo; Salinet, Angela Macedo; Nogueira, Ricardo Carvalho; Ping, Brasil Chian; Paiva, Wellingson Silva; Teixeira, Manoel Jacobsen; Bor-Seng-Shu, Edson			The influence of intracranial hypertension on static cerebral autoregulation	BRAIN INJURY			English	Article						Mild intracranial hypertension; cerebral autoregulation; intracranial hypertension; experimental model	BLOOD-FLOW AUTOREGULATION; TRAUMATIC BRAIN-INJURY; CEREBROVASCULAR PRESSURE REACTIVITY; SUBARACHNOID HEMORRHAGE; PERFUSION-PRESSURE; CARBON-DIOXIDE; HEAD-INJURY; LOWER LIMIT; METABOLISM; RESPONSES	Objectives To analyze the influences of mild and severe intracranial hypertension on cerebral autoregulation (CA). Patients and Methods Duroc piglets were monitored with an intracranial pressure (ICP) catheter. Intracranial hypertension was induced via infusion of 4 or 7 ml of saline solution by a bladder catheter that was inserted into the parietal lobe. The static cerebral autoregulation (sCA) index was evaluated via cerebral blood flow velocities (CBFv). Piglets with ICPs <= 25 and > 25 mmHg were considered as group 1 and 2, respectively. Continuous variables were evaluated using the Kolmogorov-Smirnov goodness-of-fit test. The main parameters were collected before and after ICH induction and compared using two-factor mixed-design ANOVAs with the factor of experimental group (mild and severe ICH). Results In group 1 (ICP <= 25 mmHg), there were significant differences in sCA (p= .01) and ICP (p= .0002) between the basal and balloon inflation conditions. In group 2 (ICP > 25 mmHg), there were significant differences in CBFv (p= .0072), the sCA index (p= .0001) and ICP (p= .00001) between the basal and balloon inflation conditions. Conclusion We conclude that ICH may have a direct effect on mild and severe sCA.	[de-Lima-Oliveira, Marcelo; Ferreira, Almir Andrade; Salinet, Angela Macedo; Ping, Brasil Chian; Paiva, Wellingson Silva; Teixeira, Manoel Jacobsen; Bor-Seng-Shu, Edson] Hosp Clin FMUSP, Neurol Dept, Sao Paulo, Brazil; [Belon, Alessandro Rodrigo] Univ Sao Paulo, Fac Med, Neurol Dept, Sao Paulo, Brazil; [Nogueira, Ricardo Carvalho] Hosp Nove Julho, Neurol Dept, Sao Paulo, Brazil		de-Lima-Oliveira, M (corresponding author), Ave Dr Eneias de Carvalho Aguiar 255, BR-05403000 Sao Paulo, Brazil.	marcelodtc@gmail.com	de Carvalho Nogueira, Ricardo/V-3482-2019; Paiva, Wellingson S/G-5517-2013; BOR-SENG-SHU, EDSON/AAC-9762-2019	de Carvalho Nogueira, Ricardo/0000-0003-3309-3760; Paiva, Wellingson S/0000-0002-5165-7040; BOR-SENG-SHU, EDSON/0000-0002-6713-8974; de-Lima-Oliveira, Marcelo/0000-0002-7418-1516	Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo provided financial support in the form of grant funding. The sponsor had no role in the design or conduct of this research	Anile C, 2009, CHILD NERV SYST, V25, P325, DOI 10.1007/s00381-008-0749-7; BARZO P, 1991, NEUROSURGERY, V28, P821, DOI 10.1227/00006123-199106000-00006; Bay-Hansen R, 2003, J NEUROSURG ANESTH, V15, P110, DOI 10.1097/00008506-200304000-00008; Bor-Seng-Shu E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/750809; Brady KM, 2009, ANESTH ANALG, V108, P1278, DOI 10.1213/ane.0b013e3181964848; Bragin DE, 2016, ACTA NEUROCHIR SUPPL, V122, P255, DOI 10.1007/978-3-319-22533-3_51; Cremer OL, 2004, ANESTH ANALG, V99, P1211, DOI 10.1213/01.ANE.0000133917.67728.2A; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; de Andrade AF, 2013, ARQ NEURO-PSIQUIAT, V71, P802, DOI 10.1590/0004-282X20130126; de Lima Oliveira M, 2018, W NEUROSURG, V113, DOI [10.1016/j.wneu.2018.01.194, DOI 10.1016/J.WNEU.2018.01.194]; de Lima Oliveira M, 2018, ACHTA NEUROCHIR, V160, DOI [10.1007/s00701-018-3484-1, DOI 10.1007/S00701-018-3484-1]; Dethloff TJ, 2008, J CEREBR BLOOD F MET, V28, P916, DOI 10.1038/sj.jcbfm.9600589; Dias C, 2014, J NEUROTRAUM, V31, P1872, DOI 10.1089/neu.2014.3376; Hahn GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063069; Hauerberg J, 1998, J NEUROSURG ANESTH, V10, P106, DOI 10.1097/00008506-199804000-00007; HAUERBERG J, 1994, J CEREBR BLOOD F MET, V14, P519, DOI 10.1038/jcbfm.1994.64; Hlatky R, 2006, NEUROCRIT CARE, V4, P127, DOI 10.1385/NCC:4:2:127; Jalan R, 2001, HEPATOLOGY, V34, P50, DOI 10.1053/jhep.2001.25386; KIM MS, 2011, CRITIC CARE MED, V39, DOI DOI 10.1097/CCM.0B013E318223B910; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; Lewis PM, 2014, NEUROCRIT CARE, V21, P514, DOI 10.1007/s12028-014-9994-7; Mascia L, 2000, INTENS CARE MED, V26, P202, DOI 10.1007/s001340050046; MILLER JD, 1973, J NEUROSURG, V39, P186, DOI 10.3171/jns.1973.39.2.0186; Morgalla MH, 2008, J NEUROSURGERY, V109; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; Nusbaum D, 2014, NEUROL RES, V36, P1063, DOI 10.1179/1743132814Y.0000000397; Oliveira MD, 2018, NEUROL RES INT, V2018, DOI 10.1155/2018/7053932; Oliveira MD, 2014, J NEUROTRAUM, V31, P1750, DOI 10.1089/neu.2014.3386; Oliveira MD, 2014, NEUROCRIT CARE, V21, P152, DOI 10.1007/s12028-013-9884-4; Sahuquillo J, 2000, ACTA NEUROCHIR S, V76, DOI [10.1007/978-3-7091-6346-7_102, DOI 10.1007/978-3-7091-6346-7_102]; Salinet ASM, 2014, CEREBROVASC DIS EXTR, V4, P186, DOI 10.1159/000366017; Steiner LA, 2003, J NEUROL NEUROSUR PS, V74, P765, DOI 10.1136/jnnp.74.6.765; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; Tang SC, 2015, J FORMOS MED ASSOC, V114, P842, DOI 10.1016/j.jfma.2013.09.002; Thorat JD, 2008, J CLIN NEUROSCI, V15, P143, DOI 10.1016/j.jocn.2006.08.014; TUREEN JH, 1990, J CLIN INVEST, V85, P577, DOI 10.1172/JCI114475; Watts ADJ, 2002, J NEUROSURG ANESTH, V14, P31, DOI 10.1097/00008506-200201000-00006; Yamamoto S, 1998, BRAIN RES, V782, P194, DOI 10.1016/S0006-8993(97)01278-X	39	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 28	2020	34	9					1270	1276		10.1080/02699052.2020.1797166		AUG 2020	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ND6FI	WOS:000555187500001	32744909				2022-02-06	
J	Bastien, C; Neal-Sturgess, C; Christensen, J; Wen, L				Bastien, C.; Neal-Sturgess, C.; Christensen, J.; Wen, L.			A METHOD TO CALCULATE THE AIS TRAUMA SCORE FROM A FINITE ELEMENT MODEL	JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY			English	Article						Peak virtual power; Abbreviated injury scale; Organ trauma model		In the real world, traumatic injuries are measured using the Abbreviated Injury Scale (AIS), however, such a scale cannot be computed to date or the injury precisely located by using human computer models. These models use stresses and strains to evaluate whether serious or fatal injuries are reached, which unfortunately bear no direct relation to AIS. This paper proposes to overcome this deficiency and suggests a unique Organ Trauma Model (OTM) able to calculate the risk to life of any organ injury, focussing in this case on real-life pedestrian head injuries. The OTM uses a power method, named Peak Virtual Power (PVP), and defines a brain white and gray matters trauma response as a function of impact direction and impact speed. The OTM was tested against four real-life pedestrian accidents and proved to predict the head trauma severity and location. In some cases, the method did however under-estimate the trauma by 1 AIS level because of post-impact haemorrhage which cannot be captured with Lagrangian Finite Element solvers. The OTM has the potential to create an important advance in vehicle safety by adding more information on the risk of head trauma.	[Bastien, C.; Christensen, J.; Wen, L.] Coventry Univ, Inst Transport & Cities, Priory St, Coventry CV1 5FB, W Midlands, England; [Neal-Sturgess, C.] Univ Birmingham, Sch Mech Engn, Birmingham B15 2TT, W Midlands, England		Bastien, C (corresponding author), Coventry Univ, Inst Transport & Cities, Priory St, Coventry CV1 5FB, W Midlands, England.	aa3425@coventry.ac.uk		Christensen, Jesper/0000-0001-8345-0127; Neal-Sturgess, Clive Edward/0000-0003-2113-545X; Bastien, Christophe/0000-0001-6194-4548			APROSYS (Advanced Protection Systems), APROSYS REP SUMM; Association for the Advancement of Automotive, 2015, ASS ADV AUT MED ABBR; Bastien C, 2018, ACCIDENT ANAL PREV, V118, P66, DOI 10.1016/j.aap.2018.05.020; Bastien C, 2017, LS DYN EUR C 2017 WU; College of Policing, 2018, COLL POLICING INFORM; EuroNCAP, 2018, TECHNICAL REPORT; European Parliament, UNECE 127 PED PROT; Hayes WC, 2007, ANNU REV BIOMED ENG, V9, P55, DOI 10.1146/annurev.bioeng.9.060906.151946; Kleinberger M, 1998, DEV IMPROVED INJURY; Livermore Software Technology Corporation, 2011, TOT HUM MOD SAF THUM; Neal-Sturgess CE, 2002, P I MECH ENG D-J AUT, V216, P883, DOI 10.1243/095440702321031432; NealSturgess CE, ENTROPY MORBIDITY TR; NealSturgess CE, 2001, PASS SAF NETW WORKSH; Shanahan DF, HUMAN TOLERANCE CRAS, DOI 10.1.1.212.5449&rep=rep1&type=pdf; Shao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052366; Sparks JL, 2007, THESIS; Tomoyuki M, 2011, DEV FINITE ELEMENT M; Toyota Motor Corporation, 2011, DOC TOT HUM MOD SAF; Ulman M, 1986, 1986 INT IRCOBI C BI, P2; Umale S, 2013, INT RES COUNC BIOM I; Warwickshire County Council, 2018, POL PROV PED CROSS P; Wen L., 2019, THESIS; Wen L, 2015, LS DYN EUR C 2015 SA	23	1	1	0	2	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5194	1793-6810		J MECH MED BIOL	J. Mech. Med. Biol.	AUG	2020	20	6							2050034	10.1142/S0219519420500347			28	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	NN2LY	WOS:000568624900006					2022-02-06	
J	Becker, A; Hershkovitz, Y; Peleg, K; Dubose, J; Adi, G; Kessel, B				Becker, Alexander; Hershkovitz, Yehuda; Peleg, Kobi; Dubose, Joseph; Adi, Givon; Kessel, Boris		Zahalka AalaIsraeli Trauma Grp	Hypotension on admission in patients with isolated traumatic brain injury: contemporary examination of the incidence and outcomes using a national registry	BRAIN INJURY			English	Article						Trauma; traumatic brain injury; hypotension	OF-HOSPITAL HYPOTENSION; BLOOD-PRESSURE; HEAD-INJURY; HYPOXIA; MORTALITY; DURATION; IMPACT	Purpose This study was primarily aimed at establishing the incidence and impact of hypotension in patients with blunt traumatic brain injury based on National Trauma Registry Database. Methods A retrospective cohort study using the National Trauma Registry was conducted. Patients with TBI following blunt mechanisms of injury were examined, comparing those with and without hypotension (SBP < 90 mm Hg) on arrival. Results During the period from 1998 to 2017, the registry included 437.354 blunt trauma patients. Of them, 7818 patients were hemodynamically unstable (SBP < 90 mm Hg) on admission. 513 met the inclusion criteria. Significant percentages of patients with high grade injures (ISS >= 16) and low admission's GCS 3-12 (46% vs 16.4%), were found in the group of hypotensive TBI patients (p<0.0001). 323 (62.9%) patients had head AIS score 3-4 and only 190 (37.1%) patients AIS 5-6 (p<0.0001). Mortality in the hypotensive TBI group was 32.3%, whereas 6.1% patients died in the TBI hemodynamically stable group (p<0.0001) Conclusion TBI patients presenting with hypotension represent an appreciable portion blunt trauma patients. Prompt brain CT, expedient efforts at optimal resuscitation and possibly early inotropic and vasopressors agents use may have an impact on final outcome in these patients.	[Becker, Alexander] Emek Med Ctr, Surg Div, Afula, Israel; [Becker, Alexander; Kessel, Boris] Technion, Rappaport Sch Med, Haifa, Israel; [Hershkovitz, Yehuda] Tel Aviv Univ, Dept Surg, Shamir Med Ctr, Sackler Fac Med, Tel Aviv, Israel; [Peleg, Kobi] Gertner Inst Epidemiol & Hlth Policy Res, Natl Ctr Trauma & Emergency Med Res, Tel Hashomer, Israel; [Dubose, Joseph] Univ Maryland Med Syst, R Adams Cowley Shock Trauma Ctr, Baltimore, MD USA; [Kessel, Boris; Zahalka AalaIsraeli Trauma Grp] Hillel Yaffe Med Ctr, Surg Div, Hadera, Israel		Becker, A (corresponding author), Emek Med Ctr, Dept Surg A, IL-18000 Afula, Israel.	becker_al@clalit.org.il					Bell J, 2014, TRAUMATIC BRAIN INJU; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Chesnut R, 1993, ACTA NEUROCHIR S WIE, V59; Chesnut RM, 1998, J TRAUMA, V44, P958, DOI 10.1097/00005373-199806000-00003; Committee on Trauma, 2018, ADV TRAUM LIF SUPP A; Fulton R L, 1993, J Invest Surg, V6, P117, DOI 10.3109/08941939309141603; Gavrilovski M, 2018, INJURY, V49, P1675, DOI 10.1016/j.injury.2018.04.019; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Mahoney EJ, 2003, J TRAUMA, V55, P1065, DOI 10.1097/01.TA.0000100381.89107.93; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; NEWFIELD P, 1980, CRIT CARE MED, V8, P254, DOI 10.1097/00003246-198004000-00123; Partrick DA, 2002, AM J SURG, V184, P555, DOI 10.1016/S0002-9610(02)01052-8; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; POPP AJ, 1982, J SURG RES, V32, P416, DOI 10.1016/0022-4804(82)90121-4; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Shibahashi K, 2018, WORLD NEUROSURG, V120, pE667, DOI 10.1016/j.wneu.2018.08.142; Spaite D, 2017, JAMA SURG, V152; Spaite DW, 2017, ANN EMERG MED, V70, P522, DOI 10.1016/j.annemergmed.2017.03.027; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57	23	1	1	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 23	2020	34	10					1422	1426		10.1080/02699052.2020.1797170		AUG 2020	5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NI5TJ	WOS:000555134900001	32735766				2022-02-06	
J	Black, AM; Yeates, KO; Babul, S; Nettel-Aguirre, A; Emery, CA				Black, Amanda M.; Yeates, Keith Owen; Babul, Shelina; Nettel-Aguirre, Alberto; Emery, Carolyn A.			Association between concussion education and concussion knowledge, beliefs and behaviours among youth ice hockey parents and coaches: a cross-sectional study	BMJ OPEN			English	Article						sports medicine; public health; medical education & training	SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; MANAGEMENT; SYMPTOMS	Objectives To examine the association between self-reported exposure to concussion education and knowledge, beliefs and self-reported behaviour among parents and coaches of youth ice hockey players. Design Cross-sectional. Setting Community ice hockey teams from Calgary and Edmonton, Alberta, Canada. Participants Parents and coaches of ice hockey players (ages 11-17, all divisions of play). Primary and secondary outcome measures Participants completed a questionnaire developed and validated to measure concussion knowledge, beliefs and concussion management behaviour (ie, coaches removing athletes from play; parents taking children with suspected concussions to physicians) consistent with the Health Action Process Approach (HAPA). The questionnaire examined specific HAPA constructs (ie, risk perception, outcome expectancies, action self-efficacy, intention, action planning, maintenance self-efficacy, recovery self-efficacy) relevant to concussion management behaviour. Results Participants included 786 parents (31.8% with coaching experience) and 10 non-parent coaches. Of the participants, 649 (82.6%) previously received concussion education. Based on a multivariable regression analysis adjusting for coaching experience, previous history of a child sustaining one or more concussions, first aid experience and cluster by team, exposure to concussion education was associated with a mean score difference of 1.36 (95% CI 0.68 to 2.03), p<0.0001, in the knowledge score. Exposure to concussion education was not significantly associated with any of the HAPA constructs based on Wilcoxon rank-sum tests. Conclusion Exposure to concussion education may be associated with small overall differences in concussion knowledge but may not be associated with significant differences in beliefs or intended behaviours related to concussion management among youth hockey parents and coaches. When providing education or recommendations for concussion education sources to coaches and parents, educational strategies grounded in behavioural change theory that specifically target the motivators of behavioural change should be considered.	[Black, Amanda M.; Nettel-Aguirre, Alberto; Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Black, Amanda M.; Yeates, Keith Owen; Nettel-Aguirre, Alberto; Emery, Carolyn A.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Black, Amanda M.; Yeates, Keith Owen; Emery, Carolyn A.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Black, Amanda M.; Nettel-Aguirre, Alberto; Emery, Carolyn A.] Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Neurosci, Calgary, AB, Canada; [Babul, Shelina] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada; [Babul, Shelina] BC Childrens Hosp, Vancouver, BC, Canada; [Nettel-Aguirre, Alberto; Emery, Carolyn A.] Univ Calgary, Cumming Sch Med, Dept Pediat, Calgary, AB, Canada; [Nettel-Aguirre, Alberto; Emery, Carolyn A.] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada		Black, AM (corresponding author), Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada.; Black, AM (corresponding author), Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada.; Black, AM (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.; Black, AM (corresponding author), Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada.	ablack@ucalgary.ca	Yeates, Keith/AAJ-4223-2020; Nettel-Aguirre, Alberto/ABB-9412-2021; Black, Amanda/O-7675-2017	Babul, Shelina/0000-0002-0227-2574; Nettel-Aguirre, Alberto/0000-0001-6604-0652; Emery, Carolyn Ann/0000-0002-9499-6691; Black, Amanda/0000-0001-5668-9706	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Hotchkiss Brain Institute; Alberta Children's Hospital Foundation; Alberta Innovates Health Solutions; Hotchkiss Brain Institute Dr T Chen Fong Doctoral Scholarship in Neuroscience; Canada Research Chair (Tier 1) Concussion; Ronald and Irene Ward Chair in Pediatric Brain Injury from the Alberta Children's Hospital Foundation; International Olympic Committee	This study was funded by the Canadian Institutes of Health Research (CIHR), Hotchkiss Brain Institute, Alberta Children's Hospital Foundation, and Alberta Innovates Health Solutions. AMB was supported by the Hotchkiss Brain Institute Dr T Chen Fong Doctoral Scholarship in Neuroscience. CAE is supported by a Canada Research Chair (Tier 1) Concussion. KOY is supported by the Ronald and Irene Ward Chair in Pediatric Brain Injury from the Alberta Children's Hospital Foundation. The University of Calgary Sport Injury Prevention Research Centre is one of the International Research Centres for Prevention of Injury and Protection of Athlete Health supported by the International Olympic Committee. The role of the sponsors and funding bodies was to provide financial support for this research and the translation of the findings to all community partners.	Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bramley H, 2012, CLIN PEDIATR, V51, P283, DOI 10.1177/0009922811422434; Canada H, 2016, ANN REPORT 2015 2016; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Concannon LG, 2016, PHYS MED REH CLIN N, V27, P513, DOI 10.1016/j.pmr.2015.12.006; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Glang AE, 2015, J ADOLESCENT HEALTH, V56, P91, DOI 10.1016/j.jadohealth.2014.08.011; Glanz K, 2010, ANNU REV PUBL HEALTH, V31, P399, DOI 10.1146/annurev.publhealth.012809.103604; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Hecimovicha M, 2016, SPORT J, P1; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Krol AL, 2011, BRAIN INJURY, V25, P1300, DOI 10.3109/02699052.2011.624571; Kroshus E, 2016, CLIN J SPORT MED, V26, P391, DOI 10.1097/JSM.0000000000000272; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Murgraff V, 2003, J APPL SOC PSYCHOL, V33, P339, DOI 10.1111/j.1559-1816.2003.tb01900.x; Parker EM, 2015, J HEAD TRAUMA REHAB, V30, P198, DOI 10.1097/HTR.0000000000000097; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Renner B., 2005, RISK HLTH BEHAV DOCU; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Schwarzer R., 1992, SELF EFFICACY THOUGH; Schwarzer R, 2008, EUR PSYCHOL, V13, P141, DOI 10.1027/1016-9040.13.2.141; Schwarzer R, 2008, APPL PSYCHOL-INT REV, V57, P84, DOI 10.1111/j.1464-0597.2007.00324.x; Schwarzer R, 2008, APPL PSYCHOL-INT REV, V57, P1, DOI 10.1111/j.1464-0597.2007.00325.x; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785	34	1	1	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	AUG	2020	10	8							e038166	10.1136/bmjopen-2020-038166			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NL4JC	WOS:000567383300014	32830117	Green Published, gold			2022-02-06	
J	Bliss, RA; Carr, WD				Bliss, Rebecca A.; Carr, W. David			KNOWLEDGE OF VESTIBULAR OCULAR DYSFUNCTION AND UTILIZATION OF VESTIBULAR OCULAR MOTOR SCREENING (VOMS) TOOL COMPONENTS AMONG PROFESSIONAL SPORTS LEAGUE ATHLETIC TRAINERS	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						Vestibular ocular dysfunction; movement system; screening; concussion management	CONCUSSION; RELIABILITY; PERFORMANCE; DIZZINESS	Background: The Vestibular Ocular Motor Screen (VOMS) is a relatively new measurement tool intended for the non-vestibular practitioner to identify vestibular ocular dysfunction (VOD) following sport related concussion (SRC). Specific knowledge of VOD and usage of the VOMS among athletic trainers in professional sports leagues is currently unknown. Hypothesis/Purpose: The purpose of this study was to examine knowledge of VOD following SRC and utilization of the VOMS tool and other vestibular ocular tests and measures among athletic trainers in professional sports. Study Design: Cross Sectional Study Methods: A total of 117 athletic trainers from Major League Baseball, the National Basketball Association, the National Football League and Major League Soccer, with a mean of 17 +/- 9 years in the athletic training profession were surveyed via Qualtrics (TM) with a response rate of 33%. The survey contained three primary sub-sections; demographics, knowledge of vestibular ocular deficits following SRC, and VOMS component utilization at baseline, acute and return-to-play phases of management. Total knowledge scores as well as percentage of utilization based on concussion management stages were calculated. Results: The average percentage correct on the knowledge items was 56% (range of 30% to 65%). There was no difference in knowledge score among athletic trainers with formal post-professional concussion training (p = 0.29) compared to those with no formal training. There was no relationship found between total years practicing and total knowledge score, r = -.128, (p = 0.17). Smooth pursuit testing was the most commonly utilized (70%) in clinical practice and Visual Motion Sensitivity (VMS) was the least utilized (17%). Balance assessment measures to examine vestibular functioning remained the highest utilized examination technique at all-time points in management of SRC. Conclusion: The range of correct responses from 30% to 65% indicates that at the time of survey the participants had decreased knowledge of VOD following SRC. There was low overall utilization of all VOMS components despite recent evidence showing good sensitivity and low false positive rates in SRC. The results of this study identify an opportunity for future training specific to vestibular-ocular impairments and assessment following concussion injury.	[Bliss, Rebecca A.] Univ Missouri, Dept Phys Therapy, 801 Clark Hall, Columbia, MO 65211 USA; [Carr, W. David] Missouri State Univ, Dept Publ Hlth & Sports Med, Springfi Ed, MO USA		Bliss, RA (corresponding author), Univ Missouri, Dept Phys Therapy, 801 Clark Hall, Columbia, MO 65211 USA.	Rebecca.bliss@health.missouri.edu					[Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Herdman SJ, 2014, VESTIBULAR REHABILIT; Kelly KC, 2016, J ATHL TRAINING, V49, P665; Kitson AL, 2016, J NURS SCHOLARSHIP, V48, P294, DOI 10.1111/jnu.12206; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Reneker JC, 2017, SCAND J MED SCI SPOR, V27, P2009, DOI 10.1111/sms.12827; Russell-Giller S, 2018, SPORTS HEALTH, V10, P334, DOI 10.1177/1941738118765450; Savage JL, 2018, J ATHL TRAINING, V53, P983, DOI 10.4085/1062-6050-394-17; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Worts PR, 2018, AM J SPORT MED, V46, P2004, DOI 10.1177/0363546518768750; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720	21	1	1	3	3	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	AUG	2020	15	4					603	610		10.26603/ijspt20200603			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	PK6ZV	WOS:000602591200011	33354393				2022-02-06	
J	Blitzer, DN; Ottochian, M; O'Connor, J; Feliciano, DV; Morrison, JJ; DuBose, JJ; Scalea, TM				Blitzer, David N.; Ottochian, Marcus; O'Connor, James; Feliciano, David V.; Morrison, Jonathan J.; DuBose, Joseph J.; Scalea, Thomas M.			Penetrating Injury to the Carotid Artery: Characterizing Presentation and Outcomes from the National Trauma Data Bank	ANNALS OF VASCULAR SURGERY			English	Article							NECK TRAUMA; MANAGEMENT; BLUNT; COMPLEX	Background: Penetrating injury to the neck can be devastating because of the multiple vital structures in close proximity. In the event of injury to the carotid artery, there is a significantly increased likelihood of morbidity or mortality. The purpose of this study was to assess presenting characteristics associated with penetrating injury to the carotid artery and directly compare approaches to surgical management. Methods: Data from the National Trauma Data Bank from 2002-2016 were accessed to evaluate adult patients sustaining penetrating injury to the common or internal carotid artery. Management (operative versus nonoperative) and surgical approach (open versus endovascular) were evaluated based on presentation characteristics, and outcomes were compared after propensity score matching. Results: Three thousand three hundred ninety-one patients fitting inclusion criteria and surviving past the emergency department were included in analyses (nonoperative: 1,976 [58.3%] patients and operative: 1,415 [41.7%] patients). The operative group was further classified by intervention as open = 1,192 patients and endovascular: 154 patients. On presentation, the nonoperative group demonstrated significantly higher prevalence of coma (Glasgow Coma Scale <= 8: nonoperative = 49.3% versus operative = 40.8%, P < 0.001), severe overall injury burden (Injury Severity Score >= 25: nonoperative = 42.3% versus operative = 33.3%, P < 0.001), and severe head injury (Abbreviated Injury Score >= 3: nonoperative = 44.9% versus operative = 22.0%, P < 0.001). After propensity score matching, the nonoperative group demonstrated higher mortality (nonoperative = 28.9% versus operative = 18.5%, P < 0.001), and lower rates of stroke (nonoperative = 6.6% versus operative - = 10.5%, P < 0.001). There were no differences in outcomes relating to surgical approach. Conclusions: These results indicate that nonoperative patients often present with a more severe overall injury burden, particularly injury to the head, and not surprisingly, have higher rates of mortality. The lack of significant differences in outcomes relating to surgical approach indicates open versus endovascular invention should be individualized to the patient-for example, based on presenting characteristics and the location of the injury.	[Blitzer, David N.] MedStar Hlth Baltimore, Dept Surg, Baltimore, MD USA; [Ottochian, Marcus; O'Connor, James; Feliciano, David V.; Morrison, Jonathan J.; DuBose, Joseph J.; Scalea, Thomas M.] Univ Maryland, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA		Morrison, JJ (corresponding author), R Adams Cowley Shock Trauma Ctr, 22 S Greene St, Baltimore, MD 21201 USA.	Jonathan.Morrison@som.umaryland.edu					American College of Surgeons Commitee on Trauma, 2018, NAT TRAUM DAT BANK; Asensio JA, 2011, EUR J TRAUMA EMERG S, V37, P429, DOI 10.1007/s00068-011-0132-3; ASENSIO JA, 1991, SURG CLIN N AM, V71, P267; BLADERGROEN M, 1989, AM J SURG, V157, P483, DOI 10.1016/0002-9610(89)90640-5; Blitzer DN, 2020, J VASC SURG, V71, P1323, DOI 10.1016/j.jvs.2019.05.059; BROWN MF, 1982, AM J SURG, V144, P748, DOI 10.1016/0002-9610(82)90563-3; Burlew CC, 2014, J AM COLL SURGEONS, V218, P1012, DOI 10.1016/j.jamcollsurg.2014.01.042; Demetriades D, 1997, WORLD J SURG, V21, P41, DOI 10.1007/s002689900191; Demetriades D, 1996, SURG CLIN N AM, V76, P661, DOI 10.1016/S0039-6109(05)70475-8; du Toit DF, 2003, J VASC SURG, V38, P257, DOI 10.1016/S0741-5214(03)00143-5; Feliciano DV, 2001, WORLD J SURG, V25, P1028, DOI 10.1007/s00268-001-0055-y; FOGELMAN MJ, 1956, AM J SURG, V91, P581, DOI 10.1016/0002-9610(56)90289-6; JEBARA VA, 1991, J VASC SURG, V14, P117; Karnecki K, 2014, J THROMB THROMBOLYS, V38, P409, DOI 10.1007/s11239-014-1077-2; Lee TS, 2014, CRANIOMAX TRAUM REC, V7, P175, DOI 10.1055/s-0034-1372521; Li W, 2010, J VASC SURG, V51, P593, DOI 10.1016/j.jvs.2009.10.108; Madsen AS, 2016, INJURY, V47, P64, DOI 10.1016/j.injury.2015.07.032; Martin MJ, 2005, J TRAUMA, V59, P860, DOI 10.1097/01.ta.0000187964.47703.e9; McConnell D B, 1994, Adv Surg, V27, P97; MONSON DO, 1969, J TRAUM, V9, P987, DOI 10.1097/00005373-196912000-00003; Mulloy JP, 1998, RADIOLOGY, V207, P571, DOI 10.1148/radiology.207.3.9609876; Navsaria P, 2002, EUR J VASC ENDOVASC, V24, P349, DOI 10.1053/ejvs.2002.1736; R Core Team, R LANG ENV STAT COMP; RAMADAN F, 1995, J VASC SURG, V21, P46, DOI 10.1016/S0741-5214(95)70243-1; RStudio Team, 2015, RSTUDIO IN DEV R; Schroll R, 2015, J TRAUMA ACUTE CARE, V79, P943, DOI 10.1097/TA.0000000000000713; Shiroff AM, 2013, AM SURGEON, V79, P23; Sperry JL, 2013, J TRAUMA ACUTE CARE, V75, P936, DOI 10.1097/TA.0b013e31829e20e3; Starnes Benjamin W, 2006, Perspect Vasc Surg Endovasc Ther, V18, P114, DOI 10.1177/1531003506293418; Stone ME, 2016, J TRAUMA ACUTE CARE, V80, P604, DOI 10.1097/TA.0000000000000976; Tisherman SA, 2008, J TRAUMA, V64, P1392, DOI 10.1097/TA.0b013e3181692116; WEAVER FA, 1988, ARCH SURG-CHICAGO, V123, P1106; Weinberg JA, 2016, J TRAUMA ACUTE CARE, V81, P302, DOI 10.1097/TA.0000000000001103; *WHO, 1998, INT STAT CLASS DIS R; WHO, 1992, INT STAT CLASS DIS R	35	1	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0890-5096	1615-5947		ANN VASC SURG	Ann. Vasc. Surg.	AUG	2020	67						192	199		10.1016/j.avsg.2020.03.013			8	Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Cardiovascular System & Cardiology	NQ8PX	WOS:000571131000026	32217135				2022-02-06	
J	Borrie, SA; Wynn, CJ; Berisha, V; Lubold, N; Willi, MM; Coelho, CA; Barrette, TS				Borrie, Stephanie A.; Wynn, Camille J.; Berisha, Visar; Lubold, Nichola; Willi, Megan M.; Coelho, Carl A.; Barrette, Tyson S.			Conversational Coordination of Articulation Responds to Context: A Clinical Test Case With Traumatic Brain Injury	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article							CLEAR SPEECH; ENTRAINMENT; INTELLIGIBILITY; INDIVIDUALS; CONVERGENCE; PERCEPTION; SPEAKING; HEARING; TALKER; WORDS	Purpose: Coordination of communicative behavior supports shared understanding in conversation. The current study brings together analysis of two speech coordination strategies, entrainment and compensation of articulation, in a preliminary investigation into whether strategy organization is shaped by a challenging communicative context-conversing with a person who has a communication disorder. Method: As an initial clinical test case, an automated measure of articulatory precision was analyzed in a corpus of spoken dialogue, where a confederate conversed with participants with traumatic brain injury (n = 28) and participants with no brain injury (n = 48). Results: Overall, the confederate engaged in significant entrainment and high compensation (hyperarticulation) in conversations with participants with traumatic brain injury relative to significant entrainment and low compensation (hypoarticulation) in conversations with participants with no brain injury. Furthermore, the confederate's articulatory precision changed over the course of the conversations. Conclusions: Findings suggest that the organization of conversational coordination is sensitive to context, supporting synergistic models of spoken dialogue. While corpus limitations are acknowledged, these initial results point to differences in the way in which speech strategies are realized in challenging communicative contexts, highlighting a viable and important target for investigation with clinical populations. A framework for investigating speech coordination strategies in tandem and ideas for advancing this line of inquiry serve as key contributions of this work.	[Borrie, Stephanie A.; Wynn, Camille J.] Utah State Univ, Dept Commun Disorders & Deaf Educ, Logan, UT 84322 USA; [Berisha, Visar; Lubold, Nichola] Arizona State Univ, Sch Elect Comp & Energy Engn, Tempe, AZ USA; [Willi, Megan M.] Calif State Univ Chico, Commun Sci & Disorders Program, Chico, CA 95929 USA; [Coelho, Carl A.] Univ Connecticut, Dept Speech Language & Hearing Sci, Storrs, CT USA; [Barrette, Tyson S.] Utah State Univ, Dept Psychol, Logan, UT 84322 USA		Borrie, SA (corresponding author), Utah State Univ, Dept Commun Disorders & Deaf Educ, Logan, UT 84322 USA.	stephanie.borrie@usu.edu		Borrie, Stephanie/0000-0002-2336-0071	National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R21DC016084]	This research was supported by National Institute on Deafness and Other Communication Disorders Grant R21DC016084 awarded to Stephanie Borrie and Visar Berisha.	Babel M, 2014, LAB PHONOL, V5, P123, DOI 10.1515/lp-2014-0006; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Borrie SA, 2020, J SPEECH LANG HEAR R, V63, P83, DOI 10.1044/2019_JSLHR-19-00194; Borrie SA, 2019, J SPEECH LANG HEAR R, V62, P283, DOI 10.1044/2018_JSLHR-S-18-0210; Borrie SA, 2017, J VOICE, V31, DOI 10.1016/j.jvoice.2016.12.005; Borrie SA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01187; Bradlow AR, 2002, J ACOUST SOC AM, V112, P272, DOI 10.1121/1.1487837; Bradlow AR, 1996, SPEECH COMMUN, V20, P255, DOI 10.1016/S0167-6393(96)00063-5; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Clark H.H., 1991, PERSPECTIVES SOCIALL, P127; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; Cooke M, 2010, J ACOUST SOC AM, V128, P2059, DOI 10.1121/1.3478775; Dideriksen C., 2019, P 41 ANN C COGN SCI, P261, DOI [10.31234/osf.io/fd8y9, DOI 10.31234/OSF.IO/FD8Y9]; Duran ND, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178140; Ferguson SH, 2002, J ACOUST SOC AM, V112, P259, DOI 10.1121/1.1482078; FOWLER CA, 1987, J MEM LANG, V26, P489, DOI 10.1016/0749-596X(87)90136-7; FOWLER CA, 1988, LANG SPEECH, V31, P307, DOI 10.1177/002383098803100401; Fusaroli R, 2014, NEW IDEAS PSYCHOL, V32, P147, DOI 10.1016/j.newideapsych.2013.03.005; Gordon RG, 2015, BRAIN INJURY, V29, P1300, DOI 10.3109/02699052.2015.1042408; Granlund S, 2018, J SPEECH LANG HEAR R, V61, P1055, DOI 10.1044/2017_JSLHR-S-16-0456; Hazan V, 2018, J ACOUST SOC AM, V144, P1331, DOI 10.1121/1.5053218; Hazan V, 2011, J ACOUST SOC AM, V130, P2139, DOI 10.1121/1.3623753; Hox J. J., 2010, MULTILEVEL ANAL TECH, DOI [10.4324/9781315650982, DOI 10.4324/9781315650982]; Ivanova I, 2020, J MEM LANG, V110, DOI 10.1016/j.jml.2019.104052; Ko ES, 2016, J CHILD LANG, V43, P284, DOI 10.1017/S0305000915000203; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lee CC, 2014, COMPUT SPEECH LANG, V28, P518, DOI 10.1016/j.csl.2012.06.006; Lee DY, 2020, J ACOUST SOC AM, V147, P3702, DOI 10.1121/10.0001315; LINDBLOM B, 1990, NATO ADV SCI I D-BEH, V55, P403; Lubold N., 2019, P INTERSPEECH 2019; Manson JH, 2013, EVOL HUM BEHAV, V34, P419, DOI 10.1016/j.evolhumbehav.2013.08.001; Mefferd AS, 2010, J SPEECH LANG HEAR R, V53, P1206, DOI 10.1044/1092-4388(2010/09-0083); NATALE M, 1975, J PERS SOC PSYCHOL, V32, P790, DOI 10.1037/0022-3514.32.5.790; Nenkova A., 2008, P 46 ANN M ASS COMP, P169, DOI DOI 10.3115/1557690.1557737; Neumann D., 2019, TXB TRAUMATIC BRAIN; Panayotov V, 2015, INT CONF ACOUST SPEE, P5206, DOI 10.1109/ICASSP.2015.7178964; Paxton A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01135; PERKELL JS, 1990, NATO ADV SCI I D-BEH, V55, P263; Pickering MJ, 2008, PSYCHOL BULL, V134, P427, DOI 10.1037/0033-2909.134.3.427; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; R Development Core Team, 2019, R LANG ENV STAT COMP; Riley MA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00038; Seidl A, 2018, J SPEECH LANG HEAR R, V61, P1369, DOI 10.1044/2018_JSLHR-S-17-0287; Shockley K, 2003, J EXP PSYCHOL HUMAN, V29, P326, DOI 10.1037/0096-1523.29.2.326; Smiljanic R, 2009, LANG LINGUIST COMPAS, V3, P236, DOI 10.1111/j.1749-818x.2008.00112.x; Tu M, 2018, INTERSPEECH, P1636, DOI 10.21437/Interspeech.2018-1350; Weise A, 2019, SPEECH COMMUN, V115, P78, DOI 10.1016/j.specom.2019.10.007; Westbury JR, 1998, SPEECH COMMUN, V26, P203, DOI 10.1016/S0167-6393(98)00058-2; Wickham H, 2016, GGPLOT2 ELEGANT GRAP, DOI [10.1007/978-3-319-24277-4_9, DOI 10.1007/978-3-319-24277-4_9, 10.1007/978-3-319-24277-4]; Wilson M, 2005, PSYCHON B REV, V12, P957, DOI 10.3758/BF03206432; Witt SM, 2000, SPEECH COMMUN, V30, P95, DOI 10.1016/S0167-6393(99)00044-8	53	1	1	0	2	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	AUG	2020	63	8					2567	2577		10.1044/2020_JSLHR-20-00104			11	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	MZ3RR	WOS:000559039900006	32755503	Green Published			2022-02-06	
J	Budzinskiy, S; Beuter, A; Volpert, V				Budzinskiy, S.; Beuter, A.; Volpert, V.			Nonlinear analysis of periodic waves in a neural field model	CHAOS			English	Article							SPATIALLY STRUCTURED ACTIVITY; COUPLED NEURONAL NETWORKS; TRAVELING-WAVES; PROPAGATING WAVES; DYNAMICS	Various types of brain activity, including motor, visual, and language, are accompanied by the propagation of periodic waves of electric potential in the cortex, possibly providing the synchronization of the epicenters involved in these activities. One example is cortical electrical activity propagating during sleep and described as traveling waves [Massimini et al., J. Neurosci. 24, 6862-6870 (2004)]. These waves modulate cortical excitability as they progress. Clinically related examples include cortical spreading depression in which a wave of depolarization propagates not only in migraine but also in stroke, hemorrhage, or traumatic brain injury [Whalen et al., Sci. Rep. 8, 1-9 (2018)]. Here, we consider the possible role of epicenters and explore a neural field model with two nonlinear integrodifferential equations for the distributions of activating and inhibiting signals. It is studied with symmetric connectivity functions characterizing signal exchange between two populations of neurons, excitatory and inhibitory. Bifurcation analysis is used to investigate the emergence of periodic traveling waves and of standing oscillations from the stationary, spatially homogeneous solutions, and the stability of these solutions. Both types of solutions can be started by local oscillations indicating a possible role of epicenters in the initiation of wave propagation. Published under license by AIP Publishing. The concept of periodic traveling waves appeared in the early 1970s and since that time investigators have actively explored themechanisms, computational principles, and functional role of these waveforms.3,4 This paper focuses on howmodeling information can be used to guide electrical stimulation in the targeted manipulation of brain networks in human patients affected by neurological disorders. We explore a neural field model with two nonlinear integrodifferential equations and perform a bifurcation analysis. Results suggest that it is possible to determine the direction of propagation and that epicenters may play a role in the initiation of wave propagating in the cortex. These results will guide the determination of the optimal localization to apply external brain stimulation (forcing term) to restore wave propagation in damaged cortical tissue.	[Budzinskiy, S.] Lomonosov Moscow State Univ, Fac Computat Math & Cybernet, Leninskie Gory 1, Moscow 119991, Russia; [Budzinskiy, S.] RAS, Marchuk Inst Numer Math, Gubkina St 8, Moscow 119333, Russia; [Budzinskiy, S.; Volpert, V.] RUDN Univ, Peoples Friendship Univ Russia, Miklukho Maklaya St 6, Moscow 117198, Russia; [Beuter, A.] Bordeaux INP, Bordeaux, France; [Beuter, A.] CorStim SAS, Montpellier, France; [Volpert, V.] Univ Lyon, Inst Camille Jordan, CNRS, UMR 5208, F-69622 Villeurbanne, France; [Volpert, V.] INRIA Lyon La Doua, INRIA Team Dracula, F-69603 Villeurbanne, France		Beuter, A (corresponding author), Bordeaux INP, Bordeaux, France.; Beuter, A (corresponding author), CorStim SAS, Montpellier, France.	anne.beuter@wanadoo.fr	Volpert, Vitaly/E-2969-2019	Budzinskiy, Stanislav/0000-0001-7983-7900; Beuter, Anne/0000-0001-6464-2879	RUDN University Program 5-100; CorStim; Moscow Center for Fundamental and Applied Mathematics; Ministry of Education and Science of the Russian FederationMinistry of Education and Science, Russian Federation [075-15-2019-1624]	Funding was provided by the "RUDN University Program 5-100" (S.B. and V.V.), the CorStim (A.B.), and the Moscow Center for Fundamental and Applied Mathematics [S.B.; agreement with the Ministry of Education and Science of the Russian Federation (No. 075-15-2019-1624)].	Alexander DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148413; Atasoy S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10340; Atay FM, 2006, SIAM J APPL DYN SYST, V5, P670, DOI 10.1137/050629367; Bahramisharif A, 2013, J NEUROSCI, V33, P18849, DOI 10.1523/JNEUROSCI.2455-13.2013; Bessonov N, 2019, APPL MATH LETT, V88, P103, DOI 10.1016/j.aml.2018.07.037; Bessonov N, 2019, MATH METHOD APPL SCI, V42, P3912, DOI 10.1002/mma.5620; Beuter A, 2018, MATH BIOSCI, V305, P146, DOI 10.1016/j.mbs.2018.08.014; Beuter A, 2020, BIOL CYBERN, V114, P5, DOI 10.1007/s00422-020-00818-w; Botella-Soler V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030757; Chen ZX, 1998, J COMPUT NEUROSCI, V5, P53, DOI 10.1023/A:1008878310900; ERMENTROUT GB, 1993, P ROY SOC EDINB A, V123, P461, DOI 10.1017/S030821050002583X; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; Ermentrout GB, 2014, NEURAL FIELDS, P119; Halgren M, 2019, P NATL ACAD SCI USA, V116, P23772, DOI 10.1073/pnas.1913092116; Heitmann S, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00067; Huang XY, 2010, NEURON, V68, P978, DOI 10.1016/j.neuron.2010.11.007; Huang XY, 2004, J NEUROSCI, V24, P9897, DOI 10.1523/JNEUROSCI.2705-04.2004; Keane A, 2015, J NEUROSCI, V35, P1591, DOI 10.1523/JNEUROSCI.1669-14.2015; KOPELL N, 1973, STUD APPL MATH, V52, P291; KOPELL N, 1973, SCIENCE, V180, P1171, DOI 10.1126/science.180.4091.1171; Lozano-Soldevilla D, 2019, CELL REP, V26, P374, DOI 10.1016/j.celrep.2018.12.058; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Meijer HGE, 2014, J MATH BIOL, V68, P1249, DOI 10.1007/s00285-013-0670-x; Muller L, 2018, NAT REV NEUROSCI, V19, P255, DOI 10.1038/nrn.2018.20; Opitz A., 2016, SCI REP, V6, P1, DOI DOI 10.1038/SREP31236; Pinotsis D, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00149; Pinto DJ, 2001, SIAM J APPL MATH, V62, P226, DOI 10.1137/S0036139900346465; Pinto DJ, 2001, SIAM J APPL MATH, V62, P206, DOI 10.1137/S0036139900346453; Rapela J., 2018, ARXIV180609559QBIO; Senk J, 2020, PHYS REV RES, V2, DOI 10.1103/PhysRevResearch.2.023174; Stead M, 2010, BRAIN, V133, P2789, DOI 10.1093/brain/awq190; Takahashi K, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00040; VANGILS SA, 1986, P ROY SOC EDINB A, V104, P279, DOI 10.1017/S0308210500019223; Venkov NA, 2007, PHYSICA D, V232, P1, DOI 10.1016/j.physd.2007.04.011; Weaver J, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001753; Whalen A. J., 2018, SCI REP, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786; Wu JY, 2008, NEUROSCIENTIST, V14, P487, DOI 10.1177/1073858408317066; Zhang HH, 2018, NEURON, V98, P1269, DOI 10.1016/j.neuron.2018.05.019	39	1	1	0	6	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	1054-1500	1089-7682		CHAOS	Chaos	AUG	2020	30	8							083144	10.1063/5.0012010			12	Mathematics, Applied; Physics, Mathematical	Science Citation Index Expanded (SCI-EXPANDED)	Mathematics; Physics	NK7FX	WOS:000566899800002	32872829	Green Submitted			2022-02-06	
J	Cherry, JD; Babcock, KJ; Goldstein, LE				Cherry, Jonathan D.; Babcock, Katharine J.; Goldstein, Lee E.			Repetitive Head Trauma Induces Chronic Traumatic Encephalopathy by Multiple Mechanisms	SEMINARS IN NEUROLOGY			English	Article						chronic traumatic encephalopathy (CTE); concussion; neurodegeneration; tau protein traumatic brain injury (TBI)	BLOOD-BRAIN-BARRIER; TAU PATHOLOGY; ALZHEIMERS-DISEASE; AXONAL INJURY; MOUSE MODEL; PROPAGATION; NEUROINFLAMMATION; PHOSPHORYLATION; MICROGLIA; NEUROPATHOLOGY	Exposure to repetitive neurotrauma increases lifetime risk for developing progressive cognitive deficits, neurobehavioral abnormalities, and chronic traumatic encephalopathy (CTE). CTE is a tau protein neurodegenerative disease first identified in boxers and recently described in athletes participating in other contact sports (notably American football, ice hockey, rugby, and wrestling) and in military veterans with blast exposure. Currently, CTE can only be diagnosed by neuropathological examination of the brain after death. The defining diagnostic lesion of CTE consists of patchy perivascular accumulations of hyperphosphorylated tau protein that localize in the sulcal depths of the cerebral cortex. Neuronal abnormalities, axonopathy, neurovascular dysfunction, and neuroinflammation are triggered by repetitive head impacts (RHIs) and likely act as catalysts for CTE pathogenesis and progression. However, the specific mechanisms that link RHI to CTE are unknown. This review will explore two important areas of CTE pathobiology. First, we will review what is known about the biomechanical properties of RHI that initiate CTE-related pathologies. Second, we will provide an overview of key features of CTE neuropathology and how these contribute to abnormal tau hyperphosphorylation, accumulation, and spread.	[Cherry, Jonathan D.; Babcock, Katharine J.; Goldstein, Lee E.] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Cherry, Jonathan D.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Cherry, Jonathan D.; Goldstein, Lee E.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Cherry, Jonathan D.; Babcock, Katharine J.] VA Boston Healthcare Syst, Boston, MA USA; [Babcock, Katharine J.; Goldstein, Lee E.] Boston Univ, Sch Med, Mol Aging & Dev Lab, Boston, MA 02118 USA; [Babcock, Katharine J.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Coll Engn, Boston, MA 02118 USA		Goldstein, LE (corresponding author), Boston Univ, Sch Med, 670 Albany St, Boston, MA 02118 USA.	lgold@bu.edu					Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; [Anonymous], 2019, SURV REP TRAUM BRAIN; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Carmona S, 2018, LANCET NEUROL, V17, P721, DOI 10.1016/S1474-4422(18)30232-1; Cherry C, 2018, ONE HEALTH-AMSTERDAM, V6, P1, DOI 10.1016/j.onehlt.2018.05.003; Cherry JD, 2018, J NEUROPATH EXP NEUR, V77, P40, DOI 10.1093/jnen/nlx100; Cherry JD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185541; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Chong FP, 2018, CELL MOL NEUROBIOL, V38, P965, DOI 10.1007/s10571-017-0574-1; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Collins-Praino LE, 2017, BRAIN BEHAV IMMUN, V60, P369, DOI 10.1016/j.bbi.2016.09.027; Correa Fernando G, 2013, Methods Mol Biol, V1041, P215, DOI 10.1007/978-1-62703-520-0_20; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Ghosh S, 2013, J NEUROSCI, V33, P5053, DOI 10.1523/JNEUROSCI.4361-12.2013; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goedert M, 2017, ANNU REV NEUROSCI, V40, P189, DOI 10.1146/annurev-neuro-072116-031153; Goedert M, 2017, BRAIN, V140, P266, DOI 10.1093/brain/aww230; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Greenfield J.G., 2008, GREENFIELDS NEUROPAT; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jurgens HA, 2012, EXP NEUROL, V233, P40, DOI 10.1016/j.expneurol.2010.11.014; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kopeikina KJ, 2011, AM J PATHOL, V179, P2071, DOI 10.1016/j.ajpath.2011.07.004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li YK, 2003, J NEUROSCI, V23, P1605; Lu KP, 2016, JAMA NEUROL, V73, P1356, DOI 10.1001/jamaneurol.2016.2027; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Maphis N, 2015, BRAIN, V138, P1738, DOI 10.1093/brain/awv081; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Nedergaard M, 2013, SCIENCE, V340, P1529, DOI 10.1126/science.1240514; Parri R, 2003, NAT NEUROSCI, V6, P5, DOI 10.1038/nn0103-5; Puntambekar SS, 2018, BRAIN BEHAV IMMUN, V71, P9, DOI 10.1016/j.bbi.2018.03.033; Quintanilla RA, 2004, EXP CELL RES, V295, P245, DOI 10.1016/j.yexcr.2004.01.002; Roberts AL, 2019, AM J SPORT MED, V47, P2871, DOI 10.1177/0363546519868989; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Sheng JG, 2000, EXP NEUROL, V163, P388, DOI 10.1006/exnr.2000.7393; Shi JQ, 2011, BRAIN RES, V1368, P239, DOI 10.1016/j.brainres.2010.10.053; Shively SB, 2017, ACTA NEUROPATHOL, V133, P353, DOI 10.1007/s00401-016-1649-7; Shreiber DI, 1999, NEUROSCI LETT, V259, P5, DOI 10.1016/S0304-3940(98)00853-2; Simic G, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010006; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004; Stopschinski BE, 2017, LANCET NEUROL, V16, P323, DOI 10.1016/S1474-4422(17)30037-6; Sweeney MD, 2018, NAT NEUROSCI, V21, P1318, DOI 10.1038/s41593-018-0234-x; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Ulrich JD, 2017, NEURON, V94, P237, DOI 10.1016/j.neuron.2017.02.042; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Weissberg I, 2015, NEUROBIOL DIS, V78, P115, DOI 10.1016/j.nbd.2015.02.029; Wojnarowicz MW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00240; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Zanier ER, 2018, BRAIN, V141, P2685, DOI 10.1093/brain/awy193; Zilka N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-47; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; [No title captured]	92	1	1	5	19	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	AUG	2020	40	04					430	438		10.1055/s-0040-1713620			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NL6KK	WOS:000567521900010	32674181				2022-02-06	
J	Clark, JMR; Seewald, PM; Wu, K; Jak, AJ; Twamley, EW				Clark, Jillian M. R.; Seewald, P. Michelle; Wu, Kevin; Jak, Amy J.; Twamley, Elizabeth W.			Aspects of Executive Dysfunction and Racial/Ethnic Minority Status Are Associated With Unemployment Duration in Veterans With a History of Mild-to-Moderate Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Cognition; Depression; Employment; Neuropsychological tests; Stress disorders; post-traumatic; Rehabilitation	SUPPORTED EMPLOYMENT; AFGHANISTAN; OUTCOMES; FREEDOM	Objective: To examine demographic, psychiatric symptom, and neuropsychological performance factors associated with duration of unemployment in Iraq/Afghanistan Veterans with a history of mild-to-moderate traumatic brain injury (TBI). Design: Cross-sectional, secondary data analysis of baseline measures in a supported employment study. Setting: VA medical center. Participants: Participants (N=50) were veterans with a history of mild-to-moderate TBI who were unemployed, stating a goal of returning to work, and had documented impairment in at least 1 neuropsychological domain. Participants were referred from VA vocational and assessment-based clinics. Interventions: Not applicable. Main Outcome Measures: Duration of unemployment, neuropsychological, and psychiatric symptom assessments. Results: Bivariate correlations revealed that longer duration of unemployment was associated with greater posttraumatic stress disorder (P<.10) and depressive (P<.05) symptom severity, worse executive functioning (P<.05), and racial/ethnic minority status (P<.05). A multiple linear regression analysis including these independent variables explained 26.5% of the variance in duration of unemployment. Worse executive functioning, specifically reasoning and set-shifting, and minority status were each associated with longer duration of unemployment in the context of multiple independent variables. Conclusions: Our results underscore the importance of objective assessment of cognitive functioning in job-seeking Veterans with TBI histories. It may be useful to target aspects of executive functioning in vocational rehabilitation interventions and to provide additional assistance to Veterans from racial/ethnic minority groups. Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Clark, Jillian M. R.; Seewald, P. Michelle; Jak, Amy J.; Twamley, Elizabeth W.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA 92161 USA; [Clark, Jillian M. R.; Jak, Amy J.; Twamley, Elizabeth W.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Seewald, P. Michelle; Twamley, Elizabeth W.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA 92161 USA; [Wu, Kevin] Univ Calif San Diego, Psychol Dept, La Jolla, CA 92093 USA; [Jak, Amy J.] VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA 92161 USA		Twamley, EW (corresponding author), VA San Diego Healthcare Syst, 3350 La Jolla Village Dr,116A, San Diego, CA 92161 USA.	etwamley@ucsd.edu			Department of DefenseUnited States Department of Defense [W81XWH-08-2-0193]; VA Center of Excellence for Stress and Mental Health (CESAMH); Office of Academic Affiliations, CESAMH Advanced Fellowship Program in Mental Illness Research and Treatment, Department of Veterans Affairs	Supported by the Department of Defense (award no. W81XWH-08-2-0193 to Dr Elizabeth Twamley) and the VA Center of Excellence for Stress and Mental Health (CESAMH) and the Office of Academic Affiliations, CESAMH Advanced Fellowship Program in Mental Illness Research and Treatment, Department of Veterans Affairs.	Abraham KM, 2017, PSYCHIAT SERV, V68, P938, DOI 10.1176/appi.ps.201600412; Adler DA, 2011, PSYCHIAT SERV, V62, P39, DOI 10.1176/ps.62.1.pss6201_0039; Amick MM, 2018, J HEAD TRAUMA REHAB, V33, pE30, DOI 10.1097/HTR.0000000000000308; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Carlson KF, 2018, ARCH PHYS MED REHAB, V99, pS4, DOI 10.1016/j.apmr.2017.06.027; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Delis D.C., 2000, CVLT 2 CALIFORNIA VE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Fan JQ, 2008, J R STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; Kongs S. K., 2000, WCST 64 WISCONSIN CA; Lo CC, 2014, SOC PSYCH PSYCH EPID, V49, P1119, DOI 10.1007/s00127-014-0844-x; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; National Center for Veterans Analysis and Statistics, 2017, MIN VET REP MIL SERV; Olsen DC, 2018, BRAIN INJURY, V32, P544, DOI 10.1080/02699052.2018.1431845; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Raskin S, 2004, J INT NEUROPSYCHO S1, V10, P110, DOI DOI 10.1017/S1355617704040019; Ritter JA, 2011, REV ECON STAT, V93, P30, DOI 10.1162/REST_a_00063; Scaratti C, 2017, DISABIL REHABIL, V39, P847, DOI 10.3109/09638288.2016.1162854; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; US Bureau of Labor Statistics, 2017, THE EC DAILY; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME	31	1	1	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2020	101	8					1383	1388		10.1016/j.apmr.2020.04.008			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	MT3YW	WOS:000554905500013	32416150				2022-02-06	
J	Distel, DF; Amodeo, M; Joshi, S; Abramoff, BA				Distel, Donald F.; Amodeo, Matthew; Joshi, Shawn; Abramoff, Benjamin A.			Cognitive Dysfunction in Persons with Chronic Spinal Cord Injuries	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Cognitive dysfunction; Spinal cord injury; Cognitive impairment; Neuroinflammation; Cortical reorganization; Rehabilitation	TRAUMATIC BRAIN-INJURY; CLOSED HEAD-INJURY; DOUBLE-BLIND; CHRONIC PAIN; IMPAIRMENT; BACLOFEN; RISK; GABAPENTIN; DEFICITS; DISORDERS	Cognitive dysfunction (CD) is pervasive in individuals who have chronic spinal cord injuries (SCI). Although classically associated with concomitant traumatic brain injuries, many other causes have been proposed, including premorbid neuropsychological conditions, mood disorders, substance abuse, polypharmacy, chronic pain and fatigue, sleep apnea, autonomic dysregulation, post-intensive care unit syndrome, cortical re-organizations, and neuroinflammation. The consequences of CD are likely widespread, affecting rehabilitation and function. CD in those with SCI should be recognized, and potentially treated, in order to provide the best patient care.	[Distel, Donald F.; Amodeo, Matthew; Abramoff, Benjamin A.] Univ Penn, Dept Phys Med & Rehabil, Perelman Sch Med, 1800 Lombard St, Philadelphia, PA 19146 USA; [Joshi, Shawn] Drexel Sch Med, 2900 W Queen Lane, Philadelphia, PA 19129 USA		Abramoff, BA (corresponding author), Univ Penn, Dept Phys Med & Rehabil, Perelman Sch Med, 1800 Lombard St, Philadelphia, PA 19146 USA.	Benjamin.Abramoff@pennmedicine.upenn.edu					Allison DJ, 2015, SPINAL CORD, V53, P14, DOI 10.1038/sc.2014.184; Areza-Fegyveres Renata, 2010, Dement. neuropsychol., V4, P14, DOI 10.1590/S1980-57642010DN40100003; Berlowitz DJ, 2016, BREATHE, V12, P329, DOI 10.1183/20734735.012616; Berry JW, 2007, J PERS ASSESS, V89, P292, DOI 10.1080/00223890701629813; Berryman C, 2014, CLIN PSYCHOL REV, V34, P563, DOI 10.1016/j.cpr.2014.08.003; Bockian NR, 2003, J CLIN PSYCHOL MED S, V10, P307, DOI 10.1023/A:1026309622586; Bors M, 2015, CHRON RESP DIS, V12, P365, DOI 10.1177/1479972315603552; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Brown R, 2006, RESP CARE, V51, P853; Caldera-Alvarado G, 2013, ALLERGY, V68, P545, DOI 10.1111/all.12125; Chavant F, 2011, BRIT J CLIN PHARMACO, V72, P898, DOI 10.1111/j.1365-2125.2011.04009.x; Chiodo AE, 2016, J SPINAL CORD MED, V39, P374, DOI 10.1080/10790268.2015.1126449; Cleutjens FAHM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/697825; Cohen ML, 2017, REHABIL PSYCHOL, V62, P425, DOI 10.1037/rep0000140; Colbenson GA, 2019, BREATHE, V15, P98, DOI 10.1183/20734735.0013-2019; Craig A, 2017, J NEUROTRAUM, V34, P1156, DOI 10.1089/neu.2016.4632; Craig A, 2015, BRIT J HEALTH PSYCH, V20, P807, DOI 10.1111/bjhp.12143; Craig A, 2015, ARCH PHYS MED REHAB, V96, P1426, DOI 10.1016/j.apmr.2015.02.027; Craig A, 2012, J PSYCHOSOM RES, V73, P205, DOI 10.1016/j.jpsychores.2012.07.005; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DAVIDOFF G, 1990, ARCH PHYS MED REHAB, V71, P121; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; Davidoff G, 1990, Arch Clin Neuropsychol, V5, P77, DOI 10.1016/0887-6177(90)90009-E; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; DeJong G, 2013, ARCH PHYS MED REHAB, V94, pS87, DOI 10.1016/j.apmr.2012.10.037; Dodrill CB, 1999, EPILEPSY RES, V35, P109, DOI 10.1016/S0920-1211(99)00006-6; Dowler R N, 1995, Appl Neuropsychol, V2, P124, DOI 10.1207/s15324826an0203&4_4; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; Eddy Clare M, 2011, Ther Adv Neurol Disord, V4, P385, DOI 10.1177/1756285611417920; Elliott TR, 2006, REHABIL PSYCHOL, V51, P69, DOI 10.1037/0090-5550.51.1.69; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Finnerup NB, 2013, PAIN, V154, pS71, DOI 10.1016/j.pain.2012.12.007; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Girard TD, 2008, CRIT CARE, V12, DOI 10.1186/cc6149; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Grassmann M, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8146809; Gris D, 2008, EXP NEUROL, V211, P259, DOI 10.1016/j.expneurol.2008.01.033; Guttmann L., 1963, SPINAL INJURIES; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Hall W, 2016, JAMA INTERN MED, V176, P362, DOI 10.1001/jamainternmed.2015.7850; Harris P, 1968, Paraplegia, V5, P215; Hawkins DA, 1998, REHABIL PSYCHOL, V43, P219, DOI 10.1037/0090-5550.43.3.219; Heims HC, 2006, CLIN AUTON RES, V16, P113, DOI 10.1007/s10286-006-0318-7; Jegede AB, 2010, CLIN AUTON RES, V20, P3, DOI 10.1007/s10286-009-0036-z; Jure I, 2017, NEURAL REGEN RES, V12, P1044, DOI 10.4103/1673-5374.211177; Kang JH, 2013, ACTA PAEDIATR, V102, P640, DOI 10.1111/apa.12213; Kitzman P., 2016, J SPINAL CORD MED, V40, P1; Krebs J, 2018, SPINAL CORD, V56, P22, DOI 10.1038/sc.2017.94; Leach JP, 1997, J NEUROL NEUROSUR PS, V62, P372, DOI 10.1136/jnnp.62.4.372; Leng Y, 2017, JAMA NEUROL, V74, P1237, DOI 10.1001/jamaneurol.2017.2180; Levin ED, 2004, PHARMACOL BIOCHEM BE, V79, P343, DOI 10.1016/j.pbb.2004.08.013; Lombard L, 2019, SPINAL CORD MED, P573; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Macciocchi S, 2012, ARCH PHYS MED REHAB, V93, P1788, DOI 10.1016/j.apmr.2012.01.022; Macciocchi SN, 2013, ARCH CLIN NEUROPSYCH, V28, P684, DOI 10.1093/arclin/act049; Marvel CL, 2004, PSYCHIAT CLIN N AM, V27, P19, DOI 10.1016/S0193-953X(03)00106-0; Mawson AR, 1996, AM J EPIDEMIOL, V144, P463; Mazza S, 2018, PROG NEURO-PSYCHOPH, V87, P183, DOI 10.1016/j.pnpbp.2017.08.006; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Mortimore C, 1998, SEIZURE-EUR J EPILEP, V7, P359, DOI 10.1016/S1059-1311(05)80003-2; Nardone R, 2013, BRAIN RES, V1504, P58, DOI 10.1016/j.brainres.2012.12.034; Nicotra A, 2006, BRAIN, V129, P718, DOI 10.1093/brain/awh699; Perkes SJ, 2014, J HEALTH PSYCHOL, V19, P1597, DOI 10.1177/1359105313496445; Phillips AA, 2017, J NEUROTRAUM, V34, P1283, DOI 10.1089/neu.2016.4751; Phillips AA, 2014, J CEREBR BLOOD F MET, V34, P794, DOI 10.1038/jcbfm.2014.3; Pilipenko V, 2018, EUR J PHARMACOL, V818, P381, DOI 10.1016/j.ejphar.2017.11.012; Pujol CN, 2018, PROG NEURO-PSYCHOPH, V81, P306, DOI 10.1016/j.pnpbp.2017.09.008; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Sachdeva R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102464; Sachdeva R, 2018, NEUROLOGY, V91, P611, DOI 10.1212/WNL.0000000000006244; Sajkov D, 1998, SPINAL CORD, V36, P231, DOI 10.1038/sj.sc.3100563; Salimzade A, 2017, RES PHARM SCI, V12, P204, DOI 10.4103/1735-5362.207201; Salinsky M, 2010, NEUROLOGY, V74, P755, DOI 10.1212/WNL.0b013e3181d25b34; Salinsky MC, 2005, NEUROLOGY, V64, P792, DOI 10.1212/01.WNL.0000152877.08088.87; Sarkis RA, 2018, J NEUROL, V265, P2137, DOI 10.1007/s00415-018-8971-z; Scheife R, 2005, CLIN THER, V27, P144, DOI 10.1016/j.clinthera.2005.02.014; Schembri Rachel, 2017, Sleep, V40, DOI 10.1093/sleep/zsw037; Sharma B, 2014, J REHABIL MED, V46, P370, DOI 10.2340/16501977-1261; Shem Kazuko, 2018, Spinal Cord Ser Cases, V4, P9, DOI 10.1038/s41394-018-0038-y; Stoppel LJ, 2018, NEUROPSYCHOPHARMACOL, V43, P513, DOI 10.1038/npp.2017.236; Strubreither W, 1997, SPINAL CORD, V35, P487, DOI 10.1038/sj.sc.3100495; Tang AC, 1996, BEHAV BRAIN RES, V74, P145, DOI 10.1016/0166-4328(95)00038-0; Tannenbaum C, 2012, DRUG AGING, V29, P639, DOI 10.2165/11633250-000000000-00000; Tate DG, 2004, ARCH PHYS MED REHAB, V85, P1837, DOI 10.1016/j.apmr.2004.02.022; Tolonen A, 2007, J REHABIL MED, V39, P622, DOI 10.2340/16501977-0101; Tun CG, 1997, REHABIL PSYCHOL, V42, P163, DOI 10.1037/0090-5550.42.3.163; van Middendorp JJ, 2010, EUR SPINE J, V19, P1815, DOI 10.1007/s00586-010-1523-6; Warren AM, 2008, NEUROPSYCHOLOGY INPA, P79; Wecht JM, 2013, J SPINAL CORD MED, V36, P74, DOI 10.1179/2045772312Y.0000000056; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014; Zarrindast MR, 2001, EUR J PHARMACOL, V411, P283, DOI 10.1016/S0014-2999(00)00906-7; Zuccala G, 2001, NEUROLOGY, V57, P1986, DOI 10.1212/WNL.57.11.1986	96	1	2	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	AUG	2020	31	3					345	+		10.1016/j.pmr.2020.04.001			25	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	MH7XZ	WOS:000546938300006	32624099				2022-02-06	
J	Ernst, N; Schatz, P; Trbovich, AM; Emami, K; Eagle, SR; Mucha, A; Collins, MW; Kontos, AP				Ernst, Nathan; Schatz, Philip; Trbovich, Alicia M.; Emami, Kouros; Eagle, Shawn R.; Mucha, Anne; Collins, Michael W.; Kontos, Anthony P.			Utility of 1 Measurement Versus Multiple Measurements of Near Point of Convergence After Concussion	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injury; convergence; Vestibular/Ocular Motor Screening (VOMS)	MOTOR SCREENING VOMS; RELIABILITY; RECOVERY; INSUFFICIENCY; DYSFUNCTIONS; IMPAIRMENT; NEARPOINT; SYMPTOMS; COMMON; RISK	Context: Increased near point of convergence (NPC) distance is a common finding after concussion and is associated with physical symptoms and worsened neurocognitive performance. Vestibular/Ocular Motor Screening measures NPC distance across 3 trials and uses the average measurement to inform clinical care. However, whether 3 trials are necessary, are consistent, or add clinical utility is unknown. Objective: To investigate the consistency across 3 trials of NPC and establish the classification accuracy (ie, clinical utility) of 1 or 2 trials compared with the standardized average of 3 trials. Design: Retrospective cohort study. Setting: Sports medicine clinic and research laboratory. Patients or Other Participants: Consecutively enrolled patients aged 10 to 22 years with diagnosed concussions (74% sport related; n = 380). Main Outcome Measure(s): The previously reported clinical cutoff value of >5 cm across 3 trials was used. Pearson correlation and intraclass correlation coefficients were used to evaluate agreement between trials and average scores. Reliable change indices (RCIs) using 95% confidence intervals were also calculated. Results: The Pearson correlation (r = .98) and intraclass correlation (0.98) coefficients revealed excellent agreement between the first measurement and average NPC distance across 3 measurements. The RCI across all trials was 2 cm. When the first NPC measurement was <= 3 cm or >= 7 cm, agreement existed within the RCI between the first measurement and the average of 3 measurements in 99.6% of cases. When we averaged the first and second measurements, 379/ 380 (99.7%) participants had the same classification (ie, <5 cm = normal, >= 5 cm = abnormal) as the average NPC distance across 3 measurements. Conclusions: Our findings suggest limited utility of multiple or average NPC distance measurements when the initial NPC distance is outside of RCI clinical cutoffs (ie, <3 cm or >7 cm). Given the high consistency between the first measurement and average NPC distance across 3 trials, only 1 measurement of NPC distance is warranted unless the first measurement is between 3 and 7 cm.	[Ernst, Nathan; Trbovich, Alicia M.; Emami, Kouros; Eagle, Shawn R.; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15203 USA; [Ernst, Nathan; Trbovich, Alicia M.; Emami, Kouros; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, UPMC Sports Med Concuss Program, Pittsburgh, PA 15203 USA; [Schatz, Philip] St Josephs Univ, Philadelphia, PA 19131 USA; [Mucha, Anne] Univ Pittsburgh, UPMC Ctr Rehab Serv, Pittsburgh, PA 15203 USA		Kontos, AP (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, Concuss Res Lab, 3580 South Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu	Eagle, Shawn/ABG-1388-2020	Eagle, Shawn/0000-0001-6767-1042			Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; DAVIES CE, 1946, CAN MED ASSOC J, V55, P47; DuPrey KM, 2017, AM J SPORT MED, V45, P2388, DOI 10.1177/0363546517705640; Hayes GJ, 1998, OPTOMETRY VISION SCI, V75, P506, DOI 10.1097/00006324-199807000-00019; Iverson GL, 2001, LUPUS, V10, P266, DOI 10.1191/096120301680416959; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kontos AP, 2019, ARCH CLIN NEUROPSYCH, V34, P762, DOI 10.1093/arclin/acz026.32; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Maples WC, 2007, OPTOMETRY VISION SCI, V84, P224, DOI 10.1097/OPX.0b013e3180339f44; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Mullen SJ, 2014, CAN J NEUROL SCI, V41, P58, DOI 10.1017/S0317167100016279; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Raghuram A, 2019, AM J OPHTHALMOL, V206, P235, DOI 10.1016/j.ajo.2019.04.008; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Swanson MW, 2017, OPTOMETRY VISION SCI, V94, P60, DOI 10.1097/OPX.0000000000000977; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Worts PR, 2018, AM J SPORT MED, V46, P2004, DOI 10.1177/0363546518768750; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	28	1	1	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	AUG	2020	55	8					850	855		10.4085/1062-6050-431-19			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	NK5CJ	WOS:000566748600010	32577736	gold, Green Published			2022-02-06	
J	Even, KM; Subramanian, S; Berger, RP; Kochanek, PM; Zuccoli, G; Gaines, BA; Fink, EL				Even, Katelyn M.; Subramanian, Subramanian; Berger, Rachel P.; Kochanek, Patrick M.; Zuccoli, Giulio; Gaines, Barbara A.; Fink, Ericka L.			The Presence of Anemia in Children with Abusive Head Trauma	JOURNAL OF PEDIATRICS			English	Article							INTRACEREBRAL HEMORRHAGE VOLUME; OPERATIONAL CASE-DEFINITION; BRAIN-INJURY; YOUNG-CHILDREN; CLINICAL-TRIAL; COAGULOPATHY; TRANSFUSION; MANAGEMENT; CONSENSUS; OUTCOMES	Objectives To evaluate the incidence of anemia in patients with abusive head trauma (AHT), noninflicted traumatic brain injury (TBI), and physical abuse without AHT and the effect of anemia on outcome. Study design In a retrospective, single-center cohort study, we included children under the age of 3 years diagnosed with either AHT (n = 75), noninflicted TBI (n = 77), or physical abuse without AHT (n = 60) between January 1, 2014, and December 31, 2016. Neuroimaging was prospectively analyzed by pediatric neuroradiologists. Primary outcome was anemia at hospital presentation. Secondary outcomes included unfavorable outcome at hospital discharge, defined as a Glasgow Outcome Scale between 1 and 3, and intracranial hemorrhage (ICH) volume. Results Patients with AHT had a higher rate of anemia on presentation (47.3%) vs noninflicted TBI (15.6%) and physical abuse without AHT (10%) (P < .001). Patients with AHT had larger ICH volumes (33.3 mL [10.1-76.4 mL] vs 1.5 mL [0.6-5.2 mL]; P < .001) and greater ICH/total brain volume percentages than patients with noninflicted TBI (4.6% [1.4-8.2 %] vs 0.2% [0.1-0.7%]; P < .001). Anemia was associated with AHT (OR, 4.7; 95% CI, 2.2-10.2) and larger ICH/total brain volume percentage (OR, 1.1; 95% CI, 1.1-1.2) in univariate analysis. Unfavorable outcome at hospital discharge was associated with anemia (OR, 4.4; 95% CI, 1.6-12.6) in univariate analysis, but not after controlling for covariates. Conclusions Patients with AHT were more likely to present to the hospital with anemia and increased traumatic ICH volume than patients with noninflicted TBI or physical abuse without AHT. Children with anemia and AHT may be at increased risk for an unfavorable outcome.	[Even, Katelyn M.; Kochanek, Patrick M.; Fink, Ericka L.] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Subramanian, Subramanian; Zuccoli, Giulio] Univ Pittsburgh, Dept Radiol, UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA; [Berger, Rachel P.] Univ Pittsburgh, Dept Pediat, UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA; [Berger, Rachel P.; Kochanek, Patrick M.; Fink, Ericka L.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Gaines, Barbara A.] Univ Pittsburgh, Dept Surg, UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA USA		Even, KM (corresponding author), Penn State Hershey Childrens Hosp, Pediat Crit Care Med, H085,500 Univ Dr,POB 850, Hershey, PA 17033 USA.	keven@pennstatehealth.psu.edu	Fink, Ericka/AAU-9792-2021; Subramanian, Subramanian/AAI-6251-2021	/0000-0001-9734-8035			Acker SN, 2014, J PEDIATR SURG, V49, P338, DOI 10.1016/j.jpedsurg.2013.10.008; Adelson PD, 1998, ACT NEUR S, V71, P250; Baker RD, 2010, PEDIATRICS, V126, P1040, DOI 10.1542/peds.2010-2576; Becker PJ, 2014, J ACAD NUTR DIET, V114, P1988, DOI 10.1016/j.jand.2014.08.026; Berger RP, 2015, J PEDIATR-US, V166, P383, DOI 10.1016/j.jpeds.2014.10.036; Berger RP, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-3756; Beslow LA, 2014, STROKE, V45, P66, DOI 10.1161/STROKEAHA.113.003448; Beslow LA, 2010, STROKE, V41, P313, DOI 10.1161/STROKEAHA.109.568071; Choi PM, 2014, CURR OPIN PEDIATR, V26, P343, DOI 10.1097/MOP.0000000000000086; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Dunn JOC, 2016, BJA EDUC, V16, P341, DOI 10.1093/bjaed/mkw012; Flanders MM, 2005, CLIN CHEM, V51, P1738, DOI 10.1373/clinchem.2005.050211; Gaines BA, 2009, J TRAUMA, V67, pS135, DOI 10.1097/TA.0b013e3181adc17a; Gangat N, 2013, SEMIN HEMATOL, V50, P232, DOI 10.1053/j.seminhematol.2013.06.006; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Greenland S, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1981; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; Ichord RN, 2007, J NEUROTRAUM, V24, P106, DOI 10.1089/neu.2006.0087; JENNETT B, 1975, LANCET, V1, P480; Jordan LC, 2009, STROKE, V40, P1666, DOI 10.1161/STROKEAHA.108.541383; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; King WJ, 2003, CAN MED ASSOC J, V168, P155; Kleinman JT, 2011, DEV MED CHILD NEUROL, V53, P281, DOI 10.1111/j.1469-8749.2010.03798.x; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P269, DOI 10.1097/PCC.0000000000001737; Kochanek PM, 2019, NEUROSURGERY, V84, P1169, DOI 10.1093/neuros/nyz051; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Leeper CM, 2016, J TRAUMA ACUTE CARE, V80, P711, DOI 10.1097/TA.0000000000000954; Lelubre C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1321-6; Litofsky NS, 2018, BRAIN INJURY, V32, P342, DOI 10.1080/02699052.2018.1425913; Litofsky NS, 2016, WORLD NEUROSURG, V90, P82, DOI 10.1016/j.wneu.2016.02.076; Oluigbo CO, 2012, J NEUROSURG-PEDIATR, V9, P125, DOI 10.3171/2011.11.PEDS09449; Parks SE., 2012, PEDIAT ABUSIVE HEAD; Parks S, 2012, INJURY PREV, V18, P392, DOI 10.1136/injuryprev-2011-040234; Parks SE, 2012, INJURY PREV, V18, P193, DOI 10.1136/injuryprev-2011-040128; Pellicer A, 2013, NEONATOLOGY, V104, P171, DOI 10.1159/000351346; Peterson C, 2015, CHILD MALTREATMENT, V20, P162, DOI 10.1177/1077559515583549; Potter MA, 1999, CLIN INVEST MED, V22, P44; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Samuels JM, 2019, J TRAUMA ACUTE CARE, V86, P686, DOI 10.1097/TA.0000000000002173; Schibler A, 2012, CRIT CARE RESUSC, V14, P20; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Sen AN, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031409; Seres David S, 2005, Nutr Clin Pract, V20, P308; Shanahan ME, 2013, PEDIATRICS, V132, pE1546, DOI 10.1542/peds.2013-2049; Shander A, 2004, CRIT CARE CLIN, V20, P159, DOI 10.1016/j.ccc.2004.01.002; Skowno J, 2015, PEDIATR ANESTH, V25, P654, DOI 10.1111/pan.12698; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; Stippler M, 2012, J NEUROSURG-PEDIATR, V10, P383, DOI 10.3171/2012.8.PEDS12165; Suemori T, 2016, PEDIATR ANESTH, V26, P182, DOI 10.1111/pan.12800; Tasker Robert C, 2018, Pediatr Crit Care Med, V19, pS133, DOI 10.1097/PCC.0000000000001589; Valentine SL, 2018, PEDIATR CRIT CARE ME, V19, P884, DOI 10.1097/PCC.0000000000001613; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Webb AJS, 2015, STROKE, V46, P2470, DOI 10.1161/STROKEAHA.114.007343; Weiss G, 2019, BLOOD, V133, P40, DOI 10.1182/blood-2018-06-856500; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb; Wisner DH, 2015, J TRAUMA ACUTE CARE, V79, P206, DOI 10.1097/TA.0000000000000731; Won SY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199809; Yee KF, 2016, CAN RESPIR J, V2016, DOI 10.1155/2016/6803860; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108	66	1	1	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	AUG	2020	223						148	+		10.1016/j.jpeds.2020.04.008			10	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	MO1GM	WOS:000551283500032	32532650				2022-02-06	
J	Farrell, DH; Rick, EA; Dewey, EN; Schreiber, MA; Rowell, SE				Farrell, David H.; Rick, Elizabeth A.; Dewey, Elizabeth N.; Schreiber, Martin A.; Rowell, Susan E.			gamma ' fibrinogen levels are associated with blood clot strength in traumatic brain injury patients	AMERICAN JOURNAL OF SURGERY			English	Article						Fibrinogen; Coagulation; Hemostasis; Thrombelastography; Traumatic brain injury	FACTOR-V-LEIDEN; THROMBIN; RISK; GENES; THROMBOEMBOLISM; SENSITIVITY; INHIBITION; INCREASES; ETIOLOGY; BINDING	Background: gamma' fibrinogen is an alternatively-spliced fibrinogen variant that displays different coagulation parameters in vitro than the major form of fibrinogen. Purified gamma' fibrinogen has slower clotting kinetics than unfractionated fibrinogen, but forms clots that are stronger and resistant to fibrinolysis. However, these properties have only been investigated in human populations in a limited number of studies. We therefore performed a retrospective analysis to test the hypothesis that gamma' fibrinogen levels influence coagulation in vivo. Methods: In the present study, we utilized blood samples that were collected from traumatic brain injury patients to probe the relationship between gamma' fibrinogen levels and traditional coagulation parameters. Results: The results show that the levels of gamma' fibrinogen were inversely associated with clotting kinetics, indicated by a shortened INR. In addition, the levels of gamma' fibrinogen were associated with stronger clots by thrombelastography. However, these changes were not associated with significant changes in hemorrhage progression. Conclusions: These findings verify that gamma' fibrinogen properties observed in purified systems result in similar properties in a clinical setting, and may affect coagulation. (c) 2020 Elsevier Inc. All rights reserved.	[Farrell, David H.; Rick, Elizabeth A.; Dewey, Elizabeth N.; Schreiber, Martin A.] Oregon Hlth & Sci Univ, Div Trauma Crit Care & Acute Care Surg, Dept Surg, Portland, OR 97201 USA; [Rowell, Susan E.] Duke Univ, Dept Surg, Sch Med, Div Trauma Crit Care & Acute Care Surg, Durham, NC USA		Farrell, DH (corresponding author), Oregon Hlth & Sci Univ, Div Trauma Crit Care & Acute Care Surg, Dept Surg, Portland, OR 97201 USA.	farrelld@ohsu.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5K12HLK108974, UL1TR000128]	This work was supported by the National Institutes of Health [grant numbers 5K12HLK108974, UL1TR000128].	Alexander KS, 2011, THROMB HAEMOSTASIS, V105, P605, DOI 10.1160/TH10-09-0626; Allan P, 2012, J THROMB HAEMOST, V10, P1072, DOI 10.1111/j.1538-7836.2012.04717.x; Appiah D, 2015, ARTERIOSCL THROM VAS, V35, P2700, DOI 10.1161/ATVBAHA.115.306284; Cheung EYL, 2008, STROKE, V39, P1033, DOI 10.1161/STROKEAHA.107.495499; Cheung EYL, 2009, BLOOD, V114, P4603, DOI 10.1182/blood-2009-08-236240; Collet JP, 2004, ARTERIOSCL THROM VAS, V24, P382, DOI 10.1161/01.ATV.0000109748.77727.3e; de Willige SU, 2005, BLOOD, V106, P4176, DOI 10.1182/blood-2005-05-2180; Fair KA, 2021, J NEUROTRAUM, V38, P960, DOI 10.1089/neu.2018.6234; Falls LA, 1997, J BIOL CHEM, V272, P14251, DOI 10.1074/jbc.272.22.14251; Farrell DH, 2012, CLIN CHEM LAB MED, V50, P1903, DOI 10.1515/cclm-2012-0005; Folsom AR, 2016, THROMB RES, V139, P44, DOI 10.1016/j.thromres.2016.01.008; Fredenburgh JC, 2008, J BIOL CHEM, V283, P2470, DOI 10.1074/jbc.M707710200; Gersh KC, 2009, THROMB RES, V124, P356, DOI 10.1016/j.thromres.2008.11.016; Kattula S, 2017, ARTERIOSCL THROM VAS, V37, pE13, DOI 10.1161/ATVBAHA.117.308564; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kremers RMW, 2014, THROMB HAEMOSTASIS, V112, P486, DOI 10.1160/TH14-02-0172; Lancellotti S, 2008, J BIOL CHEM, V283, P30193, DOI 10.1074/jbc.M803659200; Lovely RS, 2008, THROMB HAEMOSTASIS, V100, P837, DOI 10.1160/TH08-03-0145; Lovely RS, 2007, BRIT J HAEMATOL, V139, P494, DOI 10.1111/j.1365-2141.2007.06825.x; Lovely RS, 2010, CLIN CHEM, V56, P781, DOI 10.1373/clinchem.2009.138347; Macrae FL, 2016, SEMIN THROMB HEMOST, V42, P344, DOI 10.1055/s-0036-1572353; Manco-Johnson MJ, 2009, J THROMB HAEMOST, V7, P2064, DOI 10.1111/j.1538-7836.2009.03633.x; Mannila MN, 2007, J THROMB HAEMOST, V5, P766, DOI 10.1111/j.1538-7836.2007.02406.x; Mosesson MW, 2009, J THROMB HAEMOST, V7, P102, DOI 10.1111/j.1538-7836.2008.03213.x; Mosesson MW, 2007, THROMB HAEMOSTASIS, V98, P105, DOI 10.1160/Th07-04-0274; Nowak-Gottl U, 2009, BLOOD, V114, P1947, DOI 10.1182/blood-2009-04-218727; Omarova F, 2013, J THROMB HAEMOST, V11, P1669, DOI 10.1111/jth.12354; Omarova F, 2014, BLOOD, V124, P1531, DOI 10.1182/blood-2014-02-554055; Petrera NS, 2009, J BIOL CHEM, V284, P25620, DOI 10.1074/jbc.M109.000042; Pieters M, 2013, BLOOD, V121, P3254, DOI 10.1182/blood-2012-12-471482; Rein-Smith CM, 2013, THROMB RES, V131, P89, DOI 10.1016/j.thromres.2012.09.017; Ridker PM, 2016, J AM COLL CARDIOL, V67, P712, DOI 10.1016/j.jacc.2015.11.037; SEEGERS WH, 1945, SCIENCE, V101, P520, DOI 10.1126/science.101.2629.520; Siebenlist KR, 2005, BLOOD, V106, P2730, DOI 10.1182/blood-2005-01-0240; Smalberg JH, 2013, THROMB HAEMOSTASIS, V109, P558, DOI 10.1160/TH12-08-0632; van den Herik EG, 2011, THROMB HAEMOSTASIS, V105, P430, DOI 10.1160/TH10-09-0569; Walton BL, 2014, J THROMB HAEMOST, V12, P680, DOI 10.1111/jth.12534; Yoshimura T, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00278	38	1	1	0	3	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	AUG	2020	220	2					459	463		10.1016/j.amjsurg.2019.12.028			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	MF8CC	WOS:000545564400043	31948701	Green Accepted			2022-02-06	
J	Forsse, A; Nielsen, TH; Molstrom, S; Hjelmborg, J; Nielsen, KS; Nygaard, KH; Yilmaz, S; Nordstrom, CH; Poulsen, FR				Forsse, Axel; Nielsen, Troels Halfeld; Molstrom, Simon; Hjelmborg, Jacob; Nielsen, Kasper Stokbro; Nygaard, Kevin Heboll; Yilmaz, Sibel; Nordstrom, Carl-Henrik; Poulsen, Frantz Rom			A Prospective Observational Feasibility Study of Jugular Bulb Microdialysis in Subarachnoid Hemorrhage	NEUROCRITICAL CARE			English	Article						Jugular bulb; Microdialysis; Cerebral metabolism; Multimodal monitoring; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; INTRACEREBRAL MICRODIALYSIS; LACTATE METABOLISM; ISCHEMIA; DIAGNOSIS; GLUTAMATE	Background Cerebral metabolic perturbations are common in aneurysmal subarachnoid hemorrhage (aSAH). Monitoring cerebral metabolism with intracerebral microdialysis (CMD) allows early detection of secondary injury and may guide decisions on neurocritical care interventions, affecting outcome. However, CMD is a regional measuring technique that is influenced by proximity to focal lesions. Continuous microdialysis of the cerebral venous drainage may provide information on global cerebral metabolism relevant for the care of aSAH patients. This observational study aimed to explore the feasibility of jugular bulb microdialysis (JBMD) in aSAH and describe the output characteristics in relation to conventional multimodal monitoring. Methods Patients with severe aSAH were included at admission or after in-house deterioration when local clinical guidelines prompted extended multimodal monitoring. Non-dominant frontal CMD, intracranial pressure (ICP), partial brain tissue oxygenation pressure (PbtO(2)), and cerebral perfusion pressure (CPP) were recorded every hour. The dominant jugular vein was accessed by retrograde insertion of a microdialysis catheter with the tip placed in the jugular bulb under ultrasound guidance. Glucose, lactate, pyruvate, lactate/pyruvate ratio, glycerol, and glutamate were studied for correlation to intracranial measurements. Modified Rankin scale was assessed at 6 months. Results Twelve adult aSAH patients were monitored during a mean 4.2 +/- 2.6 days yielding 22,041 data points for analysis. No complications related to JBMD were observed. Moderate or strong significant monotonic CMD-to-JBMD correlations were observed most often for glucose (7 patients), followed by lactate (5 patients), and pyruvate, glycerol, and glutamate (3 patients). Moderate correlation for lactate/pyruvate ratio was only seen in one patient. Analysis of critical periods defined by ICP > 20, CPP < 65, or PbtO(2) < 15 revealed a tendency toward stronger CMD-to-JBMD associations in patients with many or long critical periods. Possible time lags between CMD and JBMD measurements were only identified in 6 out of 60 patient variables. With the exception of pyruvate, a dichotomized outcome was associated with similar metabolite patterns in JBMD and CMD. A nonsignificant tendency toward greater differences between outcome groups was seen in JBMD. Conclusions Continuous microdialysis monitoring of the cerebral drainage in the jugular bulb is feasible and safe. JBMD-to-CMD correlation is influenced by the type of metabolite measured, with glucose and lactate displaying the strongest associations. JBMD lactate correlated more often than CMD lactate to CPP, implying utility for detection of global cerebral metabolic perturbations. Studies comparing JBMD to other global measures of cerebral metabolism, e.g., PET CT or Xenon CT, are warranted.	[Forsse, Axel; Nielsen, Troels Halfeld; Nygaard, Kevin Heboll; Yilmaz, Sibel; Nordstrom, Carl-Henrik; Poulsen, Frantz Rom] Odense Univ Hosp, Dept Neurosurg, Sonder Blvd 29, DK-5000 Odense, Denmark; [Forsse, Axel; Nielsen, Troels Halfeld; Nygaard, Kevin Heboll; Nordstrom, Carl-Henrik; Poulsen, Frantz Rom] Univ Southern Denmark, Dept Clin Res, BRIDGE Brain Res Inter Disciplinary Guided Excell, Odense, Denmark; [Molstrom, Simon] Odense Univ Hosp, Dept Anesthesiol & Intens Care, Odense, Denmark; [Hjelmborg, Jacob] Univ Southern Denmark, Dept Biostat & Epidemiol, Odense, Denmark; [Nielsen, Kasper Stokbro] Odense Univ Hosp, Dept Oral & Maxillofacial Surg, Odense, Denmark		Forsse, A (corresponding author), Odense Univ Hosp, Dept Neurosurg, Sonder Blvd 29, DK-5000 Odense, Denmark.	aforsse@health.sdu.dk		Forsse, Axel/0000-0002-0325-0262; Stokbro, Kasper/0000-0002-2754-7001; Molstrom, Simon/0000-0002-2778-8075; Hjelmborg, Jacob/0000-0001-9630-9149			Akoglu H, 2018, TURK J EMERG MED, V18, P91, DOI 10.1016/j.tjem.2018.08.001; Alten Jeffrey, 2005, Pediatr Crit Care Med, V6, P480, DOI 10.1097/01.PCC.0000162450.62812.AE; Arshi B, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/987934; Beards SC, 1998, ANAESTHESIA, V53, P627; Blixt C, 2013, CRIT CARE, V17, DOI 10.1186/cc12713; Carpenter KLH, 2017, CURR OPIN CRIT CARE, V23, P103, DOI 10.1097/MCC.0000000000000400; Carteron L, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00601; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cormio M, 2001, J NEUROSURG ANESTH, V13, P250, DOI 10.1097/00008506-200107000-00014; Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175; Enblad P, 1996, J CEREBR BLOOD F MET, V16, P637, DOI 10.1097/00004647-199607000-00014; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Forsse A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40245-x; Gouezel C, 2017, BRIT J ANAESTH, V119, P1110, DOI 10.1093/bja/aex338; Hawkins Richard A., 2016, Biology-Basel, V5, P37, DOI 10.3390/biology5040037; Helbok R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00565; Helbok R, 2010, NEUROCRIT CARE, V12, P317, DOI 10.1007/s12028-009-9327-4; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Jakobsen Rasmus, 2016, Intensive Care Med Exp, V4, P3, DOI 10.1186/s40635-016-0077-2; Jalloh I, 2018, J NEUROTRAUM, V35, P2025, DOI 10.1089/neu.2017.5459; Ibanez FAL, 2011, WORLD NEUROSURG, V75, P709, DOI 10.1016/j.wneu.2010.11.010; McGreevy DT, 2019, ANN VASC SURG, V58, P134, DOI 10.1016/j.avsg.2018.09.041; Moller Fanny, 2011, J Diabetes Sci Technol, V5, P1099; Molstrom S, 2017, J CARDIOTHOR VASC AN, V31, P1166, DOI 10.1053/j.jvca.2016.11.001; Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916; Newell D W, 1990, Neurosurg Clin N Am, V1, P319; Nielsen TH, 2014, NEUROCRIT CARE, V21, P35, DOI 10.1007/s12028-013-9875-5; Nordstrom CH, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00274; Perez Augusto, 2003, Pediatr Crit Care Med, V4, P33; Poca MA, 2007, J NEUROSURG, V106, P530, DOI 10.3171/jns.2007.106.4.530; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Rostami E, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00369; Rostami E, 2018, J NEUROSURG, V128, P1762, DOI 10.3171/2016.11.JNS161140; Rostami Elham, 2011, J Diabetes Sci Technol, V5, P596; Sahuquillo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102540; Sarrafzadeh AS, 2004, STROKE, V35, P638, DOI 10.1161/01.STR.0000116101.66624.F1; Smith QR, 2000, J NUTR, V130, p1016S, DOI 10.1093/jn/130.4.1016S; Taccone FS, 2020, J NEUROSURG ANESTH, V32, P170, DOI 10.1097/ANA.0000000000000584; Thelin EP, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00159; Tholance Y, 2015, NEUROL RES, V37, P578, DOI 10.1179/1743132815Y.0000000012; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740; Vajkoczy P, 2003, J NEUROSURG, V98, P1227, DOI 10.3171/jns.2003.98.6.1227; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Verbeeck RK, 2000, ADV DRUG DELIVER REV, V45, P217, DOI 10.1016/S0169-409X(00)00110-1; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073	49	1	1	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2020	33	1					241	255		10.1007/s12028-019-00888-0			15	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	MT1KH	WOS:000554726700026	31845174				2022-02-06	
J	Freeman, AD; McCracken, CE; Stockwell, JA				Freeman, Ashley D.; McCracken, Courtney E.; Stockwell, Jana A.			Automated Pupillary Measurements Inversely Correlate With Increased Intracranial Pressure in Pediatric Patients With Acute Brain Injury or Encephalopathy	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						acute brain injury; encephalopathy; neurologic examination; traumatic brain injury	QUANTITATIVE PUPILLOMETRY; CLINICAL UTILITY; NORMATIVE DATA	Objectives: The purpose of this study was to determine correlation and temporal association between automated pupillary measurements and intracranial pressure in pediatric patients with brain injury or encephalopathy requiring intracranial pressure monitoring. We hypothesized that abnormal pupillary measurements would precede increases in intracranial pressure. Design: A prospective cohort study was performed. Automated pupillometry measurements were obtained at the same frequency as the patients' neurologic assessments with concurrent measurement of intracranial pressure, for up to 72 hours. Pupillary measurements and the Neurologic Pupil index, an algorithmic score that combines measures of pupillary reactivity, were assessed for correlation with concurrent and future intracranial pressure measurements. Setting: Single-center pediatric quaternary ICU, from July 2017 to October 2018. Patients: Pediatric patients 18 years or younger with a diagnosis of acute brain injury or encephalopathy requiring an intracranial pressure monitor. Interventions: None. Measurements and Main Results: Twenty-eight patients were analyzed with a total of 1,171 intracranial pressure measurements. When intracranial pressure was elevated, the Neurologic Pupil index, percent change in pupillary size, constriction velocity, and dilation velocity were significantly lower than when intracranial pressure was within normal range (p< 0.001 for all). There were mild to moderate negative correlations between concurrent intracranial pressure and pupillary measurements. However, there was an inconsistent pattern of abnormal pupillary measurements preceding increases in intracranial pressure; some patients had a negative association, while others had a positive relationship or no relationship between Neurologic Pupil index and intracranial pressure. Conclusions: Our data indicate automated assessments of pupillary reactivity inversely correlate with intracranial pressure, demonstrating that pupillary reactivity decreases as intracranial pressure increases. However, a temporal association in which abnormal pupillary measurements precede increases in intracranial pressure was not consistently observed. This work contributes to limited data available regarding automated pupillometry in neurocritically ill patients, and the even more restricted subset available in pediatrics.	[Freeman, Ashley D.] Augusta Univ, Dept Pediat, Div Critical Care Med, Med Coll Georgia, Augusta, GA 30912 USA; [Freeman, Ashley D.; McCracken, Courtney E.; Stockwell, Jana A.] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Freeman, Ashley D.; McCracken, Courtney E.; Stockwell, Jana A.] Childrens Healthcare Atlanta, Dept Pediat, Div Critical Care Med, Egleston Campus, Atlanta, GA 30322 USA		Freeman, AD (corresponding author), Augusta Univ, Dept Pediat, Div Critical Care Med, Med Coll Georgia, Augusta, GA 30912 USA.; Freeman, AD (corresponding author), Emory Univ, Sch Med, Atlanta, GA 30322 USA.; Freeman, AD (corresponding author), Childrens Healthcare Atlanta, Dept Pediat, Div Critical Care Med, Egleston Campus, Atlanta, GA 30322 USA.	afreeman1@augusta.edu					Boev AN, 2005, J NEUROSURG, V103, P496, DOI 10.3171/ped.2005.103.6.0496; Bower MM, 2021, J INTENSIVE CARE MED, V36, P383, DOI 10.1177/0885066619881124; Centers for Disease Control and Prevention, 2018, C MAN TRAUM BRAIN IN; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Couret D, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1239-z; Dongsheng YDJ, 2012, UNIFIED APPROACH MEA; Gray AT, 1997, ARCH NEUROL-CHICAGO, V54, P579, DOI 10.1001/archneur.1997.00550170055014; Hamlett A, 2004, 29 SUGI SAS INT; Hou RH, 2007, PSYCHOPHARMACOLOGY, V195, P41, DOI 10.1007/s00213-007-0884-y; Jahns FP, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2436-3; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Kuo JR, 2011, J FORMOS MED ASSOC, V110, P258, DOI 10.1016/S0929-6646(11)60038-7; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; McNett M, 2017, J NEUROSCI NURS, V49, P229, DOI 10.1097/JNN.0000000000000290; Meeker Michele, 2005, J Neurosci Nurs, V37, P34; Olson DM, 2016, NEUROCRIT CARE, V24, P251, DOI 10.1007/s12028-015-0182-1; Park JG, 2015, J KOREAN NEUROSURG S, V58, P363, DOI 10.3340/jkns.2015.58.4.363; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205; Yan S, 2009, LIVER TRANSPLANT, V15, P1718, DOI 10.1002/lt.21924; Zafar SF, 2014, J CRIT CARE, V29, P599, DOI 10.1016/j.jcrc.2014.01.012	20	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	AUG	2020	21	8					753	759		10.1097/PCC.0000000000002327			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	NC7ZX	WOS:000561434200023	32195898				2022-02-06	
J	Howell, DR; Bonnette, S; Diekfuss, JA; Grooms, DR; Myer, GD; Meehan, WP				Howell, David R.; Bonnette, Scott; Diekfuss, Jed A.; Grooms, Dustin R.; Myer, Gregory D.; Meehan, William P.			Youth With Concussion Have Less Adaptable Gait Patterns Than Their Uninjured Peers: Implications for Concussion Management	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						human locomotion; inertial sensors; mild traumatic brain injury; nonlinear analysis; postural balance	DUAL-TASK GAIT; RECURRENCE QUANTIFICATION ANALYSIS; DYNAMIC STABILITY; ADOLESCENTS; VARIABILITY; ASSOCIATION; PERFORMANCE; ATTENTION; SINGLE; INJURY	OBJECTIVE: To compare cross-recurrence quantification analysis measurements obtained during gait between adolescents who sustained a diagnosed concussion within 14 days of assessment and healthy adolescents. DESIGN: Cross-sectional study. METHODS: Youth athletes with concussion (n = 43; mean SD age, 14.4 2.3 years; 56% female; tested median, 7 days post concussion) and healthy controls (n = 38; age, 14.9 +/- 2.0 years; 55% female) completed a single-task and dual task gait protocol while wearing a set of inertial sensors. We used cross-recurrence quantification analysis techniques to quantify the similarity between accelerations obtained from the sensor on the dorsum of each foot. Four outcome variables were compared between groups: percent determinism, average diagonal-line length, laminarity, and trapping time. RESULTS: Athletes with concussion had significantly higher percent determinism, laminarity, and trapping time than the control group in single-task and dual-task conditions (P<.05). Gait patterns, when simultaneously completing a secondary cognitive task (dual task), were no different from gait patterns under a single-task condition. CONCLUSION: Higher percent determinism, laminarity, and trapping time among athletes with concussion suggest that concussion may be associated with a more stuck and predictable gait pattern. These altered movement patterns may be one reason for underlying slower gait speeds that have been observed following concussion.	[Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, 13123 East 16th Ave,B060, Aurora, CO 80045 USA; [Howell, David R.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO USA; [Meehan, William P.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Bonnette, Scott; Diekfuss, Jed A.; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, SPORT Ctr, Cincinnati, OH 45229 USA; [Grooms, Dustin R.] Ohio Univ, Coll Hlth Sci & Profess, Sch Appl Hlth Sci & Wellness, Div Athlet Training, Athens, OH 45701 USA; [Meehan, William P.] Boston Childrens Hosp, Sports Med Div, Boston, MA USA; [Meehan, William P.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Meehan, William P.] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA 02115 USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Sports Med Ctr, 13123 East 16th Ave,B060, Aurora, CO 80045 USA.	David.Howell@CUAnschutz.edu	Myer, Gregory/H-6572-2016	Myer, Gregory/0000-0002-9983-8422	Cincinnati Children's Hospital Medical Center [4U01AI778109]; ElMindA Ltd [4U01AI778109]; Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03HD094560, R01NS100952, R43NS108823]; MINDSOURCE Brain Injury Network; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [U01AR067997, R01 AR070474, R01 AR056259-01]; Q30 Innovations, LLC; ElMindA Ltd; National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament; National Football League; National Institutes of Health/National Center for Complementary and Integrative Health [R21 AT009339-02]; Department of Defense Peer Reviewed Orthopaedic Research ProgramUnited States Department of Defense [OR170266]; Boston Children's Hospital	This study was funded by a research contract between Boston Children's Hospital, Cincinnati Children's Hospital Medical Center, and ElMindA Ltd (4U01AI778109). Dr. Howell has received research support from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R03HD094560), the National Institute of Neurological Disorders and Stroke (R01NS100952, R03HD094560, and R43NS108823), and the MINDSOURCE Brain Injury Network. Dr Myer has current and ongoing funding support from National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases grants U01AR067997, R01 AR070474, and R01 AR056259-01, and from industry-sponsored research funding related to brain injury prevention and assessment (Q30 Innovations, LLC and ElMindA Ltd). He also receives book royalties from Human Kinetics. Dr Meehan receives royalties from ABC-CLIO for the sale of his books Kids, Sports, and Concussion: A Guide for Coaches and Parents and Concussions, from Springer International for the book Head and Neck Injuries in Young Athletes, and from Wolters Kluwer for working as an author for UpToDate. His research is funded, in part, by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament and a grant from the National Football League. Dr Grooms has current and ongoing funding support from the National Institutes of Health/National Center for Complementary and Integrative Health (R21 AT009339-02) and the Department of Defense Peer Reviewed Orthopaedic Research Program (OR170266). The other authors certify that they have no affiliations with or financial involvement in any organization or entity with a direct financial interest in the subject matter or materials discussed in the article. Address correspondence to Dr David R. Howell (ORCID: 0000-0002-2955-0191), Sports Medicine Center, Children's Hospital Colorado, 13123 East 16th Avenue, B060, Aurora, CO 80045. E-mail:David.Howell@CUAnschutz.edut Copyright (c) 2020 Journal of Orthopaedic & Sports Physical Therapy	Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Bisi MC, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0159-0; Bonnette S, 2018, EXP BRAIN RES, V236, P2691, DOI 10.1007/s00221-018-5328-x; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Chiu SL, 2013, GAIT POSTURE, V38, P717, DOI 10.1016/j.gaitpost.2013.03.010; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Gao JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024446; Guskiewicz KM, 2011, PM&R, V3, pS445, DOI 10.1016/j.pmrj.2011.08.009; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Howell DR, 2018, J SCI MED SPORT, V21, P358, DOI 10.1016/j.jsams.2017.08.004; Howell DR, 2017, J NEUROTRAUM, V34, P3288, DOI 10.1089/neu.2017.5191; Howell DR, 2016, GAIT POSTURE, V49, P176, DOI 10.1016/j.gaitpost.2016.07.008; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Hunt N, 2014, SCI REP-UK, V4, DOI 10.1038/srep05879; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Labini FS, 2012, GAIT POSTURE, V35, P48, DOI 10.1016/j.gaitpost.2011.08.004; Leitner Y, 2007, J NEUROL, V254, P1330, DOI 10.1007/s00415-006-0522-3; Marmelat V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091949; Marwan N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026702; Marwan N, 2002, PHYS LETT A, V302, P299, DOI 10.1016/S0375-9601(02)01170-2; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Powers KC, 2014, GAIT POSTURE, V39, P728, DOI 10.1016/j.gaitpost.2013.10.005; Quatman-Yates CC, 2015, PEDIATR PHYS THER, V27, P316, DOI 10.1097/PEP.0000000000000193; Rhea CK, 2014, HUM MOVEMENT SCI, V36, P20, DOI 10.1016/j.humov.2014.04.006; Rhea CK, 2014, GAIT BIOMETRICS BASI; Riva F, 2014, COMPUT BIOL MED, V50, P9, DOI 10.1016/j.compbiomed.2014.04.001; Rizzi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31129; Romano MC, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036211; Roulston MS, 1999, PHYSICA D, V125, P285, DOI 10.1016/S0167-2789(98)00269-3; Shockley K, 2002, PHYS LETT A, V305, P59, DOI 10.1016/S0375-9601(02)01411-1; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; Zbilut JP, 1998, PROTEIN ENG, V11, P87, DOI 10.1093/protein/11.2.87	46	1	1	1	2	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	AUG	2020	50	8					438	446		10.2519/jospt.2020.9133			9	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation; Sport Sciences	OX3CV	WOS:000593447900005	32441192	Bronze			2022-02-06	
J	Ide, K; Uematsu, S; Hayano, S; Hagiwara, Y; Tetsuhara, K; Ito, T; Nakazawa, T; Sekine, I; Mikami, M; Kobayashi, T				Ide, Kentaro; Uematsu, Satoko; Hayano, Shunsuke; Hagiwara, Yusuke; Tetsuhara, Kenichi; Ito, Tomoya; Nakazawa, Taichi; Sekine, Ichiro; Mikami, Masashi; Kobayashi, Tohru			Validation of the PECARN head trauma prediction rules in Japan: A multicenter prospective study	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	46th Annual Meeting of the Japanese-Association-for-Acute-Medicine	NOV 19-21, 2018	Yokohama, JAPAN	Japanese Assoc Acute Med		Minor head trauma; Traumatic brain injuries; Computed tomography; Prediction rules; Decision support techniques	CLINICAL DECISION RULE; COMPUTED-TOMOGRAPHY; EXTERNAL VALIDATION; RADIATION-EXPOSURE; CT SCANS; CHILDREN; INJURY	Background: Head trauma in children is one of the most common causes for emergency department visits. Although most trauma cases are minor, identifying those patients who have clinically important traumatic brain injury (ciTBI) is challenging. The Pediatric Emergency Care Applied Research Network (PECARN) head trauma prediction rules identifying children who do not require cranial computed tomography (CT) were validated and are used all over the world. However, these rules have not been validated with large cohort multicenter studies in Asia. Objectives: To investigate whether the PECARN rules can be safely applied to Japanese children. Methods: We conducted a multicenter, prospective, observational cohort study. We included children younger than 16 with minor head trauma (Glasgow Coma Scale >= 14) who presented to the six participating centers within 24 h of their injuries between June 2016 and September 2017. The primary analysis was set to calculate the negative predictive value of the patients with very low risk by the PECARN rules, compared with a preset threshold of 99.85%. Results: We included 6585 children of which 463 (7.0%) had head CT scans performed and 23 (0.35%) had ciTBI. There were two patients with ciTBI who were classified as very low risk. The negative predictive value, calculated as 99.96% (95%CI: 99.86-100.00; P=.019), was significantly superior compared with the preset threshold of 99.85%. Conclusions: The PECARN head trauma prediction rules seemed to be safely applicable to Japanese children. Further studies are needed to determine safety in hospitals where physicians do not have expertise in managing children. (c) 2019 Elsevier Inc. All rights reserved.	[Ide, Kentaro] Natl Ctr Child Hlth & Dev, Crit Care Med, Tokyo, Japan; [Uematsu, Satoko; Tetsuhara, Kenichi] Natl Ctr Child Hlth & Dev, Div Pediat Emergency & Transport Serv, Tokyo, Japan; [Hayano, Shunsuke] Kitakyushu Municipal Yahata Hosp, Kitakyushu, Fukuoka, Japan; [Hagiwara, Yusuke] Tokyo Metropolitan Childrens Med Ctr, Dept Pediat Emergency & Crit Care Med, Tokyo, Japan; [Ito, Tomoya] Aichi Childrens Hlth & Med Ctr, Dept Pediat Emergency Med, Obu, Aichi, Japan; [Nakazawa, Taichi] Tokyo Bay Urayasu Ichikawa Iryo Ctr, Dept Emergency & Crit Care Med, Urayasu, Japan; [Sekine, Ichiro] Shonan Kamakura Gen Hosp, Emergency Dept, Kamakura, Kanagawa, Japan; [Mikami, Masashi] Natl Ctr Child Hlth & Dev, Div Biostat, Clin Res Ctr, Setagaya Ku, Tokyo, Japan; [Kobayashi, Tohru] Natl Ctr Child Hlth & Dev, Div Biostat, Clin Res Ctr, Tokyo, Japan		Ide, K (corresponding author), Natl Ctr Child Hlth & Dev, Crit Care Med, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	ide-k@ncchd.go.jp; uematsu-s@ncchd.go.jp; yusukehagiwara-tky@umin.ac.jp; tetsuhara-k@ncchd.go.jp; mikami-ms@ncchd.go.jp; kobayashi-tr@ncchd.go.jp	Ito, Tomoya/AAR-5364-2021; Hagiwara, Yusuke/L-1886-2019; Tetsuhara, Kenichi/AAD-2776-2019; Hagiwara, Yusuke/AAQ-4748-2021	Tetsuhara, Kenichi/0000-0001-6473-0326; Hagiwara, Yusuke/0000-0002-9677-6000	Foundation for Growth Science [26-44]; MEXT KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP16K11436]	The authors would like to thank physicians, nurses, and medical assistants in the participating centers for logistic support with patient recruitment and follow-up. This work was supported by the Foundation for Growth Science (26-44) and MEXT KAKENHI JP16K11436.	Babl FE, 2018, ANN EMERG MED, V71, P703, DOI 10.1016/j.annemergmed.2018.01.015; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Easter JS, 2014, ANN EMERG MED, V10, P92; Freund Y, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-016-0346-9; Hagiwara Y, 2018, PEDIATR EMERG CARE, DOI 10.1097; Ide K, 2017, ACAD EMERG MED, V24, P308, DOI 10.1111/acem.13129; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lorton F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0287-3; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Ono K, 2011, HEALTH PHYS, V100, P491, DOI 10.1097/HP.0b013e3181f497ef; Ozaki M, 2010, JPN J NEUROSURG TOKY, V19, P474; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Schonfeld D, 2013, ANN EMERG MED, V62, P597, DOI 10.1016/j.annemergmed.2013.06.020; Thiam DW, 2015, ANN ACAD MED SINGAP, V44, P335	17	1	1	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	AUG	2020	38	8					1599	1603		10.1016/j.ajem.2019.158439			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	MR0XM	WOS:000553316500011	31522928				2022-02-06	
J	Lee, SH; Yun, SJ				Lee, Sun Hwa; Yun, Seong Jong			Optic nerve sheath diameter on facial CT: a tool to predict traumatic brain injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Facial injury; Traumatic brain injury; Optic nerve sheath diameter; Computed tomography; Emergency medicine	COMPUTED-TOMOGRAPHY; INTRACRANIAL INJURY; HEAD-INJURY; FRACTURES; DIAGNOSIS	Purpose To evaluate and compare the optic nerve sheath diameters (ONSDs) of facial trauma patients as observed on facial CT and brain CT, and to evaluate the predictive performance of ONSD as seen on facial CT for traumatic brain injury (TBI). Methods We retrospectively enrolled 262 patients with facial trauma who underwent both facial CT and brain CT. Two reviewers independently measured ONSD at 3 mm (ONSD3) and 10 mm behind the globe (ONSD10) for each patient on both CT scans. Final CT reports with clinical progress notes were used as the reference standard. Statistically, multivariate logistic regression analysis, receiver operating characteristic (ROC) curves, and intraclass correlation coefficients (ICCs) were used. Results Eighty-seven (33.2%) patients were diagnosed with facial fracture, and 21 (8.0%) were diagnosed with intracranial haemorrhage. Neither reviewer observed significant differences (p = 0.15-0.61) between facial CT and brain CT when comparing ONSD3 and ONSD10. ONSD3 on facial CT was a significantly independent factor for distinguishing TBI from negative brain CT scan (p = 0.001); as ONSD3 increased, the risk of TBI increased 8.1-fold. ONSD3 >= 4.13 mm exhibited the highest area under the ROC curve (AUC) for predicting TBI (AUC, 0.968; sensitivity, 90.5%; specificity, 98.8%). There were good or excellent interobserver agreements for all measurements (ICC, 0.750-0.875). Conclusion ONSD3 as determined by facial CT is a feasible predictive marker of TBI in facial trauma patients. It can assist emergency physicians in deciding whether immediate further brain imaging is warranted.	[Lee, Sun Hwa] Inje Univ, Sanggye Paik Hosp, Dept Emergency Med, Coll Med, 1342 Dongil Ro, Seoul 01757, South Korea; [Yun, Seong Jong] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Dept Radiol, Sch Med, 892 Dongnam Ro, Seoul 05278, South Korea		Yun, SJ (corresponding author), Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Dept Radiol, Sch Med, 892 Dongnam Ro, Seoul 05278, South Korea.	zoomknight@naver.com		lee, sunhwa/0000-0002-3491-6223			[Anonymous], 2009, 160 BETH NAT COUNC R; Bauerle J, 2012, J NEUROIMAGING, V22, P42, DOI 10.1111/j.1552-6569.2010.00546.x; Ballantyne S A, 2002, Eur J Ultrasound, V15, P145, DOI 10.1016/S0929-8266(02)00036-8; Bekerman I, 2016, J NEUROL SCI, V368, P285, DOI 10.1016/j.jns.2016.07.023; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; Das SK, 2017, POL J RADIOL, V82, P240, DOI 10.12659/PJR.900196; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hansen HC, 1996, SURG RADIOL ANAT, V18, P323, DOI 10.1007/BF01627611; Helmke K, 1996, PEDIATR RADIOL, V26, P701, DOI 10.1007/BF01383383; Holmgren EP, 2004, J ORAL MAXIL SURG, V62, P913, DOI 10.1016/j.joms.2003.12.026; Huang LK, 2017, INJURY, V48, P1417, DOI 10.1016/j.injury.2017.04.046; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Kraus JF, 2003, ANN EMERG MED, V41, P18, DOI 10.1067/mem.2003.1; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lee HJ, 2018, INJURY, V49, P963, DOI 10.1016/j.injury.2018.02.025; Lee SH, 2017, J PEDIATR-US, V184, P32, DOI 10.1016/j.jpeds.2017.01.036; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Lim D, 2014, AM J EMERG MED, V32, P1051, DOI 10.1016/j.ajem.2014.06.020; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Puljula J, 2012, INJURY, V43, P2100, DOI 10.1016/j.injury.2012.04.010; Rajandram RK, 2014, DENT TRAUMATOL, V30, P128, DOI 10.1111/edt.12052; Ryu J, 2020, PEDIATR EMERG CARE, V36, P125, DOI 10.1097/PEC.0000000000001397; Soldatos T, 2008, CRIT CARE, V12, DOI 10.1186/cc6897; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Tan DW, 2018, SINGAP MED J, V59, P199, DOI 10.11622/smedj.2017046; Zandi M, 2013, ORAL MAXILLOFAC SURG, V17, P201, DOI 10.1007/s10006-012-0368-z	31	1	1	0	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	AUG	2020	46	4					879	885		10.1007/s00068-018-1035-3			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	NA4ON	WOS:000559797500026	30324239				2022-02-06	
J	Mack, C; Sendor, RR; Solomon, G; Ellenbogen, RG; Myers, E; Berger, M; Sills, A				Mack, Christina; Sendor, Rachel R.; Solomon, Gary; Ellenbogen, Richard G.; Myers, Emily; Berger, Mitchel; Sills, Allen			Enhancing Concussion Management in the National Football League: Evolution and Initial Results of the Unaffiliated Neurotrauma Consultants Program, 2012-2017	NEUROSURGERY			English	Article						Concussion; Sports; NFL; Neurotrauma; Football; Health and safety programs; Traumatic brain injury; Sports safety program	VIDEO ANALYSIS; RELIABILITY; VALIDITY	BACKGROUND: The real-time detection of concussive injury in professional sports can be challenging for the healthcare provider on the sideline. It can be difficult to monitor all onfield players during active game play and diagnose complex injuries such as concussion during a fast-paced athletic event. OBJECTIVE: To enhance the in-game identification of potentially concussed professional athletes, the National Football League (NFL) initiated an Unaffiliated Neurotrauma Consultants (UNC) program in 2013, which, in tandem with other in-arena spotters and live video review systems, is designed to improve the safety of the players through enhanced concussion detection efforts. METHODS: This paper reports on the evolution of the UNC program, describes its participants and training requirements, details the role of UNC involvement, and delineates the systematic revisions and enhancements completed each year in the program. RESULTS: UNC reporting compliance has increased from 56% in 2014 to 100% in 2017. During the 2016 and 2017 seasons, (1) UNCs submitted an average of 1.9 evaluations per game, and (2) the UNC concussion assessments yielded sensitivity (93.4%-97.4%) and specificity (81.0%-88.3%) values. CONCLUSION: The UNC program has enhanced the detection of concussion in NFL players. Directions for research and future program improvements are addressed.	[Mack, Christina; Sendor, Rachel R.] IQVIA, Durham, NC USA; [Solomon, Gary; Sills, Allen] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA; [Ellenbogen, Richard G.] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA; [Solomon, Gary; Myers, Emily; Sills, Allen] Natl Football League, New York, NY USA; [Berger, Mitchel] Univ Calif San Francisco, Sch Med, Dept Neurol Surg, San Francisco, CA USA		Solomon, G (corresponding author), Dept Neurol Surg, 1500 21st Ave South,Suite 1506, Nashville, TN 37212 USA.	garysolomon17a@gmail.com					Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Ellenbogen RG, 2018, BRIT J SPORT MED, V52, P894, DOI 10.1136/bjsports-2018-099203; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0097-9; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Mack C, 2019, J ATHL TRAINING, V54, P852, DOI 10.4085/1062-6050-181-19; Makdissi M, 2018, BRIT J SPORT MED, V52, P903, DOI 10.1136/bjsports-2018-099402; Makdissi M, 2016, J SCI MED SPORT, V19, P958, DOI 10.1016/j.jsams.2016.02.014; Makdissi M, 2016, J SCI MED SPORT, V19, P859, DOI 10.1016/j.jsams.2016.02.015; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102	15	1	1	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	AUG	2020	87	2					312	319		10.1093/neuros/nyz481			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OW8HL	WOS:000593120500089	31792503				2022-02-06	
J	Moran, RN; Broglio, SP; Francioni, KK; Sosnoff, JJ				Moran, Ryan N.; Broglio, Steven P.; Francioni, Karla K.; Sosnoff, Jacob J.			Exploring Baseline Concussion-Assessment Performance in Adapted Wheelchair Sport Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						disability; balance; baseline testing; traumatic brain injuries	PARTICIPATION; EPIDEMIOLOGY; DISABILITY	Context: With growing awareness of and advocacy for including individuals with disabilities in sport, implementation of concussion-assessment and -management strategies is warranted. Limited research is available on concussion assessment in adapted wheelchair sport athletes. Objective: To examine baseline symptom reporting, computerized neurocognitive testing, and a modified balance scoring system in adapted athletes. A secondary objective was to provide preliminary normative data for this population. Design: Cross-sectional study. Setting: University athletic training room and computer laboratory. Patients or Other Participants: Twenty-one athletes (age = 22.1 +/- 3.0 years) from 1 institution's collegiate adapted athletics program. Main Outcome Measure(s): Athletes completed baseline Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) and the Wheelchair Error Scoring System (WESS) before the start of their respective seasons. Symptom reporting variables consisted of total symptoms, symptom severity scores, and baseline symptom factors (eg, vestibular-somatic, sleep arousal, cognitive-sensory, and affective). We analyzed ImPACT composite scores of verbal memory, visual memory, visual motor processing speed, and reaction time and impulse control to determine neurocognitive function. Balance performance was quantified using the WESS condition and overall errors. Results: Compared with normative reference values, 17 (81%) of adapted athletes reported greater symptoms and 20 (95%) performed at or below average on at least 1 neurocognitive composite score. Mean errors on the WESS were 3.14 +/- 2.9, with 81% committing >1 error. Sex differences were not present for symptoms, neurocognitive testing, or balance measures. Conclusions: Our findings provide context for baseline performance in adapted athletes and help to further develop the WESS as an assessment of balance in these athletes.	[Moran, Ryan N.] Univ Alabama, Athlet Training Res Lab, 478 Capital Hall,Box 870325, Tuscaloosa, AL 35487 USA; [Broglio, Steven P.] Univ Michigan, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA; [Francioni, Karla K.] Georgetown Coll, Georgetown, KY USA; [Sosnoff, Jacob J.] Univ Illinois, Motor Control Res Lab, Urbana, IL USA		Moran, RN (corresponding author), Univ Alabama, Athlet Training Res Lab, 478 Capital Hall,Box 870325, Tuscaloosa, AL 35487 USA.	rnmoran@ua.edu					Abou Libak, 2020, J Spinal Cord Med, V43, P846, DOI 10.1080/10790268.2019.1605749; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Blauwet C, 2012, PM&R, V4, P851, DOI 10.1016/j.pmrj.2012.08.015; Crossman MW, 1996, SPINAL CORD, V34, P573, DOI 10.1038/sc.1996.102; Dawson N, 2018, HEALTH SCI REP-US, V1, DOI 10.1002/hsr2.98; Di Russo F, 2010, J NEUROTRAUM, V27, P2309, DOI 10.1089/neu.2010.1501; Hollander K, 2020, SCAND J MED SCI SPOR, V30, P199, DOI 10.1111/sms.13558; Karl A, 2004, PAIN, V110, P40, DOI 10.1016/j.pain.2004.03.003; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; Khoo SL, 2018, PERCEPT MOTOR SKILL, V125, P525, DOI 10.1177/0031512518760350; Kim DH, 2018, TECHNOL HEALTH CARE, V26, P761, DOI 10.3233/THC-181301; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kroshus E, 2019, BRIT J SPORT MED, V53, P731, DOI 10.1136/bjsports-2019-100590; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moran RN, 2020, BRAIN INJURY, V34, P20, DOI 10.1080/02699052.2019.1669824; Ozinga SJ, 2018, J ATHL TRAINING, V53, P636, DOI 10.4085/1062-6050-129-17; Ozunlu N, 2012, TURK J PHYSIOTHER R, V23, P44; Patel DR, 2010, PEDIATR CLIN N AM, V57, P795, DOI 10.1016/j.pcl.2010.03.002; Plinta R., 2005, J HUM KINET, V14, P41; Rice LA, 2015, DISABIL REHABIL, V37, P1697, DOI 10.3109/09638288.2014.976718; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Shapiro DR, 2014, J SPORT MANAGE, V28, P657, DOI 10.1123/JSM.2013-0258; Webborn N, 2018, BRIT J SPORT MED, V52, P1157, DOI 10.1136/bjsports-2016-097236; Webborn N, 2014, PM&R, V6, pS18, DOI 10.1016/j.pmrj.2014.06.003; Weiler R, 2018, CLIN J SPORT MED, V28, P43, DOI 10.1097/JSM.0000000000000407; Wessels KK, 2012, ARCH PHYS MED REHAB, V93, P275, DOI 10.1016/j.apmr.2011.09.009; Wessels KK, 2013, THESIS; Willick SE, 2013, BRIT J SPORT MED, V47, P426, DOI 10.1136/bjsports-2013-092374; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265	29	1	1	0	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	AUG	2020	55	8					856	862		10.4085/1062-6050-294-19			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	NK5CJ	WOS:000566748600011	32607535	gold, Green Published			2022-02-06	
J	Nakae, R; Fujiki, Y; Takayama, Y; Kanaya, T; Igarashi, Y; Suzuki, G; Naoe, Y; Yokobori, S				Nakae, Ryuta; Fujiki, Yu; Takayama, Yasuhiro; Kanaya, Takahiro; Igarashi, Yutaka; Suzuki, Go; Naoe, Yasutaka; Yokobori, Shoji			Age-Related Differences in the Time Course of Coagulation and Fibrinolytic Parameters in Patients with Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						brain injuries; traumatic; aged; middle aged; blood coagulation disorders; fibrinogen; fibrin fibrinogen degradation products	SEVERE HEAD-INJURY; CEREBRAL ENDOTHELIAL INJURY; HEMORRHAGIC PROGRESSION; SERUM THROMBOMODULIN; PLASMA-FIBRINOGEN; TISSUE FACTOR; BODY-WEIGHT; D-DIMERS; COAGULOPATHY; TRANSFUSION	Coagulopathy and older age are common and well-recognized risk factors for poorer outcomes in traumatic brain injury (TBI) patients; however, the relationships between coagulopathy and age remain unclear. We hypothesized that coagulation/fibrinolytic abnormalities are more pronounced in older patients and may be a factor in poorer outcomes. We retrospectively evaluated severe TBI cases in which fibrinogen and D-dimer were measured on arrival and 3-6 h after injury. Propensity score-matched analyses were performed to adjust baseline characteristics between older patients (the "elderly group," aged >= 75 y) and younger patients (the "non-elderly group," aged 16-74 y). A total of 1294 cases (elderly group: 395, non-elderly group: 899) were assessed, and propensity score matching created a matched cohort of 324 pairs. Fibrinogen on admission, the degree of reduction in fibrinogen between admission and 3-6 h post-injury, and D-dimer levels between admission and 3-6 h post-injury were significantly more abnormal in the elderly group than in the non-elderly group. On multivariate logistic regression analysis, independent risk factors for poor prognosis included low fibrinogen and high D-dimer levels on admission. Posttraumatic coagulation and fibrinolytic abnormalities are more severe in older patients, and fibrinogen and D-dimer abnormalities are negative predictive factors.	[Nakae, Ryuta; Takayama, Yasuhiro; Kanaya, Takahiro; Igarashi, Yutaka; Yokobori, Shoji] Nippon Med Sch, Dept Emergency & Crit Care Med, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan; [Fujiki, Yu; Suzuki, Go; Naoe, Yasutaka] Kawaguchi Municipal Med Ctr, Emergency & Crit Care Ctr, 180 Nishiaraijuku, Kawaguchi, Saitama 3330833, Japan		Nakae, R (corresponding author), Nippon Med Sch, Dept Emergency & Crit Care Med, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	nakae@nms.ac.jp; siam1999@nms.ac.jp; ccm2199@yahoo.co.jp; t-kanaya@nms.ac.jp; igarashiy@nms.ac.jp; g.suzuki417@gmail.com; ynaoe1120@mac.com; shoji@nms.ac.jp		Nakae, Ryuta/0000-0003-1820-2463; Naoe, Yasutaka/0000-0002-9170-0605	JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [19K18367]	This study was supported in part by JSPS KAKENHI Grant Number 19K18367.	Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Association for the Advancement of Automotive Medicine, 1998, ABBR INJ SCAL AIS; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BALLEISEN L, 1985, THROMB HAEMOSTASIS, V54, P475; CADROY Y, 1992, NOUV REV FR HEMATOL, V34, P43; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Chen H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/685174; EDDLESTON M, 1993, J CLIN INVEST, V92, P349, DOI 10.1172/JCI116573; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Gando S, 1999, J TRAUMA, V46, P1070, DOI 10.1097/00005373-199906000-00018; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Guidelines Committee on the Management of Severe Head Injury Japan Society of Neurotraumatology, 2013, GUID MAN SEV HEAD IN, V3rd; HAGER K, 1994, AGING-CLIN EXP RES, V6, P133, DOI 10.1007/BF03324226; HAGER K, 1995, GERONTOLOGY, V41, P159; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hoffman M, 2009, STROKE, V40, P2882, DOI 10.1161/STROKEAHA.109.555433; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Katz MH, 2003, ANN INTERN MED, V138, P644, DOI 10.7326/0003-4819-138-8-200304150-00012; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; Ko GTC, 1997, ATHEROSCLEROSIS, V131, P211, DOI 10.1016/S0021-9150(97)06109-1; KROBOT K, 1992, ARTERIOSCLER THROMB, V12, P780, DOI 10.1161/01.ATV.12.7.780; Kucuk U, 2016, INTERACT CARDIOV TH, V22, P258, DOI 10.1093/icvts/ivv403; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Kushimoto S, 2001, NEUROSURGERY, V49, P1084, DOI 10.1097/00006123-200111000-00011; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; MARI D, 1995, BLOOD, V85, P3144, DOI 10.1182/blood.V85.11.3144.bloodjournal85113144; Meredith JW, 2002, J TRAUMA, V53, P621, DOI 10.1097/00005373-200210000-00001; Nakae R, 2019, ACTA NEUROCHIR, V161, P1943, DOI 10.1007/s00701-019-04010-3; Nakae Ryuta, 2017, Surg Neurol Int, V8, P214, DOI 10.4103/sni.sni_56_17; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Ouchi Y, 2017, GERIATR GERONTOL INT, V17, P1045, DOI 10.1111/ggi.13118; Pahatouridis D, 2010, BRAIN INJURY, V24, P1189, DOI 10.3109/02699052.2010.490510; Pieper CF, 2000, J GERONTOL A-BIOL, V55, pM649, DOI 10.1093/gerona/55.11.M649; Shigemori M, 2012, NEUROL MED-CHIR, V52, P1; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Stephenson SCR, 2002, J TRAUMA, V53, P326, DOI 10.1097/00005373-200208000-00023; Teraz-Orosz A, 2019, J IMMUNOL METHODS, V471, P27, DOI 10.1016/j.jim.2019.05.004; Tita-Nwa F, 2010, AGING CLIN EXP RES, V22, P20, DOI 10.1007/BF03324810; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wilkerson WR, 2002, SEMIN THROMB HEMOST, V28, P555, DOI 10.1055/s-2002-36700; Yokota H, 2002, J NEUROTRAUM, V19, P1007, DOI 10.1089/089771502760341929; Yokota H, 2007, NEUROL MED-CHIR, V47, P383, DOI 10.2176/nmc.47.383; Zhang LM, 2017, WORLD NEUROSURG, V104, P381, DOI 10.1016/j.wneu.2017.04.140	49	1	2	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	AUG	2020	21	16							5613	10.3390/ijms21165613			13	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	NI2LC	WOS:000565186000001	32764459	Green Published, gold			2022-02-06	
J	Peran, P; Malagurski, B; Nemmi, F; Sarton, B; Vinour, H; Ferre, F; Bounes, F; Rousset, D; Mrozeck, S; Seguin, T; Riu, B; Minville, V; Geeraerts, T; Lotterie, JA; Deboissezon, X; Albucher, JF; Fourcade, O; Olivot, JM; Naccache, L; Silva, S				Peran, Patrice; Malagurski, Briguitta; Nemmi, Federico; Sarton, Benjamine; Vinour, Helene; Ferre, Fabrice; Bounes, Fanny; Rousset, David; Mrozeck, Segolene; Seguin, Thierry; Riu, Beatrice; Minville, Vincent; Geeraerts, Thomas; Lotterie, Jean Albert; Deboissezon, Xavier; Albucher, Jean Francois; Fourcade, Olivier; Olivot, Jean Marc; Naccache, Lionel; Silva, Stein			Functional and Structural Integrity of Frontoparietal Connectivity in Traumatic and Anoxic Coma	CRITICAL CARE MEDICINE			English	Article						brain anoxia; brain trauma; coma; functional magnetic resonance imaging; prognosis	DEFAULT MODE NETWORK; BRAIN-INJURY; CONSCIOUSNESS; DISORDERS; RECOVERY; SCALE; STATE; CARE; MRI	Objectives: Recovery from coma might critically depend on the structural and functional integrity of frontoparietal networks. We aimed to measure this integrity in traumatic brain injury and anoxo-ischemic (cardiac arrest) coma patients by using an original multimodal MRI protocol. Design: Prospective cohort study. Setting: Three Intensive Critical Care Units affiliated to the University in Toulouse (France). Patients: We longitudinally recruited 43 coma patients (Glasgow Coma Scale at the admission < 8; 29 cardiac arrest and 14 traumatic brain injury) and 34 age-matched healthy volunteers. Exclusion criteria were disorders of consciousness lasting more than 30 days and focal brain damage within the explored brain regions. Patient assessments were conducted at least 2 days (5 +/- 2 d) after complete withdrawal of sedation. All patients were followed up (Coma Recovery Scale-Revised) 3 months after acute brain injury. Interventions: None. Measurements and Main Results: Functional and structural MRI data were recorded, and the analysis was targeted on the posteromedial cortex, the medial prefrontal cortex, and the cingulum. Univariate analyses and machine learning techniques were used to assess diagnostic and predictive values. Coma patients displayed significantly lower medial prefrontal cortex-posteromedial cortex functional connectivity (area under the curve, 0.94; 95% CI, 0.93-0.95). Cardiac arrest patients showed specific structural disturbances within posteromedial cortex. Significant cingulum architectural disturbances were observed in traumatic brain injury patients. The machine learning medial prefrontal cortex-posteromedial cortex multimodal classifier had a significant predictive value (area under the curve, 0.96; 95% CI, 0.95-0.97), best combination of subregions that discriminates a binary outcome based on Coma Recovery Scale-Revised). Conclusions: This exploratory study suggests that frontoparietal functional disconnections are specifically observed in coma and their structural counterpart provides information about brain injury mechanisms. Multimodal MRI biomarkers of frontoparietal disconnection predict 3-month outcome in our sample. These findings suggest that fronto-parietal disconnection might be particularly relevant for coma outcome prediction and could inspire innovative precision medicine approaches.	[Peran, Patrice; Malagurski, Briguitta; Nemmi, Federico; Sarton, Benjamine; Ferre, Fabrice; Lotterie, Jean Albert; Deboissezon, Xavier; Albucher, Jean Francois; Olivot, Jean Marc; Silva, Stein] Toulouse Univ, Toulouse NeuroImaging Ctr, INSERM, UPS, Toulouse, France; [Sarton, Benjamine; Vinour, Helene; Ferre, Fabrice; Riu, Beatrice; Silva, Stein] Univ Teaching Hosp Purpan, Crit Care Unit, Pl Dr Baylac, Toulouse, France; [Bounes, Fanny; Seguin, Thierry] Univ Teaching Hosp Rangueil, Crit Care Unit, Ave Pr Jean Poulhes, Toulouse, France; [Rousset, David; Mrozeck, Segolene; Geeraerts, Thomas; Fourcade, Olivier] Univ Teaching Hosp Purpan, Neurocrit Care Unit, Pl Dr Baylac, Toulouse, France; [Minville, Vincent] Univ Teaching Hosp Purpan, Anesthesiol Dept, Pl Dr Baylac, Toulouse, France; [Deboissezon, Xavier] Univ Teaching Hosp Purpan, Phys Med & Rehabil Dept, Pl Dr Baylac, Toulouse, France; [Albucher, Jean Francois; Olivot, Jean Marc] Univ Teaching Hosp Purpan, Neurol Dept, Pl Dr Baylac, Toulouse, France; [Naccache, Lionel] Inst Cerveau & Moelle Epiniere, PICNIC Lab, ICM, Paris, France		Silva, S (corresponding author), Toulouse Univ, Toulouse NeuroImaging Ctr, INSERM, UPS, Toulouse, France.; Silva, S (corresponding author), Univ Teaching Hosp Purpan, Crit Care Unit, Pl Dr Baylac, Toulouse, France.	silvastein@me.com	Bounes, Fanny/ABG-6128-2021; Minville, Vincent/ABE-4286-2020; Peran, Patrice/N-7561-2015	Minville, Vincent/0000-0003-0516-4939; Peran, Patrice/0000-0001-7200-0139; Malagurski, Brigitta/0000-0002-7510-5187	Association des Traumatises du Crane et de la Face; University Hospital of Toulouse; Institut des Sciences du Cerveau de Toulouse	This work was supported by the "Association des Traumatises du Crane et de la Face", "Institut des Sciences du Cerveau de Toulouse," and grant from University Hospital of Toulouse.	Achard S, 2012, P NATL ACAD SCI USA, V109, P20608, DOI 10.1073/pnas.1208933109; Amico E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100012; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Di Perri C, 2016, LANCET NEUROL, V15, P830, DOI 10.1016/S1474-4422(16)00111-3; Di Perri C, 2013, NEUROLOGY, V81, P1417, DOI 10.1212/WNL.0b013e3182a43b78; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2018, NEUROLOGY, V91, P461, DOI 10.1212/WNL.0000000000005928; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hannawi Y, 2015, NEUROLOGY, V84, P1272, DOI 10.1212/WNL.0000000000001404; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Malagurski B, 2019, NEUROIMAGE, V195, P354, DOI 10.1016/j.neuroimage.2019.03.012; Malagurski B, 2017, NEUROIMAGE-CLIN, V15, P315, DOI 10.1016/j.nicl.2017.03.017; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Monti MM, 2015, NEUROLOGY, V84, P167, DOI 10.1212/WNL.0000000000001123; Norton L, 2012, NEUROLOGY, V78, P175, DOI 10.1212/WNL.0b013e31823fcd61; Qiu J, 2007, LANCET NEUROL, V6, P946, DOI 10.1016/S1474-4422(07)70255-7; Rosazza C, 2016, ANN NEUROL, V79, P841, DOI 10.1002/ana.24634; Rossetti AO, 2016, LANCET NEUROL, V15, P597, DOI 10.1016/S1474-4422(16)00015-6; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Shrestha GS, 2018, JAMA NEUROL, V75, P1463, DOI 10.1001/jamaneurol.2018.3157; Silva S, 2010, NEUROLOGY, V74, P313, DOI 10.1212/WNL.0b013e3181cbcd96; Silva S, 2017, CRIT CARE MED, V45, pE763, DOI 10.1097/CCM.0000000000002379; Silva S, 2015, NEUROLOGY, V85, P2036, DOI 10.1212/WNL.0000000000002196; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; TEASDALE G, 1974, LANCET, V2, P81; Threlkeld ZD, 2018, CORTEX, V106, P299, DOI 10.1016/j.cortex.2018.05.004; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Velly L, 2018, LANCET NEUROL, V17, P317, DOI 10.1016/S1474-4422(18)30027-9; Wijdicks EFM, 2011, NEUROLOGY, V77, P84, DOI 10.1212/WNL.0b013e318220ac06	37	1	2	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	AUG	2020	48	8					E639	E647		10.1097/CCM.0000000000004406			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE7JC	WOS:000562776400001	32697504	hybrid, Green Published			2022-02-06	
J	Peterson, R; Burkhardt, E; Sin, A				Peterson, Racheal; Burkhardt, Edward; Sin, Anthony			Traumatic Atlantoaxial Dislocation without Neurologic Deficit	WORLD NEUROSURGERY			English	Article						Atlantoaxial dislocation; Neurotrauma; Spine trauma	FRACTURE	Traumatic atlantoaxial dislocation without associated odontoid fracture or neurologic deficit is rare. We present the case of a 39-year-old male pedestrian who was struck by a vehicle and sustained a traumatic grade 4 C1-2 retrolisthesis. Closed reduction was successful, and the patient underwent posterior occipitocervical fusion. His neurologic status was good throughout the hospital stay, and he was discharged to a rehabilitation facility with full strength.	[Peterson, Racheal; Burkhardt, Edward; Sin, Anthony] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Neurosurg, Shreveport, LA 71105 USA		Burkhardt, E (corresponding author), Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Neurosurg, Shreveport, LA 71105 USA.	ecabib@lsuhsc.edu		Burkhardt, Edward/0000-0003-4959-8106			HARALSON RH, 1969, J BONE JOINT SURG AM, VA 51, P561, DOI 10.2106/00004623-196951030-00016; Hu DC, 2015, J ORTHOP TRAUMA, V29, pE342, DOI 10.1097/BOT.0000000000000334	2	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2020	140						188	190		10.1016/j.wneu.2020.05.064			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NA7WY	WOS:000560029600003	32428720				2022-02-06	
J	Phelps, A; Mez, J; Stern, RA; Alosco, ML				Phelps, Alyssa; Mez, Jesse; Stern, Robert A.; Alosco, Michael L.			Risk Factors for Chronic Traumatic Encephalopathy: A Proposed Framework	SEMINARS IN NEUROLOGY			English	Article						chronic traumatic encephalopathy; concussion; subconcussions; repetitive head impacts; risk factors	HEAD IMPACT EXPOSURE; HIGH-SCHOOL FOOTBALL; LIFE COGNITIVE IMPAIRMENT; SMALLER THALAMIC VOLUMES; ALZHEIMERS-DISEASE; 1ST EXPOSURE; RECURRENT CONCUSSION; DEPRESSIVE SYMPTOMS; NEUROLOGIC FUNCTION; SINGLE SEASON	Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease that has been neuropathologically diagnosed in contact and collision sport athletes, military veterans, and others with a history of exposure to repetitive head impacts (RHI). Identifying methods to diagnose and prevent CTE during life is a high priority. Timely diagnosis and implementation of treatment and preventative strategies for neurodegenerative diseases, including CTE, partially hinge upon early and accurate risk characterization. Here, we propose a framework of risk factors that influence the neuropathological development of CTE. We provide an up-to-date review of the literature examining cumulative exposure to RHI as the environmental trigger for CTE. Because not all individuals exposed to RHI develop CTE, the direct and/or indirect influence of nonhead trauma exposure characteristics (e.g., age, sex, race, genetics) on the pathological development of CTE is reviewed. We conclude with recommendations for future directions, as well as opinions for preventative strategies that could mitigate risk.	[Phelps, Alyssa; Mez, Jesse; Stern, Robert A.; Alosco, Michael L.] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; [Phelps, Alyssa; Mez, Jesse; Stern, Robert A.; Alosco, Michael L.] Boston Univ, Sch Med, CTE Ctr, Dept Neurol, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA		Alosco, ML (corresponding author), 72 E Concord St,Suite B7800, Boston, MA 02118 USA.	malosco@bu.edu	, Bob/ABA-8507-2020	Phelps, Alyssa/0000-0001-9379-2796	K23NS102399 [NIH] Funding Source: Medline; R01AG061028 [NIH] Funding Source: Medline; K23AG046377 [NIH] Funding Source: Medline; P30 AG13846-22S2 [NIH] Funding Source: Medline; 1UL1TR001430 [National Center for Advancing Translational Sciences, National Institutes of Health, BU-CTSI] Funding Source: Medline; U01NS086659-01 [NIH] Funding Source: Medline; DOD W81XWH1810580 [NIH] Funding Source: Medline		ALOSCO M, 2017, ALZHEIMERS DEMENT, V10, P56, DOI DOI 10.1016/J.DADM.2017.10.003; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco M L, 2019, JAMA NEUROL; Alosco ML, 2018, ALZHEIMERS DEMENT, V14, P1159, DOI 10.1016/j.jalz.2018.05.004; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Alosco ML, 2017, J NEUROPSYCH CLIN N, V29, P6, DOI 10.1176/appi.neuropsych.16030043; Alosco ML, 2016, ALZHEIMERS DEMENT, V7, P33; Asken BM, 2016, NEUROPSYCHOL REV, V26, P340, DOI 10.1007/s11065-016-9327-z; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bari S, 2019, BRAIN IMAGING BEHAV, V13, P735, DOI 10.1007/s11682-018-9861-9; Barnes LL, 2014, HEALTH AFFAIR, V33, P580, DOI 10.1377/hlthaff.2013.1353; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bieniek KF, 2020, BRAIN PATHOL, V30, P63, DOI 10.1111/bpa.12757; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Caccese JB, 2020, J NEUROTRAUM, V37, P334, DOI 10.1089/neu.2019.6571; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Catenaccio E, 2016, RES SPORTS MED, V24, P416, DOI 10.1080/15438627.2016.1234472; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cottler LB, 2011, DRUG ALCOHOL DEPEN, V116, P188, DOI 10.1016/j.drugalcdep.2010.12.003; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Dolle JP, 2018, EXP NEUROL, V300, P121, DOI 10.1016/j.expneurol.2017.11.001; Gardner Raquel C, 2015, Neurol Clin Pract, V5, P285; Genin E, 2011, MOL PSYCHIATR, V16, P903, DOI 10.1038/mp.2011.52; George CFP, 2003, NEW ENGL J MED, V348, P367, DOI 10.1056/NEJM200301233480422; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goldstein LE, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0064-3; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Kerr ZY, 2015, J NEUROTRAUM, V32, P1083, DOI 10.1089/neu.2014.3666; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; KUUSISTO J, 1994, BRIT MED J, V309, P636, DOI 10.1136/bmj.309.6955.636; Kuzminski SJ, 2018, AM J NEURORADIOL, V39, P245, DOI 10.3174/ajnr.A5489; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lesman-Segev OH, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.102025; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Levy ML, 2004, NEUROSURGERY, V55, P649, DOI 10.1227/01.NEU.0000134598.06114.89; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; Levy ML, 2004, NEUROSURGERY, V55, P661; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Merritt VC, 2018, ARCH CLIN NEUROPSYCH, V33, P36, DOI 10.1093/arclin/acx051; Merritt VC, 2016, J CLIN EXP NEUROPSYC, V38, P941, DOI 10.1080/13803395.2016.1177491; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Mishra VR, 2017, RADIOLOGY, V285, P555, DOI 10.1148/radiol.2017162403; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Montenigro PH, 2015, BRAIN PATHOL, V25, P304, DOI 10.1111/bpa.12250; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Morley WA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00166; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Namjoshi DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146540; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Reynolds BB, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117701708; Roberts AL, 2019, AM J SPORT MED, V47, P2871, DOI 10.1177/0363546519868989; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Rutherford A, 2005, J CLIN EXP NEUROPSYC, V27, P299, DOI 10.1080/13803390490515504; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stamp J, 2012, LEATHERHEAD RADIO HE; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stewart WF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00240; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Strain JF, 2017, J NEUROTRAUM, V34, P372, DOI 10.1089/neu.2016.4446; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Taylor KM, 2018, AM J SPORT MED, V46, P3262, DOI 10.1177/0363546518798801; Vina J, 2010, J ALZHEIMERS DIS, V20, pS527, DOI 10.3233/JAD-2010-100501; Willer BS, 2018, J HEAD TRAUMA REHAB, V33, pE9, DOI 10.1097/HTR.0000000000000423; Willeumier K, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.67; Wright MJ, 2016, J CLIN EXP NEUROPSYC, V38, P561, DOI 10.1080/13803395.2016.1139057; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	98	1	1	0	3	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	AUG	2020	40	04					439	449		10.1055/s-0040-1713633			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NL6KK	WOS:000567521900011	32674182				2022-02-06	
J	Prabhakaran, K; Azim, A; Khan, M; Jehan, F; Feeney, J; Anderson, P; Policastro, A; Latifi, R				Prabhakaran, Kartik; Azim, Asad; Khan, Muhammad; Jehan, Faisal; Feeney, James; Anderson, Patrice; Policastro, Anthony; Latifi, Rifat			Predicting the need for tracheostomy in trauma patients without severe head injury	AMERICAN JOURNAL OF SURGERY			English	Article						Tracheostomy; Traumatic brain injury; TQIP; Trauma; Scoring system	MECHANICAL VENTILATION; TRACHEOTOMY; CARE	Background: Early tracheostomy is recommended in patients with severe traumatic brain injury (TBI); however, predicting the timing of tracheostomy in trauma patients without severe TBI can be challenging. Methods: A one year retrospective analysis of all trauma patients who were admitted to intensive Care Unit for 7 days was performed, using the ACS-TQIP database. Univariate and Multivariate regression analyses were performed to assess the appropriate weight of each factor in determining the eventual need for early tracheostomy. Results: A total of 21,663 trauma patients who met inclusion and exclusion criteria were identi fied. Overall, tracheostomy was performed in 18.3% of patients. On multivariate regression analysis age >70, flail chest, major operative intervention, ventilator days >5 days and underlying COPD were indepen- dently associated with need of tracheostomy. Based on these data, we developed a scoring system to predict risk for requiring tracheostomy. Conclusion: Age >70, presence of flail chest, need for major operative intervention, ventilator days >5 and underlying COPD are independent predictors of need for tracheostomy in trauma patients without severe TBI. (c) 2020 Elsevier Inc. All rights reserved.	[Prabhakaran, Kartik] New York Med Coll, Westchester Med Ctr, Dept Surg, 100 Woods Rd,Taylor Pavil,Off E15, Valhalla, NY 10595 USA; [Azim, Asad; Khan, Muhammad; Jehan, Faisal] Westchester Med Ctr, Dept Surg, Taylor Pavil,Room E-130, Valhalla, NY 10595 USA; [Feeney, James] MidHudson Reg Hosp, Westchester Med Ctr, 241 North Rd, Poughkeepsie, NY 12601 USA; [Anderson, Patrice] Westchester Med Ctr, Trauma Intens Care Unit, Dept Surg, Surg Crit Care Fellowship, 100 Woods Rd,Taylor Pavil,Off E145, Valhalla, NY 10595 USA; [Policastro, Anthony] Westchester Med Ctr, Trauma Intens Care Unit, Dept Surg, Surg Crit Care Fellowship, 100 Woods Rd,Taylor Pavil,Off E136, Valhalla, NY 10595 USA; [Latifi, Rifat] New York Med Coll, Westchester Med Ctr, Dept Surg, 100 Woods Rd,Taylor Pavil,Off Suite 353, Valhalla, NY 10595 USA		Prabhakaran, K (corresponding author), New York Med Coll, Westchester Med Ctr, Dept Surg, 100 Woods Rd,Taylor Pavil,Off E15, Valhalla, NY 10595 USA.; Feeney, J (corresponding author), MidHudson Reg Hosp, Westchester Med Ctr, 241 North Rd, Poughkeepsie, NY 12601 USA.	Kartik.prabhakaran@wmchealth.org; Asad.Azim@wmchealth.org; Muhammad.Khan@wmchealth.org; Faisal.Jehan@wmchealth.org; James.Feeney@wmchealth.org; PatriceLynn.Anderson@wmchealth.org; Anthony.Policastro@wmchealth.org; Rifat.Latifi@wmchealth.org		Latifi, Rifat/0000-0003-1091-3682			Alali AS, 2014, J TRAUMA ACUTE CARE, V76, P76; Alali Aziz S, 2014, J Trauma Acute Care Surg, V76, P70, DOI 10.1097/TA.0b013e3182a8fd6a; Brook A D, 2000, Am J Crit Care, V9, P352; Carney N., 2016, GUIDELINES MANAGEMEN, V4th; Cox CE, 2007, CRIT CARE MED, V35, P1918, DOI 10.1097/01.CCM.0000275391.35834.10; Goettler CE, 2006, J TRAUMA, V60, P991, DOI 10.1097/01.ta.0000217270.16860.32; Jeon YT, 2014, J NEUROSURG ANESTH, V26, P22, DOI 10.1097/ANA.0b013e31829770a0; Khalili H, 2017, WORLD NEUROSURG, V103, P88, DOI 10.1016/j.wneu.2017.02.060; Mahmood Saeed, 2014, Oman Med J, V29, P289, DOI 10.5001/omj.2014.75; Nieszkowska A, 2005, CRIT CARE MED, V33, P2527, DOI 10.1097/01.CCM.0000186898.58709.AA; Ross BJ, 1996, AM SURGEON, V62, P19; Sugerman HJ, 1997, J TRAUMA, V43, P741, DOI 10.1097/00005373-199711000-00002; Terragni PP, 2010, JAMA-J AM MED ASSOC, V303, P1483, DOI 10.1001/jama.2010.447; Unroe M, 2010, ANN INTERN MED, V153, P167, DOI 10.7326/0003-4819-153-3-201008030-00007; Young D, 2013, JAMA-J AM MED ASSOC, V309, P2121, DOI 10.1001/jama.2013.5154	15	1	1	0	0	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	AUG	2020	220	2					495	498		10.1016/j.amjsurg.2019.12.018			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	MF8CC	WOS:000545564400049	31948704				2022-02-06	
J	Rafay, M; Gulzar, F; Iqbal, N; Sharif, S				Rafay, Muhammad; Gulzar, Farhan; Iqbal, Noorulain; Sharif, Salman			Prognostic computed tomography Scores in traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						CT scan scoring; Predictive CT scan score; Helsinki score; Rotterdam score	NONPENETRATING HEAD-INJURY; SUBARACHNOID HEMORRHAGE; IMPACT; CLASSIFICATION; COMA	Background: Traumatic brain injuries represent a significant cause of morbidity and mortality worldwide and road traffic crashes account for a significant proportion of these injuries. It is one of the leading causes of death, especially among young adults, and, according to the World Health Organization, this will surpass many diseases as the major cause of death and disability by the year 2020 and lifelong disability is common in those who survive. It is also known as the silent epidemic. Many CT scan scoring systems for brain injury have been developed but none of them are validated. These scores are based on structural findings of CT scan to predict the prognosis. Marshall and Rotterdam are the two most widely used scoring systems. Method: This was an observational study with prospectively collected data. 903 consecutive patients with TBI. This study aimed to compare the Helsinki CT scoring system with the Rotterdam scoring system to find out the better score for the prognostic purpose by using the Glasgow outcome score. Results: Helsinki CT scoring system was found to be the most accurate score among the others in predicting the outcome of the patient based on morphological findings in CT scan. These scores also guided us regarding the treatment plan and patients with the good prognostic outcome are usually treated aggressively. Also these scores guide clinicians whether to opt for a conservative approach or any intervention. Conclusion: In this study we compared, Rotterdam vs. Helsinki CT Scoring System. We observed that the Helsinki score was a better outcome predictor for TBI than the Rotterdam score and can be used as a single validated score in predicting outcome and guiding the treatment.	[Rafay, Muhammad; Gulzar, Farhan; Iqbal, Noorulain; Sharif, Salman] Liaquat Natl Hosp, Dept Neurosurg, Natl Stadium Rd, Karachi 74800, Pakistan		Rafay, M (corresponding author), Liaquat Natl Hosp, Dept Neurosurg, Natl Stadium Rd, Karachi 74800, Pakistan.	drmuhammadrafay@yahoo.com; farhan_gulzar@hotmail.com; noorulain.iqbal89@gmail.com; sharifsalman73@gmail.com					Bhatti JA, 2015, BMC EMERG MED, V15, DOI 10.1186/1471-227X-15-S2-S12; Boniface Respicious, 2017, Pan Afr Med J, V26, P140, DOI 10.11604/pamj.2017.26.140.10345; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JENNETT B, 1975, LANCET, V1, P480; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Raja IA, 2001, WORLD J SURG, V25, P1230; Shamim MS, 2011, INT J INJ CONTROL SA, V18, P213, DOI 10.1080/17457300.2011.555559; TEASDALE G, 1974, LANCET, V2, P81; World Health Organization, 2003, WORLD HLTH REP SHAP	18	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	AUG	2020	195								105957	10.1016/j.clineuro.2020.105957			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	PI8VI	WOS:000601361200043	32485552				2022-02-06	
J	Root, BK; Kanter, JH; Calnan, DC; Reyes-Zaragosa, M; Gill, HS; Lanter, PL				Root, Brandon K.; Kanter, John H.; Calnan, Dan C.; Reyes-Zaragosa, Miguel; Gill, Harman S.; Lanter, Patricia L.			Emergency department observation of mild traumatic brain injury with minor radiographic findings: shorter stays, less expensive, and no increased risk compared to hospital admission	JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN			English	Article						ED observation; EDOU; mild TBI	INTRACRANIAL HEMORRHAGE; HEAD-INJURY; CARE; UNIT; DETERIORATION; MANAGEMENT; COSTS; PAIN	ObjectiveThe management of mild traumatic brain injury (mTBI) with minor radiographic findings traditionally involves hospital admission for monitoring, although this practice is expensive with unclear benefit. We implemented a protocol to manage these patients in our emergency department observation unit (EDOU), hypothesizing that this pathway was cost effective and not associated with any difference in clinical outcome. MethodsmTBI patients with minor radiographic findings were managed under the EDOU protocol over a 3-year period from May 1, 2015 to April 30, 2018 (inclusions: >= 19 years old, isolated acute head trauma, normal neurological exam [except transient alteration in consciousness], and a computed tomography [CT] scan of the head with at least 1 of the following: cerebral contusions <1 cm in maximum extent, convexity subarachnoid hemorrhage, or closed, non-displaced skull fractures). These patients were retrospectively analyzed; clinical outcomes and charges were compared to a control cohort of matched mTBI hospital admissions over the preceding 3 years. ResultsSixty patients were observed in the EDOU over the 3-year period, and 85 patients were identified for the control cohort. There were no differences in rate of radiographic progression, neurological exam change, or surgical intervention, and the overall incidence of hemorrhagic expansion was low in both groups. The EDOU group had a significantly faster time to interval CT scan (Mean Difference (MD) 3.92 hours, [95%CI 1.65, 6.19]), P = 0.001), shorter length of stay (MD 0.59 days [95% CI 0.29, 0.89], P = 0.001), and lower encounter charges (MD $3428.51 [95%CI 925.60, 5931.42], P = 0.008). There were no differences in 30-day re-admission, 30-day mortality, or delayed chronic subdural formation, although there was a high rate of loss to follow-up in both groups. ConclusionsCompared to hospital admission, observing mTBI patients with minor radiographic findings in the EDOU was associated with significantly shorter time to interval scanning, shorter length of stay, and lower encounter charges, but no difference in observed clinical outcome. The overall risk of hemorrhagic progression in this subset of mTBI was very low. Using this approach can reduce unnecessary admissions while potentially yielding patient care and economic benefits. When designing a protocol, close attention should be given to clear inclusion criteria and a formal mechanism for patient follow-up.	[Root, Brandon K.; Kanter, John H.; Calnan, Dan C.] Dartmouth Hitchcock Med Ctr, Sect Neurosurg, Lebanon, NH 03766 USA; [Reyes-Zaragosa, Miguel] Geisel Sch Med Dartmouth, Hanover, NH USA; [Gill, Harman S.; Lanter, Patricia L.] Dartmouth Hitchcock Med Ctr, Dept Emergency Med, Lebanon, NH 03766 USA		Root, BK (corresponding author), Campus Box 8057,660S Euclid Ave, St Louis, MO 63110 USA.	brandonrootmd@gmail.com					Ajmera S, 2019, NEUROSURGERY, V84, P624; Bai G, 2015, HEALTH AFFAIR, V34, P922, DOI 10.1377/hlthaff.2014.1414; Bardes JM, 2016, AM SURGEON, V82, P36; Bellew SD, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002984; Bonow RH, 2019, NEUROCRIT CARE, V30, P157, DOI 10.1007/s12028-018-0590-0; Budde J, 2018, LUNG, V196, P267, DOI 10.1007/s00408-018-0102-1; Choudhry OJ, 2013, NEUROSURGERY, V73, P753, DOI 10.1227/NEU.0000000000000105; Cooper JG, 2016, EUR J EMERG MED, V23, P356, DOI 10.1097/MEJ.0000000000000266; Dengler BA, 2020, NEUROSURGERY, V86, P374, DOI 10.1093/neuros/nyz092; FINKLER SA, 1982, ANN INTERN MED, V96, P102, DOI 10.7326/0003-4819-96-1-102; Galarraga JE, 2016, AM J EMERG MED, V34, P357, DOI 10.1016/j.ajem.2015.06.001; Galarraga JE, 2015, ACAD EMERG MED, V22, P172, DOI 10.1111/acem.12579; Graff LG, 1997, AM J CARDIOL, V80, P563, DOI 10.1016/S0002-9149(97)00422-0; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Institute of Medicine Committee on the Future of Emergency Care in the United States Health System, 2007, HOSP BAS EM CAR BREA; Ismail MF, 2019, EMERG MED J, V36, P18, DOI 10.1136/emermed-2017-206997; Joseph B, 2015, BRAIN INJURY, V29, P11, DOI 10.3109/02699052.2014.945959; Lewis Paul R, 2017, J Trauma Acute Care Surg, V82, P776, DOI 10.1097/TA.0000000000001388; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Marshall JR, 2017, WEST J EMERG MED, V18, P181, DOI 10.5811/westjem.2016.10.32042; McDermott MF, 1997, ARCH INTERN MED, V157, P2055, DOI 10.1001/archinte.157.18.2055; Nahab F, 2012, J STROKE CEREBROVASC, V21, P673, DOI 10.1016/j.jstrokecerebrovasdis.2011.02.017; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Orlando A, 2019, J NEUROSURG, V130, P1626, DOI 10.3171/2018.1.JNS171906; Pfuntner A., 2006, HEALTHCARE COST UTIL; Pruitt P, 2017, ACAD EMERG MED, V24, P1377, DOI 10.1111/acem.13306; Pruitt P, 2017, AM J EMERG MED, V35, P255, DOI 10.1016/j.ajem.2016.10.064; Richter S, 2019, J NEUROTRAUM, V36, P2743, DOI 10.1089/neu.2018.6216; Ross MA, 2013, HEALTH AFFAIR, V32, P2149, DOI 10.1377/hlthaff.2013.0662; Ross Michael A, 2012, Crit Pathw Cardiol, V11, P128; Sweeney TE, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0017-6; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Yun BJ, 2018, ACAD EMERG MED, V25, P769, DOI 10.1111/acem.13350	34	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2688-1152		JACEP OPEN	J. Am. Coll. Emerg. Phys. Open	AUG	2020	1	4					609	617		10.1002/emp2.12124			9	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	RZ6GN	WOS:000648695100038	33000079	gold, Green Published			2022-02-06	
J	Schwebel, DC; Long, DL; McClure, LA				Schwebel, David C.; Long, D. Leann; McClure, Leslie A.			Injuries on the Youth Soccer (Football) Field: Do Additional Referees Reduce Risk? Randomized Crossover Trial	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						football; injury; safety; soccer; supervision	IN-SAFETY PROGRAM; INTERVENTION; SUPERVISION; CONCUSSION; CHILDREN; SPORTS	Objective Youth soccer injury can be prevented through various means, but few studies consider the role of referees. Following previous research suggesting children take fewer risks when supervised intensely, this randomized crossover trial evaluated whether risky play and injuries decrease under supervision from three referees instead of one referee. Methods Youth soccer clubs serving a metropolitan U.S. area participated. Boys' and girls' clubs at under age 10 (U10) and under age 11 (U11) levels were randomly assigned such that when the same clubs played each other twice in the same season, they played once with one referee and once with three referees. A total of 98 games were videotaped and subsequently coded to obtain four outcomes: collisions between players, aggressive fouls (involving physical player-to-player contact) called by the referee(s) on the field, aggressive fouls judged by trained coders, and injuries requiring adult attention or play stoppage. Results Poisson mixed model results suggest players in the 98 games committed fewer aggressive fouls, as identified independently by referees (rate ratio [RR] 0.58; 95% confidence interval [CI] 0.35-0.96) and by researchers (RR 0.67; 95% CI 0.50-0.90), when there were three referees versus one referee. Collisions (RR 0.98; 95% CI 0.86-1.12) and injury rates (RR 1.15; 95% CI 0.60-2.19) were similar across conditions. Conclusion When the same youth soccer clubs played with three referees rather than one, they committed fewer aggressive fouls. More intense supervision created better rule adherence. Injury rates were unchanged with increased supervision. Results raise questions concerning whether financial investment in additional referees on youth soccer fields yields safety benefits.	[Schwebel, David C.] Univ Alabama Birmingham, Dept Psychol, 1300 Univ Blvd,CH 415, Birmingham, AL 35294 USA; [Long, D. Leann] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [McClure, Leslie A.] Drexel Univ, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA		Schwebel, DC (corresponding author), Univ Alabama Birmingham, Dept Psychol, 1300 Univ Blvd,CH 415, Birmingham, AL 35294 USA.	schwebel@uab.edu			Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [R21HD089887]	Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number R21HD089887. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This trial is registered at clinicaltrials.gov (NCT04266925).	Anderson SJ, 2000, PEDIATRICS, V105, P659, DOI 10.1542/peds.105.3.640; Barton BK, 2007, J PEDIATR PSYCHOL, V32, P517, DOI 10.1093/jpepsy/jsm014; Belechri M, 2001, EUR J EPIDEMIOL, V17, P1005, DOI 10.1023/A:1020078522493; Brito J, 2012, J ATHL TRAINING, V47, P191; BROWN BW, 1980, BIOMETRICS, V36, P69, DOI 10.2307/2530496; Chelvakumar G, 2010, INJURY PREV, V16, P352, DOI 10.1136/ip.2009.025056; Chorney JM, 2015, J PEDIATR PSYCHOL, V40, P154, DOI 10.1093/jpepsy/jsu099; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Drape J., 2018, NY TIMES; Fridman L, 2013, BMC SPORTS SCI MED R, V5, DOI 10.1186/2052-1847-5-30; Hallgren Kevin A, 2012, Tutor Quant Methods Psychol, V8, P23; Junge A, 2002, AM J SPORT MED, V30, P652, DOI 10.1177/03635465020300050401; Junge Astrid, 2004, Sports Med, V34, P929, DOI 10.2165/00007256-200434130-00004; Khodaee M, 2017, BRIT J SPORT MED, V51, P185, DOI 10.1136/bjsports-2015-095946; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Mitchell J, 2016, KNEE SURG SPORT TR A, V24, P715, DOI 10.1007/s00167-015-3814-2; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Rapids Youth Soccer, 2016, US YOUTH SOCC STAT; Schwebel D. C., 2011, International Journal of Aquatic Research and Education, V5, P210; Schwebel DC, 2007, J PEDIATR PSYCHOL, V32, P862, DOI 10.1093/jpepsy/jsm019; Schwebel DC, 2006, J SAFETY RES, V37, P507, DOI 10.1016/j.jsr.2006.08.002; Schwebel DC, 2015, HEALTH EDUC J, V74, P37, DOI 10.1177/0017896914522030; Schwebel DC, 2014, J ATHL TRAINING, V49, P780, DOI 10.4085/1062-6050-49.3.41; Schwebel DC, 2006, J PEDIATR PSYCHOL, V31, P152, DOI 10.1093/jpepsy/jsj001; Schwebel DC, 2003, J PEDIATR PSYCHOL, V28, P505, DOI 10.1093/jpepsy/jsg041; Wiersma LD, 2005, RES Q EXERCISE SPORT, V76, P324; WILLAN AR, 1986, BIOMETRICS, V42, P593, DOI 10.2307/2531209; Yang YT, 2016, JAMA PEDIATR, V170, P413, DOI 10.1001/jamapediatrics.2016.0338	28	1	1	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	AUG	2020	45	7					759	766		10.1093/jpepsy/jsaa050			8	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	OW7WM	WOS:000593092000007	32651582	Green Published			2022-02-06	
J	Shahim, P; Gill, JM; Blennow, K; Zetterberg, H				Shahim, Pashtun; Gill, Jessica M.; Blennow, Kaj; Zetterberg, Henrik			Fluid Biomarkers for Chronic Traumatic Encephalopathy	SEMINARS IN NEUROLOGY			English	Article						biomarkers; cerebrospinal fluid; concussion; chronic traumatic encephalopathy; plasma; serum; neurofilament; tau	SPECTRIN BREAKDOWN PRODUCTS; SERUM NEUROFILAMENT LIGHT; ALPHA-II-SPECTRIN; BRAIN-INJURY; CEREBROSPINAL-FLUID; ICE HOCKEY; NEUROCHEMICAL AFTERMATH; BLOOD BIOMARKERS; TAU PROTEINS; EXOSOMAL TAU	Chronic traumatic encephalopathy (CTE) is a neuropathological condition that has been described in individuals who have been exposed to repetitive head impacts, including concussions and subconcussive trauma. Currently, there is no fluid or imaging biomarker for diagnosing CTE during life. Based on retrospective clinical data, symptoms of CTE include changes in behavior, cognition, and mood, and may develop after a latency phase following the injuries. However, these symptoms are often nonspecific, making differential diagnosis based solely on clinical symptoms unreliable. Thus, objective biomarkers for CTE pathophysiology would be helpful in understanding the course of the disease as well as in the development of preventive and therapeutic measures. Herein, we review the literature regarding fluid biomarkers for repetitive concussive and subconcussive head trauma, postconcussive syndrome, as well as potential candidate biomarkers for CTE. We also discuss technical challenges with regard to the current fluid biomarkers and potential pathways to advance the most promising biomarker candidates into clinical routine.	[Shahim, Pashtun; Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, S-43180 Molndal, Sweden; [Shahim, Pashtun; Blennow, Kaj; Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Shahim, Pashtun; Gill, Jessica M.] NIH, Bldg 10, Bethesda, MD 20892 USA; [Shahim, Pashtun] Ctr Neurosci & Regenerat Med CNRM, Bethesda, MD USA; [Shahim, Pashtun] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Zetterberg, Henrik] UCL Queen Sq Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England		Zetterberg, H (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, S-43180 Molndal, Sweden.	henrik.zetterberg@clinchem.gu.se					Alosco ML, 2018, ALZHEIMERS DEMENT, V14, P1159, DOI 10.1016/j.jalz.2018.05.004; Alosco ML, 2016, ALZHEIMERS DEMENT, V7, P33; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Apweiler R, 2009, CLIN CHEM LAB MED, V47, P724, DOI 10.1515/CCLM.2009.167; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Bolstad N, 2013, BEST PRACT RES CL EN, V27, P647, DOI 10.1016/j.beem.2013.05.011; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Chen AQ, 2016, NEUROBIOL AGING, V38, P56, DOI 10.1016/j.neurobiolaging.2015.10.021; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Cicognola C, 2019, ACTA NEUROPATHOL, V137, P279, DOI 10.1007/s00401-018-1948-2; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Duits FH, 2016, ALZHEIMERS DEMENT, V12, P154, DOI 10.1016/j.jalz.2015.08.003; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; FRIEDE RL, 1970, ANAT REC, V167, P379, DOI 10.1002/ar.1091670402; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Ghidoni R, 2018, J ALZHEIMERS DIS, V62, P1507, DOI 10.3233/JAD-170953; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Gisslen M, 2016, EBIOMEDICINE, V3, P135, DOI 10.1016/j.ebiom.2015.11.036; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hampel H, 2004, ARCH GEN PSYCHIAT, V61, P95, DOI 10.1001/archpsyc.61.1.95; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; HARRIS AS, 1988, J BIOL CHEM, V263, P15754; Heslegrave A, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0071-x; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; Kricka LJ, 1999, CLIN CHEM, V45, P942; Kuhle J, 2016, CLIN CHEM LAB MED, V54, P1655, DOI 10.1515/cclm-2015-1195; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lundberg M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr424; Mattsson N, 2016, NEUROLOGY, V87, P1827, DOI 10.1212/WNL.0000000000003246; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McKee AC, 2018, HAND CLINIC, V158, P297, DOI 10.1016/B978-0-444-63954-7.00028-8; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMahon M, 2014, INT CULT PSYCHOL, P29, DOI 10.1007/978-1-4614-9460-7_3; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Olsson B, 2011, PROG NEUROBIOL, V95, P520, DOI 10.1016/j.pneurobio.2011.04.006; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Posti J P, 2017, J NEUROTRAUM, P27; Randall J, 2013, RESUSCITATION, V84, P351, DOI 10.1016/j.resuscitation.2012.07.027; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Rothoerl RD, 2001, NEUROSURGERY, V49, P1490, DOI 10.1097/00006123-200112000-00054; Schulte S, 2016, EPMA J, V7, DOI 10.1186/s13167-016-0050-x; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2017, NEUROLOGY, V88, P1400, DOI 10.1212/WNL.0000000000003816; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; SIMAN R, 1989, J NEUROSCI, V9, P1579; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Sundman M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00334; Todd J, 2007, CLIN CHEM, V53, P1990, DOI 10.1373/clinchem.2007.091181; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zetterberg H, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt163; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	95	1	1	3	10	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	AUG	2020	40	04					411	419		10.1055/s-0040-1715095			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NL6KK	WOS:000567521900008	32740901	Green Submitted			2022-02-06	
J	Solomon, NP; Dietsch, AM; Dietrich-Burns, K				Solomon, Nancy Pearl; Dietsch, Angela M.; Dietrich-Burns, Katie			Predictors of swallowing outcomes in patients with combat-injury related dysphagia	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; combat; maxillofacial trauma; swallowing; dysphagia; database		BACKGROUND Traumatic injuries, such as those from combat-related activities, can lead to complicated clinical presentations that may include dysphagia. METHODS This retrospective observational database study captured dysphagia-related information for 215 US military service members admitted to the first stateside military treatment facility after sustaining combat-related or combat-like traumatic injuries. A multidimensional relational database was developed to document the nature, course, and management for dysphagia in this unique population and to explore variables predictive of swallowing recovery using Bayesian statistical modeling and inferential statistical methods. RESULTS Bayesian statistical modeling revealed the importance of maxillofacial fractures and soft tissue loss as primary predictors of poor swallowing outcomes. The presence of traumatic brain injury (TBI), though common, did not further complicate dysphagia outcomes. A more detailed examination and rating of videofluoroscopic swallow studies from a subset of 161 participants supported greater impairment for participants with maxillofacial trauma and no apparent relationship between having sustained a TBI and swallow functioning. CONCLUSION These analyses revealed that maxillofacial trauma is a stronger indicator than TBI of dysphagia severity and slower or incomplete recovery following combat-related injuries.	[Solomon, Nancy Pearl; Dietsch, Angela M.; Dietrich-Burns, Katie] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Dietsch, Angela M.] Univ Nebraska Lincoln, Lincoln, NE USA; [Dietrich-Burns, Katie] SonoSante LLC, Columbia, MD USA		Solomon, NP (corresponding author), Natl Mil Audiol & Speech Pathol Ctr, Bldg 19,Floor 5,4954 North Palmer Rd, Bethesda, MD 20889 USA.	nancy.p.solomon.civ@mail.mil	Dietsch, Angela/H-6552-2013	Dietsch, Angela/0000-0003-4554-5365; Solomon, Nancy/0000-0002-5018-7569	United States Army Medical Research and Development Program [W81XWH-12-2-0021]; Speech Pathology Clinic at WRNMMC	This research was funded with a grant from the United States Army Medical Research and Development Program (W81XWH-12-2-0021; PI: Solomon), andwas administered through the HenryM. Jackson Foundation for the Advancement of Military Medicine. Database development and BBN modeling were conducted in collaboration with Edda Styrmisdottir at DecisionQ Corporation, Arlington, VA, through a grant subaward. Inferential statistics were guided by Daniel I. Brooks, statisticianwith the Department of Research Programs at the Defense Health Agency, Naval Support Activity, Bethesda, MD. The authors are also grateful for the expertise and support provided by the Speech Pathology Clinic at WRNMMC through the leadership and direct contributions of W. Bryan Lewis and Laura L. Cord.	Ajemian MS, 2001, ARCH SURG-CHICAGO, V136, P434, DOI 10.1001/archsurg.136.4.434; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Borders JC, 2018, J CRIT CARE, V44, P312, DOI 10.1016/j.jcrc.2017.12.004; Brard C, 2017, CLIN TRIALS, V14, P78, DOI 10.1177/1740774516673362; Christensen J, 2015, J CRANIOFAC SURG, V26, P1487, DOI 10.1097/SCS.0000000000001789; Clark N, 1996, PLAST RECONSTR SURG, V98, P583, DOI 10.1097/00006534-199609001-00001; Cottrell JE, 2020, J NEUROSURG ANESTH, V32, P9, DOI 10.1097/ANA.0000000000000640; Dietsch AM, 2019, J SPEECH LANG HEAR R, V62, P2703, DOI 10.1044/2019_JSLHR-S-18-0381; Dietsch AM, 2017, J SPEECH LANG HEAR R, V60, P2442, DOI 10.1044/2017_JSLHR-S-16-0431; Eckert MJ, 2006, ARCH SURG-CHICAGO, V141, P806, DOI 10.1001/archsurg.141.8.806; Esnault P, 2017, J NEUROSURG, V127, P16, DOI 10.3171/2016.4.JNS152600; Fodale V, 2017, EXPERT OPIN DRUG SAF, V16, P997, DOI 10.1080/14740338.2017.1351539; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Jha RM, 2017, HAND CLINIC, V141, P633, DOI 10.1016/B978-0-444-63599-0.00034-X; Koren I, 2003, AM J OTOLARYNG, V24, P75, DOI 10.1053/ajot.2003.4; Leder SB, 1998, DYSPHAGIA, V13, P208, DOI 10.1007/PL00009573; Leder SB, 2019, ANN OTO RHINOL LARYN, V128, P619, DOI 10.1177/0003489419836115; Leder SB, 2010, DYSPHAGIA, V25, P35, DOI 10.1007/s00455-009-9226-z; Leder SB, 2009, DYSPHAGIA, V24, P290, DOI 10.1007/s00455-008-9204-x; Macht M, 2011, CRIT CARE, V15, DOI 10.1186/cc10472; Mandaville A, 2014, DYSPHAGIA, V29, P310, DOI 10.1007/s00455-013-9509-2; Martin-Harris B, 2008, DYSPHAGIA, V23, P392, DOI 10.1007/s00455-008-9185-9; Mukdad L, 2019, J CARDIOTHOR VASC AN, V33, P45, DOI 10.1053/j.jvca.2018.05.040; O'Neil ME., 2013, COMPLICATIONS MILD; Oshodi A, 2011, PEDIATR CRIT CARE ME, V12, pE34, DOI 10.1097/PCC.0b013e3181dbeb28; Pai AB, 2012, J REHABIL RES DEV, V49, P1191, DOI 10.1682/JRRD.2011.11.0224; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1028; Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897; Skoretz SA, 2010, CHEST, V137, P665, DOI 10.1378/chest.09-1823; Smith Hayden, 2012, J Trauma Nurs, V19, P57, DOI 10.1097/JTN.0b013e31823a4c0e; Solomon NP, 2016, MIL MED, V181, P138, DOI 10.7205/MILMED-D-15-00170; TELISCHI FF, 1994, OTOLARYNG HEAD NECK, V111, P446, DOI 10.1177/019459989411100409; Zor F, 2015, J CRANIOFAC SURG, V26, P691, DOI 10.1097/SCS.0000000000001588	34	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2020	89	2S		2			S192	S199		10.1097/TA.0000000000002623			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	QB5BE	WOS:000614154300029	32068719				2022-02-06	
J	Steinberg, A; Callaway, C; Dezfulian, C; Elmer, J				Steinberg, Alexis; Callaway, Clifton; Dezfulian, Cameron; Elmer, Jonathan			Are providers overconfident in predicting outcome after cardiac arrest?	RESUSCITATION			English	Article						Cardiac arrest; Prognosis; Coma; Outcome	EUROPEAN RESUSCITATION COUNCIL; TRAUMATIC BRAIN-INJURY; CARDIOPULMONARY-RESUSCITATION; COMATOSE SURVIVORS; CARE; PROGNOSIS; WITHDRAWAL; ASSOCIATION; PROGNOSTICATION; SUPPRESSION	Aim: To quantify the accuracy of health care providers' predictions of survival and function at hospital discharge in a prospective cohort of patients resuscitated from cardiac arrest. To test whether self-reported confidence in their predictions was associated with increased accuracy and whether this relationship varied across providers. Methodology: We presented critical care and neurology providers with clinical vignettes using real data from post-arrest patients. We asked providers to predict survival, function at discharge, and report their confidence in these predictions. We used mixed effects models to explore predictors of confidence, accuracy, and the relationship between the two. Results: We completed 470 assessments of 62 patients with 65 providers. Of patients, 49 (78%) died and 9 (15%) had functionally favourable survival. Providers accurately predicted survival in 308/470 (66%) assessments. In most errors (146/162, 90%), providers incorrectly predicted survival. Providers accurately predicted function in 349/470 (74%) assessments. In most errors (114/121, 94%), providers incorrectly predicted favourable functional recovery. Providers were confident (median confidence predicting survival 80 [IQR 60-90]; median confidence predicting function 80 [IQR 60-95]). Confidence explained 9% and 18% of variation in accuracy predicting survival and function, respectively. We observed significant between-provider variability in accuracy (median odds ratio (MOR) for predicting survival 2.93, 95%CI 1.94-5.52; MOR for predicting function 5.42, 95%CI 3.01-13.2). Conclusions: Providers varied in accuracy predicting post-arrest outcomes and most errors were optimistic. Self-reported confidence explained little variation in accuracy.	[Steinberg, Alexis] Univ Pittsburgh, Dept Crit Care Med & Neurol, Pittsburgh, PA USA; [Callaway, Clifton] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA USA; [Dezfulian, Cameron] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Elmer, Jonathan] Univ Pittsburgh, Dept Crit Care Med Emergency Med & Neurol, Pittsburgh, PA USA		Elmer, J (corresponding author), Iroquois Bldg,Suite 400A,3600 Forbes Ave, Pittsburgh, PA 15213 USA.	steinberga2@upmc.edu; callawaycw@upmc.edu; dezfulianc@upmc.edu; elmerjp@upmc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5K23NS097629]	The REDCap platform used in this work was supported by NIH grant UL1-TR-001857. Jonathan Elmer - research time is supported by the NIH through grant 5K23NS097629.	Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Cook D, 2003, NEW ENGL J MED, V349, P1123, DOI 10.1056/NEJMoa030083; Coppler PJ, 2015, RESUSCITATION, V89, P86, DOI 10.1016/j.resuscitation.2015.01.020; Detsky ME, 2017, JAMA-J AM MED ASSOC, V317, P2187, DOI 10.1001/jama.2017.4078; Efendijev I, 2018, RESUSCITATION, V131, P128, DOI 10.1016/j.resuscitation.2018.06.028; Elmer J, 2016, NEUROCRIT CARE, V25, P415, DOI 10.1007/s12028-016-0263-9; Elmer J, 2016, RESUSCITATION, V102, P127, DOI 10.1016/j.resuscitation.2016.01.016; Fernando SM, 2020, RESUSCITATION, V146, P138, DOI 10.1016/j.resuscitation.2019.11.011; Fernando SM, 2019, INTENS CARE MED, V45, P1580, DOI 10.1007/s00134-019-05766-z; Fukuda T, 2013, RESUSCITATION, V84, P964, DOI 10.1016/j.resuscitation.2013.02.019; Geocadin RG, 2019, CIRCULATION, V140, pE517, DOI 10.1161/CIR.0000000000000702; Geocadin RG, 2012, CRIT CARE MED, V40, P979, DOI 10.1097/CCM.0b013e3182410146; Gold B, 2014, RESUSCITATION, V85, P211, DOI 10.1016/j.resuscitation.2013.10.030; Hofmeijer J, 2014, CLIN NEUROPHYSIOL, V125, P947, DOI 10.1016/j.clinph.2013.10.017; Hwang DY, 2016, NEUROLOGY, V86, P126, DOI 10.1212/WNL.0000000000002266; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Javaudin F, 2018, RESUSCITATION, V127, P8, DOI 10.1016/j.resuscitation.2018.03.020; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kahneman D., 2012, THINKING FAST SLOW; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Lybeck A, 2018, RESUSCITATION, V126, P166, DOI 10.1016/j.resuscitation.2018.01.027; Maciel CB, 2020, CRIT CARE MED, V48, pE107, DOI 10.1097/CCM.0000000000004107; Meadow W, 2011, CRIT CARE MED, V39, P474, DOI 10.1097/CCM.0b013e318205df9b; Metter RB, 2011, RESUSCITATION, V82, P1180, DOI 10.1016/j.resuscitation.2011.04.001; Mohan D, 2016, JAMA-J AM MED ASSOC, V316, P1867, DOI 10.1001/jama.2016.14174; Morgenstern LB, 2015, NEUROLOGY, V84, P1739, DOI 10.1212/WNL.0000000000001525; Mulder M, 2014, CRIT CARE MED, V42, P2493, DOI 10.1097/CCM.0000000000000540; Nolan JP, 2015, INTENS CARE MED, V41, P2039, DOI 10.1007/s00134-015-4051-3; Petrie J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005797; Sandroni C, 2015, CURR OPIN CRIT CARE, V21, P209, DOI 10.1097/MCC.0000000000000202; Sandroni C, 2014, RESUSCITATION, V85, P1779, DOI 10.1016/j.resuscitation.2014.08.011; Soliman IW, 2018, J CRIT CARE, V43, P148, DOI 10.1016/j.jcrc.2017.09.007; Steinberg A, 2019, RESUSCITATION, V138, P190, DOI 10.1016/j.resuscitation.2019.03.016; Teresa LM, 2019, RESUSCITATION, V139, P308, DOI 10.1016/j.resuscitation.2019.02.031; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Wartenberg KE, 2019, NEUROCRIT CARE, V31, P231, DOI 10.1007/s12028-019-00769-6; Wendler D, 2011, ANN INTERN MED, V154, P336, DOI 10.7326/0003-4819-154-5-201103010-00008; Westhall E, 2016, NEUROLOGY, V86, P1482, DOI 10.1212/WNL.0000000000002462; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wolfe J, 2000, JAMA-J AM MED ASSOC, V284, P2469, DOI 10.1001/jama.284.19.2469; Zahuranec DB, 2016, NEUROLOGY, V86, P1864, DOI 10.1212/WNL.0000000000002676; Zive DM, 2018, RESUSCITATION, V131, P74, DOI 10.1016/j.resuscitation.2018.07.023	43	1	1	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	AUG	2020	153						97	104		10.1016/j.resuscitation.2020.06.004			8	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	MP7MX	WOS:000552386600023	32544415	Green Accepted			2022-02-06	
J	Subedi, S; Davison, C; Bartels, S				Subedi, Sony; Davison, Colleen; Bartels, Susan			Analysis of the relationship between earthquake-related losses and the frequency of child-directed emotional, physical, and severe physical abuse in Haiti	CHILD ABUSE & NEGLECT			English	Article						Emotional abuse; Physical abuse; Child abuse; Natural disasters; Humanitarian crisis; Haiti	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; CHRONIC PAIN; WOMEN; CONSEQUENCES; MALTREATMENT; VIOLENCE; HISTORY; SCHOOL; RISK	Background: Child abuse is a public health and human rights issue that is prevalent worldwide. All forms of abuse against children can have negative physical and mental health consequences. Under post-disaster situations, where there is a potential for increased stress and decreased social support among caregivers, the risk of child abuse may be higher. Objective: To explore the association between earthquake-related losses (family-related and property-related) and the experience of emotional, physical, and severe physical child abuse in the household for children aged 2-14 in Hail. Methods: A nationally representative sample of Haitian households from the 2012 Demographic and Health Survey (DHS) was used. Descriptive analyses were summarized using frequencies and measures of central tendency. Associations between earthquake-related loss and child abuse was assessed using log-binomial regression modelling. Results: Two years following the earthquake, and after considering potentially confounding variables, death of a household member was associated with a higher likelihood of a child being victim to emotional (RR = 1.11, 95 % CI: 1.05 -1.17) and severe physical abuse (RR = 1.50, 95 % CI: 1.15 -1.96). Conversely, injury of a household member was associated with a lower likelihood of a child experiencing emotional abuse (RR = 0.93, 95 % CI: 0.87 - 0.99). Conclusions: There were associations between earthquake-related losses and some forms of child abuse; the results were not consistent across all exposures and outcomes. The high prevalence of reported child abuse indicates a need for interventions to reduce child abuse in homes overall. There is also need for further research into the aetiology and influences specific to different types of abuse.	[Subedi, Sony; Davison, Colleen; Bartels, Susan] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada; [Bartels, Susan] Queens Univ, Dept Emergency Med, Kingston, ON, Canada		Subedi, S (corresponding author), 928 Richards St, Vancouver, BC V6B 3C1, Canada.	16ss71@queensu.ca	Davison, Colleen M/L-3157-2016	Davison, Colleen M/0000-0002-0410-3352			Achecar M. M., 2013, ENCUESTA DEMOGRAFICA; Ahmed MS, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10041106; [Anonymous], 2012, CHILD ABUSE NEGLECT; Antai Diddy, 2016, J Inj Violence Res, V8, P25, DOI 10.5249/jivr.v8i1.630; Arisman, 2014, THESIS, P1, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2]; Assembly U. G, 1989, UN TREATY SERIES, V1577, P1; Bensley LS, 2000, AM J PREV MED, V18, P151, DOI 10.1016/S0749-3797(99)00084-7; Cavallo E, 2010, ECON J, V120, pF298, DOI 10.1111/j.1468-0297.2010.02378.x; Cayemittes M., 2013, HAITI DHS 2012 FINAL; Center for Disease Control and Prevention, 2018, CHILD AB NEGL RISK P; Cerna-Turoff I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217719; Curtis T, 2000, CHILD ABUSE NEGLECT, V24, P1151, DOI 10.1016/S0145-2134(00)00176-9; Demographic and Health Surveys Program, 2016, DHS OV; DEPAUL J, 1995, CHILD ABUSE NEGLECT, V19, P409, DOI 10.1016/0145-2134(95)00009-W; Derivois D, 2017, CHILD ABUSE NEGLECT, V67, P174, DOI 10.1016/j.chiabu.2017.02.034; DesRoches R, 2011, EARTHQ SPECTRA, V27, pS1, DOI 10.1193/1.3630129; Dollard J., 1939, FRUSTRATION AGGRESS, P1; ECKENRODE J, 1993, DEV PSYCHOL, V29, P53, DOI 10.1037/0012-1649.29.1.53; FALLER KC, 1989, CHILD ABUSE NEGLECT, V13, P281, DOI 10.1016/0145-2134(89)90015-X; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Finestone HM, 2000, CHILD ABUSE NEGLECT, V24, P547, DOI 10.1016/S0145-2134(00)00112-5; Fischer S, 2010, EAT BEHAV, V11, P190, DOI 10.1016/j.eatbeh.2010.01.001; Fry D, 2012, TRAUMA VIOLENCE ABUS, V13, P209, DOI 10.1177/1524838012455873; GELLES RJ, 1989, AM J ORTHOPSYCHIAT, V59, P492, DOI 10.1111/j.1939-0025.1989.tb02738.x; Gilbert L, 2018, CHILD ABUSE NEGLECT, V76, P184, DOI 10.1016/j.chiabu.2017.10.014; Government of Haiti, 2010, ACT PLAN NAT REC DEV; Grelotti DJ, 2018, PSYCHIAT RES, V269, P369, DOI 10.1016/j.psychres.2018.08.074; Heim C, 1998, PSYCHOSOM MED, V60, P309, DOI 10.1097/00006842-199805000-00017; Hillis S, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4079; Jenny C, 2008, PEDIATRICS, V122, P667, DOI 10.1542/peds.2008-1885; Keenan HT, 2004, AM J PREV MED, V26, P189, DOI 10.1016/j.amepre.2003.10.023; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kohlboeck G, 2012, ANN NUTR METAB, V60, P247, DOI 10.1159/000337552; Law & Conflict Working Group, 2008, CHILDR LEG RIGHTS HA; Locke LM, 2002, CLIN PSYCHOL REV, V22, P895, DOI 10.1016/S0272-7358(02)00133-2; Malcolm M., 2017, CHILD DISCIPLINE TIM; Mathews Ben., 2014, SOCIAL SCI, V3, P460, DOI 10.3390/socsci3030460; McCauley J, 1997, JAMA-J AM MED ASSOC, V277, P1362, DOI 10.1001/jama.277.17.1362; Melorose J., 1997, NCPC ISSUES, V8, P1, DOI [10.1017/J.242546, DOI 10.1017/J.242546]; Meng XF, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1071-7; Mikton C, 2009, B WORLD HEALTH ORGAN, V87, P353, DOI 10.2471/BLT.08.057075; Nicholas PK, 2012, ADV NURS SCI, V35, P182, DOI 10.1097/ANS.0b013e318253f005; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Obikane E, 2018, J AFFECT DISORDERS, V234, P224, DOI 10.1016/j.jad.2018.02.034; Pfrimmer DM, 2010, J CONTIN EDUC NURS, V41, P536, DOI 10.3928/00220124-20101122-04; Rutstein S., 2004, 6 DHS COMP ORC MACR; SCOTT AJ, 1991, BIOMETRICS, V47, P497, DOI 10.2307/2532141; Sedlak A. J, 2010, 4 NATL INCIDENCE STU, DOI [10.1037/e659872010-001, DOI 10.1037/E659872010-001]; Shapira S, 2015, NAT HAZARDS, V78, P1447, DOI 10.1007/s11069-015-1780-0; Shonk SM, 2001, DEV PSYCHOL, V37, P3, DOI 10.1037//0012-1649.37.1.3; Sloand E, 2017, J ADV NURS, V73, P3200, DOI 10.1111/jan.13316; Springer KW, 2007, CHILD ABUSE NEGLECT, V31, P517, DOI 10.1016/j.chiabu.2007.01.003; Subedi S, 2019, DISASTER MED PUBLIC, V13, P927, DOI 10.1017/dmp.2019.16; Thompson MP, 2002, J INTERPERS VIOLENCE, V17, P1115, DOI 10.1177/088626002236663; UNICEF, 2010, CHILD DIS PRACT HOM; Unicef, 2011, UNICEF UNIT CHILDR, P30; UNICEF, 2014, J CHEM INF MODEL, V53, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Walker EA, 1997, PSYCHOSOM MED, V59, P572, DOI 10.1097/00006842-199711000-00003; WALLING MK, 1994, OBSTET GYNECOL, V84, P200; Webb P., 2016, ESSENTIAL EPIDEMIOLO, DOI [10.1017/9781316275948, DOI 10.1017/9781316275948]; World Health Organization, 2009, CTR PUBL HLTH LIV J, DOI [10.4135/9781446269930, DOI 10.4135/9781446269930]; World Health Organization, 2005, INT VIOL DIS; World Health Organization, 2002, WORLD REPORT VIOLENC, DOI [10.1136/ip.9.1.93, DOI 10.1136/IP.9.1.93]	63	1	1	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134	1873-7757		CHILD ABUSE NEGLECT	Child Abuse Negl.	AUG	2020	106								104509	10.1016/j.chiabu.2020.104509			10	Family Studies; Psychology, Social; Social Work	Social Science Citation Index (SSCI)	Family Studies; Psychology; Social Work	MC5YL	WOS:000543362000013	32413776				2022-02-06	
J	Uretsky, M; Nowinski, CJ				Uretsky, Madeline; Nowinski, Christopher J.			Chronic Traumatic Encephalopathy: Advocacy and Communicating with the Public	SEMINARS IN NEUROLOGY			English	Article						advocacy; chronic traumatic encephalopathy; concussion; football	1ST EXPOSURE; FOOTBALL; CONCUSSION; AGE; TAUOPATHY; INJURY	Over the past 40 years, advocacy groups have been instrumental in raising awareness for neurodegenerative diseases such as Alzheimer's disease. More recently, advocates have emerged to educate about sports concussions and chronic traumatic encephalopathy (CTE), including the Concussion Legacy Foundation (CLF). CTE is a neurodegenerative disease caused in part by repetitive head impacts (RHI). While the majority of CTE research has focused on studying former American football players, CTE has also been found in military personnel, victims of domestic violence, and contact sport athletes from high school to professional levels of play. Advocates' many goals include creating a culture of brain donation and modifying youth contact sports to decrease RHI. Here, we provide the first review of CTE advocacy, summarize the accomplishments of the CLF, and consider the connections between CTE advocacy, research, and legislation over the last decade.	[Uretsky, Madeline; Nowinski, Christopher J.] Boston Univ, Sch Med, Alzheimers Dis & Chron Traumat Encephalopathy Ctr, Boston, MA 02118 USA; [Uretsky, Madeline] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Nowinski, Christopher J.] Concuss Legacy Fdn, Boston, MA USA		Uretsky, M (corresponding author), Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, 72 East Concord St,Suite B-7800, Boston, MA 02118 USA.	muretsky@bu.edu		Uretsky, Madeline/0000-0002-7604-3619	R56NS078337 [National Institute of Neurological Disorders and Stroke] Funding Source: Medline; W81XWH-13-2-0064 [Department of Defense] Funding Source: Medline; U01NS093334 [National Institute of Neurological Disorders and Stroke] Funding Source: Medline; 1U01NS086659-01 [National Institute of Neurological Disorders and Stroke] Funding Source: Medline; R01NS078337 [National Institute of Neurological Disorders and Stroke] Funding Source: Medline		Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Belson K, NY TIMES; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; Cantu R., 2012, CONCUSSIONS OUR KIDS; Coghlin Craig J, 2009, J Can Chiropr Assoc, V53, P233; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Du M, 2018, YALE J BIOL MED, V91, P185; Farrey T, WHAT FLAG BECOMES ST; Friedman MJ, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0822-6; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goulet K, STOP CONCUSSION 2509; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; Irick E., NCAA SPORTS SPONSORS; Jones AL, 2018, NEUROLOGY, V90, pE474, DOI 10.1212/WNL.0000000000004927; Keene CD, 2018, ACTA NEUROPATHOL, V135, P303, DOI 10.1007/s00401-017-1801-z; Kilgore A, WASHINGTON POST; Legislative Assembly of Ontario, ROW LAW CONC SAF; Levy DT, 2018, TOB CONTROL, V27, P50, DOI 10.1136/tobaccocontrol-2016-053381; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2016, JAMA NEUROL, V73, P353, DOI 10.1001/jamaneurol.2015.3998; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Morris DH, 2014, ALCOHOL CLIN EXP RES, V38, P521, DOI 10.1111/acer.12252; National Council of Youth Sports, REP TRENDS PART ORG; National Federation of State High School Associations, 2017 2018 HIGH SCH A; National Football League, PLAYERS; Nowinski C, 2006, HEAD GAMES FOOTBALLS; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pop Warner National Staff, LTD CONT PRACT RUL; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Schwarz A, NY TIMES; Snedaker K, PINK CONCUSSION 2509; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Uretsky J, CONCUSSION MOM  2509; US Lacrosse, US LACR US LACR ANN	52	1	1	3	4	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	AUG	2020	40	04					461	468		10.1055/s-0040-1713621			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NL6KK	WOS:000567521900013	32712947				2022-02-06	
J	van Veen, E; van der Jagt, M; Citerio, G; Stocchetti, N; Epker, JL; Gommers, D; Burdorf, L; Menon, DK; Maas, AIR; Lingsma, HF; Kompanje, EJO				van Veen, Ernest; van der Jagt, Mathieu; Citerio, Giuseppe; Stocchetti, Nino; Epker, Jelle L.; Gommers, Diederik; Burdorf, Lex; Menon, David K.; Maas, Andrew I. R.; Lingsma, Hester F.; Kompanje, Erwin J. O.		CENTER-TBI Investigators Participa	End -of -life practices in traumatic brain injury patients: Report of a questionnaire from the CENTER-TBI study	JOURNAL OF CRITICAL CARE			English	Article						Traumatic brain injury; Withdrawing life-sustaining measures; Withholding treatment; End-of-life; Critical care	INTENSIVE-CARE UNITS; SUSTAINING THERAPIES; DECISION-MAKING; LARGE COHORT; WITHDRAWAL; SUPPORT; STATEMENT; ETHICS; RECOMMENDATIONS; VARIABILITY	Purpose: We aimed to study variation regarding speci fic end -of -life (EoL) practices in the intensive care unit (ICU) in traumatic brain injury (TBI) patients. Materials and methods: Respondents from 67 hospitals participating in The Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study completed several questionnaires on man- agement of TBI patients. Results: In 60% of the centers, ?50% of all patients with severe neurological damage dying in the ICU, die after withdrawal of life -sustaining measures (LSM). The decision to withhold/withdraw LSM was made following multidisciplinary consensus in every center. Legal representatives/relatives played a role in the decision - making process in 81% of the centers. In 82% of the centers, age played a role in the decision to withhold/with- draw LSM. Furthermore, palliative therapy was initiated in 79% of the centers after the decision to withdraw LSM was made. Last, withholding/withdrawing LSM was, generally, more often considered after more time had passed, in a patient with TBI, who remained in a very poor prognostic condition. Conclusion: We found variation regarding EoL practices in TBI patients. These results provide insight into variabil- ity regarding important issues pertaining to EoL practices in TBI, which can be useful to stimulate discussions on EoL practices, comparative effectiveness research, and, ultimately, development of recommendations. ? 2020 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).	[van Veen, Ernest; van der Jagt, Mathieu; Epker, Jelle L.; Gommers, Diederik; Kompanje, Erwin J. O.] Erasmus MC, Dept Intens Care, POB 2040, NL-3000 CA Rotterdam, Netherlands; [van Veen, Ernest; Burdorf, Lex; Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [van Veen, Ernest; Kompanje, Erwin J. O.] Erasmus MC, Dept Med Eth & Philosophy Med, Rotterdam, Netherlands; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Citerio, Giuseppe] ASST Monza, San Gerardo Hosp, Monza, Italy; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Stocchetti, Nino] Neuro ICU Fdn IRCCS Ca Granda Osped Maggiore Poli, Milan, Italy; [Menon, David K.] Univ Cambridge, Dept Anaesthesia, Cambridge, England; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium		Kompanje, EJO (corresponding author), Erasmus MC, Dept Intens Care, POB 2040, NL-3000 CA Rotterdam, Netherlands.	e.vanveen.1@erasmusmc.nl; m.vanderjagt@erasmusmc.nl; giuseppe.citerio@unimib.it; nino.stocchetti@policlinico.mi.it; j.epker@erasmusmc.nl; d.gommers@erasmusmc.nl; a.burdurf@erasmusmc.nl; dkm13@cam.ac.uk; andrew.Maas@uza.be; h.lingsma@erasmusmc.nl; e.j.o.kompanje@erasmusmc.nl	Posti, Jussi P./Y-2908-2019; van der Jagt, Mathieu/G-1905-2017	Posti, Jussi P./0000-0002-5925-5193; van der Jagt, Mathieu/0000-0003-2566-8325	Framework 7 program of the European Union [602150]; National Institute for Health Research (UK)National Institute for Health Research (NIHR)	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project, supported by the Framework 7 program of the European Union (602150). The funder had no role in the design of the study, the collection, analysis, and interpretation of data, or in writing the manuscript.; David K. Menon was supported by a Senior Investigator Award from the National Institute for Health Research (UK). The funder had no role in the design of the study, the collection, analysis, and interpretation of data, or in writing the manuscript.	Asch DA, 1996, MED CARE, V34, P103, DOI 10.1097/00005650-199602000-00002; Azoulay E, 2009, INTENS CARE MED, V35, P623, DOI 10.1007/s00134-008-1310-6; Bosslet GT, 2015, AM J RESP CRIT CARE, V191, P1318, DOI 10.1164/rccm.201505-0924ST; Bulow HH, 2012, INTENS CARE MED, V38, P1126, DOI 10.1007/s00134-012-2554-8; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; COOK DJ, 1995, JAMA-J AM MED ASSOC, V273, P703, DOI 10.1001/jama.273.9.703; Cooper Z, 2009, J TRAUMA, V66, P1327, DOI 10.1097/TA.0b013e31819ea047; Curtis JR, 2010, LANCET, V376, P1347, DOI 10.1016/S0140-6736(10)60143-2; Downar J, 2016, INTENS CARE MED, V42, P1003, DOI 10.1007/s00134-016-4330-7; Esteban A, 2001, INTENS CARE MED, V27, P1744, DOI 10.1007/s00134-001-1111-7; Ferrand E, 2001, LANCET, V357, P9, DOI 10.1016/S0140-6736(00)03564-9; Garland A, 2007, J PALLIAT MED, V10, P1298, DOI 10.1089/jpm.2007.0061; Guidet B, 2014, J CRIT CARE, V29, P896, DOI 10.1016/j.jcrc.2014.08.004; Hawryluck Laura A, 2002, BMC Med Ethics, V3, pE3; Heyland DK, 2003, INTENS CARE MED, V29, P75, DOI 10.1007/s00134-002-1569-y; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Joynt GM, 2015, J CRIT CARE, V30, P224, DOI 10.1016/j.jcrc.2014.10.011; Kapadia F, 2005, CRIT CARE MED, V33, P1272, DOI 10.1097/01.CCM.0000165557.02879.29; Keenan SP, 1998, CRIT CARE MED, V26, P245, DOI 10.1097/00003246-199802000-00018; Keenan SP, 1997, CRIT CARE MED, V25, P1324, DOI 10.1097/00003246-199708000-00019; Kompanje EJO, 2013, CURR OPIN CRIT CARE, V19, P630, DOI 10.1097/MCC.0000000000000026; Kon AA, 2016, CRIT CARE MED, V44, P188, DOI 10.1097/CCM.0000000000001396; Lazaridis C, 2019, NEUROCRIT CARE, V30, P33, DOI 10.1007/s12028-018-0595-8; Long AC, 2019, CRIT CARE MED, V47, P1396, DOI 10.1097/CCM.0000000000003922; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Mark NM, 2015, INTENS CARE MED, V41, P1572, DOI 10.1007/s00134-015-3810-5; McLean RF, 2000, CRIT CARE MED, V28, P100, DOI 10.1097/00003246-200001000-00016; MERTON Robert. K., 1948, ANTIOCH REV, V8, P193, DOI [10.2307/4609267, DOI 10.2307/4609267]; Myburgh J, 2016, J CRIT CARE, V34, P125, DOI 10.1016/j.jcrc.2016.04.017; Nesseler N, 2018, EUR J ANAESTH, V35, P511, DOI 10.1097/EJA.0000000000000783; Ouanes I, 2012, INTENS CARE MED, V38, P710, DOI 10.1007/s00134-012-2500-9; Payer L., 1988, MED CULTURE, P204; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Prendergast TJ, 1997, AM J RESP CRIT CARE, V155, P15, DOI 10.1164/ajrccm.155.1.9001282; Quill CM, 2014, CHEST, V146, P573, DOI 10.1378/chest.13-2529; Smith AK, 2013, NEW ENGL J MED, V368, P2448, DOI 10.1056/NEJMp1303295; Souter MJ, 2015, NEUROCRIT CARE, V23, P4, DOI 10.1007/s12028-015-0137-6; Sprung CL, 2007, INTENS CARE MED, V33, P1732, DOI 10.1007/s00134-007-0693-0; Sprung CL, 2014, AM J RESP CRIT CARE, V190, P855, DOI 10.1164/rccm.201403-0593CC; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Steinberg A, 2006, INTENS CARE MED, V32, P1234, DOI 10.1007/s00134-006-0186-6; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Truog RD, 2008, CRIT CARE MED, V36, P953, DOI 10.1097/CCM.0B013E3181659096; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Wendler D, 2011, ANN INTERN MED, V154, P336, DOI 10.7326/0003-4819-154-5-201103010-00008; Wilkinson DJC, 2013, INTENS CARE MED, V39, P1128, DOI 10.1007/s00134-013-2871-6; Wunsch H, 2005, INTENS CARE MED, V31, P823, DOI 10.1007/s00134-005-2644-y	49	1	1	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	AUG	2020	58						78	88		10.1016/j.jcrc.2020.04.001			11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MB9MU	WOS:000542921700014	32387842	Green Published, hybrid			2022-02-06	
J	Wang, RR; He, M; Kang, Y; Xu, JG				Wang, Ruoran; He, Min; Kang, Yan; Xu, Jianguo			Controlling nutritional status (CONUT) score is a predictive marker for patients with traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						CONUT; Traumatic brain injury; Controlling nutritional status score; Prognosis marker	BODY-MASS INDEX; INDEPENDENT PREDICTOR; ACUTE-PHASE; IMPACT; HYPOCHOLESTEROLEMIA; MALNUTRITION; MORTALITY; OUTCOMES; EPIDEMIOLOGY; INFLAMMATION	Object: We designed this study to evaluate whether controlling nutritional status (CONUT) score was valuable in predicting outcome of patients with traumatic brain injury (TBI). Methods: Clinical and laboratory data of patients admitted with TBI in our hospital between January 2015 and January 2018 was retrospectively collected. We divided patients into two groups according to in-hospital and 90-day outcome respectively and compared baseline characteristics of two groups. Multivariate analyses were conducted to evaluate whether CONUT score was associated with outcome of included patients. Receiver operating characteristics (ROC) curves were drawn to compare the predictive value of CONUT score and constructed models. Results: A total of 365 patients were included in our study. Multivariate logistic regression analyses showed that CONUT score was independently associated with in-hospital mortality (OR = 1.244, 95% CI: 1.099-1.408, p = 0.001) and 90-day outcome (OR = 1.441, 95% CI: 1.193-1.741, p < 0.001). ROC curve showed that area under the ROC curve (AUC) of CONUT score for predicting in-hospital mortality and 90-day outcome were 0.790 (95% CI: 0.745-0.836, p < 0.001) and 0.839 (95% CI: 0.792-0.886, p < 0.001), respectively. Conclusion: CONUT score is independently associated with in-hospital mortality and 90-day outcome of patients with TBI.	[Wang, Ruoran; He, Min; Kang, Yan] Sichuan Univ, West China Hosp, Dept Crit Care Med, Chengdu 610041, Sichuan, Peoples R China; [Xu, Jianguo] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu 610041, Sichuan, Peoples R China		Xu, JG (corresponding author), West China Hosp, Dept Neurosurg, 37 Guo Xue Xiang, Chengdu, Sichuan, Peoples R China.; Kang, Y (corresponding author), West China Hosp, Dept Crit Care Med, 37 Guo Xue Xiang, Chengdu, Sichuan, Peoples R China.	kangyan@scu.edu.cn; jianguo_1229@126.com					Agarwal E, 2013, CLIN NUTR, V32, P737, DOI 10.1016/j.clnu.2012.11.021; Ahiko Y, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6218-8; Alwarawrah Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01055; Baltazar GA, 2015, AM SURGEON, V81, pE61; Bentz MH, 1998, REV MED INTERNE, V19, P168, DOI 10.1016/S0248-8663(97)80715-1; Bonnefoy M, 2002, REV MED INTERNE, V23, P991, DOI 10.1016/S0248-8663(02)00718-X; Burke DT, 2019, PM&R, V11, P1045, DOI 10.1002/pmrj.12091; Chabok SY, 2014, EUR J TRAUMA EMERG S, V40, P51, DOI 10.1007/s00068-013-0314-2; Chen D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093167; Chen JG, 2019, NEUROCRIT CARE, V30, P334, DOI 10.1007/s12028-018-0622-9; Chen WQ, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000320; Cohen S, 2017, EUR J IMMUNOL, V47, P225, DOI 10.1002/eji.201646423; Czorlich P, 2017, WORLD NEUROSURG, V107, P515, DOI 10.1016/j.wneu.2017.08.010; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Dinet V, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01178; Dunham CM, 2003, CRIT CARE, V7, pR145, DOI 10.1186/cc2382; Esper Dema Halasa, 2005, Nutr Clin Pract, V20, P369, DOI 10.1177/0115426505020004369; Fukushima K, 2011, TOHOKU J EXP MED, V224, P215, DOI 10.1620/tjem.224.215; Gui D, 1996, INTENS CARE MED, V22, P790, DOI 10.1007/s001340050168; Hu P, 2018, J NEUROTRAUM, V35, P2400, DOI 10.1089/neu.2017.5422; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ignacio de Ulíbarri J., 2005, Nutr. Hosp., V20, P38; Jacome T, 2018, NEUROCRIT CARE, V28, P110, DOI 10.1007/s12028-017-0410-y; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jia K, 2018, NEUROPSYCH DIS TREAT, V14, P1561, DOI 10.2147/NDT.S149802; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lim SL, 2012, CLIN NUTR, V31, P345, DOI 10.1016/j.clnu.2011.11.001; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Montalcini T, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0660-4; Naito H, 2018, NUTRITION, V55-56, P1, DOI 10.1016/j.nut.2018.02.025; Nakagomi A, 2016, J ATHEROSCLER THROMB, V23, P713, DOI 10.5551/jat.31526; Ohba T, 2019, J THORAC DIS, V11, P3757, DOI 10.21037/jtd.2019.09.29; Okamoto S, 2020, ANN HEMATOL, V99, P113, DOI 10.1007/s00277-019-03844-2; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peters SJAC, 2010, CELL TISSUE RES, V340, P451, DOI 10.1007/s00441-010-0955-y; Qi SY, 2016, J BIOL REG HOMEOS AG, V30, P227; Rodney T, 2018, CYTOKINE, V110, P248, DOI 10.1016/j.cyto.2018.01.012; Shibahashi K, 2017, WORLD NEUROSURG, V106, P589, DOI 10.1016/j.wneu.2017.07.025; Suzuki H., 2019, UROL ONCOL; Takamori S, 2017, CLIN LUNG CANCER, V18, DOI 10.1016/j.cllc.2017.01.008; Thelin EP, 2018, J NEUROTRAUM, V35, P341, DOI 10.1089/neu.2017.5155; Zhao JL, 2019, WORLD NEUROSURG	44	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	AUG	2020	195								105909	10.1016/j.clineuro.2020.105909			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	PI8VI	WOS:000601361200027	32652392				2022-02-06	
J	Wang, XP; Zhong, J; Lei, T; Wang, HJ; Zhu, LN; Chu, SS; Liu, L				Wang, Xue-ping; Zhong, Jie; Lei, Ting; Wang, Hai-jiao; Zhu, Li-na; Chu, Shanshan; Liu, Ling			Epidemiology of traumatic brain injury-associated epilepsy in western China: An analysis of multicenter data	EPILEPSY RESEARCH			English	Article						Posttraumatic; Epilepsy; Traumatic brain injury; Incidence; Risk factors	LATE POSTTRAUMATIC SEIZURES; RISK-FACTORS; HEAD-INJURY; HOSPITALIZATION; HIPPOCAMPAL; PREDICTION; OUTCOMES	Objectives: This study aims to explore the probability of developing posttraumatic epilepsy (PTE) in the following 8 years after traumatic brain injury (TBI), the risk factors associated with PTE and its cumulative prevalence. Methods: This is a retrospective follow-up study of patients with traumatic brain injury (TBI) discharged from the West China Hospital between January 1, 2011 and December 31, 2017, Chengdu Shang Jin Nan Fu Hospital and Sichuan Provincial People's Hospital from January 1, 2013 to March 1, 2015. We used forward stepwise method to build the final multivariate cox proportional hazard regression model to obtain estimates of hazard ratio (HR) of PTE and 95% confidence intervals (CI). We also conducted Kaplan-Meier survival analysis to investigate the cumulative prevalence of PTE. Results: The cumulative incidence of PTE rose from 6.2% in one year to 10.6% in eight years. There were more male patients in PTE group and generally older. Besides, patients with PTE tended to have abnormal CT scan results. The risk factors of PTE were male (HR= 1.6, 95% CI: 1.1-2.2, P = 0.009), early posttraumatic seizures (HR= 2.9, 95% CI: 2.2-4.1, P < 0.001), TBI severity (moderate TBI: HR= 3.0, 95% CI: 1.8-5.0, P= 0.001; severe TBI: HR= 4.3, 95% CI: 2.3-7.6, P < 0.029), loss of consciousness (LOC) more than 30 min (30 min-24 h: HR= 1.8, 95% CI: 1.02-3.1, P= 0.041;> 24 h: HR= 2.4, 95% CI: 1.4-2.4, P= 0.001), subdural hematoma (SDH) (HR= 1.9, 95% CI: 1.4-2.5, P < 0.001), brain contusion sites (frontal-temporal lobe: HR= 2.7, 95% CI: 1.9-3.9, P < 0.001; other sites: HR= 1.5, 95% CI: 1.01-2.3, P= 0.042) and cranial surgery (HR = 1.7, 95% CI: 1.3-2.3, P < 0.001). Significance: The probability of developing PTE increased during the study period. In addition, the risk of developing PTE was significantly associated with gender, EPTS, LOC time, SDH, brain contusion sites, surgery and TBI severity. However, further researches may be needed to predict the risk of PTE in combination with quantitative factors.	[Wang, Xue-ping; Wang, Hai-jiao; Zhu, Li-na; Chu, Shanshan; Liu, Ling] Sichuan Univ, West China Hosp, Dept Neurol, 37 Guo Xue Xiang, Chengdu 610041, Sichuan, Peoples R China; [Zhong, Jie] Sichuan Prov Peoples Hosp, Dept Ophthalmol, 32 West Second Sect First Ring Rd, Chengdu, Sichuan, Peoples R China; [Lei, Ting] Sichuan Univ, Shang Jin Nan Fu Hosp, Dept Neurosurg, West China Hosp, 253 Shang Jin Rd, Chengdu 610041, Sichuan, Peoples R China		Liu, L (corresponding author), Sichuan Univ, West China Hosp, Dept Neurol, 37 Guo Xue Xiang, Chengdu 610041, Sichuan, Peoples R China.	zjllxx1968@163.com			1.3.5 project for disciplines of excellence - Clinical Research Incubation Project, West China Hospital, Sichuan University [2019HXFH048]	This study was funded by 1.3.5 project for disciplines of excellence - Clinical Research Incubation Project, West China Hospital, Sichuan University (2019HXFH048).	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; ARMSTRONG KK, 1990, ARCH PHYS MED REHAB, V71, P156; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Chen LLK, 2014, MIL MED, V179, P492, DOI 10.7205/MILMED-D-13-00413; Chen W, 2017, NEUROPSYCH DIS TREAT, V13, P2301, DOI 10.2147/NDT.S141486; Christensen J, 2012, EPILEPSIA, V53, P43, DOI 10.1111/j.1528-1167.2012.03612.x; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Da Silva A Martins, 2012, Handb Clin Neurol, V108, P585, DOI 10.1016/B978-0-444-52899-5.00017-4; De Santis A, 1992, Acta Neurochir Suppl (Wien), V55, P64; DeGrauw X, 2018, EPILEPSY RES, V146, P41, DOI 10.1016/j.eplepsyres.2018.07.012; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fisher RS, 2012, EPILEPSY BEHAV, V24, P304, DOI 10.1016/j.yebeh.2012.04.128; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Iudice A, 2000, DRUGS, V59, P1091, DOI 10.2165/00003495-200059050-00005; Kim JA, 2018, ANN NEUROL, V83, P858, DOI 10.1002/ana.25211; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Mahler B, 2015, EPILEPSIA, V56, P1438, DOI 10.1111/epi.13096; Mamad O, 2018, BRAIN RES, V1681, P64, DOI 10.1016/j.brainres.2017.12.036; Messori A, 2005, EPILEPSIA, V46, P1472, DOI 10.1111/j.1528-1167.2005.34004.x; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Pitkanen A., 2012, HEAD TRAUMA EPILEPSY; Ritter AC, 2016, EPILEPSIA, V57, P1968, DOI 10.1111/epi.13582; Ritter AC, 2016, EPILEPSIA, V57, P1503, DOI 10.1111/epi.13470; Scharfman HE, 2007, CURR NEUROL NEUROSCI, V7, P348, DOI 10.1007/s11910-007-0053-z; Sills Graeme J, 2007, Epilepsy Curr, V7, P103, DOI 10.1111/j.1535-7511.2007.00189.x; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Statler KD, 2006, DEV NEUROSCI-BASEL, V28, P354, DOI 10.1159/000094162; Tubiv MA, 2019, NEUROBIOL DIS, V123, P115, DOI 10.1016/j.nbd.2018.05.014; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Walker WC, 2015, J HEAD TRAUMA REHAB, V30, P231, DOI 10.1097/HTR.0000000000000127; Wang HQ, 2013, EPILEPSY RES, V107, P272, DOI 10.1016/j.eplepsyres.2013.10.006; Wang HC, 2008, J TRAUMA, V64, P883, DOI 10.1097/TA.0b013e31804a7fa4; Xu T, 2017, EPILEPSY BEHAV, V67, P1, DOI 10.1016/j.yebeh.2016.10.026; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; Zhao YQ, 2012, SEIZURE-EUR J EPILEP, V21, P322, DOI 10.1016/j.seizure.2012.02.007	43	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	AUG	2020	164								106354	10.1016/j.eplepsyres.2020.106354			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LW7RG	WOS:000539340300004	32438297				2022-02-06	
J	Watson, J; Brown, CC; Hirst, RB; Thompson, RC				Watson, Jessica; Brown, Colin C.; Hirst, Rayna B.; Thompson, Ryan C.			Commonality in Abnormality: "Abnormal" Neuropsychological Scores Are Common in Baseline Testing of Youth Athletes	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Assessment; Childhood brain insult; Head injury; Traumatic brain injury; Intelligence; Norms/normative studies	MILD COGNITIVE IMPAIRMENT; PERFORMANCE VALIDITY; PREVALENCE; CHILDREN; ADULTS; RATES	Objective: Although research shows that abnormal scores are common in adults, fewer studies examine the frequency of abnormal scores within children. The present study assessed how specific tests, cognitive domains, and patient factors affect the likelihood of abnormally low scores among healthy youth athletes. Method: Youth athletes (n = 85, M-age = 11.72, SD = 2.23) completed a comprehensive neuropsychological battery (n = 23 tests) during baseline testing for a sport-related concussion clinical research program. "Abnormal" scores were defined using cutoffs at 1, 1.5, and 2 standard deviations (SDs) below the population mean. Univariate and multivariate Poisson regression models examined abnormal test scores as a function of age, sex, ethnicity, and Full-Scale Intelligence Quotient (FSIQ). Results: Using cutoffs of 1, 1.5, and 2 SDs, the percent of healthy participants with at least one abnormal test score was 61.2, 36.5, and 22.4%, respectively, indicating a high proportion of healthy participants with abnormal scores and low specificity for tests using these cutoffs. In univariate Poisson regression analyses, FSIQ and abnormal score were negatively correlated (p <.001), wherein lower FSIQ was associated with more abnormal scores. In multivariate regression analyses, lower performance on executive function, memory, and processing speed tests was significantly associated with an increased frequency of abnormal scores. Conclusions: Abnormally low scores in healthy youth occur frequently and do not necessarily represent functional deficits. Cutoffs of 2 SDs should be considered for many tests to increase specificity and reduce the risk of false positive errors that could lead to negative clinical outcomes.	[Watson, Jessica; Brown, Colin C.; Hirst, Rayna B.; Thompson, Ryan C.] Palo Alto Univ, Palo Alto, CA 94304 USA		Watson, J (corresponding author), Palo Alto Univ, Dept Psychol, 1791 Arastradero Rd, Palo Alto, CA 94304 USA.	jwatson@paloaltou.edu					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Axelrod BN, 2008, APPL NEUROPSYCHOL, V15, P170, DOI 10.1080/09084280802324184; BENTON A, 1978, TEST FACIAL RECOGNIT; Benton A. L., 1977, TEST JUDGEMENT LINE; Bickel H, 2006, DEMENT GERIATR COGN, V21, P242, DOI 10.1159/000091397; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Brooks BL, 2007, J INT NEUROPSYCH SOC, V13, P490, DOI 10.1017/D1355617707070531; Brooks BL, 2010, PSYCHOL ASSESSMENT, V22, P650, DOI 10.1037/a0019781; Brooks BL, 2010, ARCH CLIN NEUROPSYCH, V25, P182, DOI 10.1093/arclin/acq005; Busse A, 2006, NEUROLOGY, V67, P2176, DOI 10.1212/01.wnl.0000249117.23318.e1; Cook NE, 2019, CHILD NEUROPSYCHOL, V25, P836, DOI 10.1080/09297049.2018.1543389; Crawford J. R., 2008, J INT NEUROPSYCHOLOG, V14; Crawford JR, 2007, NEUROPSYCHOLOGY, V21, P419, DOI 10.1037/0894-4105.21.4.419; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davis JJ, 2013, J CLIN EXP NEUROPSYC, V35, P413, DOI 10.1080/13803395.2013.781134; Davis JJ, 2012, CLIN NEUROPSYCHOL, V26, P850, DOI 10.1080/13854046.2012.686631; Delis DC., 2001, DELIS KAPLAN EXECUTI; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P1082, DOI 10.1037/pas0000561; Golden C. J., 2003, STROOP COLOR WORD TE; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Heaton R. K., 2004, REVISED COMPREHENSIV; Heaton RK, 1991, COMPREHENSIVE NORMS; Iverson GL, 2008, NEUROPSYCHOLOGY COUR, P243; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P923, DOI 10.1007/978-0-387-76978-3_32; Jak AJ, 2009, AM J GERIAT PSYCHIAT, V17, P368, DOI 10.1097/JGP.0b013e31819431d5; Korkman M., 2007, NEPSY II ADM MANUAL; Langner R, 2010, ACTA PSYCHOL, V133, P64, DOI 10.1016/j.actpsy.2009.10.001; LeMonda BC, 2017, DEV NEUROPSYCHOL, V42, P113, DOI 10.1080/87565641.2016.1274315; Macher RB, 2012, J CLIN EXP NEUROPSYC, V34, P405, DOI 10.1080/13803395.2011.646957; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; National Council of Youth Sports, 2008, REP TRENDS PART ORG; Palmer BW, 1998, ARCH CLIN NEUROPSYCH, V13, P503, DOI 10.1016/S0887-6177(97)00037-1; Rey A., 1964, EXAMEN CLIN PSYCHOL, P121; Ross S, 2009, 1 COURSE PROBABILITY; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Sheslow DA, 2003, WIDE RANGE ASSESSMEN; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vinck A, 2010, EUR J PAEDIATR NEURO, V14, P86, DOI 10.1016/j.ejpn.2009.01.003; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 1997, MANUAL WECHSLER ADUL; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Yeates KO, 2003, J INT NEUROPSYCH SOC, V9, P653, DOI 10.1017/S1355617703940057	45	1	1	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2020	35	5					469	481		10.1093/arclin/acaa015			13	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	NY8KY	WOS:000576633100002	32186667	Bronze			2022-02-06	
J	Winans, NJ; Liang, JJ; Ashcroft, B; Doyle, S; Fry, A; Fiore, SM; Mofakham, S; Mikell, CB				Winans, Nathan J.; Liang, Justine J.; Ashcroft, Bradley; Doyle, Stephen; Fry, Adam; Fiore, Susan M.; Mofakham, Sima; Mikell, Charles B.			Modeling the return to consciousness after severe traumatic brain injury at a large academic level 1 trauma center	JOURNAL OF NEUROSURGERY			English	Article						severe TBI; traumatic brain injury; traumatic coma; time to follow commands	SCORE	OBJECTIVE Severe traumatic brain injury (sTBI) carries significant morbidity and mortality. It remains difficult to counsel families on functional prognosis and plan research initiatives aimed at treating traumatic coma. In order to better address these problems, the authors set out to develop statistical models using retrospective data to identify admission characteristics that correlate with time until the return of consciousness, defined as the time to follow commands (TFC). These results were then used to create a TFC score, allowing for rapid identification of patients with predicted prolonged TFC. METHODS Data were reviewed and collected from medical records of sTBI patients with Glasgow Coma Scale (GCS) motor subscores <= 5 who were admitted to Stony Brook University Hospital from January 2011 to July 2018. Data were used to calculate descriptive statistics and build binary logistic regression models to identify admission characteristics that correlated with in-hospital mortality and in-hospital command-following. A Cox proportional hazards model was used to identify admission characteristics that correlated with the length of TFC. A TFC score was developed using the significant variables identified in the Cox regression model. RESULTS There were 402 adult patients who met the inclusion criteria for this study. The average age was 50.5 years, and 122 (30.3%) patients were women. In-hospital mortality was associated with older age, higher Injury Severity Score (ISS), higher Rotterdam score (head CT grading system), and the presence of bilateral fixed and dilated pupils (p < 0.01). In-hospital command-following was anticorrelated with age, ISS, Rotterdam score, and the presence of a single fixed and dilated pupil (p < 0.05). TFC was anticorrelated with age, ISS, Rotterdam score, and the presence of a single fixed and dilated pupil. Additionally, patients who sustained injuries from falls from standing height had a shorter average TFC. The 3 significant variables from the Cox regression model that explained the most variance were used to create a 4-point TFC score. The most significant of these characteristics were Rotterdam head CT scores, high impact traumas, and the presence of a single fixed and dilated pupil. Importantly, the presence of a single fixed and dilated pupil was correlated with longer TFC but no increase in likelihood of in-hospital mortality. CONCLUSIONS The creation of the 4-point TFC score will allow clinicians to quickly identify patients with predicted prolonged TFC and estimate the likelihood of command-following at different times after injury. Discussions with family members should take into account the likelihood that patients will return to consciousness and survive after TBI.	[Winans, Nathan J.; Liang, Justine J.; Ashcroft, Bradley; Fiore, Susan M.; Mofakham, Sima; Mikell, Charles B.] SUNY Stony Brook, Sch Med, Dept Neurol Surg, Stony Brook, NY 11794 USA; [Doyle, Stephen] Christiana Care Hlth Syst, Dept Emergency Med, Newark, DE USA; [Fry, Adam] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA		Mikell, CB (corresponding author), SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA.	charles.mikell@stonybrookmedicine.edu			Department of Neurosurgery, Stony Brook University School of Medicine	Funding was provided by the Department of Neurosurgery, Stony Brook University School of Medicine, for medical student summer research scholarships.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brennan PM, 2018, J NEUROSURG, V128, P1612, DOI 10.3171/2017.12.JNS172780; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; COX DR, 1972, J R STAT SOC B, V34, P187; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Sterling P, 2015, PRINCIPLES NEURAL DE; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Vedantam A, 2018, J NEUROSURG, V129, P234, DOI 10.3171/2017.3.JNS162720; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016	13	1	1	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2020	133	2					477	485		10.3171/2019.2.JNS183568			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OM5TQ	WOS:000586087300024	31200372				2022-02-06	
J	Yoneoka, Y; Aizawa, N; Nonomura, Y; Ogi, M; Seki, Y; Akiyama, K				Yoneoka, Yuichiro; Aizawa, Naotaka; Nonomura, Yoriko; Ogi, Manabu; Seki, Yasuhiro; Akiyama, Katsuhiko			Traumatic Nonmissile Penetrating Transnasal Anterior Skull Base Fracture and Brain Injury with Cerebrospinal Fluid Leak: Intraoperative Leak Detection and an Effective Reconstruction Procedure for a Localized Skull Base Defect Especially After Coronavirus Disease 2019 Outbreak	WORLD NEUROSURGERY			English	Article						Cerebrospinal fluid leakage; COVID-19 era; Endonasal endoscopic repair; Fat-on-fascia graft; Fluorescein; Skull base defect; Traumatic nonmissile penetrating transnasal skull base fracture	MANAGEMENT; REPAIR; 3RD-VENTRICLE; INFUNDIBULUM; RESECTION	BACKGROUND: Cerebrospinal fluid (CSF) leakage after penetrating skull base injury is relatively rare compared with close head injuries involving skull base fractures. CASE DESCRIPTION: We report the case of a 65-year-old man who had presented with epistaxis and serous rhinorrhea. When he had fallen to the ground near his bee boxes, a garden pole had poked into his right nostril. He had instantly removed the pole from his nostril himself. However, immediately after removal of the pole, he had developed nasal bleeding and serous rhinorrhea. He then drove to our emergency room. Computed tomography showed pneumocephalus with a minor cerebral contusion in the left frontal lobe and a penetrating injury in the left anterior skull base. His CSF leakage had not resolve spontaneously within 1 week after the injury with strict bed rest. We repaired the CSF leakage using a fat (adipose tissue)-on-fascia autograft plug and caulked the defect in the anterior skull base with the fat-on-fascia graft (FFG) plug through the left nostril with endoscopic guidance. The CSF rhinorrhea was successfully controlled. Intranasal local application of fluorescein aided in the detection of the direction of flow of the CSF leakage. CONCLUSIONS: Endonasal endoscopic caulking of a skull base defect using an FFG plug can be useful to treat CSF leakage due to the localized skull base defect, especially in the coronavirus disease 2019 pandemic. It is simple, inexpensive, and timesaving. It requires no special skills nor sophisticated instruments that can cause aerosolization, reducing the risk of infection during the surgery.	[Yoneoka, Yuichiro; Seki, Yasuhiro; Akiyama, Katsuhiko] Niigata Univ, Med & Dent Hosp, Dept Neuorsurg, Uonuma Inst Community, Niigata, Japan; [Aizawa, Naotaka; Nonomura, Yoriko; Ogi, Manabu] Niigata Univ, Med & Dent Hosp, Dept Otorhinolaryngol, Uonuma Inst Community, Niigata, Japan		Yoneoka, Y (corresponding author), Niigata Univ, Med & Dent Hosp, Dept Neuorsurg, Uonuma Inst Community, Niigata, Japan.	yone@bri.niigata-u.ac.jp		Yoneoka, Yuichiro/0000-0002-1467-5864			Bai WL, 2011, AM J OTOLARYNG, V32, P165, DOI 10.1016/j.amjoto.2009.11.005; Cetinkaya EA, 2006, J LARYNGOL OTOL, V120, P325, DOI 10.1017/S0022215106000181; Gardner P, 2008, J NEUROSURG, V108, P395, DOI 10.3171/JNS/2008/108/2/0395; Ghadersohi S, 2017, AM J RHINOL ALLERGY, V31, pE29, DOI 10.2500/ajra.2017.31.4421; Giwa A L, 2020, Pediatr Emerg Med Pract, V17, P1; Jahanshahi J, 2017, AM J RHINOL ALLERGY, V31, P406, DOI 10.2500/ajra.2017.31.4478; Jinguji S, 2013, ACTA NEUROCHIR, V155, P119, DOI 10.1007/s00701-012-1543-6; Kassam Amin, 2005, Neurosurg Focus, V19, pE8; Le C, 2016, J NEUROL SURG PART B, V77, P404, DOI 10.1055/s-0036-1584229; Lee DH, 2011, J CRANIOFAC SURG, V22, P1800, DOI 10.1097/SCS.0b013e31822e829f; Locatelli D, 2006, NEUROSURGERY, V58, P246, DOI 10.1227/01.NEU.0000193924.65297.3F; Nguyen HS, 2016, WORLD NEUROSURG, V96, DOI 10.1016/j.wneu.2016.09.021; Oakley GM, 2016, INT FORUM ALLERGY RH, V6, P8, DOI 10.1002/alr.21637; Oh Ji-Woong, 2017, Korean J Neurotrauma, V13, P63, DOI 10.13004/kjnt.2017.13.2.63; Patron V, 2015, EUR ANN OTORHINOLARY, V132, P347, DOI 10.1016/j.anorl.2015.08.031; Saafan ME, 2014, EUR ARCH OTO-RHINO-L, V271, P1073, DOI 10.1007/s00405-013-2674-y; Teng TS, 2019, EXCLI J, V18, P223, DOI 10.17179/excli2018-1971; Virgin F, 2011, OTOLARYNG HEAD NECK, V145, P338, DOI 10.1177/0194599811404527; Workman AD, 2020, INT FORUM ALLERGY RH, V10, P798, DOI 10.1002/alr.22577; Yoneoka Y, 2017, INTERDISCIP NEUROSUR, V10, P122, DOI 10.1016/j.inat.2017.08.004; Yoneoka Y, 2018, PEDIATR NEUROSURG, V53, P49, DOI 10.1159/000480021; Yoneoka Y, 2014, INTERDISCIP NEUROSUR, V1, P21, DOI 10.1016/j.inat.2014.03.001; Yoneoka Y, 2013, ACTA NEUROCHIR, V155, P1049, DOI 10.1007/s00701-013-1687-z; Yucel A, 2018, J CRANIOFAC SURG, V29, pE694, DOI 10.1097/SCS.0000000000004940	24	1	1	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2020	140						166	172		10.1016/j.wneu.2020.05.236			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NA3SR	WOS:000559734600032	32497852	Green Published, Bronze			2022-02-06	
J	Zhao, JJ; Wang, B; Wu, X; Yang, ZB; Huang, TQ; Guo, XY; Guo, D; Liu, ZW; Song, JN				Zhao, Junjie; Wang, Bo; Wu, Xiang; Yang, Zhongbo; Huang, Tingqin; Guo, Xiaoye; Guo, Dan; Liu, Zunwei; Song, Jinning			TGF beta 1 alleviates axonal injury by regulating microglia/macrophages alternative activation in traumatic brain injury	BRAIN RESEARCH BULLETIN			English	Article						TGF beta 1; Traumatic brain injury; Axonal injury; Microglia/macrophages; Classical activation; Alternative activation	BETA-R-I; NEUROINFLAMMATORY RESPONSES; WHITE-MATTER; MICROGLIA; POLARIZATION; INFLAMMATION; MACROPHAGES	Traumatic brain injury (TBI) causes substantial mortality and long-term disability worldwide. TGF beta 1 is a unique molecular and functional signature in microglia, but the role of TGF beta 1 in TBI is not clear. The purpose of this study was to investigate the role of TGF beta 1 in TBI. The weight dropping device was used to establish TBI model of rats. Hematoxylin eosin staining and Bielschowsky silver staining were used to assess tissue loss. Beam walking and muscle strength tests were used to assess neurological deficits. Immunohistochemical staining was used to assess axonal injures. Western blotting was used to detect expression of related proteins. RT-PCR was used to detect expression of cytokines. Immunofluorescence staining was used to assess the microglia/macrophages activation. We observed obvious axonal injury and microglia/macrophages activation in the peri-lesion cortex. The expression of inflammatory cytokines was markedly high after TBI. The expression of TGF beta 1 and TGF beta RI were significantly reduced after TBI. TGF beta 1 promoted the functional recovery and alleviated axonal injury 1 day after TBI. TGF beta 1 promoted microglia/macrophages polarizing to alternative activation and alleviated neuroinflammation. These effects of TGF beta 1 could be inhibited by LY2109761, the inhibitor of TGFRI/II. These results suggested that TGF beta 1 played a protective role in axonal injury and could be a potential therapeutic target in early stages following TBI.	[Zhao, Junjie; Wang, Bo; Wu, Xiang; Yang, Zhongbo; Guo, Xiaoye; Song, Jinning] Xi An Jiao Tong Univ, Dept Neurosurg, Affiliated Hosp 1, Xian 710061, Shaanxi, Peoples R China; [Huang, Tingqin] Xi An Jiao Tong Univ, Dept Neurosurg, Affiliated Hosp 2, Xian 710004, Shaanxi, Peoples R China; [Guo, Dan] Xian Med Univ, Dept Sci & Technol, Xian 710021, Shaanxi, Peoples R China; [Liu, Zunwei] Xi An Jiao Tong Univ, Inst Organ Transplantat, Affiliated Hosp 1, Xian 710061, Shaanxi, Peoples R China; [Liu, Zunwei] Xi An Jiao Tong Univ, Nephropathy Hosp, Affiliated Hosp 1, Dept Renal Transplantat, Xian 710061, Shaanxi, Peoples R China		Song, JN (corresponding author), Xi An Jiao Tong Univ, Dept Neurosurg, Affiliated Hosp 1, Xian 710061, Shaanxi, Peoples R China.	jinningsong@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471179]	We gratefully acknowledge the National Natural Science Foundation of China (No. 81471179) in funding this research. We also acknowledge Translational Medicine of the First Affiliated Hospital of Xi'an Jiaotong University for support of laboratory instruments.	Ajmone-Cat MA, 2013, GLIA, V61, P1698, DOI 10.1002/glia.22550; Baas PW, 2013, BRAIN, V136, P2937, DOI 10.1093/brain/awt153; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chen M, 2018, J ALZHEIMERS DIS, V66, P751, DOI 10.3233/JAD-180726; Chio CC, 2016, EUR J CLIN INVEST, V46, P1063, DOI 10.1111/eci.12693; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Gerdts J, 2016, NEURON, V89, P449, DOI 10.1016/j.neuron.2015.12.023; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Ginhoux F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00045; Huang TQ, 2018, NEUROREPORT, V29, P661, DOI [10.1097/WNR.0000000000001015, 10.1097/wnr.0000000000001015]; Islam A, 2018, BBA-MOL BASIS DIS, V1864, P721, DOI 10.1016/j.bbadis.2017.12.022; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kapitein LC, 2015, NEURON, V87, P492, DOI 10.1016/j.neuron.2015.05.046; Karibe H, 2017, NEUROL MED-CHIR, V57, P418, DOI 10.2176/nmc.st.2017-0058; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Khan M, 2018, BEHAV BRAIN RES, V340, P63, DOI 10.1016/j.bbr.2016.10.037; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Lam TI, 2013, NEUROREHAB NEURAL RE, V27, P889, DOI 10.1177/1545968313491003; Lin C, 2016, J PINEAL RES, V61, P177, DOI 10.1111/jpi.12337; Liu Z, 2016, BRAIN BEHAV IMMUN, V51, P131, DOI 10.1016/j.bbi.2015.08.006; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Michell-Robinson MA, 2015, BRAIN, V138, P1138, DOI 10.1093/brain/awv066; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Patel RK, 2017, BRAIN BEHAV IMMUN, V64, P244, DOI 10.1016/j.bbi.2017.04.012; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schreckinger M, 2007, RESUSCITATION, V75, P105, DOI 10.1016/j.resuscitation.2007.02.017; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Starossom SC, 2012, IMMUNITY, V37, P249, DOI 10.1016/j.immuni.2012.05.023; Taylor RA, 2017, J CLIN INVEST, V127, P280, DOI 10.1172/JCI88647; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu D, 2019, BRAIN RES, V1710, P173, DOI 10.1016/j.brainres.2018.12.033; Xiong XY, 2016, PROG NEUROBIOL, V142, P23, DOI 10.1016/j.pneurobio.2016.05.001; Yin JR, 2009, BRAIN RES, V1263, P10, DOI 10.1016/j.brainres.2009.01.042; Zhang M, 2011, CANCER RES, V71, P7155, DOI 10.1158/0008-5472.CAN-11-1212	50	1	1	2	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	AUG	2020	161						21	32		10.1016/j.brainresbull.2020.04.011			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MB4WG	WOS:000542603900003	32389801				2022-02-06	
J	Ahmed, ME; Selvakumar, GP; Kempuraj, D; Raikwar, SP; Thangavel, R; Bazley, K; Wu, K; Khan, O; Khan, A; Zaheer, S; Iyer, S; Burton, C; James, D; Zaheer, A				Ahmed, Mohammad Ejaz; Selvakumar, Govindhasamy Pushpavathi; Kempuraj, Duraisamy; Raikwar, Sudhanshu P.; Thangavel, Ramasamy; Bazley, Kieran; Wu, Kristopher; Khan, Osaid; Khan, Asher; Zaheer, Smita; Iyer, Shankar; Burton, Casey; James, Donald; Zaheer, Asgar			Glia Maturation Factor (GMF) Regulates Microglial Expression Phenotypes and the Associated Neurological Deficits in a Mouse Model of Traumatic Brain Injury	MOLECULAR NEUROBIOLOGY			English	Article						Glia maturation factor; Neuroinflammation; M1-like; M2-like; Microglia; macrophage; Polarization; Traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; FACTOR-BETA; APOPTOSIS; CELLS; DAMAGE; NEUROTOXICITY; RECOGNITION; ACTIVATION; INHIBITOR	Traumatic brain injury (TBI) induces inflammatory responses through microglial activation and polarization towards a more inflammatory state that contributes to the deleterious secondary brain injury. Glia maturation factor (GMF) is a pro-inflammatory protein that is responsible for neuroinflammation following insult to the brain, such as in TBI. We hypothesized that the absence of GMF in GMF-knockout (GMF-KO) mice would regulate microglial activation state and the M1/M2 phenotypes following TBI. We used the weight drop model of TBI in C57BL/6 mice wild-type (WT) and GMF-KO mice. Immunofluorescence staining, Western blot, and ELISA assays were performed to confirm TBI-induced histopathological and neuroinflammatory changes. Behavioral analysis was done to check motor coordination ability and cognitive function. We demonstrated that the deletion of GMF in GMF-KO mice significantly limited lesion volume, attenuated neuronal loss, inhibited gliosis, and activated microglia adopted predominantly anti-inflammatory (M2) phenotypes. Using an ELISA method, we found a gradual decrease in pro-inflammatory cytokines (TNF-alpha and IL-6) and upregulation of anti-inflammatory cytokines (IL-4 and IL-10) in GMF-KO mice compared with WT mice, thus, promoting the transition of microglia towards a more predominantly anti-inflammatory (M2) phenotype. GMF-KO mice showed significant improvement in motor ability, memory, and cognition. Overall, our results demonstrate that GMF deficiency regulates microglial polarization, which ameliorates neuronal injury and behavioral impairments following TBI in mice and concludes that GMF is a regulator of neuroinflammation and an ideal therapeutic target for the treatment of TBI.	[Ahmed, Mohammad Ejaz; Selvakumar, Govindhasamy Pushpavathi; Kempuraj, Duraisamy; Raikwar, Sudhanshu P.; Thangavel, Ramasamy; Bazley, Kieran; Wu, Kristopher; Khan, Osaid; Khan, Asher; Zaheer, Smita; Iyer, Shankar; Zaheer, Asgar] Univ Missouri, Sch Med, Dept Neurol, Columbia, MO 65211 USA; [Ahmed, Mohammad Ejaz; Selvakumar, Govindhasamy Pushpavathi; Kempuraj, Duraisamy; Raikwar, Sudhanshu P.; Thangavel, Ramasamy; Bazley, Kieran; Wu, Kristopher; Khan, Osaid; Khan, Asher; Zaheer, Smita; Iyer, Shankar; Zaheer, Asgar] Univ Missouri, Ctr Translat Neurosci, Sch Med, Columbia, MO 65211 USA; [Ahmed, Mohammad Ejaz; Selvakumar, Govindhasamy Pushpavathi; Kempuraj, Duraisamy; Raikwar, Sudhanshu P.; Thangavel, Ramasamy; Iyer, Shankar; Zaheer, Asgar] Harry S Truman Mem Vet Hosp, Columbia, MO 65211 USA; [Burton, Casey; James, Donald] Phelps Hlth, Rolla, MO 65401 USA		Zaheer, A (corresponding author), Univ Missouri, Sch Med, Dept Neurol, Columbia, MO 65211 USA.; Zaheer, A (corresponding author), Univ Missouri, Ctr Translat Neurosci, Sch Med, Columbia, MO 65211 USA.; Zaheer, A (corresponding author), Harry S Truman Mem Vet Hosp, Columbia, MO 65211 USA.	zaheera@health.missouri.edu	Raikwar, Sudhanshu/AAT-5128-2021	Raikwar, Sudhanshu/0000-0001-8549-8570; Khan, Asher/0000-0001-6314-240X	US Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL) [W911NF-14-2-0034]	The research was sponsored by the LeonardWood Institute in cooperation with the US Army Research Laboratory and was accomplished under Cooperative Agreement Number W911NF-14-2-0034.	Ahmed ME, 2013, PROTOPLASMA, V250, P1067, DOI 10.1007/s00709-013-0482-2; Ahmed ME, 2017, J ALZHEIMERS DIS, V60, P1143, DOI 10.3233/JAD-170634; Ahmed ME, 2017, J MOL NEUROSCI, V61, P42, DOI 10.1007/s12031-016-0830-8; Ahmed ME, 2016, NEUROSCIENCE, V336, P39, DOI 10.1016/j.neuroscience.2016.08.036; Al Nimer F, 2013, BRAIN BEHAV IMMUN, V27, P109, DOI 10.1016/j.bbi.2012.10.002; Alfieri JA, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00310; ALIMOV G A, 1981, Arkhiv Anatomii Gistologii i Embriologii, V81, P39; Anderson MJ, 2008, BEHAV PROCESS, V78, P481, DOI 10.1016/j.beproc.2008.02.005; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Cernuda-Morollon E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012393; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; ENNACEUR A, 1994, EXP BRAIN RES, V100, P85; Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gan SD, 2013, J INVEST DERMATOL, V133, pE10, DOI 10.1038/jid.2013.287; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Jin XM, 2016, J BIOCHEM, V159, P491, DOI 10.1093/jb/mvw009; Keller JN, 1998, J NEUROSCI, V18, P687; Kempuraj D, 2013, J NEUROIMMUNE PHARM, V8, P643, DOI 10.1007/s11481-013-9439-7; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Liang JW, 2018, DRUG DES DEV THER, V12, P845, DOI 10.2147/DDDT.S160046; Lim R, 2004, BRAIN RES, V1024, P225, DOI 10.1016/j.brainres.2004.08.003; LIM RM, 1990, FASEB J, V4, P3360, DOI 10.1096/fasebj.4.15.2253851; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mioranzza S, 2011, PROG NEURO-PSYCHOPH, V35, P169, DOI 10.1016/j.pnpbp.2010.10.022; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Selvakumar GP, 2020, BRAIN BEHAV IMMUN, V87, P429, DOI 10.1016/j.bbi.2020.01.013; Selvakumar GP, 2018, MOL NEUROBIOL, V55, P7132, DOI 10.1007/s12035-018-0882-6; Serrador JM, 2002, J BIOL CHEM, V277, P10400, DOI 10.1074/jbc.M110694200; Steckler T, 1998, PROG NEUROBIOL, V54, P289, DOI 10.1016/S0301-0082(97)00060-9; Thangavel R, 2013, NEUROCHEM RES, V38, P1777, DOI 10.1007/s11064-013-1080-6; Vaibhav K, 2013, PHARMACOL BIOCHEM BE, V113, P53, DOI 10.1016/j.pbb.2013.10.008; Vaibhav K, 2013, NEUROL SCI, V34, P1321, DOI 10.1007/s10072-012-1238-z; Vilhardt F, 2005, INT J BIOCHEM CELL B, V37, P17, DOI 10.1016/j.biocel.2004.06.010; Yamada KH, 2012, J BIOL CHEM, V287, P13182, DOI 10.1074/jbc.M111.302612; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; ZAHEER A, 1993, J NEUROCHEM, V60, P914, DOI 10.1111/j.1471-4159.1993.tb03237.x; Zaheer A, 2007, BRAIN RES, V1144, P239, DOI 10.1016/j.brainres.2007.01.075; Zaheer A, 2007, J NEUROCHEM, V101, P364, DOI 10.1111/j.1471-4159.2006.04385.x; Zaheer A, 2006, NEUROCHEM RES, V31, P579, DOI 10.1007/s11064-006-9049-3; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zhao NJ, 2017, MOL NEUROBIOL, V54, P4936, DOI 10.1007/s12035-016-0034-9	55	1	2	1	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	NOV	2020	57	11					4438	4450		10.1007/s12035-020-02040-y		JUL 2020	13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NS9CD	WOS:000554333900002	32737763				2022-02-06	
J	Attari, F; Ghadiri, T; Hashemi, M				Attari, Fatemeh; Ghadiri, Tahereh; Hashemi, Mansoureh			Combination of curcumin with autologous transplantation of adult neural stem/progenitor cells leads to more efficient repair of damaged cerebral tissue of rat	EXPERIMENTAL PHYSIOLOGY			English	Article						autologous transplantation; brain injury; curcumin; neural stem cells; PuraMatrix	TRAUMATIC BRAIN-INJURY; MESENCHYMAL STEM-CELLS; SPINAL-CORD; HEME OXYGENASE-1; ACTIVATION; NEUROPROTECTION; NEUROGENESIS; APOPTOSIS; HYDROGEL; THERAPY	New Findings What is the central question of this study?Can the neuroprotective agent curcumin affect restorative action of neural stem/progenitor cells in the injured rat brain? What is the main finding and its importance?In the presence of curcumin, transplantation of neural stem/progenitor cells in the context of PuraMatrix reduced lesion size and reactive inflammatory responses, and boosted survival rate of grafted neurons. In addition it improved the neurological status of injured animals. This could be beneficial in designing new therapeutic approaches for brain injury based on this combination therapy. Traumatic brain injury (TBI) is catastrophic neurological damage associated with substantial morbidity and mortality. To date, there is no specific treatment for restoring lost brain tissue. In light of the complex pathology of brain injury, the present study evaluated the effects of combination therapy using autologous neural stem/progenitor cells (NS/PCs), PuraMatrix (PM) and curcumin in an animal model of brain injury. After stereotactic biopsy of subventricular zone tissue and culture of NS/PCs, 36 male Wistar rats (150-200 g) were randomly divided into six groups receiving dimethyl sulfoxide (DMSO), curcumin (100 mg kg(-1)in DMSO), PM + curcumin (100 mg kg(-1)in DMSO), NS/PCs + curcumin (100 mg kg(-1)in DMSO), NS/PCs + PM + curcumin (100 mg kg(-1)in DMSO) and NS/PCs + PM + curcumin (1 mu m) following acute brain injury. The animals were evaluated in term of neurological status for 4 weeks, then decapitated. Nissl and TUNEL staining and immunohistochemistry for bromodeoxyuridine, glial fibrillary acidic protein, doublecortin, Map2, Olig2, Iba1 and CD68 were performed. We found that combination therapy by NS/PCs + PM + curcumin reduced the lesion size, astrogliosis, macrophage and microglial reaction as well as the number of apoptotic cells. Moreover, the transplanted cells were able to survive and differentiate after 4 weeks. Besides these findings, transplantation of NS/PCs in the context of PM and curcumin improved the neurological status of injured animals. In conclusion, our data suggest that this combination therapy can be beneficial in developing future therapeutic approaches for brain injury.	[Attari, Fatemeh] Univ Tehran Med Sci, Dept Neurosci, Sch Adv Technol, Tehran, Iran; [Ghadiri, Tahereh] Tabriz Univ Med Sci, Dept Neurosci, Sch Adv Med Sci, Tabriz, Iran; [Ghadiri, Tahereh] Khatam Alanbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran; [Hashemi, Mansoureh] Shahid Beheshti Univ Med Sci, Funct Neurosurg Res Ctr, Tehran, Iran		Ghadiri, T (corresponding author), Tabriz Univ Med Sci, Fac Adv Med Sci, Dept Neurosci, 29 Bahman Blvd, Tabriz, Iran.	ghadirit@tbzmed.ac.ir	Ghadiri, Tahereh/AAU-7811-2020	Ghadiri, Tahereh/0000-0002-3568-8699	Tehran University of Medical SciencesTehran University of Medical Sciences; Shefa Neuroscience Research Center [90-3-87-14565]	Tehran University of Medical Sciences; Shefa Neuroscience Research Center, Grant/Award Number: 90-3-87-14565	Aligholi H, 2016, BRAIN RES, V1642, P197, DOI 10.1016/j.brainres.2016.03.043; Anto RJ, 2002, CARCINOGENESIS, V23, P143, DOI 10.1093/carcin/23.1.143; Attari F., 2016, ARCH NEUROSCIENCE, V3, P1; Attari F, 2015, DARU, V23, DOI 10.1186/s40199-015-0115-8; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Chen F, 2014, J SURG RES, V192, P298, DOI 10.1016/j.jss.2014.06.026; Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084; Dong SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031211; Gorgoraptis N, 2019, NEUROREHABILITATION, V44, P321, DOI 10.3233/NRE-182618; Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003; Guo JS, 2009, NANOMED-NANOTECHNOL, V5, P345, DOI 10.1016/j.nano.2008.12.001; Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P2222, DOI 10.1089/scd.2011.0596; Kang SK, 2006, STEM CELLS DEV, V15, P165, DOI 10.1089/scd.2006.15.165; Kim HY, 2003, J IMMUNOL, V171, P6072, DOI 10.4049/jimmunol.171.11.6072; Kim SJ, 2008, J BIOL CHEM, V283, P14497, DOI 10.1074/jbc.M708373200; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lee YS, 2019, SPINE J, V19, P2025, DOI 10.1016/j.spinee.2019.07.013; Li WC, 2021, J SPINAL CORD MED, V44, P37, DOI 10.1080/10790268.2019.1616147; Lin MS, 2011, J SURG RES, V166, P280, DOI 10.1016/j.jss.2009.07.001; Mansoor SR, 2018, BRAIN RES BULL, V142, P281, DOI 10.1016/j.brainresbull.2018.08.010; McNally SJ, 2007, INT J MOL MED, V19, P165; Mingming Z., 2011, J 3 MILITARY MED U, V8, P1; Moradi F, 2012, J NEUROSCI RES, V90, P2335, DOI 10.1002/jnr.23120; Muraoka K, 2006, EXP NEUROL, V199, P311, DOI 10.1016/j.expneurol.2005.12.004; Negah SS, 2017, MOL NEUROBIOL, V54, P8050, DOI 10.1007/s12035-016-0295-3; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Ormond DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088916; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pluta R, 2015, FOLIA NEUROPATHOL, V53, P89, DOI 10.5114/fn.2015.52405; Rossi F, 2002, NAT REV NEUROSCI, V3, P401, DOI 10.1038/nrn809; Ruzicka J, 2018, ACTA NEUROBIOL EXP, V78, P358, DOI 10.21307/ane-2018-035; Samini F, 2013, PHARMACOL BIOCHEM BE, V110, P238, DOI 10.1016/j.pbb.2013.07.019; Son S, 2014, J KOREAN NEUROSURG S, V56, P1, DOI 10.3340/jkns.2014.56.1.1; Sumanont Y, 2006, LIFE SCI, V78, P1884, DOI 10.1016/j.lfs.2005.08.028; Teixeira FG, 2013, CELL MOL LIFE SCI, V70, P3871, DOI 10.1007/s00018-013-1290-8; Tiwari SK, 2014, ACS NANO, V8, P76, DOI 10.1021/nn405077y; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang JL, 2018, INT J MOL MED, V42, P2481, DOI 10.3892/ijmm.2018.3847; Wang YH, 2017, INT J NANOMED, V12, P1369, DOI 10.2147/IJN.S124276; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Yang Z, 2014, IMMUNOL LETT, V160, P89, DOI 10.1016/j.imlet.2014.03.005	41	1	1	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0958-0670	1469-445X		EXP PHYSIOL	Exp. Physiol.	SEP 1	2020	105	9					1610	1622		10.1113/EP088697		JUL 2020	13	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	OY0EU	WOS:000553995500001	32627273	Bronze			2022-02-06	
J	Bryant, E; Williams, C; Horry, R; Worthington, A				Bryant, Eleanor; Williams, Claire; Horry, Ruth; Worthington, Andrew			Measuring misconceptions about traumatic brain injury: are existing scales misconceived?	BRAIN INJURY			English	Article						Traumatic brain injury; public perceptions; misconceptions; measurement; validity; psychometric	COMMON MISCONCEPTIONS; KNOWLEDGE; ATTITUDES; PROFESSIONALS; ATTRIBUTIONS; CONCUSSION; SURVIVORS; BELIEFS	Primary Objectives The aim of this paper was to conduct a review of the misconception literature relating to traumatic brain injury (TBI) and to critically review the comprehensiveness, psychometric properties and other qualities of existing scales designed to measure knowledge and misconceptions of TBI. Methods Terms relating to misconceptions, misconception scales, public perceptions and traumatic brain injury were used to identify existing scales. The initial search was expanded using the reference lists and citations of relevant articles. Main Outcomes Eight scales were identified for full review, with several sharing a common set of items. The majority of scales were designed to measure public perceptions of TBI, although some were developed for use in specific populations (e.g. sports, professional samples). Existing scales are limited by their scope and breadth of coverage, adoption of a medicalized view of TBI, scaling and scoring issues, failure to use a conceptual framework, and by numerous psychometric issues related to reliability and validity. Conclusions There are a number of weaknesses attached to existing scales. Several recommendations are made to promote and inform future scale development.	[Bryant, Eleanor; Williams, Claire; Horry, Ruth; Worthington, Andrew] Swansea Univ, Dept Psychol, Swansea, W Glam, Wales; [Worthington, Andrew] Headwise, Birmingham, W Midlands, England; [Worthington, Andrew] Swansea Univ, Sch Med, Swansea, W Glam, Wales		Williams, C (corresponding author), Swansea Univ, Dept Psychol, Coll Human & Hlth Sci, Swansea SA2 8PP, W Glam, Wales.	claire.williams@swansea.ac.uk		Williams, Claire/0000-0002-0791-744X; Bryant, Eleanor/0000-0001-9899-1305			Baxendale S, 2004, BMJ-BRIT MED J, V329, P1480, DOI 10.1136/bmj.329.7480.1480; Block CK, 2016, AM ACAD PHYS MED REH, V8; Cassidy JD, 2004, J REHABIL MED, P43; Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; De Iorio ML, 2017, REHABIL PSYCHOL, V62, P516, DOI 10.1037/rep0000131; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Fazel S, 2009, J NEUROL, V256, P1591, DOI 10.1007/s00415-009-5134-2; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; KELLY JA, 1987, J MED EDUC, V62, P549; King MF, 2000, PSYCHOL MARKET, V17, P79, DOI 10.1002/(SICI)1520-6793(200002)17:2<79::AID-MAR2>3.0.CO;2-0; Linden MA, 2006, ARCH CLIN NEUROPSYCH, V21, P763, DOI 10.1016/j.acn.2006.08.010; Linden MA, 2010, BRAIN INJURY, V24, P642, DOI 10.3109/02699051003601689; Linden MA, 2005, DISABIL REHABIL, V27, P1353, DOI 10.1080/09638280500164180; Linden MA, 2013, BRAIN INJURY, V27, P92, DOI 10.3109/02699052.2012.722262; Linden MA, 2011, INT J NURS STUD, V48, P62, DOI 10.1016/j.ijnurstu.2010.05.011; McClure J, 2006, BRAIN INJURY, V20, P1029, DOI 10.1080/02699050600909870; McClure J, 2011, REHABIL PSYCHOL, V56, P85, DOI 10.1037/a0023354; McKendry Y, 2014, PSYCHIAT RES, V219, P225, DOI 10.1016/j.psychres.2014.05.019; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; Mckinlay A, 2019, DISABIL REHABIL, V41, P1419, DOI 10.1080/09638288.2018.1429500; Menon DK, 2019, LANCET NEUROL, V18, P28, DOI 10.1016/S1474-4422(18)30463-0; Multon K., 2012, ENCY RES DESIGN; O'Rourke C, 2018, DISABIL REHABIL, V40, P1119, DOI 10.1080/09638288.2017.1288274; Ono MY, 2011, BRAIN INJURY, V25, P237, DOI 10.3109/02699052.2010.541893; Oyesanya TO, 2018, J SPEC PEDIATR NURS, V23, DOI 10.1111/jspn.12209; Oyesanya TO, 2016, WESTERN J NURS RES, V38, P1114, DOI 10.1177/0193945916636629; Pappadis MR, 2011, J HEAD TRAUMA REHAB, V26, P301, DOI 10.1097/HTR.0b013e3181e7832b; Parsonage M, 2016, REPORT EC ANAL TRAUM; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Redpath SJ, 2010, BRAIN INJURY, V24, P802, DOI 10.3109/02699051003709623; Redpath SJ, 2004, BRAIN INJURY, V18, P861, DOI 10.1080/02699050410001671838; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Scottish Prison Service/NHS Scotland, 2016, NAT PRIS HEALTHC NET; Sefton J, 2003, THESIS; Simonds CB, 2004, THESIS; Springer JA, 1997, J HEAD TRAUMA REHAB, V12, P41, DOI 10.1097/00001199-199706000-00005; Stergiou-Kita M, 2017, WORK, V57, P245, DOI 10.3233/WOR-172556; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Thomas M, 2015, BRAIN IMPAIR, V16, P104, DOI 10.1017/BrImp.2015.16; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; Williams JM, 2016, J SPORT HEALTH SCI, V5, P197, DOI 10.1016/j.jshs.2015.01.009; World Health Organization, 2002, COMM LANG FUNCT DIS; Yuhasz JE, 2013, J CORRECT HEALTH CAR, V19, P135, DOI 10.1177/1078345812474644	51	1	1	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 28	2020	34	9					1150	1158		10.1080/02699052.2020.1795721		JUL 2020	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ND6FI	WOS:000553343700001	32726148	Green Accepted			2022-02-06	
J	McCulloch, KL; Osborne, MBA; Ramsey, CR				McCulloch, Karen L.; Osborne, Mary Beth A.; Ramsey, Crystal R.			Geriatric Mild Traumatic Brain Injury (mTBI)	CURRENT GERIATRICS REPORTS			English	Article						Concussion; Mild traumatic brain injury; Older adults; Geriatric	POST-CONCUSSION SYMPTOMS; CT HEAD RULE; ELDERLY-PATIENTS; OLDER-ADULTS; RISK-FACTORS; INTRACRANIAL LESIONS; UNITED-STATES; PATHOPHYSIOLOGY; EPIDEMIOLOGY; RELIABILITY	Purpose of Review Studies that focus on geriatric mild traumatic brain injury (mTBI) are limited, although these injuries occur commonly as a result of falls in the older adult population. This review aims to explore current literature in this area and summarize common practices in diagnosis and treatment of this condition. Recent Findings Older adults who sustain a fall should be evaluated for the possibility of mTBI, with reported falls forward or the presence of upper extremity fractures being associated with increased risk of trauma to the head. Efforts to determine pre-injury cognitive status may improve the ability to diagnose mTBI and possible alteration in mental status associated with the condition. Imaging and observation may be indicated to rule out an intracranial bleed acutely. Clinical outcomes after mTBI are generally positive in older adults, so an expectation for recovery should be conveyed, with a short period of rest recommended prior to gradual resumption of routine activity that avoids risk of additional injury. Those who have prolonged symptoms that do not improve with return gradual activity may benefit from referral to a rehabilitation team that can address physical, cognitive, and psychological symptoms following mTBI. Diagnosis of mTBI is difficult in older adults given the challenges in determining pre-injury cognitive status and the similarity of concussive symptoms with symptoms commonly attributed to aging. Post-concussion management in older adults is not well studied, and further research is needed to evaluate the efficacy of current concussion clinical practice guidelines developed for younger populations when applied to older adults.	[McCulloch, Karen L.] Univ N Carolina, Sch Med, Dept Allied Hlth Sci, Div Phys Therapy, Bondurant Hall Suite 3030, Chapel Hill, NC 27599 USA; [Osborne, Mary Beth A.] Duke Univ Hlth Syst, 3000 Erwin Rd, Durham, NC 27705 USA; [Ramsey, Crystal R.] Elon Univ, Sch Hlth Sci, Dept Phys Therapy Educ, 2085 Campus Box, Elon, NC 27244 USA		McCulloch, KL (corresponding author), Univ N Carolina, Sch Med, Dept Allied Hlth Sci, Div Phys Therapy, Bondurant Hall Suite 3030, Chapel Hill, NC 27599 USA.	kmac@med.unc.edu; Marybeth.osborne@duke.edu; Cramsey6@elon.edu		Ramsey, Crystal/0000-0002-0102-3998; McCulloch, Karen/0000-0003-4228-0517			Abdulle AE, 2018, J HEAD TRAUMA REHAB, V33, pE59, DOI 10.1097/HTR.0000000000000368; Alsalaheen B, 2019, J ORTHOP SPORT PHYS, V49, P829, DOI 10.2519/jospt.2019.8869; Altman J., 2015, ACAD EMERG MED, V22, pS255; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Bergen G, 2016, MMWR-MORBID MORTAL W, V65, P993, DOI 10.15585/mmwr.mm6537a2; Bhattacharyya N, 2017, OTOLARYNG HEAD NECK, V156, P403, DOI 10.1177/0194599816689660; Bisdorff Alexandre R, 2011, Ther Adv Neurol Disord, V4, P183, DOI 10.1177/1756285611401647; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Bosch M, 2019, IMPLEMENT SCI, V14, DOI 10.1186/s13012-018-0841-7; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Chorney SR, 2017, LARYNGOSCOPE, V127, P2850, DOI 10.1002/lary.26564; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cleland JA, 2006, SPINE, V31, P598, DOI 10.1097/01.brs.0000201241.90914.22; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; COHEN H, 1993, PHYS THER, V73, P346, DOI 10.1093/ptj/73.6.346; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; d'Arcy JL, 2016, EUR HEART J, V37, P3515, DOI 10.1093/eurheartj/ehw229; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889; Koning ME, 2017, J NEUROTRAUM, V34, P257, DOI 10.1089/neu.2015.4377; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Fife TD, 2015, ANN NY ACAD SCI, V1343, P97, DOI 10.1111/nyas.12678; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Galili SF, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017735; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Hartvigsen J, 2006, EUR SPINE J, V15, P802, DOI 10.1007/s00586-005-0983-6; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P67, DOI 10.1007/BF01809175; De la Blanca MAIP, 2018, BRAIN INJURY, V32, P99, DOI 10.1080/02699052.2017.1382716; IIGiovine Z, 2014, BRAIN INJURY, V28, P769; Ikonomovic MD, 2017, AGEING RES REV, V34, P51, DOI 10.1016/j.arr.2016.11.003; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; JACKSON P, 1981, J NEUROL SCI, V49, P429, DOI 10.1016/0022-510X(81)90032-0; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jodoin M, 2016, INJURY, V47, P1835, DOI 10.1016/j.injury.2016.05.036; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kirkwood MW, 2016, J PEDIATR-US, V169, P244, DOI 10.1016/j.jpeds.2015.10.014; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kovar M, 2006, J GERONTOL NURS, V32, P22, DOI 10.3928/00989134-20061201-04; Kristman VL, 2016, J HEAD TRAUMA REHAB, V31, pE33, DOI 10.1097/HTR.0000000000000226; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Liu H, 2017, AGEING RES REV, V34, P64, DOI 10.1016/j.arr.2016.11.006; Lumba-Brown A, 2020, NEUROSURGERY, V86, P2, DOI 10.1093/neuros/nyz332; Lumba-Brown Angela, 2019, Concussion, V4, pCNC65, DOI 10.2217/cnc-2019-0005; Marcus HJ, 2019, J NEUROL, V266, P2430, DOI 10.1007/s00415-019-09403-z; Marshall S., 2018, GUIDELINE CONCUSSION, V3rd; Mercier E, 2016, INJURY, V47, P985, DOI 10.1016/j.injury.2016.04.001; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Morin S, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/7841380; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murray DA, 2017, BRIT J SPORT MED, V51, P442, DOI 10.1136/bjsports-2016-096081; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Negrila-Mezei A, 2011, J Med Life, V4, P412; Nelson LD, 2015, J ATHL TRAINING, V50, P1319, DOI 10.4085/1062-6050-51.1.09; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Petridis AK, 2009, CENT EUR NEUROSURG, V70, P73, DOI 10.1055/s-0029-1224096; Prasad GL, 2018, WORLD NEUROSURG, V111, pE221, DOI 10.1016/j.wneu.2017.12.034; Prevention CfDCa, 2015, C TRAUM BRAIN INJ US; Quatman-Yates CC, 2020, J ORTHOP SPORT PHYS, V50, pCPG1, DOI 10.2519/jospt.2020.0301; Reed N, 2019, ARCH PHYS MED REHAB, V100, P789, DOI 10.1016/j.apmr.2018.11.022; Reiffel JA, 2017, JAMA CARDIOL, V2, P1120, DOI 10.1001/jamacardio.2017.3180; Reilly JL, 2008, BRAIN COGNITION, V68, P415, DOI 10.1016/j.bandc.2008.08.026; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rigaud AS, 2001, J GERONTOL A-BIOL, V56, pM217, DOI 10.1093/gerona/56.4.M217; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Seno S, 2019, J CLIN NEUROSCI, V67, P124, DOI 10.1016/j.jocn.2019.06.007; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Singh P, 2016, THER ADV GASTROENTER, V9, P98, DOI 10.1177/1756283X15618131; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Sufrinko AM, 2017, J PEDIATR-US, V185, P167, DOI 10.1016/j.jpeds.2017.02.072; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Techar K, 2019, J SURG RES, V242, P4, DOI 10.1016/j.jss.2019.04.006; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Uccella L, 2018, WORLD NEUROSURG, V110, pE339, DOI 10.1016/j.wneu.2017.10.173; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Ward MD, 2020, J APPL LAB MED, V5, P91, DOI 10.1093/jalm.2019.031393; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Wolf H, 2014, J NEUROSURG, V120, P447, DOI 10.3171/2013.10.JNS13726; Yang Y, 2017, J HEAD TRAUMA REHAB, V32, P168, DOI 10.1097/HTR.0000000000000257	98	1	1	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES		2196-7865		CURR GERIATR REP	Curr. Geriatr. Rep.	SEP	2020	9	3					142	153		10.1007/s13670-020-00329-3		JUL 2020	12	Geriatrics & Gerontology	Emerging Sources Citation Index (ESCI)	Geriatrics & Gerontology	NF2LD	WOS:000554344200001					2022-02-06	
J	Saber, M; Pathak, KV; McGilvrey, M; Garcia-Mansfield, K; Harrison, JL; Rowe, RK; Lifshitz, J; Pirrotte, P				Saber, Maha; Pathak, Khyati V.; McGilvrey, Marissa; Garcia-Mansfield, Krystine; Harrison, Jordan L.; Rowe, Rachel K.; Lifshitz, Jonathan; Pirrotte, Patrick			Proteomic analysis identifies plasma correlates of remote ischemic conditioning in the context of experimental traumatic brain injury	SCIENTIFIC REPORTS			English	Article							CEREBROSPINAL-FLUID; OXIDATIVE STRESS; PITUITARY DYSFUNCTION; PROGRESSIVE ATROPHY; REPERFUSION INJURY; AMINO-ACIDS; SUPPRESSION; HEMORRHAGE; BIOMARKER	Remote ischemic conditioning (RIC), transient restriction and recirculation of blood flow to a limb after traumatic brain injury (TBI), can modify levels of pathology-associated circulating protein. This study sought to identify TBI-induced molecular alterations in plasma and whether RIC would modulate protein and metabolite levels at 24 h after diffuse TBI. Adult male C57BL/6 mice received diffuse TBI by midline fluid percussion or were sham-injured. Mice were assigned to treatment groups 1 h after recovery of righting reflex: sham, TBI, sham RIC, TBI RIC. Nine plasma metabolites were significantly lower post-TBI (six amino acids, two acylcarnitines, one carnosine). RIC intervention returned metabolites to sham levels. Using proteomics analysis, twenty-four putative protein markers for TBI and RIC were identified. After application of Benjamini-Hochberg correction, actin, alpha 1, skeletal muscle (ACTA1) was found to be significantly increased in TBI compared to both sham groups and TBI RIC. Thus, identified metabolites and proteins provide potential biomarkers for TBI and therapeutic RIC in order to monitor disease progression and therapeutic efficacy.	[Saber, Maha; Harrison, Jordan L.; Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Childrens Hosp, BARROW Neurol Inst, Phoenix, AZ 85013 USA; [Saber, Maha; Harrison, Jordan L.; Rowe, Rachel K.; Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Child Hlth, 425 N 5th St ABC1, Phoenix, AZ 85004 USA; [Pathak, Khyati V.; McGilvrey, Marissa; Garcia-Mansfield, Krystine; Pirrotte, Patrick] Translat Genom Res Inst, Collaborat Ctr Translat Mass Spectrometry, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix VA Hlth Care Syst, Phoenix, AZ 85012 USA		Lifshitz, J (corresponding author), Phoenix Childrens Hosp, BARROW Neurol Inst, Phoenix, AZ 85013 USA.; Lifshitz, J (corresponding author), Univ Arizona, Coll Med Phoenix, Child Hlth, 425 N 5th St ABC1, Phoenix, AZ 85004 USA.; Lifshitz, J (corresponding author), Phoenix VA Hlth Care Syst, Phoenix, AZ 85012 USA.	jlifshitz@email.arizona.edu		McGilvrey, Marissa/0000-0003-1707-8886; Saber, Maha/0000-0001-6120-3993; Rowe, Rachel/0000-0002-9034-3159	 [NIH-R21-NS096515];  [F31-NS090921];  [T32-AG044402]	The authors would like to thank Bret R. Tallent for his assistance in optimizing and running samples. The authors would like to thank Ritin Sharma for help in metabolomics and proteomic sample preparation. This research was funded by NIH-R21-NS096515, F31-NS090921, and T32-AG044402.	Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimo A, 2015, WORLD J CARDIOL, V7, P621, DOI 10.4330/wjc.v7.i10.621; Amorini AM, 2017, J CELL MOL MED, V21, P530, DOI 10.1111/jcmm.12998; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Aquilani R, 2003, ARCH PHYS MED REHAB, V84, P1258, DOI 10.1016/S0003-9993(03)00148-5; Bao AM, 2010, NEUROSCIENTIST, V16, P550, DOI 10.1177/1073858410377005; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Bromage DI, 2017, CARDIOVASC RES, V113, P288, DOI 10.1093/cvr/cvw219; Chen GL, 2014, INDIAN J EXP BIOL, V52, P597; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; de la Barca JMC, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003891; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Erdtmann F, 2015, MIL MED, V180, P123, DOI 10.7205/MILMED-D-14-00516; Harrison JL, 2014, EXP BRAIN RES, V232, P2709, DOI 10.1007/s00221-014-3948-3; Heinen A, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1480-0; Hilbe Joseph M., 2007, NEGATIVE BINOMIAL RE, pi; Hoshino T, 2011, J NEUROSCI, V31, P5225, DOI 10.1523/JNEUROSCI.5478-10.2011; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Jones A, 2017, CLIN EXP EMERG MED, V4, P121, DOI 10.15441/ceem.17.226; Joseph B, 2015, J TRAUMA ACUTE CARE, V78, P698, DOI 10.1097/TA.0000000000000584; Koza L, 2019, NEURAL REGEN RES, V14, P1701, DOI 10.4103/1673-5374.257520; Lecci L, 2020, ARCH CLIN NEUROPSYCH, V35, P265, DOI 10.1093/arclin/acz041; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; Louin G, 2007, NITRIC OXIDE-BIOL CH, V17, P91, DOI 10.1016/j.niox.2007.05.006; Madathil S. K., 2015, BRAIN NEUROTRAUMA MO; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Mrozek S, 2014, CRIT CARE, V18, DOI 10.1186/cc13841; Ottens AK, 2010, J NEUROTRAUM, V27, P1837, DOI 10.1089/neu.2010.1374; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Posti JP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00398; Raupach EA, 2019, BIORXIV, V1, DOI [10.1101/794776, DOI 10.1101/794776]; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Rowe RK, 2014, SLEEP, V37, P743, DOI 10.5665/sleep.3582; Sandweiss AJ, 2017, J TRAUMA ACUTE CARE, V83, P1074, DOI 10.1097/TA.0000000000001626; Seki Y, 2005, NEUROCHEM RES, V30, P123, DOI 10.1007/s11064-004-9693-4; Sjodin MOD, 2010, J CHROMATOGR B, V878, P2003, DOI 10.1016/j.jchromb.2010.05.036; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Song YJ, 2019, J CELL PHYSIOL, V234, P1190, DOI 10.1002/jcp.27110; Su YS, 2019, J NEUROTRAUM, V36, P2083, DOI 10.1089/neu.2018.6020; Sun Y, 2017, EXP THER MED, V14, P5267, DOI 10.3892/etm.2017.5253; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Turturici G, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/618127; van der Putten H, 2013, NEUROTHERAPEUTICS, V10, P416, DOI 10.1007/s13311-013-0186-5; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Xie RX, 2017, NEUROCHEM RES, V42, P541, DOI 10.1007/s11064-016-2104-9; Yao W, 2012, STROKE, V43, P2212, DOI 10.1161/STROKEAHA.111.645994; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Zhang ZY, 2015, CELL MOL NEUROBIOL, V35, P147, DOI 10.1007/s10571-014-0106-1	56	1	1	2	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUL 31	2020	10	1							12989	10.1038/s41598-020-69865-4			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MV5QX	WOS:000556413400037	32737368	Green Published, gold			2022-02-06	
J	Kroshus, E; Bowen, D; Opel, D; Chrisman, SPD; Rivara, FP				Kroshus, Emily; Bowen, Deborah; Opel, Douglas; Chrisman, Sara P. D.; Rivara, Frederick P.			Understanding Decision Making by Families About Youth Football Participation Postconcussion	HEALTH PROMOTION PRACTICE			English	Article						concussion; football; risk communication; shared decision making; parenting	CHRONIC TRAUMATIC ENCEPHALOPATHY; HIGH-SCHOOL FOOTBALL; SPORT; RETIREMENT; DISPARITIES; CONCUSSION; ATHLETE	Many families are concerned about their child's risk of concussion, and some seek counsel from clinicians about whether or not to return to contact sports participation postinjury. The present study sought to identify factors that parents weight most heavily in forming their preferences regarding whether their child should return to contact sport after recovering from a concussion. Survey data were collected from 568 parents of youth football players (aged 7-14 years) in the Pacific Northwest region of the United States (73% response rate). Approximately two thirds (63%) of parents preferred that their child retire from football after one or two concussions. Multivariable linear regression indicated parents above the sample mean in terms of how strongly they valued football participation preferred their child stop after more concussions than parents below the sample mean (beta = .44, standard error [SE]= 0.06,p< .001). Factors endorsed by the most parents as making them "much more likely" to want their child to stop playing football included the belief that their child will experience cognitive issues later in life as a result of concussions (65.0%) and that their child will get another concussion while playing football (43.5%). Within the context of a clinical visit postconcussion, physicians may need to help families clarify their values related to football participation and provide information about the potential outcomes of returning to contact sport. A formalized shared decision aid could help support consistent implementation of this potentially challenging conversation.	[Kroshus, Emily; Bowen, Deborah; Opel, Douglas; Chrisman, Sara P. D.; Rivara, Frederick P.] Univ Washington, Seattle, WA 98195 USA		Kroshus, E (corresponding author), Univ Washington, Dept Pediat, 2001 8th Ave,Suite 400, Seattle, WA 98121 USA.; Kroshus, E (corresponding author), Seattle Childrens Res Inst Seattle, 2001 8th Ave,Suite 400, Seattle, WA 98121 USA.	ekroshus@u.washington.edu		Kroshus, Emily/0000-0002-7484-2601; Chrisman, Sara/0000-0001-5373-7223	Seattle Pediatric Concussion Research Collaborative; University of Washington Sports Health and Safety Institute	Funding for this project was provided by the Seattle Pediatric Concussion Research Collaborative and the University of Washington Sports Health and Safety Institute. Address correspondence to Emily Kroshus, University of Washington, Department of Pediatrics and Seattle Children's Research Institute in Seattle, 2001 8th Avenue, Suite 400, Seattle, WA 98121, USA; e-mail: ekroshus@u.washington.edu.	Beamon KK, 2010, J BLACK STUD, V41, P281, DOI 10.1177/0021934709340873; Boneau RD, 2020, COMMUN SPORT, V8, P26, DOI 10.1177/2167479518816104; Bremmer K., 2012, J FAM THEORY REV, V4, P235, DOI [10.1111/j.1756-2589.2012.00129.x, DOI 10.1111/J.1756-2589.2012.00129.X]; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cantu RC, 2009, CURR SPORT MED REP, V8, P6, DOI 10.1249/JSR.0b013e31819677db; Cassilo D, 2018, COMMUN SPORT, V6, P86, DOI 10.1177/2167479516654513; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Davis-Hayes C, 2018, NEUROL-CLIN PRACT, V8, P40, DOI 10.1212/CPJ.0000000000000424; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; DiFiori JP, 2014, CLIN J SPORT MED, V24, P3, DOI 10.1097/JSM.0000000000000060; Dunn CR, 2016, FAM RELAT, V65, P287, DOI 10.1111/fare.12193; Eccles J., 1991, J APPL SPORT PSYCHOL, V3, P7, DOI [10.1080/10413209108406432, DOI 10.1080/10413209108406432]; Ellis MJ, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15600; Epstein RM, 2009, JAMA-J AM MED ASSOC, V302, P195, DOI 10.1001/jama.2009.984; Franzini L, 2010, HEALTH PLACE, V16, P267, DOI 10.1016/j.healthplace.2009.10.009; Garcia-Retamero R, 2013, CURR DIR PSYCHOL SCI, V22, P392, DOI 10.1177/0963721413491570; Guthrie LC, 2009, SOC SCI MED, V68, P2145, DOI 10.1016/j.socscimed.2009.04.004; Kroshus E, 2019, INJURY PREV, V25, P278, DOI 10.1136/injuryprev-2017-042677; Kroshus E, 2019, SOC SCI MED, V222, P359, DOI 10.1016/j.socscimed.2018.12.037; Kroshus E, 2018, SOC SCI MED, V218, P37, DOI 10.1016/j.socscimed.2018.07.050; Kroshus E, 2018, HEALTH EDUC BEHAV, V45, P254, DOI 10.1177/1090198117715669; Kroshus E, 2017, J LAW MED ETHICS, V45, P421, DOI 10.1177/1073110517737542; Laker SR, 2016, PHYS MED REH CLIN N, V27, P487, DOI 10.1016/j.pmr.2016.01.001; Legare F, 2006, CAN FAM PHYSICIAN, V52, P476; Love S, 2015, AM J SPORT MED, V43, P1260, DOI 10.1177/0363546514535187; Lundgren T, 2012, COGN BEHAV PRACT, V19, P518, DOI 10.1016/j.cbpra.2012.01.004; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Masic Izet, 2008, Acta Inform Med, V16, P219, DOI 10.5455/aim.2008.16.219-225; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; NCAA, PROB COMP HIGH SCH; Opel DJ, 2018, PEDIATRICS, V142, pS149, DOI 10.1542/peds.2018-0516E; Parsons JT, 2018, HAND CLINIC, V158, P257, DOI 10.1016/B978-0-444-63954-7.00025-2; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; SARIN RK, 1993, EUR J OPER RES, V70, P135, DOI 10.1016/0377-2217(93)90033-J; Sedney CL, 2011, CLIN SPORT MED, V30, P189, DOI 10.1016/j.csm.2010.08.005; Taylor KM, 2018, AM J SPORT MED, V46, P3262, DOI 10.1177/0363546518798801; Tjong VK, 2017, JAAOS GLOB RES REV, V1, DOI 10.5435/JAAOSGlobal-D-17-00070; Wilson KG, 2010, PSYCHOL REC, V60, P249, DOI 10.1007/BF03395706	39	1	1	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1524-8399	1552-6372		HEALTH PROMOT PRACT	Health Promot. Pract.	NOV	2021	22	6					829	839	1524839920945255	10.1177/1524839920945255		JUL 2020	11	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	WQ3FS	WOS:000559356200001	32729330				2022-02-06	
J	Arabi, SM; Sedaghat, A; Ehsaei, MR; Safarian, M; Ranjbar, G; Rezaee, H; Rezvani, R; Tabesh, H; Norouzy, A				Arabi, Seyed Mostafa; Sedaghat, Alireza; Ehsaei, Mohammad Reza; Safarian, Mohammad; Ranjbar, Golnaz; Rezaee, Hamid; Rezvani, Reza; Tabesh, Hamed; Norouzy, Abdolreza			Efficacy of high-dose versus low-dose vitamin D supplementation on serum levels of inflammatory factors and mortality rate in severe traumatic brain injury patients: study protocol for a randomized placebo-controlled trial	TRIALS			English	Article						Traumatic brain injury; Vitamin D; Inflammation; Mortality	CRITICALLY-ILL; D DEFICIENCY; ADULTS	BackgroundTraumatic brain injury (TBI) is the most common trauma worldwide and is a leading cause of injury-related death and disability. Inflammation is initiated as a result of the TBI, which is in association with severity of illness and mortality in brain trauma patients, especially in subdural hemorrhage and epidural hemorrhage cases. A high percentage of adults admitted to the intensive care unit with TBI are diagnosed with vitamin D deficiency; this deficiency may induce impaired immune responses and increase the risk of infections. Vitamin D intervention has been shown to modulate pro- and anti-inflammatory cytokines in non-critically ill patients, but to date, there is no substantial data on the effectiveness of vitamin D for the improvement of immune function in traumatic brain injury patients.Methods/designA randomized clinical trial (RCT) will be performed on 74 Iranian adults 18-65years old with brain trauma and will be treated daily with vitamin D supplements (100,000IU oral drop) or a similar placebo (1000IU) for 5days.DiscussionIf this randomized clinical trial demonstrates reductions in inflammatory cytokines, it would provide evidence for a multicenter clinical trial to evaluate the efficacy of vitamin D supplementation in neurocritically ill patients. Since vitamin D supplements are inexpensive and safe, this clinical trial could have the potential to improve clinical outcomes in traumatic brain injury patients through reduction of inflammation and infection-associated morbidity and mortality rates.Trial registrationIranian Registry of Clinical Trials, IRCT20180619040151N3. Registered on 10 August 2019.	[Arabi, Seyed Mostafa] Mashhad Univ Med Sci, Fac Med, Student Res Comm, Mashhad, Razavi Khorasan, Iran; [Sedaghat, Alireza] Mashhad Univ Med Sci, Cardiac Anesthesia Res Ctr, Mashhad, Razavi Khorasan, Iran; [Ehsaei, Mohammad Reza; Rezaee, Hamid] Mashhad Univ Med Sci, Shahid Kamiab Hosp, Fac Med, Dept Neurosurg, Mashhad, Razavi Khorasan, Iran; [Safarian, Mohammad; Ranjbar, Golnaz; Rezvani, Reza; Norouzy, Abdolreza] Mashhad Univ Med Sci, Metab Syndrome Res Ctr, Mashhad, Razavi Khorasan, Iran; [Tabesh, Hamed] Mashhad Univ Med Sci, Fac Med, Dept Med Informat, Mashhad, Razavi Khorasan, Iran		Norouzy, A (corresponding author), Mashhad Univ Med Sci, Metab Syndrome Res Ctr, Mashhad, Razavi Khorasan, Iran.	Norouzya97@gmail.com	Arabi, Seyyed Mostafa/ABF-1610-2021	Arabi, Seyyed Mostafa/0000-0002-6876-7828; Rezvani, Reza/0000-0003-3585-9854	Mashhad University of Medical Sciences [961867]	This trial is funded by Mashhad University of Medical Sciences (grant #961867).	Alizadeh N, 2016, INT J CLIN PRACT, V70, P396, DOI 10.1111/ijcp.12795; Amrein K, 2014, JAMA-J AM MED ASSOC, V312, P1520, DOI 10.1001/jama.2014.13204; Arabi SM, 2020, NUTR J, V19, DOI 10.1186/s12937-020-0526-3; Ardehali SH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21177-4; Brenner ZR, 2012, CRIT CARE NURS CLIN, V24, P527, DOI 10.1016/j.ccell.2012.07.009; Cariolou M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027666; Christopher KB, 2015, CURR OPIN CLIN NUTR, V18, P187, DOI 10.1097/MCO.0000000000000147; Common terminology criteria for adverse events (CTCAE) version 4.0, 2017, COMM TERM CRIT ADV E; Guan J, 2017, J NEUROSURG, V127, P1, DOI 10.3171/2016.4.JNS16169; Guillot X, 2010, JOINT BONE SPINE, V77, P552, DOI 10.1016/j.jbspin.2010.09.018; Han JE, 2016, J CLIN TRANSL ENDOCR, V4, P59, DOI 10.1016/j.jcte.2016.04.004; Hewison M, 2011, NAT REV ENDOCRINOL, V7, P336, DOI 10.1038/nrendo.2010.226; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Jamall OA, 2016, CLIN ENDOCRINOL, V85, P636, DOI 10.1111/cen.13045; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Lee JM, 2019, WORLD NEUROSURG, V126, pE1421, DOI 10.1016/j.wneu.2019.02.244; Lee P, 2009, INTENS CARE MED, V35, P2028, DOI 10.1007/s00134-009-1642-x; Mangin M, 2014, INFLAMM RES, V63, P803, DOI 10.1007/s00011-014-0755-z; Miroliaee AE, 2018, J CRIT CARE, V44, P300, DOI 10.1016/j.jcrc.2017.08.040; Quraishi SA, 2015, CRIT CARE MED, V43, P1928, DOI 10.1097/CCM.0000000000001148; Schulz KF, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-18; Viglianti EM, 2019, CRIT CARE RESUSC, V21, P39; White JH, 2010, J STEROID BIOCHEM, V121, P234, DOI 10.1016/j.jsbmb.2010.03.034; Williams S, 2016, AM J THER, V23, pE1890, DOI 10.1097/MJT.0000000000000281	24	1	1	3	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	JUL 29	2020	21	1							685	10.1186/s13063-020-04622-6			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	MX4NT	WOS:000557701900003	32727558	gold, Green Published, Green Submitted			2022-02-06	
J	Cantarero, G; Choynowski, J; St Pierre, M; Anaya, M; Statton, M; Stokes, W; Capaldi, V; Chib, V; Celnik, P				Cantarero, Gabriela; Choynowski, Jake; St Pierre, Maria; Anaya, Manuel; Statton, Matthew; Stokes, William; Capaldi, Vincent; Chib, Vikram; Celnik, Pablo			Repeated Concussions Impair Behavioral and Neurophysiological Changes in the Motor Learning System	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						concussion; motor learning; neuroplasticity	TERM POTENTIATION-LIKE; LONG-TERM; RECURRENT CONCUSSION; MAGNETIC STIMULATION; CORTICAL PLASTICITY; SPORTS CONCUSSION; HEAD TRAUMA; CORTEX; CEREBELLAR; BRAIN	Background. Concussions affect nearly 3 million people a year and are the leading cause of traumatic brain injury-related emergency department visits among youth. Evidence shows neuromotor regions are sensitive to concussive events and that motor symptoms may be the earliest clinical manifestations of neurodegenerative traumatic brain injuries. However, little is known about the effects repeated concussions play on motor learning. Namely, how does concussion acuity (time since injury) affect different behavioral and neurophysiological components of motor learning?Methods. Using a 3-pronged approach, we assessed (1) behavioral measures of motor learning, (2) neurophysiological measures underlying retention of motor learning known as occlusion, and (3) quantitative survey data capturing affective symptoms of each participant. Collegiate student athletes were stratified across 3 groups depending on their concussion history: (1) NonCon, no history of concussion; (2) Chronic, chronic-state of concussion (>1 year postinjury), or (3) Acute, acute state of concussion (<2 weeks postinjury).Results. We found that athletes in both the acute and chronic state of injury following a concussion had impaired retention and aberrant occlusion in motor skill learning as compared with athletes with no history of concussion. Moreover, higher numbers of previous concussions (regardless of the time since injury) correlated with more severe behavioral and neurophysiological motor impairments by specifically hindering neurophysiological mechanisms of learning to affect behavior.Conclusions. These results indicate the presence of motor learning impairment that is evident within 2 weeks postinjury. Our findings have significant implications for the prognosis of concussion and emphasize the need for prevention, but can also direct more relevant rehabilitation treatment targets.	[Cantarero, Gabriela; Anaya, Manuel; Stokes, William; Chib, Vikram; Celnik, Pablo] Johns Hopkins Univ, Baltimore, MD USA; [Choynowski, Jake; St Pierre, Maria; Capaldi, Vincent] Walter Reed Army Inst Res, Silver Spring, MD USA; [Statton, Matthew] Kennedy Krieger Inst, Baltimore, MD USA		Cantarero, G (corresponding author), Johns Hopkins, Phys Med & Rehabil, 707 N Brodway,G-04C, Baltimore, MD 21205 USA.	gcantar1@jhmi.edu		Statton, Matthew/0000-0001-5733-0615; Cantarero, Gabriela/0000-0001-7383-1743	 [MOMRP18650];  [R01 HD073147 04]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Study funded by MOMRP18650, R01 HD073147 04.	Bailes JE, 2001, J ATHL TRAINING, V36, P236; Bailes JE, 2009, J INT NEUROPSYCH SOC, V15, P509, DOI 10.1017/S1355617709090936; Cantarero G, 2013, J NEUROSCI, V33, P12862, DOI 10.1523/JNEUROSCI.1399-13.2013; Cantarero G, 2013, J NEUROSCI, V33, P4634, DOI 10.1523/JNEUROSCI.4706-12.2013; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Chistyakov AV, 1999, CLIN NEUROPHYSIOL, V110, P1080, DOI 10.1016/S1388-2457(99)00029-2; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Cothros N, 2006, J COGNITIVE NEUROSCI, V18, P2167, DOI 10.1162/jocn.2006.18.12.2167; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Faul M, 2010, TRAUMATIC BRAIN INJU; Galea JM, 2011, CEREB CORTEX, V21, P1761, DOI 10.1093/cercor/bhq246; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hadipour-Niktarash A, 2007, J NEUROSCI, V27, P13413, DOI 10.1523/JNEUROSCI.2570-07.2007; Jayaram G, 2012, J NEUROPHYSIOL, V107, P2950, DOI 10.1152/jn.00645.2011; Jayaram G, 2011, CEREB CORTEX, V21, P1901, DOI 10.1093/cercor/bhq263; JUDD CM, 1981, EVALUATION REV, V5, P602, DOI 10.1177/0193841X8100500502; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Muellbacher W, 2001, EXP BRAIN RES, V136, P431, DOI 10.1007/s002210000614; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Richardson AG, 2006, J NEUROSCI, V26, P12466, DOI 10.1523/JNEUROSCI.1139-06.2006; Rioult-Pedotti MS, 2007, J NEUROPHYSIOL, V98, P3688, DOI 10.1152/jn.00164.2007; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Robertson EM, 2005, J NEUROSCI, V25, P6372, DOI 10.1523/JNEUROSCI.1851-05.2005; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Rosenkranz K, 2007, J NEUROSCI, V27, P12058, DOI 10.1523/JNEUROSCI.2663-07.2007; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Schlerf JE, 2012, J NEUROSCI, V32, P11610, DOI 10.1523/JNEUROSCI.1609-12.2012; Spampinato D, 2017, SCI REP-UK, V7, DOI 10.1038/srep40715; Stefan K, 2006, CEREB CORTEX, V16, P376, DOI 10.1093/cercorbhi116; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Uehara S, 2018, CEREB CORTEX, V28, P3478, DOI 10.1093/cercor/bhx214; Ziemann U, 2004, J NEUROSCI, V24, P1666, DOI 10.1523/JNEUROSCI.5016-03.2004	43	1	1	2	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	SEP	2020	34	9					804	813	1545968320943578	10.1177/1545968320943578		JUL 2020	10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NQ2IX	WOS:000559595800001	32723160	Green Accepted			2022-02-06	
J	Zeller, M; Bluhm, P; Gassner, M; Ugalde, V; Abele, T; Condron, M				Zeller, Matthew; Bluhm, Paul; Gassner, Marika; Ugalde, Viviane; Abele, Travis; Condron, Mary			Firework discharge leading to cerebral contusion and motor paraplegia	TRAUMA-ENGLAND			English	Article; Early Access						Traumatic paraplegia; bilateral precentral gyri contusion; firework injury; pure motor paralysis; traumatic brain injury; rehabilitation	INJURY	A 57-year-old male sustained a blunt head injury after discharging a mortar firework off the vertex of his head. Physical examination revealed a stellate scalp lesion and pure bilateral leg paraplegia. Initial spinal computed tomography and magnetic resonance imaging were negative for pathology. Initial head computed tomography revealed open, nondisplaced, frontal, and parietal skull fractures with underlying subdural and subarachnoid hemorrhage. Follow-up magnetic resonance imaging one week later showed bilateral precentral gyri frontal lobe contusions involving the lower extremity motor cortices and subcortical white matter extending anteriorly into the region of the supplementary motor areas. The patient's complete paraplegia informed the subsequent hospital rehabilitation. However, motor recovery was more rapid than anticipated, with the patient regaining ambulatory function before inpatient rehabilitation discharge after 27 days of hospitalization. He continued to have issues with spasticity after discharge. We discuss the current literature surrounding paraplegia secondary to head trauma and the recovery that follows. Firework misuse is a known cause of head injury but has not been recorded as a cause of isolated bilateral paraplegia. Isolated precentral gyri contusion must be considered in patients presenting with paraplegia following trauma to the vertex of the head and normal spinal imaging. We show the importance of repeat imaging to follow the evolving nature of traumatic head injuries presenting with paraplegia. We also illustrate the variability in rehabilitation planning and the need for adjustment in rehabilitation planning for paraplegic patients following head trauma.	[Zeller, Matthew; Bluhm, Paul; Gassner, Marika; Condron, Mary] Western Univ Hlth Sci, Coll Osteopath Med Pacific Northwest, Portland, OR 97355 USA; [Gassner, Marika; Condron, Mary] Trauma & Acute Care Surg Serv, St Charles Med Ctr, Bend, OR USA; [Ugalde, Viviane] Ctr Orthoped & Neurosurg Care & Res, Bend, OR USA; [Abele, Travis] Cent Oregon Radiol Associates, Bend, OR USA; [Condron, Mary] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA		Zeller, M (corresponding author), Western Univ Hlth Sci, Coll Osteopath Med Pacific Northwest, Portland, OR 97355 USA.	matthew.zeller@westernu.edu		Ugalde, Viviane/0000-0003-2747-5842; Zeller, Matthew/0000-0002-6061-2215			Ando Kazuhiro, 2012, Brain and Nerve (Tokyo), V64, P1427; Arcy RCND, 2016, J HEAD TRAUMA REHAB, V31, P50; Dobkin B, 2007, NEUROREHAB NEURAL RE, V21, P25, DOI 10.1177/1545968306295556; Gauge N, 2010, INJURY EXTRA, V41, P112; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; Lega BC, 2010, BRAIN INJURY, V24, P1231, DOI 10.3109/02699052.2010.495698; Matsumura Hideaki, 2016, Surg Neurol Int, V7, pS752; Messori A, 2001, AM J NEURORADIOL, V22, P1748; Moore JX, 2014, INJURY, V45, P1704, DOI 10.1016/j.injury.2014.06.024; Taniguchi LU, 2011, BMC EMERG MED, V11, DOI 10.1186/1471-227X-11-10; TEDDY PJ, 1984, PARAPLEGIA, V22, P320, DOI 10.1038/sc.1984.52; Tu Y, 2018, 1 US CONS PROD SAF C	12	1	1	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1460-4086	1477-0350		TRAUMA	Trauma											1460408620943487	10.1177/1460408620943487		JUL 2020	5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	MS1XD	WOS:000554076400001					2022-02-06	
J	Karsy, M; Kim, R; Azab, M; Harper, J; Guan, J; Eli, I; Couldwell, W				Karsy, Michael; Kim, Robert; Azab, Mohammed; Harper, Jonathan; Guan, Jian; Eli, Ilyas; Couldwell, William			Higher Admission D-Dimer Values Are Associated With an Increased Risk of Nonroutine Discharge in Neurosurgery Patients	CUREUS			English	Article						d-dimer; biomarker; outcomes; neurosurgery	ANEURYSMAL SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; ACUTE-PHASE PROTEINS; PLASMA D-DIMER; OUTCOMES; VALIDATION	Background D-dimers are serum acute-phase proteins with a role in mediating inflammation that may be used as biomarkers for the prediction of deep vein thrombosis. Recent studies have shown that D-dimers can he used to predict prognosis and stratify risk in neurosurgical patients; however, a comparative analysis across diagnostic subtypes has yet to be performed. Methods A bioinformatics analysis evaluated neurosurgical patients with admission D-dimer levels between 2008 and 2017. Nonroutine disposition (e.g., skilled nursing facility, rehabilitation, other hospital, mortality) was primarily evaluated. Results A total of 1,854 patients (mean age 55.1 +/- 18.2 years, 55.4% male; mean admission D-dimer 4.83 +/- 7.78 mu g/ml) were identified. Patient diagnoses included vascular (27.1%), trauma (16.4%), multiple diagnoses (15.7%), spine (15.6%), tumor (13.0%), and other (12.2%) causes. Univariate analysis showed that older age (p=0.0001), higher American Society of Anesthesiologists (ASA) score (p=0.0001), lower Glasgow Coma Scale (GCS) score (p=0.0001), diagnosis type (p=0.0001), longer length of stay (LOS) (p=0.0001), higher infection rate (p=0.0001), surgery in the past year (p=0.02), and higher D-dimer levels (3.4 +/- 4.9 vs. 5.4 +/- 8.7 mu g/ml, p=0.0001) were associated with nonroutine disposition. Multivariate logistic regression showed that elevated D-dimers were independently associated with a greater relative risk of nonroutine disposition (relative risk [RR] 1.026, 95% CI 1.02-1.033, p=0.0001). Conclusions Elevated admission D-dimer values were independently associated with a 3% increased risk of nonroutine disposition per D-dimer unit after accounting for other factors. These results suggest that D-dimer values may help in stratifying patient risk models despite clinical heterogeneity. Further refinement of neurosurgical patient risk models using clinical variables and biomarkers may aid in resource allocation and early warning.	[Karsy, Michael; Kim, Robert; Azab, Mohammed; Harper, Jonathan; Guan, Jian; Eli, Ilyas; Couldwell, William] Univ Utah, Neurosurg, Salt Lake City, UT 84112 USA		Couldwell, W (corresponding author), Univ Utah, Neurosurg, Salt Lake City, UT 84112 USA.	william.couldwell@hsc.utah.edu					Berger RP, 2015, J PEDIATR-US, V166, P383, DOI 10.1016/j.jpeds.2014.10.036; Boluijt J, 2015, J CEREBR BLOOD F MET, V35, P724, DOI 10.1038/jcbfm.2015.13; Chen CW, 2016, J CLIN NEUROSCI, V29, P149, DOI 10.1016/j.jocn.2015.10.036; Chen H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/685174; Cho Tack Geun, 2014, J Cerebrovasc Endovasc Neurosurg, V16, P159, DOI 10.7461/jcen.2014.16.3.159; Fukuda H, 2017, J NEUROSURG, V127, P284, DOI 10.3171/2016.5.JNS16767; Gerlach R, 2008, NEUROSURGERY, V63, P693, DOI 10.1227/01.NEU.0000325730.77263.7E; Goldenberg NA, 2013, J PEDIATR-US, V162, P1041, DOI 10.1016/j.jpeds.2012.11.035; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Gupta G, 2016, J CLIN DIAGN RES, V10, pPC4, DOI 10.7860/JCDR/2016/14638.7029; Hoke M, 2011, WIEN KLIN WOCHENSCHR, V123, P199, DOI 10.1007/s00508-011-1556-9; Hu X, 2014, J CLIN NEUROSCI, V21, P1364, DOI 10.1016/j.jocn.2013.11.030; Ilveskero S, 2005, NEUROSURGERY, V57, P16, DOI 10.1227/01.NEU.0000163085.48999.D6; Izumi T, 2007, NEUROSURGERY, V61, P262, DOI 10.1227/01.NEU.0000255529.46092.7C; Jain S, 2011, J PHARM BIOALLIED SC, V3, P118, DOI 10.4103/0975-7406.76489; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Karsy M, 2020, WORLD NEUROSURG, V133, pE774, DOI 10.1016/j.wneu.2019.09.160; Li B, 2019, EUR SPINE J, V28, P1480, DOI 10.1007/s00586-018-05872-4; Liu JH, 2017, NEURAL REGEN RES, V12, P2014, DOI 10.4103/1673-5374.221158; Navone SE, 2019, WORLD NEUROSURG, V121, pE621, DOI 10.1016/j.wneu.2018.09.177; Pulivarthi S, 2014, N AM J MED SCI, V6, P491, DOI 10.4103/1947-2714.143278; Squizzato A, 2006, BLOOD COAGUL FIBRIN, V17, P303, DOI 10.1097/01.mbc.0000224850.57872.d0; Sugimoto K, 2017, J NEUROTRAUM, V34, P3245, DOI 10.1089/neu.2017.5240; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; Watterson C, 2009, TOXICOL PATHOL, V37, P28, DOI 10.1177/0192623308329286; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Yang ML, 2019, SPINE, V44, P246, DOI 10.1097/BRS.0000000000002816; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac; Zhang J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211458	30	1	1	1	3	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUL 27	2020	12	7							e9425	10.7759/cureus.9425			10	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	MQ0TA	WOS:000552608500016	32864251	gold, Green Published			2022-02-06	
J	Makarevich, O; Sabirzhanov, B; Aubrecht, TG; Glaser, EP; Polster, BM; Henry, RJ; Faden, AI; Stoica, BA				Makarevich, Oleg; Sabirzhanov, Boris; Aubrecht, Taryn G.; Glaser, Ethan P.; Polster, Brian M.; Henry, Rebecca J.; Faden, Alan I.; Stoica, Bogdan A.			Mithramycin selectively attenuates DNA-damage-induced neuronal cell death	CELL DEATH & DISEASE			English	Article							TRAUMATIC BRAIN-INJURY; SUPPRESSOR PROTEIN P53; OXIDATIVE STRESS; GENE-EXPRESSION; TRANSCRIPTION FACTORS; MOLECULAR-MECHANISMS; THERAPEUTIC TARGETS; FODRIN PROTEOLYSIS; DOWN-REGULATION; CDK INHIBITOR	DNA damage triggers cell death mechanisms contributing to neuronal loss and cognitive decline in neurological disorders, including traumatic brain injury (TBI), and as a side effect of chemotherapy. Mithramycin, which competitively targets chromatin-binding sites of specificity protein 1 (Sp1), was used to examine previously unexplored neuronal cell death regulatory mechanisms via rat primary neurons in vitro and after TBI in mice (males). In primary neurons exposed to DNA-damage-inducing chemotherapy drugs in vitro we showed that DNA breaks sequentially initiate DNA-damage responses, including phosphorylation of ATM, H(2)AX and tumor protein 53 (p53), transcriptional activation of pro-apoptotic BH3-only proteins, and mitochondrial outer membrane permeabilization (MOMP), activating caspase-dependent and caspase-independent intrinsic apoptosis. Mithramycin was highly neuroprotective in DNA-damage-dependent neuronal cell death, inhibiting chemotherapeutic-induced cell death cascades downstream of ATM and p53 phosphorylation/activation but upstream of p53-induced expression of pro-apoptotic molecules. Mithramycin reduced neuronal upregulation of BH3-only proteins and mitochondrial dysfunction, attenuated caspase-3/7 activation and caspase substrates' cleavage, and limited c-Jun activation. Chromatin immunoprecipitation indicated that mithramycin attenuates Sp1 binding to pro-apoptotic gene promoters without altering p53 binding suggesting it acts by removing cofactors required for p53 transactivation. In contrast, the DNA-damage-independent neuronal death models displayed caspase initiation in the absence of p53/BH3 activation and were not protected even when mithramycin reduced caspase activation. Interestingly, experimental TBI triggers a multiplicity of neuronal death mechanisms. Although markers of DNA-damage/p53-dependent intrinsic apoptosis are detected acutely in the injured cortex and are attenuated by mithramycin, these processes may play a reduced role in early neuronal death after TBI, as caspase-dependent mechanisms are repressed in mature neurons while other, mithramycin-resistant mechanisms are active. Our data suggest that Sp1 is required for p53-mediated transactivation of neuronal pro-apoptotic molecules and that mithramycin may attenuate neuronal cell death in conditions predominantly involving DNA-damage-induced p53-dependent intrinsic apoptosis.	[Makarevich, Oleg; Sabirzhanov, Boris; Aubrecht, Taryn G.; Glaser, Ethan P.; Polster, Brian M.; Henry, Rebecca J.; Faden, Alan I.; Stoica, Bogdan A.] Univ Maryland, Dept Anesthesiol, Sch Med, Baltimore, MD 21201 USA; [Makarevich, Oleg; Sabirzhanov, Boris; Aubrecht, Taryn G.; Glaser, Ethan P.; Polster, Brian M.; Henry, Rebecca J.; Faden, Alan I.; Stoica, Bogdan A.] Univ Maryland, Shock Trauma & Anesthesiol Res STAR Ctr, Sch Med, Baltimore, MD 21201 USA		Stoica, BA (corresponding author), Univ Maryland, Dept Anesthesiol, Sch Med, Baltimore, MD 21201 USA.; Stoica, BA (corresponding author), Univ Maryland, Shock Trauma & Anesthesiol Res STAR Ctr, Sch Med, Baltimore, MD 21201 USA.	bstoica@som.umaryland.edu			National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS091191, R01 NS096002]	This work was supported by National Institutes of Health (NIH) grants R01 NS091191 to A.I.F. and R01 NS096002 to B.A.S. and B.S. We are grateful for the technical support provided by Nicholas Braganca and Xiaoyi Lin.	Arai M, 2019, J NEUROCHEM, V151, P795, DOI 10.1111/jnc.14803; Aubrecht TG, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1156-y; Aubrey BJ, 2018, CELL DEATH DIFFER, V25, P104, DOI 10.1038/cdd.2017.169; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Chatterjee S, 2001, ANN NEUROL, V49, P345, DOI 10.1002/ana.71; Chen BK, 2000, P NATL ACAD SCI USA, V97, P10406, DOI 10.1073/pnas.180321497; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Clark RSB, 2001, J NEUROTRAUM, V18, P675, DOI 10.1089/089771501750357627; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Clerc P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034465; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; Czubowicz K, 2014, MOL NEUROBIOL, V50, P26, DOI 10.1007/s12035-013-8606-4; Deshmukh M, 2000, CELL DEATH DIFFER, V7, P250, DOI 10.1038/sj.cdd.4400641; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; El-Agamy SE, 2019, CANCER CHEMOTH PHARM, V84, P1, DOI 10.1007/s00280-019-03827-0; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Ferrante RJ, 2004, J NEUROSCI, V24, P10335, DOI 10.1523/JNEUROSCI.2599-04.2004; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Garcia-Saez AJ, 2012, CELL DEATH DIFFER, V19, P1733, DOI 10.1038/cdd.2012.105; Graupner V, 2011, CELL DEATH DIFFER, V18, P1130, DOI 10.1038/cdd.2010.179; Hemann MT, 2006, CELL DEATH DIFFER, V13, P1256, DOI 10.1038/sj.cdd.4401962; Huang Y-N, 2018, SCI REP, V8, DOI DOI 10.1038/S41598-018-19654-X; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kabadi SV, 2012, NEUROTHERAPEUTICS, V9, P405, DOI 10.1007/s13311-011-0095-4; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kim B-J, 2016, MOL NEURODEGENERATIO, V11; Kiryu-Seo S, 2008, J BIOL CHEM, V283, P6988, DOI 10.1074/jbc.M707514200; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Koutsodontis G, 2005, BIOCHEM J, V389, P443, DOI 10.1042/BJ20041980; Koutsodontis G, 2004, ONCOGENE, V23, P9190, DOI 10.1038/sj.onc.1208141; Lee JY, 2018, J NEUROTRAUM, V35, P508, DOI 10.1089/neu.2017.5235; Li H, 2014, CELL DEATH DIFFER, V21, P1493, DOI 10.1038/cdd.2014.69; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Merlo P, 2014, P NATL ACAD SCI USA, V111, P18055, DOI 10.1073/pnas.1419083111; Moore JD, 2002, BRIT J PHARMACOL, V135, P1069, DOI 10.1038/sj.bjp.0704538; Morris EJ, 1996, J CELL BIOL, V134, P757, DOI 10.1083/jcb.134.3.757; Muslimovic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005859; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; Nowsheen S., 2012, Experimental Oncology, V34, P243; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ongnok B, 2020, EXP NEUROL, V324, DOI 10.1016/j.expneurol.2019.113118; Osada N, 2013, J PHARMACOL SCI, V122, P251, DOI 10.1254/jphs.13R02CP; Pennypacker KR, 2001, EXP NEUROL, V172, P307, DOI 10.1006/exnr.2001.7817; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piedrafita FJ, 1997, MOL CELL BIOL, V17, P6348, DOI 10.1128/MCB.17.11.6348; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; RINK A, 1995, AM J PATHOL, V147, P1575; Riss T., 2019, ASSAY GUIDANCE MANUA; Rumana A., 2015, J NEUROCHEM, V134, P1091; Ryu H, 2003, J NEUROSCI, V23, P3597; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Sabirzhanov B, 2018, J NEUROTRAUM, V35, P2462, DOI 10.1089/neu.2017.5572; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; Shamas-Din A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008714; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; SIMAN R, 1987, J NEUROSCI, V7, P55; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Sleiman SF, 2011, J NEUROSCI, V31, P6858, DOI 10.1523/JNEUROSCI.0710-11.2011; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; Sokolowski JD, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-16; Spalm FHP, 2019, MOL NEUROBIOL, V56, P4760, DOI 10.1007/s12035-018-1402-4; Suhaili Siti Haji, 2017, Biophys Rev, V9, P443, DOI 10.1007/s12551-017-0308-0; Tapias A, 2008, CELL CYCLE, V7, P2856, DOI 10.4161/cc.7.18.6671; Thorn CF, 2011, PHARMACOGENET GENOM, V21, P440, DOI 10.1097/FPC.0b013e32833ffb56; Thornborrow EC, 2001, J BIOL CHEM, V276, P15598, DOI 10.1074/jbc.M011643200; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; YOKOTA M, 1995, STROKE, V26, P1901, DOI 10.1161/01.STR.26.10.1901; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Zhu WY, 2014, INT J MOL SCI, V15, P3336, DOI 10.3390/ijms15023336	80	1	1	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	JUL 27	2020	11	7							587	10.1038/s41419-020-02774-6			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	MV9XZ	WOS:000556702900006	32719328	gold, Green Published			2022-02-06	
J	Marini, CP; Stoller, C; McNelis, J; Del Deo, V; Prabhakaran, K; Petrone, P				Marini, Corrado P.; Stoller, Christy; McNelis, John; Del Deo, Vito; Prabhakaran, Kartik; Petrone, Patrizio			Correlation of brain flow variables and metabolic crisis: a prospective study in patients with severe traumatic brain injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						CBF; Multimodality monitoring; Oxygen crisis; Cerebral microdialysis	MICRODIALYSIS; DELIVERY; HYPOXIA; IMPACT	Introduction Current treatment guidelines for patients with severe TBI (sTBI) are aimed at preventing secondary brain injury targeting specific endpoints of intracranial physiology to avoid the development of metabolic crisis. We sought to identify factors contributing to development of metabolic crisis in the setting of a Multi-modality Monitoring and Goal-Directed Therapy (MM&GDTP) approach to patients with severe TBI. Methods Prospective monitoring of sTBI patients was performed, with retrospective data analysis. MM&GDTP was targeted to intracranial pressure (ICP) <= 20 mmHg, cerebral perfusion pressure (CPP) >= 60 mmHg, brain tissue oxygen pressure (PbtO(2)) >= 20 mmHg, and cerebral oxygen extraction measured by bi-frontal Near infrared Spectroscopy (NIRS) > 55%. Brain flow abnormality was defined by one of the following combinations: CPP < 60 mmHg with NIRS < 55% (Type 1), CPP < 60 mmHg with PbtO(2) < 20 mmHg (Type 2), or PbtO(2) < 20 mmHg with NIRS < 55% (Type 3). Cerebral micro-dialysate was analyzed hourly for glucose, lactate, pyruvate, glutamate, glycerol, and lactate/pyruvate ratio (LPR). Statistical analysis was performed with studentt-test, chi-square and Pearson's tests as applicable. Results A total of 109,474 consecutive minutes of recorded multimodality monitoring was available for analysis. There was a significant difference in the number of minutes of brain flow abnormalities between survivors and non-survivors: 0.8% (875) versus 7.49% (8,199), respectively (p < 0.05). The duration of Type 1-3 flow abnormality per patient was higher in non-survivors (5.7 +/- 2.5 h) compared to survivors (0.7 +/- 0.6 h) as well as the duration of metabolic crisis, namely, 5.2 +/- 2.2 versus 0.6 +/- 1.0 h per patient. The occurrence of severe metabolic crisis was associated with a Type 2 flow abnormality (CPP < 60 mmHg and PbtO(2) < 20 mmHg),r = 0.97,p < 0.001, but not with Type 1 and 3. Conclusions Metabolic crisis can occur despite a MM&GDTP approach aimed at optimizing cerebral blood flow. Severe metabolic crisis is associated to failure to maintain CPP and PbtO(2)above 60 and 20 mmHg, respectively(.)The occurrence of severe metabolic crisis portends a poor prognosis in patients with sTBI.	[Marini, Corrado P.; McNelis, John] Albert Einstein Coll Med, Jacobi Med Ctr, Dept Surg, Bronx, NY 10467 USA; [Marini, Corrado P.; Stoller, Christy; Prabhakaran, Kartik] New York Med Coll, Dept Surg, Valhalla, NY 10595 USA; [Del Deo, Vito] San Michele Hosp, Integrated Serv Maxillofacial Surg, Maddaloni, Caserta, Italy; [Petrone, Patrizio] NYU, Dept Surg, Langone Hlth, Winthrop Hosp,Long Isl Sch Med, 222 Stn Plaza North,Suite 300, Mineola, NY 11501 USA		Petrone, P (corresponding author), NYU, Dept Surg, Langone Hlth, Winthrop Hosp,Long Isl Sch Med, 222 Stn Plaza North,Suite 300, Mineola, NY 11501 USA.	patrizio.petrone@gmail.com		Petrone, Patrizio/0000-0002-7629-1663			[Anonymous], 2008, BMJ-BRIT MED J, V336, P425, DOI DOI 10.1136/bmj.39461.643438.25; Asgari S, 2013, NEUROCRIT CARE, V19, P56, DOI 10.1007/s12028-013-9821-6; Bardt TF, 1998, ACT NEUR S, V71, P153; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Brain Trauma Foundation American Association of Neurological Surgeons, 2007, J NEUROTRAUMA S, V24, pS1, DOI DOI 10.1089/NEU.2007.9997; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Dunham CM, 2002, J TRAUMA, V52, P40, DOI 10.1097/00005373-200201000-00009; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Nelson DW, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-21; Reinstrup P, 2011, NEUROCRIT CARE, V14, P441, DOI 10.1007/s12028-010-9486-3; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Timofeev I, 2011, BRAIN, V1, P1; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029	22	1	1	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-020-01447-5		JUL 2020	8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	MQ9TW	WOS:000553235700001	32719895				2022-02-06	
J	Tsai, YWV; Fawzy, JH; Durkin, JB; Then, JE; McGinnis, CB				Tsai, Yuwei V.; Fawzy, John H.; Durkin, Joseph B.; Then, Janine E.; McGinnis, Cory B.			Off-Label Use of Intravenous Olanzapine for Agitation After Neurologic Injury	HOSPITAL PHARMACY			English	Article						olanzapine; delirium; critically ill patients; agitation; neurological injuries	TRAUMATIC BRAIN-INJURY; INTRAMUSCULAR OLANZAPINE; ANTIPSYCHOTIC AGENTS; HALOPERIDOL; DROPERIDOL; MIDAZOLAM; PLACEBO; DRUGS; QTC	Background:Small studies have described the off-label use of intravenous (IV) olanzapine for the management of acute agitation.Objective:The purpose of this study was to evaluate the efficacy and safety of IV olanzapine to manage acutely agitated patients with neurological injuries.Methods:This was a retrospective analysis of IV olanzapine use in patients admitted to the neurotrauma and neurovascular intensive care units at a single academic center. The primary endpoint was the requirement of additional IV olanzapine, IV benzodiazepine, or IV haloperidol within 60 minutes from the time of first IV olanzapine dose. Secondary safety endpoints included QTc prolongation and respiratory depression.Results:Forty-six patients received IV olanzapine during the study period. One patient required an additional dose of IV olanzapine and two patients received benzodiazepine or antipsychotic agents within 60 minutes of IV olanzapine administration. One patient had a post-administration QTc level >500 ms. Two patients had an increased oxygen requirement, but none required intubation.Conclusion:IV olanzapine appears to be efficacious in reducing the need for sedatives and antipsychotics with low risk for QTc prolongation and respiratory depression in acutely agitated patients with neurological injuries.	[Tsai, Yuwei V.] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA 15213 USA; [Fawzy, John H.; Durkin, Joseph B.; Then, Janine E.; McGinnis, Cory B.] UPMC Presbyterian Hosp, Pittsburgh, PA USA		McGinnis, CB (corresponding author), UPMC Presbyterian Hosp, Dept Pharm, 200 Lothrop St, Pittsburgh, PA 15213 USA.	weavercb@upmc.edu		McGinnis, Cory/0000-0001-7847-4650			Bellamy CJ, 2009, J TRAUMA, V66, P954, DOI 10.1097/TA.0b013e31818e90ed; Chan EW, 2013, ANN EMERG MED, V61, P72, DOI 10.1016/j.annemergmed.2012.07.118; Cole JB, 2017, ANN EMERG MED, V69, P327, DOI 10.1016/j.annemergmed.2016.08.008; Crumb WJ, 2006, PHARM RES-DORDR, V23, P1133, DOI 10.1007/s11095-006-0070-7; Eli Lilly and Company, 1997, OL; Harrigan EP, 2004, J CLIN PSYCHOPHARM, V24, P62, DOI 10.1097/01.jcp.0000104913.75206.62; Khorassani F, 2019, ANN PHARMACOTHER, V53, P853, DOI 10.1177/1060028019831634; Kumlien E, 2010, SEIZURE-EUR J EPILEP, V19, P69, DOI 10.1016/j.seizure.2009.11.005; Lindborg SR, 2003, PSYCHIAT RES, V119, P113, DOI 10.1016/S0165-1781(03)00107-0; Lorenzo MP, 2020, HOSP PHARM, V55, P108, DOI 10.1177/0018578718823484; Martel ML, 2016, ACAD EMERG MED, V23, P29, DOI 10.1111/acem.12842; Pisani MA, 2009, AM J RESP CRIT CARE, V180, P1092, DOI 10.1164/rccm.200904-0537OC; Prekker ME, 2017, AM J RESP CRIT CARE, V195; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; Skrobik YK, 2004, INTENS CARE MED, V30, P444, DOI 10.1007/s00134-003-2117-0; Stanislav SW, 1997, BRAIN INJURY, V11, P335, DOI 10.1080/026990597123494; Taylor DM, 2017, ANN EMERG MED, V69, P318, DOI 10.1016/j.annemergmed.2016.07.033; Wassenaar A, 2019, CRIT CARE MED, V47, pE827, DOI 10.1097/CCM.0000000000003911; Wilson MS, 2003, AM J PHYS MED REHAB, V82, P871, DOI 10.1097/01.PHM.0000091982.33232.CB	19	1	1	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0018-5787	1945-1253		HOSP PHARM	Hosp. Pharm.	DEC	2021	56	6					697	701	0018578720946767	10.1177/0018578720946767		JUL 2020	5	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	WO4RN	WOS:000553089200001	34732924				2022-02-06	
J	Gridina, NY; Gupal, AM; Tarasov, AL; Ushenin, YV				Gridina, N. Ya; Gupal, A. M.; Tarasov, A. L.; Ushenin, Yu, V			Analysis of Neurosurgical Pathologies Using Bayesian Recognition Procedures for Indicators of Surface Plasmon Resonance in the Aggregation of Blood Cells	CYBERNETICS AND SYSTEMS ANALYSIS			English	Article						Bayesian recognition procedure; brain gliomas; metastases; traumatic brain injury; surface plasmon resonance; differential diagnosis; modified erythrocyte sedimentation rate	CANCER; INFLAMMATION	The use of Bayesian recognition procedure for surface plasmon resonance with the addition of verapamil hydrochloride and ketamine to the blood in the analysis of neurosurgical tumor pathologies significantly improved recognition compared to pure blood samples. An analysis of the difference in such pathologies due to the method of surface plasmon resonance with the addition of ketamine made it possible to improve the results of recognition of pathologies as compared with the method of the modified erythrocyte sedimentation rate.	[Gridina, N. Ya] Natl Acad Med Sci Ukraine, State Inst Romodanov Neurosurg Inst, Kiev, Ukraine; [Gupal, A. M.; Tarasov, A. L.] Natl Acad Sci Ukraine, VM Glushkov Inst Cybernet, Kiev, Ukraine; [Ushenin, Yu, V] Natl Acad Sci Ukraine, VE Lashkaryov Inst Semicond Phys, Kiev, Ukraine		Gridina, NY (corresponding author), Natl Acad Med Sci Ukraine, State Inst Romodanov Neurosurg Inst, Kiev, Ukraine.	gridinanina@ukr.net; gupalanatol@gmail.com; freearcher@ukr.net; ushyury68@gmail.com		Samoylov, Anton/0000-0001-5149-693X			Boldyrev AA., 2007, ANN KLIN EKSPERIMENT, V1, P28; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Fernandes JV, 2015, PATHOL ONCOL RES, V21, P527, DOI 10.1007/s12253-015-9913-z; Gridina NJ, 2017, CYBERN SYST ANAL+, V53, P366, DOI 10.1007/s10559-017-9936-4; Gridina N.Ya., 2015, SCHOLAR J APPL MED S, V3, P2156; Gridina N.Ya., 2016, EUROPEAN J PHARM MED, V3, P73; Kudravi SA, 2000, IN VIVO, V14, P83; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Matsko DE, 1998, ATLAS CEREBROSPINAL; Olyushin V. E., 2005, RUSSIAN J NEUROSURGE, P41; Rozumenko A. V., 2018, UKRAINIAN NEUROSURGI, P33, DOI [10.25305/unj.124878, DOI 10.25305/UNJ.124878]; Vdovin V. A., 2012, YAROSLAVL PEDAGOG NS, P151; Zozulya YA, 2007, BRAIN GLIOMAS, P383	15	1	1	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1060-0396	1573-8337		CYBERN SYST ANAL+	Cybern. Syst. Anal.	JUL	2020	56	4					550	558		10.1007/s10559-020-00271-4		JUL 2020	9	Computer Science, Cybernetics; Mathematics, Interdisciplinary Applications	Emerging Sources Citation Index (ESCI)	Computer Science; Mathematics	MT1FL	WOS:000553050700003					2022-02-06	
J	Bukhary, S				Bukhary, Sundus			Assessment of Knowledge and Attitudes of Traumatic Dental Injuries among Saudi Dental Students: A Multicenter Cross-Sectional Study	INTERNATIONAL JOURNAL OF DENTISTRY			English	Article							QUALITY-OF-LIFE; DENTISTS KNOWLEDGE; MANAGEMENT; CHILDREN; PERCEPTIONS; PREVALENCE; FRACTURES	Introduction. The aim of this multicenter cross-sectional study was to assess the knowledge and attitudes of senior dental students in Riyadh, Saudi Arabia, regarding the management of traumatic dental injuries. Materials and Methods. A stratified random sample of fourth- and fifth-year dental students in different dental schools was given a two-part questionnaire; the first part included demographic questions, while the second part included case scenario questions related to knowledge and attitudes regarding the emergency management of concussion, crown fractures, luxation injuries, root fracture, and alveolar bone fracture. Data were statistically analysed using chi-square and ordinal logistic regression tests. The significance was set atp<0.05. Results. A total of 359 dental students participated in this study. The proportion of students from all dental schools with correct responses to each set of questions was as follows: alveolar bone fracture (78.4%), root fracture (70.1%), intrusive luxation (57.1%), complicated crown fracture (39.7%), uncomplicated crown fracture (35.5%), extrusive luxation (35%), concussion (31.1%), and lateral luxation (26.8%). The mean overall knowledge score of the participants was 3.421 +/- 0.49. No statistically significant difference was found on any of the questions regarding the gender or year of study (p > 0.05). Conclusion. Based on the findings of this study, dental students' knowledge of the management of traumatic dental injuries in the Riyadh region of Saudi Arabia ranges from low to moderate. Thus, there is a need to improve the knowledge of management of traumatic dental injuries among dental students.	[Bukhary, Sundus] King Saud Univ, Coll Dent, Dept Restorat Dent Sci, Div Endodont, POB 45347, Riyadh 11512, Saudi Arabia		Bukhary, S (corresponding author), King Saud Univ, Coll Dent, Dept Restorat Dent Sci, Div Endodont, POB 45347, Riyadh 11512, Saudi Arabia.	sbukhary@ksu.edu.sa		Bukhary, Sundus/0000-0002-9202-8291			Al-Majed I, 2001, DENT TRAUMATOL, V17, P153, DOI 10.1034/j.1600-9657.2001.170403.x; Al-Malik M, 2009, J MAXILLOFAC ORAL SU, V8, P34, DOI 10.1007/s12663-009-0009-8; Al-Shamiri Hashem Motahir, 2015, Eur J Dent, V9, P518, DOI 10.4103/1305-7456.172636; Ali SNA, 2020, INT J PEDIAT, V2020, DOI 10.1155/2020/6059346; AlZoubi F, 2015, DENT TRAUMATOL, V31, P482, DOI 10.1111/edt.12198; American Academy of Pediatric Dentistry, 2013, GUID MAN TRAUM DENT; American Association of Endodontists, 2013, REC GUID AM ASS END; Buldur B, 2018, J CLIN PEDIATR DENT, V42, P119, DOI 10.17796/1053-4628-42.2.7; Buldur B, 2020, INT J PAEDIATR DENT, V30, P181, DOI 10.1111/ipd.12583; Buldur B, 2018, PESQUI BRAS ODONTOPE, V18, DOI 10.4034/PBOCI.2018.181.30; Buldur B, 2018, EUR J ORAL SCI, V126, P46, DOI 10.1111/eos.12397; Cauwels RGEC, 2014, DENT TRAUMATOL, V30, P133, DOI 10.1111/edt.12069; Cortes MID, 2002, COMMUNITY DENT ORAL, V30, P193; DiAngelis AJ, 2012, DENT TRAUMATOL, V28, P2, DOI 10.1111/j.1600-9657.2011.01103.x; Diaz J, 2009, DENT TRAUMATOL, V25, P611, DOI 10.1111/j.1600-9657.2009.00835.x; Hamilton FA, 1997, BRIT DENT J, V182, P91, DOI 10.1038/sj.bdj.4809313; Hartmann RC, 2019, DENT TRAUMATOL, V35, P27, DOI 10.1111/edt.12450; de Franca R, 2007, DENT TRAUMATOL, V23, P287, DOI 10.1111/j.1600-9657.2006.00444.x; Kazandag M, 2018, BIOMED RES-TOKYO, V29, P1756; Kostopoulou M N, 2005, Int J Paediatr Dent, V15, P10, DOI 10.1111/j.1365-263X.2005.00588.x; Krastl G, 2009, DENT TRAUMATOL, V25, P88, DOI 10.1111/j.1600-9657.2008.00706.x; Lenzi MM, 2015, DENT TRAUMATOL, V31, P79, DOI 10.1111/edt.12149; Pagliarini A, 2000, QUINTESSENCE INT, V31, P133; Richards Derek, 2018, Evid Based Dent, V19, P34, DOI 10.1038/sj.ebd.6401297; Rodd HD, 2010, BRIT DENT J, V208, P221, DOI 10.1038/sj.bdj.2010.207; Flores MT, 2019, DENT TRAUMATOL, V35, P312, DOI 10.1111/edt.12496; Vanderas AP, 1999, ENDOD DENT TRAUMATOL, V15, P235	27	1	1	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-8728	1687-8736		INT J DENT	Int. J. Dent.	JUL 25	2020	2020								8814123	10.1155/2020/8814123			6	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	MY6ZM	WOS:000558562700001	32774377	gold, Green Published			2022-02-06	
J	Furtan, S; Pochcial, P; Timler, D; Ricci, F; Sutton, R; Fedorowski, A; Zysko, D				Furtan, Stanislaw; Pochcial, Pawel; Timler, Dariusz; Ricci, Fabrizio; Sutton, Richard; Fedorowski, Artur; Zysko, Dorota			Prognosis of Syncope With Head Injury: a Tertiary Center Perspective	FRONTIERS IN CARDIOVASCULAR MEDICINE			English	Article						syncope; head injury; mortality; prognosis; Glasgow Coma Scale	TRAUMATIC BRAIN-INJURY; EMERGENCY-DEPARTMENT; SHORT-TERM; RISK; CONSCIOUSNESS; MORTALITY; OUTCOMES	Aim: Head injury is the most common trauma occurring in syncope. We aimed to assess whether syncope as cause of head-trauma affects short-and long-term prognosis. Methods: From a database retrospective analysis of 97,014 individuals attending Emergency Department (ED), we selected data of patients with traumatic head injury including age, gender, injury mechanism, brain imaging, multiple traumas, bone fracture, intracranial bleeding, and mortality. Mean follow-up was 6.4 +/- 1.8 years. Outcome data were obtained from a digital national population register. The study population included 3,470 ED head injury patients: 117 of them (50.0 +/- 23.6 years, 42.7% men) reported syncope as cause of head trauma and 3,315 (32.2 +/- 21.1 years, 68.5% men) without syncope preceding head trauma. Results: Thirty-day mortality was low and similar in traumatic head injury with or without syncope. One year and long-term all-cause mortality were both significantly higher in syncopal vs. non-syncopal traumatic head injury (11.1 vs. 2.8% and 32 vs. 10.2%, respectively; both p< 0.001). In adjusted logistic regression analysis, death between 121st-day and 1 year in patients with head-trauma was associated with male gender [odds ratio (OR): 6.48; 95% CI: 2.59-16.25], advancing age (per year) (OR 1.09; 95% CI 1.07-1.11), Glasgow Coma Scale < 13 (OR: 6.18; 95% CI:1.68-22.8), bone fracture (OR 4.72; 95% CI 2.13-10.5), and syncope (OR 3.70; 95% CI: 1;48-9.31). In multivariable Cox regression analysis, syncope was one of the strongest independent predictors of long-term all-cause death (hazard ratio: 1.95; 95% CI 1.37-2.78). Conclusion: In patients with head trauma, history of syncope preceding injury does not increase 30-day all-cause mortality but portends increased 1 year and long-term mortality.	[Furtan, Stanislaw; Pochcial, Pawel; Zysko, Dorota] Wroclaw Med Univ, Dept Emergency Med, Wroclaw, Poland; [Timler, Dariusz] Med Univ Lodz, Dept Emergency Med & Disaster Med, Lodz, Poland; [Ricci, Fabrizio] Univ G dAnnunzio, Inst Adv Biomed Technol, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Ricci, Fabrizio; Sutton, Richard; Fedorowski, Artur] Lund Univ, Fac Med, Clin Res Ctr, Dept Clin Sci, Malmo, Sweden; [Sutton, Richard] Imperial Coll, Natl Heart & Lung Inst, Hammersmith Hosp Campus, London, England; [Fedorowski, Artur] Skane Univ Hosp, Dept Cardiol, Malmo, Sweden		Fedorowski, A (corresponding author), Skane Univ Hosp, Dept Cardiol, Malmo, Sweden.	artur.fedorowski@med.lu.se	Sutton, Richard/ABC-4436-2020; Ricci, Fabrizio/L-5529-2017; Fedorowski, Artur/I-3937-2019; Timler, Dariusz/I-3072-2014	Sutton, Richard/0000-0002-5710-1094; Ricci, Fabrizio/0000-0002-1401-6623; Fedorowski, Artur/0000-0002-5352-6327; Timler, Dariusz/0000-0002-5415-5660; Pochcial, Pawel/0000-0001-6580-5705			Ammirati F, 2001, Ital Heart J, V2, P38; Bagi HR, 2017, EMERGENCY, V5, P1, DOI 10.22037/emergency.v5i1.18497; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Bartoletti A, 2008, EUR HEART J, V29, P618, DOI 10.1093/eurheartj/ehm563; Bozorgi Ali, 2018, Crit Pathw Cardiol, V17, P151, DOI 10.1097/HPC.0000000000000146; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Budrewicz K, 2019, SHORT TERM PROGNOSIS; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Clark CL, 2019, ACAD EMERG MED, V26, P528, DOI 10.1111/acem.13709; Colivicchi F, 2003, EUR HEART J, V24, P811, DOI 10.1016/S0195-668X(02)00827-8; Costantino G, 2008, J AM COLL CARDIOL, V51, P276, DOI 10.1016/j.jacc.2007.08.059; Davis T, 2015, ARCH DIS CHILDHOOD-E, V100, P97, DOI 10.1136/archdischild-2014-306797; Ferraris VA, 2010, J TRAUMA, V69, P645, DOI 10.1097/TA.0b013e3181d8941d; Gajek Jacek, 2003, Kardiol Pol, V58, P294; Gibson TA, 2018, WEST J EMERG MED, V19, P517, DOI 10.5811/westjem.2018.2.37100; Gill SS, 2009, ARCH INTERN MED, V169, P867, DOI 10.1001/archinternmed.2009.43; Guzman JC, 2015, CARDIOL CLIN, V33, P465, DOI 10.1016/j.ccl.2015.04.014; Hino S, 2019, DENT TRAUMATOL, V35, P48, DOI 10.1111/edt.12452; Newman BH, 2001, TRANSFUSION, V41, P1475, DOI 10.1046/j.1537-2995.2001.41121475.x; Nume AK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206936; Nume AK, 2016, JAMA INTERN MED, V176, P503, DOI 10.1001/jamainternmed.2015.8606; Numeroso F, 2018, J EMERG MED, V55, P612, DOI 10.1016/j.jemermed.2018.07.028; Parry SW, 2005, J AM COLL CARDIOL, V45, P1840, DOI 10.1016/j.jacc.2005.02.060; Saadat S, 2012, ULUS TRAVMA ACIL CER, V18, P219, DOI [10.5505/tjtes.2012.03453, 10.5505/tjtes.2012. 03453]; Schuchert A, 2005, AM J CARDIOL, V95, P1101, DOI 10.1016/j.amjcard.2005.01.027; Solbiati M, 2018, INTERN EMERG MED, V13, P593, DOI 10.1007/s11739-018-1788-z; Sutherland A., 2008, Morbidity and Mortality Weekly Report, V57, P457; Ungar A, 2010, EUR HEART J, V31, P2021, DOI 10.1093/eurheartj/ehq017; Zysko D, 2014, CARDIOL J, V21, P674, DOI 10.5603/CJ.2014.0099	29	1	1	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2297-055X			FRONT CARDIOVASC MED	Front. Cardiovasc. Med.	JUL 23	2020	7								125	10.3389/fcvm.2020.00125			6	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	NB2KY	WOS:000560343000001	32793639	gold, Green Published			2022-02-06	
J	Gontkovsky, ST; Kreiner, DS; Ryan, JJ				Gontkovsky, Samuel T.; Kreiner, David S.; Ryan, Joseph J.			Principal components analysis of the Hesitation Scale: More than just social support seeking	CLINICAL PSYCHOLOGY & PSYCHOTHERAPY			English	Article						assessment; Hesitation Scale; principal components analysis; social support seeking; testing	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; INDIVIDUALS; HEALTH	The seeking of support from others during times of need is a critical strategy for overcoming challenging life events and ameliorating associated stress. The larger percentage of research examining help-seeking behaviour has been conducted with nonclinical samples, and conclusions remain somewhat unclear due to several limitations, including methodological inconsistencies across studies. The Hesitation Scale (HS) was developed to measure social support seeking in patients with traumatic brain injury but has not undergone thorough psychometric evaluation. The goal of this study primarily was to provide a clearer understanding of the specific aspects of support-seeking behaviour assessed by the HS, which is fundamental to the identification of factors that can be modified through targeted clinical interventions. A principal components analysis of the HS in an outpatient sample of 89 patients with spinal cord injury revealed that although the HS may provide an overall indication of respondents' attitudes and beliefs regarding social support seeking, the six significant extracted components of the scale appear to assess distinct aspects of support seeking behaviour. Results also suggested that the HS may have clinical utility in evaluating social support seeking in individuals with spinal cord injury.	[Gontkovsky, Samuel T.] Twin Valley Behav Healthcare, Dept Psychol, Columbus, OH 43223 USA; [Kreiner, David S.; Ryan, Joseph J.] Univ Cent Missouri, Sch Nutr Kinesiol & Psychol Sci, Warrensburg, MO USA		Gontkovsky, ST (corresponding author), Twin Valley Behav Healthcare, Dept Psychol, Columbus, OH 43223 USA.	sgontkovsky@hotmail.com					American Psychological Association, 2017, ETH PRINC PSYCH COD; Au A, 2013, AGEING SOC, V33, P1422, DOI 10.1017/S0144686X12000724; Bender M, 2019, J CROSS CULT PSYCHOL, V50, P827, DOI 10.1177/0022022119861151; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; CATTELL RB, 1977, MULTIVAR BEHAV RES, V12, P289, DOI 10.1207/s15327906mbr1203_2; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Costello A., 2005, PAN PACIFIC MANAGEME, V10, P1, DOI DOI 10.7275/JYJ1-4868; Farmer JE, 2003, J HEAD TRAUMA REHAB, V18, P116, DOI 10.1097/00001199-200303000-00003; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Kim HS, 2006, PERS SOC PSYCHOL B, V32, P1595, DOI 10.1177/0146167206291991; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nagai S, 2015, JPN PSYCHOL RES, V57, P313, DOI 10.1111/jpr.12091; Naganuma Y, 2006, PSYCHIAT CLIN NEUROS, V60, P240, DOI 10.1111/j.1440-1819.2006.01492.x; Proctor CJ, 2019, DISABIL HEALTH J, V12, P387, DOI 10.1016/j.dhjo.2019.01.001; Reid-Arndt SA, 2010, J RURAL HEALTH, V26, P402, DOI 10.1111/j.1748-0361.2010.00295.x; Reid-Arndt SA, 2010, PSYCHO-ONCOLOGY, V19, P535, DOI 10.1002/pon.1581; Reid-Arndt SA, 2009, J PSYCHOSOC ONCOL, V27, P415, DOI 10.1080/07347330903183117; Schara McAnulty S. L., 2014, COGNITIVE THERAPEUTI, P87; Seeman TE, 1996, ANN EPIDEMIOL, V6, P442, DOI 10.1016/S1047-2797(96)00095-6; VELICER WF, 1990, MULTIVAR BEHAV RES, V25, P1, DOI 10.1207/s15327906mbr2501_1; Wilson C.J., 2005, CAN J COUNS, V39, P15, DOI [10.1037/t42876-000, DOI 10.1037/T42876-000]	23	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1063-3995	1099-0879		CLIN PSYCHOL PSYCHOT	Clin. Psychol. Psychother.	JAN	2021	28	1					233	238		10.1002/cpp.2492		JUL 2020	6	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	QA5SR	WOS:000551220400001	32659046				2022-02-06	
J	Zhang, X; Qin, C; Jing, YL; Yang, DG; Liu, CB; Gao, F; Zhang, C; Talifu, Z; Yang, ML; Du, LJ; Li, JJ				Zhang, Xin; Qin, Chuan; Jing, Yingli; Yang, Degang; Liu, Changbin; Gao, Feng; Zhang, Chao; Talifu, Zuliyaer; Yang, Mingliang; Du, Liangjie; Li, Jianjun			Therapeutic effects of rapamycin and surgical decompression in a rabbit spinal cord injury model	CELL DEATH & DISEASE			English	Article							INTRASPINAL PRESSURE; POTASSIUM CHANNELS; AUTOPHAGY; PROMOTES; RATS; MYELOTOMY; RECOVERY; PROTEIN; INFLAMMATION; ACTIVATION	Surgical decompression after spinal cord injury (SCI) is a conventional treatment. Although it has been proven to have clinical effects, there are certain limitations, such as the surgical conditions that must be met and the invasive nature of the treatment. Therefore, there is an urgent need to develop a simple and maneuverable therapy for the emergency treatment of patients with SCI before surgery. Rapamycin (RAPA) has been reported to have potential as a therapeutic agent for SCI. In this study, we observed the therapeutic effects of rapamycin and surgical decompression, in combination or separately, on the histopathology in rabbits with SCI. After combination therapy, intramedullary pressure (IMP) decreased significantly, autophagic flux increased, and apoptosis and demyelination were significantly reduced. Compared with RAPA/surgical decompression alone, the combination therapy had a significantly better effect. In addition, we evaluated the effects of mechanical pressure on autophagy after SCI by assessing changes in autophagic initiation, degradation, and flux. Increased IMP after SCI inhibited autophagic degradation and impaired autophagic flux. Decompression improved autophagic flux after SCI. Our findings provide novel evidence of a promising strategy for the treatment of SCI in the future. The combination therapy may effectively improve emergency treatment after SCI and promote the therapeutic effect of decompression. This study also contributes to a better understanding of the effects of mechanical pressure on autophagy after neurotrauma.	[Zhang, Xin; Qin, Chuan; Yang, Degang; Gao, Feng; Zhang, Chao; Talifu, Zuliyaer; Yang, Mingliang; Du, Liangjie; Li, Jianjun] Capital Med Univ, Sch Rehabil Med, Beijing 100068, Peoples R China; [Zhang, Xin; Qin, Chuan; Jing, Yingli; Yang, Degang; Gao, Feng; Zhang, Chao; Talifu, Zuliyaer; Yang, Mingliang; Du, Liangjie; Li, Jianjun] China Rehabil Sci Inst, Beijing 100068, Peoples R China; [Zhang, Xin; Qin, Chuan; Jing, Yingli; Yang, Degang; Gao, Feng; Zhang, Chao; Talifu, Zuliyaer; Yang, Mingliang; Du, Liangjie; Li, Jianjun] Beijing Inst Brain Disorders, Ctr Neural Injury & Repair, Beijing 100068, Peoples R China; [Zhang, Xin; Qin, Chuan; Yang, Degang; Gao, Feng; Zhang, Chao; Talifu, Zuliyaer; Yang, Mingliang; Du, Liangjie; Li, Jianjun] China Rehabil Res Ctr, Dept Spinal & Neural Funct Reconstruct, Beijing 100068, Peoples R China; [Zhang, Xin; Qin, Chuan; Jing, Yingli; Yang, Degang; Gao, Feng; Zhang, Chao; Talifu, Zuliyaer; Yang, Mingliang; Du, Liangjie; Li, Jianjun] Beijing Key Lab Neural Injury & Rehabil, Beijing 100068, Peoples R China; [Jing, Yingli] China Rehabil Res Ctr, Inst Rehabil Med, Beijing 100068, Peoples R China; [Liu, Changbin] Beijing Tiantan Hosp, Dept Rehabil Med, Beijing 100050, Peoples R China		Li, JJ (corresponding author), Capital Med Univ, Sch Rehabil Med, Beijing 100068, Peoples R China.; Li, JJ (corresponding author), China Rehabil Sci Inst, Beijing 100068, Peoples R China.; Li, JJ (corresponding author), Beijing Inst Brain Disorders, Ctr Neural Injury & Repair, Beijing 100068, Peoples R China.; Li, JJ (corresponding author), China Rehabil Res Ctr, Dept Spinal & Neural Funct Reconstruct, Beijing 100068, Peoples R China.; Li, JJ (corresponding author), Beijing Key Lab Neural Injury & Rehabil, Beijing 100068, Peoples R China.	13718331416@163.com	qin, chuan/ABG-4508-2020		Special Fund for Basic Scientific Research of the Central Public Research Institutes in China [2019CZ-1, 2018CZ-1]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81870979]; National Key RAMP;D Program of China [2018YFF0301104]; Major Science and Technology Project of Beijing of China [D161100002816004]; Special Capital Health Research and Development of China [2018-1-6011]	This study was supported by the Special Fund for Basic Scientific Research of the Central Public Research Institutes in China (No. 2019CZ-1, 2018CZ-1); the National Natural Science Foundation of China (No. 81870979); the National Key R&D Program of China (No. 2018YFF0301104); the Major Science and Technology Project of Beijing of China (No. D161100002816004); and the Special Capital Health Research and Development of China (No. 2018-1-6011).	Aarabi B, 2013, NEUROSURGERY, V72, P195, DOI 10.1227/NEU.0b013e318276f64b; Cai Zhiyou, 2013, J Biochem Pharmacol Res, V1, P84; Castillo K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.421; Chang YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22147; Dong X, 2016, SPINAL CORD, V54, P947, DOI 10.1038/sc.2016.35; Dvorak MF, 2015, J NEUROTRAUM, V32, P645, DOI 10.1089/neu.2014.3632; Fang B, 2016, NEUROSCIENCE, V328, P107, DOI 10.1016/j.neuroscience.2016.04.019; Gao L, 2013, INT J BIOL SCI, V9, P322, DOI 10.7150/ijbs.5925; Goldshmit Y, 2015, MOL CELL NEUROSCI, V68, P82, DOI 10.1016/j.mcn.2015.04.006; Gu R, 2012, NEUROL ASIA, V17, P141; Haack TB, 2016, AM J HUM GENET, V99, P735, DOI 10.1016/j.ajhg.2016.06.026; Hu AM, 2015, SPINAL CORD, V53, P98, DOI 10.1038/sc.2014.209; Ishii T, 2013, FREE RADICAL BIO MED, V65, P102, DOI 10.1016/j.freeradbiomed.2013.06.019; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kanno H, 2011, SPINE, V36, pE1427, DOI 10.1097/BRS.0b013e3182028c3a; Kanno H, 2009, AUTOPHAGY, V5, P390, DOI 10.4161/auto.5.3.7724; Kanno H, 2009, NEUROBIOL DIS, V33, P143, DOI 10.1016/j.nbd.2008.09.009; Khaing ZZ, 2017, J NEUROTRAUM, V34, P645, DOI 10.1089/neu.2016.4490; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; King JS, 2012, TRENDS MOL MED, V18, P583, DOI 10.1016/j.molmed.2012.08.002; King JS, 2011, AUTOPHAGY, V7, P1490, DOI 10.4161/auto.7.12.17924; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Leonard AV, 2015, J NEUROTRAUM, V32, P397, DOI 10.1089/neu.2014.3543; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Liu D, 2002, J CEREBR BLOOD F MET, V22, P431, DOI 10.1097/00004647-200204000-00007; Liu JM, 2016, WORLD NEUROSURG, V87, P124, DOI 10.1016/j.wneu.2015.11.098; Liu S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0469-1; Martirosyan NL, 2015, NEUROSURGERY, V76, P461, DOI 10.1227/NEU.0000000000000638; Moreno L, 2007, MOL PHARMACOL, V72, P1301, DOI 10.1124/mol.107.037002; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Phang I, 2015, J NEUROTRAUM, V32, P865, DOI 10.1089/neu.2014.3668; Porter KM, 2014, BBA-MOL CELL RES, V1843, P1054, DOI 10.1016/j.bbamcr.2014.02.010; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Qin C, 2018, NEURAL REGEN RES, V13, P1096, DOI 10.4103/1673-5374.233454; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Sekiguchi A, 2012, J NEUROTRAUM, V29, P946, DOI 10.1089/neu.2011.1919; Simon HU, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag2791; Smith JS, 2010, J BONE JOINT SURG AM, V92A, P1206, DOI 10.2106/JBJS.I.00740; Song Y, 2015, J BIOCHEM MOL TOXIC, V29, P29, DOI 10.1002/jbt.21603; Sun YM, 2016, NEUROSCI LETT, V618, P139, DOI 10.1016/j.neulet.2016.02.054; Tateda S, 2017, J ORTHOP RES, V35, P93, DOI 10.1002/jor.23328; Tong MJ, 2018, BIOCHEM BIOPH RES CO, V495, P2525, DOI 10.1016/j.bbrc.2017.12.119; Wang CG, 2018, J CELL MOL MED, V22, P1148, DOI 10.1111/jcmm.13368; Wang ZY, 2014, APOPTOSIS, V19, P933, DOI 10.1007/s10495-014-0976-1; Wei YM, 2013, CELL PHYSIOL BIOCHEM, V31, P925, DOI 10.1159/000350111; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Zeng XJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0316-4; Zhang X, 2019, NEURAL REGEN RES, V14, P886, DOI 10.4103/1673-5374.249237	51	1	1	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	JUL 23	2020	11	7							567	10.1038/s41419-020-02767-5			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	MU8FT	WOS:000555903900009	32703937	gold, Green Published			2022-02-06	
J	Edwards-Stewart, A; Smolenski, DJ; Peters, ZJ; Quah, RF; Bush, NE; Campbell, MS; Skopp, NA; Belsher, BE; Kennedy, CH				Edwards-Stewart, Amanda; Smolenski, Derek J.; Peters, Zachary J.; Quah, Ruth F.; Bush, Nigel E.; Campbell, Marjorie S.; Skopp, Nancy A.; Belsher, Bradley E.; Kennedy, Carrie H.			More than expected? Assessing departures from additivity in health care utilization after mild traumatic brain injury in military personnel with pre-existing mental health conditions	CLINICAL NEUROPSYCHOLOGIST			English	Article						Department of Defense; health-care utilization; service members; mental health disorders; mild traumatic brain injury		Objective Prior research indicates that there is an additive association between traumatic brain injury and mental health diagnoses on health-care utilization. This assumed additivity has not been formally assessed. The objective of this study was to estimate additive and multiplicative interactions associated with mild traumatic brain injury (mTBI) and pre-existing health conditions. Method Active-duty military patient records over a nine-year period were sampled within four exposure groups (N = 4500 per group) defined jointly by incident mTBI and pre-existing mental health diagnoses. Outpatient and inpatient health encounters were compared between the four exposure groups using generalized linear models for count and proportion outcomes. Additive interactions were estimated using the interaction contrast ratio. Multiplicative interactions were estimated as a product term in the generalized linear models. Results The joint association of mTBI and pre-existing mental health diagnoses with health-care utilization, overall, was less than multiplicative and greater than additive. Patients with both exposures experienced more health-care utilization than expected under the assumed additivity (independence) of the two exposures. PTSD and anxiety diagnoses were the MH diagnoses associated with the largest interaction contrast values specific to total outpatient encounters. Conclusions Studies of the interaction of two diagnoses on subsequent health-care utilization should examine both additive and multiplicative interactions. The greater-than-additive findings in this study indicate that there may be synergy, for at least some patients, between mTBI injury and mental health that complicates the treatment course.	[Edwards-Stewart, Amanda; Smolenski, Derek J.; Bush, Nigel E.; Skopp, Nancy A.] Psychol Hlth Ctr Excellence, 9933 West Hayes St, Tacoma, WA 98433 USA; [Peters, Zachary J.; Quah, Ruth F.; Campbell, Marjorie S.; Belsher, Bradley E.; Kennedy, Carrie H.] Psychol Hlth Ctr Excellence, Silver Spring, MD USA		Edwards-Stewart, A (corresponding author), Psychol Hlth Ctr Excellence, 9933 West Hayes St, Tacoma, WA 98433 USA.	amanda.e.stewart7.civ@mail.mil		Bush, Nigel/0000-0002-8137-7998; Belsher, Bradley/0000-0003-2243-1170			Armed Forces Health Surveillance Branch [AFHSB], 2019, SURV CAS DEF; Barlas F. M., 2013, DEP DEFENSE HLTH REL; Ding P, 2016, EPIDEMIOLOGY, V27, P368, DOI 10.1097/EDE.0000000000000457; DMDC, 2019, DOD PERS WORKF REP P; DVBIC. Defense and Veterans Brain Injury Center, 2018, DOD NUMB TRAUM BRAIN; Galatzer-Levy IR, 2013, PERSPECT PSYCHOL SCI, V8, P651, DOI 10.1177/1745691613504115; Hilbe, 2011, NEGATIVE BINOMIAL RE; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Kehle-Forbes SM, 2017, J HEAD TRAUMA REHAB, V32, pE16, DOI 10.1097/HTR.0000000000000227; King PR, 2013, MIL BEHAV HLTH, V1, P74, DOI DOI 10.1080/21635781.2012.759168; Military Health System, 2019, MIL HLTH SYST DAT RE; Richardson DB, 2009, AM J EPIDEMIOL, V169, P756, DOI 10.1093/aje/kwn411; Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P258; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; StataCorp, 2015, STAT STAT SOFTW VERS; Stroupe KT, 2013, J REHABIL RES DEV, V50, P1047, DOI 10.1682/JRRD.2012.06.0107; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; VanderWeele TJ, 2007, EPIDEMIOLOGY, V18, P329, DOI 10.1097/01.ede.0000260218.66432.88; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	20	1	1	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUL 22	2020	34	6			SI		1124	1133		10.1080/13854046.2020.1713399			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	MV0HS	WOS:000556045500005	31985330				2022-02-06	
J	Toglia, J; Chen, P				Toglia, Joan; Chen, Peii			Spatial exploration strategy training for spatial neglect: A pilot study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Stroke rehabilitation; Brain injury; Occupational therapy; Cognitive rehabilitation; Anosognosia	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; STROKE REHABILITATION; METACOGNITIVE KNOWLEDGE; UNILATERAL NEGLECT; LASTING RECOVERY; VIDEO FEEDBACK; SELF-EFFICACY; ATTENTION; AWARENESS	Spatial neglect is a syndrome due to impaired neural networks critical for spatial attention and related cognitive and motor functions. Affected individuals also have impaired self-awareness of their own neglect symptoms. The present randomized controlled study was the first proof-of-concept pilot examining the multi-context treatment approach using a protocol of spatial exploration strategy training in one brief session (20-30 minutes). The therapist provided supportive feedback and semi-structured guidance to promote strategy learning and self-discovery of omission errors. 40 patients with left-sided neglect after right brain stroke were included. The results showed that the treatment reduced lateralized bias toward the ipsilesional side of space but did not improve overall detection performance. Impaired general self-awareness of daily-life spatial difficulties was found independent of treatment outcome. This implies that judgment regarding responsiveness to treatment should not be made based on an awareness interview or the severity of neglect symptoms. Lastly, the treatment showed the potential of improving online contextual self-awareness of spatial abilities. A collaborative and interactive approach that focuses on helping the patient self-discover, monitor and self-manage their errors, appears to have a potential for decreasing neglect symptoms. Future studies are required to examine additional aspects of the multi-context treatment approach.	[Toglia, Joan] Mercy Coll, Sch Hlth & Nat Sci, 555 Broadway, Dobbs Ferry, NY 10522 USA; [Toglia, Joan] New York Presbyterian Hosp, Rehabil Med Dept, Weill Cornell Med Ctr, New York, NY USA; [Chen, Peii] Kessler Fdn, W Orange, NJ USA; [Chen, Peii] Rutgers State Univ, Dept Phys Med & Rehabil, Newark, NJ USA		Toglia, J (corresponding author), Mercy Coll, Sch Hlth & Nat Sci, 555 Broadway, Dobbs Ferry, NY 10522 USA.	jtoglia@mercy.edu	Toglia, Joan/AAN-6674-2021	Toglia, Joan/0000-0002-6902-6853; Chen, Peii/0000-0002-6724-7046	Extramural Research Development Award (Eunice Kennedy Shriver National Institute of Child Health and Human Development), National Institutes of Health, Pilot grant - Mercy College, Dobbs Ferry, NY [2G11HD035965]	This research was partially supported by an Extramural Research Development Award (Eunice Kennedy Shriver National Institute of Child Health and Human Development), National Institutes of Health No. 2G11HD035965, Pilot grant awarded to Joan Toglia, through award received by Mercy College, Dobbs Ferry, NY.	ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; Belanger HG, 2020, NEUROPSYCHOL REHABIL, V30, P1190, DOI 10.1080/09602011.2019.1575245; Berti A, 1996, J Int Neuropsychol Soc, V2, P426; Bowen A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003586.pub3; Brands I, 2017, NEUROREHABILITATION, V40, P587, DOI 10.3233/NRE-171446; Brands I, 2014, ARCH PHYS MED REHAB, V95, P2327, DOI 10.1016/j.apmr.2014.06.006; Brands IMH, 2019, CLIN REHABIL, V33, P327, DOI 10.1177/0269215518795249; Cave KR, 1999, PSYCHON B REV, V6, P204, DOI 10.3758/BF03212327; Chen P, 2019, REHABIL PSYCHOL, V64, P50, DOI 10.1037/rep0000207; Chen P, 2018, DISABIL REHABIL, V40, P2677, DOI 10.1080/09638288.2017.1347720; Chen PI, 2015, ARCH PHYS MED REHAB, V96, P1458, DOI 10.1016/j.apmr.2015.03.019; Chen PI, 2015, ARCH PHYS MED REHAB, V96, P869, DOI 10.1016/j.apmr.2014.10.023; Chen P, 2012, J NEUROPSYCHOL, V6, P270, DOI 10.1111/j.1748-6653.2012.02028.x; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; ERIKSEN CW, 1987, PERCEPT PSYCHOPHYS, V42, P299, DOI 10.3758/BF03203082; Goedert KM, 2020, NEUROPSYCHOL REHABIL, V30, P32, DOI 10.1080/09602011.2018.1448287; Goverover Y, 2014, NEUROREHABILITATION, V35, P315, DOI 10.3233/NRE-141113; Halligan P. W., 1991, NEUROPSYCHOL REHABIL, V1, P281; Hamilton RH, 2010, CORTEX, V46, P68, DOI 10.1016/j.cortex.2009.02.005; Hebert D, 2016, INT J STROKE, V11, P459, DOI 10.1177/1747493016643553; Jehkonen M, 2001, ACTA NEUROL SCAND, V104, P136, DOI 10.1034/j.1600-0404.2001.00025.x; Kerkhoff G, 2006, RESTOR NEUROL NEUROS, V24, P357; Marshall RS, 2009, NEUROLOGIST, V15, P185, DOI 10.1097/NRL.0b013e3181942894; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Niemeier J P, 2001, Top Stroke Rehabil, V8, P10; Niemeier JP, 1998, BRAIN INJURY, V12, P399, DOI 10.1080/026990598122511; Nott M, 2021, DISABIL REHABIL, V43, P1410, DOI 10.1080/09638288.2019.1666431; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; ROBERTSON IH, 1995, J CLIN EXP NEUROPSYC, V17, P416, DOI 10.1080/01688639508405133; ROBERTSON IH, 1990, NEUROPSYCHOLOGIA, V28, P217, DOI 10.1016/0028-3932(90)90103-U; Robertson K, 2015, BRAIN INJURY, V29, P848, DOI 10.3109/02699052.2015.1005135; Ronchi R, 2014, CORTEX, V61, P167, DOI 10.1016/j.cortex.2014.10.004; Schindler I, 2002, J NEUROL NEUROSUR PS, V73, P412, DOI 10.1136/jnnp.73.4.412; Schrijnemaekers AC, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/01.HTR.0000438117.63852.b4; SODERBACK I, 1992, ARCH PHYS MED REHAB, V73, P1140; Tham K, 1997, ARCH PHYS MED REHAB, V78, P410, DOI 10.1016/S0003-9993(97)90234-3; Tham K, 1996, NEUROPSYCHOL REHABIL, V6, P19, DOI 10.1080/713755496; Tham K, 2001, AM J OCCUP THER, V55, P46, DOI 10.5014/ajot.55.1.46; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Toglia J., 2004, THESIS COLUMBIA U NE; Toglia J.P., 2011, COGNITION OCCUPATION, P116; Toglia J.P., 2019, WILLARD SPACKMANS OC, V13th ed., P901; Toglia J, 2009, AM J OCCUP THER, V63, P569, DOI 10.5014/ajot.63.5.569; Valenstein, 2012, CLIN NEUROPSYCHOLOGY, P296; Wee JYM, 2008, AM J PHYS MED REHAB, V87, P910, DOI 10.1097/PHM.0b013e31818a58bd; WEINBERG J, 1977, ARCH PHYS MED REHAB, V58, P479; Wilson B., 1999, BEHAVIOURAL INATTENT BEHAV INATTENTION TE; Wilson FC, 2000, RESTOR NEUROL NEUROS, V16, P1; Winstein CJ, 2016, STROKE, V47, pE98, DOI 10.1161/STR.0000000000000098	50	1	1	1	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2020.1790394		JUL 2020	22	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	MM3WB	WOS:000550089400001	32684100	Green Accepted			2022-02-06	
J	Romeo-Guitart, D; Marmolejo-Martinez-Artesero, S; Casas, C				Romeo-Guitart, David; Marmolejo-Martinez-Artesero, Sara; Casas, Caty			Is it the time of autophagy fine-tuners for neuroprotection?	AUTOPHAGY			English	Article						Cellular resilience; endogenous mechanisms of protection; fine-tuned autophagy; multitarget; neurodegeneration; neuroheal; neuroprotection		Cells and organisms are intrinsically prepared to effectively deal with damage caused by insults and heal themselves by triggering a plethora of stress responses including macroautophagy/autophagy. However, autophagy may become malfunctional during aging, neurodegeneration, and neurotrauma. We aimed to overcome autophagy dysfunction by refining therapeutics using multi-target approaches. Thus, we have demonstrated that modulation of autophagy with the multitarget drug NeuroHeal is neuroprotective in several neurodegeneration models in which previous autophagy modulators have failed. The key element of success is the coordinated activation of opposing forces that modulate autophagy with NeuroHeal, probably leading to the autophagy-dependent degradation of death executors such as PARP1. The precise tuning of autophagy thus allows the neuron to adapt to insults, survive and repair itself. These findings support the advent a new era of neuroprotectants that counteract neuronal damage by targeting in unison different pathways of the self-repair process, including autophagy.	[Romeo-Guitart, David; Marmolejo-Martinez-Artesero, Sara; Casas, Caty] Univ Autonoma Barcelona UAB, Inst Neurociencies Inc, Barcelona, Spain; [Romeo-Guitart, David; Marmolejo-Martinez-Artesero, Sara; Casas, Caty] Univ Autonoma Barcelona UAB, Dept Cell Biol Physiol & Immunol, Barcelona, Spain; [Romeo-Guitart, David] Univ Paris 05, Inst Necker Enfants Malad INEM, INSERM U1151, Lab Hormonal Regulat Brain Dev & Funct Team 8, Paris, France		Romeo-Guitart, D; Casas, C (corresponding author), Univ Autonoma Barcelona UAB, Inst Neurociencies Inc, Barcelona, Spain.; Romeo-Guitart, D; Casas, C (corresponding author), Univ Autonoma Barcelona UAB, Dept Cell Biol Physiol & Immunol, Barcelona, Spain.	david.romeo-guitart@inserm.fr; Caty.Casas@uab.cat		Romeo-Guitart, David/0000-0003-3368-9302	Ministerio de Economia y CompetitividadSpanish Government [2014-59701]	This work was supported by the Ministerio de Economia y Competitividad [2014-59701].	Romeo-Guitart D, 2020, THERANOSTICS, V10, P5154, DOI 10.7150/thno.43765	1	1	1	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1554-8627	1554-8635		AUTOPHAGY	Autophagy	NOV 1	2020	16	11					2108	2109		10.1080/15548627.2020.1794355		JUL 2020	2	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	OI6MP	WOS:000549036000001	32677502	Bronze, Green Published			2022-02-06	
J	Aguiar, OMG; Potvin, BM; Yang, YJ; Hua, KN; Bruschetta, ML; Virani, S; Robinovitch, SN				Aguiar, Olivia M. G.; Potvin, Brigitte M.; Yang, Yijian; Hua, Kevin N.; Bruschetta, Megan L.; Virani, Shane; Robinovitch, Stephen N.			American society of biomechanics journal of biomechanics award 2019: Circumstances of head impacts in men's university ice hockey	JOURNAL OF BIOMECHANICS			English	Article						Impact biomechanics; Sport; Ice hockey; Video analysis; Traumatic brain injury	SYSTEMATIC VIDEO ANALYSIS; LEAGUE NHL; CONCUSSION; COEFFICIENT; MECHANISMS; AGREEMENT; INJURY; KAPPA	This observational study examined the circumstances of head impacts in men's university ice hockey. Video footage was collected of 449 head impacts experienced by 37 players over 33 games. Videos were analyzed using a reliable, structured questionnaire to classify: playing zone, location on ice, puck possession, direction of gaze, object striking the head, location of head impact, trajectory of colliding players, and penalties. Generalized Linear Models were used to compare response categories for the proportion of players experiencing at least one head impact, and the number of head impacts per player. The majority of events resulting in head impact involved contact with another player (93%). Head impacts occurred most often to players who did not have puck possession, who were checked along the boards in their offensive zone. Players were just as likely to experience head impact with an environmental object, as with an opposing player's body part. Glass-to-head impacts represented 30% of cases, four times as common as board-to-head impacts. Hand-to-head impacts accounted for 23% of cases, twice as common as shoulder- or elbow-to-head impacts. In 27% of events, there were two or more successive impacts to the head (e.g., contact with shoulder and then boards). Only 16% of head impacts which involved contact with another player resulted in infractions. Our results support the need for additional research on the benefits of stricter rule enforcement, and modifications to the stiffness of glass and padding of gloves, for reducing the frequency and severity of head impacts in ice hockey. (C) 2020 Elsevier Ltd. All rights reserved.	[Aguiar, Olivia M. G.; Potvin, Brigitte M.; Yang, Yijian; Hua, Kevin N.; Bruschetta, Megan L.; Virani, Shane; Robinovitch, Stephen N.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada; [Yang, Yijian] Chinese Univ Hong Kong, Dept Sports Sci & Phys Educ, Shatin, Hong Kong, Peoples R China; [Virani, Shane] Alberta Childrens Prov Gen Hosp, Neurosci Program, Calgary, AB T3B 6AB, Canada; [Robinovitch, Stephen N.] Simon Fraser Univ, Sch Engn Sci, Burnaby, BC V5A 1S6, Canada		Aguiar, OMG (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	oaguiar@sfu.ca	Yang, Yijian/G-1580-2016	Yang, Yijian/0000-0002-5831-186X; Aguiar, Olivia/0000-0001-9131-9049; Robinovitch, Stephen/0000-0003-3881-6227	Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN/04065]; Simon Fraser University	We thank the Simon Fraser University men's ice hockey team for their participation in our study, and the many volunteers who worked to collect and analyze data. We are grateful to the Natural Sciences and Engineering Research Council of Canada for funding this study (NSERC Graduate Scholarship to O. Aguiar, and NSERC RGPIN/04065 Discovery Grant to S. Robinovitch). O. Aguiar was also supported by a Dean's Graduate Entrance Scholarship from Simon Fraser University.	Abbott K, 2014, CURR SPORT MED REP, V13, P377, DOI 10.1249/JSR.0000000000000102; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; BRENNAN RL, 1981, EDUC PSYCHOL MEAS, V41, P687, DOI 10.1177/001316448104100307; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058868; Delaney JS, 2014, CLIN J SPORT MED, V24, P233, DOI 10.1097/JSM.0000000000000017; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Hutchison MG, 2014, BRIT J SPORT MED, V48, P125, DOI 10.1136/bjsports-2012-092059; Karton C, 2018, HAND CLINIC, V158, P39, DOI 10.1016/B978-0-444-63954-7.00005-7; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Pauelsen M, 2017, CLIN J SPORT MED, V27, P283, DOI 10.1097/JSM.0000000000000347; Potvin BM, 2019, J BIOMECH, V91, P43, DOI 10.1016/j.jbiomech.2019.05.002; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Ruhe A, 2014, BRIT J SPORT MED, V48, P102, DOI 10.1136/bjsports-2012-091609; Schmitt KU, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2017-097735; Sim J, 2005, PHYS THER, V85, P257; Tuominen M, 2017, BRIT J SPORT MED, V51, P244, DOI 10.1136/bjsports-2016-097119; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	27	1	1	2	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	JUL 17	2020	108								109882	10.1016/j.jbiomech.2020.109882			7	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	MH3QB	WOS:000546647000007	32635996				2022-02-06	
J	Fu, CY; Wu, Q; Zhang, ZM; Xia, ZA; Liu, ZY; Lu, HM; Wang, Y; Huang, G				Fu, Chunyan; Wu, Qian; Zhang, Zhimin; Xia, Zian; Liu, Zhaoying; Lu, Hongmei; Wang, Yang; Huang, Gang			Development of a sensitive and rapid UHPLC-MS/MS method for simultaneous quantification of nine compounds in rat plasma and application in a comparative pharmacokinetic study after oral administration of Xuefu Zhuyu Decoction and nimodipine	BIOMEDICAL CHROMATOGRAPHY			English	Article						nimodipine; pharmacokinetics; rat plasma; traumatic brain injury; UHPLC-MS; MS; Xuefu Zhuyu decoction	PERFORMANCE LIQUID-CHROMATOGRAPHY; TRADITIONAL CHINESE MEDICINE; TRAUMATIC BRAIN-INJURY; MAJOR CONSTITUENTS; HYDROXYSAFFLOR-YELLOW; TISSUE DISTRIBUTION; YU DECOCTION; IN-VITRO; BIOAVAILABILITY; ABSORPTION	Xuefu Zhuyu Decoction (XFZYD) is a traditional Chinese medicine prescription used for the clinical treatment of traumatic brain injury (TBI). The purpose of this work was to develop a sensitive and rapid UHPLC-MS/MS method to simultaneously study the pharmacokinetics of nimodipine and eight components of XFZYD, namely, amygdalin, hydroxysafflor yellow A, rutin, liquiritin, narirutin, naringin, neohesperidin and saikosaponin A, in rats with and without TBI. Multiple reaction monitoring was highly selective in the detection of nine analytes and the internal standard without obvious interference. The calibration curves displayed good linearity (r > 0.99) over a wide concentration range. The mean absolute recoveries of the nine analytes were 85-106%, and all matrix effects were in the range 80-120%. The intra- and inter-day precision and accuracy were acceptable (RSD, <15%; RE%, +/- 20%). The validated method was successfully applied to compare the pharmacokinetics in four experimental groups, including control rats orally administered XFZYD and TBI model rats orally administered XFZYD, XFZYD and nimodipine, or nimodipine alone. The results showed that herb-drug interactions occurred between XFZYD and nimodipine in the treatment of TBI, nimodipine affected the pharmacokinetics of XFZYD, and XFZYD affected the absorption, distribution and excretion of nimodipinein vivo.	[Fu, Chunyan; Wu, Qian; Zhang, Zhimin; Lu, Hongmei] Cent South Univ, Coll Chem & Chem Engn, Changsha 410083, Hunan, Peoples R China; [Fu, Chunyan] Shaoyang Univ, Coll Pharm, Shaoyang, Hunan, Peoples R China; [Xia, Zian; Wang, Yang] Cent South Univ, Xiangya Hosp, Inst Integrated Tradit Chinese & Western Med, Lab Ethnopharmacol, Changsha 410008, Hunan, Peoples R China; [Liu, Zhaoying] Hunan Agr Univ, Coll Vet Med, Hunan Engn Res Ctr Vet Drug, Changsha, Hunan, Peoples R China; [Huang, Gang] Shimadzu Co Ltd, Guangzhou Analyt Applicat Ctr, Guangzhou, Peoples R China		Lu, HM (corresponding author), Cent South Univ, Coll Chem & Chem Engn, Changsha 410083, Hunan, Peoples R China.; Wang, Y (corresponding author), Cent South Univ, Xiangya Hosp, Inst Integrated Tradit Chinese & Western Med, Lab Ethnopharmacol, Changsha 410008, Hunan, Peoples R China.	hongmeilu@csu.edu.cn; wangyang_xy87@csu.edu.cn		Lu, Hongmei/0000-0002-4686-4491	Hunan Provincial Natural Science Foundation of ChinaNatural Science Foundation of Hunan Province [2019JJ30042]; Hunan Provincial Technology Innovation Guidance Plan, China [2018SK51902]; National Natural Scientific Foundation of ChinaNational Natural Science Foundation of China (NSFC) [21675174, 21804142, 21873116, 81673719]	Hunan Provincial Natural Science Foundation of China, Grant/Award Number: 2019JJ30042; Hunan Provincial Technology Innovation Guidance Plan, China, Grant/Award Number: 2018SK51902; National Natural Scientific Foundation of China, Grant/Award Numbers: 21675174, 21804142, 21873116, 81673719	Batuecas A, 1998, EUR J PHARMACOL, V350, P141, DOI 10.1016/S0014-2999(98)00250-7; Bie XD, 2010, J ASIAN NAT PROD RES, V12, P239, DOI 10.1080/10286020903510636; Cho YA, 2011, PHARMACOL REP, V63, P1066, DOI 10.1016/S1734-1140(11)70624-7; Dolberg OT, 2005, PSYCHOPHARMACOLOGY, V179, P838, DOI 10.1007/s00213-004-2117-y; Dong D, 2016, J CHROMATOGR B, V1020, P142, DOI 10.1016/j.jchromb.2016.03.033; Fei YX, 2018, J INT MED RES, V46, P335, DOI 10.1177/0300060517720056; Feng DD, 2017, ONCOTARGET, V8, P94692, DOI 10.18632/oncotarget.21876; Fu CY, 2016, J SEP SCI, V39, P3457, DOI 10.1002/jssc.201600083; Fugh-Berman A, 2001, BRIT J CLIN PHARMACO, V52, P587, DOI 10.1046/j.0306-5251.2001.01469.x; Gao D, 2010, CHIN J INTEGR MED, V16, P50, DOI 10.1007/s11655-010-0050-y; Gu Xi-xi, 2005, Chin J Integr Med, V11, P22; Gurkoff G, 2013, PHARMACEUTICALS, V6, P788, DOI 10.3390/ph6070788; Hollman PCH, 2004, PHARM BIOL, V42, P74, DOI 10.3109/13880200490893492; HUND E, 1990, ACTA NEUROCHIR, V102, P73, DOI 10.1007/BF01402190; Jin Y, 2017, MOLECULES, V22, DOI 10.3390/molecules22101746; Kammalla AK, 2015, EUR J DRUG METAB PH, V40, P277, DOI 10.1007/s13318-014-0206-9; Karabekir HS, 2008, NEUROSCIENCES, V13, P239; LANGLEY MS, 1989, DRUGS, V37, P669, DOI 10.2165/00003495-198937050-00004; Lee JJ, 2011, J ETHNOPHARMACOL, V134, P824, DOI 10.1016/j.jep.2011.01.033; LEVERE TE, 1989, BEHAV NEUROSCI, V103, P561, DOI 10.1037/0735-7044.103.3.561; Liu L, 2004, CHEM PHARM BULL, V52, P1295, DOI 10.1248/cpb.52.1295; Lu AP, 2015, CHIN J INTEGR MED, V21, P163, DOI 10.1007/s11655-014-1961-9; Ma BL, 2016, DRUG METAB REV, V48, P1, DOI 10.3109/03602532.2015.1124888; Manach C, 2003, EUR J CLIN NUTR, V57, P235, DOI 10.1038/sj.ejcn.1601547; Marinho MMF, 1997, NEUROSCI LETT, V235, P13, DOI 10.1016/S0304-3940(97)00687-3; Peng C, 2013, J PHARM PHARMACOL, V65, P1064, DOI 10.1111/jphp.12069; Quintard H, 2014, NEUROSCIENCE, V277, P72, DOI 10.1016/j.neuroscience.2014.06.047; SCHARF MB, 1982, CLIN PHARMACOL THER, V31, P175, DOI 10.1038/clpt.1982.27; Shah V P, 2000, Pharm Res, V17, P1551, DOI 10.1023/A:1007669411738; Shaw LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043848; Sherman M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0641-4; Shi J, 2013, J ETHNOPHARMACOL, V145, P25, DOI 10.1016/j.jep.2012.10.028; Shi XW, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1822-0; Shoja MM, 2010, INT J CARDIOL, V145, P305, DOI 10.1016/j.ijcard.2009.10.042; Song XF, 2013, J PHARMACEUT BIOMED, V78-79, P202, DOI 10.1016/j.jpba.2013.02.014; Stein DM, 2017, CRIT CARE CLIN, V33, P1, DOI 10.1016/j.ccc.2016.08.008; Tang YH, 2017, EUR J DRUG METAB PH, V42, P527, DOI 10.1007/s13318-016-0368-8; Tong L, 2012, J PHARMACEUT BIOMED, V58, P58, DOI 10.1016/j.jpba.2011.05.001; Wang C, 2010, BIOMED CHROMATOGR, V24, P235, DOI 10.1002/bmc.1278; Wang N, 2011, NEURAL REGEN RES, V6, P1635, DOI 10.3969/j.issn.1673-5374.2011.21.006; Wang X., 2017, WORLD CHINESE J DIGE, V25, P392, DOI [10.11569/wcjd.v25.i4.392, DOI 10.11569/WCJD.V25.I4.392]; Wu H., 2017, BIOMEDICAL RES, V28, P9028; Wu YP, 2013, J ETHNOPHARMACOL, V148, P266, DOI 10.1016/j.jep.2013.04.024; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Wang Jie, 2013, Evid Based Complement Alternat Med, V2013, P978398, DOI [10.1155/2013/982380, 10.1155/2013/978398]; Xu YP, 2013, J CHROMATOGR B, V932, P92, DOI 10.1016/j.jchromb.2013.06.011; Yan Y, 2014, J PHARMACEUT BIOMED, V95, P76, DOI 10.1016/j.jpba.2014.02.013; Yeh CW, 2017, J ETHNOPHARMACOL, V209, P50, DOI 10.1016/j.jep.2017.07.036; Yin OQP, 2003, CLIN PHARMACOKINET, V42, P179, DOI 10.2165/00003088-200342020-00005; Yue SJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40318; Zhan Y, 2008, CHROMATOGRAPHIA, V68, P71, DOI 10.1365/s10337-008-0652-0; Zhang GS, 2015, MOLECULES, V20, P5889, DOI 10.3390/molecules20045889; Zhang HJ, 2006, BIOMED CHROMATOGR, V20, P821, DOI 10.1002/bmc.607; Zhang JZ, 2012, J ETHNOPHARMACOL, V144, P277, DOI 10.1016/j.jep.2012.09.009; Zhang L, 2015, J FOOD DRUG ANAL, V23, P811, DOI 10.1016/j.jfda.2015.06.004; Zhang L, 2012, J PHARMACEUT BIOMED, V62, P203, DOI 10.1016/j.jpba.2011.12.026; Zhang MM, 2004, WORLD J GASTROENTERO, V10, P3500; Zhang Zhuang, 2000, Zhongguo Zhongyao Zazhi, V25, P688; Zhao GW, 2014, J ETHNOPHARMACOL, V151, P694, DOI 10.1016/j.jep.2013.11.041; Zhou YN, 2014, J ETHNOPHARMACOL, V153, P659, DOI 10.1016/j.jep.2014.03.019; Zhu HY, 2013, J PHARMACEUT BIOMED, V78-79, P136, DOI 10.1016/j.jpba.2013.01.041	61	1	1	6	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-3879	1099-0801		BIOMED CHROMATOGR	Biomed. Chromatogr.	SEP	2020	34	9							e4872	10.1002/bmc.4872		JUL 2020	18	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy	NE3HD	WOS:000552760700001	32358897				2022-02-06	
J	Voormolen, DC; Polinder, S; von Steinbuechel, N; Feng, Y; Wilson, L; Oppe, M; Haagsma, JA				Voormolen, Daphne C.; Polinder, Suzanne; von Steinbuechel, Nicole; Feng, Yan; Wilson, Lindsay; Oppe, Mark; Haagsma, Juanita A.		CENTER-TBI Participants Investigat	Health-related quality of life after traumatic brain injury: deriving value sets for the QOLIBRI-OS for Italy, The Netherlands and The United Kingdom	QUALITY OF LIFE RESEARCH			English	Article						Health-related quality of life; Quality of life after brain injury overall scale (QOLIBRI-OS); Health utilities; Value set; Traumatic brain injury	DISCRETE-CHOICE EXPERIMENTS; PREFERENCE-BASED MEASURES; CONJOINT-ANALYSIS; STATE; VALUATION; EUROQOL; SCALE	Purpose The Quality of Life after Brain Injury overall scale (QOLIBRI-OS) measures health-related quality of life (HRQoL) after traumatic brain injury (TBI). The aim of this study was to derive value sets for the QOLIBRI-OS in three European countries, which will allow calculation of utility scores for TBI health states. Methods A QOLIBRI-OS value set was derived by using discrete choice experiments (DCEs) and visual analogue scales (VAS) in general population samples from the Netherlands, United Kingdom and Italy. A three-stage procedure was used: (1) A selection of health states, covering the entire spectrum of severity, was defined; (2) General population samples performed the health state valuation task using a web-based survey with three VAS questions and an at random selection of sixteen DCEs; (3) DCEs were analysed using a conditional logistic regression and were then anchored on the VAS data. Utility scores for QOLIBRI-OS health states were generated resulting in estimates for all potential health states. Results The questionnaire was completed by 13,623 respondents. The biggest weight increase for all attributes is seen from "slightly" to "not at all satisfied", resulting in the largest impact on HRQoL. "Not at all satisfied with how brain is working" should receive the greatest weight in utility calculations in all three countries. Conclusion By transforming the QOLIBRI-OS into utility scores, we enabled the application in economic evaluations and in summary measures of population health, which may be used to inform decision-makers on the best interventions and strategies for TBI patients.	[Voormolen, Daphne C.; Polinder, Suzanne; Haagsma, Juanita A.] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, POB 2040, NL-3000 CA Rotterdam, Netherlands; [von Steinbuechel, Nicole] Georg August Univ, Inst Med Psychol & Med Sociol, Waldweg 37, D-37073 Gottingen, Germany; [Feng, Yan] Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London, England; [Wilson, Lindsay] Univ Stirling, Dept Psychol, Stirling, Scotland; [Oppe, Mark] Axent Solut, C Calvario 271-B 1 IZQ, Tacoronte 38350, Santa Cruz De T, Spain; [Haagsma, Juanita A.] Univ Med Ctr Rotterdam, Dept Emergency Med, Erasmus MC, Rotterdam, Netherlands		Voormolen, DC (corresponding author), Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, POB 2040, NL-3000 CA Rotterdam, Netherlands.	d.voormolen@erasmusmc.nldd; s.polinder@erasmusmc.nl; nvsteinbuechel@med.uni-goettingen.de; yan.feng@qmul.ac.uk; l.wilson@stir.ac.uk; moppe@axentiva.com; j.haagsma@erasmusmc.nl	Castano-Leon, Ana M/ABF-6322-2020; Ercole, Ari/B-6288-2009; Oresic, Matej/K-7673-2016; Vande Vyvere, Thijs/AAB-5180-2022; Wilson, Lindsay/A-3659-2009; Lagares, Alfonso/B-2969-2011; Sahuquillo, Juan/B-3577-2008; Volovici, Victor/AAZ-8901-2020; Posti, Jussi P./Y-2908-2019; Raj, Rahul/K-7693-2012; Gomez, Pedro/E-2411-2014	Castano-Leon, Ana M/0000-0002-7918-5049; Ercole, Ari/0000-0001-8350-8093; Oresic, Matej/0000-0002-2856-9165; Vande Vyvere, Thijs/0000-0003-4032-5443; Wilson, Lindsay/0000-0003-4113-2328; Lagares, Alfonso/0000-0003-3996-0554; Sahuquillo, Juan/0000-0003-0713-5875; Volovici, Victor/0000-0002-5798-5360; Posti, Jussi P./0000-0002-5925-5193; Kondziella, Daniel/0000-0001-5562-9808; Newcombe, Virginia/0000-0001-6044-9035; Parizel, Paul M./0000-0002-0221-2854; Raj, Rahul/0000-0003-4243-9591; Stewart, William/0000-0003-2199-2582; Della Corte, Francesco/0000-0003-1736-2318; van der Naalt, Joukje/0000-0001-9873-2418; Sanchez-Porras, Renan/0000-0002-9084-8114; Van Essen, Thomas/0000-0003-4657-5283; Radoi, Andreea/0000-0002-0677-3544; Sakowitz, Oliver/0000-0003-3248-6335; Rossi, Sandra/0000-0002-9963-8121; Zeiler, Frederick/0000-0003-1737-0510; Coles, Jonathan/0000-0003-4013-679X; Gomez, Pedro/0000-0002-4185-5238; Gratz, Johannes/0000-0001-8717-0544	European Union Seventh Framework Programme (FP7/2007-2013) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	The paper has been written in the context of the CENTERTBI project. CENTER-TBI has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 602150. Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, EXCELLENCE NIFHC; Bansback N, 2012, J HEALTH ECON, V31, P306, DOI 10.1016/j.jhealeco.2011.11.004; Brazier JE, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16320; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Clark MD, 2014, PHARMACOECONOMICS, V32, P883, DOI 10.1007/s40273-014-0170-x; Cole A, 2018, EUR J HEALTH ECON, V19, P595, DOI 10.1007/s10198-017-0905-7; de Bekker-Grob EW, 2008, OSTEOPOROSIS INT, V19, P1029, DOI 10.1007/s00198-007-0535-5; de Bekker-Grob E.W., 2009, DISCRETE CHOICE EXPT; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; Feng Y, 2016, NEW METHODS MODELLIN; Goodwin E, 2016, APPL HEALTH ECON HEA, V14, P161, DOI 10.1007/s40258-015-0219-9; Hakim Z, 1999, HEALTH ECON, V8, P103; Hauber AB, 2016, VALUE HEALTH, V19, P300, DOI 10.1016/j.jval.2016.04.004; Jonker MF, 2018, VALUE HEALTH, V21, P767, DOI 10.1016/j.jval.2017.10.002; Krabbe PFM, 2006, QUAL LIFE RES, V15, P1651, DOI 10.1007/s11136-006-0027-7; Kuklys W, 2002, J APPL ECONOM, V17, P701, DOI 10.1002/jae.701; Louviere J.J., 2000, STATED CHOICE METHOD; LOUVIERE JJ, 1983, J MARKETING RES, V20, P350, DOI 10.2307/3151440; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; McCabe C, 2006, J HEALTH ECON, V25, P418, DOI 10.1016/j.jhealeco.2005.07.008; McFadden D., 1974, J PUBLIC ECON, V3, P303, DOI DOI 10.1016/0047-2727(74)90003-6; McIntosh E, 2006, J FAM PLAN REPROD H, V32, P107, DOI 10.1783/147118906776276549; McKenzie L, 2001, HEALTH POLICY, V57, P193, DOI 10.1016/S0168-8510(01)00128-2; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mulhern B, 2013, VALUE HEALTH, V16, P104, DOI 10.1016/j.jval.2012.09.001; Oppe M, 2017, EUROQOL WORKING PAPE, V17003; Oppe M, 2014, VALUE HEALTH, V17, P445, DOI 10.1016/j.jval.2014.04.002; Ratcliffe J, 2009, HEALTH ECON, V18, P1261, DOI 10.1002/hec.1426; Ryan M, 2008, ECON NON-MARK GOOD, V11, P1, DOI 10.1007/978-1-4020-5753-3; Stolk EA, 2010, VALUE HEALTH, V13, P1005, DOI 10.1111/j.1524-4733.2010.00783.x; Szeinbach SL, 1999, DRUG INF J, V33, P849, DOI 10.1177/009286159903300326; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Umlauf N., 2019, BAMLSS LEGO TOOLBOX; Umlauf N, 2018, J COMPUT GRAPH STAT, V27, P612, DOI 10.1080/10618600.2017.1407325; Van Hout B., 2016, VALUING HLTH RELATED; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077	39	1	1	2	6	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	NOV	2020	29	11					3095	3107		10.1007/s11136-020-02583-6		JUL 2020	13	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	OK4OY	WOS:000548832800001	32671617	Green Published, hybrid, Green Accepted			2022-02-06	
J	Wallace, J; Schatz, P; Mulenga, D; Lovell, M; Muyinda, G; Sichizya, KA; Mulengag, J; Covassin, T				Wallace, Jessica; Schatz, Philip; Mulenga, Davie; Lovell, Mark; Muyinda, Gabriel; Sichizya, Kachinga Agrippa; Mulengag, Joseph; Covassin, Tracey			Cross-cultural exploration of baseline ImPACT Quick Test performance among football athletes in Zambia	PHYSICIAN AND SPORTSMEDICINE			English	Article						ImPACT Quick Test; neurocognitive testing; Africa; concussion; normative scores; baseline; Zambia	NEUROCOGNITIVE PERFORMANCE; NORMATIVE DATA; CONCUSSION; SYMPTOMS; LANGUAGE; SCORES; SEX	Objective Concussion is a global sport injury; however, this public health issue has yet to be studied across Africa. It is unknown if tests such as the Immediate Post-Concussion Assessment and Cognitive Test (ImPACT) Quick Test (QT) are culturally appropriate for implementation as part of a concussion screening protocol in Zambia or other African nations. Study objectives included: 1) establish that Zambian athletes are able to complete the iPad-based ImPACT QT with respect to language or cultural barriers that may exist, and 2) document baseline neurocognitive percentile ranks among Zambian football athletes on the ImPACT QT. Methods This study was completed with adult premiere league football athletes in Zambia (n = 125) aged 24.48 +/- 5.41. Participants completed the ImPACT QT neurocognitive assessment prior to a preseason practice. Outcome measures were average performance on 3 factor scores: Motor Speed, Memory, and Attention Tracker, presented as percentile ranks using normative data built-into the ImPACT QT. Results Zambian athletes scored nearly two standard deviations below the mean on Motor Speed (7(th)percentile), using North American normative data. However, performance on Attention Tracker (44(th)percentile) and Memory (56(th)percentile) was within the average range. Conclusion Results of the current study show that Zambian athletes are able to complete the ImPACT QT, despite any language or cultural differences that may exist. In addition, preliminary percentile ranks suggest Zambian football athletes have average scores on Attention and Memory and below average scores on Motor Speed. These data are the first to explore Zambian athletes' performance on a cognitive concussion measure.	[Wallace, Jessica] Univ Alabama, Dept Hlth Sci, Tuscaloosa, AL 35487 USA; [Wallace, Jessica] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA; [Mulenga, Davie; Muyinda, Gabriel] Univ Zambia UTH, Univ Teaching Hosp, Dept Physiotherapy, Lusaka, Zambia; [Lovell, Mark] Lovell HealthCare Grp & Fdn, Pittsburgh, PA USA; [Sichizya, Kachinga Agrippa] Univ Zambia UTH, Univ Teaching Hosp, Dept Neurosurg, Lusaka, Zambia; [Mulengag, Joseph] Football Assoc Zambia, Lusaka, Zambia; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA		Wallace, J (corresponding author), Univ Alabama, Dept Hlth Sci, Tuscaloosa, AL 35487 USA.	jswallace1@ua.edu			University Research Council faculty grant through Youngstown State University's Office of Research	This research endeavor was supported by a University Research Council faculty grant through Youngstown State University's Office of Research.	Asken B. M., 2020, SPORTS MED, P1; Blake ML, 2015, ARCH CLIN NEUROPSYCH, V30, P302, DOI 10.1093/arclin/acv021; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Echemendia RJ, 2020, ARCH CLIN NEUROPSYCH, V35, P240, DOI 10.1093/arclin/acz077; Elbin RJ, 2020, ARCH CLIN NEUROPSYCH, V35, P326, DOI 10.1093/arclin/acz072; Ferrett HL, 2014, METAB BRAIN DIS, V29, P395, DOI 10.1007/s11011-014-9495-6; Harris J. G., 2003, CLIN INTERPRETATION, P343, DOI DOI 10.1016/B978-012703570-3/50015-8; Hon KL, 2019, SEMIN PEDIATR NEUROL, V30, P117, DOI 10.1016/j.spen.2019.03.017; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Houck ZM, 2019, J INT NEUROPSYCH SOC, V25, P961, DOI 10.1017/S1355617719000729; Houck ZM, 2019, CLIN NEUROPSYCHOL, V3, P1; Jones NS, 2014, CLIN J SPORT MED, V24, P284, DOI 10.1097/JSM.0000000000000031; Lovell MR, 2017, IMPACT QUICK TEST AD; NCAA, INT CONS DIAGN MAN S; Ott S, 2014, ARCH CLIN NEUROPSYCH, V29, P152, DOI 10.1093/arclin/act091; Owoeye Oluwatoyosi Babatunde Alex, 2017, BMC Res Notes, V10, P133, DOI 10.1186/s13104-017-2451-x; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Shuttleworth-Edwards Ann B, 2009, Phys Sportsmed, V37, P45, DOI 10.3810/psm.2009.12.1741; Vartiainen MV, 2021, APPL NEUROPSYCH-ADUL, V28, P53, DOI 10.1080/23279095.2019.1592175; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P894, DOI 10.1007/s40615-017-0437-y; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	22	1	1	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	APR 3	2021	49	2					165	170		10.1080/00913847.2020.1790983		JUL 2020	6	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Orthopedics; Sport Sciences	RM8IH	WOS:000548022100001	32605469				2022-02-06	
J	Brustman, K; Eagle, SR; Mucha, A; Trbovich, A; Collins, MW; Kontos, AP				Brustman, Kelly; Eagle, Shawn R.; Mucha, Anne; Trbovich, Alicia; Collins, Michael W.; Kontos, Anthony P.			Association of sleep symptoms with mood and vestibular subtypes following sport-related concussion	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article; Early Access						Mild traumatic brain injury; mood; sleep impairment; subtype; vestibular	TRAUMATIC BRAIN-INJURY; DISORDERS; EPIDEMIOLOGY; GUIDELINES; INSOMNIA; ANXIETY	Sport-related concussion (SRC) is a heterogenous injury with diverse symptoms and impairments that can be aggregated into clinical subtypes (cognitive, headache/migraine, vestibular, ocular-motor, anxiety/mood). Sleep disruption has been defined as potential exacerbating conditions that may accompany the five clinical subtypes. The authors sought to better characterize the role of impaired sleep in each clinical subtype and to identify other risk factors for sleep impairment after SRC. 281 patients (15.3 +/- 2.1 years) aged 10-22 years within 21 days of SRC completed the Post-Concussion Symptom Scale (PCSS), the Vestibular/Ocular Motor Screening (VOMS), and a clinical assessment to identify clinical subtype. Subjects were then divided into HIGH (>= 7;n = 82) and LOW (<= 3;n = 132) sleep symptom groups for comparison. HIGH participants had greater proportions of females (p < 0.001), history of psychiatric disorder (p < 0.001); total PCSS (p < 0.001); and impairment on all VOMS items (p < 0.001). HIGH participants were associated with mood/anxiety (p < 0.001), vestibular (p = 0.003) and ocular (p = 0.03) subtypes. Results of a logistic regression (LR) model with adjusted odds ratios (OR) to predict HIGH sleep symptoms supported anxiety/mood profile (OR = 2.98), vestibular profile (OR = 2.81), psychiatric history (OR = 4.99), and history of motion sickness (OR = 2.13) as significant predictors. Prescribing behavioral and sleep interventions may improve outcomes in cases where these factors co-occur.	[Brustman, Kelly; Eagle, Shawn R.; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA; [Mucha, Anne] UPMC Ctr Rehabil Serv, Pittsburgh, PA USA; [Trbovich, Alicia; Collins, Michael W.; Kontos, Anthony P.] UPMC Sports Med Concuss Clin, Pittsburgh, PA USA		Kontos, AP (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, Concuss Res Program, 3200 S Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu	Eagle, Shawn/ABG-1388-2020	Eagle, Shawn/0000-0001-6767-1042			Albathi M, 2017, J VESTIBUL RES-EQUIL, V27, P127, DOI 10.3233/VES-170617; Bruderer SG, 2017, AUDIOL NEURO-OTOL, V22, P74, DOI 10.1159/000475875; Chung JS, 2019, J CHILD NEUROL, V34, P639, DOI 10.1177/0883073819849741; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Ivanenko A, 2004, SLEEP MED, V5, P253, DOI 10.1016/j.sleep.2004.02.001; Kontos AP, 2020, NEUROSURGERY, V87, P348, DOI 10.1093/neuros/nyz545; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lumba-Brown A, 2020, NEUROSURGERY, V86, P2, DOI 10.1093/neuros/nyz332; Lumba-Brown Angela, 2019, Concussion, V4, pCNC65, DOI 10.2217/cnc-2019-0005; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Martin T, 2015, J APPL PHYSIOL, V118, P310, DOI 10.1152/japplphysiol.00811.2014; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murdaugh DL, 2018, ARCH PHYS MED REHAB, V99, P960, DOI 10.1016/j.apmr.2018.01.005; Neckelmann D, 2007, SLEEP, V30, P873, DOI 10.1093/sleep/30.7.873; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Singh K, 2016, PEDIATR NEUROL, V60, P30, DOI 10.1016/j.pediatrneurol.2016.02.013; Sufrinko AM, 2019, CLIN J SPORT MED, V29, P318, DOI 10.1097/JSM.0000000000000528; Tkachenko N, 2016, PEDIATR NEUROL, V57, P46, DOI 10.1016/j.pediatrneurol.2015.12.019; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Vitiello MV, 2002, J PSYCHOSOM RES, V53, P555, DOI 10.1016/S0022-3999(02)00435-X; Wu J, 2020, SLEEP BREATH, V24, P1383, DOI 10.1007/s11325-019-01994-1	27	1	2	1	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child												10.1080/21622965.2020.1788563		JUL 2020	5	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	MK8FC	WOS:000549016800001	32672475				2022-02-06	
J	Chang, CL; Sim, JL; Delgardo, MW; Ruan, DT; Connolly, ES				Chang, Cory L.; Sim, Justin L.; Delgardo, Mychael W.; Ruan, Diana T.; Connolly, E. Sander, Jr.			Predicting Chronic Subdural Hematoma Resolution and Time to Resolution Following Surgical Evacuation	FRONTIERS IN NEUROLOGY			English	Article						chronic subdural hematoma; subdural hematoma; surgical evacuation; hematoma resolution; hematoma recurrence; traumatic brain injury; burr hole; craniotomy	RISK-FACTORS; RECURRENCE; SURGERY	Background:Growing evidence suggests that chronic subdural hematoma (CSDH) may have long-term adverse effects even after surgical evacuation. Hematoma recurrence is commonly reported as a short-term, postoperative outcome measure for CSDH, but other measures such as hematoma resolution may provide better insight regarding mechanisms behind longer-term sequelae. This study aims to characterize postoperative resolution times and identify predictors for this relatively unexplored metric. Methods:Consecutive cases (N= 122) of burr hole evacuation for CSDH by a single neurosurgeon at Columbia University Irving Medical Center from 2000 to 2019 were retrospectively identified. Patient characteristics, presenting factors, and date of hematoma resolution were abstracted from the electronic health record. Outcome measures included CSDH resolution at 6 months, surgery-to-resolution time, and inpatient mortality. Univariate and multivariate analyses were performed to determine predictors of outcome measures. Results:Hematoma resolution at 6 months was observed in 58 patients (47.5%), and median surgery-to-resolution time was 161 days (IQR: 85-367). Heavy drinking was predictive of non-resolution at 6 months and longer surgery-to-resolution time, while increased age was predictive of non-resolution at 6 months. Antiplatelet agent resumption was associated with non-resolution at 6 months and longer surgery-to-resolution time on univariate analysis but was not significant on multivariate analysis. Conclusion:Postoperative resolution times for most CSDHs are on the order of several months to a year, and delayed resolution is linked to heavy drinking and advanced age. Subsequent prospective studies are needed to directly assess the utility of hematoma resolution as a potential metric for long-term functional and cognitive outcomes of CSDH.	[Chang, Cory L.; Sim, Justin L.; Delgardo, Mychael W.; Ruan, Diana T.; Connolly, E. Sander, Jr.] Columbia Univ, Irving Med Ctr, Dept Neurol Surg, Cerebrovasc Res Lab, New York, NY 10027 USA		Chang, CL (corresponding author), Columbia Univ, Irving Med Ctr, Dept Neurol Surg, Cerebrovasc Res Lab, New York, NY 10027 USA.	clc2224@cumc.columbia.edu			Department of Neurological Surgery, Columbia University Irving Medical Center	Internal department funds (Department of Neurological Surgery, Columbia University Irving Medical Center) were used for open access publication fees.	Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; Bartek J, 2017, WORLD NEUROSURG, V106, P609, DOI 10.1016/j.wneu.2017.07.044; Bin Zahid A, 2018, J NEUROSURG, V129, P1579, DOI 10.3171/2017.8.JNS17477; Carlsen JG, 2011, BRIT J NEUROSURG, V25, P388, DOI 10.3109/02688697.2011.558945; Chari A, 2014, BRIT J NEUROSURG, V28, P2, DOI 10.3109/02688697.2013.812184; Edlmann E, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0881-y; Ernestus RI, 1997, SURG NEUROL, V48, P220, DOI 10.1016/S0090-3019(97)80031-6; Hammer A, 2017, TURK NEUROSURG, V27, P756, DOI 10.5137/1019-5149.JTN.17347-16.1; Han MH, 2017, J NEUROSURG, V127, P1117, DOI 10.3171/2016.8.JNS16867; Jack A, 2015, CAN J NEUROL SCI, V42, P34, DOI 10.1017/cjn.2014.122; Jang KM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58250-w; Jarrott B, 2016, NEUROCHEM RES, V41, P523, DOI 10.1007/s11064-015-1661-7; Kim SU, 2017, J KOREAN NEUROSURG S, V60, P701, DOI 10.3340/jkns.2016.1010.003; KOMOTAR RJ, 2010, NEUROSURGERY, V66; KUDO H, 1992, Neurologia Medico-Chirurgica, V32, P207, DOI 10.2176/nmc.32.207; Lindvall P, 2009, J CLIN NEUROSCI, V16, P1287, DOI 10.1016/j.jocn.2009.01.001; Moffatt CE, 2019, J CLIN NEUROSCI, V66, P133, DOI 10.1016/j.jocn.2019.04.039; Motiei-Langroudi R, 2018, J NEUROSURG, V129, P1143, DOI 10.3171/2017.6.JNS17130; Nassiri F, 2020, WORLD NEUROSURG, V135, DOI 10.1016/j.wneu.2019.12.080; Nathan S, 2017, NEUROLOGY, V88, P1889, DOI 10.1212/WNL.0000000000003918; Parlato C, 2000, SURG NEUROL, V53, P312, DOI 10.1016/S0090-3019(00)00200-7; Phan K, 2018, WORLD NEUROSURG, V109, pE792, DOI 10.1016/j.wneu.2017.10.091; Qian ZR, 2017, BRIT J NEUROSURG, V31, P84, DOI 10.1080/02688697.2016.1260686; Ramachandran R, 2007, SURG NEUROL, V67, P367, DOI 10.1016/j.surneu.2006.07.022; Santarius T, 2004, BRIT J NEUROSURG, V18, P328, DOI 10.1080/02688690400004845; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Schoedel P, 2016, WORLD NEUROSURG, V94, P465, DOI 10.1016/j.wneu.2016.07.027; Stavrinou P, 2017, WORLD NEUROSURG, V99, P465, DOI 10.1016/j.wneu.2016.12.058; Torihashi K, 2008, NEUROSURGERY, V63, P1125, DOI 10.1227/01.NEU.0000335782.60059.17; Xu CS, 2017, EUR REV MED PHARMACO, V21, P809; Yang WY, 2017, NEUROSURG CLIN N AM, V28, P205, DOI 10.1016/j.nec.2016.11.002; Yu GJ, 2009, BRIT J NEUROSURG, V23, P606, DOI 10.3109/02688690903386983; Zanaty M, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01401	33	1	1	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 14	2020	11								677	10.3389/fneur.2020.00677			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MV4DY	WOS:000556311700001	32760342	Green Published, gold			2022-02-06	
J	Muehlschlegel, S; Hwang, DY; Flahive, J; Quinn, T; Lee, C; Moskowitz, J; Goostrey, K; Jones, K; Pach, JJ; Knies, AK; Shutter, L; Goldberg, R; Mazor, KM				Muehlschlegel, Susanne; Hwang, David Y.; Flahive, Julie; Quinn, Thomas; Lee, Christopher; Moskowitz, Jesse; Goostrey, Kelsey; Jones, Kelsey; Pach, Jolanta J.; Knies, Andrea K.; Shutter, Lori; Goldberg, Robert; Mazor, Kathleen M.			Goals-of-care decision aid for critically ill patients with TBI Development and feasibility testing	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; VALIDATION; PROGNOSIS; LIFE; OPPORTUNITIES; DEPRESSION; GUIDELINES; FAMILIES; ANXIETY; END	Objective To develop and demonstrate early feasibility of a goals-of-care decision aid for surrogates of patients who are critically ill with traumatic brain injury (ciTBI) that meets accepted international decision aid guidelines. Methods We developed the decision aid in 4 stages: (1) qualitative study of goals-of-care communication and decision needs of 36 stakeholders of ciTBI (surrogates and physicians), which informed (2) development of paper-based decision aid with iterative revisions after feedback from 52 stakeholders; (3) acceptability and usability testing in 18 neurologic intensive care unit (neuroICU) family members recruited from 2 neuroICU waiting rooms using validated scales; and (4) open-label, randomized controlled feasibility trial in surrogates of ciTBI. We performed an interim analysis of 16 surrogates of 12 consecutive patients who are ciTBI to confirm early feasibility of the study protocol and report recruitment, participation, and retention rates to date. Results The resultant goals-of-care decision aid achieved excellent usability (median System Usability Scale 87.5 [possible range 0-100]) and acceptability (97% graded the tool's content as "good" or "excellent"). Early feasibility of the decision aid and the feasibility trial protocol was demonstrated by high rates of recruitment (73% consented), participation (100%), and retention (100% both after the goals-of-care clinician-family meeting and at 3 months) and complete data for the measurements of all secondary decision-related and behavioral outcomes to date. Conclusions Our systematic development process resulted in a novel goals-of-care decision aid for surrogates of patients who are ciTBI with excellent usability, acceptability, and early feasibility in the neuroICU environment, and meets international decision aid standards. This methodology may be a development model for other decision aids in neurology to promote shared decision-making.	[Muehlschlegel, Susanne; Lee, Christopher; Goostrey, Kelsey; Jones, Kelsey] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Muehlschlegel, Susanne] Univ Massachusetts, Sch Med, Dept Anesthesiol Crit Care, Worcester, MA 01605 USA; [Muehlschlegel, Susanne] Univ Massachusetts, Sch Med, Dept Surg, Worcester, MA 01605 USA; [Flahive, Julie; Goldberg, Robert] Univ Massachusetts, Sch Med, Dept Populat & Quantitat Hlth Sci, Worcester, MA 01605 USA; [Mazor, Kathleen M.] Univ Massachusetts, Sch Med, Meyers Primary Care Inst, Worcester, MA 01605 USA; [Mazor, Kathleen M.] Univ Massachusetts, Sch Med, Dept Internal Med, Worcester, MA 01605 USA; [Hwang, David Y.] Yale Sch Med, Ctr Neuroepidemiol & Clin Neurol Res, New Haven, CT USA; [Hwang, David Y.; Pach, Jolanta J.; Knies, Andrea K.] Yale Sch Med, Dept Neurol, New Haven, CT USA; [Quinn, Thomas] Harvard Med Sch, Dept Med, Beth Israel Deaconess Hosp, Boston, MA 02115 USA; [Moskowitz, Jesse] Brown Med Sch, Dept Psychiat, Providence, RI USA; [Shutter, Lori] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Shutter, Lori] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15260 USA		Muehlschlegel, S (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA.; Muehlschlegel, S (corresponding author), Univ Massachusetts, Sch Med, Dept Anesthesiol Crit Care, Worcester, MA 01605 USA.; Muehlschlegel, S (corresponding author), Univ Massachusetts, Sch Med, Dept Surg, Worcester, MA 01605 USA.	susanne.muehlschlegel@umassmemorial.org	Hwang, David/ABG-6957-2020; Shutter, Lori A/G-2957-2013	Hwang, David/0000-0002-2150-4289; Muehlschlegel, Susanne/0000-0002-5717-9246; Shutter, Lori/0000-0002-1390-0628	NIH/NICHD grant [5K23HD080971]; University of Massachusetts Medical School Center for Clinical and Translational Science - NIH Clinical and Translational Science Award [UL1TR000161]	This study was funded by NIH/NICHD grant 5K23HD080971 (PI Muehlschlegel). This project was also supported by the University of Massachusetts Medical School Center for Clinical and Translational Science, which is funded by the NIH Clinical and Translational Science Award to the University of Massachusetts Medical School (UL1TR000161).	Anderson WG, 2009, J CRIT CARE, V24, P249, DOI 10.1016/j.jcrc.2007.12.010; Arozullah AM, 2007, MED CARE, V45, P1026, DOI 10.1097/MLR.0b013e3180616c1b; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Azoulay E, 2000, CRIT CARE MED, V28, P3044, DOI 10.1097/00003246-200008000-00061; Brehaut JC, 2003, MED DECIS MAKING, V23, P281, DOI 10.1177/0272989X03256005; Brooke J., 1996, USABILITY EVALUATION, P189; Centers for Disease Control and Prevention, TRAUM BRAIN INJ STAT; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; Cox CE, 2019, ANN INTERN MED, V170, P285, DOI 10.7326/M18-2335; Cox CE, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0045-0; Cox CE, 2012, CRIT CARE MED, V40, P2327, DOI 10.1097/CCM.0b013e3182536a63; Curtis JR, 2005, AM J RESP CRIT CARE, V171, P844, DOI 10.1164/rccm.200409-1267OC; Davidson JE, 2017, CRIT CARE MED, V45, P103, DOI 10.1097/CCM.0000000000002169; Elwyn G, 2006, BMJ-BRIT MED J, V333, P417, DOI 10.1136/bmj.38926.629329.AE; Evans LR, 2009, AM J RESP CRIT CARE, V179, P48, DOI 10.1164/rccm.200806-969OC; Fagerlin A, 2005, MED DECIS MAKING, V25, P398, DOI 10.1177/0272989X05278931; Fagerlin A, 2007, MED DECIS MAKING, V27, P672, DOI 10.1177/0272989x07304449; Kon AA, 2016, CRIT CARE MED, V44, P188, DOI 10.1097/CCM.0000000000001396; Kraemer HC, 2006, ARCH GEN PSYCHIAT, V63, P484, DOI 10.1001/archpsyc.63.5.484; Legare F, 2006, CAN FAM PHYSICIAN, V52, P476; Leon AC, 2011, J PSYCHIATR RES, V45, P626, DOI 10.1016/j.jpsychires.2010.10.008; Moskowitz J, 2018, MDM POLICY PRACT, V3; Muehlschlegel S, 2015, NEUROCRIT CARE, V23, P127, DOI 10.1007/s12028-014-0097-2; O'Connor A., 1995, DECISION SELF EFFICA; O'Connor AM, 1996, ACCEPTABILITY SCALE; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; Quinn T, 2017, NEUROCRIT CARE, V27, P154, DOI 10.1007/s12028-017-0427-2; Schutz REC, 2017, J PALLIAT MED, V20, P170, DOI 10.1089/jpm.2016.0286; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sun H, 2016, J NEUROTRAUM, V33, P1535, DOI 10.1089/neu.2015.4164; Tannenbaum MJ, 2019, UNIVERSE-BASEL, V5, DOI 10.3390/universe5060140; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; White DB, 2007, ARCH INTERN MED, V167, P461, DOI 10.1001/archinte.167.5.461; White DB, 2016, JAMA-J AM MED ASSOC, V315, P2086, DOI 10.1001/jama.2016.5351; Wilson JP, 1996, ASSESSING PSYCHOL TR, P399; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zikmund-Fisher BJ, ICON ARRAYS RISK SCI	40	1	1	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JUL 14	2020	95	2					E179	E193		10.1212/WNL.0000000000009770			15	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NP3QC	WOS:000570092600015	32554766	Green Published			2022-02-06	
J	Tiba, MH; McCracken, BM; Leander, DC; Colmenero, CI; Cummings, B; Greer, NL; Picton, P; Williamson, CA; Ward, KR				Tiba, Mohamad H.; McCracken, Brendan M.; Leander, Danielle C.; Colmenero, Carmen, I; Cummings, Brandon; Greer, Nicholas L.; Picton, Paul; Williamson, Craig A.; Ward, Kevin R.			Trans-ocular brain impedance index for assessment of cerebral autoregulation in a porcine model of cerebral hemodynamic perturbation	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						Cerebral autoregulation; Bioimpedance; Pressure reactivity index; Traumatic brain injury	CEREBROVASCULAR PRESSURE REACTIVITY; PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; BLOOD-FLOW; INJURY; MANAGEMENT	Cerebrovascular autoregulation (CA) is often impaired following traumatic brain injury. Established technologies and metrics used to assess CA are invasive and conducive for measurement, but not for continuous monitoring. We developed a trans-ocular brain impedance (TOBI) method that may provide non-invasive and continuous indices to assess CA. In this study, we monitored impedance metrics such as respiratory-induced impedance amplitude changes (dz) as well as a novel impedance index (DZx), which is a moving Pearson correlation between mean arterial pressure (MAP) anddz. Yorkshire swine were instrumented to continuously record ICP, MAP, and cerebral blood flow (CBF). TOBI was recorded by placement of standard ECG electrodes on closed eyelids and connected to a data acquisition system. MAP, ICP and CBF were manipulated utilizing an intravenous vasopressor challenge. TOBI indices (dzand DZx) were compared to the hemodynamic indicators as well as pressure reactivity index (PRx). During the vasopressor challenge,dzwas highly correlated with ICP, CPP, and CBF (r = < - 0.49,p < 0.0001). ICP, CPP, and CBF had a mean percent increase (standard deviation) from baseline of 29(23.2)%, 70(25)%, and 37(72.6)% respectively whiledzdecreased by 31(15.6)%. Receiver operator curve test showed high predictive performance of DZx when compared to PRx with area under the curve above 0.86, with high sensitivity and specificity. Impedance indices appear to track changes in PRx and hemodynamics that affect cerebral autoregulation. TOBI may be a suitable less invasive surrogate to PRx and capable of tracking cerebral autoregulation.	[Tiba, Mohamad H.; McCracken, Brendan M.; Leander, Danielle C.; Colmenero, Carmen, I; Cummings, Brandon; Greer, Nicholas L.; Ward, Kevin R.] Univ Michigan, Dept Emergency Med, 2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Ward, Kevin R.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Williamson, Craig A.] Univ Michigan, Dept Neurol Surg, Ann Arbor, MI 48109 USA; [Williamson, Craig A.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Picton, Paul] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Tiba, Mohamad H.; McCracken, Brendan M.; Leander, Danielle C.; Colmenero, Carmen, I; Cummings, Brandon; Greer, Nicholas L.; Williamson, Craig A.; Ward, Kevin R.] Univ Michigan, Michigan Ctr Integrat Res Crit Care MCIRCC, Ann Arbor, MI 48109 USA		Tiba, MH (corresponding author), Univ Michigan, Dept Emergency Med, 2800 Plymouth Rd, Ann Arbor, MI 48109 USA.; Tiba, MH (corresponding author), Univ Michigan, Michigan Ctr Integrat Res Crit Care MCIRCC, Ann Arbor, MI 48109 USA.	tibam@med.umich.edu; bmccrac@med.umich.edu; danlean@umich.edu; cico@med.umich.edu; cummingb@med.umich.edu; nlgreer@med.umich.edu; ppicton@med.umich.edu; craigaw@med.umich.edu; keward@med.umich.edu		Tiba, Mohamad/0000-0002-6789-7532	Department of DefenseUnited States Department of Defense [W81XWH-18-1-0005]	This study was supported by a grant from the Department of Defense (#W81XWH-18-1-0005).	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Ang BT, 2007, J NEUROL NEUROSUR PS, V78, P298, DOI 10.1136/jnnp.2005.082735; Armstead William M, 2016, Anesthesiol Clin, V34, P465, DOI 10.1016/j.anclin.2016.04.002; Atkins ER, 2010, CEREBROVASC DIS, V29, P228, DOI 10.1159/000267845; Babu J P, 1990, J Postgrad Med, V36, P57; Bernstein D. P., 2010, J ELECT BIOMP, V1, P2, DOI [10.5617/jeb.51, DOI 10.5617/JEB.51]; Bhuta A C, 1990, J Postgrad Med, V36, P64; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Cardim D, 2016, NEUROCRIT CARE, V25, P473, DOI 10.1007/s12028-016-0258-6; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2017, ACTA NEUROCHIR, V159, P2063, DOI 10.1007/s00701-017-3310-1; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Dawson SL, 2003, CEREBROVASC DIS, V16, P69, DOI 10.1159/000070118; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Lazaridis C, 2013, NEUROL RES, V35, P138, DOI 10.1179/1743132812Y.0000000150; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Myburgh JA, 2002, ANAESTH INTENS CARE, V30, P725, DOI 10.1177/0310057X0203000602; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Prabhakar Hemanshu, 2014, J Anaesthesiol Clin Pharmacol, V30, P318, DOI 10.4103/0970-9185.137260; Reinhard M, 2012, ACTA NEUROL SCAND, V125, P156, DOI 10.1111/j.1600-0404.2011.01515.x; Rivera-Lara L, 2017, CRIT CARE MED, V45, P695, DOI 10.1097/CCM.0000000000002251; Schwarz S, 2002, STROKE, V33, P998, DOI 10.1161/01.STR.0000014584.17714.2E; Steppan J, 2014, BEST PRACT RES-CLIN, V28, P429, DOI 10.1016/j.bpa.2014.09.002; Tackla R, 2015, NEUROCRIT CARE, V23, P339, DOI 10.1007/s12028-015-0146-5; Tavakoli S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17450; Tiba MH, 2017, J NEUROTRAUM, V34, P3089, DOI 10.1089/neu.2017.5090; Tseng MY, 2005, STROKE, V36, P1627, DOI 10.1161/01.STR.0000176743.67564.5d; Tzeng YC, 2014, EUR J APPL PHYSIOL, V114, P545, DOI 10.1007/s00421-013-2667-y; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Vranken Nousjka P A, 2017, J Extra Corpor Technol, V49, P182; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	35	1	1	0	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	OCT	2021	35	5					1007	1014		10.1007/s10877-020-00556-1		JUL 2020	8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	WE9GF	WOS:000548473900001	32666400				2022-02-06	
J	Yasen, AL; Lim, MM; Weymann, KB; Christie, AD				Yasen, Alia L.; Lim, Miranda M.; Weymann, Kristianna B.; Christie, Anita D.			Excitability, Inhibition, and Neurotransmitter Levels in the Motor Cortex of Symptomatic and Asymptomatic Individuals Following Mild Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						mTBI; chronic symptoms; corticospinal excitability; intracortical inhibition; neurotransmitters	EVOKED-POTENTIALS; CONCUSSION; SPORT; RELIABILITY; AMPLITUDE; GABA; SPECTROSCOPY; GLUTAMATE; RECOVERY; TASK	Purpose:The purpose of this study was to determine the level of excitability and inhibition, as well as the concentrations of excitatory and inhibitory neurotransmitters, in the motor cortex of individuals with acute and chronic symptoms from mTBI. Methods:Fifty-three individuals were assigned to one of four groups: (i) without history of mTBI (Control), (ii) within 72-h of diagnosis of mTBI (Acute), (iii) with history of mTBI and no remaining symptoms (Chronic Asymptomatic), and (iv) with chronic symptoms from mTBI, lasting at least 3 months post-injury (Chronic Symptomatic). Measures of corticospinal excitability and inhibition were obtained using transcranial magnetic stimulation (TMS). On the same day, measures of glutamate and GABA concentrations were obtained from the primary motor cortex (M1) using proton magnetic resonance spectroscopy. Results:MEP amplitude and area were both significantly lower in the Chronic Symptomatic group compared to the Control and Chronic Asymptomatic groups (p <= 0.05). Intracortical inhibition was not significantly different among groups (p= 0.14). The concentration of glutamate in M1 was similar between groups (p= 0.93) while there was a trend for a lower concentration of GABA in the Chronic Symptomatic group compared to the Acute group (p= 0.06). Conclusions:Individuals with chronic mTBI symptoms appear to have lower corticospinal excitability compared with acutely-injured individuals and asymptomatic controls, but the absence of differences in intracortical inhibition, and concentrations of excitatory and inhibitory neurotransmitters in M1 suggests that neurotransmitter changes in the human brain post-mTBI do not follow the pattern typically seen in the animal literature.	[Yasen, Alia L.; Christie, Anita D.] Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA; [Lim, Miranda M.; Weymann, Kristianna B.] VA Portland Hlth Care Syst, Sleep Disorders Clin, Portland, OR USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Weymann, Kristianna B.] Oregon Hlth & Sci Univ, Sch Nursing, Portland, OR 97201 USA; [Christie, Anita D.] Western Univ, Fac Hlth Sci, Sch Kinesiol, London, ON, Canada		Christie, AD (corresponding author), Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA.; Christie, AD (corresponding author), Western Univ, Fac Hlth Sci, Sch Kinesiol, London, ON, Canada.	achris95@uwo.ca			Eugene & Clarissa Evonuk Memorial Graduate Fellowship; University of Oregon Center for the Study of Women in Society; VA Awards [IK2 BX002712, I01 CX002022]	This work was supported by the Eugene & Clarissa Evonuk Memorial Graduate Fellowship (AY) and the University of Oregon Center for the Study of Women in Society (AY). This work was further supported by VA Awards #IK2 BX002712 and #I01 CX002022 to ML.	Bernabeu M, 2009, J NEUROTRAUM, V26, P2185, DOI 10.1089/neu.2008.0859; Brizuela M, 2017, J NEUROTRAUM, V34, P2504, DOI 10.1089/neu.2017.4977; Christie A, 2007, J NEUROSCI METH, V164, P320, DOI 10.1016/j.jneumeth.2007.05.011; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; Edwards EK, 2017, BRAIN INJURY, V31, P1348, DOI 10.1080/02699052.2017.1327671; EISEN A, 1991, ELECTROEN CLIN NEURO, V81, P209, DOI 10.1016/0168-5597(91)90074-8; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P225; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Ives JC, 2003, CLIN BIOMECH, V18, P543, DOI 10.1016/S0268-0033(03)00089-5; Kamen G, 2004, MED SCI SPORT EXER, V36, P1574, DOI 10.1249/01.MSS.0000139804.02576.6A; Kapogiannis Dimitrios, 2008, Central Nervous System Agents in Medicinal Chemistry, V8, P234; Livingston SC, 2012, J CLIN NEUROPHYSIOL, V29, P23, DOI 10.1097/WNP.0b013e318246ae46; Livingston SC, 2010, BRAIN INJURY, V24, P904, DOI 10.3109/02699051003789245; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Miller NR, 2014, BRAIN INJURY, V28, P1270, DOI 10.3109/02699052.2014.915987; Mullins PG, 2014, NEUROIMAGE, V86, P43, DOI 10.1016/j.neuroimage.2012.12.004; Orth M, 2004, CLIN NEUROPHYSIOL, V115, P1076, DOI 10.1016/j.clinph.2003.12.025; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2013, J NEUROPHYSIOL, V109, P1343, DOI 10.1152/jn.00704.2012; van Hedel HJA, 2007, J NEUROL, V254, P1089, DOI 10.1007/s00415-006-0493-4; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x; Yasen AL, 2019, THESIS; Yasen AL, 2018, J NEUROPHYSIOL, V120, P1318, DOI 10.1152/jn.00896.2017; Yasen AL, 2017, MED SCI SPORT EXER, V49, P1066, DOI 10.1249/MSS.0000000000001217; Yasen AL, 2017, NEUROSCI LETT, V643, P121, DOI 10.1016/j.neulet.2017.02.039	33	1	1	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 14	2020	11								683	10.3389/fneur.2020.00683			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MV4DF	WOS:000556309700001	32765402	Green Published, gold			2022-02-06	
J	Vicente, SG; Rivera, D; Barbosa, F; Gaspar, N; Dores, AR; Mascialino, G; Arango-Lasprilla, JC				Vicente, Selene G.; Rivera, Diego; Barbosa, Fernando; Gaspar, Nuno; Dores, Artemisa R.; Mascialino, Guido; Carlos Arango-Lasprilla, Juan			Normative data for tests of attention and executive functions in a sample of European Portuguese adult population	AGING NEUROPSYCHOLOGY AND COGNITION			English	Article						Executive functions; attention; neuropsychological tests; standardization; European Portuguese; normative data	CARD SORTING TEST; TRAUMATIC BRAIN-INJURY; FRONTAL ASSESSMENT BATTERY; STROOP COLOR; INTELLECTUAL ABILITY; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; SUBSTITUTION TEST; FUNCTION DEFICITS; MODIFIED VERSION	Objective: The main goal of this study was to produce normative data for the Portuguese population on five neuropsychological tests frequently used to assess executive functions and attention: the Modified Wisconsin Card Sorting Test (M-WCST), the Stroop Color and Word Test, the Trail Making Test (TMT), the Brief Test of Attention (BTA), and the Symbol Digit Modalities Test (SDMT). Method: The study included 300 individuals aged between 18 and 93 years, who had educational backgrounds ranging from 3 to 25 years. Results: The influence of age, education, and sex was explored for each measure, as well as their contribution to explain the performance variance. Conclusions: The normative data are presented as regression-based algorithms to adjust direct and derived test scores for sex, age, and education. This study provides a calculator of normative data, derived from the results of the regression models.	[Vicente, Selene G.; Gaspar, Nuno] Univ Porto, Fac Psychol & Educ Sci, Ctr Psychol, Porto, Portugal; [Rivera, Diego] Univ Publ Navarra, Dept Ciencias Salud, Navarra, Spain; [Barbosa, Fernando; Dores, Artemisa R.] Univ Porto, Fac Psychol & Educ Sci, Lab Neuropsychophysiol, Porto, Portugal; [Dores, Artemisa R.] Polytech Porto, Sch Hlth, Porto, Portugal; [Mascialino, Guido] Univ Las Amer, Sch Psychol, Quito, Ecuador; [Carlos Arango-Lasprilla, Juan] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain; [Carlos Arango-Lasprilla, Juan] Biocruces Bizkaia Hlth Res Inst, Baracaldo, Spain; [Carlos Arango-Lasprilla, Juan] Univ Basque Country UPV EHU, Dept Cell Biol & Histol, Leioa, Spain		Arango-Lasprilla, JC (corresponding author), Basque Fdn Sci, IKERBASQUE, Bilbao, Spain.; Arango-Lasprilla, JC (corresponding author), Biocruces Bizkaia Hlth Res Inst, Baracaldo, Spain.; Arango-Lasprilla, JC (corresponding author), Univ Basque Country UPV EHU, Dept Cell Biol & Histol, Leioa, Spain.	jcalasprilla@gmail.com	Rivera, Diego/U-8872-2017; Barbosa, Fernando/L-3836-2014	Rivera, Diego/0000-0001-7477-1893; Barbosa, Fernando/0000-0002-3310-5613; Vicente, Selene/0000-0003-1840-118X; MASCIALINO, GUIDO/0000-0001-7408-6546	Faculty of Psychology and Educational Sciences of the University of Porto, Portugal (FPCEUP)	This work was supported by the Faculty of Psychology and Educational Sciences of the University of Porto, Portugal (FPCEUP). The Counselling Neuropsychology Unit of the FPCEUP; The Laboratory of Neuropsychophysiology of the FPCEUP; and the Centre of Psychology of the University of Porto, Porto, Portugal.	Amieva H, 2004, ARCH CLIN NEUROPSYCH, V19, P791, DOI 10.1016/j.acn.2003.09.006; Amieva H, 2003, BRAIN COGNITION, V53, P129, DOI 10.1016/S0278-2626(03)00094-0; Arango-Lasprilla JC, 2015, NEUROREHABILITATION, V37, P639, DOI 10.3233/NRE-151284; Arango-Lasprilla JC, 2015, NEUROREHABILITATION, V37, P563, DOI 10.3233/NRE-151280; Army Individual Test Battery, 1944, MAN DIR SCOR, DOI [10.1080/713755608, DOI 10.1080/713755608]; Arrufat A. S., 1999, INTRODUCCION ESTADIS, V27; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Baddeley A, 1998, J INT NEUROPSYCH SOC, V4, P523, DOI 10.1017/S135561779800513X; Benedict RHB, 2010, J INT NEUROPSYCH SOC, V16, P829, DOI 10.1017/S1355617710000688; Bezdicek O, 2012, ARCH CLIN NEUROPSYCH, V27, P906, DOI 10.1093/arclin/acs084; Binetti G, 1996, J NEUROL NEUROSUR PS, V60, P91, DOI 10.1136/jnnp.60.1.91; Brugnolo A, 2016, NEUROL SCI, V37, P365, DOI 10.1007/s10072-015-2428-2; Burzynska AZ, 2012, HUM BRAIN MAPP, V33, P1607, DOI 10.1002/hbm.21311; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caffarra P, 2004, J CLIN EXP NEUROPSYC, V26, P246, DOI 10.1076/jcen.26.2.246.28087; Caixeta L, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00194; Carter JD, 2010, SCHIZOPHR RES, V122, P104, DOI 10.1016/j.schres.2010.03.019; Cavaco S, 2013, ARCH CLIN NEUROPSYCH, V28, P189, DOI 10.1093/arclin/acs115; CICERONE KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; Craig F, 2016, NEUROPSYCH DIS TREAT, V12, P1191, DOI 10.2147/NDT.S104620; de Zubicaray GI, 1998, BRIT J CLIN PSYCHOL, V37, P457; del Pino R, 2016, REV NEUROLOGIA, V62, P193, DOI 10.33588/rn.6205.2015274; deZubicaray G, 1996, CLIN NEUROPSYCHOL, V10, P245, DOI 10.1080/13854049608406687; Dirnberger G, 2014, NEUROREPORT, V25, P1308, DOI 10.1097/WNR.0000000000000264; Dirnberger G, 2013, J NEUROPSYCHOL, V7, P193, DOI 10.1111/jnp.12028; Fernandes S., 2012, STROOP TESTE CORES P; Filipe M. G., 2019, INTRA INTER INDIVIDU, P78, DOI [10.3389/978-2-88945-837-0, DOI 10.3389/978-2-88945-837-0]; Fiorentino Natalia, 2013, Dement. neuropsychol., V7, P33, DOI 10.1590/S1980-57642013DN70100006; Firbank M, 2016, HUM BRAIN MAPP, V37, P1254, DOI 10.1002/hbm.23100; Fjell AM, 2017, CEREB CORTEX, V27, P2303, DOI 10.1093/cercor/bhw082; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gavilan JM, 2015, REV PSIQUIATR SALUD, V8, P119, DOI 10.1016/j.rpsm.2014.01.008; Golden CJ., 2002, STROOP COLOR WORD TE; Guardia-Olmos J., 2007, ANALISIS DATOS PSICO, P100; Hamdan Amer C., 2009, Psychol. Neurosci., V2, P199, DOI 10.3922/j.psns.2009.2.012; IBM Corp. Released, 2015, INP SPSS STAT WIND V; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kingdon D, 2016, J CHILD PSYCHOL PSYC, V57, P116, DOI 10.1111/jcpp.12451; Kirova AM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/748212; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kutner M.H., 2005, APPL LINEAR STAT MOD, V5th edn; LAUX LF, 1985, INTELLIGENCE, V9, P111, DOI 10.1016/0160-2896(85)90012-1; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lima C, 2008, J NEUROL, V255, P1756, DOI 10.1007/s00415-008-0024-6; Lineweaver TT, 1999, CLIN NEUROPSYCHOL, V13, P328, DOI 10.1076/clin.13.3.328.1745; Llinas-Regla J, 2013, ARCH CLIN NEUROPSYCH, V28, P282, DOI 10.1093/arclin/act003; MAHONEY F I, 1965, Md State Med J, V14, P61; Martins IP, 2013, CLIN NEUROPSYCHOL, V27, P410, DOI 10.1080/13854046.2012.748094; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Miller BC, 2015, UNCIVIL WARS, P116; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Moreira HS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221873; Moreira HS, 2014, J ALZHEIMERS DIS, V42, P261, DOI 10.3233/JAD-132348; Nagahama Y, 2003, DEMENT GERIATR COGN, V16, P103, DOI 10.1159/000070683; Naglieri, 2014, HDB EXECUTIVE FUNCTI, DOI 10.1007/978-1-4614-8106-5; Nakayama H, 1990, No To Shinkei, V42, P765; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Obonsawin MC, 1999, BRIT J CLIN PSYCHOL, V38, P27, DOI 10.1348/014466599162647; Olgiati E, 2016, PROG BRAIN RES, V229, P343, DOI 10.1016/bs.pbr.2016.06.011; Packwood S, 2011, J CLIN EXP NEUROPSYC, V33, P456, DOI 10.1080/13803395.2010.533157; Papagno C, 2018, NEUROL SCI, V39, P215, DOI 10.1007/s10072-017-3154-8; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Pohjasvaara T, 2002, EUR J NEUROL, V9, P269, DOI 10.1046/j.1468-1331.2002.00396.x; Princiotta D., 2014, HDB EXECUTIVE FUNCTI, P143, DOI DOI 10.1007/978-1-4614-8106-5; R Development Core Team, 2017, R LANG ENV STAT COMP; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reuter-Lorenz P.A., 2015, HDB PSYCHOL AGING, P245, DOI [10.1016/b978-0-12-411469-2.00013-3, DOI 10.1016/B978-0-12-411469-2.00013-3]; Rivera D, 2015, NEUROREHABILITATION, V37, P663, DOI 10.3233/NRE-151283; Rivera D, 2015, NEUROREHABILITATION, V37, P591, DOI 10.3233/NRE-151281; Rivera D, 2019, NEUROPSYCHOLOGY, V33, P287, DOI 10.1037/neu0000518; Robinson H, 2014, J INT NEUROPSYCH SOC, V20, P52, DOI 10.1017/S135561771300060X; Roldan-Tapia MD, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00340; Sachdev PS, 2014, NAT REV NEUROL, V10, P634, DOI 10.1038/nrneurol.2014.181; Schretlen D, 1996, CLIN NEUROPSYCHOL, V10, P80, DOI 10.1080/13854049608406666; Schretlen D., 1997, BRIEF TEST ATTENTION; Schretlen D. J., 2010, M WCST MODIFIED WISC; Seo EH, 2006, INT J GERIATR PSYCH, V21, P844, DOI 10.1002/gps.1570; Shah SA, 2017, NEUROIMAGE-CLIN, V14, P233, DOI 10.1016/j.nicl.2017.01.010; Sheridan LK, 2006, ARCH CLIN NEUROPSYCH, V21, P23, DOI 10.1016/j.acn.2005.07.003; Sherman E. M., 2006, COMPENDIUM NEUROPSYC; Siciliano M, 2019, NEUROL SCI, V40, P469, DOI 10.1007/s10072-018-3673-y; Slachevsky A, 2004, ARCH NEUROL-CHICAGO, V61, P1104, DOI 10.1001/archneur.61.7.1104; Smith A., 1982, SYMBOL DIGITS MODALI; Smith A., 1991, SYMBOL DIGIT MODALIT; Sohlberg M. M., 2002, MYCOLOGICAL RES, V106; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Swanberg MM, 2004, ARCH NEUROL-CHICAGO, V61, P556, DOI 10.1001/archneur.61.4.556; Tamayo F, 2012, NEUROLOGIA, V27, P319, DOI 10.1016/j.nrl.2011.12.020; Thow Megan E, 2018, Alzheimers Dement (Amst), V10, P22, DOI 10.1016/j.dadm.2017.08.004; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tramontana MG, 2014, BRAIN INJURY, V28, P1461, DOI 10.3109/02699052.2014.930179; Van Breukelen GJP, 2005, PSYCHOL ASSESSMENT, V17, P336, DOI 10.1037/1040-3590.17.3.336; Van der Elst W, 2006, J INT NEUROPSYCH SOC, V12, P80, DOI 10.1017/S1355617706060115; van der Elst W, 2006, J CLIN EXP NEUROPSYC, V28, P998, DOI 10.1080/13803390591004428; Vataja R, 2003, EUR J NEUROL, V10, P625, DOI 10.1046/j.1468-1331.2003.00676.x; Veloso A, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02983; Wagner S, 2011, ARCH CLIN NEUROPSYCH, V26, P314, DOI 10.1093/arclin/acr024; WALDMANN BW, 1992, J CLIN PSYCHOL, V48, P360, DOI 10.1002/1097-4679(199205)48:3<360::AID-JCLP2270480314>3.0.CO;2-P; West S. G., 1991, MULTIPLE REGRESSION; YEUDALL LT, 1986, J CLIN PSYCHOL, V42, P918, DOI 10.1002/1097-4679(198611)42:6<918::AID-JCLP2270420617>3.0.CO;2-Y; Zgaljardic DJ, 2006, J CLIN EXP NEUROPSYC, V28, P1127, DOI 10.1080/13803390500246910	104	1	1	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1382-5585	1744-4128		AGING NEUROPSYCHOL C	Aging Neuropsychol. Cogn.	MAY 4	2021	28	3					418	437		10.1080/13825585.2020.1781768		JUL 2020	20	Psychology, Developmental; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	QJ4GF	WOS:000547654800001	32654600	Green Accepted			2022-02-06	
J	Liu, BJ; Cao, Y; Shi, FX; Wang, L; Li, N; Cheng, XS; Du, J; Tian, Q; Zhou, XW				Liu, Bingjin; Cao, Yun; Shi, Fangxiao; Wang, Lin; Li, Na; Cheng, Xiangshu; Du, Jin; Tian, Qing; Zhou, Xinwen			The overexpression of RBM3 alleviates TBI-induced behaviour impairment and AD-like tauopathy in mice	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						cognitive deficits; hypothermia pre-treatment; RNA-binding motif protein 3; tau phosphorylation; traumatic brain injury	BINDING PROTEIN RBM3; TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; POSTTRAUMATIC HYPOTHERMIA; MECHANISMS; PLASTICITY; MODERATE; MODEL; NEURODEGENERATION; PHOSPHORYLATION	The therapeutic hypothermia is an effective tool for TBI-associated brain impairment, but its side effects limit in clinical routine use. Hypothermia up-regulates RNA-binding motif protein 3 (RBM3), which is verified to protect synaptic plasticity. Here, we found that cognitive and LTP deficits, loss of spines, AD-like tau pathologies are displayed one month after TBI in mice. In contrast, the deficits of LTP and cognitive, loss of spines and tau abnormal phosphorylation at several sites are obviously reversed in TBI mice combined with hypothermia pre-treatment (HT). But, the neuroprotective role of HT disappears in TBI mouse models under condition of blocking RBM3 expression with RBM3 shRNA. In other hand, overexpressing RBM3 by AAV-RBM3 plasmid can mimic HT-like neuroprotection against TBI-induced chronic brain injuries, such as improving LTP and cognitive, loss of spines and tau hyperphosphorylation in TBI mouse models. Taken together, hypothermia pre-treatment reverses TBI-induced chronic AD-like pathology and behaviour deficits in RBM3 expression dependent manner, RBM3 may be a potential target for neurodegeneration diseases including Alzheimer disease.	[Liu, Bingjin; Cao, Yun; Shi, Fangxiao; Wang, Lin; Li, Na; Tian, Qing; Zhou, Xinwen] Huazhong Univ Sci & Technol, Tongji Med Coll, Educ Minist, Key Lab Neurol Dis,Dept Pathophysiol, Wuhan, Peoples R China; [Liu, Bingjin] Taizhou Vocat & Tech Coll, Sch Med & Pharmaceut Engn, Taizhou, Peoples R China; [Cheng, Xiangshu; Du, Jin] Henan Univ, Huaihe Hosp, Ctr Translat Med, Dept Neurol, Kaifeng, Peoples R China		Tian, Q; Zhou, XW (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathophysiol, Wuhan, Peoples R China.	tianq@mail.hust.edu.cn; zhouxinwen@hust.edu.cn			National Nature Scientific Fund of China [81671262, 81601123, 81401062]	National Nature Scientific Fund of China, Grant/Award Number: 81671262, 81601123 and 81401062	Andresen M, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0121-3; Badshah H, 2014, NEUROCHEM INT, V74, P8, DOI 10.1016/j.neuint.2014.04.009; Bastide A, 2017, CURR BIOL, V27, P638, DOI 10.1016/j.cub.2017.01.047; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bregy A, 2012, EXP NEUROL, V233, P821, DOI 10.1016/j.expneurol.2011.12.008; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Cheng XS, 2013, J ALZHEIMERS DIS, V36, P185, DOI 10.3233/JAD-122173; Chevin M, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1258-6; Chip S, 2011, NEUROBIOL DIS, V43, P388, DOI 10.1016/j.nbd.2011.04.010; Choi HA, 2012, NAT REV NEUROL, V8, P214, DOI 10.1038/nrneurol.2012.21; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Danno S, 1997, BIOCHEM BIOPH RES CO, V236, P804, DOI 10.1006/bbrc.1997.7059; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Di Marco LY, 2014, J ALZHEIMERS DIS, V42, P119, DOI 10.3233/JAD-132225; Diaz-Gil A, 2020, DEMENTIA-LONDON, V19, P1889, DOI 10.1177/1471301218809225; Du LL, 2017, MOL NEUROBIOL, V54, P1992, DOI 10.1007/s12035-016-9758-9; Gately N, 2012, TRENDS ISS CRIME CRI, P1; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Koch G, 2016, J ALZHEIMERS DIS, V50, P605, DOI 10.3233/JAD-150813; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kreutz MR, 2012, SYNAPTIC PLASTICITY, P618; Lazorthes G, 1964, Clin Neurosurg, V12, P293; Li XH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.180; Liu BJ, 2017, BRAIN RES, V1672, P18, DOI 10.1016/j.brainres.2017.07.008; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Peretti D, 2015, NATURE, V518, P236, DOI 10.1038/nature14142; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Rosenthal LM, 2017, HYPOXIA, V5, P33, DOI 10.2147/HP.S132462; Severini C, 2015, SCI REP-UK, V5, DOI 10.1038/srep15301; SHULMAN K, 1959, AM J SURG, V98, P704, DOI 10.1016/0002-9610(59)90495-7; Smart F, 2007, J NEUROCHEM, V101, P1367, DOI 10.1111/j.1471-4159.2007.04521.x; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Soilemezi D, 2019, DEMENTIA-LONDON, V18, P1237, DOI 10.1177/1471301217692130; Tong G, 2013, BRAIN RES, V1504, P74, DOI 10.1016/j.brainres.2013.01.041; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang CF, 2016, SCI REP-UK, V6, DOI 10.1038/srep37063; Wellmann S, 2010, PEDIATR RES, V67, P35, DOI 10.1203/PDR.0b013e3181c13326; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Wu ZR, 2020, PROG NEUROBIOL, V185, DOI 10.1016/j.pneurobio.2019.101730; Yang HJ, 2019, J CELL MOL MED, V23, P7010, DOI 10.1111/jcmm.14588; Yenari MA, 2013, FRONT NEUROL NEUROSC, V32, P122, DOI 10.1159/000346428; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Zhang Z, 2015, NEUROSCIENCE, V300, P219, DOI 10.1016/j.neuroscience.2015.05.025; Zhu XZ, 2016, FASEB J, V30, P624, DOI 10.1096/fj.15-274639	49	1	1	4	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-1838	1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	AUG	2020	24	16					9176	9188		10.1111/jcmm.15555		JUL 2020	13	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	MX6GY	WOS:000549722900001	32648620	gold, Green Published			2022-02-06	
J	Morrow, EL; Dulas, MR; Cohen, NJ; Duff, MC				Morrow, Emily L.; Dulas, Michael R.; Cohen, Neal J.; Duff, Melissa C.			Relational Memory at Short and Long Delays in Individuals With Moderate-Severe Traumatic Brain Injury	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						traumatic brain injury; relational memory; hippocampus; rehabilitation; assessment	DECLARATIVE MEMORY; HIPPOCAMPUS; REPRESENTATIONS; IMPAIRMENTS; DYSFUNCTION; NAVIGATION; DEFICITS; AMNESIA; EVEN; AGE	Memory deficits are a common and frequently-cited consequence of moderate-severe traumatic brain injury (TBI). However, we know less about how TBI influences relational memory, which allows the binding of the arbitrary elements of experience and the flexible use and recombination of relational representations in novel situations. Relational memory is of special interest for individuals with TBI, given the vulnerability of the hippocampus to injury mechanisms, as well as a growing body of literature establishing the role of relational memory in flexible and goal-directed behavior. In this study, participants with and without a history of moderate-severe TBI completed a continuous relational memory task for face-scene pairings. Participants with TBI exhibited a disruption in relational memory not only when tested after a delay, but also when tested with no experimenter-imposed delay after stimulus presentation. Further, canonical assessments of working and episodic memory did not correspond with performance on the face-scene task, suggesting that this task may tap into relational memory differently and with greater sensitivity than standardized memory assessments. These results highlight the need for rigorous assessment of relational memory in TBI, which is likely to detect deficits that have specific consequences for community reintegration and long-term functional outcomes.	[Morrow, Emily L.; Duff, Melissa C.] Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37232 USA; [Dulas, Michael R.; Cohen, Neal J.] Univ Illinois, Beckman Inst, Urbana, IL USA; [Cohen, Neal J.] Univ Illinois, Interdisciplinary Hlth Sci Inst, Urbana, IL USA		Morrow, EL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37232 USA.	emily.l.morrow@vanderbilt.edu		Morrow, Emily/0000-0003-4629-2283	National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS110661]	This work was supported by National Institute of Neurological Disorders and Stroke (NINDS) grant R01 NS110661 to MCD and NC.	Aly M., 2017, HIPPOCAMPUS CELLS SY, P369, DOI DOI 10.1007/978-3-319-50406-3_12; Aly M, 2013, NEURON, V78, P1127, DOI 10.1016/j.neuron.2013.04.018; Atkins CM, 2011, TRANSL STROKE RES, V2, P546, DOI 10.1007/s12975-011-0123-z; BADDELEY AD, 1970, J VERB LEARN VERB BE, V9, P176, DOI 10.1016/S0022-5371(70)80048-2; Barense MD, 2007, NEUROPSYCHOLOGIA, V45, P2963, DOI 10.1016/j.neuropsychologia.2007.05.023; Beadle JN, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00069; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Clark R, 2017, HIPPOCAMPUS, V27, P716, DOI 10.1002/hipo.22727; Cohen, 2001, CONDITIONING CONSCIO; Cohen NJ., 1993, MEMORY AMNESIA HIPPO; Davidson PSR, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00531; Duff MC, 2020, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00471; Duff MC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00069; Eichenbaum H, 2014, NEURON, V83, P764, DOI 10.1016/j.neuron.2014.07.032; Gauthier S, 2018, J COMMUN DISORD, V73, P77, DOI 10.1016/j.jcomdis.2018.04.003; Gormley M, 2019, BRAIN INJURY, V33, P1567, DOI 10.1080/02699052.2019.1658222; Gupta R, 2009, NEUROPSYCHOLOGIA, V47, P1686, DOI 10.1016/j.neuropsychologia.2009.02.007; Hannula DE, 2006, J NEUROSCI, V26, P8352, DOI 10.1523/JNEUROSCI.5222-05.2006; Hannula DE, 2009, NEURON, V63, P592, DOI 10.1016/j.neuron.2009.08.025; Heaton RK, 2014, J INT NEUROPSYCH SOC, V20, P588, DOI 10.1017/S1355617714000241; Horecka KM, 2018, HIPPOCAMPUS, V28, P164, DOI 10.1002/hipo.22819; Incoccia C, 2004, CORTEX, V40, P111, DOI 10.1016/S0010-9452(08)70924-9; Irimia A, 2015, NEUROPSYCH DIS TREAT, V11, DOI 10.2147/NDT.S79174; Konkel A, 2009, FRONT NEUROSCI-SWITZ, V3, P166, DOI 10.3389/neuro.01.023.2009; Lee ACH, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00091; Maguire EA, 2006, BRAIN, V129, P2894, DOI 10.1093/brain/awl286; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McAndrews MP, 2020, CURR OPIN BEHAV SCI, V32, P94, DOI 10.1016/j.cobeha.2020.01.011; Mitchell KJ, 2000, COGNITIVE BRAIN RES, V10, P197, DOI 10.1016/S0926-6410(00)00029-X; Monti JM, 2015, J COGNITIVE NEUROSCI, V27, P234, DOI 10.1162/jocn_a_00717; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Morrow E, 2019, BRAIN INJURY, V33, P110; Murray Laura L., 2001, Seminars in Speech and Language, V22, P127; National Institutes of Health, 2016, NIH TOOLB SCOR INT G; Olson IR, 2006, J NEUROSCI, V26, P4596, DOI 10.1523/JNEUROSCI.1923-05.2006; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ranganath C, 2001, NEURON, V31, P865, DOI 10.1016/S0896-6273(01)00411-1; Rigon A, 2020, J CLIN EXP NEUROPSYC, V42, P14, DOI 10.1080/13803395.2019.1659755; Rubin RD, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070082; Rubin RD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00742; Salmond CH, 2006, NEUROPSYCHOLOGIA, V44, P1995, DOI 10.1016/j.neuropsychologia.2006.03.013; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Skidmore Elizabeth R, 2015, Curr Phys Med Rehabil Rep, V3, P99; Spreng RN, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00437; SQUIRE LR, 1992, J COGNITIVE NEUROSCI, V4, P232, DOI 10.1162/jocn.1992.4.3.232; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Voss JL, 2011, P NATL ACAD SCI USA, V108, pE402, DOI 10.1073/pnas.1100225108; Voss JL, 2011, NAT NEUROSCI, V14, P115, DOI 10.1038/nn.2693; Warren DE, 2010, FRONT HUM NEUROSCI, V4; Wilson BA, 1998, CURR OPIN NEUROBIOL, V8, P281, DOI 10.1016/S0959-4388(98)80152-9; Yee LTS, 2014, HIPPOCAMPUS, V24, P154, DOI 10.1002/hipo.22211; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	58	1	1	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	JUL 10	2020	14								270	10.3389/fnhum.2020.00270			12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	MU7AP	WOS:000555822500001	32754022	Green Published, gold			2022-02-06	
J	Moysenovich, AM; Tatarskiy, VV; Yastrebova, MA; Bessonov, IV; Arkhipova, AY; Kolosov, AS; Davydova, LI; Khamidullina, AI; Bogush, VG; Debabov, VG; Shaitan, KV; Shtil, AA; Moisenovich, MM				Moysenovich, Anastasia M.; Tatarskiy, Viktor V.; Yastrebova, Margarita A.; Bessonov, Ivan, V; Arkhipova, Anastasia Yu; Kolosov, Andrey S.; Davydova, Lyubov, I; Khamidullina, Alvina, I; Bogush, Vladimir G.; Debabov, Vladimir G.; Shaitan, Konstantin, V; Shtil, Alexander A.; Moisenovich, Mikhail M.			Akt and Src mediate the photocrosslinked fibroin-induced neural differentiation.	NEUROREPORT			English	Article						Akt protein kinase; cell adhesion; neural differentiation; photocrosslinking; SH-SY5Y cell line; silk fibroin; Src protein kinase; tissue engineering	MATRIX STIFFNESS; STEM-CELLS; GROWTH; ADHESION; MODULATION; SH-SY5Y	Neural transplantation is a promising modality for treatment of neurodegenerative diseases, traumatic brain injury and stroke. Biocompatible scaffolds with optimized properties improve the survival of transplanted neural cells and differentiation of progenitor cells into the desired types of neurons. Silk fibroin is a biocompatible material for tissue engineering. Here, we describe thin-film scaffolds based on photocrosslinked methacrylated silk fibroin (FBMA). These scaffolds exhibit an increased mechanical stiffness and improved water stability. Photocrosslinking of fibroin increased its rigidity from 25 to 480 kPa and the contact angle from 59.7(o)to 70.8(o), the properties important for differentiation of neural cells. Differentiation of SH-SY5Y neuroblastoma cells on FBMA increased the length of neurites as well as the levels of neural differentiation markers MAP2 and beta III-tubulin. Growth of SH-SY5Y cells on the unmodified fibroin and FBMA substrates led to a spontaneous phosphorylation of Src and Akt protein kinases critical for neuronal differentiation; this effect was paralleled by neural cell adhesion molecule elevation. Thus, FBMA is an easily manufactured, cytocompatible material with improved and sustainable properties applicable for neural tissue engineering.	[Moysenovich, Anastasia M.; Bessonov, Ivan, V; Arkhipova, Anastasia Yu; Kolosov, Andrey S.; Shaitan, Konstantin, V; Moisenovich, Mikhail M.] Lomonosov Moscow State Univ, Biol Fac, Moscow, Russia; [Tatarskiy, Viktor V.; Shtil, Alexander A.] Blokhin Natl Med Ctr Oncol, Lab Tumor Cell Death, Moscow, Russia; [Tatarskiy, Viktor V.] Natl Univ Sci & Techno MISiS Moscow, Moscow, Russia; [Tatarskiy, Viktor V.; Yastrebova, Margarita A.; Khamidullina, Alvina, I; Shtil, Alexander A.] Russian Acad Sci, Inst Gene Biol, Lab Mol Oncobiol, Moscow, Russia; [Bessonov, Ivan, V] JSC Efferon, Moscow, Russia; [Arkhipova, Anastasia Yu] Moscow Reg Res & Clin Inst MONIKI, Moscow, Russia; [Davydova, Lyubov, I; Bogush, Vladimir G.; Debabov, Vladimir G.] NRC Kurchatov Inst GOSNIIGENETIKA, Moscow, Russia		Moisenovich, MM (corresponding author), Lomonosov Moscow State Univ, Biol Fac, Moscow, Russia.	mmoisenovich@mail.ru	Arkhipova, Anastasiya Yur'evna/D-9432-2014; Yastrebova, Margarita/K-5786-2017; Khamidullina, Alvina/AAP-4230-2021; Moisenovich, Anastasia/P-6042-2017; Tatarskiy, Victor V/K-1224-2017	Arkhipova, Anastasiya Yur'evna/0000-0001-6940-0406; Khamidullina, Alvina/0000-0001-8137-0625; Tatarskiy, Victor V/0000-0002-9080-5683	Russian Foundation for Basic Research projectRussian Foundation for Basic Research (RFBR) [17-00-00359, 17-00-0356, 17-00-0357, 17-00-0358]; Ministry of Science and Higher Education of the Russian Federation [P02-2017-2-1]	We thank Ms. Ksenia A. Demina for experimental assistance. This study was funded by the Russian Foundation for Basic Research project No17-00-00359 (No 17-00-0356 (to L.I.D., V.G.B. and V.G.D.), No 17-00-0357 (to V.V.T. and A.A.S.), No 17-00-0358 (I.V.B.,A.Y.A. and M.M.M.) and by the Ministry of Science and Higher Education of the Russian Federation in the framework of Increase Competitiveness Program of MISiS (#P02-2017-2-1 to V.V.T.).	An B, 2017, PHYSIOL BEHAV, V176, P139; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004; Bessonov N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224787; Bonartsev AP, 2018, 3 BIOTECH, V8, DOI 10.1007/s13205-018-1350-8; Carre A, 2010, J ADHES SCI TECHNOL, V24, P815, DOI 10.1163/016942409X12598231567862; Forster JI, 2016, J BIOMOL SCREEN, V21, P496, DOI 10.1177/1087057115625190; Francis KR, 2015, NEUROCHEM RES, V40, P674, DOI 10.1007/s11064-015-1514-4; Hagbard L, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0230; Jin EJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20755-w; Koch D, 2012, BIOPHYS J, V102, P452, DOI 10.1016/j.bpj.2011.12.025; Lam WA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-35; Lopez-Carballo G, 2002, J BIOL CHEM, V277, P25297, DOI 10.1074/jbc.M201869200; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Sun MY, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0798-0; Tan JY, 2013, MOL MED REP, V7, P292, DOI 10.3892/mmr.2012.1127; Tang-Schomer MD, 2014, ADV FUNCT MATER, V24, P1938, DOI 10.1002/adfm.201303196; Vaitkuviene A, 2015, NEW BIOTECHNOL, V32, P7, DOI 10.1016/j.nbt.2014.06.008; Volodina YL, 2019, EUR J MED CHEM, V165, P31, DOI 10.1016/j.ejmech.2018.12.068; Wu CY, 2016, MOL CELL BIOL, V36, P1555, DOI 10.1128/MCB.00004-16; Xu YQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147184; Yeh YC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14932-6	22	1	1	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	JUL 10	2020	31	10					770	775		10.1097/WNR.0000000000001482			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MG3EU	WOS:000545918200012	32467514	hybrid, Green Published			2022-02-06	
J	Daugherty, JC; Perez-Garcia, M; Hidalgo-Ruzzante, N; Bueso-Izquierdo, N				Daugherty, Julia C.; Perez-Garcia, Miguel; Hidalgo-Ruzzante, Natalia; Bueso-Izquierdo, Natalia			Perceived Executive Functioning among Female Survivors of Intimate Partner Violence	JOURNAL OF AGGRESSION MALTREATMENT & TRAUMA			English	Article						Intimate Partner Violence; mental Health; assessment; Evaluation; perceived Cognition; Neuro-QOL-EF; females; adult Survivor; trauma	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; GENERALIZED ANXIETY DISORDER; SEX-DIFFERENCES; NEUROPSYCHOLOGICAL FUNCTION; MULTIPLE-SCLEROSIS; HEALTH; WOMEN; DEPRESSION; SYMPTOMS	Current literature demonstrates that female survivors of intimate partner violence (IPV) suffer cognitive impairment. Nonetheless, less is known about how women perceive their cognitive functioning and related factors. The main objective was to assess to what degree abuse severity and mental health are related to perceived cognitive functioning in women who have been exposed to IPV. A group of female IPV survivors (n = 82) were assessed with the Quality of Life Outcomes in Neurological Disorders (Neuro-QOL-EF), Composite Abuse Scale Revised (CASR-SF), the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5), Patient Health Questionnaire-9 (PHQ-9), and the Generalized Anxiety Disorder Scale (GAD-7). Findings revealed self-reported impairment in concentration, information processing, and attention. Associations were found between self-reported executive function (EF) and posttraumatic stress, abuse severity, and depression. Further, a model including abuse severity and posttraumatic stress explained up to 20.8% of the variance in perceived EF. Findings indicate that female survivors report a high prevalence of difficulties in the domain of EF. Self-reported impairment in EF may be indicative of higher levels of posttraumatic stress (PTSD) and depression, meriting further assessment and possibly treatment. This study opens the way for the potential use of perceived cognitive functioning screening tools with female survivors.	[Daugherty, Julia C.; Perez-Garcia, Miguel; Hidalgo-Ruzzante, Natalia] Univ Granada, Dept Personal Assessment & Psychol Treatment, Granada, Spain; [Bueso-Izquierdo, Natalia] Univ Extremadura, Dept Psychol & Anthropol, Badajoz, Spain		Hidalgo-Ruzzante, N (corresponding author), Univ Granada UGR, Sch Educ, Dept Dev & Educ Psychol, Granada 18011, Spain.	nhidalgo@ugr.es	Daugherty, Julia C./Q-8716-2017; Garcia, Miguel Perez/F-9630-2010	Daugherty, Julia C./0000-0002-1221-4394; Garcia, Miguel Perez/0000-0003-4775-7556; Bueso Izquierdo, Natalia/0000-0002-2469-8867	I+D+I Operative Program FEDER grant of the Andalusian Government in 2018 [B-CTS-493-UGR18]; Ministry of Education and Professional Training in Spain; postdoctoral Puente contract at the University of Granada (Spain)	The study was supported by the I+D+I Operative Program FEDER grant of the Andalusian Government in 2018 (B-CTS-493-UGR18). Julia C. Daugherty was funded by a predoctoral fellowship of the Ministry of Education and Professional Training in Spain as well as the postdoctoral Puente contract at the University of Granada (Spain).	Akbar N, 2011, COGN BEHAV NEUROL, V24, P115, DOI 10.1097/WNN.0b013e31822a20ae; Aupperle RL, 2012, ARCH GEN PSYCHIAT, V69, P360, DOI 10.1001/archgenpsychiatry.2011.1539; Baxter K, 2019, J AGGRESS MALTREAT T, V28, P660, DOI 10.1080/10926771.2019.1602089; Beier M, 2015, REHABIL PSYCHOL, V60, P254, DOI 10.1037/rep0000045; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Cimino AN, 2019, J AGGRESS MALTREAT T, V28, P714, DOI 10.1080/10926771.2019.1587657; Coker AL, 2005, J WOMENS HEALTH, V14, P829, DOI 10.1089/jwh.2005.14.829; Correia H, 2015, QUAL LIFE RES, V24, P753, DOI 10.1007/s11136-014-0786-5; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Daugherty JC, 2019, J FORENSIC PSYCHI PS, V30, P322, DOI 10.1080/14789949.2018.1546886; De Bellis MD, 2003, NEUROSCI BIOBEHAV R, V27, P103, DOI 10.1016/S0149-7634(03)00013-7; Dillon Gina, 2013, Int J Family Med, V2013, P313909, DOI 10.1155/2013/313909; Do Khanh Ngoc, 2013, Int Perspect Psychol, V2, DOI 10.1037/ipp0000004; Eisenstat SA, 1999, NEW ENGL J MED, V341, P886, DOI 10.1056/NEJM199909163411206; Ford-Gilboe M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012824; Garcia-Campayo J, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-8; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Haag H, 2019, J WOMENS HEALTH, V28, P990, DOI 10.1089/jwh.2018.7299; Hebenstreit CL, 2014, J AGGRESS MALTREAT T, V23, P168, DOI 10.1080/10926771.2014.872749; Hegarty K., 2012, COMPOSITE ABUSE SCAL, DOI [10.1037/t04578-000, DOI 10.1037/T04578-000]; Jackson H., 2002, PROFESSIONAL PSYCHOL, V33, P1; Jobson L, 2008, BRIT J CLIN PSYCHOL, V47, P95, DOI 10.1348/014466507X235953; Kasper CE, 2015, ANNU REV NURS RES-SE, V33, P13, DOI 10.1891/0739-6686.33.13; Kennedy C M, 2001, CNS Spectr, V6, P787; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kozlowski AJ, 2015, ARCH PHYS MED REHAB, V96, P1986, DOI 10.1016/j.apmr.2015.07.005; Krause ED, 2007, PSYCHOL ASSESSMENT, V19, P165, DOI 10.1037/1040-3590.19.2.165; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lai JS, 2017, CLIN RHEUMATOL, V36, P555, DOI 10.1007/s10067-016-3476-6; Lee MS, 2017, J COMMUNITY PSYCHOL, V45, P704, DOI 10.1002/jcop.21887; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Loxton D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178138; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Murrough JW, 2011, NEUROBIOL LEARN MEM, V96, P553, DOI 10.1016/j.nlm.2011.06.006; National Institute of Neurological Disorders and Stroke (NINDS), 2015, US MAN QUAL LIF NEUR; Nemeth JM, 2019, J AGGRESS MALTREAT T, V28, P744, DOI 10.1080/10926771.2019.1591562; Nowinski CJ, 2016, MOVEMENT DISORD, V31, P725, DOI 10.1002/mds.26546; Nowinski Cindy J, 2010, Therapy, V7, P533, DOI 10.2217/thy.10.55; Seedat S, 2005, PSYCHIAT RES-NEUROIM, V139, P249, DOI 10.1016/j.pscychresns.2005.06.001; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Straight ES, 2003, J INTERPERS VIOLENCE, V18, P1035, DOI 10.1177/0886260503254512; Turkel A., 2010, FAM INTIMATE PARTNER, V2, P339; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Valera EM, 2018, J WOMENS HEALTH, V27, P735, DOI 10.1089/jwh.2017.6838; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Wong J, 2014, CONTEMP NURSE, V46, P170, DOI 10.5172/conu.2014.46.2.170; Wu V, 2010, TRAUMA VIOLENCE ABUS, V11, P71, DOI 10.1177/1524838010367503; Yorkston KM, 2014, J COMMUN DISORD, V52, P196, DOI 10.1016/j.jcomdis.2014.05.005	54	1	1	3	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1092-6771	1545-083X		J AGGRESS MALTREAT T	J. Aggress. Maltreatment Trauma	JAN 2	2021	30	1					25	42		10.1080/10926771.2020.1783734		JUL 2020	18	Psychology, Clinical; Criminology & Penology; Family Studies; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Criminology & Penology; Family Studies; Psychiatry	QI2AJ	WOS:000556111400001					2022-02-06	
J	Grace, KT; Perrin, NA; Clough, A; Miller, E; Glass, NE				Grace, Karen Trister; Perrin, Nancy A.; Clough, Amber; Miller, Elizabeth; Glass, Nancy E.			Correlates of reproductive coercion among college women in abusive relationships: baseline data from the college safety study	JOURNAL OF AMERICAN COLLEGE HEALTH			English	Article; Early Access						Depression; intimate partner violence; reproductive coercion; sexual violence; traumatic brain injury	INTIMATE PARTNER VIOLENCE; HEALTH-CARE; DEPRESSION; PREGNANCY; PREVALENCE; RISK; INTERVENTION; OUTCOMES; CLIENTS; STRESS	Objective The purpose of this study was to examine correlates of reproductive coercion (RC) among a sample of college women in abusive relationships.Participants:354 college students reporting a recent history of intimate partner violence (IPV).Methods:This study examines baseline data from a randomized controlled trial testing effectiveness of an interactive safety decision aid (myPlan).Results:Almost a quarter (24.3%) of the sample reported RC. Associated factors included races other than White (p = 0.019), relationship instability (p = 0.022), missing class due to relationship problems (p = 0.001), IPV severity (p < 0.001), technology abuse (p < 0.001), traumatic brain injury-associated events (p < 0.001), and depression (p = 0.024).Conclusions:RC was a significant predictor of depression, with implications for providers working with abused college women regarding the need for mental health services concurrent with IPV/RC services. A larger proportion of women who experienced RC sought help from a healthcare provider for contraception, which suggests intervention opportunities for college health providers.	[Grace, Karen Trister; Perrin, Nancy A.; Clough, Amber; Glass, Nancy E.] Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA; [Miller, Elizabeth] Univ Pittsburgh, Sch Med, UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA USA		Grace, KT (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	Kgrace2@jhu.edu	Grace, Karen Trister/K-9287-2019	Grace, Karen Trister/0000-0001-6899-6535; Miller, Elizabeth/0000-0002-7266-7766; Glass, Nancy/0000-0002-6691-3684	Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R01HD076881]	This work was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development under the award number 1R01HD076881.	Aarstad-Martin S, 2017, J LOSS TRAUMA, V22, P599, DOI 10.1080/15325024.2017.1360590; Abebe KZ, 2018, CONTEMP CLIN TRIALS, V65, P130, DOI 10.1016/j.cct.2017.12.008; Ahmadabadi Z, 2019, ADDICTION, V114, P1264, DOI 10.1111/add.14592; Anderson JC, 2017, AIDS, V31, P2261, DOI [10.1097/QAD.0000000000001620, 10.1097/qad.0000000000001620]; [Anonymous], 2013, OBSTET GYNECOL, V121, P411, DOI DOI 10.1097/01.AOG.0000426427.79586.3b; Bachman J.G., 2011, MONITORING FUTURE PR; Beiter R, 2015, J AFFECT DISORDERS, V173, P90, DOI 10.1016/j.jad.2014.10.054; Bergmann JN, 2015, CONTRACEPTION, V91, P438, DOI 10.1016/j.contraception.2015.02.009; Black M C., 2011, NATL INTIMATE PARTNE; Brandy JM, 2015, J PSYCHOSOC NURS MEN, V53, P38, DOI 10.3928/02793695-20150126-03; Center for Impact Research, 2000, DOM VIOL BIRTH CONTR; Centers for Disease Control & Prevention, 2018, ALC PUBL HLTH FREQ A; Chamberlain L., 2012, ADDRESSING INTIMATE; Chang JC, 2005, PATIENT EDUC COUNS, V59, P141, DOI 10.1016/j.pec.2004.10.008; Chuang Cynthia H, 2012, Ment Health Fam Med, V9, P107; Clark LE, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.019; Fasula AM, 2018, CHILD YOUTH SERV REV, V88, P74, DOI 10.1016/j.childyouth.2018.02.041; Gee RE, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.048; Gehring KS, 2017, J INTERPERS VIOLENCE, V32, P3669, DOI 10.1177/0886260515600877; Glass N, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2191-6; Glauber A, 2007, TECH ABUSE TEEN RELA; Grace KT, 2018, TRAUMA VIOLENCE ABUS, V19, P371, DOI 10.1177/1524838016663935; Hegarty K, 1999, J FAM VIOLENCE, V14, P399, DOI 10.1023/A:1022834215681; Hegarty Kelsey, 2005, Violence Vict, V20, P529, DOI 10.1891/vivi.2005.20.5.529; Holliday CN, 2018, WOMEN HEALTH ISS, V28, P205, DOI 10.1016/j.whi.2018.02.003; Holliday CN, 2017, J WOMENS HEALTH, V26, P828, DOI 10.1089/jwh.2016.5996; IBM Corp, 2017, IBM SPSS STAT MAC VE; Ibrahim AK, 2013, J PSYCHIATR RES, V47, P391, DOI 10.1016/j.jpsychires.2012.11.015; Johnston L.D., 2016, MONITORING FUTURE NA; Jones KA, 2016, PERSPECT SEX REPRO H, V48, P57, DOI 10.1363/48e8616; Kastello JC, 2016, COMMUNITY MENT HLT J, V52, P683, DOI 10.1007/s10597-015-9977-y; Katz J, 2020, J INTERPERS VIOLENCE, V35, P4350, DOI 10.1177/0886260517715600; Katz J, 2017, J INTERPERS VIOLENCE, V32, P3301, DOI 10.1177/0886260515597441; Kazmerski T, 2015, MATERN CHILD HLTH J, V19, P1490, DOI 10.1007/s10995-014-1653-2; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Levesque S, 2016, CAN J HUM SEX, V25, P9, DOI 10.3138/cjhs.251-A5; Maruish M., 2004, USE PSYCHOL TESTING, P363, DOI DOI 10.1111/J.1083-6101.2007.00367.X; Mason R, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24815; McCauley HL, 2017, CONTRACEPTION, V95, P292, DOI 10.1016/j.contraception.2016.09.010; McKee SA, 2019, TRAUMA VIOLENCE ABUS, V20, P303, DOI 10.1177/1524838017708782; Miller E, 2015, J WOMENS HEALTH, V24, P92, DOI 10.1089/jwh.2014.4870; Miller E, 2014, CONTRACEPTION, V89, P122, DOI 10.1016/j.contraception.2013.10.011; Miller E, 2010, CONTRACEPTION, V81, P316, DOI 10.1016/j.contraception.2009.12.004; Muise A, 2009, CYBERPSYCHOL BEHAV, V12, P441, DOI 10.1089/cpb.2008.0263; Northridge JL, 2017, J PEDIATR ADOL GYNEC, V30, P603, DOI 10.1016/j.jpag.2017.06.007; Paterno MT, 2021, J INTERPERS VIOLENCE, V36, pNP2248, DOI 10.1177/0886260518756116; Phillips SJ, 2016, FAM PRACT, V33, P286, DOI 10.1093/fampra/cmw020; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Riolo SA, 2005, AM J PUBLIC HEALTH, V95, P998, DOI 10.2105/AJPH.2004.047225; Rosenbaum JE, 2016, J URBAN HEALTH, V93, P493, DOI 10.1007/s11524-016-0047-8; Rosenfeld Elian A, 2018, Am J Obstet Gynecol, V218, DOI 10.1016/j.ajog.2017.10.015; Schrag RJV, 2018, J AM COLL HEALTH, V66, P702, DOI 10.1080/07448481.2018.1456443; Silverman JG, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001723; Sutherland MA, 2018, APPL NURS RES, V39, P217, DOI 10.1016/j.apnr.2017.11.031; Sutherland MA, 2015, JOGNN-J OBST GYN NEO, V44, P218, DOI 10.1111/1552-6909.12550; Swan LET, 2021, J INTERPERS VIOLENCE, V36, P11281, DOI 10.1177/0886260519898424; Tancredi DJ, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0216-z; Tokunaga RS, 2011, COMPUT HUM BEHAV, V27, P705, DOI 10.1016/j.chb.2010.08.014; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734	59	1	1	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0744-8481	1940-3208		J AM COLL HEALTH	J. Am. Coll. Health												10.1080/07448481.2020.1790570		JUL 2020	8	Education & Educational Research; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Education & Educational Research; Public, Environmental & Occupational Health	MK8TO	WOS:000549054400001	32672505	Green Accepted			2022-02-06	
J	Khalifa, M; Magrabi, F; Luxan, BG				Khalifa, Mohamed; Magrabi, Farah; Luxan, Blanca Gallego			Evaluating the Impact of the Grading and Assessment of Predictive Tools Framework on Clinicians and Health Care Professionals' Decisions in Selecting Clinical Predictive Tools: Randomized Controlled Trial	JOURNAL OF MEDICAL INTERNET RESEARCH			English	Article						clinical prediction rule; clinical decision rules; evidence-based medicine; evaluation study	CT HEAD RULE; NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; EXTERNAL VALIDATION; SUPPORT-SYSTEMS; INJURY; GUIDELINES; SATISFACTION; PERFORMANCE; EFFICIENCY	Background: While selecting predictive tools for implementation in clinical practice or for recommendation in clinical guidelines, clinicians and health care professionals are challenged with an overwhelming number of tools. Many of these tools have never been implemented or evaluated for comparative effectiveness. To overcome this challenge, the authors developed and validated an evidence-based framework for grading and assessment of predictive tools (the GRASP framework). This framework was based on the critical appraisal of the published evidence on such tools. Objective: The aim of the study was to examine the impact of using the GRASP framework on clinicians' and health care professionals' decisions in selecting clinical predictive tools. Methods: A controlled experiment was conducted through a web-based survey. Participants were randomized to either review the derivation publications, such as studies describing the development of the predictive tools, on common traumatic brain injury predictive tools (control group) or to review an evidence-based summary, where each tool had been graded and assessed using the GRASP framework (intervention group). Participants in both groups were asked to select the best tool based on the greatest validation or implementation. A wide group of international clinicians and health care professionals were invited to participate in the survey. Task completion time, rate of correct decisions, rate of objective versus subjective decisions, and level of decisional conflict were measured. Results: We received a total of 194 valid responses. In comparison with not using GRASP, using the framework significantly increased correct decisions by 64%, from 53.7% to 88.1% (88.1/53.7=1.64; t(193)=8.53; P<.001); increased objective decision making by 32%, from 62% (3.11/5) to 82% (4.10/5; t(189)=9.24; P<.001); decreased subjective decision making based on guessing by 20%, from 49% (2.48/5) to 39% (1.98/5; t(188)=-5.47; P<.001); and decreased prior knowledge or experience by 8%, from 71% (3.55/5) to 65% (3.27/5; t(187)-2.99; P=.003). Using GRASP significantly decreased decisional conflict and increased the confidence and satisfaction of participants with their decisions by 11%, from 71% (3.55/5) to 79% (3.96/5; t(188)=4.27; P<.001), and by 13%, from 70% (3.54/5) to 79% (3.99/5; t(188)=4.89; P<.001), respectively. Using GRASP decreased the task completion time, on the 90th percentile, by 52%, from 12.4 to 6.4 min (t(193)=-0.87; P=.38). The average System Usability Scale of the GRASP framework was very good: 72.5% and 88% (108/122) of the participants found the GRASP useful. Conclusions: Using GRASP has positively supported and significantly improved evidence-based decision making It has increased the accuracy and efficiency of selecting predictive tools. GRASP is not meant to be prescriptive; it represents a high-level approach and an effective, evidence-based, and comprehensive yet simple and feasible method to evaluate, compare, and select clinical predictive tools.	[Khalifa, Mohamed; Magrabi, Farah] Macquarie Univ, Australian Inst Hlth Innovat, Ctr Hlth Informat, Fac Med & Hlth Sci, 75 Talavera Rd, Sydney, NSW 2113, Australia; [Luxan, Blanca Gallego] Univ New South Wales, Ctr Big Data Res Hlth, Fac Med, Sydney, NSW, Australia		Khalifa, M (corresponding author), Macquarie Univ, Australian Inst Hlth Innovat, Ctr Hlth Informat, Fac Med & Hlth Sci, 75 Talavera Rd, Sydney, NSW 2113, Australia.	mohamed.khalifa@mq.edu.au		Magrabi, Farah/0000-0002-8426-5588; Khalifa, Mohamed/0000-0002-5919-8352	Human Research Ethics Committee, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia [5201834324569, 3432]	This work was financially supported by the Commonwealth Government Funded Research Training Program, Australia, to help the authors carry out the study. The funding body played no role in the design of the study and collection, analysis, or interpretation of the data or in writing the manuscript. This study was approved by the Human Research Ethics Committee, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia, on October 4, 2018. Reference no: 5201834324569. Project ID: 3432.	Adams ST, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8312; Albert W., 2013, MEASURING USER EXPER; Alonso-Coello P, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2016; Ansari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049864; Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Atabaki Shireen M, 2017, Pediatr Qual Saf, V2, pe019, DOI 10.1097/pq9.0000000000000019; Bangor A, 2009, J USABILITY STUD, V4, P114; Barends E., 2018, EVIDENCE BASED MANAG; Barnhoorn JS, 2015, BEHAV RES METHODS, V47, P918, DOI 10.3758/s13428-014-0530-7; Bate L, 2012, BRIT J CLIN PHARMACO, V74, P614, DOI 10.1111/j.1365-2125.2012.04366.x; Bazeley P., 2013, QUALITATIVE DATA ANA; Beattie P, 2006, AUST J PHYSIOTHER, V52, P157, DOI 10.1016/S0004-9514(06)70024-1; Bezemer T, 2019, J MED INTERNET RES, V21, DOI 10.2196/11732; Bezuidenhout A Fourie, 2013, S Afr Med J, V103, P646, DOI 10.7196/samj.6876; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Brooke J., 1996, USABILITY EVALUATION, P189, DOI DOI 10.1002/HBM.20701; Brooke J, 2013, J USABILITY STUD, V8, P29; Brownson RC, 2009, ANNU REV PUBL HEALTH, V30, P175, DOI 10.1146/annurev.publhealth.031308.100134; Carli D, 2018, JMIR MED INF, V6, DOI 10.2196/medinform.7170; Castaneda Christian, 2015, J Clin Bioinforma, V5, P4, DOI 10.1186/s13336-015-0019-3; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Clinician, 2019, DICT MERRIAM WEBSTER; Cohen J., 2013, STAT POWER ANAL BEHA, DOI [10.4324/9780203771587, DOI 10.4324/9780203771587]; Del Fiol G, 2008, J AM MED INFORM ASSN, V15, P752, DOI 10.1197/jamia.M2725; DeLone WH, 2003, J MANAGE INFORM SYST, V19, P9, DOI 10.1080/07421222.2003.11045748; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Ebell MH, 2001, EVIDENCE BASED DIAGN, V1; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Frokjaer E., 2000, CHI 2000 Conference Proceedings. Conference on Human Factors in Computing Systems. CHI 2000. The Future is Here, P345; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Harrati N, 2016, COMPUT HUM BEHAV, V61, P463, DOI 10.1016/j.chb.2016.03.051; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Head BW, 2016, PUBLIC ADMIN REV, V76, P472, DOI 10.1111/puar.12475; Hunink MGM, 2014, DECISION MAKING IN HEALTH AND MEDICINE: INTEGRATING EVIDENCE AND VALUES, 2ND EDITION, P1, DOI 10.1017/CBO9781139506779; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Kappen Teus H, 2018, Diagn Progn Res, V2, P11, DOI 10.1186/s41512-018-0033-6; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Khajouei R, 2011, INT J MED INFORM, V80, P297, DOI 10.1016/j.ijmedinf.2011.02.009; Khalifa M, 2019, VALIDATING UPDATING, DOI [10.21203/rs.3.rs-15929/v1, DOI 10.21203/RS.3.RS-15929/V1]; Khalifa M, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0940-7; Khalifa M, 2019, BMC EMERG MED, V19, DOI 10.1186/s12873-019-0249-y; Kish MA, 2001, CLIN INFECT DIS, V32, P851, DOI 10.1086/319366; Kortum PT, 2013, INT J HUM-COMPUT INT, V29, P67, DOI 10.1080/10447318.2012.681221; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Legat L, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.8206; Maguire JL, 2011, PEDIATRICS, V128, pE666, DOI 10.1542/peds.2011-0043; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; McAlpine K, 2018, JCO CLIN CANCER INFO, V2, DOI 10.1200/CCI.17.00148; McCaughey D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-39; McLellan S, 2012, J USABILITY STUD, V7, P56; Mickan S, 2013, J MED INTERNET RES, V15, P111, DOI 10.2196/jmir.2530; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Moher D, 2012, INT J SURG, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Monteiro L, 2019, J MED INTERNET RES, V21, DOI 10.2196/15385; Musen MA, 2014, BIOMEDICAL INFORM, P643, DOI [10.1007/978-1-4471-4474-8_22, DOI 10.1007/978-1-4471-4474-8_22]; O'Connor A., 2010, USER MANUAL DECISION; Oman KS, 2010, EVIDENCE BASED PRACT; Orfanou K, 2015, INT REV RES OPEN DIS, V16, P227; Osheroff J.A., 2012, IMPROVING OUTCOMES C; Osheroff JA, 2007, J AM MED INFORM ASSN, V14, P141, DOI 10.1197/jamia.M2334; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Qualtrics XM, 2018, QUALTRICS XM LEADING; Raine R, 2005, BMJ-BRIT MED J, V331, P631, DOI 10.1136/bmj.331.7517.631; Schardt C, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-16; Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32; Shekelle PG, 1999, WESTERN J MED, V170, P348; Shortliffe EH, 2013, BIOMEDICAL INFORM CO; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Srivastava AK, 2018, NEUROMETHODS, V139, P1, DOI 10.1007/978-1-4939-8564-7_1; Steyerberg EW, 2008, CLIN PREDICTION MODE; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Taljaard M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006701; Tranfield D, 2003, BRIT J MANAGE, V14, P207, DOI 10.1111/1467-8551.00375; Ventola C Lee, 2014, P T, V39, P356; Vlemmix F, 2013, BJOG-INT J OBSTET GY, V120, P257, DOI 10.1111/1471-0528.12060; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; Westbrook JI, 2005, J AM MED INFORM ASSN, V12, P315, DOI 10.1197/jamia.M1717	82	1	1	0	2	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	1438-8871			J MED INTERNET RES	J. Med. Internet Res.	JUL 9	2020	22	7							e15770	10.2196/15770			19	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Medical Informatics	NU8OX	WOS:000573898400001	32673228	gold, Green Published			2022-02-06	
J	Moser, RS; Schatz, P				Moser, Rosemarie Scolaro; Schatz, Philip			A Cross-Cultural Examination of Parental Knowledge of Concussion in Sicily, Italy	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							BRAIN-INJURY	Forty parents of youth soccer players of ages 5-17 years, in Sicily, Italy completed a survey measuring knowledge of concussion symptoms and facts. Parents averaged 16 out of 23 correct responses (69.5%) on the survey, with no significant correlation between parental age and education and knowledge. Italian parents were more familiar with somatic symptoms (92.5%-100% correct) than emotional/behavioral (27.5%-57.5% correct) and sleep symptoms (45.0%). Comparisons to U.S. and Australian research showed general agreement on knowledge of concussion symptoms, but less awareness of other concussion facts among Italian parents. More research on cross-cultural concussion education and barriers to concussion resources is warranted.	[Moser, Rosemarie Scolaro] Sports Concuss Ctr New Jersey, Princeton, NJ 08540 USA; [Schatz, Philip] St Josephs Univ, Philadelphia, PA 19131 USA		Moser, RS (corresponding author), Sports Concuss Ctr New Jersey, Princeton, NJ 08540 USA.	rmoser@sportsconcussionNJ.com		Schatz, Philip/0000-0002-6222-6545			American Academy of Neurology, SPORTS CONC RES; [Anonymous], HEADS YOUTH SPORTS; ASD Young Pozzallo, 2019, OUR STORY; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Brain Injury Alliance of New Jersey, CONC WHAT YOUTH SPOR; Brain Injury Association of America, CRASH COURS CONC ED; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Concussion in Sport Australia, INF PAR TEACH; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Feiss RS, 2020, J CONCUSSION, DOI [10.1177/2059700219900053, DOI 10.1177/2059700219900053]; Government of Canada, CONC SPORT RECR; Hecimovicha M, 2016, SPORT J, P1; Hunt C, 2018, CAN J NEUROL SCI, V45, P283, DOI 10.1017/cjn.2017.299; International Consensus Conference on Concussion in Sport (CISG), 2021, INT CONS C CONC SPOR; Kay MC, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117742370; Konin JG, 2017, INTERNET J ALLIED HE, V15; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; Meeuwisse WH, 2017, BRIT J SPORT MED, V51, P873, DOI 10.1136/bjsports-2017-097569; Moser RS, 2018, ARCH CLIN NEUROPSYCH, V33, P417, DOI 10.1093/arclin/acx070; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; O'Brien KH, 2019, TOP LANG DISORD, V39, P313, DOI 10.1097/TLD.0000000000000190; Parachute, CONCUSSION; Rieger B, 2018, CUREUS, V10, DOI 10.7759/cureus.2268; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Solomon GS, 2014, PHYSICIAN SPORTSMED, V42, P26, DOI 10.3810/psm.2014.09.2072; Sports Neuropsychology Society, CAN SPORTS NEUR HELP; Statista Research Department, IT NUMB REG YOUTH FO; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Waltzman Dana, 2018, J Concussion, V2, P1, DOI 10.1177/2059700218769218; Weerdenburg K, 2016, PAED CHILD HEALT-CAN, V21, pE22, DOI 10.1093/pch/21.3.e22	33	1	1	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.	JUL 3	2020	45	5					330	340		10.1080/87565641.2020.1789644		JUL 2020	11	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	NB4BW	WOS:000547401000001	32627601				2022-02-06	
J	Kuchinsky, SE; Eitel, MM; Lange, RT; French, LM; Brickell, TA; Lippa, SM; Brungart, DS				Kuchinsky, Stefanie E.; Eitel, Megan M.; Lange, Rael T.; French, Louis M.; Brickell, Tracey A.; Lippa, Sara M.; Brungart, Douglas S.			Objective and Subjective Auditory Effects of Traumatic Brain Injury and Blast Exposure in Service Members and Veterans	FRONTIERS IN NEUROLOGY			English	Article						speech perception; hearing; tinnitus; traumatic brain injury; blast exposure; service members and veterans	SPEECH-PERCEPTION; HEARING-LOSS; TBI; DYSFUNCTION; ADULTS	Service members and veterans (SMVs) with a history of traumatic brain injury (TBI) or blast-related injury often report difficulties understanding speech in complex environments that are not captured by clinical tests of auditory function. Little is currently known about the relative contribution of other auditory, cognitive, and symptomological factors to these communication challenges. This study evaluated the influence of these factors on subjective and objective measures of hearing difficulties in SMVs with and without a history of TBI or blast exposure. Analyses included 212 U.S. SMVs who completed auditory and cognitive batteries and surveys of hearing and other symptoms as part of a larger longitudinal study of TBI. Objective speech recognition performance was predicted by TBI status, while subjective hearing complaints were predicted by blast exposure. Bothersome tinnitus was associated with a history of more severe TBI. Speech recognition performance deficits and tinnitus complaints were also associated with poorer cognitive function. Hearing complaints were predicted by high frequency hearing loss and reports of more severe PTSD symptoms. These results suggest that SMVs with a history of blast exposure and/or TBI experience communication deficits that go beyond what would be expected based on standard audiometric assessments of their injuries.	[Kuchinsky, Stefanie E.; Eitel, Megan M.; Lange, Rael T.; French, Louis M.; Brickell, Tracey A.; Lippa, Sara M.; Brungart, Douglas S.] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20814 USA; [Eitel, Megan M.; Lange, Rael T.; French, Louis M.; Brickell, Tracey A.; Lippa, Sara M.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Eitel, Megan M.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Lange, Rael T.; French, Louis M.; Brickell, Tracey A.; Lippa, Sara M.] Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Lange, Rael T.; Brickell, Tracey A.] Gen Dynam Informat Technol, Falls Church, VA USA; [French, Louis M.; Brickell, Tracey A.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA		Kuchinsky, SE (corresponding author), Walter Reed Natl Mil Med Ctr, Bethesda, MD 20814 USA.	stefanie.e.kuchinsky.civ@mail.mil		french, louis/0000-0002-9451-0604	Defense and Veterans Brain Injury Center (DVBIC) 15-Year Longitudinal TBI Study [Sec721 NDAA FY2007]	This work was supported by the Defense and Veterans Brain Injury Center (DVBIC) 15-Year Longitudinal TBI Study (Sec721 NDAA FY2007).	Akeroyd M, 2008, INT J AUDIOL, V47, pS53, DOI 10.1080/14992020802301142; Alamgir H, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0082-5; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; BILGER RC, 1984, J SPEECH HEAR RES, V27, P32, DOI 10.1044/jshr.2701.32; Brungart DS, 2014, J ACOUST SOC AM, V136, P777, DOI 10.1121/1.4887440; Cameron S, 2007, EAR HEARING, V28, P196, DOI 10.1097/AUD.0b013e318031267f; Carlson KF, 2019, AM J AUDIOL, V28, P181, DOI 10.1044/2018_AJA-TTR17-18-0042; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; CDC-NIOSH, 2019, TOP OCC HEAR LOSS OH; Chandler CDW, 2006, ASHA LEAD, V11, P8, DOI DOI 10.1044/LEADER.FTR4.11092006.8; Conners K., 2002, CONNERS CONTINUOUS P; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dvbic, 2020, DOD WORLDW NUMB TBI; Epidemiology Program Post-Deployment Health Group Office of Public Health Veterans Health Administration Department of Veterans Affairs, 2015, AN VA HLTH CAR UT OP; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Gieseler A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00219; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004862; Gramacy RB, 2019, MONOMVN PACKAGE ESTI; Henry JA, 2015, AM J AUDIOL, V24, P66, DOI 10.1044/2014_AJA-14-0042; Hernandez LM, 1999, GULF WAR VETERANS ME, V4th; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Holmes S, 2009, J CLIN NURS, V18, P2927, DOI 10.1111/j.1365-2702.2009.02909.x; Hoover EC, 2017, J AM ACAD AUDIOL, V28, P325, DOI 10.3766/jaaa.16051; House AS, 1963, ESDTDR63403, V86, P1; Kochkin S., 2005, IMPACT TREATED HEARI; Krause MO, 2014, BRAIN INJURY, V28, P1473, DOI 10.3109/02699052.2014.920520; Lange RT, 2020, J TRAUMA STRESS, V33, P318, DOI 10.1002/jts.22480; Lange RT, 2020, NEUROPSYCHOL REHABIL, V30, P1762, DOI 10.1080/09602011.2019.1604385; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lin FR, 2011, J GERONTOL A-BIOL, V66, P1131, DOI 10.1093/gerona/glr115; Lippa SM, 2020, J NEUROTRAUM, V37, P608, DOI 10.1089/neu.2019.6696; Lux WE, 2007, J REHABIL RES DEV, V44, P951, DOI 10.1682/JRRD.2007.01.0009; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Phatak SA, 2019, EAR HEARING, V40, P426, DOI 10.1097/AUD.0000000000000635; R Development Core Team, 2019, R LANG ENV STAT COMP; Ramsay Ian S, 2018, Schizophr Res Cogn, V11, P1, DOI 10.1016/j.scog.2017.10.001; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; ROSENHALL U, 1985, SCAND AUDIOL, V14, P187, DOI 10.3109/01050398509045940; Rudner M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/869726; Santana MVD, 2017, MIL MED, V182, pE1885, DOI 10.7205/MILMED-D-17-00020; Snow J, 2004, TINNITUS THEORY MANA, P16; Stern RA, 2003, NAB ADM SCORING INTE; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Trevis KJ, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01262; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Weathers FW., 2013, PTSD CHECKLIST DSM 5; Wechsler, 1997, WECHSLER ADULT INTEL; Wilson RH, 2007, J SPEECH LANG HEAR R, V50, P844, DOI 10.1044/1092-4388(2007/059)	52	1	1	2	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 3	2020	11								613	10.3389/fneur.2020.00613			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	MR8MB	WOS:000553843900001	32719649	gold, Green Published			2022-02-06	
J	Davis, TS; Nathan, JE; Martinez, AST; De Vis, JB; Turtzo, LC; Latour, LL				Davis, Tara S.; Nathan, Jennifer E.; Tinoco Martinez, Ana S.; De Vis, Jill B.; Turtzo, L. Christine; Latour, Lawrence L.			-----Comparison of T1-Post and FLAIR-Post MRI for identification of traumatic meningeal enhancement in traumatic brain injury patients	PLOS ONE			English	Article							CRITERIA	Traumatic meningeal enhancement (TME) is a novel biomarker observed on post-contrast fluid-attenuated inversion recovery (FLAIR) in patients who undergo contrast-enhanced magnetic resonance imaging (MRI) after suspected traumatic brain injury (TBI). TME may be seen on acute MRI despite the absence of other trauma-related intracranial findings. In this study we compare conspicuity of TME on FLAIR post-contrast and T1 weighted imaging (T1WI) post-contrast, and investigate if TME is best detected by FLAIR post-contrast or T1WI post-contrast sequences. Subjects selected for analysis enrolled in the parent study (NCT01132937) in 2016 and underwent contrast-enhanced MRI within 48 hours of suspected TBI. Two blinded readers reviewed pairs of pre- and post-contrast T1WI and FLAIR images for presence or absence of TME. Discordant pairs between the two blinded readers were reviewed by a third reader. Cohen's kappa coefficient was used to calculate agreement. Twenty-five subjects (15 males, 10 females; median age 48 (Q1:35-Q3:62; IQR: 27)) were included. The blinded readers had high agreement for presence of TME on FLAIR (Kappa of 0.90), but had no agreement for presence of TME on T1WI (Kappa of -0.24). The FLAIR and T1WI scans were compared among all three readers and 62% of the cases positive on FLAIR could be seen on T1WI. However, 38% of the cases who were read positive on FLAIR for TME were read negative for TME on T1WI. Conspicuity of TME is higher on post-contrast FLAIR MRI than on post-contrast T1WI. TME as seen on post-contrast FLAIR MRI can aid in the identification of patients with TBI.	[Davis, Tara S.; Tinoco Martinez, Ana S.] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Davis, Tara S.; Nathan, Jennifer E.; Tinoco Martinez, Ana S.] Johns Hopkins Suburban Hosp, Bethesda, MD USA; [De Vis, Jill B.; Turtzo, L. Christine; Latour, Lawrence L.] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA		Latour, LL (corresponding author), NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	LatourL@ninds.nih.gov	Latour, Larry/AAH-5663-2021	Latour, Larry/0000-0001-6160-5263; Davis, Tara/0000-0002-6293-3602	National Institutes of Health Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; U.S. Department of Defense via the Center for Neuroscience and Regenerative Medicine, Uniformed Services University of the Health Sciences	This study was supported by funding from the National Institutes of Health Intramural Research Program (https://irp.nih.gov/) (LLL) and the U.S. Department of Defense via the Center for Neuroscience and Regenerative Medicine, Uniformed Services University of the Health Sciences (https://www.usuhs.edu/cnrm) (LLL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absinta M, 2017, NEUROLOGY, V88, P1439, DOI 10.1212/WNL.0000000000003820; Absinta M, 2015, NEUROLOGY, V85, P18, DOI 10.1212/WNL.0000000000001587; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Cota MR, 2019, J NEUROTRAUM, V36, P1335, DOI 10.1089/neu.2018.5772; DECOENE B, 1992, AM J NEURORADIOL, V13, P1555; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Kim SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102229; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee EK, 2016, KOREAN J RADIOL, V17, P127, DOI 10.3348/kjr.2016.17.1.127; Livingston WS, 2017, J NEUROTRAUM, V34, P853, DOI 10.1089/neu.2016.4479; Mamourian AC, 2000, AM J NEURORADIOL, V21, P105; Mathews VP, 1999, RADIOLOGY, V211, P257, DOI 10.1148/radiology.211.1.r99mr25257; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Piechotta PL, 2018, INVEST RADIOL, V53, P223, DOI 10.1097/RLI.0000000000000432; Ricciardi MC, 2017, J NEUROTRAUM, V34, P23, DOI 10.1089/neu.2015.4338; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Russo MV, 2018, NAT IMMUNOL, V19, P442, DOI 10.1038/s41590-018-0086-2; Smirniotopoulos JG, 2007, RADIOGRAPHICS, V27, P525, DOI 10.1148/rg.272065155; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2020	15	7							e0234881	10.1371/journal.pone.0234881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MM1IV	WOS:000549913100055	32614835	Green Published, gold			2022-02-06	
J	Jenkins, R; Badjatia, N; Haac, B; Van Besien, R; Biedlingmaier, JF; Stein, DM; Chang, WT; Schwartzbauer, G; Parikh, G; Morris, NA				Jenkins, Ryne; Badjatia, Neeraj; Haac, Bryce; Van Besien, Richard; Biedlingmaier, John F.; Stein, Deborah M.; Chang, Wan-Tsu; Schwartzbauer, Gary; Parikh, Gunjan; Morris, Nicholas A.			Factors associated with tracheostomy decannulation in patients with severe traumatic brain injury	BRAIN INJURY			English	Article						Tracheostomy; traumatic Brain Injury; head Injury; decannulation	ACUTE KIDNEY INJURY; COMPLICATIONS; CLASSIFICATION; GUIDELINES; SURVIVORS	Objective To assess variables associated with decannulation in patients with traumatic brain injury (TBI). Participants 79 patients with TBI requiring tracheostomy and ICU admission from January 1(st)to December 31(st), 2014. Design Retrospective analysis. Measures Patients decannulated prior to 90 days were compared with patients who remained cannulated. Two Cox Proportional Hazards models were used to predict decannulation using variables prior to tracheostomy and throughout hospitalization. Results Median time to decannulation was 37 days (Interquartile Range [IQR] 29-67). Variables prior to tracheostomy associated with decannulation included diabetes (HR, 0.15; 95% CI, 0.03-0.84;p=.03), craniotomy (HR, 0.25; 95% CI, 0.06-1.02;p=.05) and acute kidney injury (AKI) (HR, 0.06; 95% CI, 0.01-0.48;p=.01). Variables present throughout hospitalization included age (HR, 1.12; 95% CI, 1.01-1.21;p=.03), ventilator days (HR, 0.74; 95% CI, 0.57-0.95;p=.02), reintubation (HR, 0.07; 95% CI, 0.01-0.64;p=.02), aspiration (HR, 0.01; 95% CI, 0.0-0.29,p=.01), craniotomy (HR, 0.004; 95% CI, 0.0-0.39;p=.02) and AKI (HR, 0.0; 95% CI, 0.0-0.21;p=.01). Conclusion The presence of diabetes, craniotomy and acute kidney injury may inform the conversation surrounding chances for decannulation prior to tracheostomy.	[Jenkins, Ryne; Badjatia, Neeraj; Haac, Bryce; Van Besien, Richard; Stein, Deborah M.] Univ Maryland, R Adams Cowley Shock Trauma Ctr, Sch Med, Program Trauma, Baltimore, MD 21201 USA; [Badjatia, Neeraj; Chang, Wan-Tsu; Schwartzbauer, Gary; Parikh, Gunjan; Morris, Nicholas A.] Univ Maryland, Sch Med, Dept Neurol, Sect Neurocrit Care & Emergency Neurol,Program Tr, Baltimore, MD 21201 USA; [Biedlingmaier, John F.] Univ Maryland, Dept Otolaryngol, Sch Med, Baltimore, MD 21201 USA; [Stein, Deborah M.] Univ Calif San Francisco, Sch Med, Zuckerberg San Francisco Gen Hosp, Program Trauma, San Francisco, CA USA; [Stein, Deborah M.] Univ Calif San Francisco, Sch Med, Trauma Ctr, Program Trauma, San Francisco, CA USA		Morris, NA (corresponding author), Univ Maryland, Med Ctr, Baltimore, MD 21201 USA.	Nicholas.Morris@som.umaryland.edu	Badjatia, Neeraj/AAS-4855-2021; Morris, Nicholas/S-7475-2019	Morris, Nicholas/0000-0002-1270-9805; Badjatia, Neeraj/0000-0003-1509-9034			Ahmed M, 2015, BRIT J NEUROSURG, V29, P544, DOI 10.3109/02688697.2015.1016892; Alali Aziz S, 2014, J Trauma Acute Care Surg, V76, P70, DOI 10.1097/TA.0b013e3182a8fd6a; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baron DM, 2016, WIEN KLIN WOCHENSCHR, V128, P397, DOI 10.1007/s00508-016-1004-y; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; De Corte W, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1409-z; Dunham CM, 2014, INT J BURNS TRAUMA, V4, P14; Gennarelli TA., 2008, ABBREVIATED INJURY S; Gurkin MA, 2002, AM SURGEON, V68, P324; Huang YH, 2013, INJURY, V44, P1226, DOI 10.1016/j.injury.2012.12.029; Jenkins R, 2019, NEUROCRIT CARE, V30, P387, DOI 10.1007/s12028-018-0624-7; Keren O, 2001, BRAIN INJURY, V15, P531, DOI 10.1080/02699050010007371; Khalili H, 2017, WORLD NEUROSURG, V103, P88, DOI 10.1016/j.wneu.2017.02.060; Koh WY, 1997, ANAESTH INTENS CARE, V25, P365, DOI 10.1177/0310057X9702500407; LeBlanc J, 2010, J HEAD TRAUMA REHAB, V25, P362, DOI 10.1097/HTR.0b013e3181cd67ea; Leung R, 2003, ANN OTO RHINOL LARYN, V112, P853, DOI 10.1177/000348940311201005; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mackiewicz-Nartowicz H, 2008, ADV PALL MED, V7, P69; Major KM, 2003, AM J SURG, V186, P615, DOI 10.1016/j.amjsurg.2003.08.012; Makris Konstantinos, 2016, Clin Biochem Rev, V37, P85; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mehta Y, 2014, INDIAN J CRIT CARE M, V18, P149, DOI 10.4103/0972-5229.128705; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; O'Connor Heidi H, 2009, J Intensive Care Med, V24, P187, DOI 10.1177/0885066609332701; Rosenbower TJ, 1998, AM SURGEON, V64, P82; Santus P, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-201; Shamim MS, 2011, J NEUROSURG, V115, P1007, DOI 10.3171/2011.7.JNS101829; Siddiqui Usman Tariq, 2015, Surg Neurol Int, V6, P65, DOI 10.4103/2152-7806.155757; Spataro E, 2017, LARYNGOSCOPE, V127, P2746, DOI 10.1002/lary.26668; STELFOX HT, 2008, CRIT CARE, V12, P26, DOI DOI 10.1186/CC6802; TEASDALE G, 1974, LANCET, V2, P81; WOO P, 1989, LARYNGOSCOPE, V99, P725; Zanata ID, 2014, INT ARCH OTORHINOLAR, V18, P108, DOI 10.1055/s-0033-1363467	35	1	1	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 2	2020	34	8					1106	1111		10.1080/02699052.2020.1786601			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MK8SK	WOS:000549051400014	32615825				2022-02-06	
J	Lanesman, TH; Schrieff, LE				Lanesman, Talia H.; Schrieff, Leigh E.			Implementation of an attention training programme with a sample of children who have sustained traumatic brain injuries in South Africa: A pilot study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Paediatric traumatic brain injury; Cognitive rehabilitation; Attention training; South Africa; "Pay attention!"	EXECUTIVE FUNCTIONS; ADHD; MEMORY; INTERVENTION; CHILDHOOD; ADOLESCENTS; PERFORMANCE; SYMPTOMS; DISORDER; EXPOSURE	This pilot study evaluated the feasibility of implementing an attention-training programme for children who have sustained moderate-to-severe traumatic brain injuries (TBIs) in a South African context. We compared the performance on the programme of children with TBI (TBI Intervention Group) to children who had been diagnosed with Attention Deficit Hyperactivity Disorder (ADHD Intervention Group), a TBI Art group and a TBI No-intervention Group (n=5 in each group) in this preliminary study. Children in the two Intervention Groups participated in the "Pay Attention!" programme for 45 minutes twice a week for 12 weeks. All children were aged 6-8 years and underwent neuropsychological testing pre- and post-intervention. Behavioural data were collected from parents. Children in the ADHD Intervention Group showed individual clinically significant attentional improvements on measures of the Conners' Continuous Performance Test II using the Reliable Change Index (>= 2.58 SD). Despite mixed results, the pilot study demonstrates that implementing a cognitive rehabilitation programme in South Africa is feasible and necessary, despite limited infrastructure and access to resources.	[Lanesman, Talia H.; Schrieff, Leigh E.] Univ Cape Town, Dept Psychol, ACSENT Lab, ZA-7701 Rondebosch, South Africa		Lanesman, TH (corresponding author), Univ Cape Town, Dept Psychol, ACSENT Lab, ZA-7701 Rondebosch, South Africa.	tali.lanesman@gmail.com			Ernest Oppenheimer Memorial Trust [19860/01]; National Research Foundation [89722]; University of Cape Town	This work was supported by Ernest Oppenheimer Memorial Trust: [Grant Number 19860/01]; National Research Foundation: [Grant Number 89722]; University of Cape Town: [Grant Number Siri Johnson Award].	Achenbach T, 1983, MANUAL CHILD BEHAV C; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; ANDERSON V, 2001, DEV NEUROPSYCHOLOGY; Anderson V, 2012, J HEAD TRAUMA REHAB, V27, P199, DOI 10.1097/HTR.0b013e31821a9d2b; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Backeljauw B, 2014, PM&R, V6, P814, DOI 10.1016/j.pmrj.2014.04.004; Bartgis J, 2008, INFANT CHILD DEV, V17, P491, DOI 10.1002/icd.563; Beesdo K, 2009, PSYCHIAT CLIN N AM, V32, P483, DOI 10.1016/j.psc.2009.06.002; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Betts J, 2006, CHILD NEUROPSYCHOL, V12, P205, DOI 10.1080/09297040500488522; Biederman J, 2012, NEUROPSYCH DIS TREAT, V8, P267, DOI 10.2147/NDT.S29670; Brett A W, 1998, Pediatr Rehabil, V2, P27; Buitendag JJP, 2017, SAMJ S AFR MED J, V107, P777, DOI [10.7196/SAMJ.2017.v107i9.12394, 10.7196/samj.2017.v107i9.12394]; Catroppa C, 2014, BRAIN INJURY, V28, P252, DOI 10.3109/02699052.2013.860471; Chen TJ, 2016, AM J MED GENET B, V171, P931, DOI 10.1002/ajmg.b.32411; Chenault B, 2006, DEV NEUROPSYCHOL, V29, P243, DOI 10.1207/s15326942dn2901_12; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Conners C. K., 2000, CONNERS CONTINUOUS P; Connor DF, 2010, J DEV BEHAV PEDIATR, V31, P427, DOI 10.1097/DBP.0b013e3181e121bd; de Kloet AJ, 2012, BRAIN INJURY, V26, P1021, DOI 10.3109/02699052.2012.654592; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dollman AK, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00121; Ferrett HL, 2010, DRUG ALCOHOL DEPEN, V110, P8, DOI 10.1016/j.drugalcdep.2010.01.019; Field A., 2009, DISCOVERING STAT USI, V3rd ed; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Gioia GA IP, 2000, BEHAV RATING INVENTO; Gopalan PRS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36947-3; Ho J, 2011, NEUROPSYCHOL REHABIL, V21, P183, DOI 10.1080/09602011.2010.547345; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kanaka N, 2008, PSYCHIAT CLIN NEUROS, V62, P135, DOI 10.1111/j.1440-1819.2008.01746.x; Kerns KA, 1999, DEV NEUROPSYCHOL, V16, P273, DOI 10.1207/S15326942DN1602_9; Klenberg L, 2001, DEV NEUROPSYCHOL, V20, P407, DOI 10.1207/S15326942DN2001_6; Klimkeit EI, 2004, CHILD NEUROPSYCHOL, V10, P201, DOI 10.1080/713657846; Korkman M., 2007, NEPSY 2; Leon AC, 2011, J PSYCHIATR RES, V45, P626, DOI 10.1016/j.jpsychires.2010.10.008; Levin K, 2004, DISABIL REHABIL, V26, P306, DOI 10.1080/0963828032000174089; Lusebrink VB., 2004, ART THER, V21, P125, DOI [10.1080/07421656.2004.10129496, DOI 10.1080/07421656.2004.10129496]; Manly T., 1999, TEST EVERYDAY ATTENT; Medina KL, 2007, J INT NEUROPSYCH SOC, V13, P807, DOI 10.1017/S1355617707071032; Moran LM, 2016, J INT NEUROPSYCH SOC, V22, P512, DOI 10.1017/S1355617716000175; Narad ME, 2018, JAMA PEDIATR, V172, P437, DOI 10.1001/jamapediatrics.2017.5746; Olivier L, 2016, SAMJ S AFR MED J, V106, pS103, DOI 10.7196/SAMJ.2016.v106i6.11009; Penkman Louise, 2004, Pediatr Rehabil, V7, P111, DOI 10.1080/13638490310001649417; Perold M, 2010, S AFR J EDUC, V30, P457, DOI 10.15700/saje.v30n3a364; Reynolds GD, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00015; Rommelse NNJ, 2009, J ABNORM CHILD PSYCH, V37, P793, DOI 10.1007/s10802-009-9312-6; Sala G, 2019, COLLABRA-PSYCHOL, V5, DOI 10.1525/collabra.203; Schrieff-Elson L, 2017, NEUROPSYCHOLOGICAL REHABILITATION: THE INTERNATIONAL HANDBOOK, P526; Schrieff-Elson LE, 2017, J CHILD ADOLESC MENT, V29, P147, DOI 10.2989/17280583.2017.1372285; Seguin M, 2018, ANN PHYS REHABIL MED, V61, P189, DOI 10.1016/j.rehab.2017.05.001; Sjo NM, 2010, ACTA PAEDIATR, V99, P230, DOI 10.1111/j.1651-2227.2009.01587.x; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Sohlberg MM., 2014, CLIN PRACT PEDIAT PS, V2, P263, DOI [10.1037/cpp0000072, DOI 10.1037/CPP0000072]; Sparrow S.S., 2005, VINELAND ADAPTIVE BE; Stangor C., 2011, RES METHODS BEHAV SC; Statistics South Africa, 2011, CENS 2011 CENS BRIEF; Stein D. S., 2016, CARE ADULTS CHRONIC, P39; Strawn JR, 2017, CURR PROB PEDIATR AD, V47, P3, DOI 10.1016/j.cppeds.2016.11.008; Tamm L, 2013, DEV COGN NEUROS-NETH, V4, P16, DOI 10.1016/j.dcn.2012.11.004; Tamm L, 2010, J ATTEN DISORD, V14, P86, DOI 10.1177/1087054709347446; TEASDALE G, 1974, LANCET, V2, P81; Thomas-Stonell N, 1994, J HEAD TRAUMA REHAB, V9, P25, DOI DOI 10.1097/00001199-199412000-00005; Thomson J., 2005, PAY ATTENTION CHILDR; Thomson J. B., 1995, J INT NEUROPSYCH SOC, V1, P149; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; van't Hooft I, 2003, ACTA PAEDIATR, V92, P935, DOI 10.1080/08035250310004586; van't Hooft I., 2005, COGNITIVE REHABILITA; van 't Hooft I, 2007, NEUROREHABILITATION, V22, P109; Vanker A, 2016, INT J TUBERC LUNG D, V20, P729, DOI 10.5588/ijtld.15.0697; Warton FL, 2018, METAB BRAIN DIS, V33, P507, DOI 10.1007/s11011-017-0135-9; Wassenberg R, 2008, CHILD NEUROPSYCHOL, V14, P195, DOI 10.1080/09297040601187940; Wechsler D., 2011, WECHSLER ABBREVIATED; Yeates KO, 2017, J INT NEUROPSYCH SOC, V23, P806, DOI 10.1017/S1355617717000686; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yuan WH, 2017, NEUROREHAB NEURAL RE, V31, P190, DOI 10.1177/1545968316675430; Zhan JY, 2011, CHILD NEUROPSYCHOL, V17, P82, DOI 10.1080/09297049.2010.525500	78	1	1	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	OCT 21	2021	31	9					1466	1494		10.1080/09602011.2020.1782233		JUL 2020	29	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	TY9PY	WOS:000547643500001	32615054				2022-02-06	
J	Pinggera, D; Steiger, R; Bauer, M; Kerschbaumer, J; Luger, M; Beer, R; Rietzler, A; Grams, AE; Gizewski, ER; Thome, C; Petr, O				Pinggera, Daniel; Steiger, Ruth; Bauer, Marlies; Kerschbaumer, Johannes; Luger, Markus; Beer, Ronny; Rietzler, Andreas; Grams, Astrid E.; Gizewski, Elke R.; Thome, Claudius; Petr, Ondra			Cerebral Energy Status and Altered Metabolism in Early Severe TBI: First Results of a Prospective P-31-MRS Feasibility Study	NEUROCRITICAL CARE			English	Article						MR Spectroscopy; Severe TBI; Energy Metabolism	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; PHOSPHOLIPID-METABOLISM; MRS; PH	Objective Severe traumatic brain injury (sTBI) represents a serious public health issue with high morbidity and mortality. Neuroimaging plays a crucial role in the evaluation of sTBI patients. Phosphorous magnetic resonance spectroscopy (P-31-MRS) is an imaging technique for evaluation of energy metabolites. The aim of this study is to evaluate the feasibility and the diagnostic potential of ultra-early(31)P-MRS to detect changes in cerebral energy metabolism in sTBI. Methods Adult patients with sTBI presenting with GCS <= 8 being eligible for MRI were prospectively included in the study and MRI was performed within 72 h after trauma. Imaging was performed using a 3 Tesla MRI.P-31-MRS data from the structurally affected side were compared to data from normal appearing contralateral areas symmetrically to the location of the traumatic lesions, and to data of matched healthy controls. Results Ten sTBI patients (3 female, 7 male), aged between 20 and 75 years, with a mean initial GCS of 6 were analyzed. MRI was performed 61 h (mean, range 37-71 h) after trauma. Statistical analysis revealed no significant differences between the lesioned side and contralaterally. An increased PCr/ATP ratio and a decreased PME/PDE ratio were present in structurally normal appearing, but traumatized tissue when compared to the healthy population, thus indicating significant differences in ATP resynthesis and membrane turnover (F(2,33),P = 0.005 and,P = 0.027, respectively). Conclusion P-31-MRS could provide a better understanding of pertinent global changes in cerebral energy metabolism in sTBI patients under general anesthesia.	[Pinggera, Daniel; Bauer, Marlies; Kerschbaumer, Johannes; Thome, Claudius; Petr, Ondra] Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria; [Steiger, Ruth; Rietzler, Andreas; Grams, Astrid E.; Gizewski, Elke R.] Med Univ Innsbruck, Dept Neuroradiol, Anichstr 35, A-6020 Innsbruck, Austria; [Luger, Markus] Med Univ Innsbruck, Dept Anesthesiol & Crit Care Med, Innsbruck, Austria; [Beer, Ronny] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Steiger, Ruth; Rietzler, Andreas; Grams, Astrid E.; Gizewski, Elke R.] Med Univ Innsbruck, Neuroimaging Res Core Facil, Innsbruck, Austria		Grams, AE (corresponding author), Med Univ Innsbruck, Dept Neuroradiol, Anichstr 35, A-6020 Innsbruck, Austria.; Grams, AE (corresponding author), Med Univ Innsbruck, Neuroimaging Res Core Facil, Innsbruck, Austria.	astrid.grams@i-med.ac.at	Bauer, Marlies/ABC-2537-2021	Bauer, Marlies/0000-0002-2338-8349; Gizewski, Elke Ruth/0000-0001-6859-8377			Albers MJ, 2005, MAGN RESON MED, V53, P22, DOI 10.1002/mrm.20312; Beer M, 2002, J AM COLL CARDIOL, V40, P1267, DOI 10.1016/S0735-1097(02)02160-5; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen R, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2015.1.FOCUS14745; DALY PF, 1987, J BIOL CHEM, V262, P14875; Di Pietro V, 2014, MOL MED, V20, P147, DOI 10.2119/molmed.2013.00153; Fanara B, 2010, CRIT CARE, V14, DOI 10.1186/cc9018; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; Kamble RB, 2014, J CLIN DIAGN RES, V8, DOI 10.7860/JCDR/2014/10176.5139; Kemp GJ, 2000, DEV NEUROSCI-BASEL, V22, P418, DOI 10.1159/000017471; Langan C, 2009, MOL PSYCHIATR, V14, P833, DOI 10.1038/mp.2009.39; Liu YC, 2017, QUANT IMAG MED SURG, V7, P707, DOI 10.21037/qims.2017.11.03; Maudsley A.A., 2015, J NEUROTRAUMA; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; NILSSON L, 1974, J NEUROCHEM, V23, P29, DOI 10.1111/j.1471-4159.1974.tb06912.x; Oddo M, 2012, CURR OPIN CRIT CARE, V18, P111, DOI 10.1097/MCC.0b013e32835132a5; Pan JW, 2005, ACTA NEUROL SCAND, V111, P218, DOI 10.1111/j.1600-0404.2005.00398.x; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Pinggera D, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00219; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; RANGO M, 1990, ANN NEUROL, V28, P661, DOI 10.1002/ana.410280510; Shi XF, 2015, BIPOLAR DISORD, V17, P743, DOI 10.1111/bdi.12339; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; Steen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010811; Stocchetti N, 2013, CRIT CARE, V17, DOI 10.1186/cc11513; Stovell MG, 2020, J CEREBR BLOOD F MET, V40, pNP1, DOI 10.1177/0271678X19853211; Stovell MG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00426; Tavakoli S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17450; UNTERBERG AW, 1988, J NEUROSURG, V68, P594, DOI 10.3171/jns.1988.68.4.0594; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; Vink R, 1997, J CEREBR BLOOD F MET, V17, P50, DOI 10.1097/00004647-199701000-00007; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Weber-Fahr W, 2013, PSYCHIAT RES-NEUROIM, V214, P365, DOI 10.1016/j.pscychresns.2013.06.011; WELCH KMA, 1989, NEUROLOGY, V39, P538, DOI 10.1212/WNL.39.4.538; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2; Zaninotto AL, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00095; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569	46	1	1	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2021	34	2					432	440		10.1007/s12028-020-01042-x		JUL 2020	9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SD6RK	WOS:000547560000002	32617851				2022-02-06	
J	Ahmed, N; Greenberg, P; Shin, SH				Ahmed, Nasim; Greenberg, Patricia; Shin, Seung Hoon			Pulmonary Complications and Sepsis Following Severe Acute Subdural Hematoma in Patients Who Underwent Craniotomy versus Craniectomy: A Propensity Score Matched Analysis	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						severe traumatic brain injury; subdural hematoma; craniotomy; craniectomy; pulmonary complications	TRAUMATIC BRAIN-INJURY; ACUTE LUNG INJURY; DECOMPRESSIVE CRANIECTOMY; UNITED-STATES; HEAD-INJURY; MORTALITY; EVACUATION; IMPACT; RISK	Background The purpose of the study was to evaluate the impact of craniotomy (CO) and decompressive craniectomy (DC) for evacuation of acute subdural hematoma (SDH) on pulmonary complications and sepsis. Methods Study data were obtained from the National Trauma Data Bank (2007-2010). Only patients who met all of the following criteria were included in this analysis: sustained blunt injuries, presented with severe traumatic brain injury, sustained an associated SDH, presented with an initial Glasgow Coma Scale (GCS) score <= 8 and an Abbreviated Injury Scale score of head >= 3, and underwent a CO or DC within 4 hours of hospital arrival. Patient characteristics and outcomes were compared between CO and DC, the two procedural groups. The data were first compared between the two unmatched groups; then propensity score matching and a matched pairs analysis were performed. Results From the total population of 2,370 patients, 1,852 (78%) of them underwent CO, and the remaining 518 (22%) underwent DC. Some differences were found between the CO and DC groups regarding age (mean [standard deviation (SD)]: 47.9 years [22.8] versus 39.6 years [20.1];p < 0.001), sex (male: 70.1% versus 74.7%;p = 0.05), race (white: 77.4% versus 73.4%;p = 0.06), the injury mechanism (fall: 50.7% versus 33.2%;p < 0.001), Injury Severity Score (mean [SD]: 28.0 [9.3] versus 30.5 [10.0];p < 0.001), and GCS score (median [interquartile range] 3 [3-5] versus 3 [3-4])). After the propensity score matching, no significant differences were found between the groups on the variables just listed (allp > 0.05). No significant differences were seen between the CO and DC groups in the incidences of these conditions: acute respiratory distress syndrome (ARDS) (12.0% versus 8.1%;p = 0.20), pneumonia (34.9% versus 37.6%;p = 0.60), pulmonary embolism (PE) (3.5% versus 1.6%;p = 0.30), and systemic sepsis (6.2% versus 8.1%;p = 0.5). Conclusion Although most of the patients underwent CO for acute SDH, no significant differences were observed in the incidence of ARDS, pneumonia, PE, or systemic sepsis when compared with patients who underwent DC.	[Ahmed, Nasim; Shin, Seung Hoon] Jersey Shore Univ Med Ctr, Div Trauma & Surg Crit Care, Neptune, NJ USA; [Greenberg, Patricia] Jersey Shore Univ Med Ctr, Dept Res Adm, Neptune, NJ USA		Ahmed, N (corresponding author), Jersey Shore Univ Med Ctr, Div Trauma & Surg Crit Care, Dept Surg, 1945 State Route 33, Neptune, NJ 07754 USA.	Nasim.Ahmed@hackensackmeridian.org					[Anonymous], 2014, R LANG ENV STAT COMP; Busl KM, 2015, J NEUROSURG ANESTH, V27, P31, DOI 10.1097/ANA.0000000000000085; Cardozo Júnior Luis Carlos Maia, 2014, Rev. bras. ter. intensiva, V26, P148, DOI 10.5935/0103-507X.20140022; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Ghosh S, 2012, EPIDEMIOLOGICAL TREN; Goldstein JN, 2009, NEUROCRIT CARE, V10, P28, DOI 10.1007/s12028-008-9134-3; Goyal K, 2018, INDIAN J CRIT CARE M, V22, P632, DOI 10.4103/ijccm.IJCCM_156_18; Ho DE, 2011, J STAT SOFTW, V42, p[8, 1], DOI DOI 10.18637/JSS.V042.I08; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Hothorn T, 2008, J STAT SOFTW, V28, P1; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Jehan F, 2017, J TRAUMA ACUTE CARE, V83, P1148, DOI 10.1097/TA.0000000000001658; Kalanithi P, 2011, J NEUROSURG, V115, P1013, DOI 10.3171/2011.6.JNS101989; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; Meyer KS, 2012, CRIT CARE, V16, DOI 10.1186/cc11311; Omar M, 2017, J CRIT CARE, V41, P1, DOI 10.1016/j.jcrc.2017.04.031; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Rincon-Ferrari MD, 2004, J TRAUMA, V57, P1234, DOI 10.1097/01.TA.0000119200.70853.23; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rush B, 2016, WORLD NEUROSURG, V88, P25, DOI 10.1016/j.wneu.2015.12.034; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Selassie AW, 2011, J TRAUMA, V71, P1226, DOI 10.1097/TA.0b013e318226ecfc; StataCorp, 2013, STATA STAT SOFTW REL; Tien HCN, 2011, ANN SURG, V253, P1178, DOI 10.1097/SLA.0b013e318217e339; Tsikritsaki K, 2012, EUR RESP J S56, V40, P2476; van Essen TA, 2019, ACTA NEUROCHIR, V161, P435, DOI 10.1007/s00701-018-3761-z; Vilcinis R, 2017, WORLD NEUROSURG, V101, P335, DOI 10.1016/j.wneu.2017.02.010; Woratyla S P, 1995, Conn Med, V59, P643; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	34	1	1	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	JUL	2020	81	04					297	301		10.1055/s-0040-1701235			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	MB5HA	WOS:000542632400003	32126574				2022-02-06	
J	Al-Hassani, A; Strandvik, G; Abayazeed, S; Ahmed, K; El-Menyar, A; Mahmood, I; Arumugam, SK; Asim, M; Nabir, S; Ahmed, N; Ahmed, Z; Al-Thani, H				Al-Hassani, Ammar; Strandvik, Gustav; Abayazeed, Sheraz; Ahmed, Khalid; El-Menyar, Ayman; Mahmood, Ismail; Arumugam, Suresh Kumar; Asim, Mohammad; Nabir, Syed; Ahmed, Nadeem; Ahmed, Zahoor; Al-Thani, Hassan			Relationship of optic nerve sheath diameter and intracranial hypertension in patients with traumatic brain injury	JOURNAL OF EMERGENCIES TRAUMA AND SHOCK			English	Article						Computed tomography; intracranial pressure; optic nerve sheath diameter; traumatic brain injury	COMPUTED-TOMOGRAPHY; UNITED-STATES; PRESSURE; EPIDEMIOLOGY; GUIDELINES	Background: to study the association between optic nerve sheath diameter (ONSD) and intracranial pressure (ICP) in patients with moderate-to-severe brain injury. Patients and Methods: A retrospective cohort study of traumatic brain injury (TBI) patients was conducted between 2010 and 2014. Data were analyzed and compared according to the ICP monitoring cutoff values. Outcomes included intracranial hypertension (ICH) and mortality. Results: A total of 167 patients with a mean age of 33 +/- 14 years, of them 96 had ICP monitored. ICP values correlated with ONSD measurement (r = 0.21, P = 0.04). Patients who developed ICH were more likely to have higher mean ONSD (P = 0.01) and subarachnoid hemorrhage (SAH) (P = 0.004). Receiver operating curve for ONSD showed a cutoff value of 5.6 mm to detect ICH with sensitivity 72.2% and specificity 50%. Age and ICP were independent predictors of inhospital mortality in multivariate model. Another model with same covariates showed ONSD and SAH to be independent predictors of ICH. Simple linear regression showed a significant association of ONSD with increased ICP (beta = 0.21, 95% confidence interval 0.25-5.08, P = 0.03). Conclusions: ONSD is a simple noninvasive measurement on initial CT in patients with TBI that could be a surrogate for ICP monitoring. However, further studies are warranted.	[Al-Hassani, Ammar; Strandvik, Gustav; Abayazeed, Sheraz; Ahmed, Khalid; Mahmood, Ismail; Arumugam, Suresh Kumar; Al-Thani, Hassan] Hamad Gen Hosp, Dept Surg, Doha, Qatar; [Nabir, Syed; Ahmed, Nadeem; Ahmed, Zahoor] Hamad Gen Hosp, Dept Radiol, Doha, Qatar; [El-Menyar, Ayman; Asim, Mohammad] Hamad Gen Hosp, Dept Surg Clin Res Trauma & Vasc Surg, Doha, Qatar; [El-Menyar, Ayman] Weill Cornell Med Sch, Dept Surg, Clin Med, Doha, Qatar		El-Menyar, A (corresponding author), Weill Cornell Med Sch, Clin Med, POB 3050, Doha, Qatar.; El-Menyar, A (corresponding author), Hamad Gen Hosp, Clin Res Trauma & Vasc Surg, POB 3050, Doha, Qatar.	aymanco65@yahoo.com	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X; AHMED, KHALID/0000-0003-3576-0555			Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cammarata G, 2011, J TRAUMA, V71, P779, DOI 10.1097/TA.0b013e3182220673; Chesnut RM, 2013, INTENS CARE MED, V39, P771, DOI 10.1007/s00134-013-2852-9; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Das SK, 2017, POL J RADIOL, V82, P240, DOI 10.12659/PJR.900196; Dubost C, 2012, ANESTHESIOLOGY, V116, P1066, DOI 10.1097/ALN.0b013e318246ea1a; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Geeraerts T, 2008, CRIT CARE, V12, DOI 10.1186/cc7006; Hansen HC, 2011, ACTA OPHTHALMOL, V89, pE528, DOI 10.1111/j.1755-3768.2011.02159.x; Khan Marium Naveed, 2017, Surg Neurol Int, V8, P51, DOI 10.4103/sni.sni_403_16; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Kimberly HH, 2008, CRIT CARE, V12, DOI 10.1186/cc7008; Klein SP, 2018, ACTA NEUROCHIR SUPPL, V126, P51, DOI 10.1007/978-3-319-65798-1_11; Launey Y, 2014, J NEUROTRAUM, V31, P984, DOI 10.1089/neu.2012.2829; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; Maissan IM, 2015, J NEUROSURG, V123, P743, DOI 10.3171/2014.10.JNS141197; Moretti R, 2009, NEUROCRIT CARE, V11, P406, DOI 10.1007/s12028-009-9250-8; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Pace J, 2018, J TRAUMA ACUTE CARE, V85, P380, DOI 10.1097/TA.0000000000001965; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Raffiz M, 2017, AM J EMERG MED, V35, P150, DOI 10.1016/j.ajem.2016.09.044; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Saini NS, 2012, INDIAN J NEUROTRAUM, V9, P45, DOI 10.1016/j.ijnt.2012.04.009; Sekhon MS, 2014, NEUROCRIT CARE, V21, P245, DOI 10.1007/s12028-014-0003-y; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Waheed S, 2018, J PAK MED ASSOC, V68, P268; Wang L.L., 2017, SCI REP, V7	36	1	1	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0974-2700	0974-519X		J EMERG TRAUMA SHOCK	J. Emerg. Trauma Shock	JUL-SEP	2020	13	3					183	189		10.4103/JETS.JETS_103_19			7	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	ON2DX	WOS:000586519600003	33304067	gold, Green Published			2022-02-06	
J	Alihonou, T; Quenum, K; Padonou, A; Amossou, F; Dossou, F				Alihonou, Thierry; Quenum, Kisito; Padonou, Adebola; Amossou, Francois; Dossou, Francis			Neurosurgical Emergencies at a Tertiary Referral Center in a Sub-Saharan African Country	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						trauma; spine; emergencies; neurosurgery	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; EPIDEMIOLOGY; PROFILE	Background The practice of neurosurgery in a teaching hospital requires modern diagnostic tools and a rigorous organization of care. Objectives To present and discuss the management of neurosurgical emergencies in a teaching hospital in poor and low-income country. Patients and Methods This is a retrospective and descriptive study from April 2015 to March 2017 and includes traumatic and nontraumatic neurosurgical emergencies. Epidemiological, diagnostic, operative, and outcome data were evaluated. Results During the study period, 397 cases of neurosurgery were admitted. One hundred seventy-five of them were emergencies (43%), including 168 (96%) of traumatic origin. The average age was 32.5 years (1-80 years) with a male predominance: 149 men for 26 women, the sex ratio was 6.68. The cause of the neurotraumatological emergency was mostly road accidents with 143 cases (85.1%). The trauma was brain injury in 155 patients (92.3%) and spine injury in 13 patients (7.7%). In 64.3% of cases, diagnostic imaging was done beyond 48 hours. Surgery time was more than 48 hours when it was performed (21 cases). Outcome was good for 19 patients. Overall and postoperative mortality were, respectively, 34.5% (58 cases) and 9.5% (2 cases). Conclusion Neurosurgical emergencies care at the Departmental Teaching Hospital of Oueme-Plateau has become a common activity with encouraging operating results despite difficult practice conditions.	[Alihonou, Thierry; Padonou, Adebola; Amossou, Francois; Dossou, Francis] Univ Abomey Calavi, Fac Hlth Sci, Dept Surg, Dept Teaching Hosp Oueme Plateau, 01BP5226, Cotonou, Porto Novo, Benin; [Quenum, Kisito] Univ Parakou, Fac Med, Dept Surg, Dept Teaching Hosp Borgou, Parakou, Borgou, Benin		Alihonou, T (corresponding author), Univ Abomey Calavi, Fac Hlth Sci, Dept Surg, Dept Teaching Hosp Oueme Plateau, 01BP5226, Cotonou, Porto Novo, Benin.	alihonouthierry@yahoo.fr					Ahidjo KA, 2011, J SPINAL CORD MED, V34, P308, DOI 10.1179/107902610X12883422813624; Beavogui K, 2012, NEUROCHIRURGIE, V58, P287, DOI 10.1016/j.neuchi.2012.05.006; Debebe F, 2016, AFR J EMERG MED, V6, P180, DOI 10.1016/j.afjem.2016.06.001; Dechambenoit G, 2002, J NEUROLOGICALSCI, V21, P1; El Khamlichi A, 2001, NEUROSURGERY, V48, P1344, DOI 10.1097/00006123-200106000-00034; El-Fiki M, 2010, WORLD NEUROSURG, V73, P254, DOI 10.1016/j.wneu.2010.02.012; Emejulu J K C, 2008, Afr J Med Med Sci, V37, P383; Eyichukwu G, 2011, NIGER HEAL J, V11, P27; Fatigba HO, 2013, WORLD NEUROSURG, V80, P246, DOI 10.1016/j.wneu.2011.09.016; Fatigba O H, 2011, Mali Med, V26, P4; Fatigba OH, 2010, AFR J NEUROL SCI, V29, P25; Fatigba Olatoundji Holden, 2011, Tunis Med, V89, P837; Guidah S, 2012, J AFR IMAG MED, V4, P4; Hernandez A, 2007, MED AFR NOIRE, V54, P73; Hode L, 2017, MED AFR NOIRE, V6409, P423; Hode L, 2017, WORLD NEUROSURG, V99, P210, DOI 10.1016/j.wneu.2016.11.083; Madougou S, 2016, REV CHIR ORTHOPEDIQU, V102, P211, DOI DOI 10.1016/J.RC0T.2016.01.005]; Motah M, 2014, HEAL SCI DIS, V15; Nwadiaro HC, 2011, NIGER J CLIN PRACT, V14, P186, DOI 10.4103/1119-3077.84012; Rabiou M S, 2016, ANN U ABDOU MOUMOU A, V2, P143; Sidibe S, 2005, MALI MED, V20, P1; SOSIN DM, 1992, JAMA-J AM MED ASSOC, V267, P1649, DOI 10.1001/jama.267.12.1649; Tidjani F I, 2018, J SURG NORTHBOROUGH, V6, P73; Tine I, 2013, NEUROCHIRURGIE, V59, P256; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Young PH, 2017, WORLD NEUROSURG, V99, P782, DOI 10.1016/j.wneu.2016.10.139	26	1	1	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	JUL	2020	11	03					407	410		10.1055/s-0040-1709354			4	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	MT2BS	WOS:000554772000011	32801592	gold, Green Published			2022-02-06	
J	Armstrong, T; Murtaugh, BM				Armstrong, Tiffany; Murtaugh, Brooke M.			Hope After TBI Begins with Rehabilitation	JOURNAL OF CHRISTIAN NURSING			English	Article						nursing; rehabilitation; spiritual care; TBI; traumatic brain injury		Traumatic brain injury (TBI) is one of the leading causes of long-term disability in the United States. Persons with TBI can experience numerous alterations in functional status, self-care ability, and cognitive, emotional, and social functioning. Understanding TBI features, treatment, and rehabilitation is imperative for nurses in every setting. Trauma, intensive and acute care, and rehabilitation nurses are an essential part of the interprofessional team that promotes optimum outcomes through specific interventions to foster hope for TBI patients and families.	[Armstrong, Tiffany; Murtaugh, Brooke M.] Madonna Rehabil Hosp Omaha, NE Campus, Omaha, NE 68118 USA; [Armstrong, Tiffany] Brain Injury Unit, Omaha, NE 68118 USA; [Armstrong, Tiffany] Nebraska Brain Injury Advisory Council, Kearney, NE 68845 USA; [Murtaugh, Brooke M.] Madonna Rehabil Hosp, Lincoln, NE USA; [Murtaugh, Brooke M.] Acad Certified Brain Injury Specialists, Omaha, NE USA		Armstrong, T (corresponding author), Madonna Rehabil Hosp Omaha, NE Campus, Omaha, NE 68118 USA.; Armstrong, T (corresponding author), Brain Injury Unit, Omaha, NE 68118 USA.; Armstrong, T (corresponding author), Nebraska Brain Injury Advisory Council, Kearney, NE 68845 USA.						Annon J. S, 1976, BEHAV TREATMENT SEXU; Biagianti B, 2020, J AFFECT DISORDERS, V262, P71, DOI 10.1016/j.jad.2019.10.058; Bivona U, 2012, J HEAD TRAUMA REHAB, V27, P210, DOI 10.1097/HTR.0b013e31822178a9; Arango-Lasprilla JC, 2017, BRAIN INJURY, V31, P1605, DOI 10.1080/02699052.2017.1332784; Centers for Disease Control and Prevention, 2015, SPORTS CONC POL LAWS; Centers for Disease Control and Prevention, 2019, TRAUMATIC BRAIN INJU; Centers for Medicare and Medicaid Services, 2008, TRANSMITTAL 37, V100; Cornah Deborah., 2006, IMPACT SPIRITUALITY; Crisis Prevention Institute, 2017, NONV CRIS INT FDN CO; Das-Gupta R, 2002, DISABIL REHABIL, V24, P654, DOI 10.1080/09638280110109282; Dyer K, 2014, DISABIL REHABIL, V36, P1431, DOI 10.3109/09638288.2013.859747; Fins JJ, 2015, RIGHTS COME MIND BRA; Foxx-Orenstein A, 2003, ARCH PHYS MED REHAB, V84, P231, DOI 10.1053/apmr.2003.50095; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Hammond F., 2019, AM C REH MED C CHIC; Hammond FM, 2019, J NEUROTRAUM, V36, P1136, DOI 10.1089/neu.2018.5954; Hughes B., HDB BEST PRACTICES P; Kolakowsky-Hayner S., 2016, ESSENTIAL BRAIN INJU, V5th; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McKechnie D, 2016, J CLIN NURS, V25, P213, DOI 10.1111/jocn.13087; McKechnie D, 2015, DISABIL REHABIL, V37, P2291, DOI 10.3109/09638288.2014.1002578; Nebraska Brain Injury Advisory Council, 2019, TRAUMATIC BRAIN INJU; Royal College of Physicians and Surgeons of Glasgow, GLASGOW COMA SCALE; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Shobhit J., 2020, GLASGOW COMA SCALE; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; The TBI Model Systems Knowledge Translation Center, 2011, SEXUALITY TRAUMATIC; U.S. Department of Veterans Affairs, 2019, TRAUMATIC BRAIN INJU; Waldron-Perrine B, 2011, REHABIL PSYCHOL, V56, P107, DOI 10.1037/a0023552; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Zasler N. D., 2012, BRAIN INJURY MED PRI	31	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0743-2550	1931-7662		J CHRIST NURS	J. Christ. Nurs.	JUL-SEP	2020	37	3					144	152		10.1097/CNJ.0000000000000734			9	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	QI2LN	WOS:000618806000013	32516256				2022-02-06	
J	Bajaj, J; Rathore, S; Parihar, V; Agarwal, P; Yadav, YR; Sharma, D				Bajaj, Jitin; Rathore, Sanjay; Parihar, Vijay; Agarwal, Pawan; Yadav, Yad Ram; Sharma, Dhananjaya			Teaching Glasgow Coma Scale Assessment by Videos: A Prospective Interventional Study among Surgical Residents	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						education; Glasgow Coma Scale; neurology; neurosurgery; traumatic brain injury; unconsciousness	SCORE	Objective Glasgow Coma Scale (GCS) assessment is vital for the management of various neurological, neurosurgical, and critical care disorders. Learning GCS scoring needs good training and practice. Due to limitation of teachers, the new entrants of the clinical team find it difficult to learn and use it correctly. Training through videos is being increasingly utilized in the medical field. This study aimed to evaluate the efficiency of video teaching of GCS scoring among general surgery residents. Materials and Methods A prospective study was done utilizing the freely available video at glasgowcomascale.org. The participants (general surgery residents, 1st-3rd year) were asked to assess and record their responses related to GCS both before and after watching the video. A blinded neurosurgeon recorded the correct responses separately. Statistical Analysis The difference between correct responses of the residents before and after watching the video was calculated using the "chi-square test."p-Value <= 0.05 was taken as significant. Results There was a significant improvement in GCS scoring by residents after watching the videos (p< 0.05). On estimating the responses separately, all the three responses (eye, verbal, and motor) improved significantly for 1st-year residents while only the motor response improved significantly for 2nd- and 3rd-year residents. The mode subjective improvement for the 1st-, 2nd-, and 3rd-year residents was 5, 4, and 3, respectively. Conclusion Training GCS scoring through videos is an effective way of teaching the surgery residents with maximum benefit to the junior-most ones.	[Bajaj, Jitin; Parihar, Vijay; Yadav, Yad Ram] NSCB Med Coll, Dept Neurosurg, Jabalpur 482003, India; [Rathore, Sanjay; Agarwal, Pawan; Sharma, Dhananjaya] NSCB Med Coll, Dept Surg, Jabalpur, India		Bajaj, J (corresponding author), NSCB Med Coll, Dept Neurosurg, Jabalpur 482003, India.	bajaj.jitin@gmail.com	BAJAJ, JITIN/N-6601-2016	BAJAJ, JITIN/0000-0002-1638-0015			Adeleye Amos O, 2012, Front Neurol, V3, P28, DOI 10.3389/fneur.2012.00028; Alexander M., 2000, FAMILIES SYSTEMS HLT, V18, P455, DOI DOI 10.1037/H0091869; Dale E., 1954, AUDIO VISUAL METHODS; Fat MJL, 2011, J CHILD NEUROL, V26, P804, DOI 10.1177/0883073811402345; Feldman A, 2015, ANN EMERG MED, V65, P325, DOI 10.1016/j.annemergmed.2014.07.454; GCS, GLASG STRUCT APPR AS; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; JENNETT B, 1976, LANCET, V1, P1031; Karabulut N, 2011, SURG SCI, V2, P720; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LALLEY JP, 2007, EDUCATION, V128, P64; Lane Peter L, 2002, Prehosp Disaster Med, V17, P142; Lesko MM, 2013, J NEUROTRAUM, V30, P17, DOI 10.1089/neu.2012.2438; Masters K, 2013, MED TEACH, V35, pE1584, DOI 10.3109/0142159X.2013.800636; Ogungbo B, 2003, SURG NEUROL, V59, P236, DOI 10.1016/S0090-3019(02)01049-2; Reith FCM, 2017, NEUROSURGERY, V80, P829, DOI 10.1093/neuros/nyw178; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; Shekhar Chandra, 2015, J Emerg Trauma Shock, V8, P131, DOI 10.4103/0974-2700.160700; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6	21	1	1	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	JUL	2020	11	03					381	384		10.1055/s-0040-1709263			4	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	MT2BS	WOS:000554772000007	32753801	Green Published, gold			2022-02-06	
J	Bogue, JT; Wald, G; Iosim, S; Greenfield, JP; Otterburn, DM				Bogue, Jarrod T.; Wald, Gal; Iosim, Sonia; Greenfield, Jeffrey P.; Otterburn, David M.			Submuscular Placement of Baclofen Infusion Pumps Case Series and Technique	ANNALS OF PLASTIC SURGERY			English	Article						baclofen; baclofen pump; muscle flap; submuscular; intrathecal; spasticity; subcutaneous; pressure sore; pressure injury; infection; seroma	INTRATHECAL BACLOFEN; COMPLICATIONS; SPASTICITY; MANAGEMENT; CHILDREN; THERAPY	Background Baclofen pumps provide treatment of symptoms of spasticity for disease processes such as cerebral palsy and traumatic brain injury. These devices provide continuous infusion or periodic dosing of intrathecal baclofen (ITB). Traditionally, these pumps have been placed subcutaneously. Subcutaneous device placement has been associated with infection and extrusion. Baclofen pumps are large and range from 8 to 10 cm in diameter and 4 to 8 cm in width. Patients requiring device placement typically have a paucity of subcutaneous tissue. Cachexia coupled with the size and bulk of these devices leads to increased protusion and friction. Submuscular placement provides a well-vascularized pocket that directs the device inward eliminating protrusion and decreasing the potential for soft tissue breakdown. Methods A retrospective chart review of ITB pump placement in a submuscular plane by a single plastic surgeon at a major academic center in conjunction with a neurosurgeon was performed. Inclusion criteria were cases of primary placement or replacement of ITB pumps and spasticity requiring ITB. Major complications included infection, extrusion, and reoperation. Results Five patients during a 5-month period were treated with submuscular placement of ITB pumps. Average age of patients included was 18.4 years. Average preoperative body mass index was 18.8 kg/m(2), with values ranging from 15.8 to 20.1 kg/m(2). Medical histories of patients included diagnoses of cerebral palsy and traumatic brain injury causing spasticity. The most frequently cited reason for plastic surgical consultation preoperatively was cachexia. Two patients had previous baclofen pumps placed subcutaneously. Average follow-up was 6 months and ranged from 3 to 13 months. There were no major complications. One patient had a small seroma that spontaneously resolved. No patient had wound healing problems, and there were no extrusions of implanted devices or reoperations. Conclusion Submuscular placement of baclofen pumps provides a well-vascularized and stable environment for device placement that minimizes the dangers of pump extrusion and infection. Patients who require treatment with ITB commonly have severe cachexia, which makes subcutaneous device placement high risk. Submuscular placement should be performed in all patients with body mass index less than 20 kg/m(2).	[Bogue, Jarrod T.; Wald, Gal; Iosim, Sonia; Otterburn, David M.] Weill Cornell Med, Div Plast Surg, Dept Surg, 1300 York Ave, New York, NY 10065 USA; [Greenfield, Jeffrey P.] Weill Cornell Med, Dept Neurol Surg, New York, NY 10065 USA		Otterburn, DM (corresponding author), Weill Cornell Med, Div Plast Surg, Dept Surg, 1300 York Ave, New York, NY 10065 USA.	dmo9004@med.cornell.edu					Albright AL, 2006, J NEUROSURG, V104, P233, DOI 10.3171/ped.2006.104.4.233; Borowski A, 2010, J PEDIATR ORTHOPED, V30, P76, DOI 10.1097/BPO.0b013e3181c6b257; Brennan PM, 2008, BRIT J NEUROSURG, V22, P508, DOI 10.1080/02688690802233364; COFFEY RJ, 1993, J NEUROSURG, V78, P226, DOI 10.3171/jns.1993.78.2.0226; Ghosh D, 2013, PEDIATR NEUROSURG, V49, P138, DOI 10.1159/000358307; Gilmartin R, 2000, J CHILD NEUROL, V15, P71, DOI 10.1177/088307380001500201; Kaupmann K, 1998, P NATL ACAD SCI USA, V95, P14991, DOI 10.1073/pnas.95.25.14991; Kopell BH, 2001, NEUROSURGERY, V49, P753, DOI 10.1097/00006123-200109000-00045; Krach LE, 2001, J CHILD NEUROL, V16, P31, DOI 10.1177/088307380101600106; McCormick ZL, 2016, PM&R, V8, P553, DOI 10.1016/j.pmrj.2015.10.005; Vender JR, 2006, J NEUROSURG, V104, P9, DOI 10.3171/ped.2006.104.1.9; Woolf SM, 2017, PEDIATR EMERG CARE, V33, P271, DOI 10.1097/PEC.0000000000001090	12	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-7043	1536-3708		ANN PLAS SURG	Ann. Plast. Surg.	JUL	2020	85			1			S8	S11		10.1097/SAP.0000000000002347			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	OK5SV	WOS:000584711000003	32149846				2022-02-06	
J	Bross, SP; Mongelluzzo, GJ; Conger, AR; Patel, MA; Vadakara, J; Grant, M; Gatson, NTN				Bross, Shane P.; Mongelluzzo, Gino J.; Conger, Andrew R.; Patel, Mayur A.; Vadakara, Joseph; Grant, Michelle; Gatson, Na Tosha N.			Case Report of Immuno-Oncotherapy (IO) Provoked Encephalitis Mimicking Brain Metastasis in a Patient with History of Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Autoimmune encephalitis; Cancer immunotherapy; Encephalomalacia; Immune related adverse events (irAEs); Metastatic brain tumor; Neuro-oncology; Traumatic brain injury	RENAL-CELL CARCINOMA; MELANOMA	BACKGROUND: Immuno-oncotherapy (IO) has revolutionized systemic cancer care but remains experimental in brain tumors. IO treatment risks multiorgan autoimmune inflammatory responses that limit its use. The central nervous system (CNS) is an immune-specialized compartment with restricted cellular access, thus fewer cases are reported for immune-mediated encephalitis. Interestingly, patients with history of bloodebrain barrier compromise are potentially at higher risk for immune cell trafficking to the CNS. CASE DESCRIPTION: We report the first case, to our knowledge, of a 70-year-old man with clear cell renal cell carcinoma with pulmonary metastases treated with lung irradiation, nephrectomy, and chemotherapy prior to switching to single-agent nivolumab IO. The patient presented with new-onset generalized tonic-clonic seizure and left visual field-cut. Review of patient history revealed remote traumatic brain injury (TBI). Brain imaging noted a solid-enhancing right occipital mass that was presumed metastasis versus lymphoma. Cerebrospinal fluid cytology was negative for malignancy but concerning for lymphoproliferative process not determined to be malignant. The patient started steroids and anti-epileptic therapy. After negative systemic cancer re-staging, IO was discontinued and steroids were initiated with demonstrated patient clinical improvement. CONCLUSIONS: We concluded the diagnosis of immune-mediated encephalitis secondary to IO with collection of reactive T-cells within the area of encephalomalacia. The area of encephalomalacia from prior TBI served to compartmentalize the reactive lymphocytes, giving the appearance of a mass. Taken together, new onset seizure in patients on IO might signal encephalitis and CNS metastatic mimicry should be considered in patients with a prior history of TBI and encephalomalacia.	[Bross, Shane P.; Conger, Andrew R.; Gatson, Na Tosha N.] Geisinger Med Ctr, Neurosci Inst, Danville, PA 17822 USA; [Mongelluzzo, Gino J.] Geisinger Med Ctr, Dept Radiol, Danville, PA 17822 USA; [Patel, Mayur A.; Vadakara, Joseph; Gatson, Na Tosha N.] Geisinger Med Ctr, Canc Inst, Danville, PA 17822 USA; [Grant, Michelle] Geisinger Med Ctr, Dept Pathol, Danville, PA 17822 USA		Gatson, NTN (corresponding author), Geisinger Med Ctr, Neurosci Inst, Danville, PA 17822 USA.; Gatson, NTN (corresponding author), Geisinger Med Ctr, Canc Inst, Danville, PA 17822 USA.	ngatson@geisinger.edu					Bajwa Ravneet, 2019, J Clin Med Res, V11, P225, DOI 10.14740/jocmr3750; Bianchi M, 2012, ANN ONCOL, V23, P973, DOI 10.1093/annonc/mdr362; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Fellner A, 2018, J NEURO-ONCOL, V137, P601, DOI 10.1007/s11060-018-2752-5; Fu WN, 2016, J CLIN IMAG SCI, V6, DOI 10.4103/2156-7514.197026; Ghatalia P, 2017, CURR TREAT OPTION ON, V18, DOI 10.1007/s11864-017-0458-0; Gong J, 2016, ASIAN J UROL, V3, P286, DOI 10.1016/j.ajur.2016.08.006; Harting I, 2004, ROFO-FORTSCHR RONTG, V176, P302, DOI 10.1055/s-2004-812744; Huisman Thierry A G M, 2009, Cancer Imaging, V9 Spec No A, pS10, DOI 10.1102/1470-7330.2009.9003; Johnson DB, 2019, NAT MED, V25, P1243, DOI 10.1038/s41591-019-0523-2; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kovacic M, 2015, ACTA CLIN CROAT, V54, P223; Larkin J, 2017, ONCOLOGIST, V22, P709, DOI 10.1634/theoncologist.2016-0487; Laubli H, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0249-y; Moch H, 2016, EUR UROL, V70, P93, DOI 10.1016/j.eururo.2016.02.029; Nam TS, 2011, J KOREAN NEUROSURG S, V50, P119, DOI 10.3340/jkns.2011.50.2.119; Peeraully T, 2011, ISRN NEUROLOGY, V2011; Postow MA, 2018, NEW ENGL J MED, V378, P158, DOI [10.1056/NEJMra1703481, 10.1056/NEJMc1801663]; Procopio G, 2012, BRIT J CANCER, V107, P1227, DOI 10.1038/bjc.2012.327; Rees JH, 1999, POSTGRAD MED J, V75, P728, DOI 10.1136/pgmj.75.890.727; Ross K, 2017, CLIN SCI, V131, P2627, DOI 10.1042/CS20160894; Sankineni S, 2016, UROL ONCOL-SEMIN ORI, V34, P147, DOI 10.1016/j.urolonc.2015.05.020; Simo R, 2000, HEAD NECK-J SCI SPEC, V22, P722, DOI 10.1002/1097-0347(200010)22:7<722::AID-HED13>3.0.CO;2-0; Spain L, 2017, ANN ONCOL, V28, P377, DOI 10.1093/annonc/mdw558; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003	25	1	1	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2020	139						483	487		10.1016/j.wneu.2020.04.177			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NP0SP	WOS:000569893700023	32360731				2022-02-06	
J	Dawson, L; Koncan, D; Post, A; Zemek, R; Gilchrist, MD; Marshall, S; Hoshizaki, TB				Dawson, Lauren; Koncan, David; Post, Andrew; Zemek, Roger; Gilchrist, Michael D.; Marshall, Shawn; Hoshizaki, T. Blaine			Biomechanical Comparison of Real World Concussive Impacts in Children, Adolescents, and Adults	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						concussion; pediatric; biomechanics; mTBI; Hybrid III head form; impact reconstruction; head injury	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; HEAD-INJURY; RECONSTRUCTION; POPULATION; PREDICTORS; SYMPTOMS; TISSUE; SPORT; RISK	Accidental falls occur to people of all ages, with some resulting in concussive injury. At present, it is unknown whether children and adolescents are at a comparable risk of sustaining a concussion compared to adults. This study reconstructed the impact kinematics of concussive falls for children, adolescents, and adults and simulated the associated brain tissue deformations. Patients included in this study were diagnosed with a concussion as defined by the Zurich Consensus guidelines. Eleven child, 10 adolescent, and 11 adult falls were simulated using mathematical dynamic models(MADYMO), with three ellipsoid pedestrian models sized to each age group. Laboratory impact reconstruction was conducted using Hybrid III head forms, with finite element model simulations of the brain tissue response using recorded impact kinematics from the reconstructions. The results of the child group showed lower responses than the adolescent group for impact variables of impact velocity, peak linear acceleration, and peak rotational acceleration but no statistical differences existed for any other groups. Finite element model simulations showed the child group to have lower strain values than both the adolescent and adult groups. There were no statistical differences between the adolescent and adult groups for any variables examined in this study. With the cases included in this study, young children sustained concussive injuries at lower modeled brain strains than adolescents and adults, supporting the theory that children may be more susceptible to concussive impacts than adolescents or adults.	[Dawson, Lauren; Post, Andrew; Zemek, Roger] Childrens Hosp Eastern Ontario Res Inst, Dept Pediat, Div Emergency Med, 401 Smyth Ave,Rm R139, Ottawa, ON K1H 8L1, Canada; [Dawson, Lauren; Koncan, David; Post, Andrew; Hoshizaki, T. Blaine] Univ Ottawa, Human Kinet, Ottawa, ON K1N 6N5, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland; [Marshall, Shawn] Ottawa Hosp Res Inst, Phys Med & Rehabil Bruyere Continuing Care, Ottawa, ON K1Y 4E9, Canada		Dawson, L (corresponding author), Childrens Hosp Eastern Ontario Res Inst, Dept Pediat, Div Emergency Med, 401 Smyth Ave,Rm R139, Ottawa, ON K1H 8L1, Canada.; Dawson, L (corresponding author), Univ Ottawa, Human Kinet, Ottawa, ON K1N 6N5, Canada.	ldawson@cheo.on.ca					Alvarez VS, 2018, J BIOMECH, V71, P76, DOI 10.1016/j.jbiomech.2018.01.038; [Anonymous], 2016, IEEE ASME T MECHATRO, VPP, P1; Beillas P., 2016, 14 INT C PROT CHILDR, P19; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly M.C., 2007, THESIS U COLL DUBL D; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Giordano C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187916; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Juliusson PB, 2013, ANN HUM BIOL, V40, P220, DOI 10.3109/03014460.2012.759276; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Knoch D, 2007, ANN NY ACAD SCI, V1104, P123, DOI 10.1196/annals.1390.004; Koncan D., 2018, THESIS; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Li XG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33393-z; Maxwell WL, 2012, INT J DEV NEUROSCI, V30, P167, DOI 10.1016/j.ijdevneu.2011.12.008; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Mennes M, 2014, NEUROIMAGE, V98, P513, DOI 10.1016/j.neuroimage.2014.04.030; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Nahum AM, 1977, P 21 STAPP CAR CRASH, P337; NELLHAUS G, 1968, PEDIATRICS, V41, P106; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Parker RS, 2012, CONCUSSIVE BRAIN TRAUMA: NEUROBEHAVIORAL IMPAIRMENT AND MALADAPTATION, 2ND EDITION, P609; Post A., 2013, THESIS; Post A, 2017, J NEUROSURG-PEDIATR, V19, P641, DOI 10.3171/2016.11.PEDS16383; Post A, 2017, J NEUROSURG-PEDIATR, V19, P502, DOI 10.3171/2016.10.PEDS16449; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; Roth S, 2009, COMPUT METH PROG BIO, V93, P32, DOI 10.1016/j.cmpb.2008.08.001; Ruan J, 1994, THESIS; Rueda MAF, 2009, FORENSIC SCI INT, V191, P52, DOI 10.1016/j.forsciint.2009.06.007; Theye Fred, 2004, Clin Med Res, V2, P165; Uchiyama HT, 2013, BRAIN DEV-JPN, V35, P228, DOI 10.1016/j.braindev.2012.04.005; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhou C, 1995, P STAPP CAR CRASH J, V39, P121, DOI DOI 10.4271/952714; Zong XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059569; Zwahlen RA, 2007, J CRANIO MAXILL SURG, V35, P142, DOI 10.1016/j.jcms.2007.01.006	54	1	1	0	6	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	JUL	2020	142	7								10.1115/1.4045808			8	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	MM6UQ	WOS:000550290400004	31891370				2022-02-06	
J	Fajardo, J; Milthorpe, BK; Santos, J				Fajardo, Jerome; Milthorpe, Bruce K.; Santos, Jerran			Molecular Mechanisms Involved in Neural Substructure Development during Phosphodiesterase Inhibitor Treatment of Mesenchymal Stem Cells	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						mesenchymal stem cells; neural; differentiation; phosphodiesterase inhibitor; IBMX; neurite; dendrites	MARROW STROMAL CELLS; IN-VITRO DIFFERENTIATION; NEURITE OUTGROWTH; NEURONAL DIFFERENTIATION; GLIAL SCAR; REACTIVE ASTROCYTES; CORTICAL-NEURONS; GROWTH; BRAIN; CRK	Stem cells are highly important in biology due to their unique innate ability to self-renew and differentiate into other specialised cells. In a neurological context, treating major injuries such as traumatic brain injury, spinal cord injury and stroke is a strong basis for research in this area. Mesenchymal stem cells (MSC) are a strong candidate because of their accessibility, compatibility if autologous, high yield and multipotency with a potential to generate neural cells. With the use of small-molecule chemicals, the neural induction of stem cells may occur within minutes or hours. Isobutylmethyl xanthine (IBMX) has been widely used in cocktails to induce neural differentiation. However, the key molecular mechanisms it instigates in the process are largely unknown. In this study we showed that IBMX-treated mesenchymal stem cells induced differentiation within 24 h with the unique expression of several key proteins such as Adapter protein crk, hypoxanthine-guanine phosphoribosyltransferase, DNA topoisomerase 2-beta and Cell division protein kinase 5 (CDK5), vital in linking signalling pathways. Furthermore, the increased expression of basic fibroblast growth factor in treated cells promotes phosphatidylinositol 3-kinase (PI3K), mitogen-activated protein kinase (MAPK) cascades and GTPase-Hras interactions. Bioinformatic and pathway analyses revealed upregulation in expression and an increase in the number of proteins with biological ontologies related to neural development and substructure formation. These findings enhance the understanding of the utility of IBMX in MSC neural differentiation and its involvement in neurite substructure development.	[Fajardo, Jerome; Milthorpe, Bruce K.; Santos, Jerran] Univ Technol Sydney, Fac Sci, Sch Life Sci, Adv Tissue Engn & Stem Cell Biol Grp, Sydney, NSW 2007, Australia		Santos, J (corresponding author), Univ Technol Sydney, Fac Sci, Sch Life Sci, Adv Tissue Engn & Stem Cell Biol Grp, Sydney, NSW 2007, Australia.	Jerome.Fajardo@gmail.com; Bruce.Milthorpe@uts.edu.au; Jerran.Santos@uts.edu.au	Milthorpe, Bruce/Z-1153-2019; Santos, Jerran/P-7868-2016	Milthorpe, Bruce/0000-0002-0867-9586; Santos, Jerran/0000-0003-4067-220X	Schwartz Foundation	The authors would like to thank the Schwartz Foundation philanthropic grant for the partial funding of this work.	Anghileri E, 2008, STEM CELLS DEV, V17, P909, DOI 10.1089/scd.2007.0197; Ashjian PH, 2003, PLAST RECONSTR SURG, V111, P1922, DOI 10.1097/01.PRS.0000055043.62589.05; Barman A, 2016, INDIAN J PSYCHOL MED, V38, P172, DOI 10.4103/0253-7176.183086; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Byts N, 2008, CELL DEATH DIFFER, V15, P783, DOI 10.1038/cdd.2008.1; Castellano E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11245; Chen Yuying, 2013, Top Spinal Cord Inj Rehabil, V19, P1, DOI 10.1310/sci1901-1; Dang BQ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1582182; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Efe JA, 2011, PHILOS T R SOC B, V366, P2208, DOI 10.1098/rstb.2011.0006; Elder GA, 1998, J CELL BIOL, V141, P727, DOI 10.1083/jcb.141.3.727; Essayan DM, 2001, J ALLERGY CLIN IMMUN, V108, P671, DOI 10.1067/mai.2001.119555; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fivaz M, 2008, CURR BIOL, V18, P44, DOI 10.1016/j.cub.2007.11.051; Frank CL, 2009, NEURON, V62, P312, DOI 10.1016/j.neuron.2009.03.029; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Guibinga GH, 2010, MOL THER, V18, P54, DOI 10.1038/mt.2009.178; HAUGEN PK, 1990, J NEUROSCI RES, V25, P443, DOI 10.1002/jnr.490250402; He ZS, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4649-2; Heidemann SR, 1996, INT REV CYTOL, V165, P235, DOI 10.1016/S0074-7696(08)62224-X; Heng X, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-4; Huang LJ, 2014, INT J MED SCI, V11, P344, DOI 10.7150/ijms.8140; Huebner EA, 2009, RESULTS PROBL CELL D, V48, P339, DOI 10.1007/400_2009_19; Iacovitti L, 2001, BRAIN RES, V912, P99, DOI 10.1016/S0006-8993(01)02723-8; Jang S, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-25; Jin KL, 2006, J NEUROBIOL, V66, P236, DOI 10.1002/neu.20215; Jin Y, 2012, ACTA PHARMACOL SIN, V33, P861, DOI 10.1038/aps.2012.59; Karanes C, 2008, BIOL BLOOD MARROW TR, V14, P8, DOI 10.1016/j.bbmt.2008.06.006; Kriz J, 2000, BRAIN RES, V885, P32, DOI 10.1016/S0006-8993(00)02899-7; Lepski G, 2011, STEM CELL STUD, V1, P9, DOI DOI 10.4081/SCS.2011.E9; Mao YW, 2005, J CELL BIOL, V170, P305, DOI 10.1083/jcb.200505061; Markus H, 2012, MEDICINE, V40, P484, DOI DOI 10.1016/J.MPMED.2012.06.005; Matsuki T, 2008, J CELL SCI, V121, P1869, DOI 10.1242/jcs.027334; Merot Y, 2009, SEMIN CELL DEV BIOL, V20, P726, DOI 10.1016/j.semcdb.2009.04.003; Moeendarbary E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14787; Morrison EE, 2002, MOL BRAIN RES, V98, P145, DOI 10.1016/S0169-328X(01)00290-X; Nakano R, 2015, J VET MED SCI, V77, P27, DOI 10.1292/jvms.14-0284; Nandy SB, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0083-1; Nasarre P, 2014, ONCOTARGETS THER, V7, P1663, DOI 10.2147/OTT.S37744; Oda A, 2000, BIOCHEM BIOPH RES CO, V278, P299, DOI 10.1006/bbrc.2000.3803; OHARA O, 1993, J CELL BIOL, V121, P387, DOI 10.1083/jcb.121.2.387; Park J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04632-6; Park TJ, 2008, J NEUROSCI, V28, P13551, DOI 10.1523/JNEUROSCI.4323-08.2008; PEREIRA RFP, 2018, BRAIN NEUROSCI ADV, V2; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2; Safford KM, 2004, EXP NEUROL, V187, P319, DOI 10.1016/j.expneurol.2004.01.027; SANTOS J, 2020, CELLS-BASEL, V9, DOI DOI 10.3390/CELLS9030619; Santos J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030523; Santos J, 2017, INT J STEM CELLS, V10, P193, DOI 10.15283/ijsc17036; Schafer KH, 1999, J INTERF CYTOK RES, V19, P527, DOI 10.1089/107999099313974; Shah K, 2014, J CELL SCI, V127, P2391, DOI 10.1242/jcs.147553; Sibson NR, 2008, J CEREBR BLOOD F MET, V28, P621, DOI 10.1038/sj.jcbfm.9600549; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; TANAKA S, 1993, MOL CELL BIOL, V13, P4409, DOI 10.1128/MCB.13.7.4409; Taverner T, 2012, BIOINFORMATICS, V28, P2404, DOI 10.1093/bioinformatics/bts449; Tio M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009398; Tropel P, 2006, STEM CELLS, V24, P2868, DOI 10.1634/stemcells.2005-0636; Trzaska KA, 2009, J NEUROCHEM, V110, P1058, DOI 10.1111/j.1471-4159.2009.06201.x; Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777; Ullah I, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150025; Wang HJ, 2018, INT J IMMUNOPATH PH, V31, DOI 10.1177/2058738418801406; Wang ZG, 2012, TOXICOL LETT, V212, P137, DOI 10.1016/j.toxlet.2012.05.006; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yamada S, 2007, BIOCHEM BIOPH RES CO, V363, P926, DOI 10.1016/j.bbrc.2007.09.069; Yang HJ, 2008, J BIOL CHEM, V283, P5287, DOI 10.1074/jbc.M706917200; Yuan YM, 2013, NEUROSCI BULL, V29, P421, DOI 10.1007/s12264-013-1358-3; Yun YR, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/218142; Zaim M, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0859-4; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006	77	1	1	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JUL	2020	21	14							4867	10.3390/ijms21144867			23	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	MT2KC	WOS:000554793800001	32660142	Green Published, gold			2022-02-06	
J	Flaherty, BF; Jackson, ML; Cox, CS; Clark, A; Ewing-Cobbs, L; Holubkov, R; Moore, KR; Patel, RP; Keenan, HT				Flaherty, Brian F.; Jackson, Margaret L.; Cox, Charles S., Jr.; Clark, Amy; Ewing-Cobbs, Linda; Holubkov, Richard; Moore, Kevin R.; Patel, Rajan P.; Keenan, Heather T.			Ability of the PILOT score to predict 6-month functional outcome in pediatric patients with moderate-severe traumatic brain injury	JOURNAL OF PEDIATRIC SURGERY			English	Article						Pediatrics; Traumatic brain injury; Prognosis; Intracranial pressure	GLASGOW COMA SCALE; SEVERE HEAD-INJURY; YOUNG-CHILDREN; MORTALITY; TOMOGRAPHY; DISABILITY; STRATIFICATION; EXPERIENCE; RECOVERY; THERAPY	Purpose: To assess the Pediatric Intensity Level of Therapy (PILOT) score alone and in combination with Emergency Department (ED) GCS and Rotterdam score of initial head CT to predict functional outcomes in children with traumatic brain injury (TB!). Methods: Children (n = 108) aged 31 months-15 years with moderate to severe TBI were prospectively enrolled at two sites. The ability of PILOT, ED GCS, and Rotterdam scores to predict the 6-month Pediatric Injury Functional Outcome Scale (PIFOS) was evaluated using multivariable regression models with enrollment site, age, and sex as covariates. Results: PILOT total (sum) score was more predictive of PIFOS (R-2 = 023) compared to mean (R-2 = 0.20) or peak daily PILOT scores (R-2 = 0.11). PILOT total score predicted PIFOS better than ED GCS (R2 0.01) or Rotterdam score (R-2 = 0.06) and was similar to PILOT, ED GCS, and Rotterdam score combined. PILOT total score performed better in patients with intracranial pressure monitors (n = 30, R-2 = 0.28, slope = 0.30) than without (n = 78, R-2 = 0.09, slope = 0.36). Conclusions: The PILOT score correlated moderately with functional outcome following TBI and outperformed other common predictors. PILOT may be a useful predictor or moderator of functional outcomes. (C) 2019 Elsevier Inc. All rights reserved.	[Flaherty, Brian F.; Clark, Amy; Holubkov, Richard; Keenan, Heather T.] Univ Utah, Sch Med, Dept Pediat, Div Crit Cure, Salt Lake City, UT USA; [Jackson, Margaret L.] Univ Texas Houston, Dept Surg, McGovern Med Sch, Houston, TX USA; [Cox, Charles S., Jr.] Univ Texas Houston, Dept Pediat Surg, McGovern Med Sch, Houston, TX USA; [Ewing-Cobbs, Linda] Univ Texas Houston, Dept Pediat, McGovern Med Sch, Houston, TX USA; [Ewing-Cobbs, Linda] Univ Texas Houston, Childrens Learning Inst, McGovern Med Sch, Houston, TX USA; [Moore, Kevin R.] Primary Childrens Med Ctr, Dept Med Imaging, Salt Lake City, UT USA; [Patel, Rajan P.] Univ Texas Houston, McGovern Med Sch, Dept Diagnost & Intervent Radiol, Div Neuroradiol, Houston, TX USA		Flaherty, BF (corresponding author), Dept Pediat, Div Pediat Crit Care, POB 581289, Salt Lake City, UT 84158 USA.	Brian.flaherty@hsc.utah.edu	Flaherty, Brian/ABA-2534-2020	Flaherty, Brian/0000-0002-3486-606X	Centers for Disease ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01/CE002188]; National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD072984]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008792] Funding Source: NIH RePORTER	This work was supported with funding provided by the Centers for Disease Control under Cooperative Agreement U01/CE002188. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention. This work was also supported by the National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development K24HD072984. Neither the CDC nor theNICHDplayed a role in the design or conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; and decision to submit the manuscript for publication.	Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Au AK, 2017, CURR OPIN NEUROL, V30, P565, DOI 10.1097/WCO.0000000000000504; Bahloul M, 2009, INJURY, V40, P535, DOI 10.1016/j.injury.2008.04.018; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Bennett TD, 2012, CRIT CARE MED, V40, P208, DOI 10.1097/CCM.0b013e31822e9d31; Burnham KP., 2002, MODEL SELECTION MULT; Chung CY, 2006, PEDIATR NEUROL, V34, P379, DOI 10.1016/j.pediatrneurol.2005.10.012; Teruel GC, 2007, J PEDIATR SURG, V42, P1903, DOI 10.1016/j.jpedsurg.2007.07.020; Dixon RR, 2016, PEDIATR CRIT CARE ME, V17, P1064, DOI 10.1097/PCC.0000000000000937; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Ewing-Cobbs L, 2014, J PEDIATR PSYCHOL, V39, P653, DOI 10.1093/jpepsy/jsu018; Faul M, 2010, TRAUMATIC BRAIN INJU; Fortune PM, 2010, PEDIATR CRIT CARE ME, V11, P339, DOI 10.1097/PCC.0b013e3181c014ab; Fulkerson DH, 2015, J NEUROSURG-PEDIATR, V16, P410, DOI 10.3171/2015.3.PEDS14679; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Haque Anwarul, 2018, J Ayub Med Coll Abbottabad, V30, P140; Hirsch W, 2002, PAEDIATR ANAESTH, V12, P337, DOI 10.1046/j.1460-9592.2002.00837.x; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lee Bruce, 2005, NeuroRx, V2, P372; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MSALL ME, 1994, CLIN PEDIATR, V33, P431, DOI 10.1177/000992289403300709; Murphy S, 2017, J NEUROTRAUM, V34, P2220, DOI 10.1089/neu.2016.4793; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Shore PM, 2006, CRIT CARE MED, V34, P1981, DOI 10.1097/01.CCM.0000220765.22184.ED; Stein SC, 1995, PEDIATR NEUROSURG, V23, P299, DOI 10.1159/000120975; Suskauer SJ, 2009, J PEDIATR REHAB MED, V2, P297, DOI 10.3233/PRM-2009-0092; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; TEASDALE G, 1974, LANCET, V2, P81; Vavilala MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189296; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Wilkinson AA, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0925-6; Williamson OD, 2011, J TRAUMA, V71, P63, DOI 10.1097/TA.0b013e31820e898d; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yeates KO, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017012; Young AMH, 2016, J NEUROSURG-PEDIATR, V18, P558, DOI 10.3171/2016.5.PEDS15427	46	1	1	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	JUL	2020	55	7					1238	1244		10.1016/j.jpedsurg.2019.06.022			7	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	NB4NR	WOS:000560491400011	31327541	Green Accepted			2022-02-06	
J	Galey, JL; Eagle, SR; Blaney, NA; Holland, CL; Bitzer, HB; Schneider, W; Okonkwo, DO; Mucha, A; Collins, MW; Kontos, AP				Galey, Jessica L.; Eagle, Shawn R.; Blaney, Nicholas A.; Holland, Cynthia L.; Bitzer, Hannah B.; Schneider, Walt; Okonkwo, David O.; Mucha, Anne; Collins, Michael W.; Kontos, Anthony P.			Effect of Patient Compliance With Treatment Recommendations on Clinical Outcomes in Chronic mTBI: A TEAM-TBI Study	MILITARY MEDICINE			English	Article							CONCUSSION; INTERVENTION; SYMPTOMS	Introduction Treatment approaches for mild traumatic brain injury (mTBI) have evolved to focus on active and targeted therapies, but the effect of compliance with therapy has not been investigated. The purpose of this study was to examine the role of patient compliance with prescribed therapies on clinical outcomes following mTBI. Materials and Methods Participants were aged 18-60 years with chronic (ie, 6+ months) mTBI symptoms who were previously recalcitrant (n = 66). Participants were diagnosed with a vestibular disorder and were prescribed vestibular and exertion therapies. Participants were instructed to continue the exercise regimen during the 6-month treatment phase at home. Participant compliance was evaluated by clinicians at patients' follow up visit as: (1) high, (2) moderate, or (3) low compliance based on patient report and clinician interview. High-compliance was compared to a combined low- and moderate-compliance group on the outcomes using a 2 (group) x 2 (time) analysis of variance. Results 39 of the 66 (59%) participants with vestibular disorder returned for a 6-month evaluation and were included in the analyses. Of these 39 participants, 16 (41%) were high-compliance (36.7 +/- 10.9 years, 18.8% female), 17 (44%) were moderate-compliance (32.5 +/- 5.5 years, 23.5% female), and 6 (15%) were low-compliance (32.7 +/- 3.3 years, 0% female). Conclusion High compliance significantly reduced total Vestibular/Ocular Motor Screening scores compared to low/middle compliance (P=.005). Post-Concussion Symptom Scale was reduced by 48% and dizziness symptoms reduced by 31% in the high-compliance cohort. High compliance with prescribed exertion/vestibular rehabilitation therapies enhanced clinical outcomes for previously recalcitrant patients with chronic mTBI-related vestibular disorders.	[Galey, Jessica L.] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, 645 N Michigan Ave,Suite 1100, Chicago, IL 60611 USA; [Eagle, Shawn R.; Blaney, Nicholas A.; Holland, Cynthia L.; Bitzer, Hannah B.; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, Kaufmann Med Bldg,Suite 1010,347 Fifth Ave, Pittsburgh, PA 15213 USA; [Schneider, Walt] Univ Pittsburgh, Dept Psychol, Sennott Sq,3rd Floor,210 S Bouquet St, Pittsburgh, PA 15260 USA; [Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, 200 Lothrop St Suite B-400, Pittsburgh, PA 15213 USA; [Mucha, Anne] Ctr Rehabil Serv, 300 Halket St, Pittsburgh, PA 15213 USA; [Mucha, Anne; Collins, Michael W.; Kontos, Anthony P.] UPMC Sports Med Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA		Galey, JL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, 645 N Michigan Ave,Suite 1100, Chicago, IL 60611 USA.		Eagle, Shawn/ABG-1388-2020	Eagle, Shawn/0000-0001-6767-1042	Department of Defense (DoD) United States ArmyMedical Research and Materiel Command (USAMRMC) Award [W81XWH-14-2-0002]	This research was supported in part by a grant to the University of Pittsburgh by the Department of Defense (DoD) United States ArmyMedical Research and Materiel Command (USAMRMC) Award (W81XWH-14-2-0002). Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the DoD.	Chrisman SPD, 2019, JAMA PEDIATR, V173, P315, DOI 10.1001/jamapediatrics.2018.5281; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Giza CC, 2018, JAMA NEUROL, V75, P399, DOI 10.1001/jamaneurol.2018.0006; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hugentobler JA, 2015, INT J SPORTS PHYS TH, V10, P676; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kontos AP, 2018, MIL MED, V183, P333, DOI 10.1093/milmed/usx172; Leddy JJ, 2018, CURR OPIN NEUROL, V31, P681, DOI 10.1097/WCO.0000000000000611; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pisters MF, 2010, ARTHRIT CARE RES, V62, P1087, DOI 10.1002/acr.20182; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schneider KJ, 2018, BRIT J SPORT MED, V52, P100, DOI 10.1136/bjsports-2017-098667	14	1	1	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JUL-AUG	2020	185	7-8					E1229	E1234		10.1093/milmed/usaa025			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NP0JG	WOS:000569869400049	32175565	Bronze			2022-02-06	
J	Giguere, FL; Jobin, B; Robert, J; Bastien, L; Giguere, JF; De Beaumont, L; de Guise, E; Frasnelli, J				Giguere, Fanny Lecuyer; Jobin, Benoit; Robert, Joelle; Bastien, Laurianne; Giguere, Jean-Francois; De Beaumont, Louis; de Guise, Elaine; Frasnelli, Johannes			Early Parosmia Signs and Affective States Predict Depression and Anxiety Symptoms 6 Months After a Mild Traumatic Brain Injury	CHEMICAL SENSES			English	Article						anxiety; depression; longitudinal; mild traumatic brain injury; olfaction	OLFACTORY DYSFUNCTION; ODOR IDENTIFICATION; TASTE DISORDERS; MODERATE; SMELL; DISCRIMINATION; PERCEPTION; INVENTORY; MEMORY; RISK	This longitudinal study aimed to evaluate qualitative (parosmia) and quantitative (hyposmia/anosmia) olfaction 2-4 weeks (baseline) and 6 months (follow-up) after a mild traumatic brain injury (mTBI). We further evaluated the predictive value of baseline depression, anxiety, and olfaction scores on depression and anxiety at follow-up. At baseline, olfactory function and affective state were assessed in 107 participants (53 patients with mTBI; 54 healthy controls). At follow-up, data were collected on 71 participants (32 patients and 39 controls). Both at baseline and follow-up, patients with mTBI showed more signs of parosmia, depression, and anxiety compared with controls. However, patients did not, neither at baseline nor follow-up, show quantitative olfactory impairment. Moreover, although baseline scores of depression and anxiety helped predict the development of symptoms of depression and anxiety at follow-up, adding parosmia scores to the prediction model significantly increased the amount of explained variances. Clinicians should implement affective and olfactory evaluation to predict patients' affective outcome.	[Giguere, Fanny Lecuyer; Jobin, Benoit; Bastien, Laurianne; de Guise, Elaine; Frasnelli, Johannes] Univ Montreal, Dept Psychol, 90 Av Vincent Dindy, Montreal, PQ H2V 2S9, Canada; [Giguere, Fanny Lecuyer; de Guise, Elaine] Ctr Rech Interdisciplinaire Readaptat Montreal Me, 6363 Hudson Rd,Off 061, Montreal, PQ H3S 1M9, Canada; [Giguere, Fanny Lecuyer; Jobin, Benoit; Bastien, Laurianne; Giguere, Jean-Francois; De Beaumont, Louis; Frasnelli, Johannes] CIUSSS NIM, Res Ctr, 5400 Blvd Gouin Ouest, Montreal, PQ H4J 1C4, Canada; [Robert, Joelle] Univ Sherbrooke, Dept Psychol, 2500 Blvd Univ, Sherbrooke, PQ J1K 2R1, Canada; [De Beaumont, Louis] Univ Montreal, Dept Surg, 2900 Blvd Edouard Montpetit, Montreal, PQ H3T 1J4, Canada; [de Guise, Elaine] McGill Univ, Hlth Ctr, Res Inst, 2155 Rue Guy, Montreal, PQ H3H 2L9, Canada; [Frasnelli, Johannes] Univ Quebec Trois Rivieres UQTR, Dept Anat, 3351 Blvd Forges, Trois Rivieres, PQ G8Z 4M3, Canada		Giguere, FL (corresponding author), Hop Sacre Caeur Montreal, 5400 Boul, Montreal, PQ H4J 1C5, Canada.	fanny.lecuyer.giguere@gmail.com	Jobin, Benoit/AAT-8053-2021	Jobin, Benoit/0000-0002-1357-5116	Fonds de Recherche du Quebec [173002]; Research Center of SacreCoeur Hospital [173000]	This work was supported by the Fonds de Recherche du Quebec: 173002 -Sante [Chercheur Boursier Junior 1 (JF)] and the Research Center of SacreCoeur Hospital: 173000.	Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Alves W., 1992, PHYS MED REHABIL STA, V6, P21; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bitter T, 2011, NEUROSCIENCE, V177, P177, DOI 10.1016/j.neuroscience.2011.01.016; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonfils P, 2005, ARCH OTOLARYNGOL, V131, P107, DOI 10.1001/archotol.131.2.107; Bramerson A, 2004, LARYNGOSCOPE, V114, P733; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CCSA, 2012, LOW RISK DRINK GUID; Ciofalo A, 2018, BRAIN INJURY, V32, P550, DOI 10.1080/02699052.2018.1432074; Croy I, 2017, J NEUROL, V264, P631, DOI 10.1007/s00415-016-8227-8; Croy I, 2014, CHEM SENSES, V39, P185, DOI 10.1093/chemse/bjt072; de Beurs E, 2019, DEPRESS ANXIETY, V36, P93, DOI 10.1002/da.22809; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Doty RL, 2015, HDB OLFACTION GUSTAT, Vthird; Dozois DJA, 1998, PSYCHOL ASSESSMENT, V10, P83, DOI 10.1037/1040-3590.10.2.83; Drummond M, 2018, J HEAD TRAUMA REHAB, V33, P53, DOI 10.1097/HTR.0000000000000283; Drummond M, 2017, NEUROREHABILITATION, V41, P241, DOI 10.3233/NRE-171477; Drummond M, 2015, BRAIN IMPAIR, V16, P196, DOI 10.1017/BrImp.2015.27; Drummond M, 2013, BRAIN INJURY, V27, P332, DOI 10.3109/02699052.2012.750743; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Faulcon P, 1999, Ann Otolaryngol Chir Cervicofac, V116, P351; Frasnelli J, 2005, EUR ARCH OTO-RHINO-L, V262, P231, DOI 10.1007/s00405-004-0796-y; Frasnelli J, 2016, CLIN NEUROL NEUROSUR, V140, P68, DOI 10.1016/j.clineuro.2015.11.013; Frasnelli J, 2004, EUR ARCH OTO-RHINO-L, V261, P411, DOI 10.1007/s00405-003-0703-y; Giguere FL, 2019, BRAIN INJURY, V33, P1184, DOI 10.1080/02699052.2019.1631486; Heimer L, 2008, ANATOMY OF NEUROPSYCHIATRY: THE NEW ANATOMY OF THE BASAL FOREBRAIN AND ITS IMPLICATIONS FOR NEUROPSYCHIATRIC ILLNESS, P1, DOI 10.1016/B978-012374239-1.50004-X; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Jung YG, 2014, LARYNGOSCOPE, V124, P2456, DOI 10.1002/lary.24691; Kohli P, 2016, CHEM SENSES, V41, P479, DOI 10.1093/chemse/bjw061; Krusemark EA, 2013, J NEUROSCI, V33, P587, DOI [10.1523/JNEUROSCI.1379-12.2013, 10.1523/JNEUROSCI.1835-13.2013]; Landis BN, 2010, LARYNGOSCOPE, V120, P1707, DOI 10.1002/lary.20955; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Leopold D, 2002, CHEM SENSES, V27, P611, DOI 10.1093/chemse/27.7.611; Leopold D, 1994, OLFACTION AND TASTE, VXI, P618; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lucas S, 2016, HEADACHE, V56, P323, DOI 10.1111/head.12762; Malaty J, 2013, AM FAM PHYSICIAN, V88, P852; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Mental Health Commission of Canada, 2013, MAK CAS INV MENT HLT; Negoias S, 2010, NEUROSCIENCE, V169, P415, DOI 10.1016/j.neuroscience.2010.05.012; Rao V, 2012, J NEUROPSYCH CLIN N, V24, P309, DOI 10.1176/appi.neuropsych.11080188; Rolls ET, 2015, CORTEX, V62, P119, DOI 10.1016/j.cortex.2013.12.005; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Sigurdardottir S, 2016, NEUROPSYCHOLOGY, V30, P98, DOI 10.1037/neu0000206; Soudry Y, 2011, EUR ANN OTORHINOLARY, V128, P18, DOI 10.1016/j.anorl.2010.09.007; Steer, 1990, MANUAL BECK ANXIETY; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Terpstra AR, 2017, NEUROREHAB NEURAL RE, V31, P1063, DOI 10.1177/1545968317736817; Terry DP, 2018, CLIN NEUROPSYCHOL, V4, P1; Uecker FC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170492; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; Zahniser E, 2019, J NEUROTRAUM, V36, P1786, DOI 10.1089/neu.2018.6172	65	1	1	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	JUL	2020	45	6					483	490		10.1093/chemse/bjaa037			8	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	OF1TI	WOS:000580998900008	32516412				2022-02-06	
J	Harvey, J; Farquharson, K; Schneider-Cline, W; Bush, E; Pelatti, CY				Harvey, Judy; Farquharson, Kelly; Schneider-Cline, Whitney; Bush, Erin; Pelatti, Christina Yeager			Describing the Composition of Individualized Education Plans for Students With Traumatic Brain Injury	LANGUAGE SPEECH AND HEARING SERVICES IN SCHOOLS			English	Article							POSTACUTE REHABILITATION; IEP GOALS; CHILDREN; TBI; SCHOOL; CONSEQUENCES; TRANSITION; DISABILITY; SUPPORTS; MODERATE	Purpose: The purpose of this study was to explore and describe the features of Individualized Education Plans (IEPs) for a cohort of students with traumatic brain injury (TBI) to help elucidate current special education practices for students with TBI. Method: We obtained permission from administrators of a local school district of 41,000 students in a Midwestern state to review de-identified IEP records of students verified with TBI. We examined demographic information (i.e., cause and age at time of injury), IEP services and intensity, IEP goal categories, and previous verification status. Results: Descriptive results support that intervention services were more intense for students with TBI with greater lengths of time postinjury. Target behaviors within goals were more often related to math and reading than to the cognitive processes that govern these skills, such as attention, memory, and executive functioning. Finally, more than a third of our sample had been verified with a disability and were receiving special education services via an IEP prior to their TBI. Conclusions: This work represents an important first step in understanding the special education services for students with TBI. Future research should explore interventions that are ecologically valid for school-based settings and are developed to address the idiosyncratic deficits of students with TBI, particularly interventions that focus on the underlying cognitive processes experienced by these students.	[Harvey, Judy] Univ Nebraska Lincoln, Dept Special Educ & Commun Disorders, Lincoln, NE 68588 USA; [Farquharson, Kelly] Florida State Univ, Sch Commun Sci & Disorders, Tallahassee, FL 32306 USA; [Schneider-Cline, Whitney] Univ Nebraska Kearney, Dept Commun Disorders, Kearney, NE USA; [Bush, Erin] Univ Wyoming, Dept Commun Disorders, Laramie, WY 82071 USA; [Pelatti, Christina Yeager] Towson Univ, Dept Speech Language Pathol & Audiol, Towson, MD USA		Harvey, J (corresponding author), Univ Nebraska Lincoln, Dept Special Educ & Commun Disorders, Lincoln, NE 68588 USA.	Judy.harvey@unl.edu		Farquharson, Kelly/0000-0003-1836-4681			Aldrich EM, 2012, CAN J SCH PSYCHOL, V27, P291, DOI 10.1177/0829573512455016; Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Arroyos-Jurado E, 2008, INTERV SCH CLIN, V43, P252, DOI 10.1177/1053451208314907; Ashley M.J., 2016, ESSENTIAL BRAIN INJU, V4th ed., P1; Ashman TA, 2006, MT SINAI J MED, V73, P999; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491; BRENNAN RL, 1981, EDUC PSYCHOL MEAS, V41, P687, DOI 10.1177/001316448104100307; Clark E, 1999, SCHOOL PSYCHOL REV, V28, P242; Constantinidou F, 2005, J HEAD TRAUMA REHAB, V20, P143, DOI 10.1097/00001199-200503000-00003; CONSTANTINIDOU F, 1995, J HEAD TRAUMA REHAB, V10, P90, DOI 10.1097/00001199-199508000-00009; Constantinidou F, 2008, J HEAD TRAUMA REHAB, V23, P312, DOI 10.1097/01.HTR.0000336844.99079.2c; Constantinidou F, 2010, TRAUMATIC BRAIN INJURY: REHABILITATION, TREATMENT, AND CASE MANAGEMENT, 3RD EDITION, P549, DOI 10.1201/9781439849828-c18; Crowe Louise M, 2015, Handb Clin Neurol, V128, P661, DOI 10.1016/B978-0-444-63521-1.00041-8; Dettmer J., 2018, BRAIN INJURY CHILDRE; Drasgow E, 2001, REM SPEC EDUC, V22, P359, DOI 10.1177/074193250102200606; Escobar MA, 2016, PEDIATR SURG INT, V32, P377, DOI 10.1007/s00383-016-3863-8; Ettel D, 2016, EXCEPTIONALITY ED IN, V26, P1, DOI DOI 10.5206/EEI.V26I1.7732; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Farquharson K, 2014, J COMMUN DISORD, V52, P184, DOI 10.1016/j.jcomdis.2014.09.005; Fauld M., 2010, TRAUMATIC BRAIN INJU; Feeney TJ, 2008, J POSIT BEHAV INTERV, V10, P115, DOI 10.1177/1098300707312540; Gioia GA, 2016, J HEAD TRAUMA REHAB, V31, P397, DOI 10.1097/HTR.0000000000000205; Glang A, 2015, EXCEPTIONALITY, V23, P211, DOI 10.1080/09362835.2014.986612; Glang A, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P602; GOODMAN R, 1989, BRIT J PSYCHIAT, V154, P292, DOI 10.1192/bjp.154.3.292; Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600; Haarbauer-Krupa J, 2018, JAMA PEDIATR, V172, P1078, DOI 10.1001/jamapediatrics.2018.2740; Haarbauer-Krupa J, 2018, NEUROREHABILITATION, V42, P259, DOI 10.3233/NRE-172410; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Jantz PB, 2007, SUPPORT LEARN, V22, P84, DOI 10.1111/j.1467-9604.2007.00452.x; Jiang H, 2018, READ WRIT, V31, P1449, DOI 10.1007/s11145-018-9840-y; Kaufman JN, 2017, REHABIL PSYCHOL, V62, P223, DOI 10.1037/rep0000169; Lambregts SAM, 2018, DEV NEUROREHABIL, V21, P465, DOI 10.1080/17518423.2018.1460770; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; McKinlay A, 2016, BRAIN INJURY, V30, P1656, DOI 10.1080/02699052.2016.1201592; Mealings M, 2012, BRAIN INJURY, V26, P1165, DOI 10.3109/02699052.2012.672785; MIRA MP, 1991, FOCUS EXCEPT CHILD, V23, P1; Paul AR, 2014, TRANSL PEDIATR, V3, P195, DOI 10.3978/j.issn.2224-4336.2014.06.01; Pershelli A., 2007, PHYS DISABILITIES ED, V26, P31; Popernack ML, 2015, J PEDIATR HEALTH CAR, V29, pE1, DOI 10.1016/j.pedhc.2014.09.003; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Pretti-Frontczak K, 2000, J EARLY INTERVENTION, V23, P92, DOI 10.1177/105381510002300204; Prevention C. F. D. C. a., 2019, TRAUM BRAIN INJ CONC; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Schutz LE, 2010, INT J SPEC EDUC, V25, P55; Semrud-Clikeman M, 2010, APPL NEUROPSYCHOL, V17, P116, DOI 10.1080/09084281003708985; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Sohlberg MM, 2012, ARCH CLIN NEUROPSYCH, V27, P931, DOI 10.1093/arclin/acs080; Sohlberg MM, 2003, J MED SPEECH-LANG PA, V11, pXIX; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; U.S. Department of Education, 2018, OFF SPEC ED PROGR AN; U.S. Department of Education National Center for Education Statistics, 2019, 2018070 NCES US DEP; Yell M. L., 2003, ASSES EFF INTERV, V28, P73; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	59	1	1	1	6	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	0161-1461	1558-9129		LANG SPEECH HEAR SER	Lang. Speech Hear. Serv. Sch.	JUL	2020	51	3					839	851		10.1044/2020_LSHSS-19-00074			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	MO4HM	WOS:000551489000023	32492357				2022-02-06	
J	Khoo, TC; FitzGerald, A; MacDonald, E; Bradley, L				Khoo, Teng Cheng; FitzGerald, Alasdair; MacDonald, Elizabeth; Bradley, Lloyd			Outcomes for older adults in inpatient specialist neurorehabilitation	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Neurorehabilitation; Rehabilitation; Rehabilitation potential; Older adults; UK FIM plus FAM	TRAUMATIC BRAIN-INJURY	Background: Inpatient specialist neurorehabilitation in the United Kingdom is based on providing a service to "working-age'' adults (<65 years), with little evidence for outcomes for older adults involved with these services. Objective: The aim of this study is to determine any difference in outcome after inpatient neurorehabilitation between younger and older adults assessed as having rehabilitation potential. Methods: A two-centre retrospective review was performed comparing patients aged < 65 and >= 65 years by diagnostic group in terms of length of stay, changes in UK Functional Independence Measure + Functional Assessment Measure (UK FIM + FAM) scores and discharge destination. Results: Six hundred and sixteen patients (32% >= 65 years) were included. The 2 age groups did not differ in length of stay (median difference 7 days, 95% confidence interval [CI] -2 to 15, P = 0.112), but both UK FIM + FAM change and efficiency were higher for the older than younger group (median difference 7, 95% CI 2-13, P = 0.006 and 0.10, 0.01-0.19, P = 0.031 respectively). Older age was associated with discharge to long-term care (6% < 65 years; 11% >= 65 years, x(2) = 4.10, P = 0.043). Results and trends were similar in patients with acquired brain injury (n = 429), spinal cord injury (n = 59) and peripheral neuropathy (n = 34) but not progressive neurological disorders (n = 70). Conclusion: Older adults considered to have rehabilitation potential may have greater functional gains from inpatient specialist inpatient rehabilitation than younger adults. Age alone should not exclude admission to inpatient specialist neurorehabilitation. Crown Copyright (C) 2019 Published by Elsevier Masson SAS. All rights reserved.	[Khoo, Teng Cheng; FitzGerald, Alasdair] Astley Ainslie Hosp, Dept Neurorehabil, Edinburgh, Midlothian, Scotland; [MacDonald, Elizabeth] Western Gen Hosp, Dept Med Elderly, Edinburgh, Midlothian, Scotland; [Bradley, Lloyd] Western Sussex Hosp NHS Trust, Donald Wilson House Neurol Rehabil Ctr, Chichester, England		Khoo, TC (corresponding author), Astley Ainslie Hosp, Charles Bell Pavil,133 Grange Loan, Edinburgh EH9 2HL, Midlothian, Scotland.	t.khoo@nhs.net	Khoo, Teng Cheng/AAV-3348-2020	Khoo, Teng Cheng/0000-0001-8530-5644			BACHMANN S, 2010, BRIT MED J, V0340, DOI DOI 10.1136/BMJ.C1718; Brown K, 2017, INJURY PREV, V23, P403, DOI 10.1136/injuryprev-2016-042192; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; de Bidegain I., 2015, EMPLOYMENT STAT WORK; Department for Work and Pensions, 2013, STAT PENS AG TIM; Dijkers M, 2013, NEUROREHABILITATION, V32, P233, DOI 10.3233/NRE-130841; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gaughan J, 2017, INT J HEALTH ECON MA, V17, P311, DOI 10.1007/s10754-017-9214-z; Hurn J, 2006, CLIN REHABIL, V20, P756, DOI 10.1177/0269215506070793; Jakob W, 2009, J NEUROTRAUM, V26, P2037, DOI 10.1089/neu.2008.0824; Kelly ME, 2014, AGEING RES REV, V15, P28, DOI 10.1016/j.arr.2014.02.004; Khan F, 2007, MULTIDISCIPLINARY RE; Maeshima S, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0539-x; Mitnitski Arnold B, 2002, BMC Geriatr, V2, P1; Turner-Stokes L, 2015, MULTIDISCIPLINARY RE; Turner-Stokes L, 2016, UK REHABILITATION OU; Turner-Stokes L, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010238; Turner-Stokes L, 2013, DISABIL REHABIL, V35, P1885, DOI 10.3109/09638288.2013.766271; World Health Organization, 2017, PROP WORK DEF OLD PE	20	1	1	1	4	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	JUL	2020	63	4					340	343		10.1016/j.rehab.2019.05.001			4	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	MM6SJ	WOS:000550284400011	31129224	Bronze			2022-02-06	
J	Mahan, M; Rafter, D; Casey, H; Engelking, M; Abdallah, T; Truwit, C; Oswood, M; Samadani, U				Mahan, Margaret; Rafter, Daniel; Casey, Hannah; Engelking, Marta; Abdallah, Tessneem; Truwit, Charles; Oswood, Mark; Samadani, Uzma			tbiExtractor: A framework for extracting traumatic brain injury common data elements from radiology reports	PLOS ONE			English	Article							AUTOMATED OUTCOME CLASSIFICATION; COMPUTED-TOMOGRAPHY; EMERGENCY-DEPARTMENT; HEAD-INJURY; LANGUAGE; AGREEMENT; DIAGNOSIS	Background The manual extraction of valuable data from electronic medical records is cumbersome, error-prone, and inconsistent. By automating extraction in conjunction with standardized terminology, the quality and consistency of data utilized for research and clinical purposes would be substantially improved. Here, we set out to develop and validate a framework to extract pertinent clinical conditions for traumatic brain injury (TBI) from computed tomography (CT) reports. Methods We developed tbiExtractor, which extends pyConTextNLP, a regular expression algorithm using negation detection and contextual features, to create a framework for extracting TBI common data elements from radiology reports. The algorithm inputs radiology reports and outputs a structured summary containing 27 clinical findings with their respective annotations. Development and validation of the algorithm was completed using two physician annotators as the gold standard. Results tbiExtractor displayed high sensitivity (0.92-0.94) and specificity (0.99) when compared to the gold standard. The algorithm also demonstrated a high equivalence (94.6%) with the annotators. A majority of clinical findings (85%) had minimal errors (F1 Score >= 0.80). When compared to annotators, tbiExtractor extracted information in significantly less time (0.3 sec vs 1.7 min per report). Conclusion tbiExtractor is a validated algorithm for extraction of TBI common data elements from radiology reports. This automation reduces the time spent to extract structured data and improves the consistency of data extracted. Lastly, tbiExtractor can be used to stratify subjects into groups based on visible damage by partitioning the annotations of the pertinent clinical conditions on a radiology report.	[Mahan, Margaret; Rafter, Daniel; Casey, Hannah; Engelking, Marta; Abdallah, Tessneem; Samadani, Uzma] Univ Minnesota, Dept Biomed Informat & Computat Biol, Minneapolis, MN 55455 USA; [Truwit, Charles] Philips Global, Diagnost Imaging, Maple Grove, MN USA; [Oswood, Mark] Hennepin Healthcare, Dept Radiol, Minneapolis, MN USA; [Oswood, Mark] Univ Minnesota, Dept Radiol, Minneapolis, MN 55455 USA; [Samadani, Uzma] Minneapolis VA Med Ctr, Dept Neurosurg, Minneapolis, MN 55417 USA		Samadani, U (corresponding author), Univ Minnesota, Dept Biomed Informat & Computat Biol, Minneapolis, MN 55455 USA.; Samadani, U (corresponding author), Minneapolis VA Med Ctr, Dept Neurosurg, Minneapolis, MN 55417 USA.	uzma@samadani.com	Truwit, Charles/AAL-7140-2021	Truwit, Charles/0000-0001-8598-9812; Abdallah, Tessneem/0000-0002-1604-9621; Samadani, Uzma/0000-0003-2566-5909; Mahan, Margaret/0000-0002-7332-9523; Casey, Hannah/0000-0002-6562-4020; Oswood, Mark/0000-0002-9942-4094	Minnesota Spinal Cord and Traumatic Brain Injury Research Fund; Rockswold Kaplan Endowed Chair for TBI Research	This study was funded by the Minnesota Spinal Cord and Traumatic Brain Injury Research Fund (https://www.ohe.state.mn.us/mPg.cfm?pageID=2180) as well as the Rockswold Kaplan Endowed Chair for TBI Research (https://www.hennepinhealthcare.org/specialty/brain-injuryresearch/).US was awarded these funds and MM, DR, HC, and TA were paid at least in part by the funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AWAKE, V89, P3; Artstein R, 2008, COMPUT LINGUIST, V34, P555, DOI 10.1162/coli.07-034-R2; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Cai TR, 2016, RADIOGRAPHICS, V36, P176, DOI 10.1148/rg.2016150080; Chapman BE, 2016, P 15 WORKSH BIOM NAT, P181; Chapman BE, 2011, J BIOMED INFORM, V44, P728, DOI 10.1016/j.jbi.2011.03.011; Chapman W, BIONLP 2007 BIOL TRA, P81; Chapman WW, 2001, J BIOMED INFORM, V34, P301, DOI 10.1006/jbin.2001.1029; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Demner-Fushman D, 2009, J BIOMED INFORM, V42, P760, DOI 10.1016/j.jbi.2009.08.007; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P410, DOI 10.1136/jnnp.2003.016113; Faul M, 2015, EPIDEMIOLOGY TRAUMAT, V127, P25; Friedman C, 2004, J AM MED INFORM ASSN, V11, P392, DOI 10.1197/jamia.M1552; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hagberg A. A., 2008, PROC 7 PYTHON SCI C, P11; Harkema H, 2009, J BIOMED INFORM, V42, P839, DOI 10.1016/j.jbi.2009.05.002; Hassanpour S, 2017, J DIGIT IMAGING, V30, P314, DOI 10.1007/s10278-016-9931-8; Hassanpour S, 2016, ARTIF INTELL MED, V66, P29, DOI 10.1016/j.artmed.2015.09.007; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jones E., SCIPY OPEN SOURCE SC; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McKinney W, 2010, P 9 PYTH SCI C, P56, DOI DOI 10.25080/MAJORA-92BF1922-00A; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nadkarni PM, 2011, J AM MED INFORM ASSN, V18, P544, DOI 10.1136/amiajnl-2011-000464; Oliphant T. E., 2006, A GUIDE TO NUMPY; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pons E, 2016, RADIOLOGY, V279, P329, DOI 10.1148/radiol.16142770; Rubin DL, 2017, RADIOLOGY, V283, P836, DOI 10.1148/radiol.2016161553; Sevenster M, 2015, APPL CLIN INFORM, V6, P600, DOI 10.4338/ACI-2014-11-RA-0110; Sevenster M, 2015, J BIOMED INFORM, V53, P36, DOI 10.1016/j.jbi.2014.08.015; Strauss JA, 2013, J AM MED INFORM ASSN, V20, P349, DOI 10.1136/amiajnl-2012-000928; Weng CH, 2015, TRENDS PHARMACOL SCI, V36, P706, DOI 10.1016/j.tips.2015.08.007; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Yadav K, 2016, ACAD EMERG MED, V23, P171, DOI 10.1111/acem.12859; Yadav K, 2013, ACAD EMERG MED, V20, P848, DOI 10.1111/acem.12174; Zeng Qing T, 2006, BMC Med Inform Decis Mak, V6, P30, DOI 10.1186/1472-6947-6-30; Zheng CY, 2015, CLIN THER, V37, P2048, DOI 10.1016/j.clinthera.2015.07.002	40	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2020	15	7							e0214775	10.1371/journal.pone.0214775			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MH8TI	WOS:000546994200027	32609723	gold, Green Published, Green Submitted			2022-02-06	
J	Martens, G; Bodien, Y; Thomas, A; Giacino, J				Martens, Geraldine; Bodien, Yelena; Thomas, Amber; Giacino, Joseph			Temporal Profile of Recovery of Communication in Patients With Disorders of Consciousness After Severe Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Communication; Consciousness disorders; Rehabilitation	COMA; STATE; NEEDS	Objective: Characterize the temporal profile of recovery of communication after severe brain injury. Design: Retrospective cohort study. Setting: Inpatient rehabilitation hospital. Participants: Patients with severe acquired brain injury and no evidence of communication on the Coma Recovery Scale-Revised (CRS-R) (N=175). Main Outcome Measures: Time from injury to recovery of intentional communication (IC, inconsistent yes/no responses) and functional communication (FC, consistent and accurate yes/no responses) on the CRS-R Communication subscale. Results: Patients (N=175) were included in the primary observation period of the first 8 weeks of inpatient rehabilitation (median [interquartile range, IQR]: 48 [27-61] years old, 105 men, 28 [21-38] days postinjury, 100 traumatic etiology). Fifty-four patients (31%) did not recover IC or FC. Thirty patients (17%) recovered IC only (median [IQR] days from injury to IC = 40 [34-54]), 72 patients (41%) recovered IC followed by FC (days from injury to FC=50 [42-61]), and 19 patients (11%) recovered FC without first recovering IC (43 [32-63]). The patients who recovered neither IC nor FC within 8 weeks of admission were admitted to rehabilitation later than those who recovered IC and/or FC (P<.01). Sixteen patients who did not recover communication within 8 weeks of admission to rehabilitation subsequently recovered FC prior to discharge. Conclusions: In patients with severe brain injury receiving inpatient rehabilitation, discernible yes-no responses emerged approximately 6 weeks postinjury and became reliable 1 week later. Approximately 1 in 3 patients did not demonstrate IC or FC within 8 weeks of admission to rehabilitation, although 33% of these individuals recovered communication prior to discharge. In total, 61% of patients recovered FC prior to discharge from rehabilitation. (C) 2020 by the American Congress of Rehabilitation Medicine	[Martens, Geraldine; Bodien, Yelena; Thomas, Amber; Giacino, Joseph] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Martens, Geraldine] Univ Liege, GIGA Consciousness, GIGA Res, Coma Sci Grp, 11 Ave Hop, B-4000 Liege, Sart Tilman, Belgium; [Martens, Geraldine] Univ Hosp Liege, Ctr Integre Pluridisciplinaire Etud Cerveau Cogni, Ctr Cerveau2, Liege, Belgium; [Bodien, Yelena] Massachusetts Gen Hosp, Lab Neuroimaging Coma & Consciousness, Boston, MA 02114 USA		Martens, G (corresponding author), Univ Liege, GIGA Consciousness, GIGA Res, Coma Sci Grp, 11 Ave Hop, B-4000 Liege, Sart Tilman, Belgium.	geraldine.martens@ulg.ac.be	Giacino, Joseph/AAF-1952-2021; Martens, Geraldine/ABF-1147-2020	Giacino, Joseph/0000-0002-7916-9698; Martens, Geraldine/0000-0001-7038-7165	National Institute on Disability, Independent Living, and Rehabilitation Research within the Administration for Community Living, Department of Health and Human Services [90DPTB0011]; University of Lie`ge (LEAR Foundation); Wallonia-Brussels Federation; Wallonie-Bruxelles International (WBI.World); Tiny Blue Dot Foundation; James S. McDonnell Foundation	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (grant no. 90DPTB0011), which is a Center within the Administration for Community Living, Department of Health and Human Services, University of Lie`ge (LEAR Foundation), the Wallonia-Brussels Federation, Wallonie-Bruxelles International (WBI.World), Tiny Blue Dot Foundation, and the James S. McDonnell Foundation.	ANDREWS K, 1993, BRIT MED J, V306, P1597, DOI 10.1136/bmj.306.6892.1597; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bucki B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215425; Giacino JT, 2020, J NEUROTRAUM, V37, P357, DOI 10.1089/neu.2019.6429; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Konigs M, 2018, ARCH PHYS MED REHAB, V99, P1149, DOI 10.1016/j.apmr.2018.01.013; Krishnan S, 2017, AM J PHYS MED REHAB, V96, P487, DOI 10.1097/PHM.0000000000000717; La Porta F, 2013, ARCH PHYS MED REHAB, V94, P527, DOI 10.1016/j.apmr.2012.09.035; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Lugo Z, 2017, BRAIN INJURY, V31, P1590, DOI 10.1080/02699052.2017.1347277; NAJENSON T, 1978, SCAND J REHABIL MED, V10, P15; Nakase-Richardson R, 2009, NEUROLOGY, V73, P1120, DOI 10.1212/WNL.0b013e3181bacf34; Noe E, 2012, ARCH PHYS MED REHAB, V93, P428, DOI 10.1016/j.apmr.2011.08.048; Wallace T, 2011, NEUROREHABILITATION, V28, P199, DOI 10.3233/NRE-2011-0649; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041	16	1	1	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	2020	101	7					1260	1264		10.1016/j.apmr.2020.01.015			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	MC1CG	WOS:000543033600018	32113971				2022-02-06	
J	Mayer, AR; Wertz, CJ; Robertson-Benta, CR; Reddy, SP; Stephenson, DD; Dodd, AB; Oglesbee, SJ; Bedrick, EJ; Master, CL; Grady, M; Shaff, NA; Hanlon, FM; Campbell, RA; Phillips, JP; Zemek, RL; Yeates, KO; Meier, TB; Mannix, R; Leddy, JJ; Arbogast, KB; Park, G				Mayer, Andrew R.; Wertz, Christopher J.; Robertson-Benta, Cidney R.; Reddy, Sharvani Pabbathi; Stephenson, David D.; Dodd, Andrew B.; Oglesbee, Scott J.; Bedrick, Edward J.; Master, Christina L.; Grady, Mathew; Shaff, Nicholas A.; Hanlon, Faith M.; Campbell, Richard A.; Phillips, John P.; Zemek, Roger L.; Yeates, Keith Owen; Meier, Timothy B.; Mannix, Rebekah; Leddy, John J.; Arbogast, Kristy B.; Park, Grace			Neurosensory Screening and Symptom Provocation in Pediatric Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; concussion; ocular motor; recovery; vestibular; vision	SPORT-RELATED CONCUSSION; CONVERGENCE INSUFFICIENCY; KING-DEVICK; RECOVERY; RELIABILITY; PERFORMANCE; VALIDITY; CHILDREN; COMMON; YOUTH	Objective: To evaluate diagnostic/prognostic implications of neurosensory testing during the subacute stage in patients with pediatric mild traumatic brain injury (pmTBI). Setting: Recruitment from pediatric emergency department and urgent care clinics, assessment in a controlled environment. Participants: In total, 146 pmTBI patients evaluated 7.4 +/- 2.3 days and approximately 4 months postinjury; 104 age/sex-matched healthy controls (HCs) at equivalent time points. Design: Prospective cohort study. Main Measures: Neurosensory examination based on sequence of 10 established tests of vestibular-ocular, oculomotor, vestibulospinal, and visual functioning. Results: The amount of symptom provocation (positive change from pretest symptomatology) was significantly increased in pmTBI relative to HCs on every subtest 1 week postinjury, as were deficits in monocular accommodative amplitude and King-Devick Test errors. However, symptom provocation did not meaningfully alter diagnostic sensitivity/specificity relative to more easily obtained pretest symptom ratings. Evidence of clinically significant symptom provocation 1 week postinjury improved sensitivity (Delta = +12.9%) of identifying patients with persistent postconcussive symptoms 4 months postinjury on an independent symptom measure. Conclusions: The diagnostic sensitivity/specificity of neurosensory testing in acutely concussed youth may be limited at 1 week postinjury as a function of natural recovery occurring in most emergency department cohorts. Neurosensory screening may have greater utility for identifying patients who experience delayed recovery.	[Mayer, Andrew R.; Wertz, Christopher J.; Robertson-Benta, Cidney R.; Reddy, Sharvani Pabbathi; Stephenson, David D.; Dodd, Andrew B.; Shaff, Nicholas A.; Hanlon, Faith M.; Phillips, John P.] Lovelace Biomed & Environm Res Inst, Mind Res Network, Albuquerque, NM USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychiat & Behav Sci, Albuquerque, NM 87131 USA; [Mayer, Andrew R.; Campbell, Richard A.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.; Phillips, John P.] Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA; [Oglesbee, Scott J.; Park, Grace] Univ New Mexico, Dept Emergency Med, Albuquerque, NM 87131 USA; [Bedrick, Edward J.] Univ Arizona, Dept Epidemiol & Biostat, Tucson, AZ USA; [Master, Christina L.; Grady, Mathew; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Dept Pediat, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Master, Christina L.; Grady, Mathew] Childrens Hosp Philadelphia, Div Orthoped Surg, Philadelphia, PA 19104 USA; [Zemek, Roger L.] Univ Ottawa, Childrens Hosp Eastern Ontario Res Inst, Dept Pediat & Emergency Med, Ottawa, ON, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA; [Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Leddy, John J.] Univ Buffalo, Jacobs Sch Med, UBMD Dept Orthopaed & Sports Med, Buffalo, NY USA		Mayer, AR (corresponding author), Mind Res Network, Pete & Nancy Domenici Hall,1101 Yale Blvd NE, Albuquerque, NM 87106 USA.	amayer@mrn.org	Yeates, Keith/AAJ-4223-2020		National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH01 R01 NS098494-01A1, FITBIR-STUDY0000339]	This research was supported by grants from the National Institutes of Health (NIH; https://www.nih.gov; grant nos. NIH01 R01 NS098494-01A1 and -03S1A1) to Andrew R. Mayer. The data that support the findings of this study will be openly available in FITBIR at fitbir.nih.gov upon the conclusion of the study (reference no. FITBIR-STUDY0000339).	Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; DuPrey KM, 2017, AM J SPORT MED, V45, P2388, DOI 10.1177/0363546517705640; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hoffer ME, 2015, CURR OPIN NEUROL, V28, P74, DOI 10.1097/WCO.0000000000000164; Howell DR, 2018, AM J SPORT MED, V46, P3254, DOI 10.1177/0363546518796830; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Leddy J, 2021, CLIN J SPORT MED, V31, P7, DOI 10.1097/JSM.0000000000000686; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; Mayer AR, 2018, J NEUROTRAUM, V35, P1178, DOI 10.1089/neu.2017.5340; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Sady MD, 2019, J HEAD TRAUMA REHAB, V34, pE35, DOI 10.1097/HTR.0000000000000424; Scheiman M, 2005, ARCH OPHTHALMOL-CHIC, V123, P14, DOI 10.1001/archopht.123.1.14; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Swanson MW, 2017, OPTOMETRY VISION SCI, V94, P60, DOI 10.1097/OPX.0000000000000977; Weise KK, 2017, OPTOMETRY VISION SCI, V94, P89, DOI 10.1097/OPX.0000000000000938; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	31	1	1	2	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2020	35	4			SI		270	278		10.1097/HTR.0000000000000560			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MR1MK	WOS:000553355300004	32108710	Green Accepted			2022-02-06	
J	Melcer, T; Walker, J; Sazon, J; Domasing, R; Perez, K; Bhatnagar, V; Galarneau, M				Melcer, Ted; Walker, Jay; Sazon, Jocelyn; Domasing, Robby; Perez, Katheryne; Bhatnagar, Vibha; Galarneau, Michael			Outpatient Pharmacy Prescriptions During the First Year Following Serious Combat Injury: A Retrospective Analysis	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; LOWER-LIMB AMPUTATION; OPIOID USE; SEVERITY SCORE; CHRONIC PAIN; IRAQ; VETERANS; WAR; INFECTIONS; PREVALENCE	Introduction Limited research has analyzed the full range of outpatient medication prescription activity following serious combat injury. The objectives of this study were to describe (1) outpatient medication prescriptions and refills during the first 12 months after serious combat injury, (2) longitudinal changes in medication prescriptions during the first-year postinjury, and (3) patient characteristics associated with outpatient prescriptions. Materials and methods This was a retrospective analysis of existing health and pharmacy data for a random sample of U.S. service members who sustained serious combat injuries in the Iraq and Afghanistan conflicts, 2010-2013 (n = 381). Serious injury was defined by an Injury Severity Score (ISS) of 9 or greater. These patients typically participate in military rehabilitation programs (eg, amputation care) where prescription medications are essential. Data sources were the Expeditionary Medical Encounter Database for injury-specific data, the Pharmacy Data Transaction Service for outpatient medication prescriptions and refills, and the Military Health System Data Repository for diagnostic codes of pain and psychological disorders. Military trauma nurses reviewed casualty records to identify types of injuries. Using the American Hospital Formulary Service Pharmacologic-Therapeutic Classification system, clinicians identified 13 categories of prescription medications (eg, opioid, psychotherapeutic, immunologic) for analysis. Multivariable negative binomial and logistic regression analyses evaluated significant associations between independent variables (eg, blast injury, traumatic brain injury [TBI], ISS, limb amputation, diagnoses of chronic pain, or psychological disorders) and prescription measures (ie, number or category of medication prescriptions). We also describe longitudinal changes in prescription activity postinjury across consecutive quarterly intervals (91 days) during the first-year postinjury. Results During the first-year postinjury, patients averaged 61 outpatient prescriptions, including all initial prescriptions and refills. They averaged eight different categories of medications, primarily opioid, immunologic, gastrointestinal/genitourinary, central nervous system (CNS), nonopioid analgesic, and psychotherapeutic medications (representing 82% of prescriptions) during the first year. Prescription activity generally declined across quarters. There was still substantial prescription activity during the fourth quarter, as 79% of patients had at least one prescription. From 39 to 49% of patients had fourth-quarter prescriptions for opioid, CNS, or psychotherapeutic medications. Longitudinally, we found that 24-34% of patients had an opioid, CNS, or psychotherapeutic prescription during each of the final three quarters. In multivariable analysis, ISS, limb amputation (particularly bilateral amputation), and diagnoses of chronic pain and post-traumatic stress disorder (PTSD) were associated with significantly higher counts of individual and multiple medication prescriptions. TBI was associated with significantly lower numbers of prescriptions for certain medications. Conclusions This is one of the first studies to provide a systematic analysis of outpatient medication prescriptions following serious combat injury. The results indicate substantial prescription activity from multiple medication categories throughout the first-year postinjury. Diagnoses of chronic pain, PTSD, and limb amputation and ISS were associated with significantly higher counts of prescriptions overall and more prescription medication categories. This study provides initial evidence to better understand medication prescription activity following serious combat injury. The results inform future research on medication prescription practices and planning for rehabilitation.	[Melcer, Ted; Walker, Jay; Sazon, Jocelyn; Domasing, Robby; Perez, Katheryne; Galarneau, Michael] Naval Hlth Res Ctr, 140 Sylvester Rd, San Diego, CA 92106 USA; [Walker, Jay; Perez, Katheryne] Leidos Inc, 140 Sylvester Rd, San Diego, CA 92106 USA; [Sazon, Jocelyn; Domasing, Robby] Axiom Resource Management Inc, 140 Sylvester Rd, San Diego, CA 92106 USA; [Bhatnagar, Vibha] VA San Diego Healthcare Syst, 3350 La Jolla Village Dr, San Diego, CA 92161 USA; [Bhatnagar, Vibha] Univ Calif San Diego, Dept Family Med & Publ Hlth, 9500 Gilman Dr, La Jolla, CA 92093 USA		Melcer, T (corresponding author), Naval Hlth Res Ctr, 140 Sylvester Rd, San Diego, CA 92106 USA.				DoD/VA Extremity Trauma and Amputation Center of Excellence [N3111]	This research was funded by the DoD/VA Extremity Trauma and Amputation Center of Excellence under work unit no. N3111.	Adams RS, 2019, MIL MED, V184, pE101, DOI 10.1093/milmed/usy162; Al-Azzawi IS, 2014, INJURY, V45, P885, DOI 10.1016/j.injury.2014.01.005; Andersen RC, 2014, J AM ACAD ORTHOP SUR, V22, P57, DOI 10.5435/JAAOS-22-01-57; Andersen Romney C, 2012, J Surg Orthop Adv, V21, P2; Attipoe S, 2015, MIL MED, V180, P742, DOI 10.7205/MILMED-D-14-00510; Bhatnagar V, 2015, J REHABIL RES DEV, V52, P827, DOI 10.1682/JRRD.2014.11.0288; Buckenmaier CC, 2009, PAIN MED, V10, P1487, DOI 10.1111/j.1526-4637.2009.00731.x; Butler Frank K, 2014, J Spec Oper Med, V14, P13; Castillo RC, 2006, PAIN, V124, P321, DOI 10.1016/j.pain.2006.04.020; Chaudhary MA, 2017, JAMA SURG, V152, P930, DOI 10.1001/jamasurg.2017.1685; Cohen BE, 2015, J CLIN PSYCHIAT, V76, P406, DOI 10.4088/JCP.13m08857; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Devine JW, 2009, MIL MED, V174, P958, DOI 10.7205/MILMED-D-01-2309; Eide Richard P 3rd, 2018, MSMR, V25, P2; Gailey R, 2008, J REHABIL RES DEV, V45, P15, DOI 10.1682/JRRD.2006.11.0147; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gomes T, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0217; Holbrook TL, 2010, NEW ENGL J MED, V362, P110, DOI 10.1056/NEJMoa0903326; Hudson TJ, 2017, PAIN, V158, P1039, DOI 10.1097/j.pain.0000000000000874; Hutchison TN, 2014, J SURG RES, V187, P625, DOI 10.1016/j.jss.2013.11.008; Jeffery DD, 2014, MIL MED, V179, P1141, DOI 10.7205/MILMED-D-14-00002; Kazanis W, 2018, MIL MED, V183, pE157, DOI 10.1093/milmed/usx014; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lieberman HR, 2010, AM J CLIN NUTR, V92, P985, DOI 10.3945/ajcn.2010.29274; Macdonald, 2014, HDB BIOL STAT; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; MACKENZIE EJ, 1985, MED CARE, V23, P823, DOI 10.1097/00005650-198506000-00008; Marmar CR, 2015, JAMA PSYCHIAT, V72, P875, DOI 10.1001/jamapsychiatry.2015.0803; Melcer T, 2020, MIL MED, V185, pE244, DOI 10.1093/milmed/usz149; Melcer Ted, 2016, J Rehabil Res Dev, V53, P1045, DOI 10.1682/JRRD.2014.09.0219; Melcer T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170569; Melcer T, 2013, J TRAUMA ACUTE CARE, V75, pS247, DOI 10.1097/TA.0b013e318299d95e; Military Health System, MDR M2 ICDS FUNCT RE; Mobbs MC, 2018, CLIN PSYCHOL REV, V59, P137, DOI 10.1016/j.cpr.2017.11.007; Myburgh JA, 2013, NEW ENGL J MED, V369, P1243, DOI 10.1056/NEJMra1208627; Office of the Surgeon General/Medical Command, 15039 OFF SURG GEN M; Rai A, 2017, CNS DRUGS, V31, P605, DOI 10.1007/s40263-017-0440-1; Riddle MS, 2015, AM J TROP MED HYG, V93, P912, DOI 10.4269/ajtmh.15-0200; Seal KH, 2018, J PAIN, V19, P931, DOI 10.1016/j.jpain.2018.03.005; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Toblin RL, 2014, JAMA INTERN MED, V174, P1400, DOI 10.1001/jamainternmed.2014.2726; Trice S, 2009, J MANAGE CARE PHARM, V15, P133, DOI 10.18553/jmcp.2009.15.2.133; Vicente D, 2015, COMBAT ANESTHESIA 1; Weintrob AC, 2018, SURG INFECT, V19, P286, DOI 10.1089/sur.2017.240	44	1	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JUL-AUG	2020	185	7-8					E1091	E1100		10.1093/milmed/usaa038			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NP0JG	WOS:000569869400029	32175572	hybrid			2022-02-06	
J	Neumayer, KE; Sweney, J; Fenton, SJ; Keenan, HT; Flaherty, BF				Neumayer, Katie E.; Sweney, Jill; Fenton, Stephen J.; Keenan, Heather T.; Flaherty, Brian F.			Validation of the "CHIIDA" and application for PICU triage in children with complicated mild traumatic brain injury	JOURNAL OF PEDIATRIC SURGERY			English	Article						Pediatric trauma; Mild traumatic brain injury	BLUNT HEAD TRAUMA; COMPUTED-TOMOGRAPHY; DECISION RULE; ADMISSION; TRENDS; COSTS	Background: The Children's Intracranial Injury Decision Aid (CHIIDA) was developed to predict which patients with complicated mild traumatic brain injury (cmTBI; GCS >= 13 with depressed skull fracture or infracranial injury) would achieve the composite outcome of neurosurgical intervention, inlitbalion >24 h, or death. The study also explored the CHIIDA as a triage fool Lo determine need for PICU care. The purpose of this study is Lo externally validate the CHIIDA and assess is effects on PICU triage. Methods: Retrospective cohort study (January 2016 Lo December 2017) Lo validate the CHIIDA to predict the composite outcome and assess its effects as a PICU triage tool of a level 1 pediatric trauma center. Results: Of 345 patients with cmTBI, the composite outcome occurred in 16 patients (4.6%). At a cutoff score of 2, the CHIIDA predicted the composite outcome with a sensitivity of 94% (95% Cl 67-99%,) and specificity of 69% (95% Cl 64-74%), similar to the original study. Using the same cutoff score for PICU triage resulted in 48 (71%) more patients admitted to PICU. Conclusions: In our cohort, the CHIIDA predicted the composite outcome well. If applied as a triage tool, it would have resulted in increased unnecessary PICU admissions. (C) 2019 Elsevier Inc. All rights reserved.	[Neumayer, Katie E.; Sweney, Jill; Keenan, Heather T.; Flaherty, Brian F.] Univ Utah, Sch Med, Dept Pediat, Div Crit Care, Salt Lake City, UT USA; [Fenton, Stephen J.] Univ Utah, Sch Med, Div Pediat Surg, Salt Lake City, UT USA		Neumayer, KE (corresponding author), Univ Utah, Pediat Crit Care, POB 581289, Salt Lake City, UT 84158 USA.	katieneumayer@gmail.com; jill.sweney@hsc.utah.edu; stephen.fenton@hsc.utah.edu; heather.keenan@hsc.utah.edu; brian.flaherty@hsc.utah.edu	Flaherty, Brian/ABA-2534-2020	Flaherty, Brian/0000-0002-3486-606X	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24 HD072984] Funding Source: Medline; NCIPC CDC HHS [U01 CE002188] Funding Source: Medline		Ament JD, 2017, J NEUROSURG-PEDIATR, V19, P668, DOI 10.3171/2017.2.PEDS16419; Balluffi Andrew, 2004, Pediatr Crit Care Med, V5, P547, DOI 10.1097/01.PCC.0000137354.19807.44; Bonow RH, 2019, NEUROCRIT CARE, V30, P157, DOI 10.1007/s12028-018-0590-0; Boran BO, 2006, PEDIATR NEUROSURG, V42, P203, DOI 10.1159/000092355; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Burns EC, 2019, PEDIATR EMERG CARE, V35, P161, DOI 10.1097/PEC.0000000000000950; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Chalom R, 1999, CRIT CARE MED, V27, P2079, DOI 10.1097/00003246-199910000-00001; Colville Gillian, 2009, Intensive Crit Care Nurs, V25, P72, DOI 10.1016/j.iccn.2008.10.002; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Fenton SJ, 2016, J PEDIATR SURG, V51, P1688, DOI 10.1016/j.jpedsurg.2016.05.022; Garcia S, 1997, INTENS CARE MED, V23, P218, DOI 10.1007/s001340050320; Greenberg JK, 2014, J TRAUMA ACUTE CARE, V76, P1089, DOI 10.1097/TA.0000000000000155; Greenberg JK, 2017, JAMA PEDIAT, pE1; Greening J, 2018, J ORTHOP SPORT PHYS, V48, P523, DOI 10.2519/jospt.2018.7875; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Nishijima DK, 2012, INJURY, V43, P1827, DOI 10.1016/j.injury.2011.07.020; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Shudy M, 2006, PEDIATRICS, V118, pS203, DOI 10.1542/peds.2006-0951B; Wang HE, 2012, ANN EMERG MED, V60, P632, DOI 10.1016/j.annemergmed.2012.02.020; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	27	1	1	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	JUL	2020	55	7					1255	1259		10.1016/j.jpedsurg.2019.09.027			5	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	NB4NR	WOS:000560491400014	31685269				2022-02-06	
J	Reimer, K; Ellis, V; Cordingley, DM; Russell, K; Ellis, MJ				Reimer, Karen; Ellis, Vanessa; Cordingley, Dean M.; Russell, Kelly; Ellis, Michael J.			Benign Paroxysmal Positional Vertigo After Pediatric Sports-Related Concussion	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sports-related concussion; benign paroxysmal positional vertigo; traumatic; pathophysiology; multidisciplinary; rehabilitation	ADOLESCENTS; CHILDREN	Objective: Report the clinical findings and outcomes among pediatric patients diagnosed with benign paroxysmal positional vertigo (BPPV) after sports-related concussion (SRC). Design: Retrospective case series. Setting: Multidisciplinary pediatric concussion program. Patients: Patients younger than 19 years with a sport or recreation activity-related concussion referred for comprehensive vestibular physiotherapy assessment. Main outcome measure: Symptom resolution after targeted particle repositioning (PR). Results: During the study period, 115 pediatric SRC patients underwent vestibular physiotherapy assessment including 12 (10.4%) who were diagnosed with BPPV. Unilateral posterior semicircular canal (SCC) BPPV was diagnosed in 8/12 (75%) patients, and unilateral anterior SCC BPPV diagnosed in 4/12 (25%) patients. Benign paroxysmal positional vertigo was successfully treated in all patients with a mean of 1.58 targeted PR maneuvers (range = 1-4). Conclusions: Comprehensive management of pediatric SRC requires a multidisciplinary approach to address the heterogeneous pathophysiology of persistent postconcussion symptoms. Pediatric SRC patients with coexisting BPPV should be considered for targeted PR.	[Reimer, Karen; Ellis, Vanessa; Cordingley, Dean M.; Ellis, Michael J.] Pan Am Clin, Pan Am Concuss Program, 75 Poseidon Bay, Winnipeg, MB R3M 3E4, Canada; [Ellis, Vanessa] Univ Manitoba, Sect Phys Therapy, Winnipeg, MB, Canada; [Reimer, Karen] Univ Manitoba, Coll Rehabil Serv, Winnipeg, MB, Canada; [Reimer, Karen; Cordingley, Dean M.; Russell, Kelly; Ellis, Michael J.] Canada North Concuss Network, Winnipeg, MB, Canada; [Russell, Kelly; Ellis, Michael J.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Russell, Kelly; Ellis, Michael J.] Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Sect Neurosurg, Winnipeg, MB, Canada; Univ Manitoba, Dept Surg, Winnipeg, MB, Canada		Ellis, MJ (corresponding author), Pan Am Clin, Pan Am Concuss Program, 75 Poseidon Bay, Winnipeg, MB R3M 3E4, Canada.	mellis3@panamclinic.com					Anagnostou E, 2015, J CLIN NEUROL, V11, P262, DOI 10.3988/jcn.2015.11.3.262; Aron M, 2015, OTOLARYNG HEAD NECK, V153, P721, DOI 10.1177/0194599815594384; Bhattacharyya N, 2017, OTOLARYNG HEAD NECK, V156, P403, DOI 10.1177/0194599816689660; Brodsky JR, 2018, OTOL NEUROTOL, V39, P344, DOI 10.1097/MAO.0000000000001673; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Foster CA, 2012, AUDIOLOGY NEUROTOL E, V2, P16, DOI 10.1159/000337947; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lee JD, 2017, INT J PEDIATR OTORHI, V94, P36, DOI 10.1016/j.ijporl.2017.01.012; Liu HJ, 2012, ACTA OTO-LARYNGOL, V132, P803, DOI 10.3109/00016489.2012.657359; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267	14	1	1	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2020	30	4					412	415		10.1097/JSM.0000000000000617			4	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	NA4GG	WOS:000559774000021	32644320				2022-02-06	
J	Remigio-Baker, RA; Gregory, E; Cole, WR; Bailie, JM; McCulloch, KL; Cecchini, A; Stuessi, K; Andrews, TR; Mullins, L; Ettenhofer, ML				Remigio-Baker, Rosemay A.; Gregory, Emma; Cole, Wesley R.; Bailie, Jason M.; McCulloch, Karen L.; Cecchini, Amy; Stuessi, Keith; Andrews, Taylor R.; Mullins, Lynita; Ettenhofer, Mark L.			Beliefs About the Influence of Rest During Concussion Recovery May Predict Activity and Symptom Progression Within an Active Duty Military Population	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Military Health Systems Research Symposium	AUG 19-22, 2019	Kissimmee, FL			Beliefs; Brain concussion; Education; Knowledge; Military personnel; Neurological rehabilitation; Rehabilitation; Treatment outcome	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; VERBAL INFORMATION; BED REST; MISCONCEPTIONS; RETURN; MANAGEMENT; KNOWLEDGE; RECOMMENDATIONS; ATTITUDES	Objectives: To evaluate relationships between beliefs about the impact of rest and the level of activities and symptoms over time among active duty Service members sustaining concussion, and whether these relationships vary by provision of concussion education. Design: Longitudinal study using multilevel modeling to assess the relationship between beliefs about rest within 72 hours of concussion and change in activity and symptom level over time, as well as interaction by concussion education at the initial clinic visit. Setting: Three military treatment facilities. Participants: Study participants included active duty Service members diagnosed with a concussion (N=111; median age, 24 y). Individuals with previous history of concussion within 12 months of study enrollment were excluded. Intervention: Not applicable. Main Outcome Measures: Activity questionnaire and the Neurobehavioral Symptom Inventory assessed within 72 hours of concussion; at 1 week; and at 1, 3, and 6 month(s) postinjury. Results: Receipt of concussion education from providers was significantly associated with greater belief that rest influences concussion recovery. Greater belief that rest influences symptom recovery at the acute stage of concussion was associated with a greater increase in activities over time, but only among those who received education from their provider. Additionally, greater belief about the influence of rest was related to a more rapid decrease in symptoms over time. Conclusions: Concussed Service members who underestimate the influence of rest during acute recovery may be at risk for poorer recovery. Treatment of Service members with postconcussive symptoms should consider patient knowledge and/or beliefs about rest and recovery, which may influence prognosis. Our results support the provider's use of concussion education to correct potential misconceptions that may negatively impact symptom recovery. (C) 2020 by the American Congress of Rehabilitation Medicine	[Remigio-Baker, Rosemay A.; Gregory, Emma; Cole, Wesley R.; Bailie, Jason M.; Stuessi, Keith; Andrews, Taylor R.; Mullins, Lynita; Ettenhofer, Mark L.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Remigio-Baker, Rosemay A.; Bailie, Jason M.; Stuessi, Keith] Naval Hosp Camp Pendleton, Camp Pendleton, CA USA; [Remigio-Baker, Rosemay A.; McCulloch, Karen L.] Henry M Jackson Fdn, Bethesda, MD USA; [Cole, Wesley R.; Cecchini, Amy] Womack Army Med Ctr, Ft Bragg, NC USA; [Bailie, Jason M.; Stuessi, Keith] Gen Dynam Hlth Solut, Silver Spring, MD USA; [McCulloch, Karen L.] Univ N Carolina, Dept Allied Hlth Sci, Chapel Hill, NC 27515 USA; [Cecchini, Amy] Geneva Fdn, Tacoma, WA USA; [Andrews, Taylor R.; Mullins, Lynita; Ettenhofer, Mark L.] US Navy, Med Ctr San Diego, San Diego, CA 92152 USA; [Ettenhofer, Mark L.] Amer Hosp Serv Grp LLC, Exton, PA USA		Remigio-Baker, RA (corresponding author), Henry M Jackson Fdn Adv Mil Med, Def & Vet Brain Injury Ctr, Concuss Care Clin, Intrepid Spirit 7,2016 San Jacinto Rd, Camp Pendleton, CA 92055 USA.	rosemay.a.remigio-baker.ctr@mail.mil			Defense Health Program 6.7 [D6.7_14_C2_I_14_J9_1077]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	Supported by the Defense Health Program 6.7 (award no. D6.7_14_C2_I_14_J9_1077) and the Defense and Veterans Brain Injury Center. The views expressed in this manuscript are those of the authors and do not necessarily represent the official policy or position of the Defense Health Agency, Department of Defense, or any other United States government agency. This work is defined as U.S. Government work under Title 17 U.S.C.x101. Per Title 17 U.S.C.x105, copyright protection is not available for any work of the U.S. Government. For more information, please contact dha.DVBICinfo@mail.mil.	Allen C, 1999, LANCET, V354, P1229, DOI 10.1016/S0140-6736(98)10063-6; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Bailie JM, 2019, AM J SPORT MED, V47, P3505, DOI 10.1177/0363546519883259; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Bo M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2021-x; Bradford LS, 2015, REHABIL PSYCHOL, V60, P344, DOI 10.1037/rep0000057; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; Defense and Veterans Brain Injury Center, 2018, PROGR RET ACT FOLL M; Defense and Veterans Brain Injury Center, 2019, DOD WORLDW NUMB TBI; Department of Defense, 2012, DEP DEF INSTR 6490 1; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Fortney SM, 2011, HDB PHYSL, P889; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Gregory E, 2017, CONTEMP CLIN TRIALS, V52, P95, DOI 10.1016/j.cct.2016.11.005; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI [DOI 10.1207/S15327035EX1403_5, DOI 10.1207/s15327035ex1403_5]; Itriyeva K, 2017, INT J ADOLESC MED HL, V31; Iverson GL, 2015, OXFORD HDB SPORTS RE; Johnson A, 2005, HEALTH EDUC RES, V20, P423, DOI 10.1093/her/cyg141; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Johnston KM, 2000, CLIN J SPORT MED, V10, P209; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lutz Robert H, 2010, J Spec Oper Med, V10, P23; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Meyer JE, 2015, DEV NEUROPSYCHOL, V40, P24, DOI 10.1080/87565641.2014.1001065; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Remigio-Baker RA, 2020, J HEAD TRAUMA REHAB, V35, P92, DOI 10.1097/HTR.0000000000000498; Salisbury David, 2017, Proc (Bayl Univ Med Cent), V30, P33; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Springer JA, 1997, J HEAD TRAUMA REHAB, V12, P41, DOI 10.1097/00001199-199706000-00005; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Yuhasz JE, 2013, J CORRECT HEALTH CAR, V19, P135, DOI 10.1177/1078345812474644	53	1	1	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	2020	101	7					1204	1211		10.1016/j.apmr.2020.02.015			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	MC1CG	WOS:000543033600013	32234413				2022-02-06	
J	Shah, BR; Holcomb, JM; Davenport, EM; Lack, CM; McDaniel, JM; Imphean, DM; Xi, Y; Rosenbaum, DA; Urban, JE; Wagner, BC; Powers, AK; Whitlow, CT; Stitzel, JD; Maldjian, JA				Shah, B. R.; Holcomb, J. M.; Davenport, E. M.; Lack, C. M.; McDaniel, J. M.; Imphean, D. M.; Xi, Y.; Rosenbaum, D. A.; Urban, J. E.; Wagner, B. C.; Powers, A. K.; Whitlow, C. T.; Stitzel, J. D.; Maldjian, J. A.			Prevalence and Incidence of Microhemorrhages in Adolescent Football Players	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							HEAD IMPACT EXPOSURE; CEREBRAL MICROHEMORRHAGES; BRAIN EDEMA; CONCUSSION; IRON; MICROBLEEDS; RISK; HEMORRHAGE; INJURY	BACKGROUND AND PURPOSE: SWI is an advanced imaging modality that is especially useful in cerebral microhemorrhage detection. Such microhemorrhages have been identified in adult contact sport athletes, and the sequelae of these focal bleeds are thought to contribute to neurodegeneration. The purpose of this study was to utilize SWI to determine whether the prevalence and incidence of microhemorrhages in adolescent football players are significantly greater than those of adolescent noncontact athletes. MATERIALS AND METHODS: Preseason and postseason SWI was performed and evaluated on 78 adolescent football players. SWI was also performed on 27 adolescent athletes who reported no contact sport history. Two separate one-tailed Fisher exact tests were performed to determine whether the prevalence and incidence of microhemorrhages in adolescent football players are greater than those of noncontact athlete controls. RESULTS: Microhemorrhages were observed in 12 football players. No microhemorrhages were observed in any controls. Adolescent football players demonstrated a significantly greater prevalence of microhemorrhages than adolescent noncontact controls (P=.02). Although 2 football players developed new microhemorrhages during the season, microhemorrhage incidence during 1 football season was not statistically greater in the football population than in noncontact control athletes (P=.55). CONCLUSIONS: Adolescent football players have a greater prevalence of microhemorrhages compared with adolescent athletes who have never engaged in contact sports. While microhemorrhage incidence during 1 season is not significantly greater in adolescent football players compared to adolescent controls, there is a temporal association between playing football and the appearance of new microhemorrhages.	[Shah, B. R.; Holcomb, J. M.; Davenport, E. M.; McDaniel, J. M.; Imphean, D. M.; Xi, Y.; Wagner, B. C.; Maldjian, J. A.] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Lack, C. M.; Whitlow, C. T.] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC 27101 USA; [Rosenbaum, D. A.] Wake Forest Sch Med, Dept Sports Med, Winston Salem, NC 27101 USA; [Urban, J. E.; Stitzel, J. D.] Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC 27101 USA; [Powers, A. K.] Wake Forest Sch Med, Dept Neurosurg, Winston Salem, NC 27101 USA		Holcomb, JM (corresponding author), UT Southwestern, Dept Radiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	james.holcomb@utsouthwestern.edu	; Xi, Yin/M-2268-2016	Lack, Christopher/0000-0002-3293-8963; Xi, Yin/0000-0001-9743-3010; Davenport, Elizabeth/0000-0002-8765-6584	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS082453, R01NS091602]	Support for this research was provided by National Institutes of Health grant R01NS082453 (J.A.M., J.D.S.) and R01NS091602 (C.T.W., J.A.M., J.D.S.).	Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Bonow RH, 2017, J NEUROTRAUM, V34, P2706, DOI 10.1089/neu.2017.4970; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Cordonnier C, 2011, BRAIN, V134, P335, DOI 10.1093/brain/awq321; Daugherty AM, 2017, NEUROBIOL AGING, V59, P22, DOI 10.1016/j.neurobiolaging.2017.07.003; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; Hahnel S, 2008, AM J NEURORADIOL, V29, P388, DOI 10.3174/ajnr.A0799; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hasiloglu ZI, 2011, AM J NEURORADIOL, V32, P99, DOI 10.3174/ajnr.A2250; Huang FP, 2002, J NEUROSURG, V96, P287, DOI 10.3171/jns.2002.96.2.0287; Jarrett M, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00011; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kuhn AW, 2017, SPORTS HEALTH, V9, P30, DOI 10.1177/1941738116674006; Kulich M, 2018, NEUROSENSORY DISORDE, P23; Lee JK, 2017, AM J NEURORADIOL, V38, P1303, DOI 10.3174/ajnr.A5175; Li K, 2016, J NEURAL TRANSM, V123, P389, DOI 10.1007/s00702-016-1508-7; LINDVALL M, 1978, SCIENCE, V201, P176, DOI 10.1126/science.663649; Liu W, 2016, RADIOLOGY, V278, P536, DOI 10.1148/radiol.2015150160; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Nunez MT, 2012, BIOMETALS, V25, P761, DOI 10.1007/s10534-012-9523-0; Poels MMF, 2010, STROKE, V41, pS103, DOI 10.1161/STROKEAHA.110.595181; RISSER WL, 1994, PEDIATRICS, V94, P757; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Spector Reynold, 2010, Cerebrospinal Fluid Res, V7, P14, DOI 10.1186/1743-8454-7-14; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Wagner KR, 2003, J CEREBR BLOOD F MET, V23, P629, DOI 10.1097/01.WCB.0000073905.87928.6D; Zheng HP, 2016, CEREBROVASC DIS, V42, P155, DOI 10.1159/000445170	34	1	1	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	JUL 1	2020	41	7					1263	1268		10.3174/ajnr.A6618			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	MJ4KL	WOS:000548058900027	32661051	Green Published, hybrid			2022-02-06	
J	Sinnott, AM; Kontos, AP; Collins, MW; Ortega, J				Sinnott, Aaron M.; Kontos, Anthony P.; Collins, Michael W.; Ortega, Justus			Concussion Symptoms Among Athletes: Preinjury Factors Predict Postinjury Factors	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						collegiate; high school; Post-Concussion Symptom Scale; sport-related concussion; symptom factors	SPORTS-RELATED CONCUSSION; ASSOCIATION POSITION STATEMENT; HIGH-SCHOOL; BASE-LINE; NEUROCOGNITIVE PERFORMANCE; AGE; MANAGEMENT; SEX; QUESTIONNAIRE; RECOVERY	Objective: Determine whether preinjury concussion symptom factors predict postinjury concussion symptom factors. Setting: Community concussion surveillance program between 2008 and 2017. Participants: A total of 290 high school and collegiate-aged athletes (n= 168, aged 14-17 years;n= 122, aged 18-21 years, respectively). Design: Retrospective analysis. Main Measures: Post-Concussion Symptom Scale scores prior to and within 7 days of sustaining a sport-related concussion. Methods: Post-Concussion Symptom Scale scores were aggregated into cognitive-sensory, sleep-arousal, vestibular-somatic, and affective preinjury symptom factors. These preinjury symptom factors, in conjunction with sex and previous concussion history, underwent linear regressions to predict cognitive-migraine-fatigue, somatic, sleep, and affective postinjury symptom factors. Results: The cognitive-sensory factor (P= .002) and female sex (P= .002) predicted the postinjury cognitive-migraine-fatigue factor in combined age group but not stratified age group models. Among the 14 to 17 years age group, and not the 18 to 21 years age group, the preinjury sleep-arousal symptom factor predicted postinjury somatic (P= .003) and sleep factors (P= .005). The affective preinjury factor predicted the affective factor (P= .001) and somatic factor (P= .008) in the 18 to 21 years age group. A history of previous concussions also predicted the postinjury somatic symptom factor (P= .005). Conclusion: Preinjury symptom factors predicted postinjury symptom factors and age-associated differences in symptom factors may provide clinical value in prognostic models for subsequent postinjury clinical outcomes.	[Sinnott, Aaron M.] Univ Pittsburgh, Dept Sports Med & Nutr, Warrior Human Performance Res Ctr, Neuromuscular Res Lab,Sch Hlth & Rehabil Sci, 3860 S Water St, Pittsburgh, PA 15203 USA; [Kontos, Anthony P.; Collins, Michael W.] Univ Pittsburgh, UPMC Sports Med Concuss Program, Dept Orthopaed Surg, Pittsburgh, PA USA; [Ortega, Justus] Humboldt State Univ, Kinesiol & Recreat Adm, Arcata, CA 95521 USA		Sinnott, AM (corresponding author), Univ Pittsburgh, Dept Sports Med & Nutr, Warrior Human Performance Res Ctr, Neuromuscular Res Lab,Sch Hlth & Rehabil Sci, 3860 S Water St, Pittsburgh, PA 15203 USA.	ams626@pitt.edu		Sinnott, Aaron/0000-0002-8887-759X			Alla S, 2012, BRIT J SPORT MED, V46, P562, DOI 10.1136/bjsm.2010.081299; Alla S, 2010, J SCI MED SPORT, V13, P24, DOI 10.1016/j.jsams.2008.12.629; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Baum KT, 2014, J CHILD PSYCHOL PSYC, V55, P180, DOI 10.1111/jcpp.12125; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Blume HK, 2011, PHYS MED REH CLIN N, V22, P665, DOI 10.1016/j.pmr.2011.08.007; Broglio SP, 2017, J ATHL TRAINING, V52, P160, DOI 10.4085/1062-6050-51.9.05; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bruce JM, 2004, NEUROLOGY, V63, P1516; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Cohen PE, 2020, CLIN J SPORT MED, V30, pS61, DOI 10.1097/JSM.0000000000000581; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Crowley SJ, 2014, PRINCIPLES PRACTICE, P45; Custer A, 2016, J ATHL TRAINING, V51, P136, DOI 10.4085/1062-6050-51.2.12; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Franke LM, 2015, J HEAD TRAUMA REHAB, V30, pE34, DOI 10.1097/HTR.0000000000000042; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Houston MN, 2016, BRAIN INJURY, V30, P891, DOI 10.3109/02699052.2016.1146960; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kontos A. P., 2018, CONCUSSION CLIN PROF; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lovell M, 2007, IMPACT 2007 6 0 CLIN; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2009, S AFR J SPORTS MED, V21; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P764, DOI 10.1080/13803395.2015.1060950; Moser RS, 2019, ARCH CLIN NEUROPSYCH, V34, P50, DOI 10.1093/arclin/acy007; Mosti C, 2016, NEUROL-CLIN PRACT, V6, P129, DOI 10.1212/CPJ.0000000000000225; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Putukian M, 2021, CLIN J SPORT MED, V31, P15, DOI 10.1097/JSM.0000000000000705; Rajagopalan Archana, 2017, J Nat Sci Biol Med, V8, P11, DOI 10.4103/0976-9668.198350; Reynolds Erin, 2014, Neurosurgery, V75 Suppl 4, pS71, DOI 10.1227/NEU.0000000000000471; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Sufrinko A, 2015, AM J SPORT MED, V43, P830, DOI 10.1177/0363546514566193; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031	52	1	1	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2020	35	4			SI		E361	E371		10.1097/HTR.0000000000000562			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MR1MK	WOS:000553355300011	32108712				2022-02-06	
J	Smith-Paine, J; Fisher, AP; Wade, SL; Zhang, NH; Zang, HY; Martin, LJ; Yeates, KO; Taylor, HG; Kurowski, BG				Smith-Paine, Julia; Fisher, Allison P.; Wade, Shari L.; Zhang, Nanhua; Zang, Huaiyu; Martin, Lisa J.; Yeates, Keith Owen; Taylor, H. Gerry; Kurowski, Brad G.			Dopamine-Related Genes Moderate the Association Between Family Environment and Executive Function Following Pediatric Traumatic Brain Injury: An Exploratory Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						childhood; dopamine; executive functions; genetics; traumatic brain injury	METHYLPHENIDATE DOSE-RESPONSE; CATECHOL-O-METHYLTRANSFERASE; BEHAVIOR RATING INVENTORY; EARLY-CHILDHOOD; TRANSPORTER GENE; 7-REPEAT ALLELE; YOUNG-CHILDREN; D-4 RECEPTOR; SHORT-TERM; OUTCOMES	Objective: This study examined whether carrying dopamine-related "risk" genes-either the dopamine transporter (DAT1) 10-repeat allele or dopamine receptor-4 (DRD4) 7-repeat allele-moderated the association of family environment and executive function (EF) following traumatic brain injury (TBI) in early childhood. Methods: Caregivers of children with TBI or orthopedic injury (OI) completed the Behavior Rating Inventory of Executive Function (BRIEF) at postinjury visits. General linear models examined gene by environment interactions as moderators of the effects of TBI on EF at 12 months and 7 years postinjury. Results: At 12 months, we did not find any significant gene by environment interactions. At 7 years, we found a significant 3-way interaction among combined carrier status, level of permissive parenting, and injury type. For children exposed to more optimal parenting, carriers of DAT1 and/or DRD4 risk alleles with TBI showed significantly worse parent-reported EF than carriers with OI. In those with less optimal parenting, carriers and noncarriers with TBI, as well as carriers with OI, showed significantly worse parent-reported EF than noncarriers with OI, with medium to large effect sizes. Conclusions: The findings highlight the importance of considering polygenetic and environmental factors in future studies of recovery following TBI and other injuries in childhood.	[Smith-Paine, Julia; Fisher, Allison P.; Wade, Shari L.; Kurowski, Brad G.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Pediat Rehabil Med, Cincinnati, OH 45229 USA; [Zhang, Nanhua; Zang, Huaiyu] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Martin, Lisa J.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Human Genet, Cincinnati, OH 45229 USA; Univ Cincinnati Coll Med, Cincinnati, OH USA; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp Res Inst, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Taylor, H. Gerry] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Columbus, OH USA; [Taylor, H. Gerry] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA		Fisher, AP (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	allison.fisher@cchmc.org	Zang, Huaiyu/AAY-6603-2021; Yeates, Keith/AAJ-4223-2020; Martin, Lisa/E-2425-2016	Martin, Lisa/0000-0001-8702-9946	National Institute for Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729]; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS096053]; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01NS096053]; National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) [8 UL1 TR000077]; Ohio Department of Public Safety [8 UL1 TR000077]	R01 HD42729: National Institute for Child Health and Human Development (NICHD); R01NS096053: National Institute of Neurological Disorders and Stroke (NINDS) and NICHD; grant 8 UL1 TR000077: National Center for Advancing Translational Sciences of the National Institutes of Health (NIH); and Ohio Department of Public Safety.	Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Bakermans-Kranenburg MJ, 2008, DEV PSYCHOL, V44, P293, DOI 10.1037/0012-1649.44.1.293; Bakermans-Kranenburg MJ, 2011, DEV PSYCHOPATHOL, V23, P39, DOI 10.1017/S0954579410000635; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; BAUMRIND D, 1966, CHILD DEV, V37, P887, DOI 10.1111/j.1467-8624.1966.tb05416.x; Belsky J, 2007, CURR DIR PSYCHOL SCI, V16, P300, DOI 10.1111/j.1467-8721.2007.00525.x; Berry D, 2013, DEV PSYCHOPATHOL, V25, P291, DOI 10.1017/S095457941200106X; Bradley RH, 2003, EARLY CHILD RES Q, V18, P294, DOI 10.1016/S0885-2006(03)00041-3; Brookes KJ, 2007, AM J MED GENET B, V144B, P1070, DOI 10.1002/ajmg.b.30572; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chevignard MP, 2009, DEV NEUROREHABIL, V12, P76, DOI 10.1080/17518420902777019; Congdon E, 2008, AM J MED GENET B, V147B, P27, DOI 10.1002/ajmg.b.30557; Cornish KM, 2005, MOL PSYCHIATR, V10, P686, DOI 10.1038/sj.mp.4001641; Donders J, 2010, J NEUROPSYCHOL, V4, P197, DOI 10.1348/174866409X478970; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Failla MD, 2015, J HEAD TRAUMA REHAB, V30, pE54, DOI 10.1097/HTR.0000000000000118; Faraone SV, 2001, AM J PSYCHIAT, V158, P1052, DOI 10.1176/appi.ajp.158.7.1052; Froehlich TE, 2007, BIOL PSYCHIAT, V62, P243, DOI 10.1016/j.biopsych.2006.09.039; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gelernter J, 2015, BIOL PSYCHIAT, V77, P36, DOI 10.1016/j.biopsych.2014.08.005; Gerring JP, 2012, J NEUROTRAUM, V29, P621, DOI 10.1089/neu.2011.2234; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Hamarman S, 2004, J CHILD ADOL PSYCHOP, V14, P564, DOI 10.1089/cap.2004.14.564; Kebir O, 2009, PROG NEURO-PSYCHOPH, V33, P939, DOI 10.1016/j.pnpbp.2009.04.019; Kurowski B, 2012, J PEDIATR REHAB MED, V5, P217, DOI 10.3233/PRM-2012-0214; Kurowski BG, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00481; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P404, DOI 10.1097/HTR.0000000000000281; Kurowski BG, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000162; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Logue SF, 2014, PHARMACOL BIOCHEM BE, V123, P45, DOI 10.1016/j.pbb.2013.08.007; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; MCCLELLAND GH, 1993, PSYCHOL BULL, V114, P376, DOI 10.1037/0033-2909.114.2.376; Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948; Myrga JM, 2016, J HEAD TRAUMA REHAB, V31, pE15, DOI 10.1097/HTR.0000000000000199; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Narad ME, 2018, JAMA PEDIATR, V172, P437, DOI 10.1001/jamapediatrics.2017.5746; Oak JN, 2000, EUR J PHARMACOL, V405, P303, DOI 10.1016/S0014-2999(00)00562-8; Potter JL, 2011, REHABIL PSYCHOL, V56, P351, DOI 10.1037/a0025445; ROBINSON CC, 1995, PSYCHOL REP, V77, P819, DOI 10.2466/pr0.1995.77.3.819; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schorr E, 2020, DISABIL REHABIL, V42, P2437, DOI 10.1080/09638288.2019.1602676; Smith-Paine J, 2018, J NEUROTRAUM, V35, P2796, DOI 10.1089/neu.2017.5388; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Stein MA, 2005, NEUROPSYCHOPHARMACOL, V30, P1374, DOI 10.1038/sj.npp.1300718; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Treble-Barna A, 2017, J NEUROTRAUM, V34, P1919, DOI 10.1089/neu.2016.4840; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; Volkow ND, 2007, NEUROIMAGE, V34, P1182, DOI 10.1016/j.neuroimage.2006.10.014; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yeates K. O., 2009, PEDIAT NEUROPSYCHOLO; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	58	1	1	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2020	35	4			SI		262	269		10.1097/HTR.0000000000000564			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MR1MK	WOS:000553355300003	32108714	Green Accepted			2022-02-06	
J	Song, CH; Ahmad, MZ; Siti-Azrin, A; Wan-Nor-Asyikeen, WA				Song, Cheng Hee; Ahmad, Mohammad Zikri; Siti-Azrin, Ab Hamid; Wan-Nor-Asyikeen, Wan Adnan			The identification of key factors predictive of traumatic brain injury in paediatric patients with a minor blunt head injury	HONG KONG JOURNAL OF EMERGENCY MEDICINE			English	Article						Associated factors; computed tomography; head injury; paediatric; traumatic brain injury	DECISION RULE; CHILDREN; PREVALENCE; ADULTS; RISK	Introduction: Traumatic brain injury (TBI) is a major public health concern, and contributes significantly to mortality and morbidity in paediatric patients. Objective: The study is aimed to identify the factors predictive of TBI in paediatric patients with a minor blunt head injury. Methods: This was a retrospective cohort study conducted on 274 paediatric patients with a minor head injury and registered to Hospital Universiti Sains Malaysia (USM) from the year 2009 to 2013. Patients with a minor blunt head injury aged less than 18 years who underwent computed tomography (CT) of the brain were included, while the patients with penetrating head injuries were excluded from the study. Simple and multiple logistic regression analysis were performed. Results: TBI occurred in 49% of the patients. Headache (adjusted odd ratio (AOR): 2.24; 95% confidence interval (CI): 1.24, 4.05,p = 0.008), dizziness (AOR: 3.08, 95% CI: 1.27, 7.51,p = 0.013) and the presence of scalp haematoma (AOR: 2.93, 95% CI: 1.60, 5.34,p < 0.001) were the most important clinical variables for predicting TBI following a minor blunt head injury in paediatric populations. Conclusion: Headache, dizziness and scalp haematoma were identified as important clinical variables that can be used to predict TBI on a CT scan of paediatric minor head injury. The presence of these factors should alert emergency physicians to the need to monitor such children closely.	[Song, Cheng Hee; Ahmad, Mohammad Zikri] Univ Sains Malaysia, Sch Med Sci, Dept Emergency Med, Kubang Kerian, Malaysia; [Siti-Azrin, Ab Hamid; Wan-Nor-Asyikeen, Wan Adnan] Univ Sains Malaysia, Sch Med Sci, Unit Biostat & Res Methodol, Kubang Kerian 16150, Kelantan, Malaysia		Siti-Azrin, A (corresponding author), Univ Sains Malaysia, Sch Med Sci, Unit Biostat & Res Methodol, Kubang Kerian 16150, Kelantan, Malaysia.	ctazrin@usm.my	Ab Hamid, Siti Azrin/N-4028-2015	Ab Hamid, Siti Azrin/0000-0002-8212-9849			Corp IBM., 2013, IBM SPSS STAT WINDOW; Dayan PS, 2015, PEDIATRICS, V135, P504, DOI 10.1542/peds.2014-2695; del Demanio A, 2006, J PAEDIATR CHILD H, V32, P208; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Faul M, 2010, TRAUMATIC BRAIN INJU; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hooi LL, 2017, MALAYS J MED SCI, V24, P87, DOI 10.21315/mjms2017.24.2.11; Kocyigit A, 2014, CLIN IMAG, V38, P236, DOI 10.1016/j.clinimag.2013.12.004; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA, 2004, J HEAD TRAUMA REHAB, V20, P229; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2013, IBIA INT BRAIN INJUR; Mitra B, 2007, J PAEDIATR CHILD H, V43, P154, DOI 10.1111/j.1440-1754.2007.01035.x; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Rohana J, 1998, Med J Malaysia, V53, P217	21	1	1	3	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1024-9079	2309-5407		HONG KONG J EMERG ME	Hong Kong J. Emerg. Med.	JUL	2020	27	4					211	216		10.1177/1024907919836568			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	MG3PG	WOS:000545945400004		gold			2022-02-06	
J	Tahtabasi, M; Er, S; Kalayci, M				Tahtabasi, Mehmet; Er, Sadettin; Kalayci, Mustafa			Head and neck injuries after a bomb explosion: Diagnostic findings and treatment approaches	AMERICAN JOURNAL OF OTOLARYNGOLOGY			English	Article						Blast injury; Head; Neck; Explosion; Laryngotracheal injury	MAXILLOFACIAL INJURIES; TRAUMA; IRAQ; CLASSIFICATION; PATTERNS; BLASTS	Objective: To identify the types and severity of head, face and neck (HFN) injuries, which occurred as a result of a bomb explosion and reached serious life-threatening levels, using radiological imaging methods, and to discuss the options of treatment at the time of presentation. Methods: Of the 16 patients brought to the emergency department, 14 with HFN injuries were included in the study. Computed tomography (CT) and radiography scans were performed at the time of presentation in all patients, except for one. The injuries were divided into three groups according to their localization as head, face, and neck. Results: A subgaleal hematoma was seen in 10 of 11 (78.5%) patients with head injuries. Eight (57.1%) of nine patients with facial injury had fractures and/or ocular injury in the orbital wall, and seven (50%) patients had maxillofacial bone fractures. Among ocular trauma cases, open-globe injuries were detected in three patients (21.4%), closed-globe in two (14.2%), and both types in three (21.4%). Of the five (35.7%) patients with secondary blast injuries in the neck, three (21.4%) had laryngeal trauma (Zone 2) due to shrapnel, localized in the false vocal cord, epiglottis, and thyrohyoid membrane, respectively. Emergency surgery was performed on a patient with a specific laryngeal injury. Conclusion: We consider that in patients presenting to the emergency department with blast HFN injuries, after providing airway patency and hemodynamic stability, CT and CT angiography should be performed because these modalities guide the treatment accurately and promptly.	[Tahtabasi, Mehmet] Univ Hlth Sci, Somalia Turkey Recep Tayyip Erdogan Educ & Res Ho, Dept Radiol, Mogadishu, Somalia; [Er, Sadettin] Univ Hlth Sci, Somalia Turkey Recep Tayyip Erdogan Educ & Res Ho, Dept Gen Surg, Mogadishu, Somalia; [Kalayci, Mustafa] Univ Hlth Sci, Somalia Turkey Recep Tayyip Erdogan Educ & Res Ho, Dept Ophthalmol, Mogadishu, Somalia		Tahtabasi, M (corresponding author), Mogadishu Somalia Turkey Recep Tayyip Erdogan Edu, Mogadishu, Somalia.	mehmet.tahtabasi@sbu.edu.tr; ersadettin74@gmail.com; drkalayci07@hotmail.com	KALAYCI, Mustafa/AAS-1147-2020	KALAYCI, Mustafa/0000-0001-8056-6634; TAHTABASI, MEHMET/0000-0001-9668-8062			Beckett A, 2012, INJURY, V43, P2072, DOI 10.1016/j.injury.2012.01.005; Danic D, 1996, J LARYNGOL OTOL, V110, P435; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Gataa IS, 2011, INT J ORAL MAX SURG, V40, P65, DOI 10.1016/j.ijom.2010.07.005; Go JL, 2019, RADIOGRAPHICS, V39, P1796, DOI 10.1148/rg.2019190177; Helling ER, 2005, MIL MED, V170, P991, DOI 10.7205/MILMED.170.11.991; Keller MW, 2015, MIL MED, V180, P315, DOI 10.7205/MILMED-D-14-00345; Kuhn F, 1996, GRAEF ARCH CLIN EXP, V234, P399, DOI 10.1007/BF00190717; Mirza FH, 2013, J FORENSIC LEG MED, V20, P747, DOI 10.1016/j.jflm.2013.04.014; Morley MG, 2010, DISASTER MED PUBLIC, V4, P154, DOI 10.1001/dmp.v4n2.hra10003; Noh Dongsub, 2017, Trauma Case Rep, V12, P31, DOI 10.1016/j.tcr.2017.10.013; Rahman I, 2006, EYE, V20, P1336, DOI 10.1038/sj.eye.6702099; Schmidt GW, 2008, OPHTHALMOLOGY, V115, P202, DOI 10.1016/j.ophtha.2007.04.008; Sharma N, 2009, J LARYNGOL OTOL, V123, P253, DOI 10.1017/S0022215108002120; Singh AK, 2016, RADIOGRAPHICS, V36, P295, DOI 10.1148/rg.2016150114; Singh AK, 2015, EMERG RADIOL, V22, P527, DOI 10.1007/s10140-015-1322-9; Singh AK, 2014, AM J ROENTGENOL, V203, P235, DOI 10.2214/AJR.14.12549; Sosna J, 2005, RADIOLOGY, V237, P28, DOI 10.1148/radiol.2371040585; Stassen NA, 2004, AM SURGEON, V70, P522; Steenburg SD, 2010, RADIOGRAPHICS, V30, P869, DOI 10.1148/rg.304105022; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Woodcock MGL, 2006, OPHTHALMOLOGY, V113, P2262, DOI 10.1016/j.ophtha.2006.06.002; Yazgan C, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20160063	23	1	1	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0196-0709	1532-818X		AM J OTOLARYNG	Am. J. Otolaryngol.	JUL-AUG	2020	41	4							102489	10.1016/j.amjoto.2020.102489			9	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	MC5YR	WOS:000543362600026	32340761				2022-02-06	
J	Van Pelt, KL; Allred, CD; Brodeur, R; Cameron, KL; Campbell, DE; D'Lauro, CJ; He, XM; Houston, MN; Johnson, BR; Kelly, TF; McGinty, G; Meehan, SK; O'Donnell, PG; Peck, KY; Svoboda, SJ; Pasquina, P; McAllister, T; McCrea, M; Broglio, SP				Van Pelt, Kathryn L.; Allred, C. Dain; Brodeur, Rachel; Cameron, Kenneth L.; Campbell, Darren E.; D'Lauro, Christopher J.; He, Xuming; Houston, Megan N.; Johnson, Brian R.; Kelly, Tim F.; McGinty, Gerald; Meehan, Sean K.; O'Donnell, Patrick G.; Peck, Karen Y.; Svoboda, Steven J.; Pasquina, Paul; McAllister, Thomas; McCrea, Michael; Broglio, Steven P.			Concussion-Recovery Trajectories Among Tactical Athletes: Results From the CARE Consortium	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injury; return to activity; athletes	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; RETURN; COLLEGIATE; TIME; PREDICTORS; INJURY; SEX; EPIDEMIOLOGY; SYMPTOMS	Context: Assessments of the duration of concussion recovery have primarily been limited to sport-related concussions and male contact sports. Furthermore, whereas durations of symptoms and return-to-activity (RTA) protocols encompass total recovery, the trajectory of each duration has not been examined separately. Objective: To identify individual (eg, demographics, medical history), initial concussion injury (eg, symptoms), and external (eg, site) factors associated with symptom duration and RTA-protocol duration after concussion. Design: Cohort study. Setting: Three US military service academies. Patients or Other Participants: A total of 10 604 cadets at participating US military service academies enrolled in the study and completed a baseline evaluation and up to 5 postinjury evaluations. A total of 726 cadets (451 men, 275 women) sustained concussions during the study period. Main Outcome Measure(s): Number of days from injury (1) until the participant became asymptomatic and (2) to complete the RTA protocol. Results: Varsity athlete cadets took less time than nonvarsity cadets to become asymptomatic (hazard ratio [HR] = 1.75, 95% confidence interval = 1.38, 2.23). Cadets who reported less symptom severity on the Sport Concussion Assessment Tool, third edition (SCAT3), within 48 hours of concussion had 1.45 to 3.77 times shorter symptom-recovery durations than those with more symptom severity. Similar to symptom duration, varsity status was associated with a shorter RTA-protocol duration (HR = 1.74, 95% confidence interval = 1.34, 2.25), and less symptom severity on the SCAT3 was associated with a shorter RTA-protocol duration (HR range = 1.31 to 1.47). The academy that the cadet attended was associated with the RTA-protocol duration (P < .05). Conclusions: The initial total number of symptoms reported and varsity athlete status were strongly associated with symptom and RTA-protocol durations. These findings suggested that external (varsity status and academy) and injury (symptom burden) factors influenced the time until RTA.	[Van Pelt, Kathryn L.; Broglio, Steven P.] Univ Michigan, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA; [Allred, C. Dain; D'Lauro, Christopher J.; Johnson, Brian R.; McGinty, Gerald] US Air Force Acad, Colorado Springs, CO 80840 USA; [Brodeur, Rachel; O'Donnell, Patrick G.] US Coast Guard Acad, New London, CT USA; [Cameron, Kenneth L.; Houston, Megan N.; Peck, Karen Y.] Keller Army Community Hosp, John A Feagin Jr Sports Med Fellowship, West Point, NY USA; [Campbell, Darren E.; O'Donnell, Patrick G.] Brigham Young Univ, Provo, UT 84602 USA; [He, Xuming] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA; [Kelly, Tim F.] US Mil Acad, Dept Intercollegiate Athlet, West Point, NY 10996 USA; [Meehan, Sean K.] Univ Waterloo, Waterloo, ON, Canada; [Svoboda, Steven J.] MedStar, Washington, DC USA; [Pasquina, Paul] Uniformed Serv Univ Hlth Sci, Dept Rehabil Med, Walter Reed Natl Mil Med Ctr, Bethesda, MD 20814 USA; [McAllister, Thomas] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [McCrea, Michael] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Van Pelt, Kathryn L.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA		Van Pelt, KL (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA.	Kathryn.OConnor@uky.edu		Van Pelt, Kathryn/0000-0002-5494-2357; Meehan, Sean/0000-0002-9848-8803; D'Lauro, Christopher/0000-0003-0894-6602			Asken BM, 2020, ARCH CLIN NEUROPSYCH, V35, P291, DOI 10.1093/arclin/acz007; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Celorrio-Navarro M, 2019, J NEUROTRAUM, V36, pA2; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; D'Lauro C, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118760854; Davis-Hayes C, 2017, J AM ACAD ORTHOP SUR, V25, P818, DOI 10.5435/JAAOS-D-17-00276; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; Derogatis L. R., 2001, 18 BSI; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Foster CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215030; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGuine TA, 2018, J ATHL TRAINING, V53, P1017, DOI 10.4085/1062-6050-209-18; Merport A, 2012, J PEDIATR PSYCHOL, V37, P650, DOI 10.1093/jpepsy/jss050; Nelson LD, 2018, J NEUROTRAUM, V35, P249, DOI 10.1089/neu.2017.4988; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Pfaller AY, 2016, AM J SPORT MED, V44, P2941, DOI 10.1177/0363546516651821; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Wallace J, 2018, J SPORT HEALTH SCI, V7, P204, DOI 10.1016/j.jshs.2016.11.002; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	32	1	1	1	3	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2020	55	7					658	665		10.4085/1062-6050-10-19			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	NK5AQ	WOS:000566744100002	32556201	Green Published, gold			2022-02-06	
J	Wang, P; Gao, BB; Wang, M; Sheng, QY; Tu, MM				Wang, Ping; Gao, Bingbing; Wang, Ming; Sheng, Qingyu; Tu, Mingmin			Challenges in the nursing care of intracranial carbapenem-resistant Escherichia coli infection after severe traumatic brain injury: a case report	ANNALS OF PALLIATIVE MEDICINE			English	Article						Traumatic brain injury (TBI); carbapenem-resistant Escherichia coli (CRE); intracranial infection; nursing	STRATEGIES; MANAGEMENT; BACTERIA	This article described a case of intracranial carbapenem-resistant Escherichia coli (CRE) infection after severe traumatic brain injury (TBI) and summarized the nursing experience. Since the intracranial infection was confirmed in the early stage and added secondary intracranial hypertension will directly affect the prognosis, the responsible nurse is required to increase the frequency of ward patrol, carefully observe the patient's consciousness and pupil changes, monitor vital signs and improve relevant records, communicate with the competent doctor in time, use drugs, or physical cooling to control high fever as soon as possible. Intensive observation and nursing care included: (I) position management; (II) observation on the state of illness during injection; (III) observation on the state of illness during tube clamping period; (IV) nursing after recovery of drainage; and (V) drug treatment after removing the drainage tube of the lumbar cistern. Artificial airway management included (I) position management, (II) periodically evaluate the artificial airway, (III) airway humidification and warming, (IV) management over airbags, (V) aspirate sputum as needed and (VI) oral care. With appropriate antibiotic drugs, reasonable arrangements to observe the curative effect, and cooperation with doctors, targeted artificial airway management to reduce the risk of airway infections, we treated this patient effectively and successfully. The intracranial infection was effectively controlled after 15-day treatment and nursing in our department, and the patient received an excellent prognosis finally.	[Wang, Ping; Gao, Bingbing; Wang, Ming; Sheng, Qingyu] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Neurosurg, Hangzhou, Peoples R China; [Tu, Mingmin] Zhejiang Shuren Univ, Shulan Hangzhou Hosp, Shulan Int Med Coll, Hangzhou, Peoples R China		Tu, MM (corresponding author), Zhejiang Shuren Univ, Shulan Hangzhou Hosp, Shulan Int Med Coll, Hangzhou, Peoples R China.	1200038@zju.edu.cn					Akova M, 2012, CLIN MICROBIOL INFEC, V18, P439, DOI 10.1111/j.1469-0691.2012.03823.x; Branson RD, 2014, RESP CARE, V59, P974, DOI 10.4187/respcare.03246; Chen QH, 2017, NEUROCHIRURGIE, V63, P13, DOI 10.1016/j.neuchi.2016.05.002; Collins-Praino L, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.10.22; Davis K, 2001, CRIT CARE, V5, P81, DOI 10.1186/cc991; De Rosa FG, 2015, FUTURE MICROBIOL, V10, P285, DOI [10.2217/fmb.14.121, 10.2217/FMB.14.121]; Kaiser JA, 2018, J NURS MANAGE, V26, P555, DOI 10.1111/jonm.12582; Martin A, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy150; Nunes LD, 2019, RESP PHYSIOL NEUROBI, V266, P115, DOI 10.1016/j.resp.2019.05.008; Ray MJ, 2016, CLIN INFECT DIS, V63, P889, DOI 10.1093/cid/ciw461; Sader HS, 2016, INT J ANTIMICROB AG, V48, P144, DOI 10.1016/j.ijantimicag.2016.04.021; Silva YR, 2017, RESP CARE, V62, P1291, DOI 10.4187/respcare.04929; Tijet N, 2016, J ANTIMICROB CHEMOTH, V71, P344, DOI 10.1093/jac/dkv356; Yang HF, 2018, J MICROBIOL IMMUNOL, V51, P70, DOI 10.1016/j.jmii.2016.01.003; Yildirim E, 2018, THORAC SURG CLIN, V28, P415, DOI 10.1016/j.thorsurg.2018.05.006; Zusman O, 2017, J ANTIMICROB CHEMOTH, V72, P29, DOI 10.1093/jac/dkw377	16	1	1	2	2	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2224-5820	2224-5839		ANN PALLIAT MED	Ann. Pallliat. Med.	JUL	2020	9	4					2381	2385		10.21037/apm-20-1264			5	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	MT5WK	WOS:000555045100118	32692234	gold			2022-02-06	
J	Winning, AM; Stiles-Shields, C; Driscoll, CFB; Ohanian, DM; Crowe, AN; Holmbeck, GN				Winning, Adrien M.; Stiles-Shields, Colleen; Driscoll, Colleen F. Bechtel; Ohanian, Diana M.; Crowe, Autumn N.; Holmbeck, Grayson N.			Development of an Observational Parental Scaffolding Measure for Youth with Spina Bifida	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						parenting; psychosocial functioning; spina bifida	TRAUMATIC BRAIN-INJURY; RANDOMIZED-TRIAL; CHILDREN; MULTIMETHOD; ADOLESCENTS; PERCEPTIONS; COMPETENCE; BEHAVIORS; CONFLICT; MOTHER	Objective To examine the reliability and validity of a new observational measure of parental scaffolding, as well as the impact of parental scaffolding on academic and social outcomes among youth with spina bifida (SB). Methods As part of a larger study, 137 families of youth with SB participated in family interaction tasks and self-report questionnaires at the baseline assessment. Teachers also reported on youth's academic independence and competence, as well as social skills. Guided by previous research and theoretical formulations, a rational approach to measure development was employed whereby maternal and paternal scaffolding composites were created using the Family Interaction Macro-coding System (Holmbeck, Zebracki, Johnson, Belvedere, & Hommeyer (2007). Parent-child interaction macro-coding manual. Unpublished coding system. Chicago: Loyola University Chicago). Results The scaffolding measure demonstrated acceptable interrater and scale reliabilities. Additionally, both the maternal and paternal scaffolding composites were significantly associated with scores from self-report questionnaires of parenting behaviors in the expected directions. Maternal scaffolding was positively associated with IQ, academic competence, academic independence, and social self-control in youth with SB, whereas paternal scaffolding was positively associated with social cooperation and social self-control. Differences in scaffolding emerged between mothers and fathers, as well as across demographic variables. Conclusion Initial findings support the use of the scaffolding measure. Future research should continue to examine the utility of this scaffolding measure in families of youth with SB.	[Winning, Adrien M.; Driscoll, Colleen F. Bechtel; Ohanian, Diana M.; Crowe, Autumn N.; Holmbeck, Grayson N.] Loyola Univ, Dept Psychol, 1032 W Sheridan Rd, Chicago, IL 60660 USA; [Stiles-Shields, Colleen] Rush Univ, Med Ctr, Dept Psychiat & Behav Sci, Sect Populat Behav Hlth, Chicago, IL 60612 USA		Holmbeck, GN (corresponding author), Loyola Univ, Dept Psychol, 1032 W Sheridan Rd, Chicago, IL 60660 USA.	gholmbe@luc.edu		Driscoll, Colleen/0000-0002-5797-9024; Stiles-Shields, Colleen/0000-0002-6759-8380	National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR); Office of Behavioral and Social Sciences ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NR016235]; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD048629]; March of Dimes Birth Defects FoundationMarch of Dimes [12-FY13-271]	This work was supported by grants from the National Institute of Nursing Research and the Office of Behavioral and Social Sciences Research (R01 NR016235), National Institute of Child Health and Human Development (R01 HD048629), and the March of Dimes Birth Defects Foundation (12-FY13-271).	Abbeduto L, 1999, J INTELL DISABIL RES, V43, P540, DOI 10.1046/j.1365-2788.1999.00249.x; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Alderfer MA, 2008, J PEDIATR PSYCHOL, V33, P1046, DOI 10.1093/jpepsy/jsm083; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Baker JK, 2007, AM J MENT RETARD, V112, P375, DOI 10.1352/0895-8017(2007)112[0375:POSSIY]2.0.CO;2; Baumrind D., 1989, CHILD DEV TODAY TOMO, P349; Bernier A, 2010, CHILD DEV, V81, P326, DOI 10.1111/j.1467-8624.2009.01397.x; Bibok MB, 2009, NEW DIR CHILD ADOLES, V123, P17, DOI 10.1002/cd.233; Bier JAB, 2005, DEV MED CHILD NEUROL, V47, P609, DOI 10.1017/S0012162205001209; Boulet SL, 2008, BIRTH DEFECTS RES A, V82, P527, DOI 10.1002/bdra.20468; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cole DA, 1998, PSYCHOL ASSESSMENT, V10, P241, DOI 10.1037/1040-3590.10.3.241; Copp AJ, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.7; EGELAND B, 1993, DEV PSYCHOPATHOL, V5, P359, DOI 10.1017/S0954579400004466; Garcia Coll C. G., 1995, HDB PARENTING, V2, P189; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Gresham FM., 1990, SOCIAL SKILLS RATING; Guralnick MJ, 2008, AM J MENT RETARD, V113, P1, DOI 10.1352/0895-8017(2008)113[1:MSCATY]2.0.CO;2; Hammond SI, 2015, SOC DEV, V24, P367, DOI 10.1111/sode.12104; Hammond SI, 2012, DEV PSYCHOL, V48, P271, DOI 10.1037/a0025519; Harter S., 1985, MANUAL SELF PERCEPTI; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Holmbeck G. N., 2007, PARENT CHILD I UNPUB; Holmbeck GN, 2003, J CONSULT CLIN PSYCH, V71, P782, DOI 10.1037/0022-006X.71.4.782; Holmbeck GN, 2002, J PEDIATR PSYCHOL, V27, P5, DOI 10.1093/jpepsy/27.1.5; HOLMBECK GN, 2002, INTRUSIVE PARENTING, P191, DOI DOI 10.1037/10422-007; Holmbeck GN, 2010, DEV DISABIL RES REV, V16, P40, DOI 10.1002/ddrr.90; Holmbeck GN, 2009, J PEDIATR PSYCHOL, V34, P691, DOI 10.1093/jpepsy/jsp046; Kaugars AS, 2011, J PEDIATR PSYCHOL, V36, P539, DOI 10.1093/jpepsy/jsq106; LaGreca AM, 1996, J PEDIATR PSYCHOL, V21, P137, DOI 10.1093/jpepsy/21.2.137; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Landry SH, 2002, DEV NEUROPSYCHOL, V21, P15, DOI 10.1207/S15326942DN2101_2; Lansford JE, 2014, J YOUTH ADOLESCENCE, V43, P1742, DOI 10.1007/s10964-014-0175-y; Loomis JW, 1997, DEV MED CHILD NEUROL, V39, P620; Mattanah JF, 2005, J APPL DEV PSYCHOL, V26, P85, DOI 10.1016/j.appdev.2004.10.007; MCLAUGHLIN JF, 1985, NEW ENGL J MED, V312, P1589, DOI 10.1056/NEJM198506203122501; McLean KC, 2012, DEV PSYCHOL, V48, P436, DOI 10.1037/a0025563; Neitzel C, 2003, J FAM PSYCHOL, V17, P147, DOI 10.1037/0893-3200.17.1.147; Norona AN, 2014, RES DEV DISABIL, V35, P3209, DOI 10.1016/j.ridd.2014.07.048; O'Hara LK, 2013, J PEDIATR PSYCHOL, V38, P675, DOI 10.1093/jpepsy/jst007; PRINZ RJ, 1979, J APPL BEHAV ANAL, V12, P691, DOI 10.1901/jaba.1979.12-691; Psihogios AM, 2013, J PEDIATR PSYCHOL, V38, P859, DOI 10.1093/jpepsy/jst047; SCHLUDER.E, 1970, J PSYCHOL, V76, P239, DOI 10.1080/00223980.1970.9916845; Schuhmann EM, 1998, J CLIN CHILD PSYCHOL, V27, P34, DOI 10.1207/s15374424jccp2701_4; Steele, 2017, HDB PEDIAT PSYCHOL, P566; Steinberg L., 2002, HDB PARENTING; Stiles-Shields C, 2019, J PEDIATR PSYCHOL, V44, P349, DOI 10.1093/jpepsy/jsy097; Treble-Barna A, 2016, DEV PSYCHOL, V52, P1777, DOI 10.1037/dev0000208; Vygotsky Lev., 1978, MIND SOC DEV HIGHER; WOOD D, 1976, J CHILD PSYCHOL PSYC, V17, P89, DOI 10.1111/j.1469-7610.1976.tb00381.x	50	1	1	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	JUL	2020	45	6					695	706		10.1093/jpepsy/jsaa042			12	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	NE2FI	WOS:000562412500011	32567662	Green Published			2022-02-06	
J	Yumul, JN; McKinlay, A; Than, M; Anderson, V; Catroppa, C				Yumul, Joy Noelle; McKinlay, Audrey; Than, Martin; Anderson, Vicki; Catroppa, Cathy			Concussive Symptoms Following Pediatric Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						mild TBI; postconcussive symptoms; preschool; school-aged; superficial head injury	POSTCONCUSSION SYNDROME; HEAD-INJURY; REFERRAL CENTER; CHILDREN; PREDICTORS; EPIDEMIOLOGY; APPROPRIATE; ADOLESCENTS; PERFORMANCE; PREVALENCE	Objectives: To determine the proportion of children with postconcussive symptoms (PCSs) and to explore the influence of noninjury and injury factors on parents' PCS report at 3 months postinjury. Design: A cross-sectional analysis of the 3-month postinjury data from a larger, prospective, longitudinal study. Methods: Parents and their child aged 2 to 12 years who presented at the emergency department with either a mild traumatic brain injury (mTBI) or a superficial injury to the head (SIH) were recruited. Parents reported their child's symptoms at the time of injury and at 3 months postinjury. Child, family/parent, and injury characteristics were considered as potential predictors. Logistic regression was conducted to determine which factors increase the likelihood of parents' PCS report. Results: At 3 months postinjury, 30% and 13% of children in the mTBI and SIH groups exhibited 1 or more symptoms, respectively. On the other hand, 18% (mTBI) and 8% (SIH) continued to have ongoing problems when 2 or more symptoms were considered at follow-up. The final model, which included child's sex, injury group, number of symptoms at the time of injury, and parental stress, had a significant predictive utility in determining parents' report of 1 or more symptoms at follow-up. Only parental stress continued to be a significant predictor when considering 2 or more symptoms at 3 months postinjury. Conclusions: Children with mTBI have worse outcomes than children with SIH at follow-up, with parents more likely to report 1 or more ongoing symptoms if their children had an mTBI. Postinjury assessment of parental stress and ongoing symptom monitoring in young children with mTBI will allow for timely provision of support for the family.	[Yumul, Joy Noelle; McKinlay, Audrey; Anderson, Vicki; Catroppa, Cathy] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Yumul, Joy Noelle; McKinlay, Audrey; Anderson, Vicki; Catroppa, Cathy] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Yumul, Joy Noelle; Anderson, Vicki; Catroppa, Cathy] Royal Childrens Hosp, Melbourne, Vic, Australia; [McKinlay, Audrey] Univ Canterbury, Dept Psychol, Christchurch, New Zealand; [Than, Martin] Canterbury Dist Hlth Board, Dept Emergency Med, Canterbury, New Zealand		Yumul, JN (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, 50 Flemington Rd, Parkville, Vic 3052, Australia.	joynoelle.yumul@mcri.edu.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436	Health Research Council/Accident Compensation Corporation of New Zealand; University of MelbourneUniversity of Melbourne	A. McKinlay was supported by a postdoctoral fellowship from the Health Research Council/Accident Compensation Corporation of New Zealand. J. Yumul is supported by theMelbourneResearch Scholarship from the University of Melbourne.	Abidin R. R., 2012, PARENTING STRESS IND; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barroso NE, 2016, PSYCHOL ASSESSMENT, V28, P1331, DOI 10.1037/pas0000257; Bernard C, 2017, BRAIN INJURY, V31, P1414, DOI 10.1080/02699052.2017.1350999; Bernard CO, 2017, J HEAD TRAUMA REHAB, V32, P413, DOI 10.1097/HTR.0000000000000298; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Borgialli DA, 2016, ACAD EMERG MED, V23, P878, DOI 10.1111/acem.13014; Buntsma D, 2017, EMERG MED AUSTRALAS, V29, P678, DOI 10.1111/1742-6723.12853; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Ewing-Cobbs L, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0939; Falk AC, 2006, ACTA PAEDIATR, V95, P1533, DOI 10.1080/08035250600731957; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Hearps SJC, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2003; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2018, J CLIN EXP NEUROPSYC, V40, P285, DOI 10.1080/13803395.2017.1342771; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P233, DOI 10.1097/HTR.0b013e3182a2dd7f; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Starkey NJ, 2018, BRAIN INJURY, V32, P617, DOI 10.1080/02699052.2018.1439533; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Studer M, 2014, J INT NEUROPSYCH SOC, V20, P982, DOI 10.1017/S1355617714000927; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; TEASDALE G, 1974, LANCET, V2, P81; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	37	1	1	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2020	35	4			SI		279	287		10.1097/HTR.0000000000000565			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MR1MK	WOS:000553355300005	32108715				2022-02-06	
J	Zhou, J; Yang, CS; Shen, LJ; Lv, QW; Xu, QC				Zhou, Jing; Yang, Chun-Song; Shen, Liang-Jun; Lv, Qing-Wei; Xu, Qi-Chen			Usefulness of serum glucose and potassium ratio as a predictor for 30-day death among patients with severe traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; Glucose and potassium ratio; Mortality; Severity	PROGNOSTIC VALUE; MORTALITY; S100B	Background: Serum glucose and potassium ratio (GPR) was recently found to be related to outcome of aneurysmal subarachnoid hemorrhage. This retrospectively study was to investigate the association of serum GPR with mortality in severe traumatic brain injury (sTBI). Methods: Clinical data were retrospectively reviewed of isolated sTBI patients admitted within 12 h after trauma between January 2014 and January 2019. We analyzed relationships between admission serum GPR and post-traumatic 30-day mortality in addition to admission Glasgow coma scale (GCS) scores. Discriminative ability was evaluated using area under receiver operating characteristic curve (AUC). Results: A total of 146 patients, of whom 37 (25.3%) died within 30 days following trauma, were included. Admission serum GPR emerged as an independent predictor for 30-day mortality (odds ratio, 5.256; 95% confidence interval (CI), 1.111-14.856) and overall survival (hazard ratio, 4.822; 95% CI, 1.157-12.870), with an AUC of 0.777 (95% CI, 0.693-0.835), which was equivalent to that of GCS scores (AUC, 0.831; 95% CI, 0.760-0.888; P = 0.179). There was a significant correlation between admission serum GPR and GCS scores (r(2) = 0.293). Conclusions: Serum GPR in cases of sTBI is substantially associated with trauma severity and 30-day mortality. Therefore, the potential value of serum GPR for predicting short-term mortality of sTBI patients is favorable.	[Zhou, Jing; Yang, Chun-Song; Shen, Liang-Jun; Lv, Qing-Wei; Xu, Qi-Chen] Zhejiang Univ, Dept Neurosurg, Shengzhou Branch, Shengzhou Peoples Hosp,Affiliated Hosp 1, 666 Dangui Rd, Shengzhou 312400, Zhejiang, Peoples R China		Yang, CS (corresponding author), Zhejiang Univ, Dept Neurosurg, Shengzhou Branch, Shengzhou Peoples Hosp,Affiliated Hosp 1, 666 Dangui Rd, Shengzhou 312400, Zhejiang, Peoples R China.	shengzhouzhoujing@163.com					BESSEY PQ, 1984, ANN SURG, V200, P264, DOI 10.1097/00000658-198409000-00004; de Oliveira DV, 2017, ONCOTARGET, V8, P18622, DOI 10.18632/oncotarget.15740; Dolmans R.G.F., 2019, WORLD NEUROSURG, VS1878-8750, P32705; Fujiki Y, 2018, J NEUROSURG, V129, P870, DOI 10.3171/2017.5.JNS162799; Fujimoto K, 2016, J NEUROSURG, V124, P1640, DOI 10.3171/2015.4.JNS142760; Geeraerts T, 2018, ANAESTH CRIT CARE PA, V37, P171, DOI 10.1016/j.accpm.2017.12.001; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Jochems D, 2018, CRIT CARE RES PRACT, V2018, DOI 10.1155/2018/3769418; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kellermann I, 2016, CLIN NEUROL NEUROSUR, V145, P79, DOI 10.1016/j.clineuro.2016.04.005; Kurtz P, 2013, NEUROCRIT CARE, V19, P311, DOI 10.1007/s12028-013-9919-x; Marehbian J, 2017, NEUROCRIT CARE, V27, P430, DOI 10.1007/s12028-017-0408-5; MASSARA F, 1970, EUR J PHARMACOL, V10, P404, DOI 10.1016/0014-2999(70)90214-1; Matano F, 2019, J STROKE CEREBROVASC, V28, P1951, DOI 10.1016/j.jstrokecerebrovasdis.2019.03.041; Nik Amir, 2018, Bull Emerg Trauma, V6, P141, DOI 10.29252/beat-060208; Ogura T, 2012, NEUROL RES, V34, P484, DOI 10.1179/1743132812Y.0000000033; Osler T, 2016, INJURY, V47, P1879, DOI 10.1016/j.injury.2016.04.016; Ostermann RC, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0975-y; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Poon WS, 2005, ACT NEUR S, V93, P207; Rau CS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111340; Reid J.L., 1986, AM J CARDIOL, V57, p23F; Saika A, 2015, ACTA NEUROCHIR, V157, P1323, DOI 10.1007/s00701-015-2469-6; Sinha S, 2016, J CLIN NEUROSCI, V30, P31, DOI 10.1016/j.jocn.2015.10.051; Wang KY, 2012, CLIN CHIM ACTA, V413, P1737, DOI 10.1016/j.cca.2012.07.002; Wu X, 2015, INJURY, V46, P35, DOI 10.1016/j.injury.2014.08.002; Zhang DD, 2019, WORLD NEUROSURG, V127, pE1145, DOI 10.1016/j.wneu.2019.04.071	27	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	JUL	2020	506						166	171		10.1016/j.cca.2020.03.039			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	LP5PW	WOS:000534370700024	32240656				2022-02-06	
J	Zhou, ZW; Gao, S; Li, YD; Peng, RL; Zheng, ZT; Wei, W; Zhao, ZL; Liu, XL; Li, LY; Zhang, JN				Zhou, Ziwei; Gao, Shan; Li, Yadan; Peng, Ruilong; Zheng, Zhitong; Wei, Wei; Zhao, Zilong; Liu, Xilei; Li, Luyuan; Zhang, Jianning			VEGI Improves Outcomes in the Early Phase of Experimental Traumatic Brain Injury	NEUROSCIENCE			English	Article						traumatic brain injury; vascular endothelial growth factor; blood brain barrier	PROMOTES ANGIOGENESIS; FUNCTIONAL RECOVERY; BARRIER BREAKDOWN; ENDOTHELIAL-CELLS; TIE2 RECEPTOR; TNFSF15; GROWTH; ANGIOPOIETIN-2; EXPRESSION; SUPPRESSES	Excessive expression of vascular endothelial growth factor (VEGF) is a common cause of blood-brain barrier (BBB) breakdown that triggers severe complications following traumatic brain injury (TBI). It has been shown that inhibition of VEGF activities may attenuate cerebral edema in pathological conditions. Vascular endothelial growth inhibitor (VEGI; also known as TNFSF15), a cytokine produced largely by vascular endothelial cells, is capable of downregulating VEGF expression and inhibiting VEGF receptor-2 (VEGFR2) activation. In this study we found that TBI can cause breakdown of BBB and sharp increases of VEGF/VEGI and Angpt2/Angpt1 ratios in the injured tissues. VEGI treatment resulted in a marked decrease of BBB permeability and concomitant restoration of normal ratios of VEGF/VEGI and Angpt2/Angpt1. Consistently, alleviated edema, decreased neuron cell death, and improved neurological functions were observed when the experimental animals were treated with VEGI in the early phase of TBI. Our findings suggest that administration of VEGI recombinant protein at early phases of TBI is beneficial to stabilization of the disease conditions.	[Zhou, Ziwei; Peng, Ruilong; Zheng, Zhitong; Wei, Wei; Zhao, Zilong; Liu, Xilei; Zhang, Jianning] Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Zhou, Ziwei; Zhao, Zilong; Zhang, Jianning] Tianjin Neurol Inst, Tianjin, Peoples R China; [Zhou, Ziwei; Zhao, Zilong; Zhang, Jianning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China; [Zhou, Ziwei; Zhao, Zilong; Zhang, Jianning] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin, Peoples R China; [Li, Yadan] Tianjin Huanhu Hosp, Intens Care Units, Tianjin, Peoples R China; [Gao, Shan; Li, Luyuan] Nankai Univ, State Key Lab Med Chem Biol, Coll Pharm, Tianjin, Peoples R China		Li, LY; Zhang, JN (corresponding author), Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China.	liluyuan@nankai.edu.cn; jianningzhang@hotmail.com	Zhao, Zilong/AAZ-2196-2020		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81330029, 81930031, 81801234, 81720108015]; Scientific research project of Tianjin Education Commission [2018KJ052]	This study was supported by the National Natural Science Foundation of China, (81330029, 81930031, 81801234 and 81720108015) and the Scientific research project of Tianjin Education Commission (2018KJ052). We wish to thank the timely help given by Dr. Liqun He in revising the part of introduction.	Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bohn KA, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00193; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Chew LJ, 2002, FASEB J, V16, P742, DOI 10.1096/fj.01-0757fje; Conway Kevin P, 2007, Int Wound J, V4, P55, DOI 10.1111/j.1742-481X.2006.00295.x; Daly C, 2013, CANCER RES, V73, P108, DOI 10.1158/0008-5472.CAN-12-2064; Deng WM, 2012, ANGIOGENESIS, V15, P71, DOI 10.1007/s10456-011-9244-y; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Gerstner ER, 2009, NAT REV CLIN ONCOL, V6, P229, DOI 10.1038/nrclinonc.2009.14; Guilfoyle MR, 2015, J NEUROTRAUM, V32, P1553, DOI 10.1089/neu.2014.3764; Hakanpaa L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6962; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Hou W, 2005, CLIN CANCER RES, V11, P5595, DOI 10.1158/1078-0432.CCR-05-0384; Huang XT, 2013, J NEUROTRAUM, V30, P2080, DOI 10.1089/neu.2013.2996; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Jiang, 2009, INT J MOL MED, V24; Jiang F, 2016, INT J MOL SCI, V17; Kienast Y, 2013, CLIN CANCER RES, V19, P6730, DOI 10.1158/1078-0432.CCR-13-0081; Kirton JP, 2010, MICROVASC RES, V79, P193, DOI 10.1016/j.mvr.2010.02.009; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Nourhaghighi N, 2003, LAB INVEST, V83, P1211, DOI 10.1097/01.LAB.0000082383.40635.FE; Park DY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15296; Qi JW, 2013, P NATL ACAD SCI USA, V110, P13863, DOI 10.1073/pnas.1304529110; Rigamonti N, 2014, CELL REP, V8, P696, DOI 10.1016/j.celrep.2014.06.059; Sawai H, 2011, BIOCHEM BIOPH RES CO, V411, P569, DOI 10.1016/j.bbrc.2011.06.186; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tado M, 2014, J NEUROTRAUM, V31, P691, DOI 10.1089/neu.2013.2940; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yang GL, 2017, FASEB J, V31, P2001, DOI 10.1096/fj.201600800R; Yang JP, 2010, J INVEST SURG, V23, P149, DOI 10.3109/08941930903469482; Yu JY, 2001, CIRC RES, V89, P1161, DOI 10.1161/hh2401.101909; Yuksel H, 2013, NEUROL SCI, V34, P1941, DOI 10.1007/s10072-013-1411-z; Zhai YF, 1999, FASEB J, V13, P181, DOI 10.1096/fasebj.13.1.181; Zhang K, 2016, ONCOTARGET, V7, P69436, DOI 10.18632/oncotarget.11683; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhang ZS, 2012, CANCER MICROENVIRON, V5, P237, DOI 10.1007/s12307-012-0117-8; Zhou Y, 2018, BLOOD, V131, P563, DOI 10.1182/blood-2017-08-801738	45	1	1	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUL 1	2020	438						60	69		10.1016/j.neuroscience.2020.04.042			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY0YC	WOS:000540248600006	32380270				2022-02-06	
J	Jecko, V; Sesay, M; Liguoro, D				Jecko, Vincent; Sesay, Musa; Liguoro, Dominique			Anatomical location of the abducens nerves (VI) in the ventral approach of clival tumors	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						Abducens nerve; Petrous apex; Petro-sphenoidal foramen; Anterior clival surgical approach	INTERNAL CAROTID-ARTERY; SKULL BASE SURGERY; MICROSURGICAL ANATOMY; ENDONASAL SURGERY; INJURY; ANTERIOR	The aim of this work was to determine reliable anatomical landmarks for locating and preserving the abducens nerves (6th cranial nerves) during trans-facial or trans-nasal endoscopic approaches of skull base tumors involving the clivus and the petrous apex. In order to describe this specific anatomy, we carefully dissected 10 cadaveric heads under optic magnification. Several measurements were taken between the two petro-sphenoidal foramina, from the bottom of the sella and the dorsum sellae. The close relationship between the nerves and the internal carotid artery were taken into account. We defined a trapezoid area that allowed drilling the clivus safely, preserving the 6th cranial nerve while being attentive to the internal carotid artery. The caudal part of this trapezium is, on average, 20 mm long at mi-distance between the two petro-sphenoidal foramina. The cranial part is at the sella level, a line between both paraclival internal carotid arteries. Oblique lateral edges between the cranial and caudal parts completed the trapezium.	[Jecko, Vincent] Bordeaux Univ Hosp, Neurosurg A Unit, F-33076 Bordeaux, France; [Liguoro, Dominique] Univ Bordeaux, Dept Anat, F-33076 Bordeaux, France; [Sesay, Musa] Bordeaux Univ Hosp, Dept Anesthesia & Crit Care, F-33076 Bordeaux, France		Jecko, V (corresponding author), Bordeaux Univ Hosp, Neurosurg A Unit, F-33076 Bordeaux, France.	vincent.jecko@chu-bordeaux.fr	jecko, vincent/AAO-5784-2020	jecko, vincent/0000-0002-4811-490X			Al-Mefty O, 2008, J NEUROSURG, V109, P783, DOI 10.3171/JNS/2008/109/11/0783; AlQahtani A, 2016, OTOLARYNG CLIN N AM, V49, P237, DOI 10.1016/j.otc.2015.09.009; [Anonymous], 2016, J NEUROSURG, V125; Barges-Coll J, 2010, NEUROSURGERY, V67, P144, DOI 10.1227/01.NEU.0000370892.11284.EA; Bouthillier A, 1996, NEUROSURGERY, V38, P425, DOI 10.1097/00006123-199603000-00001; Campero A, 2010, J CLIN NEUROSCI, V17, P746, DOI 10.1016/j.jocn.2009.10.015; Catapano D, 2006, J NEUROSURG, V104, P419, DOI 10.3171/jns.2006.104.3.419; Chin OY, 2016, LARYNGOSCOPE, V126, P582, DOI 10.1002/lary.25748; Destrieux C, 1997, J NEUROSURG, V87, P67, DOI 10.3171/jns.1997.87.1.0067; Dolci RLL, 2018, J NEUROSURG, V128, P174, DOI 10.3171/2016.10.JNS16381; Ferreira T, 2010, EUR J RADIOL, V74, P314, DOI 10.1016/j.ejrad.2009.05.066; Gardner PA, 2013, NEUROSURGERY, V73, P261, DOI 10.1227/01.neu.0000430821.71267.f2; Joo W, 2012, CLIN ANAT, V25, P1030, DOI 10.1002/ca.22047; Kaspera W, 2015, ADV MED SCI-POLAND, V60, P25, DOI 10.1016/j.advms.2014.08.009; Lang J, 1991, RIV NEURORADIOL, V4, P125, DOI [10.1177/19714009910040S119, DOI 10.1177/19714009910040S119]; Li ZY, 2017, ACTA NEUROCHIR, V159, P1925, DOI 10.1007/s00701-017-3268-z; Miyagi A, 1998, NEUROL SURG TOKYO, V26, P169; NATHAN H, 1974, J NEUROSURG, V41, P561, DOI 10.3171/jns.1974.41.5.0561; Ono K, 2004, AM J NEURORADIOL, V25, P623; Oostra A, 2012, ANZ J SURG, V82, P122, DOI 10.1111/j.1445-2197.2011.05971.x; Ozer E, 2010, TURK NEUROSURG, V20, P449, DOI 10.5137/1019-5149.JTN.3303-10.1; Ozgur A, 2017, CLIN NEURORADIOL, V27, P97, DOI 10.1007/s00062-015-0415-x; Schlake HP, 2001, ACTA NEUROCHIR, V143, P251; Thirumala PD, 2013, J NEUROL SURG REP, V74, P43, DOI 10.1055/s-0033-1346975; Tubbs RS, 2012, WORLD NEUROSURG, V77, P119, DOI 10.1016/j.wneu.2011.03.046; Vail HH, 1922, LARYNGOSCOPE, V32, P569, DOI DOI 10.1288/00005537-192208000-00001; Zada G, 2011, J NEUROSURG, V114, P1319, DOI 10.3171/2010.11.JNS10768; Zhang Y, 2012, SURG RADIOL ANAT, V34, P3, DOI 10.1007/s00276-011-0850-6	28	1	1	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0930-1038	1279-8517		SURG RADIOL ANAT	Surg. Radiol. Anat.	NOV	2020	42	11					1371	1375		10.1007/s00276-020-02525-4		JUN 2020	5	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	NW6LR	WOS:000544609000001	32607642				2022-02-06	
J	Paget, LM; Gilard-Pioc, S; Cottenet, J; Beltzer, N; Quantin, C				Paget, Louis-Marie; Gilard-Pioc, Severine; Cottenet, Jonathan; Beltzer, Nathalie; Quantin, Catherine			Identification of Infant Victims of Abusive Head Trauma Hospitalised in France from 2015 to 2017	CHILD ABUSE REVIEW			English	Article						maltreatment; abusive head trauma; shaken baby syndrome; hospitalisations	SHAKEN-BABY-SYNDROME; INTERNATIONAL CLASSIFICATION; BRAIN-INJURY; MORTALITY; DISEASES; OUTCOMES; CHILDREN; CODES	To our knowledge, there are no recent national epidemiological studies in France on abusive head trauma (AHT). The objective of this study was to quantify cases of AHT as a result of child abuse admitted to French hospitals, based on the French hospital discharge database (PMSI) from 2015 to 2017. Among infants aged between one and 11 months who were hospitalised for subdural haematoma or traumatic subarachnoid haemorrhage, we distinguished probable cases (stays with International Statistical Classification of Diseases and Related Health Problems, 10(th)Revision codes suggestive of child abuse or retinal haemorrhage) from possible cases (all other children), in order to make comparisons and estimate hospital incidence rates. We identified 512 probable cases and 703 possible cases. The incidence was 22.1 cases (20.2-24.0) per 100 000 live births for probable cases, and 52.4 cases (49.5-55.4) per 100 000 live births for combined probable and possible cases. The overall median age was four months with a male predominance. Among probable cases, lesions suggestive of abuse were more frequent, and there were fewer skull fractures and accidental falls than in possible cases. This exploratory analysis shows that it is complicated to determine precisely the number of cases of AHT from PMSI data. The implementation of a specific code for AHT in this database would identify these cases more accurately. Key Practitioner Messages Among probable cases, lesions suggestive of abuse were more frequent, and there were fewer skull fractures and accidental falls than among the possible cases. Implementation of a specific code for AHT in hospital discharge databases would identify these cases more accurately.	[Paget, Louis-Marie; Beltzer, Nathalie] Sante Publ France, St Maurice, France; [Gilard-Pioc, Severine; Cottenet, Jonathan; Quantin, Catherine] Dijon Univ Hosp, Serv Biostat & Informat Med DIM, Dijon, France; [Gilard-Pioc, Severine; Cottenet, Jonathan; Quantin, Catherine] Univ Burgundy Franche Comte, Dijon, France; [Quantin, Catherine] INSERM, CIC 1432, Dijon, France; [Quantin, Catherine] Dijon Univ Hosp, Clin Trials Unit, Clin Epidemiol, Clin Invest Ctr, Dijon, France; [Quantin, Catherine] Univ Paris Saclay, Inst Pasteur, Biostat Biomath Pharmacoepidemiol & Infect Dis B2, INSERM,UVSQ, Paris, France		Quantin, C (corresponding author), CHU Dijon, Serv Biostat & Informat Med, BP 77908, F-21079 Dijon, France.	catherine.quantin@chu-dijon.fr		Quantin, Catherine/0000-0001-5134-9411			Barber I, 2014, PEDIATR RADIOL, V44, P613, DOI 10.1007/s00247-014-3099-5; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; Berger RP, 2015, INJURY PREV, V21, pE133, DOI 10.1136/injuryprev-2013-040924; Creuzot-Garcher CP, 2019, BRIT J OPHTHALMOL, V103, P534, DOI 10.1136/bjophthalmol-2018-312171; Ellingson KD, 2008, AM J PREV MED, V34, pS157, DOI 10.1016/j.amepre.2007.12.021; Fujiwara T, 2012, AM J PREV MED, V43, P215, DOI 10.1016/j.amepre.2012.04.028; Gilard-Pioc S, 2016, PUBLIC HEALTH, V141, P23, DOI 10.1016/j.puhe.2016.06.020; Gilard-Pioc S, 2019, CHILD ABUSE REV, V28, P353, DOI 10.1002/car.2597; Goueslard K, 2018, DIABETES CARE, V41, P2316, DOI 10.2337/dc18-0657; Greeley CS, 2015, AM J ROENTGENOL, V204, P967, DOI 10.2214/AJR.14.14191; Haute Autorite de Sante, 2017, SYNDR BEB SEC TRAUM; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Hobbs C, 2005, ARCH DIS CHILD, V90, P952, DOI 10.1136/adc.2003.037739; Iacobelli S, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0787-y; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kelly P, 2008, J PAEDIATR CHILD H, V44, P99, DOI 10.1111/j.1440-1754.2007.01234.x; King WJ, 2003, CAN MED ASSOC J, V168, P155; Lind K, 2013, REV SAGE FEMME, V12, P136; Lorgis L, 2013, CIRCULATION, V127, P1767, DOI 10.1161/CIRCULATIONAHA.113.001874; Luu M, 2018, AM J GASTROENTEROL, V113, P1669, DOI 10.1038/s41395-018-0176-7; Maitre T, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00359-2018; Mireau E., 2005, THESIS; Niederkrotenthaler T, 2013, CHILD ABUSE NEGLECT, V37, P446, DOI 10.1016/j.chiabu.2013.02.002; Pages PB, 2016, EUR RESPIR J, V47, P1809, DOI 10.1183/13993003.00052-2016; Parks SE., 2012, PEDIAT ABUSIVE HEAD; Parks S, 2012, INJURY PREV, V18, P392, DOI 10.1136/injuryprev-2011-040234; Parrish J, 2013, INT J CIRCUMPOL HEAL, V72, P472, DOI 10.3402/ijch.v72i0.21216; Republique Francaise, 2017, PLAN INT MOB UTE CON; Revert M, 2018, OBSTET GYNECOL, V131, P143, DOI 10.1097/AOG.0000000000002405; Shanahan ME, 2013, PEDIATRICS, V132, pE1546, DOI 10.1542/peds.2013-2049; Talvik I, 2006, ACTA PAEDIATR, V95, P799, DOI 10.1080/08035250500464923; Tiyyagura G, 2015, ANN EMERG MED, V66, P447, DOI 10.1016/j.annemergmed.2015.06.020; World Health Organization, 2016, INT STAT CLASS DIS R, V5TH; Yamaoka Y, 2020, J EPIDEMIOL, V30, P91, DOI 10.2188/jea.JE20180094	35	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-9136	1099-0852		CHILD ABUSE REV	Child Abus. Rev.	MAY	2020	29	3			SI		182	194		10.1002/car.2639		JUN 2020	13	Family Studies; Social Work	Social Science Citation Index (SSCI)	Family Studies; Social Work	ML4VA	WOS:000544113000001					2022-02-06	
J	Raji, CA; Wang, MB; Nguyen, N; Owen, JP; Palacios, EM; Yuh, EL; Mukherjee, P				Raji, Cyrus A.; Wang, Maxwell B.; NhuNhu Nguyen; Owen, Julia P.; Palacios, Eva M.; Yuh, Esther L.; Mukherjee, Pratik			Connectome mapping with edge density imaging differentiates pediatric mild traumatic brain injury from typically developing controls: proof of concept	PEDIATRIC RADIOLOGY			English	Article						Brain; Children; Concussion; Diffusion tensor imaging; Edge density imaging; Magnetic resonance imaging; Traumatic brain injury	WHITE-MATTER; CONCUSSION; REGISTRATION; SUPERRESOLUTION; ABNORMALITIES; SYMPTOMS; VALIDITY; SPORTS; ROBUST; YOUTH	Background Although acute neurologic impairment might be transient, other long-term effects can be observed with mild traumatic brain injury. However, when pediatric patients with mild traumatic brain injury present for medical care, conventional imaging with CT and MR imaging often does not reveal abnormalities. Objective To determine whether edge density imaging can separate pediatric mild traumatic brain injury from typically developing controls. Materials and methods Subjects were recruited as part of the "Therapeutic Resources for Attention Improvement using Neuroimaging in Traumatic Brain Injury" (TRAIN-TBI) study. We included 24 adolescents (chi=14.1 years of age, sigma=1.6 years, range 10-16 years), 14 with mild traumatic brain injury (TBI) and 10 typically developing controls. Neurocognitive assessments included the pediatric version of the California Verbal Learning Test (CVLT) and the Attention Network Task (ANT). Diffusion MR imaging was acquired on a 3-tesla (T) scanner. Edge density images were computed utilizing fiber tractography. Principal component analysis (PCA) and support vector machines (SVM) were used in an exploratory analysis to separate mild TBI and control groups. The diagnostic accuracy of edge density imaging, neurocognitive tests, and fractional anisotropy (FA) from diffusion tensor imaging (DTI) was computed with two-samplet-tests and receiver operating characteristic (ROC) metrics. Results Support vector machine-principal component analysis of edge density imaging maps identified three white matter regions distinguishing pediatric mild TBI from controls. The bilateral tapetum, sagittal stratum, and callosal splenium identified mild TBI subjects with sensitivity of 79% and specificity of 100%. Accuracy from the area under the ROC curve (AUC) was 94%. Neurocognitive testing provided an AUC of 61% (CVLT) and 71% (ANT). Fractional anisotropy yielded an AUC of 48%. Conclusion In this proof-of-concept study, we show that edge density imaging is a new form of connectome mapping that provides better diagnostic delineation between pediatric mild TBI and healthy controls than DTI or neurocognitive assessments of memory or attention.	[Raji, Cyrus A.; Wang, Maxwell B.; NhuNhu Nguyen; Owen, Julia P.; Palacios, Eva M.; Yuh, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Neural Connect Lab, Dept Radiol & Biomed Imaging, 185 Berry St,Suite 350, San Francisco, CA 94158 USA; [Raji, Cyrus A.] Washington Univ, Mallinckrodt Inst Radiol, Div Neuroradiol, St Louis, MO 63110 USA		Raji, CA (corresponding author), Univ Calif San Francisco, Neural Connect Lab, Dept Radiol & Biomed Imaging, 185 Berry St,Suite 350, San Francisco, CA 94158 USA.; Raji, CA (corresponding author), Washington Univ, Mallinckrodt Inst Radiol, Div Neuroradiol, St Louis, MO 63110 USA.	cyrusraji@gmail.com			National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [NIH T32 EB001631]; American Society of Neuroradiology Boerger Research Grant; Radiological Society of North America Research Scholar Award; WUSTL NIH KL2 Grant (ICTS Multidisciplinary Clinical Research Career Development Program) [KL2 TR000450]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NIH R01 NS060776]	The TRAIN-TBI project was generously supported by a gift from Dennis J. & Shannon Wong. Dr. Raji was supported by a training grant from the National Institute of Biomedical Imaging and Bioengineering (NIH T32 EB001631), administered by the UCSF Department of Radiology and Biomedical Imaging, and the American Society of Neuroradiology Boerger Research Grant. He is currently supported by additional grants from the Radiological Society of North America Research Scholar Award and WUSTL NIH KL2 Grant (KL2 TR000450 - ICTS Multidisciplinary Clinical Research Career Development Program). Dr. Mukherjee received support from the National Institute of Neurological Disorders and Stroke (NIH R01 NS060776).	Abdullah N., 2011, 2011 Proceedings of IEEE International Conference on Imaging Systems and Techniques (IST 2011), P242, DOI 10.1109/IST.2011.5962185; Alexiou George A, 2011, J Emerg Trauma Shock, V4, P403, DOI 10.4103/0974-2700.83872; Babcock L, 2015, J PEDIATR REHAB MED, V8, P285, DOI 10.3233/PRM-150347; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; Baker DA, 2014, CLIN NEUROPSYCHOL, V28, P116, DOI 10.1080/13854046.2013.858184; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buethe J, 2016, AM J NEURORADIOL, V37, P2182, DOI 10.3174/ajnr.A4821; Buttram Sandra D W, 2015, Hosp Pediatr, V5, P79, DOI 10.1542/hpeds.2014-0094; Calamante F, 2011, NEUROIMAGE, V56, P1259, DOI 10.1016/j.neuroimage.2011.02.059; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Cicuendez M, 2017, ACTA NEUROCHIR, V159, P25, DOI 10.1007/s00701-016-3000-4; DeMaster D, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.832; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Georgieva P, 2013, LECT NOTES COMPUT SC, V8131, P288, DOI 10.1007/978-3-642-40728-4_36; Guo XY, 2017, NEUROPSYCHOLOGY, V31, P84, DOI 10.1037/neu0000305; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Habeck C, 2010, CELL BIOCHEM BIOPHYS, V58, P53, DOI 10.1007/s12013-010-9093-0; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Jbabdi S, 2010, NEUROIMAGE, V49, P247, DOI 10.1016/j.neuroimage.2009.08.039; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Levin HS, 2011, DEV NEUROPSYCHOL, V36, P273, DOI 10.1080/87565641.2010.549885; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCauley SR, 2011, J NEUROTRAUM, V28, P503, DOI 10.1089/neu.2010.1555; Mioni G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00269; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Owen JP, 2016, BRAIN CONNECT, V6, P548, DOI 10.1089/brain.2016.0431; Owen JP, 2015, NEUROIMAGE, V109, P402, DOI 10.1016/j.neuroimage.2015.01.007; Payabvash S, 2019, BRAIN CONNECT, V9, P209, DOI 10.1089/brain.2018.0658; Peled S, 2001, MAGN RESON MED, V45, P29, DOI 10.1002/1522-2594(200101)45:1<29::AID-MRM1005>3.0.CO;2-Z; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Tkachenko N, 2016, PEDIATR NEUROL, V57, P46, DOI 10.1016/j.pediatrneurol.2015.12.019; Toga AW, 2001, IMAGE VISION COMPUT, V19, P3, DOI 10.1016/S0262-8856(00)00055-X; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wilde EA, 2006, J CHILD NEUROL, V21, P769, DOI 10.1177/08830738060210090201; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	55	1	1	2	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	OCT	2020	50	11					1594	1601		10.1007/s00247-020-04743-9		JUN 2020	8	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	NO3EJ	WOS:000544592900001	32607611	Green Accepted			2022-02-06	
J	Bree, D; Stratton, J; Levy, D				Bree, Dara; Stratton, Jennifer; Levy, Dan			Increased severity of closed head injury or repetitive subconcussive head impacts enhances post-traumatic headache-like behaviors in a rat model	CEPHALALGIA			English	Article						Posttraumatic headache; concussion; repetitive subconcussive head impacts; cutaneous pain hypersensitivity; anti-CGRP monoclonal antibody	TRAUMATIC BRAIN-INJURY; DURAL STIMULATION; NATURAL-HISTORY; PAIN; PREVALENCE; AFFERENTS; MICE	Introduction Posttraumatic headache is one of the most common, debilitating, and difficult symptoms to manage after a traumatic head injury. The development of novel therapeutic approaches is nevertheless hampered by the paucity of preclinical models and poor understanding of the mechanisms underlying posttraumatic headache. To address these shortcomings, we previously characterized the development of posttraumatic headache-like pain behaviors in rats subjected to a single mild closed head injury using a 250 g weight drop. Here, we conducted a follow-up study to further extend the preclinical research toolbox for studying posttraumatic headache by exploring the development of headache-like pain behaviors in male rats subjected to a single, but more severe head trauma (450 g) as well as following repetitive, subconcussive head impacts (150 g). In addition, we tested whether these behaviors involve peripheral calcitonin gene-related peptide signaling by testing the effect of systemic treatment with an anti-calcitonin gene-related peptide monoclonal antibody (anti-calcitonin gene-related peptide mAb). Methods Adult male Sprague Dawley rats (total n = 138) were subjected to diffuse closed head injury using a weight-drop device, or a sham procedure. Three injury paradigms were employed: A single hit, using 450 g or 150 g weight drop, and three successive 150 g weight drop events conducted 72 hours apart. Changes in open field activity and development of cephalic and extracephalic tactile pain hypersensitivity were assessed up to 42 days post head trauma. Systemic administration of the anti-calcitonin gene-related peptide mAb or its control IgG (30 mg/kg) began immediately after the 450 g injury or the third 150 g weight drop with additional doses given every 6 days subsequently. Results Rats subjected to 450 g closed head injury displayed an acute decrease in rearing and increased thigmotaxis, together with cephalic tactile pain hypersensitivity that resolved by 6 weeks post-injury. Injured animals also displayed delayed and prolonged extracephalic tactile pain hypersensitivity that remained present at 6 weeks post-injury. Repetitive subconcussive head impacts using the 150 g weight drop, but not a single event, led to decreased vertical rearing as well as cephalic and extracephalic tactile pain hypersensitivity that resolved by 6 weeks post-injury. Early and prolonged anti-calcitonin gene-related peptide mAb treatment inhibited the development of the cephalic tactile pain hypersensitivity in both the severe and repetitive subconcussive head impact models. Conclusions Severe head injury gives rise to a prolonged state of cephalic and extracephalic tactile pain hypersensitivity. These pain behaviors also develop following repetitive, subconcussive head impacts. Extended cephalic tactile pain hypersensitivity following severe and repetitive mild closed head injury are ameliorated by early and prolonged anti-calcitonin gene-related peptide mAb treatment, suggesting a mechanism linked to calcitonin gene-related peptide signaling, potentially of trigeminal origin.	[Bree, Dara; Levy, Dan] Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, 330 Brookline Ave, Boston, MA 02215 USA; [Stratton, Jennifer] Teva Biol, Redwood City, CA USA; [Levy, Dan] Harvard Med Sch, Boston, MA 02115 USA		Levy, D (corresponding author), Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, 330 Brookline Ave, Boston, MA 02215 USA.	dlevy1@bidmc.harvard.edu	Levy, Dan/AAF-1871-2021	Levy, Dan/0000-0003-0630-6660	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS078263, R01NS086830, R21NS101405]	Dr Levy is supported by NIH Grants R01NS078263; R01NS086830, R21NS101405.	Ashina H, 2020, CEPHALALGIA, V40, P554, DOI 10.1177/0333102420909865; Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Benromano T, 2015, EUR J PAIN, V19, P621, DOI 10.1002/ejp.583; Bree D, 2020, CEPHALALGIA, V40, P748, DOI 10.1177/0333102420907597; Bree D, 2019, PAIN, V160, P1050, DOI 10.1097/j.pain.0000000000001481; Bree D, 2018, CEPHALALGIA, V38, P246, DOI 10.1177/0333102416681571; Burgos-Vega CC, 2016, PAIN, V157, P2722, DOI 10.1097/j.pain.0000000000000692; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Edelmayer RM, 2012, PAIN, V153, P1949, DOI 10.1016/j.pain.2012.06.012; Ennaceur A, 2014, PHYSIOL BEHAV, V135, P55, DOI 10.1016/j.physbeh.2014.05.032; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Kopruszinski CM, 2017, CEPHALALGIA, V37, P560, DOI 10.1177/0333102416650702; Levy D, 2020, CEPHALALGIA, V40, P675, DOI 10.1177/0333102419896368; Levy D, 2019, CEPHALALGIA, V39, P1606, DOI 10.1177/0333102418771350; Levy D, 2016, CEPHALALGIA, V36, P915, DOI 10.1177/0333102415617412; Levy D, 2012, BRAIN BEHAV IMMUN, V26, P311, DOI 10.1016/j.bbi.2011.09.016; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S, 2018, HEADACHE, V58, P873, DOI 10.1111/head.13311; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Mason BN, 2017, J NEUROSCI, V37, P204, DOI 10.1523/JNEUROSCI.2967-16.2016; McDonald SJ, 2020, J NEUROTRAUM, V37, P770, DOI 10.1089/neu.2019.6885; McEvoy H, 2020, CEPHALALGIA, V40, P701, DOI 10.1177/0333102419896754; Meehan W, 2015, NEUROLOGY, V85, P1504, DOI 10.1212/WNL.0000000000001893; Mills C, 2012, J PAIN, V13, P519, DOI 10.1016/j.jpain.2012.02.009; Moye LS, 2019, CEPHALALGIA, V39, P77, DOI 10.1177/0333102418777507; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nation KM, 2019, CEPHALALGIA, V39, P617, DOI 10.1177/0333102418804157; Navratilova E, 2019, CEPHALALGIA, V39, P1762, DOI 10.1177/0333102419877662; Oshinsky ML, 2007, HEADACHE, V47, P1026, DOI 10.1111/j.1526-4610.2007.00871.x; Reichling DB, 2009, TRENDS NEUROSCI, V32, P611, DOI 10.1016/j.tins.2009.07.007; Sallis RE, 2000, MED SCI SPORT EXER, V32, P1820, DOI 10.1097/00005768-200011000-00002; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Tyburski AL, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0726-1; VOS BP, 1994, J NEUROSCI, V14, P2708; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; Yan J, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-6; Zhao J, 2014, PAIN, V155, P1392, DOI 10.1016/j.pain.2014.04.019	42	1	1	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	OCT	2020	40	11					1224	1239	0333102420937664	10.1177/0333102420937664		JUN 2020	16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NV7OO	WOS:000545452500001	32600065	Green Submitted, Green Accepted			2022-02-06	
J	Vale, TC; Echenique, L; Barsottini, OGP; Pedroso, JL				Vale, Thiago Cardoso; Echenique, Leandro; Povoas Barsottini, Orlando Graziani; Pedroso, Jose Luiz			Paroxysmal Autonomic Instability with Dystonia after Severe Traumatic Brain Injury	TREMOR AND OTHER HYPERKINETIC MOVEMENTS			English	Article						traumatic brain injuries; dystonia; movement disorders		Background: Paroxysmal autonomic instability with dystonia (PAID) syndrome, a subset of dysautonomia, is characterized by paroxysms of marked agitation, diaphoresis, hyperthermia, hypertension, tachycardia and tachypnea accompanied by hypertonia and extensor posturing. Case Report: We report a 52-year-old man who was severely brain injured and developed spastic tetraparesis with cognitive impairment. During his intensive care unit stay and rehabilitation period, he presented with paroxysmal episodes of dystonic posturing accompanied by dysautonomia. Discussion: Our case raises awareness of PAID, a life-threatening condition which can mimic many others and poses significant challenges in the acute management and rehabilitation of patients.	[Vale, Thiago Cardoso] Univ Fed Juiz de Fora, Dept Internal Med, Movement Disorders Unit, Juiz De Fora, Brazil; [Echenique, Leandro; Povoas Barsottini, Orlando Graziani; Pedroso, Jose Luiz] Univ Fed Sao Paulo, Div Gen Neurol, Dept Neurol, Sao Paulo, Brazil; [Echenique, Leandro; Povoas Barsottini, Orlando Graziani; Pedroso, Jose Luiz] Univ Fed Sao Paulo, Dept Neurol, Ataxia Unit, Sao Paulo, Brazil		Barsottini, OGP (corresponding author), Univ Fed Sao Paulo, Div Gen Neurol, Dept Neurol, Sao Paulo, Brazil.; Barsottini, OGP (corresponding author), Univ Fed Sao Paulo, Dept Neurol, Ataxia Unit, Sao Paulo, Brazil.	orlandobarsottini@gmail.com	Barsottini, O/E-9117-2010; Pedroso, Jose L/F-1757-2013	Barsottini, O/0000-0002-0107-0831; Pedroso, Jose L/0000-0002-1672-8894			Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; Chittiboina P, 2011, NEUROL INDIA, V59, P906, DOI 10.4103/0028-3886.91377; Goddeau RP, 2007, NEUROCRIT CARE, V7, P217, DOI 10.1007/s12028-007-0066-0; Kapoor D, 2014, SINGAP MED J, V55, pE123, DOI 10.11622/smedj.2013264; Lee HS, 2015, ANN REHABIL MED-ARM, V39, P308, DOI 10.5535/arm.2015.39.2.308; Rabinstein AA, 2008, CURR TREAT OPTION N, V10, P151, DOI 10.1007/s11940-008-0016-y; Ramdhani Navin A, 2010, J Med Case Rep, V4, P304, DOI 10.1186/1752-1947-4-304; Safadieh L, 2012, CASE REP MED, V2012, DOI 10.1155/2012/965932; Singh DK, 2011, PEDIATR NEUROSURG, V47, P275, DOI 10.1159/000334276	10	1	1	0	1	COLUMBIA UNIV LIBRARIES, CENTER DIGITAL RESEARCH & SCHOLARSHIP	NEW YORK	201 LEHMAN LIBRARY, INT AFFAIRS BLDG-SIPA, NEW YORK, NY 10027 USA	2160-8288			TREMOR OTHER HYPERK	Tremor Other Hyperkinetic Mov.	JUN 29	2020	10								12	10.5334/tohm.81			4	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	MH2LW	WOS:000546564200001	32775026	Green Published, gold			2022-02-06	
J	Kent, JB; Wood, CL; Pugh, K; Statuta, SM; MacKnight, JM				Kent, Jeremy B.; Wood, Colton L.; Pugh, Kelli; Statuta, Siobhan M.; MacKnight, John M.			The medical observer in American football: a survey of use and efficacy	BRAIN INJURY			English	Article						Sport-related concussion; NCAA football; ATC spotter; medical observer; eye in the sky	SELF-REPORTED CONCUSSIONS; POSITION STATEMENT; MANAGEMENT; NONDISCLOSURE	Objectives The growing concern over player safety and long-term health effects of sport-related concussion (SRC) led the Atlantic Coast Conference (ACC) to implement the medical observer, whose primary job is to identify SRCs not seen by sideline medical staff. The primary aim of this survey was to determine if the MO identifies SRCs the sideline medical staff missed during gameplay. Methods The authors distributed a 19-item questionnaire to all ACC athletic departments that assessed for SRCs or non-concussion injuries that were detected by the MO during the 2015-2016 ACC football season. Results Nineteen MOs completed the survey accounting for coverage of 56% of the total halves played by all ACC teams. A call to the field for concerns of an SRC carried a significantly higher risk of SRC diagnosis than no call to the field (RR 400.1, CI 244.6-654.1,P< .001). Four SRCs were identified by an MO that were not seen by the sideline medical staff. Conclusions The MO detects SRCs that are not seen by the sideline medical staff. The survey also showed many ACC teams used the MO as a secondary injury observer. Each MO should be provided with the best available tools, communication, and viewing angles.	[Kent, Jeremy B.] Univ Virginia Hlth Syst, Dept Family Med, UVa Sports Med, Charlottesville, VA USA; [Wood, Colton L.] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27515 USA; [Pugh, Kelli] Univ Virginia, Sports Med, Charlottesville, VA USA; [Statuta, Siobhan M.] Univ Virginia Hlth Syst, Family Med & Phys Med & Rehabil, Charlottesville, VA USA; [MacKnight, John M.] Univ Virginia Hlth Syst, UVA Sports Med, Internal Med & Orthopaed Surg, Charlottesville, VA USA		Kent, JB (corresponding author), POB 800729, Charlottesville, VA 22908 USA.	Jbk7y@virginia.edu		Kent, Jeremy/0000-0002-5348-1018			[Anonymous], FOOTB REC YEAR; Asplund CA, 2015, BRIT J SPORT MED, V49, P1015, DOI 10.1136/bjsports-2014-h1381rep; Austin AV, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120903294; Baugh C.M., 2016, CONCUSSION, V1, P1, DOI [DOI 10.2217/CNC.15.6, 10.2217/cnc.15.6]; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broome G, CHARLOTTEOBSERVER; Buckley TA, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117702606; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Carollo B, 2015, 2015 BIG 10 FOOTBALL; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Cochrane GD, 2017, PHYSICIAN SPORTSMED, V45, P178, DOI 10.1080/00913847.2017.1305875; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Dopher M, 2015, ACC FOOTBALL GAMES W; Ellenbogen RG, 2018, BRIT J SPORT MED, V52, P894, DOI 10.1136/bjsports-2018-099203; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Florio M, ATC SPOTTER FAILED C; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hebert O, 2016, J SCI MED SPORT, V19, P789, DOI 10.1016/j.jsams.2015.12.517; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Johnson G., 2015, NCAA APPROVES EXPT R; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kekis J, US TODAY; Kerr ZY, 2018, AM J SPORT MED, V46, P22, DOI 10.1177/0363546517728264; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; Mack C, 2019, J ATHL TRAINING, V54, P852, DOI 10.4085/1062-6050-181-19; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; Navarro SM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117740847; New J, DIFFERENT PERSPECTIV; Patricios JS, 2018, BRIT J SPORT MED, V52, P635, DOI 10.1136/bjsports-2018-099079; SECsports, SEC OUTL MED OBS PRO; Teel D, DAILY PRESS; Teel EF, 2017, J ATHL TRAINING, V52, P288, DOI 10.4085/1062-6050-52.1.12; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	39	1	1	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 2	2020	34	8					1100	1105		10.1080/02699052.2020.1782473		JUN 2020	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MK8SK	WOS:000547341200001	32579417				2022-02-06	
J	Navarro-Oviedo, M; Munoz-Arrondo, R; Zandio, B; Marta-Enguita, J; Bonaterra-Pastra, A; Rodriguez, JA; Roncal, C; Paramo, JA; Toledo, E; Montaner, J; Hernandez-Guillamon, M; Orbe, J				Navarro-Oviedo, Manuel; Munoz-Arrondo, Roberto; Zandio, Beatriz; Marta-Enguita, Juan; Bonaterra-Pastra, Anna; Antonio Rodriguez, Jose; Roncal, Carmen; Paramo, Jose A.; Toledo, Estefania; Montaner, Joan; Hernandez-Guillamon, Mar; Orbe, Josune			Circulating TIMP-1 is associated with hematoma volume in patients with spontaneous intracranial hemorrhage	SCIENTIFIC REPORTS			English	Article							SPONTANEOUS INTRACEREBRAL HEMORRHAGE; BLOOD-BRAIN-BARRIER; MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; MMP-9/TIMP-1 RATIO; MATRIX-METALLOPROTEINASE-9; PREDICTS; INJURY; SCALE; RISK	Matrix metalloproteinases (MMPs) are proteolytic zinc-endopeptidases regulated by tissue Inhibitors of matrix metalloproteinases (TIMPs). We evaluated the potential of MMPs and TIMPs as clinical tools for Intracranial Haemorrhage (ICH). Spontaneous non-traumatic ICH patients were recruited from two hospitals: Complejo Hospitalario de Navarra (CHN=29) and Vall d ' Hebron (VdH=76). Plasmatic levels of MMP-1, -2, -7, -9, -10 and TIMP-1 and their relationship with clinical, radiological and functional variables were evaluated. We further studied the effect of TIMP-1 (0.05-0.2mg/Kg) in an experimental tail-bleeding model. In CHN, TIMP-1 was associated with admission-hematoma volume and MMP-7 was elevated in patients with deep when compared to lobar hematoma. In VdH, admission-hematoma volume was associated with TIMP-1 and MMP-7. When data from both hospitals were combined, we observed that an increase in 1ng/ml in TIMP-1 was associated with an increase of 0.14ml in haemorrhage (combined beta =0.14, 95% CI=0.08-0.21). Likewise, mice receiving TIMP-1 (0.2mg/Kg) showed a shorter bleeding time (p<0.01). Therefore, the association of TIMP-1 with hematoma volume in two independent ICH cohorts suggests its potential as ICH biomarker. Moreover, increased TIMP-1 might not be sufficient to counterbalance MMPs upregulation indicating that TIMP-1 administration might be a beneficial strategy for ICH.	[Navarro-Oviedo, Manuel; Marta-Enguita, Juan; Antonio Rodriguez, Jose; Roncal, Carmen; Paramo, Jose A.; Orbe, Josune] Univ Navarra, Inst Invest Sanitaria Navarra, IdisNA, Lab Atherothrombosis,CIMA, Pamplona, Spain; [Munoz-Arrondo, Roberto; Zandio, Beatriz; Marta-Enguita, Juan] Complejo Hosp Navarra, Neurol Serv, IdisNA, Pamplona, Spain; [Bonaterra-Pastra, Anna; Montaner, Joan; Hernandez-Guillamon, Mar] Univ Autonoma Barcelona, Vall dHebron Res Inst, Neurovasc Res Lab, Barcelona, Spain; [Antonio Rodriguez, Jose; Roncal, Carmen; Paramo, Jose A.; Orbe, Josune] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain; [Paramo, Jose A.] Clin Univ Navarra, Haematol Serv, Pamplona, Spain; [Toledo, Estefania] Univ Navarra, Sch Med, Dept Prevent Med & Publ Hlth, IdiSNA, Pamplona, Spain; [Toledo, Estefania] ISCIII, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain		Orbe, J (corresponding author), Univ Navarra, Inst Invest Sanitaria Navarra, IdisNA, Lab Atherothrombosis,CIMA, Pamplona, Spain.; Orbe, J (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain.	josuneor@unav.es	Toledo, Estefania/H-6211-2014; Montaner, Joan/D-3063-2015; Rodriguez, Jose/G-7324-2015	Toledo, Estefania/0000-0002-6263-4434; Montaner, Joan/0000-0003-4845-2279; Navarro-Oviedo, Manuel/0000-0003-2095-5501; Roncal, Carmen/0000-0003-0616-9600; Bonaterra Pastra, Anna/0000-0002-1480-622X; Hernandez Guillamon, Maria Mar/0000-0001-8844-0091; Munoz, Roberto/0000-0001-5518-7085; Marta-Enguita, Juan/0000-0003-1807-4297; Rodriguez, Jose/0000-0002-2094-264X	Ministerio de Economia y Competitividad, Instituto de Salud Carlos III [PI15/01807, PI19/00065]; Federal Ministry of Education and Research (FEDER) funds; Spanish Society of Thrombosis and Haemostasis (SETH); Patrimonio Praga (Mexico); Virto Group (Navarra, Spain); Asociacion de Amigos de la Universidad de Navarra (ADA); Navarra Government [02/2015]	We would like to thank all patients that kindly participated in this study, the nurses from the Stroke Unit of the Complejo Hospitalario de Navarra and the Hospital Universitario Vall d'Hebron for the collection of the samples and Lara Montori and Miriam Belzunce for their help with the experimental work. This work was supported by the Ministerio de Economia y Competitividad, Instituto de Salud Carlos III [PI15/01807, PI19/00065] and Federal Ministry of Education and Research (FEDER) funds; grants from the Spanish Society of Thrombosis and Haemostasis (SETH), Navarra Government (02/2015), Patrimonio Praga (Mexico) and Virto Group (Navarra, Spain); and a PhD scholarship from the Asociacion de Amigos de la Universidad de Navarra (ADA).	Abilleira S, 2003, J NEUROSURG, V99, P65, DOI 10.3171/jns.2003.99.1.0065; Aguilar MI, 2011, NEUROHOSPITALIST, V1, P148, DOI 10.1177/1941875211409050; Alg VS, 2018, BRIT J NEUROSURG, V32, P255, DOI 10.1080/02688697.2018.1427213; Alvarez-Sabin J, 2004, STROKE, V35, P1316, DOI 10.1161/01.STR.0000126827.69286.90; Barrett A. J., 2004, HDB PROTEOLYTIC ENZY, DOI [10.1016/C2009-0-03628-9, DOI 10.1016/C2009-0-03628-9]; Biffi A, 2015, JAMA-J AM MED ASSOC, V314, P904, DOI 10.1001/jama.2015.10082; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Broderick JP, 2017, STROKE, V48, P2007, DOI 10.1161/STROKEAHA.117.017866; Cunningham LA, 2005, GLIA, V50, P329, DOI 10.1002/glia.20169; Dichgans M, 2019, LANCET NEUROL, V18, P587, DOI 10.1016/S1474-4422(19)30043-2; Duits FH, 2015, J ALZHEIMERS DIS, V48, P711, DOI 10.3233/JAD-143186; Fischer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059952; Florczak-Rzepka M, 2012, CEREBROVASC DIS, V34, P249, DOI 10.1159/000341686; Fujimoto M, 2008, J CEREBR BLOOD F MET, V28, P1674, DOI 10.1038/jcbfm.2008.59; George J, 2005, AM HEART J, V150, P484, DOI 10.1016/j.ahj.2004.11.016; Haller JT, 2019, CRIT CARE NURS Q, V42, P129, DOI 10.1097/CNQ.0000000000000247; Hanley DF, 2019, LANCET, V393, P1021, DOI 10.1016/S0140-6736(19)30195-3; Hernandez-Guillamon M, 2012, BRAIN PATHOL, V22, P133, DOI 10.1111/j.1750-3639.2011.00512.x; Howe MD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00746; Huttner HB, 2006, STROKE, V37, P404, DOI 10.1161/01.STR.0000198806.67472.5c; Ironside N, 2020, INT J STROKE, V15, P90, DOI 10.1177/1747493019830589; Kim SC, 1997, NEUROSURGERY, V41, P642, DOI 10.1097/00006123-199709000-00027; Kranz PG, 2018, NEUROIMAG CLIN N AM, V28, P353, DOI 10.1016/j.nic.2018.03.003; Kwah LK, 2014, J PHYSIOTHER, V60, P61, DOI 10.1016/j.jphys.2013.12.012; Li N, 2013, STROKE, V44, P658, DOI 10.1161/STROKEAHA.112.673590; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Lorente L, 2020, WORLD NEUROSURG, V134, pE476, DOI 10.1016/j.wneu.2019.10.106; Lorente L, 2019, J CRIT CARE, V51, P117, DOI 10.1016/j.jcrc.2019.02.014; Lorente L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0364-7; Lorente L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094370; Magnoni S, 2007, GENE THER, V14, P621, DOI 10.1038/sj.gt.3302894; Orbe J, 2015, J MED CHEM, V58, P2465, DOI 10.1021/jm501940y; Peeters SA, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0539-1; Peeters SA, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0195-2; Piccardi B, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00121; Purroy A, 2018, ATHEROSCLEROSIS, V278, P124, DOI 10.1016/j.atherosclerosis.2018.09.022; Rodriguez JA, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006042; Salman RAS, 2018, LANCET NEUROL, V17, P885, DOI 10.1016/S1474-4422(18)30253-9; Schmidt FA, 2018, NEUROLOGY, V91, pE939, DOI 10.1212/WNL.0000000000006117; Selim M, 2018, STROKE, V49, P1299, DOI 10.1161/STROKEAHA.117.019541; Sellner J, 2006, NEUROBIOL DIS, V21, P647, DOI 10.1016/j.nbd.2005.09.007; Soderholm M, 2018, STROKE, V49, P1626, DOI 10.1161/STROKEAHA.118.020660; Toni M, 2013, DIABETOLOGIA, V56, P2743, DOI 10.1007/s00125-013-3052-4; Urday S, 2015, NAT REV NEUROL, V11, P111, DOI 10.1038/nrneurol.2014.264; Waubant E, 2003, NEUROLOGY, V60, P52, DOI 10.1212/WNL.60.1.52; Yang Y, 2015, BRAIN RES, V1623, P30, DOI 10.1016/j.brainres.2015.04.024; Zhang JX, 2017, INT J CLIN EXP MED, V10, P16555; Zhang X, 2019, MED SCI MONITOR, V25, P794, DOI 10.12659/MSM.908500; Zhao LZ, 2015, NEUROBIOL AGING, V36, P2963, DOI 10.1016/j.neurobiolaging.2015.07.016; Zia WC, 2019, INT J STROKE, V14, P548, DOI 10.1177/1747493019839280	50	1	1	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUN 25	2020	10	1							10329	10.1038/s41598-020-67250-9			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MH2OU	WOS:000546571800006	32587306	Green Published, gold			2022-02-06	
J	Taylor, K; Hoshizaki, TB; Post, A; Gilchrist, MD				Taylor, Karen; Hoshizaki, T. Blaine; Post, Andrew; Gilchrist, Michael D.			The relationship between directional components of dynamic response and maximum principal strain for impacts to an American football helmet	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Dominant coordinate component; brain injury; maximum principal strain	HIGH-SCHOOL FOOTBALL; TRAUMATIC BRAIN-INJURY; FINITE-ELEMENT MODELS; PROFESSIONAL FOOTBALL; HEAD IMPACTS; ACCIDENT RECONSTRUCTION; ANGULAR ACCELERATION; CONCUSSION; LOCATION; MILD	Impact parameters used to design the American football helmet and the parameters associated with mechanisms of concussive injury are not consistent. Head impacts resulting in concussive injury in football are characterized as events creating rotational motion of the head that generate brain tissue strain. The extent of tissue strain influences the resulting severity of injury. Helmet technology aimed to decrease brain tissue strain by reducing the extent of brain motion could help reduce injury risk. Current helmet performance and evaluation measures, such as peak resultant of linear and rotational acceleration, do not fully define directional brain motion and therefore cannot provide sufficient information for this type of improvement. This study was conducted to determine whether coordinate components (X, Y, and Z) of linear and rotational acceleration would correlate with maximum principal strain, a common measure of brain injury risk. Coordinate components define directional motion of the head and offer a specific design parameter more easily reduced using engineered structures than peak resultant acceleration. In addition to coordinate components, this study introduces the dominant component, defined as the coordinate component with the highest contribution to the resultant acceleration, for additional evaluation. The results show that the relationship between the X, Y, and Z coordinate components of acceleration and maximum principal strain is location- and direction-dependent. The study indicates a strong relationship between the peak resultant and dominant components of acceleration to maximum principal strain. Because the dominant component of acceleration accounts for direction and location, identifying the relationship between dominant acceleration and maximum principal strain demonstrates the potential use of this metric to improve future helmet innovation aimed at reducing tissue strain.	[Taylor, Karen; Hoshizaki, T. Blaine; Post, Andrew; Gilchrist, Michael D.] Univ Ottawa, Neurotrauma Impact Sci Lab, A106-200 Lees Ave, Ottawa, ON K1N 6N5, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Taylor, K (corresponding author), Univ Ottawa, Neurotrauma Impact Sci Lab, A106-200 Lees Ave, Ottawa, ON K1N 6N5, Canada.	ktayl078@uottawa.ca		Taylor, Karen/0000-0003-1578-2343; Post, Andrew/0000-0002-5960-5552			[Anonymous], F14462013 ASTM; Bailes JE, 2001, J ATHL TRAINING, V36, P236; Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; Beckwith J, 2018, ANN BIOMED ENG, V46, P819, DOI 10.1007/s10439-018-1999-5; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Clark MD, 2017, AM J SPORT MED, V45, P929, DOI 10.1177/0363546516677793; Cournoyer J, 2016, J ATHL TRAINING, V51, P258, DOI 10.4085/1062-6050-51.4.08; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Elkin BS, 2019, CLIN BIOMECH, V64, P49, DOI 10.1016/j.clinbiomech.2018.03.021; Gennarelli TA, 1987, 31 STAPP CAR CRASH C; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gharjari M, 2011, INT J CRASHWORTHINES, V16, P621; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Horgan T, 2005, THESIS; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kerr ZY, 2014, PEDIATRICS, V134, P489, DOI 10.1542/peds.2014-0770; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Krzeminski DE, 2016, POLYM TEST, V55, P190, DOI 10.1016/j.polymertesting.2016.08.019; Liao S, 2016, MED SCI SPORT EXER, V48, P1239, DOI 10.1249/MSS.0000000000000896; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Nahum AM, 1977, 21 ANN STAPP CAR CRA; National Operating Committee on Standards for Athletic Equipment, 2004, 00104M05 NOCSAE; National Operating Committee on Standards for Athletic Equipment, 2014, 00214 NOCSAE DOC ND; NEWMAN JA, 1993, ACCIDENTAL INJURY BI, P292; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2012, INT RES COUNCIL BIOM; Post A, 2013, P 1 INT C HELM PERF; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Post A, 2014, COMPUT METHOD BIOMEC, V17, P1785, DOI 10.1080/10255842.2013.766724; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Post A, 2012, P I MECH ENG P-J SPO, V226, P200, DOI 10.1177/1754337112449420; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Takhounts EG, 2008, STAPP CAR C, V52, P1; Trosseille X, 1992, 36 STAPP CAR CRASH C; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	61	1	1	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	SEP	2020	234	3					193	204	1754337120932016	10.1177/1754337120932016		JUN 2020	12	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	MZ1UH	WOS:000543411000001					2022-02-06	
J	Eskander, N; Prabhudesai, S; Imran, H; Amuk, OC; Patel, RS				Eskander, Noha; Prabhudesai, Shruti; Imran, Hira; Amuk, Ozge Ceren; Patel, Rikinkumar S.			Alcohol Use Disorder Increases Risk of Traumatic Brain Injury-Related Hospitalization: Insights From 3.8 Million Children and Adolescent Inpatients	CUREUS			English	Article						alcohol use; alcohol dependence; alcohol misuse; traumatic brain injury; concussion; substance use; children		Objectives We conducted a cross-sectional study to identify the demographic predictors of traumatic brain injury (TBI), and the risk of association of psychiatric comorbidities including alcohol use disorder (AUD) and TBI-related hospitalizations in the children and adolescent population. Methods We included 3,825,523 children and adolescent inpatients (age 8-18 years) using the nationwide inpatient sample (NIS) database (2010-2014), and 61,948 inpatients had a primary diagnosis of TBI. These inpatients were grouped by comorbid AUD (N = 2,644). Multivariable logistic regression model adjusted for demographics, and psychiatric comorbidities including other substance use disorders (SUDs) was used to evaluate the odds ratio (OR) of AUD as a risk factor for TBI-related hospitalization. Results The majority of the TBI inpatients were adolescents (12-18 years, 82.2%), males (71.2%), and whites (59.2%). Males had three times higher odds (95% CI 3.14-3.26) for TBI-related hospitalization compared to females. Among psychiatric comorbidities, mood (4.1%) and anxiety (2.2%) disorders were prevalent in TBI inpatients, and were not associated with increased odds for TBI-related hospitalization. Among SUD, alcohol and tobacco use (4.4% each), and cannabis use (3.5%) were prevalent, and among all substances, AUD was associated with higher odds (OR 3.5, 95% CI 3.35-3.67) of TBI-related hospitalization. These patients with TBI and comorbid AUD also had higher odds for abusing stimulants (OR 5.11, 95% CI 3.85-6.77), cannabis (OR 4.69, 95% CI 4.12-5.34), and tobacco (OR 3.77, 95% CI 3.34-4.27). Conclusion AUD is an independent risk factor for TBI-related hospitalization with an increased risk of 50% in the children and adolescent population compared to non-alcohol users. TBI inpatients with AUD are prevalent in white, and male adolescents. These at-risk populations are also at higher risk of comorbid mood disorders and increased substance use including stimulants, cannabis, and tobacco.	[Eskander, Noha] Ain Shams Univ Hosp, Psychiat, Cairo, Egypt; [Prabhudesai, Shruti] Rajarshi Chhatrapati Shahu Maharaj Govt Med Coll, Psychiat, Kolhapur, Maharashtra, India; [Imran, Hira] Rawalpindi Med Univ, Med, Rawalpindi, Pakistan; [Amuk, Ozge Ceren] Koc Univ, Sch Med, Psychiat, Istanbul, Turkey; [Patel, Rikinkumar S.] Griffin Mem Hosp, Psychiat, Norman, OK 73071 USA		Patel, RS (corresponding author), Griffin Mem Hosp, Psychiat, Norman, OK 73071 USA.	rpatel_09@arcadia.edu	Patel, Rikinkumar/J-7277-2019	Patel, Rikinkumar/0000-0002-2895-9155			AHRQ, 2021, OV NAT NAT INP SAMPL; [Anonymous], 2019, EMOTIONAL PROBLEMS T; [Anonymous], 2019, ALCOHOL HISPANIC COM; [Anonymous], 2016, REPORT C TRAUMATIC B; [Anonymous], 2020, ALCOHOL FACTS STAT; [Anonymous], 2012, SUBSTANCE USE ABUSE; [Anonymous], 2020, PEDIAT TRAUMATIC BRA; Banks DE, 2017, DRUG ALCOHOL DEPEN, V179, P71, DOI 10.1016/j.drugalcdep.2017.06.026; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Collins NC, 2013, EMERG MED J, V30, P675, DOI 10.1136/emermed-2011-200496; HCUP, 2021, NIS DESCR DAT EL; Herrold AA., 2015, CURR ADDICT REP, V2, P273, DOI [10.1007/S40429-015-0078-3, DOI 10.1007/S40429-015-0078-3, 10.1007/s40429-015-0078-3, DOI 10.1007/s40429-015-0078-3]; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lyons TW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00690; Morse Anne M, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6010015; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Pagulayan KF, 2016, J NEUROTRAUM, V33, P1390, DOI 10.1089/neu.2015.4071; Patel RS, 2019, AM J ADDICTION, V28, P353, DOI 10.1111/ajad.12898; Reuter-Rice K, 2017, J PEDIATR NURS, V34, P84, DOI 10.1016/j.pedn.2016.12.017; Schlienz NJ, 2018, INT REV PSYCHIATR, V30, P226, DOI 10.1080/09540261.2018.1465399; Schulte MT, 2009, CLIN PSYCHOL REV, V29, P535, DOI 10.1016/j.cpr.2009.06.003; Singh AK, 2019, BIOMEDICINES, V7, DOI 10.3390/biomedicines7010016; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Urban NBL, 2010, BIOL PSYCHIAT, V68, P689, DOI 10.1016/j.biopsych.2010.06.005; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Weil ZM, 2018, ALCOHOL RES-CURR REV, V39, P171; Weil ZM, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00135; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	30	1	1	1	1	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUN 21	2020	12	6							e8740	10.7759/cureus.8740			10	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	MB2HZ	WOS:000542426800010	32714678	Green Published, gold			2022-02-06	
J	Anderson, JFI; Jordan, AS				Anderson, Jacqueline F. I.; Jordan, Amy S.			An observational study of the association between sleep disturbance, fatigue and cognition in the post-acute period after mild traumatic brain injury in prospectively studied premorbidly healthy adults	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Mild traumatic brain injury; Fatigue; Sleep disturbance; Cognition	COMPLEX FIGURE TEST; MENTAL FATIGUE; PERFORMANCE; MOOD; DEPRESSION; COMPLAINTS; INVENTORY; PATTERNS; CAFFEINE; RECOVERY	The literature examining the relationship between sleep disturbance, fatigue, and cognition in premorbidly healthy civilian adults after mTBI is very limited. The current study aimed to investigate the relationships of sleep disturbance and fatigue with cognition while controlling for psychological distress and age. Using a prospective observational design, we assessed 60 premorbidly healthy individuals approximately 8 weeks after mTBI. Participants were assessed with the Pittsburgh Sleep Quality Index and the Multidimensional Fatigue Inventory as well as measures of speed of information processing, attention, memory, and executive function; depression and anxiety were also assessed. Findings revealed associations between sleep disturbance and cognition (r(2 )= .586,p < .001) as well as between fatigue and cognition (r(2 )= .390,p < .01), independent of the impact of psychological status and age. Associations were evident in the domains of processing speed, attention, and memory, but were most consistently apparent on measures of executive function. Greater sleep disturbance was most consistently associated with poorer cognitive function. Unexpectedly, higher levels of fatigue were associated with better cognitive function, which may be explained by the coping hypothesis. Given sleep interventions have been shown to improve sleep disturbance, these findings suggest that sleep intervention may also result in improved cognition after mTBI.	[Anderson, Jacqueline F. I.; Jordan, Amy S.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [Anderson, Jacqueline F. I.] Alfred Hosp, Psychol Dept, Prahran, Vic, Australia; [Jordan, Amy S.] Austin Hlth, Inst Breathing & Sleep, Heidelberg, Vic, Australia		Anderson, JFI (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	jfande@unimelb.edu.au	Jordan, Amy/I-5626-2019	Jordan, Amy/0000-0001-8561-9766			Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Allegri N, 2019, PAIN PRACT, V19, P328, DOI 10.1111/papr.12741; Anderson JFI, 2020, NEUROPSYCHOL REHABIL, V30, P1115, DOI 10.1080/09602011.2018.1556706; Ashbaugh AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161645; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Beaulieu-Bonneau Simon, 2017, Neuropsychol Rehabil, V27, P983, DOI 10.1080/09602011.2016.1162176; Beck AT, 1993, BECK ANXIETY INVENTO; Beebe DW, 2002, J SLEEP RES, V11, P1, DOI 10.1046/j.1365-2869.2002.00289.x; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENNETTLEVY J, 1984, BRIT J CLIN PSYCHOL, V23, P109, DOI 10.1111/j.2044-8260.1984.tb00634.x; Buysse D J, 1989, Psychiatry Res, V28, P193; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cheung YT, 2017, CANCER-AM CANCER SOC, V123, P3410, DOI 10.1002/cncr.30742; Childs E, 2008, EXP CLIN PSYCHOPHARM, V16, P13, DOI 10.1037/1064-1297.16.1.13; Clanton NR, 2011, CANCER-AM CANCER SOC, V117, P2559, DOI 10.1002/cncr.25797; COPE H, 1995, BRIT J PSYCHIAT, V167, P86, DOI 10.1192/bjp.167.1.86; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Diamond BJ, 2008, ARCH CLIN NEUROPSYCH, V23, P189, DOI 10.1016/j.acn.2007.10.002; Distelberg Brian J., 2017, Journal of Caffeine Research, V7, P59, DOI 10.1089/jcr.2016.0023; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Helmes E., 2000, NEUROPSYCHOLOGICAL A; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Izaks GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017045; Johansson B, 2015, NEUROREHABILITATION, V36, P195, DOI 10.3233/NRE-151207; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Johnson S K, 1997, Appl Neuropsychol, V4, P145, DOI 10.1207/s15324826an0403_1; Lichstein KL, 1997, BEHAV RES THER, V35, P733, DOI 10.1016/S0005-7967(97)00029-6; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Martin TA, 2003, APPL NEUROPSYCHOL, V10, P163, DOI 10.1207/S15324826AN1003_05; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; Nordin LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep21183; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Parmenter BA, 2003, MULT SCLER, V9, P111, DOI 10.1191/1352458503ms859oa; Partington JE, 1949, PSYCHOL SERV CTR B, V1, P9; Pedron Ana Cristina, 2015, Paidéia (Ribeirão Preto), V25, P229, DOI 10.1590/1982-43272561201511; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; RUFF RM, 1987, DEV NEUROPSYCHOL, V3, P37, DOI 10.1080/87565648709540362; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Salthouse TA, 2004, CURR DIR PSYCHOL SCI, V13, P140, DOI 10.1111/j.0963-7214.2004.00293.x; Schiehser DM, 2017, NEUROPSYCHOL REHABIL, V27, P1031, DOI 10.1080/09602011.2016.1215999; Schmidt M., 1996, REY AUDITORY VERBAL; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Schwarz L, 2009, CLIN NEUROPSYCHOL, V23, P255, DOI 10.1080/13854040802220034; Shin MS, 2006, NAT PROTOC, V1, P892, DOI 10.1038/nprot.2006.115; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Steward KA, 2017, ARCH CLIN NEUROPSYCH, V32, P98, DOI 10.1093/arclin/acw081; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Suhr JA, 2003, J PSYCHOSOM RES, V55, P321, DOI 10.1016/S0022-3999(02)00628-1; Sullivan KA, 2018, J NEUROTRAUM, V35, P195, DOI 10.1089/neu.2016.4958; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Thomas Maria L., 2003, Thalamus & Related Systems, V2, P199, DOI 10.1017/S1472928803000207; Tolonen A, 2007, J REHABIL MED, V39, P622, DOI 10.2340/16501977-0101; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Volker I, 2016, ERGONOMICS, V59, P1259, DOI 10.1080/00140139.2015.1110622; Waldron-Perrine B, 2012, MIL MED, V177, P1293, DOI 10.7205/MILMED-D-12-00169; Waljas M, 2012, BRAIN INJURY, V26, P972, DOI 10.3109/02699052.2012.660511; Weathers FW., 2013, PTSD CHECKLIST DSM 5; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; WechslerD, 2001, WECHSLER TEST ADULT; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139	74	1	1	1	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	OCT 21	2021	31	9					1444	1465		10.1080/09602011.2020.1781665		JUN 2020	22	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	TY9PY	WOS:000546467400001	32558623				2022-02-06	
J	Corten, L; van As, AB; Rahim, S; Kleinsmith, J; Kleyn, A; Kwinana, T; Ndaba, N; Sillito, E; Smith, JT; Williams, N; Figaji, A				Corten, Lieselotte; van As, Arjan Bastiaan; Rahim, Sameer; Kleinsmith, Jason; Kleyn, Andrew; Kwinana, Tia; Ndaba, Nandi; Sillito, Emma; Smith, Jammi Tiffany; Williams, Nikita; Figaji, Anthony			Physiotherapy in children hospitalized with traumatic brain injury in a South African tertiary paediatric hospital	PHYSIOTHERAPY RESEARCH INTERNATIONAL			English	Article						inpatient rehabilitation; paediatrics; physiotherapy; traumatic brain injury	KWAZULU-NATAL PROVINCE; SPEECH-THERAPY; REHABILITATION	Introduction Physical impairments following traumatic brain injury (TBI) may limit participation in daily living. Physiotherapy could assist in managing these limitations, however, there is a paucity of literature on the physiotherapy management of children in the acute phase of TBI. Objectives To describe the characteristics, course and outcome of children hospitalized with TBI, with specific reference to the role of physiotherapy. Methods A retrospective folder review of all children (n= 130, median 5.37 years [IQR 1.88-7.88]) admitted in 2016 with a primary diagnosis of TBI was conducted at a tertiary paediatric hospital. Results Most cases presented with mild TBI (66.2%). The most common cranial manifestation of the TBI was brain bleeds (80%) and most occurred as a result of road traffic accidents (50%, including both pedestrian and motor vehicle accidents). Physiotherapy was administered in 35 cases (26.9%), with functional interventions, such as mobilizations out of bed, the most common form of therapy (71.4%). Children involved in road traffic accidents, presenting with severe diffuse TBI, resulting in altered tone and coordination problems, admitted to intensive care, monitored with an intracranial pressure or Licox monitor, and receiving occupational therapy and/or been followed up by dieticians, were more likely to receive physiotherapy. The duration of hospitalization (median 4 days [IQR 2-9]) was associated with infections, severity of TBI, presence of an intracranial monitoring, and parietal lobe injury. Conclusion This is the first study in South Africa investigating standard physiotherapy care in children admitted with TBI. Physiotherapy was provided in a small portion of children and appeared to be well tolerated. However, due to the limited information recorded in the physiotherapy notes, results of this study need to be confirmed in larger, more well-documented studies before generalizations can be made.	[Corten, Lieselotte] Univ Brighton, Sch Hlth Sci Physiotherapy, Eastbourne, England; [Kleinsmith, Jason; Kleyn, Andrew; Kwinana, Tia; Ndaba, Nandi; Sillito, Emma; Smith, Jammi Tiffany; Williams, Nikita] Univ Cape Town, Dept Hlth & Rehabil Sci Physiotherapy, Observatory, South Africa; [van As, Arjan Bastiaan; Figaji, Anthony] Univ Cape Town, Hlth Sci Fac, Div Paediat Surg, Rondebosch, South Africa; [Rahim, Sameer] Red Cross War Mem Childrens Hosp, Physiotherapy Dept, Rondebosch, South Africa		Corten, L (corresponding author), Univ Brighton, Sch Hlth Sci, Robert Dodd Bldg,49 Darley Rd, Eastbourne BN20 7UR, England.	l.corten@brighton.ac.uk		Corten, Lieselotte/0000-0002-3110-2195; Figaji, Anthony/0000-0002-3357-6490			Abend NS, 2010, SEMIN PEDIATR NEUROL, V17, P123, DOI 10.1016/j.spen.2010.04.001; Beaulieu CL, 2015, ARCH PHYS MED REHAB, V96, pS222, DOI 10.1016/j.apmr.2014.10.028; Bennett TD, 2013, ARCH PHYS MED REHAB, V94, P1268, DOI 10.1016/j.apmr.2013.02.021; Buitendag JJP, 2017, SAMJ S AFR MED J, V107, P777, DOI [10.7196/SAMJ.2017.v107i9.12394, 10.7196/samj.2017.v107i9.12394]; DiBrito SR, 2018, J PEDIATR SURG, V53, P1789, DOI 10.1016/j.jpedsurg.2017.12.027; Figaji AA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00685; Fiori S, 2015, SEMIN PERINATOL, V39, P141, DOI 10.1053/j.semperi.2015.01.007; Granie MA, 2010, ACCIDENT ANAL PREV, V42, P726, DOI 10.1016/j.aap.2009.10.022; Gray MP, 2012, EUR J TRAUMA EMERG S, V38, P423, DOI 10.1007/s00068-012-0177-y; Gresham L S, 2001, J Pediatr Nurs, V16, P79, DOI 10.1053/jpdn.2001.23148; Katz-Leurer M., 2017, CAMPBELLS PHYS THERA, P525; KIBEL SM, 1990, S AFR MED J, V78, P387; KNOBEL GJ, 1984, S AFR MED J, V66, P795; Konigs M, 2018, ARCH PHYS MED REHAB, V99, P1149, DOI 10.1016/j.apmr.2018.01.013; NICE, 2014, HEAD INJ ASS EARL MA; Okyere-Dede EK, 2013, TROP DOCT, V43, P1, DOI 10.1177/0049475513480490; Popernack ML, 2015, J PEDIATR HEALTH CAR, V29, pE1, DOI 10.1016/j.pedhc.2014.09.003; Schrieff L E, 2013, SAMJ, S. Afr. med. j., V103, P616, DOI 10.7196/samj.7137; Schwebel DC, 2012, AM J LIFESTYLE MED, V6, P292, DOI 10.1177/0885066611404876; Tepas JJ, 2009, J PEDIATR SURG, V44, P368, DOI 10.1016/j.jpedsurg.2008.10.089; Trefan L, 2016, ARCH DIS CHILD, V101, P527, DOI 10.1136/archdischild-2015-308424; Udoh David O, 2013, Afr J Paediatr Surg, V10, P154, DOI 10.4103/0189-6725.115043; World Health Organisation, 2008, WORLD REPORT CHILD I; World Health Organization, 2006, NEUROLOGICAL DISORDE, P164	24	1	1	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1358-2267	1471-2865		PHYSIOTHER RES INT	Physiother. Res. Int.	OCT	2020	25	4							e1860	10.1002/pri.1860		JUN 2020	9	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	OB3UD	WOS:000540850900001	32557970	Green Published, hybrid			2022-02-06	
J	Parmar, A; Zurcher, NR; Hooker, JM				Parmar, Anjali; Zuercher, Nicole R.; Hooker, Jacob M.			Time Will Tell the Utility of Biomarkers	ACS CHEMICAL NEUROSCIENCE			English	Article						Biomarkers; Alzheimer's disease; traumatic brain injury; brain disease		A biomarker, such as protein accumulation as an indicator of disease, can be used to predict disease manifestation, determine intervention, and monitor treatment efficacy. Biomarker development frequently focuses on early detection of disease as this is typically considered the only or most pressing need. However, the ideal time point for biomarker use may not always be early in disease but instead, as we will discuss, could be when enough information is available to predict the association between biomarker (protein accumulation) and disease manifestation (symptom severity, progression, prognosis). This Viewpoint highlights the importance of clearly defining the notion of "time" when discussing the development and utility of biomarkers. Using two disease examples, one with a clearly defined starting point (traumatic brain injury) and one with an indistinct starting point (Alzheimer's disease), we explore the concept of timing in biomarker development and utility.	[Parmar, Anjali; Zuercher, Nicole R.; Hooker, Jacob M.] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Zuercher, Nicole R.; Hooker, Jacob M.] Harvard Med Sch, Charlestown, MA 02129 USA		Hooker, JM (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.; Hooker, JM (corresponding author), Harvard Med Sch, Charlestown, MA 02129 USA.	jhooker@mgh.harvard.edu	; Hooker, Jacob/P-5716-2018	Parmar, Anjali/0000-0002-3645-638X; Hooker, Jacob/0000-0002-9394-7708			Barthelemy NR, 2020, NAT MED, V26, P398, DOI 10.1038/s41591-020-0781-z; Chetelat G, 2013, NEUROIMAGE-CLIN, V2, P356, DOI 10.1016/j.nicl.2013.02.006; Gan Z. S., 2019, FRONT NEUROL, V10, P1; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; US FDA, BIOM QUAL	5	1	1	1	5	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	JUN 17	2020	11	12					1692	1695		10.1021/acschemneuro.0c00238			4	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	MB9PV	WOS:000542930500001	32463674				2022-02-06	
J	Burns, TG; Semmel, ES; Reisner, A				Burns, Thomas G.; Semmel, Eric S.; Reisner, Andrew			A longitudinal evaluation of a penetrating traumatic brain injury: Theories of plasticity and vulnerability	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Traumatic brain injury; plasticity; vulnerability; epilepsy; hemispherectomy	EPILEPSY SURGERY; LANGUAGE; CHILDREN; LESIONS; HEMISPHERECTOMY; MECHANISMS; RECOVERY; OUTCOMES; PERIOD	Penetrating traumatic brain injury (TBI) is uncommon in infancy. The consequences may be devastating, especially when the injury is extensive and affects eloquent areas of the brain. There is the potential for neuropsychological dysfunction that may impact the individual's development and well-being into adulthood. In the context of early brain injury, the developing brain is both remarkably resilient and vulnerable. The present case study describes a patient who experienced a penetrating TBI at 9 days of age, subsequently developed intractable seizures, and underwent left hemispherectomy. Neuropsychological testing at ages 5, 10, 11, and 19 years are presented alongside fMRI and Wada testing. While the patient initially developed cognitive functions in the low-average range by age 5, scores on neuropsychological assessments began to decrease thereafter. This case is discussed with attention to vulnerability and plasticity theories. It highlights the ability of the brain to reorganize and allow the development of functions that would normally be sub-served by damaged areas and the limits of plasticity. Further, this case illustrates the vulnerability of the early brain to insult, the potential to grow into deficits, and the need to consider a variety of factors when predicting outcomes for cases of pediatric brain injury.	[Burns, Thomas G.] Emory Univ, Sch Med, Dept Neuropsychol, Atlanta, GA 30322 USA; [Burns, Thomas G.; Reisner, Andrew] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Burns, Thomas G.; Reisner, Andrew] Childrens Healthcare Atlanta, Atlanta, GA USA; [Semmel, Eric S.] Georgia State Univ, Dept Psychol, Univ Plaza, Atlanta, GA 30303 USA; [Semmel, Eric S.] Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA; [Reisner, Andrew] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA		Burns, TG (corresponding author), Emory Univ, Sch Med, Dept Neuropsychol, Atlanta, GA 30322 USA.; Burns, TG (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.; Burns, TG (corresponding author), Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA.	TBurns@PeachtreeNeuropsych.com	Morden, Frances/AAY-4233-2020	Burns, Thomas/0000-0003-3719-653X; Semmel, Eric/0000-0001-6996-5335			Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Bates E, 2001, BRAIN LANG, V79, P223, DOI 10.1006/brln.2001.2482; BURGESS JW, 1986, BEHAV BRAIN RES, V20, P1, DOI 10.1016/0166-4328(86)90096-3; Burns TG, 2009, EPILEPSY BEHAV, V15, P240, DOI 10.1016/j.yebeh.2009.01.006; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; de Holanda LF, 2016, WORLD NEUROSURG, V90, P420, DOI 10.1016/j.wneu.2016.03.015; DENNIS M, 1976, BRAIN LANG, V3, P404, DOI 10.1016/0093-934X(76)90036-5; DOMINGO Z, 1994, PEDIATR NEUROSURG, V21, P45, DOI 10.1159/000120813; Duffau H, 2006, J CLIN NEUROSCI, V13, P885, DOI 10.1016/j.jocn.2005.11.045; Gioia G. A., 2000, PSYCHOL ASSESSMENT R; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Gleissner U, 2003, EPILEPSY BEHAV, V4, P746, DOI 10.1016/j.yebeh.2003.09.003; Heiferman DM, 2016, PEDIATR NEUROSURG, V51, P25, DOI 10.1159/000441389; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hoskinson KR, 2018, PSYCHO-ONCOLOGY, V27, P178, DOI 10.1002/pon.4394; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lidzba K, 2006, NEUROPSYCHOLOGIA, V44, P1088, DOI 10.1016/j.neuropsychologia.2005.10.022; Liegeois F, 2008, BRAIN LANG, V106, P195, DOI 10.1016/j.bandl.2008.01.010; Loddenkemper T, 2007, PEDIATRICS, V119, P930, DOI 10.1542/peds.2006-2530; Mosch SC, 2005, COGN BEHAV NEUROL, V18, P5, DOI 10.1097/01.wnn.0000152207.80819.3c; Pearson CM, 2019, NEUROSURGICAL NEUROPSYCHOLOGY: THE PRACTICAL APPLICATION OF NEUROPSYCHOLOGY IN THE NEUROSURGICAL PRACTICE, P99, DOI 10.1016/B978-0-12-809961-2.00007-2; SCHAROUN SM, 2014, FRONT PSYCHOL, V5, DOI DOI https://doi.org/10.3389/fpsyg.2014.00082; Sherman EMS, 2011, EPILEPSIA, V52, P857, DOI 10.1111/j.1528-1167.2011.03022.x; Sihver S, 2001, J NEUROCHEM, V78, P417, DOI 10.1046/j.1471-4159.2001.00428.x; Szabo CA, 1998, EPILEPSIA, V39, P814, DOI 10.1111/j.1528-1157.1998.tb01174.x; VILLABLANCA JR, 1993, BEHAV BRAIN RES, V57, P63, DOI 10.1016/0166-4328(93)90062-U; Villablanca JR, 1998, DEV BRAIN RES, V105, P309, DOI 10.1016/S0165-3806(97)00187-9; Yeates K. O., 2009, PEDIAT NEUROPSYCHOLO; Yeates KO, 2014, CLIN PSYCHOL SCI, V2, P97, DOI 10.1177/2167702613499734	31	1	1	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2020.1780239		JUN 2020	6	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	ME8LH	WOS:000544904300001	32546024				2022-02-06	
J	Menshchikov, P; Ivantsova, A; Manzhurtsev, A; Ublinskiy, M; Yakovlev, A; Melnikov, I; Kupriyanov, D; Akhadov, T; Semenova, N				Menshchikov, Petr; Ivantsova, Anna; Manzhurtsev, Andrei; Ublinskiy, Maxim; Yakovlev, Alexey; Melnikov, Ilya; Kupriyanov, Dmitrii; Akhadov, Tolib; Semenova, Natalia			Separate N-acetyl aspartyl glutamate, N-acetyl aspartate, aspartate, and glutamate quantification after pediatric mild traumatic brain injury in the acute phase	MAGNETIC RESONANCE IN MEDICINE			English	Article						H-1 MRS; aspartate; glutamate; MEGA-PRESS; mild TBI; NAA; NAAG	CEREBRAL-BLOOD-FLOW; MAGNETIC-RESONANCE-SPECTROSCOPY; EDITED MR SPECTROSCOPY; T-2 RELAXATION-TIMES; IN-VIVO; ACETYLASPARTYLGLUTAMATE; NAAG; METABOLITES; ACETYLASPARTATE; WATER	Purpose To separately measure N-acetyl aspartul glutamate (NAAG), N-acetyl aspartate (NAA), aspartate (Asp), and glutamate (Glu) concentrations in white matter (WM) using J-editing techniques in patients with mild traumatic brain injury (mTBI) in the acute phase. Methods Twenty-four patients with closed concussive head injury and 29 healthy volunteers were enrolled in the current study. For extended(1)H MRS examination, patients and controls were equally divided into two subgroups. In subgroup 1 (12 patients/15 controls), NAAG and NAA concentrations were measured in WM separately with MEGA-PRESS (echo time/repetition time [TE/TR] = 140/2000 ms;delta ONNAA/delta OFFNAA= 4.84/4.38 ppm,delta ONNAAG/delta OFFNAAG= 4.61/4.15 ppm). In subgroup 2 (12 patients/14 controls), Asp and Glu concentrations were acquired with MEGA-PRESS (TE/TR = 90/2000 ms;delta ONAsp/delta OFFAsp= 3.89/5.21 ppm) and TE-averaged PRESS (TE from 35 ms to 185 ms with 2.5-ms increments; TR = 2000 ms) pulse sequences, respectively. Results tNAA and NAAG concentrations were found to be reduced, while NAA concentrations were unchanged, after mild mTBI. Reduced Asp and elevated myo-inositol (mI) concentrations were also found. Conclusion The main finding of the study is that the tNAA signal reduction in WM after mTBI is associated with a decrease in the NAAG concentration rather than a decrease in the NAA concentration, as was thought previously. This finding highlights the importance of separating these signals, at least for WM studies, to avoid misinterpretation of the results. NAAG plays an important role in selectively activating mGluR3 receptors, thus providing neuroprotective and neuroreparative functions immediately after mTBI. NAAG shows potential for the development of new therapeutic strategies for patients with injuries of varying severity.	[Menshchikov, Petr; Yakovlev, Alexey; Semenova, Natalia] Russian Acad Sci, Semenov Inst Chem Phys, Kosygina St 4, Moscow 119334, Russia; [Menshchikov, Petr; Manzhurtsev, Andrei; Ublinskiy, Maxim; Yakovlev, Alexey; Semenova, Natalia] Russian Acad Sci, Emanuel Inst Biochem Phys, Moscow, Russia; [Menshchikov, Petr; Ivantsova, Anna; Manzhurtsev, Andrei; Ublinskiy, Maxim; Yakovlev, Alexey; Melnikov, Ilya; Akhadov, Tolib; Semenova, Natalia] Clin & Res Inst Emergency Paediat Surg & Traumato, Moscow, Russia; [Kupriyanov, Dmitrii] LLC Philips Healthcare, Moscow, Russia		Menshchikov, P (corresponding author), Russian Acad Sci, Semenov Inst Chem Phys, Kosygina St 4, Moscow 119334, Russia.	peeterem@gmail.com	Menshchikov, Petr/G-8343-2017; Menshchikov, Petr/AAH-2135-2021; Akhadov, Tolib/AAD-2906-2022	Menshchikov, Petr/0000-0001-8193-6991; Menshchikov, Petr/0000-0001-8193-6991; Yakovlev, Alexey/0000-0002-9450-7827; Ublinskiy, Maxim/0000-0002-4627-9874	Russian Foundation for Basic ResearchRussian Foundation for Basic Research (RFBR) [17-04-01149, 19-29-10040]; Russian Scientific FoundationRussian Science Foundation (RSF) [18-1300030]	Russian Foundation for Basic Research, Grant/Award Number: 17-04-01149 and 19-29-10040; Russian Scientific Foundation, Grant/Award Number: 18-1300030	Arun P, 2006, J NEUROCHEM, V98, P2034, DOI 10.1111/j.1471-4159.2006.04068.x; Baslow MH, 2016, J GLYCOMICS METAB, V1, P25; Bergeron R, 2005, NEUROPSYCHOPHARMACOL, V30, P7, DOI 10.1038/sj.npp.1300559; Billups D, 2006, J NEUROSCI, V26, P9983, DOI 10.1523/JNEUROSCI.2773-06.2006; Brown M, 2018, J NEURORADIOLOGY, V45, P123, DOI 10.1016/j.neurad.2017.09.004; CANGRO CB, 1987, J NEUROCHEM, V49, P1579, DOI 10.1111/j.1471-4159.1987.tb01030.x; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chan KL, 2017, NEUROIMAGE, V155, P587, DOI 10.1016/j.neuroimage.2017.04.043; Choi CH, 2010, MAGN RESON MED, V64, P1247, DOI 10.1002/mrm.22536; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Edden RAE, 2007, MAGN RESON MED, V57, P977, DOI 10.1002/mrm.21234; Edden RAE, 2014, J MAGN RESON IMAGING, V40, P1445, DOI 10.1002/jmri.24478; Feng JF, 2012, BRAIN RES, V1469, P144, DOI 10.1016/j.brainres.2012.06.021; FORLONI G, 1987, SYNAPSE, V1, P455, DOI 10.1002/syn.890010509; Ganji SK, 2012, NMR BIOMED, V25, P523, DOI 10.1002/nbm.1767; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gasparovic C, 2006, MAGN RESON MED, V55, P1219, DOI 10.1002/mrm.20901; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Goryawala MZ, 2016, NMR BIOMED, V29, P1108, DOI 10.1002/nbm.3575; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Guo HF, 2015, NEUROTOXICOLOGY, V48, P180, DOI 10.1016/j.neuro.2015.03.010; Hancu I, 2009, J MAGN RESON IMAGING, V30, P1155, DOI 10.1002/jmri.21936; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Hurd R, 2004, MAGNET RESON MED, V51, P435, DOI 10.1002/mrm.20007; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jessen F, 2013, SCHIZOPHRENIA BULL, V39, P197, DOI 10.1093/schbul/sbr127; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Kolodziejczyk K, 2009, BRAIN, V132, P1496, DOI 10.1093/brain/awp087; KREIS R, 1993, J MAGN RESON SER B, V102, P9, DOI 10.1006/jmrb.1993.1056; Lieberman EM, 2006, ADV EXP MED BIOL, V576, P303; Lu XCM, 2000, EUR J PHARMACOL, V408, P233, DOI 10.1016/S0014-2999(00)00762-7; Lyeth B, 2015, SOURCE BRAIN NEUROTR, P549; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Menshchikov PE, 2018, RUSS CHEM B+, V67, P655, DOI 10.1007/s11172-018-2119-2; Menshchikov P, 2019, MAGN RESON MED, V82, P11, DOI 10.1002/mrm.27700; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Meyer EJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00556; Mikkelsen M, 2018, MAGN RESON MED, V80, P21, DOI 10.1002/mrm.27027; Mikkelsen M, 2017, NEUROIMAGE, V159, P32, DOI 10.1016/j.neuroimage.2017.07.021; Mlynarik V, 2001, NMR BIOMED, V14, P325, DOI 10.1002/nbm.713; Moffet J, PROG NEUROBIOL, V81, P89; Moffett John R, 2013, Front Neuroenergetics, V5, P11, DOI 10.3389/fnene.2013.00011; Mullins PG, 2014, NEUROIMAGE, V86, P43, DOI 10.1016/j.neuroimage.2012.12.004; Narayana PA, 2017, CONCUSSION, V2; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Neale JH, 2005, TRENDS PHARMACOL SCI, V26, P477, DOI 10.1016/j.tips.2005.07.004; Neale JH, 2011, J NEUROCHEM, V119, P891, DOI 10.1111/j.1471-4159.2011.07380.x; Neale JH, 2011, J NEUROCHEM, V118, P490, DOI 10.1111/j.1471-4159.2011.07338.x; Oeltzschner G, 2018, MAGN RESON IMAGING, V77, P16; Oeltzschner G., 2020, BIORXIV PREPRINT, DOI [10.1101/2020.02.12.944207, DOI 10.1101/2020.02.12.944207]; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Quadrelli S, 2016, MAGN RESON INSIGHTS, V9, P1, DOI 10.4137/MRI.S32903; Ramadan S, 2013, NMR BIOMED, V26, P1630, DOI 10.1002/nbm.3045; Saleh MG, 2019, NEUROIMAGE, V189, P425, DOI 10.1016/j.neuroimage.2019.01.056; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Simpson R, 2017, MAGN RESON MED, V77, P23, DOI 10.1002/mrm.26091; Sivak S, 2014, BRAIN INJURY, V28, P341, DOI 10.3109/02699052.2013.865270; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Stefan D, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/10/104035; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; TEASDALE G, 1974, LANCET, V2, P81; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Veeramuthu V, 2018, ACAD RADIOL, V25, P1167, DOI 10.1016/j.acra.2018.01.005; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wibom R, 2009, NEW ENGL J MED, V361, P489, DOI 10.1056/NEJMoa0900591; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; Zaaraoui W, 2007, MAGN RESON MED, V57, P983, DOI 10.1002/mrm.21250; Zhou J, 2005, NAT REV DRUG DISCOV, V4, P1015, DOI 10.1038/nrd1903; Zhu H, 2011, MAGN RESON MED, V65, P603, DOI 10.1002/mrm.22671	77	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0740-3194	1522-2594		MAGN RESON MED	Magn. Reson. Med.	DEC	2020	84	6					2918	2931		10.1002/mrm.28332		JUN 2020	14	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	PI2GF	WOS:000540357400001	32544309				2022-02-06	
J	Schmidt, JD; Rawlins, MLW; Lynall, RC; D'Lauro, C; Clugston, JR; McAllister, TW; McCrea, M; Broglio, SP				Schmidt, Julianne D.; Rawlins, Michelle L. Weber; Lynall, Robert C.; D'Lauro, Christopher; Clugston, James R.; McAllister, Tom W.; McCrea, Michael; Broglio, Steven P.		CARE Consortium Investigators	Medical Disqualification Following Concussion in Collegiate Student-Athletes: Findings from the CARE Consortium	SPORTS MEDICINE			English	Article							SPORT-RELATED CONCUSSION; POSITION STATEMENT; RETIREMENT; SOCIETY	Background The absence of evidence-based guidelines make medical disqualification (MDQ) following concussion one of the most challenging decision-making processes faced by sports medicine professionals. Objective We aimed to compare premorbid and postmorbid factors between student-athletes that were and were not medically disqualified from sport following a concussion. Methods Among 1832 student-athletes diagnosed with concussion within the CARE Consortium, 53 (2.9%) were medically disqualified (MDQ +) and 1779 (97.1%) were not medically disqualified (MDQ-). We used contingency tables and descriptive statistics for an initial evaluation of a broad list of premorbid and postmorbid factors. For those factors showing association with MDQ status, we calculated odds ratios and 95% confidence intervals for the odds of being MDQ + in the presence of the identified factor. Results History of 2 (OR: 3.2, 95% CI 1.5, 6.9) or 3 + (OR: 7.4, 95% CI 3.4, 15.9) previous concussions; 1 + headaches in past 3 months (OR: 1.8, 95% CI 1.0, 3.2); immediate removal from play (OR: 2.4, 95% CI 1.2, 4.9); alcohol (OR: 2.6, 95% CI 1.2, 5.4), tobacco (OR: 3.3, 95% CI 1.1, 9.5), or marijuana use since injury (OR: 5.4, 95% CI 1.5, 19.0); as well as prolonged recovery due to mental health alterations (OR: 5.3, 95% CI 2.0, 14.1) or motivation/malingering (OR: 7.5, 95% CI 3.3, 17.0) increased odds of being MDQ + . The MDQ + group took longer to become asymptomatic relative to the MDQ- group (MDQ + : 23.5 days, 95% CI 15.8, 31.2; MDQ-: 10.6 days, 95% CI 9.5, 11.6;p < 0.001). Conclusions MDQ following concussion was relatively rare. We identified three patterns related to MDQ following concussion: (1) concussion and headache history were the only premorbid factors that differed (2) initial concussion presentation was more severe and more immediate in the MDQ + group, and (3) post-concussion recovery outcomes expressed the greatest differences between groups.	[Schmidt, Julianne D.; Lynall, Robert C.] Univ Georgia, UGA Concuss Res Lab, 330 River Rd, Athens, GA 30602 USA; [Schmidt, Julianne D.; Lynall, Robert C.] Univ Georgia, Dept Kinesiol, 330 River Rd, Athens, GA 30602 USA; [Rawlins, Michelle L. Weber] AT Still Univ, Dept Interdisciplinary Hlth Sci, Mesa, AZ USA; [D'Lauro, Christopher] US Air Force Acad, Dept Behav Sci & Leadership, USAF, Colorado Springs, CO 80840 USA; [Clugston, James R.] Univ Florida, Dept Community Hlth & Family Med, Gainesville, FL USA; [McAllister, Tom W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA		Schmidt, JD (corresponding author), Univ Georgia, UGA Concuss Res Lab, 330 River Rd, Athens, GA 30602 USA.; Schmidt, JD (corresponding author), Univ Georgia, Dept Kinesiol, 330 River Rd, Athens, GA 30602 USA.	schmidtj@uga.edu; michelleweber@atsu.edu; rlynall@uga.edu; chris.dlauro@usafa.edu; jayclug@ufl.edu; twmcalli@iupui.edu; mmccrea@mcw.edu; broglio@umich.edu	; Rowson, Steven/B-1270-2012; Lynall, Robert/M-2888-2014	Reis, AlessanRSS/0000-0001-8486-7469; Susmarski, Adam/0000-0003-3698-4163; Rowson, Steven/0000-0002-3227-0596; Lynall, Robert/0000-0002-0785-6640; Chrisman, Sara/0000-0001-5373-7223; D'Lauro, Christopher/0000-0003-0894-6602	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium by the National Collegiate Athletic Association (NCAA); Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium by the Department of Defense (DOD); U.S. Army Medical Research Acquisition Activity, Fort Detrick; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; Air Force Research Laboratory's Summer Faculty Fellowship Program	This publication was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award NO W81XWH-14-2-0151. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense (DHP funds). This manuscript was also made possible, in part, with support from the Air Force Research Laboratory's Summer Faculty Fellowship Program.	Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Cantu RC, 2003, RECURRENT ATHLETIC H, P593; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Conley KM, 2014, J ATHL TRAINING, V49, P102, DOI 10.4085/1062-6050-48.6.05; Davidhizar R, 1994, Health Care Superv, V13, P10; Davis-Hayes C, 2018, NEUROL-CLIN PRACT, V8, P40, DOI 10.1212/CPJ.0000000000000424; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hoyle RH, 2002, PERS INDIV DIFFER, V32, P401, DOI 10.1016/S0191-8869(01)00032-0; Huml MR, 2018, J COLL STUDENT DEV, V59, P376, DOI 10.1353/csd.2018.0035; Kaier E, 2015, J COLL STUDENT DEV, V56, P735, DOI 10.1353/csd.2015.0079; Kroshus E, 2018, SOC SCI MED, V218, P37, DOI 10.1016/j.socscimed.2018.07.050; Merckelbach H, 2019, CURR DIR PSYCHOL SCI, V28, P321, DOI 10.1177/0963721419837681; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Sedney CL, 2011, CLIN SPORT MED, V30, P189, DOI 10.1016/j.csm.2010.08.005; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Tirabassi J, 2016, AM J SPORT MED, V44, P2925, DOI 10.1177/0363546516644604; Welton KL, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967117745788	23	1	1	0	3	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.	OCT	2020	50	10					1843	1855		10.1007/s40279-020-01302-y		JUN 2020	13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	NO8UE	WOS:000541013200001	32557231				2022-02-06	
J	Sekely, A; Dhillon, S; Zakzanis, KK				Sekely, Angela; Dhillon, Sonya; Zakzanis, Konstantine K.			The effect of diagnostic terminology on cognitive, emotional, and post-concussive sequelae following mild brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Concussion; diagnosis threat; diagnostic terminology; expectations as etiology; mild traumatic brain injury	POSTCONCUSSION-LIKE SYMPTOMS; HEAD-INJURY; ILLNESS PERCEPTIONS; EXPECTATION; PERFORMANCE; THREAT; NEUROPSYCHOLOGY; RECOMMENDATIONS; INDIVIDUALS; STATEMENT	Objective:We sought to determine whether the diagnostic terms 'mild traumatic brain injury (mTBI)' and 'concussion' result in differences in perceived cognitive, emotional, and post-concussive sequelae. Method:A total of 81 healthy university students (79% female; 69% of Asian descent) were randomly assigned to one of two conditions: mTBI (n = 41), or concussion (n = 40), and were instructed to simulate on a battery of cognitive (Neuropsychological Assessment Battery - Screening Module), emotional (Beck Anxiety Inventory, Beck Depression Inventory-II), and post-concussive (Rivermead Postconcussive Symptoms Questionnaire) measures. Results: There were no significant group differences between expected cognitive, emotional, or post-concussive consequences. However, both groups received poorer scores than the normative data. Conclusions:These results suggest that diagnostic terminology does not appear to influence anticipated recovery following mild brain injury. However, the presentation of information about the injury itself may impact recovery outcomes. This study provides preliminary support for the potential negative effects that may arise as a result of providing participants with non-evidence based information about mild brain injuries.	[Sekely, Angela; Dhillon, Sonya; Zakzanis, Konstantine K.] Univ Toronto, Grad Dept Psychol Clin Sci, Toronto, ON, Canada; [Zakzanis, Konstantine K.] Univ Toronto, Dept Psychol, 1265 Mil Trail, Toronto, ON M1C 1A4, Canada		Sekely, A (corresponding author), Univ Toronto, Dept Psychol, 1265 Mil Trail, Toronto, ON M1C 1A4, Canada.	angie.sekely@mail.utoronto.ca					Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; Beck AT, 1993, BECK ANXIETY INVENTO; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Cohen J., 2013, STAT POWER ANAL BEHA; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Edmed SL, 2015, BRAIN INJURY, V29, P623, DOI 10.3109/02699052.2014.998709; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Fresson M, 2018, J CLIN EXP NEUROPSYC, V40, P682, DOI 10.1080/13803395.2017.1420143; Gordon KE, 2010, PEDIATR NEUROL, V43, P253, DOI 10.1016/j.pediatrneurol.2010.05.012; Greville-Harris M, 2015, AM J MED, V128, P126, DOI 10.1016/j.amjmed.2014.08.031; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; HAMZAH N, 2019, APPL NEUROPSYCH 0817, DOI DOI https://doi.org/10.1080/23279095.2019.1648264; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson G.L., 2012, PTSD MILD TRAUMATIC; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kempe CB, 2013, CLIN NEUROPSYCHOL, V27, P762, DOI 10.1080/13854046.2013.795245; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Langer L, 2020, J HEAD TRAUMA REHAB, V35, pE60, DOI 10.1097/HTR.0000000000000503; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Mah K, 2018, DISABIL REHABIL, V40, P960, DOI 10.1080/09638288.2016.1277402; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McLellan T, 2010, J INT NEUROPSYCH SOC, V16, P705, DOI 10.1017/S1355617710000524; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mittenberg W, 1993, PSYCHOTHERAPY PRIVAT, V12, P37, DOI DOI 10.1300/1294V12N02_03; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; MVI Corp, 2019, IBM SPSS STAT VERS 2; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Rogers R, 1998, LAW HUMAN BEHAV, V22, P273, DOI 10.1023/A:1025702405865; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Ruff RM, 2009, PSYCHOL INJ LAW, V2, P34, DOI 10.1007/s12207-009-9029-4; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sullivan KA, 2017, J CLIN EXP NEUROPSYC, V39, P408, DOI 10.1080/13803395.2016.1230597; Sullivan KA, 2014, J HEAD TRAUMA REHAB, V29, P54, DOI 10.1097/HTR.0b013e31828c708a; Sullivan KA, 2012, CLIN NEUROPSYCHOL, V26, P1255, DOI 10.1080/13854046.2012.735254; Sussman ES, 2018, HAND CLINIC, V158, P21, DOI 10.1016/B978-0-444-63954-7.00003-3; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vanderploeg RD, 2014, PSYCHOL INJ LAW, V7, P245, DOI 10.1007/s12207-014-9201-3; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Weber M, 2010, BRAIN INJURY, V24, P1364, DOI 10.3109/02699052.2010.507110; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7; Zakzanis KK, 2011, ARCH CLIN NEUROPSYCH, V26, P461, DOI 10.1093/arclin/acr021; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V17, P283, DOI 10.1080/09084282.2010.525118	74	1	1	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2020.1775599		JUN 2020	10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	MF6ZO	WOS:000545488200001	32546013				2022-02-06	
J	Nakase-Richardson, R; Dahdah, MN; Almeida, E; Ricketti, P; Silva, MA; Calero, K; Magalang, U; Schwartz, DJ				Nakase-Richardson, Risa; Dahdah, Marie N.; Almeida, Emily; Ricketti, Peter; Silva, Marc A.; Calero, Karel; Magalang, Ulysses; Schwartz, Daniel J.			Concordance between current American Academy of Sleep Medicine and Centers for Medicare and Medicare scoring criteria for obstructive sleep apnea in hospitalized persons with traumatic brain injury: a VATBI Model System study	JOURNAL OF CLINICAL SLEEP MEDICINE			English	Article						obstructive sleep apnea; policy; traumatic brain injuries	LONG-TERM CONSEQUENCES; INPATIENT REHABILITATION; DISORDERS; INDIVIDUALS; REPRESENTATIVENESS; CONSCIOUSNESS; COMORBIDITIES; ASSOCIATION; DEPRIVATION; GUIDELINE	Study Objectives: The objective of this study was to compare obstructive sleep apnea (OSA), demographic, and traumatic brain injury (TBI) characteristics across the American Academy of Sleep Medicine (AASM) and Centers for Medicare and Medicare (CMS) scoring rules in moderate to severe TBI undergoing inpatient neurorehabilitation. Methods: This is a secondary analysis from a prospective clinical trial of sleep apnea at 6 TBI Model System study sites (n = 248). Scoring was completed by a centralized center using both the AASM and CMS criteria for OSA. Hospitalization and injury characteristics were abstracted from the medical record, and demographics were obtained by interview by trained research assistants using TBI Model System standard procedures. Results: OSA was prevalent using the AASM (66%) and CMS (41.5%) criteria with moderate to strong agreement (weighted kappa = 0.64; 95% confidence interval = 0.58-0.70). Significant differences were observed for participants meeting AASM and CMS criteria (concordant group) compared with those meeting criteria for AASM but not CMS (discordant group). At an apnea-hypopnea index >= 5 events/h, the discordant group (n = 61) had lower Emergency Department Glasgow Coma Scale Scores consistent with greater injury severity (median, 5 vs 13; P = .0050), younger age (median, 38 vs 58; P <.0001), and lower body mass index (median, 22.1 vs 24.8; P =.0007) compared with the concordant group (n = 103). At an apnea-hypopnea index >= 15 events/h, female sex but no other differences were noted, possibly because of the smaller sample size. Conclusions: The underestimation of sleep apnea using CMS criteria is consistent with prior literature; however, this is the first study to report the impact of the criteria in persons with moderate to severe TBI during a critical stage of neural recovery. Management of comorbidities in TBI has become an increasing focus for optimizing TBI outcomes. Given the chronic morbidity after moderate to severe TBI, the impact of CMS policy for OSA diagnosis for persons with chronic disability and young age are considerable.	[Nakase-Richardson, Risa; Silva, Marc A.] James A Haley Vet Hosp, Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Nakase-Richardson, Risa; Silva, Marc A.] James A Haley Vet Hosp, Def & Vet Brain Injury Ctr, Tampa, FL 33612 USA; [Nakase-Richardson, Risa; Ricketti, Peter; Calero, Karel] Univ S Florida, Morsani Coll Med, Div Pulm & Sleep Med, Tampa, FL 33620 USA; [Dahdah, Marie N.] Baylor Scott & White Inst Rehabil, Dallas, TX USA; [Dahdah, Marie N.] Baylor Scott & White Med Ctr, Plano, TX USA; [Almeida, Emily; Schwartz, Daniel J.] Craig Hosp, Res Dept, Englewood, CO USA; [Almeida, Emily] Natl Data & Stat Ctr, Traumat Brain Injury Model Syst, Englewood, CO USA; [Ricketti, Peter; Calero, Karel; Schwartz, Daniel J.] James A Haley Vet Hosp, Med Serv, Tampa, FL 33612 USA; [Silva, Marc A.] Univ S Florida, Morsani Coll Med, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA; [Silva, Marc A.] Univ S Florida, Coll Arts & Sci, Dept Psychol, Tampa, FL 33620 USA; [Magalang, Ulysses] Ohio State Univ, Div Pulm Crit Care & Sleep Med, Wexner Med Ctr, Columbus, OH 43210 USA; [Magalang, Ulysses] Ohio State Univ, Neurosci Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA		Nakase-Richardson, R (corresponding author), James A Haley Vet Hosp, Polytrauma TBI Rehabil, Mail Code 117,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	risa.richardson@va.gov	Silva, Marc A./J-1874-2019	Silva, Marc A./0000-0002-3879-6054	Patient Centered Outcomes Research Institute (PCORI)Patient-Centered Outcomes Research Institute - PCORI [CER-1511-33005]; VHA Central Office VA TBI Model Systems Program of Research; General Dynamics Information Technology [W91YTZ-13-C-0015, HT0014-19-C-0004]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; National Institute on Disability, Independent Living, and Rehabilitation Research (NSDC)United States Department of Health & Human Services [90DPTB00070, 90DP0084, 90DPTB0013-01-00, 90DPTB0008, 90DPT80004-02]	All authors have seen and approved the manuscript. Work for this study was performed at James A. HaleyVeterans'Hospital, Tampa, Florida; WexnerMedicalCenter atOhio State University, Columbus, Ohio; Harborview Medical Center, Seattle, Washington; Craig Hospital, Englewood, Colorado; Rehabilitation Hospital of Indiana, Indianapolis, Indiana; Baylor Scott andWhite Institute forRehabilitation, Dallas, Texas; andMoss Rehabilitation Research Institute, Elkins Park, Pennsylvania. This study was funded by Patient Centered Outcomes Research Institute (PCORI) Award CER-1511-33005 and was sponsored by the VHA Central Office VA TBI Model Systems Program of Research; subcontract from General Dynamics Information Technology (W91YTZ-13-C-0015 and HT0014-19-C-0004) and from the Defense and Veterans Brain Injury Center and National Institute on Disability, Independent Living, and Rehabilitation Research (NSDC Grants 90DPTB00070, 90DP0084, 90DPTB0013-01-00, 90DPTB0008, and 90DPT80004-02). The authors report no conflicts of interest. The statements presented in this publication are solely the responsibility of the author(s) and do not represent the Department of Veterans Affairs, US Government, the Patient-Centered Outcomes Research Institute (PCORI), or its Board of Governors or Methodology Committee.	[Anonymous], 2016, SLEEPWARE G3; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Berry RB, 2012, AASM MANUAL SCORING; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Campos-Rodriguez F, 2016, SLEEP MED, V27-28, P54, DOI 10.1016/j.sleep.2016.05.020; Castronovo V, 2014, SLEEP, V37, P1465, DOI 10.5665/sleep.3994; Chan L, 2001, ARCH PHYS MED REHAB, V82, P1151, DOI 10.1053/apmr.2001.24892; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96, pS209, DOI 10.1016/j.apmr.2015.03.026; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cuthbert JP, 2012, J HEAD TRAUMA REHAB, V27, pE15, DOI 10.1097/HTR.0b013e31826da983; Dams-O'Connor K, 2020, J HEAD TRAUMA REHAB, V35, P127, DOI 10.1097/HTR.0000000000000484; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Dean DA, 2015, SLEEP, V38, P587, DOI 10.5665/sleep.4576; Duce B, 2016, SLEEP MED, V26, P23, DOI 10.1016/j.sleep.2016.07.013; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Flanagan SR, 2015, BRAIN INJ PROF, V12, P8; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; Garcia AM, 2019, SLEEP S1, V42, pA230; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Greenwald BD, 2015, J NEUROTRAUM, V32, P1883, DOI 10.1089/neu.2014.3454; Guilleminault C, 2009, SLEEP BREATH, V13, P341, DOI 10.1007/s11325-009-0253-7; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS256, DOI 10.1016/j.apmr.2015.01.025; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix C, 2009, J HEAD TRAUMA REHAB, V24, P421; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Holcomb EM, 2016, J HEAD TRAUMA REHAB, V31, P82, DOI 10.1097/HTR.0000000000000230; Iber C., 2007, AASM MANUAL SCORING, P7; JENNETT B, 1977, LANCET, V1, P878; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kapur VK, 2019, J CLIN SLEEP MED, V15, P683, DOI 10.5664/jcsm.7746; Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506; Lamm AG, 2019, J NEUROTRAUM, V36, P2513, DOI 10.1089/neu.2018.6014; Larson EB, 2010, J HEAD TRAUMA REHAB, V25, P61, DOI 10.1097/HTR.0b013e3181c1d1e1; Leow LC, 2014, EUR RESP J S58, V44, P2010; Longordo F, 2009, EUR J NEUROSCI, V29, P1810, DOI 10.1111/j.1460-9568.2009.06719.x; Mansukhani MP, 2019, J CLIN SLEEP MED, V15, P687, DOI 10.5664/jcsm.7750; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McDermott CM, 2003, J NEUROSCI, V23, P9687; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2009, NEUROLOGY, V73, P1120, DOI 10.1212/WNL.0b013e3181bacf34; Nakase-Richardson R, CHEST; Nakase-Richardson R, 2020, ARCH PHYS MED REHAB, V101, P283, DOI 10.1016/j.apmr.2019.09.019; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Nakase-Richardson Schwartz DJ, 2018, BRAIN INJURY PROFESS, V14, P8; NAKASERICHARDSON R, 2017, SLEEP S1, V40, pA22; O'Hara R, 2009, J REHABIL RES DEV, V46, P837, DOI 10.1682/JRRD.2008.10.0140; Pistoia F, 2015, J NEUROTRAUM, V32, P682, DOI 10.1089/neu.2014.3659; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Punjabi NM, 2008, AM J RESP CRIT CARE, V177, P1150, DOI 10.1164/rccm.200712-1884OC; Rutherford GW, 2009, J HEAD TRAUMA REHAB, V24, P421, DOI 10.1097/HTR.0b013e3181c13439; Silva MA, 2012, AM J PHYS MED REHAB, V91, P890, DOI 10.1097/PHM.0b013e31825a1648; Sjosten N, 2009, CHEST, V136, P130, DOI 10.1378/chest.08-2201; TEASDALE G, 1974, LANCET, V2, P81; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Wei WH, 2005, ARCH PHYS MED REHAB, V86, P905, DOI 10.1016/j.apmr.2004.09.026; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Young T, 1997, SLEEP, V20, P608, DOI 10.1093/sleep/20.8.608; Zunzunegui C, 2011, SLEEP, V34, P1261, DOI 10.5665/SLEEP.1252	64	1	1	0	0	AMER ACAD SLEEP MEDICINE	DARIEN	2510 N FRONTAGE RD, DARIEN, IL 60561 USA	1550-9389	1550-9397		J CLIN SLEEP MED	J. Clin. Sleep Med.	JUN 15	2020	16	6					879	888		10.5664/jcsm.8352			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	MM2OI	WOS:000549995900007	32043962	Bronze, Green Published			2022-02-06	
J	Sun, MJ; Brady, RD; Wanrooy, B; Mychasiuk, R; Yamakawa, GR; Casillas-Espinosa, PM; Wong, CHY; Shultz, SR; McDonald, SJ				Sun, Mujun; Brady, Rhys D.; Wanrooy, Brooke; Mychasiuk, Richelle; Yamakawa, Glenn R.; Casillas-Espinosa, Pablo M.; Wong, Connie H. Y.; Shultz, Sandy R.; McDonald, Stuart J.			Experimental traumatic brain injury does not lead to lung infection	JOURNAL OF NEUROIMMUNOLOGY			English	Article						TBI; Pneumonia; Lower respiratory tract infection; Pulmonary infection; Spleen	VENTILATOR-ASSOCIATED PNEUMONIA; IMMUNE; PATHOPHYSIOLOGY; ACTIVATION	Traumatic brain injury (TBI) patients often experience post-traumatic infections, especially in the lung. Pulmonary infection is associated with unfavorable outcomes and increased mortality rates in TBI patients; however, our understanding of the underlying mechanisms is poor. Here we used a lateral fluid percussion injury (LFPI) model in rats to investigate whether TBI could lead to spontaneous lung infection. Analysis of bacterial load in lung tissue indicated no occurrence of spontaneous lung infection at 24 h, 48 h, and 7 d following LFPI. This may suggest that exogenous infectious agents play a crucial role in post-TBI infection in patients.	[Sun, Mujun; Brady, Rhys D.; Mychasiuk, Richelle; Yamakawa, Glenn R.; Casillas-Espinosa, Pablo M.; Shultz, Sandy R.; McDonald, Stuart J.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic 3004, Australia; [Brady, Rhys D.; Casillas-Espinosa, Pablo M.; Shultz, Sandy R.] Univ Melbourne, Dept Med, Melbourne, Vic 3052, Australia; [Wanrooy, Brooke; Wong, Connie H. Y.] Monash Univ, Ctr Inflammatory Dis, Sch Clin Sci, Dept Med, Melbourne, Vic 3168, Australia; [McDonald, Stuart J.] La Trobe Univ, Sch Life Sci, Dept Physiol Anat & Microbiol, Melbourne, Vic 3086, Australia		McDonald, SJ (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic 3004, Australia.	mujun.sun@monash.edu; rhys.brady@monash.edu; brooke.wanrooy1@monash.edu; richelle.mychasiuk@monash.edu; Glenn.Yamakawa@monash.edu; pablo.casillas-espinosa@monash.edu; connie.wong@monash.edu; sandy.shultz@monash.edu; stuart.mcdonald@monash.edu		Yamakawa, Glenn/0000-0003-3079-6532; McDonald, Stuart/0000-0001-5190-3179; Wong, Connie/0000-0002-9020-1847; Sun, Mujun/0000-0002-9923-9913	National Health and Medical Research Council - ECR Fellowship from National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	This study was funded by grants and fellowship to SRS from the National Health and Medical Research Council. PMCE was funded by ECR Fellowship from National Health and Medical Research Council.	Alharfi IM, 2014, J NEUROTRAUM, V31, P452, DOI [10.1089/neu.2013.2904, 10.1089/NEU.2013.2904]; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Bao Y, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-92; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Collins-Praino LE, 2018, BEHAV BRAIN RES, V336, P22, DOI 10.1016/j.bbr.2017.08.035; Corrigan F, 2017, BRAIN BEHAV IMMUN, V64, P124, DOI 10.1016/j.bbi.2017.04.006; Dong TT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0663-y; Doran SJ, 2020, CRIT CARE MED, V48, pE418, DOI 10.1097/CCM.0000000000004273; Draxler DF, 2019, J NEUROTRAUM, V36, P3297, DOI 10.1089/neu.2018.6030; Failli V, 2012, BRAIN, V135, P3238, DOI 10.1093/brain/aws267; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Ho C., 2018, PLOS ONE, V13; Hu PJ, 2017, AM J PHYSIOL-LUNG C, V313, pL1, DOI 10.1152/ajplung.00485.2016; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Immonen R, 2019, EPILEPSY RES, V150, P46, DOI 10.1016/j.eplepsyres.2019.01.001; Jayaraj RL, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1516-2; Jin R, 2013, STROKE, V44, P1135, DOI 10.1161/STROKEAHA.111.000633; Kong XD, 2014, NEUROSCI BULL, V30, P903, DOI 10.1007/s12264-014-1481-9; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Marks W, 2013, CENT EUR J IMMUNOL, V38, P494, DOI 10.5114/ceji.2013.39767; Mrakovcic-Sutic I, 2010, SCAND J IMMUNOL, V72, P57, DOI 10.1111/j.1365-3083.2010.02407.x; Ndode-Ekane XE, 2019, EPILEPSY RES, V151, P7, DOI 10.1016/j.eplepsyres.2019.01.006; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Plurad DS, 2013, J SURG RES, V183, P371, DOI 10.1016/j.jss.2013.01.036; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Rincon-Ferrari MD, 2004, J TRAUMA, V57, P1234, DOI 10.1097/01.TA.0000119200.70853.23; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Sharma R, 2019, BRAIN BEHAV IMMUN, V79, P63, DOI 10.1016/j.bbi.2019.04.034; Shim R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010064; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Stanley D, 2016, NAT MED, V22, P1277, DOI 10.1038/nm.4194; Sun M., 2019, BRAIN BEHAV IMMUN, V69, P618; Sun MJ, 2018, BRAIN BEHAV IMMUN, V69, P618, DOI 10.1016/j.bbi.2018.01.007; Vermeij JD, 2013, J NEUROTRAUM, V30, P2073, DOI 10.1089/neu.2013.3060; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254	40	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	JUN 15	2020	343								577239	10.1016/j.jneuroim.2020.577239			4	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	LJ2UJ	WOS:000530024500006	32302792				2022-02-06	
J	Knight, E; Norman, A; Simpson, GK				Knight, Ellie; Norman, Alyson; Simpson, Grahame K.			Living with suicidality following traumatic brain injury: a qualitative study	BRAIN INJURY			English	Article						Traumatic Brain Injury; suicide; suicide ideation; hopelessness; lived experience; protective factors	INTERPERSONAL-PSYCHOLOGICAL THEORY; PSYCHIATRIC-DISORDERS; PROTECTIVE FACTORS; HEAD-INJURY; PREVENTION; PEOPLE; RISK; REHABILITATION; SELF; DISABILITY	Purpose Numbers of traumatic brain injury (TBI) are increasing, and with suicidality post-injury presenting at 3-4 times higher than in the general population, understanding this is crucial in reducing a devastating outcome. Given the lack of literature, this study investigated the experiences of living with suicidality after TBI. Methods Interview data from nineteen participants with TBI from a Brain Injury Rehabilitation Unit (BIRU) in New South Wales (NSW), Australia were collected and thematically analyzed. Findings The participants (predominantly male) sustained extremely severe injuries (median PTA 60 [IQR 81.0] days) and were in the chronic phase post-injury (median 8.0 [IQR 9.0] years). Six main themes were identified; Loss of sense of self, TBI as a hidden disability, Chronic but transient suicidality, Reliance, Protective factors, and Hope. Tentative relationships between themes and subthemes were identified. Conclusion Chronic suicidality after TBI was demonstrated consistently regardless of receiving long-term support. However, their engagement with protective factors such as social support, spirituality and positive personal qualities was identified. Implementing these as coping strategies during long-term rehabilitation may reduce the levels of suicidal distress. Implications, methodological considerations and future research were discussed, with the aim of improving experiences of individuals with TBI to reduce suicidality.	[Knight, Ellie] Hywel Dda Univ Hlth Board, Dept Psychol, Haverfordwest, Wales; [Norman, Alyson] Univ Plymouth, Sch Psychol, 212 Portland Sq, Plymouth PL4 8AA, Devon, England; [Simpson, Grahame K.] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Sydney, NSW, Australia		Norman, A (corresponding author), Univ Plymouth, Sch Psychol, 212 Portland Sq, Plymouth PL4 8AA, Devon, England.	alyson.norman@plymouth.ac.uk		Norman, Alyson`/0000-0002-4332-6049; Simpson, Grahame/0000-0001-8156-9060			ACHTE KA, 1971, ACTA PSYCHIAT SCAND, P1; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Bay EH, 2012, J MARITAL FAM THER, V38, P556, DOI 10.1111/j.1752-0606.2011.00231.x; Blakey SM, 2018, J PAIN, V19, P797, DOI 10.1016/j.jpain.2018.02.012; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brenner LA, 2018, J HEAD TRAUMA REHAB, V33, pE64, DOI 10.1097/HTR.0000000000000351; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Bryson CN, 2017, DEATH STUD, V41, P399, DOI 10.1080/07481187.2017.1320340; Burshtein S, 2016, ACTA PSYCHIAT SCAND, V133, P481, DOI 10.1111/acps.12555; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Chesley K., 2003, J AM PSYCHIAT NURSES, V9, P41, DOI DOI 10.1016/S1078-3903(03)00051-X; Driver K, 2004, INT J PSYCHIAT CLIN, V8, P25, DOI 10.1080/13651500310004506; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Esang M, 2018, AM J PSYCHIAT RESID, V13, P6, DOI DOI 10.1176/APPI.AJP-RJ.2018.130603; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Gordon WR, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199812000-00006; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Holloway M., 2014, SOCIAL CARE NEURODIS, V5, P201, DOI [10.1108/SCN-12-2013-0043, DOI 10.1108/SCN-12-2013-0043]; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Joiner T.E., 2005, WHY PEOPLE DIE SUICI; Joiner TE, 2009, J ABNORM PSYCHOL, V118, P634, DOI 10.1037/a0016500; Jones KF, 2018, BRAIN INJURY, V32, P1612, DOI 10.1080/02699052.2018.1511066; Judd D. P., 1999, COUNSELLING PSYCHOL, V14, P4; Linden MA, 2013, BRAIN INJURY, V27, P92, DOI 10.3109/02699052.2012.722262; Lorenz LS, 2010, SOCIOL HEALTH ILL, V32, P862, DOI 10.1111/j.1467-9566.2010.01244.x; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; Mcrae P, 2016, AUST J REHABIL COUNS, V22, P76, DOI 10.1017/jrc.2016.14; Meadows LA, 2005, AM J COMMUN PSYCHOL, V36, P109, DOI 10.1007/s10464-005-6236-3; New South Wales Agency for Clinical Innovation, 2014, BRAIN INJ REH DIR DI; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Norman A, 2020, HEALTH SOC CARE COMM, V28, P2037, DOI 10.1111/hsc.13015; Norman A, 2016, J ADULT PROT, V18, P341, DOI 10.1108/JAP-08-2016-0017; Odumuyiwa M, 2019, J LONG TERM CARE, P164, DOI DOI 10.31389/JLTC.6; Opdenakker R.J.G, 2006, FORUM QUAL SOCIAL RE, V7, DOI [DOI 10.17169/FQS-7.4.175, 10.17169/fqs-7.4.175]; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Ponsford J, 2014, BRAIN INJURY, V28, P146, DOI 10.3109/02699052.2013.859733; SCHERZER BP, 1993, BRAIN INJURY, V7, P411, DOI 10.3109/02699059309029684; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G., 2002, AUST SOC WORK, V55, P24, DOI [10.1080/03124070208411669, DOI 10.1080/03124070208411669]; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Simpson G, 2007, CRISIS, V28, P35, DOI 10.1027/0227-5910.28.1.35; Simpson GK, 2020, NEUROPSYCHOL REHABIL, V30, P995, DOI 10.1080/09602011.2018.1531769; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; SOLOMON RL, 1980, AM PSYCHOL, V35, P691, DOI 10.1037/0003-066X.35.8.691; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Tyerman A, 2012, NEUROREHABILITATION, V31, P51, DOI 10.3233/NRE-2012-0774; UKABIF, 2018, ACQ BRAIN INJ NEUR T; Van Bost G, 2017, PEERJ, V5, DOI 10.7717/peerj.3545; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343, DOI 10.1080/02791072.2003.10400017; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wylie Glenn R, 2017, Concussion, V2, pCNC50, DOI 10.2217/cnc-2017-0003; Yamokoski CA, 2011, SUICIDE LIFE-THREAT, V41, P160, DOI 10.1111/j.1943-278X.2011.00019.x	61	1	1	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 2	2020	34	8					1010	1019		10.1080/02699052.2020.1763463		JUN 2020	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MK8SK	WOS:000545155700001	32529858	Green Submitted			2022-02-06	
J	Meningher, I; Bernstein-Eliav, M; Rubovitch, V; Pick, CG; Tavor, I				Meningher, Inbar; Bernstein-Eliav, Michal; Rubovitch, Vardit; Pick, Chaim G.; Tavor, Ido			Alterations in Network Connectivity after Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; diffusion MRI; graph theory; structural connectivity; TBI	AXONAL INJURY; MOUSE MODEL; HIPPOCAMPAL; IMMATURE; DEFICITS; MTBI	Victims of mild traumatic brain injury (mTBI) usually do not display clear morphological brain defects, but frequently have long-lasting cognitive deficits, emotional difficulties, and behavioral disturbances. In the present study we used diffusion magnetic resonance imaging (dMRI) combined with graph theory measurements to investigate the effects of mTBI on brain network connectivity. We employed a non-invasive closed-head weight-drop mouse model to produce mTBI. Mice were scanned at two time points, 24 h before the injury and either 7 or 30 days following the injury. Connectivity matrices were computed for each animal at each time point, and these were subsequently used to extract graph theory measures reflecting network integration and segregation, on both the global (i.e., whole brain) and local (i.e., single regions) levels. We found that cluster coefficient, reflecting network segregation, decreased 7 days post-injury and then returned to baseline level 30 days following the injury. Global efficiency, reflecting network integration, demonstrated opposite patterns in the left and right hemispheres, with an increase of right hemisphere efficiency at 7 days and then a decrease in efficiency following 30 days, and vice versa in the left hemisphere. These findings suggest a possible compensation mechanism acting to moderate the influence of mTBI on the global network. Moreover, these results highlight the importance of tracking the dynamic changes in mTBI over time, and the potential of structural connectivity as a promising approach for studying network integrity and pathology progression in mTBI.	[Meningher, Inbar; Bernstein-Eliav, Michal; Rubovitch, Vardit; Pick, Chaim G.; Tavor, Ido] Tel Aviv Univ, Dept Anat & Anthropol, Sackler Sch Med, Tel Aviv, Israel; [Meningher, Inbar; Bernstein-Eliav, Michal; Pick, Chaim G.; Tavor, Ido] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Dr Miriam & Sheldon G Adelson Chair, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Ctr Biol Addict Dis, Tel Aviv, Israel		Tavor, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel.	idotavor@tauex.tau.ac.il	Tavor, Ido/AAB-1345-2019	Tavor, Ido/0000-0002-9117-4449	Ari and Regine Aprijaskis Fund at Tel-Aviv University; Dr. Miriam and Sheldon G. Adelson Chair for the Biology of Addictive Diseases in Tel-Aviv University, Tel-Aviv, Israel	This research was supported in part by the Ari and Regine Aprijaskis Fund at Tel-Aviv University and the Dr. Miriam and Sheldon G. Adelson Chair for the Biology of Addictive Diseases in Tel-Aviv University, Tel-Aviv, Israel.	Bader M, 2020, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00356; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Benady A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31623-y; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Card JP, 2005, J NEUROTRAUM, V22, P989, DOI 10.1089/neu.2005.22.989; Casella EM, 2014, CHILD NERV SYST, V30, P1333, DOI 10.1007/s00381-014-2446-z; Dorr AE, 2008, NEUROIMAGE, V42, P60, DOI 10.1016/j.neuroimage.2008.03.037; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Heim LR, 2017, J NEUROTRAUM, V34, P2518, DOI 10.1089/neu.2016.4909; Imms P, 2019, NEUROSCI BIOBEHAV R, V99, P128, DOI 10.1016/j.neubiorev.2019.01.002; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kikinis Z, 2017, BRAIN INJURY, V31, P1376, DOI 10.1080/02699052.2017.1318450; Kim J, 2014, J INT NEUROPSYCH SOC, V20, P887, DOI 10.1017/S1355617714000812; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; LEBIHAN D, 1992, AM J ROENTGENOL, V159, P591, DOI 10.2214/ajr.159.3.1503032; Leemans A., 2009, 17 ANN M INT SOC MAG, DOI DOI 10.1093/OCCMED/KQR069; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Mayer AR, 2014, J NEUROTRAUM, V31, pA66; Medaglia JD, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00407; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Rachmany L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03792-9; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubovitch V, 2015, NEUROMOL MED, V17, P58, DOI 10.1007/s12017-015-8340-3; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Steward KA, 2018, J HEAD TRAUMA REHAB, V33, pE18, DOI 10.1097/HTR.0000000000000325; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Tweedie D, 2016, J NEUROSCI METH, V272, P4, DOI 10.1016/j.jneumeth.2016.02.003; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; van der Horn HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171031; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Younger D, 2019, MOL NEUROBIOL, V56, P5202, DOI 10.1007/s12035-018-1428-7; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Zhou YX, 2017, J MAGN RESON IMAGING, V46, P518, DOI 10.1002/jmri.25548; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	59	1	1	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2020	37	20					2169	2179		10.1089/neu.2020.7063		JUN 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	OA4HP	WOS:000547514800001	32434427				2022-02-06	
J	Promlek, K; Currey, J; Damkliang, J; Considine, J				Promlek, Kesorn; Currey, Judy; Damkliang, Jintana; Considine, Julie			Thai trauma nurses' knowledge of neuroprotective nursing care of traumatic brain injury patients: A survey study	NURSING & HEALTH SCIENCES			English	Article						brain injury; evidence-based nursing; knowledge; neuroprotection; Thailand; trauma	MANAGEMENT; EDUCATION; UNIT; GUIDELINES; BUNDLE	Thai trauma nurses play a vital role in neuroprotective nursing care of patients with moderate or severe traumatic brain injury. Nurses' knowledge of the evidence underpinning initial neuroprotective nursing care vital to safe and high-quality patient care. However, the current state of knowledge of Thai trauma nurses is poorly understood. In this study, we investigated Thai nurses' knowledge of neuroprotective nursing care of patients with moderate or severe traumatic brain injury. Data were collected by a survey, comprising a section on participant characteristics and series of multiple-choice questions. All registered nurses (n= 22) and nursing assistants (n= 13) from the trauma ward of a regional Thai hospital were invited to participate: the response rate was 100%. Participants had limited knowledge of carbon dioxide monitoring; causes and implications of hypercapnia; mean arterial pressure and cerebral perfusion pressure targets; management of sedatives and analgesics; and management of hyperthermia. Improving their knowledge focusing on knowledge deficits through educational training and implementation of evidence-based practice is essential to improve the safety and quality of care for Thai patients with moderate or severe traumatic brain injury.	[Promlek, Kesorn; Currey, Judy; Considine, Julie] Deakin Univ Geelong, Ctr Qual & Patient Safety Res, Sch Nursing & Midwifery, Geelong, Vic, Australia; [Promlek, Kesorn; Currey, Judy; Considine, Julie] Inst Hlth Transformat, Geelong, Vic, Australia; [Promlek, Kesorn; Damkliang, Jintana] Prince Songkla Univ, Fac Nursing, Hat Yai, Thailand; [Considine, Julie] Ctr Qual & Patient Safety Res Eastern Hlth Partne, Box Hill, Vic, Australia		Promlek, K (corresponding author), Deakin Univ, Sch Nursing & Midwifery, 221 Burwood Hwy, Burwood, Vic 3125, Australia.	kesorn.p@psu.ac.th			Deakin University, Australia; Faculty of Nursing, Prince of Songkla University, Thailand; 2019 Deakin University Faculty of Health Publication Award	Ms Promlek is supported by a PhD scholarship from Deakin University, Australia, and Faculty of Nursing, Prince of Songkla University, Thailand, and a 2019 Deakin University Faculty of Health Publication Award.	Alvis-Miranda Hernando Raphael, 2014, Bull Emerg Trauma, V2, P3; American College of Surgeons, 2015, BEST PRACT MAN TRAUM; [Anonymous], 2010, RESP CARE, V55, P758; Barr J, 2013, AM J HEALTH-SYST PH, V70, P53, DOI 10.1093/ajhp/70.1.53; Bureau of Policy and Strategy Thai Ministry of Public Health, 2017, PUBL HLTH STAT AD 20; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Considine Julie, 2005, Collegian, V12, P19, DOI 10.1016/S1322-7696(08)60478-3; Craig J. V, 2011, EVIDENCE BASED PRACT, P3; Damkliang J, 2014, THESIS; Damkliang J, 2015, NURSE EDUC PRACT, V15, P284, DOI 10.1016/j.nepr.2015.03.007; Damkliang J, 2014, AUSTRALAS EMERG NURS, V17, P152, DOI 10.1016/j.aenj.2014.05.005; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Douglas B, 2011, EMERGENCY TRAUMA CAR, P1169; Gijbels Harry, 2010, Nurse Educ Pract, V10, P64, DOI 10.1016/j.nepr.2009.03.011; Gill FJ, 2013, NURS CRIT CARE, V18, P93, DOI 10.1111/j.1478-5153.2012.00543.x; Gray D.E., 2018, DOING RES REAL WORLD, V4th ed.; Griffiths P, 2018, J ADV NURS, V74, P1474, DOI 10.1111/jan.13564; Heavey E, 2011, STAT NURSING PRACTIC, P63; Hurst Keith, 2010, Nurs Stand, V24, P14; Jackson C., 2000, DESIGNING ANAL QUEST; Jasemi M, 2018, NURS EDUC TODAY, V67, P21, DOI 10.1016/j.nedt.2018.04.010; Jordan P, 2016, SOUTH AFR J CRIT CAR, V32, P50, DOI [10.7196/SAJCC.2016.v32i2.253, 10.7196/sajcc.2016.v32i2.253]; Karacsony S, 2019, BMC PALLIAT CARE, V18, DOI 10.1186/s12904-019-0447-0; Khammarnia M, 2015, NURS RES PRACT, V2015, DOI 10.1155/2015/357140; Madhuvu AE, 2018, AUST CRIT CARE, V31, P311, DOI 10.1016/j.aucc.2017.08.005; Massenburg BB, 2017, NEUROL INDIA, V65, P305, DOI 10.4103/neuroindia.NI_719_16; Mcilvoy L., 2009, NURSING MANAGEMENT A; Melnyk B.M., 2015, EVIDENCE BASED PRACT; Mulenga Chisomo, 2017, Curationis, V40, P1, DOI 10.4102/curationis.v40i1.1656; National Institute for Health and Care Excellence, 2014, HEAD INJ TRIAG ASS I, DOI [10.1136/bmj.g409, DOI 10.1136/BMJ.G409]; National Statistical Office of Thailand, 2019, HOSP MORT SIGN CAUS; O'Driscoll BR, 2017, BMJ OPEN RESPIR RES, V4, DOI 10.1136/bmjresp-2016-000170; Office of Transport and Traffic Policy and Planning Ministry of Transport Thailand, 2019, REP ROAD TRANSP STAT; Oyesanya TO, 2017, J CLIN NURS, V26, P1562, DOI 10.1111/jocn.13457; Panahi Y, 2018, J PHARMACOPUNCT, V21, P226, DOI 10.3831/KPI.2018.21.026; Panjaisri S., 2013, CLIN PRACTICE GUIDEL; Polit DF, 2008, NURSING RES GENERATI; Promlek K, 2019, THESIS; Rockett H, 2015, J NEUROSCI NURS, V47, P66, DOI 10.1097/JNN.0000000000000118; Ruksakun P., 2013, SAKON NAKHON HOSP, V16, P11; Sasat S, 2013, GERONTOLOGIST, V53, P711, DOI 10.1093/geront/gnt038; Sawaengdee K, 2016, BMC NURS, V15, DOI 10.1186/s12912-016-0131-0; Schug S, 2015, ACUTE PAIN MANAGEMEN, V4th; Smeland AH, 2018, PAIN MANAG NURS, V19, P585, DOI 10.1016/j.pmn.2018.04.006; Smets T, 2018, PALLIATIVE MED, V32, P1487, DOI 10.1177/0269216318785295; Subramanian P, 2013, SINGAP MED J, V54, P281, DOI 10.11622/smedj.2013109; Thai Ministry of Public Health, 2016, WORKF PLAN PRACT NUR; Varghese R, 2017, INDIAN J CRIT CARE M, V21, P684, DOI 10.4103/ijccm.IJCCM_233_17; Victorian State Trauma System, 2014, TRAUM BRAIN INJ GUID; World Health Organization, 2018, GLOB STAT REP SAF SU	50	1	1	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1441-0745	1442-2018		NURS HEALTH SCI	Nurs. Health Sci.	SEP	2020	22	3					787	794		10.1111/nhs.12730		JUN 2020	8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	NI7WH	WOS:000539664600001	32336019	Green Published			2022-02-06	
J	Qian, Y; Gao, C; Zhao, XN; Song, YM; Luo, HL; An, S; Huang, JH; Zhang, JN; Jiang, RC				Qian, Yu; Gao, Chuang; Zhao, Xiaonan; Song, Yiming; Luo, Hongliang; An, Shuo; Huang, Jinhao; Zhang, Jianning; Jiang, Rongcai			Fingolimod Attenuates Lung Injury and Cardiac Dysfunction after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cardiac injury; fingolimod; inflammation; lung injury; TBI	ISCHEMIA-REPERFUSION INJURY; NEUROGENIC PULMONARY-EDEMA; MYOCARDIAL-INFARCTION; IN-VIVO; BARRIER ENHANCEMENT; ADHESION MOLECULE-1; PRESSURE-OVERLOAD; TROPONIN-T; FTY720; SPHINGOSINE-1-PHOSPHATE	Acute lung injury (ALI) and cardiac dysfunction are common in traumatic brain injury (TBI) patients and always indicate poor outcomes. Inflammatory responses play important roles in TBI-induced cardiac and pulmonary damage. Fingolimod, an immunomodulatory agent, alleviates brain edema, restores the integrity of the blood-brain barrier (BBB), and improves functional deficits by inhibiting multiple inflammatory responses. Fingolimod (1 mg/kg) was injected intraperitoneally at 2 h after the controlled cortical impact (CCI) model was established in adult male mice. The concentration of inflammatory cytokines in the lung and heart after TBI was measured with a cytokine array. The lung wet/dry weight ratio and Evans blue dye leakage were used to quantify pulmonary edema and capillary leakage. Immunofluorescence, electron microscopy, and echocardiographic examination were used to assess the pathology and functional deficits in hearts. We found that TBI caused significant heart and lung damage. The administration of fingolimod significantly reduced the elevated inflammatory cytokine production, neutrophil infiltration, the leakage of protein in bronchoalveolar lavage fluid (BALF), and the wet/dry weight ratio in lung tissue at 3 days after TBI. In addition, fingolimod treatment also alleviated the inflammatory response in the heart; decreased cardiac apoptosis, fibrosis, and histological microstructural changes; and improved cardiac function from 3 days after TBI and maintained it for 30 days after TBI as measured by echocardiography. These results suggest that TBI resulted in significant cardiac and pulmonary damage accompanied by significant inflammatory responses in heart and lung tissue. Fingolimod treatment reduced the inflammatory response and alleviated TBI-induced lung and heart injury.	[Qian, Yu] Tianjin Med Univ Gen Hosp, Dept Neurol, Tianjin, Peoples R China; [Gao, Chuang; Song, Yiming; Luo, Hongliang; An, Shuo; Huang, Jinhao; Zhang, Jianning; Jiang, Rongcai] Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Qian, Yu; Gao, Chuang; Song, Yiming; Luo, Hongliang; An, Shuo; Huang, Jinhao; Zhang, Jianning; Jiang, Rongcai] Minist Educ & Tianjin City, Tianjin Neurol Inst, Key Lab Postneuroinjury Neurorepair & Regenerat C, Tianjin, Peoples R China; [Zhao, Xiaonan] Tianjin Childrens Hosp, Tianjin, Peoples R China		Jiang, RC (corresponding author), Tianjin Med Univ Gen Hosp, Dept Neurosurg, Key Lab Postneurotrauma Neurorepair & Regenerat C, Minist Educ & Tianjin,Tianjin Neurol Inst, 154 Anshan Rd, Tianjin 300052, Peoples R China.	jiang116216@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671221]; Tianjin Research Program of Application Foundation and Advanced Technology [14ZCZDSY00179]; Clinical Study of Tianjin Medical University [2017kylc007]; Zhao Yi-Cheng Medical Science Foundation	This study was supported by the National Natural Science Foundation of China (No. 81671221 Rongcai Jiang), the Tianjin Research Program of Application Foundation and Advanced Technology (No: 14ZCZDSY00179 Rongcai Jiang), the Clinical Study of Tianjin Medical University (No: 2017kylc007 Rongcai Jiang), and Zhao Yi-Cheng Medical Science Foundation.	Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; Ahmed N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00645; Atkinson JLD, 1997, NEUROSURGERY, V41, P1214, DOI 10.1097/00006123-199711000-00052; Bahloul M, 2006, AM J CRIT CARE, V15, P462; Bauer M, 2011, CIRC RES, V108, P908, DOI 10.1161/CIRCRESAHA.110.239574; Bracke KR, 2013, AM J RESP CRIT CARE, V188, P343, DOI 10.1164/rccm.201211-2055OC; Camerer E, 2009, J CLIN INVEST, V119, P1871, DOI 10.1172/JCI38575; Camp SM, 2016, CHEM PHYS LIPIDS, V194, P85, DOI 10.1016/j.chemphyslip.2015.10.004; Chen JR, 2016, J ETHNOPHARMACOL, V194, P559, DOI 10.1016/j.jep.2016.10.025; Chen ZL, 2017, CIRC RES, V121, P451, DOI 10.1161/CIRCRESAHA.117.311170; Chiba K, 1998, J IMMUNOL, V160, P5037; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Davison DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11226; de Haan JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16957-3; DEMLING R, 1990, CRIT CARE MED, V18, P768, DOI 10.1097/00003246-199007000-00019; Duan HF, 2007, HUM GENE THER, V18, P1119, DOI 10.1089/hum.2007.036; Emad A, 2007, J CLIN IMMUNOL, V27, P605, DOI 10.1007/s10875-007-9114-y; Fu Y, 2014, P NATL ACAD SCI USA, V111, P18315, DOI 10.1073/pnas.1416166111; Fu Y, 2014, JAMA NEUROL, V71, P1092, DOI 10.1001/jamaneurol.2014.1065; Gao Chuang, 2017, Mol Neurobiol, V54, P8348, DOI 10.1007/s12035-016-0318-0; Gill S, 2010, ANAT REC, V293, P968, DOI 10.1002/ar.21094; Gomez L, 2011, BASIC RES CARDIOL, V106, P1341, DOI 10.1007/s00395-011-0223-7; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hafner C, 2017, SHOCK, V47, P436, DOI 10.1097/SHK.0000000000000740; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; James P, 2000, BRIT MED J, V320, P1502, DOI 10.1136/bmj.320.7248.1502; Jin ZQ, 2007, CARDIOVASC RES, V76, P41, DOI 10.1016/j.cardiores.2007.05.029; Kahan BD, 2003, TRANSPLANTATION, V76, P1079, DOI 10.1097/01.TP.0000084822.01372.AC; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; Karin N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00609; Karliner JS, 2001, J MOL CELL CARDIOL, V33, P1713, DOI 10.1006/jmcc.2001.1429; KOLIN A, 1984, STROKE, V15, P990, DOI 10.1161/01.STR.15.6.990; Koutsoukou Antonia, 2016, World J Crit Care Med, V5, P65, DOI 10.5492/wjccm.v5.i1.65; Krishnamoorthy V, 2016, CHEST, V149, P1325, DOI 10.1016/j.chest.2015.12.014; Lagler H, 2009, J IMMUNOL, V183, P2027, DOI 10.4049/jimmunol.0803862; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Means CK, 2007, AM J PHYSIOL-HEART C, V292, pH2944, DOI 10.1152/ajpheart.01331.2006; Mencl S, 2014, J NEUROIMMUNOL, V274, P125, DOI 10.1016/j.jneuroim.2014.07.010; Mito S, 2008, HYPERTENSION, V51, P1570, DOI 10.1161/HYPERTENSIONAHA.107.102566; Muhlstedt S, 2016, J MOL MED, V94, P1005, DOI 10.1007/s00109-016-1432-1; Mulligan MS, 1996, J CLIN INVEST, V98, P503, DOI 10.1172/JCI118818; Natarajan V, 2013, AM J RESP CELL MOL, V49, P6, DOI 10.1165/rcmb.2012-0411TR; Okazaki M, 2007, AM J TRANSPLANT, V7, P751, DOI 10.1111/j.1600-6143.2006.01710.x; Parr MJA, 1996, BRIT MED J, V313, P681; Paudel S, 2019, BLOOD, V133, P1335, DOI 10.1182/blood-2018-10-878082; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Qian J, 2014, INT IMMUNOPHARMACOL, V21, P426, DOI 10.1016/j.intimp.2014.05.025; Qin C, 2017, STROKE, V48, P3336, DOI 10.1161/STROKEAHA.117.018505; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; ROGERS FB, 1995, J TRAUMA, V39, P860, DOI 10.1097/00005373-199511000-00009; Rolland WB, 2013, EXP NEUROL, V241, P45, DOI 10.1016/j.expneurol.2012.12.009; Rose CE, 2003, MICROCIRCULATION, V10, P273, DOI 10.1038/sj.mn.7800193; Santos-Gallego CG, 2016, CIRCULATION, V133, P954, DOI 10.1161/CIRCULATIONAHA.115.012427; Schmal H, 1998, J IMMUNOL, V161, P3685; SEKO Y, 1993, J CLIN INVEST, V91, P1327, DOI 10.1172/JCI116333; Song HS, 2008, J CLIN NEUROL, V4, P75, DOI 10.3988/jcn.2008.4.2.75; Speidl WS, 2005, EUR HEART J, V26, P2294, DOI 10.1093/eurheartj/ehi339; Stone ML, 2015, AM J PHYSIOL-LUNG C, V308, pL1245, DOI 10.1152/ajplung.00302.2014; Talman V, 2016, CELL TISSUE RES, V365, P563, DOI 10.1007/s00441-016-2431-9; Tamaki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068893; Tao R, 2007, CARDIOVASC RES, V74, P56, DOI 10.1016/j.cardiores.2007.01.015; Teiger E, 1996, J CLIN INVEST, V97, P2891, DOI 10.1172/JCI118747; Theilmeier G, 2006, CIRCULATION, V114, P1403, DOI 10.1161/CIRCULATIONAHA.105.607135; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; Verma A, 2008, JACC-CARDIOVASC IMAG, V1, P582, DOI 10.1016/j.jcmg.2008.05.012; Wang GY, 2014, J CARDIOVASC PHARM, V63, P132, DOI 10.1097/FJC.0000000000000031; Wang LC, 2015, MICROVASC RES, V99, P102, DOI 10.1016/j.mvr.2015.03.007; Wang LC, 2014, CRIT CARE MED, V42, pE189, DOI 10.1097/CCM.0000000000000097; Weber DJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009443; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yasui H, 2016, AM J PHYSIOL-LUNG C, V311, pL74, DOI 10.1152/ajplung.00429.2015; YOUKER KA, 1994, CIRCULATION, V89, P2736, DOI 10.1161/01.CIR.89.6.2736; Yusuf-Makagiansar H, 2002, MED RES REV, V22, P146, DOI 10.1002/med.10001; Zhang Lijuan, 2016, Zhongguo Zhen Jiu, V36, P131; Zhao Q, 2019, J NEUROTRAUM, V36, P619, DOI 10.1089/neu.2018.5766	78	1	1	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2020	37	19					2131	2140		10.1089/neu.2019.6951		JUN 2020	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NV1ON	WOS:000539553800001	32434456				2022-02-06	
J	Haddad, YK; Shakya, I; Moreland, BL; Kakara, R; Bergen, G				Haddad, Yara K.; Shakya, Iju; Moreland, Briana L.; Kakara, Ramakrishna; Bergen, Gwen			Injury Diagnosis and Affected Body Part for Nonfatal Fall-Related Injuries in Community-Dwelling Older Adults Treated in Emergency Departments	JOURNAL OF AGING AND HEALTH			English	Article						fall injuries; elderly; emergency departments; hospitalizations	TRAUMATIC BRAIN-INJURY; AGED GREATER-THAN-OR-EQUAL-TO-65 YEARS; UNITED-STATES; BONE STRENGTH; RISK; FRACTURES; MORTALITY; OUTCOMES; SEX; HIP	Objective:To estimate frequency and type of older adult fall-related injuries treated in emergency departments (EDs).Methods:We used the 2015 National Electronic Injury Surveillance System: All Injury Program. Patient data were abstracted from the narratives describing the circumstance of injury. Data for community-dwelling older adults (n= 34,336) were analyzed to explore differences in injury diagnosis by demographic characteristics, location of fall, and disposition.Results:70% of head-related injuries were internal injuries, suggestive of a traumatic brain injury. Most hip injuries were fractures or dislocations (73.3%). Women had higher percentages of fractures/dislocations but lower percentages of internal injuries than men. About a third of fall-related ED visits required hospitalization or transfer.Discussion:Falls in older adults result in array of injuries and pose a burden on the healthcare system. Understanding how fall injuries vary by different characteristics can help inform targeted prevention strategies.	[Haddad, Yara K.; Shakya, Iju; Moreland, Briana L.; Kakara, Ramakrishna; Bergen, Gwen] Ctr Dis Control & Prevent, Atlanta, GA USA		Haddad, YK (corresponding author), Ctr Dis Control & Prevent, Div Injury Prevent, 4770 Buford Hwy NE,Mailstop S106-9, Atlanta, GA 30341 USA.	yhaddad@cdc.gov		Haddad, Yara K./0000-0001-6803-2410	Intramural CDC HHS [CC999999] Funding Source: Medline		Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bentler SE, 2009, AM J EPIDEMIOL, V170, P1290, DOI 10.1093/aje/kwp266; Bergen G, 2016, MMWR-MORBID MORTAL W, V65, P993, DOI 10.15585/mmwr.mm6537a2; Beynon C, 2012, CRIT CARE, V16, DOI 10.1186/cc11292; Boye NDA, 2014, INJURY, V45, P1224, DOI 10.1016/j.injury.2014.03.021; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Burns E, 2018, MMWR-MORBID MORTAL W, V67, P509, DOI 10.15585/mmwr.mm6718a1; Burns ER, 2016, J SAFETY RES, V58, P99, DOI 10.1016/j.jsr.2016.05.001; Cawthon PM, 2011, CLIN ORTHOP RELAT R, V469, P1900, DOI 10.1007/s11999-011-1780-7; Centers for Disease Control and Prevention, 2018, WEB BAS INJ STAT QUE; Chauny JM, 2016, J EMERG MED, V51, P519, DOI 10.1016/j.jemermed.2016.05.045; Cummings SR, 2006, J BONE MINER RES, V21, P1550, DOI 10.1359/JBMR.060708; Duckham RL, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-133; Florence CS, 2018, J AM GERIATR SOC, V66, P693, DOI 10.1111/jgs.15304; Coutinho ESF, 2012, CAD SAUDE PUBLICA, V28, P801, DOI 10.1590/S0102-311X2012000400019; Gassmann KG, 2009, Z GERONTOL GERIATR, V42, P3, DOI 10.1007/s00391-008-0506-2; Gill TM, 2013, AM J EPIDEMIOL, V178, P418, DOI 10.1093/aje/kws554; Greenspan AI, 2006, J TRAUMA, V61, P1234, DOI 10.1097/01.ta.0000231558.71696.1a; Hartholt KA, 2010, ARCH INTERN MED, V170, P905, DOI 10.1001/archinternmed.2010.106; Houry D, 2016, AM J LIFESTYLE MED, V10, P74, DOI 10.1177/1559827615600137; Johnston YA, 2019, GERONTOLOGIST, V59, P1182, DOI 10.1093/geront/gny101; Joseph B, 2014, JAMA SURG, V149, P766, DOI 10.1001/jamasurg.2014.296; Kelsey JL, 2010, J AM GERIATR SOC, V58, P2135, DOI 10.1111/j.1532-5415.2010.03062.x; Leavy B, 2013, OSTEOPOROSIS INT, V24, P2387, DOI 10.1007/s00198-013-2333-6; McGwin G, 2004, J TRAUMA, V56, P1291, DOI 10.1097/01.TA.0000089354.02065.D0; Miu J, 2016, AUSTRALAS EMERG NURS, V19, P179, DOI 10.1016/j.aenj.2016.07.001; Nguyen ND, 2007, J BONE MINER RES, V22, P781, DOI 10.1359/JBMR.070315; Orces CH, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001722; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Peterson AB, 2019, SURVEILLANCE REPORT; Pohl P, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-120; Qato DM, 2016, JAMA INTERN MED, V176, P473, DOI 10.1001/jamainternmed.2015.8581; Riggs BL, 2004, J BONE MINER RES, V19, P1945, DOI 10.1359/JBMR.040916; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Satariano WA, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00142; Schlecht SH, 2015, CLIN ORTHOP RELAT R, V473, P2540, DOI 10.1007/s11999-015-4229-6; Schroeder T., 2001, NEISS SAMPLE DESIGN; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sigurdsson G, 2006, BONE, V39, P644, DOI 10.1016/j.bone.2006.03.020; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Wiener JM, 2002, INT J EPIDEMIOL, V31, P776, DOI 10.1093/ije/31.4.776	46	1	1	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0898-2643	1552-6887		J AGING HEALTH	J. Aging Health	DEC	2020	32	10					1433	1442	0898264320932045	10.1177/0898264320932045		JUN 2020	10	Gerontology; Health Policy & Services	Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Health Care Sciences & Services	XH9NG	WOS:000539340400001	32515622	Green Accepted			2022-02-06	
J	Rochat, L; Renaud, O; Arnould, A; Robyn, CL; Barbot, F; Azouvi, P; Van der Linden, M				Rochat, Lucien; Renaud, Olivier; Arnould, Annabelle; Robyn, Claudia Lardi; Barbot, Frederic; Azouvi, Philippe; Van der Linden, Martial			Self-defining memories after severe traumatic brain injury: A preliminary study	JOURNAL OF NEUROPSYCHOLOGY			English	Article						traumatic brain injury; autobiographical memory; self-defining memory; self; identity; specificity; meaning-making	AUTOBIOGRAPHICAL MEMORY; EXECUTIVE FUNCTION; DEPRESSION; EXPERIENCE; ADULTS	Autobiographical memory plays a major role in the (re)construction of sense of identity, a recurrent issue after a traumatic brain injury (TBI). Although the recall of specific autobiographical events is frequently impaired in patients with TBI, little is known about how these changes affect their sense of self and identity. Thus, we examined self-defining memories (SDMs), that is, the most significant personal memories supporting one's sense of identity, in 16 patients with severe TBI and in matched controls. To this end, participants recalled three SDMs and rated their emotions in response to memory retrieval. In addition, characteristics of SDMs such as specificity, meaning-making, self-connections that reflect identity stability or identity change, content (theme, presence of tension, and redemption sequences) were analysed by independent raters. The main results showed that patients' SDMs were less specific and contained fewer redemption sequences than did those of controls but did not significantly differ in thematic content, presence of tension, meaning-making, self-connections that reflect identity stability or identity change and affective responses to memory retrieval. Furthermore, among the patients' memories that refer to the TBI-related event itself, only one contained an explicit meaning. Despite the lack of specificity in memories, patients with severe TBI were able to extract meaning from personal memories although they could struggle with integrating the TBI-related event into their sense of identity. These characteristics of SDMs may contribute to disturbances in sense of self and continuity in patients with severe TBI, as well as difficulties in personal or social adjustment. These results also open up relevant prospects for psychological interventions in identity-related issues in patients with TBI.	[Rochat, Lucien; Robyn, Claudia Lardi; Van der Linden, Martial] Univ Geneva, Fac Psychol & Educ Sci, 40 Blvd Pont Arve, CH-1205 Geneva, Switzerland; [Renaud, Olivier] Univ Geneva, Sect Psychol, Methodol & Data Anal, Geneva, Switzerland; [Arnould, Annabelle; Azouvi, Philippe] Hop Raymond Poincare, AP HP, Dept Phys Med & Rehabil, Garches, France; [Arnould, Annabelle; Azouvi, Philippe] Univ Versailles St Quentin En Yvelines, HANDIReSP, EA 4047, Versailles, France; [Barbot, Frederic] Hop Raymond Poincare, AP HP, INSERM CIC 1429, Garches, France		Rochat, L (corresponding author), Univ Geneva, Fac Psychol & Educ Sci, 40 Blvd Pont Arve, CH-1205 Geneva, Switzerland.	Lucien.Rochat@unige.ch		Rochat, Lucien/0000-0002-9992-2720			Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Blagov PS, 2004, J PERS, V72, P481, DOI 10.1111/j.0022-3506.2004.00270.x; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; Conway MA, 2004, SOC COGNITION, V22, P491, DOI 10.1521/soco.22.5.491.50768; Coste C, 2015, NEUROPSYCHOLOGIA, V71, P133, DOI 10.1016/j.neuropsychologia.2015.03.014; Coste C, 2011, CORTEX, V47, P771, DOI 10.1016/j.cortex.2010.07.004; Dalgleish T, 2013, CLIN PSYCHOL SCI, V1, P156, DOI 10.1177/2167702612468111; Delis D.C., 2000, CALIFORNIA VERBAL LE; Esopenko C, 2017, CORTEX, V89, P1, DOI 10.1016/j.cortex.2017.01.007; Foley Center for the Study of Lives, 1999, COD NARR ACC AUT SCE; Goddard L, 1997, BRIT J CLIN PSYCHOL, V36, P449, DOI 10.1111/j.2044-8260.1997.tb01252.x; Godefroy O., 2008, FONCTIONS EXECUTIVES; Habermas T., 2014, OXFORD HDB IDENTITY; Jenkins K., 2010, SOCIAL CARE NEURODIS, V1, P14, DOI 10.5042/scn.2010.0429; Knight RG, 2009, J CLIN EXP NEUROPSYC, V31, P575, DOI 10.1080/13803390802363710; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Lardi C, 2010, MEMORY, V18, P293, DOI 10.1080/09658211003601522; Levack WMM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004630; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Lilgendahl JP, 2011, J PERS, V79, P391, DOI 10.1111/j.1467-6494.2010.00688.x; McAdams, 2001, REV GEN PSYCHOL, V5, P100, DOI [DOI 10.1037/1089-2680.5.2.100, 10.1037/1089-2680.5.2.100]; McAdams DP, 2001, PERS SOC PSYCHOL B, V27, P474, DOI 10.1177/0146167201274008; McKay C., 2012, PHENOMENOLOGICAL NEU; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; MOFFITT KH, 1994, J ABNORM PSYCHOL, V103, P581, DOI 10.1037/0021-843X.103.3.581; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; O'Rourke N, 2017, MEMORY, V25, P403, DOI 10.1080/09658211.2016.1179331; Ownsworth T., 2014, SELF IDENTITY BRAIN; Ownsworth T, 2016, NEUROPSYCHOL REHABIL, V26, P1, DOI 10.1080/09602011.2014.977924; Pasupathi M, 2007, HUM DEV, V50, P85, DOI 10.1159/000100939; Pasupathi M, 2006, DEV PSYCHOL, V42, P798, DOI 10.1037/0012-1649.42.5.798; Pillemer D.B., 2001, REV GEN PSYCHOL, V5, P123, DOI [10.1037/1089-2680.5.2.123, DOI 10.1037/1089-2680.5.2.123]; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; Rasmussen KW, 2018, J NEUROPSYCHOL, V12, P78, DOI 10.1111/jnp.12108; Rasmussen KW, 2014, J NEUROPSYCHOL, V8, P34, DOI 10.1111/jnp.12003; Reitan R., 1979, MANUAL ADM NEUROPSYC; Rochat L, 2013, J INT NEUROPSYCH SOC, V19, P890, DOI 10.1017/S1355617713000672; Roddy C, 2020, NEUROPSYCHOL REHABIL, V30, P166, DOI 10.1080/09602011.2018.1448288; Singer FJ, 2004, AFTER THE FIRES, P117; Singer J. A., 1993, REMEMBERED SELF EMOT; Singer J. A., 1992, IMAGINATION COGNITIO, V11, P233, DOI [10.2190/72A3-8UPY-GDB9-GX9K, DOI 10.2190/72A3-8UPY-GDB9-GX9K]; Singer JeffersonA., 2000, CLASSIFICATION SYSTE; Sutin AR, 2005, J PERS, V73, P793, DOI 10.1111/j.1467-6494.2005.00329.x; Thorne A, 2004, J PERS, V72, P513, DOI 10.1111/j.0022-3506.2004.00271.x; Thorne A., 2001, MANUAL CODING EVENTS; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Wechsler, 1997, WECHSLER ADULT INTEL; Werner-Seidler A, 2018, BEHAV RES THER, V105, P1, DOI 10.1016/j.brat.2018.03.004; Wright DB, 1998, APPL COGNITIVE PSYCH, V12, P339; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	56	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.	MAR	2021	15	1					112	128		10.1111/jnp.12212		JUN 2020	17	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	RC7VI	WOS:000538883400001	32515900				2022-02-06	
J	Saadi, R; Brandt, K; Madlinger, R; Nerenberg, SF				Saadi, Raghad; Brandt, Kimberly; Madlinger, Robert; Nerenberg, Steven F.			Assessment of the Use of Pharmacologic Venous Thromboembolism Prophylaxis in Post-Traumatic Brain Injury Patients	JOURNAL OF PHARMACY PRACTICE			English	Article						traumatic brain injury; venous thromboembolism; prophylaxis; intracranial hemorrhage; trauma	TRAUMA PATIENTS; THROMBOSIS; GUIDELINES; MANAGEMENT; PREDICTORS; MORTALITY; SCORE	Background: Traumatic brain injury (TBI) is an independent risk factor for venous thromboembolism (VTE). Prophylaxis (PPX) beyond 48 hours increases VTE risk 3- to 4-fold. Pharmacologic VTE PPX initiation is controversial due to potential bleeding complications. Objective: To evaluate VTE PPX in patients with TBI for practice variation, efficacy, and safety. Methods: Retrospective review from January 2013 to September 2016 in adults admitted to the intensive care unit with moderate to severe TBI. Demographics, time to stable computerized tomography scan, time to PPX initiation, PPX regimen, and incidences of VTE and adverse effects were collected. Data were analyzed via descriptive statistics, analysis of variance, and linear regression models. Results: Of 96 patients included, 14.6% did not receive VTE PPX (G1), 7.3% initiated therapy within 0 to 24 hours (G2), 14.6% after 24 to 48 hours (G3), and 63.5% after 48 hours (G4). VTE occurred in 0% of G1 and G2, 28.6% of G3, and 8.2% of G4 patients (P = .038). Of 9 VTE cases, 8 received medical and 1 received trauma PPX dosing (P = .44). There were 3 major bleeds (P = .79) and 19 minor bleeds (P = .042). Of 14 fatalities, 42.9% were in G1, 0% in G2, 14.2% in G3, and 42.9% in G4 (P = .009). Conclusion: The majority of patients received delayed PPX, with no correlation between VTE incidence and PPX regimen. There was a significant difference in VTE incidence stratified by time to PPX. Further studies are required to determine optimal timing of PPX. Higher mortality rate was correlated with the lack of PPX. Increased minor bleeds occurred with earlier PPX initiation.	[Saadi, Raghad] Atlantic Hlth Syst, Morristown Med Ctr, 100 Madison Ave, Morristown, NJ 07960 USA; [Brandt, Kimberly] Jewish Hosp Mercy Hlth, Cincinnati, OH USA; [Madlinger, Robert; Nerenberg, Steven F.] St Josephs Univ, Med Ctr, Paterson, NJ USA; [Nerenberg, Steven F.] Rutgers State Univ, Ernest Mario Sch Pharm, Piscataway, NJ USA		Saadi, R (corresponding author), Atlantic Hlth Syst, Morristown Med Ctr, 100 Madison Ave, Morristown, NJ 07960 USA.	raghad.saadi@outlook.com		Saadi, Raghad/0000-0003-4353-3942			Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Gearhart MM, 2000, SURGERY, V128, P631, DOI 10.1067/msy.2000.108224; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Jamjoom AAB, 2016, BRIT J NEUROSURG, V30, P240, DOI 10.3109/02688697.2016.1161170; Kuhls DA, 2002, J AM COLL SURGEONS, V194, P695, DOI 10.1016/S1072-7515(02)01211-5; MacLeod JBA, 2004, AM SURGEON, V70, P805; Galan LAM, 2016, J TRAUMA ACUTE CARE, V81, P567, DOI 10.1097/TA.0000000000001134; Mohseni Shahin, 2012, J Emerg Trauma Shock, V5, P11, DOI 10.4103/0974-2700.93102; Nathens AB, 2007, J TRAUMA, V62, P557, DOI 10.1097/TA.0b013e318031b5f5; Nyquist P, 2016, NEUROCRIT CARE, V24, P47, DOI 10.1007/s12028-015-0221-y; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Strollo BP, 2018, J CRIT CARE, V43, P75, DOI 10.1016/j.jcrc.2017.08.012	18	1	1	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0897-1900	1531-1937		J PHARM PRACT	J. Pharm. Pract.	DEC	2021	34	6					864	869	0897190020929811	10.1177/0897190020929811		JUN 2020	6	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	XG8JM	WOS:000539076800001	32508232				2022-02-06	
J	Hausted, HS; Nielsen, JF; Odgaard, L				Siig Hausted, Hanna; Nielsen, Jorgen F.; Odgaard, Lene			Epilepsy after severe traumatic brain injury: frequency and injury severity	BRAIN INJURY			English	Article						Epilepsy; posttraumatic epilepsy; traumatic brain injury; seizures; anticonvulsants	LATE POSTTRAUMATIC SEIZURES; RISK-FACTORS; EPIDEMIOLOGY; REHABILITATION; PREDICTORS; DURATION; PEOPLE; MODELS; ADULTS; SCALE	Objective: To estimate national frequency of posttraumatic epilepsy (PTE) after severe traumatic brain injury (TBI) and assess injury severity (Glasgow Coma Scale (GCS) and posttraumatic amnesia (PTA)) as prognostic factors for PTE. Methods Data on patients >= 18 years surviving severe TBI 2004-2016 were retrieved from the Danish Head Trauma Database (n = 1010). The cumulative incidence proportion (CIP) was estimated using death as competing event. The association between injury severity and PTE was assessed using multivariable competing risk regressions. Results CIP of PTE 28 days and one year post-TBI was 6.8% (95% confidence interval (CI) 5.4-8.5) and 18.5% (95% CI 16.1-21.1%), respectively. Injury severity was not associated with PTE within 28 days post-TBI but indicated higher PTE-rates in less severely injured patients. PTA-duration >70 days was associated with PTE 29-365 days post-TBI (Adjusted sub-hazard ratio 4.23 (95% CI 1.79-9.99)). GCS was not associated with PTE 29-365 days post-TBI. Conclusion The PTE frequency was higher compared to previous estimates. Increasing injury severity was associated with PTE 29-365 days post-TBI when measured with PTA, but not with GCS. Though nonsignificant, the increased PTE-risk within 28 days in lower severity suggests an underdiagnosing of PTE.	Aarhus Univ, Hammel Neurorehabil Ctr, Aarhus, Denmark; Aarhus Univ, Univ Res Clin, Aarhus, Denmark		Hausted, HS (corresponding author), Voldbyvej 15A, DK-8450 Hammel, Denmark.	hannasiighausted@gmail.com	Nielsen, Jorgen Feldbak/AAR-6384-2021	Nielsen, Jorgen Feldbak/0000-0001-5339-171X; Siig Hausted, Hanna/0000-0001-7307-4957; Odgaard, Lene/0000-0002-9830-3282			Achterberg TJ, 2009, J OCCUP REHABIL, V19, P129, DOI 10.1007/s10926-009-9169-0; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Brown JWL, 2015, J NEUROL NEUROSUR PS, V86, P60, DOI 10.1136/jnnp-2013-307529; Christensen J, 2015, SEMIN NEUROL, V35, P218, DOI 10.1055/s-0035-1552923; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Engberg AW, 2007, J HEAD TRAUMA REHAB, V22, P221, DOI 10.1097/01.HTR.0000281837.62226.54; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Fabricius M, 2014, DAN MED J, V176; Fisher Robert S, 2018, Neurodiagn J, V58, P1, DOI 10.1080/21646821.2018.1428455; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gaitatzis A, 2004, BRAIN, V127, P2427, DOI 10.1093/brain/awh267; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Hart T, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000210; Hart T, 2014, ARCH PHYS MED REHAB, V95, P2103, DOI 10.1016/j.apmr.2014.07.001; Hocker Sara E, 2015, Continuum (Minneap Minn), V21, P1362, DOI 10.1212/CON.0000000000000225; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Malmgren K, 2018, LAKARTIDNINGEN, V115; MATTSON RH, 1992, NEW ENGL J MED, V327, P765, DOI 10.1056/NEJM199209103271104; Mazzini L, 2003, EPILEPSIA, V44, P569, DOI 10.1046/j.1528-1157.2003.34902.x; McKay A, 2020, NEUROPSYCHOL REHABIL, V30, P579, DOI 10.1080/09602011.2018.1479276; Messori A, 2005, EPILEPSIA, V46, P1472, DOI 10.1111/j.1528-1167.2005.34004.x; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Odgaard L, 2015, CLIN EPIDEMIOL, V7, P225, DOI 10.2147/CLEP.S78141; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; PohlmannEden B, 1997, ACTA NEUROL SCAND, V95, P257, DOI 10.1111/j.1600-0404.1997.tb00206.x; Ritter AC, 2016, EPILEPSIA, V57, P1968, DOI 10.1111/epi.13582; Ritter AC, 2016, EPILEPSIA, V57, P1503, DOI 10.1111/epi.13470; Shih JJ, 2017, EPILEPSY BEHAV, V69, P186, DOI 10.1016/j.yebeh.2016.11.018; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Xu T, 2017, EPILEPSY BEHAV, V67, P1, DOI 10.1016/j.yebeh.2016.10.026; Zhao YQ, 2012, SEIZURE-EUR J EPILEP, V21, P322, DOI 10.1016/j.seizure.2012.02.007	36	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 6	2020	34	7					889	894		10.1080/02699052.2020.1763467		JUN 2020	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MI1BE	WOS:000543967100001	32506958				2022-02-06	
J	Stenberg, M; Stalnacke, BM; Saveman, BI				Stenberg, Maud; Stalnacke, Britt-Marie; Saveman, Britt-Inger			Family experiences up to seven years after a severe traumatic brain injury-family interviews	DISABILITY AND REHABILITATION			English	Article; Early Access						Severe traumatic brain injury; long-term perspective; family interviews	QUALITATIVE CONTENT-ANALYSIS; CLOSE RELATIVES; 1ST YEAR; PERSPECTIVES; CAREGIVERS; CARE; STRESS; PEOPLE; CONSCIOUSNESS; TRANSITION	Purpose:To explore the experiences of being a family with one member suffering from severe traumatic brain injury (STBI) up to 7 years earlier through narrative family interviews. Methods:There are few studies where a family as a unit, including persons with STBI, are interviewed together. This study used a family systems research approach following a qualitative interpretative design. Therefore, 21 families with a total of 47 family members were interviewed. Qualitative content analysis was used to reveal categories with sub-categories and a theme. Results:"From surviving STBI towards stability, through the unknown, into a new everyday life and a new future as a family" characterized the implicit message. The results revealed two categories both with three subcategories. The first category characterized the rapid change from a normal everyday life to one of uncertainty and finally to one of stability, and the second category described how it is to adapt as a family after STBI. Conclusions:Long-term experiences of STBI show the importance for the whole family of belonging to a context, having a job, and having something to belong to as a way to achieve stability. Families` feelings of loneliness and lack of treatment and support are challenges for professionals when trying to involve families in care and rehabilitation.	[Stenberg, Maud; Stalnacke, Britt-Marie] Umea Univ, Rehabil Med, Dept Community Med & Rehabil, Umea, Sweden; [Saveman, Britt-Inger] Umea Univ, Dept Nursing, Umea, Sweden		Stenberg, M (corresponding author), Umea Univ, Rehabil Med, Dept Community Med & Rehabil, Umea, Sweden.	maud.stenberg@rehabmed.umu.se	Stenberg, Maud/AAX-4366-2021	Saveman, Britt-Inger/0000-0003-3716-6445	Vasterbotten County Council; Swedish Association for Survivors of Polio, Accident and Injury; Swedish Brain Foundation	This work was supported by the Vasterbotten County Council, the Swedish Association for Survivors of Polio, Accident and Injury and the Swedish Brain Foundation.	Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; Anke A, 2020, BRAIN INJURY, V34, P89, DOI 10.1080/02699052.2019.1682191; Benzein EG, 2008, NURS INQ, V15, P106, DOI 10.1111/j.1440-1800.2008.00401.x; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Chronister J, 2016, REHABIL COUNS BULL, V59, P235, DOI 10.1177/0034355215601072; D'Cruz K, 2019, NEUROPSYCHOL REHABIL, V29, P985, DOI 10.1080/09602011.2017.1361844; DeBoussard CN, 2017, CLIN REHABIL, V31, P555, DOI 10.1177/0269215516652184; Denzin N.K., 2011, SAGE HDB QUALITATIVE; Doser K, 2016, BRAIN INJURY, V30, P334, DOI 10.3109/02699052.2015.1114143; Douglas J, 2020, NEUROPSYCHOL REHABIL, V30, P1277, DOI 10.1080/09602011.2019.1574589; Driver S, 2019, BRAIN INJURY, V33, P1299, DOI 10.1080/02699052.2019.1641623; Engstroem A, 2007, J ADV NURS, V59, P569, DOI 10.1111/j.1365-2648.2007.04336.x; Engstrom A, 2011, J NEUROSCI NURS, V43, P253, DOI 10.1097/JNN.0b013e318227ef9b; Godbolt AK, 2015, J HEAD TRAUMA REHAB, V30, pE41, DOI 10.1097/HTR.0000000000000050; Godbolt AK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007208; Godbolt AK, 2013, J REHABIL MED, V45, P741, DOI 10.2340/16501977-1167; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Graneheim UH, 2017, NURS EDUC TODAY, V56, P29, DOI 10.1016/j.nedt.2017.06.002; Greeff A., 2008, ACATA ACAD, V40, P78; Inzaghi M G, 2005, Eura Medicophys, V41, P265; Jourdan C, 2018, AM J PHYS MED REHAB, V97, P323, DOI 10.1097/PHM.0000000000000848; Jumisko E, 2007, DISABIL REHABIL, V29, P1535, DOI 10.1080/09638280601055816; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Kieffer-Kristensen R, 2011, BRAIN INJURY, V25, P752, DOI 10.3109/02699052.2011.579933; King G, 2021, DISABIL REHABIL, V43, P3102, DOI 10.1080/09638288.2020.1725158; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Kreitzer N, 2020, J HEAD TRAUMA REHAB, V35, pE299, DOI 10.1097/HTR.0000000000000525; Kynoch Kate, 2016, JBI Database System Rev Implement Rep, V14, P181, DOI 10.11124/JBISRIR-2016-2477; Lam Pikka, 2004, J Neurosci Nurs, V36, P142; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Manskow US, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3773-7; Manskow US, 2017, NEUROREHABILITATION, V40, P211, DOI 10.3233/NRE-161406; MCCUBBIN MA, 1993, NURSING OF FAMILIES, P46; Minnes P, 2000, BRAIN INJURY, V14, P737; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Ostlund U, 2014, J FAM NURS, V20, P259, DOI 10.1177/1074840714542962; PATTERSON JM, 1994, FAM PROCESS, V33, P287, DOI 10.1111/j.1545-5300.1994.00287.x; Pavlovic D, 2019, PITUITARY, V22, P270, DOI 10.1007/s11102-019-00957-9; Pedersen K, 2015, NEUROEPIDEMIOLOGY, V45, P20, DOI 10.1159/000381780; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Ptyushkin P, 2010, BRAIN INJURY, V24, P1519, DOI 10.3109/02699052.2010.523054; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Sieh DS, 2013, J CHILD FAM STUD, V22, P209, DOI 10.1007/s10826-012-9570-8; Soderstrom Ing-Mari K, 2009, Intensive Crit Care Nurs, V25, P250, DOI 10.1016/j.iccn.2009.06.006; Stenberg M, 2017, BRAIN INJURY, V31, P351, DOI 10.1080/02699052.2016.1261303; Stenberg M, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/680308; Stenberg M, 2013, J REHABIL MED, V45, P792, DOI 10.2340/16501977-1200; Strandberg T, 2006, VUXNA MED FORVARVAD; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; TEASDALE G, 1974, LANCET, V2, P81; Townshend J, 2018, FAM J, V26, P77, DOI 10.1177/1066480717752905; WHALL AL, 1986, PUBLIC HEALTH NURS, V3, P240, DOI 10.1111/j.1525-1446.1986.tb00495.x; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whiffin CJ, 2019, NEUROPSYCHOL REHABIL, V29, P1256, DOI 10.1080/09602011.2017.1387577; Whiffin CJ, 2015, J ADV NURS, V71, P849, DOI 10.1111/jan.12551; Wright D, 2013, WOR BANK STUD, P5	58	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2020.1774668		JUN 2020	9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	ME8MP	WOS:000544907700001	32520596	Green Published, hybrid			2022-02-06	
J	Brooks, BL; Virani, S; Khetani, A; Carlson, H; Jadavji, Z; Mauthner, M; Low, TA; Plourde, V; MacMaster, FP; Bray, S; Harris, AD; Lebel, C; Lebel, RM; Esser, MJ; Yeates, KO; Barlow, KM				Brooks, Brian L.; Virani, Shane; Khetani, Aneesh; Carlson, Helen; Jadavji, Zeanna; Mauthner, Micaela; Low, Trevor A.; Plourde, Vickie; MacMaster, Frank P.; Bray, Signe; Harris, Ashley D.; Lebel, Catherine; Lebel, R. Marc; Esser, Michael J.; Yeates, Keith Owen; Barlow, Karen M.			Functional magnetic resonance imaging study of working memory several years after pediatric concussion	BRAIN INJURY			English	Article						Brain injury; children; adolescent; chronic; mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; MULTIPLE PAST CONCUSSIONS; SELF-REPORTED CONCUSSIONS; SPORTS-RELATED CONCUSSION; EMERGENCY-DEPARTMENT; POSTCONCUSSIVE SYMPTOMS; RISK-FACTORS; CHILDREN; HISTORY; ADOLESCENTS	Primary objective: The neurophysiological effects of pediatric concussion several years after injury remain inadequately characterized. The objective of this study was to determine if a history of concussion was associated with BOLD response differences during an n-back working memory task in youth. Research Design: Observational, cross-sectional. Methods and Procedures: Participants include 52 children and adolescents (M = 15.1 years, 95%CI = 14.4-15.8, range = 9-19) with past concussion (n = 33) or orthopedic injury (OI; n = 19). Mean time since injury was 2.5 years (95%CI = 2.0-3.0). Measures included postconcussion symptom ratings, neuropsychological testing, and blood-oxygen-dependent-level (BOLD) functional magnetic resonance imaging (fMRI) during an n-back working memory task. Main Outcomes and Results: Groups did not differ on accuracy or speed during the three n-back conditions. They also did not differ in BOLD signal change for the 1- vs. 0-back or 2- vs. 0-back contrasts (controlling for task performance). Conclusions: This study does not support group differences in BOLD response during an n-back working memory task in youth who are on average 2.5 years post-concussion. The findings are encouraging from the perspective of understanding recovery after pediatric concussion.	[Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Program, Calgary, AB, Canada; [Brooks, Brian L.; Carlson, Helen; Jadavji, Zeanna; MacMaster, Frank P.; Bray, Signe; Harris, Ashley D.; Lebel, Catherine; Lebel, R. Marc; Esser, Michael J.; Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Brooks, Brian L.; MacMaster, Frank P.; Yeates, Keith Owen; Barlow, Karen M.] Univ Calgary, Dept Paediat, Calgary, AB, Canada; [Brooks, Brian L.; Yeates, Keith Owen; Barlow, Karen M.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.; Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Virani, Shane] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Virani, Shane] Alberta Childrens Hosp Res Inst, Vi Riddell Pain & Rehabil Program, Calgary, AB, Canada; [Khetani, Aneesh; Jadavji, Zeanna; Mauthner, Micaela; Low, Trevor A.] Univ Calgary, Dept Neurosci, Calgary, AB, Canada; [Carlson, Helen; Esser, Michael J.] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Carlson, Helen; Bray, Signe; Lebel, Catherine; Esser, Michael J.; Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Plourde, Vickie] Univ Moncton, Fac Sci Sante & Serv Communautaires, Ecole Psychol, Monton, NB, Canada; [Plourde, Vickie] Univ Alberta, Fac St Jean, Edmonton, AB, Canada; [MacMaster, Frank P.] Univ Calgary, Dept Psychiat, Calgary, AB, Canada; [MacMaster, Frank P.] Hotchkiss Brain Inst, Mathison Ctr Mental Hlth Res & Educ, Calgary, AB, Canada; [MacMaster, Frank P.] Alberta Hlth Serv, Strateg Clin Network Addict & Mental Hlth, Edmonton, AB, Canada; [Harris, Ashley D.; Lebel, Catherine; Lebel, R. Marc] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Lebel, R. Marc] Univ Calgary, Dept Biomed Engn, Calgary, AB, Canada; [Lebel, R. Marc] GE Healthcare, MR Applicat & Workflow, Calgary, AB, Canada; [Barlow, Karen M.] Univ Queensland, Fac Med, Brisbane, Qld, Australia		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, 28 Oki Dr NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@ahs.ca	Yeates, Keith/AAJ-4223-2020; Barlow, Karen/C-1323-2014	Barlow, Karen/0000-0003-2612-8507; Plourde, Vickie/0000-0002-0098-5431; MacMaster, Frank/0000-0002-7159-7583; Low, Trevor/0000-0002-8564-845X	Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR) Funding Source: Medline		Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-271; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00055; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bijur PE, 1996, J DEV BEHAV PEDIATR, V17, P143, DOI 10.1097/00004703-199606000-00001; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Brooks BL, 2018, AM J SPORTS MED, V46, P1; Brooks BL, 2019, BRAIN INJURY, V33, P233, DOI 10.1080/02699052.2018.1540798; Brooks BL, 2016, AM J SPORT MED, V44, P3243, DOI 10.1177/0363546516655095; Brooks BL, 2016, J INT NEUROPSYCH SOC, V22, P379, DOI 10.1017/S1355617715001368; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Brooks BL, 2014, J HEAD TRAUMA REHAB, V29, P257, DOI 10.1097/HTR.0000000000000016; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Brooks BL, 2012, J CHILD NEUROL, V27, P982, DOI 10.1177/0883073811430863; Brooks BL, 2011, J CHILD NEUROL, V26, P786, DOI 10.1177/0883073810391532; Brooks BL, 2010, APPL NEUROPSYCHOL, V17, P37, DOI 10.1080/09084280903526083; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chamard E, 2018, BRAIN INJURY, V32, P816, DOI 10.1080/02699052.2018.1463106; CNS Vital Signs, 2014, CNS VIT SIGNS TEST I; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Elbin RJ, 2012, BRAIN INJURY, V26, P1217, DOI 10.3109/02699052.2012.672788; Filippi CG, 2016, J PEDIATR NEURORADIO, V5, P32, DOI 10.1055/s-0036-1584416; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hammeke TA, 2013, J INT NEUROPSYCH SOC, V19, P863, DOI 10.1017/S1355617713000702; Haring RS, 2015, BRAIN INJURY, V29, P989, DOI 10.3109/02699052.2015.1033014; Henry LC, 2017, NEUROSCIENTIST, V23, P567, DOI 10.1177/1073858416651034; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hockey A, 2004, INTELLIGENCE, V32, P591, DOI 10.1016/j.intell.2004.07.009; Honce JM, 2016, PHYS MED REH CLIN N, V27, P411, DOI 10.1016/j.pmr.2016.01.002; IBM Corp, 2016, IBM SPSS STAT WIND V; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/316575; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Khetani A, 2019, J NEUROTRAUM, V36, P3274, DOI 10.1089/neu.2018.6117; Krivitzky LS, 2011, J INT NEUROPSYCH SOC, V17, P1143, DOI 10.1017/S1355617711001226; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McKay C, 2012, CLIN J SPORT MED, V22, P307; Mckay C, 2013, CLIN J SPORT MED, V23, P216, DOI 10.1097/JSM.0b013e31826a86c9; McKinlay A, 2018, J CLIN EXP NEUROPSYC, V40, P285, DOI 10.1080/13803395.2017.1342771; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Plourde V, 2018, ARCH CLIN NEUROPSYCH, V33, P247, DOI 10.1093/arclin/acx067; Plourde V, 2017, J INT NEUROPSYCH SOC, V23, P304, DOI 10.1017/S1355617717000066; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Schmidt J, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3406; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Talavage TM, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00273; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Thornton AE, 2008, J CLIN EXP NEUROPSYC, V30, P398, DOI 10.1080/13803390701443662; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tsushima WT, 2016, APPL NEUROPSYCH-CHIL, V5, P9, DOI 10.1080/21622965.2014.902762; Tsushima WT, 2013, APPL NEUROPSYCH-CHIL, V2, P13, DOI 10.1080/09084282.2011.643967; Vincent, 2008, J INT NEUROPSYCH SOC, V1, P204; Westfall DR, 2015, J PEDIATR REHAB MED, V8, P297, DOI 10.3233/PRM-150348; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Yang Z, 2012, J NEUROTRAUM, V29, P2124, DOI 10.1089/neu.2012.2395; Yue JK, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15612	89	1	1	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 6	2020	34	7					895	904		10.1080/02699052.2020.1753240			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MI1BE	WOS:000547150000007	32396403				2022-02-06	
J	Alkashkari, W; Albugami, S; Al-Husayni, F; AlRahimi, J; Althobaiti, M				Alkashkari, Wail; Albugami, Saad; Al-Husayni, Faisal; AlRahimi, Jamilah; Althobaiti, Mohammed			Percutaneous Intervention With Balloon-Expandable Covered Stent for the Treatment of Traumatic Aortic Pseudoaneurysm in a Paediatric Patient	CUREUS			English	Article						injury; aortic trauma; aortic surgery; endograft; aortic stenting; motor vehicle accident; aortic diseases; aortic pseudoaneurysm	IMPLANTATION	In this report, we describe the case of a 13-year-old male who presented to our hospital after sustaining injuries from a motor vehicle accident (MVA). A full-body CT scan revealed multiple injuries, including subgaleal hematoma, hemorrhagic brain contusion, moderate-size aortic pseudoaneurysm with associated mediastinal hematoma, and multiple stable visceral organ lacerations. Additionally, there were numerous fractures, including in the right femur associated with large hematoma. The patient was deemed at high risk for systemic anticoagulation required for an urgent operative aortic repair. Available percutaneous endograft sizes were deemed too large for his descending aortic diameter, and the associated potential risk of vessel injury from the large sheath required to implant the endograft removed this option from consideration. The decision was made to use a balloon-expandable covered stent, which is routinely used to treat coarctation of the aorta (CoA) as a life-saving alternative. A BeGraft aortic stent (Bentley InnoMed, Hechingen, Germany) measuring 16x38 mm was successfully implanted percutaneously with complete exclusion of the pseudoaneurysm without any procedural complications.	[Alkashkari, Wail; Albugami, Saad; AlRahimi, Jamilah] Minist Natl Guard Hlth Affairs, King Abdulaziz Med City, King Faisal Cardiac Ctr, Cardiol, Jeddah, Saudi Arabia; [Alkashkari, Wail; Albugami, Saad; AlRahimi, Jamilah] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Cardiol, Jeddah, Saudi Arabia; [Al-Husayni, Faisal] King Abdul Aziz Med City, Natl Guard Hosp, Internal Med, Jeddah, Saudi Arabia; [Althobaiti, Mohammed] Minist Natl Guard Hlth Affairs, King Abdulaziz Med City, Radiol, Jeddah, Saudi Arabia; [Althobaiti, Mohammed] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Radiol, Jeddah, Saudi Arabia		Alkashkari, W (corresponding author), Minist Natl Guard Hlth Affairs, King Abdulaziz Med City, King Faisal Cardiac Ctr, Cardiol, Jeddah, Saudi Arabia.; Alkashkari, W (corresponding author), King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Cardiol, Jeddah, Saudi Arabia.	wakash73@hotmail.com		Al-Husayni, Faisal/0000-0002-3213-9125			Alkashkari W, 2020, J CLIN TRIALS, V10, P402, DOI DOI 10.35248/2167-0870.20.10.402; Alkashkari W, 2019, KOREAN CIRC J, V49, P298, DOI 10.4070/kcj.2018.0433; Goldstein BH, 2012, AM J CARDIOL, V110, P1541, DOI 10.1016/j.amjcard.2012.06.063; Heal ME, 2016, J THORAC CARDIOV SUR, V152, pE109, DOI 10.1016/j.jtcvs.2016.07.022; Martin Mark Alan, 2009, J Trauma, V67, pE136, DOI 10.1097/TA.0b013e3181469b66; Neschis DG, 2007, J VASC SURG, V45, P487, DOI 10.1016/j.jvs.2006.11.038; Rahimi SA, 2010, J VASC SURG, V52, P891, DOI 10.1016/j.jvs.2010.05.014	7	1	1	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUN 5	2020	12	6							e8453	10.7759/cureus.8453			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	LV3WR	WOS:000538370300005	32523859	gold, Green Published			2022-02-06	
J	Proessl, F; Dretsch, MN; Connaboy, C; Lovalekar, M; Dunn-Lewis, C; Canino, MC; Sterczala, AJ; Deshpande, G; Katz, JS; Denney, TS; Flanagan, SD				Proessl, Felix; Dretsch, Michael N.; Connaboy, Chris; Lovalekar, Mita; Dunn-Lewis, Courtenay; Canino, Maria C.; Sterczala, Adam J.; Deshpande, Gopikrishna; Katz, Jeffrey S.; Denney, Thomas S., Jr.; Flanagan, Shawn D.			Structural Connectome Disruptions in Military Personnel with Mild Traumatic Brain Injury and Post-Traumatic Stress Disorder	JOURNAL OF NEUROTRAUMA			English	Article						covariance network; graph theory; military service members; mTBI; PTSD	CORTICAL THICKNESS; FUNCTIONAL CONNECTIVITY; PREFRONTAL CORTEX; COGNITIVE IMPAIRMENT; ORBITOFRONTAL CORTEX; NETWORK TOPOLOGY; VETERANS; DISEASE; PTSD; ORGANIZATION	Mild traumatic brain injury (mTBI) and post-traumatic stress disorder (PTSD) are common in military populations and share numerous symptoms. Functional graph theory studies demonstrate altered small-world brain networks in mTBI and PTSD, but little is known about structural covariance networks or the potentially distinct topology of mTBI-PTSD comorbidity. The purpose of this study was to compare brain structural covariance networks in healthy active duty military service members (CON) to those with PTSD, mTBI, and mTBI-PTSD. Seventy-six service members (31 CON, 14 PTSD, 12 mTBI, 19 mTBI-PTSD) completed clinical questionnaires and structural magnetic resonance imaging scans. Cortical thickness-derived adjacency matrices were used to determine structural covariance network topologies. Pairwise comparisons for characteristic path length, clustering coefficient, modularity (global), closeness centrality (nodal), and local efficiency were made across a range of network densities (5-35%) using non-parametric permutation tests. All clinical groups showed greater levels of arousal, stress, anxiety, and depression compared with CON. Global network analysis revealed greater clustering and local efficiency in PTSD compared with CON, whereas nodal analysis indicated altered path lengths and closeness centrality in fronto-limbic areas with mTBI-PTSD. Global and nodal graph outcomes suggest distinct pathophysiological manifestations of mTBI, PTSD, and mTBI-PTSD in structural brain networks. Greater network segregation and nodal differences in fronto-limbic areas may be tied to emotional fluctuations.	[Proessl, Felix; Connaboy, Chris; Lovalekar, Mita; Dunn-Lewis, Courtenay; Canino, Maria C.; Sterczala, Adam J.; Flanagan, Shawn D.] Univ Pittsburgh, Dept Sports Med & Nutr, Pittsburgh, PA 15203 USA; [Dretsch, Michael N.] US Army Med Res Directorate West, Walter Reed Army Inst Res, Joint Base Lewis McChord, Washington, DC USA; [Dretsch, Michael N.] US Army Aeromed Res Lab, Ft Rucker, AL USA; [Dretsch, Michael N.; Deshpande, Gopikrishna; Katz, Jeffrey S.; Denney, Thomas S., Jr.] Auburn Univ, Dept Psychol Sci, Auburn, AL 36849 USA; [Deshpande, Gopikrishna; Katz, Jeffrey S.; Denney, Thomas S., Jr.] Auburn Univ, Dept Elect & Comp Engn, Auburn, AL 36849 USA; [Deshpande, Gopikrishna; Katz, Jeffrey S.; Denney, Thomas S., Jr.] Auburn Univ, Ctr Neurosci, Auburn, AL 36849 USA; [Deshpande, Gopikrishna; Katz, Jeffrey S.; Denney, Thomas S., Jr.] Alabama Adv Imaging Consortium, Auburn, AL USA; [Deshpande, Gopikrishna] Capital Normal Univ, Sch Psychol, Beijing, Peoples R China; [Deshpande, Gopikrishna] Capital Normal Univ, Key Lab Learning & Cognit, Beijing, Peoples R China; [Deshpande, Gopikrishna] Natl Inst Mental Hlth & Neurosci, Dept Psychiat, Bangalore, Karnataka, India		Flanagan, SD (corresponding author), Univ Pittsburgh, Neuromuscular Res Lab, Sch Hlth & Rehabil Sci, Dept Sports Med & Nutr, 3860 South Water St, Pittsburgh, PA 15203 USA.; Flanagan, SD (corresponding author), Univ Pittsburgh, Warrior Human Performance Res Ctr, Sch Hlth & Rehabil Sci, Dept Sports Med & Nutr, 3860 South Water St, Pittsburgh, PA 15203 USA.	sdf29@pitt.edu	Connaboy, Christopher/AAH-4514-2020; Flanagan, Shawn/AAC-6018-2021; Dunn-Lewis, Courtenay/G-8524-2017	Connaboy, Christopher/0000-0002-9031-2192; Flanagan, Shawn/0000-0002-6531-4567; Dunn-Lewis, Courtenay/0000-0002-2406-4215; Sterczala, Adam/0000-0002-0322-6836	U.S. Army Medical Research and Development Command (USAMRDC); Military Operational Medicine Research Program	This work was supported by the U.S. Army Medical Research and Development Command (USAMRDC) and Military Operational Medicine Research Program and was supported in part by an appointment to the Internship/Research Participation Program for the USAMRDC, administered by the Oak Ridge Institute for Science and Education (ORISE) through an agreement between the U.S. Department of Energy and the USAMRDC. Dr. Dretsch was the principal investigator (PI) of the study.	Akiki TJ, 2018, DATA BRIEF, V20, P1658, DOI 10.1016/j.dib.2018.08.198; Akiki TJ, 2018, NEUROIMAGE, V176, P489, DOI 10.1016/j.neuroimage.2018.05.005; Arnemann KL, 2015, NEUROLOGY, V84, P1568, DOI 10.1212/WNL.0000000000001476; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Bassett DS, 2017, NEUROSCIENTIST, V23, P499, DOI 10.1177/1073858416667720; Bassett DS, 2017, NAT NEUROSCI, V20, P353, DOI 10.1038/nn.4502; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buysse D J, 1989, Psychiatry Res, V28, P193; Cazalis Fabienne, 2011, Front Neurol, V1, P158, DOI 10.3389/fneur.2010.00158; Choi S, 2017, NEUROIMAGE-CLIN, V15, P239, DOI 10.1016/j.nicl.2017.04.023; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark AL, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00873; Dretsch MN, 2019, APPL NEUROPSYCH-ADUL, V26, P76, DOI 10.1080/23279095.2017.1362406; Dretsch MN, 2019, J EXP NEUROSCI, V13, DOI [10.1177/1179069519833966, 10.1177/1179069619833966]; Dretsch Michael N, 2017, Open Neuroimag J, V11, P46, DOI 10.2174/1874440001711010046; Drevets WC, 2007, ANN NY ACAD SCI, V1121, P499, DOI 10.1196/annals.1401.029; Eierued C, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101793; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Geuze E, 2008, NEUROIMAGE, V41, P675, DOI 10.1016/j.neuroimage.2008.03.007; Gong GL, 2012, NEUROIMAGE, V59, P1239, DOI 10.1016/j.neuroimage.2011.08.017; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Guyker WM, 2013, MIL MED, V178, P377, DOI 10.7205/MILMED-D-12-00223; Hallquist MN, 2018, NETW NEUROSCI, V3, P1, DOI 10.1162/netn_a_00054; Hamner M B, 1999, Depress Anxiety, V9, P1; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hayes JP, 2017, BRAIN, V140, P813, DOI 10.1093/brain/aww344; Hayes JP, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-9; Helpman L, 2016, DEPRESS ANXIETY, V33, P384, DOI 10.1002/da.22471; Hoge CW, 2014, LANCET PSYCHIAT, V1, P269, DOI 10.1016/S2215-0366(14)70235-4; Imms P, 2019, NEUROSCI BIOBEHAV R, V99, P128, DOI 10.1016/j.neubiorev.2019.01.002; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Joshi AA, 2005, LECT NOTES COMPUT SC, V3565, P186; Joshi AA, 2017, PROC SPIE, V10133, DOI 10.1117/12.2254681; Joshi Anand A, 2012, Biomed Image Regist Proc, V7359, P180, DOI 10.1007/978-3-642-31340-0_19; Lei D, 2015, RADIOLOGY, V276, P818, DOI 10.1148/radiol.15141700; Lindemer ER, 2013, NEUROIMAGE-CLIN, V2, P601, DOI 10.1016/j.nicl.2013.04.009; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039025; Lorensen W., 1987, COMPUT GRAPH, V87, P163, DOI [10.1145/37401.37422, 10.1145/37402.37422, DOI 10.1145/37402.37422]; Messe A, 2015, NEUROIMAGE, V111, P65, DOI 10.1016/j.neuroimage.2015.02.001; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Michael AP, 2015, J NEUROTRAUM, V32, P1751, DOI 10.1089/neu.2015.3918; Milad MR, 2007, ANN NY ACAD SCI, V1121, P546, DOI 10.1196/annals.1401.006; Paban V, 2018, BRAIN CONNECT, V8, P475, DOI 10.1089/brain.2018.0613; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Pereira JB, 2018, CEREB CORTEX, V28, P3638, DOI 10.1093/cercor/bhx236; Pereira JB, 2016, CEREB CORTEX, V26, P3476, DOI 10.1093/cercor/bhw128; Pereira JB, 2015, HUM BRAIN MAPP, V36, P2980, DOI 10.1002/hbm.22822; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Rangaprakash D, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00803; Rangaprakash D, 2018, HUM BRAIN MAPP, V39, P264, DOI 10.1002/hbm.23841; Rangaprakash D, 2017, HUM BRAIN MAPP, V38, P2843, DOI 10.1002/hbm.23551; Rowland JA, 2018, BRAIN CONNECT, V8, P205, DOI 10.1089/brain.2017.0556; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Shattuck DW, 2001, NEUROIMAGE, V13, P856, DOI 10.1006/nimg.2000.0730; Shattuck DW, 2001, IEEE T MED IMAGING, V20, P1167, DOI 10.1109/42.963819; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O., 2011, NETWORKS BRAIN; Sporns O, 2018, DIALOGUES CLIN NEURO, V20, P111; Sporns O, 2014, NAT NEUROSCI, V17, P652, DOI 10.1038/nn.3690; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Sun D, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00090; Sun DL, 2018, J PSYCHIATR RES, V98, P70, DOI 10.1016/j.jpsychires.2017.12.015; Tewarie P, 2015, NEUROIMAGE, V104, P177, DOI 10.1016/j.neuroimage.2014.10.015; Tewarie P, 2014, NEUROIMAGE, V97, P296, DOI 10.1016/j.neuroimage.2014.04.038; Thomaes K, 2013, SOC COGN AFFECT NEUR, V8, P190, DOI 10.1093/scan/nsr084; Tolan Ertan, 2018, Bioinformatics and Biomedical Engineering. 6th International Work-Conference, IWBBIO 2018. Proceedings: LNB 10813, P520, DOI 10.1007/978-3-319-78723-7_45; van den Heuvel MP, 2016, TRENDS COGN SCI, V20, P345, DOI 10.1016/j.tics.2016.03.001; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Vasterling JJ, 2012, J INT NEUROPSYCH SOC, V18, P390, DOI 10.1017/S1355617712000367; Verger A, 2018, HUM BRAIN MAPP, V39, P3178, DOI 10.1002/hbm.24068; Vermetten E, 2012, HAND CLINIC, V106, P291, DOI 10.1016/B978-0-444-52002-9.00018-8; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Westman E, 2013, BRAIN TOPOGR, V26, P9, DOI 10.1007/s10548-012-0246-x; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; Xu J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00709; Xu JL, 2016, J SLEEP RES, V25, P169, DOI 10.1111/jsr.12354; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	91	1	1	5	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2020	37	19					2102	2112		10.1089/neu.2020.6999		JUN 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	NV1ON	WOS:000539515300001	32340548				2022-02-06	
J	Forster, YM; Green, JL; Khatiwada, A; Liberato, JL; Reddy, PAN; Salvino, JM; Bienz, S; Bigler, L; dos Santos, WF; Fontana, ACK				Forster, Yvonne M.; Green, Jennifer Leigh; Khatiwada, Apeksha; Liberato, Jose Luiz; Reddy, Poli Adi Narayana; Salvino, Joseph M.; Bienz, Stefan; Bigler, Laurent; dos Santos, Wagner Ferreira; Fontana, Andreia Cristina Karklin			Elucidation of the Structure and Synthesis of Neuroprotective Low Molecular Mass Components of the Parawixia bistriata Spider Venom	ACS CHEMICAL NEUROSCIENCE			English	Article						Acylpolyamine; Parawixin10 (Pwx10); UHPLC; high-resolution MS; MS/MS; neurotransmitter; GABA; EAAT1; EAAT2; neuroprotection	TRAUMATIC BRAIN-INJURY; GLIAL GLUTAMATE TRANSPORTER; EXCITATORY AMINO-ACIDS; GABA UPTAKE INHIBITOR; CHEMICAL-CHARACTERIZATION; ANTIEPILEPTIC DRUGS; EAAT2 REGULATION; SPINAL-CORD; EXPRESSION; RECEPTOR	The South American social spider Parawixia bistriata produces a venom containing complex organic compounds with intriguing biological activities. The crude venom leads to paralysis in termites and stimulates L-glutamate uptake and inhibits GABA uptake in rat brain synaptosomes. Glutamate is the major neurotransmitter at the insect neuromuscular junction and at the mammalian central nervous system, suggesting a modulation of the glutamatergic system by the venom. Parawixin1, 2, and 10 (Pwx1, 2 and 10) are HPLC fractions that demonstrate this bioactivity. Pwx1 stimulates L-glutamate uptake through the main transporter in the brain, EAAT2, and is neuroprotective in in vivo glaucoma models. Pxw2 inhibits GABA and glycine uptake in synaptosomes and inhibits seizures and neurodegeneration, and Pwx10 increases L-glutamate uptake in synaptosomes and is neuroprotective and anticonvulsant, shown in in vivo epilepsy models. Herein, we investigated the low molecular mass compounds in this venom and have found over 20 small compounds and 36 unique acylpolyamines with and without amino acid linkers. The active substances in fractions Pwx1 and Pwx2 require further investigation. We elucidated and confirmed the structure of the active acylpolyamine in Pwx10. Both fraction Pwx10 and the synthesized component enhance the activity of transporters EAAT1 and EAAT2, and, importantly, offer in vitro neuroprotection against excitotoxicity in primary cultures. These data suggest that compounds with this mechanism could be developed into therapies for disorders in which L-glutamate excitotoxicity is involved.	[Liberato, Jose Luiz; dos Santos, Wagner Ferreira] Univ Sao Paulo, Dept Biol, BR-14040900 Ribeirao Preto, SP, Brazil; [Green, Jennifer Leigh; Khatiwada, Apeksha; Fontana, Andreia Cristina Karklin] Drexel Univ, Dept Pharmacol & Physiol, Coll Med, Philadelphia, PA 19102 USA; [Forster, Yvonne M.; Bienz, Stefan; Bigler, Laurent] Univ Zurich, Dept Chem, CH-8057 Zurich, Switzerland; [Reddy, Poli Adi Narayana; Salvino, Joseph M.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA		dos Santos, WF (corresponding author), Univ Sao Paulo, Dept Biol, BR-14040900 Ribeirao Preto, SP, Brazil.; Fontana, ACK (corresponding author), Drexel Univ, Dept Pharmacol & Physiol, Coll Med, Philadelphia, PA 19102 USA.	wagnerf@usp.br; acm83@drexel.edu	Mortensen, Andreia/AAR-2177-2020; Bigler, Laurent/AAP-3799-2020; dos Santos, Wagner Ferreira/D-9605-2012; POLI, ADI NARAYANA REDDY/ABH-2003-2020; LIBERATO, JOSE L./A-6222-2014; Bienz, Stefan/C-3785-2014	Mortensen, Andreia/0000-0002-4791-8746; Bigler, Laurent/0000-0003-3548-3594; dos Santos, Wagner Ferreira/0000-0002-9371-279X; LIBERATO, JOSE L./0000-0002-6538-8312; Bienz, Stefan/0000-0002-5262-6756; Poli, Adi Narayana Reddy/0000-0001-6288-9229	Sao Paulo State Research Foundation (FAPESP, Brazil)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/214192, 2005/60254-0]; Brazilian National Council for Scientific and Technological Development (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Coordination for the Improvement of Higher Education Personnel (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	This work was supported by Sao Paulo State Research Foundation (FAPESP, Brazil) (Grant Numbers 2014/214192 and 2005/60254-0 to W.F.S). Brazilian National Council for Scientific and Technological Development (CNPq) and Coordination for the Improvement of Higher Education Personnel (CAPES) sponsored J.L.L.	ADAMS ME, 1987, BIOCHEM BIOPH RES CO, V148, P678, DOI 10.1016/0006-291X(87)90930-2; Akyuz N, 2015, NATURE, V518, P68, DOI 10.1038/nature14158; Akyuz N, 2013, NATURE, V502, P114, DOI 10.1038/nature12265; Alam MA, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01510; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Beleboni RO, 2006, MOL PHARMACOL, V69, P1998, DOI 10.1124/mol.105.017319; Bjorn-Yoshimoto WE, 2016, NEUROCHEM INT, V98, P4, DOI 10.1016/j.neuint.2016.05.007; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; BUDD T, 1988, BRAIN RES, V448, P30, DOI 10.1016/0006-8993(88)91098-0; Canul-Tec JC, 2017, NATURE, V544, P446, DOI 10.1038/nature22064; Cesar LMM, 2005, TOXICON, V46, P786, DOI 10.1016/j.toxicon.2005.08.005; Cesar LMM, 2005, HELV CHIM ACTA, V88, P796, DOI 10.1002/hlca.200590056; CHAN TK, 1975, TOXICON, V13, P61, DOI 10.1016/0041-0101(75)90159-2; Chao XD, 2010, NEUROCHEM RES, V35, P1224, DOI 10.1007/s11064-010-0178-3; Chaudhry FA, 2002, J CELL BIOL, V157, P349, DOI 10.1083/jcb.200201070; Chernova T, 2007, J NEUROSCI, V27, P8475, DOI 10.1523/JNEUROSCI.0792-07.2007; Chi H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103082; Chu K, 2007, STROKE, V38, P177, DOI 10.1161/01.STR.0000252091.36912.65; Cioffi CL, 2016, CURR TOP MED CHEM, V16, P3404, DOI 10.2174/1568026616666160405113340; Cook A, 2010, J BIOL CHEM, V285, P10563, DOI 10.1074/jbc.M109.035477; Cook DR, 2011, J NEUROCHEM, V118, P1113, DOI 10.1111/j.1471-4159.2011.07383.x; COUTINHONETTO J, 1981, EPILEPSIA, V22, P289, DOI 10.1111/j.1528-1157.1981.tb04112.x; Cristina A, 2007, MOL PHARMACOL, V72, P1228, DOI 10.1124/mol.107.037127; Dalby NO, 2003, EUR J PHARMACOL, V479, P127, DOI 10.1016/j.ejphar.2003.08.063; Damgaard M, 2015, ACS CHEM NEUROSCI, V6, P1591, DOI 10.1021/acschemneuro.5b00150; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dunlop J, 2003, J NEUROSCI, V23, P1688; Eichenberger S., 2009, DEV HIGH RESOLUTION, DOI [10.5167/uzh-12787, DOI 10.5167/UZH-12787]; Estrada-Sanchez AM, 2012, BASAL GANGLIA, V2, P57, DOI 10.1016/j.baga.2012.04.029; Fachim HA, 2015, PHARMACOGN MAG, V11, P579, DOI 10.4103/0973-1296.160450; Fachim HA, 2011, EPILEPSY BEHAV, V22, P158, DOI 10.1016/j.yebeh.2011.05.008; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Falcucci RM, 2019, ACS CHEM NEUROSCI, V10, P3437, DOI 10.1021/acschemneuro.9b00061; Fontana ACK, 2003, BRIT J PHARMACOL, V139, P1297, DOI 10.1038/sj.bjp.0705352; Fontana ACK, 2000, TOXICON, V38, P133, DOI 10.1016/S0041-0101(99)00133-6; Fontana ACK, 2015, J NEUROCHEM, V134, P982, DOI 10.1111/jnc.13200; Gegelashvili G, 1997, J NEUROCHEM, V69, P2612; Gegelashvili G, 1996, NEUROREPORT, V8, P261, DOI 10.1097/00001756-199612200-00052; Gelfuso EA, 2013, NEUROSCI LETT, V543, P12, DOI 10.1016/j.neulet.2013.02.074; Gelfuso EA, 2007, LIFE SCI, V80, P566, DOI 10.1016/j.lfs.2006.10.002; Godoy LD, 2017, TOXINS, V9, DOI 10.3390/toxins9090262; GRISHIN EV, 1989, TOXICON, V27, P541, DOI 10.1016/0041-0101(89)90115-3; Guillet B, 2002, NEUROCHEM INT, V40, P661, DOI 10.1016/S0197-0186(01)00110-3; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; HARDY J, 1987, NEUROSCI LETT, V73, P77, DOI 10.1016/0304-3940(87)90034-6; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Hazell AS, 2007, NEUROCHEM INT, V50, P941, DOI 10.1016/j.neuint.2007.04.026; Hertz L, 2017, FRONT INTEGR NEUROSC, V11, DOI 10.3389/fnint.2017.00018; Holloway PM, 2016, STROKE, V47, P561, DOI 10.1161/STROKEAHA.115.011932; Horni A, 2001, TOXICON, V39, P425, DOI 10.1016/S0041-0101(00)00147-1; Hurtado O, 2005, NEUROBIOL DIS, V18, P336, DOI 10.1016/j.nbd.2004.10.006; Jabs R, 2008, EPILEPSIA, V49, P3, DOI 10.1111/j.1528-1167.2008.01488.x; Jin XT, 2011, EUR J NEUROSCI, V33, P1504, DOI 10.1111/j.1460-9568.2011.07636.x; Jong YJI, 2017, NEUROCHEM RES, V42, P166, DOI 10.1007/s11064-016-2026-6; Jong YJI, 2009, J BIOL CHEM, V284, P35827, DOI 10.1074/jbc.M109.046276; Kim K, 2011, J CELL PHYSIOL, V226, P2484, DOI 10.1002/jcp.22609; KONDO K, 1995, NEUROSCI LETT, V188, P140, DOI 10.1016/0304-3940(95)11408-O; Kortagere S, 2018, ACS CHEM NEUROSCI, V9, P522, DOI 10.1021/acschemneuro.7b00308; Kosugi T, 2006, NEUROCHEM RES, V31, P933, DOI 10.1007/s11064-006-9099-6; Kovalevich J, 2012, FUTURE VIROL, V7, P687, DOI 10.2217/FVL.12.57; Krause S, 2005, MOL PHARMACOL, V68, P1728, DOI 10.1124/mol.105.013870; KROGSGAARDLARSEN P, 1987, EPILEPSY RES, V1, P77, DOI 10.1016/0920-1211(87)90012-X; Krzyzanowska W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186243; Krzyzanowska W, 2014, ACTA PHARMACOL SIN, V35, P444, DOI 10.1038/aps.2014.1; Kuhn-Nentwig L, 2011, ADV INSECT PHYSIOL, V40, P1, DOI 10.1016/B978-0-12-387668-3.00001-5; KUHNNENTWIG L, 1994, TOXICON, V32, P287, DOI 10.1016/0041-0101(94)90082-5; Laughlin TM, 2002, J PHARMACOL EXP THER, V302, P1168, DOI 10.1124/jpet.302.3.1168; Lauriat TL, 2007, MOL PSYCHIATR, V12, P1065, DOI 10.1038/sj.mp.4002065; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Lewerenz J, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00469; Liberato JL, 2018, TOXINS, V10, P2; Liberato JL, 2006, BRAIN RES, V1124, P19, DOI 10.1016/j.brainres.2006.09.052; Lipski J, 2007, NEUROSCIENCE, V146, P617, DOI 10.1016/j.neuroscience.2007.02.003; LOUZADAJUNIOR P, 1992, J NEUROCHEM, V59, P358, DOI 10.1111/j.1471-4159.1992.tb08912.x; Maeda S, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-65; Maragakis NJ, 2004, ANN NEUROL, V55, P469, DOI 10.1002/ana.20003; Massieu L, 1998, Neurobiology (Bp), V6, P99; Matute C, 2006, GLIA, V53, P212, DOI 10.1002/glia.20275; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Menniti FS, 2013, CURR TOP MED CHEM, V13, P26, DOI 10.2174/1568026611313010005; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Moore S, 2009, RAPID COMMUN MASS SP, V23, P1747, DOI 10.1002/rcm.4063; Mortensen OV, 2015, J NEUROCHEM, V133, P199, DOI 10.1111/jnc.13047; Mostyn SN, 2019, ELIFE, V8, DOI 10.7554/eLife.47150; Nakajima Y, 2016, J TOXICOL SCI, V41, P311, DOI 10.2131/jts.41.311; Nicolai J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.10; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; O'Donnell LA, 2006, J NEUROSCI, V26, P981, DOI 10.1523/JNEUROSCI.4617-05.2006; O'Donovan SM, 2017, NPJ SCHIZOPHR, V3, DOI 10.1038/s41537-017-0037-1; Osborne RH, 1996, PHARMACOL THERAPEUT, V69, P117, DOI 10.1016/0163-7258(95)02054-3; Pajarillo E, 2019, NEUROPHARMACOLOGY, V161, DOI 10.1016/j.neuropharm.2019.03.002; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Pereira LS, 2007, BIOCHEM BIOPH RES CO, V352, P953, DOI 10.1016/j.bbrc.2006.11.128; Perkins Emma M, 2018, Hum Mol Genet, V27, P2614, DOI 10.1093/hmg/ddy169; Phillis JW, 2000, BRAIN RES, V880, P224, DOI 10.1016/S0006-8993(00)02755-4; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Plachez C, 2000, J NEUROSCI RES, V59, P587; Potter MC, 2013, J NEUROIMMUNE PHARM, V8, P594, DOI 10.1007/s11481-013-9442-z; Reyes N., 2009, TRANSPORT MECH BACTE; Robinson MB, 2016, NEUROCHEM INT, V98, P56, DOI 10.1016/j.neuint.2016.03.014; Rodrigues MCA, 2004, TOXICON, V43, P375, DOI 10.1016/j.toxicon.2004.01.009; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Sabri F, 2003, BRAIN PATHOL, V13, P84, DOI 10.1111/j.1750-3639.2003.tb00009.x; Saidemberg DM, 2009, TOXICON, V54, P717, DOI 10.1016/j.toxicon.2009.05.027; Schousboe A, 2017, ADV NEUROBIOL, V16, P283, DOI 10.1007/978-3-319-55769-4_14; Schousboe A, 2014, NEUROCHEM RES, V39, P1980, DOI 10.1007/s11064-014-1263-9; Schroeder FC, 2008, P NATL ACAD SCI USA, V105, P14283, DOI 10.1073/pnas.0806840105; Scofield MD, 2014, NEUROSCIENTIST, V20, P610, DOI 10.1177/1073858413520347; Seal RP, 1999, ANNU REV PHARMACOL, V39, P431, DOI 10.1146/annurev.pharmtox.39.1.431; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; SISK DR, 1985, GRAEF ARCH CLIN EXP, V223, P250, DOI 10.1007/BF02153655; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; Suchak SK, 2003, J NEUROCHEM, V84, P522, DOI 10.1046/j.1471-4159.2003.01553.x; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Szafran M, 2006, J MOL STRUCT, V797, P66, DOI 10.1016/j.molstruc.2006.02.062; Takahashi K, 2015, CELL MOL LIFE SCI, V72, P3489, DOI 10.1007/s00018-015-1937-8; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Timple JMV, 2013, J NAT PROD, V76, P1889, DOI 10.1021/np400452n; TOKI T, 1988, BIOMED RES-TOKYO, V9, P421; Tse DY, 2014, VISION RES, V103, P49, DOI 10.1016/j.visres.2014.07.020; Tzouros M, 2004, J AM SOC MASS SPECTR, V15, P1636, DOI 10.1016/j.jasms.2004.07.020; Tzouros M, 2013, EUR J MASS SPECTROM, V19, P57, DOI 10.1255/ejms.1213; USHERWOOD PN, 1966, NATURE, V210, P634, DOI 10.1038/210634a0; USHERWOOD PNR, 1984, J PHYSIOLOGY PARIS, V79, P241; USHERWOOD PNR, 1991, PHARMACOL THERAPEUT, V52, P245, DOI 10.1016/0163-7258(91)90012-B; Vandenberg RJ, 2014, TRENDS PHARMACOL SCI, V35, P423, DOI 10.1016/j.tips.2014.05.006; Verma R, 2010, EUR J PHARMACOL, V638, P65, DOI 10.1016/j.ejphar.2010.04.021; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vishnoi S, 2016, J ENVIRON PATHOL TOX, V35, P365, DOI 10.1615/JEnvironPatholToxicolOncol.2016016399; von Bartheld CS, 2016, J COMP NEUROL, V524, P3865, DOI 10.1002/cne.24040; Wakamiya T, 2004, B CHEM SOC JPN, V77, P331, DOI 10.1246/bcsj.77.331; Wakamiya T, 2001, B CHEM SOC JPN, V74, P1743, DOI 10.1246/bcsj.74.1743; Walker MC, 2018, NEUROSCI LETT, V667, P84, DOI 10.1016/j.neulet.2016.12.044; Wang Y, 2010, APOPTOSIS, V15, P1382, DOI 10.1007/s10495-010-0481-0; Wang Y, 2007, J NEUROCHEM, V103, P439, DOI 10.1111/j.1471-4159.2007.04746.x; White MG, 2011, NEUROSCI RES, V70, P220, DOI 10.1016/j.neures.2011.01.013; Wilson D, 2017, TOXINS, V9, DOI 10.3390/toxins9110346; Xiong XF, 2014, CHEMMEDCHEM, V9, P2661, DOI 10.1002/cmdc.201402278; Yamaji N, 2004, TETRAHEDRON LETT, V45, P5371, DOI 10.1016/j.tetlet.2004.05.076; Yamamoto T, 1999, ACT NEUR S, V75, P17; Yatomi Y, 2013, NEUROSCIENCE, V244, P113, DOI 10.1016/j.neuroscience.2013.04.018; Yi Z, 2013, FOREIGN LIT STUD, V35, P1; Yoshikawa K, 2000, NEUROSCI RES, V37, P1, DOI 10.1016/S0168-0102(00)00101-2	147	1	1	1	7	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	JUN 3	2020	11	11					1573	1596		10.1021/acschemneuro.0c00007			24	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	LV6BU	WOS:000538519600009	32343555	Green Accepted			2022-02-06	
J	Ketharanathan, N; De Jonge, RCJ; Klouwen, I; Wildschut, ED; Reiss, IKM; Tibboel, D; Haitsma, LKM; Buysse, CMP				Ketharanathan, Naomi; De Jonge, Rogier C. J.; Klouwen, Ilse; Wildschut, Enno D.; Reiss, Irwin K. M.; Tibboel, Dick; Haitsma, Lain K. M.; Buysse, Corinne M. P.			Hyperoxia in pediatric severe traumatic brain injury (TBI): a comparison of patient classification by cutoff versus cumulative (area-under-the-curve) analysis	BRAIN INJURY			English	Article						Traumatic brain injury; pediatrics; hyperoxia; cutoff; area-under-the-curve	NORMOBARIC HYPEROXIA; ARTERIAL HYPEROXIA; INTRACRANIAL-PRESSURE; OXYGENATION; SURVIVAL; OUTCOMES; ASSOCIATION; METABOLISM; GUIDELINES; MANAGEMENT	Objective Hyperoxia is associated with adverse outcome in severe traumatic brain injury (TBI). This study explored differences in patient classification of oxygen exposure by PaO(2)cutoff and cumulative area-under-the-curve (AUC) analysis. Methods Retrospective, explorative study including children (<18 years) with accidental severe TBI (2002-2015). Oxygen exposure analysis used three PaO(2)cutoff values and four PaO(2)AUC categories during the first 24 hours of Pediatric Intensive Care Unit (PICU) admission. Results Seventy-one patients were included (median age 8.9 years [IQR 4.6-12.9]), mortality 18.3% (n = 13). Patient hyperoxia classification differed depending on PaO(2)cutoff vs AUC analysis: 52% vs. 26%, respectively, were classified in the highest hyperoxia category. Eleven patients (17%) classified as 'intermediate oxygen exposure' based on cumulative PaO(2)analysis whereby they did not exceed the 200 mmHg PaO2 cutoff threshold. Patient classification variability was reflected by Pearson correlation coefficient of 0.40 (p-value 0.001). Conclusions Hyperoxia classification in pediatric severe TBI during the first 24 hours of PICU admission differed depending on PaO(2)cutoff or cumulative AUC analysis. We consider PaO(2)cumulative (AUC) better approximates (patho-)physiological circumstances due to its time- and dose-dependent approach. Prospective studies exploring the association betweencumulativePaO(2), physiological parameters (e.g. ICP, PbtO(2)) and outcome are warranted as different patient classifications of oxygen exposure influences how its relationship to outcome is interpreted.	[Ketharanathan, Naomi; De Jonge, Rogier C. J.; Klouwen, Ilse; Wildschut, Enno D.; Tibboel, Dick; Buysse, Corinne M. P.] Sophia Childrens Univ Hosp, Intens Care & Dept Pediat Surg, Erasmus MC, NL-3000 CB Rotterdam, Netherlands; [Reiss, Irwin K. M.] Sophia Childrens Univ Hosp, Dept Pediat, Div Neonatol, Erasmus MC, Rotterdam, Netherlands; [Haitsma, Lain K. M.] Sophia Childrens Univ Hosp, Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands		Ketharanathan, N (corresponding author), Sophia Childrens Univ Hosp, Intens Care & Dept Pediat Surg, Erasmus MC, NL-3000 CB Rotterdam, Netherlands.	n.ketharanathan@erasmusmc.nl	de Jonge, R. C.J./M-9912-2014	de Jonge, R. C.J./0000-0003-0595-1983	Sophia Children's Hospital Research Fund (SSWO) [S16-26]	This work was supported by the Sophia Children's Hospital Research Fund (SSWO) [S16-26].	Alali AS, 2020, J NEUROSURG, V132, P537, DOI 10.3171/2018.10.JNS18964; Asher SR, 2013, J NEUROSURG ANESTH, V25, P168, DOI 10.1097/ANA.0b013e318283d350; Bitterman H, 2009, CRIT CARE, V13, DOI 10.1186/cc7151; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Brown DL, 2013, THER DRUG MONIT, V35, P443, DOI 10.1097/FTD.0b013e31828b2a50; Chu DK, 2018, LANCET, V391, P1693, DOI 10.1016/S0140-6736(18)30479-3; Damiani E, 2018, CURR OPIN ANESTHESIO, V31, P129, DOI 10.1097/ACO.0000000000000559; Damiani E, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0711-x; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Diringer MN, 2008, CURR OPIN CRIT CARE, V14, P167, DOI 10.1097/MCC.0b013e3282f57552; Figaji AA, 2010, NEUROCRIT CARE, V12, P430, DOI 10.1007/s12028-010-9344-3; Finch NA, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01293-17, 10.1128/aac.01293-17]; Floyd TF, 2003, J APPL PHYSIOL, V95, P2453, DOI 10.1152/japplphysiol.00303.2003; Girardis M, 2016, JAMA-J AM MED ASSOC, V316, P1583, DOI 10.1001/jama.2016.11993; Helmerhorst HJF, 2017, CRIT CARE MED, V45, P187, DOI 10.1097/CCM.0000000000002084; Helmerhorst HJF, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0996-4; Helmerhorst HJF, 2015, CRIT CARE MED, V43, P1508, DOI 10.1097/CCM.0000000000000998; Kanthimathinathan HK, 2015, RESUSCITATION, V90, pA1, DOI 10.1016/j.resuscitation.2015.02.001; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P269, DOI 10.1097/PCC.0000000000001737; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P280, DOI 10.1097/PCC.0000000000001736; Kumaria A, 2009, BRIT J NEUROSURG, V23, P576, DOI 10.3109/02688690903050352; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6; Quintard H, 2015, NEUROCRIT CARE, V22, P243, DOI 10.1007/s12028-014-0062-0; Raj R, 2013, CRIT CARE, V17, DOI 10.1186/cc12856; Ramaiah VK, 2013, CHILD NERV SYST, V29, P629, DOI 10.1007/s00381-012-1984-5; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Rohlwink UK, 2012, NEUROSURGERY, V70, P1220, DOI 10.1227/NEU.0b013e318243fc59; Russell DW, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0370-1; Schrieff-Elson LE, 2015, CHILD NERV SYST, V31, P2257, DOI 10.1007/s00381-015-2892-2; Smallwood CD, 2017, RESP CARE, V62, P751, DOI 10.4187/respcare.05243; Soldin OP, 2002, THER DRUG MONIT, V24, P1, DOI 10.1097/00007691-200202000-00001; TAI MM, 1994, DIABETES CARE, V17, P152, DOI 10.2337/diacare.17.2.152; van Zellem L, 2015, RESUSCITATION, V90, P150, DOI 10.1016/j.resuscitation.2014.12.013; Veenith TV, 2014, J CEREBR BLOOD F MET, V34, P1622, DOI 10.1038/jcbfm.2014.123	36	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 6	2020	34	7					958	964		10.1080/02699052.2020.1765021		JUN 2020	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MI1BE	WOS:000542998400001	32485120	Green Published, Bronze			2022-02-06	
J	Womack, KB; Dubiel, R; Callender, L; Dunklin, C; Dahdah, M; Harris, TS; Devous, MD; Juengst, SB; Bell, K; Diaz-Arrastia, R; Ding, K				Womack, Kyle B.; Dubiel, Rosemary; Callender, Librada; Dunklin, Cynthia; Dahdah, Marie; Harris, Thomas S.; Devous, Michael D.; Juengst, Shannon B.; Bell, Kathleen; Diaz-Arrastia, Ramon; Ding, Kan			I-123-Iofluopane Single-Photon Emission Computed Tomography as an Imaging Biomarker of Pre-Synaptic Dopaminergic System after Moderate-to-Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						dopamine pathway; I-123-iofluopane SPECT; specific binding ratio; traumatic brain injury	VENTRAL TEGMENTAL AREA; ATTENTION-DEFICIT; METHYLPHENIDATE TREATMENT; COGNITIVE DYSFUNCTION; ORAL METHYLPHENIDATE; SUBSTANTIA-NIGRA; PLACEBO; TRANSPORTER; CONNECTIVITY; INCREASES	Dopaminergic (DA) system function is frequently disrupted after traumatic brain injury (TBI). However, published interventions that target the DA system with the hope of enhancing functional outcomes are inconclusive, partially because of the lack of DA signaling biomarkers that can be used to select patients likely to benefit from DA-directed therapies or to monitor treatment efficacy. The aim of this study was to evaluate the feasibility of using I-123-iofluopane single-photon emission computerized tomography (SPECT) to assess pre-synaptic DA system dysfunction after severe TBI. Eighteen patients with severe TBI were enrolled in this study. I-123-iofluopane SPECT imaging was performed at baseline and again 2.5 h after a single dose of methylphenidate (MP) administered enterally. DA transporter (DAT) specific binding ratio (SBR) before and after MP was measured. Functional outcomes included the Disability Rating Scale, JFK Coma Recovery Scale-Revised, Functional Independence Measure, and Functional Assessment Measure. Thirteen of 18 patients completed the study. Average time from injury to SPECT scan was 48 days (standard deviation [SD], 24 days; median, 31). Baseline ioflupane striatal SBR was 1.51 +/- 0.46 (median, 1.67). A 43.1% (SD, 16; median, 46.5) displacement of ioflupane from pre-synaptic DAT was observed after MP administration. Baseline SBR positively correlated with functional status at baseline and 4 weeks after completion of the study. Serum MP levels correlated with relative change in SBR (r(s) = 0.60; p = 0.04). Our findings suggest that I-123-iofluopane SPECT is a promising tool to determine the severity of pre-synaptic DA terminal disruption and for monitoring pharmacokinetics and pharmacodynamics of therapeutic interventions targeting the DA system.	[Womack, Kyle B.; Ding, Kan] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Womack, Kyle B.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Juengst, Shannon B.; Bell, Kathleen] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Dubiel, Rosemary; Callender, Librada; Dunklin, Cynthia] Baylor Scott & White Inst Rehabil, Dallas, TX USA; [Dubiel, Rosemary; Callender, Librada; Dunklin, Cynthia; Dahdah, Marie] Baylor Scott & White Hlth, Dallas, TX USA; [Harris, Thomas S.; Devous, Michael D.] Avid Radiopharmaceut Inc, Philadelphia, PA USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA		Ding, K (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	kan.ding@utsouthwestern.edu			National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133A120098-11]	Supported by a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR; grant no. H133A120098-11). The NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this article do not necessarily represent the policy of the NIDILRR, ACL, or HHS, and the reader should not assume endorsement by the federal government.	Anthofer JM, 2015, ACTA NEUROCHIR, V157, P469, DOI 10.1007/s00701-014-2335-y; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Chowdhury R, 2013, NEUROIMAGE, V81, P191, DOI 10.1016/j.neuroimage.2013.05.043; Clatworthy PL, 2009, J NEUROSCI, V29, P4690, DOI 10.1523/JNEUROSCI.3266-08.2009; Coenen VA, 2009, NEUROSURGERY, V64, P1106, DOI 10.1227/01.NEU.0000345631.54446.06; Devous M.D., 2005, EUR J NUCL MED MO S1, V1, P31; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Duzel E, 2009, TRENDS NEUROSCI, V32, P321, DOI 10.1016/j.tins.2009.02.005; Feron FJM, 2005, PEDIATR NEUROL, V33, P179, DOI 10.1016/j.pediatrneurol.2005.04.008; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; Hannestad J, 2010, BIOL PSYCHIAT, V68, P854, DOI 10.1016/j.biopsych.2010.06.017; Iverson L., 1975, HDB PSYCHOPHARMACOLO, VII; Jenkins PO, 2019, BRAIN, V142, P2367, DOI 10.1093/brain/awz149; Jenkins PO, 2018, BRAIN, V141, P797, DOI 10.1093/brain/awx357; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; Mah LWY, 2005, J NEUROPSYCH CLIN N, V17, P66, DOI 10.1176/appi.neuropsych.17.1.66; MOONEY GF, 1993, ARCH PHYS MED REHAB, V74, P153; Murty VP, 2014, NEUROIMAGE, V100, P580, DOI 10.1016/j.neuroimage.2014.06.047; Myrga JM, 2016, J HEAD TRAUMA REHAB, V31, pE15, DOI 10.1097/HTR.0000000000000199; Osier ND, 2016, BRAIN RES, V1640, P15, DOI 10.1016/j.brainres.2015.12.026; Pavlovskaya M, 2007, BRAIN INJURY, V21, P489, DOI 10.1080/02699050701311117; Penny W., 2006, STAT PARAMETRIC MAPP, V1; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; Stelmaschuk S, 2015, J TRAUMA NURS, V22, P194, DOI 10.1097/JTN.0000000000000138; Tomasi D, 2014, CEREB CORTEX, V24, P935, DOI 10.1093/cercor/bhs382; Vles JSH, 2003, NEUROPEDIATRICS, V34, P77; Volkow ND, 2005, BIOL PSYCHIAT, V57, P1410, DOI 10.1016/j.biopsych.2004.11.006; Volkow ND, 2002, SYNAPSE, V43, P181, DOI 10.1002/syn.10038; Volkow ND, 2012, J NEUROSCI, V32, P841, DOI 10.1523/JNEUROSCI.4461-11.2012; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002	41	1	1	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2020	37	19					2113	2119		10.1089/neu.2019.6892		JUN 2020	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NV1ON	WOS:000538186900001	32216525				2022-02-06	
J	Zlotnik, S; Gal, E; Weiss, PL				Zlotnik, Sharon; Gal, Eynat; Weiss, Patrice L.			Video modelling as a tool to evaluate self-perception of strategies used by adolescents during daily tasks	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article; Early Access						Adolescents; self-perception; cognitive strategies; video-modeling; daily performance; Weekly Calendar Planing Activity (WCPA)	TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTIONS; RATING INVENTORY; AWARENESS; PERFORMANCE; STUDENTS; ACHIEVEMENT; INTERVENTION; EFFICACY; BEHAVIOR	Introduction:Metacognition is defined as the process of regulating behavior and having self-perception of own performance. An application of video modeling (VM) was used as a technological solution for assessing self-perception in daily situations among typical adolescents, compared to parental reports and to an objective performance-based assessment. Method:One hundred and three adolescents (30 boys, 73 girls, mean age =15.1, SD = 1.9), viewed five clusters of videotaped scenarios of teen actors performing daily activities entailing strategy use. Half of the scenarios were classified as "Type A" indicating a more organized approach to accomplishing a task, the other half were "Type B" scenarios indicated a less organized approach to accomplishing the same tasks. Participants were asked to choose the scenarios that best represent their own daily performance using the VM application. The participants then completed the WCPA, an executive function (EF) performance-based assessment. Their parents completed the BRIEF as an indication of EF behaviors in the home environment. Results:46% of the adolescents associated their performance with a less organized approach yet parental reports indicated adaptive daily performance and their ability to complete the WCPA was as correct as it was for the 56% of participants who associated their performance with a more organized approach. Conclusions:Unexpectedly, the participants who associated their ability as less organized presented successful behaviors in the home environment and successfully performed the WCPA. Therapists should be aware that clients may achieve success in daily tasks even though they may cope with cognitive challenges in unexpected ways.Implication for rehabilitation Therapists may expect adolescent clients to approach tasks in a variety of ways, using different strategies for coping with everyday cognitive challenge. Therapists need to acknowledge that there is no ideal strategy that provides a solution for all individuals. Mediating a guided discovery of strategies through use of VM technology may customize intervention for each client's needs, assuring a client-centered approach and may encourage a collaboration of therapists and clients in search for the strategies that work best for them.	[Zlotnik, Sharon; Gal, Eynat; Weiss, Patrice L.] Univ Haifa, Dept Occupat Therapy, Fac Social Welf & Hlth Sci, Haifa, Israel		Zlotnik, S (corresponding author), Univ Haifa, Dept Occupat Therapy, Fac Social Welf & Hlth Sci, Haifa, Israel.	sharonzlotnik5@gmail.com			Learning in a NetworKed Society Centre of Excellence at the University of Haifa	This research was funded, in part, by the Learning in a NetworKed Society Centre of Excellence at the University of Haifa.	Allen JB, 1998, J SPORT EXERCISE PSY, V20, P280; BANDURA A, 1968, J PERS SOC PSYCHOL, V8, P99, DOI 10.1037/h0025260; Bandura A., 2010, CORSINI ENCY PSYCHOL, DOI 10.1002/9780470479216; Beaudoin M, 2011, PSYCHOL BULL, V137, P211, DOI 10.1037/a0022106; Blanch-Hartigan D, 2011, PATIENT EDUC COUNS, V84, P3, DOI 10.1016/j.pec.2010.06.037; Britner SL, 2006, J RES SCI TEACH, V43, P485, DOI 10.1002/tea.20131; Conley MW, 2008, M CHALL AD LIT RES W, P88; Dowrick PW, 1999, APPL PREV PSYCHOL, V8, P23, DOI 10.1016/S0962-1849(99)80009-2; Dziobek I, 2006, J AUTISM DEV DISORD, V36, P623, DOI 10.1007/s10803-006-0107-0; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Fraser B., 2015, GENERATION Z TECHNOL; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Godefroy O, 2003, J NEUROL, V250, P1, DOI 10.1007/s00415-003-0918-2; Grist R, 2019, CLIN CHILD FAM PSYCH, V22, P147, DOI 10.1007/s10567-018-0271-8; Hahn-Markowitz J, 2011, AM J OCCUP THER, V65, P384, DOI 10.5014/ajot.2011.000901; Harris KR, 2008, EDUC PSYCHOL-US, V43, P86, DOI 10.1080/00461520801942300; Harter S., 2012, HDB SELF IDENTITY, P680; Hewitt J, 2005, J LEARN SCI, V14, P567, DOI 10.1207/s15327809jls1404_4; Hochhauser M, 2015, INT J HUM-COMPUT INT, V31, P472, DOI 10.1080/10447318.2015.1045242; Igel C., 2012, MIDDLE SCH J, V43, P16; Josman N, 2014, J STROKE CEREBROVASC, V23, P879, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.013; Lahav O, 2018, J ATTEN DISORD, V22, P368, DOI 10.1177/1087054714564621; Lahav O, 2014, BRIT J OCCUP THER, V77, P614, DOI 10.4276/030802214X14176260335309; Lew MDN, 2010, ASSESS EVAL HIGH EDU, V35, P135, DOI 10.1080/02602930802687737; Linder N, 2010, CHILD NEUROPSYCHOL, V16, P494, DOI 10.1080/09297041003781884; Mandich, 2004, ENABLING OCCUPATION; Marsh HW, 2008, PERS SOC PSYCHOL B, V34, P542, DOI 10.1177/0146167207312313; Mechling L, 2005, J SPEC EDUC TECHNOL, V20, P25, DOI 10.1177/016264340502000203; Meltzer L., 2004, LEARN DISABIL RES PR, V19, P33, DOI DOI 10.1111/J.1540-5826.2004.00087.X; MOHR K, 2017, J EMPOWERING TEACHIN, V1, P84; Moritz SE, 2000, RES Q EXERCISE SPORT, V71, P280, DOI 10.1080/02701367.2000.10608908; NICHOLLS JG, 1984, PSYCHOL REV, V91, P328, DOI 10.1037/0033-295X.91.3.328; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T, 2016, NEUROPSYCHOL REHABIL, V26, P1, DOI 10.1080/09602011.2014.977924; Pajares F., 2003, READ WRIT Q, V19, P139, DOI [DOI 10.1080/10573560308222, 10.1080/10573560308222]; Prensky M., 2001, HORIZON, V9, P1, DOI [DOI 10.1108/10748120110424816, 10.1108/10748120110424816]; Pressiey M, 1985, STRATEGY, V4, P89; Rasmussen C., 2007, J FAS INT, V5, P1; Reeves E, 2008, PUBLIC ADMIN, V86, P969, DOI 10.1111/j.1467-9299.2008.00743.x; Rith-Najarian LR, 2014, STRESS, V17, P193, DOI 10.3109/10253890.2014.891102; Roebers CM, 2017, DEV REV, V45, P31, DOI 10.1016/j.dr.2017.04.001; Rosen LD, 2013, COMPUT HUM BEHAV, V29, P948, DOI 10.1016/j.chb.2012.12.001; Rothman D., 2016, TSUNAMI LEARNERS CAL; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Seemiller C, 2016, GENERATION Z GOES CO, V35, P286; Steinberg C, 2019, FUNCTIONAL COGNITION; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Toglia J., 2017, CHANGES BRAIN IMPACT, P117, DOI [10.1007/978-0-387-98188-8_6, DOI 10.1007/978-0-387-98188-8_6]; Toglia J, 2015, WEEKLY CALENDAR PLAN, P176; Toglia J, 2013, AM J OCCUP THER, V67, P515, DOI 10.5014/ajot.2013.008482; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Toglia JP, 2012, CAN J OCCUP THER, V79, P225, DOI 10.2182/cjot.2012.79.4.4; Walsh MM, 2009, COGNITIVE PSYCHOL, V58, P416, DOI 10.1016/j.cogpsych.2008.09.003; Weiss PL, 2015, P INT C VIRT REH ICV; Wigfield A, 2000, CONTEMP EDUC PSYCHOL, V25, P68, DOI 10.1006/ceps.1999.1015; Winsler A, 2003, CHILD DEV, V74, P659, DOI 10.1111/1467-8624.00561; You S, 2016, CHILD YOUTH CARE FOR, V45, P221, DOI 10.1007/s10566-015-9326-x; Zell E, 2014, PERSPECT PSYCHOL SCI, V9, P111, DOI 10.1177/1745691613518075; Zlotnik S, 2020, NEUROPSYCHOL REHABIL, V30, P333, DOI 10.1080/09602011.2018.1468272; Zlotnik S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00015	60	1	1	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.												10.1080/17483107.2020.1774809		JUN 2020	7	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	MD8XZ	WOS:000544252500001	32501780				2022-02-06	
J	Steinman, J; Cahill, LS; Stortz, G; Macgowan, CK; Stefanovic, B; Sled, JG				Steinman, Joe; Cahill, Lindsay S.; Stortz, Greg; Macgowan, Christopher K.; Stefanovic, Bojana; Sled, John G.			Non-Invasive Ultrasound Detection of Cerebrovascular Changes in a Mouse Model of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; discriminant analysis; input impedance; ultrasound; vasculature	CORTICAL IMPACT INJURY; PULSE-WAVE VELOCITY; CEREBRAL-BLOOD-FLOW; TRANSCRANIAL DOPPLER; PULSATILITY INDEX; ARTERIAL COMPLIANCE; ELASTIC PROPERTIES; HEART-RATE; L-ARGININE; IMPEDANCE	Traumatic brain injury (TBI) can induce changes in vascular architecture. Although ultrasound metrics such as pulsatility index (PI) are sensitive to changes in hemodynamic resistance downstream from major arteries, these metrics depend on features unrelated to vessel architecture, such as blood pressure and heart rate. In contrast, input impedance and reflection coefficient that are derived from wave reflection theory seek to minimize the effects of altered cardiac output or heart rate. In this article, we investigate the use of ultrasound to assess changes in vascular impedance and wave reflection in the common carotid arteries of mice exposed to a controlled cortical impact. Focusing on the first harmonics of the reflected waves, the impedance phase was increased ipsilaterally in impacted mice compared with shams, whereas the magnitude of the impedance was unchanged. In contrast, PI was reduced bilaterally. Interestingly, PI and the first harmonic magnitude of input impedance in the carotid artery were correlated on the contralateral but not ipsilateral side. We investigated the use of these metrics to classify mice as sham or TBI, finding an area under the receiver operating characteristic curve ipsilaterally of 0.792 (confidence interval [CI]: 0.648-0.936) for correct classification with first harmonic impedance magnitude and phase as predictors and 0.716 (CI: 0.553-0.879) using carotid artery PI and diameter as predictors. Overall, the findings support the use of wave reflection analysis as a more specific measure of vascular changes following TBI and motivate the translation of this approach for monitoring vascular changes in humans affected by TBI.	[Steinman, Joe; Cahill, Lindsay S.; Stortz, Greg; Macgowan, Christopher K.; Sled, John G.] Hosp Sick Children, Toronto, ON, Canada; [Steinman, Joe; Macgowan, Christopher K.; Stefanovic, Bojana; Sled, John G.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Stefanovic, Bojana] Sunnybrook Res Inst, Toronto, ON, Canada; [Cahill, Lindsay S.] Mem Univ Newfoundland, Dept Chem, St John, NF, Canada		Steinman, J (corresponding author), Hosp Sick Children, Mouse Imaging Ctr, 25 Orde St, Toronto, ON M5T 3H7, Canada.	joe.steinman@mail.utoronto.ca	Sled, John G/D-8268-2012	Sled, John G/0000-0002-4461-283X; Steinman, Joe/0000-0002-1354-4221; Macgowan, Christopher/0000-0002-7016-0662	Canadian Institutes of Health Research GrantCanadian Institutes of Health Research (CIHR) [FRN-152961]	This work was supported by the Canadian Institutes of Health Research Grant FRN-152961.	Adams C, 2018, THERANOSTICS, V8, P4824, DOI 10.7150/thno.24747; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Barsha G, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0110-x; BERGEL DH, 1961, J PHYSIOL-LONDON, V156, P445, DOI 10.1113/jphysiol.1961.sp006686; Bouzat P, 2016, ANESTHESIOLOGY, V125, P346, DOI 10.1097/ALN.0000000000001165; Cahill LS, 2019, ULTRASOUND MED BIOL, V45, P3269, DOI 10.1016/j.ultrasmedbio.2019.08.017; Cherian L, 2004, J NEUROTRAUM, V21, P1196; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; Christofaro DGD, 2017, ARQ BRAS CARDIOL, V108, P405, DOI 10.5935/abc.20170050; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dobrzeniecki M, 2018, ACTA NEUROCHIR SUPPL, V126, P21, DOI 10.1007/978-3-319-65798-1_5; Doevendans PA, 1998, CARDIOVASC RES, V39, P34, DOI 10.1016/S0008-6363(98)00073-X; Doonan RJ, 2013, HYPERTENS RES, V36, P226, DOI 10.1038/hr.2012.158; FARRAR DJ, 1978, CIRC RES, V43, P52, DOI 10.1161/01.RES.43.1.52; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Gao YR, 2015, NEUROIMAGE, V115, P162, DOI 10.1016/j.neuroimage.2015.04.054; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; James G., 2017, SPRINGER TEXTS STAT, DOI [DOI 10.1007/978-1-4614-7138-7_8, 10.1007/978-1-4614-7138-7]; Karamzadeh N, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.541; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; LAXMINARAYAN S, 1979, MED BIOL ENG COMPUT, V17, P623, DOI 10.1007/BF02440907; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Macgowan CK, 2015, J CEREBR BLOOD F MET, V35, P521, DOI 10.1038/jcbfm.2014.229; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Monson KL, 2019, CLIN BIOMECH, V64, P98, DOI 10.1016/j.clinbiomech.2018.02.011; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Obenaus A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00161-4; OROURKE MF, 1966, CIRC RES, V18, P126, DOI 10.1161/01.RES.18.2.126; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Plog BA, 2020, J NEUROSURG, V133, P210, DOI 10.3171/2019.2.JNS182675; Prasad B.K.D., 2017, INT J CONT MED SURG, V2, P139; Qu WR, 2016, NEURAL REGEN RES, V11, P248, DOI 10.4103/1673-5374.177732; Rahman A, 2017, AM J PHYSIOL-HEART C, V312, pH1021, DOI 10.1152/ajpheart.00791.2016; Rajajee V, 2012, NEUROSURGERY, V70, P1195, DOI 10.1227/NEU.0b013e3182417dca; Reule S, 2012, CURR HYPERTENS REP, V14, P478, DOI 10.1007/s11906-012-0306-3; Reuter-Rice Karin, 2017, J Radiol Nurs, V36, P3, DOI 10.1016/j.jradnu.2016.11.003; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Segers P, 2014, PHYSIOL MEAS, V35, P847, DOI 10.1088/0967-3334/35/5/847; Steinman J, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116101; TAYLOR MG, 1966, BIOPHYS J, V6, P29, DOI 10.1016/S0006-3495(66)86638-9; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thibeault CM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00200; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Vulliemoz S, 2002, MAGNET RESON MED, V47, P649, DOI 10.1002/mrm.10100; Williams R, 2007, ULTRASOUND MED BIOL, V33, P1368, DOI 10.1016/j.ultrasmedbio.2007.03.012; Wong KS, 2000, STROKE, V31, P2641, DOI 10.1161/01.STR.31.11.2641; Wright AD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00196; Zweifel C, 2012, NEUROSURGERY, V71, P853, DOI 10.1227/NEU.0b013e3182675b42	53	1	1	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2020	37	20					2157	2168		10.1089/neu.2019.6872		JUN 2020	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	OA4HP	WOS:000538179900001	32326817				2022-02-06	
J	Ahn, HJ; Jung, S; You, Y; Park, JS; Min, JH; Jeong, W; Kang, C; Yoo, I; Cho, Y; Ryu, S; Lee, J; Kim, SW; Cho, SU; Oh, SK; Lee, J; Lee, IH				Ahn, Hong Joon; Jung, Sangmin; You, Yeonho; Park, Jung Soo; Min, Jin Hong; Jeong, Wonjoon; Kang, Changshin; Yoo, Insool; Cho, Yongchul; Ryu, Seung; Lee, Jinwoong; Kim, Seung Whan; Cho, Sung Uk; Oh, Se Kwang; Lee, Junwan; Lee, In Ho			The value of cerebrospinal fluid ubiquitin C-terminal hydrolase-L1 protein as a prognostic predictor of neurologic outcome in post-cardiac arrest patients treated with targeted temperature management	RESUSCITATION			English	Article						Cardiac arrest; Prognostication; UCHL1 protein	NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; GLASGOW-COMA-SCALE; SERUM-LEVELS; BIOMARKERS; ASSOCIATION; CHILDREN; S100B; L1	Aim: We evaluated the prognostic value of serum- and cerebrospinal fluid (CSF)-ubiquitin carboxyl-terminal esterase L1 protein (UCHL1) measurements in post- post-out of hospital cardiac arrest (OHCA) patients treated with target temperature management (TTM), to predict neurologic outcome. Methods: This was a prospective single-centre observational cohort study, conducted from April 2018 to September 2019. Serum- and CSF-UCHL1 were obtained immediately (UCHL1(initial)), 24 h (UCHL1(24)), 48 h (UCHL1(48)), and 72 h (UCHL1(72)) after return of spontaneous circulation (ROSC). The area under the receiver operating characteristic curves (AUROC) and Delong method were used to identify cut-off values of serum- and CSF-UCHL1(initial), UCHL1(24), UCHL1(48), UCHL1(72) for predicting neurologic outcomes. Results: Of 38 patients enrolled, 16 comprised the poor outcome group. The AUROCs for serum- and CSF-UCHL1(initial) were 0.71 and 0.93 in predicting poor neurological outcomes, respectively (p = 0.01). The AUROCs for serum- and CSF-UCHL1(24) were 0.85 and 0.91 (p = 0.24). The AUROCs for serum- and CSF-UCHL1(48) were 0.90 and 0.97 (p = 0.07). The AUROCs for serum- and CSF-UCHL1(72) were 0.94 and 0.98 (p = 0.25). Conclusion: Findings of this study demonstrate that CSF-UCHL1 measured immediately, 24, 48, and 72 h after ROSC is a valuable predictor for evaluating neurologic outcomes, whereas serum-UCHL1 measured at 24, 48, and 72 h after ROSC showed a significant performance in the prognostication of poor outcomes in post-OHCA patients treated with TTM.	[Ahn, Hong Joon; You, Yeonho; Park, Jung Soo; Min, Jin Hong; Jeong, Wonjoon; Kang, Changshin; Yoo, Insool; Cho, Yongchul; Ryu, Seung; Lee, Jinwoong; Kim, Seung Whan; Cho, Sung Uk; Oh, Se Kwang; Lee, Junwan] Chungnam Natl Univ Hosp, Dept Emergency Med, 282 Munhwa Ro, Daejeon, South Korea; [Jung, Sangmin] Cheju Halla Gen Hosp, Dept Emergency Med, 65 Doryeong Ro, Jeju Si, Jeju Do, South Korea; [Park, Jung Soo; Yoo, Insool; Kim, Seung Whan] Chungnam Natl Univ, Sch Med, Coll Med, Dept Emergency Med, 282 Mokdong Ro, Daejeon, South Korea; [Lee, In Ho] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Sch Med, Dept Radiol, Daejeon, South Korea		You, Y (corresponding author), Chungnam Natl Univ Hosp, Dept Emergency Med, 282 Munhwa Ro, Daejeon, South Korea.	yyo1003@naver.com	Kang, Changshin/AAS-9279-2021; You, Yeonho/M-5106-2015	You, Yeonho/0000-0001-9105-1222	National Research Foundation of Korea (NRF) - Korea Government (MSIT)	This project was funded in whole by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MSIT).	Abend NS, 2008, PEDIATR CRIT CARE ME, V9, P32, DOI 10.1097/01.PCC.0000288714.61037.56; Ameloot K, 2017, AM HEART J, V191, P91, DOI 10.1016/j.ahj.2017.06.010; Arnaoutakis GJ, 2011, J THORAC CARDIOV SUR, V142, P902, DOI 10.1016/j.jtcvs.2011.06.027; Bassetti C, 1996, J NEUROL NEUROSUR PS, V61, P610, DOI 10.1136/jnnp.61.6.610; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Bishop P, 2014, J BIOL CHEM, V289, P36140, DOI 10.1074/jbc.M114.557124; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Bouwes A, 2012, ANN NEUROL, V71, P206, DOI 10.1002/ana.22632; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Cronberg T, 2009, RESUSCITATION, V80, P1119, DOI 10.1016/j.resuscitation.2009.06.021; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Day INM, 2010, PROG NEUROBIOL, V90, P327, DOI 10.1016/j.pneurobio.2009.10.020; Douglas-Escobar M, 2010, PEDIATR RES, V68, P531, DOI 10.1203/PDR.0b013e3181f85a03; Engelborghs Sebastiaan, 2017, Alzheimers Dement (Amst), V8, P111, DOI 10.1016/j.dadm.2017.04.007; Fugate JE, 2010, ANN NEUROL, V68, P907, DOI 10.1002/ana.22133; Guzel A, 2008, NEUROSURG REV, V31, P439, DOI 10.1007/s10143-008-0148-2; JACKSON P, 1981, J NEUROL SCI, V49, P429, DOI 10.1016/0022-510X(81)90032-0; Joffe Ari R, 2007, J Intensive Care Med, V22, P194, DOI 10.1177/0885066607299516; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Longstreth WT, 2010, RESUSCITATION, V81, P530, DOI 10.1016/j.resuscitation.2010.01.011; Manet R, 2017, ACTA NEUROCHIR, V159, P2003, DOI 10.1007/s00701-017-3290-1; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Munch EC, 2001, CRIT CARE MED, V29, P976; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Pardridge WM, 1997, J CEREBR BLOOD F MET, V17, P713, DOI 10.1097/00004647-199707000-00001; Park JH, 2019, CLIN EXP EMERG MED, V6, P9, DOI 10.15441/ceem.17.273; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Tiainen M, 2003, STROKE, V34, P2881, DOI 10.1161/01.STR.0000103320.90706.35; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; van Alem AP, 2004, AM J CARDIOL, V93, P131, DOI 10.1016/j.amjcard.2003.09.027; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC	40	1	1	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	JUN	2020	151						50	58		10.1016/j.resuscitation.2020.03.022			9	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	MI4ID	WOS:000547372900014	32272234				2022-02-06	
J	Bailey, KC; Burmaster, SA; Schaffert, J; Lobue, C; Vela, D; Rossetti, H; Cullum, CM				Bailey, K. Chase; Burmaster, Sandra A.; Schaffert, Jeff; Lobue, Christian; Vela, Daniela; Rossetti, Heidi; Cullum, C. Munro			Associations of Race-Ethnicity and History of Traumatic Brain Injury With Age at Onset of Alzheimer's Disease	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							INTIMATE PARTNER VIOLENCE; EARLIER AGE; DEMENTIA RISK; POPULATION; DIAGNOSIS	Objective: This study examined whether a history of traumatic brain injury (TBI) is associated with age at onset of Alzheimer's disease (AD) in three racial-ethnic groups. Methods: Data from 7,577 non-Hispanic Caucasian, 792 African American, and 870 Hispanic participants with clinically diagnosed AD were obtained from the National Alzheimer's Coordinating Center. Participants were categorized by the presence or absence of self-reported remote history of TBI (>1 year before diagnosis of AD) with loss of consciousness (LOC) (TBI+) or no history of TBI with LOC (TBI-). Any group differences in education; sex; APOE epsilon 4 alleles; family history of dementia; or history of depression, stroke, hypertension, hypercholesterolemia, and diabetes were included in analyses of covariance comparing clinicianestimated age at AD symptom onset for the TBI+ and TBI- groups. Results: AD onset occurred 2.3 years earlier for non-Hispanic Caucasians (F=30.49, df=1, 7,572, p,0.001) and 3.4 years earlier for African Americans (F=5.17, df=1, 772, p=0.023) in the TBI+ group. In the Hispanic cohort, females in the TBI+ group had AD onset 5.6 years earlier, compared with females in the TBI- group (F=6.96, df=1, 865, p=0.008); little difference in age at AD onset was observed for Hispanic males with and without a TBI history. Conclusions: A history of TBI with LOC was associated with AD onset 2-3 years earlier in non-Hispanic Caucasians and African Americans and an onset nearly 6 years earlier in Hispanic females; no associationwas observed inHispanicmales. Further work in underserved populations is needed to understand possible underlying mechanisms for these differences.	[Bailey, K. Chase; Burmaster, Sandra A.; Schaffert, Jeff; Lobue, Christian; Vela, Daniela; Rossetti, Heidi; Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Lobue, Christian; Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA		Bailey, KC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	KennethC.Bailey@UTSouthwestern.edu		Schaffert, Jeff/0000-0002-8842-980X; Bailey, Kenneth/0000-0002-5389-5229	University of Texas Southwestern Alzheimer's Disease Center (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 AG12300]; Texas Alzheimer's Research and Care Consortium; National Institute on Aging (NIA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01 AG016976]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50 AG047366, P30 AG010129, P50 AG016573, P50 AG005131, P50 AG023501, P30 AG035982, P30 AG028383, P30 AG053760, P30 AG010124, P50 AG005133, P50 AG005142, P30 AG012300, P30 AG049638, P50 AG005136, P50 AG033514, P50 AG005681, P50 AG047270];  [P30 AG019610];  [P30 AG013846];  [P50 AG008702];  [P50 AG025688];  [P50 AG047266];  [P30 AG010133];  [P50 AG005146];  [P50 AG005134];  [P50 AG016574];  [P50 AG005138];  [P30 AG008051];  [P30 AG013854];  [P30 AG008017];  [P30 AG010161]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005146, U01AG016976, P30AG010129, P30AG013846, P50AG008702, P50AG047366, P30AG049638, P50AG025688, P50AG016573, P30AG013854, P30AG008017, P50AG047266, P30AG028383, P30AG008051, P50AG005131, P30AG010133, P50AG047270, P30AG019610, P50AG005134, P50AG005142, P50AG005681, P30AG012300, P50AG005138, P50AG023501, P50AG033514, P30AG053760, P50AG016574, P30AG035982, P50AG005136, P30AG010124, P50AG005133, P30AG010161] Funding Source: NIH RePORTER	Supported in part by the University of Texas Southwestern Alzheimer's Disease Center (NIH grant P30 AG12300) and the Texas Alzheimer's Research and Care Consortium. The National Alzheimer's Coordinating Center (NACC) database is funded by grant U01 AG016976 from the National Institute on Aging (NIA). NACC data were contributed by the following NIA-funded Alzheimer's Disease Centers: P30 AG019610 (principal investigator, Eric Reiman, M.D.), P30 AG013846 (principal investigator, Neil Kowall, M.D.), P50 AG008702 (principal investigator, Scott Small, M.D.), P50 AG025688 (principal investigator, Allan Levey, M.D., Ph.D.), P50 AG047266 (principal investigator, Todd Golde, M.D., Ph.D.), P30 AG010133 (principal investigator, Andrew Saykin, Psy.D.), P50 AG005146 (principal investigator, Marilyn Albert, Ph.D.), P50 AG005134 (principal investigator, Bradley Hyman, M.D., Ph.D.), P50 AG016574 (principal investigator, Ronald Petersen, M.D., Ph.D.), P50 AG005138 (principal investigator, Mary Sano, Ph.D.), P30 AG008051 (principal investigator, Thomas Wisniewski, M.D.), P30 AG013854 (principal investigator, M. Marsel Mesulam, M.D.), P30 AG008017 (principal investigator, Jeffrey Kaye, M.D.), P30 AG010161 (principal investigator, David Bennett, M.D.), P50 AG047366 (principal investigator, Victor Henderson, M.D., MS), P30 AG010129 (principal investigator, Charles DeCarli, M.D.), P50 AG016573 (principal investigator, Frank LaFerla, Ph.D.), P50 AG005131 (principal investigator, James Brewer, M.D., Ph.D.), P50 AG023501 (principal investigator, Bruce Miller, M.D.), P30 AG035982 (principal investigator, Russell Swerdlow, M.D.), P30 AG028383 (principal investigator, Linda Van Eldik, Ph.D.), P30 AG053760 (principal investigator, Henry Paulson, M.D., Ph.D.), P30 AG010124 (principal investigator, John Trojanowski, M.D., Ph.D.), P50 AG005133 (principal investigator, Oscar Lopez, M.D.), P50 AG005142 (principal investigator, Helena Chui, M.D.), P30 AG012300 (principal investigator, Roger Rosenberg, M.D.), P30 AG049638 (principal investigator, Suzanne Craft, Ph.D.), P50 AG005136 (principal investigator, Thomas Grabowski, M.D.), P50 AG033514 (principal investigator, Sanjay Asthana, M.D., F.R.C.P.), P50 AG005681 (principal investigator, John Morris, M.D.), and P50 AG047270 (principal investigator, Stephen Strittmatter, M.D., Ph.D.).	Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; [Anonymous], 2011, OV VIOL WOM UN MEX S; Caetano R, 2008, J FAM VIOLENCE, V23, P507, DOI 10.1007/s10896-008-9178-3; Chen HY, 2016, J ALZHEIMERS DIS, V51, P515, DOI 10.3233/JAD-151089; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Fitten LJ, 2014, INT J GERIATR PSYCH, V29, P586, DOI 10.1002/gps.4040; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; LoBue C, 2018, J NEUROPSYCH CLIN N, V30, P7, DOI 10.1176/appi.neuropsych.17070145; LoBue C, 2017, CLIN NEUROPSYCHOL, V31, P85, DOI 10.1080/13854046.2016.1257069; Lobue C, 2016, J ALZHEIMERS DIS, V51, P727, DOI 10.3233/JAD-150895; Mayeda ER, 2014, DIABETES CARE, V37, P1009, DOI 10.2337/dc13-0215; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Monserud MA, 2015, RES AGING, V37, P856, DOI 10.1177/0164027514568104; Murray CE, 2016, TRAUMA VIOLENCE ABUS, V17, P298, DOI 10.1177/1524838015584364; O'Bryant SE, 2007, J PSYCHOPATHOL BEHAV, V29, P137, DOI 10.1007/s10862-006-9042-9; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Raj R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002316; Sabina C, 2015, J FAM VIOLENCE, V30, P35, DOI 10.1007/s10896-014-9652-z; Schaffert J, 2018, NEUROPSYCHOLOGY, V32, P410, DOI 10.1037/neu0000423; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Seaton EK, 2018, AM PSYCHOL, V73, P768, DOI 10.1037/amp0000315; Vega IE, 2017, J ALZHEIMERS DIS, V58, P979, DOI 10.3233/JAD-161261; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	25	1	1	1	6	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	2020	32	3					280	285		10.1176/appi.neuropsych.19010002			6	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	MV7XN	WOS:000556565800087	31619118	Green Accepted			2022-02-06	
J	Ben Zvi, I; Matsri, S; Felzensztein, D; Yassin, S; Orlev, A; Ben Shalom, N; Gavrielli, S; Inbar, E; Loeub, A; Schwartz, N; Rajz, G; Novitsky, I; Kanner, A; Berkowitz, S; Harnof, S				Ben Zvi, Ido; Matsri, Sher; Felzensztein, David; Yassin, Saeed; Orlev, Alon; Ben Shalom, Netanel; Gavrielli, Shlomo; Inbar, Edna; Loeub, Adam; Schwartz, Noa; Rajz, Gustavo; Novitsky, Ivan; Kanner, Andrew; Berkowitz, Shani; Harnof, Sagi			The Utility of Early Postoperative Neuroimaging in Elective/Semielective Craniotomy Patients: A Single -Arm Prospective Trial	WORLD NEUROSURGERY			English	Article; Proceedings Paper	Annual Scientific Meeting of the American-Association-of-Neurological-Surgeons (AANS)	APR 13-17, 2019	San Diego, CA	Amer Assoc Neurol Surg			SERIAL COMPUTED-TOMOGRAPHY; TRAUMATIC BRAIN-INJURY; HEAD CT; INFLUENCE MANAGEMENT; MALIGNANT GLIOMA; SHUNT INSERTION; RADIATION; INFECTIONS; RESECTION; HEMORRHAGE		[Ben Zvi, Ido; Matsri, Sher; Felzensztein, David; Yassin, Saeed; Orlev, Alon; Ben Shalom, Netanel; Loeub, Adam; Schwartz, Noa; Rajz, Gustavo; Novitsky, Ivan; Kanner, Andrew; Berkowitz, Shani; Harnof, Sagi] Rabin Med Ctr, Neurosurg Dept, Petah Tiqwa, Israel; [Gavrielli, Shlomo; Inbar, Edna] Rabin Med Ctr, Dept Diagnost Radiol, Petah Tiqwa, Israel		Ben Zvi, I (corresponding author), Rabin Med Ctr, Neurosurg Dept, Petah Tiqwa, Israel.	idobenz@gmail.com		Kanner, Andrew Ariye/0000-0002-0812-8573			ALBERT FK, 1994, NEUROSURGERY, V34, P45, DOI 10.1097/00006123-199401000-00008; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Betlazar C, 2016, REDOX BIOL, V9, P144, DOI 10.1016/j.redox.2016.08.002; Braman S, 1988, SURV ANESTHESIOL, V32, P195; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Connon FF, 2011, ANN SURG, V254, P1028, DOI 10.1097/SLA.0b013e318219727f; Foerster BR, 2007, ACTA RADIOL, V48, P875, DOI 10.1080/02841850701477728; Fontes RBV, 2014, J NEUROSURG, V121, P307, DOI 10.3171/2014.4.JNS132429; FUKAMACHI A, 1985, SURG NEUROL, V23, P575, DOI 10.1016/0090-3019(85)90006-0; FUKAMACHI A, 1986, NEUROSURGERY, V19, P589, DOI 10.1227/00006123-198610000-00013; Garrett MC, 2013, NEUROSURGERY, V73, P209, DOI 10.1227/01.neu.0000430328.25516.dd; Giussani C, 2009, PEDIATR NEUROSURG, V45, P345, DOI 10.1159/000257522; Kamp MA, 2015, ACTA NEUROCHIR, V157, P1573, DOI 10.1007/s00701-015-2479-4; Kestle JRW, 2003, J NEUROSURG, V98, P284, DOI 10.3171/jns.2003.98.2.0284; Khaldi A, 2010, J NEUROSURG, V113, P1021, DOI 10.3171/2009.11.JNS081048; Lin EC, 2010, MAYO CLIN PROC, V85, P1142, DOI 10.4065/mcp.2010.0260; LIN JP, 1977, NEURORADIOLOGY, V12, P185, DOI 10.1007/BF00332366; Ma SM, 2013, INT J RADIAT BIOL, V89, P326, DOI 10.3109/09553002.2013.756595; Mao ZQ, 2014, CHINESE MED J-PEKING, V127, P633, DOI 10.3760/cma.j.issn.0366-6999.20131846; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Offiah CE, 2006, CLIN RADIOL, V61, P393, DOI 10.1016/j.crad.2006.01.008; Pantos I, 2011, BRIT J RADIOL, V84, P293, DOI 10.1259/bjr/69070614; Paul AB, 2015, J AM COLL RADIOL, V12, P453, DOI 10.1016/j.jacr.2014.12.016; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; Sarmey N, 2015, CHILD NERV SYST, V31, P541, DOI 10.1007/s00381-015-2637-2; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Wen L, 2016, ACTA NEUROCHIR, V158, P1447, DOI 10.1007/s00701-016-2883-4; Whitehead WE, 2013, J NEUROSURG-PEDIATR, V12, P565, DOI 10.3171/2013.9.PEDS1346; Zaidi HA, 2014, NEUROSURGERY, V74, pE335, DOI 10.1227/NEU.0000000000000191; Zygourakis CC, 2017, J NEUROSURG, V126, P558, DOI 10.3171/2016.1.JNS152242	34	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2020	138						E381	E388		10.1016/j.wneu.2020.02.130			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Surgery	LY7QX	WOS:000540723500008	32145412				2022-02-06	
J	Chen, CH; Gan, D; Yang, CS; Shen, Y				Chen, Chunhua; Gan, Di; Yang, Chensong; Shen, Yang			Discussion on bone healing rate and expression of cytokines and growth factors in rat models with simple fracture and brain injury	JOURNAL OF KING SAUD UNIVERSITY SCIENCE			English	Article						Fracture of tibia; Fracture with brain injury; Callus; NGF; BMP7		This research aims to analyze the differences in bone healing rate, cytokines content, and growth factor content in rats with fracture and traumatic brain injury. In this study, rat models of tibial fracture (fracture group) and tibial fracture combined with brain injury (combined group) were first constructed. Callus and brain tissue sections of the two groups of rat models were made, and the pathological changes were analyzed by hematoxylin - eosin staining. Tissue sections were made to compare the differences in callus volume, trabecular width, and trabecular bone ratio between the two groups of rats. Taking normal rats as controls, serum samples were collected from rats in the control group, fracture group, and combined group. The differences of levels in nerve growth factor (NGF), insulin-like growth factor 1 (IGF1), bone morphogenetic protein 7 (BMP7), and transforming growth factor beta 1 (TGF beta 1) in serum of different groups of rats were detected by enzyme-linked immunosorbent assay, and the expression of NGF, IGF 1, BMPR7, and TGF beta R1 in rat callus was detected by Western-Blot. It was found that the rate of bone healing in the combined group was faster than that in the fracture group. The bone callus volume, trabecular width, and trabecular proportion of the rats in the combined group were significantly higher than those in the fracture group (P < 0.05). The content of NGF, IGF1, BMP7, and TGF beta 1 in the serum of the fracture group and the combined group and the expression of their receptor proteins were significantly higher than that of the control group (P < 0.05), but the content of NGF, IGF1, BMP7, and TGF 1 in the serum and the expression of their receptor proteins of the combined group were significantly higher than that of the fracture group (P < 0.05). Accordingly, tibial fractures combined with brain injury can accelerate bone healing, which may be caused by regulating the expression of NGF, IGF1, BMP7, and TGF beta 1 and accelerating the binding of its receptors. (C) 2020 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.	[Chen, Chunhua; Gan, Di; Yang, Chensong; Shen, Yang] South Court East Hosp, Emergency Truma Surg, 1800 Yuntai Rd, Shanghai 200120, Peoples R China		Chen, CH (corresponding author), South Court East Hosp, Emergency Truma Surg, 1800 Yuntai Rd, Shanghai 200120, Peoples R China.	chenchunhuasceh@yeah.net					Chisalita SI, 2017, ORTHOP SURG, V9, P380, DOI 10.1111/os.12358; Dehghan F., 2017, INFLAMMOPHARMACOLOGY, V26, P1; Graef F, 2017, J MUSCULOSKEL NEURON, V17, P78; Huang H, 2018, J ORTHOP TRANSL, V12, P16, DOI 10.1016/j.jot.2017.10.002; Ono T., 2017, CURR OSTEOPOROS REP, V15, P1; Pietsch M, 2018, COMPUT METHOD BIOMEC, V21, P512, DOI 10.1080/10255842.2018.1487554; Sreekumar V, 2017, ARCH TOXICOL, V91, P1353, DOI 10.1007/s00204-016-1796-6; Suto Y, 2018, J TRAUMA ACUTE CARE, V85, P275, DOI 10.1097/TA.0000000000001957; Yan X, 2018, EXP THER MED, V16, P1381, DOI 10.3892/etm.2018.6339; Zhuang YF, 2013, ASIAN PAC J TROP MED, V6, P383, DOI 10.1016/S1995-7645(13)60043-7	10	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1018-3647	2213-686X		J KING SAUD UNIV SCI	J. King Saud Univ. Sci.	JUN	2020	32	4					2439	2444		10.1016/j.jksus.2020.03.035			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7MU	WOS:000537251600004		gold			2022-02-06	
J	Chen, S; Ocak, PE; Xia, Y; Zhang, H				Chen, S.; Ocak, P. E.; Xia, Y.; Zhang, H.			Intra-Arterial Onyx-18 embolization of a dural arteriovenous fistula of the sphenoparietal sinus using scepter C balloon microcatheter: Case report	NIGERIAN JOURNAL OF CLINICAL PRACTICE			English	Article						Balloon catheter; dural arteriovenous fistula; embolization; Onyx-18; sphenoparietal sinus		Dural arteriovenous fistulas (DAVFs) of the sphenoparietal sinus are extremely rare. In the present report, we describe a 46-year-old male patient who presented with headache, pulsatile tinnitus on the right side, and a single course of focal seizure starting 2 months after a closed head injury causing right temporal and occipital bone fractures. Cranial magnetic resonance imaging which was obtained 11 months after the injury showed white matter necrosis in the right frontal lobe while digital subtraction angiography (DSA) revealed a right-sided DAVF in the region of sphenoparietal sinus. The patient underwent successful intra-arterial Onyx-18 embolization using Scepter C balloon microcatheter. Complete occlusion of the fistula was confirmed by control cerebral DSA at 6-month follow-up. Thus, we conclude that double lumen Scepter C balloon microcatheter is a feasible, safe and effective treatment for intra-arterial Onyx-18 embolization of the DAVFs of the sphenoparietal sinus, particularly in cases with high tortuosity.	[Chen, S.; Zhang, H.] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, 45 Changchun St, Beijing 10053, Peoples R China; [Ocak, P. E.] Uludag Univ, Dept Neurosurg, Sch Med, Bursa, Turkey; [Xia, Y.] Cent South Univ, Affiliated Haikou Hosp, Xiangya Sch Med, Dept Neurosurg, Haikou, Hainan, Peoples R China		Zhang, H (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, 45 Changchun St, Beijing 10053, Peoples R China.	xwzhanghq@163.com	Eser, Pinar/AAI-2073-2021	Eser Ocak, Pinar/0000-0003-0132-9927			COGNARD C, 1995, RADIOLOGY, V194, P671, DOI 10.1148/radiology.194.3.7862961; Gory B, 2012, INTERV NEURORADIOL, V18, P284, DOI 10.1177/159101991201800306; Jagadeesan BD, 2013, NEUROSURGERY, V73, P238, DOI 10.1227/NEU.0000000000000186; Kim MS, 2002, J CLIN NEUROSCI, V9, P147, DOI 10.1054/jocn.2001.1029; Lebovitz J, 2020, WORLD NEUROSURG, V134, P62, DOI 10.1016/j.wneu.2019.10.112; PAKARINEN S, 1965, J NEUROSURG, V23, P438, DOI 10.3171/jns.1965.23.4.0438; Rammos S, 2014, NEUROSURG CLIN N AM, V25, P539, DOI 10.1016/j.nec.2014.04.010; Unterhofer C, 2009, ACTA NEUROCHIR, V151, P1301, DOI 10.1007/s00701-009-0251-3; Ye M, 2018, NEURORADIOLOGY, V60, P971, DOI 10.1007/s00234-018-2059-4	9	1	1	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1119-3077			NIGER J CLIN PRACT	Niger. J. Clin. Pract.	JUN	2020	23	6					879	882		10.4103/njcp.njcp_620_18			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MC6MI	WOS:000543398100021	32525126				2022-02-06	
J	Cooper, S; Bendinelli, C; Bivard, A; Parsons, M; Balogh, ZJ				Cooper, Shannon; Bendinelli, Cino; Bivard, Andrew; Parsons, Mark; Balogh, Zsolt J.			Abnormalities on Perfusion CT and Intervention for Intracranial Hypertension in Severe Traumatic Brain Injury	JOURNAL OF CLINICAL MEDICINE			English	Article						perfusion CT; traumatic brain injury; intracranial hypertension; intracranial pressure monitoring	CEREBRAL-BLOOD-FLOW; COMPUTED-TOMOGRAPHY; DECOMPRESSIVE CRANIECTOMY; XENON CT; GUIDELINES; PRESSURE; MANAGEMENT	The role of invasive intracranial pressure (ICP) monitoring in patients with severe traumatic brain injury (STBI) remain unclear. Perfusion computed tomography (CTP) provides crucial information about the cerebral perfusion status in these patients. We hypothesised that CTP abnormalities would be associated with the severity of intracranial hypertension (ICH). To investigate this hypothesis, twenty-eight patients with STBI and ICP monitors were investigated with CTP within 48 h from admission. Treating teams were blind to these results. Patients were divided into five groups based on increasing intervention required to control ICH and were compared. Group I required no intervention above routine sedation, group II required a single first tier intervention, group III required multiple different first-tier interventions, group IV required second-tier medical therapy and group V required second-tier surgical therapy. Analysis of the results showed demographics and injury severity did not differ among groups. In group I no patients showed CTP abnormality, while patients in all other groups had abnormal CTP (p= 0.003). Severe ischaemia observed on CTP was associated with increasing intervention for ICH. This study, although limited by small sample size, suggests that CTP abnormalities are associated with the need to intervene for ICH. Larger scale assessment of our results is warranted to potentially avoid unnecessary invasive procedures in head injury patients.	[Cooper, Shannon; Bendinelli, Cino; Balogh, Zsolt J.] John Hunter Hosp Newcastle, Dept Traumatol, Newcastle, NSW 2305, Australia; [Bendinelli, Cino; Bivard, Andrew; Parsons, Mark; Balogh, Zsolt J.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2300, Australia; [Bivard, Andrew; Parsons, Mark] Univ Melbourne, Dept Neurol, Melbourne, Vic 3050, Australia		Balogh, ZJ (corresponding author), John Hunter Hosp Newcastle, Dept Traumatol, Newcastle, NSW 2305, Australia.; Balogh, ZJ (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2300, Australia.	shannon.cooper@health.nsw.gov.au; cino.bendinelli@health.nsw.gov.au; andrew.bivard@newcastle.edu.au; mark.parson@health.nsw.gov.au; zsolt.balogh@health.nsw.gov.au					Amorim RL, 2012, J NEURORADIOLOGY, V39, P346, DOI 10.1016/j.neurad.2012.02.006; Bendinelli C, 2017, WORLD J SURG, V41, P2512, DOI 10.1007/s00268-017-4030-7; Bendinelli C, 2013, INJURY, V44, P1208, DOI 10.1016/j.injury.2013.03.039; Bindu T S, 2017, Indian J Radiol Imaging, V27, P268, DOI 10.4103/ijri.IJRI_454_16; Bivard A, 2011, BRAIN, V134, P3408, DOI 10.1093/brain/awr257; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen KF, 2019, EXP THER MED, V18, P2104, DOI 10.3892/etm.2019.7785; Chen KF, 2015, CHIN J TRAUMATOL, V18, P90, DOI 10.1016/j.cjtee.2015.04.001; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Dorn F, 2011, EUR RADIOL, V21, P1803, DOI 10.1007/s00330-011-2128-0; Forsyth RJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002043.pub3; Furtado AD, 2010, AM J NEURORADIOL, V31, P691, DOI 10.3174/ajnr.A1880; Honda M, 2017, NEUROCRIT CARE, V27, P308, DOI 10.1007/s12028-017-0432-5; Honda M, 2016, NEUROL MED-CHIR, V56, P501, DOI 10.2176/nmc.oa.2015-0341; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Metting Z, 2014, BRAIN COGNITION, V86, P24, DOI 10.1016/j.bandc.2014.01.012; Metting Z, 2010, J NEUROTRAUM, V27, P2183, DOI 10.1089/neu.2010.1395; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; PATCHANA T, 2019, CUREUS, V0011; Shankar JJS, 2020, AM J ROENTGENOL, V214, P872, DOI 10.2214/AJR.19.21599; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Trofimov AO, 2016, ADV EXP MED BIOL, V876, P145, DOI 10.1007/978-1-4939-3023-4_18; Wen L, 2015, BRAIN INJURY, V29, P1654, DOI 10.3109/02699052.2015.1075248; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wintermark M, 2006, J NEURORADIOLOGY, V33, P27, DOI 10.1016/S0150-9861(06)77225-X; Wintermark M, 2005, AM J NEURORADIOL, V26, P104; Wintermark M, 2004, CRIT CARE MED, V32, P1579, DOI 10.1097/01.CCM.0000130171.08842.72; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; Wintermark M, 2008, J NEURORADIOLOGY, V35, P253, DOI 10.1016/j.neurad.2008.03.005	30	1	1	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	JUN	2020	9	6							2000	10.3390/jcm9062000			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MP8NX	WOS:000552457300001	32630511	Green Published, gold			2022-02-06	
J	Drake, ED; Seckington, AS; Sullivan, SGB; Behrens, S				Drake, Emily D.; Seckington, Angela S.; Sullivan, Stephanie G. B.; Behrens, Shannan			The sensory-motor auditory visual education (SAVE) program for adults with prior concussions: a prospective case study	INTEGRATIVE MEDICINE RESEARCH			English	Article						SAVE program; Concussion; Multisensory integration; Symptomatology; Case series	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; INTEGRATION	Background: The Sensory-Motor Auditory Visual Education (SAVE) Program is an intervention that uti-lizes an accelerated multisensory integration process to facilitate neuroplasticity. This study aimed to determine if the SAVE Program might benefit individuals with residual symptoms from a prior concussion. Methods: The study consists of two 1-hour sessions per day for 5 consecutive days. Five individuals were recruited and completed a symptom questionnaire, static postural assessment, auditory detection assessment, peripheral vision assessment, and a battery of computerized cognitive tests. Results: Following the treatment program, 5 individuals showed significant (p < 0.05) improvements in various reported symptoms, significant (p < 0.05) improvements in recognizing colors further from the center of a target, and better detection of an auditory stimulus in the right ear. All tested cognitive domains improved, except for episodic memory accuracy and choice reaction time. The most notable improvements were in planning latency (29.94%), planning accuracy (19%), and working memory accu-racy (34.30%). The results of the balance assessment were mixed. Conclusion: The results suggested that the SAVE Program may be a beneficial treatment of residual symptoms from a prior concussion. However, the intrinsic caveats of a case series require more rigorous research. (C) 2020 Korea Institute of Oriental Medicine. Publishing services by Elsevier B.V.	[Drake, Emily D.; Seckington, Angela S.; Sullivan, Stephanie G. B.; Behrens, Shannan] Life Univ, Dr Sid E Williams Ctr Chiropract Res, Marietta, GA 30060 USA		Drake, ED (corresponding author), Life Univ, 1269 Barclay Circle, Marietta, GA 30060 USA.	edrake@life.edu		Behrens, Shannan/0000-0002-5621-4038; Drake, Emily/0000-0002-4127-891X			Adams J, 2017, PHYSIOTHER CAN, V69, P249, DOI [10.3138/ptc.2015-81ep, 10.3138/ptc.2015-81EP]; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Cappe C, 2009, HEARING RES, V258, P28, DOI 10.1016/j.heares.2009.04.017; Centers for Disease Control and Prevention, 2015, TRAUM BRAIN US EP RE; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Hugentobler JA, 2015, INT J SPORTS PHYS TH, V10, P676; Konigs M, 2018, ARCH PHYS MED REHAB, V99, P1149, DOI 10.1016/j.apmr.2018.01.013; Lin LF, 2015, BRAIN INJURY, V29, P41, DOI 10.3109/02699052.2014.955881; Macaluso E, 2005, TRENDS NEUROSCI, V28, P264, DOI 10.1016/j.tins.2005.03.008; Paraskevopoulos E, 2013, TRANSL NEUROSCI, V4, P337, DOI 10.2478/s13380-013-0134-1; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Stillman A, 2017, CLEV CLIN J MED, V84, P623, DOI 10.3949/ccjm.84a.16013; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158	16	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2213-4220	2213-4239		INTEGR MED RES	Integr. Med. Res.	JUN	2020	9	2							100397	10.1016/j.imr.2020.02.005			4	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	MD7DU	WOS:000544132200001	32300525	Green Published, gold			2022-02-06	
J	Faruqui, SHA; Alaeddini, A; Chang, MC; Shirinkam, S; Jaramillo, C; NajafiRad, P; Wang, J; Pugh, MJ				Faruqui, Syed Hasib Akhter; Alaeddini, Adel; Chang, Mike C.; Shirinkam, Sara; Jaramillo, Carlos; NajafiRad, Peyman; Wang, Jing; Pugh, Mary Jo			Summarizing Complex Graphical Models of Multiple Chronic Conditions Using the Second Eigenvalue of Graph Laplacian: Algorithm Development and Validation	JMIR MEDICAL INFORMATICS			English	Article						graphical models; graph summarization; graph Laplacian; disease network; multiple chronic conditions	DEPRESSION; NETWORK; MULTIMORBIDITY; DISORDERS; VETERANS	Background: It is important but challenging to understand the interactions of multiple chronic conditions (MCC) and how they develop over time in patients and populations. Clinical data on MCC can now be represented using graphical models to study their interaction and identify the path toward the development of MCC. However, the current graphical models representing MCC are often complex and difficult to analyze. Therefore, it is necessary to develop improved methods for generating these models. Objective: This study aimed to summarize the complex graphical models of MCC interactions to improve comprehension and aid analysis. Methods: We examined the emergence of 5 chronic medical conditions (ie, traumatic brain injury [TBI], posttraumatic stress disorder [PTSD], depression [Depr], substance abuse [SuAb], and back pain [BaPa]) over 5 years among 257,633 veteran patients. We developed 3 algorithms that utilize the second eigenvalue of the graph Laplacian to summarize the complex graphical models of MCC by removing less significant edges. The first algorithm learns a sparse probabilistic graphical model of MCC interactions directly from the data. The second algorithm summarizes an existing probabilistic graphical model of MCC interactions when a supporting data set is available. The third algorithm, which is a variation of the second algorithm, summarizes the existing graphical model of MCC interactions with no supporting data. Finally, we examined the coappearance of the 100 most common terms in the literature of MCC to validate the performance of the proposed model. Results: The proposed summarization algorithms demonstrate considerable performance in extracting major connections among MCC without reducing the predictive accuracy of the resulting graphical models. For the model learned directly from the data, the area under the curve (AUC) performance for predicting TBI, PTSD, BaPa, SuAb, and Depr, respectively, during the next 4 years is as follows-year 2: 79.91%, 84.04%, 78.83%, 82.50%, and 81.47%; year 3: 76.23%, 80.61%, 73.51%, 79.84%, and 77.13%; year 4: 72.38%, 78.22%, 72.96%, 77.92%, and 72.65%; and year 5: 69.51%, 76.15%, 73.04%, 76.72%, and 69.99%, respectively. This demonstrates an overall 12.07% increase in the cumulative sum of AUC in comparison with the classic multilevel temporal Bayesian network. Conclusions: Using graph summarization can improve the interpretability and the predictive power of the complex graphical models of MCC.	[Faruqui, Syed Hasib Akhter; Alaeddini, Adel; Chang, Mike C.] Univ Texas San Antonio, Dept Mech Engn, One UTSA Circle, San Antonio, TX 78249 USA; [Shirinkam, Sara] Univ Incarnate Word, Dept Math & Stat, San Antonio, TX USA; [Jaramillo, Carlos] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [NajafiRad, Peyman] Univ Texas San Antonio, Dept Informat Syst & Cyber Secur, San Antonio, TX 78249 USA; [Wang, Jing] UT Hlth San Antonio, Sch Nursing, San Antonio, TX USA; [Pugh, Mary Jo] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA		Alaeddini, A (corresponding author), Univ Texas San Antonio, Dept Mech Engn, One UTSA Circle, San Antonio, TX 78249 USA.	adel.alaeddini@utsa.edu		Wang, Jing/0000-0002-4012-0977; najafirad, peyman/0000-0001-9671-577X; Chang, Mike/0000-0003-0070-9119; Pugh, Mary Jo/0000-0003-4196-7763; Faruqui, Syed Hasib Akhter/0000-0002-5073-8690	National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [1SC2GM118266-01]; US Department of Veterans Affairs funds [I01HX000329, IK6HX002608]	This research work was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number 1SC2GM118266-01 and the US Department of Veterans Affairs funds, I01HX000329 and IK6HX002608 to MP. The sponsors played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the US Government or the US Department of Veterans Affairs, and no official endorsement should be inferred.	Akoglu L, 2010, LECT NOTES ARTIF INT, V6119, P410; Alaeddini A, 2017, METHOD INFORM MED, V56, P391, DOI 10.3414/ME16-01-0135; ALON N, 1986, COMBINATORICA, V6, P83, DOI 10.1007/BF02579166; Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; Bhattacharya R, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0964-9; Bramoweth AD, 2017, BEHAV SLEEP MED, DOI [10.1080/15402002.2017.1318752, DOI :10.1080/15402002.2017.1318752]; Buehrer G, 2008, P 2008 INT C WEB SEA, P95; Cai ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120805; Causality PJ., 2009, CAUSALITY MODELS REA, VSecond; CHAIKEN S, 1978, J COMB THEORY A, V24, P377, DOI 10.1016/0097-3165(78)90067-5; Chakrabarti D., 2004, SIGKDD, P79, DOI DOI 10.1145/1014052.1014064; Chan SY, 2012, CIRC RES, V111, P359, DOI 10.1161/CIRCRESAHA.111.258541; Chen C., 2015, P 2015 SIAM INT C DA, P559; Chierichetti F, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P219; Chung F, 2005, ANN COMB, V9, P1, DOI 10.1007/s00026-005-0237-z; Concato J, 2017, RANDOMIZED CONTROLLE, P207; Cook DJ, 1993, J ARTIF INTELL RES, V1, P231, DOI 10.1613/jair.43; COOPER GF, 1986, COMPUT METH PROG BIO, V22, P223; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1023/A:1022649401552; Corson K, 2013, J AFFECT DISORDERS, V149, P291, DOI 10.1016/j.jad.2013.01.043; Darwiche A., 2009, MODELING REASONING B; Dhillon I. S., 2003, P 9 ACM SIGKDD INT C, P89, DOI DOI 10.1145/956750.956764; Diederichs C, 2011, J GERONTOL A-BIOL, V66, P301, DOI 10.1093/gerona/glq208; Faloutsos C., 2012, CIKM, P245, DOI DOI 10.1145/2396761.2396795; Faruqui SHA, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/14452; Faruqui SHA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199768; FEINSTEIN AR, 1970, J CHRON DIS, V23, P455, DOI 10.1016/0021-9681(70)90054-8; Fenton BT, 2018, PAIN MED, V19, pS61, DOI 10.1093/pm/pny145; Fill, 2002, REVERSIBLE MARKOV CH; Fitzpatrick SL, 2015, J BEHAV MED, V38, P787, DOI 10.1007/s10865-014-9603-4; Gatti E., 2011, FLEX SERV MANUF J, V24, P496, DOI DOI 10.1007/S10696-011-9131-2]; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gore R, 2008, 2008 WINTER SIMULATION CONFERENCE, VOLS 1-5, P712, DOI 10.1109/WSC.2008.4736133; Graham FC, 1997, PAGE REGIONAL C SERI; Gunn JM, 2012, SOC PSYCH PSYCH EPID, V47, P175, DOI 10.1007/s00127-010-0330-z; Haibach JP, 2017, J BEHAV MED, V40, P175, DOI 10.1007/s10865-016-9794-y; HARARY F, 1979, PAC J MATH, V80, P443, DOI 10.2140/pjm.1979.80.443; Heckerman D, 2008, STUD COMPUT INTELL, V156, P33; Hunter G, 2015, PSYCHIAT SERV, V66, P952, DOI 10.1176/appi.ps.201400286; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; KAHN AB, 1962, COMMUN ACM, V5, P558, DOI 10.1145/368996.369025; Kang U, 2009, IEEE DATA MINING, P229, DOI 10.1109/ICDM.2009.14; Karypis G, 1998, J PARALLEL DISTR COM, V48, P96, DOI 10.1006/jpdc.1997.1404; Koutra D, 2015, STAT ANAL DATA MIN, V8, P183, DOI 10.1002/sam.11267; Lappenschaar M, 2013, J CLIN EPIDEMIOL, V66, P1405, DOI 10.1016/j.jclinepi.2013.06.018; LeFevre K., 2010, P SIAM INT C DAT MIN, DOI DOI 10.1137/1.9781611972801.40; Li CT, 2009, 2009 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING, P255, DOI 10.1109/ASONAM.2009.38; Li L, 2015, P 2015 SIAM INT C DA, P280, DOI [10.1137/1.978, DOI 10.1137/1.9781611974010.32]; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lim Y, 2014, IEEE T KNOWL DATA EN, V26, P3077, DOI 10.1109/TKDE.2014.2320716; Liu YK, 2018, ACM COMPUT SURV, V51, DOI 10.1145/3186727; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Low Y, 2012, PROC VLDB ENDOW, V5, P716, DOI 10.14778/2212351.2212354; Lu X, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100138; Maccioni A, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1755, DOI 10.1145/2939672.2939856; Maglogiannis I, 2006, J BIOMED INFORM, V39, P637, DOI 10.1016/j.jbi.2005.10.003; Magnavita N, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111347; Mastrocola EL, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0331-9; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; Miettinen P, 2014, ACM T KNOWL DISCOV D, V8, DOI 10.1145/2601437; Murray BS, 2010, MOL BIOSYST, V6, P1853, DOI 10.1039/c003961f; NEWMAN MEJ, 2004, PHYS REV E 2, V69, DOI DOI 10.1103/PHYSREVE.69.026113; Ng AY, 2002, ADV NEUR IN, V14, P849; Pearl J., 1988, PROBABILISTIC REASON; Pepe M S, 2003, STAT EVALUATION MED; Peterson J, 2016, INT J HIGH ED, V6, P1, DOI [10.5430/ijhe.v6n1p1, DOI 10.5430/IJHE.V6N1P1]; Pradhan M., 1994, Uncertainty in Artificial Intelligence. Proceedings of the Tenth Conference (1994), P484; Prakash BA, 2012, KNOWL INF SYST, V33, P549, DOI 10.1007/s10115-012-0520-y; Pugh MJ, 2018, ARCH PHYS MED REHAB, V99, pS40, DOI 10.1016/j.apmr.2017.05.021; Purohit M, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P1296, DOI 10.1145/2623330.2623701; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Sandri M, 2014, J BIOMED INFORM, V48, P106, DOI 10.1016/j.jbi.2013.12.008; Shen ZQ, 2006, IEEE T VIS COMPUT GR, V12, P1427, DOI 10.1109/TVCG.2006.107; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Swartz JA, 2011, J URBAN HEALTH, V88, P700, DOI 10.1007/s11524-011-9554-9; Tarjan R., 1972, SIAM Journal on Computing, V1, P146, DOI 10.1137/0201010; Thabrew H, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012488.pub2; Toivonen Hannu, 2011, KDD, P965; Tong H, 2014, P 2014 SIAM INT C DA, P325, DOI DOI 10.1137/1.9781611973440.37; Tsamardinos I, 2006, MACH LEARN, V65, P31, DOI 10.1007/s10994-006-6889-7; Vreeken, 2011, P 17 ACM SIGKDD INT, P51; Yang W, 2003, P S REL DISTR SYST, DOI [10.1109/reldis.2003.1238052, DOI 10.1109/RELDIS.2003.1238052]; Yang YY, 2013, PROCEEDINGS OF THE 2013 8TH INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE & EDUCATION (ICCSE 2013), P587; Zis P, 2017, CLIN INTERV AGING, V12, P709, DOI 10.2147/CIA.S113576	85	1	1	0	0	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA		2291-9694		JMIR MED INF	JMIR Med. Inf.	JUN	2020	8	6							e16372	10.2196/16372			20	Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Medical Informatics	MG9YS	WOS:000546388900007	32554376	Green Published, gold			2022-02-06	
J	Gesslein, M; Frodl, A; Millrose, M; Biber, R; Bail, HJ; Wolpert, AK				Gesslein, Markus; Frodl, Andreas; Millrose, Michael; Biber, Roland; Bail, Hermann Josef; Wolpert, Alexander Karl			How dangerous is American football in a German amateur league? An injury analysis according to playing position over a period of four seasons	UNFALLCHIRURG			English	Article						Athletic injuries; Injury rates; Amateur sports; Shoulder injuries; Knee injuries	HIGH-SCHOOL; COLLEGIATE FOOTBALL; EPIDEMIOLOGY; SPORTS; TEAM	Background. American football is known for its high risk of injury, especially in the professional field. Although the number of players in the German football league (GFL) has risen in recent years, data concerning the injury rates of German amateur players in American football are scarce. Objective. Analysis of the injury rates in league games and training sessions in amateur football according to playing positions and body region. Material and methods. Injuries of 123 American football players in a club playing in the second GFL (first and second team) were prospectively recorded over a period of 4 seasons (2014-2018). A complete history of injuries was obtained from 72 players. The injuries were classified using the Orchard sports injury classification system 10.1 (OSICS 10.1). The injury rates were calculated per 1000 athlete exposures (AE) for training as well as for league games with respect to the playing position and for each body region. Results. Overall 142 injuries were recorded. On average there were 35.5 injuries per season and 1.9 injuries per player. Of the injuries 54.7% occurred during training and 46.1% during games. The risk of injury was significantly increased during league games (15.6 +/- 16.3) compared to training (3.1 +/- 2.7, p<0.0001). While wide receivers and cornerbacks had the highest overall injury rates, running backs had the highest injury risk during games (p=0.046). Injuries to knees (27.3%) and shoulders (20.1%) were the most frequent. The shoulder was the body region injured most frequently during games (p=0.002). Regarding the injury pattern, distorsions (30.9%) and contusions (22.5%) occurred more often compared to fractures (12.6%) and dislocations (16.1%). Concussion only contributed to 2.9% of the injuries. Conclusion. American football is a contact sport with high injury rates even in the German amateur field, especially during league games. Regarding body regions, shoulders and knees were predominantly affected while regarding the playing position, wide receivers and cornerbacks were particularly jeopardized. Therefore, a continuous close medical supervision during games and an intensive position-specific training seem to be necessary even in the amateur field in order to reduce the injury rate.	[Gesslein, Markus; Frodl, Andreas; Bail, Hermann Josef; Wolpert, Alexander Karl] Paracelsus Med Privatuniv Nurnberg, Klinikum Nurnberg Sud, Klin Orthopadie & Unfallchirurg, Breslauer Str 201, D-90471 Nurnberg, Germany; [Millrose, Michael] BG Unfallklin Murnau, Murnau, Germany; [Biber, Roland] Kliniken Dr Erler gGmbH, Klin Unfallchirurg, Nurnberg, Germany		Gesslein, M (corresponding author), Paracelsus Med Privatuniv Nurnberg, Klinikum Nurnberg Sud, Klin Orthopadie & Unfallchirurg, Breslauer Str 201, D-90471 Nurnberg, Germany.	markus.gesslein@klinikum-nuernberg.de	Millrose, Michael/AAI-2406-2020; Frodl, Andreas/AAM-9014-2021; Biber, Roland/AAP-6691-2021; GeSSlein, Markus/O-4858-2019	Millrose, Michael/0000-0002-8856-6441; GeSSlein, Markus/0000-0003-3863-1580			Baltzer A W, 1998, Unfallchirurgie, V24, P60, DOI 10.1007/BF02044355; Baltzer A W, 1997, Knee Surg Sports Traumatol Arthrosc, V5, P46, DOI 10.1007/s001670050024; Beaulieu-Jones BR, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117708744; Bowy E, 2016, AM FOOTBALL KICK OFF; DELEE JC, 1992, AM J SPORT MED, V20, P575, DOI 10.1177/036354659202000515; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Emery CA, 1999, CLIN J SPORT MED, V9, P151, DOI 10.1097/00042752-199907000-00006; Feeley BT, 2008, AM J SPORT MED, V36, P1597, DOI 10.1177/0363546508316021; Fukuda T, 2012, EPIDEMIOLOGY COLLEGI; Hagel BE, 2003, AM J EPIDEMIOL, V157, P825, DOI 10.1093/aje/kwg050; Iguchi J, 2013, J ATHL TRAINING, V48, P818, DOI 10.4085/1062-6050-48.4.15; Jackson RW, 1991, CLIN J SPORT MED, V1, P1; Junge A, 2008, BRIT J SPORT MED, V42, P413, DOI 10.1136/bjsm.2008.046631; Krutsch W, 2018, SPORTVERLETZ SPORTSC, V32, P111, DOI 10.1055/s-0583-3792; Mathews EM, 2008, J AM COLL HEALTH, V57, P33, DOI 10.3200/JACH.57.1.33-38; PRITCHETT JW, 1982, J BONE JOINT SURG AM, V64, P240, DOI 10.2106/00004623-198264020-00015; Rae K, 2005, BRIT J SPORT MED, V39, P907, DOI 10.1136/bjsm.2004.017517; SAAL JA, 1991, SPORTS MED, V12, P132, DOI 10.2165/00007256-199112020-00005; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Walden M, 2018, UNFALLCHIRURG, V121, P470, DOI 10.1007/s00113-018-0496-5; Whiteside J A, 1985, Phys Sportsmed, V13, P102, DOI 10.1080/00913847.1985.11708730; Willigenburg NW, 2016, AM J SPORT MED, V44, P753, DOI 10.1177/0363546515622389; Zuckerman SL, 2018, BRIT J SPORT MED, V52, P261, DOI 10.1136/bjsports-2016-096005	23	1	1	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	JUN	2020	123	6			SI		473	478		10.1007/s00113-019-00743-z			6	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	NR2KM	WOS:000571391600001	31720735				2022-02-06	
J	Gorleku, PN; Edzie, EK; Dzefi-Tettey, K; Setorglo, J; Piersson, AD; Ocansey, S; Morny, EKA; Armah, CDG				Gorleku, Philip N.; Edzie, Emmanuel K.; Dzefi-Tettey, Klenam; Setorglo, Jacob; Piersson, Albert D.; Ocansey, Stephen; Morny, Enyam K. A.; Armah, Celso D. G.			Computed tomography estimation of the prevalence of neuro-ophthalmic injuries in head trauma patients seen in a tertiary health facility in Ghana	HELIYON			English	Article						Neuroscience; Public health; Disability; Medical imaging; Radiology; Clinical research; Health promotion; Diagnostics; Road traff ic accident; Traumatic brain injury; Neuro-ophthalmic injury; CT scan; Clinical audit; Vision loss	GLOBE; MANIFESTATIONS; CT	Introduction: Prevalence of traumatic brain injury (TBI) is extremely high and potentially associated with severe incapacitating consequences. Literature reports that 90% of road traf fic deaths and injuries including TBI occur in low and middle -income countries including Ghana. Computed Tomography (CT) scan is the imaging modality of choice for the initial assessment of the extent of head injury. Some Neuro-ophthalmic injuries (NOI) may sometimes be ambiguous and indistinct although a serious injury with potential damaging consequences. Data on the prevalence of NOI post trauma is non-existent in Ghana to inform policy. The onus therefore lies on the Radiologist who will review the head CT scan to be very meticulous not to miss any NOI if present. We therefore decided to diligently review a large cross-sectional retrospective post trauma head CT scans for occurrence of NOI. Objective: To determine the incidence of NOI secondary to head trauma and the possible loss of vision thereof in a retrospective study using patients' head CT scan data from a tertiary hospital's CT centre in Cape Coast, Ghana. Method: All head CT scans secondary to trauma for the period January 2016 to December 2018, were retrieved and carefully analysed. A total number of 1043 of head CT scan images were analyzed by Consultant Radiologists. Results: Results showed out of 1043 CT scans reviewed, 742 (71,1%) were males and 301 (28.9%) were females. A total of 609 (58.4%) out of the 1043 patients sustained NOIs of various anatomical types. More Males 398 (65.4%) sustained NOI than females 211 (34.6%). The incidence of NOI was more among the youth as majority 167 (27.4%) of the patients were within the 18 -29 years followed by 30 -39 years bracket of 148 (24.3%). Fourteen anatomical types of NOI were elicited and further analysis revealed, intra-ocular foreign body to be the highest 107 (17.6%) cases, orbital floor fractures injury was 92 (15.1%) cases, with globe rupture injury and intraocular hemorrhage recording 79 (13.0%) cases each. Optic nerve injury was the least revealing 7 (1.1%) cases. There was a relationship between the gender of patient and the propensity to sustain NOI as males were more disposed to NOI than females. Road traf fic accident (RTA) was the main pervasive cause of TBI and this accounted for 71.9% of all cases, followed by fall from height 24%, and the least cause of TBI was ascribed to gunshot injury of 0.33%. Conclusion: Prevalence of NOI is high. Urgent measures must therefore be implemented to reduce the RTA menace in general and to mitigate the associated NOI and possible loss of vision thereof.	[Gorleku, Philip N.; Edzie, Emmanuel K.] Univ Cape Coast, Sch Med Sci, Dept Med Imaging, Coll Hlth & Allied Sci, Cape Coast, Ghana; [Gorleku, Philip N.; Edzie, Emmanuel K.; Setorglo, Jacob; Piersson, Albert D.; Ocansey, Stephen; Morny, Enyam K. A.; Armah, Celso D. G.] PMB Univ Cape Coast, Cape Coast, Ghana; [Dzefi-Tettey, Klenam] Korle Bu Teaching Hosp, Dept Radiol, Accra, Ghana; [Dzefi-Tettey, Klenam] PMB, Accra, Ghana; [Setorglo, Jacob] Univ Cape Coast, Sch Med Sci, Dept Med Biochem, Coll Hlth & Allied Sci, Cape Coast, Ghana; [Piersson, Albert D.] Univ Cape Coast, Sch Allied Hlth Sci, Dept Imaging Technol & Sonog, Coll Hlth & Allied Sci, Cape Coast, Ghana; [Ocansey, Stephen; Morny, Enyam K. A.; Armah, Celso D. G.] Univ Cape Coast, Sch Allied Hlth Sci, Dept Optometry, Coll Hlth & Allied Sci, Cape Coast, Ghana		Gorleku, PN (corresponding author), Univ Cape Coast, Sch Med Sci, Dept Med Imaging, Coll Hlth & Allied Sci, Cape Coast, Ghana.; Gorleku, PN (corresponding author), PMB Univ Cape Coast, Cape Coast, Ghana.	pgorleku@ucc.edu.gh	EDZIE, EMMANUEL KOBINA MESI/ABD-1211-2020	EDZIE, EMMANUEL KOBINA MESI/0000-0002-5485-2386; Ocansey, Stephen/0000-0002-3992-0969; DZEFI-TETTEY, KLENAM/0000-0002-6322-5341; Gorleku, Philip/0000-0002-6225-2284			[Anonymous], 2019, GEN NEWS WEDNESDAY; Brau RH, 2018, P R HEALTH SCI J, V37, P67; Catalano R.A., 1992, OCULAR EMERGENCIES; Chaudhary R, 2015, EYE, V29, P867, DOI 10.1038/eye.2015.39; Chaudhry IA, 2008, GRAEF ARCH CLIN EXP, V246, P181, DOI 10.1007/s00417-007-0586-5; Farzaneh E, 2017, EMERG MED INT, V2017, DOI 10.1155/2017/1439486; GE Healthcare Partners, 2018, WORKF REV RAD AL DEM; Ghana Urbanisation Think Tank, 2019, GHANA URBANISATION T; Guly CM, 2006, EMERG MED J, V23, P915, DOI 10.1136/emj.2006.038562; Iinuma T., 1994, Rhinology (Utrecht), V32, P81; KERSTEN RC, 1987, AM J OPHTHALMOL, V103, P215, DOI 10.1016/S0002-9394(14)74230-8; Kubal WS, 2008, RADIOGRAPHICS, V28, P1729, DOI 10.1148/rg.286085523; Kuhn Ferenc, 2002, Ophthalmol Clin North Am, V15, P145, DOI 10.1016/S0896-1549(02)00005-6; Kulkarni AR, 2005, EYE, V19, P1257, DOI 10.1038/sj.eye.6701753; Lee AG, 2000, SURV OPHTHALMOL, V45, P237, DOI 10.1016/S0039-6257(00)00152-1; Lima LB, 2015, REV PORT ESTOMATOL M, V56, P122, DOI 10.1016/j.rpemd.2015.04.010; Morcos SK, 2001, EUR RADIOL, V11, P1267, DOI 10.1007/s003300000729; Pieramici DJ, 2003, J TRAUMA, V54, P750, DOI 10.1097/01.TA.0000047053.53821.C8; Piersson A.D, 2017, RADIOGRAPHY, V23, P75; Rhea JT, 1999, RADIOL CLIN N AM, V37, P489, DOI 10.1016/S0033-8389(05)70108-1; Shams-Vahdati S, 2015, INJURY, V46, P1238, DOI 10.1016/j.injury.2014.10.056; Sung EK, 2014, RADIOGRAPHICS, V34, P764, DOI 10.1148/rg.343135120; Van Stavern GP, 2001, J NEURO-OPHTHALMOL, V21, P112, DOI 10.1097/00041327-200106000-00012; Walle T.A., 2018, INT J AFR NURS SCI, V9, P57; World Health Organisation, 2016, HUM RES HLTH OBS, V17, P1; Yuan WH, 2014, AM J ROENTGENOL, V202, P1100, DOI 10.2214/AJR.13.11010	26	1	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND		2405-8440		HELIYON	Heliyon	JUN	2020	6	6							e04200	10.1016/j.heliyon.2020.e04200			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MG1LG	WOS:000545793800017	32613105	Green Published, gold			2022-02-06	
J	Gravel, J; Ledoux, AA; Tang, K; Yeates, KO; Craig, W; Osmond, M; Boutis, K; Burns, E; Sangha, G; Dubrovsky, AS; Beer, D; Zemek, R				Gravel, Jocelyn; Ledoux, Andree-Ann; Tang, Ken; Yeates, Keith Owens; Craig, William; Osmond, Martin; Boutis, Kathy; Burns, Emma; Sangha, Gurinder; Dubrovsky, Alexander Sasha; Beer, Darcy; Zemek, Roger			Early versus delayed emergency department presentation following mild Traumatic Brain Injury and the presence of symptom at 1, 4 and 12 weeks in children	EMERGENCY MEDICINE JOURNAL			English	Article						trauma; head; paediatric injury; paediatric emergency med	CONCUSSION	Objectives We evaluated the association between timing of presentation and postconcussive symptoms (PCS) at 1, 4 and 12 weeks after injury. Methods This was a secondary analysis of a prospective cohort study conducted in nine Canadian paediatric EDs in 2013-2015 (5P study). Participants were children who suffered a head injury within the preceding 48 hours and met Zurich consensus concussion diagnostic criteria. The exposure was the time between head injury and ED presentation. The primary outcome was the presence of PCS at 1 week defined by the presence of at least three symptoms on the Post-Concussion Symptom Inventory (PCSI). Secondary outcomes evaluated PCS at 4 and 12 weeks. Multivariable logistic regression analyses were adjusted for ED PCSI and other potential confounders. Results There were 3041 patients with a concussion in which timing of the injury was known. 2287 (75%) participants sought care in the first 12 hours, 388 (13%) 12-24 hours after trauma and 366 (12%) between 24 and 48 hours. Compared with children who sought care >24 hours after trauma, children who sought care in the first 12 hours had a significantly lower incidence of PCS at 1 week (OR: 0.55 (95% CI 0.41 to 0.75)) and 4 weeks (OR: 0.74 (95% CI 0.56 to 0.99)) but not at 12 weeks (OR: 0.88 (95% CI 0.63 to 1.23)). Conclusions Patients who present early after a concussion appear to have a shorter duration of PCS than those presenting more than 12 hours later. Patients/families should be informed of the higher probability of PCS in children with delayed presentation.	[Gravel, Jocelyn] CHU St Justine, Dept Pediat, Montreal, PQ H3T 1C5, Canada; [Gravel, Jocelyn] Univ Montreal, Paediat, Montreal, PQ, Canada; [Ledoux, Andree-Ann; Tang, Ken] CHEO Res Inst, Ottawa, ON, Canada; [Yeates, Keith Owens] Univ Calgary, Psychol, Calgary, AB, Canada; [Craig, William] Stollery Childrens Hosp, Pediat, Edmonton, AB, Canada; [Osmond, Martin; Zemek, Roger] CHEO, Pediat, Ottawa, ON, Canada; [Boutis, Kathy] Hosp Sick Children, Res Inst, Pediat, Toronto, ON, Canada; [Boutis, Kathy; Sangha, Gurinder] Childrens Hosp, Paediat, London, ON, Canada; [Burns, Emma] Dalhousie Univ, Emergency, Halifax, NS, Canada; [Dubrovsky, Alexander Sasha] Montreal Childrens Hosp, Pediat Emergency, Montreal, PQ, Canada; [Beer, Darcy] Univ Manitoba, Pediat, Winnipeg, MB, Canada		Gravel, J (corresponding author), CHU St Justine, Dept Pediat, Montreal, PQ H3T 1C5, Canada.	graveljocelyn@hotmail.com	Yeates, Keith/AAJ-4223-2020	Boutis, Kathy/0000-0001-5863-0177; Craig, William/0000-0002-4804-194X; Gravel, Jocelyn/0000-0001-5901-4990; Burns, Emma/0000-0001-8042-7124	Canadian Institute of Research HealthCanadian Institutes of Health Research (CIHR) [293380]	This work was supported by the Canadian Institute of Research Health (grant number 293380).	Amoo-Achampong K, 2017, PHYSICIAN SPORTSMED, V45, P239, DOI 10.1080/00913847.2017.1327304; Bialy L, 2018, PEDIATR EMERG CARE, V34, P138, DOI 10.1097/PEC.0000000000001360; Borland ML, 2019, ANN EMERG MED, V74, P1, DOI 10.1016/j.annemergmed.2018.11.035; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Howell DR, 2018, AM J SPORT MED, V46, P3254, DOI 10.1177/0363546518796830; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Team RC, 2018, R LANG ENV STAT COMP; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	16	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JUN	2020	37	6					338	343		10.1136/emermed-2019-209054			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	LY6DV	WOS:000540618900009	32139516				2022-02-06	
J	Hardy, MS; Kennedy, JE; Cooper, DB				Hardy, Morgan S.; Kennedy, Jan E.; Cooper, Douglas B.			Patient Attribution of Posttraumatic Symptoms to Brain Injury Versus PTSD in Military-Related Mild TBI	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							PERSISTENT POSTCONCUSSIVE SYMPTOMS; STRESS-DISORDER; HEAD-INJURY; VETERANS; SOLDIERS; HEALTH; AFGHANISTAN; ASSOCIATION; DEPRESSION; COMPLAINTS	Objective: Persistent cognitive, somatic, and neuropsychiatric symptoms following mild traumatic brain injury (TBI) are influenced by posttraumatic stress disorder (PTSD), particularly in military patients. The authors evaluated the degree to which military service members with a history of mild TBI attributed posttraumatic symptoms to TBI versus PTSD. Methods: Service members (N=372) with mild TBI were surveyed about the severity of posttraumatic symptoms across four symptom clusters (cognitive, affective, somatosensory, and vestibular) with the Neurobehavioral Symptom Inventory (NSI). Participants rated the degree to which they believed TBI, PTSD, or other conditions contributed to their symptoms. Differences in cognitive, affective, somatosensory, and vestibular symptom severity were evaluated across participants with TBI, PTSD, or combined TBI-PTSD attribution. Logistic regression was used to evaluate the association between symptom profiles and attribution. Results: Participants attributed symptoms mostly to TBI, followed by insufficient sleep, PTSD, chronic pain, depression, and deployment-readjustment stress. PTSD and combined TBI-PTSD attribution were associated with higher total NSI scores (39.5 and 51.6, respectively), compared with TBI attribution only (31.4) (F=29.08, df=3, 358, p<0.01), as well as higher scores in every symptom category. More severe affective symptoms were associated with decreased odds of TBI attribution (odds ratio=0.90, 95% CI=0.83-0.97) and increased odds of PTSD attribution (odds ratio= 1.14, 95% CI=1.03-1.26). A PTSD diagnosis was highly associated with PTSD attribution (odds ratio=2.44, 95% CI=1.07-5.58). Conclusions: The nature and severity of posttraumatic symptoms appear to play a role in patient beliefs about the causes of symptoms, whether from TBI or PTSD.	[Hardy, Morgan S.] Wilford Hall Ambulatory Surg Ctr, 59th Med Wing, San Antonio, TX 78236 USA; [Hardy, Morgan S.; Cooper, Douglas B.] Univ Texas Hlth San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Kennedy, Jan E.] Brooke Army Med Ctr, Def & Vet Brain Injury Ctr, San Antonio, TX USA; [Kennedy, Jan E.; Cooper, Douglas B.] Gen Dynam Informat Technol, Falls Church, VA USA; [Cooper, Douglas B.] Audie L Murphy Mem VA Hosp, Def & Vet Brain Injury Ctr, San Antonio Polytrauma Rehabil Ctr, San Antonio, TX USA		Hardy, MS (corresponding author), Wilford Hall Ambulatory Surg Ctr, 59th Med Wing, San Antonio, TX 78236 USA.; Hardy, MS (corresponding author), Univ Texas Hlth San Antonio, Dept Psychiat, San Antonio, TX 78229 USA.	hardym@uthscsa.edu					[Anonymous], 2018, WORLDW TBI NUMB; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Carlson K, 2009, VA EVIDENCE SYNTHESI; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; DePalma RG, 2018, BEHAV BRAIN RES, V340, P102, DOI 10.1016/j.bbr.2016.08.036; Department of Veterans Affairs & Department of Defense, 2016, VA DOD CLIN PRACT GU; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dismuke Clara E, 2015, Glob J Health Sci, V7, P156, DOI 10.5539/gjhs.v7n6p156; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Finn JA, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000357; Hardy M, J HEAD TRAUMA REHABI; Hebert JR, 2018, J HEAD TRAUMA REHAB, V33, P403, DOI 10.1097/HTR.0000000000000385; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Larson EB, 2013, J INT NEUROPSYCH SOC, V19, P88, DOI 10.1017/S1355617712000999; Martindale SL, 2017, NEUROPSYCHOLOGY, V31, P93, DOI 10.1037/neu0000312; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Neurobehavioral Symptom Inventory (NSI), 2014, NEUR SYMPT INV NSI R; Ouellet MC, 2018, J NEUROTRAUM, V35, P1620, DOI 10.1089/neu.2017.5379; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604	34	1	1	1	1	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	2020	32	3					252	258		10.1176/appi.neuropsych.19090202			7	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	MV7XN	WOS:000556565800083	32054399				2022-02-06	
J	Harrigan, MR; Griffin, RL; Deveikis, JP; Prattipati, V; Chimowitz, MI; Jansen, JO				Harrigan, Mark R.; Griffin, Russell L.; Deveikis, John P.; Prattipati, Veeranjaneyulu; Chimowitz, Marc I.; Jansen, Jan O.			New ischemic lesions on brain magnetic resonance imaging in patients with blunt traumatic cerebrovascular injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic dissection; ischemic stroke; brain MRI	VERTEBRAL ARTERY INJURIES; SCREENING CRITERIA; VALVE-REPLACEMENT; DIAGNOSIS; OUTCOMES; STROKE; BCVI; DISSECTIONS; ANGIOGRAPHY; DEFINITION	BACKGROUND Patients with blunt cerebrovascular injuries are at risk of thromboembolic stroke. Although primary prevention with antithrombotic therapy is widely used in this setting, its effectiveness is not well defined and requires further investigation. The aim of this study was to evaluate the utility of magnetic resonance imaging (MRI)-detected ischemic brain lesions as a possible future outcome for randomized clinical trials in this patient population. METHODS This prospective observational study included 20 adult blunt trauma patients admitted to a level I trauma center with a screening neck CTA showing extracranial carotid or vertebral artery injury. All subjects lacked initial evidence of an ischemic stroke and were managed with antithrombotic therapy and observation and then underwent brain MRI within 30 days of the injury to assess for ischemic lesions. The MRI scans included diffusion, susceptibility, and Fluid-attenuated Inversion Recovery (FLAIR) sequences, and were reviewed by two neuroradiologists blinded to the computed tomography angiography (CTA) findings. RESULTS Eleven CTAs were done in the emergency department upon admission. There were 12 carotid artery dissections and 11 unilateral or bilateral vertebral artery injuries. Median interval between injury and MRI scan was 4 days (range, 0.1-14; interquartile range, 3-7 days). Diffusion-weighted imaging evidence of new ischemic lesions was present in 10 (43%) of 23 of the injured artery territories. In those injuries with ischemic lesions, the median number was 8 (range, 2-25; interquartile range, 5-8). None of the lesions were symptomatic. Blunt cerebrovascular injury was associated with a higher mean ischemic lesion count (mean count of 3.17 vs. 0.14,p< 0.0001), with the association remaining after adjusting for injury severity score (p< 0.0001). CONCLUSION In asymptomatic blunt trauma patients with CTA evidence of extracranial cerebrovascular injury and treated with antithrombotic therapy, nearly half of arterial injuries are associated with ischemic lesions on MRI.	[Harrigan, Mark R.] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL USA; [Griffin, Russell L.; Jansen, Jan O.] Univ Alabama Birmingham, Ctr Injury Sci, 1922 7th Ave S, Birmingham, AL 35294 USA; [Deveikis, John P.] Johns Hopkins All Childrens Hosp, Dept Radiol, St Petersburg, FL USA; [Prattipati, Veeranjaneyulu] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL USA; [Chimowitz, Marc I.] Med Univ South Carolina, Dept Neurol, Charleston, SC 29425 USA		Jansen, JO (corresponding author), Univ Alabama Birmingham, Ctr Injury Sci, 1922 7th Ave S, Birmingham, AL 35294 USA.	jjansen@uabmc.edu			University of Alabama, Birmingham Radiology/CCTS Pilot Research Initiative	This work was supported by a grant from the University of Alabama, Birmingham Radiology/CCTS Pilot Research Initiative.	[Anonymous], 2017, BACKGR BIOL EFF RAD; Bensch FV, 2019, EMERG RADIOL, V26, P365, DOI 10.1007/s10140-019-01677-0; Berne JD, 2009, J TRAUMA, V67, P1333, DOI 10.1097/TA.0b013e31818888c7; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Bonati LH, 2010, LANCET NEUROL, V9, P353, DOI 10.1016/S1474-4422(10)70057-0; Brandt T, 2001, NEUROLOGY, V57, P24, DOI 10.1212/WNL.57.1.24; Burlew CC, 2018, J TRAUMA ACUTE CARE, V85, P858, DOI 10.1097/TA.0000000000001989; Crawford JD, 2015, JAMA SURG, V150, P841, DOI 10.1001/jamasurg.2015.1692; DiCocco JM, 2011, J AM COLL SURGEONS, V212, P549, DOI 10.1016/j.jamcollsurg.2010.12.035; Dutra Aurélio Pimenta, 2012, Dement. neuropsychol., V6, P127, DOI 10.1590/S1980-57642012DN06030003; Eastman AL, 2006, J TRAUMA, V60, P925, DOI 10.1097/01.ta.0000197479.28714.62; Eastwood JD, 2003, AM J NEURORADIOL, V24, P680; Emmett KP, 2011, J TRAUMA, V70, P1058, DOI 10.1097/TA.0b013e318213f849; Fassett DR, 2008, J SPINAL DISORD TECH, V21, P252, DOI 10.1097/BSD.0b013e3180cab162; Franz RW, 2012, J AM COLL SURGEONS, V214, P313, DOI 10.1016/j.jamcollsurg.2011.11.012; Geddes AE, 2016, AM J SURG, V212, P1167, DOI 10.1016/j.amjsurg.2016.09.016; Gensicke H, 2015, J AM COLL CARDIOL, V65, P521, DOI 10.1016/j.jacc.2014.11.038; Griessenauer CJ, 2016, J NEUROSURG, V124, P305, DOI 10.3171/2015.1.JNS142840; Griessenauer CJ, 2013, J NEUROSURG, V118, P397, DOI 10.3171/2012.11.JNS121038; Grigorian A, 2018, SURGERY, V164, P494, DOI 10.1016/j.surg.2018.04.032; Harrigan MR, 2014, J NEUROTRAUM, V31, P1056, DOI 10.1089/neu.2013.3309; Harrigan MR, 2011, WORLD J EMERG SURG, V6, DOI 10.1186/1749-7922-6-11; Hoit DA, 2008, J SPINAL DISORD TECH, V21, P259, DOI 10.1097/BSD.0b013e318141fce8; Howard VJ, 2017, INT J STROKE, V12, P770, DOI 10.1177/1747493017706238; Hrbac T, 2017, TRIALS, V18, DOI 10.1186/s13063-016-1754-x; Knipp SC, 2005, EUR J CARDIO-THORAC, V28, P88, DOI 10.1016/j.ejcts.2005.02.043; Lell MM, 2006, RADIOGRAPHICS, V26, pS45, DOI 10.1148/rg.26si065508; Manninen AL, 2012, AM J NEURORADIOL, V33, P2038, DOI 10.3174/ajnr.A3123; McNutt MK, 2018, INJURY, V49, P67, DOI 10.1016/j.injury.2017.07.036; Morton RP, 2014, J NEUROSURG, V120, P1446, DOI 10.3171/2014.2.JNS131658; Newhall K, 2016, ANN VASC SURG, V36, P145, DOI 10.1016/j.avsg.2016.06.001; Orlowski HLP, 2018, CLIN NEUROL NEUROSUR, V172, P27, DOI 10.1016/j.clineuro.2018.06.001; Park MS, 2009, J TRAUMA, V67, P266, DOI 10.1097/TA.0b013e3181ae6f1c; Rodallec MH, 2008, RADIOGRAPHICS, V28, P1711, DOI 10.1148/rg.286085512; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Saver JL, 2008, STROKE, V39, P3110, DOI 10.1161/STROKEAHA.108.518415; Stein DM, 2009, J TRAUMA, V66, P132, DOI 10.1097/TA.0b013e318142d146; Van Belle E, 2016, J AM COLL CARDIOL, V68, P589, DOI 10.1016/j.jacc.2016.05.006; Vanninen R, 1998, ARCH NEUROL-CHICAGO, V55, P618, DOI 10.1001/archneur.55.5.618; Volker W, 2011, NEUROLOGY, V76, P1463, DOI 10.1212/WNL.0b013e318217e71c; Weber CD, 2018, WORLD J SURG, V42, P2043, DOI 10.1007/s00268-017-4408-6	41	1	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUN	2020	88	6					796	802		10.1097/TA.0000000000002660			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	NE5VY	WOS:000562670100031	32176175				2022-02-06	
J	Higgins, JP; Elliott, JM; Parrish, TB				Higgins, J. P.; Elliott, J. M.; Parrish, T. B.			Brain Network Disruption in Whiplash	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							CERVICAL EXTENSOR MUSCLES; NECK-DISABILITY-INDEX; CEREBRAL-BLOOD-FLOW; FUNCTIONAL CONNECTIVITY; MODULAR ORGANIZATION; FAT INFILTRATION; INJURY PATIENTS; SYMPTOMS; MODEL; CONCUSSION	BACKGROUND AND PURPOSE: Whiplash-associated disorders frequently develop following motor vehicle collisions and often involve a range of cognitive and affective symptoms, though the neural correlates of the disorder are largely unknown. In this study, a sample of participants with chronic whiplash injuries were scanned by using resting-state fMRI to assess brain network changes associated with long-term outcome metrics. MATERIALS AND METHODS: Resting-state fMRI was collected for 23 participants and used to calculate network modularity, a quantitative measure of the functional segregation of brain region communities. This was analyzed for associations with whiplash-associated disorder outcome metrics, including scales of neck disability, traumatic distress, depression, and pain. In addition to these clinical scales, cervical muscle fat infiltration was quantified by using Dixon fat-water imaging, which has shown promise as a biomarker for assessing disorder severity and predicting recovery in chronic whiplash. RESULTS: An association was found between brain network structure and muscle fat infiltration, wherein lower network modularity was associated with larger amounts of cervical muscle fat infiltration after controlling for age, sex, body mass index, and scan motion (t?=??4.02, partial R-2?=?0.49, P?<?.001). CONCLUSIONS: This work contributes to the existing whiplash literature by examining a sample of participants with whiplash-associated disorder by using resting-state fMRI. Less modular brain networks were found to be associated with greater amounts of cervical muscle fat infiltration suggesting a connection between disorder severity and neurologic changes, and a potential role for neuroimaging in understanding the pathophysiology of chronic whiplash-associated disorders.	[Higgins, J. P.; Parrish, T. B.] Northwestern Univ, Dept Radiol, Feinberg Sch Med, 737 N Michigan Ave,Suite 1600, Chicago, IL 60611 USA; [Elliott, J. M.] Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Elliott, J. M.] Univ Sydney, Discipline Physiotherapy, Fac Hlth Sci, Sydney, NSW, Australia; [Elliott, J. M.] Northern Sydney Local Hlth Dist, Sydney, NSW, Australia; Kolling Res Inst, St Leonards, NSW, Australia		Parrish, TB (corresponding author), Northwestern Univ, Dept Radiol, Feinberg Sch Med, 737 N Michigan Ave,Suite 1600, Chicago, IL 60611 USA.	toddp@northwestern.edu		Elliott, James/0000-0002-8890-6012; Higgins, James/0000-0002-7916-8468; Parrish, Todd/0000-0002-1184-1572	National Institutes of Health (NIH): Eunice Kennedy Shriver National Institute of Child Health & Human Development [R01HD079076]; National Center for Medical Rehabilitation Research	The project described originated at Northwestern University, Feinberg School of Medicine, Department of Physical Therapy and Human Movement Sciences, and was supported by the National Institutes of Health (NIH) through Grant Number R01HD079076: Eunice Kennedy Shriver National Institute of Child Health & Human Development; National Center for Medical Rehabilitation Research (J.M.E., T.B.P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Abbott R, 2018, SPINE J, V18, P717, DOI 10.1016/j.spinee.2017.08.233; Akiki TJ, 2018, NEUROIMAGE, V176, P489, DOI 10.1016/j.neuroimage.2018.05.005; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Arnemann KL, 2015, NEUROLOGY, V84, P1568, DOI 10.1212/WNL.0000000000001476; Baniqued PL, 2018, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00426; Beeckmans K, 2017, ACTA NEUROL BELG, V117, P493, DOI 10.1007/s13760-017-0745-3; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Carroll LJ, 2008, SPINE, V33, pS93, DOI 10.1097/BRS.0b013e31816445d4; Churchill NW, 2018, NEUROIMAGE-CLIN, V18, P518, DOI 10.1016/j.nicl.2018.02.011; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; de Haan W, 2012, NEUROIMAGE, V59, P3085, DOI 10.1016/j.neuroimage.2011.11.055; Elkin BS, 2016, J ORTHOP SPORT PHYS, V46, P874, DOI 10.2519/jospt.2016.7049; Elliott J, 2008, CLIN RADIOL, V63, P681, DOI 10.1016/j.crad.2007.11.011; Elliott J, 2006, SPINE, V31, pE847, DOI 10.1097/01.brs.0000240841.07050.34; Elliott JM, 2015, SPINE, V40, pE694, DOI 10.1097/BRS.0000000000000891; Elliott JM, 2010, SPINE, V35, P948, DOI 10.1097/BRS.0b013e3181bb0e55; Esteban O, 2019, NAT METHODS, V16, P111, DOI 10.1038/s41592-018-0235-4; Esteban O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184661; ETTLIN TM, 1992, J NEUROL NEUROSUR PS, V55, P943, DOI 10.1136/jnnp.55.10.943; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Gallen CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169015; Gargan M F, 1994, Eur Spine J, V3, P162, DOI 10.1007/BF02190579; Gorgolewski Krzysztof, 2011, Front Neuroinform, V5, P13, DOI 10.3389/fninf.2011.00013; Gratton C, 2012, J COGNITIVE NEUROSCI, V24, P1275, DOI 10.1162/jocn_a_00222; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Jang SH, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00057; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Karlsson A, 2016, J ORTHOP SPORT PHYS, V46, P886, DOI 10.2519/jospt.2016.6553; Konstantinou N, 2019, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01163; Linnman C, 2009, EUR J PAIN, V13, P65, DOI 10.1016/j.ejpain.2008.03.001; Mano Hiroaki, 1800, Wellcome Open Res, V3, P19, DOI 10.12688/wellcomeopenres.14069.1; Matsumoto M, 2013, INJURY, V44, P819, DOI 10.1016/j.injury.2012.12.001; Matsumoto M, 2012, INJURY, V43, P912, DOI 10.1016/j.injury.2012.01.017; McCarthy S, 2008, OCCUP MED-OXFORD, V58, P379, DOI 10.1093/occmed/kqn062; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2002, COMPUT PHYS COMMUN, V147, P40, DOI 10.1016/S0010-4655(02)00201-1; Nusslock R, 2019, BIOL PSYCHIAT, V86, P153, DOI 10.1016/j.biopsych.2019.03.968; Passatore M, 2006, EUR J APPL PHYSIOL, V98, P423, DOI 10.1007/s00421-006-0312-8; Peolsson A, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2433-3; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; R Core Team, 2020, LANG ENV STAT COMP V; Radanov BP, 1999, J NEUROL NEUROSUR PS, V66, P485, DOI 10.1136/jnnp.66.4.485; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Ronnen HR, 1996, RADIOLOGY, V201, P93, DOI 10.1148/radiology.201.1.8816527; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rudie JD, 2013, NEUROIMAGE-CLIN, V2, P79, DOI 10.1016/j.nicl.2012.11.006; Sartin-Tarm A, 2018, BIOL PSYCHIAT, V83, pS137, DOI 10.1016/j.biopsych.2018.02.359; Song J, 2014, BRAIN CONNECT, V4, P662, DOI 10.1089/brain.2014.0286; SPITZER WO, 1995, SPINE S8, V20, P1, DOI DOI 10.1097/00007632-199504151-00001; Sporns O, 2016, ANNU REV PSYCHOL, V67, P613, DOI 10.1146/annurev-psych-122414-033634; Sturzenegger M, 2008, ACTA NEUROL SCAND, V117, P49, DOI 10.1111/j.1600-0404.2007.00939.x; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Vallez Garcia D, 2016, EBIOMEDICINE, V10, P249, DOI 10.1016/j.ebiom.2016.07.008; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Vernon H, 2008, J MANIP PHYSIOL THER, V31, P491, DOI 10.1016/j.jmpt.2008.08.006; Walton DM, 2018, MUSCULOSKEL SCI PRAC, V36, P17, DOI 10.1016/j.msksp.2018.03.006; Walton DM, 2017, J ORTHOP SPORT PHYS, V47, P462, DOI 10.2519/jospt.2017.7455; Walton DM, 2016, J ORTHOP SPORT PHYS, V46, P920, DOI 10.2519/jospt.2016.6594; Wig GS, 2017, TRENDS COGN SCI, V21, P981, DOI 10.1016/j.tics.2017.09.006; Ye M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133775; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	65	1	1	2	2	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	JUN 1	2020	41	6					994	1000		10.3174/ajnr.A6569			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	MJ4KJ	WOS:000548058500019	32499250	hybrid, Green Published			2022-02-06	
J	Horio, T; Ozawa, A; Kamiie, J; Sakaue, M				Horio, Tomoyo; Ozawa, Aisa; Kamiie, Junichi; Sakaue, Motoharu			Immunohistochemical analysis for acetylcholinesterase and choline acetyltransferase in mouse cerebral cortex after traumatic brain injury	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						acetylcholine; acetylcholinesterase; choline acetyltransferase; immunohistochemistry; traumatic brain injury	MICROGLIA; ASTROCYTES; EXPRESSION	The regulation of glial cells, especially astrocytes and microglia, is important to prevent the exacerbation of a brain injury because over-reactive glial cells promote neuronal death. Acetylcholine (ACh), a neurotransmitter synthesized and hydrolyzed by choline acetyltransferase (ChAT) and acetylcholinesterase (AChE), respectively, in the central nervous system, has the potential to regulate glial cells' states, i.e., non-reactive and reactive states. However, the expression levels of these ACh-related enzymes in areas containing reactive glial cells are unclear. Herein we immunohistochemically investigated the distributions of AChE and ChAT with reactive glial cells in the cryo-injured brain of mice as a traumatic brain injury model. lmmunohistochemistry revealed AChE- and ChAT-immunopositive signals in injured areas at 7 days post-injury. The signals were observed in and around glial fibrillary acidic protein (GFAP)- or CD68-immunopositive cells, and the numbers of cells doubly positive for GFAP/AChE, GFAP/ChAT, CD68/AChE, and CD68/ChAT were significantly increased in injured areas compared to sham-operated areas. Enzyme histochemistry for AChE showed intensely positive signals in injured areas. These results suggest that reactive astrocytes and microglia express and secrete AChE and ChAT in brain-injury areas. These glial cells may adjust the ACh concentration around themselves through the regulation of the expression of ACh-related enzymes in order to control their reactive states.	[Horio, Tomoyo; Ozawa, Aisa; Sakaue, Motoharu] Azabu Univ, Sch Vet Med, Dept Vet Med, Lab Anat 2, Sagamihara, Kanagawa 2525201, Japan; [Kamiie, Junichi] Azabu Univ, Sch Vet Med, Dept Vet Med, Lab Vet Pathol, Sagamihara, Kanagawa 2525201, Japan		Sakaue, M (corresponding author), Azabu Univ, Sch Vet Med, Dept Vet Med, Lab Anat 2, Sagamihara, Kanagawa 2525201, Japan.	sakaue@azabu-u.ac.jp		Tomoyo, Horio/0000-0001-8566-4663	JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP 17K08117]	This work was supported by JSPS KAKENHI, Grant-in-Aid for Scientific Research (C), Grant Number JP 17K08117.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Chen ZH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5486; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Darreh-Shori T, 2013, NEUROBIOL AGING, V34, P2465, DOI 10.1016/j.neurobiolaging.2013.04.027; Du AY, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.2; Graham AJ, 2003, J CHEM NEUROANAT, V25, P97, DOI 10.1016/S0891-0618(02)00100-X; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu Y, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-98; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Luque MCA, 2015, MOL IMMUNOL, V67, P559, DOI 10.1016/j.molimm.2015.07.028; Marin-Teva JL, 2011, NEURON GLIA BIOL, V7, P25, DOI 10.1017/S1740925X12000014; Morizawa YM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00037-1; Mukherjee S, 2016, INT J CANCER, V139, P2838, DOI 10.1002/ijc.30398; Ozawa A, 2019, NEUROSCI LETT, V698, P146, DOI 10.1016/j.neulet.2019.01.020; Ozawa A, 2013, BRAIN RES, V1537, P37, DOI 10.1016/j.brainres.2013.08.031; Phatnani H, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020628; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Sharma G, 2002, J NEUROBIOL, V53, P524, DOI 10.1002/neu.10114; Shinozaki Y, 2017, CELL REP, V19, P1151, DOI 10.1016/j.celrep.2017.04.047; Shytle RD, 2004, J NEUROCHEM, V89, P337, DOI 10.1046/j.1471-4159.2004.02347.x; Sidoryk-Wegrzynowicz M, 2011, TOXICOL PATHOL, V39, P115, DOI 10.1177/0192623310385254; Strauss D, 1999, J INSUR MED, V31, P104; Tatsumi K, 2005, NEUROCHEM INT, V46, P381, DOI 10.1016/j.neuint.2004.12.007; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Vijayaraghavan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065936; Xu HZ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/5405104	30	1	1	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	JUN	2020	82	6					827	835		10.1292/jvms.19-0551			9	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	MG3WT	WOS:000545964900026	32321871	Green Published, gold			2022-02-06	
J	Huh, KR; Kim, JY; Choi, SH; Yoon, YH; Park, SJ; Lee, ES				Huh, Kwang Real; Kim, Jung-Youn; Choi, Sung-Hyuk; Yoon, Young-Hoon; Park, Sung Jun; Lee, Eu Sun			Comparison of traumatic brain injury patients with brain computed tomography in the emergency department by age group	CLINICAL AND EXPERIMENTAL EMERGENCY MEDICINE			English	Article						Trauma; Brain injuries; traumatic; Emergency service; hospital	EPIDEMIOLOGY; MANAGEMENT; OUTCOMES	Objective Traumatic brain injury (TBI) is an important public health concern due to its high prevalence and mortality rate among young people. We investigated the clinical and social characteristics of patients who visited the emergency department due to TBI in whom brain computed tomography, was performed by age. Methods We retrospectively analyzed 15,567 TBI patients who received a brain computed tomography evaluation at the emergency department of Korea University Hospital from March 2013 to February 2016. We divided patients into age groups by decade and analyzed factors such as sex, trauma mechanism, need for operation, hospitalization, and results of treatment. Results The mean age was 42.0 +/- 22.8 years; the most common age group was the 50s (16.5%). Except for the age group over 70 years, males predominated. Under 9 years of age, public ambulance usage rate was lower than in other age groups. Regarding severity based on the Glasgow Coma Scale score, the proportion of mild cases was higher in those under 9 years of age (99.3 %) and the proportion of severe cases was higher in those in their 20s (4.6%). The most common injury mechanism was blunt trauma, followed by car accidents. For those under 9 years of age, falls were more common than in other age groups. Only 20.5% of TBI patients were hospitalized and 11.99% were treated surgically, while 70.6% of patients were discharged home after treatment. Conclusion TBI may present with different characteristics depending on the age of the patients, thus prevention policies and clinical practice should be tailored to age.	[Huh, Kwang Real; Kim, Jung-Youn; Choi, Sung-Hyuk; Yoon, Young-Hoon; Park, Sung Jun; Lee, Eu Sun] Korea Univ, Dept Emergency Med, Coll Med, Seoul, South Korea		Kim, JY (corresponding author), Korea Univ, Dept Emergency Med, Guro Hosp, 148 Gurodong Ro, Seoul 08308, South Korea.	yellowwizard@hanmail.net	YOON, Young-Hoon/ABA-8810-2020	Choi, Sung-Hyuk/0000-0002-6686-6937; Yoon, Young-Hoon/0000-0002-1916-2080	Korea University Grant [K1710681]	This study was supported by the Korea University Grant (K1710681).	Barlow KM, 2013, HAND CLINIC, V112, P891, DOI 10.1016/B978-0-444-52910-7.00011-8; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Faul M, 2010, TRAUMATIC BRAIN INJU; Haring RS, 2015, BRAIN INJURY, V29, P989, DOI 10.3109/02699052.2015.1033014; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; 안기옥, 2004, [Journal of The Korean Society of Emergency Medicine, 대한응급의학회지], V15, P261; Kasmaei VM, 2015, EMERGENCY, V3, P141; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kim HB, 2012, J KOREAN MED SCI, V27, P437, DOI 10.3346/jkms.2012.27.4.437; Marehbian J, 2017, NEUROCRIT CARE, V27, P430, DOI 10.1007/s12028-017-0408-5; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x	17	1	1	0	3	SEOUL KOREAN SOC EMERGENCY MEDICINE	SEOUL	101-3305, BROWNSTONE SEOUL, 464 CHEONGPA-RO, JUNG-GU, SEOUL, 06351, SOUTH KOREA	2383-4625			CLIN EXP EMERG MED	Clin. Exp. Emerg. Med.	JUN	2020	7	2					81	86		10.15441/ceem.19.076			6	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	MG7TS	WOS:000546233300003	32635698	Green Published, gold			2022-02-06	
J	Hurth, H; Schlak, D; Ebner, FH				Hurth, Helene; Schlak, Dennis; Ebner, Florian Heinrich			Microdialysis Findings in a Patient with New Onset Refractory Non-convulsive Status Epilepticus	NEUROCRITICAL CARE			English	Article						Status epilepticus; Microdialysis; Intensive care	TRAUMATIC BRAIN-INJURY; GLUTAMATE; METABOLISM; SEIZURES; GABA		[Hurth, Helene; Ebner, Florian Heinrich] Eberhard Karls Univ Tuebingen, Dept Neurosurg, Intens Care Unit, Hoppe Seyler Str 3, D-72076 Tubingen, Germany; [Schlak, Dennis] Eberhard Karls Univ Tuebingen, Dept Neurol, Tubingen, Germany		Hurth, H (corresponding author), Eberhard Karls Univ Tuebingen, Dept Neurosurg, Intens Care Unit, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	helene.hurth@med.uni-tuebingen.de					Bascunana P, 2020, J CEREBR BLOOD F MET, V40, P204, DOI 10.1177/0271678X18809886; Cavus I, 2016, ANN NEUROL, V80, P35, DOI 10.1002/ana.24673; CHAPMAN AG, 1977, J NEUROCHEM, V28, P1025, DOI 10.1111/j.1471-4159.1977.tb10665.x; Cornford EM, 2000, AM J PHYSIOL-HEART C, V279, pH1346, DOI 10.1152/ajpheart.2000.279.3.H1346; DURING MJ, 1993, LANCET, V341, P1607; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Lonjon M, 2001, NEUROSCI LETT, V304, P21, DOI 10.1016/S0304-3940(01)01739-6; Meurs A, 2008, EPILEPSY RES, V78, P50, DOI 10.1016/j.eplepsyres.2007.10.007; Nehlig A, 2006, BRAIN RES, V1082, P32, DOI 10.1016/j.brainres.2006.01.078; Pan JW, 2008, EPILEPSIA, V49, P31, DOI 10.1111/j.1528-1167.2008.01508.x; RONNEENGSTROM E, 1992, J CEREBR BLOOD F MET, V12, P873, DOI 10.1038/jcbfm.1992.119; Schiefecker AJ, 2013, SEIZURE-EUR J EPILEP, V22, P236, DOI 10.1016/j.seizure.2012.11.016; Slais K, 2008, EXP NEUROL, V209, P145, DOI 10.1016/j.expneurol.2007.09.008; Thomas PM, 2004, ACTA NEUROCHIR, V146, P143, DOI 10.1007/s00701-003-0189-9; Ungerstedt U, 2004, CURR PHARM DESIGN, V10, P2145, DOI 10.2174/1381612043384105; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF	17	1	1	2	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2020	32	3					889	893		10.1007/s12028-019-00848-8			5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LV6MP	WOS:000538548700029	31556003				2022-02-06	
J	Jensen, AR; Bullaro, F; Falcone, RA; Daugherty, M; Young, LC; McLaughlin, C; Park, C; Lane, C; Prince, JM; Scherzer, DJ; Maa, TS; Dunn, J; Wining, L; Hess, J; Santos, MC; O'Neill, J; Katz, E; O'Bosky, K; Young, T; Christison-Lagay, E; Ahmed, O; Burd, RS; Auerbach, M				Jensen, Aaron R.; Bullaro, Francesca; Falcone, Richard A.; Daugherty, Margot; Young, L. Caulette; McLaughlin, Cory; Park, Caron; Lane, Christianne; Prince, Jose M.; Scherzer, Daniel J.; Maa, Tensing; Dunn, Julie; Wining, Laura; Hess, Joseph; Santos, Mary C.; O'Neill, James; Katz, Eric; O'Bosky, Karen; Young, Timothy; Christison-Lagay, Emily; Ahmed, Omar; Burd, Randall S.; Auerbach, Marc			EAST multicenter trial of simulation-based team training for pediatric trauma: Resuscitation task completion is highly variable during simulated traumatic brain injury resuscitation	AMERICAN JOURNAL OF SURGERY			English	Article							IN-SITU; PERFORMANCE; CARE; MORTALITY; IMPROVES; IMPACT; SKILLS; TIME; MULTIDISCIPLINARY; EMERGENCIES	Background: Best practices for benchmarking the efficacy of simulation-based training programs are not well defined. This study sought to assess feasibility of standardized data collection with multicenter implementation of simulation-based training, and to characterize variability in pediatric trauma resuscitation task completion associated with program characteristics. Methods: A prospective multicenter observational cohort of resuscitation teams (N= 30) was used to measure task completion and teamwork during simulated resuscitation of a child with traumatic brain injury. A survey was used to measure center-specific trauma volume and simulation-based training program characteristics among participating centers. Results: No task was consistently performed across all centers. Teamwork skills were associated with faster time to computed tomography notification (r -0.51, p <0.01). Notification of the operating room by the resuscitation team occurred more frequently in in situ simulation than in laboratory-based simulation (13/22 versus 0/8, p <0.01). Conclusions: Multicenter implementation of a standardized pediatric trauma resuscitation simulation scenario is feasible. Standardized data collection showed wide variability in simulated resuscitation task completion. (C) 2019 Elsevier Inc. All rights reserved.	[Jensen, Aaron R.] UCSF Benioff Childrens Hosp Oakland, Oakland, CA USA; [Bullaro, Francesca; Prince, Jose M.] Cohen Childrens Med Ctr Northwell Hlth, New Hyde Pk, NY USA; [Falcone, Richard A.; Daugherty, Margot] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Young, L. Caulette; McLaughlin, Cory] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Park, Caron; Lane, Christianne] Univ Southern Calif, Southern Calif Clin & Translat Sci Inst, Los Angeles, CA 90007 USA; [Scherzer, Daniel J.; Maa, Tensing] Nationwide Childrens Hosp, Columbus, OH USA; [Dunn, Julie; Wining, Laura] Univ Colorado, Hlth Med Ctr Rockies, Loveland, CO USA; [Hess, Joseph; Santos, Mary C.] Penn State Childrens Hosp, Hershey, PA USA; [O'Neill, James; Katz, Eric] Wake Forest Baptist Hlth, Winston Salem, NC USA; [O'Bosky, Karen; Young, Timothy] Loma Linda Univ, Med Ctr, Loma Linda, CA USA; [O'Bosky, Karen; Young, Timothy] Childrens Hosp, Loma Linda, CA USA; [Christison-Lagay, Emily; Auerbach, Marc] Yale Childrens Hosp, New Haven, CT USA; [Ahmed, Omar; Burd, Randall S.] Childrens Natl Med Ctr, Washington, DC 20010 USA		Jensen, AR (corresponding author), UCSF Benioff Childrens Hosp Oakland, Pediat Gen Surg, 744 52nd St,OPC2 4th Floor, Oakland, CA 94609 USA.	aaron.jensen@ucsf.edu; fbullaro@northwell.edu; richard.falcone@cchmc.org; margot.daugherty@cchmc.org; lyoung@chla.usc.edu; cory.mclaughlin@bswhealth.org; caronpar@usc.edu; christianne.lane@med.usc.edu; jprince@northwell.edu; daniel.scherzer@nationwidechildrens.org; Tensing.Maa@nationwidechildrens.org; julie.dunn@uchealth.org; laura.wining@uchealth.org; jhess1@pennstatehealth.psu.edu; msantos2@pennstatehealth.psu.edu; joneill@wakehealth.edu; ekatz@wakehealth.edu; kobosky@llu.edu; tpyoung@llu.edu; emily.christison-lagay@yale.edu; oahmed3@childrensnational.org; rburd@childrensnational.org; marc.auerbach@yale.edu	Scherzer, Daniel/ABC-3879-2020; Maa, Tensing/J-9791-2012	Maa, Tensing/0000-0001-6104-8401; Christison-Lagay, Emily/0000-0001-6277-0906	Eastern Association for the Surgery of Trauma (EAST) 2017 Multicenter Junior Investigator Award; National Center for Advancing Translational Science (NCATS) of the U.S. National Institutes of Health [KL2TR001854, UL1TR001855, UL1TR000130]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001854, UL1TR001855] Funding Source: NIH RePORTER	This study was supported by the Eastern Association for the Surgery of Trauma (EAST) 2017 Multicenter Junior Investigator Award and by grants KL2TR001854, UL1TR001855, and UL1TR000130 from the National Center for Advancing Translational Science (NCATS) of the U.S. National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abd El-Shafy I, 2018, J SURG EDUC, V75, P58, DOI 10.1016/j.jsurg.2017.06.025; Auerbach M, 2014, PEDIATR EMERG CARE, V30, P884, DOI 10.1097/PEC.0000000000000297; Bittencourt T, 2015, SIMUL HEALTHC, V10, P76, DOI 10.1097/SIH.0000000000000081; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Burke RV, 2017, SURGERY, V161, P1357, DOI 10.1016/j.surg.2016.09.023; Capella J, 2010, J SURG EDUC, V67, P439, DOI 10.1016/j.jsurg.2010.06.006; Cheng A, 2016, SIMUL HEALTHC, V11, P238, DOI 10.1097/SIH.0000000000000150; Cook JM, 2015, ASSESSMENT, V22, P704, DOI 10.1177/1073191114561254; Ehrhart MG, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0157-1; Emergency Nurses Association, 2014, TRAUM NURS COR COURS; Falcone RA, 2008, J PEDIATR SURG, V43, P1065, DOI 10.1016/j.jpedsurg.2008.02.033; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Institute of Medicine, 1999, ERR IS HUMAN BUILDIN; Ivatury RR, 2008, J TRAUMA, V64, P265, DOI 10.1097/TA.0b013e318163359d; Jensen AR, 2019, AM J SURG, V217, P180, DOI 10.1016/j.amjsurg.2018.06.009; Kelleher DC, 2014, ACAD EMERG MED, V21, P1129, DOI 10.1111/acem.12487; Knudson MM, 2008, J TRAUMA, V64, P255, DOI 10.1097/TA.0b013e31816275b0; McLaughlin C, 2019, J SURG EDUC, V76, P1669, DOI 10.1016/j.jsurg.2019.05.002; McLaughlin C, 2018, J PEDIATR SURG, V53, P344, DOI 10.1016/j.jpedsurg.2017.10.006; Meizoso JP, 2016, J TRAUMA ACUTE CARE, V81, P685, DOI 10.1097/TA.0000000000001198; Miller D, 2012, ACAD EMERG MED, V19, P608, DOI 10.1111/j.1553-2712.2012.01354.x; Miyasaka KW, 2015, J SURG EDUC, V72, P803, DOI 10.1016/j.jsurg.2015.03.001; Newgard CD, 2015, ANN EMERG MED, V66, P30, DOI 10.1016/j.annemergmed.2014.12.004; Oyetunji TA, 2011, AM J SURG, V201, P445, DOI 10.1016/j.amjsurg.2010.10.006; Parsons SE, 2014, ANN SURG, V259, P807, DOI 10.1097/SLA.0000000000000259; Pascual JL, 2011, J TRAUMA, V71, P330, DOI 10.1097/TA.0b013e31821f4721; Potoka DA, 2001, J TRAUMA, V51, P824, DOI 10.1097/00005373-200111000-00002; Potoka DA, 2000, J TRAUMA, V49, P237, DOI 10.1097/00005373-200008000-00009; Steinemann S, 2012, AM J SURG, V203, P69, DOI 10.1016/j.amjsurg.2011.08.004; Steinemann S, 2011, J SURG EDUC, V68, P472, DOI 10.1016/j.jsurg.2011.05.009; Swanberg SM, 2016, J MED LIBR ASSOC, V104, P250; Vioque SM, 2014, AM J SURG, V208, P187, DOI 10.1016/j.amjsurg.2014.02.006; Wieck MM, 2018, AM J SURG, V216, P630, DOI 10.1016/j.amjsurg.2018.01.010	33	1	1	1	1	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	JUN	2020	219	6					1057	1064		10.1016/j.amjsurg.2019.07.037			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	LW7YH	WOS:000539359400036	31421895				2022-02-06	
J	Jeyaraj, P				Jeyaraj, Priya			Cranial Vault Defects and Deformities Resulting from Combat-Related Gunshot, Blast and Splinter Injuries: How Best to Deal with Them	JOURNAL OF MAXILLOFACIAL & ORAL SURGERY			English	Article						Gunshot wound (GSW); Improvised explosive device (IED) blast; Craniomaxillofacial (CMF) injury; Traumatic brain injury (TBI); Decompressive craniectomy (DC); Splinter and shrapnel injury; Cranioplasty; Fronto-temporo-parietal craniectomy; Autologous calvarial bone flap; 3-D Dynamic Titanium mesh implant	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; EARLY CRANIOPLASTY; MISSILE INJURIES; BLOOD-FLOW; WOUNDS; MANAGEMENT; HEAD; MULTICENTER; INFECTION	Combat-related gunshot and blast injuries of the craniomaxillofacial region present a unique and challenging situation for the maxillofacial and reconstructive surgeon. The devastating cosmetic deformities and severe functional debility ensuing as a result of extensive hard and soft tissue disruption caused by these highly complex injuries, can have disastrous consequences, unless managed in a swift and efficient manner, by a multidisciplinary team approach. Large calvarial defects and deformities are frequent sequelae of these injuries and could result from shattering of the cranial vault by the force of an exploding shell, mine or improvised explosive device, or due to penetration of the skull by the projectile, such as a bullet, flying splinters or shrapnel. It could also result from the decompressive craniectomy carried out in these patients as a neurosurgical procedure to deal with the traumatic brain injury sustained. Management of such injuries is significantly different from that of other craniomaxillofacial injuries, owing to the quantum and severity of hard and soft tissue destruction encountered in the former and also the need to deal with aspects such as splinters from the projectile deeply embedded within vital structures such as the delicate brain tissue and meninges. Further, restoration of the lost structural and functional integrity of the cranial vault using the most suitable cranioplasty material, is imperative to provide protection to the vulnerable and vital cranial contents. Correction of the cranial deformity is also essential from an esthetic and psychosocial standpoint, to restore the morale of the patient. The present study elaborates the immediate/primary management as well as the secondary/definitive management of blast and ballistic head injury patients. Comprehensive treatment and rehabilitation of these patients, including reconstruction of extensive calvarial defects and deformities, resulting either directly or indirectly from combat injuries, have been described in detail. This study also aims to analyze, review and reassess the currently accepted management perspectives and treatment protocols of combat-related cranial injuries and proposes a useful algorithm to best manage them.	[Jeyaraj, Priya] Mil Dent Ctr Gough Lines, Div Oral & Maxillofacial Surg, Secunderabad, India		Jeyaraj, P (corresponding author), Mil Dent Ctr Gough Lines, Div Oral & Maxillofacial Surg, Secunderabad, India.	jeyarajpriya@yahoo.com					Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Amole O, 2017, CRANIOMAX TRAUM REC, V10, P130, DOI 10.1055/s-0037-1601341; Archavlis E, 2012, ACTA NEUROCHIR, V154, P1055, DOI 10.1007/s00701-012-1333-1; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Breeze J, 2009, J R Army Med Corps, V155, P274; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; Chun HJ, 2011, J CRANIOFAC SURG, V22, P203, DOI 10.1097/SCS.0b013e3181f753bd; Clasper JC, 2002, INJURY, V33, P157, DOI 10.1016/S0020-1383(01)00136-X; COLE RD, 1994, OTOLARYNG HEAD NECK, V111, P739, DOI 10.1016/S0194-5998(94)70561-5; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; DOLIN J, 1992, J TRAUMA, V33, P508, DOI 10.1097/00005373-199210000-00004; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; Honeybul Stephen, 2014, Surg Neurol Int, V5, P83, DOI 10.4103/2152-7806.133886; Honeybul S, 2013, BRIT J NEUROSURG, V27, P636, DOI 10.3109/02688697.2013.817532; Huang APH, 2008, J NEUROTRAUM, V25, P1347, DOI 10.1089/neu.2008.0625; Isago T, 2004, ANN PLAS SURG, V53, P288, DOI 10.1097/01.sap.0000106433.89983.72; Jeyaraj P, 2015, J MAXILLOFAC ORAL SU, V14, P666, DOI 10.1007/s12663-014-0673-1; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Joseph V, 2009, J NEUROSURG, V111, P650, DOI 10.3171/2009.3.JNS0984; Kaufman Y, 2009, CRANIOMAX TRAUM REC, V2, P85, DOI 10.1055/s-0029-1202595; Kummoona R, 2006, J CRANIOFAC SURG, V17, P217, DOI 10.1097/00001665-200603000-00003; Kummoona R, 2008, J CRANIOFAC SURG, V19, P300, DOI 10.1097/SCS.0b013e3181577b97; Kuo JR, 2004, J CLIN NEUROSCI, V11, P486, DOI 10.1016/j.jocn.2003.06.005; Kwon SM, 2012, J KOREAN NEUROSURG S, V51, P117, DOI 10.3340/jkns.2012.51.2.117; Motamedi MHK, 2003, J ORAL MAXIL SURG, V61, P1390, DOI 10.1016/j.joms.2003.07.001; Powers David B, 2013, Atlas Oral Maxillofac Surg Clin North Am, V21, P15, DOI 10.1016/j.cxom.2012.12.001; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; SEGAL DH, 1994, NEUROSURGERY, V34, P729, DOI 10.1227/00006123-199404000-00024; Stuehmer C, 2009, J ORAL MAXIL SURG, V67, P775, DOI 10.1016/j.joms.2008.08.036; Thavarajah D, 2012, BRIT J NEUROSURG, V26, P78, DOI 10.3109/02688697.2011.603850; THORESBY FP, 1967, BRIT J SURG, V54, P359, DOI 10.1002/bjs.1800540509; Vayvada H, 2005, J CRANIOFAC SURG, V16, P794, DOI 10.1097/01.scs.0000180014.06352.65; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Yetiser S, 1998, MIL MED, V163, P346, DOI 10.1093/milmed/163.5.346	36	1	1	0	1	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0972-8279	0974-942X		J MAXILLOFAC ORAL SU	J. Maxillofac. Oral. Surg.	JUN	2020	19	2					184	207		10.1007/s12663-019-01258-1			24	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	LG2OU	WOS:000527947500006	32346228	Green Published			2022-02-06	
J	Lau, G; Gabbe, BJ; Collie, A; Ponsford, J; Ameratunga, S; Cameron, PA; Harrison, JE; Giummarra, MJ				Lau, Georgina; Gabbe, Belinda J.; Collie, Alex; Ponsford, Jennie; Ameratunga, Shanthi; Cameron, Peter A.; Harrison, James E.; Giummarra, Melita J.			The Association Between Fault Attribution and Work Participation After Road Traffic Injury: A Registry-Based Observational Study	JOURNAL OF OCCUPATIONAL REHABILITATION			English	Article						Trauma; Return to work; Recovery; Injury; Accidents; Traffic	QUALITY-OF-LIFE; PERCEIVED INJUSTICE; TRAUMATIC INJURY; HEALTH; RETURN; COMPENSATION; OUTCOMES; DISABILITY; PAIN; RESPONSIBILITY	PurposeTo characterise associations between fault attribution and work participation and capacity after road traffic injury.MethodsPeople aged 15-65 years, working pre-injury, without serious brain injury, who survived to 12 months after road traffic injury were included from two Victorian trauma registries (n = 2942). Fault profiles from linked compensation claims were defined as no other at fault, another at fault, denied another at fault, claimed another at fault, and unknown. Claimant reports in the denied and claimed another at fault groups contradicted police reports. Patients reported work capacity (Glasgow outcome scale-extended) and return to work (RTW) at 6, 12 and 24 months post-injury (early and sustained RTW, delayed RTW (>= 12 months), failed RTW attempts, no RTW attempts). Analyses adjusted for demographic, clinical and injury covariates.ResultsThe risk of not returning to work was higher if another was at fault [adjusted relative risk ratio (aRRR) = 1.67, 95% confidence interval (CI) 1.29, 2.17] or was claimed to be at fault (aRRR = 1.58, 95% CI 1.04, 2.41), and lower for those who denied that another was at fault (aRRR = 0.51, 95% CI 0.29, 0.91), compared to cases with no other at fault. Similarly, people had higher odds of work capacity limitations if another was at fault (12m: AOR = 1.49, 95% CI 1.24, 1.80; 24m: 1.63, 95% CI 1.35, 1.97) or was claimed to be at fault (12m: AOR = 1.54, 95% CI 1.16, 2.05; 24m: AOR = 1.80, 95% CI 1.34, 2.41), and lower odds if they denied another was at fault (6m: AOR = 0.67, 95% CI 0.48, 0.95), compared to cases with no other at fault.ConclusionTargeted interventions are needed to support work participation in people at risk of poor RTW post-injury. While interventions targeting fault and justice-related attributions are currently lacking, these may be beneficial for people who believe that another caused their injury. Graphic	[Lau, Georgina; Gabbe, Belinda J.; Collie, Alex; Cameron, Peter A.; Giummarra, Melita J.] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia; [Gabbe, Belinda J.] Swansea Univ, Med Sch, Hlth Data Res UK, Singleton Pk, Swansea SA2 8PP, W Glam, Wales; [Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia; [Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand; [Harrison, James E.] Flinders Univ S Australia, Res Ctr Injury Studies, Adelaide, SA, Australia; [Giummarra, Melita J.] Caulfield Hosp, Caulfield Pain Management & Res Ctr, Caulfield, Vic, Australia		Giummarra, MJ (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia.; Giummarra, MJ (corresponding author), Caulfield Hosp, Caulfield Pain Management & Res Ctr, Caulfield, Vic, Australia.	melita.giummarra@monash.edu	Giummarra, Melita/H-8387-2012; Harrison, James/B-8958-2009	Giummarra, Melita/0000-0001-7839-6058; Harrison, James/0000-0001-9893-8491			Allan A, 2010, INT J QUAL HEALTH C, V22, P126, DOI 10.1093/intqhc/mzq001; Australian Automobile Association, 2017, COST ROAD TRAUM AUST; Australian Bureau of Statistics, 1997, AUSTR STAND CLASS OC, V2nd; Bae SM, 2015, ASIA-PAC PSYCHIAT, V7, P164, DOI 10.1111/appy.12142; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baldwin ML, 1996, AM J IND MED, V29, P632; Beck B, 2018, VICTORIAN ORTHOPAEDI; Beck B, 2016, ACCIDENT ANAL PREV, V96, P219, DOI 10.1016/j.aap.2016.08.012; Berecki-Gisolf J, 2013, ACCIDENT ANAL PREV, V51, P129, DOI 10.1016/j.aap.2012.11.010; Braaf S, 2019, J OCCUP ENVIRON MED, V61, pE461, DOI 10.1097/JOM.0000000000001719; Burton A.K., 2006, IS WORK GOOD YOUR HL; Cameron PA, 2005, J TRAUMA, V59, P1469, DOI 10.1097/01.ta.0000198350.15936.a1; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chossegros L, 2011, ACCIDENT ANAL PREV, V43, P471, DOI 10.1016/j.aap.2010.10.004; Clay FJ, 2014, J OCCUP REHABIL, V24, P111, DOI 10.1007/s10926-013-9435-z; Collie A, 2019, ANN SURG, V269, P972, DOI 10.1097/SLA.0000000000002666; Department of Health and Aged Care (GISCA), 2001, MEAS REM ACC REM IND; Devlin A, 2019, ACCIDENT ANAL PREV, V132, DOI 10.1016/j.aap.2019.105279; Ehring T, 2008, PSYCHIAT RES, V161, P67, DOI 10.1016/j.psychres.2007.08.014; Elbers NA, 2013, INJURY, V44, P1431, DOI 10.1016/j.injury.2012.08.034; Fort E, 2011, J REHABIL MED, V43, P283, DOI 10.2340/16501977-0670; Gabbe BJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002322; Gabbe BJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009907; Gabbe BJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-30; Gabbe BJ, 2005, ACAD EMERG MED, V12, P318, DOI 10.1197/j.aem.2004.12.002; Giummarra MJ, 2020, PAIN MED, V21, P291, DOI 10.1093/pm/pnz209; Giummarra MJ, 2018, INJURY, V49, P1787, DOI 10.1016/j.injury.2018.08.008; Giummarra MJ, 2017, J OCCUP REHABIL, V27, P173, DOI 10.1007/s10926-016-9642-5; Giummarra MJ, 2019, ACCID ANAL PREV; Gopinath B, 2015, INJURY, V46, P909, DOI 10.1016/j.injury.2015.01.002; Grant GM, 2014, JAMA PSYCHIAT, V71, P446, DOI 10.1001/jamapsychiatry.2013.4023; Gray SE, 2018, J TRANSP HEALTH, V10, P167, DOI 10.1016/j.jth.2018.07.006; Gray SE, 2018, J OCCUP REHABIL, V28, P740, DOI 10.1007/s10926-018-9761-2; Hepburn CG, 2010, J OCCUP HEALTH PSYCH, V15, P409, DOI 10.1037/a0021001; Hoefsmit N, 2012, J OCCUP REHABIL, V22, P462, DOI 10.1007/s10926-012-9359-z; Ioannou LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178894; Jenewein J, 2009, J PSYCHOSOM RES, V66, P119, DOI 10.1016/j.jpsychores.2008.07.011; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Matsuoka Y, 2008, CRIT CARE MED, V36, P74, DOI 10.1097/01.CCM.0000291650.70816.D6; Mayou R, 2002, BRIT J PSYCHIAT, V180, P441, DOI 10.1192/bjp.180.5.441; McAllister S, 2013, SOC SCI MED, V85, P93, DOI 10.1016/j.socscimed.2013.02.041; Menendez M, 2007, SOC SCI MED, V64, P776, DOI 10.1016/j.socscimed.2006.10.035; Misra J, 2014, SOCIOL COMPASS, V8, P1281, DOI 10.1111/soc4.12213; Murgatroyd DF, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1019-6; Nguyen TQ, 2017, AUST HEALTH REV, V41, P283, DOI 10.1071/AH16050; Paul C, 2013, SPINAL CORD, V51, P919, DOI 10.1038/sc.2013.110; Pelissier C, 2017, ACCIDENT ANAL PREV, V106, P411, DOI 10.1016/j.aap.2017.06.020; Pink B., 2008, INFORM PAPER INTRO S; Rubin D.B., 1987, MULTIPLE IMPUTATION; Rueda S, 2012, AM J PUBLIC HEALTH, V102, P541, DOI 10.2105/AJPH.2011.300401; Scott W, 2013, PAIN, V154, P1691, DOI 10.1016/j.pain.2013.05.015; Stewart AE, 2005, ACCIDENT ANAL PREV, V37, P681, DOI 10.1016/j.aap.2005.03.010; Thompson J, 2014, REHABIL PSYCHOL, V59, P376, DOI 10.1037/rep0000012; Trost Z, 2015, REHABIL PSYCHOL, V60, P213, DOI 10.1037/rep0000043; Urquhart DM, 2006, INJURY, V37, P120, DOI 10.1016/j.injury.2005.10.016; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Williamson OD, 2013, INJURY PREV, V19, P238, DOI 10.1136/injuryprev-2012-040457	57	1	1	1	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1053-0487	1573-3688		J OCCUP REHABIL	J. Occup. Rehabil.	JUN	2020	30	2					235	254		10.1007/s10926-019-09867-w			20	Rehabilitation; Social Issues	Social Science Citation Index (SSCI)	Rehabilitation; Social Issues	LX9LG	WOS:000540144900011	31820220				2022-02-06	
J	Lee, SB; Kim, H; Kim, YT; Zeiler, FA; Smielewski, P; Czosnyka, M; Kim, DJ				Lee, Seung-Bo; Kim, Hakseung; Kim, Young-Tak; Zeiler, Frederick A.; Smielewski, Peter; Czosnyka, Marek; Kim, Dong-Joo			Artifact removal from neurophysiological signals: impact on intracranial and arterial pressure monitoring in traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						intracranial pressure; traumatic brain injury; convolutional neural network; stacked convolutional autoencoder; cerebral hypoperfusion	CEREBRAL PERFUSION-PRESSURE; SUPPORT VECTOR MACHINE; WAVE-FORM; REACTIVITY; MANAGEMENT; NETWORK	OBJECTIVE Monitoring intracranial and arterial blood pressure (ICP and ABP, respectively) provides crucial information regarding the neurological status of patients with traumatic brain injury (TBI). However, these signals are often heavily affected by artifacts, which may significantly reduce the reliability of the clinical determinations derived from the signals. The goal of this work was to eliminate signal artifacts from continuous ICP and ABP monitoring via deep learning techniques and to assess the changes in the prognostic capacities of clinical parameters after artifact elimination. METHODS The first 24 hours of monitoring ICP and ABP in a total of 309 patients with TBI was retrospectively analyzed. An artifact elimination model for ICP and ABP was constructed via a stacked convolutional autoencoder (SCAE) and convolutional neural network (CNN) with 10-fold cross-validation tests. The prevalence and prognostic capacity of ICP- and ABP-related clinical events were compared before and after artifact elimination. RESULTS The proposed SCAE-CNN model exhibited reliable accuracy in eliminating ABP and ICP artifacts (net prediction rates of 97% and 94%, respectively). The prevalence of ICP- and ABP-related clinical events (i.e., systemic hypotension, intracranial hypertension, cerebral hypoperfusion, and poor cerebrovascular reactivity) all decreased significantly after artifact removal. CONCLUSIONS The SCAE-CNN model can be reliably used to eliminate artifacts, which significantly improves the reliability and efficacy of ICP- and ABP-derived clinical parameters for prognostic determinations after TBI.	[Lee, Seung-Bo; Kim, Hakseung; Kim, Young-Tak; Kim, Dong-Joo] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB, Canada; [Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Kim, DJ (corresponding author), Korea Univ, Seoul, South Korea.	dongjookim@korea.ac.kr	Kim, Hakseung/AAZ-8626-2021	Kim, Hakseung/0000-0001-5407-293X; Zeiler, Frederick/0000-0003-1737-0510	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea [HI17C1790]; Cambridge Commonwealth Trust Scholarship; University of Manitoba Clinician Investigator Program	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (grant no. HI17C1790). F. A. Zeiler has received salary support for dedicated research time, during which this project was completed; such salary support came from the Cambridge Commonwealth Trust Scholarship and the University of Manitoba Clinician Investigator Program. We sincerely thank all staff at the Neurocritical Care Unit in Addenbrookes Hospital, Cambridge, United Kingdom, for their support and professional help with the computer pressure recordings of patients with TBI.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; BROWNER WS, 1987, JAMA-J AM MED ASSOC, V257, P2459, DOI 10.1001/jama.257.18.2459; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 1998, ACT NEUR S, V71, P74; Department of Health (UK), GOV ARR RES ETH COMM; Du B, 2017, IEEE T CYBERNETICS, V47, P1017, DOI 10.1109/TCYB.2016.2536638; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Hripcsak G, 2005, J AM MED INFORM ASSN, V12, P296, DOI 10.1197/jamia.M1733; Hu X, 2009, IEEE T BIO-MED ENG, V56, P696, DOI 10.1109/TBME.2008.2008636; Jin XJ, 2016, THIRTIETH AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE, P1737; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; KEYS RG, 1981, IEEE T ACOUST SPEECH, V29, P1153, DOI 10.1109/TASSP.1981.1163711; Kim H, 2018, J NEUROSURG ANESTH, V30, P347, DOI 10.1097/ANA.0000000000000462; Kim P, 2017, MATLAB DEEP LEARNING, DOI [10.1007/978-1-4842-2845-6, DOI 10.1007/978-1-4842-2845-6]; Kumar Y, 2014, NEUROCOMPUTING, V133, P271, DOI 10.1016/j.neucom.2013.11.009; Lang EW, 2015, J NEUROSURG, V122, P588, DOI 10.3171/2014.10.JNS14602; Li Q, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-13; Liu XY, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002348; Meyer D, 2003, NEUROCOMPUTING, V55, P169, DOI 10.1016/S0925-2312(03)00431-4; Tich SNT, 2015, NEUROPHYSIOL CLIN, V45, P75, DOI 10.1016/j.neucli.2014.11.010; Nizami Shermeen, 2013, IEEE Rev Biomed Eng, V6, P127, DOI 10.1109/RBME.2013.2243724; Oskoei MA, 2008, IEEE T BIO-MED ENG, V55, P1956, DOI 10.1109/TBME.2008.919734; Pimentel MAF, 2016, ACTA NEUROCHIR SUPPL, V122, P85, DOI 10.1007/978-3-319-22533-3_17; Rajagopal A, 2016, BIOMED SIGNAL PROCES, V28, P19, DOI 10.1016/j.bspc.2016.03.003; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; ROSNER MJ, 1993, RECENT ADVANCES IN NEUROTRAUMATOLOGY, P293; Scalzo F, 2013, PHYSIOL MEAS, V34, P465, DOI 10.1088/0967-3334/34/4/465; Scalzo F, 2013, IEEE T BIO-MED ENG, V60, P235, DOI 10.1109/TBME.2012.2210042; Scalzo F, 2012, ARTIF INTELL MED, V54, P115, DOI 10.1016/j.artmed.2011.08.007; Son Y, 2018, INFORM SCIENCES, V456, P145, DOI 10.1016/j.ins.2018.05.018; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Sun J.X., 2006, 2006 COMPUTERS CARDI, P13; Sykora M, 2016, CRIT CARE MED, V44, P1173, DOI 10.1097/CCM.0000000000001624; Tabar YR, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2560/14/1/016003; Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4; Vigue B, 2012, ANN UPDATE INTENSIVE, P722; Wen L, 2018, IEEE T IND ELECTRON, V65, P5990, DOI 10.1109/TIE.2017.2774777; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Widodo A, 2007, MECH SYST SIGNAL PR, V21, P2560, DOI 10.1016/j.ymssp.2006.12.007	44	1	1	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2020	132	6					1952	1960		10.3171/2019.2.JNS182260			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LU6FW	WOS:000537850100033	31075774				2022-02-06	
J	Lewis, JW; Lama, AM; Hurst, PD; Paserba, BA				Lewis, James W.; Lama, Anna M.; Hurst, Philip D.; Paserba, Benjamin A.			Interactive Large Group Lecture Demonstrations: Dramatization of Medical Neurobiology Concepts to Improve Student Perception of Understanding Fluid Mechanisms of the Central Nervous System	MEDICAL SCIENCE EDUCATOR			English	Article						On-stage demonstrations; Generation Z; First-year medical school curriculum; Large group teaching; Medical neurobiology; students; Teaching; methods	FLIPPED CLASSROOM; EDUCATION; PARTICIPATION; DESIGN	With the advent of recorded lectures, face-to-face teaching in medical school large classroom settings is increasingly under pressure to incorporate engaging activities that encourage attendance and can translate to greater attainment and long-term retention for learners, especially of "Generation Z" learning styles. This places a greater onus on lecturers to convey key concepts in a manner that holds value beyond their recorded substitute. The present article details several on-stage Medical Gross Anatomy and Neurobiology demonstrations that involve the teaching of an intuitive understanding of brain fluidic mechanics, such as hematoma formation and the protective functions of an intact cerebral spinal fluid system (addressing concussion and lumbar punctures). These demonstrations can be presented relatively quickly on stage and are suitable for engaging large classroom sizes (n>100), which can be used in conjunction with traditional lecture formats. Ideally, these in-class demonstrations, together with the continued contributions of other quantitatively assessed demonstrations from other institutions, will help to maintain a growing body of large class face-to-face teaching approaches and strategies to help influence decisions regarding what basic medical knowledge may best be taught in class live versus by recorded substitute or other non-traditional lecture methods.	[Lewis, James W.; Hurst, Philip D.; Paserba, Benjamin A.] West Virginia Univ, Rockefeller Neurosci Inst, Dept Neurosci, POB 9303, Morgantown, WV 26506 USA; [Lama, Anna M.; Hurst, Philip D.; Paserba, Benjamin A.] West Virginia Univ, Dept Med Educ, Morgantown, WV 26506 USA		Lewis, JW (corresponding author), West Virginia Univ, Rockefeller Neurosci Inst, Dept Neurosci, POB 9303, Morgantown, WV 26506 USA.	jwlewis@hsc.wvu.edu					[Anonymous], 2016, MEDB MEDB CURR INV S; [Anonymous], 2011, ESSENTIAL CLIN ANATO; Bovill C, 2016, HIGH EDUC, V71, P195, DOI 10.1007/s10734-015-9896-4; Bovill C, 2011, INT J ACAD DEV, V16, P133, DOI 10.1080/1360144X.2011.568690; Bradbury NA, 2016, ADV PHYSIOL EDUC, V40, P509, DOI 10.1152/advan.00109.2016; Carvalho H, 2011, ADV PHYSIOL EDUC, V35, P53, DOI 10.1152/advan.00011.2010; Carvalho H, 2009, ADV PHYSIOL EDUC, V33, P132, DOI 10.1152/advan.00024.2009; Cheang KI, 2009, AM J PHARM EDUC, V73, DOI 10.5688/aj730342; Cilliers Elizelle Juanee, 2017, INT J SOCIAL SCI, V3, P188, DOI DOI 10.20319/pijss.2017.31.188198; Cowan M, 2014, GENERATION Z NEW KID; Drake RL, 2019, GRAYS ANATOMY STUDEN, P4; Edwards MR, 2019, HIGH EDUC, V77, P403, DOI 10.1007/s10734-018-0275-9; Fatima SS, 2017, PAK J MED SCI, V33, P1424, DOI 10.12669/pjms.336.13699; Gagne R, 1992, PRINCIPLES INSTRUCTI, P4; Harpe SE, 2008, AM J PHARM EDUC, V72, DOI 10.5688/aj7206135; Hobson E, 2002, AM J PHARM ED, V65, p82S; Kushner DS, 2001, AM FAM PHYSICIAN, V64, P1007; Li AYL, 2016, ADV PHYSIOL EDUC, V40, P462, DOI 10.1152/advan.00071.2016; Martens SE, 2019, MED TEACH, V41, P1203, DOI 10.1080/0142159X.2019.1615610; Narayanan SN, 2011, TEACH LEARN MED, V23, P269, DOI 10.1080/10401334.2011.586930; Nayak S, 2006, ADV PHYSIOL EDUC, V30, P95, DOI 10.1152/advan.00071.2005; Peters H, 2019, MED TEACH, V41, P632, DOI 10.1080/0142159X.2018.1459530; PINTRICH PR, 1993, EDUC PSYCHOL MEAS, V53, P801, DOI 10.1177/0013164493053003024; Ramnanan CJ, 2017, ADV MED EDUC PRACT, V8, P63, DOI 10.2147/AMEP.S109037; Riddell Jeff, 2017, J Grad Med Educ, V9, P491, DOI 10.4300/JGME-D-16-00817.1; Riley B, 2018, J AM OSTEOPATH ASSOC, V118, P673, DOI 10.7556/jaoa.2018.147; Roberts JC, 2015, J POLITICAL SCI EDUC, V11, P45, DOI 10.1080/15512169.2014.985104; ROSKI RA, 1982, SURG NEUROL, V17, P200, DOI 10.1016/0090-3019(82)90280-4; Sait MS, 2017, ADV MED EDUC PRACT, V8, P317, DOI 10.2147/AMEP.S133328; Sharma MD, 2010, PHYS REV SPEC TOP-PH, V6, DOI 10.1103/PhysRevSTPER.6.020119; Singh K, 2018, INDIAN PEDIATR, V55, P507, DOI 10.1007/s13312-018-1342-0; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Walling A, 2017, TEACH LEARN MED, V29, P173, DOI 10.1080/10401334.2016.1247708; Weimer M., 2002, LEARNER CTR TEACHING; Zimrot R, 2007, CHEM EDUC RES PRACT, V8, P197	35	1	1	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2156-8650		MED SCI EDUC	Med. Sci. Educ.	JUN	2020	30	2					811	822		10.1007/s40670-020-00953-w			12	Education, Scientific Disciplines	Emerging Sources Citation Index (ESCI)	Education & Educational Research	QQ3MB	WOS:000624427300021	34457738	Green Published			2022-02-06	
J	Madi, SM; Alraddadi, NI				Madi, Sanaa Mohammed; Alraddadi, Naif Ibrahim			Association Between Pediatric Inpatient Rehabilitation Services and Children's Functional Outcomes: King Fahad Medical City Experience	REHABILITATION PROCESS AND OUTCOME			English	Article						Pediatric rehabilitation; outcomes; Wee-FIM	TRAUMATIC BRAIN-INJURY; LENGTH-OF-STAY; SAUDI-ARABIA TIME; INDEPENDENCE MEASURE; WEEFIM; INSTRUMENT; ADMISSION; PROGRAM; RIYADH; SAMPLE	Background: Disability may affect children's performance of functional activities. This may translate to difficulties in returning to home and/or school. It has been documented that intensive rehabilitation programs for children with disabilities lead to an improvement in their functional abilities. Wee-FIM is a valid and reliable outcome measure that is used commonly with children undergoing rehabilitation. Objectives: To study changes in the functional status of children admitted to a specialized pediatric inpatient rehabilitation unit. Design: A retrospective cohort study. Setting: King Fahad Medical City-Rehabilitation Hospital, Riyadh, Saudi Arabia. Methods: Investigators reviewed records of children admitted to a pediatric rehabilitation unit between January 1, 2012, and December 31, 2017. The outcome measures used were rehabilitation length of stay (LOS), Wee-FIM gain, and Wee-FIM efficiency. Results: The total number of records included in this study was 361 records. Sixty percent of the children were boys. The mean age was 8.7 +/- 3.8 years (range, 3-17 years). Children with cerebral palsy accounted for 45.2% of the children. The mean LOS was 43 days. Children with brain tumors had the shortest LOS compared with children with other diagnoses. Mean (SD) Wee-FIM efficiency was 0.58 (+/- 0.6). Highest Wee-FIM efficiency was observed in children with brain tumors. Average Wee-FIM gain was 20 (+/- 15). The highest functional gain was 27 in children with brain tumors while the lowest was 16 in children with cerebral palsy. Conclusions: Intensive inpatient rehabilitation program is associated with improvement in functional performance in children with a variety of impairments and disabilities.	[Madi, Sanaa Mohammed; Alraddadi, Naif Ibrahim] King Fahad Med City, Phys Therapy Dept, Aldabab St, Riyadh 11525, Saudi Arabia		Madi, SM (corresponding author), King Fahad Med City, Phys Therapy Dept, Aldabab St, Riyadh 11525, Saudi Arabia.	sanamadi@hotmail.com		Madi, Sanaa M/0000-0001-9671-200X	Biostatistics Department at King Fahad Medical City	The authors would like to extend their appreciation to The Biostatistics Department at King Fahad Medical City for their support.	Al Salloum AA, 2011, J CHILD NEUROL, V26, P21, DOI 10.1177/0883073810371510; Allen DD, 2009, SPINAL CORD, V47, P213, DOI 10.1038/sc.2008.94; Brooke V, 2012, PM&R, V4, P349, DOI 10.1016/j.pmrj.2012.01.014; Case-Smith A, 2009, OCCUPATIONAL THERAPY; Chen CC, 2004, AM J OCCUP THER, V58, P44, DOI 10.5014/ajot.58.1.44; Dumas Helene M, 2002, Pediatr Phys Ther, V14, P85, DOI 10.1097/00001577-200214020-00004; Dumas HM, 2002, AM J PHYS MED REHAB, V81, P661, DOI 10.1097/00002060-200209000-00005; Fuentes MM, 2016, ARCH PHYS MED REHAB, V97, P1407, DOI 10.1016/j.apmr.2016.02.026; Garcia RA, 2002, AM J PHYS MED REHAB, V81, P458, DOI 10.1097/00002060-200206000-00011; General Authority for Statistics, 2016, DEM SURV 2016, P2016; Harvey A, 2008, DEV MED CHILD NEUROL, V50, P190, DOI 10.1111/j.1469-8749.2008.02027.x; Hefford C, 2011, PHYS THER REV, V16, P155, DOI 10.1179/1743288X11Y.0000000004; Jimenez N, 2015, ARCH PHYS MED REHAB, V96, P1255, DOI 10.1016/j.apmr.2015.02.019; Kim CT, 2013, J PEDIATR REHAB MED, V6, P11, DOI 10.3233/PRM-130232; Kose N, 2014, NEURAL REGEN RES, V9, P129, DOI 10.4103/1673-5374.125340; Kramer ME, 2013, J HEAD TRAUMA REHAB, V28, P361, DOI 10.1097/HTR.0b013e31824da031; Lee CL, 2018, AM J MED GENET A, V176, P1309, DOI 10.1002/ajmg.a.38705; Liu MG, 1998, AM J PHYS MED REHAB, V77, P36, DOI 10.1097/00002060-199801000-00006; Mahmoud H, 2017, SPINAL CORD, V55, P509, DOI 10.1038/sc.2016.165; Mazer Barbara, 2006, Pediatr Rehabil, V9, P340, DOI 10.1080/13638490600668087; McAuliffe CA, 1998, PEDIAT PHYS THER, V10, P23; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; MSALL ME, 1994, CLIN PEDIATR, V33, P431, DOI 10.1177/000992289403300709; O'Brien JE, 2013, J PEDIATR REHAB MED, V6, P29, DOI 10.3233/PRM-130234; Ottenbacher KJ, 1997, ARCH PHYS MED REHAB, V78, P1309, DOI 10.1016/S0003-9993(97)90302-6; Ottenbacher KJ, 2000, ARCH PHYS MED REHAB, V81, P1317, DOI 10.1053/apmr.2000.9387; Peters G. O., 2008, African Journal of Biomedical Research, V11, P281; Qannam H, 2017, BRAIN INJURY, V31, P702, DOI 10.1080/02699052.2017.1286386; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; Rice SA, 2004, AM J PHYS MED REHAB, V83, P27, DOI 10.1097/01.PHM.0000104667.81620.FA; Rosenberg, 2013, APPL REGRESSION ANAL; Serghiou MH, 2008, DEV NEUROREHABIL, V11, P39, DOI 10.1080/17518420701520644; Shevell M, 2003, NEUROLOGY, V60, P367, DOI 10.1212/01.WNL.0000031431.81555.16; Sturrock B, 2017, PHYSIOTHERAPY, V103, DOI [10.1016/j.physio.2017.11.215, DOI 10.1016/J.PHYSIO.2017.11.215]; Swaine BR, 2000, AM J PHYS MED REHAB, V79, P412, DOI 10.1097/00002060-200009000-00002; Zonfrillo MR, 2013, PEDIATRICS, V131, pE206, DOI 10.1542/peds.2012-1418	36	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1179-5727			REHABIL PROCESS OUTC	Rehabil. Process Outcome	JUN	2020	9								1179572720928394	10.1177/1179572720928394			8	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	MB4NF	WOS:000542579600001	34497465	Green Published, gold			2022-02-06	
J	Maya-Casalprim, G; Ortiz, J; Tercero, A; Reyes, D; Iranzo, A; Santamaria, J; Bosch, X; Gaig, C				Maya-Casalprim, Gerard; Ortiz, Jose; Tercero, Ana; Reyes, David; Iranzo, Alex; Santamaria, Joan; Bosch, Xavier; Gaig, Carles			Cervical spinal cord injury by a low-impact trauma as an unnoticed cause of cardiorespiratory arrest	EUROPEAN HEART JOURNAL-CASE REPORTS			English	Article						Cardiorespiratory arrest; Traumatic cervical spinal cord injury; Low-impact trauma; Somatosensory evoked potentials; Motor evoked potentials; Post-anoxic coma; Case report	NERVOUS-SYSTEM	Background Cardiorespiratory arrest (CA) secondary to traumatic cervical spinal cord injury can occur in minor accidents with low-impact trauma and may be overlooked as the cause of CA in patients admitted in the coronary care unit. Case summary We present two patients admitted to the coronary care unit because of suspected CA of cardiac origin. Both patients were found in CA with asystole, one after collapsing in a shopping mall and falling down a few steps and the other in the street next to his bicycle. They underwent early pharmacologically induced coma and hypothermia precluding neurological examination. Both patients remained in coma after rewarming, with preserved brainstem reflexes but absent motor response to pain. One patient had postanoxic myoclonus in the face without limb involvement. In both patients, median nerve somatosensory evoked potentials demonstrated bilateral absence of thalamocortical N19 responses and abnormal cervicomedullary junction potentials (N13 wave). Extensive diagnostic work-up did not find a cardiac cause of the CA, pulmonary thromboembolism, or intracranial haemorrhage. In both patients, cervical spinal cord injury was diagnosed incidentally 5 and 6 days after CA, when a brain magnetic resonance imaging performed to assess post-anoxic brain injuries detected spinal cord hyperintensities with fracture and luxation of the odontoid. Both patients died 11 and 8 days after CA. Discussion Low-impact traumatic cervical spinal cord injury should be considered in the diagnostic work-up of patients with CA of unknown cause.	[Maya-Casalprim, Gerard; Tercero, Ana; Reyes, David; Iranzo, Alex; Santamaria, Joan; Gaig, Carles] Hosp Clin Barcelona, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Neurol Dept, C Villarroel 170, Barcelona 0008036, Spain; [Ortiz, Jose; Bosch, Xavier] Hosp Clin Barcelona, Cardiol Dept, Coronary Unit, Barcelona, Spain		Gaig, C (corresponding author), Hosp Clin Barcelona, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Neurol Dept, C Villarroel 170, Barcelona 0008036, Spain.	cgaig@clinic.cat	Bosch, Xavier/E-7890-2014	Bosch, Xavier/0000-0002-0133-1587; Reyes-Leiva, David/0000-0001-6983-7130; Ortiz Perez, Jose Tomas/0000-0001-8043-6055; Maya, Gerard/0000-0002-5025-2615; Santamaria Cano, Joan/0000-0003-0879-4135			Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Clayton JL, 2012, INJURY, V43, P431, DOI 10.1016/j.injury.2011.06.022; Desroziers Milene, 2016, BMJ Case Rep, V2016, DOI 10.1136/bcr-2016-214659; Grigorean Valentin Titus, 2009, J Med Life, V2, P133; Kim SW, 2017, CHIN J TRAUMATOL, V20, P118, DOI 10.1016/j.cjtee.2016.11.004; LEHMANN KG, 1987, J AM COLL CARDIOL, V10, P46, DOI 10.1016/S0735-1097(87)80158-4; Miyata K, 2016, ACUTE MED SURG, V3, P86, DOI 10.1002/ams2.142; Rossetti AO, 2016, LANCET NEUROL, V15, P597, DOI 10.1016/S1474-4422(16)00015-6; Teasell RW, 2000, ARCH PHYS MED REHAB, V81, P506, DOI 10.1053/mr.2000.3848	9	1	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2514-2119		EUR HEART J-CASE REP	Eur. Heart J.-Case Rep.	JUN	2020	4	2							ytaa044	10.1093/ehjcr/ytaa044			6	Cardiac & Cardiovascular Systems	Emerging Sources Citation Index (ESCI)	Cardiovascular System & Cardiology	RV1QU	WOS:000645616100028	32352051	Green Published, gold			2022-02-06	
J	Montroull, LE; Rothbard, DE; Kanal, HD; D'Mello, V; Dodson, V; Troy, CM; Zanin, JP; Levison, SW; Friedman, WJ				Montroull, Laura E.; Rothbard, Deborah E.; Kanal, Hur D.; D'Mello, Veera; Dodson, Vincent; Troy, Carol M.; Zanin, Juan P.; Levison, Steven W.; Friedman, Wilma J.			Proneurotrophins Induce Apoptotic Neuronal Death After Controlled Cortical Impact Injury in Adult Mice	ASN NEURO			English	Article						neuroprotection; pro-brain-derived neurotrophic factor; pro-nerve growth factor; p75 neurotrophin receptor; traumatic brain injury; intranasal delivery	P75 NEUROTROPHIN RECEPTOR; TRAUMATIC BRAIN-INJURY; NERVE GROWTH-FACTOR; MOLECULE P75(NTR) LIGAND; HIPPOCAMPAL-NEURONS; SPINAL-CORD; INTRANASAL DELIVERY; FUNCTIONAL RECOVERY; P75-MEDIATED DEATH; PRONGF	The p75 neurotrophin receptor (p75NTR) can regulate multiple cellular functions including proliferation, survival, and apoptotic cell death. The p75NTR is widely expressed in the developing brain and is downregulated as the nervous system matures, with only a few neuronal subpopulations retaining expression into adulthood. However, p75NTR expression is induced following damage to the adult brain, including after traumatic brain injury, which is a leading cause of mortality and disability worldwide. A major consequence of traumatic brain injury is the progressive neuronal loss that continues secondary to the initial trauma, which ultimately contributes to cognitive decline. Understanding mechanisms governing this progressive neuronal death is key to developing targeted therapeutic strategies to provide neuroprotection and salvage cognitive function. In this study, we demonstrate that a cortical impact injury to the sensorimotor cortex elicits p75NTR expression in apoptotic neurons in the injury penumbra, confirming previous studies. To establish whether preventing p75NTR induction or blocking the ligands would reduce the extent of secondary neuronal cell death, we used a noninvasive intranasal strategy to deliver either siRNA to block the induction of p75NTR, or function-blocking antibodies to the ligands pro-nerve growth factor and pro-brain-derived neurotrophic factor. We demonstrate that either preventing the induction of p75NTR or blocking the proneurotrophin ligands provides neuroprotection and preserves sensorimotor function.	[Montroull, Laura E.; Zanin, Juan P.; Friedman, Wilma J.] Rutgers State Univ, Dept Biol Sci, 225 Univ Ave, Newark, NJ 07102 USA; [Rothbard, Deborah E.; Kanal, Hur D.; D'Mello, Veera; Dodson, Vincent; Levison, Steven W.] Rutgers State Univ, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA; [Troy, Carol M.] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY USA		Montroull, LE (corresponding author), Rutgers State Univ, Dept Biol Sci, 225 Univ Ave, Newark, NJ 07102 USA.	lem157@newark.rutgers.edu	Troy, Carol/ABC-2771-2020	Friedman, Wilma/0000-0002-3638-3504; Kanal, Hur/0000-0002-6863-3651; Rothbard, Deborah/0000-0003-3629-1367	New Jersey Commission for Brain Injury Research [CBIR14IRG006, CBIR17IRG019]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the New Jersey Commission for Brain Injury Research CBIR14IRG006 awarded to W. J. F. and CBIR17IRG019 awarded to S. W. L.	Akpan N, 2011, J NEUROSCI, V31, P8894, DOI 10.1523/JNEUROSCI.0698-11.2011; Alder J, 2016, BRAIN INJURY, V30, P48, DOI 10.3109/02699052.2015.1088963; Cragnolini AB, 2018, MOL CELL NEUROSCI, V88, P240, DOI 10.1016/j.mcn.2018.02.007; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Bronfman FC, 2004, EMBO REP, V5, P867, DOI 10.1038/sj.embor.7400219; Cantarella C, 2008, DEV NEUROBIOL, V68, P223, DOI 10.1002/dneu.20588; Cattepoel S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018296; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Cragnolini AB, 2009, GLIA, V57, P1386, DOI 10.1002/glia.20857; Davidson TJ, 2004, J NEUROSCI, V24, P10040, DOI 10.1523/JNEUROSCI.3643-04.2004; Delbary-Gossart S, 2016, BRAIN, V139, P1762, DOI 10.1093/brain/aww074; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Frade JM, 1998, BIOESSAYS, V20, P137, DOI 10.1002/(SICI)1521-1878(199802)20:2<137::AID-BIES6>3.0.CO;2-Q; Friedman WJ, 2000, J NEUROSCI, V20, P6340, DOI 10.1523/JNEUROSCI.20-17-06340.2000; Gentry JJ, 2004, PROG BRAIN RES, V146, P25, DOI 10.1016/S0079-6123(03)46002-0; Grabenstatter HL, 2014, J NEUROSCI RES, V92, P1307, DOI 10.1002/jnr.23402; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jin KL, 2003, ANN NEUROL, V53, P405, DOI 10.1002/ana.10506; Knowles JK, 2013, NEUROBIOL AGING, V34, P2052, DOI 10.1016/j.neurobiolaging.2013.02.015; Le AP, 2012, J NEUROSCI, V32, P703, DOI 10.1523/JNEUROSCI.4128-11.2012; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Malerba F, 2011, EXPERT OPIN DRUG DEL, V8, P1277, DOI 10.1517/17425247.2011.588204; Meng YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106238; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; OPPENHEIM RW, 1989, TRENDS NEUROSCI, V12, P252, DOI 10.1016/0166-2236(89)90021-0; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Robertson IH, 2008, ARCH PHYS MED REHAB, V89, pS1, DOI 10.1016/j.apmr.2008.10.001; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Scafidi J, 2014, NATURE, V506, P230, DOI 10.1038/nature12880; Sebastiani A, 2015, J NEUROTRAUM, V32, P1599, DOI 10.1089/neu.2014.3751; Shi J, 2013, STEM CELLS, V31, P2561, DOI 10.1002/stem.1516; Soblosky JS, 1997, BEHAV BRAIN RES, V89, P51, DOI 10.1016/S0166-4328(97)00049-1; Tep C, 2013, J NEUROSCI, V33, P397, DOI 10.1523/JNEUROSCI.0399-12.2013; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Tian LL, 2012, BRAIN RES, V1440, P47, DOI 10.1016/j.brainres.2011.12.059; Troy CM, 2002, J BIOL CHEM, V277, P34295, DOI 10.1074/jbc.M205167200; Volosin M, 2008, J NEUROSCI, V28, P9870, DOI 10.1523/JNEUROSCI.2841-08.2008; Volosin M, 2006, J NEUROSCI, V26, P7756, DOI 10.1523/JNEUROSCI.1560-06.2006; Wu WF, 2010, J CLIN NEUROSCI, V17, P92, DOI 10.1016/j.jocn.2009.03.039; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	46	1	1	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1759-0914			ASN NEURO	ASN Neuro	JUN	2020	12								1759091420930865	10.1177/1759091420930865			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY5RO	WOS:000540586900001	32493127	Green Published, gold			2022-02-06	
J	Park, E; McCutcheon, V; Telliyan, T; Liu, ELN; Eisen, R; Kinio, A; Tavakkoli, J; Baker, AJ				Park, Eugene; McCutcheon, Victoria; Telliyan, Tamar; Liu, Elaine; Eisen, Rebecca; Kinio, Anna; Tavakkoli, Jahan; Baker, Andrew J.			Remote ischemic conditioning improves outcome independent of anesthetic effects following shockwave-induced traumatic brain injury	IBRO REPORTS			English	Article						Behavior; Blast injury; Concussion; Ischemic conditioning; Preconditioning; Primary blast; Traumatic brain injury; Zebrafish	INFARCT SIZE; MOUSE MODEL; ADULT; ISOFLURANE; PROTECTS; NEUROPROTECTION; ACTIVATION; DEFICITS; SURGERY	Traumatic brain injury due to primary blast exposure is a major cause of ongoing neurological and psychological impairment in soldiers and civilians. Animal and human evidence suggests that low-level blast exposure is capable of inducing white matter injury and behavioural deficits. There are currently no effective therapies to treat the underlying suspected pathophysiology of low-level primary blast or concussion. Remote ischemic conditioning (RIC) has been shown to have cardiac, renal and neuro-protective effects in response to brief cycles of ischemia. Here we examined the effects of RIC in two models of blast injury. We used a model of low-level primary blast in rats to evaluate the effects of RIC neurofilament expression. We subsequently used a model of traumatic brain injury in adult zebrafish using pulsed high intensity focused ultrasound (pHIFU) to evaluate the effects of RIC on behavioural outcome and apoptosis in a post-traumatic setting. In blast exposed rats, RIC pretreatment modulated NF200 expression suggesting an innate biological buffering effect. In zebrafish, behavioural deficits and apoptosis due to pHIFU-induced brain injury were reduced following administration of serum derived from RIC rats. The results in the zebrafish model demonstrate the humoral effects of RIC independent of anesthetic effects that were observed in the rat model of injury. Our results indicate that RIC is effective in improving outcome following modeled brain trauma in pre- and post-injury paradigms. The results suggest a potential role for innate biological systems in the protection against pathophysiological processes associated with impairment following shockwave induced trauma.	[Park, Eugene; McCutcheon, Victoria; Telliyan, Tamar; Liu, Elaine; Eisen, Rebecca; Kinio, Anna; Tavakkoli, Jahan; Baker, Andrew J.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [McCutcheon, Victoria; Baker, Andrew J.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Tavakkoli, Jahan] Ryerson Univ, Dept Phys, Toronto, ON, Canada; [Baker, Andrew J.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Baker, Andrew J.] Univ Toronto, Dept Surg, Toronto, ON, Canada		Park, E (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, 209 Victoria St,6-656 LKSKI West, Toronto, ON M5B 1T8, Canada.	parke@smh.ca		Peterson, Victoria/0000-0003-1627-0526			Aldag M, 2017, J NEUROTRAUM, V34, pS26, DOI 10.1089/neu.2017.5218; Alhamami M, 2014, MED PHYS, V41, DOI 10.1118/1.4871621; Baker AJ, 2011, J TRAUMA, V71, pS472, DOI 10.1097/TA.0b013e318232e7da; Basalay M, 2012, EXP PHYSIOL, V97, P908, DOI 10.1113/expphysiol.2012.064923; Basalay MV, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-018-0684-z; Bell JD, 2017, ANESTH ANALG, V124, P1237, DOI 10.1213/ANE.0000000000001856; Benstoem C, 2017, BRIT J ANAESTH, V119, P1234, DOI 10.1093/bja/aex357; Benstoem C, 2018, MINERVA ANESTESIOL, V84, P1298, DOI 10.23736/S0375-9393.18.12465-5; Bromage DI, 2017, CARDIOVASC RES, V113, P288, DOI 10.1093/cvr/cvw219; Cacialli P, 2018, NEURAL REGEN RES, V13, P941, DOI 10.4103/1673-5374.233430; Candilio L, 2015, HEART, V101, P185, DOI 10.1136/heartjnl-2014-306178; Ceci M, 2019, REV NEUROSCIENCE, V30, P45, DOI 10.1515/revneuro-2018-0020; Chen G, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00040; Cheng X, 2018, BRAIN RES, V1686, P94, DOI 10.1016/j.brainres.2018.02.019; Collymore C, 2014, J AM ASSOC LAB ANIM, V53, P198; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Fievisohn E, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038710; Hausenloy DJ, 2015, NEW ENGL J MED, V373, P1408, DOI 10.1056/NEJMoa1413534; Herzog C, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.174698; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hu S, 2012, BRAIN RES, V1459, P81, DOI 10.1016/j.brainres.2012.04.017; Jevtovic-Todorovic V, 2013, BRIT J ANAESTH, V111, P143, DOI 10.1093/bja/aet177; Jiang M, 2017, MED GAS RES, V7, P48, DOI 10.4103/2045-9912.202910; Kerendi F, 2005, BASIC RES CARDIOL, V100, P404, DOI 10.1007/s00395-005-0539-2; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Li P, 2016, INT J NEUROSCI, V126, P552, DOI 10.3109/00207454.2015.1042973; Maheras AL, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0208-17.2017; McClelland AC, 2018, NEURORADIOLOGY, V60, P1019, DOI 10.1007/s00234-018-2070-9; McCutcheon V, 2017, J NEUROTRAUM, V34, P1382, DOI 10.1089/neu.2016.4497; Meybohm P, 2015, NEW ENGL J MED, V373, P1397, DOI 10.1056/NEJMoa1413579; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Pandit V, 2018, J TRAUMA ACUTE CARE, V85, P48, DOI 10.1097/TA.0000000000001835; Park E, 2013, NEUROBIOL DIS, V52, P150, DOI 10.1016/j.nbd.2012.12.002; Park E, 2011, J NEUROTRAUM, V28, P343, DOI 10.1089/neu.2009.1050; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Platholi J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102978; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Pugach E.K., 2009, J VIS EXP; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Ren CH, 2018, BEHAV BRAIN RES, V340, P87, DOI 10.1016/j.bbr.2016.10.036; Saab BJ, 2010, ANESTHESIOLOGY, V113, P1061, DOI 10.1097/ALN.0b013e3181f56228; Sandweiss AJ, 2017, J TRAUMA ACUTE CARE, V83, P1074, DOI 10.1097/TA.0000000000001626; Shimizu Y, 2018, GLIA, V66, P1382, DOI 10.1002/glia.23311; Silachev DN, 2017, BIOCHEMISTRY-MOSCOW+, V82, P1006, DOI 10.1134/S0006297917090036; Slupe AM, 2018, J CEREBR BLOOD F MET, V38, P2192, DOI 10.1177/0271678X18789273; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Steensrud T, 2010, AM J PHYSIOL-HEART C, V299, pH1598, DOI 10.1152/ajpheart.00396.2010; Sullivan DR, 2018, J INT NEUROPSYCH SOC, V24, P662, DOI 10.1017/S1355617718000279; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Zheng W, 2017, HEPATOL RES, V47, P234, DOI 10.1111/hepr.12702; Zong YH, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0235-6	55	1	1	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2451-8301			IBRO REP	IBRO Rep.	JUN	2020	8						18	27		10.1016/j.ibror.2019.12.001			10	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	PT4YN	WOS:000608622300003	31909289	Green Published, gold			2022-02-06	
J	Pasquesi, SA; Seidi, M; Hajiaghamemar, M; Margulies, SS				Pasquesi, Stephanie A.; Seidi, Morteza; Hajiaghamemar, Marzieh; Margulies, Susan S.			Predictions of neonatal porcine bridging vein rupture and extra-axial hemorrhage during rapid head rotations	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Traumatic brain injury; Subdural hemorrhage; Bridging veins; Finite element modeling; Pediatric; Abusive head trauma	INTRACRANIAL HEMORRHAGE; INJURY; DIRECTION; SIMULATIONS; BRAIN; MODEL; AGE	When the head is rotated rapidly, the movement of the brain lags that of the skull. Intracranial contents between the brain and skull include meninges, cerebrospinal fluid (CSF), and cerebral vasculature. Among the cerebral vasculature in this space are the parasagittal bridging veins (BVs), which drain blood from the brain into the superior sagittal sinus (SSS), which is housed within the falx cerebri, adhered to the inner surface of the skull. Differential motion between the brain and skull that may occur during a traumatic event is thought to stretch BVs, causing damage and producing extra-axial hemorrhage (EAH). Finite element (FE) modeling is a technique often used to aid in the understanding and prediction of traumatic brain injury (TBI), and estimation of tissue deformation during traumatic events provides insight into kinematic injury thresholds. Using a FE model of the newborn porcine head with neonatal porcine brain and BV properties, single and cyclic rapid head rotations without impact were simulated. Measured BV failure properties were used to predict BV rupture. By comparing simulation outputs to observations of EAH in a development group of in vivo studies of rapid non-impact head rotations in the piglet, it was determined that failure of 16.7% of BV elements was associated with a 50% risk of EAH, and showed in a separate validation group that this threshold predicted the occurrence of EAH with 100% sensitivity and 100% specificity for single rapid non-impact rotations. This threshold for failed BV elements performed with 90% overall correct prediction in simulations of cyclic rotational head injuries. A 50% risk of EAH was associated with head angular velocities of 94.74 rad/s and angular accelerations of 29.60 krad/s(2) in the newborn piglet. Future studies may build on these findings for BV failure in the piglet to develop predictive models for BV failure in human infants.	[Pasquesi, Stephanie A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Seidi, Morteza; Hajiaghamemar, Marzieh; Margulies, Susan S.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Seidi, Morteza; Hajiaghamemar, Marzieh; Margulies, Susan S.] Emory Univ, Atlanta, GA 30322 USA		Margulies, SS (corresponding author), Emory Univ, Georgia Tech Coll Engn, Wallace H Coulter Dept Biomed Engn, Georgia Inst Technol,Sch Med, UA Whitaker Bldg,313 Ferst Dr,Suite 2116, Atlanta, GA 30332 USA.	susan.margulies@gatech.edu			American Heart AssociationAmerican Heart Association [12PRE12040315]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21HD078842, R01NS039679, R01NS097549]; Children's Hospital of Philadelphia Critical Care Fund; Georgia Research Alliance	We are grateful for the support of the American Heart Association (12PRE12040315), the National Institutes of Health (R21HD078842, R01NS039679 and R01NS097549), the Children's Hospital of Philadelphia Critical Care Fund, and the Georgia Research Alliance.	Coats B, 2003, P INT RES COUNC BIOM; Coats B., 2016, J NEUROTRAUMA; Coats B, 2012, INT J DEV NEUROSCI, V30, P191, DOI 10.1016/j.ijdevneu.2011.12.009; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Hajiaghamemar M., 2019, BIOMECH MODEL MECHAN; Hajiaghamemar M, 2019, INT J LEGAL MED, V133, P847, DOI 10.1007/s00414-018-1918-1; Han H, 2007, NEURORADIOLOGY, V49, P169, DOI 10.1007/s00234-006-0175-z; Han IS, 2014, INT J PRECIS ENG MAN, V15, P2405, DOI 10.1007/s12541-014-0607-3; Ibrahim NG, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000956; Jin Xin, 2006, Stapp Car Crash J, V50, P637; Jin X, 2011, J BIOMECH, V44, P467, DOI 10.1016/j.jbiomech.2010.09.035; Jin X, 2007, STAPP CAR CRASH JO, V51, P115; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Li XG, 2017, BIOMECH MODEL MECHAN, V16, P823, DOI 10.1007/s10237-016-0855-5; Migueis GFJ, 2019, CLIN BIOMECH, V63, P104, DOI 10.1016/j.clinbiomech.2019.02.010; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Pasquesi S.A., 2017, ANN BIOMED ENG; Pasquesi SA, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00016; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Saboori P, 2014, ADV BIOMECH APPL, V1, P253, DOI DOI 10.12989/aba.2014.1.4.253; Scott G.G., 2015, BIOMECH MODEL MECHAN; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Untaroiu C., 2007, P 20 INT TECHN C ENH; Weeks D, 2014, J NEUROTRAUM, V31, P206, DOI 10.1089/neu.2013.3113; YAMASHIMA T, 1984, J NEUROL NEUROSUR PS, V47, P121, DOI 10.1136/jnnp.47.2.121; Yang N, 2019, PROCEEDINGS OF THE 2019 3RD INTERNATIONAL CONFERENCE ON MANAGEMENT ENGINEERING, SOFTWARE ENGINEERING AND SERVICE SCIENCES (ICMSS 2019), P97, DOI 10.1145/3312662.3312702; Zhou Z, 2020, J NEUROTRAUM, V37, P1074, DOI 10.1089/neu.2019.6634; Zhou Z, 2019, BIOMECH MODEL MECHAN, V18, P155, DOI 10.1007/s10237-018-1074-z	34	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	JUN	2020	106								103740	10.1016/j.jmbbm.2020.103740			12	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	LG6MX	WOS:000528213800010	32250951	Green Accepted, hybrid			2022-02-06	
J	Peiffer, AJ; MacDonald, J; Duerson, D; Mitchell, G; Hartwick, ATE; McDaniel, CE				Peiffer, Adam J.; MacDonald, James; Duerson, Drew; Mitchell, Gladys; Hartwick, Andrew T. E.; McDaniel, Catherine E.			The Influence of Binocular Vision Symptoms on Computerized Neurocognitive Testing of Adolescents With Concussion	CLINICAL PEDIATRICS			English	Article						sport-related concussion; cognitive performance; binocular vision; convergence insufficiency; sports medicine	TRAUMATIC BRAIN-INJURY; CONVERGENCE INSUFFICIENCY; HIGH-SCHOOL; BASE-LINE; COGNITIVE IMPAIRMENT; VALIDITY; RELIABILITY; CHILDREN; SENSITIVITY; PREVALENCE	Binocular vision disorders are commonly found postconcussion and associated with high symptom burden. We investigated the relationship between binocular vision symptoms and neurocognitive test performance. Thirty-four adolescents with concussion and 18 without concussion were assessed for cognitive performance using the CogState Brief Battery. Binocular vision disorders were determined using clinical examination and vision symptoms with the Convergence Insufficiency Symptoms Survey (CISS). A cutoff CISS score of 13 had high predictive accuracy for identifying individuals with a binocular vision disorder. CogState scores for processing speed and attention were significantly lower in the concussion group compared with the control group. Within the concussion group, scores for attention, learning, and working memory were significantly lower in those with vision symptoms. The presence of vision symptoms did not significantly affect CogState scores within the control group. The presence of vision symptoms in individuals with concussion is associated with significantly reduced scores on individual components of the CogState.	[Peiffer, Adam J.; MacDonald, James; Duerson, Drew; Mitchell, Gladys; Hartwick, Andrew T. E.; McDaniel, Catherine E.] Ohio State Univ, Columbus, OH 43210 USA; [MacDonald, James; Duerson, Drew] Nationwide Childrens Hosp, Columbus, OH USA		McDaniel, CE (corresponding author), Ohio State Univ, Coll Optometry, 338 West,10th Ave, Columbus, OH 43210 USA.	mcdaniel.547@osu.edu		MacDonald, James/0000-0002-0432-0808	American Academy of Optometry Foundation Beta Sigma Kappa Research Fellowship	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: American Academy of Optometry Foundation Beta Sigma Kappa Research Fellowship.	Barnhardt C, 2012, OPTOMETRY VISION SCI, V89, P1512, DOI 10.1097/OPX.0b013e318269c8f9; Borsting EJ, 2003, OPTOMETRY VISION SCI, V80, P832, DOI 10.1097/00006324-200312000-00014; Borsting Eric, 2003, Optometry, V74, P25; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Cogstate, ACAD RES; Cromer JA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00704; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hartman M, 2008, PEDIATRICS, V122, pE172, DOI 10.1542/peds.2007-3399; Lara F, 2001, OPHTHAL PHYSL OPT, V21, P70, DOI 10.1046/j.1475-1313.2001.00540.x; Laukkanen H, 2017, OPTOMETRY VISION SCI, V94, P43, DOI 10.1097/OPX.0000000000000940; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; MacDonald J, 2015, CLIN J SPORT MED, V25, P367, DOI 10.1097/JSM.0000000000000139; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Maples W C, 2003, Optometry, V74, P35; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P764, DOI 10.1080/13803395.2015.1060950; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Porcar E, 1997, OPTOMETRY VISION SCI, V74, P111, DOI 10.1097/00006324-199702000-00023; Rouse M, 2009, OPTOMETRY VISION SCI, V86, P357, DOI 10.1097/OPX.0b013e3181989252; Rouse MW, 1999, OPTOMETRY VISION SCI, V76, P643, DOI 10.1097/00006324-199909000-00022; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Shin HS, 2009, OPHTHAL PHYSL OPT, V29, P615, DOI 10.1111/j.1475-1313.2009.00684.x; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Swanson MW, 2017, OPTOMETRY VISION SCI, V94, P60, DOI 10.1097/OPX.0000000000000977; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wick B., 2008, CLIN MANAGEMENT BINO; Yue JK, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15612; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	37	1	1	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	OCT	2020	59	11					961	969	0009922820927477	10.1177/0009922820927477		JUN 2020	9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	MU7ST	WOS:000537173800001	32476458				2022-02-06	
J	Pundik, S; McCabe, J; Kesner, S; Skelly, M; Fatone, S				Pundik, Svetlana; McCabe, Jessica; Kesner, Samuel; Skelly, Margaret; Fatone, Stefania			Use of a myoelectric upper limb orthosis for rehabilitation of the upper limb in traumatic brain injury: A case report	JOURNAL OF REHABILITATION AND ASSISTIVE TECHNOLOGIES ENGINEERING			English	Article						Traumatic brain injury; rehabilitation; motor learning-based therapy; upper extremity; robotics; myoelectric orthosis; orthotic devices	FUNCTIONAL ELECTRICAL-STIMULATION; MODIFIED ASHWORTH SCALE; INTERRATER RELIABILITY; MOTOR RECOVERY; STROKE; ROBOTICS; ARM; EXERCISE; THERAPY	Background: Upper limb motor deficits following traumatic brain injury are prevalent and effective therapies are needed. The purpose of this case report was to illustrate response to a novel therapy using a myoelectric orthosis in a person with TBI. Case description: A 42-year-old female, 29.5 years post-traumatic brain injury with diminished motor control/coordination, and learned nonuse of the right arm. She also had cognitive deficits and did not spontaneously use her right arm functionally. Intervention: Study included three phases: baseline data collection/device fabrication (five weeks); in-clinic training (2x/week for nine weeks); and home-use phase nine weeks). The orthosis was incorporated into motor learning-based therapy. Outcomes: During in-clinic training, active range of motion, tone, muscle power, Fugl-Meyer, box and blocks test, and Chedoke assessment score improved. During the home-use phase, decrease in tone was maintained and all other outcomes declined but were still better upon study completion than baseline. The participant trained with the orthosis 70.12 h, logging over 13,000 repetitions of elbow flexion/extension and hand open/close. Discussion: Despite long-standing traumatic brain injury, meaningful improvements in motor function were observed and were likely the results of high repetition practice of functional movement delivered over a long duration. Further assessment in a larger cohort is warranted.	[Pundik, Svetlana; McCabe, Jessica; Skelly, Margaret] Vet Affairs Med Ctr, Louis Stokes Cleveland Dept, Brain Plast & NeuroRecovery Lab, 10701 E Blvd,Neurol Serv 127W, Cleveland, OH 44106 USA; [Pundik, Svetlana] Case Western Reserve Univ, Sch Med, Dept Neurol, Cleveland, OH 44106 USA; [Kesner, Samuel] Myomo Inc, Res & Dev, Cambridge, MA USA; [Fatone, Stefania] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA		Pundik, S (corresponding author), Vet Affairs Med Ctr, Louis Stokes Cleveland Dept, Brain Plast & NeuroRecovery Lab, 10701 E Blvd,Neurol Serv 127W, Cleveland, OH 44106 USA.	svetlana.pundik@case.edu			Office of Secretary of Defense for Health Affairs, through the Orthotics and Prosthetics Outcomes Research Program, Orthotics Outcomes Research [W81XWH-16-1-0733]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Office of Secretary of Defense for Health Affairs, through the Orthotics and Prosthetics Outcomes Research Program, Orthotics Outcomes Research Award under Award No. W81XWH-16-1-0733. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.	Barreca SR, 2006, PHYS THER, V86, P245, DOI 10.1093/ptj/86.2.245; Barreca Susan, 2004, Top Stroke Rehabil, V11, P31; BENJUYA N, 1990, J PROSTHET ORTHOT, V2, P149; Bermudez i Badia S, 2012, P 9 INT C DIS VIRT R, P187; Bleakley SM., 2013, THESIS; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Breceda EY, 2013, CURR OPIN NEUROL, V26, P595, DOI 10.1097/WCO.0000000000000024; Brown EVD, 2015, DISABIL HEALTH J, V8, P507, DOI 10.1016/j.dhjo.2015.03.007; Chan L, 2009, PM&R, V1, P997, DOI 10.1016/j.pmrj.2009.09.019; Chen HM, 2009, NEUROREHAB NEURAL RE, V23, P435, DOI 10.1177/1545968308331146; Daly JJ, 2005, J REHABIL RES DEV, V42, P723, DOI 10.1682/JRRD.2005.02.0048; Daly JJ, 2019, NEUROREHABIL NEURAL; DiCicco M, 2004, IEEE INT CONF ROBOT, P1622, DOI 10.1109/ROBOT.2004.1308056; Faul M, 2010, TRAUMATIC BRAIN INJU; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Hu XL, 2009, NEUROREHAB NEURAL RE, V23, P837, DOI 10.1177/1545968309338191; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; Kafri M, 2015, ANN BIOMED ENG, V43, P451, DOI 10.1007/s10439-014-1148-8; Kendall FP, 2005, MUSCLES TESTING FUNC; Kim GJ, 2015, ARCH PHYS MED REHAB, V96, P2243, DOI 10.1016/j.apmr.2015.06.019; Krakauer JW, 2017, BROKEN MOVEMENT NEUR; Krebs HI and, 2013, HDB CLIN NEUROL, V110, P285; Lang Catherine E, 2007, J Neurol Phys Ther, V31, P3; Linder SM, 2017, AM J OCCUPATIONAL TH, V71, P1, DOI [10.5014/ajot.2017.020297, DOI 10.5014/AJOT.2017.020297]]; McCabe J, 2015, ARCH PHYS MED REHAB, V96, P981, DOI 10.1016/j.apmr.2014.10.022; Mccabe JP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215311; Naft J., 2013, C P AM ACAD ORTHOTIS; Naghdi Soofia, 2008, Physiotherapy Theory and Practice, V24, P372, DOI 10.1080/09593980802278959; O'Sullivan SB., 2019, PHYS REHABILITATION, V6th; Page SJ, 2013, CLIN REHABIL, V27, P494, DOI 10.1177/0269215512464795; Page SJ, 2012, PHYS THER, V92, P791, DOI 10.2522/ptj.20110009; Page SJ, 2011, J NEUROL PHYS THER, V35, P41, DOI 10.1097/NPT.0b013e31820c4b00; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; Shumway-Cook A, 2017, MOTOR CONTROL TRANSL, V5th; Sivan M, 2011, J REHABIL MED, V43, P181, DOI 10.2340/16501977-0674; Slack M., 1992, J PROSTH ORTH, V4, P171; Stein J, 2007, AM J PHYS MED REHAB, V86, P255, DOI 10.1097/PHM.0b013e3180383cc5; World Health Organization, 2002, COMM LANG FUNCT DIS	39	1	1	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2055-6683			J REHABIL ASSIST TER	J. Rehabil. Assist. Technol. Eng.	JUN	2020	7									10.1177/2055668320921067			11	Engineering, Biomedical	Emerging Sources Citation Index (ESCI)	Engineering	ME5WT	WOS:000544726600001	32612847	Green Published, gold			2022-02-06	
J	Puppo, C; Kasprowicz, M; Steiner, LA; Yelicich, B; Lalou, DA; Smielewski, P; Czosnyka, M				Puppo, Corina; Kasprowicz, Magdalena; Steiner, Luzius A.; Yelicich, Bernardo; Lalou, Despina Afrodite; Smielewski, Peter; Czosnyka, Marek			Hypocapnia after traumatic brain injury: how does it affect the time constant of the cerebral circulation?	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article							CEREBROSPINAL-FLUID; ARTERIAL COMPLIANCE; CARBON-DIOXIDE; BLOOD-FLOW; PRESSURE	The time constant of the cerebral arterial bed ("tau") estimates how fast the blood entering the brain fills the arterial vascular sector. Analogous to an electrical resistor-capacitor circuit, it is expressed as the product of arterial compliance (Ca) and cerebrovascular resistance (CVR). Hypocapnia increases the time constant in healthy volunteers and decreases arterial compliance in head trauma. How the combination of hyocapnia and trauma affects this parameter has yet to be studied. We hypothesized that in TBI patients the intense vasoconstrictive action of hypocapnia would dominate over the decrease in compliance seen after hyperventilation. The predominant vasoconstrictive response would maintain an incoming blood volume in the arterial circulation, thereby lengthening tau. We retrospectively analyzed recordings of intracranial pressure (ICP), arterial blood pressure (ABP), and blood flow velocity (FV) obtained from a cohort of 27 severe TBI patients [(39/30 years (median/IQR), 5 women; admission GCS 6/5 (median/IQR)] studied during a standard clinical CO2 reactivity test. The reactivity test was performed by means of a 50-min increase in ventilation (20% increase in respiratory minute volume). CVR and Ca were estimated from these recordings, and their product calculated to find the time constant. CVR significantly increased [median CVR pre-hypocapnia/during hypocapnia: 1.05/1.35 mmHg/(cm(3)/s)]. Ca decreased (median Ca pre-hypocapnia/during hypocapnia: 0.130/0.124 arbitrary units) to statistical significance (p = 0.005). The product of these two parameters resulted in a significant prolongation of the time constant (median tau pre-hypocapnia/during hypocapnia: 0.136 s/0.152 s, p < .001). Overall, the increase in CVR dominated over the decrease in compliance, hence tau was longer. We demonstrate a significant increase in the time constant of the cerebral circulation during hypocapnia after severe TBI, and attribute this to an increase in cerebrovascular resistance which outweighs the decrease in cerebral arterial bed compliance.	[Puppo, Corina; Yelicich, Bernardo] Univ Republica, Hosp Clin, Intens Care Unit, Av Italia S-N, Montevideo 11600, Uruguay; [Kasprowicz, Magdalena] Wroclaw Univ Sci & Technol, Fac Fundamental Problems Technol, Dept Biomed Engn, Wybrzeze Stanislawa Wyspianskiego 27, Wroclaw 50370, Poland; [Steiner, Luzius A.] Univ Basel, Univ Hosp Basel, Surg Intens Care Prehosp Emergency Med & Pain The, Spitalstr 21, Basel 4031, Switzerland; [Lalou, Despina Afrodite; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Div Acad Neurosurg, Dept Clin Neurosci, Hills Rd, Cambridge CB2 0QQ, England		Puppo, C (corresponding author), Univ Republica, Hosp Clin, Intens Care Unit, Av Italia S-N, Montevideo 11600, Uruguay.	coripuppo@gmail.com; mkasprow@gmail.com; Luzius.Steiner@usb.ch; beryeli@gmail.com; alfadt.lalou@gmail.com; ps10011@cam.ac.uk; mc141@medschl.cam.ac.uk	Lalou, Afroditi Despina/D-2938-2017	Lalou, Afroditi Despina/0000-0003-3768-8681; Smielewski, Peter/0000-0001-5096-3938; czosnyka, marek/0000-0003-2446-8006; Puppo, Corina/0000-0002-5808-795X; Kasprowicz, Magdalena/0000-0002-2271-7737			AASLID R, 1991, STROKE, V22, P1148, DOI 10.1161/01.STR.22.9.1148; Alperin N, 2005, J NEUROSURG, V103, P46, DOI 10.3171/jns.2005.103.1.0046; Avezaat C, 1984, CEREBROSPINAL FLUID; Capel C, 2014, NEUROL RES, V36, P255, DOI 10.1179/1743132813Y.0000000282; Carrera E, 2011, J NEUROIMAGING, V21, P121, DOI 10.1111/j.1552-6569.2009.00439.x; Carrera E, 2011, J NEUROTRAUM, V28, P889, DOI 10.1089/neu.2010.1377; Coverdale NS, 2015, AM J PHYSIOL-HEART C, V308, pH1030, DOI 10.1152/ajpheart.00761.2014; Czosnyka M, 2012, NEUROL RES, V34, P17, DOI 10.1179/1743132811Y.0000000040; Dobrzeniecki M, 2018, ACTA NEUROCHIR SUPPL, V126, P21, DOI 10.1007/978-3-319-65798-1_5; GILLER CA, 1993, NEUROSURGERY, V32, P737, DOI 10.1227/00006123-199305000-00006; Hoiland RL, 2016, J PHYSIOL-LONDON, V594, P4073, DOI 10.1113/JP271981; Kasprowicz M, 2016, ACTA NEUROCHIR SUPPL, V122, P211, DOI 10.1007/978-3-319-22533-3_42; Kasprowicz M, 2012, ULTRASOUND MED BIOL, V38, P1129, DOI 10.1016/j.ultrasmedbio.2012.02.014; Kasprowicz Magdalena, 1800, Acta Neurochir Suppl, V114, P17, DOI 10.1007/978-3-7091-0956-4_4; Kasprowicz M, 2012, NEUROCRIT CARE, V16, P213, DOI 10.1007/s12028-011-9653-1; Smielewski P, 2018, ACTA NEUROCHIR SUPPL, V126, P139, DOI 10.1007/978-3-319-65798-1_29; Smielewski Peter, 2012, Acta Neurochir Suppl, V114, P75, DOI 10.1007/978-3-7091-0956-4_13; Steiner LA, 2004, INTENS CARE MED, V30, P2180, DOI 10.1007/s00134-004-2463-6; Stolz E, 1999, STROKE, V30, P1070, DOI 10.1161/01.STR.30.5.1070; Trofimov A, 2016, ACTA NEUROCHIR SUPPL, V121, P295, DOI 10.1007/978-3-319-18497-5_51; VANEIJNDHOVEN JHM, 1986, NEUROSURGERY, V19, P507, DOI 10.1227/00006123-198610000-00004; Varsos GV, 2014, NEUROCRIT CARE, V20, P142, DOI 10.1007/s12028-013-9868-4	22	1	1	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	JUN	2020	34	3					461	468		10.1007/s10877-019-00331-x			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	LK7CH	WOS:000531019700007	31175502	Bronze, Green Published			2022-02-06	
J	Rangasamy, SB; Ghosh, S; Pahan, K				Rangasamy, Suresh B.; Ghosh, Supurna; Pahan, Kalipada			RNS60, a physically-modified saline, inhibits glial activation, suppresses neuronal apoptosis and protects memory in a mouse model of traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Physically-modified saline; TBI; Glial activation; Neuronal apoptosis; Memory and learning	NITRIC-OXIDE SYNTHASE; DOPAMINERGIC-NEURONS; UP-REGULATION; GENE-EXPRESSION; KAPPA-B; EDEMA; PREVENTS; IMPACT; MICE; NEUROPROTECTION	Traumatic brain injury (TBI) is a serious health issue that causes long-term neurological disability, particularly in young adults, athletes and war veterans. Despite the use of different medications or surgical procedures, no effective therapy is currently available to halt its pathogenesis. Here, we have undertaken a novel approach to reduce neuroinflammation and improve cognitive, social and locomotor behaviors in a mouse model of TBI. RNS60 is a physiologic saline solution containing oxygen nanobubbles that is generated by subjecting normal saline to Taylor-Couette-Poiseuille (TCP) flow under elevated oxygen pressure. Recently we have delineated that RNS60 inhibits the expression of proinflammatory molecules in glial cells via type 1A phosphatidylinositol-3 kinase (PI3K)-mediated upregulation of I kappa B alpha. In this study, we found that TBI decreased the level of I kappa B alpha and increased the activation of NF-kappa B in hippocampus and cortex as monitored by the upregulation of p-p65. However, intraperitoneal administration of RNS60 increased and/or restored the level of I kappa B alpha and inhibited the activation of NF-kappa B in hippocampus and cortex of TBI mice. Accordingly, RNS60 treatment decreased the activation of astrocytes and microglia and reduced neuronal apoptosis in the brain of TBI mice. RNS60 treatment also reduced vascular damage, attenuated blood-brain barrier leakage and decreased the size of lesion in the brain of TBI mice. Importantly, RNS60 treated mice showed significant improvements in memory, social behavior and locomotor activities while displaying reduction in depression-like behaviors. These results delineate a novel neuroprotective property of RNS60 and suggest its possible therapeutic use in TBI.	[Rangasamy, Suresh B.; Pahan, Kalipada] Jesse Brown Vet Affairs Med Ctr, Div Res & Dev, Chicago, IL 60612 USA; [Rangasamy, Suresh B.; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, 1735 West Harrison St,Suite 310, Chicago, IL 60612 USA; [Ghosh, Supurna] Revalesio Corp, 1202 East D St, Tacoma, WA 98421 USA		Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, 1735 West Harrison St,Suite 310, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu			Revalesio	This study was supported by Revalesio.	Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Bachstetter AD, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-146; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Bruschetta Giuseppe, 2017, Front Neurosci, V11, P6, DOI 10.3389/fnins.2017.00006; Campolo M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0196-1; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3769; Chandra G, 2018, J NEUROIMMUNE PHARM, V13, P143, DOI 10.1007/s11481-017-9771-4; Chandra G, 2017, J IMMUNOL, V198, P4312, DOI 10.4049/jimmunol.1700149; Chandra G, 2016, J BIOL CHEM, V291, P15267, DOI 10.1074/jbc.M116.714824; Cunha MP, 2008, PROG NEURO-PSYCHOPH, V32, P1913, DOI 10.1016/j.pnpbp.2008.09.006; Deacon R, 2012, JOVE-J VIS EXP, DOI 10.3791/2607; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; Ghosh A, 2009, J NEUROSCI, V29, P13543, DOI 10.1523/JNEUROSCI.4144-09.2009; Ghosh A, 2017, J NEUROCHEM, V141, P423, DOI 10.1111/jnc.13987; Hakon J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120074; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Inoue T, 2013, EXP NEUROL, V248, P136, DOI 10.1016/j.expneurol.2013.06.006; Jana M, 2001, J BIOL CHEM, V276, P44527, DOI 10.1074/jbc.M106771200; Jana M, 2018, NEUROCHEM RES, V43, P407, DOI 10.1007/s11064-017-2435-1; Kabadi SV, 2012, J NEUROTRAUM, V29, P813, DOI 10.1089/neu.2011.1980; Kalish BT, 2016, METHODS MOL BIOL, V1462, P193, DOI 10.1007/978-1-4939-3816-2_12; Khasnavis S, 2014, J NEUROIMMUNE PHARM, V9, P218, DOI 10.1007/s11481-013-9503-3; Khasnavis S, 2012, J BIOL CHEM, V287, P29529, DOI 10.1074/jbc.M111.338012; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Modi KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130398; Modi KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103606; Mondal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051869; Patel D, 2018, P NATL ACAD SCI USA, V115, pE7408, DOI 10.1073/pnas.1802021115; Rangasamy SB, 2018, J CLIN INVEST, V128, P4297, DOI 10.1172/JCI96209; Rangasamy SB, 2015, J ALZHEIMERS DIS, V47, P385, DOI 10.3233/JAD-150040; ROSSNER W, 1966, MED PHARMACOL EXP, V14, P169; Roy AA, 2006, J BIOL CHEM, V281, P32684, DOI 10.1074/jbc.M604416200; Saha RN, 2006, ANTIOXID REDOX SIGN, V8, P929, DOI 10.1089/ars.2006.8.929; Shelton SB, 2008, J NEUROSCI METH, V168, P431, DOI 10.1016/j.jneumeth.2007.11.003; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vallarola A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1101-0; WEISSMAN DE, 1988, J NEURO-ONCOL, V6, P339; Yang Xiao-feng, 2005, Chin J Traumatol, V8, P96; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	49	1	1	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUN	2020	328								113279	10.1016/j.expneurol.2020.113279			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LG1SA	WOS:000527888300021	32151546	hybrid			2022-02-06	
J	Ronz, K; Hirschi, T; Becker, S; Krummrey, G; Exadaktylos, AK; Sauter, TC; Hautz, WE; Muller, M				Roenz, Katharina; Hirschi, Trevor; Becker, Sebastian; Krummrey, Gert; Exadaktylos, Aristomenis K.; Sauter, Thomas C.; Hautz, Wolf E.; Mueller, Martin			Predictors of High Resource Consumption in Alcohol Intoxicated Patients in the Emergency Department	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						alcohol intoxication; alcoholism; emergency departments utilisation; emergency admissions	INJURY; VISITS; HEALTH; IMPACT	Background: previous studies have reported that the incidence of alcohol-related visits to emergency departments (ED) has increased, but little is known about how the necessary resources per visit have changed, or about the predictors and reasons for resource consumption. Methods: a retrospective analysis was performed of all consultations with a primary or secondary diagnosis of acute alcohol intoxication admitted to the ED of Bern University Hospital, Switzerland, between 1 June 2012, and 31 May 2017. Clinical characteristics and resource consumption were extracted and analysed over time. Results: in all, 196,045 ED consultations included 2586 acute alcohol intoxications, corresponding to 1.3% of the total. The incidences of acute alcohol intoxications have tended to increase over the last five years, and a growing number of visits have consumed high resources (consultations above the 75th percentile for total resource consumption). High resource consumption was associated with greater age and the male gender (p < 0.001). The main predictors of resource consumption were fractures (Odds ratio (OR): 3.9, 95% CI 2.8-5.3, p < 0.001), dislocations (OR 3.7, 95%: 1.5-9.1, p < 0.001), and traumatic brain injury (3.5, 2.5-5.1, p < 0.001). Consultations consuming high resources mostly required radiology resources (45%); consultations consuming low or normal resources mostly required physicians' work (45%) or nurses' work (27%). Conclusions: the number of alcohol intoxications consuming high resources has increased over the last five years. Acute alcohol intoxication associated with trauma is resource intensive, especially with regard to radiology resources. This underlines the need for further efforts to prevent alcohol-related traffic accidents, for examples.	[Roenz, Katharina; Becker, Sebastian; Krummrey, Gert; Exadaktylos, Aristomenis K.; Sauter, Thomas C.; Hautz, Wolf E.; Mueller, Martin] Univ Bern, Bern Univ Hosp, Dept Emergency Med, Inselspital, CH-3010 Bern, Switzerland; [Roenz, Katharina] Lindenhofspital, Dept Emergency Med, CH-3012 Bern, Switzerland; [Hirschi, Trevor] Univ Bern, Bern Univ Hosp, Dept Anaesthesiol, Inselspital, CH-3010 Bern, Switzerland; [Sauter, Thomas C.] Univ Med Berlin, Med Skills Lab, Charite, D-12203 Berlin, Germany; [Mueller, Martin] Univ Hosp Cologne, Inst Hlth Econ & Clin Epidemiol, D-50935 Cologne, Germany		Ronz, K (corresponding author), Univ Bern, Bern Univ Hosp, Dept Emergency Med, Inselspital, CH-3010 Bern, Switzerland.; Ronz, K (corresponding author), Lindenhofspital, Dept Emergency Med, CH-3012 Bern, Switzerland.	katharina.roenz@lindenhofgruppe.ch; Trevor.hirschi@insel.ch; Sebastian.Becker@insel.ch; gert.krummrey@insel.ch; aristomenis.exadaktylos@insel.ch; thomas.sauter@insel.ch; wolf.hautz@insel.ch; martin.mueller2@insel.ch		Muller, Martin/0000-0003-4067-7174; Roenz, Katharina/0000-0001-8939-2933	Bangerter Foundation; Swiss Academy of Medical Sciences [TCR 14/17]	M.M. was funded by the Bangerter Foundation and the Swiss Academy of Medical Sciences through the "Young Talents in Clinical Research" grant (TCR 14/17). This research received no other external funding.	Adam A, 2016, ALCOHOL ALCOHOLISM, V51, P567, DOI 10.1093/alcalc/agw035; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Downes MA, 2009, EMERG MED AUSTRALAS, V21, P196, DOI 10.1111/j.1742-6723.2009.01182.x; Eidgenossische Alkoholverwaltung [Federal Alcohol Administration], ALC NUMB; Exadaktylos AHW, 2015, ICU MANAG, V15, P160; Gmel Gerhard, 2007, Rev Med Suisse, V3, P1964; Gmel G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-40; Holzer BM, 2012, PREHOSP EMERG CARE, V16, P497, DOI 10.3109/10903127.2012.695437; Homma Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174408; MAYOR S, 2016, BMJ-BRIT MED J, V354, DOI DOI 10.1136/bmj.i3829; Mica Ladislav, 2015, Praxis (Bern 1994), V104, P397, DOI 10.1024/1661-8157/a001971; Mitra B, 2017, EMERG MED AUSTRALAS, V29, P96, DOI 10.1111/1742-6723.12682; Mullins PM, 2017, ALCOHOL ALCOHOLISM, V52, P119, DOI 10.1093/alcalc/agw074; O'Farrell A, 2004, ADDICTION, V99, P1279, DOI 10.1111/j.1360-0443.2004.00822.x; Page N, 2017, INJURY PREV, V23, P33, DOI 10.1136/injuryprev-2015-041884; Parkinson K, 2016, EMERG MED J, V33, P187, DOI 10.1136/emermed-2014-204581; Purssell RA, 2001, ANN EMERG MED, V38, P653, DOI 10.1067/mem.2001.119455; Sethi M, 2016, ALCOHOL, V53, P1, DOI 10.1016/j.alcohol.2016.03.005; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Swiss Federal Office of Public Health, FIN REP STUD ALC REL; Swiss Federal Office of Public Health, COMP HLTH INS NUTSH; Swiss Federal Office of Public Health, CONS SWITZ 2016; TARMED Suisse, SUISS TARMED 01 08 0; Vardy J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010005; Verelst S, 2012, ALCOHOL ALCOHOLISM, V47, P433, DOI 10.1093/alcalc/ags035; Vonghia L, 2008, EUR J INTERN MED, V19, P561, DOI 10.1016/j.ejim.2007.06.033; World Health Organization, 2016, WORLD HLTH STAT DAT; World Health Organization [WHO] Europe, 2018, EUR FACT SHEET ALC C; Wurdak Mara, 2016, Prev Med Rep, V3, P83, DOI 10.1016/j.pmedr.2015.12.009; Zeisser C, 2013, ALCOHOL CLIN EXP RES, V37, pE1, DOI 10.1111/j.1530-0277.2012.01919.x	30	1	1	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	JUN	2020	17	11							4122	10.3390/ijerph17114122			13	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	MB5FY	WOS:000542629600375	32527025	gold, Green Published			2022-02-06	
J	Shorer, M; Segev, S; Rassovsky, Y; Fennig, S; Apter, A; Peleg, TP				Shorer, Maayan; Segev, Shira; Rassovsky, Yuri; Fennig, Silvana; Apter, Alan; Peleg, Tammy Pilowsky			Efficacy of Psychological Intervention for Children with Concurrent Posttraumatic Stress Disorder and Mild Traumatic Brain Injury	JOURNAL OF TRAUMATIC STRESS			English	Article							PTSD SYMPTOM SCALE; PROLONGED EXPOSURE; POSTCONCUSSION SYNDROME; PERFORMANCE; THERAPY; VETERANS	Posttraumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI) are common conditions following motor vehicle accidents (MVAs). Mild TBI and PTSD not only share similar features but may also coexist and interact. Nonetheless, research on psychotherapeutic interventions for PTSD in patients with a history of mTBI, particularly regarding pediatric populations, is limited. The present study compared the efficacy of the prolonged exposure treatment protocol for children and adolescents (PE-A) with PTSD and mTBI (n= 16) versus PTSD alone (n= 21); treatment commenced at least 3 months following an MVA. Emotional status and cognitive functioning were assessed pre- and postintervention using questionnaires and standardized neuropsychological tests. Participants from both groups benefitted from the intervention, as reflected in their emotional status via increased ratings of well-being and decreased ratings of PTSD, anxiety, depression, and postconcussive symptoms, eta(2)= .21-.50. Ratings of cognitive function also improved for cognitive flexibility, eta(2)= .30; executive function in everyday life, eta(2)= .27; and attention and inhibition, eta(2)= .16. Parental PTSD was the strongest predictor of improvement after intervention,sr(2)= .35. Thus, it appears that PE-A is an effective intervention for children with MVA-related PTSD regardless of its comorbidity with mTBI.	[Shorer, Maayan; Fennig, Silvana; Apter, Alan; Peleg, Tammy Pilowsky] Schneider Childrens Med Ctr Israel, Dept Psychol Med, IL-49202 Petah Tiqwa, Israel; [Shorer, Maayan; Apter, Alan] Ruppin Acad Ctr, Clin Psychol Program, Emek Hefer, Israel; [Segev, Shira; Rassovsky, Yuri] Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel; [Fennig, Silvana; Apter, Alan] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Peleg, Tammy Pilowsky] Hebrew Univ Jerusalem, Dept Psychol, Jerusalem, Israel		Shorer, M (corresponding author), Schneider Childrens Med Ctr Israel, Dept Psychol Med, IL-49202 Petah Tiqwa, Israel.	maayans@clalit.org.il		Rassovsky, Yuri/0000-0002-6362-9944			American Congress of Rehabilitation Medicine, 1993, DEF MILD TRAUM BRAIN; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Beesdo K, 2009, PSYCHIAT CLIN N AM, V32, P483, DOI 10.1016/j.psc.2009.06.002; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Conners C.K., 2004, CONNERS CONTINUOUS P; Conners CK, 1997, CONNERS RATING SCALE; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Cottingham ME, 2014, CLIN NEUROPSYCHOL, V28, P1030, DOI 10.1080/13854046.2014.951397; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Delis DC., 2001, DELIS KAPLAN EXECUTI; Donlon K, 2015, CHILD NEUROPSYCHOL, V21, P803, DOI 10.1080/09297049.2014.944491; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Ferguson RJ, 1996, SOURCEBOOK PSYCHOL T, P615; Foa E.B., 2008, PROLONGED EXPOSURE T; Foa EB, 2001, J CLIN CHILD PSYCHOL, V30, P376, DOI 10.1207/S15374424JCCP3003_9; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Gilboa-Schechtman E, 2010, J AM ACAD CHILD PSY, V49, P1034, DOI 10.1016/j.jaac.2010.07.014; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Granacher Jr RP, 2007, TRAUMATIC BRAIN INJU; Homack S, 2005, J CLIN EXP NEUROPSYC, V27, P599, DOI 10.1080/13803390490918444; Hovland D., 2000, NEUROPSYCHOLOGICAL M, P171; Jamshidian M, 1999, J EDUC BEHAV STAT, V24, P21, DOI 10.2307/1165260; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kirk JW, 2011, CHILD NEUROPSYCHOL, V17, P242, DOI 10.1080/09297049.2010.533166; Kolaitis G, 2011, J TRAUMA STRESS, V24, P414, DOI 10.1002/jts.20667; Kovacs M., 1992, MANUAL CHILDRENS DEP; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; McLean CP, 2011, EXPERT REV NEUROTHER, V11, P1151, DOI [10.1586/ern.11.94, 10.1586/ERN.11.94]; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Newman J, 2017, EXECUTIVE FUNCTIONS IN HEALTH AND DISEASE, P487, DOI 10.1016/B978-0-12-803676-1.00020-9; Nixon RDV, 2013, PSYCHOL ASSESSMENT, V25, P1025, DOI 10.1037/a0033324; Perry Bruce D., 1999, Current Opinion in Pediatrics, V11, P310, DOI 10.1097/00008480-199908000-00008; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; PsychTech LLC., 2010, WECHSLER INTELLIGENC; Raven J., 2003, MANUAL RAVENS PROGR; Segev S, 2016, NEUROPSYCHOLOGY, V30, P800, DOI 10.1037/neu0000299; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; Spielberger CD, 1973, STATE TRAIT ANXIETY; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585; WHO, 1998, WELLB MEAS PRIM HLTH; Wolf GK, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000344; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082	52	1	1	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	JUN	2020	33	3					330	337		10.1002/jts.22512			8	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	LX9HH	WOS:000540134500014	32277800				2022-02-06	
J	Silva, B; Canas-Simiao, H; Cavanna, AE				Silva, Bruno; Canas-Simiao, Hugo; Cavanna, Andrea E.			Neuropsychiatric Aspects of Impulse Control Disorders	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Attention-deficit/hyperactivity disorder; Impulse control disorders; Neurodegenerative disorders; Neurodevelopmental disorders; Parkinson disease; Tourette syndrome	TRAUMATIC BRAIN-INJURY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; FRONTOTEMPORAL DEMENTIA; SKIN-PICKING; TOURETTE-SYNDROME; CLINICAL CHARACTERISTICS; PARKINSONS-DISEASE; DSM-IV; PSYCHIATRIC COMORBIDITY; RESPONSE-INHIBITION	Impulse control disorders (ICDs) are neuropsychiatric conditions characterized by the repeated inability to resist an impulse, drive, or temptation to perform an act that is harmful to the person or others. Although classification approaches to ICDs vary both diachronically and synchronically, this group of conditions encompasses a wide range of syndromes, including pathologic gambling, kleptomania, trichotillomania, excoriation (skin picking) disorder, intermittent explosive disorder, pyromania, oppositional defiant, conduct, and antisocial personality disorders. ICDs can play a significant role as comorbidities in both neurodevelopmental (eg, attention-deficit/hyperactivity disorder, Tourette syndrome) and neurodegenerative (eg, Parkinson disease) disorders.	[Silva, Bruno; Cavanna, Andrea E.] Birmingham & Solihull Mental Hlth NHS Fdn Trust, Dept Neuropsychiat, Birmingham, W Midlands, England; [Silva, Bruno] Univ Nova Lisboa, NOVA Med Sch, Fac Ciencias Med, Lisbon, Portugal; [Canas-Simiao, Hugo] Ctr Hosp Lisboa Ocidental, Dept Psychiat, Lisbon, Portugal; [Cavanna, Andrea E.] Univ Birmingham, Inst Clin Sci, Birmingham, W Midlands, England; [Cavanna, Andrea E.] Aston Univ, Sch Life & Hlth Sci, Birmingham, W Midlands, England; [Cavanna, Andrea E.] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Silva, Bruno; Cavanna, Andrea E.] Barberry Natl Ctr Mental Hlth, Dept Neuropsychiat, 25 Vincent Dr, Birmingham B15 2FG, W Midlands, England; [Canas-Simiao, Hugo] Ctr Hosp Psiquiat Lisboa, Ave Brasil 53, P-1749002 Lisbon, Portugal		Cavanna, AE (corresponding author), Birmingham & Solihull Mental Hlth NHS Fdn Trust, Dept Neuropsychiat, Birmingham, W Midlands, England.; Cavanna, AE (corresponding author), Univ Birmingham, Inst Clin Sci, Birmingham, W Midlands, England.; Cavanna, AE (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham, W Midlands, England.; Cavanna, AE (corresponding author), UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England.; Cavanna, AE (corresponding author), Barberry Natl Ctr Mental Hlth, Dept Neuropsychiat, 25 Vincent Dr, Birmingham B15 2FG, W Midlands, England.	a.e.cavanna@bham.ac.uk	Silva, Bruno/T-4721-2017	Silva, Bruno/0000-0002-1839-7697			Agrawal A, 2011, ADDICTION, V106, P1935, DOI 10.1111/j.1360-0443.2011.03517.x; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Antonelli F, 2011, J NEUROL SCI, V310, P202, DOI 10.1016/j.jns.2011.06.006; Arnould A, 2016, ANN PHYS REHABIL MED, V59, P18, DOI 10.1016/j.rehab.2015.09.002; Arns M, 2009, CLIN EEG NEUROSCI, V40, P180, DOI 10.1177/155005940904000311; Aron AR, 2003, BIOL PSYCHIAT, V54, P1465, DOI 10.1016/S0006-3223(03)00609-7; Bayle FJ, 2003, AM J PSYCHIAT, V160, P1509, DOI 10.1176/appi.ajp.160.8.1509; Bechara A, 2005, CURR OPIN NEUROL, V18, P734, DOI 10.1097/01.wco.0000194141.56429.3c; Bernardes C, 2018, REV BRAS PSIQUIATR, V40, P110, DOI 10.1590/1516-4446-2017-2395; Birkhoff JM, 2016, INT J LAW PSYCHIAT, V47, P157, DOI 10.1016/j.ijlp.2016.04.001; Black DW, 2004, J CLIN PSYCHOPHARM, V24, P108, DOI 10.1097/01.jcp.0000114844.58996.4a; Bohne A, 2002, BEHAV MODIF, V26, P320, DOI 10.1177/01445502026003002; Bukstein OG, 2000, J PSYCHOACTIVE DRUGS, V32, P67, DOI 10.1080/02791072.2000.10400213; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Cavanna AE, 2018, REV NEUROL-FRANCE, V174, P621, DOI 10.1016/j.neurol.2018.06.006; Cavanna AE, 2020, PHARM TREATMENT TICS; Cavanna AE, 2018, CNS SPECTRUMS, V23, P213, DOI 10.1017/S1092852918000834; Chamberlain SR, 2007, BIOL PSYCHIAT, V62, P977, DOI 10.1016/j.biopsych.2007.03.003; Chamberlain SR, 2017, CNS SPECTRUMS, V22, P22, DOI 10.1017/S1092852915000875; CHAMPION LM, 1988, NEUROSCI BIOBEHAV R, V12, P255, DOI 10.1016/S0149-7634(88)80054-X; CHRISTENSON GA, 1994, J CLIN PSYCHIAT, V55, P5; CHRISTENSON GA, 1991, J CLIN PSYCHIAT, V52, P415; CHRISTENSON GA, 1995, PSYCHIAT TIMES, V12, P44; Cimminella F, 2015, ACTA NEUROL BELG, V115, P759, DOI 10.1007/s13760-015-0440-1; Coccaro EF, 2005, J CLIN PSYCHIAT, V66, P1221, DOI 10.4088/JCP.v66n1003; COHEN LJ, 1995, J CLIN PSYCHIAT, V56, P319; Coleman E., 1991, J PSYCHOL HUMAN SEXU, V4, P37, DOI DOI 10.1300/J056V04N02_; Cossu G, 2018, PARKINSONISM RELAT D, V46, pS24, DOI 10.1016/j.parkreldis.2017.07.030; Debes NMMM, 2008, J CHILD NEUROL, V23, P1017, DOI 10.1177/0883073808316370; Deepmala, 2015, NEUROSCI BIOBEHAV R, V55, P294, DOI 10.1016/j.neubiorev.2015.04.015; Eddy CM, 2009, J PSYCHOSOM RES, V67, P503, DOI 10.1016/j.jpsychores.2009.08.001; Erenberg Gerald, 2005, Semin Pediatr Neurol, V12, P217, DOI 10.1016/j.spen.2005.12.003; Ferguson SD, 2009, J PERS DISORD, V23, P230, DOI 10.1521/pedi.2009.23.3.230; Frank MC, 2011, J NEUROL SCI, V310, P276, DOI 10.1016/j.jns.2011.06.032; Freeman RD, 2007, EUR CHILD ADOLES PSY, V16, P15, DOI 10.1007/s00787-007-1003-7; FRICK PJ, 1991, J CONSULT CLIN PSYCH, V59, P289, DOI 10.1037/0022-006X.59.2.289; Gathright M, 2012, DISRUPTIVE BEHAV CHI; Gatto EM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00351; Glenn AL, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0427-7; GOLDMAN MJ, 1991, AM J PSYCHIAT, V148, P986; Grall-Bronnec M, 2011, EUR ADDICT RES, V17, P231, DOI 10.1159/000328628; Grant J. E., 2008, IMPULSE CONTROL DISO; Grant JE, 2003, COMPR PSYCHIAT, V44, P437, DOI 10.1016/S0010-440X(03)00150-0; Grant JE, 2011, OXFORD HDB IMPULSE C; Grant JE, 2007, PSYCHIAT QUART, V78, P259, DOI 10.1007/s11126-007-9045-z; Grant JE, 2014, WORLD PSYCHIATRY, V13, P125, DOI 10.1002/wps.20115; Guercio JM, 2012, J APPL BEHAV ANAL, V45, P485, DOI 10.1901/jaba.2012.45-485; Gyant JE, 2007, J CLIN PSYCHIAT, V68, P1717, DOI 10.4088/JCP.v68n1111; Hodgins DC, 2015, INT J MENT HEALTH AD, V13, P699, DOI 10.1007/s11469-015-9572-z; Hodgins DC, 2007, BRAZ J PSYCHIAT S1, V30, P31; Houeto JL, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00091; Janik P, 2007, NEUROL NEUROCHIR POL, V41, P381; Kafka Martin P, 2002, Sex Abuse, V14, P349, DOI 10.1023/A:1020007004436; Kafka MP, 2010, ARCH SEX BEHAV, V39, P377, DOI 10.1007/s10508-009-9574-7; Kaufman KR, 2015, ANN CLIN PSYCHIATRY, V27, P65; Keuthen NJ, 2010, COMPR PSYCHIAT, V51, P183, DOI 10.1016/j.comppsych.2009.04.003; Keuthen NJ, 2000, PSYCHOSOMATICS, V41, P210, DOI 10.1176/appi.psy.41.3.210; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kollins SH, 2008, J ATTEN DISORD, V12, P115, DOI 10.1177/1087054707311654; Koran LM, 2006, AM J PSYCHIAT, V163, P1806, DOI 10.1176/appi.ajp.163.10.1806; LADOUCEUR R, 1994, CAN J PSYCHIAT, V39, P289, DOI 10.1177/070674379403900509; Leeman RF, 2011, NEUROPSYCHIATRY-LOND, V1, P133, DOI 10.2217/NPY.11.11; Lenzenweger MF, 2007, BIOL PSYCHIAT, V62, P553, DOI 10.1016/j.biopsych.2006.09.019; Lo Coco D, 2004, J NEUROPSYCH CLIN N, V16, P117; LoBue C, 2019, J ALZHEIMERS DIS, V70, P629, DOI 10.3233/JAD-190028; Lochner C, 2002, DEPRESS ANXIETY, V15, P83, DOI 10.1002/da.10034; Lorains FK, 2011, ADDICTION, V106, P490, DOI 10.1111/j.1360-0443.2010.03300.x; Mak C, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071307; Mamikonyan E, 2008, MOVEMENT DISORD, V23, P75, DOI 10.1002/mds.21770; Manes FF, 2010, NAT REV NEUROL, V6, P347, DOI 10.1038/nrneurol.2010.34; Martino D, 2013, INT REV NEUROBIOL, V112, P1, DOI 10.1016/B978-0-12-411546-0.00001-9; MCELROY SL, 1994, J CLIN PSYCHIAT, V55, P242; MCELROY SL, 1991, AM J PSYCHIAT, V148, P652; Mendez MF, 2002, J NEUROPSYCH CLIN N, V14, P424, DOI 10.1176/appi.neuropsych.14.4.424; Miller B, 2019, HAND CLINIC, V165, P33, DOI 10.1016/B978-0-444-64012-3.00003-4; Murphy M, 2001, DISORDERS CHILDHOOD; Nakaaki S, 2007, COGN BEHAV NEUROL, V20, P121, DOI 10.1097/WNN.0b013e31804c6ff7; Nathaniel-James DA, 2002, NEUROIMAGE, V16, P1094, DOI 10.1006/nimg.2002.1167; Odlaug BL, 2008, GEN HOSP PSYCHIAT, V30, P61, DOI 10.1016/j.genhosppsych.2007.07.009; Odlaug BL, 2008, ANN CLIN PSYCHIATRY, V20, P57, DOI 10.1080/10401230802017027; Okai D, 2013, NEUROLOGY, V80, P792, DOI 10.1212/WNL.0b013e3182840678; Ozel-Kizil ET, 2013, J CLIN NEUROL, V9, P133, DOI 10.3988/jcn.2013.9.2.133; Peterson BS, 2001, ARCH GEN PSYCHIAT, V58, P427, DOI 10.1001/archpsyc.58.5.427; Petry NM, 2005, J CLIN PSYCHIAT, V66, P564, DOI 10.4088/JCP.v66n0504; Pompanin S, 2014, GEN HOSP PSYCHIAT, V36, DOI 10.1016/j.genhosppsych.2014.06.005; Porteret R, 2016, ENCEPHALE, V42, P130, DOI 10.1016/j.encep.2015.12.013; Potenza MN, 2006, ADDICTION, V101, P142, DOI 10.1111/j.1360-0443.2006.01591.x; Potenza MN, 2009, BIOL PSYCHIAT, V66, P714, DOI 10.1016/j.biopsych.2009.08.004; Presta S, 2002, COMPR PSYCHIAT, V43, P7, DOI 10.1053/comp.2002.29851; Probst CC, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0386-8; Riley M, 2016, AM FAM PHYSICIAN, V93, P586; Rochat L, 2013, J INT NEUROPSYCH SOC, V19, P890, DOI 10.1017/S1355617713000672; Rochat L, 2011, PSYCHOPATHOLOGY, V44, P158, DOI 10.1159/000322454; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Rogier G, 2020, SCAND J PSYCHOL, V61, P262, DOI 10.1111/sjop.12579; ROSENTHAL RJ, 1992, PSYCHIAT ANN, V22, P72, DOI 10.3928/0048-5713-19920201-09; Rowe R, 2010, J ABNORM PSYCHOL, V119, P726, DOI 10.1037/a0020798; SCHLOSSER S, 1994, GEN HOSP PSYCHIAT, V16, P205, DOI 10.1016/0163-8343(94)90103-1; Schrag A, 2004, J NEUROL, V251, P795, DOI 10.1007/s00415-004-0483-3; Schreiber L., 2011, FRONT PSYCHIATRY, V2, P1, DOI [10.3389/fpsyt.2011.00001, DOI 10.3389/FPSYT.2011.00001]; Shaffer HJ, 1999, AM J PUBLIC HEALTH, V89, P1369, DOI 10.2105/AJPH.89.9.1369; Smith KM, 2016, J NEUROL NEUROSUR PS, V87, P864, DOI 10.1136/jnnp-2015-311827; Solanto MV, 2002, BEHAV BRAIN RES, V130, P65, DOI 10.1016/S0166-4328(01)00431-4; Stein DJ, 2010, DEPRESS ANXIETY, V27, P611, DOI 10.1002/da.20700; Tanwani P, 2015, PSYCHIAT RES, V225, P402, DOI 10.1016/j.psychres.2014.12.005; Thomas A, 2010, ANN NEUROL, V68, P400, DOI 10.1002/ana.22029; Tondo G, 2017, COGN BEHAV NEUROL, V30, P62, DOI 10.1097/WNN.0000000000000122; Turner NE, 2019, PSYCHIAT RES, V272, P692, DOI 10.1016/j.psychres.2018.12.170; van Oosten RV, 2005, EXP NEUROL, V191, P24, DOI 10.1016/j.expneurol.2004.09.004; VOLBERG RA, 1994, AM J PUBLIC HEALTH, V84, P237, DOI 10.2105/AJPH.84.2.237; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Waluk OR, 2016, J GAMBL STUD, V32, P591, DOI 10.1007/s10899-015-9564-8; Weder Natalie D, 2007, Ann Gen Psychiatry, V6, P15, DOI 10.1186/1744-859X-6-15; Weintraub D, 2017, INT REV NEUROBIOL, V133, P679, DOI [10.1016/bs.im.2017.04.006, 10.1016/bs.irn.2017.04.006]; Werner KB, 2015, PSYCHIAT ANN, V45, P195, DOI 10.3928/00485713-20150401-08; Whiting SW, 2016, J BEHAV ADDICT, V5, P213, DOI 10.1556/2006.5.2016.027; Woods D, 2007, TIC DISORDERS TRICHO; Woods DW, 2006, J CLIN PSYCHIAT, V67, P1877, DOI 10.4088/JCP.v67n1207; Wright A, 2012, J NEUROPSYCH CLIN N, V24, P16, DOI 10.1176/appi.neuropsych.10010013	120	1	1	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	JUN	2020	43	2					249	+		10.1016/j.psc.2020.02.001			15	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	LQ0DE	WOS:000534683000004	32439020				2022-02-06	
J	Srienc, AI; Chiang, PP; Schmitt, AJ; Newman, EA				Srienc, Anja I.; Chiang, Pei-Pei; Schmitt, Abby J.; Newman, Eric A.			Cortical spreading depolarizations induced by surgical field blood in a mouse model of neurosurgery	JOURNAL OF NEUROSURGERY			English	Article						cortical spreading depolarization; CSD; electrocautery; GCaMP6f; mouse model; intraoperative bleeding; ketamine; vascular disorders; traumatic brain injury	DEPRESSION; HEMORRHAGE; GLUTAMATE; CLUSTERS	OBJECTIVE Cortical spreading depolarization (CSD) has been linked to poor clinical outcomes in the setting of traumatic brain injury, malignant stroke, and subarachnoid hemorrhage. There is evidence that electrocautery during neurosurgical procedures can also evoke CSD waves in the brain. It is unknown whether blood contacting the cortical surface during surgical bleeding affects the frequency of spontaneous or surgery-induced CSDs. Using a mouse neurosurgical model, the authors tested the hypothesis that electrocautery can induce CSD waves and that surgical field blood (SFB) is associated with more CSDs. The authors also investigated whether CSD can be reliably observed by monitoring the fluorescence of GCaMP6f expressed in neurons. METHODS CSD waves were monitored by using confocal microscopy to detect fluorescence increases at the cortical surface in mice expressing GCaMP6f in CamKII-positive neurons. The cortical surface was electrocauterized through an adjacent burr hole. SFB was simulated by applying a drop of tail vein blood to the brain through the same burr hole. RESULTS CSD waves were readily detected in GCaMP6f-expressing mice. Monitoring GCaMP6f fluorescence provided far better sensitivity and spatial resolution than detecting CSD events by observing changes in the intrinsic optical signal (IOS). Forty-nine percent of the CSD waves identified by GCaMP6f had no corresponding IOS signal. Electrocautery evoked CSD waves. On average, 0.67 +/- 0.08 CSD events were generated per electrocautery episode, and multiple CSD waves could be induced in the same mouse by repeated cauterization (average, 7.9 +/- 1.3 events; maximum number in 1 animal, 13 events). In the presence of SFB, significantly more spontaneous CSDs were generated (1.35 +/- 0.37 vs 0.13 +/- 0.16 events per hour, p = 0.002). Ketamine effectively decreased the frequency of spontaneous CSD waves (1.35 +/- 0.37 to 0.36 +/- 0.15 CSD waves per hour, p = 0.016) and electrocautery-stimulated CSD waves (0.80 +/- 0.05 to 0.18 +/- 0.08 CSD waves per electrocautery, p = 0.00002). CONCLUSIONS CSD waves are detected with far greater sensitivity and fidelity by monitoring GCaMP6f signals in neurons than by monitoring IOSs. Electrocautery reliably evokes CSD waves, and the frequency of spontaneous CSD waves is increased when blood is applied to the cortical surface. These experimental conditions recapitulate common scenarios in the neurosurgical operating room. Ketamine, a clinically available pharmaceutical agent, can block stimulated and spontaneous CSDs. More research is required to understand the clinical importance of intraoperative CSD.	[Srienc, Anja I.; Chiang, Pei-Pei; Schmitt, Abby J.; Newman, Eric A.] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA; [Srienc, Anja I.] Univ Minnesota, Med Scientist Training Program, Minneapolis, MN USA		Srienc, AI (corresponding author), Washington Univ, Sch Med, St Louis, MO 63110 USA.	asrienc@wustl.edu		Srienc, Anja/0000-0003-1038-2156	National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000114]; National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY026514, R01EY026882]	Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health award number UL1TR000114 (to Anja I. Srienc) and the National Eye Institute awards R01EY026514 and R01EY026882 (to Eric A. Newman). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akerman S, 2008, BRAIN RES, V1229, P27, DOI 10.1016/j.brainres.2008.07.014; Alessandri B, 2012, Acta Neurochir Suppl, V114, P373, DOI 10.1007/978-3-7091-0956-4_72; AMEMORI T, 1990, BRAIN RES, V519, P351, DOI 10.1016/0006-8993(90)90101-G; Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Carlson AP, 2017, J NEUROSURG, V126, P266, DOI 10.3171/2015.11.JNS151871; Carlson AP, 2012, NEUROL RES, V34, P223, DOI 10.1179/1743132811Y.0000000077; Chen SP, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0574-8; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Enger R, 2015, CEREB CORTEX, V25, P4469, DOI 10.1093/cercor/bhv054; HERNANDEZCACERES J, 1987, BRAIN RES, V437, P360, DOI 10.1016/0006-8993(87)91652-0; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Jahan-Abad AJ, 2018, MOL NEUROBIOL, V55, P4225, DOI 10.1007/s12035-017-0642-z; Kahn E, 2017, J NEUROSURG, V127, P1461, DOI 10.3171/2017.3.JNS17659; Kudo C, 2013, NEUROPHARMACOLOGY, V67, P32, DOI 10.1016/j.neuropharm.2012.10.018; LAURITZEN M, 1985, CEPHALALGIA, V5, P47, DOI 10.1177/03331024850050S208; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; Li X, 2015, ANGEW CHEM INT EDIT, V54, P7815, DOI 10.1002/anie.201503312; Netto M, 1999, BRAIN RES, V827, P221, DOI 10.1016/S0006-8993(99)01296-2; Nyirenda MJ, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4114; OBRENOVITCH TP, 1995, J NEUROPHYSIOL, V73, P2107, DOI 10.1152/jn.1995.73.5.2107; Sadeghian H, 2012, EXP NEUROL, V233, P438, DOI 10.1016/j.expneurol.2011.11.017; Sakowitz OW, 2013, STROKE, V44, P220, DOI 10.1161/STROKEAHA.112.672352; Sakowitz OW, 2009, STROKE, V40, pE519, DOI 10.1161/STROKEAHA.109.549303; Shih Andy Y, 2012, J Vis Exp, DOI 10.3791/3742; Shin HK, 2006, J CEREBR BLOOD F MET, V26, P1018, DOI 10.1038/sj.jcbfm.9600252; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Srienc AI, 2016, J CEREBR BLOOD F MET, V36, P1579, DOI 10.1177/0271678X16657836; von Bornstadt D, 2015, NEURON, V85, P1117, DOI 10.1016/j.neuron.2015.02.007; Yu YF, 2012, P NATL ACAD SCI USA, V109, P2585, DOI 10.1073/pnas.1121111109; Zhou N, 2013, J CEREBR BLOOD F MET, V33, P1582, DOI 10.1038/jcbfm.2013.113	32	1	1	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2020	132	6					1820	1828		10.3171/2018.12.JNS181130			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LU6FW	WOS:000537850100017	30952117	Green Accepted			2022-02-06	
J	Taylor, DJ; Straud, C; Hale, W; Grieser, E; Garb, L; Garb, H				Taylor, Daniel J.; Straud, Casey; Hale, Willie; Grieser, Emily; Garb, Leanna; Garb, Howard			Sleep difficulties as a predictor of attrition in United States Air Force recruits	SLEEP HEALTH			English	Article						Sleep; Difficulties; Insomnia; Military; Discharge; Attrition	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS; INSOMNIA; PREVALENCE; DISTURBANCES; DEPRESSION; DEPLOYMENT; SOLDIERS	Study Objectives: The objective of the study was to estimate the rates of "difficulty sleeping at night" in newly enlisted United Slates Air Force (USAF) recruits and determine if these sleep difficulties predicted 1-year attrition (discharge for any reason) independently and after controlling for all other Lackland Behavioral Questionnaire (LBQ) predictors. Methods: The LBQ was administered Lo 202,339 active duly, enlisted USAF trainees completing basic military training al Joint Base San Anionio-Lackland, Texas, from January 2006 Lo December 2012. Attrition data were obtained through he Defense Manpower Data Center. Results: Fifty percent of the sample reported at least occasional sleep difficulties in the past year, with 9% reporting frequent (6% = often and 3% = most of the time) sleep difficulties. Twelve percent of trainees had been discharged within one year, and sleep difficulties were the second strongest significant predictor of this attrition after accounting for all other predictor variables in the LBQ Wald chi(2) = 254.19, p < .0001. Trainees with frequent sleep difficulties were 2.7 times more likely to be discharged than those without sleep difficulties based on the odds ratio statistic. Conclusions. Rates of self-reported frequent "difficulty sleeping...," before basic training started, were similar to civilian populations and were the second strongest predictor of one-year attrition. "Difficulty sleeping..." encompasses many sleep problems (e.g., insomnia, sleep deprivation, circaclian misalignment). Future studies should determine what specific sleep difficulties pose the greatest risk for attrition and then determine if they can be remediateci, thus decreasing attrition risk, or if they should be a focus of scTeening. (C) 2020 National Sleep Foundation. Published by Elsevier Inc All rights reserved.	[Taylor, Daniel J.] Univ Arizona, 1503 East Univ Blvd, Tucson, AZ 85721 USA; [Straud, Casey; Hale, Willie] Univ Texas Hlth Sci Ctr San Antonio, 7550 Interstate Highway 10 West,Suite 1325, San Antonio, TX 78229 USA; [Straud, Casey; Hale, Willie] Univ Texas San Antonio, One UTSA Circle, San Antonio, TX 78249 USA; [Grieser, Emily] US Air Force, Cannon Air Force Base, Clovis, NM USA; [Garb, Leanna] Univ Texas Austin, 1925 San Jacinto Blvd, Austin, TX 78712 USA; [Garb, Howard] Joint Base San Antonio Lackland, 1940 Carswell Ave, San Antonio, TX 78236 USA		Taylor, DJ (corresponding author), Univ Arizona, 1503 East Univ Blvd, Tucson, AZ 85721 USA.	DanielJTaylor@email.arizona.edu					Andrews CH, 2004, RELATIONSHIP SLEEP R; Baldus BR, 2002, SLEEP PATTERNS US NA; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; COREN S, 1994, INT J NEUROSCI, V79, P67, DOI 10.3109/00207459408986068; DAWES RM, 1989, SCIENCE, V243, P1668, DOI 10.1126/science.2648573; Garb HN, 2005, LACKLAND BEHAV QUEST; Garb HN, 2019, PSYCHOL ASSESSMENT, V31, P1456, DOI 10.1037/pas0000673; Garb HN, 2018, PSYCHOL ASSESSMENT, V30, P1039, DOI 10.1037/pas0000542; Garb HN, 2013, MIL PSYCHOL, V25, P82, DOI 10.1037/h0094759; Gehrman P, 2013, SLEEP, V36, P1009, DOI 10.5665/sleep.2798; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; JOHNSON LC, 1983, MIL MED, V148, P727; Johnson LC, 1982, DTIC DOCUMENT; Koffel E, 2013, J ANXIETY DISORD, V27, P512, DOI 10.1016/j.janxdis.2013.07.003; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; Meehl P.E., 1954, CLIN VERSUS STAT PRE; MILLER NL, 2011, ROLE SLEEP MILITARY; Morrow CE, 2013, MIL PSYCHOL, V25, P568, DOI 10.1037/mil0000021; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Osgood JM, 2019, SLEEP, V42, DOI 10.1093/sleep/zsy257; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; Seelig AD, 2016, SLEEP, V39, P1111, DOI 10.5665/sleep.5766; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Tabachnick B.G., 2014, USING MULTIVARIATE S, V6th; Taylor DJ, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy069; Taylor Daniel J, 2003, Behav Sleep Med, V1, P227, DOI 10.1207/S15402010BSM0104_5; Taylor DJ, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx075; Taylor DJ, 2016, SLEEP, V39, P1795, DOI 10.5665/sleep.6156; Taylor DJ, 2014, INT REV PSYCHIATR, V26, P205, DOI 10.3109/09540261.2014.902808; Troxel WM, 2015, SLEEP MILITARY PROMO; United States General Accounting Office, 2000, MIL PERS 1 TERM REC	33	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2352-7218	2352-7226		SLEEP HEALTH	Sleep Health	JUN	2020	6	3					338	343		10.1016/j.sleh.2020.01.007			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MW9EX	WOS:000557335600013	32273194				2022-02-06	
J	Tsur, N; Haller, CS				Tsur, Noga; Haller, Chiara S.			Physical and Mental Health and Functioning Among Traumatic Brain Injury Close Relatives: The Role of Posttraumatic Stress Symptoms	FAMILY PROCESS			English	Article						Severe traumatic brain injury; Posttraumatic stress symptoms; Relatives; Health-related quality of life; Functioning	QUALITY-OF-LIFE; SHORT SCREENING SCALE; SECONDARY TRAUMATIZATION; CAREGIVER DEPRESSION; MARITAL ADJUSTMENT; UNITED-STATES; EX-PRISONERS; TBI; PTSD; TRAJECTORIES	Severe Traumatic brain injury (sTBI) often instigates widespread long-lasting disability and is accompanied by extensive rehabilitation. Unsurprisingly, sTBI also holds malignant consequences for patients' close relatives. The burden caused by the injury and its severity explains some of the ramifications for the relatives. Additionally, some findings demonstrate that patients with sTBI and their relatives develop posttraumatic stress (PTS) symptoms. However, although the link between PTS symptoms and physical and mental health is well-documented in literature, the effect of PTS symptoms on relatives of patients with sTBI has barely been examined. This study examines the influence of PTS symptoms of patients with sTBI and their relatives on the physical and mental health and functioning of the relatives. Patients who sustained a severe sTBI (Abbreviated Injury Scale of the head region > 3) and close relatives were included in a multi-center, prospective cohort study (TRAST-MI). One-hundred patients and their relatives were assessed at 2, 6, and 12 months post injury. Outcome variables included health-related quality of life (SF-12) as well as emotional, cognitive, interpersonal, and total functioning (PCRS). Relatives' physical health was predicted by relatives' PTS symptoms (Slope=-1.76; p = .043), and mental health was predicted by both patients' (Slope=-2.77; p = .034) and relatives' (Slope=-6.59; p < .001) PTS symptoms. Functioning level was only predicted by patients' PTS symptoms (Slope=-.25; p(<).001). The findings emphasize that TBI should be considered a comprehensive traumatic experience reaching further than mere physical damage to the brain and its direct consequences, affecting the injured individual and close relatives.	[Tsur, Noga] Tel Aviv Univ, Bob Shapell Sch Social Work, Tel Aviv, Israel; [Haller, Chiara S.] Harvard Univ, Dept Psychol, Cambridge, MA USA; [Haller, Chiara S.] Harvard Med Sch, Massachusetts Mental Hlth Ctr, Div Publ Psychiat, Boston, MA 02115 USA		Tsur, N (corresponding author), Tel Aviv Univ, Sch Social Work, Tel Aviv, Israel.	nogatsur@tauex.tau.ac.il					American Association for the Advancement for Automotive Medicine, 2001, ABBR INJ SCAL 1990 R; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Ben Arzi N, 2000, BRAIN INJURY, V14, P725; Beristianos MH, 2016, AM J GERIAT PSYCHIAT, V24, P192, DOI 10.1016/j.jagp.2014.12.003; Bohnert KM, 2011, INT J METH PSYCH RES, V20, pE1, DOI 10.1002/mpr.331; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; Bosma CM, 2018, ARCH PHYS MED REHAB, V99, P1576, DOI 10.1016/j.apmr.2018.02.008; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Breslau N, 1999, AM J PSYCHIAT, V156, P908, DOI 10.1176/ajp.156.6.908; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Campbell TA, 2009, PSYCHIAT ANN, V39, P796, DOI 10.3928/00485713-20090728-01; Chwalisz K, 1996, REHABIL PSYCHOL, V41, P91, DOI 10.1037/0090-5550.41.2.91; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Corrigan JD, 2008, JAMA-J AM MED ASSOC, V300, P720, DOI 10.1001/jama.300.6.720; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Doyle ST, 2013, BRAIN INJURY, V27, P1441, DOI 10.3109/02699052.2013.826505; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Figley CR., 1997, BURNOUT FAMILIES SYS; Gad AM., 2017, INT J STAT DISTRIBUT, V3, P72, DOI DOI 10.11648/J.IJSD.20170304.13; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; Godwin EE, 2011, J HEAD TRAUMA REHAB, V26, P43, DOI 10.1097/HTR.0b013e3182048f54; Gulin SL, 2014, FAM SYST HEALTH, V32, P53, DOI 10.1037/a0032623; Haller C. S., 2017, BRAIN INJURY, V31, P13; Haller CS, 2017, J PERS, V85, P481, DOI 10.1111/jopy.12254; Haller CS, 2017, BRAIN INJURY, V31, P319, DOI 10.1080/02699052.2016.1255777; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Honaker J, 2011, J STAT SOFTW, V45, P1; Kean S, 2010, NURS CRIT CARE, V15, P66, DOI 10.1111/j.1478-5153.2010.00379.x; Kelley K, 2012, PSYCHOL METHODS, V17, P137, DOI 10.1037/a0028086; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Kreutzer JS, 2010, NEUROREHABILITATION, V27, P19, DOI 10.3233/NRE-2010-0578; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Lahav Y, 2017, J TRAUMA STRESS, V30, P399, DOI 10.1002/jts.22204; Lahav Y, 2016, J PSYCHOSOM RES, V89, P61, DOI 10.1016/j.jpsychores.2016.08.008; Lahav Y, 2015, PSYCHIATRY, V78, P354, DOI 10.1080/00332747.2015.1061311; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Landau J., 2008, FAMILIES SYSTEMS HLT, V26, P69, DOI [10.1037/1091-7527.26.1.69, DOI 10.1037/1091-7527.26.1.69]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin Y, 2017, FAM PROCESS, V56, P926, DOI 10.1111/famp.12257; Levin Y, 2016, J FAM PSYCHOL, V30, P72, DOI 10.1037/fam0000170; Maercker A, 1998, DIAGNOSTICA, V44, P130; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; McFarlane AC, 2010, WORLD PSYCHIATRY, V9, P3; O'Donovan A, 2015, PSYCHONEUROENDOCRINO, V51, P557, DOI 10.1016/j.psyneuen.2014.11.010; Ownsworth T, 2010, PSYCHO-ONCOLOGY, V19, P1116, DOI 10.1002/pon.1663; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pielmaier L, 2013, J LOSS TRAUMA, V18, P521, DOI 10.1080/15325024.2012.719342; Pielmaier L, 2011, BRAIN INJURY, V25, P259, DOI 10.3109/02699052.2010.542429; Pinheiro J, 2018, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1111/J.1654-1103.2009.05548.X; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Rohleder N, 2010, NEUROSCI BIOBEHAV R, V35, P104, DOI 10.1016/j.neubiorev.2009.12.003; Rolland JS, 2017, FAM PROCESS, V56, P799, DOI 10.1111/famp.12316; Rothschield B., 2003, BODY REMEMBERS CASEB; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Shields CG, 2012, J MARITAL FAM THER, V38, P265, DOI 10.1111/j.1752-0606.2011.00269.x; Siegrist P., 2010, TRAUMA GEWALT, V3, P208; SOLOMON Z, 1992, FAM PROCESS, V31, P289, DOI 10.1111/j.1545-5300.1992.00289.x; Solomon Z, 2017, PSYCHONEUROENDOCRINO, V81, P122, DOI 10.1016/j.psyneuen.2017.04.004; Solomon Z, 2012, PSYCHIAT RES, V199, P188, DOI 10.1016/j.psychres.2012.03.035; Steele F, 2008, J R STAT SOC A STAT, V171, P5; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Tsur N, 2018, PSYCHIAT RES, V261, P281, DOI 10.1016/j.psychres.2017.12.083; Tsur N, 2017, PSYCHOSOM MED, V79, P655, DOI 10.1097/PSY.0000000000000461; van Buuren S, 2011, HDB ADV MULTILEVEL A, P173, DOI DOI 10.4324/9780203848852-18; Van der Kolk B, 2014, BODY KEEPS SCORE; VANDERKOLK BA, 1994, HARVARD REV PSYCHIAT, V1, P253, DOI 10.3109/10673229409017088; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weiss D.S., 2007, CROSS CULTURAL ASSES, P219, DOI 10.1007/978-0-387-70990-1_10; Zalli A, 2014, P NATL ACAD SCI USA, V111, P4519, DOI 10.1073/pnas.1322145111; Zerach G, 2015, J HEALTH PSYCHOL, V20, P222, DOI 10.1177/1359105313502563	77	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-7370	1545-5300		FAM PROCESS	Fam. Process	JUN	2020	59	2					666	680		10.1111/famp.12454			15	Psychology, Clinical; Family Studies	Social Science Citation Index (SSCI)	Psychology; Family Studies	LV8KE	WOS:000538685400024	31013369				2022-02-06	
J	Weiss, E; Dhir, T; Collett, A; Reola, M; Kaplan, M; Minimo, C; Omert, L; Leung, P				Weiss, Eric; Dhir, Teena; Collett, Abigail; Reola, Michal; Kaplan, Mark; Minimo, Corrado; Omert, Laurel; Leung, Pak			Effect of complement C1-esterase inhibitor on brain edema and inflammation after mild traumatic brain injury in an animal mode	CLINICAL AND EXPERIMENTAL EMERGENCY MEDICINE			English	Article						Brain injuries; traumatic; Complement system proteins; Edema; Inflammation; Cytokines	MEMBRANE ATTACK COMPLEX; C1 INHIBITOR; ACTIVATION; SYSTEM; VOLUME	Objective Traumatic brain injury (TBI) is characterized by damage to the blood-brain barrier, inflammation, and edema formation. In this pilot study, we aimed to investigate the effects of a complement inhibitor, C1-esterase inhibitor (C1 INH), on brain edema and inflammation in a rat model of mild TBI. Methods Thirty-six male Sprague Dawley rats were randomly assigned to control, TBI, or TBI plus C1 INH groups. TBI and TBI plus C1 INH rats received an injection of saline or 25 IU/kg C1 INH, respectively, with TBI using a weight drop model. Control rats received saline only. Rats were subsequently euthanized and their brain tissue harvested for analysis. The primary outcome was the extent of edema as assessed by the brain's water content. Secondary outcomes included enzyme-linked immunosorbent assays to determine levels of pro-inflammatory mediators. Results Tumor necrosis factor-alpha levels were significantly greater in TBI rats than control rats, indicating that inflammation was generated by the weight drop impact. Brain water content following TBI was significantly different between TBI rats treated with C1-INH (78.7%+/- 0.12), untreated TBI rats (79.3%+/- 0.12), and control rats (78.6%+/- 0.15, P=0.001). There was a significant decrease in C3a and interleukin 2 levels among C1 INH-treated rats compared with untreated TBI rats, but no change in levels of tumor necrosis factor-alpha and 5100 beta. Conclusion C1-INH inhibited the complement pathway, suggesting that C1-INH may have a therapeutic benefit in TBI. Further studies are needed to investigate the effect of C1-INH on clinical outcomes.	[Weiss, Eric; Dhir, Teena; Reola, Michal; Kaplan, Mark; Minimo, Corrado; Omert, Laurel; Leung, Pak] Einstein Healthcare Network, Dept Surg, Klein Bldg 510, Philadelphia, PA 19141 USA; [Collett, Abigail; Kaplan, Mark] Philadelphia Coll Osteopath Med, Philadelphia, PA USA; [Leung, Pak] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA		Weiss, E (corresponding author), Einstein Healthcare Network, Dept Surg, Klein Bldg 510, Philadelphia, PA 19141 USA.	WeissEri@einstein.edu			Albert Einstein Society [8579]; CSL Behring	Project funding was obtained through Albert Einstein Society $10k Seed Grant no. 8579.; Medical writing support in the form of developing drafts based on author input and editorial assistance was provided by Leigh O'Connor of Fishawack Communications Ltd., and was funded by CSL Behring.	ALBERTWEISSENBERGE, 2014, FRONT CELL NEUROSCI, V0008, DOI DOI 10.3389/FNCEL.2014.00269; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Campbell JC, 2016, SHOCK, V46, P177, DOI 10.1097/SHK.0000000000000677; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; CUI LX, 1994, PROTEIN SCI, V3, P1169, DOI 10.1002/pro.5560030803; Davis AE, 2010, THROMB HAEMOSTASIS, V104, P886, DOI 10.1160/TH10-01-0073; Duehrkop C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072059; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Ganter MT, 2007, SHOCK, V28, P29, DOI 10.1097/shk.0b013e3180342439; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Kalish BT, 2016, METHODS MOL BIOL, V1462, P193, DOI 10.1007/978-1-4939-3816-2_12; Keep RF, 2012, TRANSL STROKE RES, V3, P263, DOI 10.1007/s12975-012-0152-2; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; Longhi L, 2008, ACTA NEUROCHIR SUPPL, V102, P381, DOI 10.1007/978-3-211-85578-2_73; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; Lucca JJD, 2012, SHOCK, V38, P82, DOI 10.1097/SHK.0b013e31825a3522; Marmarou Christina R., 2009, P393, DOI 10.1007/978-1-60327-185-1_34; Mathern DR, 2015, CLIN J AM SOC NEPHRO, V10, P1636, DOI 10.2215/CJN.06230614; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008	30	1	1	0	1	SEOUL KOREAN SOC EMERGENCY MEDICINE	SEOUL	101-3305, BROWNSTONE SEOUL, 464 CHEONGPA-RO, JUNG-GU, SEOUL, 06351, SOUTH KOREA	2383-4625			CLIN EXP EMERG MED	Clin. Exp. Emerg. Med.	JUN	2020	7	2					87	94		10.15441/ceem.19.050			8	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	MG7TS	WOS:000546233300004	32635699	Green Published, gold			2022-02-06	
J	Perovic, M; Jovic, M; Todorovic, S; Dordevic, AM; Milanovic, D; Kanazir, S; Loncarevic-Vasiljkovic, N				Perovic, Milka; Jovic, Milena; Todorovic, Smilja; Dordevic, Aleksandra Mladenovic; Milanovic, Desanka; Kanazir, Selma; Loncarevic-Vasiljkovic, Natasa			Neuroprotective effects of food restriction in a rat model of traumatic brain injury - the role of glucocorticoid signaling	NUTRITIONAL NEUROSCIENCE			English	Article; Early Access						Brain injury; food restriction; glucocorticoids; neuroprotection; GR signaling; NF-kB; 11-beta HSD1; HSP70	CALORIC RESTRICTION; DIETARY RESTRICTION; STRESS; MECHANISMS; PLASTICITY; SHOCK	Objective: Traumatic brain injury (TBI) is one of the most common causes of neurological damage in young and middle aged people. Food restriction (FR) has been shown to act neuroprotectively in animal models of stroke and TBI. Indeed, our previous studies showed that FR attenuates inflammation, through suppression of microglial activation and TNF-alpha production, suppresses caspase-3-induced neuronal cell death and enhances neuroplasticity in the rat model of TBI. Glucocorticoids (GCs) play a central role in mediating both molecular and behavioral responses to food restriction. However, the exact mechanisms of FR neuroprotection in TBI are still unclear. The goal of the present study was to examine whether FR exerts its beneficial effects by altering the glucocorticoid receptor (GR) signaling alone and/or together with other protective factors. Methods: To this end, we examined the effects of FR (50% of regular daily food intake for 3 months prior to TBI) on the protein levels of total GR, GR phosphoisoform Ser232 (p-GR) and its transcriptional activity, as well as 11 beta-HSD1, NF kappa B (p65) and HSP70 as factors related to the GR signaling. Results: Our results demonstrate that FR applied prior to TBI significantly changes p-GR levels, and it's transcriptional activity during the recovery period after TBI. Moreover, as a pretreatment, FR modulates other protective factors in response to TBI, such as 11 beta-HSD1, NF-kappa B (p65) and HSP70 that act in parallel with GR in it's anti-inflammatory and neuroprotective effects in the rat model of brain injury. Conclusion: Our results suggest that prophylactic FR represents a potent non-invasive approach capable of changing GR signalling, together with other factors related to the GR signaling in the model of TBI.	[Perovic, Milka; Jovic, Milena; Todorovic, Smilja; Dordevic, Aleksandra Mladenovic; Milanovic, Desanka; Kanazir, Selma; Loncarevic-Vasiljkovic, Natasa] Univ Belgrade, Dept Neurobiol, Natl Inst Republ Serbia, Inst Biol Res Sinisa Stankovic, Bulevar Despota Stefana 142, Belgrade 11060, Serbia		Loncarevic-Vasiljkovic, N (corresponding author), Univ Belgrade, Dept Neurobiol, Natl Inst Republ Serbia, Inst Biol Res Sinisa Stankovic, Bulevar Despota Stefana 142, Belgrade 11060, Serbia.	natasa.loncarevic@ibiss.bg.ac.rs	; Kanazir, Selma/E-5495-2015	Milanovic, Desanka/0000-0001-9799-0335; Todorovic, Smilja/0000-0001-7155-4914; Loncarevic-Vasiljkovic, Natasa/0000-0002-8350-1390; Mladenovic Djordjevic, Aleksandra/0000-0001-9011-5634; jovic, milena/0000-0002-9474-7097; Kanazir, Selma/0000-0002-7229-5296; Perovic, Milka/0000-0003-0941-6988	Ministry of Education and Science, Republic of Serbia [ON173056]	This work is funded by the Ministry of Education and Science, Republic of Serbia (grant ON173056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank to Dr Jelena Dinic (Institute for Biological Research 'Sinia Stankovi') for assistance in confocal imaging and analysis of obtained data.	Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Amsterdam A, 2002, MOL CELL ENDOCRINOL, V189, P1, DOI 10.1016/S0303-7207(01)00722-5; Beere HM, 2001, TRENDS CELL BIOL, V11, P6, DOI 10.1016/S0962-8924(00)01874-2; Bethea JR, 2000, PROG BRAIN RES, V128, P33; Breuner CW, 2002, J ENDOCRINOL, V175, P99, DOI 10.1677/joe.0.1750099; Brown GC, 2007, BIOCHEM SOC T, V35, P1119, DOI 10.1042/BST0351119; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Chen X, 2010, NEUROL RES, V32, P1097, DOI 10.1179/016164110X12681290831162; Guarnieri DJ, 2012, BIOL PSYCHIAT, V71, P358, DOI 10.1016/j.biopsych.2011.06.028; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Jamieson, 1997, Stress, V2, P123; Jeong MA, 2011, J NEUROTRAUM, V28, P479, DOI 10.1089/neu.2010.1609; Kim JY, 2018, EXPERT OPIN THER TAR, V22, P191, DOI 10.1080/14728222.2018.1439477; Latchman DS, 1995, NEUROPATH APPL NEURO, V21, P475, DOI 10.1111/j.1365-2990.1995.tb01089.x; LEAKEY JEA, 1994, ANN NY ACAD SCI, V719, P171, DOI 10.1111/j.1749-6632.1994.tb56828.x; Loncarevic-Vasiljkovic N, 2016, NEUROCHEM INT, V96, P69, DOI 10.1016/j.neuint.2016.02.017; Loncarevic-Vasiljkovic N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037215; Loncarevic-Vasiljkovic N, 2009, EXP NEUROL, V220, P198, DOI 10.1016/j.expneurol.2009.08.024; LOW SC, 1994, J MOL ENDOCRINOL, V13, P167, DOI 10.1677/jme.0.0130167; MANDERS EMM, 1992, J CELL SCI, V103, P857; Mattson Mark P, 2004, NeuroRx, V1, P111, DOI 10.1007/BF03206571; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Mattson MP, 2003, J NEUROCHEM, V84, P417, DOI 10.1046/j.1471-4159.2003.01586.x; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; Patel NV, 2002, NEUROBIOL AGING, V23, P707, DOI 10.1016/S0197-4580(02)00017-9; Pelletier G, 2007, NEUROSCIENCE, V145, P110, DOI 10.1016/j.neuroscience.2006.11.038; Qi L, 2012, MOL MED, V18, P186, DOI 10.2119/molmed.2011.00390; Rigg JL, 2006, J HEAD TRAUMA REHAB, V21, P285, DOI 10.1097/00001199-200605000-00010; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Sasson R, 2001, ENDOCRINOLOGY, V142, P802, DOI 10.1210/en.142.2.802; Sharma S, 2007, ANN NY ACAD SCI, V1114, P419, DOI 10.1196/annals.1396.031; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Spencer SJ, 2013, BRAIN SCI, V3, P344, DOI 10.3390/brainsci3010344; Strozyk E, 2005, SIGNAL TRANSDUCTION, V5, P334, DOI [10.1002/sita.200500070, DOI 10.1002/SITA.200500070]; Tanic N, 2007, J MOL NEUROSCI, V32, P38, DOI 10.1007/s12031-007-0006-7; Veenith Tonny, 2009, World J Emerg Surg, V4, P7, DOI 10.1186/1749-7922-4-7; Xu JJ, 2009, NEUROSCI LETT, V453, P58, DOI 10.1016/j.neulet.2009.01.067	37	1	1	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1028-415X	1476-8305		NUTR NEUROSCI	Nutr. Neurosci.												10.1080/1028415X.2020.1769410		MAY 2020	13	Neurosciences; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Nutrition & Dietetics	MA5XI	WOS:000541985500001	32476608	Green Accepted			2022-02-06	
J	Castor, N; El Massioui, F				Castor, Naomie; El Massioui, Farid			Resilience after a neurological pathology: What impact on the cognitive abilities of patients with brain damage?	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; stroke; resilience; cognitive abilities; recovery	POSITIVE EMOTIONS; INJURY; DEPRESSION; RECOVERY; ANXIETY; STROKE; SCALE; MOOD	The aim of this study is to examine resilience in patients with traumatic brain injury and patients who suffered from stroke. As traumatic brain injury and stroke both have a recovery potential, we investigate cognitive recovery in this context. Given the involvement of resilience in physiological recovery and positive emotions in enhancing cognitive capacities, we hypothesised that resilience could be related to cognitive abilities and recovery following traumatic brain injury and stroke. Our results show the same degree of resilience and cognitive capacities in our participants in two separate assessments. An improvement in cognitive abilities was observed, as was a correlation between these abilities and resilience. In other words, the greater the resilience, the higher the patient's cognitive performances. Resilience appears to influence cognitive abilities in participants with brain damage and also be involved in recovery.	[Castor, Naomie; El Massioui, Farid] Univ Paris 08, Dept Psychol, Paris, France		Castor, N (corresponding author), Univ Paris 08, Dept Psychol, Paris, France.	castor.naomie@gmail.com					Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Bigler Erin D, 2015, Handb Clin Neurol, V128, P691, DOI 10.1016/B978-0-444-63521-1.00043-1; Block J, 1996, J PERS SOC PSYCHOL, V70, P349, DOI 10.1037/0022-3514.70.2.349; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; CICCHETTI D, 1994, DEV PSYCHOPATHOL, V6, P533, DOI 10.1017/S0954579400004673; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Cyrulnik B., 2012, RESILIENCE CONNAISSA; Davidson RJ, 2000, AM PSYCHOL, V55, P1196, DOI 10.1037/0003-066X.55.11.1196; Fredrickson BL, 2013, ADV EXP SOC PSYCHOL, V47, P1, DOI 10.1016/B978-0-12-407236-7.00001-2; Fredrickson BL, 2000, MOTIV EMOTION, V24, P237, DOI 10.1023/A:1010796329158; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hammar A, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.026.2009; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; JONGBLOED L, 1986, STROKE, V17, P765, DOI 10.1161/01.STR.17.4.765; Klohnen EC, 1996, J PERS SOC PSYCHOL, V70, P1067, DOI 10.1037/0022-3514.70.5.1067; Kreutzer JS, 2016, ARCH PHYS MED REHAB, V97, P708, DOI 10.1016/j.apmr.2015.12.003; LECOURS AR, 1988, NEUROPSYCHOLOGIA, V26, P575, DOI 10.1016/0028-3932(88)90114-5; Lincoln NB, 2013, DISABIL REHABIL, V35, P140, DOI 10.3109/09638288.2012.691939; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Losoi H, 2015, J HEAD TRAUMA REHAB, V30, pE24, DOI 10.1097/HTR.0000000000000055; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Luthar S., 2003, RESILIENCE VULNERABI; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; Mirabel-Sarron C, 2001, ANN MED-PSYCHOL, V159, P144, DOI 10.1016/S0003-4487(01)00021-X; Nadler RT, 2010, PSYCHOL SCI, V21, P1770, DOI 10.1177/0956797610387441; Neils-Strunjas J, 2017, BRAIN INJURY, V31, P131, DOI 10.1080/02699052.2016.1229032; Newman R, 2005, PROF PSYCHOL-RES PR, V36, P227, DOI 10.1037/0735-7028.36.3.227; Papazacharias A, 2012, PSYCHIAT DANUB, V24, pS179; Prigatano G. P., 1995, BNI Q, V7, P2; Rainey EE, 2014, AM J SURG, V208, P517, DOI 10.1016/j.amjsurg.2014.05.016; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Richardson GE, 2002, J CLIN PSYCHOL, V58, P307, DOI 10.1002/jclp.10020; Rosenberg M., 1965, ACCEPTANCE COMMITMEN, V61, P52, DOI DOI 10.1037/T01038-000; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Sherer M, 2015, REHABIL PSYCHOL, V60, P138, DOI 10.1037/rep0000030; TEASDALE G, 1974, LANCET, V2, P81; Tugade MM, 2004, J PERS SOC PSYCHOL, V86, P320, DOI 10.1037/0022-3514.86.2.320; Waugh CE, 2008, SOC COGN AFFECT NEUR, V3, P322, DOI 10.1093/scan/nsn024; White JH, 2012, ANN FAM MED, V10, P435, DOI 10.1370/afm.1374; Wolin S., 1993, BOUND DETERMINED GRO; Yang HJ, 2013, COGNITION EMOTION, V27, P474, DOI 10.1080/02699931.2012.713325	45	1	1	1	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAY 27	2020	30	5					853	871		10.1080/09602011.2018.1512873			19	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	LK7GF	WOS:000531029900004	30136623				2022-02-06	
J	Ramos, SD; Liddement, J; Addicott, C; Fortescue, D; Oddy, M				Ramos, Sara da Silva; Liddement, James; Addicott, Charlotte; Fortescue, Deborah; Oddy, Michael			The development of the Brain Injury Screening Index (BISI): A self-report measure	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Head injury; Concussion; Triage; Offenders	HEAD-INJURY; PREVALENCE; VETERANS; HEALTH; RELIABILITY; OFFENDERS; VALIDITY; TBI; AFGHANISTAN; PRISONERS	The aim of this study was to investigate the psychometric properties and screening accuracy of the Brain Injury Screening Index (BISI), a self-report questionnaire designed to identify a history of acquired brain injury. The study was conducted in a closed male prison in the UK. The purposive sample comprised 55 male prisoners who arrived at the establishment during the study. A repeated measures design was used, where the Brain Injury Screening Index (BISI) was administered on three occasions. Inter-rater reliability was poor to moderate, but test retest reliability was moderate to good. Medical records were not available for all participants, but the limited number obtained resulted in a sensitivity of .38 to .71 and specificity of .47 to .70 across the three screening administrations of the BISI. The limitations of the present findings are discussed in the context of the use of the tool in custodial environments. It is argued that these results suggest that, when used as recommended, the BISI has acceptable reliability and validity as an initial screen for identifying individuals who should receive support and a comprehensive neuropsychological assessment, and it merits further investigation and development.	[Ramos, Sara da Silva; Fortescue, Deborah] Disabil Trust, Burgess Hill, England; [Ramos, Sara da Silva; Liddement, James; Fortescue, Deborah; Oddy, Michael] Disabil Trust Fdn, Burgess Hill, England; [Ramos, Sara da Silva; Addicott, Charlotte; Oddy, Michael] Brain Injury Rehabil Trust, Burgess Hill, England		Ramos, SD (corresponding author), 32 Market Pl, Burgess Hill RH15 9NP, W Sussex, England.	sara.dasilvaramos@thedtgroup.org			HMP Leeds	We would like to thank HMP Leeds for supporting this project, the health care team for their role in recruitment and first assessment, and to all those who agreed to take part in the study. We also thank The Disabilities Trust Linkworker service team at Leeds for accommodating the volume of referrals arising from the project.	Allely CS, 2016, BRAIN INJURY, V30, P1161, DOI 10.1080/02699052.2016.1191674; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Chitsabesan P, 2015, J HEAD TRAUMA REHAB, V30, P106, DOI 10.1097/HTR.0000000000000129; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Fazel M, 2008, SOC PSYCH PSYCH EPID, V43, P319, DOI 10.1007/s00127-007-0295-8; HM Chief Inspector of Prisons, 2016, REP UN INSP; Hughes N, 2015, J HEAD TRAUMA REHAB, V30, P94, DOI 10.1097/HTR.0000000000000124; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; IBM, 2010, IBM SPSS STAT 19; Keatley E, 2013, J HEAD TRAUMA REHAB, V28, pE8, DOI 10.1097/HTR.0b013e3182776a70; Lennox C., 2013, DEV COMPREHENSIVE HL; McMillan TM, 2015, J NEUROTRAUM, V32, P116, DOI 10.1089/neu.2014.3387; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Norman RS, 2013, BRAIN INJURY, V27, P1623, DOI 10.3109/02699052.2013.834380; Oddy M, 2012, BRAIN INJURY, V26, P1058, DOI 10.3109/02699052.2012.667595; Olson-Madden JH, 2014, ARCH PHYS MED REHAB, V95, P925, DOI 10.1016/j.apmr.2014.01.008; Pitman I, 2015, NEUROPSYCHOL REHABIL, V25, P763, DOI 10.1080/09602011.2014.973887; Ramos SDS, 2018, INT J OFFENDER THER, V62, P1854, DOI 10.1177/0306624X17708351; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; Russell LM, 2013, AM J PUBLIC HEALTH, V103, pS211, DOI 10.2105/AJPH.2013.301485; Sahler CS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/659652; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Scholten J, 2013, J HEAD TRAUMA REHAB, V28, P219, DOI 10.1097/HTR.0b013e318291daca; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Walker R, 2007, J HEAD TRAUMA REHAB, V22, P360, DOI 10.1097/01.HTR.0000300231.90619.50; Williams W. H., 2016, BRAIN INJURY CUSTODY; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697	35	1	1	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAY 27	2020	30	5					948	960		10.1080/09602011.2018.1526692			13	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	LK7GF	WOS:000531029900008	30272531				2022-02-06	
J	Johnstone, B; Ramsey, KG; Beydoun, HA				Johnstone, Brick; Ramsey, Kathryn G.; Beydoun, Hind A.			Comparing indices of objective and subjective neuropsychological impairments in service members with mild traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Neurobehavioral Symptom Inventory (NSI); Personality Assessment Inventory (PAI); relative decline; traumatic brain injury (TBI)	PREMORBID INTELLIGENCE; WECHSLER TEST; READING TEST; PERFORMANCE; ALZHEIMERS; COMPLAINTS	Neuropsychological impairments are evaluated using subjective measures and objective tests, although their relationship remains unclear. This is likely because objective data is interpreted in terms of absolute level of functioning (e.g., high average, average, low average) while subjective complaints are interpreted in terms of relative decline from premorbid levels (e.g., mild, moderate, severe). The current study calculated objective indices of estimated degree of relative decline (i.e., difference between current cognitive ability and estimated premorbid level) to compare objective and subjective indices of relative decline for military service members with mild traumatic brain injury (mTBI). Contrary to hypotheses, more indices of absolute level of functioning were significantly correlated with subjective neuropsychological (i.e., Neurobehavioral Symptom Inventory) and psychological complaints (e.g., Personality Assessment Inventory) than relative decline scores. The results suggest stronger cognitive abilities may be associated with greater cognitive reserve or emotional resilience and, thereby, less subjective complaints for individuals with TBI, regardless of the extent of neuropsychological decline experienced.	[Johnstone, Brick] Def & Vet Brain Injury Ctr, Ft Belvoir, VA USA; [Ramsey, Kathryn G.] Ft Belvoir Intrepid Spirit Ctr, Def & Vet Brain Injury Ctr, Ft Belvoir, VA USA; [Beydoun, Hind A.] Ft Belvoir Community Hosp, Dept Res Programs, Ft Belvoir, VA USA		Johnstone, B (corresponding author), Sheperd Ctr, 2020 Peachtree Rd NW, Atlanta, GA 30309 USA.	Brick.Johnstone@Shepherd.org					CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2018, J HEAD TRAUMA REHAB, V33, P81, DOI 10.1097/HTR.0000000000000375; Delis D.C., 2000, CVLT 2 CALIFORNIA VE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Elliott TR, 2019, REHABIL PSYCHOL, V64, P383, DOI 10.1037/rep0000282; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Hayes D. K., 2015, OTOLARYNGOLOGY HEAD, P87; Heaton R. K., 1991, PSYCHOL ASSESSMENT R; Hinkebein JH, 2003, BRAIN INJURY, V17, P1035, DOI 10.1080/0269905031000110490; Holdnack JA, 2017, REHABIL PSYCHOL, V62, P496, DOI 10.1037/rep0000198; Johnstone B, 1996, J Int Neuropsychol Soc, V2, P282; Johnstone B, 1996, ARCH CLIN NEUROPSYCH, V11, P513, DOI 10.1016/0887-6177(96)82330-4; Johnstone B, 1998, BRAIN INJURY, V12, P569, DOI 10.1080/026990598122331; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; Johnstone B, 2002, ARCH CLIN NEUROPSYCH, V17, P273, DOI 10.1016/S0887-6177(01)00112-3; Johnstone B, 1999, J HEAD TRAUMA REHAB, V14, P220, DOI 10.1097/00001199-199906000-00003; Johnstone B, 1997, ARCH CLIN NEUROPSYCH, V12, P591, DOI 10.1016/S0887-6177(97)00002-4; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Morey L.C., 2007, PERSONALITY ASSESSME; Orme DR, 2004, REHABIL PSYCHOL, V49, P250, DOI 10.1037/0090-5550.49.3.250; Skeel R L, 2000, Appl Neuropsychol, V7, P96, DOI 10.1207/S15324826AN0702_5; Skell RL, 2000, BRAIN INJURY, V14, P705; Slaughter J, 1999, BRAIN INJURY, V13, P125, DOI 10.1080/026990599121782; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sternberg RJ, 2001, MERRILL PALMER QUART, V47, P1, DOI 10.1353/mpq.2001.0005; Steward KA, 2017, ARCH CLIN NEUROPSYCH, V32, P98, DOI 10.1093/arclin/acw081; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Vanderploeg RD, 2019, REHABIL PSYCHOL, V64, P1, DOI 10.1037/rep0000255; Wechsler D., 2008, WECHSLER ADULT INTEL; WechslerD, 2001, WECHSLER TEST ADULT; WIENS AN, 1993, CLIN NEUROPSYCHOL, V7, P70, DOI 10.1080/13854049308401889	34	1	1	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2020.1763999		MAY 2020	8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	MB5UR	WOS:000542668400001	32476468				2022-02-06	
J	Clark, JM; Williams, C; Clissold, J; McGoldrick, A; Hill, J; Annaidh, AN; Gilchrist, MD				Clark, J. Michio; Williams, Claire; Clissold, Jonathan; McGoldrick, Adrian; Hill, Jerry; Annaidh, Aisling Ni; Gilchrist, Michael D.			Video analysis of head injury incidents in equestrian sports	SPORTS ENGINEERING			English	Article						Head injury; Concussion; Oblique impact; Equestrian; Helmets	DEFORMATION RESPONSE; GREAT-BRITAIN; EPS FOAM; FOOTBALL; IMPACTS; CONCUSSION; HELMETS; KINEMATICS	Current helmet certification tests involve linear impacts on rigid anvils. The associated kinematics by which a jockey falls from a horse while riding are believed to be fundamentally different to those in the certification tests, i.e., they involve oblique falls (falls at an angle) to compliant surfaces. This paper provides primary data from real-world equestrian accidents to characterise such kinematics, and constitutes a basis for future helmet developments and improvements in certification tests. The purpose of this study was to use well-documented video footage of equestrian accidents to characterise associated head injuries. 1119 equestrian accidents were collected from professionally regulated horse races and eventing during an 8-year period. Head injury incidents were analysed on a frame-by-frame basis to characterise the impact event, location, and surface. A total of 73 head injury incidents afforded a set of documentary data that were analysed: these involved 69 concussions, two hematomas, two orbital fractures, a fractured zygoma, and a fractured mandible. Based on the results of this study, priorities for future helmet designs and certification tests should be informed by the present findings. Since all of the observed cases involved the head impacting compliant surfaces (turf or sand) in an oblique manner, it is recommended that the protective capacity of equestrian helmets be assessed for oblique impacts to compliant surfaces. Furthermore, since the most frequently impacted locations were the lower region of the helmet and the mid-region on the back of the helmet, it is suggested that additional protection in these areas could be beneficial.	[Clark, J. Michio; Annaidh, Aisling Ni; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland; [Clark, J. Michio] Vector Sci Inc, Golden, CO USA; [Williams, Claire] British Equestrian Trade Assoc, Wetherby, England; [Clissold, Jonathan] British Eventing, Kenilworth, Warwick, England; [McGoldrick, Adrian] Irish Horseracing Regulatory Author, The Curragh, Kildare, Ireland; [Hill, Jerry] British Horseracing Author, London, England		Gilchrist, MD (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland.	michael.gilchrist@ucd.ie	Ni Annaidh, Aisling/ABF-8938-2021	Ni Annaidh, Aisling/0000-0002-9929-4541	European UnionEuropean Commission [642662]	This research has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant agreement no. 642662.	Andersen TE, 2003, BRIT J SPORT MED, V37, P226, DOI 10.1136/bjsm.37.3.226; [Anonymous], 2016, HELM EQ ACT; [Anonymous], 2015, US MOT OTH MOT VEH; [Anonymous], 2011, HELM EQ US; [Anonymous], 1997, SPEC HELM EQ ACT; ASTM F1163-15, 2015, F116315 ASTM; Bland ML, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040019; Campolettano Eamon T, 2018, Proc Int IRCOBI Conf Biomech Impacts, V2018, P326; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Clark JM, 2020, ANN BIOMED ENG, V48, P2247, DOI 10.1007/s10439-020-02531-y; Clark JM, 2020, J SCI MED SPORT, V23, P222, DOI 10.1016/j.jsams.2019.10.006; Clark JM, 2018, ANN BIOMED ENG, V46, P986, DOI 10.1007/s10439-018-2017-7; Clark JM, 2017, COMPUT METHOD BIOMEC, V20, P1299, DOI 10.1080/10255842.2017.1341977; Clark JM, 2016, ANN BIOMED ENG, V44, P3693, DOI 10.1007/s10439-016-1686-3; Connor TA, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10072623; Connor TA, 2019, INT J CRASHWORTHINES, V24, P677, DOI 10.1080/13588265.2018.1525859; Connor TA, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0193-0; Cowley S, 2007, BRIT J SPORT MED, V41, P639, DOI 10.1136/bjsm.2006.032888; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Foote C.E., 2011, HLTH SAFETY AUSTR HO; Forero Rueda M. A., 2010, INJURY, V41, P533, DOI DOI 10.1016/j.injury.2009.05.009; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Gilchrist MD, 2001, INT J CRASHWORTHINES, V6, P253, DOI 10.1533/cras.2001.0176; Halldin P, 2015, TC158WG11 CEN; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Hitchens PL, 2009, MED J AUSTRALIA, V190, P83, DOI 10.5694/j.1326-5377.2009.tb02284.x; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Kuhn EN, 2017, SPORTS ENG, V20, P29, DOI 10.1007/s12283-016-0215-9; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Ling C, 2018, INT J MECH SCI, V145, P9, DOI 10.1016/j.ijmecsci.2018.06.015; Ling C, 2018, INT J MECH SCI, V144, P480, DOI 10.1016/j.ijmecsci.2018.06.014; Lloyd R G, 1987, Br J Sports Med, V21, P22; McCrory P, 2006, BRIT J SPORT MED, V40, P614, DOI 10.1136/bjsm.2006.028449; McIntosh A., 1992, IRCOBI, P51; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Meredith L, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000398; Mihalik JP, 2008, P I MECH ENG P-J SPO, V222, P45, DOI 10.1243/17543371JSET4; MILLS NJ, 1989, INJURY, V20, P189, DOI 10.1016/0020-1383(89)90108-3; National Operating Committee on Standards for Athletic Equipment, 2017, STAND TEST METH EQ U; Oikawa M., 2004, JPN RACING J, V12, P5; Parkin TDH, 2006, PREV VET MED, V74, P44, DOI 10.1016/j.prevetmed.2006.01.006; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2018, SPORTS ENG, V21, P235, DOI 10.1007/s12283-018-0263-4; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Rueda MAF, 2009, FORENSIC SCI INT, V191, P52, DOI 10.1016/j.forsciint.2009.06.007; Scher IS, 2020, SPORTS ENG, V23, DOI 10.1007/s12283-020-0321-6; Stigson H, 2017, IRCOBI C ANTW BELG, P13; Tanini I, 2018, 8 WORLD C BIOM DUBL; Tierney GJ, 2016, BRAIN INJURY, V30, P1350, DOI 10.1080/02699052.2016.1193630; Turner M, 2002, BRIT J SPORT MED, V36, P403, DOI 10.1136/bjsm.36.6.403; UEDA Y, 1993, J EQUINE VET SCI, V13, P707, DOI 10.1016/S0737-0806(06)81572-8; Ueeck BA, 2004, J ORAL MAXIL SURG, V62, P693, DOI 10.1016/j.joms.2003.12.010; Waller AE, 2000, JAMA-J AM MED ASSOC, V283, P1326, DOI 10.1001/jama.283.10.1326; Winkler EA, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15613; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	58	1	1	2	9	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1369-7072	1460-2687		SPORTS ENG	Sports Eng.	MAY 25	2020	23	1							10	10.1007/s12283-020-00323-0			9	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	LR0CB	WOS:000535363400001					2022-02-06	
J	Driessen, A; Wafaisade, A; Lefering, R; Migliorini, F; Frohlich, M; Arbab, D; Maegele, M; Mutschler, M				Driessen, Arne; Wafaisade, Arasch; Lefering, Rolf; Migliorini, Filippo; Froehlich, Matthias; Arbab, Dariusch; Maegele, Marc; Mutschler, Manuel			Mechanism, frequency, transfusion and outcome of severe trauma in coagulopathic paediatric patients	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						Coagulopathy; Haemorrhage; Paediatric trauma; Transfusion; Mortality	MASSIVE TRANSFUSION; RISK STRATIFICATION; GLOBAL BURDEN; MORTALITY; INJURY; REGISTRY; DEATHS; EPIDEMIOLOGY; TEMPERATURE; MANAGEMENT	Purpose Acute traumatic coagulopathy can result in uncontrolled haemorrhage responsible for the majority of early deaths after adult trauma. Data on the frequency, transfusion practice and outcome of severe trauma haemorrhage in paediatric patients are inconsistent. Methods Datasets from paediatric trauma patients were retrieved from the registry of the German trauma society (TR-DGU(R)) between 2009 and 2016. Coagulopathy was defined by a Quick's value < 70% (INR (international normalized ratio) > 1.4) and/or thrombocytes <= 100 k upon emergency room admission. Children were grouped according to age in 4 different groups (A: 1-5, B: 6-10, C: 11-15 and D: 16-17 years). Prevalence of coagulopathy was assessed. Demographics, injury severity, haemostatic management including transfusions and mortality were described. Results 5351 primary admitted children <= 17 years with an abbreviated injury scale (AIS) >= 3 and complete datasets were included. The prevalence of coagulopathy was 13.7% (733/5351). The majority of the children sustained blunt trauma (more than 90% independent of age group) and a combination of traumatic brain injury (TBI) and any other trauma in more than 60% (A, C, D) and in 53.8% in group B. Coagulopathy occurred the most among the youngest (A: 18.2%), followed by all other age groups with approximately 13%. Overall mortality was the highest in the youngest (A: 40.9%) and among the youngest patients with traumatic brain injury (A: 71.4% and B: 47.1%). Transfusion of packed red blood cells (pRBCs) and fresh frozen plasma (FFPs) occurred almost in a 2:1 ratio (or less) across all age subgroups. Conclusion Traumatic haemorrhage in association with coagulopathy and severe shock is a major challenge in paediatric trauma across all age groups.	[Driessen, Arne; Migliorini, Filippo] Rhein Westfal TH Aachen, Univ Hosp RWTH Aachen, Dept Orthopaed Surg, Pauwelsstr 30, D-52074 Aachen, Germany; [Wafaisade, Arasch; Froehlich, Matthias; Maegele, Marc; Mutschler, Manuel] Univ Witten Herdecke, Cologne Merheim Med Ctr CMMC, Dept Orthopaed Surg Trauma Surg & Sports Traumato, Cologne, Germany; [Driessen, Arne; Wafaisade, Arasch; Lefering, Rolf; Froehlich, Matthias; Maegele, Marc; Mutschler, Manuel] Univ Witten Herdecke, Cologne Merheim Med Ctr CMMC, Inst Res Operat Med IFOM, Cologne, Germany; [Arbab, Dariusch] Klinikum Dortmund, Dept Orthopaed Surg, Dortmund, Germany; [Mutschler, Manuel] Johanniter Waldkrankenhaus Bonn, Dept Foot & Ankle Surg, Bonn, Germany		Driessen, A (corresponding author), Rhein Westfal TH Aachen, Univ Hosp RWTH Aachen, Dept Orthopaed Surg, Pauwelsstr 30, D-52074 Aachen, Germany.; Driessen, A (corresponding author), Univ Witten Herdecke, Cologne Merheim Med Ctr CMMC, Inst Res Operat Med IFOM, Cologne, Germany.	adriessen@ukaachen.de	migliorini, filippo/AAZ-9529-2021	migliorini, filippo/0000-0001-7220-1221	Projekt DEAL	Open Access funding provided by Projekt DEAL. We would like to thank the TR-DGU and the AUC staff for crucial help and support. Furthermore, the authors would like to thank all active centres and participants of the TR-DGU (R) for data entry into the registry. For an overview of all active centres, please see https://www.traumaregister-dgu.de/.	Barcelona SL, 2005, PEDIATR ANESTH, V15, P814, DOI 10.1111/j.1460-9592.2004.01549.x; BARDENHEUE M, 1994, UNFALLCHIRURG, V97, P230; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Chidester SJ, 2012, J TRAUMA ACUTE CARE, V73, P1273, DOI 10.1097/TA.0b013e318265d267; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Cosgriff N, 1997, J TRAUMA, V42, P857, DOI 10.1097/00005373-199705000-00016; Dehmer JJ, 2010, SEMIN PEDIATR SURG, V19, P286, DOI 10.1053/j.sempedsurg.2010.07.002; Driessen A, 2015, EUR J TRAUMA EMERG S, V41, P413, DOI 10.1007/s00068-014-0455-y; Driessen A, 2015, NOTFALL RETTUNGSMED, V18, P1; Driessen A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0233-4; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Floccard B, 2012, INJURY, V43, P26, DOI 10.1016/j.injury.2010.11.003; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Hendrickson JE, 2012, TRANSFUSION, V52, P1228, DOI 10.1111/j.1537-2995.2011.03458.x; Hendrickson JE, 2012, J PEDIATR-US, V160, P204, DOI 10.1016/j.jpeds.2011.08.019; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; MacLeod JBA, 2007, AM J SURG, V193, P195, DOI 10.1016/j.amjsurg.2006.09.010; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maegele M, 2008, VOX SANG, V95, P112, DOI 10.1111/j.1423-0410.2008.01074.x; Maegele M, 2009, VOX SANG, V97, P39, DOI 10.1111/j.1423-0410.2009.01179.x; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Maegele M, 2011, DTSCH ARZTEBL INT, V108, P827, DOI [10.3238/arztebl.2011.0827, 10.3238/arztebl.2011.0836a]; Meng ZH, 2003, J TRAUMA, V55, P886, DOI 10.1097/01.TA.0000066184.20808.A5; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Mutschler M, 2015, EMERG MED J, V32, P134, DOI 10.1136/emermed-2013-202727; Neugebauer EAM, 2012, DTSCH ARZTEBL INT, V109, P102, DOI 10.3238/arztebl.2012.0102; Niles SE, 2008, J TRAUMA, V64, P1459, DOI 10.1097/TA.0b013e318174e8bc; Nystrup KB, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0097-z; Patregnani JT, 2012, PEDIATR CRIT CARE ME, V13, P273, DOI 10.1097/PCC.0b013e31822f1727; Peng R, 1998, AM SURGEON, V64, P950; Reed CR, 2019, SURGERY, V165, P1108, DOI 10.1016/j.surg.2019.03.003; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schafer N, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0147-6; Sperry JL, 2008, J TRAUMA, V65, P986, DOI 10.1097/TA.0b013e3181878028; Thomas L, 2000, LABOR DIAGNOSE INDIK; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Wafaisade A, 2010, EMERG MED J, V27, P934, DOI 10.1136/emj.2009.088484; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC	41	1	1	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-020-01398-x		MAY 2020	9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	LR7CI	WOS:000535848000002	32448940	Green Published, hybrid			2022-02-06	
J	Bagnato, S; Galardi, G; Ribaudo, F; Boccagni, C; Fiorilla, TV; Rubino, F; D'Ippolito, ME; Andriolo, M				Bagnato, Sergio; Galardi, Giuseppe; Ribaudo, Francesco; Boccagni, Cristina; Fiorilla, Teresa Valentina; Rubino, Francesca; D'Ippolito, Maria Enza; Andriolo, Maria			Serum BDNF Levels Are Reduced in Patients with Disorders of Consciousness and Are Not Modified by Verticalization with Robot-Assisted Lower-Limb Training	NEURAL PLASTICITY			English	Article							NEUROTROPHIC FACTOR LEVELS; TRAUMATIC BRAIN-INJURY; UNRESPONSIVE WAKEFULNESS SYNDROME; NEURONAL APOPTOSIS; VAL66MET POLYMORPHISM; VEGETATIVE STATE; ACUTE EXERCISE; BLOOD-BRAIN; HIPPOCAMPUS; EXPRESSION	Little is known about plastic changes occurring in the brains of patients with severe disorders of consciousness (DOCs) caused by acute brain injuries at rest and during rehabilitative treatment. Brain-derived neurotrophic factor (BDNF) is a neurotrophin involved in neurogenesis and synaptic plasticity whose production is powerfully modulated by physical exercise. In this study, we compared serum BDNF levels in 18 patients with unresponsive wakefulness syndrome (UWS) and in a minimally conscious state (MCS) with those in 16 sex- and age-matched healthy controls. In 12 patients, serum BDNF levels before and after verticalization with ErigoPro robot-assisted lower-limb training were compared. Serum BDNF levels were significantly lower in patients (median, 1141 pg/ml; 25th and 75th percentiles, 1016 and 1704 pg/ml) than in controls (median, 2450 pg/ml; 25th and 75th percentiles, 2100 and 2875 pg/ml; p<0.001). BDNF levels measured before and after verticalization with robot-assisted lower-limb training did not change (p=0.5). Moreover, BDNF levels did not differ between patients with UWS and MCS (p=0.2), or between patients with traumatic and nontraumatic brain injuries (p=0.6). BDNF level correlated positively with the time since brain injury (p=0.025). In conclusion, serum BDNF levels are reduced in patients with UWS and MCS and cannot be improved by verticalization associated with passive lower-limb training. Additional studies are needed to better understand the mechanisms underlying BDNF reduction in patients with DOCs and to determine the best rehabilitative strategies to promote restorative plastic changes in these patients.	[Bagnato, Sergio; Ribaudo, Francesco; Boccagni, Cristina; Fiorilla, Teresa Valentina; Rubino, Francesca] Giuseppe Giglio Fdn, Rehabil Dept, Unit Neurophysiol, Cefalu, Italy; [Bagnato, Sergio; Ribaudo, Francesco; Boccagni, Cristina; Fiorilla, Teresa Valentina; Rubino, Francesca] Giuseppe Giglio Fdn, Rehabil Dept, Unit Severe Acquired Brain Injuries, Cefalu, Italy; [Galardi, Giuseppe] IRCCS Neuromed, Neurorehabil Dept, Pozzilli, Italy; [D'Ippolito, Maria Enza; Andriolo, Maria] Giuseppe Giglio Fdn, Clin Pathol & Microbiol Lab, Cefalu, Italy		Bagnato, S (corresponding author), Giuseppe Giglio Fdn, Rehabil Dept, Unit Neurophysiol, Cefalu, Italy.; Bagnato, S (corresponding author), Giuseppe Giglio Fdn, Rehabil Dept, Unit Severe Acquired Brain Injuries, Cefalu, Italy.	sergiobagnato@gmail.com; giuseppe.galardi@neuromed.it; francescoribaudo@gmail.com; cboccagni@gmail.com; terryfiorilla@yahoo.it; francesca.rubino@hsrgiglio.it; astutapc@yahoo.it; maria.andriolo@hsrgiglio.it	Bagnato, Sergio/H-6842-2013	Bagnato, Sergio/0000-0002-6289-1887			Bagnato S, 2020, NEURAL REGEN RES, V15, P1247, DOI 10.4103/1673-5374.272574; Bagnato S, 2020, J NEUROTRAUM, V37, P423, DOI 10.1089/neu.2019.6449; Bagnato S, 2013, NEUROSCI BIOBEHAV R, V37, P2721, DOI 10.1016/j.neubiorev.2013.09.007; Bagnato S, 2012, J NEUROTRAUM, V29, P2050, DOI 10.1089/neu.2011.2184; Buonora JE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00068; Chen HY, 2019, EXP THER MED, V18, P3837, DOI 10.3892/etm.2019.8029; Cho HC, 2012, NEUROSCI LETT, V519, P78, DOI 10.1016/j.neulet.2012.05.025; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Elliott L, 2005, J NEUROL NEUROSUR PS, V76, P298, DOI 10.1136/jnnp.2004.047357; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P419, DOI 10.1177/1545968315600525; Ferris LT, 2007, MED SCI SPORT EXER, V39, P728, DOI 10.1249/mss.0b013e31802f04c7; Fleitas C, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0411-6; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gonzalez A, 2016, CYTOSKELETON, V73, P612, DOI 10.1002/cm.21312; Guldenmund P, 2016, BRAIN INJURY, V30, P343, DOI 10.3109/02699052.2015.1118765; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hota SK, 2008, EXP NEUROL, V212, P5, DOI 10.1016/j.expneurol.2008.01.030; Huang WD, 2017, J MOL NEUROSCI, V62, P35, DOI 10.1007/s12031-017-0907-z; Hung PL, 2013, STROKE, V44, P2275, DOI 10.1161/STROKEAHA.113.001552; Kalish H, 2010, J CHROMATOGR B, V878, P194, DOI 10.1016/j.jchromb.2009.10.022; Kobori N, 2002, MOL BRAIN RES, V104, P148, DOI 10.1016/S0169-328X(02)00331-5; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Kowiaski P, 2018, CELL MOL NEUROBIOL, V38, P579, DOI [DOI 10.1007/S10571-017-0510-4, 10.1007/s10571-017-0510-4]; Krewer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143180; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lutkenhoff ES, 2015, ANN NEUROL, V78, P68, DOI 10.1002/ana.24423; Massaro AN, 2018, J PEDIATR-US, V194, P67, DOI 10.1016/j.jpeds.2017.10.060; Morozova S, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8080144; Nascimento CMC, 2014, CURR ALZHEIMER RES, V11, P799, DOI 10.2174/156720501108140910122849; Nofuji Y, 2012, J SPORT SCI MED, V11, P83; Numakawa T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113650; Ohira K, 2009, CURR NEUROPHARMACOL, V7, P276, DOI 10.2174/157015909790031210; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Pearn ML, 2012, ANESTHESIOLOGY, V116, P352, DOI 10.1097/ALN.0b013e318242a48c; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Qiao HJ, 2017, J NEUROIMMUNOL, V307, P69, DOI 10.1016/j.jneuroim.2017.04.002; Rasmussen P, 2009, EXP PHYSIOL, V94, P1062, DOI 10.1113/expphysiol.2009.048512; Riberholt CG, 2013, DAN MED J, V60; Royal College of Physicians, 2013, PROL DIS CONSC NAT C; Schmidt HD, 2010, NEUROPSYCHOPHARMACOL, V35, P2378, DOI 10.1038/npp.2010.114; Sebastiani A, 2016, CRIT CARE MED, V44, pE70, DOI 10.1097/CCM.0000000000001284; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Sharma D, 2019, J NEUROCHEM, V148, P238, DOI 10.1111/jnc.14609; Shulga A, 2013, NEUROSCIENCE, V239, P241, DOI 10.1016/j.neuroscience.2012.12.007; Stanne TM, 2016, STROKE, V47, P1943, DOI 10.1161/STROKEAHA.115.012383; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Wade DT, 2018, EUR J NEUROL, V25, P619, DOI 10.1111/ene.13572; Wang R, 2018, AGEING RES REV, V48, P109, DOI 10.1016/j.arr.2018.10.002; Xu Z, 2018, MOL NEUROBIOL, V55, P3499, DOI 10.1007/s12035-017-0576-5	54	1	1	1	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-5904	1687-5443		NEURAL PLAST	Neural. Plast.	MAY 22	2020	2020								5608145	10.1155/2020/5608145			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LV5GX	WOS:000538464500001	32565776	gold, Green Published			2022-02-06	
J	Bressan, S; Clarke, CJ; Anderson, V; Takagi, M; Hearps, SJC; Rausa, V; Anderson, N; Doyle, M; Dunne, K; Oakley, E; Davis, GA; Babl, FE				Bressan, Silvia; Clarke, Cathriona J.; Anderson, Vicki; Takagi, Michael; Hearps, Stephen J. C.; Rausa, Vanessa; Anderson, Nicholas; Doyle, Melissa; Dunne, Kevin; Oakley, Ed; Davis, Gavin A.; Babl, Franz E.			Use of the sport concussion assessment tools in the emergency department to predict persistent post-concussive symptoms in children	JOURNAL OF PAEDIATRICS AND CHILD HEALTH			English	Article						child; emergency department; mild traumatic brain injury; post-concussive symptom; SCAT	INTERNATIONAL-CONFERENCE; POSTCONCUSSION SYNDROME; CONSENSUS STATEMENT; RECOVERY; EPIDEMIOLOGY; INJURY; ZURICH	Aim The Sport Concussion Assessment Tool v3 (SCAT3) and its child version (ChildSCAT3) are composite tools including a symptom scale, a rapid cognitive assessment (standardised assessment of concussion (SAC)) and the modified Balance Error Scoring System (mBESS). It is unclear whether their use for the acute assessment of paediatric concussion in the emergency department (ED) may help predict persistent post-concussive symptoms (PPCS). We aim to assess the predictive value of the main SCAT3/ChildSCAT3 components for PPCS when applied in the ED. Methods A single-site, prospective longitudinal cohort study of children aged 5-18 years assessed within 48 h of their concussion at the ED of a state-wide tertiary paediatric hospital and followed up at the affiliated concussion clinic, between November 2013 and August 2017. PPCS was defined as >= 2 new or worsening symptoms at 1 month post-injury using the Post-Concussive Symptom Inventory. Results Of the 370 children enrolled, 213 (57.7% <13 years old) provided complete data. Of these, 34.7% had PPCS at 1 month post-injury (38.2% of children <13 years and 30.0% >= 13 years of age, P = 0.272). The adjusted ORs from multiple logistic regression models, for number and severity of symptoms, and for the SAC and mBESS performance in both the ChildSCAT3/SCAT3, were all not significant. The area under the curve of receiver operator characteristic curves for all analysed ChildSCAT3/SCAT3 components was below 0.6. Conclusions Although SCAT3 and ChildSCAT3 are recommended tools to assist with concussion diagnosis and monitoring of patient recovery, their use in the ED does not seem to help predict PPCS.	[Bressan, Silvia; Clarke, Cathriona J.; Anderson, Vicki; Takagi, Michael; Hearps, Stephen J. C.; Rausa, Vanessa; Anderson, Nicholas; Doyle, Melissa; Dunne, Kevin; Oakley, Ed; Davis, Gavin A.; Babl, Franz E.] Univ Melbourne, Clin Sci, Murdoch Childrens Res Inst, Royal Childrens Hosp, Melbourne, Vic, Australia; [Anderson, Vicki] Univ Melbourne, Psychol Dept, Royal Childrens Hosp, Melbourne, Vic, Australia; [Dunne, Kevin] Univ Melbourne, Royal Childrens Hosp, Dept Rehabil Med, Melbourne, Vic, Australia; [Oakley, Ed; Babl, Franz E.] Univ Melbourne, Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Anderson, Vicki; Takagi, Michael] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Anderson, Vicki; Oakley, Ed; Babl, Franz E.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Davis, Gavin A.] Austin Hlth & Cabrini Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy		Anderson, V (corresponding author), Univ Melbourne, Royal Childrens Hosp, Psychol Sci & Paediat, 50 Flemington Rd, Parkville, Vic 3052, Australia.	vicki.anderson@rch.org.au		Visser, Melissa/0000-0002-5313-3347; Hearps, Stephen/0000-0003-2984-1172; Takagi, Michael/0000-0003-2903-7598	Royal Children's Hospital Foundation [RCHF 2014-370]; Murdoch Children's Research Institute, Melbourne; Australia National Health and Medical Research Council-NHMRC-(Centre of Research Excellence), Canberra, Australia [GNT1058560]; Victorian Government Research Infrastructure Support programme; Royal Children's Hospital Foundation, Melbourne, Victoria, Australia; Melbourne Campus Clinician Scientist Fellowship Melbourne, Victoria, Australia; NHMRC Practitioner FellowshipNational Health and Medical Research Council of Australia; NHMRCNational Health and Medical Research Council of Australia	We acknowledge the support of the families involved in the study, the assistance of ED medical and nursing staff and the volunteers and research assistants who have supported this study. The study was funded in part by grants from the Royal Children's Hospital Foundation (RCHF 2014-370), Murdoch Children's Research Institute, Melbourne, the Australia National Health and Medical Research Council-NHMRC-(Centre of Research Excellence grant GNT1058560), Canberra, Australia; and the Victorian Government Research Infrastructure Support programme. FEB's time was part funded by a grant from the Royal Children's Hospital Foundation, Melbourne, Victoria, Australia; a Melbourne Campus Clinician Scientist Fellowship Melbourne, Victoria, Australia and NHMRC Practitioner Fellowship. VA is funded by an NHMRC Senior Practitioner fellowship. The sponsors had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; and decision to submit the manuscript for publication.	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babl FE, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3258; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bressan S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009427; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; de Dhaem OB, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0767-5; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Hayden MG, 2007, CHILD NERV SYST, V23, P431, DOI 10.1007/s00381-006-0277-2; Hearps SJC, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Teel EF, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00672; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	27	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1034-4810	1440-1754		J PAEDIATR CHILD H	J. Paediatr. Child Health	AUG	2020	56	8					1249	1256		10.1111/jpc.14910		MAY 2020	8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	ND4VB	WOS:000534351200001	32436608	Green Published			2022-02-06	
J	Kulesza, B; Mazurek, M; Rams, L; Nogalski, A				Kulesza, Bartlomiej; Mazurek, Marek; Rams, Lukasz; Nogalski, Adam			Acute Epidural and Subdural Hematomas After Head Injury: Clinical Distinguishing Features	INDIAN JOURNAL OF SURGERY			English	Article						Traumatic brain injury; Extra-axial hematoma; Epidural hematoma; Subdural hematoma	TRAUMATIC BRAIN-INJURY; PROGNOSTIC-FACTORS; COAGULOPATHY; EPIDEMIOLOGY; CRANIECTOMY; CRANIOTOMY; MORTALITY; SURGERY	Head injury remains the most common cause of death and disability in young people. The most frequent consequences of traumatic brain injury (TBI) are extra-axial hemorrhage, i.e., an acute subdural hematoma (SDH) and epidural hematoma (EDH), which usually require a surgical treatment. The aim of the study is to present the distinguished clinical features associated with patients being surgically treated for post-traumatic EDH and SDH. The study included a group of 128 patients with isolated craniocerebral injuries. All the patients were operated. The following factors from the groups were analyzed: demographic data, physiological factors, laboratory factors, computed tomography scan characteristics, the time between trauma and surgery, and the in-hospital mortality. Using statistical analysis, we compared the studied factors in patients operated on due to EDH and SDH. Patients with SDH were older than patients with EDH. Most often, extra-axial hematomas affected men. Patients with SDH were more severe condition than patients with EDH on admission. Abnormal systolic blood pressure was the most common manifestation of dysautonomia in both groups. In the SDH group, we observed hypotension more often than hypertension. Hyperglycemia was one of the most common anomalies in laboratory factors in both groups. Hypotension and hyperglycemia were that factors significantly associated with outcome after head injuries. SDH caused greater midline shift and often pressed in basal cisterns. Patients with SDH died more often than patients with EDH.	[Kulesza, Bartlomiej; Mazurek, Marek] Med Univ Lublin, Chair & Dept Neurosurg & Paediat Neurosurg, Independent Publ Clin Hosp Lublin 4, Jaczewskiego 8, PL-20954 Lublin, Poland; [Rams, Lukasz] AK Altona Hamburg, Neurosurg, Paul Ehrlich Str 1, D-22763 Hamburg, Germany; [Nogalski, Adam] Med Univ Lublin, Chair & Dept Trauma Surg & Emergency Med, Independent Publ Clin Hosp Lublin Poland 1, Stanislawa Stasz 16, PL-20400 Lublin, Poland		Kulesza, B (corresponding author), Med Univ Lublin, Chair & Dept Neurosurg & Paediat Neurosurg, Independent Publ Clin Hosp Lublin 4, Jaczewskiego 8, PL-20954 Lublin, Poland.	kuleszabartek88@gmail.com; Marekmazurek@hotmail.com; rams.lukasz@gmail.com; chirurgiaurazowalublin@tlen.pl	Kulesza, Bartlomiej/AAY-3156-2020	Kulesza, Bartlomiej/0000-0002-9973-9571; Nogalski, Adam/0000-0003-0720-4690			Atanasov VA, 2016, ROM NEUROSURG, V3, P366; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Greenberg M., 2016, HDB NEUROSURGERY, V8, P913, DOI [10.1055/b-006-149702, DOI 10.1055/B-006-149702]; Gurer B, 2017, TURK NEUROSURG, V27, P37, DOI 10.5137/1019-5149.JTN.14809-15.0; Kalayci M, 2013, J PAK MED ASSOC, V63, P38; Karasu A, 2010, ULUS TRAVMA ACIL CER, V16, P233; Khaled SMCN, 2008, INDIAN J NEUROTRAUM, V5, P75; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; Kulesza Bartlomiej, 2020, Folia Med (Plovdiv), V62, P94, DOI 10.3897/folmed.62.e47743; Kulesza B, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10030174; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Lustenberger T, 2011, J NEUROTRAUM, V28, P1699, DOI 10.1089/neu.2011.1866; Matsushima K, 2015, J TRAUMA ACUTE CARE, V79, P838, DOI 10.1097/TA.0000000000000719; Mayr R, 2012, ARCH ORTHOP TRAUM SU, V132, P1445, DOI 10.1007/s00402-012-1559-7; Moran GE, 2018, REV ASOC MEX MED CRI, V32, P208; Ndoumbe A., 2016, OPEN J MOD NEUROSURG, V6, P89, DOI [10.4236/ojmn.2016.63016, DOI 10.4236/OJMN.2016.63016]; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Osborn AG, 2017, OSBORNS BRAIN, P21; Paiva WS, 2011, THER CLIN RISK MANAG, V7, P345, DOI 10.2147/TCRM.S17692; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Rovlias A, 2001, SURG NEUROL, V55, P190, DOI 10.1016/S0090-3019(01)00414-1; Rush B, 2016, WORLD NEUROSURG, V88, P25, DOI 10.1016/j.wneu.2015.12.034; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Tallon JM, 2008, CAN J SURG, V51, P339; Tang J, 2012, ZHONGGUO YISHI ZAZHI, V14, P1472; Tian HL, 2008, CHINESE MED J-PEKING, V121, P1080, DOI 10.1097/00029330-200806020-00007; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Walcott BP, 2014, J CLIN NEUROSCI, V21, P2107, DOI 10.1016/j.jocn.2014.05.016; Yurt I, 1996, TURKISH NEUROSURG, V6, P63; Zhang SJ, 2017, BRAIN INJURY, V31, P215, DOI 10.1080/02699052.2016.1227088	30	1	1	0	1	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0972-2068	0973-9793		INDIAN J SURG	Indian J. Surg	APR	2021	83	SUPPL 1		1	SI		S96	S104		10.1007/s12262-020-02304-w		MAY 2020	9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	TB9DV	WOS:000534471900007		hybrid			2022-02-06	
J	Lopez-Lopez, C; Arranz-Esteban, A; Arias-Rivera, S; Solis-Munoz, M; Perez-Perez, T; Latorre-Marco, I				Lopez-Lopez, Candelas; Arranz-Esteban, Antonio; Arias-Rivera, Susana; Solis-Munoz, Montserrat; Perez-Perez, Teresa; Latorre-Marco, Ignacio			Application of the Behavioural Indicators of Pain Scale in patients with traumatic brain injury	JOURNAL OF ADVANCED NURSING			English	Article						instrument development; intensive care unit; nursing; pain; traumatic brain injury	INTENSIVE-CARE-UNIT; OBSERVATION TOOL; VALIDATION; CONSCIOUSNESS; DISORDERS; COMA	Aim To develop and psychometrically test the Behavioural Indicators of Pain Scale (ESCID) in patients with traumatic brain injury (TBI). Design A prospective observational study to test the psychometric properties of the Behavioural Indicators of Pain Scale in patients with TBI. Method A convenience sample of patients with TBI, who were non-communicative and using invasive mechanical ventilation was selected. Pain was evaluated by two observers who were blinded from each other. Assessments were performed at baseline via the performance of a painful procedure (aspiration of secretions) and a non-painful procedure (rubbing with a gauze). Assessments were repeated after application of procedures on days 1 and 6 of hospitalization in an intensive care unit. Data were collected between January-December 2016. Results About 134 patients were included in the study. Of these, 76.1% were men. The mean age of participants was 45.2 (SD 17.5) years. The pain score significantly increased during the painful procedure when compared with the baseline measure and non-painful procedure (p < .001). Patients displayed a greater number of pain-indicating behaviours during the painful procedure on day 6, compared with day 1 (p < .05). This finding coincided with a reduced level of sedation and a greater level of consciousness. Conclusion The ESCID scale detects pain behaviours and discriminates among the different types of stimulation in patients with brain injury, who are uncommunicative and with mechanical ventilation, with good reliability. The ability for patients with brain injury to express behaviours is limited because of the low level of consciousness and the deep level of sedation. Impact This research will have an impact on the practice of pain assessment in patients with brain injury, representing a first step to adapt the content of the ESCID.	[Lopez-Lopez, Candelas] 12 Octubre Univ Hosp H12O, Dept Intens Care, Madrid, Spain; [Lopez-Lopez, Candelas] 12 Octubre Univ Hosp Imas12, Care Res Grp Invecuid, Inst Invest Sanitaria, Madrid, Spain; [Lopez-Lopez, Candelas] Univ Complutense Madrid, Nursery Physiotherapy & Podiatry Fac, Madrid, Spain; [Arranz-Esteban, Antonio] 12 Octubre Univ Hosp H12O, Emergency & Trauma Intens Care Unit, Madrid, Spain; [Arias-Rivera, Susana] Getafe Univ Hosp HUG, Hosp Nurse & Hlth Care Res, Madrid, Spain; [Arias-Rivera, Susana] Carlos III Hlth Inst, CIBER Resp Dis, Madrid, Spain; [Solis-Munoz, Montserrat] Puerta de Hierro Majadahonda Univ Hosp HUPHM, Nursing Dept, Madrid, Spain; [Solis-Munoz, Montserrat; Latorre-Marco, Ignacio] Puerta de Hierro Segovia de Arana Hlth Res Inst, Nursing & Hlth Care Res Grp, Madrid, Spain; [Perez-Perez, Teresa] Univ Complutense Madrid, Dept Stat & OR 3, Madrid, Spain; [Perez-Perez, Teresa] Dept Stat & Data Sci, Madrid, Spain; [Latorre-Marco, Ignacio] Puerta de Hierro Majadahonda Univ Hosp HUPHM, Intens Care Unit, Madrid, Spain		Lopez-Lopez, C (corresponding author), 12 Octubre Univ Hosp H12O, Dept Intens Care, Madrid, Spain.	candelaslopezlopez@gmail.com	Perez, Teresa/G-6333-2017; Arias-Rivera, Susana/AAJ-4546-2021; Lopez-Lopez, Candelas/Y-5943-2018; Solis-Munoz, Montserrat/ABG-7839-2020	Perez, Teresa/0000-0003-0439-8952; Arias-Rivera, Susana/0000-0002-8192-6897; Lopez-Lopez, Candelas/0000-0003-1536-8660; Solis-Munoz, Montserrat/0000-0003-4078-3540; Latorre-Marco, Ignacio/0000-0002-7528-0890; Arranz Esteban, Antonio/0000-0003-4898-1365			Arbour C, 2014, CLIN J PAIN, V30, P960, DOI 10.1097/AJP.0000000000000061; Arbour C, 2014, PAIN MANAG NURS, V15, P506, DOI 10.1016/j.pmn.2012.03.004; Bernard C, 2019, PAIN, V160, P2535, DOI 10.1097/j.pain.0000000000001637; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Chatelle C, 2016, CLIN J PAIN, V32, P321, DOI 10.1097/AJP.0000000000000259; Chatelle C, 2012, J NEUROL NEUROSUR PS, V83, P1233, DOI 10.1136/jnnp-2012-302987; Devlin JW, 2018, CRIT CARE MED, V46, pE825, DOI 10.1097/CCM.0000000000003299; Echegaray-Benites C, 2014, INTENS CRIT CARE NUR, V30, P257, DOI 10.1016/j.iccn.2014.04.002; Feeley Kathy, 2006, Aust Crit Care, V19, P73, DOI 10.1016/S1036-7314(06)80012-3; Flexman AM, 2010, CURR OPIN ANESTHESIO, V23, P551, DOI 10.1097/ACO.0b013e32833e15b9; Gelinas C, 2019, J PAIN SYMPTOM MANAG, V57, P761, DOI 10.1016/j.jpainsymman.2018.12.333; Gelinas C, 2013, SEMIN RESP CRIT CARE, V34, P153, DOI 10.1055/s-0033-1342970; Gelinas C, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2009.01.013; Gosselin RA, 2009, TECH ORTHOP, V24, P230, DOI 10.1097/BTO.0b013e3181bfd56c; Joffe AM, 2016, J CRIT CARE, V36, P76, DOI 10.1016/j.jcrc.2016.05.011; LATORRE MI, 2011, ENFERMERIA INTENSIVA, V22, P3, DOI DOI 10.1016/J.ENFI.2010.09.005; Latorre-Marco I, 2016, MED INTENSIVA, V40, P463, DOI 10.1016/j.medin.2016.06.004; Le Q, 2013, PAIN MANAG NURS, V14, pE251, DOI 10.1016/j.pmn.2012.02.005; Lee K, 2013, PAIN MANAG NURS, V14, P259, DOI 10.1016/j.pmn.2011.05.005; Mandrekar JN, 2010, J THORAC ONCOL, V5, P1315, DOI 10.1097/JTO.0b013e3181ec173d; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Puntillo K, 2017, INTENS CARE MED, V43, P1386, DOI 10.1007/s00134-017-4694-3; Puntillo KA, 2014, AM J RESP CRIT CARE, V189, P39, DOI 10.1164/rccm.201306-1174OC; Ribeiro CJN, 2019, PAIN MANAG NURS, V20, P152, DOI 10.1016/j.pmn.2018.09.004; Roulin MJ, 2014, INTENS CARE MED, V40, P1115, DOI 10.1007/s00134-014-3380-y; TEASDALE G, 1974, LANCET, V2, P81	28	1	1	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-2402	1365-2648		J ADV NURS	J. Adv. Nurs.	JUL	2020	76	7					1862	1870		10.1111/jan.14400		MAY 2020	9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	MB4GJ	WOS:000535216600001	32338391				2022-02-06	
J	Bressan, S; Berlese, P; Arpone, M; Steiner, I; Titomanlio, L; Da Dalt, L				Bressan, Silvia; Berlese, Paola; Arpone, Marta; Steiner, Ivan; Titomanlio, Luigi; Da Dalt, Liviana			Missed intracranial injuries are rare in emergency departments using the PECARN head injury decision rules	CHILDS NERVOUS SYSTEM			English	Article						Minor head trauma; Missed brain injury; Clinical predictive rule; Return visit	TRAUMATIC BRAIN-INJURY; RETURN VISITS; COMPUTED-TOMOGRAPHY; CHILDREN; IMPLEMENTATION; EPIDEMIOLOGY; RISK	Purpose The PECARN head trauma (HT) prediction rules have been developed to guide computed tomography-related decision-making for children with minor HT (mHT). There are currently limited data on the rate of unscheduled revisits to emergency departments (EDs), and initially missed intracranial injuries, in children with mHT initially assessed using the PECARN rules. This study aimed to fill this gap in knowledge. Methods Clinical charts of children assessed for mHT over a 5-year period at two EDs that implemented the PECARN rules in Italy and France were reviewed retrospectively. Children who returned to EDs for mHT-related, or potentially related complaints, within 1 month of initial assessment were included. Results The total number of children with mHT presenting for the first time to the EDs of both sites was 11,749. Overall, 180 (1.5%) unscheduled revisits to the EDs occurred for mHT-related or potentially related complaints. Twenty-three of these 180 patients underwent neuroimaging, and seven had an intracranial injury (including one ischemic stroke). Of these, three were hospitalized and none needed neurosurgery or intensive care. Conclusion Unscheduled revisits for mHT in EDs using the PECARN rules were very uncommon. Initially missed intracranial injuries were rare, and none needed neurosurgery or intensive care.	[Bressan, Silvia; Berlese, Paola; Arpone, Marta; Da Dalt, Liviana] Univ Padua, Dept Womens & Childrens Hlth, Div Pediat Emergency Med, Via Giustiniani 3, I-35128 Padua, Italy; [Berlese, Paola; Titomanlio, Luigi] Robert Debre Hosp, Pediat Emergency Dept, Paris, France; [Steiner, Ivan] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada		Bressan, S (corresponding author), Univ Padua, Dept Womens & Childrens Hlth, Div Pediat Emergency Med, Via Giustiniani 3, I-35128 Padua, Italy.	silvia.bressan.1@unipd.it					Alessandrini EA, 2004, PEDIATR EMERG CARE, V20, P166, DOI 10.1097/01.pec.0000117924.65522.a1; Babl FE, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3258; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Borland ML, 2019, ANN EMERG MED, V74, P1, DOI 10.1016/j.annemergmed.2018.11.035; Bressan S, 2017, EUR J EMERG MED, V24, P308, DOI 10.1097/MEJ.0000000000000459; Bressan S, 2015, ACTA PAEDIATR, V104, P47, DOI 10.1111/apa.12797; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Chen C, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061171; Cho CS, 2012, PEDIATR EMERG CARE, V28, P606, DOI 10.1097/PEC.0b013e31825cf7cf; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Ewing-Cobbs L, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0939; Ganti L, 2015, WEST J EMERG MED, V16, P481, DOI 10.5811/westjem.2015.2.23546; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Goldman RD, 2006, PEDIATR EMERG CARE, V22, P545, DOI 10.1097/01.pec.0000230553.01917.05; Goldman RD, 2011, PEDIATR EMERG CARE, V27, P808, DOI 10.1097/PEC.0b013e31822c1273; Goldwasser T, 2015, EUR J EMERG MED, V22, P413, DOI 10.1097/MEJ.0000000000000201; Jeong JH, 2015, EMERG MED J, V32, P426, DOI 10.1136/emermed-2013-203382; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Nunez S, 2006, QUAL SAF HEALTH CARE, V15, P102, DOI 10.1136/qshc.2005.016618; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Shahaf DB, 2018, BRAIN INJURY, V32, P331, DOI 10.1080/02699052.2018.1425914; Wang KC, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8963102	29	1	1	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JAN	2021	37	1					55	62		10.1007/s00381-020-04660-0		MAY 2020	8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	PR6TR	WOS:000533834600001	32424442				2022-02-06	
J	Motnikar, L; Stojmenova, K; Staba, UC; Klun, T; Robida, KR; Sodnik, J				Motnikar, Lenart; Stojmenova, Kristina; Staba, Ursa Cizman; Klun, Tara; Robida, Karmen Resnik; Sodnik, Jaka			Exploring driving characteristics of fit- and unfit-to-drive neurological patients: a driving simulator study	TRAFFIC INJURY PREVENTION			English	Article						driving simulation; driving assessment; driving fitness evaluation; neurological deficit; brain injury; neurodegenerative disease	TRAUMATIC BRAIN-INJURY; ON-ROAD; PERFORMANCE; IMPACT	Objective: To identify driving characteristics of fit-, unfit-, and conditionally fit-to-drive neurological patient populations using a driving simulator with three high-risk scenarios comprising rural, highway, and urban environments. Methods: The study included 91 neurological patients undergoing a multidisciplinary assessment for driver's license revalidation, consisting of a clinical, neuropsychological, functional, and on-road evaluation. The groups drove through three independent driving scenarios, during which a variety of measures describing reaction time, vehicular control, and traffic rule compliance were performed. One-way analysis of variance (ANOVA) with Bonferroni correction was used for group comparison, independently for each driving scenario, and Pearson correlations were calculated between simulator variables and neuropsychological test scores. Results: The fit- and unfit-to-drive population significantly differed (p < .05) in reaction times, regardless of the scenario. No significant differences in traffic rule compliance or vehicular control parameters were observed in the rural environment (p > .05). On the highway, the unfit group exhibited greater variability of steering wheel angle, higher steering reversal rate, and a higher rate of turn signal errors. In the urban environment, the unfit group oversped more, had more collisions, and exhibited greater lane position variability. The latter, along with reaction times in the rural and highway scenarios, was also shown to significantly differ between the conditional and unfit group (p < .05). No significant differences were observed between the fit and the conditional group (p > .05). Weak to moderate associations (range: -0.5 to 0.29) between neuropsychological tests and various simulator variables were also observed. Conclusions: Our results show that driving simulators are able to capture differences between (fit- and unfit-to-drive) neurological patient populations and therefore bear the potential for being used as a deficit-independent screening, assessment, or rehabilitation tool. The conditionally-fit-to-drive group exhibited less discriminative features, which points to greater importance of human judgment for this population. The observation that differences in most of the parameters were environment-dependent suggests that developers of future driver simulation tools should carefully design scenarios in order to fully exploit their assessment potential.	[Motnikar, Lenart; Stojmenova, Kristina; Sodnik, Jaka] Univ Ljubljana, Fac Elect Engn, Trzaska Cesta 25, Ljubljana 1000, Slovenia; [Staba, Ursa Cizman; Klun, Tara; Robida, Karmen Resnik] Univ Rehabil Inst Republ Slovenia, Ljubljana, Slovenia		Stojmenova, K (corresponding author), Univ Ljubljana, Fac Elect Engn, Trzaska Cesta 25, Ljubljana 1000, Slovenia.	kristina.stojmenova@fe.uni-lj.si		Motnikar, Lenart/0000-0003-3874-7946	Slovenian Research Agency within the research program ICT4QoL - Information and Communications Technologies for Quality of Life [P2-0246]; Slovenian Research Agency within the research project Neurophysiological and Cognitive Profiling of Driving Skills [L2-8178]	This research was financially supported by the Slovenian Research Agency within the research program ICT4QoL - Information and Communications Technologies for Quality of Life, grant number P2-0246, and the research project Neurophysiological and Cognitive Profiling of Driving Skills, grant number L2-8178.	Akinwuntan AE, 2012, J STROKE CEREBROVASC, V21, P478, DOI 10.1016/j.jstrokecerebrovasdis.2010.12.001; Classen S, 2011, AM J OCCUP THER, V65, P419, DOI 10.5014/ajot.2011.000893; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Coulthard E, 2006, CURR OPIN NEUROL, V19, P613, DOI 10.1097/01.wco.0000247605.57567.9a; Cyr AA, 2009, J CLIN EXP NEUROPSYC, V31, P472, DOI 10.1080/13803390802255627; D'apolito A. -C., 2013, Annals of Physical and Rehabilitation Medicine, V56, P63, DOI 10.1016/j.rehab.2012.12.002; Devos H, 2013, DISABIL REHABIL, V35, P1387, DOI 10.3109/09638288.2012.731468; Hoffman L, 2010, PSYCHOL AGING, V25, P741, DOI 10.1037/a0019198; Kotterba S, 2003, EUR NEUROL, V50, P160, DOI 10.1159/000073057; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; Marcotte TA, 2008, ARCH PHYS MED REHAB, V89, P1753, DOI 10.1016/j.apmr.2007.12.049; Mayhew DR, 2011, J SAFETY RES, V42, P267, DOI 10.1016/j.jsr.2011.06.004; McKay A, 2016, J HEAD TRAUMA REHAB, V31, pE44, DOI 10.1097/HTR.0000000000000209; Milleville-Pennel I, 2010, BRAIN INJURY, V24, P678, DOI 10.3109/02699051003692159; Naumann RB, 2011, J SAFETY RES, V42, P67, DOI 10.1016/j.jsr.2010.12.001; Pavlou D, 2016, ADV TRANSP STUD, V1, P83, DOI [10.4399/978885489179108, DOI 10.4399/978885489179108]; Pavlou D, 2016, TRANSP RES PROC, V14, P4393, DOI 10.1016/j.trpro.2016.05.361; Rizzo M, 2001, ALZ DIS ASSOC DIS, V15, P10, DOI 10.1097/00002093-200101000-00002; Stolwyk RJ, 2005, MOVEMENT DISORD, V20, P846, DOI 10.1002/mds.20420; Uc EY, 2006, J NEUROL SCI, V251, P35, DOI 10.1016/j.jns.2006.08.011; Uc EY, 2004, NEUROLOGY, V63, P832, DOI 10.1212/01.WNL.0000139301.01177.35; Underwood G, 2011, TRANSPORT RES F-TRAF, V14, P435, DOI 10.1016/j.trf.2011.04.008; Vengust M, 2017, AUTOMOTIVEUI'17: PROCEEDINGS OF THE 9TH INTERNATIONAL CONFERENCE ON AUTOMOTIVE USER INTERFACES AND INTERACTIVE VEHICULAR APPLICATIONS, P242, DOI 10.1145/3131726.3132047; Vickers KL, 2018, NEUROREHABILITATION, V42, P213, DOI 10.3233/NRE-172301; Vrkljan BH, 2011, CAN J OCCUP THER, V78, P80, DOI 10.2182/cjot.2011.78.2.3	25	1	1	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.	AUG 17	2020	21	6					359	364		10.1080/15389588.2020.1764547		MAY 2020	6	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	ME7HC	WOS:000535347200001	32421399				2022-02-06	
J	Hadgu, RM; Borghol, A; Gillard, C; Wilson, C; Mossa, SE; McKay, M; Jastram, C; Onor, IO				Hadgu, Rim M.; Borghol, Amne; Gillard, Christopher; Wilson, Candice; Mossa, Suzan Elqess; McKay, Megan; Jastram, Charles Jr Jr; Onor, Ifeanyi O.			Evaluation of Outcomes in Patients Receiving Amantadine to Improve Alertness After Traumatic Brain Injury	HOSPITAL PHARMACY			English	Article						amantadine; traumatic brain injury; alertness	IMPAIRED CONSCIOUSNESS; MODAFINIL; AROUSAL; TRIAL; COMA	Background: Amantadine has been used off-label to improve alertness after traumatic brain injury (TBI). The goal of this study is to assess the mean change at 72 hours and in course of therapy (COT) Glasgow Coma Scale (GCS) score after amantadine initiation and to correlate the change in GCS score with participation in physical therapy (PT) and occupational therapy (OT) among patients with TBI receiving amantadine during the first hospitalization. Methods: This single-center, retrospective, cohort study included patients >= 18 years old hospitalized for a TBI from August 2012 to February 2018 and received >= 1 dose of amantadine to increase alertness. The primary endpoint is the mean change in 72-hour GCS score after amantadine initiation. The secondary endpoint is the mean change in COT GCS score after amantadine initiation and the correlation between the change in GCS score and percent PT and OT participation at 72 hours and during the COT. Results: Seventy-nine patients were included. The mean age of patients was 41 years, and 79.8% of the patients were men. The mean change in 72-hour GCS score was +0.75 (95% confidence interval [CI] = 0.09-1.42, P = .027), and the mean change in COT GCS score was +2.29 (95% CI = 1.68-2.90, P < .001). There was no significant correlation between the increase in GCS score and percent PT/OT session participation at 72 hours and during the COT, r = -0.15 (P = .24) and r = -0.02 (P = .74), respectively. The percent PT/OT session participation at 72-hour post-amantadine initiation was 61.3% compared with 65.9% during the COT. Conclusion: There were small but statistically significant increases in the mean change at 72 hours and in COT GCS score; however, they were not correlated with percent PT/OT participation. Other studies are needed to determine the appropriate time and GCS score to initiate amantadine along with the optimal dose in the inpatient setting.	[Hadgu, Rim M.; Borghol, Amne; Gillard, Christopher; Wilson, Candice; Mossa, Suzan Elqess; McKay, Megan; Onor, Ifeanyi O.] Xavier Univ Louisiana, New Orleans, LA USA; [Hadgu, Rim M.] Midwestern Univ, Glendale, AZ 85308 USA; [Jastram, Charles Jr Jr] Univ Med Ctr New Orleans, New Orleans, LA USA		Hadgu, RM (corresponding author), Midwestern Univ, Coll Pharm Glendale, Dept Pharm Practice, 19555 N 59th Ave, Glendale, AZ 85308 USA.	rhadgu@midwestern.edu		ONOR, IFEANYICHUKWU/0000-0002-8005-8602			Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; Carroll BT, 2007, J NEUROPSYCH CLIN N, V19, P406, DOI 10.1176/appi.neuropsych.19.4.406; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Cossu G, 2014, BRIT J NEUROSURG, V28, P187, DOI 10.3109/02688697.2013.841845; Friedland D, 2013, ADV CLIN NEUROSCI RE, V13; Ghalaenovi H, 2018, BRAIN INJURY, V32, P1050, DOI 10.1080/02699052.2018.1476733; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS256, DOI 10.1016/j.apmr.2015.01.025; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; McMahon MA, 2009, AM J PHYS MED REHAB, V88, P525, DOI 10.1097/PHM.0b013e3181a5ade3; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Oommen JK, 2019, P & T, V44, P676; Parry SM, 2015, EXTREME PHYSIOL MED, V4, DOI 10.1186/s13728-015-0036-7; Patil M, 2017, J NEUROSCI RURAL PRA, V8, P357, DOI 10.4103/jnrp.jnrp_53_17; Saniova B, 2004, J NEURAL TRANSM, V111, P511, DOI 10.1007/s00702-004-0112-4; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Shohami E, 2014, CNS NEUROL DISORD-DR, V13, P567, DOI 10.2174/18715273113126660196; StataCorp, 2011, STAT STAT SOFTW REL; Talsky A., 2011, BRIT COLOMBIA MED J, V53, P26; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6	23	1	1	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0018-5787	1945-1253		HOSP PHARM	Hosp. Pharm.	OCT	2021	56	5					486	494	0018578720920803	10.1177/0018578720920803		MAY 2020	9	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	WN7GS	WOS:000534107600001	34720150				2022-02-06	
